PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	DAHDAL, RY; COLLEY, KJ				DAHDAL, RY; COLLEY, KJ			SPECIFIC SEQUENCES IN THE SIGNAL ANCHOR OF THE BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE ARE NOT ESSENTIAL FOR GOLGI LOCALIZATION - MEMBRANE FLANKING SEQUENCES MAY SPECIFY GOLGI RETENTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; SPANNING DOMAIN; PROTEIN; APPARATUS; GLYCOSYLATION; CELLS; BETA-1,4-GALACTOSYLTRANSFERASE; GLYCOPROTEINS; SUFFICIENT	The beta-galactoside alpha-2,6-sialyltransferase is a trans Golgi/trans Golgi network glycosyltransferase which adds sialic acid residues to Asn-linked oligosaccharides of glycoproteins. Previous results suggested that the sialyltransferase stem and signal anchor including flanking sequences may be two independent Golgi retention regions. However, other experiments demonstrated that the sequence of the signal anchor itself was not important. To investigate whether the sialyltransferase signal anchor was necessary and sufficient for Golgi retention, several mutant and chimeric proteins were expressed and localized in Cos-1 and Chinese hamster ovary cells. We found that the signal anchor and flanking sequences were able to retain the sialyltransferase catalytic domain in the Golgi. However, efficient Golgi retention was still observed when the signal anchor was altered or entirely replaced in either the presence or absence of most of the luminal stem region. Chimeric proteins consisting of the sialyltransferase cytoplasmic tail and signal anchor fused to the extracellular domains of two different cell surface proteins demonstrated poor Golgi retention. A significant increase in the Golgi retention of one of these chimeras was observed when two lysines were placed next to the signal anchor on the luminal side. Taken together these results suggest that the sialyltransferase signal anchor is not necessary or sufficient for Golgi retention, rather, appropriately spaced cytoplasmic and luminal flanking sequences are the important elements of the sialyltransferase Golgi retention region.	UNIV ILLINOIS, COLL MED, DEPT BIOCHEM, 1819 W POLK ST, M-C 536, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048134, R01GM048134] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48134] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; FLEISCHER B, 1993, BIOCHEMISTRY-US, V32, P2076, DOI 10.1021/bi00059a027; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KEENAN TW, 1970, BIOCHEMISTRY-US, V9, P19, DOI 10.1021/bi00803a003; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0; KUNDU A, 1991, MOL CELL BIOL, V11, P2675, DOI 10.1128/MCB.11.5.2675; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Griffiths Gareth, 1993, Trends in Cell Biology, V3, P214, DOI 10.1016/0962-8924(93)90114-G; Machamer C E, 1991, Trends Cell Biol, V1, P141, DOI 10.1016/0962-8924(91)90001-P; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PORUCHYNSKY MS, 1988, J CELL BIOL, V107, P1697, DOI 10.1083/jcb.107.5.1697; ROTH J, 1987, BIOCHIM BIOPHYS ACTA, V906, P405, DOI 10.1016/0304-4157(87)90018-9; ROTH J, 1986, J BIOL CHEM, V261, P14307; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SHAPER JH, 1992, CURR OPIN STRUC BIOL, V2, P701; STIRZAKER SC, 1989, CELL, V56, P741, DOI 10.1016/0092-8674(89)90677-6; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; TANG BL, 1992, J BIOL CHEM, V267, P10122; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WEISZ OA, MOL BIOL CELL, V3, pA189; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	51	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26310	26319						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253753				2022-12-27	WOS:A1993MK42500047
J	DASILVA, EF; SORENSON, MM; SMILLIE, LB; BARRABIN, H; SCOFANO, HM				DASILVA, EF; SORENSON, MM; SMILLIE, LB; BARRABIN, H; SCOFANO, HM			COMPARISON OF CALMODULIN AND TROPONIN-C WITH AND WITHOUT ITS AMINO-TERMINAL HELIX (RESIDUES-1-11) IN THE ACTIVATION OF ERYTHROCYTE CA2+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CA-2+ PUMP; RED-CELL MEMBRANES; CALCIUM-BINDING PROTEIN; RABBIT SKELETAL-MUSCLE; PLASMA-MEMBRANE; CA2+ PUMP; ADENOSINE-TRIPHOSPHATASE; ATP; DOMAIN; CA-2+-ATPASE	Troponin C can replace calmodulin in the activation of the Ca2+-ATPase of pig erythrocytes provided that the reaction medium contains relatively high free Ca2+ concentrations (>0.5 muM). In the presence of 10 muM free Ca2+, the troponin C-activated ATPase reaches a maximal velocity of approximately 70% of that attained with calmodulin. The half-maximal concentration for troponin C activation is about 200 times greater than for calmodulin. Troponin C displaces the half-maximal concentration for activation by Ca2+ to pCa 5.46 and the cooperativity between the Ca2+ binding sites to n(H) 1.1, compared with pCa 6.14 and n(H) 1.72 when calmodulin is used. Both EF-hand proteins also elicit activation by ATP at a nucleotide regulatory site, as well as a Ca2+-dependent p-nitrophenyl phosphatase activity. Troponin I prevents activation of the enzyme by troponin C. A mutant of troponin C with the amino-terminal helix deleted (NHdel) activates the Ca2+-ATPase to the same extent and with the same Ca2+ dependence as wild-type troponin C (rTnC); the half-maximal concentration for activation by NHdel is 2.5 times smaller than that for rTnC. We conclude that the structural features that distinguish the two EF-hand proteins affect their binding to the target enzyme more than their ability to transform the enzyme's response to Ca2+ or ATP. The differences in the amino-terminal domains of troponin C and calmodulin cannot account for the differences in ability of these proteins to activate the target system used as a model.	UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOQUIM,CIDADE UNIV,BR-21941590 RIO JANEIRO,BRAZIL; UNIV ALBERTA,DEPT BIOCHEM,MRC,PROT STRUCT & FUNCT GRP,EDMONTON T6G 2H7,ALBERTA,CANADA	Universidade Federal do Rio de Janeiro; University of Alberta				Fidalgo da Silva, Elizabeth/0000-0003-3540-9335				ADAMO HP, 1990, J BIOL CHEM, V265, P3789; BABU A, 1988, J BIOL CHEM, V263, P15485; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; CARAFOLI E, 1982, BIOCHIM BIOPHYS ACTA, V683, P279, DOI 10.1016/0304-4173(82)90004-0; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CARIDE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1027, P21, DOI 10.1016/0005-2736(90)90042-M; CARVALHOALVES PC, 1987, J BIOL CHEM, V262, P6610; COHEN P, 1988, CALMODULIN, P123; DEDMAN JR, 1977, J BIOL CHEM, V252, P2437; DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; FUJIMORI K, 1990, NATURE, V345, P182, DOI 10.1038/345182a0; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; GOLOSINSKA K, 1991, J BIOL CHEM, V266, P15797; GOPINATH RM, 1977, BIOCHEM BIOPH RES CO, V77, P1203, DOI 10.1016/S0006-291X(77)80107-1; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; GULATI J, 1993, J BIOL CHEM, V268, P11685; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; JAMES P, 1991, FEBS LETT, V278, P155, DOI 10.1016/0014-5793(91)80106-D; JEFFERY DA, 1981, BIOCHEM J, V194, P481, DOI 10.1042/bj1940481; KELLER CH, 1982, BIOCHEMISTRY-US, V21, P156, DOI 10.1021/bi00530a027; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KOBAYASHI T, 1989, J BIOL CHEM, V264, P18247; KOSKKOSICKA D, 1991, BIOCHEMISTRY-US, V30, P65, DOI 10.1021/bi00215a010; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KRETSINGER RH, 1987, COLD SPRING HARB SYM, V52, P499, DOI 10.1101/SQB.1987.052.01.057; LAN JQ, 1989, BIOCHEMISTRY-US, V28, P7380, DOI 10.1021/bi00444a035; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAK AS, 1983, J BIOL CHEM, V258, P4330; MINOCHERHOMJEE AM, 1988, CALMODULIN, P249; MISSIAEN L, 1989, BIOCHEM J, V263, P687, DOI 10.1042/bj2630687; MORIMOTO S, 1988, J BIOCHEM-TOKYO, V104, P149, DOI 10.1093/oxfordjournals.jbchem.a122412; MUALLEM S, 1980, BIOCHIM BIOPHYS ACTA, V597, P631, DOI 10.1016/0005-2736(80)90235-7; NIGGLI V, 1979, J BIOL CHEM, V193, P265; PASA TC, 1991, J MOL CELL CARDIOL, V24, P233; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PICTON C, 1983, METHOD ENZYMOL, V102, P219; PUTKEY JA, 1988, J BIOL CHEM, V263, P11242; Rega A., 1979, CATION FLUX BIOMEMBR, P67; REINACH FC, 1988, J BIOL CHEM, V263, P2371; REISNER PD, 1992, FEBS LETT, V297, P127, DOI 10.1016/0014-5793(92)80342-E; ROSSI JPFC, 1985, BIOCHIM BIOPHYS ACTA, V816, P379, DOI 10.1016/0005-2736(85)90505-X; ROSSI JPFC, 1986, BIOCHIM BIOPHYS ACTA, V858, P21, DOI 10.1016/0005-2736(86)90287-7; SCHWARZENBACH G, 1957, HELV CHIM ACTA, V40, P1886, DOI 10.1002/hlca.19570400640; STIEGER J, 1981, BIOCHIM BIOPHYS ACTA, V641, P270, DOI 10.1016/0005-2736(81)90591-5; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; STRYNADKA NCJ, 1990, PROTEINS, V7, P234, DOI 10.1002/prot.340070305; Szebenyi DME, 1981, NATURE, V294, P327, DOI 10.1038/294327a0; VERMA AK, 1984, BIOCHEMISTRY-US, V23, P5010, DOI 10.1021/bi00316a028; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; WUYTACK F, 1992, J BIOENERG BIOMEMBR, V24, P285; YANG SD, 1984, ARCH BIOCHEM BIOPHYS, V232, P269	59	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26220	26225						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253742				2022-12-27	WOS:A1993MK42500034
J	FANKHAUSER, C; HOMANS, SW; THOMASOATES, JE; MCCONVILLE, MJ; DESPONDS, C; CONZELMANN, A; FERGUSON, MAJ				FANKHAUSER, C; HOMANS, SW; THOMASOATES, JE; MCCONVILLE, MJ; DESPONDS, C; CONZELMANN, A; FERGUSON, MAJ			STRUCTURES OF GLYCOSYLPHOSPHATIDYLINOSITOL MEMBRANE ANCHORS FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; CLEAVAGE ATTACHMENT SITE; TRYPANOSOMA-BRUCEI; LEISHMANIA-MAJOR; PHOSPHOLIPASE-C; PROTEINS; BIOSYNTHESIS; ACID; OLIGOSACCHARIDES	Metabolic labeling studies suggest that Saccharomyces cerevisiae contains many glycoproteins that are anchored in the lipid bilayer by glycosylphosphatidylinositol membrane anchors. Membrane anchors were purified from a crude yeast membrane protein fraction and analyzed by two-dimensional H-1-H-1 NMR, fast atom bombardment-mass spectrometry, compositional and methylation linkage analyses, as well as chemical and enzymatic modifications. The yeast glycosylphosphatidylinositol anchors consist of the following structures: ethanolamine-PO4-6(R-2)Manalpha1-2Manalpha1-6Manalpha1-4Glc-NH2alpha1-6myo-inositol-1-PO4-lipid, where R is mainly Manalpha1- (80%) with some Manalpha1-2Manalpha1- (15%) and Manalpha1-3Manalpha1- (5%). The core region of the yeast anchors (ethanolamine-PO4-6Manalpha1-2Manalpha1-6Manalpha1-4GlcNH2alpha1-6myo-inositol-1-PO4) is identical to the conserved core region found in glycosylphosphatidylinositol anchors from protozoa and mammals. The lipid moieties of the total yeast glycosylphosphatidylinositol anchors are mainly ceramides, consisting mostly of C18:0 phytosphingosine and C26:0 fatty acid. However, the lipid moiety of the glycosylphosphatidylinositol anchor of the purified ggp125 protein is a lyso- or diacylglycerol, containing C26:0 fatty acids. This suggests that yeast adds different lipid components to the glycosylphosphatidylinositol anchors of different proteins.	UNIV FRIBOURG,INST BIOCHEM,CH-1700 FRIBOURG,SWITZERLAND; UNIV LAUSANNE,CH-1066 EPALINGES,SWITZERLAND; UNIV DUNDEE,DUNDEE DD1 4HN,SCOTLAND	University of Fribourg; University of Lausanne; University of Dundee			Ferguson, Michael A. J./F-7829-2010	Ferguson, Michael A. J./0000-0003-1321-8714	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENDIAK B, 1985, CARBOHYD RES, V144, P1, DOI 10.1016/0008-6215(85)85001-1; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUTIKOFER P, 1990, J BIOL CHEM, V265, P18983; CHAPLIN MF, 1986, CARBOHYDRATE ANAL PR, P2; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CONZELMANN A, 1988, EMBO J, V7, P2233, DOI 10.1002/j.1460-2075.1988.tb03063.x; CONZELMANN A, 1992, EMBO J, V11, P457, DOI 10.1002/j.1460-2075.1992.tb05075.x; CONZELMANN A, 1990, EMBO J, V9, P653, DOI 10.1002/j.1460-2075.1990.tb08157.x; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DEEG MA, 1992, J BIOL CHEM, V267, P18573; DELL A, 1987, ADV CARBOHYD CHEM BI, V45, P19, DOI 10.1016/S0065-2318(08)60136-5; DOERING TL, 1990, J BIOL CHEM, V265, P611; FANKHAUSER C, 1991, EUR J BIOCHEM, V195, P439, DOI 10.1111/j.1432-1033.1991.tb15723.x; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1992, BIOCHEM J, V284, P297, DOI 10.1042/bj2840297; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Ferguson MAJ, 1991, CURR OPIN STRUC BIOL, V1, P522, DOI 10.1016/S0959-440X(05)80072-7; FIELD MC, 1991, J BIOL CHEM, V266, P8392; GUTHER ML, 1992, J BIOL CHEM, V257, P6820; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERKREMER RM, 1990, EUR J BIOCHEM, V192, P337; LEDERKREMER RM, 1991, J BIOL CHEM, V266, P23670; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; MORAN P, 1991, J BIOL CHEM, V266, P1250; NUOFFER C, 1991, MOL CELL BIOL, V11, P7; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STADLER J, 1989, EMBO J, V8, P371, DOI 10.1002/j.1460-2075.1989.tb03387.x; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001; VAI M, 1991, J BIOL CHEM, V266, P12242; VAI M, 1990, BIOCHIM BIOPHYS ACTA, V1038, P277, DOI 10.1016/0167-4838(90)90237-A; WALTER EI, 1990, J IMMUNOL, V144, P1030; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105	49	146	146	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26365	26374						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253761				2022-12-27	WOS:A1993MK42500055
J	LORENZ, RG; GORDON, JI				LORENZ, RG; GORDON, JI			USE OF TRANSGENIC MICE TO STUDY REGULATION OF GENE-EXPRESSION IN THE PARIETAL-CELL LINEAGE OF GASTRIC UNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING-PROTEIN; BETA-SUBUNIT GENE; SMALL INTESTINAL EPITHELIUM; HORMONE FUSION GENES; PEPSINOGEN-C GENE; INTRINSIC-FACTOR; DYNAMIC HISTOLOGY; ANTRAL EPITHELIUM; MOUSE STOMACH; ALPHA-SUBUNIT	The mechanisms that regulate cell lineage-specific and differentiation-dependent patterns of gene expression in the gastric units of the stomach are largely unknown. Transgenic mice were generated in order to identify cis-acting sequences that determine the zymogenic cell-specific pattern of expression of the mouse intrinsic factor (InF) gene and the parietal cell-specific pattern of expression of the mouse H+/K+-ATPase beta-subunit gene. Portions of the 5'-nontranscribed domains of each gene were linked to the human growth hormone (hGH) gene beginning at its nucleotide +3. RNA blot hybridization studies combined with multilabel immunocytochemical surveys using a panel of lineage-specific antibodies and lectins indicated that nucleotides -1035 to +24 of the mouse H+/K+-ATPase beta-subunit gene direct a pattern of reporter production which recapitulates the parietal cell-specific and developmental patterns of expression of the endogenous gene. Analysis of three mosaic founders containing H+/K+-ATPase beta-subunit -1035 to +24/hGH+3 revealed that they had monophenotypic gastric units: a given unit contained either a wholly hGH-positive or a wholly hGH-negative population of parietal cells. These latter findings provide very strong evidence that gastric units are monoclonal, i.e. they are supplied by stem cells having one genotype. Although some, but not all, parietal cells are apparently derived from the same committed progenitor as zymogenic cells, virtually all parietal cells in a given gastric unit, but none of its zymogenic cells, express InF-1029 to +55/hGH+3. This suggests that InF-1029 to +55 may contain cis-acting sequences which allow parietal cell expression in other species (e.g. humans) but lack additional elements which normally function in mice to suppress InF expression in this lineage. The absence of hGH in zymogenic cells also means that the transcriptional regulatory environments of parietal and zymogenic cells derived from the same precursor are distinguishable by InF-1029 to +55. H+/K-ATPase beta-subunit-1035 to +24 and InF-1029 to +55 are the only two sequences reported to date that are able to direct foreign gene expression exclusively to a gastric epithelial cell lineage in transgenic mice. This ability to deliver gene products to parietal cells can now be exploited to identify factors that control their normal proliferation and differentiation programs and/or to specifically alter their biological properties.	WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,BOX 8103,660 S EUCLID AVE,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Lorenz, Robin G/AAJ-1499-2021	Lorenz, Robin G/0000-0002-2514-9819	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033487] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 33487] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN RH, 1978, J CLIN INVEST, V61, P47, DOI 10.1172/JCI108924; CANFIELD VA, 1991, P NATL ACAD SCI USA, V88, P8247, DOI 10.1073/pnas.88.18.8247; CECI JD, 1991, ONCOGENE, V6, P323; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHWALINSKI S, 1988, CELL TISSUE KINET, V21, P317, DOI 10.1111/j.1365-2184.1988.tb00790.x; COHN SM, 1984, J BIOL CHEM, V259, P2456; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; COHN SM, 1991, P NATL ACAD SCI USA, V88, P1034, DOI 10.1073/pnas.88.3.1034; DAVIS BP, 1992, J BIOL CHEM, V267, P26070; DIECKGRAEFE BK, 1988, P NATL ACAD SCI USA, V85, P46, DOI 10.1073/pnas.85.1.46; FARLEY RA, 1985, J BIOL CHEM, V260, P3899; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; HAYANO T, 1988, J BIOL CHEM, V263, P1382; HERMISTON ML, 1992, J HISTOCHEM CYTOCHEM, V40, P1283, DOI 10.1177/40.9.1506665; HEWITT JE, 1991, GENOMICS, V10, P432, DOI 10.1016/0888-7543(91)90329-D; HOGAN BML, 1986, MANIPULATING MOUSE E, P171; ISHIHARA T, 1989, J BIOL CHEM, V264, P10193; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KAPADIA CR, 1983, J CLIN INVEST, V71, P440, DOI 10.1172/JCI110788; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; LEE ER, 1985, AM J ANAT, V172, P205, DOI 10.1002/aja.1001720304; LEE ER, 1985, AM J ANAT, V172, P187, DOI 10.1002/aja.1001720303; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; LEE ER, 1985, AM J ANAT, V172, P225, DOI 10.1002/aja.1001720305; LEE ER, 1985, AM J ANAT, V172, P241, DOI 10.1002/aja.1001720306; LEE EY, 1989, GASTROENTEROLOGY, V97, P1171, DOI 10.1016/0016-5085(89)91687-9; MAEDA M, 1991, J BIOL CHEM, V266, P21584; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MORLEY GP, 1992, J BIOL CHEM, V267, P1165; NEWMAN PR, 1991, GENOMICS, V11, P252, DOI 10.1016/0888-7543(91)90131-W; NEWMAN PR, 1990, DNA CELL BIOL, V9, P749, DOI 10.1089/dna.1990.9.749; OSHIMAN KI, 1991, FEBS LETT, V281, P250, DOI 10.1016/0014-5793(91)80404-Q; PILLER V, 1990, EUR J BIOCHEM, V191, P461, DOI 10.1111/j.1432-1033.1990.tb19144.x; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; ROTH KA, 1991, J BIOL CHEM, V266, P5949; ROTH KA, 1992, AM J PHYSIOL, V263, pG186, DOI 10.1152/ajpgi.1992.263.2.G186; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; ROTH KA, 1991, P NATL ACAD SCI USA, V88, P9407, DOI 10.1073/pnas.88.21.9407; RUPP RAW, 1987, NUCLEIC ACIDS RES, V15, P9707, DOI 10.1093/nar/15.23.9707; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHENGRUND CL, 1989, J BIOL CHEM, V264, P13233; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; SEETHARAM B, 1985, AM J PHYSIOL, V248, pG326, DOI 10.1152/ajpgi.1985.248.3.G326; SIMON TC, 1993, J BIOL CHEM, V268, P18345; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TAMURA S, 1992, FEBS LETT, V298, P137, DOI 10.1016/0014-5793(92)80040-N; THOMPSON EM, 1990, DEVELOPMENT, V110, P477; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; WOOD C, 1978, ANN INST PASTEUR IMM, VC129, P143	59	62	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26559	26570						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253786				2022-12-27	WOS:A1993MK42500080
J	ONO, K; RADKE, GA; ROCHE, TE; RAHMATULLAH, M				ONO, K; RADKE, GA; ROCHE, TE; RAHMATULLAH, M			PARTIAL ACTIVATION OF THE PYRUVATE-DEHYDROGENASE KINASE BY THE LIPOYL DOMAIN REGION OF E2 AND INTERCHANGE OF THE KINASE BETWEEN LIPOYL DOMAIN REGIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROLIPOYL TRANSACETYLASE COMPONENT; PROTEIN-X COMPONENT; BOVINE KIDNEY; PHOSPHATASE-ACTIVITY; BINDING-SITES; COMPLEX; SUBUNIT; HEART; PURIFICATION; CORE	The binding of the pyruvate dehydrogenase (E1) component and the E1-specific kinase to the core-forming dihydrolipoyl acetyltransferase (E2) component facilitates a severalfold enhancement in the rate at which the kinase phosphorylates E1 (i.e. versus free kinase phosphorylating free E1). The kinase and E1 associate with small exterior linker region-connected domains in the E2 structure. The kinase binds to one of two lipoyl domains, and the E1 component binds to a domain in E2''s structure between the lipoyl domain region and the inner domain. Sixty of the latter domains assemble to form a dodecahedron-shaped inner core. Binding of the kinase to a detached lipoyl domain region enhanced kinase activity. This bi-lipoyl domain fragment induced a 2-fold enhancement in the slow rate of phosphorylation of peptide substrate and intact E260 gave only a 50% higher rate. In contrast, the lipoyl domain fragment gave only a 40% enhancement in the faster rate of phosphorylation of E1; whereas the rate of phosphorylation of E1 was markedly increased (4-10-fold depending on conditions) by kinase interaction with the intact E2 core. Binding of E1 to an E2 structure lacking only the bi-lipoyl domain region did not enhance kinase activity. Thus, binding of the kinase to the lipoyl domain region elicits a structural change which enhances kinase activity; however, other processes are required to explain the very large enhancement in phosphorylation of E1 effected by intact E2 core. Among the latter is a need for a mechanism allowing one kinase molecule to phosphorylate many E1 tetramers, whereas both E1 and the kinase stay bound to the oligomeric E2 core (i.e. phosphorylation appears to be much faster than the dissociation of either the kinase or E1 tetramers from E260 core). Exposure of kinase bound to the lipoyl domain fragment to intact E2 core for 10 s allowed a transition to a maximal (7-fold) activation of the kinase. In the opposite direction, an increasing level of the free bi-lipoyl domain fragment rapidly reduced, in a concentration-dependent manner, the activity of kinase bound initially to intact E2. The data strongly support kinase transfer between free lipoyl domains and the intact E2 core and fit about a 12-fold tighter binding of the kinase to intact E2 cores over binding to free lipoyl domains. Such an interchange of the kinase between these E2 structures was confirmed by sucrose gradient studies. Our results are consistent with movement of the tightly bound kinase between lipoyl domains and suggest the possibility of rapid movement by direct kinase transfer (i.e. without an intermediate step of kinase dissociation).	KANSAS STATE UNIV AGR & APPL SCI, DEPT BIOCHEM, 104 WILLARD HALL, MANHATTAN, KS 66506 USA	Kansas State University					NIDDK NIH HHS [DK18320] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK018320, R01DK018320] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLEILE DM, 1981, J BIOL CHEM, V256, P514; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P2958, DOI 10.1021/bi00281a027; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P2966, DOI 10.1021/bi00281a028; CATE RL, 1978, J BIOL CHEM, V253, P496; CATE RL, 1980, J BIOL CHEM, V255, P7556; DAVIS PF, 1977, BIOCHEM BIOPH RES CO, V75, P541, DOI 10.1016/0006-291X(77)91506-6; GOPALAKRISHNAN S, 1989, BIOCHEM BIOPH RES CO, V160, P715, DOI 10.1016/0006-291X(89)92492-3; GORMAN JJ, 1984, ANAL BIOCHEM, V136, P397, DOI 10.1016/0003-2697(84)90235-5; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; HUCHO F, 1972, Archives of Biochemistry and Biophysics, V151, P328, DOI 10.1016/0003-9861(72)90504-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; LI L, 1992, ARCH BIOCHEM BIOPHYS, V296, P497, DOI 10.1016/0003-9861(92)90603-T; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; LIU S, 1992, FASEB J, V6, pA460; LIU S, 1993, FASEB J, V7, pA1239; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PETTIT FH, 1975, BIOCHEM BIOPH RES CO, V65, P575, DOI 10.1016/S0006-291X(75)80185-9; PETTIT FH, 1972, BIOCHEM BIOPH RES CO, V49, P563, DOI 10.1016/0006-291X(72)90448-2; POWERSGREENWOOD SL, 1989, J BIOL CHEM, V264, P3655; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; RAHMATULLAH M, 1986, J BIOL CHEM, V261, P6515; RAHMATULLAH M, 1990, J BIOL CHEM, V265, P14512; RAHMATULLAH M, 1988, J BIOL CHEM, V263, P8106; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P1245; RAHMATULLAH M, 1985, J BIOL CHEM, V260, P146; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P2221; RAHMATULLAH M, 1987, J BIOL CHEM, V262, P10265; ROCHE TE, 1993, BIOCHEMISTRY-US, V32, P5629, DOI 10.1021/bi00072a019; ROCHE TE, 1976, BIOCHEM BIOPH RES CO, V72, P1375, DOI 10.1016/S0006-291X(76)80166-0; ROCHE TE, 1989, ANN NY ACAD SCI, V573, P168, DOI 10.1111/j.1749-6632.1989.tb14994.x; ROCHE TE, 1977, ARCH BIOCHEM BIOPHYS, V183, P664, DOI 10.1016/0003-9861(77)90400-3; SCHMITZ KS, 1972, J PHYS CHEM-US, V76, P534, DOI 10.1021/j100648a015; STEPP LR, 1983, J BIOL CHEM, V258, P9454; WAGENKNECHT T, 1991, J BIOL CHEM, V266, P24650; WU TL, 1984, BIOCHEMISTRY-US, V23, P221, DOI 10.1021/bi00297a008; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	38	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26135	26143						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253731				2022-12-27	WOS:A1993MK42500022
J	SARIBANSOHRABY, S; FISHER, RS; ABRAMOW, M				SARIBANSOHRABY, S; FISHER, RS; ABRAMOW, M			ALDOSTERONE-INDUCED AND GTP-STIMULATED METHYLATION OF A 90-KDA POLYPEPTIDE IN THE APICAL MEMBRANE OF A(6) EPITHELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE SODIUM-CHANNEL; NA+ CHANNEL; CELL-LINE; AMILORIDE; TRANSPORT; PROTEIN; A6; SUBUNIT; CARBOXYL; MINERALOCORTICOIDS	Aldosterone treatment of A6 cultured renal epithelial cells methylates the apical membrane, and we examined the aldosterone-induced carboxymethylation of the apical membrane of these cells to determine the targeted polypeptides. Methionine-deprived A6 cells were incubated with aldosterone and [H-3]methionine. Homogenates and apical membranes were solubilized and analyzed by SDS-polyacrylamide gel electrophoresis. Label incorporation in a 90-kDa polypeptide was more intense (4-fold) in membranes after aldosterone compared to control. For in vitro methylation, membranes were isolated, incubated with S-adenosyl-L-[methyl-H-3]methionine, and analyzed for H-3-methyl uptake. Label incorporation was low in control membranes but markedly stimulated (4-fold) in membrane preparations from aldosterone-treated cells. Guanosine 5'-O-(3-thiotriphosphate) increased in vitro methylation of a 90-kDa polypeptide 5-fold in control membranes but after aldosterone, where methylation was already stimulated, little change was observed. We conclude that aldosterone induces methylation of an apical membrane 90-kDa polypeptide, possibly a subunit of the epithelial Na+ channel, in a GTP-dependent manner, and this may be one of the final steps in a cascade of reactions leading to the natriferic action of this hormone.	WALTER REED ARMY INST RES, DEPT NEPHROL, WASHINGTON, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	SARIBANSOHRABY, S (corresponding author), UNIV LIBRE BRUXELLES, PHYSIOPATHOL LAB, BAT E24107, 808 ROUTE LENNIK, B-1070 BRUSSELS, BELGIUM.							AUSIELLO DA, 1992, J BIOL CHEM, V267, P4759; BACKLUND PS, 1988, J BIOL CHEM, V263, P15864; BARBRY P, 1990, BIOCHEMISTRY-US, V29, P1039, DOI 10.1021/bi00456a028; BEAUWENS R, 1990, BASIC PRINCIPLES TRA, P1; BENOS DJ, 1987, J BIOL CHEM, V262, P10613; BENOS DJ, 1986, P NATL ACAD SCI USA, V83, P8525, DOI 10.1073/pnas.83.22.8525; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CANTIELLO HF, 1989, J BIOL CHEM, V264, P20867; CHELSKY D, 1985, BIOCHEMISTRY-US, V24, P6651, DOI 10.1021/bi00344a053; CLARKE S, 1985, ANNU REV BIOCHEM, V54, P479, DOI 10.1146/annurev.bi.54.070185.002403; CRABBE J, 1961, J CLIN INVEST, V40, P2103, DOI 10.1172/JCI104436; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; GARTY H, 1983, J GEN PHYSIOL, V81, P785, DOI 10.1085/jgp.81.6.785; GARTY H, 1989, AM J PHYSIOL, V256, pF965, DOI 10.1152/ajprenal.1989.256.5.F965; GOODMAN DBP, 1975, BIOCHEMISTRY-US, V14, P2803, DOI 10.1021/bi00684a003; HANDLER JS, 1981, AM J PHYSIOL, V240, pC103, DOI 10.1152/ajpcell.1981.240.3.C103; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; KEMENDY A, 1990, FASEB Journal, V4, pA445; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; KIPNOWSKI J, 1983, AM J PHYSIOL, V245, pF726, DOI 10.1152/ajprenal.1983.245.6.F726; KLEYMAN TR, 1991, J BIOL CHEM, V266, P3907; KLEYMAN TR, 1986, J BIOL CHEM, V261, P2839; KLEYMAN TR, 1989, J BIOL CHEM, V264, P11995; KOSHLAND DE, 1981, ANNU REV BIOCHEM, V50, P765, DOI 10.1146/annurev.bi.50.070181.004001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; LUDENS JH, 1978, J MEMBRANE BIOL, V40, P199, DOI 10.1007/BF02026006; PALMER LG, 1982, J MEMBRANE BIOL, V64, P91, DOI 10.1007/BF01870771; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; PORTER GA, 1968, MOL PHARMACOL, V4, P224; ROSSIER BC, 1989, CURR TOP MEMBR TRANS, V34, P167; SARIBANSOHRABY S, 1984, SCIENCE, V225, P745, DOI 10.1126/science.6463652; SARIBANSOHRABY S, 1992, AM J PHYSIOL, V263, pC1111, DOI 10.1152/ajpcell.1992.263.5.C1111; SARIBANSOHRABY S, 1988, J BIOL CHEM, V263, P13875; SARIBANSOHRABY S, 1984, J BIOL CHEM, V259, P1221; SCHAFER JA, 1992, KIDNEY INT, V41, P255, DOI 10.1038/ki.1992.37; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; TOUSSON A, 1989, J CELL SCI, V93, P349; WIESMANN WP, 1985, AM J PHYSIOL, V248, pF43, DOI 10.1152/ajprenal.1985.248.1.F43; YAMANE HK, 1993, ANNU REV PHARMACOL, V33, P201, DOI 10.1146/annurev.pharmtox.33.1.201; YORIO T, 1978, NATURE, V271, P79, DOI 10.1038/271079a0	42	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26613	26617						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253792				2022-12-27	WOS:A1993MK42500087
J	ORITA, S; KAIBUCHI, K; KURODA, S; SHIMIZU, K; NAKANISHI, H; TAKAI, Y				ORITA, S; KAIBUCHI, K; KURODA, S; SHIMIZU, K; NAKANISHI, H; TAKAI, Y			COMPARISON OF KINETIC-PROPERTIES BETWEEN 2 MAMMALIAN RAS P21 GDP GTP EXCHANGE PROTEINS, RAS GUANINE NUCLEOTIDE-RELEASING FACTOR AND SMG GDP DISSOCIATION STIMULATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; PURIFICATION; IDENTIFICATION; CDC25; CDNA; GENE	The mammalian counterpart of the yeast ras p21 GDP/GTP exchange protein CDC25, ras GRF, was expressed in Escherichia coli and purified, and its kinetic properties were compared with those of another mammalian ras p21 GDP/GTP exchange protein, smg GDS. ras GRF was active on Ki- and Ha-ras p21s but inactive on rap1A p21, rhoA p21, rac1 p21, and rab3A p25, whereas smg GDS was active on Ki-ras p21, rap1A p21, rhoA p21, and rac1 p21 but inactive on Ha-ras p21 and rab3A p25. The K(cat) values of ras GRF and smg GDS for Ki-ras p21 as a common substrate were calculated to be 1.2 and 0.37 nmol/min/nmol, respectively. The K(m) values of ras GRF and smg GDS for Ki-ras p21 were 680 and 220 nM, respectively. ras GRF was slightly active on post-translationally unprocessed Ki-ras p21 but much more effective on post-translationally processed Ki-ras p21 than on post-translationally unprocessed Ki-ras p21. smg GDS was active on post-translationally processed Ki-ras p21 but inactive on post-translationally unprocessed Ki-ras p21. Moreover, as described for smg GDS, ras GRF showed a potency to inhibit the binding of Ki-ras p21 to membrane and to induce the dissociation of prebound Ki-ras p21 from the membrane. These results indicate that ras GRF and smg GDS show apparently similar kinetic properties except for the different substrate specificities and the requirement of the post-translational processing of Ki-ras p21.	KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN; SHIONOGI INST MED SCI,SETTSU 566,JAPAN; NATL INST PHYSIOL SCI,OKAZAKI,AICHI 444,JAPAN	Kobe University; Shionogi & Company Limited; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)				Nakanishi, Hiroyuki/0000-0002-9765-0266				ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; ANDO S, 1992, J BIOL CHEM, V267, P25709; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; ITOH T, 1993, J BIOL CHEM, V268, P3025; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; KAWAMURA M, 1993, BIOCHEM BIOPH RES CO, V190, P832, DOI 10.1006/bbrc.1993.1124; KIKUCHI A, 1988, J BIOL CHEM, V263, P2897; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SHIRATAKI H, 1991, J BIOL CHEM, V266, P20672; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; Steck T L, 1974, Methods Enzymol, V31, P172; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; WEI W, 1992, P NATL ACAD SCI USA, V89, P7100, DOI 10.1073/pnas.89.15.7100; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOSHIDA K, 1988, CANCER RES, V48, P5503	34	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25542	25546						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244990				2022-12-27	WOS:A1993MK10000041
J	STOUT, CD				STOUT, CD			CRYSTAL-STRUCTURES OF OXIDIZED AND REDUCED AZOTOBACTER-VINELANDII FERREDOXIN AT PH-8 AND PH-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PUTIDA 7-IRON FERREDOXINS; 4FE-4S CLUSTER; REFINEMENT; RESONANCES; PROTEIN; FORMS	Crystal structures of Azotobacter vinelandii ferredoxin I (FdI) have been solved and refined at 2.2 to 1.9-angstrom resolution at pH 8 and 6 for both the oxidized and dithionite-reduced proteins. Only the [3Fe-4S] cluster is reduced by dithionite. The four structures (denoted FdI8ox, FdI8red , FdI6ox, and FdI6red) have been compared to address three questions: the effect of reduction at pH 8, the effect of pH change on the structure, and the effect of reduction at pH 6. Comparison of the FdI8ox and FdI8red structures shows that Asp-15 changes conformation in a manner consistent with increased anionic repulsion between this residue and the reduced [3Fe-4S]0 cluster. By revealing an electrostatic interaction between Asp-15 and the [3Fe-4S] cluster, this result supports the conclusion in the accompanying paper (Shen, B., Martin, L. L., Butt, J. N., Armstrong, F. A., Stout, C. D., Jensen, G. M., Stephens, P. J., LaMar, G. N., Gorst, C. M., and Burgess, B. K. (1993) J. Biol. Chem. 268,25928-25939) that Asp-15 participates in protonation of the reduced [3Fe-4S]0 cluster at acid pH. The [3Fe-4S]0 cluster in the FdI8red structure also displays a distinct shift within the protein as well as internal distortions when compared to the [3Fe-4S]+ cluster in the FdI8ox structure. Comparison of the FdI8ox and FdI6ox structures shows that pH change does not have any significant effect on the [3Fe-4S]+ cluster or surrounding residues. Comparison of the FdI6ox and FdIred structures shows that reduction at pH 6 also does not have any significant effect on the [3Fe-4S] cluster or Asp-15. The absence of structural change supports the conclusion that at acid pH, the reduced [3Fe-4S] cluster is protonated, i.e. [3Fe-4S]0-H+ (Shen et al., 1993). The cluster is not shifted or distorted as in the FdI8red structure. Instead, the [3Fe-4S]0-H+ cluster (FdI6red) is structurally similar to the [3Fe-4S]+ cluster (FdI8ox, FdI6ox), which has the same net charge. An Asp-15-Lys-84 salt bridge is observed in all four structures, indicating that Asp-15 is ionized at pH 8 and 6. An ionized state for Asp-15 is also implied by a lack of conformational change in Lys-84; the side chain of this residue rearranges when Asp-15 is substituted with a neutral amino acid (Shen et al., 1993). The absence of significant conformational change in Asp-15, i.e. anionic repulsion as in the FdI8red Structure, indicates that the reduced [3Fe-4S] cluster at pH 6 has the same net charge as the [3Fe-4S]' cluster, i.e. is protonated.			STOUT, CD (corresponding author), SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA.				NIGMS NIH HHS [GM-45209, GM-36325] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036325, R01GM045209] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MWW, 1992, ADV INORG CHEM, V38, P341, DOI 10.1016/S0898-8838(08)60068-9; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; CARTER CW, 1974, J BIOL CHEM, V249, P6339; CHENG H, 1990, J BIOL CHEM, V265, P12388; CHENG H, 1992, J BIOL CHEM, V267, P8073; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; DUS K, 1967, BIOCHIM BIOPHYS ACTA, V140, P291, DOI 10.1016/0005-2795(67)90470-9; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; IISMAA SE, 1991, J BIOL CHEM, V266, P21563; KISSINGER CR, 1988, J AM CHEM SOC, V110, P8721, DOI 10.1021/ja00234a038; MARTIN AE, 1990, P NATL ACAD SCI USA, V87, P598, DOI 10.1073/pnas.87.2.598; MATSUBARA H, 1992, ADV INORG CHEM, V38, P223, DOI 10.1016/S0898-8838(08)60065-3; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1993, ACTA CRYSTALLOGR D, V49, P272, DOI 10.1107/S0907444992007248; MORGAN TV, 1988, J BIOL CHEM, V263, P1370; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; SHEN BH, 1993, J BIOL CHEM, V268, P25928; SOMAN J, 1991, J BIOL CHEM, V266, P21558; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOUT CD, 1989, J MOL BIOL, V205, P545, DOI 10.1016/0022-2836(89)90225-8; STOUT CD, 1979, J BIOL CHEM, V254, P3598; STOUT GH, 1988, P NATL ACAD SCI USA, V85, P1020, DOI 10.1073/pnas.85.4.1020	22	68	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25920	25927						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245025				2022-12-27	WOS:A1993MK10000091
J	MATSUDA, C; ENDO, H; OHTA, S; KAGAWA, Y				MATSUDA, C; ENDO, H; OHTA, S; KAGAWA, Y			GENE STRUCTURE OF HUMAN MITOCHONDRIAL ATP SYNTHASE GAMMA-SUBUNIT - TISSUE-SPECIFICITY PRODUCED BY ALTERNATIVE RNA SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE ADP/ATP TRANSLOCATOR; ADENOSINE-TRIPHOSPHATE SYNTHASE; BETA-SUBUNIT; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; PROMOTER SEQUENCES; IMPORT PRECURSOR	We completely sequenced the human gene for ATP synthase gamma-subunit, which was approximately 23 kilobases long and was composed of 10 exons. Exons 1 and 2 encoded the N-terminal presequence required for mitochondrial import, while exons 9 and 10 encoded the C-terminal portions of mature protein. Enzymatic amplification of human heart and liver cDNAs using the polymerase chain reaction revealed two mRNA transcripts that were predicted to encode two 30-kDa isoforms of the gamma-subunit, which differed by the addition of a single amino acid (Asp273) at the C terminus of the liver type isoform. These two mRNA transcripts of the heart (H) type and liver (L) type were generated by alternative splicing of an exon. The same alternative splicing event was observed in bovine tissue. In human tissues, the H type mRNA devoid of exon 9 was expressed specifically in the heart and skeletal muscle, which require rapid energy supply. The L type mRNA was expressed in the brain, liver, kidney etc. Both transcripts were expressed in the skin, intestine, stomach, and aorta. This tissue specificity of transcript heterogeneity suggests the distinct functional or regulatory roles of the gamma-subunit isoforms in the catalysis of ATP synthase. This is the first report on tissue-specific isoforms generated by alternative splicing in an energy transducing mitochondrial protein.	JICHI MED SCH, DEPT BIOCHEM, 3311-1 MINAMIKAWACHI MACHI, MINAMI KAWACHI, TOCHIGI 32904, JAPAN	Jichi Medical University								ALOISE P, 1991, J BIOL CHEM, V266, P10368; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; DODGSON JB, 1983, J BIOL CHEM, V258, P4623; DUNN SD, 1980, J BIOL CHEM, V255, P113; DYER MR, 1989, BIOCHEMISTRY-US, V28, P3670, DOI 10.1021/bi00435a008; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; IVEY DM, 1991, MOL GEN GENET, V229, P292, DOI 10.1007/BF00272169; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; JORDAN EM, 1992, BIOCHIM BIOPHYS ACTA, V1130, P123, DOI 10.1016/0167-4781(92)90477-H; KAGAWA Y, 1989, FEBS LETT, V249, P67, DOI 10.1016/0014-5793(89)80017-1; KAGAWA Y, 1992, ANN NY ACAD SCI, V671, P366, DOI 10.1111/j.1749-6632.1992.tb43810.x; KAGAWA Y, 1984, BIOENERGETICS, P149; KATAOKA H, 1991, BIOCHIM BIOPHYS ACTA, V1089, P393, DOI 10.1016/0167-4781(91)90183-M; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; LI K, 1989, J BIOL CHEM, V264, P13998; LI K, 1990, J BIOL CHEM, V265, P20585; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Maniatis T., 1982, MOL CLONING; MATSUDA C, 1993, FEBS LETT, V325, P281, DOI 10.1016/0014-5793(93)81089-I; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NECKELMANN N, 1989, GENOMICS, V5, P829, DOI 10.1016/0888-7543(89)90125-0; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; OHTA S, 1988, J BIOL CHEM, V263, P11257; OHTA S, 1986, J BIOCHEM-TOKYO, V99, P135, DOI 10.1093/oxfordjournals.jbchem.a135452; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; PIERCE DJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P265, DOI 10.1016/0167-4781(92)90160-2; RACKER E, 1976, NEW LOOK MECHANISMS; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEJA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P91, DOI 10.1016/0167-4781(92)90059-9; SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x; SEELAN RS, 1991, J BIOL CHEM, V266, P19752; SHIBAHARA S, 1985, EUR J BIOCHEM, V146, P15, DOI 10.1111/j.1432-1033.1985.tb08614.x; SUZUKI H, 1991, J BIOL CHEM, V266, P2333; SUZUKI H, 1990, J BIOL CHEM, V265, P8159; TOMURA H, 1990, J BIOL CHEM, V265, P6525; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; WALKER JE, 1990, PHILOS T ROY SOC B, V326, P367, DOI 10.1098/rstb.1990.0018; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525	55	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24950	24958						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227057				2022-12-27	WOS:A1993MG67300065
J	TIMMER, RT; LAX, SR; HUGHES, DL; MERRICK, WC; RAVEL, JM; BROWNING, KS				TIMMER, RT; LAX, SR; HUGHES, DL; MERRICK, WC; RAVEL, JM; BROWNING, KS			CHARACTERIZATION OF WHEAT-GERM PROTEIN-SYNTHESIS INITIATION FACTOR-EIF-4C AND COMPARISON OF EIF-4C FROM WHEAT-GERM AND RABBIT RETICULOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN MESSENGER-RNA; ELONGATION-FACTORS; PURIFICATION; MECHANISM; TRANSLATION	Eukaryotic protein synthesis initiation factor (eIF)-4C was purified from wheat germ and the molecular weight was calculated to be approximately 19,000 by SDS-polyacrylamide gel electrophoresis. A similar molecular weight was determined by gel filtration chromatography indicating that wheat germ eIF-4C is functional as a single polypeptide chain. An efficient in vitro translation system dependent upon the addition of eIF-4C was developed. This system was used to determine the concentrations of eIF-4C required for the half-maximal rate of translation of satellite tobacco necrosis virus RNA, alfalfa mosaic virus RNA 4, and barley alpha-amylase mRNA. No significant differences in the concentrations of eIF-4C required for the translation of these mRNAs were observed, although differences were noted for eIF-4A and eIF-4F. This finding suggests that eIF-4C is not involved in the binding of mRNA to 40 S ribosomal subunits. In heterologous assays, rabbit reticulocyte eIF-4C was as active as wheat germ eIF-4C in the wheat germ eIF-4C-dependent system. In addition, wheat germ eIF-4C substituted for rabbit reticulocyte eIF-4C in in vitro assay systems from rabbit reticulocytes. These results indicate that eIF-4C from wheat and rabbit contain conserved functional domains.	UNIV TEXAS,DEPT CHEM & BIOCHEM,AUSTIN,TX 78712; CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	University of Texas System; University of Texas Austin; Case Western Reserve University					NIGMS NIH HHS [GM-26796, GM-18775] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018775, R01GM026796] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; BENNE R, 1978, J BIOL CHEM, V253, P3078; BENNE R, 1978, P NATL ACAD SCI USA, V75, P108, DOI 10.1073/pnas.75.1.108; BENNE R, 1978, J BIOL CHEM, V253, P3070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; BROWNING KS, 1987, J BIOL CHEM, V262, P538; BROWNING KS, 1988, J BIOL CHEM, V263, P9630; FLETCHER L, 1990, J BIOL CHEM, V265, P19582; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Merrick W C, 1979, Methods Enzymol, V60, P108, DOI 10.1016/S0076-6879(79)60011-3; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6; SEAL SN, 1983, J BIOL CHEM, V258, P866; SEAL SN, 1982, J BIOL CHEM, V257, P8634; THOMAS A, 1980, EUR J BIOCHEM, V107, P39, DOI 10.1111/j.1432-1033.1980.tb04621.x; TIMMER RT, 1993, J BIOL CHEM, V268, P9504; YANG WN, 1993, J BIOL CHEM, V268, P392	25	20	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24863	24867						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227048				2022-12-27	WOS:A1993MG67300053
J	WYMAN, C; VASILIKIOTIS, C; ANG, D; GEORGOPOULOS, C; ECHOLS, H				WYMAN, C; VASILIKIOTIS, C; ANG, D; GEORGOPOULOS, C; ECHOLS, H			FUNCTION OF THE GRPE HEAT-SHOCK PROTEIN IN BIDIRECTIONAL UNWINDING AND REPLICATION FROM THE ORIGIN OF PHAGE-GAMMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-DNA-REPLICATION; SPECIALIZED NUCLEOPROTEIN STRUCTURES; POLYMERASE-III HOLOENZYME; ESCHERICHIA-COLI DNAK; BACTERIOPHAGE-LAMBDA; O-PROTEIN; INITIATION; PURIFICATION; STABILITY	The initiation of DNA replication by phage lambda depends on a specialized nucleoprotein structure that provides for the precise localization and activity of the Escherichia coli DnaB helicase at the lambda replication origin. Previous work has shown that the DnaJ and DnaK heat shock proteins function in the initiation pathway by releasing the DnaB helicase from the initiation complex to carry out localized unwinding of origin DNA. This DnaJ.DnaK pathway results in mainly unidirectional DNA unwinding and replication, whereas replication in vivo is mainly bidirectional. Based on recent replication work indicating an important role for the GrpE heat shock protein, we have used electron microscopy to study the action of GrpE in the DNA unwinding and replication reactions. We have found that GrpE acts with DnaJ and DnaK to facilitate the unwinding reaction at low concentrations of DnaK. In the presence of GrpE, bidirectional unwinding occurs in approximately half of the unwound DNA molecules. In addition, GrpE significantly increases the frequency of replication proceeding leftward from the origin. We suggest that reactions including GrpE result in more complete disassembly of the preinitiation nucleoprotein structure, thus allowing replication to proceed in both directions from the origin.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, 401 BARKER HALL, BERKELEY, CA 94720 USA; UNIV GENEVA, MED CTR, DEPT BIOCHIM MED, CH-1211 GENEVA 4, SWITZERLAND	University of California System; University of California Berkeley; University of Geneva					NCI NIH HHS [CA09278] Funding Source: Medline; NIGMS NIH HHS [GM17078] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; ALFANO C, 1989, J BIOL CHEM, V264, P10699; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; ECHOLS H, 1990, UCLA SYM BI, V127, P1; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; Furth M., 1983, LAMBDA 2, P145; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; KORNBERG A, 1988, J BIOL CHEM, V263, P1; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MAKI H, 1988, J BIOL CHEM, V263, P6570; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; MANIATIS T, 1982, MOL CLONING LABORATO, P90; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; OTTER R, 1983, METHOD ENZYMOL, V100, P171; ROBERTS JD, 1983, NUCLEIC ACIDS RES, V11, P7435, DOI 10.1093/nar/11.21.7435; SAITO H, 1977, J MOL BIOL, V113, P1, DOI 10.1016/0022-2836(77)90038-9; SCHNOS M, 1970, J MOL BIOL, V51, P61, DOI 10.1016/0022-2836(70)90270-6; SCHNOS M, 1982, J MOL BIOL, V159, P441, DOI 10.1016/0022-2836(82)90293-5; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; TSURIMOTO T, 1981, NUCLEIC ACIDS RES, V9, P1789, DOI 10.1093/nar/9.8.1789; WICKNER SH, 1979, COLD SPRING HARB SYM, V43, P303, DOI 10.1101/SQB.1979.043.01.037; WILLIAMS RC, 1977, P NATL ACAD SCI USA, V74, P2311, DOI 10.1073/pnas.74.6.2311; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P6176, DOI 10.1073/pnas.79.20.6176; ZAHN K, 1987, SCIENCE, V236, P416, DOI 10.1126/science.2951850; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	39	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25192	25196						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227083				2022-12-27	WOS:A1993MG67300096
J	YAN, H; GROSSMAN, A; WANG, H; DEUSTACHIO, P; MOSSIE, K; MUSACCHIO, JM; SILVENNOINEN, O; SCHLESSINGER, J				YAN, H; GROSSMAN, A; WANG, H; DEUSTACHIO, P; MOSSIE, K; MUSACCHIO, JM; SILVENNOINEN, O; SCHLESSINGER, J			A NOVEL RECEPTOR TYROSINE PHOSPHATASE-SIGMA THAT IS HIGHLY EXPRESSED IN THE NERVOUS-SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; HUMAN-PLACENTA; DOMAINS; LINKAGE; FIBRONECTIN; DROSOPHILA; BINDING; MEMBER; MOUSE	A novel transmembrane receptor protein tyrosine phosphatase-sigma (RPTP-sigma) was cloned from a rat brain stem cDNA library. The extracellular segment of one form of RPTP-sigma contains 824 amino acids and is composed of three immunoglobulin-like and five fibronectin type III (FNIII)-like repeats. The 627-amino acid cytoplasmic region of RPTP-sigma consists of two catalytic domains oriented in tandem. Northern blot analyses indicate that RPTP-sigma is highly expressed in the brain as two major transcripts of 5.7 and 6.9 kilobases (kb). The 5.7-kb transcript is expressed exclusively in the brain while the 6.9-kb species can be detected in the lung and heart, but at significantly lower levels. In situ hybridization studies confirm that RPTP-sigma is localized predominately in the nervous system and can be detected in the rat as early as embryonic day 12. During embryonic development, RPTP-sigma is expressed extensively in the central and peripheral nervous systems, including the trigeminal and dorsal root ganglia as well as the retina. In adult rat brain, expression is restricted primarily to the olfactory tubercule, cerebellum, and hippocampus. Within the latter structure, RPTP-sigma is present in the pyramidal cell layer and granular layer of the dentate gyrus. Transfection of RPTP-sigma cDNA into human embryonic kidney 293 cells results in the synthesis of a protein with an apparent molecular mass of 200 kDa as detected by immunoprecipitation and immunoblot analyses using polyclonal antibodies against the FNIII-like repeats present in the extracellular domain of RPTP-sigma. The gene for RPTP-sigma has been mapped to distal chromosome 17 in the mouse.	NYU MED CTR,DEPT PHARMACOL,550 1ST AVE,NEW YORK,NY 10016; NYU MED CTR,DEPT BIOCHEM,NEW YORK,NY 10016; SUGEN INC,REDWOOD CITY,CA 94063	New York University; New York University				D'Eustachio, Peter/0000-0002-5494-626X	NIMH NIH HHS [MH-17785] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ausubel FM, 1988, MOL REPROD DEV; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; BARR PJ, 1991, CELL, V68, P1; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BLANK RD, 1988, GENETICS, V120, P1073; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DESAI DV, 1993, CELL, V73, P1; DEUSTACHIO P, 1987, IMMUNOGENETICS, V26, P339, DOI 10.1007/BF00343701; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GEBBINK MFBG, 1991, FEBS LETT, V290, P123, DOI 10.1016/0014-5793(91)81241-Y; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; JIANG YP, 1993, MOL CELL BIOL, V13, P2942, DOI 10.1128/MCB.13.5.2942; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; POT DA, 1992, J BIOL CHEM, V267, P140; ROSS CA, 1988, P NATL ACAD SCI USA, V85, P9831, DOI 10.1073/pnas.85.24.9831; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; SAITO H, 1991, CELL GROWTH DIFFER, V2, P59; Sambrook J, 1989, MOL CLONING LABORATO; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Shaw A, 1991, CURR OPIN CELL BIOL, V3, P862, DOI 10.1016/0955-0674(91)90061-3; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SILVER J, 1985, J HERED, V76, P436, DOI 10.1093/oxfordjournals.jhered.a110140; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; STREULI M, 1992, EMBO J, V11, P879; SUDOL M, 1989, MOL CELL BIOL, V9, P4545, DOI 10.1128/MCB.9.10.4545; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; TSAI AYM, 1991, J BIOL CHEM, V266, P10534; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; YU Q, 1992, ONCOGENE, V7, P1051	53	106	118	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24880	24886						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227050				2022-12-27	WOS:A1993MG67300056
J	ZHENG, Y; HART, MJ; SHINJO, K; EVANS, T; BENDER, A; CERIONE, RA				ZHENG, Y; HART, MJ; SHINJO, K; EVANS, T; BENDER, A; CERIONE, RA			BIOCHEMICAL COMPARISONS OF THE SACCHAROMYCES-CEREVISIAE BEM2 AND BEM3 PROTEINS - DELINEATION OF A LIMIT CDC42 GTPASE-ACTIVATING PROTEIN DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; BINDING PROTEIN; CELL POLARITY; MOLECULAR-CLONING; ESCHERICHIA-COLI; FUSION PROTEINS; BCR GENE; RHO; YEAST; IDENTIFICATION	The Bem2 and Bem3 proteins, which appear to play roles in the regulation of bud site formation in Saccharomyces cerevisiae, show striking homology to a number of proteins that compose a family of GTPase-activating proteins (GAPs) for the rho-subgroup of ras-related GTP-binding proteins. These members include human platelet GAP for Cdc42Hs (the human homolog of a S. cerevisiae GTP-binding protein that regulates bud site assembly), the break point cluster region protein, the brain protein chimerin, the 85-kDa regulatory subunit (p85) of the phosphatidylinositol 3-kinase, and the ras-GAP-binding protein (p190). A fusion protein composed of the glutathione S-transferase protein and the rho-GAP homology region of Bem3 (designated GST-Bem3) stimulates the GTPase activity of the wild-type Cdc42Hs protein (Cdc42Hs(Gly-12)), but has no stimulatory effect on a GTPase-defective mutant (Cdc42Hs(Val-12)), whereas a GST-Bem2 fusion protein does not stimulate the GTPase activity of either form of Cdc42Hs. We have compared the ability of GST-Bem3 to serve as a GAP for Cdc42Hs relative to other members of the rho-GAP subfamily and found the following order of potency: human platelet Cdc42Hs GAP > p190 > Bem3 > break point cluster region protein, whereas p85, like Bem2, shows no GAP activity or any ability to bind to the GTP-bound form of Cdc42Hs. We have taken advantage of the functional specificity exhibited by Bem3 (versus Bem2) in using Bem2/Bem3 chimeras, as well as different deletion mutant versions of the Bem3 protein, to delineate the limits of a functional Cdc42 GAP domain. The results of this study indicate that the carboxyl-terminal approximately 224 amino acids (which contain three regions of homology to the other members of the rho-GAP family) represent a ''limit GAP.'' The first two appear to be important for binding to Cdc42Hs and for partial GAP activity.	ONYX PHARMACEUT,RICHMOND,CA 94806; INDIANA UNIV,DEPT BIOL,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	ZHENG, Y (corresponding author), CORNELL UNIV,DEPT PHARMACOL & FIELD BIOCHEM MOLEC & CELL BIOL,ITHACA,NY 14853, USA.		Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Hart, Matthew/0000-0002-2683-480X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HART MJ, 1991, J BIOL CHEM, V266, P20840; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KOLAND JG, 1990, BIOCHEM BIOPH RES CO, V166, P90, DOI 10.1016/0006-291X(90)91915-F; LEONARD D, 1992, J BIOL CHEM, V267, P22860; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; MORII N, 1991, J BIOL CHEM, V266, P7646; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; UEDA T, 1990, J BIOL CHEM, V265, P9373; VANGARRETT MD, 1989, J BIOL CHEM, V264, P10	29	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24629	24634						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227021				2022-12-27	WOS:A1993MG67300021
J	GIANNAKOUROS, T; NEWMAN, CMH; CRAIGHEAD, MW; ARMSTRONG, J; MAGEE, AI				GIANNAKOUROS, T; NEWMAN, CMH; CRAIGHEAD, MW; ARMSTRONG, J; MAGEE, AI			POSTTRANSLATIONAL PROCESSING OF SCHIZOSACCHAROMYCES-POMBE YPT5-PROTEIN - IN-VITRO AND IN-VIVO ANALYSIS OF PROCESSING MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; RAB GERANYLGERANYL TRANSFERASE; CARBOXYL-METHYLATION; VESICULAR TRANSPORT; TERMINAL CYSTEINE; C-TERMINUS; MEMBRANE; YEAST; MOTIF; PROTEOLYSIS	SpYPT5p is a member of the rab/YPT small GTP-binding protein family, which is believed to be involved in the regulation of intracellular trafficking. The protein sequence terminates with a CXC motif, and in our previous report (Newman, C. M. H., Giannakouros, T., Hancock, J. F., Fawell, E. H., Armstrong, J., and Magee, A. I. (1992) J. Biol. Chem. 267, 11329-11336) we have shown that SpYPT5p is prenylated both in vivo and in vitro, where geranylgeranylation was confirmed, and carboxyl-methylated. In order to dissect the role of prenylation of each cysteine, we have generated C-terminal mutants where either one or both cysteine(s) were replaced by serine and expressed them in vitro in reticulocyte lysates and in vivo in transfected COS cells. Our results suggest that both cysteines of the CXC motif are prenylated but that the rate of prenylation of the two cysteines is different. The upstream cysteine was found to be preferentially prenylated in reticulocyte lysates unless cytosol from COS cells was added. A separate activity could therefore be required for prenylation of the second cysteine, or the presence of an additional factor is needed to allow accumulation of doubly prenylated SpYPT5p. However, the modification of the upstream cysteine is not a prerequisite for the prenylation of the other. Furthermore, gene replacement in Schizosaccharomyces pombe revealed that each cysteine of the CXC motif can individually support function. Carboxyl methylation occurred only on protein which had been prenylated on the C-terminal cysteine and was required for efficient membrane binding in vitro.	NATL INST MED RES, RIDGEWAY, MILL HILL, LONDON NW7 1AA, ENGLAND; IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND	MRC National Institute for Medical Research; Cancer Research UK			Magee, Anthony/V-8345-2019; GIANNAKOUROS, THOMAS/R-3204-2019					BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROKER M, 1987, BIOTECHNIQUES, V5, P516; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHELSKY D, 1989, J BIOL CHEM, V264, P7637; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; GIANNAKOUROS T, 1992, LIPID MODIFICATIONS, P135; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; HORIUCHI H, 1991, J BIOL CHEM, V266, P16981; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Magee Tony, 1992, Trends in Cell Biology, V2, P318, DOI 10.1016/0962-8924(92)90172-J; MCGEOCH C, 1991, TECHNIQUE PHILA, V3, P179; MOLENAAR CMT, 1988, EMBO J, V7, P971, DOI 10.1002/j.1460-2075.1988.tb02903.x; MOORES SL, 1991, J BIOL CHEM, V266, P14603; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MUSHA T, 1992, J BIOL CHEM, V267, P9821; NEWMAN CMH, 1992, J BIOL CHEM, V267, P11329; PEREZSALA D, 1992, BIOCHEM J, V284, P835, DOI 10.1042/bj2840835; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; VOLKER C, 1991, FEBS LETT, V295, P189, DOI 10.1016/0014-5793(91)81415-5; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WEI C, 1992, ONCOGENE, V7, P467	39	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24467	24474						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226998				2022-12-27	WOS:A1993MF29400111
J	IUCHI, S				IUCHI, S			PHOSPHORYLATION DEPHOSPHORYLATION OF THE RECEIVER MODULE AT THE CONSERVED ASPARTATE RESIDUE CONTROLS TRANSPHOSPHORYLATION ACTIVITY OF HISTIDINE KINASE IN SENSOR PROTEIN ARCB OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; BORDETELLA-PERTUSSIS; RESPONSE REGULATOR; AEROBIC PATHWAYS; GENE-EXPRESSION; MEDIATING REPRESSION; ANAEROBIC REPRESSION; PHOSPHATE REGULON; BACTERIA; CHEMOTAXIS	A membrane sensor protein, ArcB, recognizes anaerobic environments and signals the information to the cognate regulator, ArcA. This in vitro study presents the process and control of the signal-transduction phosphorylation. In the presence of ATP, the ArcB transmitter module undergoes autophosphorylation and then transfers the phosphoryl group to its own receiver module as well as to the ArcA receiver module. Results suggest that the phosphoryl group of the ArcB receiver module is released by an intrinsic phosphatase activity. D-Lactate inhibits the phosphatase activity that removes phosphoaspartate groups from the receiver module in ArcB, and the associated increase in phosphorylation of this module leads to an activation of transphosphorylation of subsequently added phosphohistidine groups on ArcB to the receiver module of ArcA. A similar effect was also observed in the presence of pyruvate, acetate, or NADH. Conversely, the non-phosphorylated ArcB receiver module completely inhibits the intermolecular transphosphorylation. Thus, the phosphorylation state of the ArcB receiver module controls signal transduction from ArcB to ArcA. Since the intrinsic phosphatase activity is inhibited by cellular metabolites that increasingly accumulate by anaerobiosis, the enzyme portion of ArcB may be involved in sensing anaerobic environments through cellular metabolites in vivo.			IUCHI, S (corresponding author), HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA.				NIGMS NIH HHS [R01-GM11983, R01-GM40993] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040993, R01GM011983] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES GF, 1989, J BIOL CHEM, V264, P3998; ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; IUCHI S, 1991, CELL, V66, P5, DOI 10.1016/0092-8674(91)90130-Q; IUCHI S, 1989, J BACTERIOL, V171, P868, DOI 10.1128/jb.171.2.868-873.1989; IUCHI S, 1992, J BACTERIOL, V174, P3972, DOI 10.1128/jb.174.12.3972-3980.1992; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1992, J BACTERIOL, V174, P5617, DOI 10.1128/JB.174.17.5617-5623.1992; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; LEROUX B, 1987, EMBO J, V6, P849, DOI 10.1002/j.1460-2075.1987.tb04830.x; LIN ECC, 1991, ANNU REV GENET, V25, P361, DOI 10.1146/annurev.ge.25.120191.002045; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MAKINO K, 1989, J MOL BIOL, V210, P551, DOI 10.1016/0022-2836(89)90131-9; Maniatis T., 1982, MOL CLONING LAB MANU, P250; MCCLEARY WR, 1990, J BACTERIOL, V172, P6661, DOI 10.1128/jb.172.12.6661-6668.1990; MILLER JF, 1992, J BACTERIOL, V174, P970, DOI 10.1128/jb.174.3.970-979.1992; NINFA AJ, 1991, J BIOL CHEM, V266, P6888; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; SANDERS DA, 1992, J BACTERIOL, V174, P5117, DOI 10.1128/JB.174.15.5117-5122.1992; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; SANWAL BD, 1970, BACTERIOL REV, V34, P20, DOI 10.1128/MMBR.34.1.20-39.1970; SAWERS G, 1992, J BACTERIOL, V174, P3474, DOI 10.1128/JB.174.11.3474-3478.1992; STACHEL SE, 1986, CELL, V46, P325, DOI 10.1016/0092-8674(86)90653-7; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	38	92	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23972	23980						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226939				2022-12-27	WOS:A1993MF29400042
J	SUNDSTROM, M; LINDQVIST, Y; SCHNEIDER, G; HELLMAN, U; RONNE, H				SUNDSTROM, M; LINDQVIST, Y; SCHNEIDER, G; HELLMAN, U; RONNE, H			YEAST TKL1 GENE ENCODES A TRANSKETOLASE THAT IS REQUIRED FOR EFFICIENT GLYCOLYSIS AND BIOSYNTHESIS OF AROMATIC-AMINO-ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PYRUVATE-DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; MIG1 REPRESSOR; ALPHA-SUBUNIT; GLUCOSE; COMPONENT; CLONING; DNA; ENZYMES	A gene encoding transketolase, TKL1, was cloned from the budding yeast Saccharomyces cerevisiae using oligonucleotide primers derived from protein sequence data. The TKL1 sequence predicts a 74-kDa polypeptide which is related to other transketolases. A sequence comparison revealed that the transketolases can be subdivided into three evolutionary branches. We also found that the transketolases are related to another vitamin B1-dependent enzyme: the E1 subunit of pyruvate dehydrogenase from Escherichia coli. Gene disruption and overexpression experiments were used to investigate the function of transketolase in yeast. We found that growth on fermentable carbon sources, but not on gluconeogenic carbon sources, is reduced in cells disrupted for TKL1. This suggests that the glycolytic efficiency is impaired. Growth on fermentable carbon sources is also reduced in cells that overexpress TKL1. Finally, we found that cells disrupted for TKL1 are unable to grow in the absence of aromatic amino acids. This is most likely due to the fact that transketolase is required for the synthesis of erythrose-4-P, a precursor of the aromatic amino acids.	SWEDISH UNIV AGR SCI,UPPSALA BIOMED CTR,DEPT MOLEC BIOL,S-75124 UPPSALA,SWEDEN; UPPSALA BIOMED CTR,LUDWIG INST CANC RES,UPPSALA BRANCH,S-75124 UPPSALA,SWEDEN	Swedish University of Agricultural Sciences; Ludwig Institute for Cancer Research			Lindqvist, Ylva/F-9009-2010	Ronne, Hans/0000-0002-1645-6091; Lindqvist, Ylva/0000-0003-3162-8661; Schneider, Gunter/0000-0003-0622-5713				ABEDINIA M, 1992, BIOCHEM BIOPH RES CO, V183, P1159, DOI 10.1016/S0006-291X(05)80312-2; AGUILERA A, 1986, MOL GEN GENET, V204, P310, DOI 10.1007/BF00425515; BLANSJAAR BA, 1991, J NEUROL SCI, V106, P88, DOI 10.1016/0022-510X(91)90199-H; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; CHEN JH, 1991, J BIOL CHEM, V266, P20447; de la HABA G., 1955, JOUR BIOL CHEM, V214, P409; ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; FLETCHER TS, 1992, BIOCHEMISTRY-US, V31, P1892, DOI 10.1021/bi00121a044; GUBLER CJ, 1991, BIOCHEMISTRY AND PHYSIOLOGY OF THIAMIN DIPHOSPHATE ENZYMES, P311; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; HAWKINS CF, 1990, EUR J BIOCHEM, V191, P337, DOI 10.1111/j.1432-1033.1990.tb19128.x; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; JANOWICZ ZA, 1985, NUCLEIC ACIDS RES, V13, P3043, DOI 10.1093/nar/13.9.3043; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KOCHETOV GA, 1982, METHOD ENZYMOL, V90, P209; KOIKE K, 1988, P NATL ACAD SCI USA, V85, P41, DOI 10.1073/pnas.85.1.41; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; MAITRA PK, 1971, J BACTERIOL, V107, P759, DOI 10.1128/JB.107.3.759-769.1971; MCCOOL BA, 1993, J BIOL CHEM, V268, P1397; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NIXON PF, 1984, ALCOHOL ALCOHOLISM, V19, P219; PAOLETTI F, 1991, J NEUROL SCI, V105, P211, DOI 10.1016/0022-510X(91)90147-Y; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P244; RADNIS BA, 1990, J BACTERIOL, V172, P3669, DOI 10.1128/jb.172.7.3669-3674.1990; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHNEIDER G, 1989, J BIOL CHEM, V264, P21619; SHEU KFR, 1988, ARCH NEUROL-CHICAGO, V45, P841, DOI 10.1001/archneur.1988.00520320027010; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VINOPAL RT, 1975, J BACTERIOL, V122, P1172, DOI 10.1128/JB.122.3.1172-1174.1975; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	35	95	99	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24346	24352						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226984				2022-12-27	WOS:A1993MF29400094
J	CHENCLELAND, TA; BOFFA, LC; CARPANETO, EM; MARIANI, MR; VALENTIN, E; MENDEZ, E; ALLFREY, VG				CHENCLELAND, TA; BOFFA, LC; CARPANETO, EM; MARIANI, MR; VALENTIN, E; MENDEZ, E; ALLFREY, VG			RECOVERY OF TRANSCRIPTIONALLY ACTIVE CHROMATIN RESTRICTION FRAGMENTS BY BINDING TO ORGANOMERCURIAL-AGAROSE MAGNETIC BEADS - A RAPID AND SENSITIVE METHOD FOR MONITORING CHANGES IN HIGHER-ORDER CHROMATIN STRUCTURE DURING GENE ACTIVATION AND REPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME STRUCTURE; C-MYC; AFFINITY-CHROMATOGRAPHY; HISTONE ACETYLATION; SODIUM-BUTYRATE; DNA-SEQUENCES; YEAST; CELLS; FOS; RNA	The unfolding of nucleosomes along transcriptionally active DNA sequences uncovers previously shielded cysteinyl-thiol groups of histone H3 molecules located at the center of the nucleosome core. This change in conformation and SH reactivity of nucleosomes along transcribed DNA sequences makes it possible to separate active from inactive nucleosomes by mercury affinity chromatography. The binding of thiol-reactive nucleosomes to an organomercurial-agarose column has been shown previously to reflect, with accuracy, both the timing and extent of transcription of the associated DNA sequences (Chen, T. A., and Allfrey, V. G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84,5252-5256). Here, we extend this experimental approach to the analysis of higher order chromatin structures. Large chromatin fragments released by treating isolated nuclei with restriction endonucleases are fractionated on mercurated agarose magnetic beads that capture nucleosomes with accessible histone H3 thiols, but do not react with the hidden H3 thiols of the compactly beaded nucleosomes of inactive genes. The SH-reactive domains of c-myc and other genes are rapidly separated from the non-SH-reactive restriction fragments by the magnetic bead technique. The new method also overcomes a major limitation of mercurated agarose column chromatography, which is not suitable for studies of higher order chromatin structure because large chromatin fragments occlude the mercury column; occlusion is not a problem in magnetic separations using suspended mercurated agarose beads. Here, we describe the synthesis of mercurated agarose magnetic beads with high capacity for SH groups and test their application to the recovery of chromatin restriction fragments of c-myc and the growth arrest gene gas1.	ROCKEFELLER UNIV, CELL BIOL LAB, NEW YORK, NY 10021 USA; IST NAZL RIC CANC, I-16132 GENOA, ITALY	Rockefeller University; University of Genoa; IRCCS AOU San Martino IST					NATIONAL CANCER INSTITUTE [R01CA014908] Funding Source: NIH RePORTER; NCI NIH HHS [CA14908] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALFAGEME CR, 1974, J BIOL CHEM, V249, P3729; ALLEGRA P, 1987, J MOL BIOL, V196, P379, DOI 10.1016/0022-2836(87)90698-X; ALLFREY VG, 1991, METHOD CELL BIOL, V35, P315; BODE J, 1980, EUR J BIOCHEM, V110, P143, DOI 10.1111/j.1432-1033.1980.tb04849.x; BOFFA LC, 1981, J BIOL CHEM, V256, P9612; BOFFA LC, 1990, EUR J BIOCHEM, V194, P811, DOI 10.1111/j.1432-1033.1990.tb19474.x; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; BRANDT WF, 1982, EUR J BIOCHEM, V121, P501, DOI 10.1111/j.1432-1033.1982.tb05815.x; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CHAN S, 1988, J BIOL CHEM, V263, P15643; CHEN TA, 1991, J BIOL CHEM, V266, P6489; CHEN TA, 1990, J MOL BIOL, V212, P481, DOI 10.1016/0022-2836(90)90327-I; CHEN TA, 1987, P NATL ACAD SCI USA, V84, P5252, DOI 10.1073/pnas.84.15.5252; CHENCLELAND TA, 1993, J BIOL CHEM, V268, P1118; DAVIE JR, 1981, NUCLEIC ACIDS RES, V9, P3205, DOI 10.1093/nar/9.13.3205; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HEROLD KM, 1988, ONCOGENE, V3, P423; HORZ W, 1976, NUCLEIC ACIDS RES, V3, P3213, DOI 10.1093/nar/3.11.3213; JOHNSON EM, 1987, J BIOL CHEM, V262, P6943; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIPCHITZ L, 1976, CELL, V9, P355, DOI 10.1016/0092-8674(76)90125-2; MANIATIS T, 1975, BIOCHEMISTRY-US, V14, P3787, DOI 10.1021/bi00688a010; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MARDIAN JKW, 1978, BIOCHEMISTRY-US, V17, P3825, DOI 10.1021/bi00611a023; NELSON DA, 1982, J BIOL CHEM, V257, P1565; OLIVA R, 1990, NUCLEIC ACIDS RES, V18, P2739, DOI 10.1093/nar/18.9.2739; PFEIFFER W, 1975, NATURE, V258, P450, DOI 10.1038/258450a0; PRIOR CP, 1983, CELL, V34, P1033, DOI 10.1016/0092-8674(83)90561-5; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; RUIZCARR.A, 1973, ARCH BIOCHEM BIOPHYS, V154, P185, DOI 10.1016/0003-9861(73)90047-7; Sambrook J, 1989, MOL CLONING LABORATO; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOPER TS, 1979, J BIOL CHEM, V254, P901; STERNER R, 1981, J BIOL CHEM, V256, P8892; STERNER R, 1987, NUCLEIC ACIDS RES, V15, P4375, DOI 10.1093/nar/15.11.4375; VICENZ C, 1991, NUCLEIC ACIDS RES, V19, P1325; WALKER J, 1990, J BIOL CHEM, V265, P5736; WORKMAN JL, 1985, BIOCHEMISTRY-US, V24, P4731, DOI 10.1021/bi00339a004; YAU P, 1982, EUR J BIOCHEM, V129, P281, DOI 10.1111/j.1432-1033.1982.tb07050.x	47	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23409	23416						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226865				2022-12-27	WOS:A1993MF51500070
J	DEDMAN, JR; KAETZEL, MA; CHAN, HC; NELSON, DJ; JAMIESON, GA				DEDMAN, JR; KAETZEL, MA; CHAN, HC; NELSON, DJ; JAMIESON, GA			SELECTION OF TARGETED BIOLOGICAL MODIFIERS FROM A BACTERIOPHAGE LIBRARY OF RANDOM PEPTIDES - THE IDENTIFICATION OF NOVEL CALMODULIN REGULATORY PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; BINDING DOMAIN; ACTIVATION; COMPLEX; CONDUCTANCE; ANTIBODY; SKELETAL; CONTAINS; CALCIUM; SURFACE	The interaction of short amino acid sequences is the basis of molecular recognition and biological regulation in many cellular systems. Libraries of random peptides provide an approach to identify peptides that can be used to modulate, in a targeted fashion, the function of specific gene products. We have used a library of random peptides designed and constructed in the M13 bacteriophage to select calcium-dependent calmodulin binding-peptides. Twenty-eight independent sequences were obtained; all contained a tryptophan within the fifteen-amino acid insert. In 11 sequences, the tryptophan was located in the first possible variable position of the inserted sequence and was followed by a proline. The tryptophan-proline combination was also present in six additional isolates but at various other positions within the peptide insert. Synthetic peptides, representative of the calmodulin binding sequences, bound to calmodulin in a calcium-dependent fashion, competed with known calmodulin inhibitors and, when introduced via a patch pipette, inhibited calcium-activated chloride conductance of the colonic epithelial cell line, T84. This report demonstrates the utility of identifying modifiers of biological function and should prove to be a valuable approach in understanding the cellular role of proteins of unknown function.	UNIV CINCINNATI,COLL MED,DEPT PHYSIOL & BIOPHYS,231 BETHESDA AVE,CINCINNATI,OH 45267; UNIV CINCINNATI,COLL MED,DEPT ENVIRONM HLTH,CINCINNATI,OH 45267; UNIV CHICAGO,DEPT NEUROL,CHICAGO,IL 60637	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Chicago			Chan, Hsiao Chang/E-1507-2016					ANDERSON SR, 1986, CALCIUM CELL FUNCTIO, V6, P1; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4618; BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; BLUMENTHAL DK, 1988, BIOCHEM BIOPH RES CO, V156, P860, DOI 10.1016/S0006-291X(88)80923-9; CHAN HC, 1992, J BIOL CHEM, V267, P8411; CHARBONNEAU H, 1991, BIOCHEMISTRY-US, V30, P7931, DOI 10.1021/bi00246a009; CHOU PY, 1978, BIOCHEMISTRY-US, V17, P4277; COX JA, 1985, J BIOL CHEM, V260, P2527; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DEDMAN JR, 1984, ROLE CALCIUM HLTH DI, P135; DEGRADO W, 1985, J CELL BIOCHEM, V29, P89; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAETZEL MA, 1987, J BIOL CHEM, V262, P3726; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KLEE CB, 1988, MOL ASPECTS CELLULAR, V5, P35; KLEVIT RE, 1985, BIOCHEMISTRY-US, V24, P8152, DOI 10.1021/bi00348a047; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; LEACHMAN SA, 1992, J BIOL CHEM, V267, P4930; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEANS AR, 1991, PHARMACOL THERAPEUT, V50, P255, DOI 10.1016/0163-7258(91)90017-G; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; ONEIL KT, 1987, SCIENCE, V236, P1454, DOI 10.1126/science.3589665; PERSECHINI A, 1989, J BIOL CHEM, V264, P8052; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; SCHOPPA N, 1989, J MEMBRANE BIOL, V108, P78; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; WORRELL RT, 1991, AM J PHYSIOL, V260, pC877, DOI 10.1152/ajpcell.1991.260.4.C877; YANG JT, 1986, METHOD ENZYMOL, V130, P208	34	52	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23025	23030						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226817				2022-12-27	WOS:A1993MF51500013
J	KIM, MK; MCCLASKEY, JH; BODENNER, DL; WEINTRAUB, BD				KIM, MK; MCCLASKEY, JH; BODENNER, DL; WEINTRAUB, BD			AN AP-1-LIKE FACTOR AND THE PITUITARY-SPECIFIC FACTOR PIT-1 ARE BOTH NECESSARY TO MEDIATE HORMONAL INDUCTION OF HUMAN THYROTROPIN BETA-GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PIT-1/GHF-1; TRANSDUCTION PATHWAYS CONVERGE; FOS-PROTEIN COMPLEXES; DNA-BINDING ACTIVITY; POU-SPECIFIC DOMAIN; ALPHA-SUBUNIT GENE; THYROID-HORMONE; C-JUN; PHORBOL-ESTER; CYCLIC-AMP	The human thyrotropin beta (hTSHbeta) gene is inducible by various agents including thyrotropin-releasing hormone, phorbol esters, or the adenylyl cyclase activator forskolin. In this study, we have characterized the functional properties of the TGGGTCA motif at -1/+6 of the hTSHbeta gene that is similar to the consensus phorbol ester response element (TRE) or the consensus cyclic AMP response element (CRE). We suggest that both protein kinases C and A as well as TRH share common mediator which recognizes the TGGGTCA element in activating the hTSHbeta promoter. Following stimulation by phorbol esters, forskolin, or TRH, the TGGGTCA-specific factor acts together with the pituitary-specific transcription factor Pit-1 (or GHF-1) bound to upstream sequences at -128 to -61 to mediate the induction of the hTSHbeta promoter. The induction requires that both factors bind to their own binding sites, but Pit-1 neither increases the binding of the TGGGTCA-specific factor to its target sequences nor associates with this factor to form a heterodimer. The TGGGTCA-specific factor is present in three cell lines tested and is composed of protein(s) immunologically related to c-Jun and c-Fos but not to the CRE-binding protein, CREB. By using the hTSHbeta reporter plasmids in which the TGGGTCA element is converted to consensus TRE or CRE motifs, we found that, within the context of the hTSHbeta promoter, the TGGGTCA element is a more potent TRE or CRE than the consensus TRE or CRE sequences. Based upon the results of this study, we propose a model in which the TGGGTCA-specific AP-1-like factor functionally cooperates with the tissue-specific factor Pit-1 to activate the hTSHbeta gene.	NIDDKD,MOLEC & CELLULAR ENDOCRINOL BRANCH,BLDG 10,RM 8014,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUWERX J, 1990, NUCLEIC ACIDS RES, V18, P221, DOI 10.1093/nar/18.2.221; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BENBROOK DM, 1990, ONCOGENE, V5, P295; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNSIDE J, 1989, J BIOL CHEM, V264, P6886; BUSCHER M, 1988, ONCOGENE, V3, P301; CARR FE, 1991, BIOCHEMISTRY-US, V30, P3721, DOI 10.1021/bi00229a019; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; CHEN RP, 1990, NATURE, V346, P583, DOI 10.1038/346583a0; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CONDLIFFE PG, 1979, HORM BLOOD, P499; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1474; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FRANKLYN JA, 1986, J ENDOCRINOL, V111, pR1, DOI 10.1677/joe.0.111R001; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; FURTH J, 1955, RECENT PROG HORM RES, V11, P221; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; GORDON DF, 1992, 74TH END SOC ANN M S; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHUPNIK MA, 1985, J BIOL CHEM, V260, P2900; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P829, DOI 10.1210/mend-4-6-829; SHUPNIK MA, 1986, J BIOL CHEM, V261, P981; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; STEINFELDER HJ, 1992, J CLIN INVEST, V89, P409, DOI 10.1172/JCI115600; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130; STEINFELDER HJ, 1992, P NATL ACAD SCI USA, V89, P5942, DOI 10.1073/pnas.89.13.5942; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56; VERRIJZER CP, 1991, EMBO J, V10, P3007, DOI 10.1002/j.1460-2075.1991.tb07851.x; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; WAEBER G, 1991, MOL ENDOCRINOL, V5, P1418, DOI 10.1210/mend-5-10-1418; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; WOOD WM, 1990, MOL ENDOCRINOL, V4, P1897, DOI 10.1210/mend-4-12-1897; WOOD WM, 1989, J BIOL CHEM, V264, P14840; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0; ZABEL U, 1991, J BIOL CHEM, V266, P252; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	79	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23366	23375						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226861				2022-12-27	WOS:A1993MF51500065
J	LATHAM, GJ; ZHOU, L; HARRIS, CM; HARRIS, TM; LLOYD, RS				LATHAM, GJ; ZHOU, L; HARRIS, CM; HARRIS, TM; LLOYD, RS			THE REPLICATION FATE OF R-STYRENE AND S-STYRENE OXIDE ADDUCTS ON ADENINE N6 IS DEPENDENT ON BOTH THE CHIRALITY OF THE LESION AND THE LOCAL SEQUENCE CONTEXT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; REPAIR; OLIGODEOXYNUCLEOTIDES; O-6-METHYLGUANINE; INSERTION; KINETICS; OLIGONUCLEOTIDE; MUTAGENICITY; MUTAGENESIS; OXIDATION	In order to deduce the biological fate of adducts formed by the reaction of styrene oxide, a suspected carcinogen, with DNA, four oligodeoxynucleotides were synthesized which contained either R- or S-styrene oxide lesions on the N6 position of neighboring adenines within the human N-ras codon 61. When these adducted oligodeoxynucleotides were ligated into the single-stranded vector M13mp7L2 and the modified DNA used to transform repair-deficient Escherichia coli, the resultant plaque-forming abilities were found to vary as much as 300-fold, depending on the stereochemical configuration of the styrene oxide lesion and the sequence context in the vicinity of the damage. The frequency of mutations caused by the various styrene oxide adducts were similarly dependent on both their chirality and local sequence context. Oligodeoxynucleotide templates bearing these same four adducts were also constructed in order to evaluate their replication in vitro by the Klenow fragment. Three of the four styryl-modified templates yielded significant levels of fully extended primer upon polymerization. In contrast, the template containing R-styrene oxide at the second position of N-ras 61 was a very poor substrate for replication, a result which correlates well with the observed lethality of this lesion in vivo.	UNIV TEXAS, MED BRANCH, SEALY CTR MOLEC SCI, GALVESTON, TX 77550 USA; VANDERBILT UNIV, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37235 USA; VANDERBILT UNIV, SCH MED, DEPT CHEM, NASHVILLE, TN 37235 USA; VANDERBILT UNIV, SCH MED, CTR MOLEC TOXICOL, NASHVILLE, TN 37235 USA	University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Vanderbilt University; Vanderbilt University				Lloyd, R. Stephen/0000-0001-7273-372X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES005509, P30ES000267] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00267, ES05355, ES5509] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALLEN DJ, 1989, BIOCHEMISTRY-US, V28, P4601, DOI 10.1021/bi00437a014; BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BISHOP RE, 1991, CHEM RES TOXICOL, V4, P647, DOI 10.1021/tx00024a009; BONATTI S, 1978, MUTAT RES, V52, P295, DOI 10.1016/0027-5107(78)90151-3; BOND JA, 1989, CRC CR REV TOXICOL, V19, P227, DOI 10.3109/10408448909037472; BOROWYBOROWSKI H, 1987, BIOCHEMISTRY-US, V26, P2465, DOI 10.1021/bi00383a010; CMARIK JL, 1992, J BIOL CHEM, V267, P6672; DEMEESTER C, 1977, MUTAT RES, V56, P147, DOI 10.1016/0027-5107(77)90202-0; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; FOUREMAN GL, 1989, J PHARMACOL EXP THER, V248, P492; FUCHS RPP, 1984, J MOL BIOL, V177, P173, DOI 10.1016/0022-2836(84)90063-9; HARRIS CM, 1991, J AM CHEM SOC, V113, P4328, DOI 10.1021/ja00011a044; HEMMINKI K, 1986, J CANCER RES CLIN, V112, P181, DOI 10.1007/BF00395910; HEMMINKI K, 1983, ARCH TOXICOL, V52, P249, DOI 10.1007/BF00316495; HEMMINKI K, 1984, PROG CLIN BIOL RES, V141, P227; HORSFALL MJ, 1990, ENVIRON MOL MUTAGEN, V15, P107, DOI 10.1002/em.2850150208; KAUFMANN WK, 1989, CARCINOGENESIS, V10, P1, DOI 10.1093/carcin/10.1.1; LATIF F, 1988, CHEM RES TOXICOL, V1, P364, DOI 10.1021/tx00006a007; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; NORPPA H, 1981, MUTAT RES, V91, P243, DOI 10.1016/0165-7992(81)90040-3; NORPPA H, 1980, CARCINOGENESIS, V1, P357, DOI 10.1093/carcin/1.4.357; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; RODRIGUEZ H, 1993, CARCINOGENESIS, V14, P373, DOI 10.1093/carcin/14.3.373; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVELA K, 1986, ARCH TOXICOL, P281; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SINGER B, 1991, CARCINOGENESIS, V12, P949; Singer B., 1983, MOL BIOL MUTAGENS CA; TOPAL MD, 1986, J BIOL CHEM, V261, P9879; TOPAL MD, 1988, CARCINOGENESIS, V9, P691, DOI 10.1093/carcin/9.5.691; WADE DR, 1978, MUTAT RES, V58, P217, DOI 10.1016/0165-1218(78)90012-5; 1983, ENV HLTH CRITERIA, V26; 1987, IARC MONOGRAPH EVALU, V7	37	80	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23427	23434						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226868				2022-12-27	WOS:A1993MF51500073
J	LI, H; SCHWARTZ, B; VERTEL, BM				LI, H; SCHWARTZ, B; VERTEL, BM			CDNA CLONING OF CHICK CARTILAGE CHONDROITIN SULFATE (AGGRECAN) CORE PROTEIN AND IDENTIFICATION OF A STOP CODON IN THE AGGRECAN GENE ASSOCIATED WITH THE CHONDRODYSTROPHY, NANOMELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-ANALYSIS; PROTEOGLYCAN; CHONDROCYTES; MICE; SYNTHESIZE; ATTACHMENT; EXPRESSION; MUTATIONS; COLLAGEN; COL2A1	We previously reported the cloning and sequencing of a 1.5-kilobase cDNA which encoded a portion of the chondroitin sulfate domain from the chick cartilage proteoglycan core protein and the localization of a species-specific monoclonal antibody epitope. Using polymerase chain reaction amplification and primer extension, cDNA clones which code for the entire proteoglycan core protein have now been obtained from a 10-day chick embryo cDNA library. The composite sequence is 6464 nucleotides long, coding for a protein of 2109 amino acid residues with a calculated M(r) = 223,500. The overall arrangement of globular and carbohydrate-attachment domains is similar to human and rat chondrosarcoma aggrecan, but there are significant differences in detailed homology between chick and mammalian core proteins. Most significantly a highly repetitive region (19 repeat units of 20 residues each), not found in either human or rat, enlarges one of the characteristic serine-glycine containing regions (designated CS-2) while the other serine-glycine containing domain (designated CS-1) is approximately one-fourth the length of the mammalian CS-1. Analysis of a polymerase chain reaction-amplified fragment encoding the chick-specific repeat region revealed a single base mutation at position 4553 (G to T transversion) that converted the codon GAA for glutamate at amino acid 1513 to TAA, a stop codon, in nanomelic chondrocytes. Genomic DNA from nanomelic liver was also digested with restriction enzyme BsaBI to verify the G to T transversion. This single mutation leads to a shortened core protein precursor with a calculated M(r) = 158,300. The resulting phenotype, nanomelia, arises because the truncated core protein is neither processed to a mature proteoglycan, nor secreted from the chondrocyte.	UNIV CHICAGO,DEPT PEDIAT,5841 S MARYLAND AVE,MC 5058,CHICAGO,IL 60637; UNIV HLTH SCI CHICAGO MED SCH,DEPT CELL BIOL & ANAT,N CHICAGO,IL 60064; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	University of Chicago; Chicago Medical School; University of Chicago					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD009402, R01HD017332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR019622, R01AR019622] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-19622] Funding Source: Medline; NICHD NIH HHS [HD-17332, HD-09402] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; ATWATER JA, 1990, ANNU REV GENET, V24, P519; BALDWIN CT, 1989, J BIOL CHEM, V264, P12747; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BERZ EJ, 1978, CELL, V14, P299; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; BRENNAN MJ, 1983, DEV BIOL, V98, P139, DOI 10.1016/0012-1606(83)90342-1; CHANDRASEKARAN L, 1992, BIOCHEM J, V288, P903, DOI 10.1042/bj2880903; CHEN SZ, 1990, BIOTECHNIQUES, V8, P32; COOPER DN, 1993, ANN MED, V25, P11, DOI 10.3109/07853899309147851; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE K, 1990, EXTRACELLULAR MATRIX, P137; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FOSANG AJ, 1989, BIOCHEM J, V261, P801, DOI 10.1042/bj2610801; HOEKEMA A, 1987, MOL CELL BIOL, V7, P2914, DOI 10.1128/MCB.7.8.2914; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; KRUEGER RC, 1990, J BIOL CHEM, V265, P12088; KRUEGER RC, 1990, J BIOL CHEM, V265, P12075; KRUEGER RC, 1992, J BIOL CHEM, V267, P12149; ODONNELL CM, 1988, J BIOL CHEM, V263, P17749; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; RITTENHOUSE E, 1978, J EMBRYOL EXP MORPH, V43, P71; SAI S, 1986, P NATL ACAD SCI USA, V83, P5081, DOI 10.1073/pnas.83.14.5081; Sambrook J, 1989, MOL CLONING LABORATO; STIRPE NS, 1987, DEV BIOL, V124, P77, DOI 10.1016/0012-1606(87)90461-1; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P589, DOI 10.1016/0003-9861(82)90064-9; TANAKA T, 1988, J BIOL CHEM, V263, P15831; VERTEL BM, 1993, J CELL SCI, V104, P939; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; [No title captured]	34	127	128	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23504	23511						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226878				2022-12-27	WOS:A1993MF51500084
J	DAVLETOV, BA; SUDHOF, TC				DAVLETOV, BA; SUDHOF, TC			A SINGLE C2 DOMAIN FROM SYNAPTOTAGMIN-I IS SUFFICIENT FOR HIGH-AFFINITY CA2+/PHOSPHOLIPID BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLUTATHIONE-S-TRANSFERASE; TRANSMITTER RELEASE; ESCHERICHIA-COLI; ACTIVE ZONES; EXPRESSION; CALCIUM; RECEPTOR; FAMILY; P65	Synaptotagmin I is a Ca2+- and phospholipid-binding protein of synaptic vesicles with an essential function in neurotransmission. Ca2+/phospholipid binding by synaptotagmin I may be mediated by its C2 domains, sequence motifs that have been implicated in the Ca2+ regulation of a variety of proteins. However, it is currently unknown if C2 domains are sufficient for Ca2+/phospholipid binding or if they even directly participate in Ca2+/phospholipid binding. In order to address this question, we have studied the Ca2+/phospholipid-binding properties of the first C2 domain of synaptotagmin I. Our results show that this C2 domain by itself binds Ca2+ and phospholipids with high affinity (half-maximal binding at 4-6 muM free Ca2+) and exhibits strong positive cooperativity. The C2 domain is specific for negatively charged phospholipids and for those divalent cations that are known to stimulate synaptic vesicle exocytosis (Ca2+ > Sr2+, Ba2+ >>> Mg2+). These studies establish that C2 domains can serve as independently folding Ca2+/phospholipid-binding domains. Furthermore, the cation specificity and the cooperativity of Ca2+ binding by the C2 domain from synaptotagmin I support a role for this protein in mediating the Ca2+ signal in neurotransmitter release.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Davletov, Bazbek/ABA-8569-2021	Davletov, Bazbek/0000-0003-4658-3275				AKITA Y, 1990, J BIOL CHEM, V265, P354; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BAZZI MD, 1990, BIOCHEMISTRY-US, V29, P7624, DOI 10.1021/bi00485a012; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LUO JH, 1993, J BIOL CHEM, V268, P3715; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; ONO Y, 1988, J BIOL CHEM, V263, P6927; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	35	421	432	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26386	26390						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253763				2022-12-27	WOS:A1993MK42500057
J	GUILLOT, D; LAVERGNE, JP; REBOUD, JP				GUILLOT, D; LAVERGNE, JP; REBOUD, JP			TRP(221) IS INVOLVED IN THE PROTECTIVE EFFECT OF ELONGATION-FACTOR EEF-2 ON THE RICIN ALPHA-SARCIN SITE OF THE RIBOSOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR-II; EUKARYOTIC RIBOSOMES; BINDING PROTEINS; CDNA SEQUENCE; RNA; ACID; MECHANISM; TRANSLOCATION; GTP	Elongation factor eEF-2 treated by N-bromosuccinimide under conditions which oxidize 2 Trp residues (Trp343 and Trp221) is inactivated in ribosome-dependent GTP hydrolysis and polyphenylalanine synthesis, and inactivation correlates with the specific oxidation of Trp221 (Guillot, D., Penin, F., Di Pietro, A., Sontag, B., Lavergne, J. P., and Reboud, J. P. (1993) J. Biol. Chem. 268, 20911-20916). It is shown here that this oxidation prevents neither GTP binding to eEF-2 nor the formation of the ribosome-eEF-2-GPP(NH)P complex, but that oxidized eEF-2 is no longer able to protect ribosomes against ricin inactivation. These observations suggest that Trp221 or an amino-acid sequence containing this residue interacts with the 28 S rRNA loop including the GAGA sequence, which is the target of ricin. Such a hypothesis is discussed in relation with data on RNA recognition motifs described in different proteins.	CNRS, INST BIOL & CHIM PROT, BIOCHIM MED LAB, 7 PASSAGE VERCORS, F-69367 LYON 07, FRANCE	Centre National de la Recherche Scientifique (CNRS)								BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRIGOTTI M, 1989, BIOCHEM J, V257, P723, DOI 10.1042/bj2570723; CONQUET F, 1987, EUR J BIOCHEM, V163, P15, DOI 10.1111/j.1432-1033.1987.tb10730.x; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1982, J BIOL CHEM, V257, P9054; FERNANDEZPUENTES C, 1976, EUR J BIOCHEM, V64, P437, DOI 10.1111/j.1432-1033.1976.tb10320.x; GUILLOT D, 1993, J BIOL CHEM, V268, P20911; HOFFMAN DW, 1991, P NATL ACAD SCI USA, V88, P2495, DOI 10.1073/pnas.88.6.2495; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; KOHNO K, 1986, P NATL ACAD SCI USA, V83, P4978, DOI 10.1073/pnas.83.14.4978; LAVERGNE JP, 1990, BIOCHIM BIOPHYS ACTA, V1048, P231, DOI 10.1016/0167-4781(90)90061-6; MARZOUKI A, 1989, FEBS LETT, V255, P72, DOI 10.1016/0014-5793(89)81063-4; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; NILSSON L, 1988, EUR J BIOCHEM, V171, P293, DOI 10.1111/j.1432-1033.1988.tb13789.x; NYGARD O, 1984, EUR J BIOCHEM, V140, P93, DOI 10.1111/j.1432-1033.1984.tb08070.x; OLEINIKOV AV, 1989, FEBS LETT, V248, P131, DOI 10.1016/0014-5793(89)80447-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONTAG B, 1993, BIOCHEMISTRY-US, V32, P1976, DOI 10.1021/bi00059a014; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; [No title captured]	20	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26082	26084						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253723				2022-12-27	WOS:A1993MK42500014
J	MCPHAUL, MJ; DESLYPERE, JP; ALLMAN, DR; GERARD, RD				MCPHAUL, MJ; DESLYPERE, JP; ALLMAN, DR; GERARD, RD			THE ADENOVIRUS-MEDIATED DELIVERY OF A REPORTER GENE PERMITS THE ASSESSMENT OF ANDROGEN RECEPTOR FUNCTION IN GENITAL SKIN FIBROBLAST-CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							D-DEPENDENT RICKETS; BINDING DOMAIN; RESISTANCE; MUTATIONS; PATIENT	Defects in the androgen receptor cause a spectrum of abnormalities in genetic males ranging from phenotypic women with testicular feminization to men with minor defects in fertility and/or virilization. The diagnosis of androgen resistance can be quite cumbersome, including analysis of the family history, karyotyping, endocrine studies, measurement of androgen binding in genital skin fibroblasts, and, in some instances, sequencing of mutant cDNAs. Furthermore, androgen-binding studies may be normal in patients with qualitative receptor abnormalities or mutations in the DNA-binding domain of the receptor. To circumvent these difficulties, we have used a recombinant adenovirus to deliver an androgen-responsive reporter gene (mouse mammary tumor virusluciferase) to fibroblasts cultured from genital skin from 12 normal controls and from eight individuals with complete testicular feminization. Following incubation with androgen (2 nM mibolerone) for 72 h, luciferase activity in normal fibroblasts increased >10-fold (range 11-200-fold) in a manner that corresponded with the level of androgen receptor detected in ligand-binding assays. By contrast, luciferase activity increased negligibly in fibroblasts from individuals with testicular feminization (average = 1.2-fold increase). This assay permits a direct assessment of endogenous androgen receptor function in cells and should be a powerful aid in the diagnosis of androgen resistance.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	MCPHAUL, MJ (corresponding author), UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235, USA.		McPhaul, Michael/AAC-7124-2020					[Anonymous], METABOLIC BASIS INHE; CHEN TL, 1984, J CLIN ENDOCR METAB, V59, P383, DOI 10.1210/jcem-59-3-383; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; French F S, 1990, Recent Prog Horm Res, V46, P1; GAMBLIN GT, 1985, J CLIN INVEST, V75, P954, DOI 10.1172/JCI111796; GRIFFIN JE, 1983, J CLIN INVEST, V72, P1190, DOI 10.1172/JCI111074; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCELLI M, 1990, J CLIN INVEST, V85, P1522, DOI 10.1172/JCI114599; MCPHAUL MJ, 1992, J CLIN INVEST, V90, P2097, DOI 10.1172/JCI116093; MCPHAUL MJ, 1993, J CLIN ENDOCR METAB, V76, P17, DOI 10.1210/jc.76.1.17; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PINSKY L, 1992, CLIN INVEST MED, V15, P456; SHIH W, 1991, MOL ENDOCRINOL, V5, P300; Siegel S., 1956, NONPARAMETRIC STAT B; ZOPPI S, 1993, J CLIN INVEST, V91, P1105, DOI 10.1172/JCI116269; ZOPPI S, 1992, MOL ENDOCRINOL, V6, P409, DOI 10.1210/me.6.3.409	18	31	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26063	26066						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253718				2022-12-27	WOS:A1993MK42500009
J	OFFENZELLER, M; SU, Z; SANTER, G; MOSER, H; TRABER, R; MEMMERT, K; SCHNEIDERSCHERZER, E				OFFENZELLER, M; SU, Z; SANTER, G; MOSER, H; TRABER, R; MEMMERT, K; SCHNEIDERSCHERZER, E			BIOSYNTHESIS OF THE UNUSUAL AMINO-ACID (4R)-4-[(E)-2-BUTENYL]-4-METHYL-L-THREONINE OF CYCLOSPORINE-A - IDENTIFICATION OF 3(R)-HYDROXY-4(R)-METHYL-6(E)-OCTENOIC ACID AS A KEY INTERMEDIATE BY ENZYMATIC IN-VITRO SYNTHESIS AND BY IN-VIVO LABELING TECHNIQUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION CULTURES; POLYKETIDE BIOSYNTHESIS; 6-METHYLSALICYLIC ACID; PETROSELINUM-HORTENSE; SUBSTRATE-SPECIFICITY; FLAVANONE SYNTHASE; SYNTHETASE; DERIVATIVES; GENES	The biosynthesis of (4R)-4-[(E)-2-butenyl]-4-methyl-L-threonine (abbreviation: Bmt, systematic name: 2(S)-amino-3(R)-hydroxy-4(R)-methyl-6(E)-octenoic acid) is proposed to involve two principal phases: the formation of a polyketide backbone and a subsequent transformation process to the final product. Here we report on the identification of 3(R)-hydroxy-4(R)-methyl-6(E)-octenoic acid as the end product of the first phase. The primary indication of 3(R)-hydroxy-4(R)-methyl-6(E)-octenoic acid as the key intermediate in the proposed biosynthetic route came from in vivo labeling studies with [1-C-13, O-18(2)]acetate, demonstrating retention of O-18 in the 3-hydroxy group. Final identification of this intermediate in in vitro polyketide assays with enriched enzyme fractions of Tolypocladium niveum was achieved after development of highly sensitive and specific detection methods and by use of synthetic reference substances. Two additional methylated in vitro products could be detected and characterized as 4(R)-methyl-(E,E)-2,6-octadienoic acid and 4(R)-methyl-6(E)-octenoic acid by liquid chromatography-mass spectrometry analysis and comparison with synthetic reference samples. Their relevance for Bmt biosynthesis is discussed. Bmt polyketide synthase shows optimal activity at substrate concentrations of 200 muM acetyl-CoA, 150 muM malonyl-CoA, and 200 muM S-adenosylmethionine, around pH 7 and at 35-degrees-C. Interestingly the Bmt backbone is released from the enzyme as a coenzyme A thioester, suggesting that subsequent transformation to Bmt takes place upon this activated intermediate.	BIOCHEMIE GMBH,RES & DEV,A-6250 KUNDL,AUSTRIA; SANDOZ PHARMA LTD,ANALYT RES & DEV,CH-4002 BASEL,SWITZERLAND; SANDOZ PHARM LTD,PRECLIN RES,CH-4002 BASEL,SWITZERLAND	Novartis; Sandoz; Novartis; Sandoz								BOREL JF, 1989, PHARMACOL REV, V41, P259; DIMROTH P, 1970, EUR J BIOCHEM, V13, P98, DOI 10.1111/j.1432-1033.1970.tb00904.x; DIMROTH P, 1976, EUR J BIOCHEM, V68, P591, DOI 10.1111/j.1432-1033.1976.tb10847.x; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; EVANS DA, 1986, J AM CHEM SOC, V108, P6757, DOI 10.1021/ja00281a049; FEUTREN G, 1989, CURR OPIN IMMUNOL, V2, P239, DOI 10.1016/0952-7915(89)90194-5; FLIRI HG, 1990, BIOCH PEPTIDE ANTIBI, P246; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; HRAZDINA G, 1976, ARCH BIOCHEM BIOPHYS, V175, P392, DOI 10.1016/0003-9861(76)90526-9; JORDAN PM, 1993, BIOCHEM SOC T, V21, P222, DOI 10.1042/bst0210222; KOBEL H, 1983, EXPERIENTIA, V39, P873, DOI 10.1007/BF01990413; KREUZALER F, 1975, EUR J BIOCHEM, V56, P205, DOI 10.1111/j.1432-1033.1975.tb02223.x; KURAOSAKI F, 1993, ARCH BIOCHEM BIOPHYS, V300, P157; LANZ T, 1991, J BIOL CHEM, V266, P9971; LAWEN A, 1989, J ANTIBIOT, V42, P1283, DOI 10.7164/antibiotics.42.1283; LAWEN A, 1990, J BIOL CHEM, V265, P11355; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; MICHAL G, 1985, METHOD ENZYMAT AN, V7, P165; OHagan D., 1991, POLYKETIDE METABOLIT; OPPOLZER W, 1992, TETRAHEDRON LETT, V33, P2439, DOI 10.1016/S0040-4039(00)92209-3; OPPOLZER W, 1992, TETRAHEDRON LETT, V595, P155; PFLUGL G, 1993, NATURE, V361, P91, DOI 10.1038/361091a0; RICHARDSON DE, 1992, J CHROMATOGR, V595, P155, DOI 10.1016/0021-9673(92)85157-O; ROBINSON JA, 1991, PHILOS T ROY SOC B, V332, P107, DOI 10.1098/rstb.1991.0038; SCHUZ R, 1983, J BIOL CHEM, V258, P6730; SENN H, 1991, EUR J BIOCHEM, V199, P653, DOI 10.1111/j.1432-1033.1991.tb16167.x; SIMPSON TJ, 1987, CHEM SOC REV, V16, P123, DOI 10.1039/cs9871600123; SIMPSON TJ, 1987, NAT PROD REP, V4, P239; SPENCER JB, 1992, BIOCHEM J, V288, P839, DOI 10.1042/bj2880839; STROHL WR, 1991, J IND MICROBIOL, V7, P163, DOI 10.1007/BF01575879; THERIAULT Y, 1993, NATURE, V361, P88, DOI 10.1038/361088a0; VONWARTBURG A, 1986, PROG ALLERGY, V38, P28; [No title captured]	33	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26127	26134						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253730				2022-12-27	WOS:A1993MK42500021
J	PICCIOTTO, MR; CZERNIK, AJ; NAIRN, AC				PICCIOTTO, MR; CZERNIK, AJ; NAIRN, AC			CALCIUM CALMODULIN-DEPENDENT PROTEIN KINASE-I - CDNA CLONING AND IDENTIFICATION OF AUTOPHOSPHORYLATION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; PHOSPHORYLATION SITES; CATALYTIC SUBUNIT; INTRASTERIC REGULATION; CONSERVED FEATURES; SEQUENCE-ANALYSIS; BINDING DOMAIN; SMOOTH-MUSCLE; SYNAPSIN-I; CYCLIC-AMP	Ca2+/calmodulin-dependent protein kinase I (CaM kinase I) was previously purified from bovine brain (Nairn, A. C., and Greengard, P. (1987) J. Biol. Chem. 262, 7273-7281) based on its ability to phosphorylate the synaptic vesicle protein, synapsin I at site 1. The cDNA for this protein kinase has now been cloned from both a rat and a bovine brain cDNA library and the complete amino acid sequence of rat CaM kinase I determined. The rat cDNA encoded a protein of 331 amino acids with a calculated M(r) of 37,545, and the encoded kinase was expressed in bacteria as a glutathione S-transferase fusion protein. The resulting fusion protein was purified by Sepharose-CaM affinity chromatography and shown to be totally dependent on Ca2+ and CaM for activity. Furthermore, the purified kinase phosphorylates synapsin I at the same site (site 1) as the endogenous brain enzyme. CaM kinase I is homologous to other known protein kinases and contains all nine invariant amino acids conserved in the catalytic domain of this class of enzymes. CaM kinase I was most identical to CaM kinase II both in the catalytic domain and in a short region at the COOH-terminal that is predicted to be the calmodulin-binding domain. CaM kinase I appeared to be encoded by a single gene. RNase protection assays detected the mRNA encoding CaM kinase I in all tissues examined. High concentrations of the kinase mRNA were found in all regions of the brain with frontal cortex showing the greatest level. CaM kinase I was autophosphorylated in a Ca2+/CaM-dependent manner at a threonyl residue (Thr-177) which is located at a position equivalent to that of the threonyl residue (Thr-197) autophosphorylated in cAMP-dependent protein kinase.	ROCKEFELLER UNIV, MOLEC & CELLULAR NEUROSCI LAB, 1230 YORK AVE, NEW YORK, NY 10021 USA	Rockefeller University			Picciotto, Marina R./F-8747-2012	Picciotto, Marina R./0000-0002-4404-1280; Nairn, Angus/0000-0002-7075-0195				ALBAZZAZ F, 1981, EXP LUNG RES, V2, P121, DOI 10.3109/01902148109052308; BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; BAGCHI IC, 1992, MOL ENDOCRINOL, V6, P621, DOI 10.1210/me.6.4.621; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; Campbell A.K, 1983, INTRACELLULAR CALCIU; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18146; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DAVIS TN, 1992, CELL, V71, P557, DOI 10.1016/0092-8674(92)90590-9; DEREMER MF, 1992, J BIOL CHEM, V267, P13460; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; GRAND RJA, 1979, BIOCHEM J, V177, P521, DOI 10.1042/bj1770521; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; GUERRIERO V, 1986, BIOCHEMISTRY-US, V25, P8372, DOI 10.1021/bi00374a007; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1991, METHOD ENZYMOL, V200, P525; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; HUTTNER WB, 1981, J BIOL CHEM, V256, P1482; HUTTNER WB, 1979, P NATL ACAD SCI USA, V76, P5402, DOI 10.1073/pnas.76.10.5402; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8983, DOI 10.1073/pnas.85.23.8983; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRETSINGER RH, 1992, SCIENCE, V258, P50, DOI 10.1126/science.1439768; KWIATKOWSKI AP, 1990, BIOCHEMISTRY-US, V29, P153, DOI 10.1021/bi00453a019; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; MEANS AR, 1991, ADV EXP MED BIOL, V304, P11; MIYANO O, 1992, J BIOL CHEM, V267, P1198; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NAIRN AC, 1990, ADV SEC MESS PHOSPH, V24, P202; OHMSTEDE CA, 1991, P NATL ACAD SCI USA, V88, P5784, DOI 10.1073/pnas.88.13.5784; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; REDEREMER MF, 1992, J BIOL CHEM, V267, P13466; Sambrook J, 1989, MOL CLONING LABORATO; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENOLIKAR S, 1991, ADV 2ND MESSENGER PH, V23, P1; SILVA EFD, 1987, FEBS LETT, V220, P36, DOI 10.1016/0014-5793(87)80871-2; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; TAKIO K, 1986, BIOCHEMISTRY-US, V25, P8049, DOI 10.1021/bi00372a038; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; WILUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226	59	96	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26512	26521						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253780				2022-12-27	WOS:A1993MK42500074
J	PLAAS, AHK; WONGPALMS, S				PLAAS, AHK; WONGPALMS, S			BIOSYNTHETIC MECHANISMS FOR THE ADDITION OF POLYLACTOSAMINE TO CHONDROCYTE FIBROMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; KERATAN SULFATE PROTEOGLYCAN; POLY-N-ACETYLLACTOSAMINE; ENDO-BETA-GALACTOSIDASE; CORNEAL STROMA; LINKED OLIGOSACCHARIDES; ESCHERICHIA-FREUNDII; LINKAGE REGION; CORE PROTEIN; CHICK	The cartilage matrix glycoprotein fibromodulin contains four N-linked glycosylation sites which act as acceptors for the addition of sulfated polylactosamine (keratan sulfate). In the present study we examined the biosynthetic processing of these N-linked oligosaccharides for subsequent addition of polylactosamine. Chondrocytes were treated with castanospermine, 1-(+)deoxymannojirimycin, and swainsonine, radiolabeled with [3,4,5-H-2]leucine, [2-H-1]mannose, or [6-H-3]glucosamine, and newly synthesized fibromodulin was immunoprecipitated for analysis. Castanospermine and 1-(+)deoxymannojirimycin inhibited polylactosamine addition, whereas swainsonine was not effective. This indicated that the linkage regions must be processed to GlcNAc(Man)5(GlcNAc)2Asn but do not require further modification to GlcNAc(Man)3(GlcNAc)2Asn. In both control and swainsonine-treated cells one or two N-linked oligosaccharides per molecule were modified with polylactosamine containing 4-6 repeating disaccharide units. Moreover, a single short chain was added either to the C-3 or the C-6 branch in control cultures, whereas only the C-3 branch was substituted in the presence of swainsonine. Analysis of endo-beta-galactosidase and keratanase II digestion products of the polylactosamine chains synthesized in both culture conditions showed that only about 25% of the hexosamine residues and less than 5% of the adjacent galactose residues were substituted with sulfate. These findings are discussed in relation to the regulation of fibromodulin glycosylation and the likely influence of polylactosamine structure on the extracellular interactions and turnover of fibromodulin.	UNIV S FLORIDA, SCH MED, DEPT BIOCHEM & MOLEC BIOL, TAMPA, FL 33620 USA	State University System of Florida; University of South Florida	PLAAS, AHK (corresponding author), SHRINERS HOSP CRIPPLED CHILDREN, CELL BIOL LAB, TAMPA UNIT, 12502 N PINE DR, TAMPA, FL 33612 USA.							ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; AXELSSON I, 1975, BIOCHEM J, V145, P4914; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; COSSU G, 1983, J BIOL CHEM, V258, P5603; DEAN JW, 1990, J BIOL CHEM, V265, P12553; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FODDY L, 1986, BIOCHEM J, V233, P697, DOI 10.1042/bj2330697; FUKUDA M, 1985, Biochimica et Biophysica Acta, V780, P119; FUKUDA M, 1988, J BIOL CHEM, V263, P5314; FUKUDA M, 1984, J BIOL CHEM, V259, P4782; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GREGORY JD, 1982, J BIOL CHEM, V257, P6965; HART GW, 1978, J BIOL CHEM, V253, P5795; HASSELL JR, 1979, J BIOL CHEM, V254, P2346; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; HOPWOOD JJ, 1983, CARBOHYD RES, V117, P263, DOI 10.1016/0008-6215(83)88092-6; HUMPHRIES MJ, 1986, CANCER RES, V46, P5215; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LEE N, 1990, J BIOL CHEM, V265, P20476; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; MIDURA RJ, 1989, J BIOL CHEM, V264, P1423; Nakazawa K., 1989, KERATAN SULPHATE CHE, P99; NILSSON B, 1983, J BIOL CHEM, V258, P6056; OEBEN M, 1987, BIOCHEM J, V248, P85, DOI 10.1042/bj2480085; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; PLAAS AHK, 1990, J BIOL CHEM, V265, P20634; PLAAS AHK, 1992, TRENDS GLYCOSCI GLYC, V4, P445; RADA JA, 1991, INVEST OPHTH VIS SCI, V32, P1010; SAITOH O, 1992, J BIOL CHEM, V267, P5700; SATO S, 1992, J BIOL CHEM, V267, P6983; SCHRECENGOST PK, 1992, ARCH BIOCHEM BIOPHYS, V292, P54, DOI 10.1016/0003-9861(92)90050-7; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; Stuhlsatz H.W., 1989, KERATAN SULPHATE PRO, P1; THORPE SJ, 1988, DEVELOPMENT, V102, P193; VANDENEIJNDEN DH, 1988, J BIOL CHEM, V263, P12461; WANG WC, 1991, J BIOL CHEM, V266, P23185; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; ZHU BCR, 1985, J BIOL CHEM, V260, P4041	45	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26634	26644						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253794				2022-12-27	WOS:A1993MK42500090
J	BARTLEY, GE; SCOLNIK, PA				BARTLEY, GE; SCOLNIK, PA			CDNA CLONING, EXPRESSION DURING DEVELOPMENT, AND GENOME MAPPING OF PSY2, A 2ND TOMATO GENE ENCODING PHYTOENE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAROTENOID BIOSYNTHESIS PATHWAY; LYCOPERSICON-ESCULENTUM; ANTISENSE RNA; ENZYME	The enzyme phytoene synthase (Psy) catalyzes the formation of phytoene, an intermediate in the carotenoid biosynthesis pathway. Expression of a previously described gene (PSY1) is induced by fruit ripening in tomato (Lycopersicon esculentum). We describe here the cloning of a partial cDNA for PSY2, a gene related to PSY1. A plasmid containing the PSY2 coding region under control of a bacterial promoter complements a Rhodobacter capsulatus phytoene synthase mutant, indicating that this gene has the capacity to encode an active enzyme. We used reverse transcriptase-polymerase chain reaction followed by digestion with a restriction enzyme to determine that both PSY1 and PSY2 are expressed during tomato development. PSY1 transcripts predominate in seedlings and in late stages of fruit ripening, whereas PSY2 transcripts are relatively more abundant in mature leaves. Both genes are expressed under photooxidative conditions induced by treatment with the carotenoid biosynthesis inhibitor Norflurazon. We used polymerase chain reaction-based restriction fragment length polymorphisms and alien addition lines to map PSY2 to chromosome 2. We conclude that PSY2 is a second tomato gene encoding phytoene synthase.	DUPONT CO INC, CENT RES & DEV, EXPTL STN, WILMINGTON, DE 19880 USA	DuPont								ANDERSON IC, 1960, PLANT PHYSIOL, V35, P531, DOI 10.1104/pp.35.4.531; BARTHOLOMEW DM, 1991, PLANT PHYSIOL, V96, P291, DOI 10.1104/pp.96.1.291; BARTLEY GE, 1992, J BIOL CHEM, V267, P5036; BARTLEY GE, 1991, P NATL ACAD SCI USA, V88, P6532, DOI 10.1073/pnas.88.15.6532; BARTLEY GE, 1991, CELL CULTURE SOMAT B, V7, P331; BIRD CR, 1991, BIO-TECHNOL, V9, P635, DOI 10.1038/nbt0791-635; BRAMLEY P, 1992, PLANT J, V2, P343, DOI 10.1111/j.1365-313X.1992.00343.x; DEVERNA JW, 1990, PLANT BIOL, V11, P247; GIULIANO G, 1993, PLANT CELL, V5, P379, DOI 10.1105/tpc.5.4.379; KINZER SM, 1990, THEOR APPL GENET, V79, P489, DOI 10.1007/BF00226158; MAUNDERS MJ, 1987, PLANT CELL ENVIRON, V10, P177; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; PICHERSKY E, 1986, P NATL ACAD SCI USA, V83, P3880, DOI 10.1073/pnas.83.11.3880; RAY J, 1992, PLANT MOL BIOL, V19, P401, DOI 10.1007/BF00023387; RICK CM, 1990, PLANT BIOL, V11, P19; SAGAR AD, 1990, PLANT PHYSIOL, V94, P1663, DOI 10.1104/pp.94.4.1663; TAYLOR WC, 1989, ANNU REV PLANT PHYS, V40, P211, DOI 10.1146/annurev.pp.40.060189.001235; TONKYN JC, 1992, PLANT PHYSIOL, V99, P1403; WILLIAMS MNV, 1991, THEOR APPL GENET, V82, P489, DOI 10.1007/BF00588604	19	119	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25718	25721						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245008				2022-12-27	WOS:A1993MK10000064
J	DIIANNI, CL; MAPELLI, C; DRIER, DA; TSAO, J; NATARAJAN, S; RIEXINGER, D; FESTIN, SM; BOLGAR, M; YAMANAKA, G; WEINHEIMER, SP; MEYERS, CA; COLONNO, RJ; CORDINGLEY, MG				DIIANNI, CL; MAPELLI, C; DRIER, DA; TSAO, J; NATARAJAN, S; RIEXINGER, D; FESTIN, SM; BOLGAR, M; YAMANAKA, G; WEINHEIMER, SP; MEYERS, CA; COLONNO, RJ; CORDINGLEY, MG			IN-VITRO ACTIVITY OF THE HERPES-SIMPLEX VIRUS TYPE-1 PROTEASE WITH PEPTIDE-SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; GENE; CLEAVAGE; IDENTIFICATION; BINDING; VIRION; DOMAIN	Herpes simplex virus type-1 (HSV-1) protease is responsible for proteolytic processing of itself and the virus assembly protein ICP35 (infected cell protein 35). Two proteolytic processing sites within the protease have recently been identified between Ala247 and Ser248 and between Ala610 and Ser611. In this report we demonstrate that peptides corresponding to each of these cleavage sites are substrates for recombinant HSV protease-glutathione S-transferase fusion protein in vitro by high performance liquid chromatography analysis of cleavage reactions. Analysis of the products by fast atom bombardment-mass spectrometry confirmed that cleavage occurred at the expected position between the Ala and Ser residues of the substrate. Peptide cleavage was linear with respect to time and enzyme concentration and proceeded optimally at pH 8.0. A peptide that spans Ala99/Ser100 of the protease but does not correspond to a naturally occurring cleavage site was not a substrate for the protease in vitro confirming that sequence elements outside the conserved dipeptide sequence are required for substrate recognition and cleavage. Identification of P5-P8' as the minimal substrate peptide for the Ala610/Ser611 cleavage site revealed a requirement for residues flanking the conserved core P4-LVNA/S-P1' in substrate recognition and hydrolysis. Kinetic analysis with peptide P5-P8' yielded a K(m) of 190 muM and k(cat) of 0.2 min-1. Experiments with a panel of class-specific protease inhibitors were consistent with the protease being a member of the general class of serine proteases.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT CHEM CARDIOVASC DIS, PRINCETON, NJ 08543 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT ANALYT RES & DEV, PRINCETON, NJ 08543 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	DIIANNI, CL (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT VIROL, POB 4000, PRINCETON, NJ 08543 USA.							BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; BAUM EZ, 1993, J VIROL, V67, P497, DOI 10.1128/JVI.67.1.497-506.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN DK, 1984, J VIROL, V49, P142, DOI 10.1128/JVI.49.1.142-153.1984; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DECKMAN IC, 1992, J VIROL, V66, P7362, DOI 10.1128/JVI.66.12.7362-7367.1992; DIIANNI CL, 1993, J BIOL CHEM, V268, P2048; DREYER GB, 1989, P NATL ACAD SCI USA, V86, P9752, DOI 10.1073/pnas.86.24.9752; GIBSON W, 1972, J VIROL, V10, P1044, DOI 10.1128/JVI.10.5.1044-1052.1972; GIBSON W, 1974, J VIROL, V13, P155, DOI 10.1128/JVI.13.1.155-165.1974; KING J, 1974, NATURE, V251, P1121; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; LIU FY, 1991, J VIROL, V65, P206, DOI 10.1128/JVI.65.1.206-212.1991; LIU FY, 1993, J VIROL, V67, P1300, DOI 10.1128/JVI.67.3.1300-1309.1993; LIU FY, 1992, P NATL ACAD SCI USA, V89, P2076, DOI 10.1073/pnas.89.6.2076; NEWCOMB WW, 1989, J VIROL, V63, P4697, DOI 10.1128/JVI.63.11.4697-4702.1989; PERDUE ML, 1974, VIROLOGY, V59, P201, DOI 10.1016/0042-6822(74)90216-5; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SKOOG M, 1989, CURRENT COMMUNICATIO, P269; STUART JM, 1984, SOLID PHASE PEPTIDE; WEINHEIMER SP, 1993, J VIROL, V67, P5813, DOI 10.1128/JVI.67.10.5813-5822.1993; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792	23	28	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25449	25454						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244978				2022-12-27	WOS:A1993MK10000028
J	GRUPP, SA; CAMPBELL, K; MITCHELL, RN; CAMBIER, JC; ABBAS, AK				GRUPP, SA; CAMPBELL, K; MITCHELL, RN; CAMBIER, JC; ABBAS, AK			SIGNALING-DEFECTIVE MUTANTS OF THE B-LYMPHOCYTE ANTIGEN RECEPTOR FAIL TO ASSOCIATE WITH IG-ALPHA AND IG-BETA/GAMMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TYROSINE PHOSPHORYLATION; CELL-SURFACE; EARLY EVENT; T-CELLS; IMMUNOGLOBULIN; COMPLEX; MB-1; TRANSMEMBRANE; COMPONENTS; GENES	The B cell receptor for antigen, the membrane immunoglobulin (mIg) molecule, is normally expressed in association with at least two other proteins, mb-1 (Ig-alpha) and B29 (Ig-beta/gamma). We have previously described a set of murine B cell clones transfected with wild-type and mutated forms of membrane-bound IgM (mIgM) that vary in their ability to transduce signals to the cell interior. Analysis of the B cell receptor complex in signaling and nonsignaling mutants of mIgM reveals complete concordance between intact signaling ability and ability of the mIgM to associate with Ig-alpha and Ig-beta/gamma. These results point to the importance of the mIgM transmembrane region in mediating binding to accessory molecules, and provide support for a role of Ig-alpha and Ig-beta/gamma that extends beyond surface expression to signal transduction in B lymphocytes.	NATL JEWISH MED CTR,DEPT PEDIAT,DIV BASIC SCI,DENVER,CO 80206; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND	National Jewish Health; Harvard University; Harvard Medical School	GRUPP, SA (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV IMMUNOL RES,BOSTON,MA 02115, USA.			Cambier, John/0000-0002-7803-242X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022802, R01AI021768] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21768, AI22802] Funding Source: Medline; NIGMS NIH HHS [GM47726] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175; CAMPBELL KS, 1991, J IMMUNOL, V147, P1575; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CAMPBELL MA, 1990, EMBO J, V9, P2125, DOI 10.1002/j.1460-2075.1990.tb07381.x; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GRUPP SA, 1987, CELL IMMUNOL, V109, P181, DOI 10.1016/0008-8749(87)90303-0; GRUPP SA, 1985, J IMMUNOL, V134, P4087; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HOMBACH J, 1990, EUR J IMMUNOL, V20, P2795, DOI 10.1002/eji.1830201239; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KASHIWAMURA SI, 1990, J IMMUNOL, V145, P337; MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404; MITCHELL RN, 1991, J BIOL CHEM, V266, P8856; OETTGEN HC, 1986, NATURE, V320, P272, DOI 10.1038/320272a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; VANNOESEL CJM, 1990, EUR J IMMUNOL, V20, P2789, DOI 10.1002/eji.1830201238; VANNOESEL CJM, 1992, J EXP MED, V175, P1511, DOI 10.1084/jem.175.6.1511; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WILLIAMS GT, 1990, J EXP MED, V171, P947, DOI 10.1084/jem.171.3.947	29	64	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25776	25779						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245014				2022-12-27	WOS:A1993MK10000073
J	HASHIMOTO, Y; SEKINE, M; IWASAKI, K; SUZUKI, A				HASHIMOTO, Y; SEKINE, M; IWASAKI, K; SUZUKI, A			PURIFICATION AND CHARACTERIZATION OF UDP-N-ACETYLGALACTOSAMINE G(M3)/G(D3) N-ACETYLGALACTOSAMINYLTRANSFERASE FROM MOUSE-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; EXPRESSION; GM2; GANGLIOSIDE; GD2; PROTEINS; SYNTHASE; ASSAY; BRAIN; GM1B	A UDP-N-acetylgalactosamine: Siaalpha2-3Galbeta1-4Glcbeta1-/Siaalpha2-8Siaalpha2-3Galbeta1-4Glcbeta1-1 ceramide N-acetylgalactosaminyltransferase has been purified to apparent homogeneity from mouse liver. The purification procedure involved differential centrifugation for preparation of Golgi membranes, extraction of the enzyme with Triton X-100, and sequential chromatography on phosphocellulose, UDP-aldehyde adipic acid hydrazone agarose, UDP-hexanolamine-Sepharose, CM-Sepharose, and DEAE-Sepharose. At the phosphocellulose column chromatography step, the recovery of the enzyme activity was less than 25%, but it was enhanced up to 70% when the enzyme assay was performed in the presence of the flow-through fraction from the phosphocellulose column. With this assay, the enzyme activity was found to be quantitatively recovered during all the column chromatographies, the enzyme finally being purified 171,000-fold with a specific activity of 3.6 mumol/min/mg protein. The apparent molecular mass of the purified enzyme is 65,000 daltons. The enzyme exhibits a pH optimum of 7.5-7.9 and requires 2.5-10 mM Mn2+ for the maximal activity. The K(m) value for UDP-N-acetylgalactosamine is 7 muM. Among the glycolipids tested as acceptor substrates, NeuGcalpha2-3Galbeta1-4Glcbeta1-1 ceramide, NeuAcalpha2-3Galbeta1-4Glcbeta1-1 ceramide, NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4Glcbeta1-1 ceramide, and NeuAcalpha2-8NeuAcaalpha2-3Galbeta1-4Glcbeta1-1 ceramide are good ones, the K(m) values for them being 160, 2,100, 27, and 350 muM, respectively, but sialyllactose, NeuAcalpha2-3Galbeta1-4Glc, is not. This suggests that the enzyme recognizes not only the oligosaccharide portion but also the ceramide of gangliosides.	TOKYO METROPOLITAN INST MED SCI,DEPT MEMBRANE BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; TOKYO METROPOLITAN INST MED SCI,DEPT PHYSIOL CHEM,BUNKYO KU,TOKYO 113,JAPAN	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science								BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLANKEN WM, 1985, J BIOL CHEM, V260, P2927; CAHAN LD, 1982, P NATL ACAD SCI-BIOL, V79, P7629, DOI 10.1073/pnas.79.24.7629; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FOLCH J, 1957, J BIOL CHEM, V226, P497; GASA S, 1991, SEIKAGAKU, V63, P788; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANDA S, 1964, JPN J EXP MED, V34, P293; HASHIMOTO Y, 1984, J BIOCHEM-TOKYO, V95, P1543, DOI 10.1093/oxfordjournals.jbchem.a134766; HASHIMOTO Y, 1983, J BIOCHEM-TOKYO, V93, P895, DOI 10.1093/jb/93.3.895; HASHIMOTO Y, 1985, GLYCOCONJUGATE J, V2, P255; HASHIMOTO Y, 1986, SEIKAGAKU, V58, P862; ITOH T, 1981, J BIOL CHEM, V256, P165; KAWANO M, 1989, ANAL BIOCHEM, V182, P9, DOI 10.1016/0003-2697(89)90709-4; KONO M, 1991, J BIOCHEM-TOKYO, V109, P132, DOI 10.1093/oxfordjournals.jbchem.a123333; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDEEN R, 1988, BIOCHEMISTRY-US, V7, P2287; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; MAKITA A, 1963, JPN J EXP MED, V33, P361; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; NAKAMURA K, 1984, J BIOCHEM-TOKYO, V96, P949, DOI 10.1093/oxfordjournals.jbchem.a134954; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P7044, DOI 10.1073/pnas.85.19.7044; PRICE H, 1975, BIOCHEMISTRY-US, V14, P1512, DOI 10.1021/bi00678a026; SEKINE M, 1990, J BIOCHEM-TOKYO, V108, P103, DOI 10.1093/oxfordjournals.jbchem.a123147; SIDDIQUI B, 1971, J BIOL CHEM, V246, P5766; SUZUKI M, 1986, CARBOHYD RES, V151, P213, DOI 10.1016/S0008-6215(00)90342-2; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; SVENNERHOLM L, 1973, J BIOL CHEM, V248, P740; TANIGUCHI N, 1982, J BIOL CHEM, V257, P631; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; Wiegandt H, 1985, GLYCOLIPIDS, V10, P199, DOI DOI 10.1016/S0167-7306(08)60022-8; YAMAKAWA T, 1963, J BIOCHEM, V53, P28, DOI 10.1093/oxfordjournals.jbchem.a127654; YAMAKAWA T, 1951, J BIOCHEM-TOKYO, V38, P199, DOI 10.1093/oxfordjournals.jbchem.a126242; YANAGISAWA K, 1987, BIOCHIM BIOPHYS ACTA, V919, P213, DOI 10.1016/0005-2760(87)90260-8	38	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25857	25864						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245020				2022-12-27	WOS:A1993MK10000083
J	LEE, WNP				LEE, WNP			APPENDIX - ANALYSIS OF TRICARBOXYLIC-ACID CYCLE USING MASS ISOTOPOMER RATIOS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCONEOGENESIS; CARBON	Since the early work by Strisower et al. (1) describing the incorporation of acetate carbon in glucose, models of varying complexity have been developed for the estimation of tracer dilution through the tricarboxylic acid cycle. These models differ from each other in the number of parameters involved and the mathematical technique used (2-4). The models relate the steady state distribution of labeled carbon in oxaloacetate, citrate, glutamate, glucose, or pyruvate from a specifically labeled precursor (acetate or pyruvate labeled in one of its carbons) to rates of several key reactions (parameters) of the tricarboxylic acid cycle. From the experimentally determined distributions of isotope carbon in glucose and other compounds, parameters of tricarboxylic acid cycle metabolism and tracer dilution for gluconeogenesis can be estimated. A typical example is the determination of pyruvate carboxylase flux from the glucose labeling ratio of an experiment using C2-labeled acetate. For complex models having two or more parameters, a solution for these parameters usually requires the determination of isotope distributions in multiple tricarboxylic acid cycle intermediates. The use of precursors jointly labeled in several positions and mass isotopomer analysis offers a new and powerful approach to the study of complex metabolic systems. While singly labeled precursor yields carbon label in a maximum of three distinct positions of glucose (label in C-1, C-2, and C-3), prelabeled lactate potentially gives six labeled species (one mass isotopomer of m3, two positional isotopomers of m2, and three isotopomers of ml) doubling the amount of information from a single experiment. In the sections to follow, we detail the transformation of labeled lactate into the various isotopomers of oxaloacetate (OAA)1 and the three-carbon precursor of glucose (PEP) and present a mathematical model describing the relationship between these isotopomers and the parameters of the tricarboxylic acid cycle. Algebraic solutions of these parameters from mass isotopomers in PEP and lactate are provided.			LEE, WNP (corresponding author), UCLA,HARBOR MED CTR,TORRANCE,CA 90048, USA.							GOEBEL R, 1982, FED PROC, V41, P96; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KATZ J, 1989, J BIOL CHEM, V264, P12994; KATZ J, 1979, TECHNIQUES METABOLIC, P1; KELLEHER JK, 1986, AM J PHYSIOL, V250, pE296, DOI 10.1152/ajpendo.1986.250.3.E296; STRISOWER EH, 1952, J BIOL CHEM, V198, P115	6	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25522	25526						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244987				2022-12-27	WOS:A1993MK10000038
J	PILLOT, T; OUZZINE, M; FOURNELGIGLEUX, S; LAFAURIE, C; RADOMINSKA, A; BURCHELL, B; SIEST, G; MAGDALOU, J				PILLOT, T; OUZZINE, M; FOURNELGIGLEUX, S; LAFAURIE, C; RADOMINSKA, A; BURCHELL, B; SIEST, G; MAGDALOU, J			GLUCURONIDATION OF HYODEOXYCHOLIC ACID IN HUMAN LIVER - EVIDENCE FOR A SELECTIVE ROLE OF UDP-GLUCURONOSYLTRANSFERASE-2B4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE; BILE-ACIDS; RAT-LIVER; STABLE EXPRESSION; CELL-CULTURE; MICROSOMES; GLUCURONYLTRANSFERASE; PURIFICATION; BILIRUBIN; CLONING	Monospecific polyclonal antibodies were raised against a variable amino-terminal domain (amino acids 14-150) of a human liver form of UDP-glucuronosyltransferase conjugating bile acids, UGT2B4 (Jackson, M. R., McCarthy, L. R., Harding, D., Wilson, S., Coughtrie, M. W., and Burchell, B. (1987) Biochem. J. 242, 581-588), expressed as a fusion protein in Escherichia coli. The antibodies were able to recognize the protein, stably expressed in a genetically engineered eukaryotic V79 cell line, against which they were directed. The specificity of these antibodies allowed their use for analyzing the substrate specificity of this isoform in human liver, as well as for determining its contribution to the total hepatic and extra-hepatic glucuronidation of hyodeoxycholic acid. Western blot analysis of microsomal proteins demonstrated the presence of UGT2B4 exclusively in human liver and not in human kidney. In human liver microsomes, the antibodies were able to inhibit and precipitate up to 90% of the total hyodeoxycholic acid 6-O-glucuronidation activity, but had no effect on activities toward several other substrates, such as phenols, bilirubin, or other bile acids, especially hyocholic acid and the steroids 4-hydroxyestrone and estriol. Moreover, Western blot analysis and immunoinhibition studies of human liver microsomes from healthy patients and from patients presenting liver diseases revealed a good correlation between the glucuronidation rate of hyodeoxycholic acid and the UGT2B4 expression level. The absence of immunoinhibition of hyodeoxycholic acid conjugation with UDP sugars other than UDP-glucuronic acid suggests the involvement of different enzymatic systems in the glucosidation and xylosylation of hyodeoxycholic acid. Altogether, the results provided strong evidence for the specific and predominant involvement of UGT2B4 in the 6-O-glucuronidation of this bile acid via a UDP-glucuronic acid-dependent mechanism.	FAC SCI PHARMACEUT & BIOL NANCY,CTR MEDICAMENT,CNRS,URA 597,30 RUE LIONNOIS,F-54000 NANCY,FRANCE; UNIV ARKANSAS MED SCI HOSP,DEPT INTERNAL MED,LITTLE ROCK,AR 72205; UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT BIOCHEM MED,DUNDEE DD1 9SY,SCOTLAND	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Arkansas System; University of Arkansas Medical Sciences; University of Dundee			Ouzzine, Mohamed/G-4368-2013	SIEST, Gerard/0000-0002-3001-760X; OUZZINE, Mohamed/0000-0003-0058-4950	NIDDK NIH HHS [DK-38678] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038678] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALME B, 1980, J STEROID BIOCHEM, V13, P907, DOI 10.1016/0022-4731(80)90164-8; ALME B, 1978, CLIN CHIM ACTA, V86, P251, DOI 10.1016/0009-8981(78)90379-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCHELL B, 1991, DNA CELL BIOL, V10, P487, DOI 10.1089/dna.1991.10.487; BURCHELL B, 1989, PHARMACOL THERAPEUT, V43, P261, DOI 10.1016/0163-7258(89)90122-8; COFFMAN BL, 1990, ARCH BIOCHEM BIOPHYS, V281, P170, DOI 10.1016/0003-9861(90)90428-2; DRAGACCI S, 1987, EUR J CLIN PHARMACOL, V32, P485, DOI 10.1007/BF00637675; DRAKE RR, 1992, J BIOL CHEM, V267, P11360; Dutton G.F., 1980, GLUCURONIDATION DRUG; FOURNELGIGLEUX S, 1991, MOL PHARMACOL, V39, P177; FOURNELGIGLEUX S, 1989, FEBS LETT, V243, P119, DOI 10.1016/0014-5793(89)80111-5; HEIRWEGH KP, 1972, BIOCHEM J, V129, P605, DOI 10.1042/bj1290605; HERBER R, 1992, BIOCHIM BIOPHYS ACTA, V1139, P20, DOI 10.1016/0925-4439(92)90077-Z; IRSHAID Y, 1991, PHARMACOL TOXICOL, V68, P212, DOI 10.1111/j.1600-0773.1991.tb01225.x; IRSHAID YM, 1987, MOL PHARMACOL, V31, P27; JACKSON MR, 1987, BIOCHEM J, V242, P581, DOI 10.1042/bj2420581; JIN CJ, 1993, J PHARMACOL EXP THER, V264, P475; KIRKPATRICK RB, 1985, J LIPID RES, V26, P1431; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; Maniatis T., 1982, MOL CLONING; MARSCHALL HU, 1987, BIOCHIM BIOPHYS ACTA, V921, P392, DOI 10.1016/0005-2760(87)90041-5; Marston F. A. O., 1987, DNA CLONING, P59; MATERN H, 1991, EUR J BIOCHEM, V200, P393, DOI 10.1111/j.1432-1033.1991.tb16197.x; NILSSON B, 1985, EMBO J, V4, P1075, DOI 10.1002/j.1460-2075.1985.tb03741.x; OTANI G, 1976, BIOCHEM PHARMACOL, V25, P1293, DOI 10.1016/0006-2952(76)90092-7; PARQUET M, 1985, FEBS LETT, V189, P183, DOI 10.1016/0014-5793(85)81020-6; PARQUET M, 1988, EUR J BIOCHEM, V171, P329, DOI 10.1111/j.1432-1033.1988.tb13794.x; PARQUET M, 1985, FALK S, V40, P411; RADOMINSKA A, 1993, J BIOL CHEM, V268, P15127; RADOMINSKA A, 1988, J LIPID RES, V29, P501; RADOMINSKA A, 1990, FASEB J, V4, pA1972; RADOMINSKA A, 1990, FALK S; RADOMINSKA A, 1991, BILE ACIDS THERAPEUT, P99; RADOMINSKAPYREK A, 1987, J CLIN INVEST, V80, P234, DOI 10.1172/JCI113053; RADOMINSKAPYREK A, 1986, J LIPID RES, V27, P89; RITTER JK, 1992, BIOCHEMISTRY-US, V31, P3409, DOI 10.1021/bi00128a015; RITTER JK, 1990, J BIOL CHEM, V265, P7900; TEPHLY TR, 1990, CHEM RES TOXICOL, V3, P509, DOI 10.1021/tx00018a004; UHLEN M, 1984, J BIOL CHEM, V259, P1695; VANES HHG, 1990, J CLIN INVEST, V85, P1199, DOI 10.1172/JCI114553; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465; YOKOTA H, 1992, J BIOCHEM, V112, P192, DOI 10.1093/oxfordjournals.jbchem.a123876	43	80	80	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25636	25642						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244999				2022-12-27	WOS:A1993MK10000053
J	RINGEISEN, F; REYCAMPOS, J; YANIV, M				RINGEISEN, F; REYCAMPOS, J; YANIV, M			THE TRANSACTIVATION POTENTIAL OF VARIANT HEPATOCYTE NUCLEAR FACTOR-I IS MODIFIED BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; FACTOR-I; EXPRESSION; HNF1; DOMAIN; CELLS; TRANSCRIPTION; GENE; HOMEOPROTEIN; DIMERIZATION	Two forms of the transcription factor vHNF1 (HNF1beta or LFB3) have been previously described, derived by alternative splicing from a common premessenger RNA, and have been called vHNF1-A and vHNF1-B. vHNF1 proteins share a homologous homeo-related DNA-binding domain with the HNF1 protein, initially characterized as a liver-restricted transcription factor, and bind to a similar sequence motif. Here we demonstrate that vHNF1-A is a stronger transactivator than vHNF1-B when assayed in transient transfections using two different promoters. vHNF1-A also binds DNA with a higher affinity suggesting that a region of the protein located immediately upstream of the homeodomain can modulate the protein/DNA interaction and transactivation. Both vHNF1 transcripts were found at a constant ratio in every tissue where vHNF1 expression could be detected, using a quantitative reverse transcriptase-polymerase chain reaction.	INST PASTEUR,DEPT BIOTECHNOL,CNRS,UNITE VIRUS ONCOGENES 1644,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris								Ausubel FM., 2006, ENZYMATIC MANIPULATI; BACH I, 1991, NUCLEIC ACIDS RES, V19, P3553, DOI 10.1093/nar/19.13.3553; BAUMHUETER S, 1988, EMBO J, V7, P2485, DOI 10.1002/j.1460-2075.1988.tb03095.x; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; CEREGHINI S, 1992, DEVELOPMENT, V116, P783; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; DESIMONE V, 1991, EMBO J, V10, P1435, DOI 10.1002/j.1460-2075.1991.tb07664.x; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HERBOMEL P, 1989, MOL CELL BIOL, V9, P4750, DOI 10.1128/MCB.9.11.4750; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; LAZZARO D, 1992, DEVELOPMENT, V114, P469; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTARRAS D, 1989, EMBO J, V8, P2203, DOI 10.1002/j.1460-2075.1989.tb08343.x; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; OTT MO, 1991, MECH DEVELOP, V36, P47, DOI 10.1016/0925-4773(91)90071-D; RANEY AK, 1991, J VIROL, V65, P5774, DOI 10.1128/JVI.65.11.5774-5781.1991; REYCAMPOS J, 1991, EMBO J, V10, P1445, DOI 10.1002/j.1460-2075.1991.tb07665.x; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SOURDIVE DJD, 1993, CR ACAD SCI III-VIE, V316, P385; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; TOMEI L, 1992, EMBO J, V11, P4119, DOI 10.1002/j.1460-2075.1992.tb05505.x; TRONCHE F, 1991, J MOL BIOL, V221, P31; YEE C, 1985, AM J PATHOL, V119, P361	32	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25706	25711						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245006				2022-12-27	WOS:A1993MK10000062
J	SKOWYRA, D; WICKNER, S				SKOWYRA, D; WICKNER, S			THE INTERPLAY OF THE GRPE HEAT-SHOCK PROTEIN AND MG2+ IN REPA MONOMERIZATION BY DNAJ AND DNAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIALIZED NUCLEOPROTEIN STRUCTURES; ESCHERICHIA-COLI DNAJ; F PLASMID REPLICATION; BACTERIOPHAGE-LAMBDA; CELLULAR DEFECTS; GENE GROPC; INITIATION; CHAPERONE; ORIGIN; MUTANTS	Genetic and biochemical studies have established that the sole function of the Escherichia coli DnaJ, DnaK, and GrpE heat shock proteins in plasmid P1 DNA replication is to convert RepA dimers to monomers. Monomers bind avidly to oriP1 DNA and initiate DNA replication. However, with purified heat shock proteins, only DnaJ, DnaK, and ATP were required for the monomerization of RepA; GrpE was not required. We have found reaction conditions that mimic the physiological situation. GrpE function is absolutely necessary for RepA activation in vitro with DnaJ and DnaK when the free Mg2+ concentration is maintained at a level of approximately 1 muM by a metal ion buffer system. EDTA or physiological metabolites, including citrate, phosphate, pyrophosphate, and ATP, all elicit the GrpE requirement. With these metal ion-buffering systems, GrpE specifically lowers the concentration of Mg2+ required for the RepA activation reaction. The absence of Mg2+ blocks activation and high levels of Mg2+ in solution bypass the requirement for GrpE but not for the other two heat shock proteins. Our results imply that GrpE facilitates the utilization of Mg2+ for an essential step in RepA activation.	NCI,MOLEC BIOL LAB,BLDG 37,RM 2D19,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ALFANO C, 1989, J BIOL CHEM, V264, P10709; ANG D, 1991, J BIOL CHEM, V266, P24233; ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; BAKER JO, 1988, METHOD ENZYMOL, V158, P33, DOI 10.1016/0076-6879(88)58046-1; BAKER TA, 1992, ANNU REV GENET, V26, P447; BUKAU B, 1989, J BACTERIOL, V171, P6030, DOI 10.1128/jb.171.11.6030-6038.1989; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; EZAKI B, 1989, MOL GEN GENET, V218, P183, DOI 10.1007/BF00331267; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; GROSS CA, 1990, STRESS PROTEINS BIOL, P167; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; KAWASAKI Y, 1990, MOL GEN GENET, V220, P277; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MARTIN MT, 1988, METHOD ENZYMOL, V158, P365, DOI 10.1016/0076-6879(88)58068-0; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; PERRIN DD, 1974, BUFFERS PH METAL ION, P96; SAITO H, 1977, J MOL BIOL, V113, P1, DOI 10.1016/0022-2836(77)90038-9; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Sillen L.G., 1964, STABILITY CONSTANTS, V17; SUNSHINE M, 1977, MOL GEN GENET, V151, P27, DOI 10.1007/BF00446909; TILLY K, 1989, J BACTERIOL, V171, P6025, DOI 10.1128/jb.171.11.6025-6029.1989; WICKNER S, 1992, P NATL ACAD SCI USA, V89, P10345, DOI 10.1073/pnas.89.21.10345; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	37	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25296	25301						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244960				2022-12-27	WOS:A1993MK10000007
J	GEORGE, SE; SU, ZH; FAN, DJ; MEANS, AR				GEORGE, SE; SU, ZH; FAN, DJ; MEANS, AR			CALMODULIN-CARDIAC TROPONIN-C CHIMERAS - EFFECTS OF DOMAIN EXCHANGE ON CALCIUM-BINDING AND ENZYME ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CA2+-DEPENDENT PROTEIN MODULATOR; CENTRAL HELIX; STIMULATED PHOSPHODIESTERASE; TARGET ENZYMES; CA2+ BINDING; CHEMICAL MODIFICATION; COOPERATIVE BINDING; MAGNESIUM BINDING; PEPTIDE COMPLEX	Calmodulin (CaM) and the cardiac isoform of troponin C (cTnC) are close structural homologs, but cTnC cannot activate most CaM target enzymes. To investigate structure-function relationships, we constructed a series of CaM.cTnC chimeras and determined their ability to bind Ca2+ and activate CaM target enzymes. Previously, we exchanged domain 1 and found that the chimeras exhibited profoundly impaired activation of smooth muscle myosin light chain kinase (smMLCK) and had differential effects on other CaM target enzymes (George, S. E., VanBerkum, M. F. A., Ono, T., Cook, R., Hanley, R. M., Putkey, J. A., and Means, A. R. (1990) J. Biol. Chem. 265, 9228-9235). One of the domain 1 chimeras was a potent competitive inhibitor of smMLCK. We now extend our study of CaM.cTnC chimeras by exchanging all of the remaining functional domains of CaM and cTnC. We determined the ability of the chimeras to bind Ca2+ and activate phosphodiesterase (PDE) and smMLCK. Chimeras containing both domains 3 and 4 of cTnC exhibited high affinity Ca'' binding that was indistinguishable from cTnC, whereas chimeras containing either domain 3 or 4 of cTnC demonstrated Ca2+ affinity that was intermediate between CaM and cTnC. All of the CaM.cTnC chimeras showed near-maximal PDE activation but required 5-775-fold higher concentrations than CaM to produce half-maximal PDE activation. In contrast, all of the chimeras showed impaired ability to activate smMLCK, and some were potent competitive inhibitors of smMLCK activation by CaM.	DUKE UNIV, MED CTR, DEPT PHARMACOL, DURHAM, NC 27710 USA	Duke University	GEORGE, SE (corresponding author), DUKE UNIV, MED CTR, DEPT MED, DIV CARDIOVASC, BOX 3060, DURHAM, NC 27710 USA.				NIGMS NIH HHS [GM-33976] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BENTLEY JK, 1992, J BIOL CHEM, V267, P18676; CRAIG TA, 1987, J BIOL CHEM, V262, P3278; CROUCH TH, 1980, BIOCHEMISTRY-US, V19, P3692, DOI 10.1021/bi00557a009; CROWE JS, 1991, NUCLEIC ACIDS RES, V19, P184, DOI 10.1093/nar/19.1.184; DASILVA ACR, 1993, EUR J BIOCHEM, V213, P599; DEDMAN JR, 1977, J BIOL CHEM, V252, P8415; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; GRABAREK Z, 1983, J BIOL CHEM, V258, P4098; GRABAREK Z, 1983, J BIOL CHEM, V258, P4103; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1978, J BIOL CHEM, V253, P3775; KINCAID RL, 1984, J BIOL CHEM, V259, P5158; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KRETSINGER RH, 1987, COLD SPRING HARB SYM, V52, P499, DOI 10.1101/SQB.1987.052.01.057; LEAVIS PC, 1978, ARCH BIOCHEM BIOPHYS, V186, P411, DOI 10.1016/0003-9861(78)90453-8; LEAVIS PC, 1978, J BIOL CHEM, V253, P5452; LINSE S, 1991, BIOCHEMISTRY-US, V30, P154, DOI 10.1021/bi00215a023; LINSE S, 1991, J BIOL CHEM, V266, P8050; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MEANS AR, 1991, PHARMACOL THERAPEUT, V50, P255, DOI 10.1016/0163-7258(91)90017-G; PEARLSTONE JR, 1992, BIOCHEMISTRY-US, V31, P6545, DOI 10.1021/bi00143a026; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; PUTKEY JA, 1987, MOL CELL BIOL, V7, P1549, DOI 10.1128/MCB.7.4.1549; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; PUTKEY JA, 1988, J BIOL CHEM, V263, P11242; PUTKEY JA, 1986, J BIOL CHEM, V261, P9896; REID RE, 1985, J THEOR BIOL, V114, P353, DOI 10.1016/S0022-5193(85)80171-5; REID RE, 1980, J THEOR BIOL, V84, P401, DOI 10.1016/S0022-5193(80)80013-0; Sambrook J, 1989, MOL CLONING LABORATO; SEKHARUDU YC, 1988, PROTEIN ENG, V2, P139, DOI 10.1093/protein/2.2.139; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; VANBERKUM MFA, 1990, J BIOL CHEM, V265, P3750; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; WALSH M, 1977, BIOCHEMISTRY-US, V16, P2742, DOI 10.1021/bi00631a024; WALSH M, 1978, BIOCHEMISTRY-US, V17, P3924, DOI 10.1021/bi00612a006; WALSH MP, 1980, J BIOL CHEM, V255, P335; WANG JH, 1990, MOL PHARM CELL REGUL, V2, P19; WU ZF, 1992, ADV SEC MESS PHOSPH, V25, P29	48	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25213	25220						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227086				2022-12-27	WOS:A1993MG67300099
J	KINANE, TB; SHANG, C; FINDER, JD; ERCOLANI, L				KINANE, TB; SHANG, C; FINDER, JD; ERCOLANI, L			CAMP REGULATES G-PROTEIN-ALPHA(I-2) SUBUNIT GENE-TRANSCRIPTION IN POLARIZED LLC-PK(1) CELLS BY INDUCTION OF A CCAAT BOX NUCLEAR-BINDING FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RESPONSE ELEMENT; G-PROTEIN; ADENYLATE-CYCLASE; DOWN-REGULATION; CYCLIC-AMP; EXPRESSION; SEQUENCE; DESENSITIZATION; IDENTIFICATION; INHIBITION	Heterotrimeric G-proteins function as signal transducers for a variety of hormone-coupled enzyme systems in eukaryotic cells. In LLC-PK1 renal cells, vasopressin-stimulated adenylylcyclase activity is regulated in part, by the counterbalancing activity of stimulatory G-proteins (G(s)) and inhibitory pertussis toxin-sensitive G-proteins (G(i)). Two G(i) genes encoding the G(i) isoforms Galpha(i-2) and Galpha(i-3) are expressed in LLC-PK1 cells. In polarized cells, these isoforms are topographically segregated to different membranes, which allows for the selective inhibition of adenylylcyclase by Galpha(i-2). The genes encoding these isoforms are similarly regulated in these cells during growth and differentiation but differ in response to steroid hormone signals (Holtzman, E. J., Kinane, T. B., West, K., Soper, B. W., Karga, H., Ausiello, D. A., and Ercolani, L. (1993) J. Biol. Chem. 268, 3964-3975). We now demonstrate after stimulating polarized LLC-PK1 cells with forskolin, which raises intracellular cAMP levels 50-fold, Galpha(i-2) but not Galpha(i-3) protein is increased 3-fold at 12 h and remains elevated above control values by 24 h. In cells stably transfected with Galpha(i-2) or Galpha(i-3) gene 5'-flanking sequences fused to firefly luciferase cDNA reporter gene, forskolin treatment increased Galpha(i-2) transcription 3-fold but inhibited Galpha(i-3) transcription by 50% at 12 h. In vivo footprinting of forskolin-treated cells was performed to examine the molecular basis for activation of the Galpha(i-2) gene. Protected guanosines were identified in a 135-base pair (bp) area previously associated with enhancer activity of this gene in non-polarized cells. This DNA segment did not contain the classical cAMP response element 5'-TGACGTCA-3'. Utilizing the 135-bp DNA segment as a probe in mobility shift assays, which compared nuclear extracts from cells before and after forskolin treatment, an induced nuclear protein complex was identified. Following systematic reduction and mutation of this DNA segment, a ''CCAAT'' box motif was identified that bound the induced nuclear protein complex during forskolin-induced Galpha(i-2) gene transcriptional activation. Induction of this nuclear protein complex was prevented in forskolin-treated cells by cycloheximide. To demonstrate functional activity of the CCAAT box motif, cells were transiently transfected with plasmids encoding either the minimal 135-bp segment or a multimerized CCAAT box segment fused to a Rous sarcoma minimal promoter/firefly luciferase reporter gene. The transcriptional response of these plasmids in polarized forskolin-treated cells was similar in magnitude but retarded temporally to that observed in cells stably transfected with the Galpha(i-2) firefly luciferase gene. These studies demonstrate that chronic cAMP elevation initiates a counter-regulatory response in fully polarized renal cells that includes increased transcription of the Galpha(i-2) gene. In contrast to other cAMP-responsive genes, increased Galpha(i-2) gene transcription appears to be mediated by a cAMP pathway that requires induction of a member of the CCAAT box family of DNA-binding proteins.	MASSACHUSETTS GEN HOSP,DEPT MED,RENAL UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT MED,PEDIAT PULM UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT PEDIAT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Finder, Jonathan/AAB-2651-2021	Shang, Charles/0000-0003-4450-9557	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042543, F32DK008838, T32DK007540] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42543, T32 DK07540, F32 DK08838] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRNBAUMER L, 1990, CRIT REV BIOCHEM MOL, V25, P225, DOI 10.3109/10409239009090610; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; ERCOLANI L, 1983, CELL IMMUNOL, V77, P222, DOI 10.1016/0008-8749(83)90023-0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREEN A, 1992, J BIOL CHEM, V267, P3223; GREEN A, 1990, J BIOL CHEM, V265, P5206; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; HOLTZMAN EJ, 1991, J BIOL CHEM, V266, P1763; HOLTZMAN EJ, 1993, J BIOL CHEM, V268, P3964; JAKOBS KH, 1983, NATURE, V303, P177, DOI 10.1038/303177a0; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3440; MONTMINY MR, 1990, METABOLISM, V39, P6, DOI 10.1016/0026-0495(90)90198-L; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURO AF, 1992, J BIOL CHEM, V267, P12767; SAATCIOGLU F, 1990, J BIOL CHEM, V265, P9251; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SKORECKI KL, 1987, BIOCHEMISTRY-US, V26, P639, DOI 10.1021/bi00376a040; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801	28	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24669	24676						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227026				2022-12-27	WOS:A1993MG67300027
J	ROBBEN, J; VANDERSCHUEREN, J; VOLCKAERT, G				ROBBEN, J; VANDERSCHUEREN, J; VOLCKAERT, G			CARBOXYL-TERMINUS IS ESSENTIAL FOR INTRACELLULAR FOLDING OF CHLORAMPHENICOL ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NUCLEOTIDE-SEQUENCE ANALYSIS; HUMAN INTERFERON-GAMMA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; CLOSTRIDIUM-PERFRINGENS; RESISTANCE DETERMINANT; GENE; PROTEIN; PLASMID; EXPRESSION	Chloramphenicol acetyltransferase (CAT, EC 2.3.1.28) is a bacterial chloramphenicol resistance marker that is commonly used as a reporter enzyme in gene expression studies and as a carrier protein for the production of fused peptides. The latter can be done by insertion of target sequences into the native ScaI site near the 3'-end of the Tn9 cat gene. CAT activity in the resulting fusion proteins is retained. We observed that creation of a stop codon at this ScaI, which causes a COOH-terminal 9-amino acid deletion, results in loss of chloramphenicol resistance and total deposition of the mutant protein in inclusion bodies in Escherichia coli. Cytoplasmic solubility and enzyme activity are completely regained by elongation of this mutant with only 2 residues. Apparently, terminal residues of the alpha5-helix play a crucial role in achieving the native conformation of nascent CAT molecules. Thus, CAT provides an interesting model system for mutational analysis of protein folding in vivo.			ROBBEN, J (corresponding author), CATHOLIC UNIV LEUVEN,GENE TECHNOL LAB,WILLEM DE CROYLAAN 42,B-3001 LOUVAIN,BELGIUM.							ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; ARAKAWA T, 1990, J INTERFERON RES, V10, P321, DOI 10.1089/jir.1990.10.321; BANNAM TL, 1991, ANTIMICROB AGENTS CH, V35, P471, DOI 10.1128/AAC.35.3.471; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; BRENNER DG, 1985, EMBO J, V4, P561, DOI 10.1002/j.1460-2075.1985.tb03665.x; BRUCKNER R, 1984, GENE, V32, P151, DOI 10.1016/0378-1119(84)90043-X; CARDOSO M, 1992, J APPL BACTERIOL, V72, P289, DOI 10.1111/j.1365-2672.1992.tb01837.x; CHARLES IG, 1985, J BACTERIOL, V164, P123, DOI 10.1128/JB.164.1.123-129.1985; DYKES CW, 1988, EUR J BIOCHEM, V174, P411, DOI 10.1111/j.1432-1033.1988.tb14113.x; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; GENTZ R, 1988, J BACTERIOL, V170, P2212, DOI 10.1128/jb.170.5.2212-2220.1988; GOLDENBERG DP, 1988, ANNU REV BIOPHYS BIO, V17, P481; HARWOOD CR, 1983, GENE, V24, P163, DOI 10.1016/0378-1119(83)90076-8; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; HOGEFREE HH, 1989, J BIOL CHEM, V264, P12179; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; HUGGINS AS, 1992, ANTIMICROB AGENTS CH, V36, P2548, DOI 10.1128/AAC.36.11.2548; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; KEEFE LJ, 1993, P NATL ACAD SCI USA, V90, P3275, DOI 10.1073/pnas.90.8.3275; KENNY B, 1991, MOL MICROBIOL, V5, P2557, DOI 10.1111/j.1365-2958.1991.tb02102.x; KIM HB, 1991, BIOCHEM INT, V25, P381; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; LEWENDON A, 1988, BIOCHEMISTRY-US, V27, P7385, DOI 10.1021/bi00419a032; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MITRAKI A, 1992, FEBS LETT, V307, P20, DOI 10.1016/0014-5793(92)80894-M; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; MURRAY IA, 1989, GENE, V85, P283, DOI 10.1016/0378-1119(89)90420-4; MURRAY IA, 1990, BIOCHEM J, V272, P505, DOI 10.1042/bj2720505; MURRAY IA, 1988, BIOCHEM J, V252, P173, DOI 10.1042/bj2520173; NOVICK R, 1976, J BACTERIOL, V127, P1177, DOI 10.1128/JB.127.3.1177-1187.1976; OCHMAN H, 1988, GENETICS, V120, P621; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RAMIREZ DM, 1993, BIOTECHNOL BIOENG, V41, P557, DOI 10.1002/bit.260410508; ROBBEN J, 1993, GENE, V126, P109, DOI 10.1016/0378-1119(93)90597-V; SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291; SCHWARZ S, 1991, ANTIMICROB AGENTS CH, V35, P1551, DOI 10.1128/AAC.35.8.1551; SCHWARZ S, 1991, ANTIMICROB AGENTS CH, V35, P1277, DOI 10.1128/AAC.35.7.1277; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; STEFFEN C, 1989, GENE, V75, P349, DOI 10.1016/0378-1119(89)90282-5; TRIEUCUOT P, 1992, PLASMID, V28, P272, DOI 10.1016/0147-619X(92)90060-N; TURNER SL, 1992, PROTEIN ENG, V5, P535, DOI 10.1093/protein/5.6.535; WETZEL R, 1991, BIO-TECHNOL, V9, P731, DOI 10.1038/nbt0891-731; WREN BW, 1989, NUCLEIC ACIDS RES, V17, P4877, DOI 10.1093/nar/17.12.4877	43	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24555	24558						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227013				2022-12-27	WOS:A1993MG67300011
J	RUSINOL, AE; CHAN, EYW; VANCE, JE				RUSINOL, AE; CHAN, EYW; VANCE, JE			MOVEMENT OF APOLIPOPROTEIN-B INTO THE LUMEN OF MICROSOMES FROM HEPATOCYTES IS DISRUPTED IN MEMBRANES ENRICHED IN PHOSPHATIDYLMONOMETHYLETHANOLAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEP G2 CELLS; ENDOPLASMIC-RETICULUM; RAT HEPATOCYTES; INTRACELLULAR DEGRADATION; SECRETION; GOLGI; TRANSPORT; PROTEIN; LIVER	When monolayer cultures of rat hepatocytes are incubated with the ethanolamine/choline analogue, monomethylethanolamine, the secretion of apolipoproteins B100 and B48, as well as the lipid constituents, of very low density lipoprotein (VLDL) is inhibited by approximately 50% (Vance, J. E. (1991) J. Lipid Res. 32, 1971-1982). In the present study we have investigated the mechanism by which monomethylethanolamine disrupts VLDL secretion. Hepatocytes were treated with 400 muM monomethylethanolamine overnight, which resulted in an increase in the cellular content of the derived phospholipid, phosphatidylmonomethylethanolamine, from 0.32 +/- 0.15 to 2.92 +/- 0.74 nmol/mg of cell protein. The biosynthesis of apoproteins B100 and B48 was not impaired by treatment of cells with monomethylethanolamine. However, monomethylethanolamine decreased by approximately 50% the amount of apoproteins B, but not of the typical secretory protein, albumin, present in the luminal content subfraction of microsomes. The intracellular degradation of apoproteins B was also increased in phosphatidylmonomethylethanolamine-enriched, compared with control, cells. Moreover, the pool of apoprotein B present in intact microsomes from hepatocytes incubated with monomethylethanolamine was more accessible to exogenously added trypsin, presumably because a larger pool of the apoprotein B was exposed on the cytosolic surface of these microsomes. The data strongly suggest that an increase in the microsomal content of phosphatidylmonomethylethanolamine diminishes the ability of apoprotein B to translocate across the endoplasmic reticulum membrane into the luminal compartment. Consequently, the association of apoprotein B with lipids and/or the normal assembly of mature VLDL particles is impaired.	UNIV ALBERTA,LIPID & LIPOPROT RES GRP,315 HERITAGE MED RES CTR,EDMONTON T6G 2S2,AB,CANADA; UNIV ALBERTA,DEPT MED,EDMONTON T6G 2S2,AB,CANADA	University of Alberta; University of Alberta								ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; BAMBERGER MJ, 1988, J BIOL CHEM, V263, P11868; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOREN J, 1990, J BIOL CHEM, V265, P10556; BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CIANFLONE KM, 1990, J LIPID RES, V31, P2045; DASHTI N, 1989, J LIPID RES, V30, P1365; DAVIS RA, 1979, J BIOL CHEM, V254, P2010; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1991, J BIOL CHEM, V266, P5080; ELOVSON J, 1988, J LIPID RES, V29, P1461; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; HOWELL KE, 1982, J CELL BIOL, V92, P833, DOI 10.1083/jcb.92.3.833; JANERO DR, 1983, J BIOL CHEM, V258, P4496; KHAN BV, 1990, BIOCHIM BIOPHYS ACTA, V1044, P297, DOI 10.1016/0005-2760(90)90073-7; LACKNER KJ, 1986, J CLIN INVEST, V78, P1707, DOI 10.1172/JCI112766; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PULLINGER CR, 1989, J LIPID RES, V30, P1065; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; SATO R, 1990, J BIOL CHEM, V265, P11880; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SORCITHOMAS M, 1989, J BIOL CHEM, V264, P9039; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; VANCE JE, 1991, J LIPID RES, V32, P1971; WETTERAU JR, 1992, SCIENCE, V258, P999; YAO ZM, 1988, J BIOL CHEM, V263, P2998	35	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25168	25175						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227080				2022-12-27	WOS:A1993MG67300093
J	IBA, K; GIBSON, S; NISHIUCHI, T; FUSE, T; NISHIMURA, M; ARONDEL, V; HUGLY, S; SOMERVILLE, C				IBA, K; GIBSON, S; NISHIUCHI, T; FUSE, T; NISHIMURA, M; ARONDEL, V; HUGLY, S; SOMERVILLE, C			A GENE ENCODING A CHLOROPLAST OMEGA-3-FATTY-ACID DESATURASE COMPLEMENTS ALTERATIONS IN FATTY-ACID DESATURATION AND CHLOROPLAST COPY NUMBER OF THE FAD7 MUTANT OF ARABIDOPSIS-THALIANA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; POLYMORPHISM LINKAGE MAP; ENVELOPE MEMBRANES; YEAST; MUTATIONS; SEQUENCE	Mutations at the fad7 locus of Arabidopsis thaliana (previously called fadD) cause decreased desaturation of dienoic fatty acids in chloroplast lipids in plants grown at elevated temperatures. This suggested that the fad7 locus encodes a chloroplast omega-3 desaturase that catalyzes the desaturation of lipid-linked 18:2 and 16:2 fatty acids. In order to clone the fad7 gene, it was first genetically mapped relative to the flanking restriction fragment length polymorphism markers 4547 and 2488A on chromosome 3, and yeast artificial chromosomes covering the locus were identified. A putative desaturase cDNA clone that was isolated by low stringency heterologous probing with a cDNA for an endoplasmic reticulum-localized omega-3 desaturase (fad3) hybridized to the yeast artificial chromosomes and could not be resolved from the locus by restriction fragment length polymorphism mapping. Expression of the cDNA in transgenic fad7 mutant plants resulted in restoration of wild type fatty acid composition and suppression of a previously observed effect of the fad7 mutation on chloroplast number, indicating genetic complementation. The structural gene contained seven introns within a coding sequence of 1338 base pairs, which encodes a 446-amino acid polypeptide of 51,172 daltons. The amino-terminal region of the fad7 gene product contained a consensus chloroplast transit peptide. Except for the amino-terminal domain, the deduced amino acid sequence of the fad7 gene product had high homology to the fad3 gene product, indicating that fad7 encodes an omega-3 desaturase and that the two genes arose from a common ancestral gene. There was no apparent effect of growth temperature on the steady-state levels of fad7 mRNA in wild type plants.	MICHIGAN STATE UNIV,DEPT ENERGY PLANT RES LAB,E LANSING,MI 48824	Michigan State University	IBA, K (corresponding author), KYUSHU UNIV 33,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN.		Somerville, Christopher R/A-4048-2009; Nishiuchi, Takumi/F-1708-2013	Somerville, Christopher R/0000-0003-4647-0094; Nishiuchi, Takumi/0000-0001-9429-5396				ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BROWSE J, 1986, PLANT PHYSIOL, V81, P859, DOI 10.1104/pp.81.3.859; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; ECKER J R, 1990, Methods (Orlando), V1, P186, DOI 10.1016/S1046-2023(05)80134-3; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FOX BG, 1993, IN PRESS NATL ACAD S; Gibson S. I., 1992, Methods in Arabidopsis research., P119; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HUGLY S, 1991, J HERED, V82, P484, DOI 10.1093/oxfordjournals.jhered.a111132; KEARNS EV, 1991, ARCH BIOCHEM BIOPHYS, V284, P431, DOI 10.1016/0003-9861(91)90319-E; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; MCCOURT P, 1987, PLANT PHYSIOL, V84, P353, DOI 10.1104/pp.84.2.353; NAM HG, 1989, PLANT CELL, V1, P699, DOI 10.1105/tpc.1.7.699; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT H, 1990, PLANT PHYSIOL, V94, P214, DOI 10.1104/pp.94.1.214; SCHMIDT H, 1990, P NATL ACAD SCI USA, V87, P9477, DOI 10.1073/pnas.87.23.9477; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; UNFRIED I, 1989, NUCLEIC ACIDS RES, V17, P7513, DOI 10.1093/nar/17.18.7513; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; WADA H, 1993, IN PRESS BIOCH MOL B; WARD ER, 1990, PLANT MOL BIOL, V14, P561, DOI 10.1007/BF00027501; YADAV NS, 1993, IN PRESS PLANT PHYSL; YAMAMOTO KT, 1992, PLANT CELL PHYSIOL, V33, P13	29	172	206	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24099	24105						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226956				2022-12-27	WOS:A1993MF29400060
J	MACCARANA, M; CASU, B; LINDAHL, U				MACCARANA, M; CASU, B; LINDAHL, U			MINIMAL SEQUENCE IN HEPARIN HEPARAN-SULFATE REQUIRED FOR BINDING OF BASIC FIBROBLAST GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; 3-DIMENSIONAL STRUCTURE; SUBSTRATE-SPECIFICITY; NITROUS-ACID; BIOSYNTHESIS; OLIGOSACCHARIDES; DEPOLYMERIZATION; RECEPTOR; CELLS; GLYCOSAMINOGLYCANS	Experiments based on interaction in free solution between basic fibroblast growth factor (FGF-2) and saccharides related to heparin/heparan sulfate showed that the growth factor binds to heparin and to selectively glucosaminyl 6-O-desulfated heparin but poorly to iduronosyl 2-O-desulfated heparin. 2-O-sulfate groups thus are essential to the interaction, whereas 6-O-sulfates are not required nor do they interfere with FGF-2 binding. Comparison of various bound/nonbound oligosaccharides implicated a minimal pentasaccharide sequence for FGF-2 binding, with the structure: -hexuronic acid-glucosamine N-sulfate-hexuronic acid-glucosamine N-sulfate-iduronic acid 2-O-sulfate- (reducing terminus to the right). Such (overlapping) sequences are abundant in heparin, albeit heavily obscured by irrelevant O-sulfate groups, and occur also in heparan sulfate, with or without additional O-sulfates.	UNIV UPPSALA, CTR BIOMED, DEPT MED & PHYSIOL CHEM, BOX 575, S-75123 UPPSALA, SWEDEN; ITALFARMACO SPA, I-20126 MILAN, ITALY; G RONZONI INST CHEM & BIOCHEM RES, I-20133 MILAN, ITALY	Uppsala University; Italfarmaco			maccarana, marco/AAB-4764-2021	Maccarana, Marco/0000-0003-3549-8921				BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; ISHAIMICHAELI R, 1990, CELL REGUL, V1, P833, DOI 10.1091/mbc.1.11.833; ISHAIMICHAELI R, 1992, BIOCHEMISTRY-US, V31, P2080, DOI 10.1021/bi00122a027; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; KUSCHE M, 1991, J BIOL CHEM, V266, P7400; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; KUSCHE M, 1988, BIOCHEM J, V253, P885, DOI 10.1042/bj2530885; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLWIN BB, 1990, J CELL BIOL, V110, P503, DOI 10.1083/jcb.110.2.503; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; PEJLER G, 1988, J BIOL CHEM, V263, P5197; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RIESENFELD J, 1982, J BIOL CHEM, V257, P421; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3943, DOI 10.1021/bi00663a006; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	44	419	430	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23898	23905						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226930				2022-12-27	WOS:A1993MF29400032
J	MCCOY, JJ; MANN, BJ; VEDVICK, TS; PAK, Y; HEIMARK, DB; PETRI, WA				MCCOY, JJ; MANN, BJ; VEDVICK, TS; PAK, Y; HEIMARK, DB; PETRI, WA			STRUCTURAL-ANALYSIS OF THE LIGHT SUBUNIT OF THE ENTAMOEBA-HISTOLYTICA GALACTOSE-SPECIFIC ADHERENCE LECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEINS; PHOSPHATIDYLINOSITOL MEMBRANE ANCHORS; TERMINAL SIGNAL PEPTIDE; GLYCOSYL-PHOSPHATIDYLINOSITOL; TRYPANOSOMA-BRUCEI; PHOSPHOLIPASE-C; CYTOPATHOGENIC MECHANISMS; SEQUENCE-ANALYSIS; BINDING LECTIN; PROTEINS	Adherence of Entamoeba histolytica trophozoites to colonic mucins and resistance to lysis by the membrane attack complex of complement are mediated by a galactose- and N-acetyl-D-galactosamine-specific cell-surface lectin. This lectin is a heterodimeric glycoprotein of heavy (170 kDa) and light (35/31 kDa) subunits. In this work, the amino acid sequence and membrane anchor of the light subunit were analyzed. The light subunit cDNA encoded a protein with a calculated molecular mass of 32 kDa containing two potential sites for N-linked glycosylation and putative amino- and carboxyl-terminal signal sequences characteristic of glycosylphosphatidylinositol (GPI)-anchored proteins. No classical carbohydrate-binding domains common to C- or S-type eukaryotic lectins were detected by sequence analysis of either the heavy or light subunits, leaving the location of the ligand-binding site of the lectin unknown. Analysis of restriction enzyme-digested E. histolytica DNA by Southern blotting was consistent with the presence of more than one light subunit gene. Two light subunit isoforms of 31 and 35 kDa were identified by SDS-polyacrylamide gel electrophoresis analysis of affinity-purified lectin, and the isoforms were shown on two-dimensional gel analysis to form distinct 170/35- and 170/31-kDa heterodimers. The amino acid compositions and cyanogen bromide peptide patterns of the two light subunit isoforms were nearly identical. The 35-kDa isoform labeled more efficiently than the 31-kDa isoform with [H-3] glucosamine, while only the 31-kDa isoform labeled with [H-3]myristate and [H-3]palmitate. Nitrous acid deamination released lipid from the 31-kDa isoform, which co-migrated on thin layer chromatography with acylphosphatidylinositol, a component of some GPI anchors. Gas chromatography and mass spectrometry of the deamination product from the 31-kDa subunit identified both myo- and chiro-inositols, supporting the presence of a GPI membrane anchor. The covalent association of a transmembrane protein with a GPI-anchored protein, as suggested by the cDNA sequences of the lectin heavy and light subunits, is novel and suggests unique roles for the two subunits in the pathogenesis of amebiasis.	UNIV VIRGINIA, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, DEPT PHARMACOL, CHARLOTTESVILLE, VA 22908 USA; SIBIA INC, LA JOLLA, CA 92037 USA	University of Virginia; University of Virginia; University of Virginia			Petri, William/AAL-3642-2020; Pak, Yunbae/Q-5783-2019; Petri, William A./D-3639-2019	Petri, William/0000-0002-7268-1218; Pak, Yunbae/0000-0002-8594-5673; 	NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649] Funding Source: NIH RePORTER; NCI NIH HHS [5-T32-CA 09109] Funding Source: Medline; NIAID NIH HHS [AI-26649] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOOTHROYD JC, 1981, NUCLEIC ACIDS RES, V9, P4735, DOI 10.1093/nar/9.18.4735; BRAGA LL, 1992, J CLIN INVEST, V90, P1131, DOI 10.1172/JCI115931; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DAS S, 1991, J BIOL CHEM, V266, P21318; DAVITZ MA, 1987, SCIENCE, V238, P81, DOI 10.1126/science.2443973; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; FERGUSON MAJ, 1992, BIOCHEM SOC T, V20, P243, DOI 10.1042/bst0200243; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; GERBER LD, 1992, J BIOL CHEM, V267, P12168; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; KLEIN CE, 1990, BRIT J DERMATOL, V123, P171, DOI 10.1111/j.1365-2133.1990.tb01844.x; KODUKULA K, 1992, P NATL ACAD SCI USA, V89, P1350, DOI 10.1073/pnas.89.4.1350; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; LOW MG, 1987, BIOCHEM J, V241, P615, DOI 10.1042/bj2410615; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MANN BJ, 1993, INFECT IMMUN, V61, P1772, DOI 10.1128/IAI.61.5.1772-1778.1993; MANN BJ, 1991, P NATL ACAD SCI USA, V88, P3248, DOI 10.1073/pnas.88.8.3248; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAYOR S, 1990, J BIOL CHEM, V265, P6174; PAK Y, 1992, J BIOL CHEM, V267, P16904; PAK YB, 1992, BIOCHEM BIOPH RES CO, V184, P1042, DOI 10.1016/0006-291X(92)90696-I; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETRI WA, 1991, INFECT IMMUN, V59, P97, DOI 10.1128/IAI.59.1.97-101.1991; PETRI WA, 1989, J BIOL CHEM, V264, P3007; PETRI WA, 1987, INFECT IMMUN, V55, P2327, DOI 10.1128/IAI.55.10.2327-2331.1987; PETRI WA, 1990, J IMMUNOL, V144, P4803; PURDY JE, 1993, IN PRESS MOL BIOCH P; RAVDIN JI, 1980, J EXP MED, V152, P377, DOI 10.1084/jem.152.2.377; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SAFFER LD, 1991, EXP PARASITOL, V72, P106, DOI 10.1016/0014-4894(91)90128-J; SANDER F, 1977, P NATL ACAD SCI USA, V74, P5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAIN DC, 1992, INFECT IMMUN, V60, P2143, DOI 10.1128/IAI.60.5.2143-2146.1992; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; TANNICH E, 1991, P NATL ACAD SCI USA, V88, P1849, DOI 10.1073/pnas.88.5.1849; TANNICH E, 1992, MOL BIOCHEM PARASIT, V55, P225, DOI 10.1016/0166-6851(92)90144-9; THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001; TORIAN BE, 1990, P NATL ACAD SCI USA, V87, P6358, DOI 10.1073/pnas.87.16.6358; WALTER EI, 1990, J IMMUNOL, V144, P1030; WILLIAMS RE, 1975, BIOCHEM BIOPH RES CO, V62, P462, DOI 10.1016/S0006-291X(75)80161-6	49	62	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24223	24231						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226970				2022-12-27	WOS:A1993MF29400076
J	MCGAVIN, MJ; GURUSIDDAPPA, S; LINDGREN, PE; LINDBERG, M; RAUCCI, G; HOOK, M				MCGAVIN, MJ; GURUSIDDAPPA, S; LINDGREN, PE; LINDBERG, M; RAUCCI, G; HOOK, M			FIBRONECTIN RECEPTORS FROM STREPTOCOCCUS-DYSGALACTIAE AND STAPHYLOCOCCUS-AUREUS - INVOLVEMENT OF CONSERVED RESIDUES IN LIGAND-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 DIFFERENT GENES; NUCLEOTIDE-SEQUENCE; PROTEIN; EXPRESSION; PYOGENES; COLLAGEN; CLONING; FORM	The nucleotide sequence of two genes encoding fibronectin (Fn) receptors FnBA and FnBB of Streptococcus dysgalactiae S2 revealed the presence of repeated motifs (called R(A1-A3) and R(B1-B3), respectively) which encode Fn binding activity (Lindgren, P.-E., McGavin, M. J., Signas, C., Guss, B., Gurusiddappa, S., Hook, M., and Lindberg, M. (1993) Eur. J. Biochem. 214, 819-827). Synthetic peptides of 32-37 amino acids, corresponding to individual repeated motifs, were assayed for the ability to inhibit Fn binding to cells of S. dysgalactiae. Within the R(A) Motifs, peptide A2 was 10-fold more active than either A1 or A3, while in the R(B) motifs, only B3 was active. The same level of activity is observed when these synthetic peptides were assayed for inhibition of Fn binding to cells of Staphylococcus aureus. Likewise, synthetic peptides corresponding to the R(D1-D3) motifs, which comprise a ligand binding domain in a Fn receptor from S. aureus, inhibit binding of Fn to both S. aureus and S. dysgalactiae. Assays of chemically modified peptides and peptide fragments derived from chemical or proteolytic cleavage suggest that a conserved core sequence, defined as ED(T/S)(X9,10)GG(X3,4)(I/V)DF, within a 30-amino acid-long segment is present in the active R(A) and R(D) motifs. Analyses of the importance of individual residues of this core sequence indicate that the ED(T/S) motif is nonessential, whereas the GG and the (I/V)DF together with additional acidic residues in the C-terminal half of the peptide are required for activity.	UNIV ALABAMA,DEPT BIOCHEM,BIRMINGHAM,AL 35294; SWEDISH UNIV AGR SCI,DEPT MICROBIOL,S-75007 UPPSALA,SWEDEN	University of Alabama System; University of Alabama Birmingham; Swedish University of Agricultural Sciences				McGavin, Martin/0000-0001-5955-0689	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20624] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHARYA AS, 1984, J CHROMATOGR, V297, P37, DOI 10.1016/S0021-9673(01)89027-0; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; CROWE JS, 1991, NUCLEIC ACIDS RES, V19, P184, DOI 10.1093/nar/19.1.184; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FLOCK JI, 1987, EMBO J, V6, P697; FROMAN G, 1987, J BIOL CHEM, V262, P6564; HUNTER W, 1978, HDB EXPT IMMUNOLOGY; Hynes RO, 1990, FIBRONECTINS; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; KUUSELA P, 1984, INFECT IMMUN, V45, P433, DOI 10.1128/IAI.45.2.433-436.1984; KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0; LINDGREN PE, 1993, EUR J BIOCHEM, V214, P819, DOI 10.1111/j.1432-1033.1993.tb17985.x; LINDGREN PE, 1992, J BIOL CHEM, V267, P1924; LOFDAHL S, 1983, P NATL ACAD SCI-BIOL, V80, P697, DOI 10.1073/pnas.80.3.697; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P105; MCGAVIN MJ, 1991, J BIOL CHEM, V266, P8343; MCGAVIN MJ, 1990, CELL DIFFER DEV, V32, P433; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; PATTI JM, 1992, J BIOL CHEM, V267, P4766; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; SPEZIALE P, 1984, J BACTERIOL, V157, P420, DOI 10.1128/JB.157.2.420-427.1984; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992	23	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23946	23953						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226935				2022-12-27	WOS:A1993MF29400038
J	ROBERDS, SL; ANDERSON, RD; IBRAGHIMOVBESKROVNAYA, O; CAMPBELL, KP				ROBERDS, SL; ANDERSON, RD; IBRAGHIMOVBESKROVNAYA, O; CAMPBELL, KP			PRIMARY STRUCTURE AND MUSCLE-SPECIFIC EXPRESSION OF THE 50-KDA DYSTROPHIN-ASSOCIATED GLYCOPROTEIN (ADHALIN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; PROTEINS; COMPLEX; ORGANIZATION; PURIFICATION; DEFICIENCY; SARCOLEMMA; CLEAVAGE; CLONING	The 50-kDa dystrophin-associated glycoprotein (50-DAG) is a component of the dystrophin-glycoprotein complex, which links the muscle cytoskeleton to the extracellular matrix. 50-DAG is specifically deficient in skeletal muscle of patients with severe childhood autosomal recessive muscular dystrophy and in skeletal and cardiac muscles of BIO 14.6 cardiomyopathic hamsters. The lack of 50-DAG leads to a disruption and dysfunction of the dystrophin-glycoprotein complex in these diseases. The cDNA encoding 50-DAG has now been cloned from rabbit skeletal muscle. The 50-DAG deduced amino acid sequence predicts a novel protein having 387 amino acids, a 17-amino acid signal sequence, one transmembrane domain, and two potential sites of N-linked glycosylation. Affinity-purified antibodies against rabbit 50-DAG fusion proteins or synthetic peptides specifically recognized a 50-kDa protein in skeletal muscle sarcolemma and the 50-kDa component of the dystrophin-glycoprotein complex. In contrast to dystroglycan, which is expressed in a wide variety of muscle and non-muscle tissues, 50-DAG is expressed only in skeletal and cardiac muscles and in selected smooth muscles. Finally, 50-DAG mRNA is present in mdx and Duchenne muscular dystrophy (DMD) muscle, indicating that the down-regulation of this protein in DMD and the mdx mouse is likely a post-translational event.	UNIV IOWA, COLL MED, HOWARD HUGHES MED INST, 400 EMRB, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa			Roberds, Steven L/AAP-4985-2020	Roberds, Steven L/0000-0003-0676-272X; Campbell, Kevin/0000-0003-2066-5889				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BAJUSZ E, 1969, AM HEART J, V77, P686, DOI 10.1016/0002-8703(69)90556-0; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; Homburger F, 1979, Ann N Y Acad Sci, V317, P1, DOI 10.1111/j.1749-6632.1979.tb56503.x; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JORGENSEN AO, 1990, J CELL BIOL, V110, P1173, DOI 10.1083/jcb.110.4.1173; KLIETSCH R, 1993, CIRC RES, V72, P349, DOI 10.1161/01.RES.72.2.349; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PASSOSBUENO MR, 1993, IN PRESS HUM MOL GEN; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; ROBERDS SL, 1993, J BIOL CHEM, V268, P11496; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; Sambrook J, 1989, MOL CLONING LABORATO; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH DB, 1987, CURRENT PROTOCOLS MO; STRYNADKA NCJ, 1988, J VIROL, V62, P3474, DOI 10.1128/JVI.62.9.3474-3483.1988; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YAMAMOTO H, 1993, J BIOCHEM-TOKYO, V114, P132, DOI 10.1093/oxfordjournals.jbchem.a124128; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	41	158	161	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23739	23742						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226900				2022-12-27	WOS:A1993MF29400002
J	TAFURI, SR; WOLFFE, AP				TAFURI, SR; WOLFFE, AP			SELECTIVE RECRUITMENT OF MASKED MATERNAL MESSENGER-RNA FROM MESSENGER-RIBONUCLEOPROTEIN PARTICLES CONTAINING FRGY2 (MESSENGER RNP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTE MATURATION; TRANSCRIPTION FACTOR; BINDING-PROTEINS; 5S RNA; TRANSLATIONAL CONTROL; ESCHERICHIA-COLI; CYTOPLASMIC POLYADENYLATION; GENE; IDENTIFICATION; ELEMENTS	In Xenopus, the germ cell-specific Y-box (CTGATTGGCCAA) factor, FRGY2, facilitates in vitro transcription in egg extracts from oocyte-selective promoters containing a Y-box. This same factor is a major component of the messenger ribonucleoprotein (mRNP) storage particles of the oocyte. These particles store maternal mRNAs and inhibit their translation. FRGY2 is identical to mRNP4 and homologous to mRNP3, two previously described oocyte-specific mRNP proteins. We demonstrate that FRGY2 associates with a broad spectrum of mRNAs exhibiting no apparent sequence specificity. These interactions suggest that FRGY2 has a general role in packaging mRNA analogous to that of histone with DNA. All mRNAs examined that accumulate in oocytes appear within these mRNP storage particles, including messages coding for proteins such as FRGY2 and TFIIIA, which are translated in the oocyte. Moreover, we show that mRNAs that are translationally repressed in oocytes, such as messages coding for the proteins histone H1 and FRGY1, accumulate only within the particles. These mRNAs are subsequently recruited from the particles to the ribosomes and utilized for translation during embryogenesis prior to transcriptional activation of the zygotic genome. We propose that the assembly of mRNP storage particles represents a default state and that translational regulation is achieved via specific recruitment of the messages from the mRNP fraction to the ribosomes.	NICHHD,MOLEC EMBRYOL LAB,BLDG 6,RM B1A-13,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ANDREWS MT, 1987, CELL, V51, P445, DOI 10.1016/0092-8674(87)90640-4; AUDET RG, 1987, DEV BIOL, V121, P58, DOI 10.1016/0012-1606(87)90138-2; BACHVAROVA R, 1962, CELL, V69, P895; BIENZ M, 1986, CELL, V46, P1037, DOI 10.1016/0092-8674(86)90703-8; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CRAWFORD DR, 1987, DEVELOPMENT, V101, P741; CUMMINGS A, 1988, J CELL BIOL, V107, P45, DOI 10.1083/jcb.107.1.45; DARNBROUGH CH, 1981, EUR J BIOCHEM, V113, P415, DOI 10.1111/j.1432-1033.1981.tb05081.x; DAVIDSON EH, 1986, GENE ACTIVITY EARLY, P1; DEARSLEY AL, 1985, EUR J BIOCHEM, V150, P95, DOI 10.1111/j.1432-1033.1985.tb08993.x; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P283; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; FOX CA, 1990, GENE DEV, V4, P2287, DOI 10.1101/gad.4.12b.2287; GINSBERG AM, 1984, CELL, V39, P479, DOI 10.1016/0092-8674(84)90455-0; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; JONES PG, 1992, J BACTERIOL, V174, P5798, DOI 10.1128/jb.174.18.5798-5802.1992; KICK D, 1987, NUCLEIC ACIDS RES, V15, P4099, DOI 10.1093/nar/15.10.4099; LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; MURRAY MT, 1991, J CELL BIOL, V112, P1, DOI 10.1083/jcb.112.1.1; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PERRY M, 1985, J MOL BIOL, V185, P479, DOI 10.1016/0022-2836(85)90065-8; RICHTER JD, 1988, TRENDS BIOCHEM SCI, V13, P483, DOI 10.1016/0968-0004(88)90236-8; RICHTER JD, 1984, J BIOL CHEM, V259, P2190; RICHTER JD, 1983, J BIOL CHEM, V258, P4864; RICHTER JD, 1984, NATURE, V309, P378, DOI 10.1038/309378a0; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; SCHWARTZ SP, 1992, IN PRESS P NATL ACAD; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; SWIDERSKI RE, 1988, DEV BIOL, V128, P349, DOI 10.1016/0012-1606(88)90297-7; Tafuri Sherrie R., 1993, Trends in Cell Biology, V3, P94, DOI 10.1016/0962-8924(93)90080-K; TAFURI SR, 1992, NEW BIOL, V4, P349; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; TAFURI SR, UNPUB; VARNUM SM, 1992, DEV BIOL, V153, P283, DOI 10.1016/0012-1606(92)90113-U; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1989, NUCLEIC ACIDS RES, V17, P767, DOI 10.1093/nar/17.2.767; WOODLAND HR, 1979, CELL, V18, P165, DOI 10.1016/0092-8674(79)90365-9; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0	45	101	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24255	24261						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226972				2022-12-27	WOS:A1993MF29400080
J	ARTEMYEV, NO; MILLS, JS; THORNBURG, KR; KNAPP, DR; SCHEY, KL; HAMM, HE				ARTEMYEV, NO; MILLS, JS; THORNBURG, KR; KNAPP, DR; SCHEY, KL; HAMM, HE			A SITE ON TRANSDUCIN ALPHA-SUBUNIT OF INTERACTION WITH THE POLYCATIONIC REGION OF CGMP PHOSPHODIESTERASE INHIBITORY SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; GTP-BINDING PROTEIN; RETINAL RODS; GAMMA-SUBUNIT; ACTIVATION MECHANISM; CHROMATOGRAPHY; PURIFICATION; COMPLEX; PEPTIDE	Activation of cGMP phosphodiesterase (PDE) by the rod G-protein transducin is a key event in visual signal transduction in vertebrate photoreceptor cells. Interaction between the GTP-bound form of the alpha-subunit of transducin (alpha(t)*) and the PDE inhibitory gamma-subunit (Pgamma) is a major component of PDE activation. The central polycationic region of Pgamma, Pgamma-24-45, has been implicated as one of the sites involved in alpha(t)*.Pgamma interaction. Here we determine the site on alpha(t) that interacts with Pgamma-24-45 using a photo-cross-linking approach. The synthetic peptides Cys(ACM)Tyr-Pgamma-24-45-Cys (where ACM indicates acetamidomethyl group) and Cys-Pgamma-24-45 were labeled with 4-(N-maleimido)benzophenone at the COOH and NH2 termini, respectively, and then cross-linked to alpha(t). When the photoprobe was attached to the COOH terminus of the peptide, a specific high yield cross-linked product (80%) was formed between the peptide and alpha(t)GTPgammaS (guanosine 5'-O-(thiotriphosphate)). A lower yield of cross-linking (35%) was seen between the peptide and alpha(t)GDP. The site of cross-linking between Cys(ACM)Tyr-Pgamma-24-45-Cys and alpha(t)GTPgammaS was localized to within alpha(t)-306-310 using a variety of chemical and proteolytic cleavages of the cross-linked product, analysis of the fragments with SDS-polyacrylamide gel electrophoresis, and matrix-assisted laser desorption ionization mass spectrometry.	UNIV ILLINOIS, COLL MED, DEPT PHYSIOL & BIOPHYS, BOX 6998, CHICAGO, IL 60680 USA; MED UNIV S CAROLINA, DEPT CELL & MOLEC PHARMACOL, CHARLESTON, SC 29425 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina			Hamm, Heidi E/G-2374-2014	Artemyev, Nikolai/0000-0002-5266-6854	NATIONAL EYE INSTITUTE [R01EY006062] Funding Source: NIH RePORTER; NEI NIH HHS [EY-06062] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Bornstein P, 1977, Methods Enzymol, V47, P132; BOYD ND, 1991, BIOCHEMISTRY-US, V30, P336, DOI 10.1021/bi00216a005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; CATTY P, 1992, J BIOL CHEM, V267, P19489; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; CLERC A, 1992, J BIOL CHEM, V267, P6620; DETERRE P, 1986, Proteins Structure Function and Genetics, V1, P188, DOI 10.1002/prot.340010210; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; FUNG BKK, 1983, J BIOL CHEM, V258, P503; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KAUER JC, 1986, J BIOL CHEM, V261, P695; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; STRYER L, 1991, J BIOL CHEM, V266, P10711; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702	34	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23611	23615						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226888				2022-12-27	WOS:A1993MF51500099
J	KOMATSU, M; MCDERMOTT, AM; GILLISON, SL; SHARP, GWG				KOMATSU, M; MCDERMOTT, AM; GILLISON, SL; SHARP, GWG			MASTOPARAN STIMULATES EXOCYTOSIS AT A CA2+-INDEPENDENT LATE SITE IN STIMULUS-SECRETION COUPLING - STUDIES WITH THE RINM5F BETA-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP VENOM MASTOPARAN; GTP-BINDING PROTEINS; INSULIN-SECRETION; CHROMAFFIN CELLS; CONFORMATIONAL CHANGE; GUANINE-NUCLEOTIDES; CA-2+ CONCENTRATION; PANCREATIC-ISLETS; ACINAR-CELLS; MAST-CELLS	Mastoparan, a tetradecapeptide from wasp venom, stimulated exocytosis in a concentration-dependent manner, which was enhanced by pertussis toxin pretreatment, in the insulin secreting beta-cell line RINm5F. Mastoparan (3-20 muM) also elevated cytosolic free calcium concentration ([Ca2+]i), a rise that was not attenuated by nitrendipine. Divalent cation-free Krebs-Ringer bicarbonate (KRB) medium with 0.1 mm EGTA nullified the mastoparan-induced increase in [Ca2+]i, suggesting that the peptide increased Ca2+ influx but not through the L-type voltage-dependent Ca2+ channel. Depletion of the intracellular Ca2+ pool did not affect the mastoparan-induced elevation of [Ca2+]i. Remarkably, in divalent cation-free KRB medium with 0.1 mM EGTA and 2 muM thapsigargin in which mastoparan reduced [Ca2+]i, the mastoparan-stimulated insulin release was similar to that in normal Ca2+-containing KRB medium. Inhibitors of protein kinase C, such as bisindolylmaleimide, staurosporine, and 1-O-hexadecyl-2-O-methyl-rac-glycerol did not suppress the mastoparan-stimulated insulin release. Mastoparan at 10-20 muM did not increase cellular cAMP levels, nor did mastoparan at 5-10 muM affect [H-3]arachidonic acid release. In conclusion, although mastoparan increased [Ca2+]i, this increase was not involved in the stimulation of insulin release. Rather, the data suggest that mastoparan directly stimulates exocytosis in a Ca2+-independent manner. As GTP-binding proteins (G proteins) are thought to be involved in the process of exocytosis and as mastoparan is known to exert at least some of its effects by activation of G proteins, an action of mastoparan to activate the putative stimulatory G(e) (exocytosis) protein is likely.			KOMATSU, M (corresponding author), CORNELL UNIV,COLL VET MED,DEPT PHARMACOL,ITHACA,NY 14853, USA.							ARGIOLAS A, 1983, J BIOL CHEM, V258, P3697; ARIDOR M, 1990, J CELL BIOL, V111, P909, DOI 10.1083/jcb.111.3.909; BARROWMAN MM, 1986, NATURE, V319, P504, DOI 10.1038/319504a0; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; GIL J, 1991, J CELL BIOL, V113, P943, DOI 10.1083/jcb.113.4.943; GOMPERTS BD, 1986, TRENDS BIOCHEM SCI, V11, P290, DOI 10.1016/0968-0004(86)90032-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUSOVSKY F, 1991, EUR J PHARM-MOLEC PH, V206, P309, DOI 10.1016/0922-4106(91)90115-X; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P12655; HIGASHIJIMA T, 1984, BIOCHIM BIOPHYS ACTA, V802, P157, DOI 10.1016/0304-4165(84)90156-9; HIGASHIJIMA T, 1983, FEBS LETT, V152, P227, DOI 10.1016/0014-5793(83)80385-8; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HILLAIREBUYS D, 1992, MOL CELL BIOCHEM, V109, P133; HIRAI Y, 1979, CHEM PHARM BULL, V27, P1942; HOMAIDAN FR, 1991, P NATL ACAD SCI USA, V88, P8744, DOI 10.1073/pnas.88.19.8744; JOYCEBRADY M, 1991, J BIOL CHEM, V266, P6859; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KATSU T, 1990, BIOCHIM BIOPHYS ACTA, V1027, P185, DOI 10.1016/0005-2736(90)90083-Z; KOMATSU M, 1992, ENDOCRINOLOGY, V130, P221, DOI 10.1210/en.130.1.221; KRAMER IM, 1989, J BIOL CHEM, V264, P5876; KURIHARA H, 1986, CELL TISSUE RES, V243, P311; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; OKANO Y, 1985, FEBS LETT, V188, P363, DOI 10.1016/0014-5793(85)80403-8; OZAKI Y, 1990, BIOCHEM BIOPH RES CO, V170, P779, DOI 10.1016/0006-291X(90)92159-W; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; PERIANIN A, 1989, J IMMUNOL, V143, P1669; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; SCHERER NM, 1987, ARCH BIOCHEM BIOPHYS, V259, P431, DOI 10.1016/0003-9861(87)90509-1; SCHMIDT A, 1991, J BIOL CHEM, V266, P18025; SENYSHYN J, 1992, FEBS LETT, V309, P41, DOI 10.1016/0014-5793(92)80735-Y; SHARP GWG, 1989, J BIOL CHEM, V264, P7302; SONTAG JM, 1991, BIOCHEM J, V274, P339, DOI 10.1042/bj2740339; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TANIMURA A, 1991, BIOCHEM BIOPH RES CO, V177, P802, DOI 10.1016/0006-291X(91)91860-F; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; VALLAR L, 1987, J BIOL CHEM, V262, P5049; WAKAMATSU K, 1986, BIOPOLYMERS, V25, P193; WALLACE MA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P311, DOI 10.1016/0005-2760(89)90018-0; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; WILSON SP, 1989, FEBS LETT, V247, P239, DOI 10.1016/0014-5793(89)81343-2; WOJCIKIEWICZ RJH, 1989, FEBS LETT, V247, P341, DOI 10.1016/0014-5793(89)81366-3; YADA T, 1989, J BIOL CHEM, V264, P2455; YAMAMOTO S, 1982, EUR J PHARMACOL, V78, P225, DOI 10.1016/0014-2999(82)90240-0; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; YOKOKAWA N, 1989, BIOCHEM BIOPH RES CO, V158, P712, DOI 10.1016/0006-291X(89)92779-4; YULE DI, 1991, BIOCHEM BIOPH RES CO, V177, P159, DOI 10.1016/0006-291X(91)91962-C	48	73	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23297	23306						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226853				2022-12-27	WOS:A1993MF51500055
J	PENG, SB; STONE, DK; XIE, XS				PENG, SB; STONE, DK; XIE, XS			RECONSTITUTION OF RECOMBINANT 40-KDA SUBUNIT OF THE CLATHRIN-COATED VESICLE H+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATING COMPLEX; PROTEINS; PUMP	We have proposed a model of the ATP hydrolytic sector of the clathrin-coated vesicle H+-ATPase wherein significant catalysis requires four subunits of molecular masses of 70, 58, 40, and 33 kDa (Xie, X.-S., and Stone, D. K. (1988) J. Biol. Chem. 263, 9859-9867). We have cloned and expressed the 40-kDa component in Escherichia coli and have purified the recombinant protein to homogeneity. This subunit lacks ATP hydrolytic capacity, but when reconstituted to a 40 kDa-depleted hydrolytic sector, there is a greater than 20-fold increase in calcium-activated, N-ethylmaleimide-sensitive ATP hydrolysis, indicating that this subunit is required for vacuolar-type proton pump function.	UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DIV MOLEC TRANSPORT,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIDDK NIH HHS [DK RO1 33627] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1989, SHORT PROTOCOLS MOL; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NELSON H, 1990, J BIOL CHEM, V265, P20390; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; QIAGEN X, 1992, QIA EXPRESSIONIST; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; STONE DK, 1984, J BIOL CHEM, V259, P2701; STONE DK, 1988, KIDNEY INT, V33, P403; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUN SZ, 1987, J BIOL CHEM, V262, P14790; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1988, J BIOL CHEM, V263, P9859; XIE XS, 1983, J BIOL CHEM, V259, P11676	19	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23519	23523						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226880				2022-12-27	WOS:A1993MF51500086
J	WENGER, RH; ROCHELLE, JM; SELDIN, MF; KOHLER, G; NIELSEN, PJ				WENGER, RH; ROCHELLE, JM; SELDIN, MF; KOHLER, G; NIELSEN, PJ			THE HEAT-STABLE ANTIGEN (MOUSE-CD24) GENE IS DIFFERENTIALLY REGULATED BUT HAS A HOUSEKEEPING PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GLOBIN GENE; PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; CPG ISLANDS; CELL-LINES; B-CELLS; TRANSCRIPTION FACTORS; SURFACE-ANTIGENS; MESSENGER-RNA; LINKAGE MAP; SCG10 GENE	Expression of the mouse heat stable antigen (HSA or mouse CD24) shows tissue-specific as well as developmental regulation. During the maturation of several hematopoietic lineages, HSA expression is generally high in immature precursor cells and low or absent in terminally differentiated cells. We present evidence suggesting that this regulation of the HSA gene (Cd24a) occurs at the transcriptional level. In addition, sequence and methylation analysis of the Cd24a promoter revealed characteristics of both ''housekeeping'' and tissue-specific promoters, including a methylation-free, HpaII tiny fragment (HTF) island, multiple putative SP1 and AP-2 consensus binding sites, and a TATA box. Functional analysis of a 0.6-kilobase DNA fragment containing these elements fused to the CAT reporter gene in transient transfection experiments showed activity in both HSA expressing and non-expressing cell lines with a strength similar to that of the herpes-simplex virus-thymidine kinase promoter. Large fragments from the flanking region of the Cd24a promoter did not influence the ubiquitous nature of this promoter. Finally, we mapped the Cd24a, Cd24b, and Cd24c genes to mouse chromosomes 10, 8, and 14 respectively.	MAX PLANCK INST IMMUNBIOL,STUBEWEG 51,D-79108 FREIBURG,GERMANY; DUKE UNIV,MED CTR,MOLEC GENET LAB,DURHAM,NC 27710	Max Planck Society; Duke University			Wenger, Roland H./B-7953-2009	Wenger, Roland H./0000-0001-7592-4839	NHGRI NIH HHS [HG00101] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; ALTERMAN LA, 1990, EUR J IMMUNOL, V20, P1597, DOI 10.1002/eji.1830200728; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Ausubel FM, 1988, MOL REPROD DEV; AYANE M, 1989, NUCLEIC ACIDS RES, V17, P6722, DOI 10.1093/nar/17.16.6722; BARGOU RCEF, 1991, GENE, V99, P197, DOI 10.1016/0378-1119(91)90127-W; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; BLACKSHEAR PJ, 1992, GENOMICS, V14, P168, DOI 10.1016/S0888-7543(05)80300-3; BRUCE J, 1981, J IMMUNOL, V127, P2496; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLOMBO MP, 1992, MAMM GENOME, V2, P130, DOI 10.1007/BF00353861; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIETRICH W, 1992, GENETICS, V131, P423; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EDWARDS YH, 1990, PHILOS T R SOC B, V326, P207, DOI 10.1098/rstb.1990.0005; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FISCHER GF, 1990, J IMMUNOL, V144, P638; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Green EL, 1981, GENETICS PROBABILITY, P77; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HITSUMOTO Y, 1992, BIOCHEM BIOPH RES CO, V187, P773, DOI 10.1016/0006-291X(92)91262-O; HOWARD TA, 1991, GENOMICS, V10, P207, DOI 10.1016/0888-7543(91)90502-6; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; JARMAN AP, 1991, MOL CELL BIOL, V11, P4679, DOI 10.1128/MCB.11.9.4679; KADMON G, 1992, J CELL BIOL, V118, P1245, DOI 10.1083/jcb.118.5.1245; KAY R, 1990, J IMMUNOL, V145, P1952; KAY R, 1991, J IMMUNOL, V147, P1412; KIM KJ, 1979, J IMMUNOL, V122, P549; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; KUDO A, 1987, EMBO J, V6, P103, DOI 10.1002/j.1460-2075.1987.tb04725.x; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MEEKER TC, 1990, MOL CELL BIOL, V10, P1680, DOI 10.1128/MCB.10.4.1680; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; MULLER B, 1988, J EXP MED, V168, P2131, DOI 10.1084/jem.168.6.2131; NEDELEC J, 1992, EUR J BIOCHEM, V203, P433, DOI 10.1111/j.1432-1033.1992.tb16567.x; NIELSEN PJ, 1985, NUCLEIC ACIDS RES, V13, P6867, DOI 10.1093/nar/13.19.6867; OAKEY RJ, 1991, GENOMICS, V10, P338, DOI 10.1016/0888-7543(91)90317-8; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; PIERRES M, 1987, EUR J IMMUNOL, V17, P1781, DOI 10.1002/eji.1830171216; ROUGON G, 1991, EUR J IMMUNOL, V21, P1397, DOI 10.1002/eji.1830210611; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS AM, 1990, GENOMICS, V8, P524; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SHOWE MK, 1992, NUCLEIC ACIDS RES, V20, P3153, DOI 10.1093/nar/20.12.3153; SPANOPOULOU E, 1991, MOL CELL BIOL, V11, P2216, DOI 10.1128/MCB.11.4.2216; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STONE JC, 1989, GENOMICS, V5, P70, DOI 10.1016/0888-7543(89)90088-8; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WATSON ML, 1992, MAMM GENOME, V2, P158, DOI 10.1007/BF00302874; WENGER RH, 1991, EUR J IMMUNOL, V21, P1039, DOI 10.1002/eji.1830210427; WHITELAW E, 1989, MOL CELL BIOL, V9, P241, DOI 10.1128/MCB.9.1.241; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	65	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23345	23352						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226859				2022-12-27	WOS:A1993MF51500062
J	BROWN, AM; WRIGHT, KL; TING, JPY				BROWN, AM; WRIGHT, KL; TING, JPY			HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-ASSOCIATED INVARIANT CHAIN GENE PROMOTER - FUNCTIONAL-ANALYSIS AND IN-VIVO PROTEIN-DNA INTERACTIONS OF CONSTITUTIVE AND IFN-GAMMA-INDUCED EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HLA-DRA GENE; INTERFERON CONSENSUS SEQUENCE; NECROSIS FACTOR-ALPHA; MACROPHAGE CELL-LINE; REGULATORY ELEMENTS; CHLORAMPHENICOL ACETYLTRANSFERASE; DIFFERENTIAL EXPRESSION; TRANSCRIPTIONAL CONTROL; INDUCIBLE REGULATION	Major histocompatibility complex (MHC) class II-associated invariant chain (Ii) gene and the MHC class II molecules are physically and functionally associated within class II-expressing cell types. These genes are generally co-expressed in various cell types and coordinately induced by cytokines such as interferon-gamma (IFN-gamma). Human Ii gene shares a regulatory mechanism with MHC class II genes via the X and Y cis-acting elements. Ii X and Y are required for constitutive expression in B lymphoid cell lines and for induction by IFN-gamma in a glioblastoma cell line. The Servenius element (S) contributes 5-fold transcriptional activity to class II gene HLA-DRA, and an S homologue has been implied in Ii gene regulation. Now we report that along with X and Y, the Ii S box functions in a positive manner to regulate Ii transcription in B cell lines but not in T cell lines. In addition, S, X, and Y are all necessary for induced expression of Ii in an IFN-gamma-regulated glioblastoma cell line and in primary untransformed glial cells. Transcriptional activity of Ii X and Y elements correlates with the presence of in vivo protein/DNA interactions in Ii-expressing cells. Most interestingly, in vivo interactions are induced upon IFN-gamma induction in a time-dependent fashion. Thus, the Ii promoter contains elements that coordinately regulate expression with the MHC class II genes, and these functional sites are contacted in vivo emphasizing their importance in Ii gene transcription.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	BROWN, AM (corresponding author), UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029564, R01AI029564] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29564] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARR CL, 1991, J BIOL CHEM, V266, P3475; BASTA PV, 1987, J IMMUNOL, V138, P1275; BASTA PV, 1988, P NATL ACAD SCI USA, V85, P8618, DOI 10.1073/pnas.85.22.8618; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; BENECH P, 1987, MOL CELL BIOL, V7, P4498, DOI 10.1128/MCB.7.12.4498; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BLANAR MA, 1989, EMBO J, V8, P1139, DOI 10.1002/j.1460-2075.1989.tb03484.x; BROWN AM, 1991, J IMMUNOL, V146, P3183; COGSWELL JP, 1991, J IMMUNOL, V146, P1361; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; CRESSWELL P, 1992, CURR OPIN IMMUNOL, V4, P87, DOI 10.1016/0952-7915(92)90131-W; DEDRICK RL, 1990, MOL CELL BIOL, V10, P593, DOI 10.1128/MCB.10.2.593; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORN A, 1987, P NATL ACAD SCI USA, V84, P6249, DOI 10.1073/pnas.84.17.6249; DOYLE C, 1990, P NATL ACAD SCI USA, V87, P4590, DOI 10.1073/pnas.87.12.4590; EADES AM, 1990, J IMMUNOL, V144, P4399; FINN PW, 1990, P NATL ACAD SCI USA, V87, P914, DOI 10.1073/pnas.87.3.914; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KOCH N, 1984, J IMMUNOL, V132, P1361; KOCH N, 1984, J IMMUNOL, V132, P12; KUDO J, 1985, NUCLEIC ACIDS RES, V13, P8827, DOI 10.1093/nar/13.24.8827; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; LONG EO, 1985, SURV IMMUNOL RES, V4, P27; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; MIRKOVITCH J, 1992, MOL CELL BIOL, V12, P1; MOMBURG F, 1988, CLIN EXP IMMUNOL, V72, P367; MOMBURG F, 1986, J IMMUNOL, V136, P940; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NOELLE RJ, 1986, J IMMUNOL, V137, P1718; PAULNOCKKING D, 1985, J IMMUNOL, V135, P632; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; PESSARA U, 1990, MOL CELL BIOL, V10, P4146, DOI 10.1128/MCB.10.8.4146; PESSARA U, 1988, EUR J IMMUNOL, V18, P1719, DOI 10.1002/eji.1830181110; POLLA BS, 1986, J IMMUNOL, V137, P3332; QUARANTA V, 1984, J IMMUNOL, V132, P1900; RAHMSDORF HJ, 1983, EMBO J, V2, P811, DOI 10.1002/j.1460-2075.1983.tb01507.x; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; SASAKI A, 1989, J NEUROIMMUNOL, V25, P63, DOI 10.1016/0165-5728(89)90087-8; SHERMAN PA, 1987, P NATL ACAD SCI USA, V84, P4254, DOI 10.1073/pnas.84.12.4254; SHIRAYOSHI Y, 1988, P NATL ACAD SCI USA, V85, P5884, DOI 10.1073/pnas.85.16.5884; SUGAWARA M, 1991, P NATL ACAD SCI USA, V88, P10347, DOI 10.1073/pnas.88.22.10347; SUGITA K, 1987, MOL CELL BIOL, V7, P2625, DOI 10.1128/MCB.7.7.2625; TAKIGUCHI M, 1985, EUR J IMMUNOL, V15, P809, DOI 10.1002/eji.1830150813; Teyton L, 1992, Trends Cell Biol, V2, P52, DOI 10.1016/0962-8924(92)90163-H; TSANG SY, 1988, P NATL ACAD SCI USA, V85, P8598, DOI 10.1073/pnas.85.22.8598; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VILEN BJ, 1992, J BIOL CHEM, V267, P23728; VILEN BJ, 1990, MOL CELL BIOL, V11, P2406; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; VOLCPLATZER B, 1984, J EXP MED, V159, P1784, DOI 10.1084/jem.159.6.1784; VOLIVA CF, 1992, MOL CELL BIOL, V12, P2383, DOI 10.1128/MCB.12.5.2383; WRIGHT KL, 1992, P NATL ACAD SCI USA, V89, P7601, DOI 10.1073/pnas.89.16.7601; ZELEZNIKLE NJ, 1991, P NATL ACAD SCI USA, V88, P1873, DOI 10.1073/pnas.88.5.1873; ZHU L, 1990, MOL CELL BIOL, V10, P3906, DOI 10.1128/MCB.10.8.3906	66	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26328	26333						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253755				2022-12-27	WOS:A1993MK42500049
J	GIRARD, LR; CASTLE, AM; HAND, AR; CASTLE, JD; MIRELS, L				GIRARD, LR; CASTLE, AM; HAND, AR; CASTLE, JD; MIRELS, L			CHARACTERIZATION OF COMMON SALIVARY PROTEIN-1, A PRODUCT OF RAT SUBMANDIBULAR, SUBLINGUAL, AND PAROTID-GLANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMINE BINDING-PROTEIN; SECRETORY PROTEINS; POLYACRYLAMIDE GELS; SEQUENCE-ANALYSIS; CELL-POPULATION; LOCALIZATION; EXPRESSION; CLEAVAGE; STORAGE; MEMBRANES	We have isolated and characterized cDNA clones derived from a developmentally regulated neonatal rat submandibular gland salivary protein gene called ''common salivary protein 1'' (CSP1). Identical clones were also identified in cDNA libraries from adult male parotid, submandibular, and sublingual glands. CSP1 transcripts are at least 10-fold more abundant in the sublingual gland than in the submandibular or parotid glands. In situ hybridization and immunocytochemical localization demonstrated the presence of CSP1 transcripts and proteins in sublingual gland serous demilune cells, parotid and submandibular gland intercalated duct cells, and in the type III (proacinar) cells of the neonatal submandibular gland. This cell-type distribution is similar to that described by Ball and colleagues (Ball, W. D., Hand, A. R., and Johnson, A. O. (1988) Dev. Biol. 125, 265-279) for the developmentally regulated submandibular gland B1-immunoreactive proteins. Immunoblotting of salivary secretion identified proteins of M(r) 20,000 in sublingual, 16,000 in submandibular and 22,000 and 16,000 in parotid gland. The M(r) 20,000 sublingual and 22,000 parotid proteins represent N-glycosylated forms of a M(r) 16,000 apoprotein, suggesting that these salivary proteins arise by post-translational modification of a common precursor.	UNIV CALIF SAN DIEGO, DEPT BIOL, 2425 BONNER HALL, 9500 GILMAN DR, LA JOLLA, CA 92093 USA; UNIV VIRGINIA, HLTH SCI CTR, INST MOLEC BIOL, DEPT ANAT & CELL BIOL, CHARLOTTESVILLE, VA 22908 USA; UNIV CONNECTICUT, CTR HLTH, DEPT PEDIAT DENT & ORTHODONT, FARMINGTON, CT 06030 USA	University of California System; University of California San Diego; University of Virginia; University of Connecticut					NIDCR NIH HHS [DE09428, DE08941] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008941, R01DE009428] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANDEREGG RJ, 1988, BIOCHEMISTRY-US, V27, P4214, DOI 10.1021/bi00412a002; ANDERSON LC, 1984, J PHYSIOL-LONDON, V352, P163, DOI 10.1113/jphysiol.1984.sp015284; Arvan Peter, 1992, Trends in Cell Biology, V2, P327; AVIV H, 1977, P NATL ACAD SCI USA, V69, P1409; BALL WD, 1984, EUR J CELL BIOL, V33, P112; BALL WD, 1988, DEV BIOL, V129, P464, DOI 10.1016/0012-1606(88)90393-4; BALL WD, 1988, DEV BIOL, V125, P265, DOI 10.1016/0012-1606(88)90210-2; BALL WD, 1993, BIOL SALIVARY GLANDS, P355; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CASTLE AM, 1992, J BIOL CHEM, V267, P13093; CHANG WWL, 1974, ANAT RECORD, V178, P187, DOI 10.1002/ar.1091780204; COUWENHOVEN RI, 1990, J HISTOCHEM CYTOCHEM, V38, P1853, DOI 10.1177/38.12.2254649; CUTLER LS, 1974, DEV BIOL, V41, P31, DOI 10.1016/0012-1606(74)90280-2; Denny P C, 1990, Adv Dent Res, V4, P34; DENNY PC, 1993, BIOL SALIVARY GLANDS, P263; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HANKS CT, 1971, AM J ANAT, V130, P195, DOI 10.1002/aja.1001300206; HARLOW E, 1988, ANTIBODIES LABORATOR; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; JOHNSON DA, 1988, J DENT RES, V67, P1103, DOI 10.1177/00220345880670080801; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILLS JS, 1987, NUCLEIC ACIDS RES, V15, P7709, DOI 10.1093/nar/15.19.7709; MINAGUCHI K, 1989, J DENT RES, V68, P2, DOI 10.1177/00220345890680010201; MIRELS L, 1987, J BIOL CHEM, V262, P7289; MIRELS L, 1992, J BIOL CHEM, V267, P2679; MOREIRA JE, 1991, AM J ANAT, V191, P167, DOI 10.1002/aja.1001910204; MOREIRA JE, 1990, DEV BIOL, V139, P370, DOI 10.1016/0012-1606(90)90306-4; PAPERMASTER DS, 1976, EXP EYE RES, V23, P105, DOI 10.1016/0014-4835(76)90194-9; REDMAN RS, 1970, J CELL BIOL, V46, P81, DOI 10.1083/jcb.46.1.81; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZARAD D, 1988, J ANAT, V161, P143; SIERRA F, 1986, MOL CELL BIOL, V6, P4067, DOI 10.1128/MCB.6.11.4067; Stone K.L., 1992, TECHNIQUES PROTEIN C, P23; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONZASTROW M, 1989, J BIOL CHEM, V264, P6566; VONZASTROW M, 1987, J CELL BIOL, V105, P2675, DOI 10.1083/jcb.105.6.2675; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WARD LD, 1990, CURRENT RES PROTEIN, P179; YAMASHINA S, 1972, J HISTOCHEM CYTOCHEM, V20, P855, DOI 10.1177/20.11.855; ZAJICEK G, 1985, ANAT REC, V213, P150, DOI 10.1002/ar.1092130206	49	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26592	26601						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253789				2022-12-27	WOS:A1993MK42500084
J	LOMBARDI, P; MULDER, M; VANDERBOOM, H; FRANTS, RR; HAVEKES, LM				LOMBARDI, P; MULDER, M; VANDERBOOM, H; FRANTS, RR; HAVEKES, LM			INEFFICIENT DEGRADATION OF TRIGLYCERIDE-RICH LIPOPROTEIN BY HEPG2 CELLS IS DUE TO A RETARDED TRANSPORT TO THE LYSOSOMAL COMPARTMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E POLYMORPHISM; MOUSE PERITONEAL-MACROPHAGES; HUMAN-FIBROBLASTS; CELLULAR-BINDING; APOPROTEIN-E; HUMAN-PLASMA; RAT-LIVER; BETA-VLDL; RECEPTOR	Binding studies at 37-degrees-C showed that lipoprotein lipase-treated very low density lipoproteins (LPL-VLDL) and very low density lipoproteins (VLDL), once taken up via the low density lipoprotein (LDL) receptor, are poorly degraded by HepG2 cells as compared with LDL. Determination of the initial endocytotic rate for LPL-VLDL and VLDL as compared to LDL shows that LPL-VLDL and VLDL are internalized at a similar rate as LDL. Incubation of cells with labeled LDL, LPL-VLDL, and VLDL at 18-degrees-C for 4.5 h resulted in the accumulation of these particles in the early endosomes, without subsequent transport to the lysosomes and degradation. After washing the cells and a temperature shift to 37-degrees-C, the labeled LDL present in the early endosomes is transported to the lysosomal compartment almost completely within 15 min. Strikingly, for LPL-VLDL and for VLDL, only about 50% or less of the label was moved to the lysosomal compartment within 45 min. However, once present in the lysosomes, VLDL and LPL-VLDL are degraded about 1.6-fold more rapidly than LDL. Retroendocytosis accounts for less than 10% of the internalized LDL, whereas a higher rate of retroendocytosis, up to 20 and 40%, respectively, was observed for LPL-VLDL and VLDL. To evaluate the effect of the inefficient transport of VLDL and LPL-VLDL to the lysosomal compartment on cellular cholesterol homeostasis, acyl-CoA:cholesterol acyltransferase (ACAT) activity was measured. Incubation with 30 mug/ml of LDL induced a 2.5-fold increase in ACAT activity, whereas the incubation with similar amounts of both VLDL and LPL-VLDL failed to stimulate this enzyme. We conclude that both a slower transport to the lysosomal compartment and a higher rate of retroendocytosis, possibly as the consequence of the longer residence time in the early endosomes, are responsible for the poor degradation of VLDL and LPL-VLDL by HepG2 cells.	TNO,GAUBIUS LAB,IVVO,POB 430,2300 AK LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC								ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; AULINSKAS TH, 1985, ARTERIOSCLEROSIS, V5, P45, DOI 10.1161/01.ATV.5.1.45; BELTZ WF, 1985, J CLIN INVEST, V76, P575, DOI 10.1172/JCI112009; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; DUNN WA, 1980, J BIOL CHEM, V255, P5971; EISENBERG S, 1988, ARTERIOSCLEROSIS, V8, P480, DOI 10.1161/01.ATV.8.5.480; EVANS AJ, 1992, J BIOL CHEM, V267, P10743; FRIEDMAN G, 1990, BIOCHIM BIOPHYS ACTA, V1044, P118, DOI 10.1016/0005-2760(90)90226-N; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; HARFORD J, 1983, J BIOL CHEM, V258, P3191; HAVEKES L, 1983, BIOCHEM J, V214, P951, DOI 10.1042/bj2140951; HAVEKES LM, 1987, BIOCHEM J, V247, P739, DOI 10.1042/bj2470739; HAVEL RJ, 1989, METABOLIC BASIS INHE, P1129; HAVEL RJ, 1988, HEPATOLOGY, V8, P1869; KESANIEMI YA, 1985, J CLIN INVEST, V76, P586, DOI 10.1172/JCI112010; KRUL ES, 1985, J CLIN INVEST, V75, P361, DOI 10.1172/JCI111708; LISCUM L, 1992, J LIPID RES, V33, P1039; LOMBARDI P, 1993, BIOCHEM J, V290, P509, DOI 10.1042/bj2900509; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; MIRANIOOSTDIJK CP, 1985, SCAND J CLIN LAB INV, V45, P207, DOI 10.3109/00365518509160997; MULDER M, 1991, BIOCHIM BIOPHYS ACTA, V1081, P308, DOI 10.1016/0005-2760(91)90287-R; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; UTERMANN G, 1987, AM HEART J, V113, P433, DOI 10.1016/0002-8703(87)90610-7; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; WINDLER EET, 1980, J BIOL CHEM, V255, P464; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375; XU XX, 1991, J BIOL CHEM, V266, P17040	39	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26113	26119						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253728				2022-12-27	WOS:A1993MK42500019
J	ZHU, PP; REIZER, J; REIZER, A; PETERKOFSKY, A				ZHU, PP; REIZER, J; REIZER, A; PETERKOFSKY, A			UNIQUE MONOCISTRONIC OPERON (PTSH) IN MYCOPLASMA-CAPRICOLUM ENCODING THE PHOSPHOCARRIER PROTEIN, HPR, OF THE PHOSPHOENOLPYRUVATE-SUGAR PHOSPHOTRANSFERASE SYSTEM - CLONING, SEQUENCING, AND CHARACTERIZATION OF PTSH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-CONTAINING PROTEIN; ESCHERICHIA-COLI K-12; NUCLEOTIDE-SEQUENCE; POSITIVE REGULATION; TERTIARY STRUCTURE; BACILLUS-SUBTILIS; DNA-SEQUENCE; GENE; MUTANTS; GENOME	The region of the genome of Mycoplasma capricolum encompassing the gene (ptsH) encoding HPr, a general energy-coupling protein of the phosphoenolpyruvate: sugar phosphotransferase system, was cloned and sequenced. Examination of the sequence revealed a unique arrangement of the ptsH gene. In all other bacterial species characterized thus far, the ptsH gene is part of a polycistronic operon that includes the gene (ptsI) encoding Enzyme I of the phosphoenolpyruvate: sugar phosphotransferase system; the M. capricolum ptsH gene is part of a monocistronic operon that is situated between two open reading frames unrelated to phosphoenolpyruvate:sugar phosphotransferase system function. The gene immediately upstream of ptsH codes for a helicase, and the open reading frame immediately downstream of ptsH, although not homologous to any previously identified protein, contains a signature sequence characteristic of [C-5] cytosine-specific DNA methylases. The product of the ptsH gene has characteristics similar to the HPr protein produced by Gram-positive organisms: it has a greater sequence similarity to HPrs of Gram-positive bacteria than to those of Gram-negative organisms, it is phosphorylated by a protein kinase derived from Gram-positive organisms, and it complements sugar phosphorylation activity in Gram-positive extracts. The high calculated isoelectric point (pI = 9.18) and the absence of glutamate residues in the C-terminal region distinguish the M. capricolum HPr from all previously described HPrs.	NHLBI, BIOCHEM GENET LAB, BLDG 36, RM 4C-11, BETHESDA, MD 20892 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Diego					NIAID NIH HHS [2RO1AI14176, 5RO1AI21702] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014176, R01AI021702] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ANDERSON JW, 1991, BIOCHEMISTRY-US, V30, P9601, DOI 10.1021/bi00104a006; Ausubel FA, 1990, CURRENT PROTOCOLS MO; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; CIRILLO VP, 1979, MYCOPLASMAS, P323; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; DEREUSE H, 1992, J MOL BIOL, V226, P623, DOI 10.1016/0022-2836(92)90620-Y; DEREUSE H, 1991, J BACTERIOL, V173, P727, DOI 10.1128/jb.173.2.727-733.1991; DEREUSE H, 1985, GENE, V35, P199; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EBRIGHT RH, 1984, NATURE, V311, P232, DOI 10.1038/311232a0; ELKABBANI OAL, 1987, J BIOL CHEM, V262, P12926; FENG DF, 1990, METHOD ENZYMOL, V183, P375; FOX DK, 1992, P NATL ACAD SCI USA, V89, P7056, DOI 10.1073/pnas.89.15.7056; GEERSE RH, 1989, MOL GEN GENET, V216, P517, DOI 10.1007/BF00334399; IWAMI M, 1984, MOL GEN GENET, V196, P317, DOI 10.1007/BF00328065; KLEVIT RE, 1986, BIOCHEMISTRY-US, V25, P7774, DOI 10.1021/bi00371a073; MANILOFF J, 1983, ANNU REV MICROBIOL, V37, P477, DOI 10.1146/annurev.mi.37.100183.002401; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MILES RJ, 1992, J GEN MICROBIOL, V138, P1773, DOI 10.1099/00221287-138-9-1773; MISSET O, 1980, BIOCHEMISTRY-US, V19, P883, DOI 10.1021/bi00546a009; MIYATA M, 1991, FEMS MICROBIOL LETT, V79, P329, DOI 10.1111/j.1574-6968.1991.tb04550.x; MUGHARBIL U, 1978, J BACTERIOL, V133, P203, DOI 10.1128/JB.133.1.203-209.1978; MUTO A, 1987, ISRAEL J MED SCI, V23, P334; Muto Akira, 1992, P331; OH W, 1992, J BACTERIOL, V174, P7873, DOI 10.1128/JB.174.23.7873-7874.1992; ORCHARD LMD, 1990, P ROY SOC B-BIOL SCI, V242, P87, DOI 10.1098/rspb.1990.0108; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAZIN S, 1992, FEMS MICROBIOL LETT, V100, P423, DOI 10.1016/0378-1097(92)90241-F; RAZIN S, 1985, MICROBIOL REV, V49, P419, DOI 10.1128/MMBR.49.4.419-455.1985; Reddy P, 1991, Protein Expr Purif, V2, P179, DOI 10.1016/1046-5928(91)90069-U; REIZER A, 1993, IN PRESS METHODS MOL; REIZER J, 1992, J BIOL CHEM, V267, P9158; REIZER J, 1989, EMBO J, V8, P2111, DOI 10.1002/j.1460-2075.1989.tb03620.x; REIZER J, 1988, P NATL ACAD SCI USA, V85, P2041, DOI 10.1073/pnas.85.7.2041; REIZER J, 1984, J BACTERIOL, V160, P333, DOI 10.1128/JB.160.1.333-340.1984; REIZER J, 1993, PROTEIN SCI, V2, P506; REIZER J, 1987, SUGAR TRANSPORT META, P333; SALSER W, 1967, NATURE, V215, P588, DOI 10.1038/215588a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH DW, 1988, COMPUT APPL BIOSCI, V4, P212; ULLAH AHJ, 1976, J BACTERIOL, V127, P1298, DOI 10.1128/JB.127.3.1298-1306.1976; ULLAH AHJ, 1977, J BACTERIOL, V131, P988, DOI 10.1128/JB.131.3.988-996.1977; WITTEKIND M, 1990, BIOCHEMISTRY-US, V29, P7191, DOI 10.1021/bi00483a006; WU LF, 1990, J MOL BIOL, V213, P687, DOI 10.1016/S0022-2836(05)80256-6	47	26	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26531	26540						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253782				2022-12-27	WOS:A1993MK42500076
J	DIETMEIER, K; ZARA, V; PALMISANO, A; PALMIERI, F; VOOS, W; SCHLOSSMANN, J; MOCZKO, M; KISPAL, G; PFANNER, N				DIETMEIER, K; ZARA, V; PALMISANO, A; PALMIERI, F; VOOS, W; SCHLOSSMANN, J; MOCZKO, M; KISPAL, G; PFANNER, N			TARGETING AND TRANSLOCATION OF THE PHOSPHATE CARRIER P-32 TO THE INNER MEMBRANE OF YEAST MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-ATP CARRIER; PROTEIN IMPORT MACHINERY; SACCHAROMYCES-CEREVISIAE; PRECURSOR PROTEINS; ADP/ATP CARRIER; OUTER-MEMBRANE; UNCOUPLING PROTEIN; CONTACT SITES; NUCLEOSIDE TRIPHOSPHATES; INTERMEMBRANE SPACE	We analyzed the submitochondrial location and biogenesis pathway of the phosphate carrier (P(i)C), also termed p32, of Saccharomyces cerevisiae mitochondria. P(i)C/p32 was found to behave as an integral membrane protein that cofractionated with the ADP/ATP carrier of the inner membrane. Import of the precursor of P(i)C/p32 required a membrane potential across the inner membrane, supporting its localization to the inner membrane. This makes it unlikely that the major function of P(i)C/p32 is that of an import receptor on the surface of the mitochondrial outer membrane. Furthermore, we found that both receptors MOM72 and MOM19 were involved in the import pathway of the precursor of P(i)C/p32 with MOM72 being responsible for the bulk of import. Yeast P(i)C/p32 is thus not only structurally homologous to the ADP/ATP carrier, but has a similar targeting mechanism and submitochondrial location, supporting its classification as a member of the inner membrane carrier family.	UNIV FREIBURG, INST BIOCHEM, HERMANN HERDER STR 7, D-79104 FREIBURG, GERMANY; UNIV MUNICH, INST PHYSIOL CHEM, D-80336 MUNICH, GERMANY; UNIV BARI, DIPARTIMENTO FARMACOBIOL, I-70125 BARI, ITALY; UNIV LECCE, DIPARTIMENTO BIOL, I-73100 LECCE, ITALY	University of Freiburg; University of Munich; Universita degli Studi di Bari Aldo Moro; University of Salento			Zara, Vincenzo/AAC-2900-2019; Pfanner, Nikolaus/AAV-7878-2021; Schlossmann, Jens/I-7743-2016	Schlossmann, Jens/0000-0002-2550-6839; Zara, Vincenzo/0000-0001-6592-4501				BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BECKER K, 1992, J BIOL CHEM, V267, P5637; BRANDOLIN G, 1992, MOL MECHANISMS TRANS, P135; Dolce V., 1991, J DNA SEQUENCING MAP, V2, P133, DOI 10.3109/10425179109039683; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; EMMERMANN M, 1991, CURR GENET, V20, P405, DOI 10.1007/BF00317069; FERREIRA GC, 1990, J BIOL CHEM, V265, P21202; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; FLUGGE UI, 1989, EMBO J, V8, P39, DOI 10.1002/j.1460-2075.1989.tb03346.x; FLUGGE UI, 1991, NATURE, V353, P364, DOI 10.1038/353364a0; GLASER SM, 1990, J BIOL CHEM, V265, P8808; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GUERIN B, 1990, J BIOL CHEM, V265, P19736; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Horwich A, 1990, CURR OPIN CELL BIOL, V2, P625, DOI 10.1016/0955-0674(90)90103-L; HWANG ST, 1991, J BIOL CHEM, V266, P21083; KLINGENBERG M, 1992, BIOCHEM SOC T, V20, P547, DOI 10.1042/bst0200547; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; Krumer R., 1992, MOL MECHANISMS BIOEN, P359, DOI DOI 10.1016/50167-7306(08)60184-2; LIU XQ, 1990, J BIOL CHEM, V265, P9; LIU XQ, 1988, J CELL BIOL, V107, P503, DOI 10.1083/jcb.107.2.503; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; MURAKAMI H, 1993, P NATL ACAD SCI USA, V90, P3358, DOI 10.1073/pnas.90.8.3358; PAIN D, 1990, NATURE, V347, P444, DOI 10.1038/347444a0; PAIN D, 1988, NATURE, V331, P232, DOI 10.1038/331232a0; PFALLER R, 1988, J CELL BIOL, V107, P2483, DOI 10.1083/jcb.107.6.2483; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; PFANNER N, 1986, FEBS LETT, V209, P152, DOI 10.1016/0014-5793(86)81101-2; PFANNER N, 1987, J BIOL CHEM, V262, P14851; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; PFANNER N, 1987, J BIOL CHEM, V262, P7528; PFANNER N, 1991, TRENDS BIOCHEM SCI, V16, P63, DOI 10.1016/0968-0004(91)90026-R; PHELPS A, 1991, J BIOL CHEM, V266, P19882; PHELPS A, 1991, BIOCHEMISTRY-US, V30, P248, DOI 10.1021/bi00215a035; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; PRATT RD, 1991, J BIOL CHEM, V266, P1276; RASSOW J, 1991, FEBS LETT, V293, P85, DOI 10.1016/0014-5793(91)81157-4; RIEZMAN H, 1983, EMBO J, V2, P1113, DOI 10.1002/j.1460-2075.1983.tb01554.x; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SCHNELL DJ, 1990, J CELL BIOL, V111, P1825, DOI 10.1083/jcb.111.5.1825; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; SMAGULA C, 1988, J BIOL CHEM, V263, P6783; SMAGULA CS, 1988, J CELL BIOCHEM, V36, P323, DOI 10.1002/jcb.240360402; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; WACHTER C, 1992, EMBO J, V11, P4787, DOI 10.1002/j.1460-2075.1992.tb05584.x; Walker J.E., 1992, CURR OPIN STRUC BIOL, V2, P519, DOI DOI 10.1016/0959-440X(92)90081-H; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8; ZARA V, 1991, EUR J BIOCHEM, V198, P405, DOI 10.1111/j.1432-1033.1991.tb16029.x; ZARA V, 1992, J BIOL CHEM, V267, P12077; ZWIZINSKI C, 1984, J BIOL CHEM, V259, P7850	61	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25958	25964						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245029				2022-12-27	WOS:A1993MK10000096
J	LEONG, LEC; WALKER, PA; PORTER, AG				LEONG, LEC; WALKER, PA; PORTER, AG			HUMAN RHINOVIRUS-14 PROTEASE-3C (3C(PRO)) BINDS SPECIFICALLY TO THE 5'-NONCODING REGION OF THE VIRAL-RNA - EVIDENCE THAT 3C(PRO) HAS DIFFERENT DOMAINS FOR THE RNA-BINDING AND PROTEOLYTIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 5' NONCODING REGION; COMMON COLD VIRUS; POLIOVIRUS RNA; SERINE PROTEASES; CYSTEINE PROTEASES; PROTEIN 3CD; CLEAVAGE; SEQUENCE; INVITRO	Protease 3C (3C(pro)) encoded by human rhinovirus type 14 was purified from recombinant Escherichia coli and shown to bind specifically to the 5'-terminal 126 nucleotides of the viral RNA (126 RNA) in addition to efficiently cleaving a synthetic peptide in trans. The binding of 3C(pro) to the viral RNA may be required for the initiation of plus strand viral RNA synthesis, suggesting a second non-proteolytic function for 3C(pro). Single amino acid substitutions were generated in 3C(pro) at residues that are highly conserved among picornaviruses or that lie within the putative catalytic triad. Conservative changes at Asp-85 (D85E and D85N) destroyed the ability of 3C(pro) to bind specifically to the 126 RNA, whereas the D85N mutation resulted in almost wild-type levels of proteolytic activity. Conversely, substitutions at His-40, Glu-71, or Cys-146 (H40D, E71A, or C146S) gave proteolytically inactive mutants that bound to the 126 RNA. These results suggest that the highly conserved Asp-85 is essential for specific binding to the 126 RNA, but is unlikely to function in proteolysis as the acidic member of the catalytic triad. Moreover, 3C(pro) appears to have different domains for the RNA binding and proteolytic activities.			LEONG, LEC (corresponding author), NATL UNIV SINGAPORE, INST MOLEC & CELL BIOL, 10 KENT RIDGE CRESCENT, SINGAPORE 0511, SINGAPORE.							ANDINO R, 1990, J VIROL, V64, P607, DOI 10.1128/JVI.64.2.607-612.1990; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; CHEAH KC, 1990, J BIOL CHEM, V265, P7180; CORDINGLEY MG, 1989, J VIROL, V63, P5037, DOI 10.1128/JVI.63.12.5037-5045.1989; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; JORE J, 1988, J GEN VIROL, V69, P1627, DOI 10.1099/0022-1317-69-7-1627; KEAN KM, 1991, VIROLOGY, V181, P609, DOI 10.1016/0042-6822(91)90894-H; LEONG LEC, 1992, J CRYST GROWTH, V122, P246, DOI 10.1016/0022-0248(92)90253-F; PALLAI PV, 1989, J BIOL CHEM, V264, P9738; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; RACANIELLO VR, 1986, VIROLOGY, V155, P498, DOI 10.1016/0042-6822(86)90211-4; RICHARDS OC, 1990, CURR TOP MICROBIOL, V161, P89; RIVERA VM, 1988, VIROLOGY, V165, P42, DOI 10.1016/0042-6822(88)90656-3; SIMOES EAF, 1991, J VIROL, V65, P913, DOI 10.1128/JVI.65.2.913-921.1991; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SONENBERG N, 1990, CURR TOP MICROBIOL, V161, P23; STANWAY G, 1984, NUCLEIC ACIDS RES, V12, P7859, DOI 10.1093/nar/12.20.7859; TRONO D, 1988, J VIROL, V62, P2291, DOI 10.1128/JVI.62.7.2291-2299.1988; YPMAWONG MF, 1988, VIROLOGY, V166, P265, DOI 10.1016/0042-6822(88)90172-9	23	70	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25735	25739						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245010				2022-12-27	WOS:A1993MK10000067
J	ZOLKIEWSKA, A; MOSS, J				ZOLKIEWSKA, A; MOSS, J			INTEGRIN-ALPHA-7 AS SUBSTRATE FOR A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED ADP-RIBOSYLTRANSFERASE ON THE SURFACE OF SKELETAL-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RIBOSYLATION; PROTEINS; BINDING; INTEGRINS; ADHESION; LAMININ; ADULT	An arginine-specific mono-ADP-ribosyltransferase is expressed on the surface of differentiated mouse skeletal muscle cells and is anchored in the membrane via a glycosylphosphatidylinositol tail. Following incubation of intact cells with [adenylate-P-32]NAD and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), a 97-kDa [P-32]ADP-ribosylated protein was observed under reducing conditions and a 140-kDa complex under nonreducing conditions. The ADP-ribosylated protein was purified on a laminin affinity column. Based on its N-terminal sequence (FNLDVMGAIRKEGEPGSLFGF) and a partial internal sequence (GLMRSEELSFVAGAP), the modified protein was identified as integrin alpha7. Following partial trypsin digestion, a 39-kDa/79-kDa radiolabeled fragment was produced (reduced/nonreduced SDS-PAGE), narrowing the ADP-ribosylation site to a 39-kDa segment in the extracellular domain of integrin alpha7. Labeling under optimal conditions was at least 0.4 mol of ADP-ribose/mol of integrin alpha7. Selective expression of both ADP-ribosyltransferase and integrin alpha7 in cardiac and skeletal muscle, a similar developmental appearance, and the apparently specific ADP-ribosylation, are consistent with a regulatory association between these proteins. ADP-ribosylation may modulate integrin receptor signaling and could play a significant role in the regulation of muscle cell function by the extracellular matrix.			ZOLKIEWSKA, A (corresponding author), NHLBI,CELLULAR METAB LAB,BLDG 10,RM 5N307,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BOZYCZKO D, 1989, EXP CELL RES, V183, P72, DOI 10.1016/0014-4827(89)90419-9; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; FERGUSON MAJ, 1992, BIOCHEM SOC T, V20, P243, DOI 10.1042/bst0200243; HARA N, 1987, BIOCHEM BIOPH RES CO, V148, P989, DOI 10.1016/S0006-291X(87)80229-2; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KAUFMAN SJ, 1985, DEV BIOL, V110, P1, DOI 10.1016/0012-1606(85)90057-0; KHARADIA SV, 1992, EXP CELL RES, V201, P33, DOI 10.1016/0014-4827(92)90345-9; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; MEYER T, 1988, BIOL CHEM H-S, V369, P579, DOI 10.1515/bchm3.1988.369.2.579; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; PAYNE DM, 1985, BIOCHEMISTRY-US, V24, P7540, DOI 10.1021/bi00347a006; PETERSON JE, 1990, J BIOL CHEM, V265, P17062; PIRON KJ, 1990, BIOCHEM J, V270, P591, DOI 10.1042/bj2700591; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILLIAMSON KC, 1990, ADP RIBOSYLATING TOX, P151; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	21	141	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25273	25276						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244957				2022-12-27	WOS:A1993MK10000004
J	REYNISDOTTIR, I; LORIMER, HE; FRIEDMAN, PN; WANG, EH; PRIVES, C				REYNISDOTTIR, I; LORIMER, HE; FRIEDMAN, PN; WANG, EH; PRIVES, C			PHOSPHORYLATION AND ACTIVE ATP HYDROLYSIS ARE NOT REQUIRED FOR SV40 T-ANTIGEN HEXAMER FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-ANTIGEN; DNA-POLYMERASE-ALPHA; REPLICATION PROTEIN-A; VIRUS-40 CORE ORIGIN; SIMIAN VIRUS-40; BINDING-SITE; HELICASE ACTIVITIES; STRUCTURAL-CHANGES; UNWINDING ACTIVITY; INSECT CELLS	ATP induces structural alterations in SV40 large T antigen and promotes changes in its interaction with the viral replication origin. We have analyzed nucleotide-induced changes in T antigen structure in the absence of origin DNA. Most preparations of immunopurified T antigen contain several discrete species ranging in size from monomers through oligomers larger than hexamers. The predominant species consist of monomers and dimers. Incubation of T antigen with ATP or dATP leads to a dramatic and rapid increase in the appearance of T antigen hexamers. Weakly and nonhydrolyzable analogs of ATP are effective as well, indicating that hexamer formation does not require active ATP hydrolysis. After incubation of T antigen with [gamma-S-35]ATP, stable association of the labeled nucleotide with all detectable forms occurs. Removal of greater than 80% of the T antigen phosphate residues does not significantly affect the formation of T antigen hexamers, although changes in the distribution and mobility of the other species of T antigen are apparent. Furthermore, T antigen synthesized in and purified from Escherichia coli and, therefore, presumably un- or underphosphorylated, is capable of forming hexamers. Nucleotide-induced T antigen hexamer formation thus appears to require neither protein phosphorylation nor active ATP hydrolysis.	COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	Columbia University				Reynisdottir, Inga/0000-0002-9730-7476	NCI NIH HHS [CA26905] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA026905] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BOROWIEC JA, 1991, J VIROL, V65, P1228, DOI 10.1128/JVI.65.3.1228-1235.1991; BRADLEY MK, 1987, P NATL ACAD SCI USA, V84, P4026, DOI 10.1073/pnas.84.12.4026; BRADLEY MK, 1990, J VIROL, V64, P4939, DOI 10.1128/JVI.64.10.4939-4947.1990; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; CLERTANT P, 1982, J BIOL CHEM, V257, P6300; CLERTANT P, 1984, J BIOL CHEM, V259, P5196; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; DAN FB, 1992, J BIOL CHEM, V267, P14129; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P8981, DOI 10.1073/pnas.84.24.8981; DEAN FB, 1991, J BIOL CHEM, V266, P5062; DEAN P, 1988, TRENDS BIOTECHNOL, V6, P113, DOI 10.1016/0167-7799(88)90099-6; DEB S, 1987, J VIROL, V61, P2143, DOI 10.1128/JVI.61.7.2143-2149.1987; DEB SP, 1987, J VIROL, V61, P3649, DOI 10.1128/JVI.61.12.3649-3654.1987; DELUCIA AL, 1983, J VIROL, V46, P143, DOI 10.1128/JVI.46.1.143-150.1983; DODSON M, 1987, SCIENCE, V238, P964, DOI 10.1126/science.2823389; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; GOETZ GS, 1988, J BIOL CHEM, V263, P383; GRASSER FA, 1987, J VIROL, V61, P3373; Griffin J D, 1980, Cold Spring Harb Symp Quant Biol, V44 Pt 1,, P113; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HOSS A, 1990, J VIROL, V64, P4799; JONES KA, 1984, CELL, V36, P155, DOI 10.1016/0092-8674(84)90084-9; KLAUSING K, 1988, J VIROL, V62, P1258, DOI 10.1128/JVI.62.4.1258-1265.1988; LORIMER HE, 1991, J VIROL, V65, P687, DOI 10.1128/JVI.65.2.687-699.1991; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MOHR IJ, 1987, EMBO J, V6, P153, DOI 10.1002/j.1460-2075.1987.tb04733.x; MOHR IJ, 1989, P NATL ACAD SCI USA, V86, P6479, DOI 10.1073/pnas.86.17.6479; MYERS RM, 1980, P NATL ACAD SCI-BIOL, V77, P6491, DOI 10.1073/pnas.77.11.6491; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PARSONS R, 1992, J VIROL, V66, P1933, DOI 10.1128/JVI.66.4.1933-1942.1992; PARSONS R, 1990, J VIROL, V64, P509, DOI 10.1128/JVI.64.2.509-518.1990; PARSONS RE, 1991, J VIROL, V65, P2798, DOI 10.1128/JVI.65.6.2798-2806.1991; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; REYNISDOTTIR I, 1992, J VIROL, V66, P6517; REYNISDOTTIR I, 1990, J VIROL, V64, P6234; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TJIAN R, 1979, P NATL ACAD SCI USA, V76, P610, DOI 10.1073/pnas.76.2.610; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; VIRSHUP DM, 1992, MOL CELL BIOL, V12, P42883; WANG EH, 1991, VIROLOGY, V184, P399, DOI 10.1016/0042-6822(91)90858-9; WANG EH, 1991, J BIOL CHEM, V266, P12668; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	57	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24647	24654						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227024				2022-12-27	WOS:A1993MG67300024
J	VASHEE, S; XU, HQ; JOHNSTON, SA; KODADEK, T				VASHEE, S; XU, HQ; JOHNSTON, SA; KODADEK, T			HOW DO ZN2CYS6 PROTEINS DISTINGUISH BETWEEN SIMILAR UPSTREAM ACTIVATION SITES - COMPARISON OF THE DNA-BINDING SPECIFICITY OF THE GAL4 PROTEIN IN-VITRO AND IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ZINC FINGER; REGULATORY PROTEINS; YEAST; GENE; TRANSCRIPTION; MECHANISM; RECOGNITION; SEQUENCES; REPRESSOR	The GAL4 protein of Saccharomyces cerevisiae is the prototype of a family of transcription factors that contain a ''Zn2Cys6'' coordination complex in the DNA-binding domain. GAL4 activates the transcription of genes involved in galactose and melibiose metabolism by binding to sites that contain one or more copies of a sequence 5'-CGGN5TN5CCG-3'. Other Zn2Cys6 proteins in S. cerevisiae also recognize sequences containing two CGG triplets, but with different spacings between them. In this report we investigate the mechanism by which GAL4 distinguishes its bona fide binding site from similar sequences as well as from bulk genomic DNA. In vitro, GAL4 recognizes with moderate to high affinity a variety of sites of the general formula (A/C)GGN10-12CCG. This level of specificity is apparently insufficient for the activator to carry out its biological role. However, many of the sites to which GAL4 binds in vitro do not support GAL4-activated transcription in vivo. In most cases there is not a quantitative correlation between the relative affinity of a site for GAL4 in vitro and the level of GAL4-dependent transcription supported by it in vivo. These data imply that there is some mechanism in vivo by which the intrinsic binding specificity of GAL4 is modified.	UNIV TEXAS,DEPT CHEM & BIOCHEM,AUSTIN,TX 78712; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DEPT BIOCHEM,DALLAS,TX 75235	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIGMS NIH HHS [GM-40700, GM-47140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047140, R01GM040700] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; CORTON JC, 1989, NATURE, V340, P724, DOI 10.1038/340724a0; EMAMI KH, 1992, EMBO J, V11, P5005, DOI 10.1002/j.1460-2075.1992.tb05607.x; FINLEY RL, 1990, MOL CELL BIOL, V10, P5663, DOI 10.1128/MCB.10.11.5663; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; HALVORSEN YDC, 1991, MOL CELL BIOL, V11, P1777, DOI 10.1128/MCB.11.4.1777; HANSEN A, 1991, BIOCHEM BIOPH RES CO, V175, P492, DOI 10.1016/0006-291X(91)91591-Y; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JOHNSTON M, 1988, GENETICS, V120, P63; JOHNSTON M, 1987, P NATL ACAD SCI USA, V84, P2401, DOI 10.1073/pnas.84.8.2401; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; JOHNSTON SA, 1982, P NATL ACAD SCI-BIOL, V79, P6971, DOI 10.1073/pnas.79.22.6971; KRISTIE TM, 1993, J BIOL CHEM, V268, P6525; LEUTHER KK, 1992, SCIENCE, V256, P1333, DOI 10.1126/science.1598579; LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; LOSSON R, 1981, MOL GEN GENET, V184, P394, DOI 10.1007/BF00352511; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; NISHIZAWA M, 1990, P NATL ACAD SCI USA, V87, P5373, DOI 10.1073/pnas.87.14.5373; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; PARTHUN MR, 1992, MOL CELL BIOL, V12, P4981, DOI 10.1128/MCB.12.11.4981; PARTHUN MR, 1992, MOL CELL BIOL, V12, P5683, DOI 10.1128/MCB.12.12.5683; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SALMERON JM, 1989, MOL CELL BIOL, V9, P2950, DOI 10.1128/MCB.9.7.2950; SIDDIQUI AH, 1989, MOL CELL BIOL, V9, P4706, DOI 10.1128/MCB.9.11.4706; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; TURCOTTE B, 1992, GENE DEV, V6, P2001, DOI 10.1101/gad.6.10.2001; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613	36	76	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24699	24706						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227030				2022-12-27	WOS:A1993MG67300031
J	WEDEGAERTNER, PB; CHU, DH; WILSON, PT; LEVIS, MJ; BOURNE, HR				WEDEGAERTNER, PB; CHU, DH; WILSON, PT; LEVIS, MJ; BOURNE, HR			PALMITOYLATION IS REQUIRED FOR SIGNALING FUNCTIONS AND MEMBRANE ATTACHMENT OF G(Q)ALPHA AND G(S)ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNIT; GS-ALPHA; BETA-GAMMA; COS CELLS; BINDING; ASSOCIATION; RECEPTOR; SITE; IDENTIFICATION; STIMULATION	We have identified the palmitoylated cysteine residues of alpha(q) and alpha(s), alpha subunits of two heterotrimeric G proteins. Mutational substitutions of serines for cysteines 9 and 10 in alpha(q) and cysteine 3 in alpha(s) profoundly alter behavior of the subunits expressed in HEK293 cells. Neither mutant alpha subunit incorporates palmitate; both mutant proteins are found in the soluble rather than the particulate fraction; mutant alpha(q) or alpha(s) cannot couple a co-expressed receptor to stimulation of phospholipase C or adenylylcyclase, respectively, cysteine substitution prevents a mutationally activated alpha(q) (R183C) from stimulating phospholipase C directly, and reduces but does not abolish the ability of a similarly activated alpha(s) (R201C) to stimulate cAMP synthesis. Substitution of a myristoylation sequence for the palmitoylation sites leads to labeling of alpha(q) and alpha(s) by myristate, rather than by palmitate. Myristoylation restores the abilities of both nonpalmitoylated alpha(q) and alpha(s) to attach to membranes and, in the case of alpha(q), restores its ability to stimulate phospholipase C, whether triggered by the R183C mutation or by receptor activation. These findings identify palmitoylation as a critical determinant of membrane attachment for alpha(q) and alpha(s) and show that this modification is required for normal signaling by these proteins.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,DEPT PHARMACOL,S1212,BOX 0450,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R01CA054427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027800, R01GM027800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000961] Funding Source: NIH RePORTER; NCI NIH HHS [CA-54427] Funding Source: Medline; NIGMS NIH HHS [GM-27800] Funding Source: Medline; NIMH NIH HHS [K21MH00961] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BERGER M, 1984, J BIOL CHEM, V259, P7245; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4263; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHAPMAN ER, 1992, J BIOL CHEM, V267, P25233; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DIVECHA N, 1993, BIOCHEM J, V289, P617, DOI 10.1042/bj2890617; FIRNBAUMER L, 1990, ANN REV PHARM TOXICO, V30, P675; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; FUNG BKK, 1983, J BIOL CHEM, V258, P503; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; GUYER CA, 1990, J BIOL CHEM, V265, P17307; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P12655; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; INIQUAZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES TL, 1990, P NATL ACAD SCI USA, V57, P568; JOURNOT L, 1991, P NATL ACAD SCI USA, V88, P10054, DOI 10.1073/pnas.88.22.10054; JUHNN YS, 1992, J CELL BIOL, V119, P523, DOI 10.1083/jcb.119.3.523; KAUFMAN JF, 1984, J BIOL CHEM, V259, P7230; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUSZBEK L, 1993, J BIOL CHEM, V268, P8251; NEGISHI M, 1992, J BIOL CHEM, V267, P2364; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; PANG IH, 1990, J BIOL CHEM, V265, P18707; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TODDERUD G, 1990, SCIENCE, V249, P296, DOI 10.1126/science.2374928; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0	51	277	281	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25001	25008						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227063				2022-12-27	WOS:A1993MG67300072
J	CHIESA, GL; JOHNSON, DF; YAO, ZM; INNERARITY, TL; MAHLEY, RW; YOUNG, SG; HAMMER, RH; HOBBS, HH				CHIESA, GL; JOHNSON, DF; YAO, ZM; INNERARITY, TL; MAHLEY, RW; YOUNG, SG; HAMMER, RH; HOBBS, HH			EXPRESSION OF HUMAN APOLIPOPROTEIN B100 IN TRANSGENIC MICE - EDITING OF HUMAN APOLIPOPROTEIN-B100 MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LOW-DENSITY-LIPOPROTEIN; RAT-LIVER; MONOCLONAL-ANTIBODIES; CHOROID-PLEXUS; STOP CODON; B GENE; APO-B; INTESTINE; ELEMENTS; INVITRO	Apolipoprotein B (apoB) is a large glycoprotein that circulates in plasma as a major constituent of numerous lipoproteins. ApoB exists in two forms: apoB48 and apoB100. ApoB48 is identical in sequence to the N-terminal region of apoB100 and is generated by sequence-specific mRNA editing of the apoB100 transcript. Here, we describe the development of a line of mice expressing a human apoB transgene driven by promoter/enhancer sequences from the transthyretin gene. In these mice, immunodetectable human apoB100 is synthesized by the liver, kidney, and brain. Human apoB100 is found in low concentration (approximately 0.1 mg/dl) in the plasma of the transgenic mice and circulates in the low density lipoprotein fraction. The hepatic human apoB100 transcripts undergo mRNA editing at only slightly lower efficiency than the endogenous mouse apoB100 message. Therefore, there is no absolute species specificity to the apoB100 mRNA editing process.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,DEPT PATHOL & MED,SAN FRANCISCO,CA 94141; UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94141; UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Alberta; University of Alberta			Chiesa, Giulia/G-8987-2012	Chiesa, Giulia/0000-0001-5553-1210; Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL-47619, HL-47660, HL-20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047660, R01HL047619, P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BAUM CL, 1990, J BIOL CHEM, V265, P19263; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BOSTROM K, 1990, J BIOL CHEM, V265, P22446; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; BROOKS AR, 1992, MOL CELL BIOL, V12, P1134, DOI 10.1128/MCB.12.3.1134; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CHIESA G, 1992, J BIOL CHEM, V267, P24369; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COSTA RH, 1990, P NATL ACAD SCI USA, V87, P6589, DOI 10.1073/pnas.87.17.6589; CURTISS LK, 1982, J BIOL CHEM, V257, P14213; DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482; GARCIA ZC, 1992, ARTERIOSCLER THROMB, V12, P172, DOI 10.1161/01.ATV.12.2.172; GLICKMAN RM, 1986, P NATL ACAD SCI USA, V83, P5296, DOI 10.1073/pnas.83.14.5296; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIGUCHI K, 1992, J LIPID RES, V33, P1753; JOHNSON DF, 1993, BIOCHEM BIOPH RES CO, V195, P1204, DOI 10.1006/bbrc.1993.2172; KRUL ES, 1988, J LIPID RES, V29, P937; LEIGHTON JK, 1990, J LIPID RES, V31, P1663; MILNE R, 1989, J BIOL CHEM, V264, P19754; NAVARATNAM N, 1993, P NATL ACAD SCI USA, V90, P222, DOI 10.1073/pnas.90.1.222; PEASE RJ, 1990, J BIOL CHEM, V265, P553; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; SHAH RR, 1991, J BIOL CHEM, V266, P16301; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; TENG BB, 1990, BIOCHEM BIOPH RES CO, V173, P74, DOI 10.1016/S0006-291X(05)81023-X; TENNYSON GE, 1989, P NATL ACAD SCI USA, V86, P500, DOI 10.1073/pnas.86.2.500; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; WU JH, 1990, J BIOL CHEM, V265, P12312; XIONG WJ, 1992, J BIOL CHEM, V267, P21412; XIONG WJ, 1993, J BIOL CHEM, V268, P17647; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; YAO ZM, 1992, J BIOL CHEM, V267, P1175; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	36	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23747	23750						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226902				2022-12-27	WOS:A1993MF29400004
J	HANAI, R; WANG, JC				HANAI, R; WANG, JC			THE MECHANISM OF SEQUENCE-SPECIFIC DNA CLEAVAGE AND STRAND TRANSFER BY PHI-X174 GENE-A-ASTERISK PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; BACTERIOPHAGE-PHI-X174 GENE; MEDIATED TERMINATION; PHI-X; REPLICATION; RECOMBINATION; REINITIATION; GENOME; ORIGIN; SITE	We have examined the biological role and catalytic function of two juxtaposed tyrosyl residues in the bacteriophage phiX174 gene A protein, Tyr-343 and Tyr-347, which have been implicated in the catalysis of sequence-specific DNA strand transfer. Site-directed mutagenesis changing either tyrosine to phenylalanine abolishes phage viability. The biochemical basis of this inviability was studied using purified A* protein containing the carboxyl-terminal 341 amino acids of the A protein, as well as purified A* protein with a Y343F or Y347F mutation. All three proteins can cleave the phiX174 replication origin and perform strand transfer between oligodeoxy-nucleotides bearing the recognition sequence of the A protein; however, both Tyr-343 and Tyr-347 appear to be required for coordinated DNA strand transfer by a single A* protein molecule. The chirality of a phosphorothioate group at the site of strand transfer in the DNA was found to be retained following the strand-transfer reaction, which argues against transfer of Tyr-343-linked DNA to Tyr-347 on the same protein molecule or vice versa. These results support the current model of gene A protein function in which the two tyrosines of a single protein molecule alternate in catalyzing DNA strand transfer at the viral replication origin.	HARVARD UNIV, DEPT BIOCHEM & MOLEC BIOL, CAMBRIDGE, MA 02138 USA	Harvard University				Hanai, Ryo/0000-0002-6561-7613	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024544, R01GM024544] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24544] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN DR, 1984, J BIOL CHEM, V259, P545; COLASANTI J, 1985, J VIROL, V53, P807, DOI 10.1128/JVI.53.3.807-813.1985; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DEMPSEY LA, 1992, P NATL ACAD SCI USA, V89, P3083, DOI 10.1073/pnas.89.7.3083; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; EISENBERG S, 1977, P NATL ACAD SCI USA, V74, P3198, DOI 10.1073/pnas.74.8.3198; EISENBERG S, 1980, NUCLEIC ACIDS RES, V8, P5305; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FERSHT A, 1984, ENZYME STRUCTURE MEC, P221; FLUIT AC, 1985, EUR J BIOCHEM, V149, P579, DOI 10.1111/j.1432-1033.1985.tb08964.x; GODSON GN, 1973, BIOCHIM BIOPHYS ACTA, V299, P516, DOI 10.1016/0005-2787(73)90223-2; GODSON GN, 1978, SINGLE STRANDED DNA, P51; Hayashi M., 1988, BACTERIOPHAGES, V2, P1; KODAIRA KI, 1992, BIOCHIM BIOPHYS ACTA, V1130, P277, DOI 10.1016/0167-4781(92)90440-B; KORNBERG A, 1992, DNA REPLICATION, P298; LANGEVELD SA, 1978, NATURE, V271, P417, DOI 10.1038/271417a0; LANGEVELD SA, 1979, NUCLEIC ACIDS RES, V7, P2177, DOI 10.1093/nar/7.8.2177; LANGEVELD SA, 1981, NUCLEIC ACIDS RES, V9, P545, DOI 10.1093/nar/9.3.545; LANGEVELD SA, 1980, FEBS LETT, V114, P269, DOI 10.1016/0014-5793(80)81131-8; LAU PCK, 1985, GENE, V40, P273, DOI 10.1016/0378-1119(85)90050-2; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; ROTH MJ, 1984, J BIOL CHEM, V259, P556; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SANHUEZA S, 1984, P NATL ACAD SCI-BIOL, V81, P4285, DOI 10.1073/pnas.81.14.4285; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMAS CD, 1990, J BIOL CHEM, V265, P5519; VANDERAVOORT HGAM, 1983, BIOCHIM BIOPHYS ACTA, V741, P94, DOI 10.1016/0167-4781(83)90014-3; VANDERENDE A, 1981, NUCLEIC ACIDS RES, V9, P2037, DOI 10.1093/nar/9.9.2037; VANDERENDE A, 1984, ADV EXP MED BIOL, V179, P221; VANMANSFELD ADM, 1986, NUCLEIC ACIDS RES, V14, P4229, DOI 10.1093/nar/14.10.4229; VANMANSFELD ADM, 1980, NATURE, V288, P561, DOI 10.1038/288561a0; Wang J.C., 1979, MOL GENETICS, P65, DOI [10.1016/B978-0-12-684403-0.50009-5., DOI 10.1016/B978-0-12-684403-0.50009-5]; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665	36	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23830	23836						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226920				2022-12-27	WOS:A1993MF29400022
J	LADERMAN, KA; ASADA, K; UEMORI, T; MUKAI, H; TAGUCHI, Y; KATO, I; ANFINSEN, CB				LADERMAN, KA; ASADA, K; UEMORI, T; MUKAI, H; TAGUCHI, Y; KATO, I; ANFINSEN, CB			ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEBACTERIUM PYROCOCCUS-FURIOSUS - CLONING AND SEQUENCING OF THE GENE AND EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOGLOMUS-THERMOPHILUM; NUCLEOTIDE-SEQUENCE; AMYLOLYTIC ENZYME; SP-NOV; TRANSCRIPTION; SULFOLOBUS; PHYLOGENY	A gene encoding a highly thermostable alpha-amylase from the hyperthermophilic archaebacterium Pyrococcus furiosus was cloned and expressed in Escherichia coli. The nucleotide sequence of the gene predicts a 649-amino acid protein with a calculated molecular mass of 76.3 kDa, which corresponds well with the value obtained from purified enzyme using denaturing polyacrylamide gel electrophoresis. The NH2 terminus of the deduced amino acid sequence corresponds precisely to that obtained from the purified enzyme, excluding the NH2-terminal methionine. The amylase expressed in E. coli exhibits temperature-dependent activation characteristic of the original enzyme from P. furiosus, but has a higher apparent molecular weight which is attributed to the improper formation of the native quaternary structure. No homology was found with previously characterized promotor or termination sequences. The deduced amino acid sequence displayed strong homology to the alpha-amylase A of Dictyoglomus thermophilum, an obligately anaerobic, extremely thermophilic bacterium. Evolutionary implications of this homology are discussed.	JOHNS HOPKINS UNIV,DEPT BIOL,34TH & CHARLES ST,BALTIMORE,MD 21218; TAKARA SHUZO CO,OTSU,SHIGA 52021,JAPAN	Johns Hopkins University; Takara Holdings Inc.								BAHL H, 1991, APPL ENVIRON MICROB, V57, P1554, DOI 10.1128/AEM.57.5.1554-1559.1991; BROWN SH, 1990, APPL ENVIRON MICROB, V56, P1985, DOI 10.1128/AEM.56.7.1985-1991.1990; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FUKUSUMI S, 1988, EUR J BIOCHEM, V174, P15, DOI 10.1111/j.1432-1033.1988.tb14056.x; KOCH R, 1990, FEMS MICROBIOL LETT, V71, P21, DOI 10.1111/j.1574-6968.1990.tb03792.x; LADERMAN KA, 1993, J BIOL CHEM, V268, P24394; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; PACE NR, 1986, CELL, V45, P325, DOI 10.1016/0092-8674(86)90315-6; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REITER WD, 1988, NUCLEIC ACIDS RES, V16, P1, DOI 10.1093/nar/16.1.1; REITER WD, 1988, NUCLEIC ACIDS RES, V16, P2445, DOI 10.1093/nar/16.6.2445; SAIKI T, 1985, INT J SYST BACTERIOL, V35, P253, DOI 10.1099/00207713-35-3-253; SAMBROOK J, 1986, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TODA H, 1982, P JPN ACAD B-PHYS, V58, P208, DOI 10.2183/pjab.58.208; TSUKAGOSHI N, 1985, J BACTERIOL, V164, P1182, DOI 10.1128/JB.164.3.1182-1187.1985; Woese C.R., 1985, BACTERIA; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZWICKL P, 1990, J BACTERIOL, V172, P4329, DOI 10.1128/jb.172.8.4329-4338.1990	20	105	113	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24402	24407						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226990				2022-12-27	WOS:A1993MF29400101
J	TERAOKA, H; MINAMI, H; IIJIMA, S; TSUKADA, K; KOIWAI, O; DATE, T				TERAOKA, H; MINAMI, H; IIJIMA, S; TSUKADA, K; KOIWAI, O; DATE, T			EXPRESSION OF ACTIVE HUMAN DNA LIGASE-I IN ESCHERICHIA-COLI-CELLS THAT HARBOR A FULL-LENGTH DNA LIGASE-I CDNA CONSTRUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALF THYMUS; RAT-LIVER; DROSOPHILA-MELANOGASTER; FUNCTIONAL EXPRESSION; CATALYTIC DOMAIN; MAMMALIAN-CELLS; MOLECULAR-FORMS; BLOOMS SYNDROME; PURIFICATION; PROTEIN	A recombinant plasmid for expression of full-length human DNA ligase I (phLig-I) was constructed in a plasmid/phage chimeric vector, pTD-T7N, which was derived from pUC118 by oligonucleotide-directed mutagenesis. The insert contained a 2757-base pair coding sequence for a whole human DNA ligase I and an extra ACC codon adjacent to the ATG initiation codon. This ACC codon was required for achieving high levels of expression of full-length DNA ligase I in Escherichia coli strain BL21. The recombinant plasmid, which was designed to exploit the T7 late promoter and the ATG initiation codon for beta-galactosidase was transfected into E. coli BL21 cells that express T7 RNA polymerase. The recombinant clone produced relatively high levels of DNA ligase I with a molecular mass of 130 kDa, as estimated by SDS-polyacrylamide gel electrophoresis. The DNA ligase was purified to near-homogeneity by the two-step column chromatographic procedure from BLphLig-I cells that had been induced with isopropyl beta-D-thiogalactoside. The specific activity, chromatographic behavior, kinetic properties, molecular mass, and antigenicity of the recombinant human DNA ligase I were indistinguishable from those of purified mammalian DNA ligase I. Metabolically labeling experiments with P-32(i) indicate that the recombinant DNA ligase I was present as an enzyme-AMP reaction intermediate, but not as a phosphoprotein, in the E. coli cells.	TOKYO MED & DENT UNIV,MED RES INST,DEPT PATHOL BIOCHEM,TOKYO 101,JAPAN; AICHI CANC CTR,RES INST,BIOCHEM LAB,NAGOYA,AICHI 464,JAPAN	Tokyo Medical & Dental University (TMDU); Aichi Cancer Center	TERAOKA, H (corresponding author), KANAZAWA MED SCH,DEPT BIOCHEM,ISHIKAWA 92002,JAPAN.							ARRAND JE, 1986, J BIOL CHEM, V261, P9079; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN JYH, 1985, CARCINOGENESIS, V6, P1275, DOI 10.1093/carcin/6.9.1275; DATE T, 1990, GENE, V90, P141, DOI 10.1016/0378-1119(90)90450-6; ELDER RH, 1992, EUR J BIOCHEM, V203, P53, DOI 10.1111/j.1432-1033.1992.tb19826.x; ELDER RH, 1990, BIOCHEMISTRY-US, V29, P6009, DOI 10.1021/bi00477a019; HIGASHITANI A, 1990, CELL STRUCT FUNCT, V15, P67, DOI 10.1247/csf.15.67; IIJIMA S, 1992, EUR J BIOCHEM, V206, P595, DOI 10.1111/j.1432-1033.1992.tb16964.x; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; KURIHARA T, 1991, JPN J CANCER RES, V82, P51, DOI 10.1111/j.1349-7006.1991.tb01745.x; MEZZINA M, 1982, NUCLEIC ACIDS RES, V10, P5073, DOI 10.1093/nar/10.16.5073; NAKAYA N, 1977, J BIOCHEM-TOKYO, V81, P1575; PETRINI JHJ, 1991, P NATL ACAD SCI USA, V88, P7615, DOI 10.1073/pnas.88.17.7615; PRIGENT C, 1992, EMBO J, V11, P2925, DOI 10.1002/j.1460-2075.1992.tb05362.x; SODERHALL S, 1976, FEBS LETT, V67, P1, DOI 10.1016/0014-5793(76)80858-7; SODERHALL S, 1976, NATURE, V260, P640, DOI 10.1038/260640a0; SODERHALL S, 1975, J BIOL CHEM, V250, P8438; SODERHALL S, 1973, BIOCHEM BIOPH RES CO, V53, P910, DOI 10.1016/0006-291X(73)90178-2; STUDIER F, 1986, J MOL BIOL, V189, P141; TAKAHASHI M, 1987, FEBS LETT, V213, P345, DOI 10.1016/0014-5793(87)81520-X; TAKAHASHI M, 1990, EUR J BIOCHEM, V192, P735, DOI 10.1111/j.1432-1033.1990.tb19284.x; TERAOKA H, 1984, J BIOCHEM-TOKYO, V95, P1529, DOI 10.1093/oxfordjournals.jbchem.a134763; TERAOKA H, 1975, FEBS LETT, V54, P217, DOI 10.1016/0014-5793(75)80077-9; TERAOKA H, 1979, BIOCHIM BIOPHYS ACTA, V563, P535, DOI 10.1016/0005-2787(79)90072-8; TERAOKA H, 1986, BIOCHIM BIOPHYS ACTA, V873, P297, DOI 10.1016/0167-4838(86)90057-9; TERAOKA H, 1981, BIOCHIM BIOPHYS ACTA, V653, P408, DOI 10.1016/0005-2787(81)90196-9; TERAOKA H, 1987, J BIOCHEM-TOKYO, V101, P225, DOI 10.1093/oxfordjournals.jbchem.a121895; TERAOKA H, 1986, J BIOL CHEM, V261, P6888; TERAOKA H, 1992, BIOCHEM INT, V26, P963; TERAOKA H, 1983, BIOCHIM BIOPHYS ACTA, V747, P117, DOI 10.1016/0167-4838(83)90129-2; TERAOKA H, 1989, BIOCHEM INT, V18, P1203; TERAOKA H, 1982, J BIOL CHEM, V257, P4758; TERAOKA H, 1977, J BIOCHEM-TOKYO, V81, P1253; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; TSUKADA K, 1971, BIOCHEM BIOPH RES CO, V42, P1156, DOI 10.1016/0006-291X(71)90026-X; TSUKADA K, 1974, BIOCHEM BIOPH RES CO, V57, P758, DOI 10.1016/0006-291X(74)90611-1; TSUKADA K, 1972, J BIOCHEM-TOKYO, V72, P1299, DOI 10.1093/oxfordjournals.jbchem.a130023; TSUKADA K, 1972, CANCER RES, V32, P886; VERSHAVSKY A, 1992, CELL, V69, P725; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	43	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24156	24162						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226962				2022-12-27	WOS:A1993MF29400067
J	VALENZUELASOTO, EM; MUNOZCLARES, RA				VALENZUELASOTO, EM; MUNOZCLARES, RA			BETAINE-ALDEHYDE DEHYDROGENASE FROM LEAVES OF AMARANTHUS-HYPOCHONDRIACUS L EXHIBITS AN ISO ORDERED BI BI STEADY-STATE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; SPINACH LEAVES; WATER-STRESS; PURIFICATION; GLYCINEBETAINE; ACCUMULATION; CHLOROPLASTS; SALINITY; WHEAT	The kinetics of the oxidation of betaine aldehyde catalyzed by NAD+-betaine-aldehyde dehydrogenase, purified from amaranth leaves subjected to water deficit, were analyzed by steady state initial velocity and product and dead-end inhibition studies at low substrate concentrations. Only one product, NADH, gives inhibition. The other product of the reaction, glycine betaine, does not inhibit the enzyme even at concentrations as high as 10 mM. In dead-end inhibition experiments, AMP and choline were used as dead-end analogs of NAD+ and betaine aldehyde, respectively, The families of double-reciprocal plots in the range 0.010-0.500 mM NAD+ and 0.025-0.300 mM betaine aldehyde are linear and intersect at the left of the 1/v axis. NADH is a mixed inhibitor against NAD+ and betaine aldehyde. AMP is competitive with respect to NAD+ and mixed with betaine aldehyde. Choline is competitive against betaine aldehyde and uncompetitive with respect to NAD+. Our results are consistent with an Iso Ordered Bi Bi steady state mechanism in which NAD+ is the first substrate to bind to the enzyme and NADH is the last product to dissociate from it. To our knowledge, this is the first time that an Iso mechanism has been demonstrated by product inhibition studies, as predicted by Cleland (Cleland, W. W. (1963) Biochim. Biophys. Acta 67,104-137).	NATL AUTONOMOUS UNIV MEXICO,FAC QUIM,DEPT BIOQUIM,MEXICO CITY 04510,DF,MEXICO	Universidad Nacional Autonoma de Mexico			Valenzuela-Soto, Elisa M./A-4795-2011	Munoz-Clares, Rosario A./0000-0002-0115-3565				[Anonymous], PHYSL BIOCH DROUGHT; ARAKAWA K, 1990, PLANT CELL PHYSIOL, V31, P797; ARAKAWA K, 1987, J BIOCHEM-TOKYO, V101, P1485, DOI 10.1093/oxfordjournals.jbchem.a122019; BRADBURY SL, 1971, J BIOL CHEM, V246, P1834; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; DICKINSON FM, 1989, BIOCHEM SOC T, V17, P299, DOI 10.1042/bst0170299; FALKENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1034, P253, DOI 10.1016/0304-4165(90)90046-Y; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; GAMBOA A, 1991, J PLANT PHYSIOL, V137, P586, DOI 10.1016/S0176-1617(11)80704-2; GOLBERG AM, 1968, BIOCHIM BIOPHYS ACTA, V167, P186; HANSON AD, 1982, ANNU REV PLANT PHYS, V33, P163, DOI 10.1146/annurev.pp.33.060182.001115; HANSON AD, 1985, P NATL ACAD SCI USA, V82, P3678, DOI 10.1073/pnas.82.11.3678; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; JAKOBY WB, 1963, ENZYMES, V7, P203; MCDONNELL E, 1988, J EXP BOT, V39, P421, DOI 10.1093/jxb/39.4.421; MORI N, 1992, J FERMENT BIOENG, V73, P352, DOI 10.1016/0922-338X(92)90277-2; MORI N, 1980, AGR BIOL CHEM TOKYO, V44, P3015, DOI 10.1080/00021369.1980.10864450; NAGASAWA T, 1976, AGR BIOL CHEM TOKYO, V40, P1743, DOI 10.1080/00021369.1976.10862293; NARAYAN VS, 1990, PLANT SCI, V71, P159, DOI 10.1016/0168-9452(90)90004-8; PAN SM, 1981, PLANT PHYSIOL, V67, P1105, DOI 10.1104/pp.67.6.1105; RIVETT AJ, 1981, EUR J BIOCHEM, V117, P187; ROBINSON SP, 1986, AUST J PLANT PHYSIOL, V13, P659, DOI 10.1071/PP9860659; RYZEWSKI CN, 1980, BIOCHEMISTRY-US, V19, P4843, DOI 10.1021/bi00562a021; SEGEL IH, 1975, ENZYME KINETICS, P767; WERETILNYK EA, 1989, ARCH BIOCHEM BIOPHYS, V271, P56, DOI 10.1016/0003-9861(89)90255-5; WERETILNYK EA, 1990, P NATL ACAD SCI USA, V87, P2745, DOI 10.1073/pnas.87.7.2745; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZAGDANSKA B, 1989, J PLANT PHYSIOL, V134, P320, DOI 10.1016/S0176-1617(89)80250-0	30	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23818	23824						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226918				2022-12-27	WOS:A1993MF29400020
J	BIELAWSKA, A; CRANE, HM; LIOTTA, D; OBEID, LM; HANNUN, YA				BIELAWSKA, A; CRANE, HM; LIOTTA, D; OBEID, LM; HANNUN, YA			SELECTIVITY OF CERAMIDE-MEDIATED BIOLOGY - LACK OF ACTIVITY OF ERYTHRO-DIHYDROCERAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; CELL-DIFFERENTIATION; SPHINGOMYELIN TURNOVER; SPHINGOSINE; SPHINGOLIPIDS; BIOSYNTHESIS	Ceramide is emerging as a putative second messenger mediating effects of extracellular agents on cell growth and differentiation (Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. (1990) J. Biol. Chem. 265, 15823-15831) and programed cell death (Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. (1993) Science 259, 1769-1771). In this study, the eight stereoisomers of C2-ceramide and dihydroceramide were synthesized, and their Cellular activity was investigated. The four stereoisomers of C2-Ceramide were active in inhibition of cell growth and induction of apoptosis with modest differences in potency. On the other hand, with C2-dihydroceramide only the threo compounds were active in these assays whereas the erythro compounds were totally inactive. Thus, of the two naturally occurring molecules, the analog of D-erythro-ceramide (with the 4-5 trans double bond) was active, whereas the analog of D-erythro-dihydroceramide was inactive. These results demonstrate the specificity of ceramide action and suggest that the introduction of the double bond is critical for imparting the biochemical and biological activity of ceramide.	DUKE UNIV,MED CTR,DEPT MED,BOX 3355,DURHAM,NC 27710; EMORY UNIV,DEPT CHEM,ATLANTA,GA 30322	Duke University; Emory University				obeid, lina/0000-0002-0734-0847	NIGMS NIH HHS [GM-43825] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BIELAWSKA A, 1992, J BIOL CHEM, V267, P18493; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANNUN YA, 1992, ALFRED BENZON SYMP S, V33, P257; KIM MY, 1991, J BIOL CHEM, V266, P484; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; MERRILL AH, 1992, NUTR REV, V50, P78; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MERRILL AH, 1992, METHOD ENZYMOL, V209, P427; NIMKAR S, 1988, TETRAHEDRON LETT, V29, P3037, DOI 10.1016/0040-4039(88)85079-2; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; ROTHER J, 1992, BIOCHEM BIOPH RES CO, V189, P14, DOI 10.1016/0006-291X(92)91518-U; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P169, DOI 10.1515/bchm2.1973.354.1.169	23	296	303	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26226	26232						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253743				2022-12-27	WOS:A1993MK42500035
J	KOPPLER, P; MATTER, N; MALVIYA, AN				KOPPLER, P; MATTER, N; MALVIYA, AN			EVIDENCE FOR STEREOSPECIFIC INOSITOL 1,3,4,5-[H-3]TETRAKISPHOSPHATE BINDING-SITES ON RAT-LIVER NUCLEI - DELINEATING INOSITOL 1,3,4,5-TETRAKISPHOSPHATE INTERACTION IN NUCLEAR CALCIUM SIGNALING PROCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; SWISS 3T3 CELLS; TYROSINE KINASE; CA-2+ RELEASE; HL-60 CELLS; RECEPTOR; PHOSPHATES; BRAIN; PHOSPHORYLATION; PURIFICATION	H-3-Labeled inositol 1,3,4,5-tetrakisphosphate (IP4) binding sites are observed on nuclei isolated from rat liver and devoid of any microsomal, mitochondrial, or plasma membrane constituents. A pH of about 6.5 is found optimum for maximum [H-3]IP4 specific binding that is sensitive to changes in pH. The [H-3]IP4 binding on the nuclei can be distinguished into a high affinity site and a low affinity site. The two binding sites are characterized by distinct K(D) and B(max) (1.6 nM versus 57.0 nm K(D); 0.25 pmol/mg protein and 3.7 pmol/mg protein B(max)). IP4 is capable of Ca-45(2+) uptake even in the absence of ATP. The calcium uptake by nuclei is highly sensitive to IP4 Since it is achieved even at 1 nm IP4 concentration. Furthermore, data are documented demonstrating that a rapid and transient Ca-45(2+) release by inositol 1,4,5-trisphosphate (IP3) from the intact nuclei can be reversed by IP4. The presence of IPs potentiates the action of IP4 in nuclear calcium reuptake as attested by the rate of calcium uptake by IP4 in the absence of IP3 (0.16 nmol/s/mg of protein) and in the presence of IPs (4.0 nmol/s/mg of protein). A novel mechanism of nuclear calcium signaling is proposed where IP4 brings calcium into the nuclei mediated by its specific putative binding sites.	CNRS,CTR NEUROCHIM,NEUROBIOL MOLEC INTERACT CELLULAIRES LAB,5 RUE BLAISE PASCAL,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRCH BD, 1992, P NATL ACAD SCI USA, V89, P7978, DOI 10.1073/pnas.89.17.7978; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADFORD PG, 1987, BIOCHEM BIOPH RES CO, V149, P680, DOI 10.1016/0006-291X(87)90421-9; CHALLISS RAJ, 1991, BIOCHEM J, V274, P861, DOI 10.1042/bj2740861; DONIE F, 1989, FEBS LETT, V254, P155, DOI 10.1016/0014-5793(89)81029-4; DONIE F, 1991, BIOCHEM J, V275, P453, DOI 10.1042/bj2750453; GAWLER DJ, 1991, BIOCHEM J, V276, P163, DOI 10.1042/bj2760163; GAWLER DJ, 1991, BIOCHEM J, V273, P519; GILCHRIST JSC, 1993, J BIOL CHEM, V268, P4291; HADCOCK JR, 1992, J BIOL CHEM, V267, P26017; HANLEY MR, 1988, PHILOS T R SOC B, V320, P381, DOI 10.1098/rstb.1988.0083; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HILL TD, 1990, J CELL PHYSIOL, V142, P163, DOI 10.1002/jcp.1041420120; Irvine R F, 1992, Semin Cell Biol, V3, P225, DOI 10.1016/1043-4682(92)90024-P; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Irvine Robin F., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P161; LANINI L, 1992, J BIOL CHEM, V267, P11548; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MASMOUDI A, 1989, J BIOL CHEM, V264, P1172; MATTER N, 1993, J BIOL CHEM, V268, P732; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; NICOTERA P, 1990, P NATL ACAD SCI USA, V87, P6858, DOI 10.1073/pnas.87.17.6858; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PIETRI F, 1990, J BIOL CHEM, V265, P17478; PITTET D, 1989, J BIOL CHEM, V264, P7251; RODLAND KD, 1990, J BIOL CHEM, V265, P11000; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPAT A, 1987, BIOCHEM J, V244, P493; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; THEIBERT AB, 1990, BIOCHEM J, V267, P441, DOI 10.1042/bj2670441; THEIBERT AB, 1991, P NATL ACAD SCI USA, V88, P3165, DOI 10.1073/pnas.88.8.3165; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; YOO SH, 1991, BIOCHEM J, V278, P381, DOI 10.1042/bj2780381; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	37	46	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26248	26252						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253746				2022-12-27	WOS:A1993MK42500038
J	YONEMURA, K; RAINES, EW; AHN, NG; NARAYANAN, AS				YONEMURA, K; RAINES, EW; AHN, NG; NARAYANAN, AS			MITOGENIC SIGNALING MECHANISMS OF HUMAN CEMENTUM-DERIVED GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE CELLS; GINGIVAL FIBROBLASTS; INDUCED ACTIVATION; FACTOR RECEPTORS; PERTUSSIS TOXIN; BINDING-PROTEIN; PHOSPHOLIPASE-C; DNA-SYNTHESIS; FACTOR-BETA	Cementum-derived growth factor (CGF) is a M(r) 23,000 protein, which is sequestered in the mineralized matrix of tooth cementum. We have investigated the mitogenic signaling reactions induced by CGF using quiescent human gingival fibroblasts as target cells. Cells activated with CGF were compared with those treated with CGF plus epidermal growth factor (EGF) and other growth factors. CGF caused a transient increase in cytoplasmic Ca2+ concentration, and this was accompanied by enhancement of membrane protein kinase C activity, myelin basic protein and S6 kinase activities, inositol phosphate levels, and activation of c-fos and jun-B gene expression. Membranes obtained from cells activated with CGF contained several protein bands, which cross-reacted with antiphosphotyrosine antibody; however, proteins corresponding to a putative phosphorylated CGF receptor were not detected. DNA synthesis induced by CGF was inhibited by 65% in cells treated with pertussis toxin but only 25-29% in cultures exposed to H7 or 12-O-tetradecanoylphorbol-13-acetate; these values were different from those obtained when EGF, PDGF, or fetal bovine serum were used as mitogens. CGF and TGF-beta, but not EGF, caused an increase of PDGF-A chain mRNA expression 4 h after mitogen addition. However, while CGF was mitogenic for gingival fibroblasts, TGF-beta was not. Kinetics of DNA stimulation and experiments with anti-PDGF antibodies indicated that PDGF-A expression does not contribute significantly to CGF-induced DNA synthesis. When the stimulation of various signaling pathways induced by CGF and other growth factors was compared, the pattern of stimulation by CGF was different from other growth factors. The characteristic signaling reactions of CGF are likely to be important components of the mechanisms that regulate the formation and regeneration of cementum and adjacent connective tissues.	UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NCRR NIH HHS [RR-06236] Funding Source: Medline; NIDCR NIH HHS [DE-08229] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR006236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008229] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11495; BAIRD A, 1990, PEPTIDE GROWTH FACTO, P369; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BIRD TA, 1989, J IMMUNOL, V142, P126; BOWENPOPE DF, 1985, METHOD ENZYMOL, V109, P69; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHAO MV, 1992, CELL, V68, P95; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CUTRY AF, 1989, J BIOL CHEM, V264, P19700; DOGLIO A, 1989, P NATL ACAD SCI USA, V86, P1148, DOI 10.1073/pnas.86.4.1148; ESCOBEDO JA, 1988, J BIOL CHEM, V263, P1482; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FISCHER JB, 1988, J BIOL CHEM, V263, P2808; FRANKLIN CC, 1992, BIOCHIM BIOPHYS ACTA, V1134, P137, DOI 10.1016/0167-4889(92)90036-B; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HILL TD, 1990, SCIENCE, V248, P1660, DOI 10.1126/science.2163545; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HUANG CL, 1991, J BIOL CHEM, V266, P4045; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; KAMPS MP, 1988, ONCOGENE, V2, P305; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LETTERIO JJ, 1986, SCIENCE, V234, P1117, DOI 10.1126/science.3465038; MAGNALDO I, 1986, J BIOL CHEM, V261, P6916; MCCULLOCH CAG, 1987, ANAT RECORD, V219, P233, DOI 10.1002/ar.1092190304; MIKI Y, 1987, J DENT RES, V66, P1399, DOI 10.1177/00220345870660082301; NAKAE H, 1991, BIOCHEMISTRY-US, V30, P7047, DOI 10.1021/bi00243a002; NARAYANAN AS, 1989, BIOCHEM J, V260, P463, DOI 10.1042/bj2600463; NISHIMURA J, 1992, BIOCHEM BIOPH RES CO, V188, P1198, DOI 10.1016/0006-291X(92)91358-W; NISHIZAWA N, 1990, CELL REGUL, V1, P747, DOI 10.1091/mbc.1.10.747; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OLSON RH, 1985, J PERIODONTOL, V56, P592, DOI 10.1902/jop.1985.56.10.592; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; POLSON AM, 1986, J CLIN PERIODONTOL, V13, P95; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SAMBROOK J, 1989, MOL CLONNG LABORATO; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SOMA Y, 1992, FASEB J, V6, P2996, DOI 10.1096/fasebj.6.11.1644262; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; THOMAS TP, 1987, METHOD ENZYMOL, V141, P399; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WOSIKOWSKI K, 1992, BIOCHEM BIOPH RES CO, V188, P1067, DOI 10.1016/0006-291X(92)91340-V; YONEMURA K, 1992, BONE MINER, V18, P187, DOI 10.1016/0169-6009(92)90806-O; ZHANG H, 1990, J BIOL CHEM, V265, P76	53	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26120	26126						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253729				2022-12-27	WOS:A1993MK42500020
J	KENNER, KA; HILL, DE; OLEFSKY, JM; KUSARI, J				KENNER, KA; HILL, DE; OLEFSKY, JM; KUSARI, J			REGULATION OF PROTEIN-TYROSINE PHOSPHATASES BY INSULIN AND INSULIN-LIKE GROWTH FACTOR-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; RAT HEPATOMA-CELLS; MESSENGER-RNA; DIFFERENTIAL REGULATION; 3T3-L1 ADIPOCYTES; XENOPUS OOCYTES; GENE-EXPRESSION; HUMAN-PLACENTA; RECEPTORS; KINASE	In this study, we have examined the effects of insulin and insulin-like growth factor (IGF)-I on protein tyrosine phosphatase (PTPase) activity in rat L6 skeletal muscle cells. Under basal conditions, about 85% of total cellular PTPase activity was associated with the particulate (Triton X-100-soluble) fraction. Incubation of the cells with 100 nm insulin or IGF-I significantly increased particulate PTPase activity (p < 0.005) without altering activity in the supernatant or Triton X-100-insoluble fractions. Dose response studies suggested that the effect of each hormone was mediated through its own receptor. PTPase activity was regulated by both acute and chronic insulin and IGF-I treatment. Maximal stimulation by both ligands occurred at 32 h and then declined. By using an antibody and a cDNA specific for PTPase1B, we found that the chronic stimulation of PTPase activity was accompanied by enhanced expression of PTPase1B mRNA and protein. Maximal induction of PTPase1B mRNA and protein by insulin and IGF-I occurred at 12 and 24 h, respectively. Based on these data, it can be suggested that ligand-stimulated PTPase activity might oppose tyrosine kinase-mediated insulin or IGF-I signal transmission and thus desensitize cells to long-term action by insulin and IGF-I. However, it is also possible that PTPases act as positive mediators of insulin and IGF-I action.	ONCOGENE SCI,CAMBRIDGE,MA 02142; UNIV CALIF SAN DIEGO,DEPT MED,DIV ENDOCRINOL METAB,LA JOLLA,CA 92093; VET ADM MED CTR,MED RES SERV,SAN DIEGO,CA 92161	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Hill, David E/B-6617-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033649, R37DK033651, R01DK033651, R37DK033649] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 33651, DK 33649] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM., 1988, CURRENT PROTOCOLS MO; BACKER JM, 1990, J BIOL CHEM, V265, P14828; BALLARD FJ, 1988, BIOCHEM J, V249, P721, DOI 10.1042/bj2490721; BEGUINOT F, 1986, ENDOCRINOLOGY, V118, P446, DOI 10.1210/endo-118-1-446; BEGUINOT F, 1985, J BIOL CHEM, V260, P5892; BEGUM N, 1991, DIABETES, V40, P1620, DOI 10.2337/diabetes.40.12.1620; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUTIGAN DL, 1991, P NATL ACAD SCI USA, V88, P6696, DOI 10.1073/pnas.88.15.6696; BROWNSHIMER S, 1992, CANCER RES, V52, P478; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; BURANT CF, 1987, BIOCHEM BIOPH RES CO, V147, P100, DOI 10.1016/S0006-291X(87)80092-X; CHAN CP, 1988, P NATL ACAD SCI USA, V85, P6257, DOI 10.1073/pnas.85.17.6257; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; CLEMMONS DR, 1986, J CLIN INVEST, V77, P1548, DOI 10.1172/JCI112470; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; COOL DE, 1990, P NATL ACAD SCI USA, V87, P7280, DOI 10.1073/pnas.87.18.7280; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GOLDSTEIN BJ, 1992, J CELL BIOCHEM, V48, P33, DOI 10.1002/jcb.240480107; HILL DE, 1992, J CELL BIOCH S16B, V49, P144; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711; KAYALAR C, 1989, J BIOL CHEM, V264, P8928; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KUSARI J, 1986, MOL CELL BIOL, V6, P2062, DOI 10.1128/MCB.6.6.2062; KUSARI J, 1992, DIABETES S, V41, pA184; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE TS, 1989, J CLIN INVEST, V83, P90, DOI 10.1172/JCI113889; LIAO K, 1991, J BIOL CHEM, V266, P6544; MAHER F, 1989, MOL ENDOCRINOL, V3, P2128, DOI 10.1210/mend-3-12-2128; MCGUIRE MC, 1991, DIABETES, V40, P939, DOI 10.2337/diabetes.40.7.939; MEYEROVITCH J, 1989, J CLIN INVEST, V84, P976, DOI 10.1172/JCI114261; MEYEROVITCH J, 1991, J CLIN INVEST, V87, P1286, DOI 10.1172/JCI115131; MEYEROVITCH J, 1992, BIOCHEMISTRY-US, V31, P10338, DOI 10.1021/bi00157a023; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OLEFSKY JM, 1990, DIABETES, V39, P1009, DOI 10.2337/diabetes.39.9.1009; POPOVICH BK, 1989, AM J PHYSIOL, V257, pE573, DOI 10.1152/ajpendo.1989.257.4.E573; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; SAITO H, 1991, CELL GROWTH DIFFER, V2, P59; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; SHACTER E, 1984, ANAL BIOCHEM, V138, P416, DOI 10.1016/0003-2697(84)90831-5; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TONKS NK, 1990, MOL CELL BIOL, V10, P458, DOI 10.1128/MCB.10.2.458; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICH A, 1985, NATURE, V313, P7565; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; WALKER PS, 1989, J BIOL CHEM, V264, P6587; WANG PH, 1989, J CLIN INVEST, V84, P62, DOI 10.1172/JCI114170; YANG SD, 1987, BIOCHEM BIOPH RES CO, V142, P38, DOI 10.1016/0006-291X(87)90448-7	54	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25455	25462						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244979				2022-12-27	WOS:A1993MK10000029
J	MA, JY; NASTUK, MA; MCKECHNIE, BA; FALLON, JR				MA, JY; NASTUK, MA; MCKECHNIE, BA; FALLON, JR			THE AGRIN RECEPTOR - LOCALIZATION IN THE POSTSYNAPTIC MEMBRANE, INTERACTION WITH AGRIN, AND RELATIONSHIP TO THE ACETYLCHOLINE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORPEDO ELECTRIC ORGAN; BASAL LAMINA; NEUROMUSCULAR-JUNCTIONS; CULTURED MYOTUBES; SYNAPTIC SITES; CELL-ADHESION; MUSCLE; AGGREGATION; MOLECULES; PROTEIN	Agrin is a component of the synaptic basal lamina that induces the aggregation of acetylcholine receptors (AChRs) and other elements of the postsynaptic membrane. We have determined the localization, binding characteristics, and biochemical profile of the agrin receptor in Torpedo electric organ membranes and defined domains of agrin that bind this receptor. Postsynaptic membranes from Torpedo electric organ bind agrin as judged by depletion of AChR clustering activity from solution. A ligand-based radioimmunoassay shows that agrin binding to postsynaptic membranes is saturable and calcium-dependent. Half-maximal binding is observed at agrin concentrations less-than-or-equal-to 10(-10) m. Identification of the bound agrin polypeptides shows that at least one membrane binding domain of agrin is located in a 70-kDa proteolytic fragment. Immunofluorescent visualization and radioimmunoassay of agrin binding demonstrates that the agrin receptor is selectively concentrated in postsynaptic membranes, with little binding detected on nonsynaptic or liver membranes. Agrin binding is greatly reduced if the membranes are pretreated with trypsin, but is unaffected by phosphatidylinositol-specific phospholipase C. Membranes stripped of peripheral proteins by alkaline treatment retain full ligand binding capacity. Alpha-bungarotoxin affinity columns bind AChRs but not agrin receptors. The ratio of agrin receptors to AChRs in postsynaptic membranes is approximately 1:200. We conclude that the agrin receptor is an integral membrane glycoprotein that is selectively concentrated in postsynaptic membranes, but that is not tightly complexed with the AChR. The results also indicate that the biological activity of agrin is mediated through intracellular signal transduction events triggered by ligand binding to the agrin receptor.	WORCESTER FDN EXPTL BIOL INC,NEUROBIOL GRP,SHREWSBURY,MA 01545	Worcester Foundation for Biomedical Research					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023924] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD023924, HD 23924] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1992, CELL, V70, P1, DOI 10.1016/0092-8674(92)90525-H; FROEHNER SC, 1981, P NATL ACAD SCI-BIOL, V78, P5230, DOI 10.1073/pnas.78.8.5230; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HALL ZW, 1993, NEURON S, V10, P99; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HUNTER DD, 1991, J NEUROSCI, V11, P3960; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOV BO, 1992, NATURE, V355, P696; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; LEITH E, 1993, J NEUROSCI, V13, P2509; LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F; NASTUK M A, 1991, Society for Neuroscience Abstracts, V17, P219; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NASTUK MA, 1993, TRENDS NEUROSCI, V16, P72, DOI 10.1016/0166-2236(93)90020-M; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PARASCHOS A, 1982, BIOCHIM BIOPHYS ACTA, V691, P249, DOI 10.1016/0005-2736(82)90414-X; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; Salpeter MM, 1987, VERTEBRATE NEUROMUSC, V23, P1; SMITH MA, 1992, MOL CELL NEUROSCI, V3, P406, DOI 10.1016/1044-7431(92)90052-4; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1991, PHILOS T ROY SOC B, V331, P273, DOI 10.1098/rstb.1991.0016; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069	42	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25108	25117						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227074				2022-12-27	WOS:A1993MG67300085
J	SAIDO, TC; YOKOTA, M; NAGAO, S; YAMAURA, I; TANI, E; TSUCHIYA, T; SUZUKI, K; KAWASHIMA, S				SAIDO, TC; YOKOTA, M; NAGAO, S; YAMAURA, I; TANI, E; TSUCHIYA, T; SUZUKI, K; KAWASHIMA, S			SPATIAL-RESOLUTION OF FODRIN PROTEOLYSIS IN POSTISCHEMIC BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; DELAYED NEURONAL DEATH; GERBIL HIPPOCAMPUS; SYNAPTIC TRANSMISSION; CALPAIN INHIBITORS; PROTEIN-SYNTHESIS; ALPHA-FODRIN; MU-CALPAIN; ISCHEMIA; CALCIUM	One of the major obstacles in investigating in vivo proteolytic phenomena has been the inaccessibility to spatial information as to where in the tissue the reaction proceeds because the orthodox method employing electrophoretic analysis requires homogenization of samples and thus results in loss of such spatial information. To overcome this technical drawback, we have developed methodology to produce antibodies that specifically distinguish a proteolyzed form of a given protein from its intact form. Here we describe our immunohistochemical observation of calpain-catalyzed fodrin proteolysis in postischemic gerbil hippocampus, using an antibody exclusively specific to the proteolyzed 150-kDa form of fodrin alpha subunit. Our data establish a novel discovery that transient (10 min) global forebrain ischemia followed by reperfusion induces at least two distinct phases of fodrin proteolysis in hippocampus: an early phase in molecular layer and in stratum oriens of CA3 and CA1 sectors within 15 min and a late drastic and persistent phase in the entire CA1 after 4-24 h. The former may be one of the early events initiating the complex cascade leading to the delayed neuronal death, while the latter should be considered as a more direct cause for the actual degeneration in CA1.	HYOGO MED UNIV,DEPT NEUROSURG,NISHINOMIYA,HYOGO 663,JAPAN; SOPHIA UNIV,DEPT CHEM,CHIYODA KU,TOKYO 102,JAPAN; UNIV TOKYO,INST MOLEC & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN	Hyogo College of Medicine; University of Hyogo; Sophia University; University of Tokyo	SAIDO, TC (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC BIOL,BUNKYO KU,TOKYO 113,JAPAN.		Sado, Takaomi/AAN-2759-2021	Sado, Takaomi/0000-0003-1970-6903				ARLINGHAUS L, 1991, EUR J PHARMACOL, V209, P123, DOI 10.1016/0014-2999(91)90022-I; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; DELCERRO S, 1990, BRAIN RES, V530, P91; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; DISTASI AMM, 1991, NEURON, V6, P445, DOI 10.1016/0896-6273(91)90252-U; FRIEDRICH P, 1990, NEUROSCIENCE, V35, P1, DOI 10.1016/0306-4522(90)90115-K; GOLL ED, 1990, INTRACELLULAR CALCIU, P103; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; LYNCH G, 1990, FID RES FDN, V4, P125; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MCMAHON AP, 1987, BIOCHEM SOC T, V15, P804, DOI 10.1042/bst0150804; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; RADER RK, 1989, NEUROSCI LETT, V99, P125, DOI 10.1016/0304-3940(89)90276-0; SAIDO TC, 1993, J BIOL CHEM, V268, P7422; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SIMAN R, 1985, NATURE, V313, P225, DOI 10.1038/313225a0; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; SUZUKI K, 1991, BIOMED BIOCHIM ACTA, V50, P483; Takahashi K, 1990, INTRACELLULAR CALCIU, P55; THILMANN R, 1986, ACTA NEUROPATHOL, V71, P88, DOI 10.1007/BF00687967; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; YOKOTA M, 1992, BRAIN RES, V587, P123, DOI 10.1016/0006-8993(92)91436-I; YOSHIDA S, 1986, J NEUROCHEM, V47, P744; YOSHIDOMI M, 1989, J NEUROCHEM, V53, P1589, DOI 10.1111/j.1471-4159.1989.tb08556.x	37	265	284	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25239	25243						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227089				2022-12-27	WOS:A1993MG67300102
J	WILLIAMS, AJ; WERNETTE, CM; KAGUNI, LS				WILLIAMS, AJ; WERNETTE, CM; KAGUNI, LS			PROCESSIVITY OF MITOCHONDRIAL-DNA POLYMERASE FROM DROSOPHILA EMBRYOS - EFFECTS OF REACTION CONDITIONS AND ENZYME PURITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; ESCHERICHIA-COLI; III HOLOENZYME; BETA-SUBUNIT; CALF THYMUS; ACCESSORY PROTEINS; SIZE CLASSES; ORIGIN; ALPHA	Mitochondrial DNA polymerase from Drosophila embryos has been characterized with regard to its mechanism of DNA synthesis under the influence of a variety of compounds in moderate salt (120 mM KCl), where the enzyme is most highly active and only moderately processive, and in low salt (30 mM KCl), where it is less active yet most highly processive. Disparate activity and processivity optima were obtained in low salt in the presence of varying pH or MgCl2 and ATP concentrations; in moderate salt, optimal activity and processivity were achieved coincidentally. Whereas no correlation between processivity and activity optima was observed upon addition of polyethylene glycol in either low or moderate salt, the optima were coincident at both salt levels on addition of glycerol. None of the reaction conditions examined allowed DNA polymerase gamma to exhibit maximal activity and processivity concurrently; maximal activity was always achieved in moderate salt and the highest processivity in low salt. However, while limiting the availability of primer termini had no effect on the mechanism of DNA synthesis, we found that the ability of mitochondrial DNA polymerase to copy singly primed M13 DNA was enhanced then diminished during the course of purification, suggesting loss of an accessory factor.	MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BERTAZZONI U, 1977, EUR J BIOCHEM, V81, P237, DOI 10.1111/j.1432-1033.1977.tb11945.x; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; BOLDEN A, 1977, J BIOL CHEM, V252, P3351; BRAND MD, 1987, BIOL REV, V62, P141, DOI 10.1111/j.1469-185X.1987.tb01265.x; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; CHA TA, 1988, CANCER CELLS EUKARYO, P1; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DAS SK, 1979, J BIOL CHEM, V254, P1227; Fansler B S, 1974, Methods Enzymol, V29, P53; FAY PJ, 1981, J BIOL CHEM, V256, P976; FAY PJ, 1982, J BIOL CHEM, V257, P5692; FISHER PA, 1979, J BIOL CHEM, V254, P6128; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; GRIEP MA, 1988, BIOCHEMISTRY-US, V27, P5210, DOI 10.1021/bi00414a040; HACKENBROCK CR, 1968, P NATL ACAD SCI USA, V61, P508; Hansford R.G., 1980, CURR TOP BIOENERG, VVolume 10, P217, DOI 10.1016/B978-0-12-152510-1.50012-2; HOCKENSMITH JW, 1981, BIOCHEMISTRY-US, V20, P227, DOI 10.1021/bi00504a038; HOHN KT, 1987, BIOCHEMISTRY-US, V26, P2870, DOI 10.1021/bi00384a031; HUBSCHER U, 1977, EUR J BIOCHEM, V81, P249, DOI 10.1111/j.1432-1033.1977.tb11946.x; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; HUTSON SM, 1989, BIOCHEMISTRY-US, V28, P4325, DOI 10.1021/bi00436a030; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JOHANSON KO, 1980, J BIOL CHEM, V255, P984; KAGUNI J, 1979, J MOL BIOL, V135, P863, DOI 10.1016/0022-2836(79)90516-3; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1992, DNA REPLICATION; KWONSHIN O, 1987, J BIOL CHEM, V262, P2121; LYONS JW, 1964, J AM CHEM SOC, V86, P3634, DOI 10.1021/ja01072a009; MAKI S, 1988, J BIOL CHEM, V263, P6561; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; MORONEY PM, 1984, BIOCHEMISTRY-US, V23, P4991, DOI 10.1021/bi00316a025; NEWPORT JW, 1980, MECHANISTIC STUDIES, V19, P485; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2998, DOI 10.1021/bi00408a050; SLATER JP, 1972, J BIOL CHEM, V247, P6784; SRERE PA, 1980, TRENDS BIOCHEM SCI, V5, P120, DOI 10.1016/0968-0004(80)90051-1; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WOLSTENHOLME DR, 1979, EXTRACHROMOSOMAL DNA, P409; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871	46	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24855	24862						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227047				2022-12-27	WOS:A1993MG67300052
J	FISCHER, KD; HAESE, A; NOWOCK, J				FISCHER, KD; HAESE, A; NOWOCK, J			COOPERATION OF GATA-1 AND SP1 CAN RESULT IN SYNERGISTIC TRANSCRIPTIONAL ACTIVATION OR INTERFERENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLOBIN GENE; NUCLEAR-PROTEIN FACTORS; DOMINANT CONTROL REGION; DNA-BINDING; ERYTHROID-DIFFERENTIATION; MAMMALIAN-CELLS; CTF/NF-I; PROMOTER; EXPRESSION; REPLICATION	GATA-1 is a lineage-restricted transcription factor. Virtually all erythroid-expressed genes contain GATA recognition sites in their regulatory elements. Co-transfection/transactivation assays have revealed that, although GATA-1 as the only cell-restricted transcription factor is sufficient to activate some of the erythroid-specific promoters, not all such promoters are responsive, suggesting a requirement for cooperation with other factors. To study the interaction of GATA-1 with other transactivators, we analyzed sequence motifs of the human gamma-globin promoter as response system by in vitro transcription and by transfections into erythroid K562 cells or into heterologous Drosophila SL2 cells. GATA-1 alone did not activate the promoter. However, GATA-1 exerted an effect in concert with the ubiquitous transactivator Sp1. Depending on the factor concentrations and the sequence context of the cognate binding sites, this interaction could result in synergistic transcriptional activation or in interference. GATA-1 and Sp1 did not cooperate in DNA binding when tested in vitro. This suggests that the functional cooperation is mediated by protein interactions with additional factor(s) which transmit the activator signal. The Sp1-binding CCACCC motif was found to be critical for high activity of the gamma-globin promoter. This site overlaps with a recognition sequence for members of the NFI/CTF family. NFI did not transactivate, but it interfered with Sp1-mediated stimulation and hence with Sp1/GATA-1 cooperation. These data, together with phylogenetic evidence, suggest that the CCACCC region is likely to represent a regulatory switch element.	UNIV HAMBURG, HEINRICH PETTE INST EXPTL VIROL & IMMUNOL, MARTINISTR 52, W-2000 HAMBURG 20, GERMANY	Heinrich Pette Institute; University of Hamburg								ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CATALA F, 1989, NUCLEIC ACIDS RES, V17, P3811, DOI 10.1093/nar/17.10.3811; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DEBOER E, 1988, EMBO J, V7, P4203, DOI 10.1002/j.1460-2075.1988.tb03317.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; EMERSON BM, 1989, CELL, V57, P1189, DOI 10.1016/0092-8674(89)90056-1; EVANS T, 1991, MOL CELL BIOL, V11, P843, DOI 10.1128/MCB.11.2.843; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FISCHER KD, 1990, NUCLEIC ACIDS RES, V18, P5685, DOI 10.1093/nar/18.19.5685; FORSBERG M, 1991, EMBO J, V10, P2543, DOI 10.1002/j.1460-2075.1991.tb07794.x; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GUMUCIO DL, 1991, BLOOD, V78, P1853; GUMUCIO DL, 1988, MOL CELL BIOL, V8, P5310, DOI 10.1128/MCB.8.12.5310; HEBERLEIN C, 1992, MOL CELL BIOL, V12, P1815, DOI 10.1128/MCB.12.4.1815; HERBOMEL P, 1990, New Biologist, V2, P1063; HULL JD, 1988, J CELL BIOL, V106, P1489, DOI 10.1083/jcb.106.5.1489; JACKSON PD, 1989, GENE DEV, V3, P1860, DOI 10.1101/gad.3.12a.1860; MACLEOD K, 1991, MOL CELL BIOL, V11, P4324, DOI 10.1128/MCB.11.9.4324; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P7783, DOI 10.1093/nar/16.16.7783; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MARTINEZ E, 1991, MOL CELL BIOL, V11, P2937, DOI 10.1128/MCB.11.6.2937; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; NICOLIS S, 1989, NUCLEIC ACIDS RES, V17, P5509, DOI 10.1093/nar/17.14.5509; NOWOCK J, 1982, CELL, V30, P607, DOI 10.1016/0092-8674(82)90257-4; OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PLUMB M, 1989, NUCLEIC ACIDS RES, V17, P73, DOI 10.1093/nar/17.1.73; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RONCHI A, 1989, NUCLEIC ACIDS RES, V17, P10231, DOI 10.1093/nar/17.24.10231; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; TRAINOR CD, 1990, NATURE, V343, P92, DOI 10.1038/343092a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3	50	104	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23915	23923						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226931				2022-12-27	WOS:A1993MF29400034
J	NACHALIEL, N; JAIN, D; HOD, Y				NACHALIEL, N; JAIN, D; HOD, Y			A CAMP-REGULATED RNA-BINDING PROTEIN THAT INTERACTS WITH PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; STEM-LOOP STRUCTURE; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; DEGRADATION; STABILIZATION; TRANSCRIPTION; LYMPHOKINE; COMPLEXES; HELICASES	Cyclic-AMP stabilizes phosphoenolpyruvate carboxykinase (GTP) (PEPCK) mRNA against degradation. To investigate the mechanism of this effect, RNA mobility shift assays were used to determine the interaction of cellular proteins with specific domains from the mRNA. We report here the identification of a protein with an affinity for sequences of PEPCK mRNA with a predicted stem-loop structure. RNA-protein complex formation was significantly reduced if the double-stranded RNA probe was preheated to 90-degrees-C. The RNA-binding protein did not bind to the hairpin structure of poly(rI)-poly (rC), indicating some degree of sequence specificity and that the RNA-binding protein is not the interferon-induced double-stranded RNA-activated protein kinase. The binding activity was contained in the cytosolic fraction (100,000 x g) of rat hepatoma FTO-2B cells and was significantly enhanced by high concentrations of KCl. Chromatography on an anion exchanger separated the binding activity from a factor which, upon reconstitution, inhibited the interaction with the RNA probe. Incubation of cells with cAMP resulted in a 3-4-fold decrease in the activity of the RNA-binding protein. An inhibition in complex formation was observed with extracts as early as 60 min after exposure of cells to cAMP. Liver extracts from rats starved for 72 h also had reduced binding activity compared to extracts from fed animals. Cellular extracts treated with alkaline phosphatase exhibited an elevated level of complex formation. An analysis by SDS-polyacrylamide gel electrophoresis of the RNA-protein complex after ultraviolet light cross-linking demonstrated that the RNA-binding protein had a molecular mass of approximately 100 kDa. On the basis of these results, we suggest that liver cells contain a protein whose interaction with PEPCK mRNA is regulated by cAMP-dependent phosphorylation and which may be responsible for the cAMP-mediated control of PEPCK mRNA half-life.	SUNY STONY BROOK,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook								BEALE EG, 1985, J BIOL CHEM, V260, P748; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHRIST B, 1991, BIOCHEM BIOPH RES CO, V177, P1273, DOI 10.1016/0006-291X(91)90679-2; CLAUS TH, 1981, BIOCHEM ACTION HORM, P209; COOK JS, 1986, P NATL ACAD SCI USA, V83, P7583, DOI 10.1073/pnas.83.20.7583; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; GILLIS P, 1991, J BIOL CHEM, V266, P3172; GRANNER D, 1990, J BIOL CHEM, V265, P10173; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HOD Y, 1988, J BIOL CHEM, V263, P7747; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; HUA JL, 1992, MOL ENDOCRINOL, V6, P1418, DOI 10.1210/me.6.9.1418; KILLARY AM, 1984, BIOCHEM GENET, V22, P201, DOI 10.1007/BF00484224; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LIU J, 1991, MOL CELL BIOCHEM, V104, P89; MANZELLA JM, 1992, J BIOL CHEM, V267, P7007; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; PANDEY NB, 1987, MOL CELL BIOL, V7, P4557, DOI 10.1128/MCB.7.12.4557; PANDEY NB, 1991, NUCLEIC ACIDS RES, V19, P5653, DOI 10.1093/nar/19.20.5653; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEPHENS JM, 1992, J BIOL CHEM, V267, P8336; STOFFEL M, 1993, HUM MOL GENET, V2, P1, DOI 10.1093/hmg/2.1.1; THACH RE, 1992, CELL, V68, P177, DOI 10.1016/0092-8674(92)90461-K; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; WICKS WD, 1972, BIOCHEM BIOPH RES CO, V48, P205, DOI 10.1016/0006-291X(72)90364-6	35	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24203	24209						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226967				2022-12-27	WOS:A1993MF29400073
J	HACK, N; SUEAQUAN, A; MILLS, GB; SKORECKI, KL				HACK, N; SUEAQUAN, A; MILLS, GB; SKORECKI, KL			EXPRESSION OF HUMAN TYROSINE KINASE-NEGATIVE EPIDERMAL GROWTH-FACTOR RECEPTOR AMPLIFIES SIGNALING THROUGH ENDOGENOUS MURINE EPIDERMAL GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; EGF RECEPTOR; REGULATED KINASES; PHOSPHORYLATION; CELLS; RAS; PHOSPHOLIPASE-A2; BINDING; AUTOPHOSPHORYLATION; ACTIVATION	Recent findings have suggested that certain ligand-dependent responses to EGF may be propagated in a manner that is not dependent on the intrinsic tyrosine kinase activity of the epidermal growth factor receptor (EGF-R, Campos-Gonzalez, R., and Glenney, J. R., Jr. (1992) J. Biol. Chem. 267, 14535-14538) or, alternatively, that these responses may occur through the interaction of the human tyrosine kinase-deficient EGF-R with an as yet unidentified kinase (Selva, E., Raden, D. L., and Davis, R. J. (1993) J. Biol. Chem. 268, 2250-2254). These conclusions represent a significant departure from our current understanding of signal transduction by receptor tyrosine kinases. Therefore we examined the effect of expression of tyrosine kinase-negative human EGF receptor in murine NIH-3T3-2.2 cells on the EGF-dependent phosphorylation of mitogen-activated protein (MAP-2) kinase. In parental cells (NIH-3T3-2.2) that express low levels of endogenous murine EGF-R, there was no demonstrable EGF-dependent coupling to MAP-2 kinase. In NIH-3T3-2.2 cells transfected with tyrosine kinase-negative human EGF-R, there was unexpected EGF-dependent phosphorylation of MAP-2 kinase. Analysis of the tyrosine kinase-negative human EGF-R in these cells revealed significant tyrosine phosphorylation of the EGF-R. A low level of endogenous murine EGF-R present in these cells were also phosphorylated on tyrosine residues and displayed autokinase activity. Similar results were obtained using an unrelated cell line (B82L cells), in which EGF-dependent phosphorylation of MAP-2 kinase was previously attributed to signal propagation through a tyrosine kinase-negative human EGF-R (Campos-Gonzalez, R., and Glenney, J. R., Jr. (1992) J. Biol. Chem. 267, 14535-14538). Taken together, these results suggest that the tyrosine kinase-negative human EGF-R are able to amplify the response to activation of low levels of endogenous murine EGF-R, thus leading to EGF-dependent phosphorylation of MAP-2 kinase in cells expressing tyrosine kinase-negative human EGF-R.	UNIV TORONTO,MRC,MEMBRANE BIOL GRP,TORONTO M5S 1A1,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; TORONTO GEN HOSP,TORONTO M5G 1L7,ONTARIO,CANADA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital								Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; BACCARINI M, 1991, J BIOL CHEM, V266, P10941; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CADENA DL, 1992, FASEB J, V6, P2332, DOI 10.1096/fasebj.6.6.1312047; CAMPOSGONZALEZ R, 1992, J BIOL CHEM, V267, P14535; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GOLDBERG HJ, 1990, BIOCHEM J, V267, P461, DOI 10.1042/bj2670461; HACK N, 1990, BIOSCIENCE REP, V10, P353, DOI 10.1007/BF01117235; HACK N, 1991, BIOCHEM J, V275, P563, DOI 10.1042/bj2750563; HACK N, 1990, J AM SOC NEPHROL, V1, P471; HONNEGER AM, 1987, CELL, V51, P199; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LEE BA, 1991, J CELL BIOL, V113, P361, DOI 10.1083/jcb.113.2.361; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LICHTNER RB, 1992, J BIOL CHEM, V267, P11872; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SELVA E, 1993, J BIOL CHEM, V268, P2250; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZWILLER J, 1991, ONCOGENE, V6, P219	35	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26441	26446						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253771				2022-12-27	WOS:A1993MK42500065
J	HENNECKE, S; COSSON, P				HENNECKE, S; COSSON, P			ROLE OF TRANSMEMBRANE DOMAINS IN ASSEMBLY AND INTRACELLULAR-TRANSPORT OF THE CD8 MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; MONOCLONAL-ANTIBODIES; HELICAL INTERACTIONS; SURFACE EXPRESSION; ALPHA-CHAIN; COMPLEX; DEGRADATION; ASSOCIATION; PROTEINS; REGION	Previous studies have shown that CD8 can be present at the cell surface either as a disulfide-linked homodimer of CD8alpha or as a disulfide-linked heterodimer of CD8alpha and CD8beta. Here we analyzed the assembly and intracellular transport of CD8 with particular emphasis on the role of the transmembrane domains. A chimeric protein (alphaTalpha) made by replacing the transmembrane domain of CD8alpha with that of the interleukin-2 receptor alpha chain (Tac) exhibited reduced ability to form homodimers, while a mutant of Tac containing the CD8alpha transmembrane domain (Talphaalpha) dimerized efficiently. Contrary to CD8alpha, CD8beta expressed alone was retained in the endoplasmic reticulum (ER). Only a small amount of CD8beta formed homodimers, and these also remained in the ER. A mutant of CD8beta that dimerized efficiently was also retained in the ER, thus proving that ER retention of CD8beta is not due to its poor homodimerization. Rather, the extracellular domain of CD8beta requires interaction with that of CD8alpha to exit the ER. The transmembrane domain of CD8beta was also shown to participate in ER retention by preventing exit of monomeric CD8beta out of the ER. These findings demonstrate the role of transmembrane domains in assembly and intracellular transport of the CD8 molecule.			HENNECKE, S (corresponding author), BASEL INST IMMUNOL, GRENZACHERSTR 487 POSTFACH, CH-4005 BASEL, SWITZERLAND.							BLANC D, 1988, EUR J IMMUNOL, V18, P613, DOI 10.1002/eji.1830180419; BOLEN JB, 1989, TRENDS BIOCHEM SCI, V14, P404, DOI 10.1016/0968-0004(89)90288-0; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; GOLSTEIN P, 1982, IMMUNOL REV, V68, P5, DOI 10.1111/j.1600-065X.1982.tb01058.x; GORMAN SD, 1988, J IMMUNOL, V140, P3646; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HAMMERLING GJ, 1979, J EXP MED, V150, P108, DOI 10.1084/jem.150.1.108; HEIMER GV, 1974, J CLIN PATHOL, V27, P254, DOI 10.1136/jcp.27.3.254; JONES DH, 1990, BIOTECHNIQUES, V8, P178; KIRSZBAUM L, 1989, J IMMUNOL, V142, P3931; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LEDBETTER JA, 1982, IMMUNOL REV, V68, P197, DOI 10.1111/j.1600-065X.1982.tb01065.x; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LETOURNEUR F, 1990, P NATL ACAD SCI USA, V87, P2339, DOI 10.1073/pnas.87.6.2339; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PARNES JR, 1989, ADV IMMUNOL, V44, P265; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	32	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26607	26612						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253791				2022-12-27	WOS:A1993MK42500086
J	SUNG, CH; DAVENPORT, CM; NATHANS, J				SUNG, CH; DAVENPORT, CM; NATHANS, J			RHODOPSIN MUTATIONS RESPONSIBLE FOR AUTOSOMAL-DOMINANT RETINITIS-PIGMENTOSA - CLUSTERING OF FUNCTIONAL CLASSES ALONG THE POLYPEPTIDE-CHAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; DARK-ADAPTATION; GENE; IDENTIFICATION; DETERMINANTS	Over 40 mutations in the rhodopsin gene have been identified in patients with autosomal dominant retinitis pigmentosa. Twenty-one of these mutations have been introduced into a human rhodopsin cDNA by site-directed mutagenesis, and the encoded proteins have been produced by transfection of a human embryonic kidney cell line (293S). Three of the mutant proteins (G51V, V345M, and P347S) resemble the wild type in yield, regenerability with 11-cis-retinal, and accumulation in the plasma membrane (class I). The remaining 18 mutant proteins are produced at lower levels, regenerate variably or not at all with 11-cis-retinal, and accumulate partially or predominantly in the endoplasmic reticulum (class II). Together with an earlier analysis of 13 mutant rhodopsins (Sung, C.-H., Schneider, B., Agarwal, N., Papermaster, D. S., and Nathans, J. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8840-8844), these experiments define distinct classes of biochemical defects in human rhodopsin and further show that amino acid substitutions in class II reside within the transmembrane and extracellular domains, whereas class I mutants cluster in the first transmembrane domain and at the extreme carboxyl terminus.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OPHTHALMOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	SUNG, CH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,805 PCTB,725 N WOLFE ST,BALTIMORE,MD 21205, USA.			Nathans, Jeremy/0000-0001-8106-5460				ADAMUS G, 1988, Peptide Research, V1, P42; ARTLICH A, 1992, AM J HUM GENET, V50, P876; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P646, DOI 10.1001/archopht.1992.01080170068026; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1582, DOI 10.1001/archopht.1992.01080230082026; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HARLOWE E, 1988, ANTIBODIES LABORATOR; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KNOWLES A, 1977, PHOTOBIOLOGY VISION, P347; MIN KC, 1993, J BIOL CHEM, V268, P9400; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1992, ANNU REV GENET, V26, P401; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; STJULES RS, 1989, EXP EYE RES, V48, P653, DOI 10.1016/0014-4835(89)90007-9; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	25	263	272	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26645	26649						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253795				2022-12-27	WOS:A1993MK42500091
J	SUNG, P; REYNOLDS, P; PRAKASH, L; PRAKASH, S				SUNG, P; REYNOLDS, P; PRAKASH, L; PRAKASH, S			PURIFICATION AND CHARACTERIZATION OF THE SACCHAROMYCES-CEREVISIAE RAD1 RAD10 ENDONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCISION REPAIR GENE; YEAST DNA-REPAIR; MITOTIC RECOMBINATION; NUCLEOTIDE-SEQUENCE; PROTEINS; MUTANTS; INCISION; VIABILITY; REMOVAL; ENCODES	The Saccharomyces cerevisiae RAD1 and RAD10 genes are required for the incision step of excision repair, and in addition, they function in mitotic recombination. The RAD1 and RAD10 proteins are associated in a tight complex, and genetic studies have indicated that complex formation is essential for the RAD1/RAD10 controlled biological activities. We had previously purified the RAD10 protein to near homogeneity from yeast and shown that it is a DNA-binding protein with a strong preference for single-stranded DNA. In this study, we purify the RAD1 protein to near homogeneity from yeast and show that it also binds single-stranded DNA preferentially and that the RAD1/RAD10 complex possesses an endonuclease activity. We characterize the RAD1/RAD10 endonuclease activity on both single-stranded and double-stranded DNAs, using agarose gel electrophoresis and trichloroacetic acid precipitation. The RAD1/RAD10 nuclease exhibits a much higher level of activity on single-stranded DNA than double-stranded DNA. The susceptibility of double-stranded DNA to nicking by the RAD1/RAD10 enzyme is markedly dependent on the degree of negative superhelicity, such that a 15-fold increase in nicking rate is observed from superhelical state sigma = zero to sigma = -0.08. The enzyme produces 3'-hydroxyl and 5'-phosphate termini on both single- and double-stranded DNAs. We discuss the role of RAD1/RAD10 endonuclease in nucleotide excision repair and in mitotic recombination.	UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT BIOPHYS,ROCHESTER,NY 14642	University of Rochester; University of Rochester			Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NATIONAL CANCER INSTITUTE [R01CA035035, R37CA035035] Funding Source: NIH RePORTER; NCI NIH HHS [CA35035] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILIS AM, 1992, MOL CELL BIOL, V12, P4988, DOI 10.1128/MCB.12.11.4988; BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; BANG DD, 1992, NUCLEIC ACIDS RES, V20, P3925, DOI 10.1093/nar/20.15.3925; BANKMANN M, 1992, NATURE, V355, P555, DOI 10.1038/355555a0; BARDWELL L, 1992, MOL CELL BIOL, V12, P3041, DOI 10.1128/MCB.12.7.3041; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; HIGGINS DR, 1983, P NATL ACAD SCI-BIOL, V80, P5680, DOI 10.1073/pnas.80.18.5680; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; KIM RA, 1992, J BIOL CHEM, V267, P17178; KLEIN HL, 1988, GENETICS, V120, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN FLM, 1990, MOL CELL BIOL, V10, P103, DOI 10.1128/MCB.10.1.103; LJUNGMAN M, 1992, P NATL ACAD SCI USA, V89, P6055, DOI 10.1073/pnas.89.13.6055; MARYON E, 1991, MOL CELL BIOL, V11, P3278, DOI 10.1128/MCB.11.6.3278; MILLER RD, 1982, MOL CELL BIOL, V2, P939, DOI 10.1128/MCB.2.8.939; MILLER RD, 1982, MOL GEN GENET, V188, P235, DOI 10.1007/BF00332681; NAUMOVSKI L, 1983, P NATL ACAD SCI-BIOL, V80, P4818, DOI 10.1073/pnas.80.15.4818; NORANELLI F, 1980, P NATL ACAD SCI USA, V77, P3201; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; REYNOLDS P, 1985, EMBO J, V4, P3549, DOI 10.1002/j.1460-2075.1985.tb04115.x; REYNOLDS P, 1987, MOL CELL BIOL, V7, P1012, DOI 10.1128/MCB.7.3.1012; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; STEWART SE, 1989, MOL CELL BIOL, V9, P3464, DOI 10.1128/MCB.9.8.3464; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1992, NATURE, V355, P743, DOI 10.1038/355743a0; THOMAS BJ, 1989, GENETICS, V123, P725; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILCOX DR, 1981, J BACTERIOL, V148, P618, DOI 10.1128/JB.148.2.618-623.1981; ZEHFUS BR, 1990, GENETICS, V126, P41	37	106	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26391	26399						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253764				2022-12-27	WOS:A1993MK42500058
J	CHEN, HM; LIAO, WSL				CHEN, HM; LIAO, WSL			DIFFERENTIAL ACUTE-PHASE RESPONSE OF RAT KININOGEN GENES INVOLVES TYPE-I AND TYPE-II INTERLEUKIN-6 RESPONSE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; REACTIVE PROTEIN PROMOTER; CELL-SPECIFIC EXPRESSION; C/EBP-RELATED PROTEINS; HIGH MOLECULAR-WEIGHT; T-KININOGEN; BINDING-PROTEIN; TRANSCRIPTION FACTOR; ACTIVATOR PROTEIN	The serum concentration of rat T1 kininogen increases 20-30-fold in response to acute inflammation. This increase, induced in the liver, is regulated primarily at the transcriptional level. In contrast, synthesis of a homologous K kininogen is not induced. In this study, we further analyzed a 321-base pair interleukin (IL)-6 response element in the T1 kininogen promoter and showed that it consists of at least three functionally distinct sequences (A, B, and C boxes). All three sequences were required for full promoter activity. The B box, a strong C/EBP-binding site, was crucial for T1 kininogen's basal expression, whereas A and C boxes resembled the type II IL-6 response elements and were critical for the cytokine response. C/EBPalpha, -beta, and -delta interacted with the B box sequence; however, upon IL-6 stimulation, C/EBPdelta binding activity was dramatically induced and became the predominant factor binding to this site. Consistent with these binding studies were the cotransfection experiments, revealing that C/EBPdelta was the most potent transactivator under induced conditions and that its transactivation on the T1 kininogen promoter required an intact B box. These findings substantiated the importance of the B box in eliciting the full acute-phase response. A sequence comparison showed the K kininogen promoter contained identical A and B boxes but differed from the T1 kininogen promoter by two nucleotides at the C box. This divergence reduced the IL-6 response by approximately 4-fold, thus contributing to the differential inflammatory response. Our studies demonstrate that evolutionary divergence of a few nucleotides at a critical sequence in the promoter regions can profoundly alter the expression patterns of downstream genes.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,BOX 117,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; UTMD Anderson Cancer Center					NIAMS NIH HHS [AR 38858] Funding Source: Medline; NIA NIH HHS [AG 09853] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038858, R01AR038858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R55AG009853] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALAM T, 1992, J BIOL CHEM, V267, P5021; ANDERSON KP, 1989, GENE, V81, P119, DOI 10.1016/0378-1119(89)90342-9; ANDERSON KP, 1990, MOL ENDOCRINOL, V4, P543, DOI 10.1210/mend-4-4-543; ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; BAUMANN H, 1989, J BIOL CHEM, V264, P8046; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BAUMANN H, 1990, MOL BIOL MED, V7, P147; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHEN HM, 1991, J BIOL CHEM, V266, P2946; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; DARLINGTON GJ, 1986, J CELL BIOL, V103, P787, DOI 10.1083/jcb.103.3.787; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; FEY G, 1990, PROGR LIVER DIS, P89; FEY GH, 1987, MOL BIOL MED, V4, P323; FUNG WP, 1987, J BIOL CHEM, V262, P9298; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEIGER T, 1988, EUR J IMMUNOL, V18, P717, DOI 10.1002/eji.1830180510; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAYSON DR, 1989, ANN NY ACAD SCI, V557, P243; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; ISSHIKI H, 1991, NEW BIOL, V3, P63; JOHNSON PF, 1990, CELL GROWTH DIFFER, V1, P47; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KAGEYAMA R, 1985, J BIOL CHEM, V260, P2060; KAGEYAMA R, 1987, J BIOL CHEM, V262, P2345; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KITAGAWA H, 1987, J BIOL CHEM, V262, P2190; KITAMURA N, 1983, NATURE, V305, P545, DOI 10.1038/305545a0; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; KOJ A, 1989, ANN NY ACAD SCI, V557, P1; KONOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473; LI XX, 1990, MOL CELL BIOL, V10, P6624, DOI 10.1128/MCB.10.12.6624; LI XX, 1991, J BIOL CHEM, V266, P15192; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; MANN EA, 1991, J BIOL CHEM, V266, P16931; MILOS PM, 1992, GENE DEV, V6, P991, DOI 10.1101/gad.6.6.991; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; POLI V, 1989, NUCLEIC ACIDS RES, V17, P9351; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; RATAJCZAK T, 1992, J BIOL CHEM, V267, P11111; SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; TONIATTI C, 1990, EMBO J, V9, P4467, DOI 10.1002/j.1460-2075.1990.tb07897.x; VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553	56	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25311	25319						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244962				2022-12-27	WOS:A1993MK10000009
J	DEFORGE, LE; PRESTON, AM; TAKEUCHI, E; KENNEY, J; BOXER, LA; REMICK, DG				DEFORGE, LE; PRESTON, AM; TAKEUCHI, E; KENNEY, J; BOXER, LA; REMICK, DG			REGULATION OF INTERLEUKIN-8 GENE-EXPRESSION BY OXIDANT STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NEUTROPHIL CHEMOTACTIC FACTOR; HUMAN WHOLE-BLOOD; NF-KAPPA-B; MESSENGER-RNA; REPERFUSION INJURY; ENDOTHELIAL-CELLS; HUMAN-FIBROBLASTS; FREE-RADICALS; FACTOR-ALPHA	Interleukin 8 (IL-8) is a recently described cytokine that functions as a potent neutrophil chemoattractant and activator. We sought to examine the link between the generation of reactive oxygen intermediates (ROI) and the regulation of IL-8 gene expression to specifically test the hypothesis that ROI would induce production of IL-8 mRNA and protein. In lipopolysaccharide-stimulated human whole blood, the OH radical scavenger dimethyl sulfoxide (Me2SO) dramatically inhibited (approximately 90%) IL-8 production, but had minimal effects on the production of tumor necrosis factor, interleukin 1beta (IL-1), and IL-6. To determine whether NADPH-oxidase-generated free radicals were critical in the regulation of IL-8, studies were performed using blood from patients with chronic granulomatous disease. In both normal individuals and patients with chronic granulomatous disease, production of IL-8 could be initiated with lipopolysaccharide, phytohemagglutinin, or aggregated immune complexes, and this production could be inhibited by Me2SO (1% v/v). To examine if oxidant stress represents a ubiquitous mechanism for the induction of IL-8, experiments were performed in cultured cell lines. In the human hepatoma cell line Hep-G2, Me2SO dose-dependently inhibited tumor necrosis factor-stimulated IL-8 production, with a 74 +/- 1% reduction observed at a Me2SO concentration of 1%. Direct exposure to ROI demonstrated that H2O2 stimulated IL-8 production in a dose-dependent manner in Hep-G2 cells, A549 pulmonary type II epithelial cells, and human skin fibroblasts; this induction could be prevented by addition of catalase. The production of IL-8 appeared to be specific to an oxidant stress since exposure of the cells to heat shock or chemical stress did not induce expression of IL-8. These studies demonstrate that oxidant stress is an important regulator of IL-8 gene expression and support the hypothesis that low levels of ROI may serve to initiate IL-8 production which then serves to recruit neutrophils to sites of inflammation.	UNIV MICHIGAN, SCH MED, DEPT PATHOL, M2210 MED SCI BLDG 1, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, DEPT PEDIAT, ANN ARBOR, MI 48109 USA; SYNTEX INC, PALO ALTO, CA 94304 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Syntex Corporation				Remick, Daniel/0000-0002-2615-3713	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042455] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20065] Funding Source: Medline; NIDDK NIH HHS [DK-42455] Funding Source: Medline; NIGMS NIH HHS [GM-44918] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; BABIOR BM, 1991, AM J HEMATOL, V37, P263, DOI 10.1002/ajh.2830370410; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BAUTISTA AP, 1990, AM J PHYSIOL, V259, pG907, DOI 10.1152/ajpgi.1990.259.6.G907; COLLIER J, 1989, TRENDS PHARMACOL SCI, V10, P427, DOI 10.1016/S0165-6147(89)80001-X; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; DEFORGE LE, 1992, AM J PATHOL, V140, P1045; DEFORGE LE, 1992, J CLIN INVEST, V90, P2123, DOI 10.1172/JCI116097; FREEMAN BA, 1982, LAB INVEST, V47, P412; GHEZZI P, 1991, CYTOKINE, V3, P189, DOI 10.1016/1043-4666(91)90015-6; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; ISRAEL N, 1992, J IMMUNOL, V149, P3386; KENNEY JS, 1987, J IMMUNOL, V138, P4236; KOGA S, 1992, J CLIN INVEST, V90, P1007, DOI 10.1172/JCI115913; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MATSUBARA T, 1986, J IMMUNOL, V137, P3295; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MCCORD JM, 1987, FASEB J, V46, P2402; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953; MIELKE V, 1990, J IMMUNOL, V144, P153; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; PEREZ HD, 1980, INFLAMMATION, V4, P313, DOI 10.1007/BF00915032; PETRONE WF, 1980, P NATL ACAD SCI-BIOL, V77, P1159, DOI 10.1073/pnas.77.2.1159; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SHINGU M, 1984, AM J PATHOL, V117, P201; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; STRIETER RM, 1989, J BIOL CHEM, V264, P10621; TAWARA T, 1991, INFLAMMATION, V15, P145, DOI 10.1007/BF00917509; THORNTON AJ, 1990, J IMMUNOL, V144, P2609; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; WHARRAM BL, 1991, J IMMUNOL, V146, P1437; 1991, NEW ENGL J MED, V342, P509	41	352	356	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25568	25576						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244994				2022-12-27	WOS:A1993MK10000045
J	KOBSCONRAD, S; LEE, H; DIGEORGE, AM; KAUMAYA, PTP				KOBSCONRAD, S; LEE, H; DIGEORGE, AM; KAUMAYA, PTP			ENGINEERED TOPOGRAPHIC DETERMINANTS WITH ALPHA-BETA, BETA-ALPHA-BETA, AND BETA-ALPHA-BETA-ALPHA TOPOLOGIES SHOW HIGH-AFFINITY BINDING TO NATIVE PROTEIN ANTIGEN (LACTATE DEHYDROGENASE-C(4))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; ZINC FINGER PEPTIDE; SYNTHETIC PEPTIDES; 3-DIMENSIONAL STRUCTURE; CIRCULAR-DICHROISM; 4-HELIX BUNDLE; DENOVO DESIGN; T-CELL; IMMUNOGENIC DETERMINANTS; SECONDARY STRUCTURE	The use of peptides has attracted much interest in the development of synthetic vaccines. Although our current understanding of peptide antigens as immunogens has been greatly advanced recently, there still remain many obstacles. The B cell response elicited by a peptide antigen is governed by a number of poorly understood events such as epitope structure, T cell dependency and major histocompatibility complex restriction, adjuvancy, route of immunization, and immunogen stability. In this paper, we extend our previous studies on the problem of the topographical nature of antigenic sites on native protein antigens, in terms of how much molecular mimicry must be maintained in an antigenic determinant for the induction of high affinity antibodies specific for native protein. We show here that an antigenic epitope from the model contraceptive vaccine candidate lactate dehydrogenase (LDH-C4) can be rationally engineered into a highly structured conformation that mimics the corresponding site in the native three-dimensional protein. Our strategy is based on the selection of an antigenic segment which exhibits certain secondary structural properties and by design principles is fixed in three dimensions by appropriate grafting onto a supersecondary structural motif such as alphabeta, betaalphabeta, or betaalphabetaalpha. The biophysical data are consistent with the proposed secondary structures, and antibodies raised to the various construct show high affinity for the native protein. These studies lend further credence to the conformational nature of peptide epitopes and provide a basis for the rational design of peptide vaccines.	OHIO STATE UNIV, CTR COMPREHENS CANC, SUITE 302, 410 W 12TH AVE, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL BIOL SCI, DEPT MICROBIOL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL MED, DEPT OBSTET & GYNECOL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL MED, DEPT MED BIOCHEM, COLUMBUS, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University			Kaumaya, Pravin T. P/E-3354-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI025790] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25790] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; ANTHONYCAHILL SJ, 1992, SCIENCE, V255, P979, DOI 10.1126/science.1312255; Berzofsky J A, 1991, Semin Immunol, V3, P203; BIDART JM, 1990, SCIENCE, V248, P736, DOI 10.1126/science.1692160; BORRASCUESTA F, 1987, EUR J IMMUNOL, V17, P1213, DOI 10.1002/eji.1830170820; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076; DOROW DS, 1985, MOL IMMUNOL, V22, P1255, DOI 10.1016/0161-5890(85)90044-6; EDWARDS MS, 1987, PROTEIN ENG, V1, P173, DOI 10.1093/protein/1.3.173; EFIMOV AV, 1984, FEBS LETT, V166, P33, DOI 10.1016/0014-5793(84)80039-3; EFIMOV AV, 1991, PROTEIN ENG, V4, P245, DOI 10.1093/protein/4.3.245; ENGEL M, 1991, BIOCHEMISTRY-US, V30, P3161, DOI 10.1021/bi00227a002; FEDOROV AN, 1992, J MOL BIOL, V225, P927, DOI 10.1016/0022-2836(92)90092-X; FOURQUET P, 1988, INT J PEPT PROT RES, V32, P81; FRANCIS MJ, 1987, NATURE, V330, P168, DOI 10.1038/330168a0; GHADIRI MR, 1992, J AM CHEM SOC, V114, P4000, DOI 10.1021/ja00036a072; GOLDBERG E, 1973, SCIENCE, V181, P458, DOI 10.1126/science.181.4098.458; GOLDBERG E, 1981, FERTIL STERIL, V35, P214; GRASMASSE H, 1988, MOL IMMUNOL, V25, P673, DOI 10.1016/0161-5890(88)90102-2; GUTTE B, 1979, NATURE, V281, P650, DOI 10.1038/281650a0; HAHN KW, 1990, SCIENCE, V248, P1544, DOI 10.1126/science.2360048; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; HODGES R S, 1990, Peptide Research, V3, P123; HODGES R S, 1988, Peptide Research, V1, P19; HOGREFE HH, 1989, J BIOL CHEM, V264, P10513; JEMMERSON R, 1987, P NATL ACAD SCI USA, V84, P9180, DOI 10.1073/pnas.84.24.9180; JEMMERSON R, 1990, EUR J IMMUNOL, V20, P579, DOI 10.1002/eji.1830200318; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KARLE IL, 1990, BIOCHEMISTRY-US, V29, P6747, DOI 10.1021/bi00481a001; KAUMAYA PTP, 1992, J BIOL CHEM, V267, P6338; KAUMAYA PTP, 1990, BIOCHEMISTRY-US, V29, P13, DOI 10.1021/bi00453a002; KAUMAYA PTP, 1992, PEPTIDES CHEM BIOL, P883; KAUMAYA PTP, IN PRESS J MOL RECOG; KAUMAYA PTP, 1990, PEPTIDES, P611; KAUMAYA PTP, 1993, PEPTIDES 1992, P139; KAUMAYA PTP, 1990, PEPTIDES CHEM STRUCT, P709; KOBSCONRAD S, 1992, PEPTIDES CHEM BIOL, P886; KOBSCONRAD S, 1993, PEPTIDES, P561; KRIZEK BA, 1991, J AM CHEM SOC, V113, P4518, DOI 10.1021/ja00012a021; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; LECLERC G, 1987, EUR J IMMUNOL, V17, P1213; LEE H, 1992, PEPTIDES CHEM BIOL, P368; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LOWENADLER B, 1992, MOL IMMUNOL, V29, P1185, DOI 10.1016/0161-5890(92)90054-2; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; MARGUERITE M, 1992, MOL IMMUNOL, V29, P793, DOI 10.1016/0161-5890(92)90189-5; MERKLE DL, 1991, J AM CHEM SOC, V113, P5450, DOI 10.1021/ja00014a045; MICHAEL SF, 1992, P NATL ACAD SCI USA, V89, P4796, DOI 10.1073/pnas.89.11.4796; Milich D R, 1990, Semin Immunol, V2, P307; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; MILNERWHITE EJ, 1986, BIOCHEM J, V240, P289, DOI 10.1042/bj2400289; MOSER R, 1987, PROTEIN ENG, V1, P339, DOI 10.1093/protein/1.4.339; MUTTER M, 1986, Z NATURFORSCH B, V41, P1315, DOI 10.1515/znb-1986-1020; MUTTER M, 1992, J AM CHEM SOC, V114, P1463, DOI 10.1021/ja00030a049; MUTTER M, 1988, HELV CHIM ACTA, V71, P835, DOI 10.1002/hlca.19880710419; MUTTER M, 1988, TETRAHEDRON, V44, P771, DOI 10.1016/S0040-4020(01)86116-0; Mutter M, 1989, ANGEW CHEM, V101, P551, DOI [DOI 10.1002/ANGE.19891010504, 10.1002/ange.19891010504]; OSTERHOUT JJ, 1992, J AM CHEM SOC, V114, P331, DOI 10.1021/ja00027a043; PABO CO, 1986, BIOCHEMISTRY-US, V25, P5987, DOI 10.1021/bi00368a023; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; PARTIDOS C, 1992, MOL IMMUNOL, V29, P651, DOI 10.1016/0161-5890(92)90202-9; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROUAS N, 1992, MOL IMMUNOL, V29, P883, DOI 10.1016/0161-5890(92)90126-I; SCHULZEGAHMEN U, 1986, EUR J BIOCHEM, V159, P283, DOI 10.1111/j.1432-1033.1986.tb09865.x; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SELA M, 1969, SCIENCE, V166, P1365, DOI 10.1126/science.166.3911.1365; SEO YH, 1993, PEPTIDES, P866; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SPRANGLER BD, 1991, J IMMUNOL, V146, P1591; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; STEWARD MW, 1987, IMMUNOL TODAY, V8, P51, DOI 10.1016/0167-5699(87)90239-8; VANREGENMORTEL MHV, 1989, IMMUNOL TODAY, V10, P266, DOI 10.1016/0167-5699(89)90140-0; XU NE, 1992, J BIOL CHEM, V267, P2664; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; ZHU BY, 1992, INT J PEPT PROT RES, V40, P171	83	35	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25285	25295						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244959				2022-12-27	WOS:A1993MK10000006
J	LIU, SQ; BHATNAGAR, A; SRIVASTAVA, SK				LIU, SQ; BHATNAGAR, A; SRIVASTAVA, SK			BOVINE LENS ALDOSE REDUCTASE - PH-DEPENDENCE OF STEADY-STATE KINETIC-PARAMETERS AND NUCLEOTIDE-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-CATALYZED REACTIONS; DIABETIC COMPLICATIONS; ALDEHYDE REDUCTASE; CHEMICAL MECHANISMS; INVOLVEMENT; SITE; RESIDUES; MUSCLE	The pH-dependence of nucleotide binding and steady-state kinetic parameters of aldehyde reduction and alcohol oxidation catalyzed by bovine lens aldose reductase were studied. The maximal velocity of aldehyde reduction with NADPH and p-chlorobenzaldehyde was pH independent at low pH but decreased at high pH with a pK of 7.6. The V/K of NADPH displayed a bell-shaped dependence on pH and decreased with a pK(a) of 5.3 and a pK(b) of 7.5. The dissociation constant of NADPH and 3-acetylpyridine adenine dinucleotide phosphate (3-APADP) increased at low pH with a pK of 5.6-5.8 and at high pH with a pK of 9.4-9.7. The pK(i) of NADP and NADPH decreased below a pH of 5 and 6.7 and above a pH of 8.5 and 9.7, respectively. The pK of 8.5-9.7 appears to be due to the interaction of the 2'-phosphate of the nucleotide with a protonated base, possibly a lysine residue. The maximal velocity of alcohol oxidation was pH independent at high pH but decreased at low pH with a pK of 6.5-7.0, when p-chlorobenzyl alcohol or benzyl alcohol and 3-APADP were used. The amino acid residue for alcohol binding has a pK of 7.5-8.2 and also appears in pK(i) profiles of sorbinil, a competitive inhibitor versus the alcohol. Large (3-3.5) isotope effects on maximal velocity obtained with benzyl alcohol and 3-APADP suggest that with these substrates the hydride transfer step is rate-limiting and a pK of 6.5-7.0 may he the true pK of the acid-base catalyst, possibly a histidine.	UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77555	University of Texas System; University of Texas Medical Branch Galveston			Bhatnagar, Aruni/H-7791-2013		NATIONAL EYE INSTITUTE [R01EY001677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036118, R01DK036118] Funding Source: NIH RePORTER; NEI NIH HHS [EY 01677] Funding Source: Medline; NIDDK NIH HHS [DK 36118] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BHATNAGAR A, 1992, BIOCHEM MED METAB B, V48, P91, DOI 10.1016/0885-4505(92)90055-4; BHATNAGAR A, 1988, ARCH BIOCHEM BIOPHYS, V261, P264, DOI 10.1016/0003-9861(88)90341-4; BHATNAGAR A, 1989, MOL PHARMACOL, V36, P825; BHATNAGAR A, 1991, ARCH BIOCHEM BIOPHYS, V287, P329, DOI 10.1016/0003-9861(91)90486-3; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; COOK PF, 1981, BIOCHEMISTRY-US, V20, P1797, DOI 10.1021/bi00510a014; DALZIEL K, 1973, ENZYMES, V11, P1; DAS B, 1985, ARCH BIOCHEM BIOPHYS, V238, P670, DOI 10.1016/0003-9861(85)90213-9; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FLYNN TG, 1982, BIOCHEM PHARMACOL, V31, P2705, DOI 10.1016/0006-2952(82)90123-X; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; GRIMSHAW CE, 1990, BIOCHEMISTRY-US, V29, P9936, DOI 10.1021/bi00494a026; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510; LIU SQ, 1992, BIOCHIM BIOPHYS ACTA, V1120, P329, DOI 10.1016/0167-4838(92)90256-D; LIU SQ, 1992, BIOCHEM PHARMACOL, V44, P2427, DOI 10.1016/0006-2952(92)90693-D; MAS MT, 1984, BIOCHEMISTRY-US, V23, P1675, DOI 10.1021/bi00303a015; MORJANA NA, 1989, J BIOL CHEM, V264, P2912; MORRISON AD, 1970, BIOCHEM BIOPH RES CO, V40, P199, DOI 10.1016/0006-291X(70)91066-1; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; RASKIN P, 1987, AM J MED, V83, P298, DOI 10.1016/0002-9343(87)90702-9; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; Sarges R., 1989, ADV DRUG RES, V18, P139; SCHADE SZ, 1990, J BIOL CHEM, V265, P3628; SEGEL IH, 1975, ENZYME KINETICS, P574; VIOLA RE, 1979, ANAL BIOCHEM, V94, P334; WARD LD, 1985, METHOD ENZYMOL, V117, P400; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098	30	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25494	25499						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244985				2022-12-27	WOS:A1993MK10000035
J	HIRATSUKA, T				HIRATSUKA, T			BEHAVIOR OF CYS-707 (SH1) IN MYOSIN ASSOCIATED WITH ATP HYDROLYSIS REVEALED WITH A FLUORESCENT-PROBE LINKED DIRECTLY TO THE SULFUR ATOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; AMINO-ACID-SEQUENCE; HEAVY-CHAIN; ADENOSINE-TRIPHOSPHATASE; ENERGY-TRANSFER; CROSS-LINKING; SUBFRAGMENT-1; ACTIN; THIOLS; CONTRACTION	4-Fluoro-7-sulfamoylbenzofurazan (ABDF) has a rather small fluorophore that is linked directly to the sulfur atom of thiols without a flexible alkyl chain (Imai, K., and Toyo'oka, T. (1987) Methods Enzymol. 143, 67-75). In the present study I examined the fluorescent and chemical properties of ABDF as an environmentally sensitive probe for Cys-707 (SH1) of myosin subfragment-1 (S-1) to monitor the behavior of SH1 associated with ATP hydrolysis. ABDF was very stable to long irradiation and nonfluorescent before attachment to thiols, permitting the continuous monitoring of the labeling reaction. The fluorophore was useful as an environmentally sensitive probe for thiol groups in proteins. SH1 of S-1 was specifically labeled with ABDF. When ATP, adenyl-5'-yl imidodiphosphate, and ADP were added to the labeled S-1 (ABD-S-1), the fluorescence intensity at 500 nm increased by 110, 66, and 53%, respectively. Binding of actin to ABD-S-1 resulted in a decrease in the fluorescence by 30%. The fluorophore attached to SH1 was found to be located in a more hydrophobic environment in the presence of ATP than in the absence of ligand. KI fluorescence quenching studies suggested that the binding of ATP causes a movement of SH1 toward a more hydrophobic protein interior, whereas it goes back to the opposite direction after ATP hydrolysis. Thus, ABDF is very useful as an environmentally sensitive fluorescent probe for SH1 that monitors ligand-induced changes in the behavior of the thiol.			HIRATSUKA, T (corresponding author), ASAHIKAWA MED COLL, DEPT CHEM, ASAHIKAWA, HOKKAIDO 078, JAPAN.							AGUIRRE R, 1986, BIOCHEMISTRY-US, V25, P6827, DOI 10.1021/bi00370a015; AJTAI K, 1992, BIOCHEMISTRY-US, V31, P12431, DOI 10.1021/bi00164a019; AJTAI K, 1989, BIOCHEMISTRY-US, V28, P2204, DOI 10.1021/bi00431a035; BHANDARI DG, 1991, BIOCHIM BIOPHYS ACTA, V1077, P385, DOI 10.1016/0167-4838(91)90555-E; BOTTS J, 1984, P NATL ACAD SCI-BIOL, V81, P2060, DOI 10.1073/pnas.81.7.2060; BOTTS J, 1989, P NATL ACAD SCI USA, V86, P2204, DOI 10.1073/pnas.86.7.2204; CHANCE B, 1957, ARCH BIOCHEM BIOPHYS, V71, P130, DOI 10.1016/0003-9861(57)90015-2; CHEUNG HC, 1983, J BIOL CHEM, V258, P5775; CHEUNG HC, 1991, BIOPHYS CHEM, V40, P1, DOI 10.1016/0301-4622(91)85025-L; COLLINS JH, 1975, J BIOL CHEM, V250, P5915; DUKE J, 1976, P NATL ACAD SCI USA, V73, P302, DOI 10.1073/pnas.73.2.302; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fiske CH, 1925, J BIOL CHEM, V66, P375; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HIRATSUKA T, 1986, BIOCHEMISTRY-US, V25, P2101, DOI 10.1021/bi00356a039; HIRATSUKA T, 1986, J BIOL CHEM, V261, P7294; HIRATSUKA T, 1987, BIOCHEMISTRY-US, V26, P3168, DOI 10.1021/bi00385a034; HIRATSUKA T, 1990, J BIOL CHEM, V265, P18786; HIRATSUKA T, 1992, J BIOL CHEM, V267, P14941; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; HUXLEY HE, 1985, J MUSCLE RES CELL M, V6, P153, DOI 10.1007/BF00713057; IMAI K, 1987, METHOD ENZYMOL, V143, P67; KASPRZAK AA, 1989, BIOCHEMISTRY-US, V28, P9230, DOI 10.1021/bi00449a040; KENNER RA, 1971, BIOCHEMISTRY-US, V10, P4433, DOI 10.1021/bi00800a013; KONRAD M, 1982, EUR J BIOCHEM, V128, P547; MIYANISHI T, 1989, BIOCHEMISTRY-US, V28, P1287, DOI 10.1021/bi00429a051; MUELLER H, 1962, BIOCHEM J, V85, P431, DOI 10.1042/bj0850431; MULHERN SA, 1978, BIOCHEMISTRY-US, V17, P4419, DOI 10.1021/bi00614a010; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PERKINS WJ, 1984, J BIOL CHEM, V259, P8786; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; REES MK, 1967, J BIOL CHEM, V242, P4449; REISLER E, 1982, METHOD ENZYMOL, V85, P84; SEKINE T, 1964, BIOCHIM BIOPHYS ACTA, V81, P336, DOI 10.1016/0926-6569(64)90049-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stern O, 1919, PHYS Z, V20, P183; SUTOH K, 1981, BIOCHEMISTRY-US, V20, P3281, DOI 10.1021/bi00514a046; TAKASHI R, 1976, ARCH BIOCHEM BIOPHYS, V175, P279, DOI 10.1016/0003-9861(76)90509-9; TAYLOR EW, 1979, CRC CR REV BIOCH MOL, V6, P103, DOI 10.3109/10409237909102562; TONG SW, 1990, J BIOL CHEM, V265, P4893; TOYOOKA T, 1985, ANAL CHEM, V57, P1931, DOI 10.1021/ac00286a032; WAGNER PD, 1977, J MOL BIOL, V109, P455, DOI 10.1016/S0022-2836(77)80023-5; WEBER K, 1969, J BIOL CHEM, V244, P4406; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WELLS JA, 1980, BIOCHEMISTRY-US, V19, P1711, DOI 10.1021/bi00549a030; WIEDNER H, 1978, J BIOL CHEM, V253, P2763; YAMAGUCHI M, 1966, J BIOCHEM, V59, P24, DOI 10.1093/oxfordjournals.jbchem.a128254	48	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24742	24750						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227033				2022-12-27	WOS:A1993MG67300036
J	KLETT, C; NOBILING, R; GIERSCHIK, P; HACKENTHAL, E				KLETT, C; NOBILING, R; GIERSCHIK, P; HACKENTHAL, E			ANGIOTENSIN-II STIMULATES THE SYNTHESIS OF ANGIOTENSINOGEN IN HEPATOCYTES BY INHIBITING ADENYLYLCYCLASE ACTIVITY AND STABILIZING ANGIOTENSINOGEN MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE BINDING-FACTOR; RAT ANGIOTENSINOGEN; ADENYLATE-CYCLASE; RENIN-SUBSTRATE; HORMONAL-CONTROL; GENE-EXPRESSION; PERTUSSIS TOXIN; BLOOD-PRESSURE; PHORBOL-ESTER; PROTEIN	Angiotensin II stimulates the hepatic synthesis and secretion of angiotensinogen, the substrate of renin. In the present study performed on freshly isolated rat hepatocytes we demonstrate that this effect of angiotensin II is mainly related to a transient inhibition of adenylylcyclase. Agents known to decrease intracellular cAMP (angiotensin II, vasopressin, guanfacine) or the cAMP-antagonist Rp-adenosine-3',5'-cyclic phosphothioate stimulated, whereas cAMP-stimulating agents (isoproterenol, forskolin, glucagon) or the cAMP-agonist Sp-adenosine-3',5'-cyclic phosphothioate inhibited angiotensinogen synthesis. In contrast, all agents known to affect intracellular concentrations of calcium, as confirmed in Fura-2-loaded hepatocytes (Bay K 8644, calcimycin, calmidazolium, ionomycin, or methoxamine) failed to influence the synthesis of angiotensinogen. The inhibitory effect of angiotensin II as well as the stimulatory effect of glucagon on cAMP were inversely related to angiotensinogen mRNA and angiotensinogen secretion over a wide concentration range of both peptides. Both the angiotensin II-dependent inhibition of cAMP and the angiotensin II-induced increase in angiotensinogen mRNA were abolished by a pertussis toxin pretreatment. In hepatocyte membranes, pertussis toxin ADP-ribosylated a single protein (approximately 41 kDa) probably representing the alpha-subunit of the G(i)-protein, coupling inhibitory receptors to adenylylcyclase. We further show that the increase of angiotensinogen mRNA and secretion mainly represents the result of mRNA stabilization, since in a nuclear run-on assay, angiotensin II pretreatment of hepatocytes does not significantly alter the rate of [P-32]UTP incorporation into angiotensinogen mRNA, whereas angiotensin II prolonged the half-life of angiotensinogen mRNA in transcription-arrested as well as in [H-3]uridine pulse-labeled hepatocytes about 2.5-fold from 80 to 190 min. It is concluded that angiotensin II induces an increase in angiotensinogen synthesis in hepatocytes by stabilizing of angiotensinogen mRNA and that this effect is mediated through inhibition of adenylylcyclase.	UNIV HEIDELBERG,DEPT PHARMACOL,NEUENHEIMER FELD 366,W-6900 HEIDELBERG,GERMANY; UNIV HEIDELBERG,DEPT PHYSIOL,W-6900 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg								AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; AUGERT G, 1989, J BIOL CHEM, V264, P21689; BARRETT G, 1989, CLIN EXP PHARMACOL P, V16, P631, DOI 10.1111/j.1440-1681.1989.tb01614.x; BING J, 1972, ACTA PATH MICRO IM A, VA 80, P646; BOCCKINO SB, 1985, J BIOL CHEM, V260, P4201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASIER AR, 1989, MOL ENDOCRINOL, V3, P1022, DOI 10.1210/mend-3-6-1022; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; BUSHFIELD M, 1990, BIOCHEM J, V268, P449, DOI 10.1042/bj2680449; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; CLAUSER E, 1983, ENDOCRINOLOGY, V112, P1188, DOI 10.1210/endo-112-4-1188; DZAU BJ, 1982, LIFE SCI, V30, P577; FAIN JN, 1990, BIOCHIM BIOPHYS ACTA, V1053, P81, DOI 10.1016/0167-4889(90)90029-D; FELDMER M, 1991, J HYPERTENS, V9, P1005, DOI 10.1097/00004872-199111000-00005; GIERSCHIK P, 1989, EUR J PHARM-MOLEC PH, V172, P481, DOI 10.1016/0922-4106(89)90031-X; GIERSCHIK P, 1992, CURR TOP MICROBIOL, V175, P69; GILLIS P, 1991, J BIOL CHEM, V266, P3172; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HACKENTHAL E, 1977, CIRC RES, V41, pR249, DOI 10.1161/01.RES.41.4.49; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1076; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HECKER E, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1890; HELLMANN W, 1988, N-S ARCH PHARMACOL, V338, P327; JARD S, 1981, J BIOL CHEM, V256, P2603; JOHNSTON CI, 1990, DRUGS, V39, P21, DOI 10.2165/00003495-199000391-00005; KHAYYALL M, 1973, CLIN SCI, V44, P87, DOI 10.1042/cs0440087; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; KLETT C, 1987, CLIN EXP HYPERTENS A, V9, P2027, DOI 10.3109/10641968709159073; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; KLETT C, 1988, J HYPERTENS       S4, V6, P442; KLETT C, 1987, J HYPERTENS       S5, V5, pS19; KRUSKAL BA, 1984, J CELL BIOL, V99, P1167, DOI 10.1083/jcb.99.3.1167; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMEUR M, 1981, CELL, V23, P561, DOI 10.1016/0092-8674(81)90152-5; LEVIS R, 1977, CELL, V11, P105, DOI 10.1016/0092-8674(77)90321-X; LUDWIG G, 1986, J HYPERTENS, V4, pS431; MALTER JS, 1991, J BIOL CHEM, V266, P3167; MALTER JS, 1991, J BIOL CHEM, V266, P3171; MORGAN NG, 1983, FEBS LETT, V153, P77, DOI 10.1016/0014-5793(83)80122-7; MURRAY RD, 1982, RENAL PHYSL, V5, P296; NASJLETTI A, 1971, CAN J PHYSIOL PHARM, V49, P931, DOI 10.1139/y71-129; NASJLETTI A, 1973, P SOC EXP BIOL MED, V142, P307; NIELSEN DA, 1990, MOL ENDOCRINOL, V4, P953, DOI 10.1210/mend-4-7-953; NOBILING R, 1989, J MICROSC-OXFORD, V156, P149, DOI 10.1111/j.1365-2818.1989.tb02914.x; OHKUBO H, 1983, P NATL ACAD SCI-BIOL, V80, P2196, DOI 10.1073/pnas.80.8.2196; PFEILSCHIFTER J, 1986, BIOCHEM J, V236, P289, DOI 10.1042/bj2360289; ROTHENBERGER S, 1990, NUCLEIC ACIDS RES, V18, P1175, DOI 10.1093/nar/18.5.1175; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SERNIA C, 1989, MOL CELL ENDOCRINOL, V61, P147, DOI 10.1016/0303-7207(89)90125-1; SHIONOIRI H, 1983, BIOCHEM MED METAB B, V29, P14, DOI 10.1016/0006-2944(83)90049-2; STUZMANN M, 1986, BIOCHIM BIOPHYS ACTA, V886, P48, DOI 10.1016/0167-4889(86)90210-7; TATEISHI H, 1972, P SOC EXP BIOL MED, V139, P304; TEWKSBURY TA, 1981, BIOCH REGULATION BLO, V5, P95; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0	60	58	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25095	25107						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227073				2022-12-27	WOS:A1993MG67300084
J	LI, JY; ZHU, XM; BYRNES, M; NELSON, JW; CHANG, SH				LI, JY; ZHU, XM; BYRNES, M; NELSON, JW; CHANG, SH			SITE-DIRECTED MUTAGENESIS OF RABBIT MUSCLE PHOSPHOFRUCTOKINASE CDNA - MUTATIONS AT GLUTAMINE-200 AFFECT THE ALLOSTERIC PROPERTIES OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER PHOSPHOFRUCTOKINASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; FRUCTOSE 2,6-BISPHOSPHATE; GENE; ISOENZYMES; DUPLICATION; INHIBITION; SUBUNITS; SEQUENCE	Full-length cDNA for rabbit muscle phosphofructokinase has been cloned and characterized (Li, J., Chen, Z., Lu, L., Byrnes, M., and Chang, S. H. (1990) Biochem. Biophys. Res. Commun. 170, 1056-1060). The 2.8-kilobase cDNA was inserted in the plasmid vector pPL2 and transformed into Escherichia coli cells deficient in endogenous phosphofructokinase activity (DF 1020). The recombinant phosphofructokinase so prepared is nearly identical in kinetic properties and size of subunits to the enzyme isolated from rabbit muscle. On the basis of the sequence homology between the muscle and the bacterial phosphofructokinases and the crystallographic structure of the latter, the glutamine at position 200 of the muscle enzyme is implicated in the allosteric transitions. This residue was replaced by alanine (Q200A), glutamate (Q200E), or arginine (Q200R). The purified enzymes were analyzed for quaternary structure, activity, and allosteric properties. The native and all the altered enzymes are tetramers. At pH 7.0, the wild-type enzyme is sensitive to inhibition by ATP at concentration above 0.6 mM, and its activity responds to fructose 6-phosphate concentration cooperatively at high ATP concentration. In contrast, the mutated enzyme Q200R is virtually insensitive to ATP inhibition up to 7 mM. Thus at high ATP concentration, its activity responds to fructose 6-phosphate concentration in a manner similar to the activated form of the native enzyme. Under the same conditions, mutant Q200E exhibits cooperative behavior only at much higher concentration of fructose 6-phosphate. Mutant Q200A is active at pH 8.0 but inactive at pH 7.0. The native enzyme and all three mutants are activated by inorganic phosphate and fructose 2,6-bisphosphate and inhibited by citrate.	LOUISIANA STATE UNIV,DEPT BIOCHEM,RM 322 CHOPPIN HALL,BATON ROUGE,LA 70803	Louisiana State University System; Louisiana State University					NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR006710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031676] Funding Source: NIH RePORTER; NCRR NIH HHS [RR06710] Funding Source: Medline; NIDDK NIH HHS [DK31676] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1988, MOL REPROD DEV; Bevington P.R., 1969, DATA REDUCTION ERROR; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAS GL, 1982, BIOCHEMISTRY-US, V21, P6656; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; BROCK DJH, 1969, BIOCHEM J, V113, P235, DOI 10.1042/bj1130235; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; BUELL G, 1985, NUCLEIC ACIDS RES, V13, P1923, DOI 10.1093/nar/13.6.1923; CANTOR CH, 1980, BIOPHYSICAL CHEM, P939; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; DOTTO GP, 1983, VIROLOGY, V114, P463; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; DUNAWAY GA, 1987, BIOCHEM J, V242, P667, DOI 10.1042/bj2420667; DUNAWAY GA, 1974, ARCH BIOCHEM BIOPHYS, V162, P620, DOI 10.1016/0003-9861(74)90224-0; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; FERSHT A, 1985, ENZYME STRUCTURE MEC, P263; FOE LG, 1985, J BIOL CHEM, V260, P726; FOE LG, 1982, J BIOL CHEM, V257, P6368; GEHNRICH SC, 1988, J BIOL CHEM, V255, P4240; GREER H, 1975, VIROLOGY, V66, P589, DOI 10.1016/0042-6822(75)90231-7; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; HEINISCH J, 1989, GENE, V78, P309; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; JIANG JC, 1992, ENVIRON MOL MUTAGEN, V20, P260, DOI 10.1002/em.2850200404; KASTEN TP, 1983, BIOCHEM BIOPH RES CO, V111, P248; Kemp R G, 1975, Methods Enzymol, V42, P71; KOTLARZ D, 1981, EUR J BIOCHEM, V117, P569; LATSHAW SP, 1987, J BIOL CHEM, V262, P10672; LEE CP, 1987, J BIOL CHEM, V262, P4195; LEVANON D, 1989, DNA-J MOLEC CELL BIO, V8, P733, DOI 10.1089/dna.1989.8.733; LI J, 1990, BIOCHEM BIOPH RES CO, V166, P637; LING KH, 1965, J BIOL CHEM, V240, P1893; Maniatis T., 1982, MOL CLONING; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PASSONNEAU JV, 1963, BIOCHEM BIOPH RES CO, V13, P372, DOI 10.1016/0006-291X(63)90350-4; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; REMAUT E, 1981, GENE, V15, P81, DOI 10.1016/0378-1119(81)90106-2; RYPNIEWSKI WR, 1989, J MOL BIOL, V207, P805, DOI 10.1016/0022-2836(89)90246-5; SCHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973; SCHIRMER T, 1990, NATURE, V343, P141; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UYEDA K, 1981, J BIOL CHEM, V256, P8394; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VALAITIS AP, 1987, J BIOL CHEM, V262, P5044; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; WADA K, 1991, NUCLEIC ACIDS RES, V19, P1981, DOI 10.1093/nar/19.suppl.1981	50	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24599	24606						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227018				2022-12-27	WOS:A1993MG67300017
J	NUSING, RM; HIRATA, M; KAKIZUKA, A; EKI, T; OZAWA, K; NARUMIYA, S				NUSING, RM; HIRATA, M; KAKIZUKA, A; EKI, T; OZAWA, K; NARUMIYA, S			CHARACTERIZATION AND CHROMOSOMAL MAPPING OF THE HUMAN THROMBOXANE-A(2) RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR AP-2; HUMAN-PLATELETS; INSITU HYBRIDIZATION; MESSENGER-RNA; DNA-BINDING; SEQUENCE; PROTEIN; EXPRESSION; FAMILY; CELLS	The human thromboxane A2 gene, present as a single copy, spans over 15 kilobases (kb) and contains 3 exons divided by 2 introns. The first intron, intron 1, exists in the 5'-noncoding region, 83 base pairs upstream from the ATG start site and is 6.3 kb long. Intron 2 with a length of 4.3 kb is located at the end of the sixth transmembrane region, thereby separating it from the downstream coding sequences including the seventh transmembrane region and the 3'-untranslated region. By rapid amplification of 5'-cDNA ends, transcription initiation sites starting in two different putative promoter regions were determined. In the 5'-flanking region of these transcription initiation sites, no typical TATA box exists. The major promoter, the promoter region I, contains four potential SP-1 binding sites and several potential binding sites for other transcription factors. By polymerase chain reaction analysis, a small portion of the RNA transcribed from this gene was shown to contain an additional 115-base pair long noncoding exon, exon 1b, which is located in intron 1. No additional exon in intron 2 was detectable, indicating that a single type of thromboxane A2 receptor protein is encoded by this gene. Chromosomal localization was carried out by fluorescence in situ hybridization of cloned genomic DNA to the metaphase chromosome. The gene was assigned to 19p13.3 of human chromosome.	KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN; RIKEN,GENE BANK,TSUKUBA 305,JAPAN; RIKEN,DIV HUMAN GENOME RES,TSUKUBA 305,JAPAN	Kyoto University; RIKEN; RIKEN								BERGET SM, 1984, NATURE, V309, P179, DOI 10.1038/309179a0; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DORN GW, 1989, J CLIN INVEST, V84, P1883, DOI 10.1172/JCI114375; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEY GH, 1989, ANN NY ACAD SCI, V557, P317; FITZPATRICK FA, 1978, NATURE, V275, P764, DOI 10.1038/275764a0; FOWLKES DM, 1984, P NATL ACAD SCI-BIOL, V81, P2313, DOI 10.1073/pnas.81.8.2313; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; HANASAKI K, 1989, BIOCHEM PHARMACOL, V38, P2967, DOI 10.1016/0006-2952(89)90004-X; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JAKOBOVITS EB, 1988, MOL CELL BIOL, V8, P5549, DOI 10.1128/MCB.8.12.5549; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MAIS DE, 1985, J PHARMACOL EXP THER, V233, P413; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MORINELLI TA, 1989, J PHARMACOL EXP THER, V251, P557; MORINELLI TA, 1989, P NATL ACAD SCI USA, V86, P5600, DOI 10.1073/pnas.86.14.5600; NAKAJIMA M, 1989, BIOCHEM BIOPH RES CO, V158, P958, DOI 10.1016/0006-291X(89)92815-5; NEEDLEMAN P, 1976, SCIENCE, V193, P163, DOI 10.1126/science.945611; OGLETREE ML, 1987, FED PROC, V46, P133; OGURA M, 1985, BLOOD, V66, P1384; OZAWA K, 1992, GENOMICS, V12, P214, DOI 10.1016/0888-7543(92)90368-3; OZAWA K, 1991, GENOMICS, V10, P1103, DOI 10.1016/0888-7543(91)90210-6; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SWAYNE GTG, 1988, EUR J PHARMACOL, V152, P311, DOI 10.1016/0014-2999(88)90726-1; TYMKEWYCZ PM, 1991, BRIT J PHARMACOL, V102, P607, DOI 10.1111/j.1476-5381.1991.tb12220.x; USHIKUBI F, 1989, J BIOL CHEM, V264, P16496; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	44	139	145	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25253	25259						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227091				2022-12-27	WOS:A1993MG67300104
J	PEREZMARTIN, JM; REQUENA, JM; CRACIUNESCU, D; LOPEZ, MC; ALONSO, C				PEREZMARTIN, JM; REQUENA, JM; CRACIUNESCU, D; LOPEZ, MC; ALONSO, C			THE ANTI Z-DNA REACTIVITY OF Z-DNA FORMING SEQUENCES IS AFFECTED BY PLATINUM ANTITUMOR DRUGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANDED Z-DNA; MAJOR ADDUCT; B-DNA; CIS-DIAMMINEDICHLOROPLATINUM(II); BINDING; TRANSITION; CISPLATIN; PLASMIDS	The effect of binding of platinum antitumor drugs, cis-diamminedichloroplatinum (II) (cis-DDP) and Pt-pentamidine, on the Z-DNA reactivity of potential Z-DNA forming sequences has been studied by enzyme-linked immunosorbent assay. rhe results indicate that cis-DDP and Pt-pentamidine increase the Z-DNA reactivity of plasmids containing a (dG-dC)16 insert (pUCZ8) and a native Z-DNA forming sequence of Drosophila hydei (pF18). The molar ratio of platinum bound to nucleotides (r(b)) to produce 50% of Z-DNA reactivity was 0.10 for cis-DDP:pF18, 0.15 for Pt-pentamidine: pF18, and 0.10 for cis-DDP:pUCZ8 and Pt-pentamidine:pUCZ8. The efficacy of Pt-pentamidine to provoke Z-DNA reactivity is 2.5-fold higher than that of cis-DDP. While Pt-pentamidine was capable of inducing Z-DNA reactivity in a GC-rich DNA sequence of the hsp 70 protein of Trypanosoma cruzi (p2M4EO3) and in sequences of pUC8, cis-DDP suppresses Z-DNA reactivity. CD spectra of poly(dG-me5dC). poly(dG-me5dC) modified by the drugs suggest that the increase in Z-DNA reactivity observed in plasmids upon drug binding may be due to shifting towards Z-DNA or a Z-DNA like conformation	UNIV AUTONOMA MADRID, FAC CIENCIAS, CSIC, CTR BIOL MOLEC, E-28049 MADRID, SPAIN; UNIV COMPLUTENSE MADRID, FAC FARM, DEPT QUIM INORGAN, E-28040 MADRID, SPAIN; CSIC, INST PARASITOL LOPEZ NEYRA, E-18001 GRANADA, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)			Lopez, Manuel/Z-5641-2019; Requena, Jose M/I-2022-2019	Requena, Jose M/0000-0001-7550-0198; Lopez, Manuel Carlos/0000-0003-0002-3678				AZORIN F, 1983, EMBO J, V2, P649, DOI 10.1002/j.1460-2075.1983.tb01479.x; BARTON JK, 1985, P NATL ACAD SCI USA, V82, P6460, DOI 10.1073/pnas.82.19.6460; BIRBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; JIMENEZRUIZ A, 1989, NUCLEIC ACIDS RES, V17, P4579, DOI 10.1093/nar/17.12.4579; JIMENEZRUIZ A, 1991, P NATL ACAD SCI USA, V88, P31, DOI 10.1073/pnas.88.1.31; LAFER EM, 1985, EMBO J, V4, P3655, DOI 10.1002/j.1460-2075.1985.tb04131.x; LAFER EM, 1986, J BIOL CHEM, V261, P6438; MALFOY B, 1981, NUCLEIC ACIDS RES, V9, P5659, DOI 10.1093/nar/9.21.5659; MALINGE JM, 1984, EMBO J, V3, P1273, DOI 10.1002/j.1460-2075.1984.tb01962.x; MALINGE JM, 1984, NUCLEIC ACIDS RES, V12, P5767, DOI 10.1093/nar/12.14.5767; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; PEREZ JM, 1991, CHEM-BIOL INTERACT, V77, P341, DOI 10.1016/0009-2797(91)90042-6; PINTO A L, 1985, Biochimica et Biophysica Acta, V780, P167, DOI 10.1016/0304-419X(85)90001-0; POHL FM, 1982, NATURE, V300, P545, DOI 10.1038/300545a0; RAHMOUNI AR, 1989, SCIENCE, V246, P358, DOI 10.1126/science.2678475; REQUENA JM, 1989, NUCLEIC ACIDS RES, V17, P797, DOI 10.1093/nar/17.2.797; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; SHERMAN SE, 1985, SCIENCE, V230, P412, DOI 10.1126/science.4048939; THOMAS TJ, 1991, J BIOL CHEM, V266, P6137; THOMAS TJ, 1988, J MOL BIOL, V201, P463, DOI 10.1016/0022-2836(88)90155-6; THOMAS TJ, 1988, ANAL BIOCHEM, V168, P359; UMAPATHY P, 1989, COORDIN CHEM REV, V95, P129, DOI 10.1016/0010-8545(89)80025-6; USHAY HM, 1982, NUCLEIC ACIDS RES, V10, P3753; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4	25	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24774	24778						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227037				2022-12-27	WOS:A1993MG67300040
J	RESING, KA; ALALAWI, N; BLOMQUIST, C; FLECKMAN, P; DALE, BA				RESING, KA; ALALAWI, N; BLOMQUIST, C; FLECKMAN, P; DALE, BA			INDEPENDENT REGULATION OF 2 CYTOPLASMIC PROCESSING STAGES OF THE INTERMEDIATE FILAMENT-ASSOCIATED PROTEIN FILAGGRIN AND ROLE OF CA2+ IN THE 2ND STAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM BASIC-PROTEIN; EPIDERMAL DIFFERENTIATION; MAMMALIAN EPIDERMIS; GROWTH-FACTOR; CALPAIN-II; CALCIUM; PROFILAGGRIN; IDENTIFICATION; KERATOHYALIN; LOCALIZATION	One of the final events in cornification of epidermal cells is processing of profilaggrin to the keratin-associated protein filaggrin. Processing involves several proteolytic events and occurs in two discrete proteolytic stages (Resing, K. A., Walsh, K. A., and Dale, B. A. (1984) J. Cell Biol. 99, 1372-1378; Resing, K. A., Walsh, K. A., Haugen-Scofield, J., and Dale, B. A. (1989) J. Biol. Chem. 264, 1837-1846). In a keratinocyte cell line derived from newborn rat epidermis, these two stages are independently regulated. Profilaggrin was expressed when the cells reached confluence; processing to intermediates began 24-36 h later (stage one), with filaggrin appearing at 48 h (stage two). Stage two processing required calcium in the medium with maximum processing occurring at 5-10 mm. Furthermore, stage two processing was inhibited by nifedipine, a calcium channel blocker, suggesting that calcium influx activates this event. Second-stage processing was also inhibited by the protease inhibitor leupeptin, implicating calpain. Confluent cells had higher levels of calpain I than subconfluent cells; in confluent cells, two immunoreactive bands were detected, comigrating with inactive (80 kDa) and activated (78 kDa) calpain I. In cells processing profilaggrin, most of the calpain I was in the 78-kDa form, implying extensive activation, supporting a role for calpain in processing.	UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED DERMATOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ORAL BIOL & PERIODONT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NIADDK NIH HHS [AM21557] Funding Source: Medline; NIAMS NIH HHS [AR39730] Funding Source: Medline; NIDCR NIH HHS [DE04660] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004660, R37DE004660] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; BRENNAN JK, 1975, IN VITRO CELL DEV B, V11, P354, DOI 10.1007/BF02616371; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; DALE BA, 1987, J INVEST DERMATOL, V88, P306, DOI 10.1111/1523-1747.ep12466185; DALE BA, 1978, NATURE, V276, P729, DOI 10.1038/276729a0; DALE BA, 1979, J INVEST DERMATOL, V72, P257, DOI 10.1111/1523-1747.ep12531715; DALE BA, 1982, ARCH ORAL BIOL, V27, P529, DOI 10.1016/0003-9969(82)90066-8; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; DEMARTINO GN, 1986, J BIOL CHEM, V261, P2047; ELIAS PM, 1975, J INVEST DERMATOL, V65, P501, DOI 10.1111/1523-1747.ep12610196; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; HARDING CR, 1983, J MOL BIOL, V170, P651, DOI 10.1016/S0022-2836(83)80126-0; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HAYDOCK PV, 1990, DNA CELL BIOL, V9, P251, DOI 10.1089/dna.1990.9.251; HAYDOCK PV, 1991, J INVEST DERMATOL, V101, P118; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HIRAO T, 1984, J BIOCHEM-TOKYO, V96, P775, DOI 10.1093/oxfordjournals.jbchem.a134895; KAM E, 1993, IN PRESS J CELL SCI; KUBILUS J, 1985, J INVEST DERMATOL, V85, P513, DOI 10.1111/1523-1747.ep12277310; KUBILUS J, 1983, J INVEST DERMATOL, V80, P124; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LONSDALEECCLES JD, 1980, J BIOL CHEM, V255, P2235; LONSDALEECCLES JD, 1982, BIOCHEMISTRY-US, V21, P5940, DOI 10.1021/bi00266a033; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Polakowska R. R., 1991, PHYSL BIOCH MOL BIOL, P168; PONTREMOLI S, 1986, J BIOL CHEM, V261, P8309; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; RESING KA, 1985, BIOCHEMISTRY-US, V24, P4167, DOI 10.1021/bi00336a053; RESING KA, 1989, J BIOL CHEM, V264, P1837; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; RESING KA, 1993, IN PRESS BIOCHEMISTR; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SCHOLLMEYER JE, 1988, SCIENCE, V240, P911, DOI 10.1126/science.2834825; SCOTT I R, 1981, Biochemical Society Transactions, V9, P388; SCOTT IR, 1981, BIOCHIM BIOPHYS ACTA, V669, P65, DOI 10.1016/0005-2795(81)90224-5; SUZUKI K, 1992, ANN NY ACAD SCI, V674, P218, DOI 10.1111/j.1749-6632.1992.tb27490.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; YUSPA SH, 1983, CANCER RES, V43, P5707	44	81	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25139	25145						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227077				2022-12-27	WOS:A1993MG67300089
J	ZHENG, YW; BEY, M; LIU, H; FELDER, MR				ZHENG, YW; BEY, M; LIU, H; FELDER, MR			MOLECULAR-BASIS OF THE ALCOHOL DEHYDROGENASE-NEGATIVE DEER MOUSE - EVIDENCE FOR DELETION OF THE GENE FOR CLASS-I ENZYME AND IDENTIFICATION OF A POSSIBLE NEW ENZYME CLASS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ETHANOL-METABOLISM; NUCLEOTIDE-SEQUENCE; ADH-1 GENE; INVIVO; LIVER; ACID; PEROMYSCUS; PURIFICATION; ISOZYMES; FAMILY	The molecular basis of the alcohol dehydrogenase (ADH)-negative deer mouse (Peromyscus maniculatus) has been investigated. Several classes of mammalian ADHs have been recognized based upon biochemical and structural properties. ADH cDNA clones identified by hybridization to a mouse class I ADH cDNA clone were obtained from a deer mouse ADH-positive liver cDNA library. This cDNA has been identified as being a class I sequence and represents the deer mouse Adh-1 gene. An additional cDNA sequence identified in both the ADH-positive and -negative deer mouse cDNA libraries was identified by weak cross-hybridization to the mouse cDNA. This cDNA encodes an amino acid sequence representing a new class of mammalian ADH, and the deer mouse gene for this ADH is named Adh-2. ADH-negative deer mice do not produce mRNA, that is detected by the Adh-1 cDNA probe. However, both stocks of deer mice produce high levels of Adh-2 mRNA in liver. Southern analysis using an essentially full-length Adh-1 cDNA probe has shown that the Adh-1 gene is deleted in the ADH-negative mice. Biochemical analysis of enzyme activity suggests at least three ADH polypeptides are expressed in different tissues and have somewhat different substrate specificities, as in the mouse.	UNIV S CAROLINA, DEPT BIOL SCI, COLUMBIA, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia					NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006608] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 06608] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALDERMAN J, 1987, J BIOL CHEM, V262, P7497; ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENSON S A, 1984, Biotechniques, V2, P126; BURNETT KG, 1980, BIOCHEM PHARMACOL, V29, P125, DOI 10.1016/0006-2952(80)90318-4; BURNETT KG, 1978, BIOCHEM GENET, V16, P443, DOI 10.1007/BF00484210; BURNETT KG, 1978, BIOCHEM GENET, V16, P1093, DOI 10.1007/BF00484530; CECI JD, 1987, GENE, V59, P171, DOI 10.1016/0378-1119(87)90325-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUESTER G, 1986, J BIOL CHEM, V261, P2027; EDENBERG HJ, 1985, P NATL ACAD SCI USA, V82, P2262, DOI 10.1073/pnas.82.8.2262; FELDER MR, 1988, J BIOL CHEM, V263, P14531; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANDLER JA, 1986, BIOCHEM PHARMACOL, V35, P4487, DOI 10.1016/0006-2952(86)90768-9; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOLMES RS, 1981, J EXP ZOOL, V217, P151, DOI 10.1002/jez.1402170202; HOLMES RS, 1977, GENETICS, V87, P709; HUR MW, 1992, J DNA SEQUENCING MAP, V3, P167; IKUTA T, 1986, P NATL ACAD SCI USA, V83, P634, DOI 10.1073/pnas.83.3.634; JORNVALL H, 1987, P NATL ACAD SCI USA, V84, P2580, DOI 10.1073/pnas.84.9.2580; JULIA P, 1988, EUR J BIOCHEM, V172, P73, DOI 10.1111/j.1432-1033.1988.tb13857.x; KAISER R, 1988, BIOCHEMISTRY-US, V27, P1132, DOI 10.1021/bi00404a009; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; NORSTEN C, 1989, J BIOL CHEM, V264, P5593; PARES X, 1990, FEBS LETT, V277, P115, DOI 10.1016/0014-5793(90)80822-Z; POSCH KC, 1989, ARCH BIOCHEM BIOPHYS, V274, P171, DOI 10.1016/0003-9861(89)90428-1; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI Y, 1991, J BIOL CHEM, V266, P13243; SHIGETA Y, 1984, BIOCHEM PHARMACOL, V33, P807, DOI 10.1016/0006-2952(84)90466-0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRYDOM DJ, 1982, ANAL BIOCHEM, V123, P422, DOI 10.1016/0003-2697(82)90467-5; SUN HW, 1992, J MOL EVOL, V34, P522, DOI 10.1007/BF00160465; TAKAGI T, 1986, BIOCHEM PHARMACOL, V35, P3601, DOI 10.1016/0006-2952(86)90632-5; VISSING H, 1991, J BIOL CHEM, V266, P5244; YASUNAMI M, 1991, P NATL ACAD SCI USA, V88, P7610, DOI 10.1073/pnas.88.17.7610	38	50	52	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24933	24939						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227055				2022-12-27	WOS:A1993MG67300063
J	ISENMAN, LD; DICE, JF				ISENMAN, LD; DICE, JF			SELECTIVE RELEASE OF PEPTIDES FROM LYSOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; T-CELLS; PROTEINS; DEGRADATION; ANTIGEN; FIBROBLASTS; PATHWAYS; GLYCOPROTEIN	We demonstrate a selective release of peptides by lysosomes in vitro. A lysosomal fraction from human fibroblasts that had previously endocytosed [H-3]ribonuclease A was incubated for 2 h, and radioactivity released into the medium and radioactivity retained within lysosomes were analyzed. A variety of radiolabeled molecules including peptides of an appropriate size to serve as antigens for T cell-mediated immunity were released. One small peptide was predominantly released, while others, as well as intact ribonuclease A, were predominantly retained. A 4-5-fold range was also evident in the relative release of three H-3-labeled tripeptide probes of similar charge derived from the sequence of ribonuclease A. This selectivity and the fact that similar peptide degradation fragments were also released and retained by intact cells after endocytosis of [H-3]ribonuclease A argues strongly that the release observed in vitro is physiological and not due to damaged lysosomal membranes.			ISENMAN, LD (corresponding author), TUFTS UNIV,SCH MED,DEPT PHYSIOL,136 HARRISON AVE,BOSTON,MA 02111, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006116] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG06116] Funding Source: Medline; NIDDK NIH HHS [T32 DK07542] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BJORK I, 1992, J BIOL CHEM, V267, P1976; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; BUCHMASTER MJ, 1987, CELL BIOL INT REP, V11, P501; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Dice J F, 1990, Semin Cell Biol, V1, P449; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GURLEY R, 1988, CELL BIOL INT REP, V12, P885, DOI 10.1016/0309-1651(88)90052-5; HAKIM FT, 1991, J IMMUNOL, V147, P2310; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERMAN B, 1984, J CELL BIOL, V98, P565, DOI 10.1083/jcb.98.2.565; HOLTZMAN E, 1989, LYSOSOMES, P140; ISENMAN LD, 1989, J BIOL CHEM, V264, P21591; JIN Y, 1988, J EXP MED, V168, P293, DOI 10.1084/jem.168.1.293; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NEFF NT, 1981, J CELL BIOL, V91, P184, DOI 10.1083/jcb.91.1.184; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; ROCK KL, 1993, J IMMUNOL, V150, P438; ROMISCH K, 1992, P NATL ACAD SCI USA, V89, P7227, DOI 10.1073/pnas.89.15.7227; ROTHBARD JB, 1991, ANNU REV IMMUNOL, V9, P527, DOI 10.1146/annurev.iy.09.040191.002523; SCHAUDIES RP, 1987, BIOCHEM BIOPH RES CO, V143, P710, DOI 10.1016/0006-291X(87)91412-4; SHARMA RC, 1992, J BIOL CHEM, V267, P5731; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; STORRIE B, 1984, J CELL BIOL, V98, P108, DOI 10.1083/jcb.98.1.108; WILEY HS, 1985, J BIOL CHEM, V260, P5290	33	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23856	23859						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226924				2022-12-27	WOS:A1993MF29400026
J	LAVOIE, JN; HICKEY, E; WEBER, LA; LANDRY, J				LAVOIE, JN; HICKEY, E; WEBER, LA; LANDRY, J			MODULATION OF ACTIN MICROFILAMENT DYNAMICS AND FLUID-PHASE PINOCYTOSIS BY PHOSPHORYLATION OF HEAT-SHOCK PROTEIN-27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MAMMALIAN STRESS PROTEINS; GROWTH-FACTORS; SMOOTH-MUSCLE; HUMAN HSP27; 27 KDA; CELLS; EXPRESSION; IDENTIFICATION; POLYMERIZATION	We recently reported that overexpression of heat shock protein 27 (HSP27) in rodent fibroblasts increases the stability of stress fibers during hyperthermia and partially prevents actin depolymerization during exposure to cytochalasin D (Lavoie, J. N., Gingras-Breton, G., Tanguay, R. M., and Landry, J. (1993) J. Biol. Chem. 268, 3420-3429). Because HSP27 is a ubiquitous target of phosphorylation upon cell stimulation with a variety of growth factors and agents that affect cellular differentiation, we examined the role of HSP27 phosphorylation in regulating actin filament dynamics. Here we show that HSP27 is enriched at the leading edge of polarized fibroblasts. HSP27 is localized in lamellipodia and membrane ruffles where most actin polymerization occurs. We developed Chinese hamster cell lines that constitutively overexpressed either human HSP27 or a non-phosphorylatable mutant form of the protein. Overexpression of HSP27 caused an increased concentration of filamentous actin (F-actin) at the cell cortex and elevated pinocytotic activity. In contrast, overexpression of the non-phosphorylatable mutant form of HSP27 reduced cortical F-actin concentration and decreased pinocytosis activity relative to control cells. Mitogenic stimulation of fibroblasts resulted in a rapid polymerization of submembranous actin filaments. HSP27 enhanced growth factor-induced F-actin accumulation, whereas mutant HSP27 exerted a dominant negative effect and inhibited this response to growth factors. Thus, HSP27 is a component of a signal transduction pathway that can regulate microfilament dynamics.	UNIV LAVAL, HOTEL DIEU, CTR RECH CANCEROL, 11 COTE PALAIS, QUEBEC CITY G1R 2J6, PQ, CANADA; UNIV NEVADA, DEPT BIOL, RENO, NV 89557 USA	Laval University; Nevada System of Higher Education (NSHE); University of Nevada Reno				Lavoie, Josee N/0000-0001-6912-1132	NIGMS NIH HHS [GM 43167] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043167] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BITAR KN, 1991, BIOCHEM BIOPH RES CO, V181, P1192, DOI 10.1016/0006-291X(91)92065-R; CHAMBARD JC, 1983, J BIOL CHEM, V258, P1706; DARBON JM, 1990, BIOCHEM BIOPH RES CO, V168, P527, DOI 10.1016/0006-291X(90)92353-2; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; GROSE JH, 1991, ADV PROSTAG THROMB L, V21, P145; GUESDON F, 1991, J IMMUNOL, V147, P3402; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; JAKOB U, 1993, J BIOL CHEM, V268, P1517; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MENDELSOHN ME, 1991, P NATL ACAD SCI USA, V88, P11212, DOI 10.1073/pnas.88.24.11212; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MICHISHITA M, 1991, BIOCHEM BIOPH RES CO, V176, P979, DOI 10.1016/0006-291X(91)90378-K; MING Z, 1993, J BIOL CHEM, V268, P35; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBAYE B, 1989, BIOCHEM BIOPH RES CO, V163, P301, DOI 10.1016/0006-291X(89)92135-9; SAKLATVALA J, 1991, BIOCHEM J, V277, P635, DOI 10.1042/bj2770635; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; SHIBANUMA M, 1992, BIOCHEM BIOPH RES CO, V187, P1418, DOI 10.1016/0006-291X(92)90460-3; SHIBANUMA M, 1991, CELL GROWTH DIFFER, V2, P583; SPECTOR NL, 1992, J IMMUNOL, V148, P1668; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; STRAHLER JR, 1991, BIOCHEM BIOPH RES CO, V175, P134, DOI 10.1016/S0006-291X(05)81211-2; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; ZANTEMA A, 1989, J VIROL, V63, P3368, DOI 10.1128/JVI.63.8.3368-3375.1989	41	508	525	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24210	24214						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226968				2022-12-27	WOS:A1993MF29400074
J	NAGAYA, T; JAMESON, JL				NAGAYA, T; JAMESON, JL			DISTINCT DIMERIZATION DOMAINS PROVIDE ANTAGONIST PATHWAYS FOR THYROID-HORMONE RECEPTOR ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; 9-CIS RETINOIC ACID; C-ERBA PROTOONCOGENES; DNA-BINDING; X-RECEPTOR; TRANSCRIPTIONAL REGULATION; RESPONSE ELEMENTS; HUMAN TESTIS; RXR-BETA; PROTEIN	Transcriptional regulation by thyroid hormone is mediated through its nuclear receptors, which bind to target response elements as homodimers or as heterodimers with proteins such as retinoid X receptors (RXR). Thyroid hormone response elements exhibit remarkable flexibility in that the receptor binding half-sites can be arranged as direct repeats, inverted repeats, or everted repeats. We report that a limited region at the carboxyl-terminal end of the thyroid hormone receptor differentially contributes to the formation of receptor homo- and heterodimers. The functionally inactive thyroid hormone receptor splicing variant alpha2, which is altered at the juncture of the homo- and heterodimerization domains, cannot form homodimers. However, alpha2 can form a heterodimer when bound to half-sites arranged as a direct repeat spaced by 4 base pairs (DR4), but not with other arrangements of response element half-sites. The alpha2-RXR heterodimer strongly inhibits wild type receptor function mediated by the DR4 element, suggesting that the alpha2 isoform modulates thyroid hormone action by binding as an antagonist to a subset of response elements.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,THYROID UNIT,BOSTON,MA 02114	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital				Jameson, James/0000-0001-9538-4059	NIDDK NIH HHS [DK42144] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042144] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; CHATTERJEE VKK, 1991, J CLIN INVEST, V87, P1977; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KATZ D, 1992, MOL ENDOCRINOL, V6, P805, DOI 10.1210/me.6.5.805; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; LAZAR MA, 1989, P NATL ACAD SCI USA, V86, P7771, DOI 10.1073/pnas.86.20.7771; LEE JW, 1992, MOL ENDOCRINOL, V6, P1867, DOI 10.1210/me.6.11.1867; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NAGAYA T, 1992, J BIOL CHEM, V267, P13014; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; NAKAI A, 1988, P NATL ACAD SCI USA, V85, P2781, DOI 10.1073/pnas.85.8.2781; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; ODONNELL AL, 1991, MOL ENDOCRINOL, V5, P94, DOI 10.1210/mend-5-1-94; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; RENTOUMIS A, 1990, MOL ENDOCRINOL, V4, P1522, DOI 10.1210/mend-4-10-1522; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; SCHUELER PA, 1990, MOL ENDOCRINOL, V4, P227, DOI 10.1210/mend-4-2-227; SPANJAARD RA, 1991, P NATL ACAD SCI USA, V88, P8587, DOI 10.1073/pnas.88.19.8587; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAHLSTROM GM, 1992, MOL ENDOCRINOL, V6, P1013, DOI 10.1210/me.6.7.1013; YEN PM, 1992, J BIOL CHEM, V267, P23248; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	40	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24278	24282						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226975				2022-12-27	WOS:A1993MF29400084
J	RALTON, JE; MILNE, KG; GUTHER, MLS; FIELD, RA; FERGUSON, MAJ				RALTON, JE; MILNE, KG; GUTHER, MLS; FIELD, RA; FERGUSON, MAJ			THE MECHANISM OF INHIBITION OF GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR BIOSYNTHESIS IN TRYPANOSOMA-BRUCEI BY MANNOSAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHORS; VARIANT SURFACE GLYCOPROTEINS; LIPID-LINKED OLIGOSACCHARIDES; CELL-FREE SYSTEM; GLYCOSYL-PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE-C; GLYCOLIPID PRECURSORS; STRUCTURAL CHARACTERIZATION; RESISTANT GLYCOLIPIDS; GPI ANCHOR	The inhibition of glycosylphosphatidylinositol anchor biosynthesis by mannosamine has been described previously in the procyclic forms of Trypanosoma brucei and in mammalian cells (Lisanti, M. P., Field, M. C., Caras, I. W. J., Menon, A. K., and Rodriguez-Boulan, E. (1991) EMBO J. 10, 1969-1977). A recent report has suggested that mannosamine exerts these effects by becoming incorporated into glycosylphosphatidylinositol anchor intermediates (Pan, Y-T., Kamitani, T., Bhuvaneswaran, C., Hallaq, Y., Warren, C. D., Yeh, E. T. H., and Elbein, A. D. (1992) J. Biol. Chem.267, 21250-21255). In this paper we have analyzed the effects of mannosamine on glycosylphosphatidylinositol anchor and variant surface glycoprotein biosynthesis in the bloodstream form of T. brucei. Trypanosomes were biosynthetically labeled with [H-3]mannosamine, and [H-3]glucosamine in the presence of mannosamine, and the structures of the labeled glycolipids which accumulated were determined. The main glycolipid metabolite of mannosamine was shown to be ManN-Man-GlcN-PI. A trypanosome cell-free system preloaded with this compound was significantly impaired in its ability to synthesize glycosylphosphatidylinositol anchor intermediates beyond Manalpha1-6Manalpha1-4GlcNalpha1-6PI. This compound is therefore proposed to be an inhibitor of the Dol-P-Man:Manalpha1-6Manalpha1-4GlcNalpha1-6PI alpha1-2-mannosyltransferase of the GPI biosynthetic pathway. In living trypanosomes, 4 mM mannosamine had no effect on protein synthesis but reduced the rate of formation of mature glycosylphosphatidylinositol anchor precursors by 80%. This reduction in anchor precursor synthesis was insufficient to prevent the attachment of glycosylphosphatidylinositol anchors to newly synthesized variant surface glycoprotein molecules. These data suggest that the rate of anchor precursor synthesis in the bloodstream form of T. brucei, in contrast to mammalian cells and the procyclic form of T. brucei, is in large excess of the cellular requirements for protein anchorage.	UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND	University of Dundee			Ferguson, Michael A. J./F-7829-2010	Ferguson, Michael A. J./0000-0003-1321-8714; Field, Rob/0000-0001-8574-0275	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1990, J BIOL CHEM, V265, P611; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1992, BIOCHEM SOC T, V20, P243, DOI 10.1042/bst0200243; FERGUSON MAJ, 1992, BIOCHEM J, V284, P297, DOI 10.1042/bj2840297; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Ferguson MAJ, 1991, CURR OPIN STRUC BIOL, V1, P522, DOI 10.1016/S0959-440X(05)80072-7; FIELD MC, 1992, J BIOL CHEM, V267, P5324; GEROLD P, 1992, Biochemical Society Transactions, V20, p297S; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; HIROSE S, 1992, J BIOL CHEM, V267, P5272; KAMITANI T, 1992, J BIOL CHEM, V267, P24611; KOBATA A, 1987, METHOD ENZYMOL, V138, P84; KRAKOW JL, 1989, MOL BIOCHEM PARASIT, V36, P263, DOI 10.1016/0166-6851(89)90174-6; LISANTI MP, 1991, EMBO J, V10, P1969, DOI 10.1002/j.1460-2075.1991.tb07726.x; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1991, EMBO J, V10, P2041, DOI 10.1002/j.1460-2075.1991.tb07734.x; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MAYOR S, 1991, J CELL BIOL, V114, P61, DOI 10.1083/jcb.114.1.61; MAYOR S, 1990, J BIOL CHEM, V265, P6174; MENON AK, 1992, J BIOL CHEM, V267, P15277; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MENON AK, 1991, CELL BIOL INT REP, V15, P1007; MILNE KG, 1992, EUR J BIOCHEM, V208, P309, DOI 10.1111/j.1432-1033.1992.tb17188.x; PAN YT, 1992, J BIOL CHEM, V267, P8991; PAN YT, 1992, J BIOL CHEM, V267, P21250; PAN YT, 1985, ARCH BIOCHEM BIOPHYS, V242, P447, DOI 10.1016/0003-9861(85)90229-2; PUOTI A, 1992, J BIOL CHEM, V267, P22673; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROBINSON PJ, 1991, IMMUNOL TODAY, V12, P35, DOI 10.1016/0167-5699(91)90110-F; SINNOTT ML, 1987, ENZYME MECHANISMS, P291; THOMAS JR, 1990, BIOCHEMISTRY-US, V29, P5413, DOI 10.1021/bi00475a001; TOMAVO S, 1992, J BIOL CHEM, V267, P21446; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x	43	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24183	24189						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226965				2022-12-27	WOS:A1993MF29400070
J	SCHAAPER, RM				SCHAAPER, RM			BASE SELECTION, PROOFREADING, AND MISMATCH REPAIR DURING DNA-REPLICATION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							POLYMERASE-III HOLOENZYME; SPONTANEOUS MUTATION; EXONUCLEASE ACTIVITY; LACI GENE; MECHANISMS; FIDELITY; MUTD5; SPECIFICITY; MUTAGENESIS; INVITRO	The accuracy by which organisms duplicate their DNA is of considerable interest. At least three mechanisms operate, serially, to secure high fidelity: base selection, exonucleolytic proofreading, and postreplicative mismatch correction. To obtain insights into the efficiency and specificity of these steps in the bacterium Escherichia coli, we have performed DNA sequence analysis of mutations occurring in the bacterial lacI gene in a series of strains genetically disabled in one or more of these error avoidance pathways. The base selection efficiency was estimated from mutagenesis occurring in a mutDmutL strain, which is deficient in both proofreading (mutD5) and mismatch repair (mutL). The proofreading efficiency was derived comparing the mutD5 mutL strain to the mismatch repair-deficient mutL strain. The efficiency of mismatch repair was derived comparing the mutL strain to the wild-type strain. The results show that base selection discriminates against errors by 200,000-2,000,000-fold, proofreading by 40-200-fold, and mismatch repair by 20-400-fold, each depending on the type of error. Base selection and proofreading act more strongly against transversions than transitions, whereas mismatch repair does the opposite. The data are based on 866 sequenced lacI mutations in a target that allows the scoring of at least 127 different mutations in 76 distinct DNA sequence contexts in vivo. They may therefore have general significance.			SCHAAPER, RM (corresponding author), NIEHS,MOLEC GENET LAB,RES TRIANGLE PK,NC 27709, USA.		Schaaper, Roel M/E-6680-2019	Schaaper, Roel M/0000-0003-1344-3196				BLANCO L, 1992, GENE, V112, P139, DOI 10.1016/0378-1119(92)90316-H; BRENOWITZ S, 1991, J BIOL CHEM, V266, P7888; CARRAWAY M, 1990, MOL MICROBIOL, V4, P1645, DOI 10.1111/j.1365-2958.1990.tb00541.x; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MILLER JH, 1978, OPERON, P31; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; REHAKRANTZ LJ, 1991, P NATL ACAD SCI USA, V88, P2417, DOI 10.1073/pnas.88.6.2417; SCHAAPER RM, 1991, GENETICS, V129, P317; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1985, GENE, V39, P181, DOI 10.1016/0378-1119(85)90312-9; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SCHAAPER RM, 1993, GENETICS, V134, P1031; SCHAAPER RM, 1992, J BACTERIOL, V174, P1974, DOI 10.1128/jb.174.6.1974-1982.1992; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; SINHA NK, 1987, P NATL ACAD SCI USA, V84, P915, DOI 10.1073/pnas.84.4.915; SLOANE DL, 1988, NUCLEIC ACIDS RES, V16, P6465, DOI 10.1093/nar/16.14.6465	26	244	248	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23762	23765						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226906				2022-12-27	WOS:A1993MF29400008
J	CHEN, GFT; FANG, L; INOUYE, M				CHEN, GFT; FANG, L; INOUYE, M			EFFECT OF THE RELATIVE POSITION OF THE UGA CODON TO THE UNIQUE SECONDARY STRUCTURE IN THE FDHF MESSENGER-RNA ON ITS DECODING BY SELENOCYSTEINYL TRANSFER-RNA IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATE DEHYDROGENASE; GENE; IDENTIFICATION; PROTEIN	The fdhF mRNA for formate dehydrogenase H of Escherichia coli contains a UGA codon at position 140. This termination codon is decoded by selenocysteinyl tRNA (the selC product) with the aid of its own specific elongation factor, SelB. For this decoding, a unique secondary structure immediately downstream of the UGA codon has been shown to be essential (Zinoni, F., Heider, J., and Bock, A. (1990) Proc. NatL Acad. Sci. U. S. A. 87, 4660-4664). We examined the positional effect of the U codon relative to the secondary structure on its decoding using a fdhF-lacZ fusion gene. When the UGA codon was separated by one codon (position -1) from the secondary structure, the UGA decoding, as measured by the beta-galactosidase activity, dropped to approximately 76% of the normal level but was still almost as fully dependent upon selC and selenium in the culture medium as in the case of the UGA codon in the normal position (position 0). However, when the UGA codon was separated by two codons (position -2), the decoding level further dropped to 20% of the normal level, and in addition, became dependent only on selC but independent of selenium. When the UGA codon was further separated by three codons (position -3), the decoding level of UGA (-3) became higher than the decoding of UGA (-2) and was completely independent from selC and selenium, indicating that the UGA codon was nonspecifically suppressed. A similar nonspecific suppression was observed for the UGA codon at position -4, but at a lower level. When two UGA codons were tandemly placed at positions 0 and -1, they were still able to be decoded at 17% of the normal level in a selC- and selenium-dependent manner. In the absence of the SelB function, the decoding level of UGA(0) dropped to 1.6% of the normal level, whereas the UGA(-1) decoding dropped to 7.5%. These results indicate that the UGA codon at position 0 is not only most effectively decoded by selenocysteinyl tRNA but also tightly blocked from its nonspecific suppression in the absence of any components required for the decoding.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center								BERG BL, 1991, J BIOL CHEM, V266, P22386; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; BOCK A, 1991, MOL MICROBIOL, V5, P315; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHEN GT, 1992, MOL MICROBIOL, V6, P781, DOI 10.1111/j.1365-2958.1992.tb01528.x; COX JC, 1981, J BACTERIOL, V145, P1317, DOI 10.1128/JB.145.3.1317-1324.1981; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORSTER C, 1990, NUCLEIC ACIDS RES, V18, P487, DOI 10.1093/nar/18.3.487; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; KOHLI J, 1981, MOL GEN GENET, V182, P430, DOI 10.1007/BF00293932; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; LEINFELDER W, 1988, J BACTERIOL, V170, P540, DOI 10.1128/jb.170.2.540-546.1988; Miller J.H., 1972, EXPT MOL GENETICS; SAWERS G, 1991, J BACTERIOL, V173, P4983, DOI 10.1128/jb.173.16.4983-4993.1991; STADTMAN TC, 1991, J BIOL CHEM, V266, P16257; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660	19	32	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23128	23131						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226830				2022-12-27	WOS:A1993MF51500029
J	MACLACHLAN, I; NIMPF, J; WHITE, HB; SCHNEIDER, WJ				MACLACHLAN, I; NIMPF, J; WHITE, HB; SCHNEIDER, WJ			RIBOFLAVINURIA IN THE RD CHICKEN - 5'-SPLICE SITE MUTATION IN THE GENE FOR RIBOFLAVIN-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; BETA-GLOBIN GENE; SPLICE SITE; WHITE-RIBOFLAVIN; YOLK-RIBOFLAVIN; BASE CHANGE; SEQUENCE; ACID; REQUIREMENTS; SELECTION	Eggs of oviparous species must contain all components required for normal embryonic development. Among these, the vitamin riboflavin is deposited into egg white and yolk bound to the carrier protein, riboflavin-binding protein (ribBP). We have begun to investigate the mechanisms underlying ribBP transport pathways by molecular characterization of a relevant mutation in chicken. The autosomal recessive rd allele in Gallus gallus domesticus prevents the synthesis of functional ribBP and induces embryonic death on day 13. Polymerase chain reaction primers derived from the previously determined wild type cDNA sequence were used to amplify and clone cDNAs for ribBP from normal (Rd) and deficient (rd) animals. The rd allele was associated with a 100-nucleotide deletion in the messenger RNA for ribBP. Genomic clones were generated via polymerase chain reaction using primers flanking this 100-base pair deletion, and the resulting 2.1-kilobase pair clones were sequenced. The deletion in the rd ribBP cDNA corresponds precisely to an exon. The splice site following this exon contains a G --> A mutation at position 1 of the downstream 5'-splice donor sequence. The effect of this anomaly and the cause of the rd phenotype is the loss of the 100-base pair exon during the splicing process.	UNIV VIENNA, DEPT MOLEC GENET, DR BOHR GASSE 9-2, A-1030 VIENNA, AUSTRIA; UNIV ALBERTA, DEPT BIOCHEM, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV DELAWARE, DEPT CHEM & BIOCHEM, NEWARK, DE 19716 USA; BIOCTR VIENNA, A-1030 VIENNA, AUSTRIA	University of Vienna; University of Alberta; University of Delaware; Vienna Biocenter (VBC)			White, Harold B/B-8024-2008	Nimpf, Johannes/0000-0002-9273-3492				AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; CHIMIENTI G, 1992, BIOCHEM BIOPH RES CO, V187, P620, DOI 10.1016/0006-291X(92)91240-Q; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COWAN JW, 1966, POULTRY SCI, V45, P536, DOI 10.3382/ps.0450536; COWAN JW, 1966, POULTRY SCI, V45, P538, DOI 10.3382/ps.0450538; DAVIS LG, 1986, BASIC METHODS MOL BI, P388; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; HAMAZUME Y, 1984, J BIOCHEM-TOKYO, V95, P1633, DOI 10.1093/oxfordjournals.jbchem.a134776; HOHEISEL J, 1986, NUCLEIC ACIDS RES, V14, P3605, DOI 10.1093/nar/14.8.3605; LAWN RM, 1980, CELL, V21, P647, DOI 10.1016/0092-8674(80)90428-6; MILLER MS, 1982, J BIOL CHEM, V257, P6818; MONTELL C, 1984, NUCLEIC ACIDS RES, V12, P3821, DOI 10.1093/nar/12.9.3821; MONTELL C, 1982, NATURE, V295, P380, DOI 10.1038/295380a0; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; NORIOKA N, 1985, J BIOCHEM-TOKYO, V97, P19, DOI 10.1093/oxfordjournals.jbchem.a135044; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; Scharf SJ, 1990, PCR PROTOCOLS GUIDE, P84; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SILICIANO PG, 1988, GENE DEV, V2, P1258, DOI 10.1101/gad.2.10.1258; SOLNICK D, 1981, NATURE, V291, P508, DOI 10.1038/291508a0; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; Weatherall DJ, 1981, THALASSEMIA SYNDROME; WHITE HB, 1988, ANNU REV NUTR, V8, P279, DOI 10.1146/annurev.nu.08.070188.001431; WIERINGA B, 1983, NATURE, V301, P38, DOI 10.1038/301038a0; WINTER WP, 1967, COMP BIOCHEM PHYSIOL, V22, P897, DOI 10.1016/0010-406X(67)90780-3; WINTER WP, 1967, COMP BIOCHEM PHYSIOL, V22, P889, DOI 10.1016/0010-406X(67)90779-7; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZHENG DB, 1988, J BIOL CHEM, V263, P11126; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	32	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23222	23226						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226844				2022-12-27	WOS:A1993MF51500045
J	MURPHY, AJ; COLL, RJ				MURPHY, AJ; COLL, RJ			FORMATION OF A STABLE INACTIVE COMPLEX OF THE SARCOPLASMIC-RETICULUM CALCIUM-ATPASE WITH MAGNESIUM, BERYLLIUM, AND FLUORIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT ATPASE; VANADATE; BINDING; INHIBITION; PHOSPHATE; CAATPASE; AFFINITY; ANALOGS; SITE; SLOW	Incubation of leaky or nonionic detergent-solubilized sarcoplasmic reticulum vesicles in solutions containing magnesium, beryllium, and fluoride caused a time-dependent complete inhibition of calcium ATPase activity. The inhibited state persisted through dialysis for 2 days versus EGTA and was reversed within minutes by the presence of 0.5 mm calcium. Calcium-independent ATPase activity was unaffected. Omission of magnesium or fluoride resulted in retention of activity, while omission of beryllium produced slower inactivation, as described previously (Murphy, A. J., and Coll, R. J. (1992) J. Biol. Chem. 267, 5229-5235). Incubation of nonleaky vesicles had a similar effect, although it occurred more than 10-fold more slowly, suggesting that a component, probably beryllium, must enter the vesicles for inhibition to occur. By contrast, inhibition of nonleaky vesicles by magnesium and fluoride developed less than 2-fold more slowly. Including calcium in the incubation mixtures resulted in partial protection, so that the time course of CaATPase activity leveled off at nonzero values (for example, at 0.1 mM calcium, the activity leveled off at 43% of control). This result is most simply accounted for by a model involving simultaneous binding of calcium and a form of fluoroberyllium to the CaATPase (e.g. Ca2EMgBeFn).			MURPHY, AJ (corresponding author), UNIV PACIFIC, SCH DENT, DEPT BIOCHEM, SAN FRANCISCO, CA 94115 USA.				NIGMS NIH HHS [GM31083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031083] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KW, 1983, J BIOL CHEM, V258, P4276; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; COLL RJ, 1984, J BIOL CHEM, V259, P4249; COLL RJ, 1986, BIOCHEM BIOPH RES CO, V138, P652, DOI 10.1016/S0006-291X(86)80546-0; COLL RJ, 1992, J BIOL CHEM, V267, P21584; DUPUIS A, 1989, FEBS LETT, V255, P47, DOI 10.1016/0014-5793(89)81058-0; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; IKEMOTO N, 1975, J BIOL CHEM, V250, P7219; INESI G, 1992, ADV ENZYMOL RAMB, V65, P185; JENCKS WP, 1989, J BIOL CHEM, V264, P18855; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MARKUS S, 1986, BIOCHIM BIOPHYS ACTA, V874, P128, DOI 10.1016/0167-4838(86)90109-3; MARKUS S, 1989, BIOCHEMISTRY-US, V28, P793, DOI 10.1021/bi00428a057; MEDDA P, 1983, EUR J BIOCHEM, V137, P7, DOI 10.1111/j.1432-1033.1983.tb07788.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; MURPHY AJ, 1992, J BIOL CHEM, V267, P16990; MURPHY AJ, 1993, BIOPHYS J, V64, pA334; ONEAL SG, 1979, BIOCHEM BIOPH RES CO, V89, P845, DOI 10.1016/0006-291X(79)91855-2; PICK U, 1982, J BIOL CHEM, V257, P6111; PICKART CM, 1984, J BIOL CHEM, V259, P1629; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005; SMITH RL, 1980, J BIOL CHEM, V255, P9852; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WEBER MM, 1992, BIOCHEMISTRY-US, V31, P7190	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23307	23310						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226854				2022-12-27	WOS:A1993MF51500056
J	PEARCE, KH; HOF, M; LENTZ, BR; THOMPSON, NL				PEARCE, KH; HOF, M; LENTZ, BR; THOMPSON, NL			COMPARISON OF THE MEMBRANE-BINDING KINETICS OF BOVINE PROTHROMBIN AND ITS FRAGMENT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOTAL INTERNAL-REFLECTION; SUPPORTED PLANAR MEMBRANES; COAGULATION FACTOR-VA; FLUORESCENCE MICROSCOPY; PHOTOBLEACHING RECOVERY; PHOSPHOLIPID-MEMBRANES; VARYING COMPOSITION; BLOOD-COAGULATION; COLLISIONAL LIMIT; SELF-ASSOCIATION	Total internal reflection fluorescence microscopy has been used to compare the membrane binding characteristics of fluorescein-labeled bovine prothrombin and fluorescein-labeled bovine prothrombin fragment 1. The Ca2+-dependent association of these proteins with quartz-supported planar membranes composed of mixtures of phosphatidylserine (2-10 mol %) and phosphatidylcholine was examined. Equilibrium binding measurements showed that the apparent equilibrium dissociation constants increased with decreasing molar fractions of phosphatidylserine and that the dissociation constants were somewhat lower for intact prothrombin. Kinetic measurements, using fluorescence photobleaching recovery, showed that the measured dissociation rates were approximately equivalent for prothrombin and fragment 1 and did not change with the protein solution concentration or the molar fraction of phosphatidylserine. The kinetic data also implied that the surface binding mechanism for both proteins is more complex than a simple reversible reaction between monovalent proteins and monovalent surface sites. Measured equilibrium and kinetic constants are reported and compared for prothrombin and fragment 1 on planar membranes.	UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Hof, Martin/F-5134-2014	Hof, Martin/0000-0003-2884-3037	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045916, R01HL020161, R37HL020161] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45916, HL-20161] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT AJ, 1987, BIOCHEMISTRY-US, V26, P7994, DOI 10.1021/bi00398a067; ABBOTT AJ, 1988, FASEB J, V2, P2858, DOI 10.1096/fasebj.2.13.2844615; ANDREE HAM, 1992, J BIOL CHEM, V267, P17907; Axelrod D, 1992, TOPICS FLUORESCENCE, P289; BANGHAM AD, 1961, NATURE, V192, P1197, DOI 10.1038/1921197a0; BODE AP, 1985, THROMB RES, V39, P49, DOI 10.1016/0049-3848(85)90121-5; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; DOMBROSE FA, 1979, J BIOL CHEM, V254, P5027; GIESEN PLA, 1991, J BIOL CHEM, V266, P1379; Hellen E H, 1991, J Fluoresc, V1, P113, DOI 10.1007/BF00865207; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JACKSON CM, 1987, J BIOL CHEM, V262, P13472; JONES ME, 1985, THROMB RES, V39, P711, DOI 10.1016/0049-3848(85)90255-5; KOP JMM, 1984, J BIOL CHEM, V259, P3993; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; LENTZ BR, 1991, BIOPHYS J, V60, P942, DOI 10.1016/S0006-3495(91)82128-2; LIEBMANN LW, 1991, REV SCI INSTRUM, V62, P2083, DOI 10.1063/1.1142371; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1990, BLOOD, V76, P1; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; NAGLE JF, 1992, BIOPHYS J, V63, P366, DOI 10.1016/S0006-3495(92)81602-8; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; NESHEIM ME, 1980, REGULATION COAGULATI, P145; PEARCE KH, 1992, BIOCHEMISTRY-US, V31, P5983, DOI 10.1021/bi00141a005; PEI G, 1993, J BIOL CHEM, V268, P3226; PISARCHICK ML, 1990, BIOPHYS J, V58, P1235, DOI 10.1016/S0006-3495(90)82464-4; PISARCHICK ML, 1992, BIOPHYS J, V63, P215, DOI 10.1016/S0006-3495(92)81592-8; POGLITSCH CL, 1990, BIOCHEMISTRY-US, V29, P248, DOI 10.1021/bi00453a033; POLLOCK JS, 1988, J BIOL CHEM, V263, P14216; SANDBERG H, 1985, THROMB RES, V39, P63, DOI 10.1016/0049-3848(85)90122-7; SANDBERG H, 1982, BIOCHEM J, V203, P3036; SCHMIDT CF, 1990, BIOPHYS J, V57, P577, DOI 10.1016/S0006-3495(90)82573-X; SCHWEITZERSTENNER R, 1992, BIOPHYS J, V63, P551, DOI 10.1016/S0006-3495(92)81609-0; SHEETZ MP, 1979, P NATL ACAD SCI USA, V76, P3314, DOI 10.1073/pnas.76.7.3314; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; STEINBACH PJ, 1992, BIOPHYS J, V61, P235, DOI 10.1016/S0006-3495(92)81830-1; TARVERS RC, 1986, J BIOL CHEM, V261, P4855; TENDIAN SW, 1991, BIOCHEMISTRY-US, V30, P10991, DOI 10.1021/bi00109a026; TENDIAN SW, 1990, BIOCHEMISTRY-US, V29, P6720, DOI 10.1021/bi00480a023; Thompson N. L., 1988, Comments on Molecular and Cellular Biophysics. Comments on Modern Biology: Part A, V5, P109; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; THOMPSON NL, 1988, COMMENTS MOL CELL BI, V5, P39; WEI GJ, 1982, BIOCHEMISTRY-US, V21, P1949, DOI 10.1021/bi00537a039; WRIGHT LL, 1988, BIOPHYS J, V54, P463, DOI 10.1016/S0006-3495(88)82979-5; WU JR, 1991, BIOPHYS J, V60, P70, DOI 10.1016/S0006-3495(91)82031-8	46	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					22984	22991						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226813				2022-12-27	WOS:A1993MF51500008
J	FURUKAWA, KI; SAKAI, K; WATANABE, S; MARUYAMA, K; MURAKAMI, M; YAMAGUCHI, K; OHIZUMI, Y				FURUKAWA, KI; SAKAI, K; WATANABE, S; MARUYAMA, K; MURAKAMI, M; YAMAGUCHI, K; OHIZUMI, Y			GONIODOMIN-A INDUCES MODULATION OF ACTOMYOSIN ATPASE ACTIVITY MEDIATED THROUGH CONFORMATIONAL CHANGE OF ACTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CONTRACTION; MYOSIN SUBFRAGMENT-1; TROPOMYOSIN-TROPONIN; HEAVY-CHAIN; F-ACTIN; BINDING; POLYMERIZATION; XESTOQUINONE; MECHANISM; PUREALIN	Goniodomin A, one of the polyether macrolides, isolated from the dinoflagellate Goniodoma pseudogoniaulax stimulated skeletal actomyosin ATPase activity 2-3 times, with a peak at 3 x 10(-8) to 3 x 10(-7) M. The effect of goniodomin A was dependent on the concentration of actin, but not of myosin. The actomyosin ATPase activity was increased by pretreatment of actin (but not of myosin) with goniodomin A. Goniodomin A induced a sustained and concentration-dependent increase in the fluorescence intensity (excitation wavelength, 277 nm; emission wavelength, 329 nm) of actin. The maximum response was obtained with concentrations of goniodomin A in the 10(-5) to 10(-4) M range in the presence of 5 muM F-actin. However, the ATPase activity and fluorescence intensity of myosin were not changed by goniodomin A at concentrations from 10(-8) to 10(-5) M. Interestingly, goniodomin A induced a remarkable but transient increase in the fluorescence intensity of actomyosin in a concentration-dependent manner, with a peak at 3 X 10(-7) M. This profile was quite similar to that found in the stimulation of the actomyosin ATPase activity induced by goniodomin A. To investigate further the effect of goniodomin A, actin was labeled with N-(1-pyrenyl)iodoacetamide. Goniodomin A at 10(-6) M had no effect on the fluorescence intensity of pyrenyl-actin (excitation wavelength, 365 nm; emission wavelength, 407 nm), but increasing concentrations of goniodomin A to 3 x 10(-6) M remarkably decreased its intensity. This effect was potentiated by heavy meromyosin. Actin molecules treated with goniodomin A were completely sedimented by mild centrifugation (for 15 min at 12,000 x g). Electron microscopic observations suggest that actin filaments associate with each other to form a gel in the presence of 3 x 10(-6) M goniodomin A. The conformational change of actin molecules, resulting from stoichiometric binding of goniodomin A to actin monomers in filaments, may modify the interaction between actin and myosin.	TOHOKU UNIV,INST PHARMACEUT,DEPT PHARMACEUT MOLEC BIOL,AOBA KU,SENDAI,MIYAGI 980,JAPAN; CHIBA UNIV,FAC SCI,DEPT BIOL,INAGE KU,CHIBA 263,JAPAN; UNIV TOKYO,FAC AGR,MARINE BIOCHEM LAB,BUNKYO KU,TOKYO 113,JAPAN	Tohoku University; Chiba University; University of Tokyo			Furukawa, Ken-Ichi/N-9244-2014	Furukawa, Ken-Ichi/0000-0002-5680-007X				CHALOVICH JM, 1981, J BIOL CHEM, V256, P575; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; COOKE R, 1982, METHOD ENZYMOL, V85, P574; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; ELSALEH SC, 1986, J MUSCLE RES CELL M, V7, P387, DOI 10.1007/BF01753582; HANNON JD, 1993, BIOPHYS J, V64, P1632, DOI 10.1016/S0006-3495(93)81517-0; Hartwig JH, 1991, CURR OPIN CELL BIOL, V3, P87, DOI 10.1016/0955-0674(91)90170-4; Inoue A, 1979, Adv Biophys, V13, P1; KOBAYASHI M, 1991, J PHARMACOL EXP THER, V257, P82; KOBAYASHI M, 1991, J PHARMACOL EXP THER, V257, P90; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LABBE JP, 1982, BIOCHEMISTRY-US, V21, P6897, DOI 10.1021/bi00269a042; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MORNET D, 1981, NATURE, V292, P301, DOI 10.1038/292301a0; MURAKAMI M, 1988, TETRAHEDRON LETT, V29, P1149, DOI 10.1016/S0040-4039(00)86674-5; NAKAMURA Y, 1987, EUR J BIOCHEM, V167, P1, DOI 10.1111/j.1432-1033.1987.tb13296.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; TAKITO J, 1986, J BIOL CHEM, V261, P3861	22	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					26026	26031						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245035				2022-12-27	WOS:A1993MK10000104
J	GUO, LN; PHILLIPS, AT; ARTECA, RN				GUO, LN; PHILLIPS, AT; ARTECA, RN			AMINO-ACID N-MALONYLTRANSFERASES FROM MUNG BEANS - ACTION ON 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID AND D-PHENYLALANINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-AMINOCYCLOPROPANECARBOXYLATE MALONYLTRANSFERASE; ETHYLENE PRODUCTION; CONJUGATION; HYPOCOTYLS; PROTEINS	1-Aminocyclopropane-1-carboxylate (ACC) N-malonyltransferase from etiolated mung bean hypocotyls was examined for its relationship to D-phenylalanine N-malonyltransferase and other enzymes which transfer malonyl groups from malonyl-CoA to D-amino acids. Throughout a 3600-fold purification the ratio Of D-phenylalanine N-malonyltransferase activity to ACC N-malonyltransferase activity was unchanged. Antibodies raised against purified ACC N-malonyltransferase 55-kDa protein were also able to precipitate all D-phenylalanine-directed activity from partially purified mung bean extracts. The irreversible inhibitors phenylglyoxal and tetranitromethane reduced malonyltransferase activity towards D-phenylalanine to the same extent as that for ACC. In addition, several other D-amino acids, particularly D-tryptophan and D-tyrosine, were able to inhibit action towards both ACC and D-phenylalanine. These lines of evidence suggest that a single enzyme is capable of promoting malonylation of both ACC and D-phenylalanine. K(m) values for D-phenylalanine and malonyl-CoA were found to be 48 and 43 muM, respectively; these values are 10-fold lower than the corresponding values when ACC was substrate. Coenzyme A was a noncompetitive (mixed type) product inhibitor towards malonyl-CoA at both unsaturated and saturated ACC concentrations. The enzyme was also inhibited uncompetitively at high concentrations of malonyl-CoA. We propose that the enzyme follows an Ordered Bi-Bi reaction pathway, with the amino acid substrate being bound initially.	PENN STATE UNIV,DEPT HORT,UNIV PK,PA 16802; PENN STATE UNIV,DEPT MOLEC & CELL BIOL,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University								AMRHEIN N, 1982, PLANT GROWTH SUBSTAN, P249; AMRHEIN N, 1987, P INT S CONJUGATED P, P102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; GALLARDO M, 1991, PLANT PHYSIOL, V97, P122, DOI 10.1104/pp.97.1.122; GLAZER AN, 1976, PROTEINS, V2, P1; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; GUO LI, 1992, PLANT PHYSIOL, V100, P2041, DOI 10.1104/pp.100.4.2041; KAWASAKI Y, 1982, AGR BIOL CHEM TOKYO, V46, P1; KIONKA C, 1984, PLANTA, V162, P226, DOI 10.1007/BF00397444; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU Y, 1984, ARCH BIOCHEM BIOPHYS, V235, P319, DOI 10.1016/0003-9861(84)90204-2; LIU Y, 1985, PLANT PHYSIOL, V77, P891, DOI 10.1104/pp.77.4.891; MANSKE RHF, 1937, CANAD J RES        B, V15, P84; MATERN U, 1984, ARCH BIOCHEM BIOPHYS, V235, P218, DOI 10.1016/0003-9861(84)90271-6; PHILOSOPHHADAS S, 1985, PHYSIOL PLANTARUM, V63, P431, DOI 10.1111/j.1399-3054.1985.tb02322.x; REKOSLAVSKAYA NI, 1988, J PLANT PHYSIOL, V132, P86, DOI 10.1016/S0176-1617(88)80188-3; ROSA N, 1968, CAN J BIOCHEM CELL B, V46, P797, DOI 10.1139/o68-121; SANDERMANN H, 1991, ARCH BIOCHEM BIOPHYS, V287, P341, DOI 10.1016/0003-9861(91)90488-5; Segel I. H., 1975, ENZYME KINETICS BEHA, P505; SU LY, 1985, PHYTOCHEMISTRY, V24, P1141, DOI 10.1016/S0031-9422(00)81090-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103	22	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25389	25394						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244971				2022-12-27	WOS:A1993MK10000020
J	TROLL, H; WINCKLER, T; LASCU, I; MULLER, N; SAURIN, W; VERON, M; MUTZEL, R				TROLL, H; WINCKLER, T; LASCU, I; MULLER, N; SAURIN, W; VERON, M; MUTZEL, R			SEPARATE NUCLEAR GENES ENCODE CYTOSOLIC AND MITOCHONDRIAL NUCLEOSIDE DIPHOSPHATE KINASE IN DICTYOSTELIUM-DISCOIDEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; TUMOR-METASTASIS; PROTEIN-KINASE; DNA; EXPRESSION; ENZYME; KILLER; PRUNE; NM23	We have previously isolated cDNA clones for the gip17 gene encoding the cytosolic nucleoside diphosphate (NDP) kinase from Dictyostelium discoideum, and partial cDNAs for guk, a second member of the NDP kinase gene family (Wallet, V., Mutzel, R., Troll, H., Barzu, O., Wurster, B., Veron, M., and Lacombe, M. L. (1990) J. Natl. Cancer Inst. 80, 1199-1202). We now characterize genomic DNA clones for both NDP kinase genes, and we show that guk defines a nuclear-encoded mitochondrial NDP kinase. Isolated D. discoideum mitochondria contain 3% of the total cellular NDP kinase activity. Antibodies which specifically recognize and inhibit the activity of either cytosolic or mitochondrial NDP kinase unambiguously distinguish between these activities. The nascent mitochondrial NDP kinase contains a presequence of 57 amino acids that is removed during import into the organelle as shown by determination of the NH2 terminus of the mature protein from mitochondria. The genes for mitochondrial and cytosolic NDP kinases contain four and two introns, respectively. The positions of the introns in the gene for the cytosolic enzyme match exactly the positions of the second and fourth introns in the coding region of its mitochondrial homologue. From these results we conclude that the isozymes diverged from a common ancestor, and we discuss possible phylogenetic pathways for the evolution of cytosolic and organelle NDP kinases.	UNIV KONSTANZ,FAK BIOL,D-78434 CONSTANCE,GERMANY; UNIV BERN,INST ALLGEMEINE MIKROBIOL,CH-3012 BERN,SWITZERLAND; INST PASTEUR,CNRS,UNITE BIOCHIM CELLULAIRE 1129,F-75724 PARIS 15,FRANCE; INST PASTEUR,CNRS,UNITE PROGRAMMAT MOLEC & TOXICOL GENET,F-75724 PARIS 15,FRANCE	University of Konstanz; University of Bern; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris								ALLEN JR, 1983, J BIOL CHEM, V258, P5746; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLES AM, 1991, J BIOL CHEM, V266, P8784; GOLDSTEIN LSB, 1986, J CELL BIOL, V102, P2076, DOI 10.1083/jcb.102.6.2076; HACKSTEIN JHP, 1992, EUR J CELL BIOL, V58, P429; HAILAT N, 1991, J CLIN INVEST, V88, P341, DOI 10.1172/JCI115299; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; HERBERT E, 1955, J BIOL CHEM, V213, P923; ISHIKAWA N, 1992, J BIOL CHEM, V267, P14366; IWABE N, 1990, J MOL EVOL, V31, P205, DOI 10.1007/BF02109497; KASAHARA M, 1993, IN PRESS EVOLUTION M; KEIM D, 1992, J CLIN INVEST, V89, P919, DOI 10.1172/JCI115672; KIMURA N, 1988, J BIOL CHEM, V263, P4647; KUMURA N, 1990, J BIOL CHEM, V265, P15744; LACOMBE M L, 1992, Trends in Pharmacological Sciences, V13, P46, DOI 10.1016/0165-6147(92)90020-7; LACOMBE ML, 1991, EUR J CANCER, V27, P1302, DOI 10.1016/0277-5379(91)90101-I; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CANCER RES, V51, P2490; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MELKI R, 1992, BIOCHEM BIOPH RES CO, V187, P65, DOI 10.1016/S0006-291X(05)81459-7; MILLER LK, 1971, P NATL ACAD SCI USA, V68, P2298, DOI 10.1073/pnas.68.9.2298; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2702; MUTZEL R, 1988, BIOCHEMISTRY-US, V27, P481, DOI 10.1021/bi00401a069; NIKERSON JA, 1984, J BIOL CHEM, V259, P11297; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; PEDERSEN PL, 1973, J BIOL CHEM, V248, P3956; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMADA N, 1993, J BIOL CHEM, V268, P2583; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STURTEVANT AH, 1956, GENETICS, V41, P118; TROLL H, 1992, J BIOL CHEM, V267, P21072; URANO T, 1992, FEBS LETT, V309, P358, DOI 10.1016/0014-5793(92)80807-S; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199; WANNER R, 1990, BIOCHIM BIOPHYS ACTA, V1053, P179, DOI 10.1016/0167-4889(90)90011-2; WELKER DL, 1985, MOL CELL BIOL, V5, P273, DOI 10.1128/MCB.5.2.273; WIELAND T, 1991, EUR J BIOCHEM, V196, P707, DOI 10.1111/j.1432-1033.1991.tb15869.x; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	51	68	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25469	25475						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244981				2022-12-27	WOS:A1993MK10000031
J	WATANABE, A; HASEGAWA, M; SUZUKI, M; TAKIO, K; MORISHIMAKAWASHIMA, M; TITANI, K; ARAI, T; KOSIK, KS; IHARA, Y				WATANABE, A; HASEGAWA, M; SUZUKI, M; TAKIO, K; MORISHIMAKAWASHIMA, M; TITANI, K; ARAI, T; KOSIK, KS; IHARA, Y			IN-VIVO PHOSPHORYLATION SITES IN FETAL AND ADULT RAT-TAU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE STATE; PROTEIN-KINASE-C; NEUROFIBRILLARY TANGLES; DISEASE; EXPRESSION; SEQUENCE; EPITOPES; BRAIN; ELECTROPHORESIS	Fetal tau and tau in paired helical filaments show similar immunoreactivities with several phosphorylation-dependent paired helical filament-polyclonals and monoclonals, suggesting that the two molecules share several distinct phosphorylated epitopes. To make clear the similarities and differences between the two, we have undertaken work to identify the in vivo phosphorylation sites in fetal rat tau. We have approached this problem by identifying phosphopeptides by means of mass spectrometry and sequencing of those phosphopeptides after modification with ethanethiol. Although remarkable heterogeneity was present, fetal tau was found to bear at most 10 phosphates at Ser-189, Ser-190, Ser-193, Ser-226, Ser-387, Ser-395, Thr-172, Thr-222, and, presumably, Ser-391 and Thr-208 (numbering is according to the longest form of rat tau; Kosik, K. S., Orecchio, L. D., Bakalis, S., and Neve, R. L. (1989) Neuron 2, 1389-1397). In contrast, adult rat tau was much less phosphorylated; only Thr-172, Ser-190, Ser-193, Thr-222, and Ser-395 were phosphorylated to a slight-to-moderate extent. All these sites except for Ser-189 and Ser-391 were followed by Pro residues. Thus, tau is an in vivo substrate for proline-directed protein kinase(s), and its phosphorylation state is developmentally regulated.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,TOKYO 113,JAPAN; SCI UNIV TOKYO,FAC SCI & TECHNOL,DEPT APPL BIOL SCI,NODA,CHIBA 278,JAPAN; INST PHYS & CHEM RES,DIV BIOMOLEC CHARACTERIZAT,WARO,SAITAMA 35101,JAPAN; INST PHYS & CHEM RES,BIODESIGN RES GRP,WAKO,SAITAMA 35101,JAPAN; FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,DIV BIOMED POLYMER SCI,TOYOAKE,AICHI 47011,JAPAN; HARVARD UNIV,BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	University of Tokyo; Tokyo University of Science; RIKEN; RIKEN; Fujita Health University; Harvard University; Brigham & Women's Hospital								ARIOKA M, 1993, J NEUROCHEM, V60, P461, DOI 10.1111/j.1471-4159.1993.tb03173.x; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BUTLER M, 1986, J NEUROCHEM, V47, P1517, DOI 10.1111/j.1471-4159.1986.tb00788.x; CORREAS I, 1992, J BIOL CHEM, V267, P15721; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HOSHI M, 1987, FEBS LETT, V217, P237, DOI 10.1016/0014-5793(87)80670-1; IHARA Y, 1990, GERONTOLOGY, V36, P15; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; ISHIGURO K, 1988, J BIOCHEM-TOKYO, V104, P319, DOI 10.1093/oxfordjournals.jbchem.a122465; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; IWATSUBO T, 1992, AM J PATHOL, V140, P277; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P420, DOI 10.1002/jnr.490250320; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1992, J BIOL CHEM, V267, P25922; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705; MEYER HE, 1991, METHOD ENZYMOL, V201, P169; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WOODGETT JR, 1991, TRENDS BIOCHEM SCI, V16, P177, DOI 10.1016/0968-0004(91)90071-3; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	43	221	225	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25712	25717						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245007				2022-12-27	WOS:A1993MK10000063
J	BRAR, SK; SIU, CH				BRAR, SK; SIU, CH			CHARACTERIZATION OF THE CELL-ADHESION MOLECULE GP24 IN DICTYOSTELIUM-DISCOIDEUM - MEDIATION OF CELL-CELL ADHESION VIA A CA2+-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; SODIUM DODECYL-SULFATE; MONOCLONAL-ANTIBODIES; SURFACE GLYCOPROTEIN; POLYACRYLAMIDE GELS; CA-45 AUTORADIOGRAPHY; BLOCKING FAB; INHIBITION; EXPRESSION; STAGE	Dictyostelium discoideum cells express EDTA-sensitive cell-cell adhesion sites soon after the initiation of development and EDTA-resistant adhesion sites later at the aggregation stage. A glycoprotein of M(r) 24,000 (gp24) has been implicated in the mediation of the EDTA-sensitive type of intercellular cohesiveness (Knecht, D. A., Fuller, D. L., and Loomis, W. F. (1987) Dev. Biol. 121, 277-283). In this study, a relatively simple procedure was developed to purify gp24 to homogeneity. A highly specific rabbit antiserum was raised against gp24, and the localization of gp24 at the cell surface was shown by quantitative binding of the anti-gp24 antibodies to intact cells. To demonstrate the cell binding activity of gp24, the binding of solubilized gp24 to intact cells was examined. I-125-Labeled gp24 bound to cells in a dose-dependent and saturable manner, and the binding was displaced specifically by unlabeled gp24. Purified gp24 was capable of inhibiting the reassociation of dispersed cells previously undergoing EDTA-sensitive aggregation. Moreover, precoating cells with anti-gp24 IgG and Fab fragments blocked the binding of I-125-labeled gp24 to cells. Collectively, these in vitro assays provide direct evidence that gp24 is a cell adhesion molecule that most likely functions through a homophilic mode of interaction. The binding of gp24 to cells was sensitive to EGTA, suggesting that the activity of gp24 may involve calcium ions. Binding studies showed that Ca-45(2+) could bind to gp24 blotted onto nitrocellulose membrane. In addition, preincubation of the native protein with calcium ions resulted in a shift in its gel mobility. It is therefore likely that gp24 mediates cell-cell interactions via a Ca2+-dependent mechanism, rendering gp24 the first cell adhesion molecule in D. discoideum to utilize a Ca2+-based adhesion system.	UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5G 1L6,ONTARIO,CANADA	University of Toronto; University of Toronto								BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BONNER JT, 1959, P NATL ACAD SCI USA, V56, P379; BRODIE C, 1983, CELL, V32, P1115, DOI 10.1016/0092-8674(83)90295-7; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; CHOI AHC, 1987, J CELL BIOL, V104, P1375, DOI 10.1083/jcb.104.5.1375; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; DESBARATS L, 1992, J BIOL CHEM, V267, P19655; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FEINBERG AP, 1979, P NATL ACAD SCI USA, V76, P3977, DOI 10.1073/pnas.76.8.3977; FONTANA DR, 1989, DIFFERENTIATION, V41, P184, DOI 10.1111/j.1432-0436.1989.tb00746.x; FONTANA DR, 1991, MOL CELL BIOL, V11, P468, DOI 10.1128/MCB.11.1.468; FRITZ IB, 1989, J CELL PHYSIOL, V140, P18, DOI 10.1002/jcp.1041400104; GAO EN, 1992, J BIOL CHEM, V267, P9409; GARROD DR, 1972, EXP CELL RES, V72, P588, DOI 10.1016/0014-4827(72)90041-9; GELTOSKY JE, 1979, CELL, V18, P391, DOI 10.1016/0092-8674(79)90058-8; GELTOSKY JE, 1980, CELL, V21, P339, DOI 10.1016/0092-8674(80)90470-5; GERISCH G, 1961, EXP CELL RES, V25, P535, DOI 10.1016/0014-4827(61)90189-6; GERISCH G, 1980, CURR TOP DEV BIOL, V14, P234; GRAB DJ, 1979, J BIOL CHEM, V254, P8690; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KAMBOJ RK, 1989, CELL, V59, P615, DOI 10.1016/0092-8674(89)90007-X; KAMBOJ RK, 1990, CELL REGUL, V1, P715, DOI 10.1091/mbc.1.10.715; KNECHT DA, 1987, DEV BIOL, V121, P277, DOI 10.1016/0012-1606(87)90160-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM TY, 1981, DEV BIOL, V83, P127, DOI 10.1016/S0012-1606(81)80015-2; LAM TY, 1981, DIFFERENTIATION, V20, P22, DOI 10.1111/j.1432-0436.1981.tb01151.x; Loomis W F, 1991, Antisense Res Dev, V1, P255; LOOMIS WF, 1988, DEV GENET, V9, P549, DOI 10.1002/dvg.1020090431; LOOMIS WF, 1990, P NATL ACAD SCI USA, V87, P886, DOI 10.1073/pnas.87.3.886; LOOMIS WF, 1975, DICTYOSTELIUMDISCOID; MA PCC, 1990, MOL CELL BIOL, V10, P3297, DOI 10.1128/MCB.10.7.3297; MAEDA Y, 1969, DEV GROWTH DIFFER, V11, P232; MANN SKO, 1989, P NATL ACAD SCI USA, V86, P1924, DOI 10.1073/pnas.86.6.1924; MARCHAK DR, 1984, BIOCHEMISTRY-US, V23, P2891; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MULLER K, 1978, NATURE, V274, P445, DOI 10.1038/274445a0; MURRAY BA, 1981, J SUPRAMOL STR CELL, V17, P197, DOI 10.1002/jsscb.380170302; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; RATHI A, 1992, MECH DEVELOP, V36, P173, DOI 10.1016/0925-4773(92)90068-U; SAFFELL JL, 1992, J CELL BIOL, V118, P663, DOI 10.1083/jcb.118.3.663; SAXE CL, 1982, CELL, V29, P755, DOI 10.1016/0092-8674(82)90437-8; SCHIBECI A, 1980, ANAL BIOCHEM, V104, P335, DOI 10.1016/0003-2697(80)90084-6; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Siu C.-H., 1988, P119; SIU CH, 1990, DEV GENET, V11, P377, DOI 10.1002/dvg.1020110509; SIU CH, 1988, BIOCHEM CELL BIOL, V66, P1089, DOI 10.1139/o88-126; SIU CH, 1992, J CELL PHYSIOL, V152, P157, DOI 10.1002/jcp.1041520120; SIU CH, 1988, BIOCHIM BIOPHYS ACTA, V968, P283, DOI 10.1016/0167-4889(88)90019-5; SIU CH, 1987, J CELL BIOL, V105, P2523, DOI 10.1083/jcb.105.6.2523; SIU CH, 1983, P NATL ACAD SCI-BIOL, V80, P6596, DOI 10.1073/pnas.80.21.6596; SIU CH, 1990, BIOESSAYS, V12, P357, DOI 10.1002/bies.950120802; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPRINGER WR, 1980, J CELL BIOL, V87, P703, DOI 10.1083/jcb.87.3.703; STEINEMANN C, 1980, NATURE, V286, P621, DOI 10.1038/286621a0; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeuchi I., 1969, NUCL ACID METABOLISM, P297; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS RJP, 1986, CIBA F SYMP, V122, P145	66	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24902	24909						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227052				2022-12-27	WOS:A1993MG67300059
J	HEIKKILA, P; SOININEN, R; TRYGGVASON, K				HEIKKILA, P; SOININEN, R; TRYGGVASON, K			DIRECTIONAL REGULATORY ACTIVITY OF CIS-ACTING ELEMENTS IN THE BIDIRECTIONAL ALPHA-1(IV) AND ALPHA-2(IV) COLLAGEN GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; DIHYDROFOLATE-REDUCTASE; DIVERGENT TRANSCRIPTS; CHAIN; EXPRESSION; REGION; ACTIVATION; BOX; IDENTIFICATION	The genes for the type IV collagen alpha1 and alpha2 chains are regulated by a common approximately 130-base pair (bp) bidirectional promoter. In an attempt to explore the regulation of expression of both genes, we have constructed a minilocus plasmid containing minigenes for the human alpha1(IV) and alpha2(IV) collagen genes located head-to-head like the endogenous genes. The directional regulation of this promoter was studied by introducing site-directed mutations into the promoter of the minigenes. In transient transfections the levels of transcripts of both minigenes were measured, and the influence of mutations on the direction of transcription was studied. The mutational analysis showed that a CCCTCCC motif and a GC box located in the center of the common promoter as well as GC boxes in exon 1 of the alpha2(IV) gene are potent activating elements for both genes. The promoter of the alpha1(IV) and alpha2(IV) collagen genes contains no classical TATA boxes. Even so, A+T-rich sequence motifs, which have no obvious homology to the TATA box located 25-30 bp upstream of exon 1 in each gene, direct the initiation of transcription predominantly about 30 bp downstream of their location. Disruption of the A+T-rich sequence decreased the activity of the promoter considerably, and in addition, the generated classical TATA boxes hindered maintenance of normal bidirectional transcription and changed the ratio of the alpha1(IV) and alpha2(IV) transcripts. The CCAAT box in the alpha2(IV) chain coding strand activated the promoter in the alpha2(IV) gene direction, but not in the alpha1(IV) gene direction.	UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu								ANAKA S, 1993, J BIOL CHEM, V268, P8862; Ausubel FM, 1988, MOL REPROD DEV; BRENNER DA, 1989, NUCLEIC ACIDS RES, V17, P6055, DOI 10.1093/nar/17.15.6055; BRYGGEMAN LA, 1992, ONCOGENE, V7, P1497; BURBELO PD, 1991, J BIOL CHEM, V266, P22297; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FARNHAM PJ, 1985, P NATL ACAD SCI USA, V82, P3978, DOI 10.1073/pnas.82.12.3978; FRIDELL YWC, 1992, MOL CELL BIOL, V12, P4571, DOI 10.1128/MCB.12.10.4571; FUJII H, 1992, FEBS LETT, V314, P33, DOI 10.1016/0014-5793(92)81455-U; HOSTIKKA SL, 1987, FEBS LETT, V224, P297, DOI 10.1016/0014-5793(87)80473-8; HOSTIKKA SL, 1987, FEBS LETT, V216, P281, DOI 10.1016/0014-5793(87)80706-8; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; JOHNSON P, 1990, GENE, V88, P207, DOI 10.1016/0378-1119(90)90033-N; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; LAVIA P, 1987, EMBO J, V6, P2773, DOI 10.1002/j.1460-2075.1987.tb02572.x; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MOREAU P, 1981, NUCLEIC ACIDS RES, V9, P6047, DOI 10.1093/nar/9.22.6047; MORRISON KE, 1991, AM J HUM GENET, V49, P545; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; POLLNER R, 1990, ANN NY ACAD SCI, V580, P44, DOI 10.1111/j.1749-6632.1990.tb17916.x; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; RIZZO MG, 1990, EXP CELL RES, V188, P286, DOI 10.1016/0014-4827(90)90172-7; Sambrook J, 1989, MOL CLONING LABORATO; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SCHMIDT A, 1985, NATURE, V314, P286, DOI 10.1038/314286a0; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SOININEN R, 1986, EMBO J, V5, P2821, DOI 10.1002/j.1460-2075.1986.tb04574.x; SOININEN R, 1988, J BIOL CHEM, V263, P17217; SOININEN R, 1989, J BIOL CHEM, V264, P13565; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; WILEY SR, 1992, P NATL ACAD SCI USA, V89, P5814, DOI 10.1073/pnas.89.13.5814; XU LC, 1991, NUCLEIC ACIDS RES, V19, P6699, DOI 10.1093/nar/19.24.6699; ZHOU DX, 1991, J BIOL CHEM, V266, P23416; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	40	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24677	24682						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227027				2022-12-27	WOS:A1993MG67300028
J	LOW, MJ; LIU, B; HAMMER, GD; RUBINSTEIN, M; ALLEN, RG				LOW, MJ; LIU, B; HAMMER, GD; RUBINSTEIN, M; ALLEN, RG			POSTTRANSLATIONAL PROCESSING OF PROOPIOMELANOCORTIN (POMC) IN MOUSE PITUITARY MELANOTROPH TUMORS INDUCED BY A POMC-SIMIAN VIRUS-40 LARGE T-ANTIGEN TRANSGENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPIOMELANOCORTIN (POMC)-DERIVED PEPTIDES; PRO-OPIOMELANOCORTIN; GENE-EXPRESSION; CUSHINGS-SYNDROME; DEPENDENT HYPERADRENOCORTICISM; SECRETING TUMORS; MAMMALIAN-CELLS; RAT PITUITARY; MICE; PROHORMONE	Mice harboring a transgene composed of proopiomelanocortin (POMC) gene promoter sequences (nucleotides -706 to +64) ligated to the simian virus (SV) 40 early gene encoding large T antigen developed large POMC-expressing pituitary tumors. Histologically the tumors arose from the intermediate lobe, contained nuclear SV40 T antigen and POMC peptides, but did not express other pituitary hormones. POMC processing in the pituitary tumors was indistinguishable from normal mouse intermediate lobe melanotrophs and was characterized by high proportions of acetylated and carboxyl-terminal shortened beta-endorphins, and amino-terminal acetylated alpha-melanocyte-stimulating hormone, and virtually no adrenocorticotropic hormone (ACTH)(1-39), beta-lipotropin, or POMC. The tumors contained abundant levels of mRNA for the prohormone convertase PC2 and undetectable levels of PC1. Normal mouse neurointermediate lobe also has a high ratio of PC2/PC1 expression that is distinct from the relative abundance of PC1 in anterior lobe and AtT20 corticotroph cells. In contrast, extracts from tumors transplanted subcutaneously in nude mice contained predominantly nonacetylated forms of beta-endorphin(1-31) and -(1-27), very little ACTH(1-39), almost no corticotropin-like intermediate peptide or alpha-melanocyte-stimulating hormone, and higher proportions of intact POMC. Surprisingly, despite the less efficient proteolytic cleavage, a transplanted tumor expressed both PC1 and PC2. These studies are the first biochemical documentation of a melanotroph pituitary tumor in a rodent species and provide a new model for the investigation of pituitary oncogenesis and the molecular basis of tissue-specific prohormone post-translational processing.	OREGON HLTH SCI UNIV,CTR RES OCCUPAT & ENVIRONM TOXICOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University	LOW, MJ (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,L474,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.			Low, Malcolm/0000-0002-9900-3708	NIDDK NIH HHS [DK 40457] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040457] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIL H, 1981, PEPTIDES, V2, P289, DOI 10.1016/S0196-9781(81)80121-0; ALLEN RG, 1978, P NATL ACAD SCI USA, V75, P4972, DOI 10.1073/pnas.75.10.4972; ALLEN RG, 1988, DEV BIOL, V126, P156, DOI 10.1016/0012-1606(88)90249-7; ALLEN RG, 1984, DEV BIOL, V102, P43, DOI 10.1016/0012-1606(84)90173-8; ALSHAWI R, 1991, MOL CELL BIOL, V11, P4207, DOI 10.1128/MCB.11.8.4207; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BOTTERI FM, 1987, MOL CELL BIOL, V7, P3178, DOI 10.1128/MCB.7.9.3178; BRUBAKER PL, 1992, J BIOL CHEM, V267, P20728; CANNY BJ, 1988, NEUROENDOCRINOLOGY, V48, P603, DOI 10.1159/000125069; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; DEKEYZER Y, 1985, J CLIN INVEST, V76, P1982; DESOUZA EB, 1986, ENDOCRINOLOGY, V119, P1534, DOI 10.1210/endo-119-4-1534; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; Eipper B A, 1980, Endocr Rev, V1, P1; EIPPER BA, 1981, J BIOL CHEM, V256, P5689; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FURTH J, 1955, RECENT PROG HORM RES, V11, P221; GEE CE, 1983, NATURE, V306, P374, DOI 10.1038/306374a0; GILLIGAN A, 1989, DIABETES, V38, P1056, DOI 10.2337/diabetes.38.8.1056; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HALE AC, 1986, J ENDOCRINOL, V108, P49, DOI 10.1677/joe.0.1080049; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HAMMER GD, 1992, ENDOCRINOLOGY, V130, P1975, DOI 10.1210/en.130.4.1975; HAMMER GD, 1990, MOL ENDOCRINOL, V4, P1689, DOI 10.1210/mend-4-11-1689; HATFIELD JM, 1988, DEV BIOL, V126, P164, DOI 10.1016/0012-1606(88)90250-3; HOGAN B, 1986, MANIPULATING MOUSE E; HORN F, 1992, MOL CELL BIOL, V12, P2143, DOI 10.1128/MCB.12.5.2143; HOWLETT TA, 1986, CLIN ENDOCRINOL, V24, P699, DOI 10.1111/j.1365-2265.1986.tb01667.x; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JEX RK, 1985, AM J SURG, V149, P276; KILPATRICK DL, 1987, P NATL ACAD SCI USA, V84, P5695, DOI 10.1073/pnas.84.16.5695; KRIEGER DT, 1983, ENDOCR REV, V4, P22, DOI 10.1210/edrv-4-1-22; LEE YC, 1992, J BIOL CHEM, V267, P10705; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; LIU B, 1992, MOL CELL BIOL, V12, P3978, DOI 10.1128/MCB.12.9.3978; LONDON DR, 1992, 71TH P ANN M END SOC; LOW MJ, 1989, MOL ENDOCRINOL, V3, P2028, DOI 10.1210/mend-3-12-2028; LOW MJ, 1993, METHODS MOL BIOL, V13; MAINS RE, 1984, ENDOCRINOLOGY, V115, P1683, DOI 10.1210/endo-115-5-1683; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NOEL G, 1991, ENDOCRINOLOGY, V129, P1317, DOI 10.1210/endo-129-3-1317; PETERSON ME, 1982, ACTA ENDOCRINOL-COP, V101, P15, DOI 10.1530/acta.0.1010015; PETERSON ME, 1986, ENDOCRINOLOGY, V119, P720, DOI 10.1210/endo-119-2-720; PETERSON ME, 1987, FRONT HORM RES, V17, P37; RATTER SJ, 1983, CLIN ENDOCRINOL, V18, P211, DOI 10.1111/j.1365-2265.1983.tb03205.x; REYNOLDS RK, 1988, P NATL ACAD SCI USA, V85, P3135, DOI 10.1073/pnas.85.9.3135; RIUS RA, 1991, DEV BRAIN RES, V60, P179, DOI 10.1016/0165-3806(91)90046-L; RUBINSTEIN M, 1993, IN PRESS NEUROENDOCR; Sambrook J, 1989, MOL CLONING LABORATO; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; STEFANEANU L, 1992, ENDOCRINOLOGY, V130, P1789, DOI 10.1210/en.130.4.1789; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; THOMAS G, 1988, SCIENCE, V241, P226, DOI 10.1126/science.3291117; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; UHLER M, 1983, J BIOL CHEM, V258, P9444; VIEAU D, 1989, CLIN ENDOCRINOL, V31, P691, DOI 10.1111/j.1365-2265.1989.tb01294.x; WILSON MG, 1982, ENDOCRINOLOGY, V110, P941, DOI 10.1210/endo-110-3-941; ZAKARIAN S, 1989, NATURE, V339, P553, DOI 10.1038/339553a0	65	46	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24967	24975						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227058				2022-12-27	WOS:A1993MG67300067
J	CYR, DM; STUART, RA; NEUPERT, W				CYR, DM; STUART, RA; NEUPERT, W			A MATRIX ATP REQUIREMENT FOR PRESEQUENCE TRANSLOCATION ACROSS THE INNER MEMBRANE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN IMPORT; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; RECEPTOR; IDENTIFICATION; TRANSPORT; OUTER	The mitochondrial presequence initiates protein translocation across the inner membrane of mitochondria in a DELTApsi-dependent step. We have investigated the role of matrix ATP in this process. When matrix ATP was reduced to interfere with the function of mitochondrial heat shock protein 70, presequence translocation across the inner membrane was strongly inhibited. This was accompanied by the accumulation of an import intermediate that was unprocessed and accessible to protease added to the intact mitochondria. Both DELTApsi and matrix ATP were required for further translocation of this intermediate into the matrix. When ATP levels are insufficient to support protein import, it appears that the presequence becomes translocated across the inner membrane, but DELTApsi does not maintain it in the matrix. Presequence translocation across the inner membrane is thus a reversible reaction, and a step dependent on matrix ATP is required to make it unidirectional. Based on these observations, a model on the role of DELTApsi, mthsp70, and matrix ATP in presequence translocation across the inner membrane is presented.	UNIV MUNICH,INST PHYSIOL CHEM,GOETHESTR 33,D-80336 MUNICH,GERMANY	University of Munich				Cyr, Douglas/0000-0002-4928-3414				CHEN WJ, 1988, J BIOL CHEM, V263, P4997; CYR DM, 1991, J BIOL CHEM, V266, P21700; DAUM G, 1982, J BIOL CHEM, V257, P3028; Glick B, 1991, Trends Cell Biol, V1, P99, DOI 10.1016/0962-8924(91)90037-A; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HWANG S, 1989, J CELL BIOL, V109, P487, DOI 10.1083/jcb.109.2.487; HWANG ST, 1991, J BIOL CHEM, V266, P21083; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; MILLER BR, 1993, J CELL BIOL, V121, P1021, DOI 10.1083/jcb.121.5.1021; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9	20	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23751	23754						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226903				2022-12-27	WOS:A1993MF29400005
J	KOPKE, E; TUNG, YC; SHAIKH, S; ALONSO, AD; IQBAL, K; GRUNDKEIQBAL, I				KOPKE, E; TUNG, YC; SHAIKH, S; ALONSO, AD; IQBAL, K; GRUNDKEIQBAL, I			MICROTUBULE-ASSOCIATED PROTEIN-TAU - ABNORMAL PHOSPHORYLATION OF A NON-PAIRED HELICAL FILAMENT POOL IN ALZHEIMER-DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL NERVOUS-SYSTEM; NEUROFIBRILLARY TANGLES; MONOCLONAL-ANTIBODIES; BRAIN; UBIQUITIN; ASSAY; DEPHOSPHORYLATION; IDENTIFICATION; SUSCEPTIBILITY; POLYPEPTIDES	The major protein subunit of the paired helical filaments (PHF) of Alzheimer disease (AD) is the microtubule-associated protein tau. Tau is a family of phosphopolypeptides that are abnormally phosphorylated in PHF. In this study, a non-PHF pool of tau abnormally phosphorylated at Ser-199/202, and tau not phosphorylated at this site (AD P-tau and AD tau, respectively) were isolated from the 27,000 x g to 200,000 x g fraction of AD brain homogenate by extraction in 8 M urea, followed by dialysis against Tris buffer. AD P-tau and AD tau were further purified and separated from each other by acid precipitation, glial fibrillary acidic protein affinity chromatography, and phosphocellulose chromatography. The resulting AD P-tau and AD tau preparations were free of cytoskeletal proteins, ubiquitin, and beta-amyloid peptide. Immunochemical and morphological analysis of AD P-tau preparations revealed that most of the protein was of non-PHF origin. The AD P-tau was about 3-4-fold (approximately 8 mol P0(4)/mol protein, M(r) 41,318) more phosphorylated than cytosolic tau from AD and control brains. Unlike PHF, the AD P-tau lacked ubiquitin. In AD brain the levels of cytosolic tau were about half of those in control aged cases. These findings suggest that the abnormal phosphorylation of tau in AD occurs in the cytosol.	NEW YORK STATE INST BASIC RES DEV DISABIL,1050 FOREST HILLS RD,STATEN ISL,NY 10314	Institute for Basic Research in Developmental Disabilities					NIA NIH HHS [F32 AGO 5541, AG O4220] Funding Source: Medline; NINDS NIH HHS [NS 18105] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004220, F32AG005541] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; CHEN M, 1989, J BIOL CHEM, V264, P14282; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dustin P., 1982, AXOPLASMIC TRANSPORT, P131; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1985, ACTA NEUROPATHOL, V68, P279, DOI 10.1007/BF00690830; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LAUMAS S, 1989, P NATL ACAD SCI USA, V86, P3021, DOI 10.1073/pnas.86.9.3021; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; LIU WK, 1991, J BIOL CHEM, V266, P21723; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; NIETO A, 1990, NEUROSCIENCE, V37, P163, DOI 10.1016/0306-4522(90)90201-E; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; PAPASOZOMENOS SC, 1989, LAB INVEST, V60, P375; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PERRY G, 1989, J NEUROCHEM, V52, P1523, DOI 10.1111/j.1471-4159.1989.tb09203.x; RUBEN GC, 1992, BRAIN RES, V590, P164, DOI 10.1016/0006-8993(92)91092-S; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; RUBENSTEIN R, 1986, BRAIN RES, V372, P80, DOI 10.1016/0006-8993(86)91460-5; SAITOH T, 1986, P NATL ACAD SCI USA, V83, P9764, DOI 10.1073/pnas.83.24.9764; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; WANG GP, 1984, ACTA NEUROPATHOL, V62, P268, DOI 10.1007/BF00687608; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WISNIEWSKI HM, 1984, J NEUROPATH EXP NEUR, V43, P643, DOI 10.1097/00005072-198411000-00008; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509	55	554	590	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24374	24384						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226987				2022-12-27	WOS:A1993MF29400098
J	MITSUI, K; SHIRAKATA, M; PATERSON, BM				MITSUI, K; SHIRAKATA, M; PATERSON, BM			PHOSPHORYLATION INHIBITS THE DNA-BINDING ACTIVITY OF MYOD HOMODIMERS BUT NOT MYOD-E12 HETERODIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; MYOGENIC DETERMINATION FACTORS; MUSCLE-SPECIFIC TRANSCRIPTION; GENE FAMILY; ENHANCER; ACTIVATION; REGION; MEMBER; DIFFERENTIATION; DIMERIZATION	MyoD is a member of the basic helix-loop-helix (bHLH) family of muscle gene regulatory proteins that includes myogenin, myf-5, and MRF4. These proteins have been shown to heterodimerize with E2A bHLH proteins, E12/E47, and to bind to a consensus sequence known as an E-box, CANNTG, the target for transcriptional activation by these myogenic regulators. MyoD is also a phosphorylated nuclear protein that is present in muscle cells prior to the transcriptional activation of the muscle-specific genes, many of which contain E-box elements in their regulatory regions. Here we report that phosphorylated chicken MyoD, called CMD1, produced in sf9 cells using the baculovirus system, is qualitatively similar to CMD1 isolated by immunoaffinity purification from primary cultures of embryonic chick breast muscle. Functional analysis of phosphorylated and dephosphorylated CMD1 produced in sf9 cells indicates that, in the presence of magnesium, DNA binding of phosphorylated CMD1 is inhibited whereas binding in association with E12 is not affected. However, CMD1 binding alone is equally efficient when either EDTA is added in excess or dephosphorylated or bacterially expressed CMD1 is used in the assay. Our results suggest that cellular phosphorylation changes the CMD1 homodimer-heterodimer equilibrium which, in turn, modulates and/or eliminates binding site competition between CMD1 homodimers and CMD1/E-protein heterodimers in the cell.	NCI, BIOCHEM LAB, BLDG 37, RM 4A-21, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1991, EUR J BIOCHEM, V198, P187, DOI 10.1111/j.1432-1033.1991.tb16000.x; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRAUN T, 1991, NUCLEIC ACIDS RES, V19, P5645, DOI 10.1093/nar/19.20.5645; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HU JS, 1988, J BIOL CHEM, V263, P19670; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LI L, 1992, MOL CELL BIOL, V12, P4478, DOI 10.1128/MCB.12.10.4478; LIN ZY, 1989, GENE DEV, V3, P986, DOI 10.1101/gad.3.7.986; MAK KL, 1992, MOL CELL BIOL, V12, P4334, DOI 10.1128/MCB.12.10.4334; MEEK DW, 1992, BIOCHEM J, V287, P1; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAMURA S, 1993, J BIOL CHEM, V268, P11670; ONEILL MC, 1972, J CELL BIOL, V52, P52, DOI 10.1083/jcb.52.1.52; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SASSOON DA, 1993, DEV BIOL, V156, P11, DOI 10.1006/dbio.1993.1055; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SCHWARZ JJ, 1992, MOL CELL BIOL, V12, P266, DOI 10.1128/MCB.12.1.266; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; TAPSCOTT SJ, 1989, SCIENCE, V245, P532, DOI 10.1126/science.2547249; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WINTER B, 1993, J BIOL CHEM, V268, P9869; WINTER B, 1992, EMBO J, V11, P1843, DOI 10.1002/j.1460-2075.1992.tb05236.x; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	35	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24415	24420						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226992				2022-12-27	WOS:A1993MF29400103
J	OBRIEN, MC; MCKAY, DB				OBRIEN, MC; MCKAY, DB			THREONINE-204 OF THE CHAPERONE PROTEIN HSC70 INFLUENCES THE STRUCTURE OF THE ACTIVE-SITE, BUT IS NOT ESSENTIAL FOR ATP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; UNCOATING PROTEIN; UNFOLDED PROTEINS; STRESS PROTEINS; DNAK; CRYSTALLOGRAPHY; TRANSLOCATION; DISSOCIATION; FRAGMENT; BINDING	The chaperone protein Hsc70 is an ATPase of unknown mechanism, although the crystal structure of the 44-kDa ATPase domain has been solved. This structure shows that the hydroxyl of threonine 204 is located close to the gamma-phosphate of ATP, in a position where it might be an intermediate phosphate acceptor in the hydrolysis reaction. We made two point mutations at residue 204 of Hsc70, threonine to valine (T204V) and threonine to glutamic acid (T204E). The wild-type ATPase domain had a K(m) for ATP of approximately 1 muM; the mutants had K(m) values of approximately 90 muM. The k(cat) values for the mutant proteins were also increased. After crystallization, the structures of the T204V and T204E proteins were solved and refined with data to 2.3- and 2.4-angstrom resolution, respectively. The overall tertiary structure of the mutants showed little change from the wild type; however, significant changes were observed in the active site. Analysis of the structures suggested possible reasons for the changes in kinetic constants. Threonine 204 does not seem to be an obligatory intermediate phosphate acceptor in the hydrolysis reaction since the mutants retained appreciable ATPase activity.	STANFORD UNIV,MED CTR,SCH MED,DEPT CELL BIOL,BECKMAN LABS STRUCT BIOL,SHERMAN FAIRCHILD BLDG,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039928, F32GM015141] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 39928, GM 15141] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; BRANDHUBER BJ, 1988, PROTEINS, V3, P146, DOI 10.1002/prot.340030303; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DELUCAFLAHERTY C, 1990, NUCLEIC ACIDS RES, V18, P5569, DOI 10.1093/nar/18.18.5569; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DURBIN RM, 1986, SCIENCE, V232, P1127, DOI 10.1126/science.3704639; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; HARLOW E, 1991, ANTIBODIES LABORATOR, V42, P1; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KOERBER SC, 1987, ANAL BIOCHEM, V165, P75, DOI 10.1016/0003-2697(87)90203-X; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Orsi B A, 1979, Methods Enzymol, V63, P159; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012	24	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24323	24329						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226982				2022-12-27	WOS:A1993MF29400091
J	SCHUTZBACH, JS; ZIMMERMAN, JW; FORSEE, WT				SCHUTZBACH, JS; ZIMMERMAN, JW; FORSEE, WT			THE PURIFICATION AND CHARACTERIZATION OF RECOMBINANT YEAST DOLICHYL-PHOSPHATE-MANNOSE SYNTHASE - SITE-DIRECTED MUTAGENESIS OF THE PUTATIVE DOLICHOL RECOGNITION SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHOMANNOSE SYNTHASE; PROTEIN; ENZYME; MANNOSYLTRANSFERASE; GLYCOSYLATION; PHOSPHOLIPIDS; MODULATION; MEMBRANES; CLONING	Yeast dolichyl-phosphate-mannose synthase was purified from cultures of Escherichia coli carrying the gene for this enzyme in a high expression vector. The synthase contains a highly conserved hydrophobic amino acid sequence proposed to be involved in the recognition of dolichols (Albright, C. F., Orlean, P., and Robbins, P. W. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7366-7369) and amino acid residues in this sequence were altered by site-directed mutagenesis. Conservative substitutions had no effect on the affinity of the enzyme for dolichyl-P. The substitution of asparagine for isoleucine at position 253 resulted in higher values for the apparent K(m) for Dol-P when assayed in detergent solutions, but this substitution had no effect on K(m) when the enzyme was reconstituted with phosphatidylethanolamine. Enzyme containing a deletion of the entire putative dolichol recognition sequence retained catalytic activity. The apparent K(m) for Dol-P was increased when this enzyme was assayed in detergent solution but was the same as wild type enzyme when reconstituted in phosphatidylethanolamine. These results suggest that the amino acid composition and sequence of the conserved domain are not critically important for the recognition and binding of Dol-P when the synthase is present in a lipid matrix.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	SCHUTZBACH, JS (corresponding author), UNIV ALABAMA,DEPT BIOCHEM,309 VOLKER HALL,BIRMINGHAM,AL 35294, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047492, R01GM045188, R01GM038643] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45188, GM47492, GM38643] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRIGHT CF, 1989, P NATL ACAD SCI USA, V86, P7366, DOI 10.1073/pnas.86.19.7366; BABCZINSKI P, 1980, EUR J BIOCHEM, V105, P509, DOI 10.1111/j.1432-1033.1980.tb04526.x; BANERJEE DK, 1987, P NATL ACAD SCI USA, V84, P6389, DOI 10.1073/pnas.84.18.6389; BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V507, P207, DOI 10.1016/0005-2736(78)90417-0; DATTA AK, 1993, J BIOL CHEM, V268, P12663; DUCKCHONG CG, 1979, LIPIDS, V14, P492, DOI 10.1007/BF02533467; HASELBECK A, 1989, EUR J BIOCHEM, V181, P663, DOI 10.1111/j.1432-1033.1989.tb14774.x; HEIFETZ A, 1977, J BIOL CHEM, V252, P3057; JENSEN JW, 1985, EUR J BIOCHEM, V153, P41, DOI 10.1111/j.1432-1033.1985.tb09264.x; JENSEN JW, 1988, BIOCHEMISTRY-US, V27, P6315, DOI 10.1021/bi00417a017; JENSEN JW, 1989, BIOCHEMISTRY-US, V28, P851, DOI 10.1021/bi00428a066; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUTZBACH JS, 1992, BIOCHEM CELL BIOL, V70, P460, DOI 10.1139/o92-070; SCHUTZBACH JS, 1987, CHEM SCRIPTA, V27, P109; SCHUTZBACH JS, 1991, TRENDS BIOMEMBRANES, V1, P29; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; ZHU XY, 1990, J BIOL CHEM, V265, P14250; ZIMMERMAN JW, 1993, J BIOL CHEM, V268, P16746	27	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24190	24196						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226966				2022-12-27	WOS:A1993MF29400071
J	DRINKWATER, CC; BARKER, PA; SUTER, U; SHOOTER, EM				DRINKWATER, CC; BARKER, PA; SUTER, U; SHOOTER, EM			THE CARBOXYL-TERMINUS OF NERVE GROWTH-FACTOR IS REQUIRED FOR BIOLOGICAL-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRK PROTOONCOGENE PRODUCT; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; CHOLINERGIC NEURONS; RECOMBINANT HUMAN; NGF RECEPTOR; SURVIVAL; BINDING; DIFFERENTIATION; SPECIFICITY	A series of mouse nerve growth factor (NGF) deletion mutants have been constructed using in vitro mutagenesis to define domains of the protein essential for its activity. Deletions of the amino or carboxyl termini of mature NGF or of an internal domain, which normally produces a surface-exposed reverse turn, have been analyzed. Mutants with deletions in the amino terminus or in the reverse turn retain significant biological activity, whereas, in contrast, a mutant NGF lacking the seven most carboxyl-terminal amino acids is appropriately synthesized but shows no measurable biological activity. These results suggests that the flexible carboxyl tail of NGF, and perhaps other neurotrophins, plays a crucial role in mediating receptor recognition and/or ligand binding.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University			Suter, Ueli/A-1624-2010		NINDS NIH HHS [NS04270] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARKER PA, 1993, J BIOL CHEM, V268, P15150; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BURTON LE, 1992, J NEUROCHEM, V59, P1937, DOI 10.1111/j.1471-4159.1992.tb11030.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAUPIN S, 1992, SCIENCE, V258, P1161; DRINKWATER CC, 1991, P ROY SOC B-BIOL SCI, V246, P307, DOI 10.1098/rspb.1991.0159; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAHLE P, 1992, J BIOL CHEM, V267, P22707; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOLIATSOS VE, 1990, J NEUROSCI, V10, P3801, DOI 10.1523/JNEUROSCI.10-12-03801.1990; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LUO Y, 1992, J BIOL CHEM, V267, P12275; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOORE JB, 1974, BIOCHEMISTRY-US, V13, P833, DOI 10.1021/bi00701a030; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; ROVELLI G, 1993, IN PRESS P NATL ACAD; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMELZER CH, 1992, J NEUROCHEM, V59, P1675, DOI 10.1111/j.1471-4159.1992.tb10998.x; SCHWARZ MA, 1989, J NEUROCHEM, V52, P1203, DOI 10.1111/j.1471-4159.1989.tb01867.x; SHOOTER EM, 1989, FIDIA RES F NEUROSCI, V3, P21; SUTER U, 1992, J NEUROSCI, V12, P306; SWINDELLS MB, 1992, SCIENCE, V258, P1160, DOI 10.1126/science.1439827; TAKABE Y, 1988, MOL CELL BIOL, V8, P466; VALE RD, 1985, METHOD ENZYMOL, V109, P21; WESKAMP G, 1991, NEURON, V6, P1; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231	46	36	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23202	23207						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226840				2022-12-27	WOS:A1993MF51500041
J	HABIB, A; CREMINON, C; FROBERT, Y; GRASSI, J; PRADELLES, P; MACLOUF, J				HABIB, A; CREMINON, C; FROBERT, Y; GRASSI, J; PRADELLES, P; MACLOUF, J			DEMONSTRATION OF AN INDUCIBLE CYCLOOXYGENASE IN HUMAN ENDOTHELIAL-CELLS USING ANTIBODIES RAISED AGAINST THE CARBOXYL-TERMINAL REGION OF THE CYCLOOXYGENASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; MESSENGER-RNA; G/H SYNTHASE; MONOCLONAL-ANTIBODIES; PHORBOL ESTER; H SYNTHASE; ENZYME; INTERLEUKIN-1; EXPRESSION; PROTEINS	Cyclooxygenase (Cox) exists in two forms in human endothelial cells (HUVEC). We have raised antibodies that recognize the sequence of the carboxyl-terminal portion of the human Cox-2 (C)-NASSSRSGLD-DINPTVLLK. Cyclooxygenase activity of HUVEC challenged with interleukin 1alpha or a phorbol ester increased in parallel with the mass of a protein doublet analyzed by Western blot using antibodies directed against the Cox-2 peptide; a monoclonal antibody directed against Cox-1 showed a small change in protein mass. A S-35-labeled protein doublet with a molecular mass of approximately 70,000 daltons was immunoprecipitated with the anti-Cox-2 antiserum in L-[S-35] methionine-labeled cells stimulated with interleukin 1alpha. This protein was not recovered by pretreating the antiserum with the Cox-2 peptide before immunoprecipitation. A minor variation in S-35-immunoprecipitated protein was obtained with the polyclonal anti-Cox-1 antibody. Both immunoprecipitated Cox-1 and Cox-2 possessed cyclooxygenase activity that was inhibited by flurbiprofen. Endoglycosidase H treatment of immunoprecipitated Cox-2 proteins caused a decline in the apparent molecular size similar to that observed with immunoprecipitated Cox-1 or sheep cyclooxygenase but did not suppress the doublet. These results show by direct protein measurement that HUVEC synthesize the novel Cox-2 under appropriate stimulation, with little changes of Cox-1.	HOP LARIBOISIERE,INSERM,U348,6 RUE GUY PATIN,F-75475 PARIS 10,FRANCE; CTR ETUD SACLAY,DEPT RECH IMAGERIE PHARMACOL & PHYSIOL,SERV PHARMACOL & IMMUNOL,F-91191 GIF SUR YVETTE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite				Habib, Aida/0000-0001-6027-0043				BALLOU LR, 1992, J BIOL CHEM, V267, P2004; DEWITT DL, 1982, METHOD ENZYMOL, V86, P229; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; DIAZ A, 1992, J BIOL CHEM, V267, P10816; FUNK CD, 1991, FASEB J, V5, P2304, DOI 10.1096/fasebj.5.9.1907252; GRASSI J, 1988, ANAL BIOCHEM, V168, P436, DOI 10.1016/0003-2697(88)90341-7; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JONES DA, 1993, J BIOL CHEM, V268, P9049; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1992, J BIOL CHEM, V267, P25934; LEVIN EG, 1991, J BIOL CHEM, V266, P174; LIN AH, 1989, J BIOL CHEM, V264, P17379; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MCLAUGHLIN LL, 1987, BIOCHEM BIOPH RES CO, V144, P469, DOI 10.1016/S0006-291X(87)80533-8; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MOR A, 1989, FEBS LETT, V255, P269, DOI 10.1016/0014-5793(89)81104-4; OBANION MK, 1991, J BIOL CHEM, V266, P23261; OSULLIVAN MG, 1992, J BIOL CHEM, V267, P14547; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; RAZ A, 1988, J BIOL CHEM, V263, P3022; RENZI D, 1987, TRENDS CLUSTER HEADA, V125, P87; ROSSI V, 1985, SCIENCE, V229, P174, DOI 10.1126/science.2409598; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; SIROIS J, 1992, J BIOL CHEM, V267, P6382; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAITUKAITIS J, 1971, J CLIN ENDOCR METAB, V33, P988, DOI 10.1210/jcem-33-6-988; WHATLEY RE, 1987, SEMIN THROMB HEMOST, V13, P445, DOI 10.1055/s-2007-1003521; WU KK, 1988, J BIOL CHEM, V263, P19043; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	33	285	288	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23448	23454						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226870				2022-12-27	WOS:A1993MF51500076
J	IRONS, CE; MURRAY, SF; GLEMBOTSKI, CC				IRONS, CE; MURRAY, SF; GLEMBOTSKI, CC			IDENTIFICATION OF THE RECEPTOR SUBTYPE RESPONSIBLE FOR ENDOTHELIN-MEDIATED PROTEIN-KINASE-C ACTIVATION AND ATRIAL-NATRIURETIC-FACTOR SECRETION FROM ATRIAL MYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CARDIAC MYOCYTES; VASOCONSTRICTOR PEPTIDE; VENTRICULAR MYOCYTES; TISSUE DISTRIBUTION; GENE-EXPRESSION; RAT CARDIOCYTES; MESSENGER-RNA; CLONING; CALCIUM	Endothelin-1 (ET-1) is a potent stimulator of atrial natriuretic factor (ANF) secretion from myocardial cells. In heart tissue there are two ET receptor subtypes (ET(A)-R and ET(B)-R), which can be pharmacologically distinguished by the ET isopeptides ET-1 and ET-3. However, the identification of the ET-R subtype responsible for the rapid enhancement of ANF release, which occurs within minutes of exposing cardiac myocytes to ET, has not been investigated. In the present study ET-1 was about 100-fold more potent than ET-3 at stimulating membrane phosphoinositide hydrolysis, protein kinase C activation, and ANF release from purified primary atrial myocytes. These responses were completely abolished by BQ123, an ET(A)-R antagonist. Radioligand binding analyses showed that competitor peptides displaced I-125-ET-1 binding to atrial myocyte ET-Rs with a rank order of potency of ET-1 >> BQ123 > ET-3, a characteristic ET(A)-R pharmacological profile. While neither ET-1 or ET-3 altered forskolin-stimulated cAMP levels, suggesting the absence of the ET(B)-R, basal cAMP levels were also unaffected by the ETs. Northern analysis using ET-R subtype-specific probes demonstrated that the ETA-R transcript was present in the cultures at levels at least 50-fold greater than the ET(B)-R transcript. These findings demonstrate that the stimulation of the phosphatidylinositol/protein kinase C pathway, which is required for maximal ET-stimulated ANF release from primary atrial myocytes, is associated with the activation of only the ET(A)-R, thus defining a specific function for an endogenous ET-R in myocardial cells.	SAN DIEGO STATE UNIV,DEPT BIOL,SAN DIEGO,CA 92182; SAN DIEGO STATE UNIV,INST MOLEC BIOL,SAN DIEGO,CA 92182	California State University System; San Diego State University; California State University System; San Diego State University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-46345] Funding Source: Medline; NINDS NIH HHS [NS-25037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARAMORI I, 1992, J BIOL CHEM, V267, P12468; CHIANG CS, 1987, CLIN CHEM, V33, P1245; EGUCHI S, 1993, ENDOCRINOLOGY, V132, P524, DOI 10.1210/en.132.2.524; FUKUDA Y, 1989, BIOCHEM BIOPH RES CO, V164, P1431, DOI 10.1016/0006-291X(89)91830-5; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HILALDANDAN R, 1992, J BIOL CHEM, V267, P10620; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; IHARA M, 1992, LIFE SCI, V50, P247, DOI 10.1016/0024-3205(92)90331-I; IRONS CE, 1992, J BIOL CHEM, V267, P5211; ISHIKAWA T, 1988, PFLUG ARCH EUR J PHY, V413, P108, DOI 10.1007/BF00581239; ISHIKAWA T, 1991, CIRC RES, V69, P918, DOI 10.1161/01.RES.69.4.918; ISHIKAWA T, 1988, AM J PHYSIOL, V255, pH970, DOI 10.1152/ajpheart.1988.255.4.H970; JOHNSON CL, 1990, AM J PHYSIOL, V258, pC533, DOI 10.1152/ajpcell.1990.258.3.C533; JONES LG, 1988, CIRC RES, V62, P299, DOI 10.1161/01.RES.62.2.299; JONES LG, 1992, AM J PHYSIOL, V263, pH1447, DOI 10.1152/ajpheart.1992.263.5.H1447; KRAMER BK, 1991, CIRC RES, V68, P269, DOI 10.1161/01.RES.68.1.269; LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P111; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; LITTLE PJ, 1992, BIOCHEM BIOPH RES CO, V183, P694, DOI 10.1016/0006-291X(92)90538-V; MARTIN ER, 1990, J BIOL CHEM, V265, P14044; MATSUBARA H, 1988, AM J PHYSIOL, V255, pH405, DOI 10.1152/ajpheart.1988.255.3.H405; MOLENAAR P, 1993, CIRC RES, V72, P526, DOI 10.1161/01.RES.72.3.526; MORAVEC CS, 1989, BIOCHEM BIOPH RES CO, V159, P14, DOI 10.1016/0006-291X(89)92397-8; ROSEKI C, 1989, J PHYSL, V256, pR858; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; SAKURAI T, 1991, BIOCHEM BIOPH RES CO, V175, P44, DOI 10.1016/S0006-291X(05)81197-0; SCHIEBINGER RJ, 1990, ENDOCRINOLOGY, V127, P119, DOI 10.1210/endo-127-1-119; SEI CA, 1992, MOL ENDOCRINOL, V6, P309, DOI 10.1210/me.6.3.309; SEI CA, 1991, J BIOL CHEM, V266, P15910; SEI CA, 1990, J BIOL CHEM, V265, P7166; SHIELDS PP, 1988, J BIOL CHEM, V263, P12619; SHIELDS PP, 1988, J BIOL CHEM, V263, P8091; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMONSON MS, 1992, J BIOL CHEM, V267, P8643; STOJILKOVIC SS, 1992, ENDOCRINOLOGY, V130, P465, DOI 10.1210/en.130.1.465; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; VIGNE P, 1991, J BIOL CHEM, V266, P5925; VIGNE P, 1989, FEBS LETT, V249, P143, DOI 10.1016/0014-5793(89)80611-8; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	42	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23417	23421						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226866				2022-12-27	WOS:A1993MF51500071
J	SATO, C; KITAJIMA, K; TAZAWA, I; INOUE, Y; INOUE, S; TROY, FA				SATO, C; KITAJIMA, K; TAZAWA, I; INOUE, Y; INOUE, S; TROY, FA			STRUCTURAL DIVERSITY IN THE ALPHA-2-]8-LINKED POLYSIALIC ACID CHAINS IN SALMONID FISH EGG GLYCOPROTEINS - OCCURRENCE OF POLY(NEU5AC), POLY(NEU5GC), POLY(NEU5AC, NEU5GC), POLY(KDN), AND THEIR PARTIALLY ACETYLATED FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; DEAMINATED NEURAMINIC ACID; RAINBOW-TROUT EGGS; N-GLYCOLYLNEURAMINIC ACID; ESCHERICHIA-COLI K1; NUCLEAR MAGNETIC-RESONANCE; GROUP-B-MENINGOCOCCI; SIALIC ACIDS; CARBOHYDRATE UNITS; POLY(SIALIC ACID)	Alpha2-->8-Linked polysialic acid (polySia) chains terminate O-linked oligosaccharide chains on Salmonidae fish egg polysialoglycoproteins (PSGPs). Expression of these surface PSGPs are developmentally regulated and the polySia epitope is functionally implicated in a number of distinct species-specific cell-cell recognition events during fertilization and early embryogenesis. To better understand the functional diversity of these PSGPs, structural studies of the polySia chains isolated from three genera and eight species of Salmonidae fish eggs were carried out by chemical, immunochemical, enzymatic, and H-1 NMR methods. A remarkable degree of structural diversity was found, including differences in the N-acyl groups, i.e. N-acetylneuraminic acid (Neu5Ac) or N-glycolylneuraminic acid (Neu5Gc), and in the presence of either O-acetyl substitution at C4, C7, or C9 or O-lactyl substitution at C9. The presence of heteropolymers containing both Neu5Ac and Neu5Gc residues was also an unexpected finding. Accordingly, the different forms of alpha2-->8-linked homo- and heteropolymers of these polySia structures include: poly(Neu5Ac), poly(Neu5Gc), poly(Neu5,xAc2), poly(Neu5GcxAc), poly(Neu5Ac, Neu5Gc), poly(Neu5Ac, Neu5,xAc2), Poly(Neu5Ac, Neu5GcxAc), poly(Neu5Gc,Neu5,xAc2), and poly(Neu5Gc, Neu5GcxAc), where x represents the site of acetylation at carbon atom 4, 7, or 9. The significance of this new structural information, together with our recent finding of alpha2-->8-linked polydeaminoneuraminic acid, poly(KDN), in the rainbow trout egg vitelline envelope, is that it demonstrates the natural occurrence of multiple forms of alpha2-->8-linked polySia chains in Salmonidae fish glycoproteins that have not been previously described. The results also predict that a remarkable array of polysialylated glycoconjugates is yet to be discovered in animals other than teleost fishes.	UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,HONGO 7,TOKYO 113,JAPAN; SHOWA UNIV,SCH PHARMACEUT SCI,TOKYO 142,JAPAN; UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	University of Tokyo; Showa University; University of California System; University of California Davis			Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Naganawa, Shinji/0000-0002-0214-613X; 				ALLEN PZ, 1982, J CLIN MICROBIOL, V15, P324, DOI 10.1128/JCM.15.2.324-329.1982; Ambler R P, 1972, Methods Enzymol, V25, P143, DOI 10.1016/S0076-6879(72)25012-1; AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; BOUHOURS D, 1983, J BIOL CHEM, V258, P299; CODINGTON JF, 1983, CANCER RES, V43, P4364; Corfield A.P., 1982, Cell Biology Monographs, V10, P5; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FINNE J, 1982, J BIOL CHEM, V257, P1966; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Gray W R, 1972, Methods Enzymol, V25, P121, DOI 10.1016/S0076-6879(72)25010-8; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HAVERKAMP J, 1982, EUR J BIOCHEM, V122, P305, DOI 10.1111/j.1432-1033.1982.tb05881.x; HIGA HH, 1988, J BIOL CHEM, V263, P8872; HIGASHI H, 1985, CANCER RES, V45, P3796; INOUE S, 1986, J BIOL CHEM, V261, P5256; INOUE S, 1978, BIOCHEM BIOPH RES CO, V83, P1018, DOI 10.1016/0006-291X(78)91497-3; INOUE S, 1988, BIOCHEM BIOPH RES CO, V153, P172, DOI 10.1016/S0006-291X(88)81204-X; INOUE S, 1979, CARBOHYD RES, V74, P361, DOI 10.1016/S0008-6215(00)84795-3; INOUE Y, 1993, POLYSIALIC ACID MICR, P335; IWASAKI M, 1984, BIOCHEMISTRY-US, V23, P305, DOI 10.1021/bi00297a020; IWASAKI M, 1987, BIOCHEMISTRY-US, V26, P1452, DOI 10.1021/bi00379a036; IWASAKI M, 1990, J BIOL CHEM, V265, P2596; Iwasaki M., 1985, GLYCOCONJUGATE J, V2, P209, DOI [10.1007/BF01049269, DOI 10.1007/BF01049269]; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JENNINGS HJ, 1985, J IMMUNOL, V134, P2651; JENNINGS HJ, 1983, ADV CARBOHYD CHEM BI, V41, P155, DOI 10.1016/S0065-2318(08)60058-X; KABAT EA, 1986, J EXP MED, V164, P642, DOI 10.1084/jem.164.2.642; KAMERLING JP, 1987, EUR J BIOCHEM, V162, P601, DOI 10.1111/j.1432-1033.1987.tb10681.x; KANAMORI A, 1989, BIOCHEM BIOPH RES CO, V164, P744, DOI 10.1016/0006-291X(89)91522-2; KANAMORI A, 1990, J BIOL CHEM, V265, P21811; KITAJIMA K, 1992, ANAL BIOCHEM, V205, P244, DOI 10.1016/0003-2697(92)90430-F; KITAJIMA K, 1986, J BIOL CHEM, V261, P5262; KITAJIMA K, 1988, BIOCHEMISTRY-US, V27, P7141, DOI 10.1021/bi00418a071; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; KITAJIMA K, 1984, BIOCHEMISTRY-US, V23, P310, DOI 10.1021/bi00297a021; KITAZUME S, 1992, ANAL BIOCHEM, V202, P25, DOI 10.1016/0003-2697(92)90200-Q; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; NADANO D, 1986, J BIOL CHEM, V261, P1550; NOMOTO H, 1982, ARCH BIOCHEM BIOPHYS, V218, P335, DOI 10.1016/0003-9861(82)90352-6; OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347; POZSGAY V, 1987, EUR J BIOCHEM, V162, P445, DOI 10.1111/j.1432-1033.1987.tb10622.x; ROTH J, 1992, SCIENCE, V256, P673, DOI 10.1126/science.1585182; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SARFF LD, 1975, LANCET, V1, P1099; SCHAUER R, 1987, METHOD ENZYMOL, V138, P132, DOI 10.1016/0076-6879(87)38012-7; SHERBLOM AP, 1985, J BIOL CHEM, V260, P1484; SHIMAMURA M, 1985, BIOCHEMISTRY-US, V24, P5470, DOI 10.1021/bi00341a029; SHIMAMURA M, 1983, BIOCHEMISTRY-US, V22, P959, DOI 10.1021/bi00273a039; SHIMAMURA M, 1984, BIOCHEMISTRY-US, V23, P317, DOI 10.1021/bi00297a022; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; UCHIDA Y, 1977, J BIOCHEM-TOKYO, V82, P1425, DOI 10.1093/oxfordjournals.jbchem.a131830; VARKI A, 1983, J BIOL CHEM, V258, P2465; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; YE J, 1994, METHOD ENZYMOL, V230, P460; YU RK, 1970, J LIPID RES, V11, P506; YU S, 1990, ARCH BIOCHEM BIOPHYS, V283, P167; ZUBER C, 1992, J BIOL CHEM, V267, P9965	64	75	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23675	23684						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226894				2022-12-27	WOS:A1993MF51500108
J	GORDON, PB; HOLEN, I; FOSSE, M; ROTNES, JS; SEGLEN, PO				GORDON, PB; HOLEN, I; FOSSE, M; ROTNES, JS; SEGLEN, PO			DEPENDENCE OF HEPATOCYTIC AUTOPHAGY ON INTRACELLULARLY SEQUESTERED CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; TRANS-GOLGI NETWORK; PROTEIN-DEGRADATION; ENDOPLASMIC-RETICULUM; AMINO-ACIDS; INOSITOL TRISPHOSPHATE; PROTEOLYTIC ACTIVITY; CA-2+ CONCENTRATION; CA2+ MOBILIZATION; CYTOSOLIC CA-2+	Autophagic sequestration of endogenous lactate dehydrogenase or electroinjected [H-3]raffinose in isolated rat hepatocytes was strongly suppressed by the Ca2+ chelator EGTA, unless the cells had previously been electroloaded in the presence of high concentrations of Ca2+ (1.2 mM. The extracellular Ca2+ chelator bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA) and the intracellular Ca2+ chelator BAPTA/tetra(acetoxymethyl)-ester (BAPTA/AM) both inhibited autophagy to the same extent as did EGTA. Inhibitors of C2+2+-activated protein kinases (KN-62, H-7, W-7) had little or no effect on autophagy, indicating that the Ca2+ requirement of autophagy was not mediated by such kinases. Agents that elevate cytoslic Ca2+ by releasing Ca2+ from intracellular stores, like thapsigargin, 2,5-di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ) and the ionophores A23187 and ionomycin, inhibited autophagy strongly, implicating depletion of sequestered rather than of cytosolic intracellular Ca2+ as a common mechanism of inhibition. Lysosomal (propylamine-sensitive) protein degradation, known to be largely autophagy-dependent, was inhibited by thapsigargin and tBuBHQ. Thapsigargin had no effect on cellular ATP levels, but all agents tested (thapsigargin, tBuBHQ, ionophores) inhibited protein synthesis. Our results suggest that autophagy, like protein synthesis, is dependent on the presence of Ca2+ in some intracellular storage compartment.	NORWEGIAN RADIUM HOSP MONTEBELLO,INST CANC RES,DEPT TISSUE CULTURE,N-0310 OSLO,NORWAY; UNIV OSLO,INST PHYSIOL,N-0317 OSLO,NORWAY	University of Oslo				Holen, Ingunn/0000-0002-8759-6913				ARSTILA AU, 1968, AM J PATHOL, V53, P687; BEER DG, 1982, BIOCHEM BIOPH RES CO, V109, P1276, DOI 10.1016/0006-291X(82)91915-5; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; BLACKMORE PF, 1982, J BIOL CHEM, V257, P190; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; CARO LHP, 1989, STUDIES REGULATION A, P72; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; DECURTIS I, 1988, P NATL ACAD SCI USA, V85, P8052, DOI 10.1073/pnas.85.21.8052; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GJESSING R, 1980, EXP CELL RES, V129, P239, DOI 10.1016/0014-4827(80)90347-X; GLAUMANN H, 1981, INT REV CYTOL, V73, P149, DOI 10.1016/S0074-7696(08)61288-7; GRINDE B, 1983, BIOCHEM J, V216, P529, DOI 10.1042/bj2160529; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HINCKE MT, 1992, BIOCHEM J, V282, P877, DOI 10.1042/bj2820877; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; KASS GEN, 1990, J BIOL CHEM, V265, P17486; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KASS GEN, 1991, REGULATION HEPATIC F, P344; KIMBALL SR, 1991, BIOCHEM BIOPH RES CO, V177, P1082, DOI 10.1016/0006-291X(91)90649-R; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KOSHIYAMA H, 1991, BIOCHEM BIOPH RES CO, V177, P551, DOI 10.1016/0006-291X(91)92019-G; KOVACS AL, 1981, BIOCHIM BIOPHYS ACTA, V676, P213, DOI 10.1016/0304-4165(81)90189-6; KOVACS AL, 1981, EXP CELL RES, V133, P431, DOI 10.1016/0014-4827(81)90336-0; LANINI L, 1992, J BIOL CHEM, V267, P11548; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MIZUNO K, 1989, BIOCHEM BIOPH RES CO, V164, P780, DOI 10.1016/0006-291X(89)91527-1; MOORE L, 1975, J BIOL CHEM, V250, P4562; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; NICOTERA P, 1986, J BIOL CHEM, V261, P4628; ODA K, 1992, J BIOL CHEM, V267, P17465; PFEIFER U, 1976, VERH DTSCH GES PATH, V60, P28; PRESTON SF, 1992, CELL CALCIUM, V13, P303, DOI 10.1016/0143-4160(92)90065-Z; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O; RODEMANN HP, 1982, J BIOL CHEM, V257, P8716; ROTNES JS, 1992, CELL CALCIUM, V13, P487, DOI 10.1016/0143-4160(92)90017-M; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SEGLEN PO, 1978, BIOCHEM J, V174, P469, DOI 10.1042/bj1740469; SEGLEN PO, 1986, EXP CELL RES, V162, P273, DOI 10.1016/0014-4827(86)90446-5; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Seglen PO, 1987, LYSOSOMES THEIR ROLE, P369; Seglen PO, 1992, ENDOCYTOSIS, P247; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TAKEMURA H, 1991, BIOCHEM BIOPH RES CO, V180, P1518, DOI 10.1016/S0006-291X(05)81368-3; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TOKES ZA, 1989, J BIOL CHEM, V264, P15059; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; ZAMMIT VA, 1991, BIOCHEM J, V273, P485, DOI 10.1042/bj2730485; ZAMMIT VA, 1991, BIOCHEM J, V279, P377, DOI 10.1042/bj2790377; ZEMAN RJ, 1985, J BIOL CHEM, V260, P3619	66	150	155	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26107	26112						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253727				2022-12-27	WOS:A1993MK42500018
J	BOSSI, M; HOYLAERTS, MF; MILLAN, JL				BOSSI, M; HOYLAERTS, MF; MILLAN, JL			MODIFICATIONS IN A FLEXIBLE SURFACE LOOP MODULATE THE ISOZYME-SPECIFIC PROPERTIES OF MAMMALIAN ALKALINE-PHOSPHATASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX VESICLE PROTEINS; UNCOMPETITIVE INHIBITION; L-LEUCINE; COLLAGEN; SITE; PHOSPHATIDYLINOSITOL; ISOENZYMES; MECHANISM; CARTILAGE; SEQUENCE	We have analyzed to what extent the surface loop domain of alkaline phosphatases (APs) is responsible for isozyme-specific functional properties. Unique AatII and RsrII restriction sites were introduced by site-directed mutagenesis at identical positions in murine tissue-nonspecific AP (TNAP) and human placental AP (PLAP) cDNAs to allow the homologous exchange of the loop domain of the TNAP (T domain) and PLAP (P domain) isozymes and the generation of the reciprocally chimeric molecules PLAP-T and TNAP-P. The introduction of the T loop into PLAP reduced the heat stability of PLAP-T to almost that of TNAP. The domain substitution was accompanied by a conformational change that resulted in the loss of immune reactivity with four of 17 epitope-mapped anti-PLAP monoclonal antibodies. The T and P loops provided stabilization to the side chain of specific uncompetitive AP inhibitors. The introduction of the T domain also conferred collagen-binding properties to PLAP-T accounting for half of the binding affinity of TNAP for collagen, while not affecting PLAP binding to IgG. Our data indicate that the surface loop determines overall enzyme stability, differs conformationally in the various isozymes, and modulates catalytic parameters in the presence of protein ligands, thus, accounting in part for isozyme-specific protein interactions.	LA JOLLA CANC RES FDN,CANC RES CTR,10901 N TORREY PINES RD,LA JOLLA,CA 92037; CATHOLIC UNIV LEUVEN,CTR MOLEC & VASC BIOL,B-3000 LOUVAIN,BELGIUM	Sanford Burnham Prebys Medical Discovery Institute; KU Leuven			Millan, Jose Luis/B-6580-2008	Hoylaerts, Marc/0000-0002-6474-3933	NCI NIH HHS [CA 42595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BODANSZKY M, 1984, PRACTICE PEPTIDE SYN, P231; BRADSHAW RA, 1981, P NATL ACAD SCI-BIOL, V78, P3473, DOI 10.1073/pnas.78.6.3473; CHAIDAROGLOU A, 1989, PROTEIN ENG, V3, P127, DOI 10.1093/protein/3.2.127; CUATRECASAS P, 1970, NATURE, V228, P1327, DOI 10.1038/2281327a0; DOELLGAST GJ, 1976, NATURE, V259, P49, DOI 10.1038/259049a0; DOELLGAST GJ, 1977, CLIN CHIM ACTA, V75, P449, DOI 10.1016/0009-8981(77)90365-5; FISHMAN WH, 1971, ENZYMOLOGIA, V41, P141; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAHNEL AC, 1989, CLIN CHIM ACTA, V186, P171; HARRIS H, 1989, CLIN CHIM ACTA, V186, P133; HORIUCHI T, 1959, NATURE, V183, P1529, DOI 10.1038/1831529b0; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; HOYLAERTS MF, 1992, CLIN CHEM, V38, P2493; HOYLAERTS MF, 1991, EUR J BIOCHEM, V202, P605, DOI 10.1111/j.1432-1033.1991.tb16414.x; HUMMER C, 1991, BIOCHEM J, V274, P91, DOI 10.1042/bj2740091; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MAKIYA R, 1992, EUR J BIOCHEM, V205, P341, DOI 10.1111/j.1432-1033.1992.tb16785.x; MAKIYA R, 1992, CLIN CHEM, V38, P2543; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MILLAN JL, 1990, PROG CLIN BIOL RES, V344, P453; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MILLAN JL, 1988, ANTICANCER RES, V8, P995; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MULIVOR RA, 1978, ANN HUM GENET, V42, P1, DOI 10.1111/j.1469-1809.1978.tb00927.x; TAKAMI N, 1988, J BIOL CHEM, V263, P3016; TSONIS PA, 1988, BIOCHEM J, V254, P623, DOI 10.1042/bj2540623; VITTUR F, 1984, EXPERIENTIA, V40, P836, DOI 10.1007/BF01951980; WATANABE T, 1991, J BIOL CHEM, V266, P21178; WHITBY LG, 1975, CLIN CHIM ACTA, V59, P361, DOI 10.1016/0009-8981(75)90012-1; WU LNY, 1991, J BIOL CHEM, V266, P1195; WU LNY, 1992, BONE MINER, V17, P247, DOI 10.1016/0169-6009(92)90745-Y	34	77	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25409	25416						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244974				2022-12-27	WOS:A1993MK10000023
J	NEWMAN, J; GUTTERIDGE, S				NEWMAN, J; GUTTERIDGE, S			THE X-RAY STRUCTURE OF SYNECHOCOCCUS RIBULOSE-BISPHOSPHATE CARBOXYLASE OXYGENASE-ACTIVATED QUATERNARY COMPLEX AT 2.2-ANGSTROM RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; LARGE SUBUNIT; 1,5-BISPHOSPHATE CARBOXYLASE; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; RUBISCO; SITE	The structure of the hexadecameric ribulose-bisphosphate carboxylase/oxygenase from Synechococcus PCC6301 has been solved to 2.2-angstrom resolution. Crystallization was in the presence of CO2, Mg+, and 2'-carboxyarabinitol bisphosphate to form a stable enzyme quaternary complex that mimics one of the intermediate states of the carboxylation reaction. The structure was solved by molecular replacement using the coordinates of spinach carboxylase. The deviations in Calpha positions of the L- and S-subunits are only 0.3 and 2.0 angstrom, respectively, and localized at specific regions of the two polypeptides. One region that shows significant divergence of the peptide backbone is loop 6 of the beta barrel in the L-subunit. Two other elements, the C terminus, and a highly conserved loop of the N-terminal domain of a second L-subunit, interact with loop 6 in the quaternary complex. These three regions, plus two other flexible segments, completely enfold the bisphosphate inhibitor. Significant alteration in their spatial relationship must occur to allow substrates or products access to and from the active site. The active site residues, activating cofactors, and inhibitor are well resolved in the electron density map. The disposition of these groups around the essential metal provides some indication of their role at different stages of the catalytic cycle.	DUPONT CO INC, EXPTL STN, DEPT CENT RES & DEV, WILMINGTON, DE 19880 USA; BIOMED CTR, DEPT MOLEC BIOL, S-75124 UPPSALA, SWEDEN	DuPont			Newman, Janet M/D-1857-2011	Newman, Janet M/0000-0003-2666-3219				ALLEAUME M, 1985, CAN J CHEM, V63, P3482, DOI 10.1139/v85-571; ANDERSSON I, 1989, NATURE, V337, P229, DOI 10.1038/337229a0; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1984, PLANT PHYSIOL, V75, P508, DOI 10.1104/pp.75.2.508; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BRANDEN CI, 1991, ACTA CRYSTALLOGR B, V47, P824, DOI 10.1107/S0108768191007127; BRANDEN CI, 1986, PHILOS T ROY SOC B, V313, P359, DOI 10.1098/rstb.1986.0043; CHAPMAN MS, 1988, SCIENCE, V241, P71, DOI 10.1126/science.3133767; CHEN Z, 1989, J BIOL CHEM, V264, P3053; Crowther R. A., 1972, MOL REPLACEMENT METH, P173; CURMI PMG, 1992, J BIOL CHEM, V267, P16980; DECLERCQ JP, 1991, J MOL BIOL, V220, P1017, DOI 10.1016/0022-2836(91)90369-H; ESTELLE M, 1985, J BIOL CHEM, V260, P9523; GERLT JA, 1991, J AM CHEM SOC, V113, P9667, DOI 10.1021/ja00025a039; GUTTERIDGE S, 1990, BIOCHIM BIOPHYS ACTA, V1015, P1, DOI 10.1016/0005-2728(90)90210-U; GUTTERIDGE S, 1986, FEBS LETT, V196, P263, DOI 10.1016/0014-5793(86)80260-5; GUTTERIDGE S, 1993, J BIOL CHEM, V268, P7818; GUTTERIDGE S, 1988, PLANT PHYSIOL BIOCH, V26, P675; GUTTERIDGE S, 1984, EMBO J, V3, P2737, DOI 10.1002/j.1460-2075.1984.tb02204.x; GUTTERIDGE S, 1991, J BIOL CHEM, V266, P7359; GUTTERIDGE S, 1984, FEBS LETT, V170, P355, DOI 10.1016/0014-5793(84)81343-5; GUTTERIDGE S, 1989, BIOCHEM J, V260, P711, DOI 10.1042/bj2600711; GUTTERIDGE S, 1993, IN PRESS MOL PROCESS; HARTMAN FC, 1989, J BIOL CHEM, V264, P11784; HARTMAN FC, 1992, PLANT PROTEIN ENG, P61; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; KETTLEBOROUGH CA, 1987, EUR J BIOCHEM, V170, P335, DOI 10.1111/j.1432-1033.1987.tb13704.x; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KOMIVES EA, 1991, BIOCHEMISTRY-US, V30, P3011, DOI 10.1021/bi00226a005; LORIMER GH, 1988, J BIOL CHEM, V263, P6468; LORIMER GH, 1989, J BIOL CHEM, V264, P9873; LORIMER GH, 1988, NATO P PLANT MOL BIO, P21; LUNDQVIST T, 1991, J BIOL CHEM, V266, P12604; LUNDQVIST T, 1988, J BIOL CHEM, V263, P3643; NEWMAN J, 1990, J BIOL CHEM, V265, P15154; NEWMAN J, 1993, IN PRESS ACTA CRYS D, V49; PARRY MAJ, 1989, J EXP BOT, V40, P317, DOI 10.1093/jxb/40.3.317; PARRY MAJ, 1992, PLANTA, V187, P109, DOI 10.1007/BF00201631; PIERCE J, 1986, BIOCHEMISTRY-US, V25, P1636, DOI 10.1021/bi00355a029; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RANTY B, 1991, EUR J BIOCHEM, V200, P353, DOI 10.1111/j.1432-1033.1991.tb16192.x; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; SAILLAND A, 1986, PLANT MOL BIOL, V7, P213, DOI 10.1007/BF00021333; SCHLOSS JV, 1990, NATO ADV SCI I C-MAT, V314, P321; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; SCHNEIDER G, 1986, EMBO J, V5, P3409, DOI 10.1002/j.1460-2075.1986.tb04662.x; SHINOZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P4050, DOI 10.1073/pnas.80.13.4050; SOLTIS DE, 1990, P NATL ACAD SCI USA, V87, P4640, DOI 10.1073/pnas.87.12.4640; TABITA FR, 1985, P NATL ACAD SCI USA, V82, P6100, DOI 10.1073/pnas.82.18.6100	51	121	123	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25876	25886						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245022				2022-12-27	WOS:A1993MK10000085
J	NG, NFL; SHOOTER, EM				NG, NFL; SHOOTER, EM			ACTIVATION OF P21(RAS) BY NERVE GROWTH-FACTOR IN EMBRYONIC SENSORY NEURONS AND PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRK PROTOONCOGENE PRODUCT; TYROSINE KINASE-ACTIVITY; NEUROTROPHIC FACTOR; FACTOR RECEPTORS; LOW-AFFINITY; PHEOCHROMOCYTOMA CELLS; SIGNAL-TRANSDUCTION; P21RAS ACTIVATION; BINDING-SITES; GENE-TRANSFER	p21ras is believed to be involved in the neuronal differentiation of cells responsive to nerve growth factor (NGF). We show that NGF stimulates the activation of p21ras in embryonic sensory neurons and in PC12 cells. In the initial 5 min of exposure to NGF, the activation is concentration-dependent. In the sensory neurons and PC12 cells, the apparent maximal activation was reached at 50 and 10 ng/ml, respectively, with half-maximal activation at approximately 5 and 2-3 ng/ml, respectively. Kinetic analysis at low concentrations of NGF showed that p21ras activation slowly increases with time in both types of cells, while high concentrations result in rapid activation within 5 min. These results indicate that NGF regulates the activation state of p21ras in these cells and provides evidence suggesting that activation of p21ras is involved in NGF signal transduction. Treatment of PC12 cells with brain-derived neurotrophic factor or neurotrophin-3 (NT-3) failed to activate p21ras, suggesting that binding alone to p75LNFR is insufficient for ras activation. Treatment with the kinase inhibitor, K252a, which inhibits the NGF tyrosine kinase receptor p140trk, abolished ras activation, suggesting that p140trk is the major mediator of p21ras activation by NGF.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University					NINDS NIH HHS [NINDS (NS04270)] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BERG MM, 1992, J BIOL CHEM, V267, P13; BERND P, 1984, J BIOL CHEM, V259, P5509; BORASIO GD, 1989, NEURON, V2, P1087; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; COHEN AI, 1964, P SOC EXP BIOL MED, V116, P784; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1977, DEV BIOL, V58, P106, DOI 10.1016/0012-1606(77)90077-X; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEVIMONTALCINI R, 1963, DEV BIOL, V7, P653, DOI 10.1016/0012-1606(63)90149-0; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MUROYA K, 1992, ONCOGENE, V7, P277; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROVELLI G, 1993, IN PRESS P NATL ACAD; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUGIMOTO Y, 1988, J BIOL CHEM, V263, P12102; SUTTER A, 1979, J BIOL CHEM, V254, P5972; SUTTER A, 1979, TRANSMEMBRANE SIGNAL, P659; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TAPLEY P, 1992, ONCOGENE, V7, P371; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; TORTI M, 1992, J BIOL CHEM, V267, P8293; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	57	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25329	25333						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244964				2022-12-27	WOS:A1993MK10000011
J	SCHODIN, BA; KRANZ, DM				SCHODIN, BA; KRANZ, DM			BINDING-AFFINITY AND INHIBITORY PROPERTIES OF A SINGLE-CHAIN ANTI-T-CELL RECEPTOR ANTIBODY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; LYMPHOCYTES-T; IMMUNE INTERVENTION; TRANSGENIC MICE; FV; RESPONSES; SUPERANTIGENS; RECOGNITION; EXPRESSION	The antigen-specific function of T cells is mediated through a surface receptor (alphabeta). Antibodies to the receptor can either inhibit or activate the T cell depending on the multimeric form of the antibody and the isotype of the antibody constant regions. To further examine and eventually control these antagonistic properties, an anti-receptor antibody (1B2) was engineered by linking the variable region genes of the heavy and light chains to form a single-chain binding domain (scFv). The native 1B2 antibody recognizes determinants on the variable regions of both the alpha and beta subunits of the T cell receptor. The scFv gene was expressed in Escherichia coli, and after folding by dilution of solubilized inclusion bodies, scFv protein was purified as both a 29,000-Da monomer and a noncovalently associated 54,000-Da dimer. The binding affinity of the monomer (K(D) = 17 nM) was 20-fold lower than that of 1B2 Fab fragments (K(D) = 0.9 nM). In contrast, the binding affinity of the dimer (K(D) = 1.6 nM) was approximately 2-fold lower than that of 1B2 Fab fragments. Both forms were able to inhibit recognition by the T cell, but the dimer was significantly more effective than the monomer. Inhibition was observed for T cell recognition of either the conventional ligand (a peptide bound to a class I product of the major histocompatibility complex) or the ''superantigen'' ligand (staphylococcal enterotoxin B bound to a class II product of the major histocompatibility complex). The results suggest that scFv dimers are the most active form of at least some scFv preparations and that the dimers may have the most potential for inhibiting detrimental in vivo T cell activity.	UNIV ILLINOIS,DEPT BIOCHEM,600 S MATHEWS AVE,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NIAID NIH HHS [AI24635] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI024635] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; ALLISON JP, 1987, ANNU REV IMMUNOL, V5, P503, DOI 10.1146/annurev.iy.05.040187.002443; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BLAZAR BR, 1993, J IMMUNOL, V150, P265; BRINKMANN U, 1993, J IMMUNOL, V150, P2774; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; DAVIS GT, 1991, BIO-TECHNOL, V9, P165, DOI 10.1038/nbt0291-165; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FIELDS LE, 1992, P NATL ACAD SCI USA, V89, P5730, DOI 10.1073/pnas.89.13.5730; FRIEDMAN PN, 1993, J IMMUNOL, V150, P3054; GOSHORN SC, 1993, CANCER RES, V53, P2123; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HIRSCH R, 1990, TRANSPLANTATION, V49, P1117, DOI 10.1097/00007890-199006000-00018; HIRSCH R, 1989, J IMMUNOL, V142, P737; HOO WFS, 1992, P NATL ACAD SCI USA, V89, P4759, DOI 10.1073/pnas.89.10.4759; HOO WS, 1993, J IMMUNOL, V150, P4331; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIPES MA, 1993, SCIENCE, V259, P1165, DOI 10.1126/science.8267690; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MILENIC DE, 1991, CANCER RES, V51, P6363; MORGANELLI P, 1992, CRIT REV IMMUNOL, V12, P101; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; PATTEN PA, 1993, J IMMUNOL, V150, P2281; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; VACCHIO MS, 1992, J EXP MED, V175, P1405, DOI 10.1084/jem.175.5.1405; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; WALDMANN TA, 1992, ANNU REV IMMUNOL, V10, P675, DOI 10.1146/annurev.immunol.10.1.675; WHITLOW M, 1991, Methods (Orlando), V2, P97, DOI 10.1016/S1046-2023(05)80209-9; WOODLAND DL, 1993, J EXP MED, V177, P433, DOI 10.1084/jem.177.2.433; WOODLE ES, 1991, TRANSPLANTATION, V52, P361, DOI 10.1097/00007890-199108000-00034; WRAITH DC, 1989, CELL, V57, P709, DOI 10.1016/0092-8674(89)90786-1; WRIGHT A, 1992, CRIT REV IMMUNOL, V12, P125; YOKOTA T, 1992, CANCER RES, V52, P3402	39	28	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25722	25727						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245009				2022-12-27	WOS:A1993MK10000065
J	KOBAYASHI, K; MIKI, M; OKAMOTO, K; NISHINO, T				KOBAYASHI, K; MIKI, M; OKAMOTO, K; NISHINO, T			ELECTRON-TRANSFER PROCESS IN MILK XANTHINE DEHYDROGENASE AS STUDIED BY PULSE-RADIOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LASER FLASH-PHOTOLYSIS; IRON-SULFUR CENTERS; O-2-DEPENDENT TYPES; MOLECULAR-OXYGEN; OXIDASE; PURIFICATION; REDUCTION; FLAVIN; REDOX; SITE	The reduction of milk xanthine dehydrogenase by salicylate anion radical (SL-), nicotinamide adenine dinucleotide radical (NAD.), and 1-methylnicotinamide (NMA) radicals was investigated by the use of pulse radiolysis. Reduction of the dehydrogenase with SL- proceeded via two phases. From the kinetic difference spectra obtained, the faster and slower phases of reduction represent that of one of the iron-sulfur centers and of FAD, respectively. The rate constant of the faster phase increased with the concentration of the enzyme, suggesting that the reduction follows a bimolecular reaction of SL- with the iron-sulfur center. In contrast, the rate constant of the slower phase (510 s-1) was independent of the concentration of the enzyme at pH 7.5. In order to elucidate the contribution of the molybdenum site in the reaction, a similar reaction was performed with enzyme modified with oxipurinol. In the modified enzyme, the slower phase was lost, whereas the faster phase was not affected. These results suggest that the slower phase is due to intramolecular electron transfer from the molybdenum center to FAD. On the other hand, NAD. reacted predominantly with FAD of the dehydrogenase to form the neutral semiquinone of FAD with a second order rate constant of 1.4 x 10(7) M-1 s-1 at pH 7.5, whereas a similar reaction in the oxidase, which was converted from xanthine dehydrogenase by proteolytical cleavage, was not observed. This suggests that NAD. transfers an electron via the binding site for NAD+ on the dehydrogenase. In contrast, NMA radical reduced only an iron-sulfur center of the dehydrogenase with a second order rate constant of 6.5 x 10(7) M-1 s-1 at pH 7.5.	OSAKA UNIV, INST SCI & IND RES, IBARAKI, OSAKA 567, JAPAN; YOKOHAMA CITY UNIV, SCH MED, DEPT BIOCHEM, YOKOHAMA 236, JAPAN	Osaka University; Yokohama City University			Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112				ANDERSON RF, 1986, J BIOL CHEM, V261, P5870; ANDERSON RF, 1984, J CHEM SOC FARAD T 1, V80, P2693, DOI 10.1039/f19848002693; BHATTACHARYYA A, 1983, BIOCHEMISTRY-US, V22, P5270, DOI 10.1021/bi00292a005; Coughlan M. P., 1980, Molybdenum and molybdenum-containing enzymes, P119; DELLACOR.E, 1972, BIOCHEM J, V126, P739, DOI 10.1042/bj1260739; HILLE R, 1991, J BIOL CHEM, V266, P5608; HILLE R, 1986, J BIOL CHEM, V261, P1241; HUGHES RK, 1992, BIOCHEMISTRY-US, V31, P3073, DOI 10.1021/bi00127a007; HUNT J, 1992, J BIOL CHEM, V267, P21479; KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976; KOBAYASHI K, 1988, J BIOL CHEM, V263, P7493; LAND EJ, 1968, BIOCHIM BIOPHYS ACTA, V162, P327, DOI 10.1016/0005-2728(68)90119-9; MASSEY V, 1970, J BIOL CHEM, V245, P6595; MASSEY V, 1989, J BIOL CHEM, V264, P10567; MASSEY V, 1970, J BIOL CHEM, V245, P2837; MASSEY V, 1969, J BIOL CHEM, V244, P1682; NAKAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1279, DOI 10.1093/oxfordjournals.jbchem.a134046; NISHINO T, 1989, J BIOL CHEM, V264, P5468; NISHINO T, 1981, FEBS LETT, V131, P369, DOI 10.1016/0014-5793(81)80406-1; NISHINO T, 1989, J BIOL CHEM, V264, P2518; NISHINO T, 1989, J BIOL CHEM, V264, P6075; OLSON JS, 1974, J BIOL CHEM, V249, P4350; PORRAS AG, 1982, J BIOL CHEM, V257, P1617; SAITO T, 1989, J BIOL CHEM, V264, P10015; SAITO T, 1989, J BIOL CHEM, V264, P15930; SCHOPFER LM, 1988, J BIOL CHEM, V263, P13528; STIRPE F, 1969, J BIOL CHEM, V244, P3855; WALKER MC, 1991, BIOCHEMISTRY-US, V30, P5912, DOI 10.1021/bi00238a015; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P354, DOI 10.1016/0003-9861(76)90087-4	29	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24642	24646						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227023				2022-12-27	WOS:A1993MG67300023
J	CHAI, KX; CHEN, LM; CHAO, J; CHAO, L				CHAI, KX; CHEN, LM; CHAO, J; CHAO, L			KALLISTATIN - A NOVEL HUMAN SERINE PROTEINASE-INHIBITOR - MOLECULAR-CLONING, TISSUE DISTRIBUTION, AND EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALLIKREIN-BINDING-PROTEIN; SPONTANEOUSLY HYPERTENSIVE RATS; GENE FAMILY; SEQUENCE-ANALYSIS; URINARY KALLIKREIN; C INHIBITOR; PURIFICATION; ALPHA-1-ANTITRYPSIN; GROWTH; MOUSE	We have recently purified a novel human serine proteinase inhibitor (serpin), designated as kallistatin, which binds to tissue kallikrein and inhibits kallikrein's kininogenase and amidolytic activities. In the present studies, we have cloned a full-length cDNA encoding kallistatin from human liver RNA by the polymerase chain reaction. The cDNA is 1284 base pairs in length and encodes 427 amino acid residues, including a 26-residue signal peptide and a 401-residue mature peptide. The translated amino acid sequence of kallistatin matches with the protein sequence and shares 44-46% sequence identity with human alpha1-antichymotrypsin, protein C inhibitor, corticosteroid-binding globulin, alpha1-antitrypsin, thyroxin-binding globulin, and rat kallikrein-binding protein. Kallistatin is a new member of the serpin superfamily with a unique reactive site P1-P1' of Phe-Ser. Four potential glycosylation sites are found in the translated amino acid sequence of kallistatin. In a Southern blot analysis following reverse transcription and polymerase chain reaction, kallistatin was found to be expressed in human liver, stomach, pancreas, kidney, aorta, testes, prostate, artery, atrium, ventricle, lung, renal proximal tubular cell, and a colonic carcinoma cell line T84. A genomic Southern blot using the full-length kallistatin cDNA probe revealed simple banding patterns suggesting the gene encoding kallistatin is single-copied. The kallistatin cDNA encoding the mature peptide was expressed in Escherichia coli. The recombinant kallistatin forms an SDS-stable complex with I-125-human tissue kallikrein and has a molecular mass of 40 kDa. The cloning of human kallistatin cDNA established the identity of the novel kallikrein inhibitor and its expression in a functional form in E. coli provides means for studying its structure-function relationship through protein engineering.	MED UNIV S CAROLINA, DEPT BIOCHEM & MOLEC BIOL, CHARLESTON, SC 29425 USA	Medical University of South Carolina					NHLBI NIH HHS [HL44083] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AITKEN A, 1989, PEPTIDE PREPARATION, P63; BAIRD AW, 1991, AM J PHYSIOL, V261, pC822, DOI 10.1152/ajpcell.1991.261.5.C822; BERRY TD, 1989, HYPERTENSION, V13, P3, DOI 10.1161/01.HYP.13.1.3; BILLINGSLEY GD, 1993, AM J HUM GENET, V52, P343; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CHAI KX, 1991, J BIOL CHEM, V266, P16029; CHAI KX, 1991, BIOCHIM BIOPHYS ACTA, V1129, P127, DOI 10.1016/0167-4781(91)90227-D; CHAO J, 1990, J BIOL CHEM, V265, P16394; CHAO J, 1988, J HYPERTENS, V6, P551, DOI 10.1097/00004872-198807000-00006; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; CHAO S, 1990, BIOCHEMISTRY-US, V29, P323, DOI 10.1021/bi00454a004; CHEN LM, 1990, BIOCHEM J, V267, P79, DOI 10.1042/bj2670079; COLAU B, 1984, DNA-J MOLEC CELL BIO, V3, P327, DOI 10.1089/dna.1.1984.3.327; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ECKE S, 1992, J BIOL CHEM, V267, P7048; EVANS BA, 1987, J BIOL CHEM, V262, P8027; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; GEIGER R, 1981, H-S Z PHYSIOL CHEM, V362, P317, DOI 10.1515/bchm2.1981.362.1.317; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; INGLIS JD, 1991, EMBO J, V10, P255, DOI 10.1002/j.1460-2075.1991.tb07945.x; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; LILJA H, 1992, CANCER, V70, P230, DOI 10.1002/1097-0142(19920701)70:1+<230::AID-CNCR2820701310>3.0.CO;2-Y; MACDONALD RJ, 1988, BIOCHEM J, V253, P313, DOI 10.1042/bj2530313; Maniatis T., 1982, MOL CLONING; Marshall R D, 1974, Biochem Soc Symp, P17; MURANO G, 1985, J MED, V16, P17; PAGES G, 1990, GENE, V94, P273, DOI 10.1016/0378-1119(90)90398-B; Pisano J.J., 1979, HDB EXP PHARM S, V25, P273; PRAVENEC M, 1991, HYPERTENSION, V17, P242, DOI 10.1161/01.HYP.17.2.242; RIEGMAN PHJ, 1992, GENOMICS, V14, P6, DOI 10.1016/S0888-7543(05)80275-7; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SCHACHTER M, 1979, PHARMACOL REV, V31, P1; SERVEAU C, 1992, FEBS LETT, V309, P405, DOI 10.1016/0014-5793(92)80817-Z; SHIEH BH, 1989, J BIOL CHEM, V264, P13420; STONE KL, 1989, PRACTICAL GUIDE PROT, P37; SUZUKI K, 1987, J BIOL CHEM, V262, P611; WANG J, 1991, BIOCHEM J, V276, P63, DOI 10.1042/bj2760063; WINES DR, 1989, J BIOL CHEM, V264, P7653; WOODLEYMILLER C, 1989, J HYPERTENS, V7, P865, DOI 10.1097/00004872-198911000-00003; YOON JB, 1987, J BIOL CHEM, V262, P4284; YOON JB, 1990, J BIOL CHEM, V265, P19947; ZHOU GX, 1992, J BIOL CHEM, V267, P25873	45	79	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24498	24505						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8227002				2022-12-27	WOS:A1993MF29400115
J	PRASAD, K; BAROUCH, W; GREENE, L; EISENBERG, E				PRASAD, K; BAROUCH, W; GREENE, L; EISENBERG, E			A PROTEIN COFACTOR IS REQUIRED FOR UNCOATING OF CLATHRIN BASKETS BY UNCOATING ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							COATED VESICLES; HEAT-SHOCK; ASSEMBLY PROTEINS; STRESS PROTEINS; PURIFICATION; DISSOCIATION; TRANSLOCATION; POLYPEPTIDES; BINDING; HSP70	Immediately after clathrin-coated pits pinch off from the cell membrane to form clathrin-coated vesicles, clathrin dissociates from the vesicles. In vitro studies suggest that this dissociation is carried out by the uncoating ATPase, a constitutive member of the 70-kDa heat shock family. Aside from the requirement for ATP, nothing is known about the regulation of the uncoating process. We now show that clathrin baskets prepared from highly purified clathrin and AP2, the assembly protein associated with plasma membrane coated vesicles, cannot be uncoated by the bovine brain uncoating ATPase alone. A 100-kDa protein cofactor, which was isolated from coated vesicles, is essential for uncoating by the uncoating ATPase. This cofactor restores normal uncoating when present at a molar ratio of about 1 to 10 to clathrin and uncoating ATPase.			PRASAD, K (corresponding author), NHLBI,CELL BIOL LAB,BETHESDA,MD 20892, USA.							AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; GAO BC, 1991, J BIOL CHEM, V266, P19565; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HEUSER J, 1989, J CELL BIOL, V109, P1457, DOI 10.1083/jcb.109.4.1457; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MANFREDI JJ, 1987, J BIOL CHEM, V262, P12182; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; NANDI PK, 1982, P NATL ACAD SCI USA, V107, P5885; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PRASAD K, 1991, BIOCHEMISTRY-US, V30, P5590, DOI 10.1021/bi00236a036; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; ROBINSON MS, 1992, TRENDS CELL BIOL, V2, P295; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1990, J CELL BIOL, V111, P2307, DOI 10.1083/jcb.111.6.2307; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SMYTHE E, 1991, EUR J BIOCHEM, V202, P689, DOI 10.1111/j.1432-1033.1991.tb16424.x; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903	37	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23758	23761						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226905				2022-12-27	WOS:A1993MF29400007
J	SCHAEFFER, E; GUILLOU, F; PART, D; ZAKIN, MM				SCHAEFFER, E; GUILLOU, F; PART, D; ZAKIN, MM			A DIFFERENT COMBINATION OF TRANSCRIPTION FACTORS MODULATES THE EXPRESSION OF THE HUMAN TRANSFERRIN PROMOTER IN LIVER AND SERTOLI CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR SUPERFAMILY; ENHANCER BINDING-PROTEIN; DNA-BINDING; LEUCINE ZIPPER; GLUCOCORTICOID RECEPTOR; SIGNAL TRANSDUCTION; NUCLEAR-PROTEIN; RETINOIC ACID; C/EBP FAMILY; C-JUN	We have previously identified the functional regions involved in the regulation of human transferrin (Tf) gene expression in the liver and in Sertoli cells of the testis. Here, we show that a different cellular distribution of transcription factors, interacting with the same proximal promoter regions (PRI and PRII), modulates cell type-specific transcription. In the liver, hepatocyte nuclear factor 4 (HNF-4) and the chicken ovalbumin upstream promoter transcription factor (COUP-TF) act at the PRI site, while CCAAT/enhancer-binding proteins (C/EBPs) act at the PRII site. In the testis, distinct combinations of Sertoli proteins SP-A and SP-D and COUP-TF bind to the PRI site, while SP-alpha and SP-beta bind to the PRII site. Cotransfection experiments in Hep3B cells revealed that mostly HNF-4, C/EBP-alpha, C/EBP-delta, and, to a lesser extent, COUP-TF stimulated transcription driven by the -125/+39 region. In Sertoli cells, HNF-4 and COUP-TF appeared to repress, while the C/EBP factors were able to stimulate transcription driven by the -100/+39 region. However, the specific activating combination remains to be defined among the Sertoli proteins. In the non-Tf-expressing HeLa cells, the Tf promoter could be activated by C/EBP-delta. Our data revealed functional antagonism between HF-4 and COUP-TF, binding to PRI, as well as cross-coupling interactions between HNF-4 and C/EBP, binding to adjacent sites. Thus, cell type-specific DNA-protein interactions, together with protein-protein interactions, may explain the transcriptional regulation of the Tf gene in different cell types.	INST PASTEUR,UNITE EXPRESS GENES EUCARYOTES,F-75724 PARIS 15,FRANCE; INRA,PHYSIOL REPROD STN,F-37380 NOUZILLY,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE								AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOISSIER F, 1991, J BIOL CHEM, V266, P9822; BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237; BRUNEL F, 1988, J BIOL CHEM, V263, P10180; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; COSTA R, 1990, MOL CELL BIOL, V9, P1415; COSTA RH, 1988, P NATL ACAD SCI USA, V85, P3840, DOI 10.1073/pnas.85.11.3840; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUILLOU F, 1991, J BIOL CHEM, V266, P9876; HUSSMAN M, 1991, MOL CELL BIOL, V11, P4097; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Maxam A M, 1980, Methods Enzymol, V65, P499; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; OCHOA A, 1989, NUCLEIC ACIDS RES, V17, P119, DOI 10.1093/nar/17.1.119; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; SCHAEFFER E, 1987, GENE, V56, P109, DOI 10.1016/0378-1119(87)90163-6; SCHAEFFER E, 1989, J BIOL CHEM, V264, P7153; SCHULE R, 1991, TRENDS GENET, V7, P377, DOI 10.1016/0168-9525(91)90259-S; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SKINNER MK, 1980, J BIOL CHEM, V255, P9523; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1989, MOLCELL BIOL, V12, P1708; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	40	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23399	23408						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226864				2022-12-27	WOS:A1993MF51500069
J	THORN, P; PETERSEN, OH				THORN, P; PETERSEN, OH			CALCIUM OSCILLATIONS IN PANCREATIC ACINAR-CELLS, EVOKED BY THE CHOLECYSTOKININ ANALOG JMV-180, DEPEND ON FUNCTIONAL INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ OSCILLATIONS; HEPARIN; RAT; TRISPHOSPHATE; RELEASE; ACTIVATION; CHANNELS; MEMBRANE; SIGNALS	It has been reported that the synthetic heptapeptide cholecystokinin (CCK) analogue JMV-180 evokes cytosolic Ca2+ signals in pancreatic acinar cells via mechanisms that do not include either the generation or action of inositol 1,4,5-trisphosphate (InsP3) (Saluja, A. K., Dawra, R. K., Lerch, M. M., and Steer, M. L. (1992) J. Biol. Chem. 267, 11202-11207; Yule, D. I., and Williams, J. A. (1992) J. Biol. Chem. 267,13830-13835). We have now investigated the CCK- and JMV-180-evoked cytosolic Ca2+ oscillations by measurement of the Ca2+-sensitive ion currents in internally perfused mouse pancreatic acinar cells. We find that the InsP3 receptor antagonist heparin (500 mug/ml) blocks Ca2+ oscillations induced by both CCK (5-20 pM) and JMV 180 (10-40 nM), whereas de-N-sulfated heparin (500 mug/ml), which does not affect InsP3 binding to its receptor, fails to inhibit the responses to the two agonists. We conclude that the cytosolic Ca2+ oscillations evoked by both CCK and JMV-180 are dependent on functional InsP3 receptors.			THORN, P (corresponding author), UNIV LIVERPOOL,PHYSIOL LAB,MRC,SECRETORY CONTROL RES GRP,POB 147,LIVERPOOL L69 3BX,ENGLAND.		Petersen, Ole H/E-8708-2010; Thorn, Peter/F-7030-2010	Thorn, Peter/0000-0002-3228-770X; Petersen, Ole/0000-0002-6998-0380				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; DASSO LLT, 1991, BIOCHEM J, V280, P791, DOI 10.1042/bj2800791; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ITO H, 1990, PFLUG ARCH EUR J PHY, V417, P126, DOI 10.1007/BF00370783; MATOZAKI T, 1989, AM J PHYSIOL, V257, pG594, DOI 10.1152/ajpgi.1989.257.4.G594; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; OSIPCHUK YV, 1990, EMBO J, V9, P687; PETERSEN CCH, 1991, EMBO J, V10, P527, DOI 10.1002/j.1460-2075.1991.tb07979.x; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SALUJA AK, 1992, J BIOL CHEM, V267, P11202; SMITH PM, 1992, J PHYSIOL-LONDON, V446, pP72; THORN P, 1992, J GEN PHYSIOL, V100, P11, DOI 10.1085/jgp.100.1.11; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; THORN P, 1992, PFLUG ARCH EUR J PHY, V422, P173, DOI 10.1007/BF00370417; TONES MA, 1989, FEBS LETT, V252, P105, DOI 10.1016/0014-5793(89)80898-1; WAKUI M, 1991, J MEMBRANE BIOL, V124, P179, DOI 10.1007/BF01870462; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; YULE DI, 1992, J BIOL CHEM, V267, P13830	23	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23219	23221						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226843				2022-12-27	WOS:A1993MF51500044
J	BENKIRANE, N; FRIEDE, M; GUICHARD, G; BRIAND, JP; VANREGENMORTEL, MHV; MULLER, S				BENKIRANE, N; FRIEDE, M; GUICHARD, G; BRIAND, JP; VANREGENMORTEL, MHV; MULLER, S			ANTIGENICITY AND IMMUNOGENICITY OF MODIFIED SYNTHETIC PEPTIDES CONTAINING D-AMINO-ACID RESIDUES - ANTIBODIES TO A D-ENANTIOMER DO RECOGNIZE THE PARENT L-HEXAPEPTIDE AND RECIPROCALLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SPECIFICITY; SURFACE	The effect of introducing D-amino acid residues in an hexapeptide was examined both at the antigenic and immunogenic levels. A series of D-analogues of the model peptide of sequence IRGERA corresponding to the COOH-terminal residues 130-135 of histone H3 were produced. Four analogues contained a single change of an L-residue by the corresponding enantiomer, one peptide contained two D-residues and another one contained only D-residues (D-enantiomer). A peptide analogue was also synthesized in which the 2 Arg residues were replaced by Lys residues. The parent peptide and peptide analogues were injected into mice after covalent coupling to small unilamellar liposomes containing monophosphoryl lipid A as adjuvant. The substitution of L-Arg131 to Lys or D-Arg was found to change neither the antigenic nor immunogenic properties of the resulting peptides. In contrast, the substitution of Glu133 , Arg134, and Ala135 by the respective enantiomers drastically altered the antigenicity of the modified peptides. Each of the SiX D-analogues induced an immune response with an unusually high level of IgG3 antibodies. The D-enantiomer produced IgG3 antibodies which reacted with the homologous peptide as well as with the all L-peptide and the parent protein H3 in solution but not with analogues containing one or two D-residues only. IgG3 antibodies produced against the all L-peptide reacted with the free all D-peptide but not with the other analogues containing D-residues in position 133, 134, and 135.	CNRS, UPR 9021, INST BIOL MOLEC & CELLULAIRE, F-67000 STRASBOURG, FRANCE; FAC PHARM ILLKIRCH, CHIM BIOORGAN LAB, CNRS, URA 1386, F-67400 ILLKIRCH GRAFFENSTADEN, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS)			Muller, Sylviane/J-5319-2014; Benkirane-Jessel, Nadia/H-6438-2016; GUICHARD, Gilles/I-3858-2016	GUICHARD, Gilles/0000-0002-2584-7502; Benkirane-Jessel, Nadia/0000-0003-3059-3559				ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; ARNON R, 1992, FASEB J, V6, P3265, DOI 10.1096/fasebj.6.14.1385242; BRIAND JP, 1992, J IMMUNOL METHODS, V156, P255, DOI 10.1016/0022-1759(92)90033-P; BRIAND JP, 1985, J IMMUNOL METHODS, V78, P59, DOI 10.1016/0022-1759(85)90329-1; BROWN F, 1990, SEMINARS VIROLOGY, V1, P67; BUTLER JE, 1992, J IMMUNOL METHODS, V150, P77, DOI 10.1016/0022-1759(92)90066-3; CUNG MT, 1991, BIOPOLYMERS, V31, P769, DOI 10.1002/bip.360310622; FAUCHERE JL, 1992, ADV DRUG RES, V23, P127; FRIEDE M, 1993, MOL IMMUNOL, V30, P539, DOI 10.1016/0161-5890(93)90028-A; FRIEDE M, 1992, PEPTIDE RES, V5, P145; FRISCH B, 1991, EUR J IMMUNOL, V21, P185, DOI 10.1002/eji.1830210128; GEYSEN HM, 1986, MOL IMMUNOL, V23, P709, DOI 10.1016/0161-5890(86)90081-7; GEYSEN HM, 1987, BETTER CARBOHYDRATE, P103; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; GREENSPAN NS, 1992, IMMUNOL TODAY, V13, P164, DOI 10.1016/0167-5699(92)90120-V; GUPTASARMA P, 1992, FEBS LETT, V310, P205, DOI 10.1016/0014-5793(92)81333-H; HUDSON D, 1988, J ORG CHEM, V53, P617, DOI 10.1021/jo00238a026; JUNG G, 1992, ANGEW CHEM INT EDIT, V31, P1457, DOI 10.1002/anie.199214571; KING DS, 1990, INT J PEPT PROT RES, V36, P255; MCKEARN JP, 1982, IMMUNOL REV, V64, P5, DOI 10.1111/j.1600-065X.1982.tb00416.x; Milich D R, 1990, Semin Immunol, V2, P307; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; MULLER S, 1982, EMBO J, V1, P421, DOI 10.1002/j.1460-2075.1982.tb01185.x; MULLER S, 1989, METHOD ENZYMOL, V170, P251; MULLER S, 1988, SYNTHETIC POLYPEPTID, P159; NEIMARK J, 1993, PEPTIDE RES, V6, P219; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; SORENSEN K, 1986, J IMMUNOL METHODS, V95, P291, DOI 10.1016/0022-1759(86)90419-9; THERIEN HM, 1991, CELL IMMUNOL, V136, P402, DOI 10.1016/0008-8749(91)90362-F; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761	30	83	109	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26279	26285						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253750				2022-12-27	WOS:A1993MK42500043
J	MAREN, TH; CONROY, CW				MAREN, TH; CONROY, CW			A NEW CLASS OF CARBONIC-ANHYDRASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONAMIDES; BINDING; SECRETION; KINETICS	Aliphatic sulfonamides, as CH3SO2NH2, are very weak inhibitors of the carbonic anhydrases (K(I) congruent-to 10(-4) M) and are extremely weak acids (K(a) congruent-to 10(-10.5) M). We now find CF3SO2NH2 a very potent inhibitor of carbonic anhydrase II (K(I) = 2 x 10(-5.8) M) and a much stronger acid (K(a) = 10-5.8) M). It freely dissolves in water, a 2% solution yielding pH 3.7, the strongest known sulfonamide acid. CHCl3/aqueous partition with this solution is very low, 0.006. The plot of CH3SO2NH2 and eight hydrophilic halo-alkyl congeners gives a linear relation over 5 orders of magnitude, pK(I) increasing as pK(a) declines. Transcorneal permeability of CFsSO2NH2 in rabbits is very high; from one drop on the cornea it rapidly gains access to the ciliary process, where it fully inhibits carbonic anhydrase and gives the maximum pressure drop (for any drug) of 6 mm Hg at 30-60 min. Action is short due to rapid disappearance of free drug from the eye at the rate of aqueous humor flow. Analyses are made of binding of CF3SO2NH2 to carbonic anhydrase and melanin in ciliary process. CF3SO2NH2 is not attacked by glutathione, is 75% bound to plasma protein, and is not taken into the renal secretory system. Excretion rate follows from glomerular filtration and tubular reabsorption. Intravenous injection thus leads to prolonged plasma levels (half-life, 24 h), a general diffusion into tissues and alkalinization of the urine, as with ''classic'' inhibitors. Drug is bound to carbonic anhydrase in red cells and decays with half-life of 4 days. The rapid and effective binding to carbonic anhydrase of this small hydrophilic molecule shows that complex lipophilic structures are not necessary for powerful inhibition of the enzyme. It does not appear essential for a sulfonamide to occupy a ''hydrophobic pocket'' in the active site cavity to react effectively at the zinc center.			MAREN, TH (corresponding author), UNIV FLORIDA,COLL MED,DEPT PHARMACOL & THERAPEUT,GAINESVILLE,FL 32610, USA.				NATIONAL EYE INSTITUTE [R01EY002227] Funding Source: NIH RePORTER; NEI NIH HHS [EYO2227] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALDWIN JJ, 1989, J MED CHEM, V32, P2510, DOI 10.1021/jm00132a003; BLACKBURN GM, 1985, EUR J BIOCHEM, V153, P553, DOI 10.1111/j.1432-1033.1985.tb09336.x; BRECHUE WF, 1993, J PHARMACOL EXP THER, V264, P670; BRECHUE WF, 1991, BIOCHIM BIOPHYS ACTA, V1066, P201, DOI 10.1016/0005-2736(91)90187-D; Brice T.J., 1956, US Patent, Patent No. [2732398, 2,732,398]; BUCHHOLT HC, 1970, ACTA CHEM SCAND, V24, P2255, DOI 10.3891/acta.chem.scand.24-2255; COLEMAN JE, 1975, ANNU REV PHARMACOL, V15, P221, DOI 10.1146/annurev.pa.15.040175.001253; CONROY CW, 1992, EXP EYE RES, V55, P637, DOI 10.1016/S0014-4835(05)80176-9; CONROY CW, 1984, DRUG METAB DISPOS, V12, P614; HANSCH C, 1985, MOL PHARMACOL, V27, P493; HOWELLS RD, 1977, CHEM REV, V77, P69, DOI 10.1021/cr60305a005; JANKOWSKA LM, 1986, INVEST OPHTH VIS SCI, V27, P29; KAKEYA N, 1969, CHEM PHARM BULL, V17, P2558; KAKEYA N, 1969, CHEM PHARM BULL, V17, P1010; KHALIFAH RG, 1977, BIOCHEMISTRY-US, V16, P2241, DOI 10.1021/bi00629a031; KING RW, 1976, PROC R SOC SER B-BIO, V193, P107, DOI 10.1098/rspb.1976.0034; KREBS HA, 1948, BIOCHEM J, V43, P525, DOI 10.1042/bj0430525; Kvam D. C., 1989, U.S. Patent, Patent No. [4,824,866A, 4824866]; LINDAHL M, 1991, CARBONIC ANHYDRASE B, P110; LOGRASSO PV, 1991, BIOCHEMISTRY-US, V30, P8463, DOI 10.1021/bi00098a025; Mann T., 1940, NATURE, V146, P164, DOI [10.1038/146164a0, DOI 10.1038/146164A0]; MAREN TH, 1992, MOL PHARMACOL, V41, P419; MAREN TH, 1988, ANNU REV PHYSIOL, V50, P695; MAREN TH, 1983, ANNU REV PHARMACOL, V23, P439, DOI 10.1146/annurev.pa.23.040183.002255; MAREN TH, 1990, EXP EYE RES, V50, P27, DOI 10.1016/0014-4835(90)90007-H; MAREN TH, 1968, J MED CHEM, V11, P228, DOI 10.1021/jm00308a008; MAREN TH, 1993, MOL PHARMACOL, V44, P901; MAREN TH, 1977, INVEST OPHTH VIS SCI, V16, P730; MAREN TH, 1983, EXP EYE RES, V36, P457, DOI 10.1016/0014-4835(83)90041-6; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; MARSHALL EK, 1913, J BIOL CHEM, V15, P283; MILLER WH, 1950, J AM CHEM SOC, V72, P4893, DOI 10.1021/ja01167a012; OLANDER J, 1973, J AM CHEM SOC, V95, P1616, DOI 10.1021/ja00786a042; OLANDER J, 1973, J AM CHEM SOC, V95, P4473; PRABHANANDA BS, 1987, BIOPHYS CHEM, V26, P217, DOI 10.1016/0301-4622(87)80024-8; Smith H. W., 1951, KIDNEY; TASHIAN RE, 1991, CARBONIC ANHYDRASE, P151; TREPKA RD, 1974, J ORG CHEM, V39, P1094, DOI 10.1021/jo00922a017; VIDGREN J, 1990, INT J BIOL MACROMOL, V12, P342, DOI 10.1016/0141-8130(90)90040-H; VOGH BP, 1989, J OCUL PHARMACOL, V5, P293, DOI 10.1089/jop.1989.5.293; [No title captured]	41	82	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26233	26239						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253744				2022-12-27	WOS:A1993MK42500036
J	ROESSLER, BJ; NOSAL, JM; SMITH, PR; HEIDLER, SA; PALELLA, TD; SWITZER, RL; BECKER, MA				ROESSLER, BJ; NOSAL, JM; SMITH, PR; HEIDLER, SA; PALELLA, TD; SWITZER, RL; BECKER, MA			HUMAN X-LINKED PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY IS ASSOCIATED WITH DISTINCT POINT MUTATIONS IN THE PRPS1 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROPHOSPHATE SYNTHETASE; SALMONELLA-TYPHIMURIUM; SUBUNIT-II; NUCLEOTIDE; IDENTIFICATION; LOCALIZATION; EXPRESSION; OVERPRODUCTION; PURIFICATION; FIBROBLASTS	Superactivity of phosphoribosylpyrophosphate synthetase (PRS) is an X chromosome-linked disorder of purine metabolism, characterized by gout with uric acid overproduction and, in some families, neurodevelopmental impairment. Two highly homologous isoforms of PRS (PRS1 and PRS2), each encoded by a distinct X chromosome-linked locus, have been identified, and PRS1 and 2 cDNAs have been cloned. The entire 954-base pair translated regions of PRS1 and 2 cDNAs derived from cultured lymphoblasts and fibroblasts from two patients in whom purine nucleotide feedback resistance of PRS is associated with enzyme superactivity and neurodevelopmental defects were examined by direct sequencing after polymerase chain reaction amplification of PRS transcripts. Nucleotide sequences of PRS2 cDNAs from the patients and normal individuals were identical. In contrast, PRS1 cDNAs from the patients differ from normal PRS1 cDNA, each by a single base substitution. PRS1 cDNA from patient N. B. showed an A to G transition at nucleotide 341, corresponding to an asparagine to serine change at amino acid residue 113 of mature PRS1. A G to C transversion at nucleotide 547, indicating an aspartic acid to histidine change at amino acid 182, was found for PRS1 cDNA from patient S. M. Point mutations at the sites identified in the PRS1 cDNAs of the two patients were confirmed by the results of RNase mapping analysis. Normal, N. B., and S. M. PRS1 cDNAs were introduced into Escherichia coli BL21(DE3)/pLysS, and recombinant N. B. and S. M. PRS1s showed the purine nucleotide feedback resistance phenotypes characteristic of PRS from patients' cells.	UNIV CHICAGO,MED CTR,DEPT MED,MC0930,5841 S MARYLAND AVE,CHICAGO,IL 60637; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801	University of Chicago; University of Chicago Medical Center; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013488, R01DK028554, R29DK038932, R01DK038932] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 13488, DK 28554, DK 38932] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; Becker M A, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P281; BECKER MA, 1980, J CLIN INVEST, V65, P109, DOI 10.1172/JCI109640; BECKER MA, 1987, J BIOL CHEM, V262, P5596; BECKER MA, 1986, BIOCHIM BIOPHYS ACTA, V882, P168, DOI 10.1016/0304-4165(86)90151-0; BECKER MA, 1991, ADV EXP MED BIOL, V309, P129; BECKER MA, 1975, J BIOL CHEM, V250, P6822; BECKER MA, 1986, ARTHRITIS RHEUM, V29, P880, DOI 10.1002/art.1780290710; BECKER MA, 1988, AM J MED, V85, P383, DOI 10.1016/0002-9343(88)90591-8; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; BOWER SG, 1988, J BACTERIOL, V170, P3243, DOI 10.1128/jb.170.7.3243-3248.1988; BOWER SG, 1989, J BIOL CHEM, V264, P10287; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; FOX IH, 1971, J BIOL CHEM, V246, P5739; GIBBS RA, 1987, SCIENCE, V236, P303, DOI 10.1126/science.3563511; HARLOW KW, 1990, J BIOL CHEM, V265, P5487; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1989, MOL MICROBIOL, V3, P1437; IIZASA T, 1989, FEBS LETT, V244, P47, DOI 10.1016/0014-5793(89)81159-7; KORNBERG A, 1955, J BIOL CHEM, V215, P389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOSMAN MJ, 1985, J CLIN INVEST, V76, P1657, DOI 10.1172/JCI112151; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; ROESNBLOOM FM, 1909, J BIOL CHEM, V18, P193; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SIMMONDS HA, 1982, LANCET, V2, P68; SONODA T, 1991, J BIOCHEM-TOKYO, V109, P361; STUDIER RW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAIRA M, 1989, BIOCHIM BIOPHYS ACTA, V1007, P203, DOI 10.1016/0167-4781(89)90040-7; TAIRA M, 1987, J BIOL CHEM, V262, P14867; TAIRA M, 1989, SOMAT CELL MOLEC GEN, V15, P29, DOI 10.1007/BF01534667; YEN RCK, 1978, P NATL ACAD SCI USA, V75, P482, DOI 10.1073/pnas.75.1.482; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	39	44	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26476	26481						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253776				2022-12-27	WOS:A1993MK42500070
J	VALCARCE, C; SELANDERSUNNERHAGEN, M; TAMLITZ, AM; DRAKENBERG, T; BJORK, I; STENFLO, J				VALCARCE, C; SELANDERSUNNERHAGEN, M; TAMLITZ, AM; DRAKENBERG, T; BJORK, I; STENFLO, J			CALCIUM AFFINITY OF THE NH2-TERMINAL EPIDERMAL GROWTH FACTOR-LIKE MODULE OF FACTOR-X - EFFECT OF THE GAMMA-CARBOXYGLUTAMIC ACID-CONTAINING MODULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; HUMAN FACTOR-IX; FACTOR-LIKE DOMAIN; COAGULATION FACTOR-X; DEPENDENT PROTEIN-S; EGF-LIKE DOMAINS; FACTOR PRECURSOR; LIGHT CHAIN; BINDING; RESIDUES	The NH2-terminal epidermal growth factor (EGF)-like module of vitamin K-dependent coagulation factors IX and X and protein C each has one calcium binding site. This module (residues 45-86) from factor X has been isolated previously and found to bind calcium with a K(d) of 2.2 mM at physiological pH and ionic strength. We have now demonstrated that it binds calcium with a K(d) of 120 muM in a fragment that consists of the Gla module and the NH2-terminal EGF-like module. The presence of the Gla module (residues 1-44) increases the calcium affinity of the site in the EGF-like module approximately 20-fold, thus making it essentially saturated in vivo. Decarboxylation of the Gla residues to Glu has no significant effect on the calcium affinity of the EGF-like module. A proteolytic fragment of factor X (residues 29-86) and a synthetic peptide (residues 34-86), folded to a native conformation, were used to demonstrate that the contribution of the Gla module to the calcium affinity of the site in the EGF-like module is mediated by its 17 COOH-terminal residues, 12 of which form an alpha-helix in the intact Gla module. In the NMR structure of the NH2-terminal EGF-like module in factor X, five calcium ligating groups have been identified (Selander-Sunnerhagen, M., Ullner, M., Persson, E., Teleman, O., Stenflo, J., and Drakenberg, T. (1992) J. Biol. Chem. 267, 19642-19649). As calcium usually requires seven to eight oxygen ligands, there is reason to believe that the Gla module contributes ligands, or negative charge, to increase the calcium affinity. Our findings suggest that the calcium affinity of EGF-like modules in other proteins may also be influenced by neighboring modules.	LUND UNIV,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN; LUND UNIV,DEPT PHYS CHEM 2,S-22100 LUND,SWEDEN; SWEDISH UNIV AGR SCI,UPPSALA BIOMED CTR,DEPT VET MED,S-75123 UPPSALA,SWEDEN	Lund University; Lund University; Swedish University of Agricultural Sciences								APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; BARON M, 1992, PROTEIN SCI, V1, P81; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DRAKENBERG T, 1983, P NATL ACAD SCI-BIOL, V80, P1802, DOI 10.1073/pnas.80.7.1802; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; GARCIA MWS, 1992, BIOCHEMISTRY-US, V31, P2554; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; GRONKE RS, 1990, J BIOL CHEM, V265, P8558; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HANDFORD PA, 1991, NATUREJ, V351, P84; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; Morissey J. H., 1981, ANAL BIOCHEM, V117, P307; OHLIN AK, 1988, J BIOL CHEM, V263, P19240; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PERSSON E, 1991, J BIOL CHEM, V266, P2444; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; STENFLO J, 1987, P NATL ACAD SCI USA, V84, P368, DOI 10.1073/pnas.84.2.368; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; [No title captured]	28	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26673	26678						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253800				2022-12-27	WOS:A1993MK42500096
J	BERGE, A; SJOBRING, U				BERGE, A; SJOBRING, U			PAM, A NOVEL PLASMINOGEN-BINDING PROTEIN FROM STREPTOCOCCUS-PYOGENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; GRAM-POSITIVE COCCI; ESCHERICHIA-COLI; RECEPTOR; SURFACE; GENE; IDENTIFICATION; FIBRINOGEN; ACTIVATOR; SEQUENCE	The ability of group A streptococci to bind human plasminogen and plasmin has attracted interest, because it could provide the bacteria with a mechanism for invasion. M or M-like proteins account for the binding of several plasma proteins to group A streptococci. To investigate whether M or M-like proteins were responsible for the binding of plasminogen to group A streptococci, acid-extracted material from a type M53 streptococcal isolate was tested for its ability to bind plasminogen. Indeed, a 42-kDa plasminogen-binding protein was solubilized. Two oligonucleotides homologous with conserved sequences in known M protein genes were used as primers in the polymerase chain reaction, with chromosomal DNA from the M53 isolate. When cloned and expressed in Escherichia coli, a resulting fragment encoded a 43-kDa plasminogen-binding protein. Nucleotide sequence determination of the gene fragment revealed an open reading frame encoding a polypeptide of 43,580 Da, which matched the amino-terminal amino acid sequence of the plasminogen-binding protein extracted from M53 streptococci. The DNA sequence data also proved the relationship of the encoded protein, named PAM, to the M proteins. The plasminogen-binding domain was mapped to the amino-terminal third of PAM. Plasminogen absorbed by M53 streptococci or by immobilized PAM could be activated by streptokinase. The results provide further evidence of the diversity of the M protein family and suggest a new mechanism whereby these proteins contribute to the virulence of group A streptococci.	LUND UNIV,DEPT MED MICROBIOL,SOLVEGATAN 23,S-22362 LUND,SWEDEN; LUND UNIV,DEPT MED & PHYSIOL CHEM,S-22362 LUND,SWEDEN	Lund University; Lund University								AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; ATICHARTAKARN V, 1978, BLOOD, V51, P281; BESSEN DE, 1992, INFECT IMMUN, V60, P124, DOI 10.1128/IAI.60.1.124-135.1992; BJORCK L, 1984, SCAND J IMMUNOL, V20, P69, DOI 10.1111/j.1365-3083.1984.tb00979.x; BRODER CC, 1991, J BIOL CHEM, V266, P4922; CHRISTENSEN U, 1985, FEBS LETT, V182, P43, DOI 10.1016/0014-5793(85)81150-9; DALBOGE H, 1989, GENE, V79, P325, DOI 10.1016/0378-1119(89)90214-X; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FRICK IM, 1992, P NATL ACAD SCI USA, V89, P8532, DOI 10.1073/pnas.89.18.8532; HAANES EJ, 1989, J BACTERIOL, V171, P6397, DOI 10.1128/jb.171.12.6397-6408.1989; HAANESFRITZ E, 1988, NUCLEIC ACIDS RES, V16, P4667, DOI 10.1093/nar/16.10.4667; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; HOLLINGSHEAD SK, 1986, J BIOL CHEM, V261, P1677; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; JONES KF, 1988, P NATL ACAD SCI USA, V85, P8271, DOI 10.1073/pnas.85.21.8271; JONES PA, 1980, CANCER RES, V40, P3222; KANTOR FS, 1965, J EXP MED, V121, P849, DOI 10.1084/jem.121.5.849; KORHONEN TK, 1992, FEMS MICROBIOL LETT, V100, P307, DOI 10.1111/j.1574-6968.1992.tb05720.x; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; Lancefield RC, 1928, J EXP MED, V47, P91, DOI 10.1084/jem.47.1.91; LINDAHL G, 1989, MOL MICROBIOL, V3, P239, DOI 10.1111/j.1365-2958.1989.tb01813.x; LIOTTA LA, 1981, CANCER RES, V41, P4629; LOTTENBERG R, 1987, INFECT IMMUN, V55, P1914, DOI 10.1128/IAI.55.8.1914-1918.1987; LOTTENBERG R, 1992, J INFECT DIS, V166, P436, DOI 10.1093/infdis/166.2.436; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; OTOOLE P, 1992, P NATL ACAD SCI USA, V89, P8661, DOI 10.1073/pnas.89.18.8661; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; PANNELL R, 1988, J CLIN INVEST, V81, P853, DOI 10.1172/JCI113394; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; SJOBRING U, 1992, INFECT IMMUN, V60, P3601; SJOBRING U, 1991, J BIOL CHEM, V266, P399; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLBERG M, 1989, APMIS, V97, P996, DOI 10.1111/j.1699-0463.1989.tb00508.x; WHITNACK E, 1985, J BACTERIOL, V164, P350, DOI 10.1128/JB.164.1.350-358.1985	44	188	194	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25417	25424						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244975				2022-12-27	WOS:A1993MK10000024
J	FLINT, DH; SMYKRANDALL, E; TUMINELLO, JF; DRACZYNSKALUSIAK, B; BROWN, OR				FLINT, DH; SMYKRANDALL, E; TUMINELLO, JF; DRACZYNSKALUSIAK, B; BROWN, OR			THE INACTIVATION OF DIHYDROXY-ACID DEHYDRATASE IN ESCHERICHIA-COLI TREATED WITH HYPERBARIC-OXYGEN OCCURS BECAUSE OF THE DESTRUCTION OF ITS FE-S CLUSTER, BUT THE ENZYME REMAINS IN THE CELL IN A FORM THAT CAN BE REACTIVATED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; ELEMENT BINDING-PROTEIN; RNA-BINDING; ACONITASE; BIOSYNTHESIS; PURIFICATION; INHIBITION	The enzyme dihydroxy-acid dehydratase previously has been shown to be inactivated in vivo in Escherichia coli within minutes of exposure to hyperbaric O2. In this paper, we show its inactivation is due to the destruction of its catalytically active [4Fe-4S] cluster. The inactivation is not followed by an appreciable decrease in the amount of dihydroxy-acid dehydratase protein as determined by Western blots. Thus, the protein from the inactivated enzyme remains unproteolyzed in the cells. Dihydroxy-acid dehydratase activity recovers after the cells treated with hyperbaric O2 are returned to ambient oxygen. Since this recovery in activity is not accompanied by a significant increase in dihydroxy-acid dehydratase protein and is not prevented by chloramphenicol, it appears primarily to be due to reactivation of the previously inactivated enzyme. The reactivation occurs by reconstitution of the enzyme's Fe-S cluster. These results demonstrate that this enzyme can cycle between forms in which the Fe-S cluster is either present or absent. The facile ability to cycle between these two forms would be compatible with a regulatory role in addition to a catalytic role for this enzyme.	UNIV MISSOURI,DALTON RES CTR,COLUMBIA,MO 65201; UNIV MISSOURI,DEPT BIOMED SCI,COLUMBIA,MO 65211; UNIV MISSOURI,DEPT MOLEC MICROBIOL & IMMUNOL,COLUMBIA,MO 65211	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	FLINT, DH (corresponding author), DUPONT CO INC,DEPT CENT RES & DEV,POB 80328,WILMINGTON,DE 19880, USA.				NIEHS NIH HHS [5RO1-ES02566] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002566] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Beinert H, 1978, Methods Enzymol, V54, P435; BERNLOHR DA, 1981, BIOCHEMISTRY-US, V20, P5675, DOI 10.1021/bi00523a006; BOEHME DE, 1976, NATURE, V262, P418, DOI 10.1038/262418a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN OR, 1978, BIOCHEM BIOPH RES CO, V85, P1219, DOI 10.1016/0006-291X(78)90672-1; BROWN OR, 1972, MICROBIOS, V5, P7; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; EMPTAGE MH, 1988, METAL CLUSTERS PROTE, P343; FLINT DH, 1992, BIOCHEMISTRY-US, V31, P10331, DOI 10.1021/bi00157a022; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FLINT DH, 1988, J BIOL CHEM, V263, P3558; FLOYD RA, 1991, SCIENCE, V254, P1597, DOI 10.1126/science.1684251; FRIDOVICH I, 1972, ACCOUNTS CHEM RES, V5, P321, DOI 10.1021/ar50058a001; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; KUO CF, 1987, J BIOL CHEM, V262, P4724; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; LAWTHER RP, 1987, NUCLEIC ACIDS RES, V15, P2137, DOI 10.1093/nar/15.5.2137; LIOCHEV SI, 1993, ARCH BIOCHEM BIOPHYS, V153, P379; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; SMYKRANDALL EM, 1987, ANAL BIOCHEM, V164, P434, DOI 10.1016/0003-2697(87)90516-1	27	92	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25547	25552						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244991				2022-12-27	WOS:A1993MK10000042
J	PERRY, DK; STEVENS, VL; WIDLANSKI, TS; LAMBETH, JD				PERRY, DK; STEVENS, VL; WIDLANSKI, TS; LAMBETH, JD			A NOVEL ECTO-PHOSPHATIDIC ACID PHOSPHOHYDROLASE ACTIVITY MEDIATES ACTIVATION OF NEUTROPHIL SUPEROXIDE GENERATION BY EXOGENOUS PHOSPHATIDIC-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; PHOSPHOLIPASE-D; NADPH OXIDASE; GROWTH-FACTOR; C ACTIVITY; HYDROLYSIS; KINASE	Phosphatidic acid (PA) added to intact cells activates a variety of processes including mitogenesis in fibroblasts and superoxide generation in neutrophils. We have investigated the mechanism of activation of superoxide generation in intact human neutrophils by a short-chain (dioctanoyl) PA (diC8PA). After a lag, diC8PA caused a high rate of superoxide production (19.6 nmol of cytochrome c reduced/min/10(6) cells). Activation did not require extracellular Ca2+ and coincided with near quantitative conversion of diC8PA to dioctanoylglycerol (diC8-glycerol). diC8PA also activated cellular phospholipase D with release of long-chain PA and secondary production of long-chain diradylglycerol (sn-1,2-diacylglycerol and 1-O-alkyl-2-acylglycerol). The metabolism of diC8PA to diC8-glycerol was catalyzed by a novel PA phosphohydrolase on the outer leaflet of the plasma membrane as demonstrated by the exclusive release of P(i) into the extracellular medium. This enzyme also showed activity toward PA containing long-chain unsaturated fatty acids. The ecto-PA phosphohydrolase differed from the intracellular PA phosphohydrolase based on its relative insensitivity to desipramine and N-ethylmaleimide. The enzyme was also present in Chinese hamster ovary (CHO) cells and its activity did not change in transfected CHO cells expressing the two membrane-associated isoforms of alkaline phosphatase, indicating that the PA phosphohydrolase was not alkaline phosphatase. Non-hydrolyzable phosphonate analogs of diC8PA poorly stimulated superoxide production. Activation of superoxide generation by diC8PA was inhibited by staurosporine, suggesting a protein kinase C-dependent mechanism. We suggest that the action of a novel ecto-PA phosphohydrolase permits exogenously added short-chain PA to serve as ''timed-release diacylglycerol'' and that its biological effects in neutrophils are secondary to diacylglycerol-mediated protein kinase C activation.	EMORY UNIV, SCH MED, DEPT BIOCHEM, ATLANTA, GA 30322 USA; EMORY UNIV, SCH MED, DEPT RADIAT ONCOL, DIV CANC BIOL, ATLANTA, GA 30322 USA; INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA	Emory University; Emory University; Indiana University System; Indiana University Bloomington					NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022809] Funding Source: NIH RePORTER; NCI NIH HHS [CA46508] Funding Source: Medline; NIAID NIH HHS [AI22809] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; BELLAVITE P, 1988, J BIOL CHEM, V263, P8210; BOCCKINO SB, 1991, P NATL ACAD SCI USA, V88, P6210, DOI 10.1073/pnas.88.14.6210; DUNLOP ME, 1989, DIABETES, V38, P1187, DOI 10.2337/diabetes.38.9.1187; EPAND RM, 1990, BIOCHEM BIOPH RES CO, V171, P487, DOI 10.1016/0006-291X(90)91419-S; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; JACKOWSKI S, 1989, ARCH BIOCHEM BIOPHYS, V268, P516, DOI 10.1016/0003-9861(89)90318-4; KONDO T, 1992, J BIOL CHEM, V267, P23609; LASSEGUE B, 1991, BIOCHEM J, V276, P19, DOI 10.1042/bj2760019; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; MORITZ A, 1992, J BIOL CHEM, V267, P7207; PERRY DK, 1992, J IMMUNOL, V149, P2749; PEVERI P, 1990, BLOOD, V76, P751; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; TEEGARDEN D, 1990, J BIOL CHEM, V265, P6042	15	62	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25302	25310						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244961				2022-12-27	WOS:A1993MK10000008
J	BALAKRISHNAN, R; FROHLICH, M; RAHAIM, PT; BACKMAN, K; YOCUM, RR				BALAKRISHNAN, R; FROHLICH, M; RAHAIM, PT; BACKMAN, K; YOCUM, RR			APPENDIX - CLONING AND SEQUENCE OF THE GENE ENCODING ENZYME-E-1 FROM THE METHIONINE SALVAGE PATHWAY OF KLEBSIELLA-OXYTOCA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERSION; PNEUMONIAE	The methionine salvage pathway converts the methylthioribose moiety of 5'-(methylthio)-adenosine to methionine via a series of biochemical steps. One enzyme active in this pathway, a bifunctional enolase-phosphatase called E-1 that promotes oxidative cleavage of the synthetic substrate 2,3-diketo-1-phosphohexane to 2-ketopentanoate, has been purified from Klebsiella pneumoniae and is characterized in the preceding paper (Myers, R., Wray, J., Fish, S., and Abeles, R. H. (1993) J. Biol. Chem. 268, 24785-24791). We synthesized degenerate oligonucleotides corresponding to portions of the amino terminus of E-1. These oligonucleotides were used as polymerase chain reaction primers on whole genomic DNA from Klebsiella oxytoca. This resulted in an 82-base pair DNA fragment that was used as a hybridization probe to obtain a clone of the E-1 gene from a K. oxytoca gene library. The DNA sequence of the E-1 coding region was determined, and the amino acid sequence of E-1 was deduced. E-1 appears to represent a novel class of enzymes since no homology to known enzymes was found. Cloning the gene from K. oxytoca on a multicopy plasmid leads to overproduction of E-1 enzyme that has properties indistinguishable from those of the enzyme from K. pneumoniae.	OMNIGENE INC,763D CONCORD AVE,POB 9002,CAMBRIDGE,MA 02139									BACKMAN K, 1989, Patent No. 338790; BRENNER DJ, 1977, HEW CDC788356 CTR DI; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; GHODA LY, 1988, J BIOL CHEM, V259, P6715; HSIAO KC, 1991, NUCLEIC ACIDS RES, V19, P2787, DOI 10.1093/nar/19.10.2787; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Maniatis T., 1982, MOL CLONING; MYERS RW, 1989, J BIOL CHEM, V264, P10547; MYERS RW, 1993, J BIOL CHEM, V268, P24785; REZNIKOFF WS, 1980, OPERON, P221; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P355, DOI 10.1093/nar/16.1.355; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; [No title captured]	13	20	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24792	24795						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227040				2022-12-27	WOS:A1993MG67300043
J	KANG, ME; DAHMUS, ME				KANG, ME; DAHMUS, ME			RNA POLYMERASE-IIA AND POLYMERASE-IIO HAVE DISTINCT ROLES DURING TRANSCRIPTION FROM THE TATA-LESS MURINE DIHYDROFOLATE-REDUCTASE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; MAJOR LATE PROMOTER; LARGEST SUBUNIT; SACCHAROMYCES-CEREVISIAE; NONPHOSPHORYLATED FORM; FUNCTIONAL INTERACTION; PREINITIATION COMPLEX; INITIATION SITE; REPEAT DOMAIN; CALF THYMUS	The largest subunit of RNA polymerase II (RNAP II) contains a remarkable region of tandem heptapeptide repeats of the consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser at its carboxyl terminus. This COOH-terminal domain (CTD) is unphosphorylated in RNAP IIA, extensively phosphorylated in RNAP IIO, and absent in RNAP IIB. The reversible phosphorylation of the CTD has been proposed to be integral to each cycle of transcription from the adenovirus-2 major late promoter. The adenovirus-2 major late promoter, however, may not be a good paradigm for the study of CTD function because in vitro transcription from this promoter is not dependent on the CTD. Previous studies suggest that transcription from the murine dihydrofolate reductase (DHFR) promoter requires the CTD. In an effort to investigate the role of the CTD and its phosphorylation, a RNAP II-dependent reconstituted transcription system specific for the DHFR promoter was established. In this reconstituted system, RNAP IIA, but not RNAP IIB, can transcribe from the DHFR promoter. Furthermore, RNAP IIB does not compete with RNAP IIA for preinitiation complex assembly. These results suggest that the CTD plays a critical role in the recruitment of RNAP II to the DHFR promoter. The analysis of preinitiation complexes assembled on the DHFR promoter indicates that RNAP IIA readily assembles into functional preinitiation complexes in contrast to the inefficient assembly of RNAP IIO. However, transcript elongation is catalyzed by RNAP IIO as demonstrated by the photoactivated cross-linking of nascent DHFR transcripts to subunit IIo. These results indicate that transcription from the DHFR promoter involves the reversible phosphorylation of the CTD and support the idea that RNAPs IIA and IIO have essential but distinct functions.	UNIV CALIF DAVIS,DIV BIOL SCI,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616	University of California System; University of California Davis					NIGMS NIH HHS [GM07377, GM33300] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033300, T32GM007377] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARIAS JA, 1991, J BIOL CHEM, V266, P8055; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BUERMEYER AB, 1992, MOL CELL BIOL, V12, P2250, DOI 10.1128/MCB.12.5.2250; BURATOWSKI S, 1990, MOL CELL BIOL, V10, P5562, DOI 10.1128/MCB.10.10.5562; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CONAWAY RC, 1992, J BIOL CHEM, V267, P8464; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; DAHMUS ME, 1983, J BIOL CHEM, V258, P2303; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; FARNHAM PJ, 1990, MOL CELL BIOL, V10, P1390, DOI 10.1128/MCB.10.4.1390; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; KIM WY, 1986, J BIOL CHEM, V261, P14219; KIM WY, 1989, J BIOL CHEM, V264, P3169; KIM WY, 1988, J BIOL CHEM, V263, P18880; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE JM, 1991, GENE EXPRESSION, V1, P149; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PAYNE JM, 1993, J BIOL CHEM, V268, P80; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SCHMIDT EE, 1990, J BIOL CHEM, V265, P17397; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; USHEVA A, 1992, CELL, V69, P871, DOI 10.1016/0092-8674(92)90297-P; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; WEIL PA, 1979, J BIOL CHEM, V254, P6163; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZEHRING WA, 1990, J BIOL CHEM, V265, P8351; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	48	71	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25033	25040						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227067				2022-12-27	WOS:A1993MG67300077
J	MILLERHANCE, WC; LACORBIERE, M; FULLER, SJ; EVANS, SM; LYONS, G; SCHMIDT, C; ROBBINS, J; CHIEN, KR				MILLERHANCE, WC; LACORBIERE, M; FULLER, SJ; EVANS, SM; LYONS, G; SCHMIDT, C; ROBBINS, J; CHIEN, KR			IN-VITRO CHAMBER SPECIFICATION DURING EMBRYONIC STEM-CELL CARDIOGENESIS - EXPRESSION OF THE VENTRICULAR MYOSIN LIGHT CHAIN-2 GENE IS INDEPENDENT OF HEART TUBE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE PROTEIN GENE; RAT MYOCARDIAL-CELLS; CARDIAC-MUSCLE; ADRENERGIC STIMULATION; INDUCIBLE EXPRESSION; MOUSE EMBRYOS; SKELETAL; BODIES; MODEL; INDUCTION	The molecular cues that control patterning of the heart tube during early cardiogenesis are largely unknown. The present study has explored the embryonic stem (ES) cell differentiation system to determine if this in vitro model could be useful in studying the process of regional specification of cardiac muscle cells at the earliest possible stages. As assessed by polymerase chain reaction, ribonuclease protection, in situ hybridization, and immunohistochemical analyses, ES cell differentiation into embryoid bodies is characterized by the transcriptional and translational activation of the ventricular regulatory (phosphorylatable) myosin light chain gene, demonstrating that ventricular specification occurs during ES cell cardiogenesis. The finding of a ventricular-specific marker in an in vitro system in the absence of an intact heart tube provides evidence for cardiae regional specification independent of positional cues or physiologic stimuli. The temporal expression of the myogenic regulatory factors, myogenin and MyoD, suggests activation of the skeletal muscle program following cardiac myogenesis in vitro, indicating temporal fidelity to the progression of in vivo myogenesis. These data establish the mouse embryonic stem cell system as a model for cardiac chamber specification and suggest a promising approach in the study of regional specification in genetically engineered cardiac muscle cells.	UNIV CALIF SAN DIEGO, SCH MED, CTR MOLEC GENET, DEPT MED, 0613-C, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, CTR MOLEC BIOL, AMER HEART ASSOC BUGHER FDN, LA JOLLA, CA 92093 USA; UNIV WISCONSIN, SCH MED, DEPT ANAT, MADISON, WI 53706 USA; MAX PLANCK INST IMMUNBIOL, W-7800 FREIBURG, GERMANY; UNIV CINCINNATI, COLL MED, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; University System of Ohio; University of Cincinnati			Evans, Sylvia/G-1980-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036139, P01HL046345, R01HL045069] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45069, HL-46345, HL-36139] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADOLPH EA, 1993, J BIOL CHEM, V268, P5349; BARTON PJR, 1988, J BIOL CHEM, V263, P12669; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; CHIEN KR, 1993, ANNU REV PHYSIOL, V55, P77, DOI 10.1146/annurev.ph.55.030193.000453; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; CHIEN KR, 1993, SCIENCE, V260, P916, DOI 10.1126/science.8493528; DEGROOT IJM, 1989, ANAT REC, V224, P365, DOI 10.1002/ar.1092240305; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; LEE KJ, 1992, J BIOL CHEM, V267, P15875; LINDENBAUM MH, 1990, GENE DEV, V4, P2075, DOI 10.1101/gad.4.12a.2075; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MAHDAVI V, 1982, NATURE, V297, P659, DOI 10.1038/297659a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; METCALF D, 1991, INT J CELL CLONING, V9, P95, DOI 10.1002/stem.5530090201; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P2602; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; RISAU W, 1988, DEVELOPMENT, V102, P471; ROBBINS J, 1992, TRENDS CARDIOVAS MED, V2, P44, DOI 10.1016/1050-1738(92)90003-B; ROBBINS J, 1990, J BIOL CHEM, V265, P11905; SANCHEZ A, 1991, J BIOL CHEM, V266, P22419; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; WANG R, 1992, DEVELOPMENT, V114, P303; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WEYDERT A, 1985, P NATL ACAD SCI USA, V82, P7183, DOI 10.1073/pnas.82.21.7183; WIECZOREK DF, 1990, DYNAMIC STATE OF MUSCLE FIBERS, P91; WILES MV, 1991, DEVELOPMENT, V111, P259; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; ZHU H, 1993, MOL CELL BIOL, V13, P4432, DOI 10.1128/MCB.13.7.4432; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	40	150	154	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25244	25252						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227090				2022-12-27	WOS:A1993MG67300103
J	XIE, XS; CRIDER, BP; STONE, DK				XIE, XS; CRIDER, BP; STONE, DK			ISOLATION OF A PROTEIN ACTIVATOR OF THE CLATHRIN-COATED VESICLE PROTON PUMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING COMPLEX; ACIDIFICATION; RECONSTITUTION; TRANSPORT; PATHWAYS; ATPASES	An activator of the clathrin-coated vesicle proton translocating ATPase has been purified 1600-fold from bovine brain. The activator, which requires detergent (polyoxyethylene 9-lauryl ether) for release from clathrin-coated vesicles, is heat-stable, trypsin-sensitive, and has an apparent molecular mass of about 6 kDa as determined by high performance liquid chromotography. The activator stimulates the purified H+-ATPase of coated vesicles over 50-fold under acidic conditions. Similarly, the activator stimulates proton pumping catalyzed by the reconstituted proton pump. Importantly, this stimulation of proton pumping is observed only when the activator is reconstituted into the interior of the proteoliposomes. Moreover, the activator protein is demonstrated to protect, and co-sediment with, purified proton pump during glycerol gradient centrifugation performed in the presence of ATP. These observations support the notion that this activator serves to determine the pH set point of acidic endomembranes through interactions with the transmembranous sectors of the proton pump.	UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DIV MOLEC TRANSPORT,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIDDK NIH HHS [DK R01 33627] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ALPERN RJ, 1991, KIDNEY, P318; ANDERSON RGW, 1988, J CELL BIOL, V106, P529; BARASCH J, 1988, J CELL BIOL, V107, P2137, DOI 10.1083/jcb.107.6.2137; BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; DICKMAN KG, 1992, AM J PHYSIOL, V263, pF342, DOI 10.1152/ajprenal.1992.263.2.F342; FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; KELLY RB, 1987, NATURE, V326, P14, DOI 10.1038/326014a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Moriyama Y, 1988, Prog Clin Biol Res, V273, P387; MULBERG AE, 1991, J BIOL CHEM, V266, P20590; NANDI PK, 1982, P NATL ACAD SCI-BIOL, V79, P5881, DOI 10.1073/pnas.79.19.5881; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P261; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; STONE DK, 1984, J BIOL CHEM, V259, P2701; STONE DK, 1983, J BIOL CHEM, V258, P4059; STONE DK, 1988, KIDNEY INT, V33, P403; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1989, J BIOL CHEM, V264, P18870; XIE XS, 1986, P NATL ACAD SCI USA, V83, P8913, DOI 10.1073/pnas.83.23.8913; XIE XS, 1983, J BIOL CHEM, V259, P11676; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; ZHANG K, 1992, J BIOL CHEM, V267, P9701	26	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25063	25067						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227069				2022-12-27	WOS:A1993MG67300080
J	RASMUSSEN, C; GAREN, C				RASMUSSEN, C; GAREN, C			ACTIVATION OF CALMODULIN-DEPENDENT ENZYMES CAN BE SELECTIVELY INHIBITED BY HISTONE-H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CA-2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; CELL-CYCLE PROGRESSION; SUBSTRATE-SPECIFICITY; BINDING-PROTEIN; DNA-REPLICATION; CALCINEURIN; AUTOPHOSPHORYLATION; PHOSPHATASE; CHROMATIN; SUBUNIT	Calmodulin (CaM) and its target enzymes are important regulators of a variety of cellular processes including gene expression and cell cycle progression (Bading, H., Ginty, D. D., and Greenberg, M. E. (1993) Science 260, 181-186; Rasmussen, C. D., and Means,A. R. (1989) EMBO J. 8, 73-82). It has been previously accepted that regulation of CaM-dependent enzyme activity occurs via calcium/calmodulin-dependent activation. We have found that histone H1 is a potent inhibitor of the CaM-dependent activation of mouse calcium/calmodulin-dependent protein kinase II (CaMKII) and of the CaM-dependent protein phosphatase, calcineurin. Inhibition is mediated only by free histone H1; addition of DNA abolishes the inhibitory effect. The effect is not due to a simple interaction of basic (histone) and acidic (CaM) proteins since myelin basic protein and histone H2B, CamkII substrates more basic than histone H1, did not affect autophosphorylation of CaMKII, and myelin basic protein had no effect on calcineurin activity. The effect is specific to CaM since addition of parvalbumin, a related Ca2+-binding protein, did not reverse the effect of histone H1, whereas addition of CaM recovered enzyme activity. These results indicate that free histone H1 levels may specifically affect the ability of CaM to activate its target enzymes and suggests a novel level of control of CaM-dependent enzymes in eukaryotic cells.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,ALBERTA,CANADA; UNIV ALBERTA,DEPT ONCOL,EDMONTON T6G 2H7,ALBERTA,CANADA; UNIV ALBERTA,NATL CANC INST,MOLEC MECH GROWTH CONTROL GRP,EDMONTON T6G 2H7,ALBERTA,CANADA	University of Alberta; University of Alberta; Queens University - Canada; Canadian Cancer Trials Group; University of Alberta	RASMUSSEN, C (corresponding author), UNIV ALBERTA,DEPT ANAT & CELL BIOL,EDMONTON T6G 2H7,ALBERTA,CANADA.							BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAITINGER C, 1990, J CELL BIOL, V111, P1763, DOI 10.1083/jcb.111.5.1763; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BREEUWER M, 1990, CELL, V60, P999, DOI 10.1016/0092-8674(90)90348-I; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; CHAFOULEAS JG, 1984, CELL, V36, P73, DOI 10.1016/0092-8674(84)90075-8; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; FOOR F, 1992, NATURE, V360, P682; HAMMOND RA, 1989, BIOCHIM BIOPHYS ACTA, V951, P315; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; KEMP BE, 1976, P NATL ACAD SCI USA, V73, P1038, DOI 10.1073/pnas.73.4.1038; Kennedy MB, 1987, CALCIUM CELL FUNCTIO, P61; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LOUTERS L, 1985, BIOCHEMISTRY-US, V24, P3080, DOI 10.1021/bi00334a002; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; ROUSSEAU D, 1992, EUR J BIOCHEM, V208, P775, DOI 10.1111/j.1432-1033.1992.tb17247.x; SCHULMAN H, 1989, TRENDS BIOCHEM SCI, V14, P62, DOI 10.1016/0968-0004(89)90045-5; SCHULMAN H, 1985, BIOCHEMISTRY-US, V24, P5320, DOI 10.1021/bi00341a008; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; SUBRAMANYAM C, 1990, J CELL PHYSIOL, V144, P423, DOI 10.1002/jcp.1041440309; SUN JM, 1990, EMBO J, V9, P1651, DOI 10.1002/j.1460-2075.1990.tb08285.x; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315	31	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23788	23791						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226913				2022-12-27	WOS:A1993MF29400015
J	ZHENG, CF; GUAN, KL				ZHENG, CF; GUAN, KL			PROPERTIES OF MEKS, THE KINASES THAT PHOSPHORYLATE AND ACTIVATE THE EXTRACELLULAR SIGNAL-REGULATED KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; ERK-1 GENE-PRODUCT; PHEROMONE RESPONSE PATHWAY; TYROSINE THREONINE KINASE; MAP KINASE; SKELETAL-MUSCLE; INSULIN; CELLS; IDENTIFICATION; PURIFICATION	Activation of extracellular signal-regulated kinase (ERK) or mitogen-activated protein kinase by MEK (mitogen-activated protein kinase or extracellular signal-regulated kinase kinase) is an essential event in the mitogenic growth factor signal transduction. We now demonstrate that three recombinant MEKs (MEK1, MEK2, MEK3) show remarkably different activity toward recombinant ERK1 and ERK2. MEK2 is the most active ERK activator. The recombinant MEK1 has an activity approximately seven times lower than that of MEK2. MEK3, which is identical to MEK1 except for missing an internal 26-amino acid residue and probably represents an alternative splicing product of MEK1, shows neither autophosphorylation nor ERK-activating activity. Recombinant MEK1 and MEK2 can be activated by epidermal growth factor-stimulated SWISS3T3 cell lysate. MEK1 and MEK2 can also be activated by autophosphorylation. Autophosphorylation of MEKs correlates with their ability to phosphorylate and activate ERKs. Phosphorylation of MEK is also stimulated by ERK. Phosphoamino acid analysis showed that ERK1 preferentially phosphorylated threonine residue of MEKs. MEKs complex with ERKs in vitro. Interestingly, MEK3 also forms a complex with ERK1, although it is totally inactive as an ERK activator.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,INST GERONTOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00042] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BOULTON TG, 1990, J BIOL CHEM, V265, P2713; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; CREWS CM, 1992, CELL GROWTH DIFFER, V3, P135; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HOSHI M, 1988, J BIOL CHEM, V263, P5396; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1988, DEV BIOL, V130, P28, DOI 10.1016/0012-1606(88)90410-1; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SATOH T, 1992, J BIOL CHEM, V267, P24149; SEGER R, 1992, J BIOL CHEM, V267, P25628; SEGER R, 1992, J BIOL CHEM, V267, P14373; SMITH DS, 1989, J NEUROCHEM, V53, P800, DOI 10.1111/j.1471-4159.1989.tb11776.x; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; WU J, 1993, P NATL ACAD SCI USA, V90, P173, DOI 10.1073/pnas.90.1.173; WU J, 1992, BIOCHEM J, V285, P701, DOI 10.1042/bj2850701; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	50	176	178	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23933	23939						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226933				2022-12-27	WOS:A1993MF29400036
J	BORUKHOV, S; SAGITOV, V; JOSAITIS, CA; GOURSE, RL; GOLDFARB, A				BORUKHOV, S; SAGITOV, V; JOSAITIS, CA; GOURSE, RL; GOLDFARB, A			2 MODES OF TRANSCRIPTION INITIATION IN-VITRO AT THE RRNB-P1 PROMOTER OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDO-TEMPLATED TRANSCRIPTION; FACTOR-INDEPENDENT ACTIVATION; RIBOSOMAL-RNA TRANSCRIPTION; TERNARY COMPLEXES; BETA-SUBUNIT; POLYMERASE; PURIFICATION; DISSECTION; ELONGATION; MECHANISM	The rrnB P1 promoter of Escherichia coli (starting sequence C-4-A-3-C-2-C-1-A+1-C+2-U+3-G+4) forms a binary complex with RNA polymerase that is highly unstable and requires the presence of transcription substrates ATP and CTP for stabilizing the enzyme-DNA association (Gourse, R. L. (1988) Nucleic Acids Res. 16, 9789-9809). We show that in the absence of UTP and GTP the stabilization is accomplished by short RNA oligomers synthesized in an unusual ''-3-->'' mode whereby the primer initiated at the +1 site presumably slips back by three nucleotides into the -3 site and is then extended yielding stable ternary complexes. By contrast, short oligomers initiated in the conventional ''+1-->'' mode without slippage do not exert the stabilization effect and are readily aborted from the promoter complex. The stable -3--> ternary complexes carry sigma factor but otherwise resemble elongation complexes in their high salt stability and in the fact that they are formed with a mutant RNA polymerase deficient in promoter binding. A model is proposed explaining the stability of the -3--> ternary complexes by RNA slipping into a putative ''tight RNA binding site'' in RNA polymerase which is normally occupied by RNA during elongation.	PUBL HLTH RES INST CITY NEW YORK INC,455 1ST AVE,NEW YORK,NY 10016; UNIV WISCONSIN,DEPT BACTERIOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison			Borukhov, Sergei/AAF-3195-2019	Borukhov, Sergei/0000-0002-3517-3003	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037048, R01GM049242] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM37048, R01 GM49242] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA T, 1985, NUCLEIC ACIDS RES, V13, P4085, DOI 10.1093/nar/13.11.4085; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BOURKHOV S, 1993, CELL, V72, P459; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; GOU HC, 1990, BIOCHEMISTRY-US, V29, P10702; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; JACQUES JP, 1991, GENE DEV, V5, P707, DOI 10.1101/gad.5.5.707; JACQUES JP, 1990, GENE DEV, V4, P1801, DOI 10.1101/gad.4.10.1801; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; KRUMMEL B, 1990, THESIS U CALIFORNIA; LEE JY, 1991, P NATL ACAD SCI USA, V88, P6018, DOI 10.1073/pnas.88.14.6018; LEIRMO S, 1991, J MOL BIOL, V220, P555, DOI 10.1016/0022-2836(91)90100-K; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; MARTIN E, 1992, J BIOL CHEM, V267, P20175; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; NEWLANDS JT, 1991, J MOL BIOL, V220, P569, DOI 10.1016/0022-2836(91)90101-B; PARKER RC, 1986, BIOCHEMISTRY-US, V25, P6593, DOI 10.1021/bi00369a038; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; RHODES G, 1974, J BIOL CHEM, V249, P6675; RICHARDSON JP, 1966, J MOL BIOL, V21, P115, DOI 10.1016/0022-2836(66)90083-0; RUETSCH N, 1987, J BIOL CHEM, V262, P1674; SEVERINOV K, 1992, J BIOL CHEM, V267, P12813; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; ZACHARIAS M, 1991, BIOCHIMIE, V73, P699, DOI 10.1016/0300-9084(91)90050-B; ZALENSKAYA K, 1990, GENE, V89, P7, DOI 10.1016/0378-1119(90)90199-2	27	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23477	23482						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226874				2022-12-27	WOS:A1993MF51500080
J	CAVALLARO, U; DELVECCHIO, A; LAPPI, DA; SORIA, MR				CAVALLARO, U; DELVECCHIO, A; LAPPI, DA; SORIA, MR			A CONJUGATE BETWEEN HUMAN UROKINASE AND SAPORIN, A TYPE-1 RIBOSOME-INACTIVATING PROTEIN, IS SELECTIVELY CYTOTOXIC TO UROKINASE RECEPTOR-EXPRESSING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; ALPHA-2-MACROGLOBULIN RECEPTOR; SAPONARIA-OFFICINALIS; EUKARYOTIC RIBOSOMES; PRO-UROKINASE; SARCOMA-CELLS; DEGRADATION; IMMUNOTOXIN; COMPLEXES; BINDING	Urokinase-type plasminogen activator (uPA) confers invasive potential to transformed cells. Cancer cells express high numbers of uPA receptors (uPARs), which concentrate uPA activity at the invasive edge of cancer cells and the tumor mass. We synthesized a conjugate between human uPA and saporin (SAP), a ribosome-inactivating protein produced by Saponaria officinalis. Results of cell-killing assays showed that uPA is very effective at targeting saporin specifically to uPAR-expressing cells, whereas cell lines devoid of uPARs were not affected by the conjugate. Receptor-bound uPA is internalized only upon formation of a complex with one of its inhibitors (PAIs). However, our conjugate was highly cytotoxic even when the interaction between uPA and PAIs was prevented. Moreover, the alpha2-macroglobulin receptor, which has been reported to mediate the internalization of uPA.PAI complexes, seems not to be involved in cell killing caused by the uPA.SAP conjugate. Thus, uPA.SAP might follow a mechanism of internalization different from that of unconjugated uPA complexed to PAIs, although still uPAR-mediated. Our results also suggest that alpha2-Macroglobulin and/or its receptor could mediate the internalization and cytotoxicity of unconjugated saporin, as it has been shown for other toxins.	SAN RAFFAELE RES INST,DEPT BIOL & TECHNOL RES,DIBIT,VIA OLGETTINA 58,I-20132 MILAN,ITALY; WHITTIER INST DIABET & ENDOCRINOL,DEPT MOLEC & CELLULAR GROWTH BIOL,LA JOLLA,CA 92037				Cavallaro, Ugo/J-9745-2012	Cavallaro, Ugo/0000-0002-0884-6460; Lappi, Douglas/0000-0003-4239-7387	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK018811] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-18811] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644; BARBIERI L, 1989, SCAND J IMMUNOL, V30, P369, DOI 10.1111/j.1365-3083.1989.tb01223.x; BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; CORSARO CM, 1981, SOMAT CELL GENET, V7, P603, DOI 10.1007/BF01549662; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; GETHIE MA, 1991, CANCER RES, V51, P1482; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LAPPI DA, 1989, BIOCHEM BIOPH RES CO, V160, P917, DOI 10.1016/0006-291X(89)92522-9; LAPPI DA, 1985, BIOCHEM BIOPH RES CO, V129, P934, DOI 10.1016/0006-291X(85)91981-3; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; NYKJAER A, 1992, FEBS LETT, V300, P13, DOI 10.1016/0014-5793(92)80154-9; OLSON D, 1992, J BIOL CHEM, V267, P9129; POLLANEN J, 1988, J CELL BIOL, V106, P87, DOI 10.1083/jcb.106.1.87; PYKE C, 1991, AM J PATHOL, V138, P1059; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; SCHMITT M, 1992, FIBRINOLYSIS, V6, P3; SIENA S, 1988, BLOOD, V72, P756; SORIA M, 1989, PHARMACOL RES, V21, P35, DOI 10.1016/S1043-6618(89)80016-7; SORIA M, 1992, GENETICALLY ENG TOXI, P193; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; STIRPE F, 1983, BIOCHEM J, V216, P617, DOI 10.1042/bj2160617; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; TAZZARI PL, 1992, TRANSPLANTATION, V54, P351, DOI 10.1097/00007890-199208000-00029; THORPE PE, 1985, J NATL CANCER I, V75, P151; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86	36	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23186	23190						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226837				2022-12-27	WOS:A1993MF51500038
J	EADS, J; SACCHETTINI, JC; KROMMINGA, A; GORDON, JI				EADS, J; SACCHETTINI, JC; KROMMINGA, A; GORDON, JI			ESCHERICHIA-COLI-DERIVED RAT INTESTINAL FATTY-ACID-BINDING PROTEIN WITH BOUND MYRISTATE AT 1.5 ANGSTROM RESOLUTION AND I-FABP(ARG106-]GLN) WITH BOUND OLEATE AT 1.74 ANGSTROM RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; N-MYRISTOYLTRANSFERASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; TRANSGENIC MICE; EXPRESSION; REFINEMENT; ANALOGS; GENE	Rat intestinal fatty acid binding protein (I-FABP) is a 131-residue protein composed of two short alpha-helices (alphaI and alphaII) and 10 anti-parallel beta-strands organized into two nearly orthogonal beta-sheets. The structure of crystalline I-FABP with bound tetradecanoate (myristate) has been refined to a resolution of 1.5 angstrom and compared to the 1.2 angstrom structure of apo-I-FABP, the 1.9 angstrom structure of I-FABP:hexadecanoate (palmitate) and the 1.75 angstrom structure of I-FABP:9Z-octadecanoate (oleate) to determine how this model fatty acid receptor accommodates changes in the length of its fatty acid ligand. Myristate is located in the interior of the protein. A highly ordered, electrostatic network containing 7 hydrogen (H)-bonds links the OE1 and OE2 atoms of myristate's carboxylate group, the indole nitrogen of Trp82, NH1, and NH2 of Arg106, NE2, and OE1 of Gln115, and 2 interior ordered waters. The hydrocarbon chain of the bound fatty acid is slightly bent. Its convex face lies in a crevice, forming van der Waals contacts with the side chains of several hydrophobic and aromatic residues. Its concave face is exposed to an array of 8 interior ordered waters whose positions are stabilized by H-bond interactions with other waters, H-bond interactions with the side chains of polar/ionizable residues, and van der Waals contacts with the surface of the fatty acid. Addition of 2 or 4 methylenes to myristate produces remarkably little change in the positions of I-FABP's main chain and side chain atoms and interior ordered waters. The principal alterations are in the conformation of a surface opening (portal) connecting external and internal solvent and in the position of the benzene side chain of Phe55. Changes in the conformation of the portal reflect movement of two of its components: the backbone of alphaII and a type I turn (Ala73, Asp74) connecting two beta-strands. The positions of the main chain atoms of Ala73 and Asp74 appear to be determined by their ability to form van der Waals contacts with the omega-terminus of the fatty acid. The side chain of Phe55 appears to function as an adjustable aromatic lid, located over the portal, whose position is dependent on an ability to form van der Waals contacts with a fatty acid's omega-terminus. The structure of I-FABPArg106-->Gln with bound oleate was refined to 1.74 angstrom and compared to the 1.75 angstrom structure of I-FABpArg106:oleate so that we could assess the contribution of the electrostatic network, which binds carboxylate, to the overall positioning of the fatty acid. This mutation results in destabilization of the electrostatic network as evidenced by the presence of several alternate positions for carboxylate in the electron density map. The discrete disorder of the carboxylate group is associated with movement of the hydrocarbon chain along the length of the binding pocket and extension of the methyl terminus beyond the boundary of the aromatic lid. Movement of the acyl chain does not perturb the positions of the protein's interior ordered waters or the side chain of its Phe55 residue. These findings provide insights about the potential manner in which I-FABP can accommodate fatty acids whose chain length exceeds 18 carbons. Together, our studies emphasize the contributions of ''feeble forces'' (ion pair, H-bond, and van der Waals interactions) to the binding enthalpy in this model fatty acid receptor system.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,1300 MORRIS PK AVE,BRONX,NY 10461; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL)					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045859] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27179] Funding Source: Medline; NIDDK NIH HHS [DK30292] Funding Source: Medline; NIGMS NIH HHS [GM45859] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATWOOD JL, 1991, NATURE, V349, P683, DOI 10.1038/349683a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, XPLOR VERSION 2 1 MA; CHENG L, 1991, J BIOL CHEM, V266, P24404; CISTOLA DP, 1989, J BIOL CHEM, V264, P2700; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; JAKOBY MG, 1993, BIOCHEMISTRY-US, V32, P872, DOI 10.1021/bi00054a019; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KISHORE NS, 1991, J BIOL CHEM, V266, P8835; KISHORE NS, 1993, J BIOL CHEM, V268, P4889; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE JB, 1987, J BIOL CHEM, V262, P5931; MULLERFAHRNOW A, 1991, EUR J BIOCHEM, V199, P271, DOI 10.1111/j.1432-1033.1991.tb16120.x; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; RUDNICK DA, 1992, P NATL ACAD SCI USA, V89, P10507, DOI 10.1073/pnas.89.21.10507; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; SACCHETTINI JC, 1990, MOL CELL BIOCHEM, V98, P81; SCAPIN G, 1992, J BIOL CHEM, V267, P4253; SCAPIN G, 1993, IN PRESS MOL CELL BI; SCAPIN G, 1990, MOL CELL BIOCHEM, V98, P81; SHA RS, 1993, J BIOL CHEM, V268, P7885; STUMP DG, 1991, J BIOL CHEM, V266, P4622; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; XU ZH, 1993, J BIOL CHEM, V268, P7874; XU ZH, 1992, BIOCHEMISTRY-US, V31, P3484, DOI 10.1021/bi00128a024; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	35	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26375	26385						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253762				2022-12-27	WOS:A1993MK42500056
J	NAKANISHISHINDO, Y; NAKAYAMA, K; TANAKA, A; TODA, Y; JIGAMI, Y				NAKANISHISHINDO, Y; NAKAYAMA, K; TANAKA, A; TODA, Y; JIGAMI, Y			STRUCTURE OF THE N-LINKED OLIGOSACCHARIDES THAT SHOW THE COMPLETE LOSS OF ALPHA-1,6-POLYMANNOSE OUTER CHAIN FROM OCH1, OCH1 MNN1, AND OCH1 MNN1 ALG3 MUTANTS OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR CHAINS; PROTEIN GLYCOSYLATION; EXTERNAL INVERTASE; GLYCOPROTEINS; ELONGATION; PYRIDYLAMINATION; HYDRAZINOLYSIS; SPECTROSCOPY; DEFICIENT	The periplasmic invertase was purified from Saccharomyces cerevisiae och1=LEU2 disruptant cells (DELTAoch1), which have a defect in elongation of the outer chain attached to the N-linked core oligosaccharides (Nakayama, K., Nagasu, T., Shimma, Y., Kuromatsu, J., and Jigami, Y. (1992) EMBO J. 11, 2511-2519). Structural analysis of the pyridylaminated (PA) neutral oligosaccharides released by hydrazinolysis and N-acetylation confirmed that the ochl mutation causes a complete loss of the alpha-1,6-polymannose outer chain, although the PA oligosaccharides (Man9GlcNAc2-PA and Man10GlcNAC2-PA), in which one or two alpha-1,3-linked mannose(s) attached to the endoplasmic reticulumn (ER)-form core oligosaccharide (Man8GlcNAc2) were also detected. Analysis of the DELTAoch1 mnn1 strain oligosaccharides released from total cell mannoprotein revealed that the DELTAoch1 mnn1 mutant eliminates the alpha-1,3-mannose attached to the core and accumulates predominantly a single ER-form oligosaccharide species (Man8GlcNAc2), suggesting a potential use of this strain as a host cell to produce glycoproteins containing mammalian high mannose type oligosaccharides. The DELTAoch1 mnn1 alg3 mutants accumulated Man5GlcNAC2 and Man8GlcNAC2 in total cell Tnannoprotein, confirming the lack of outer chain addition to the incomplete corelike oligosaccharide and the leaky phenotype of the alg3 mutation. All the results suggest that the OCH1 gene encodes an alpha-1,6-mannosyltransferase that is functional in the initiation of alpha-1,6-polymannose outer chain addition to the N-linked core oligosaccharide (Man5GlcNAC2 and Man8GlcNAC2) in yeast.	NATL INST BIOSCI & HUMAN TECHNOL, 1-1 HIGASHI, TSUKUBA, IBARAKI 305, JAPAN; ASAHI CHEM IND CO LTD, FUJI, SHIZUOKA 416, JAPAN	National Institute of Advanced Industrial Science & Technology (AIST)								ALVARADO E, 1990, BIOCHEMISTRY-US, V29, P2471, DOI 10.1021/bi00462a006; BALLOU L, 1986, P NATL ACAD SCI USA, V83, P3081, DOI 10.1073/pnas.83.10.3081; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; BALLOU L, 1980, J BIOL CHEM, V255, P5986; BALLOU L, 1989, J BIOL CHEM, V264, P11857; BLANKEN WM, 1985, ANAL BIOCHEM, V145, P322, DOI 10.1016/0003-2697(85)90369-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN RE, 1980, BIOCHEMISTRY-US, V19, P4345, DOI 10.1021/bi00559a031; ESMON B, 1984, J BIOL CHEM, V259, P322; FUKUDA M, 1976, J BIOCHEM, V80, P1223, DOI 10.1093/oxfordjournals.jbchem.a131393; GRAHAM TR, 1992, YEAST, V8, pS458; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; KOBATA A, 1987, METHOD ENZYMOL, V138, P779; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NAGASU T, 1992, YEAST, V8, P535, DOI 10.1002/yea.320080705; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; NATSUKA S, 1987, ANAL BIOCHEM, V167, P154, DOI 10.1016/0003-2697(87)90146-1; NEUMANN NP, 1967, BIOCHEMISTRY-US, V6, P468, DOI 10.1021/bi00854a015; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; PEAT S, 1961, J CHEM SOC, P29, DOI 10.1039/jr9610000029; ROMERO PA, 1989, J BIOL CHEM, V264, P1946; ROMERO PA, 1992, J CELL BIOCHEM     S, V16, P175; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SMITH WL, 1974, BIOCHEMISTRY-US, V13, P355, DOI 10.1021/bi00699a021; TAKAHASHI N, 1981, BIOCHIM BIOPHYS ACTA, V657, P451; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; TRIMBLE RB, 1986, J BIOL CHEM, V261, P9815; TRIMBLE RB, 1977, J BIOL CHEM, V252, P4409; TSAI PK, 1984, J BIOL CHEM, V259, P3801; VEROSTEK MF, 1991, J BIOL CHEM, V266, P5547; ZIEGLER FD, 1988, J BIOL CHEM, V263, P6986	34	142	173	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26338	26345						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253757				2022-12-27	WOS:A1993MK42500051
J	GARDNER, AM; AVIEL, S; ARGON, Y				GARDNER, AM; AVIEL, S; ARGON, Y			RAPID DEGRADATION OF AN UNASSEMBLED IMMUNOGLOBULIN LIGHT-CHAIN IS MEDIATED BY A SERINE-PROTEASE AND OCCURS IN A PRE-GOLGI COMPARTMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL LYMPHOMA; ASIALOGLYCOPROTEIN RECEPTOR SUBUNITS; ISOLATED RAT HEPATOCYTES; ENDOPLASMIC-RETICULUM; LYMPHOCYTES-B; HEAVY-CHAINS; INTRACELLULAR DEGRADATION; SECRETED IMMUNOGLOBULIN; CYSTEINE PROTEASE; ANTIGEN RECEPTOR	The immunoglobulin kappa light chain produced by the CH12 lymphoma is unusual because it is not secreted when expressed in the absence of a heavy chain. Instead, it undergoes rapid intracellular degradation. This degradation is selective, as another light chain expressed in the same cell is not degraded. It is also a property of the CH12 kappa chain itself, since it is degraded rapidly when expressed either in another myeloma cell or in COS-1 fibroblasts. When provided a heavy chain, this kappa chain assembles into IgM and is then protected from proteolysis. The degradation of kappa requires ATP, is sensitive to reduced temperature and to the thiol reagent diamide. Of all the proteolytic inhibitors tested, 3,4-dichloroisocoumarin, L-1-tosylamido-2-phenylethyl chloromethyl ketone, and to a lesser extent 1-chloro-3-tosylamido-7-amino-2-heptanone, inhibit kappa degradation, suggesting the involvement of a serine protease. The degradation of kappa does not require transport to the Golgi complex, nor is it sensitive to a variety of lysosomotropic agents. Both immunofluorescence and the observed association with the endoplasmic reticulum (ER) stress proteins GRP78/BiP and GRP94 indicate that the kappa chain is localized mostly in the ER. When a point mutation which blocks transport to the Golgi complex is introduced into this kappa chain, the association with the stress proteins is enhanced but the rate of degradation is not significantly decreased. We conclude that the CH12 kappa chain is a particularly good substrate for an ER degradation machinery, and that its sensitivity to the protease(s) is governed by its state of assembly. This ER degradation provides a possible quality control mechanism during the differentiation of B lymphocytes.	DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27710 USA	Duke University				Gardner, Anne/0000-0001-7095-772X				ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; AMITAY R, 1991, J BIOL CHEM, V266, P12568; AMITAY R, 1992, J BIOL CHEM, V267, P20694; ARGON Y, 1984, J IMMUNOL, V133, P1627; ARNOLD LW, 1988, J IMMUNOL, V140, P4355; BACHHAWAT AK, 1991, J CELL BIOL, V115, P619, DOI 10.1083/jcb.115.3.619; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; CHAUDHURI B, 1992, EUR J BIOCHEM, V210, P811, DOI 10.1111/j.1432-1033.1992.tb17484.x; COWAN NJ, 1974, J MOL BIOL, V90, P691, DOI 10.1016/0022-2836(74)90533-6; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DUL JL, 1990, P NATL ACAD SCI USA, V87, P8135, DOI 10.1073/pnas.87.20.8135; DUL JL, 1992, J IMMUNOL, V149, P1927; DULIS BH, 1982, J BIOL CHEM, V257, P4369; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; ELOKDA M, 1992, AM J CLIN PATHOL, V97, P866, DOI 10.1093/ajcp/97.6.866; GIL G, 1985, CELL, V63, P503; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; GRINDE B, 1980, BIOCHIM BIOPHYS ACTA, V632, P73, DOI 10.1016/0304-4165(80)90250-0; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P3344; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KING LB, 1989, P NATL ACAD SCI USA, V86, P2814, DOI 10.1073/pnas.86.8.2814; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; KOSOWER EM, 1969, NATURE, V224, P117, DOI 10.1038/224117a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LE A, 1990, J BIOL CHEM, V265, P14001; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MEDDA S, 1987, CELL, V50, P301, DOI 10.1016/0092-8674(87)90225-X; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOSMANN TR, 1980, CELL, V20, P283, DOI 10.1016/0092-8674(80)90614-5; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; PENNELL CA, 1988, J IMMUNOL, V141, P2788; SATO R, 1990, J BIOL CHEM, V265, P11880; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; SPRINGER TA, 1982, HYBRIDOMA, V1, P257, DOI 10.1089/hyb.1.1982.1.257; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; Stevens R H, 1974, Contemp Top Mol Immunol, V3, P85; STOCKDALE AM, 1987, J IMMUNOL, V139, P3527; STOLLER TJ, 1988, J CELL BIOL, V107, P2087, DOI 10.1083/jcb.107.6.2087; TARTAKOFF A, 1979, J CELL BIOL, V83, P284, DOI 10.1083/jcb.83.2.284; TARTAKOFF AM, 1977, J EXP MED, V146, P1332, DOI 10.1084/jem.146.5.1332; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; URADE R, 1992, FEBS LETT, V312, P83, DOI 10.1016/0014-5793(92)81415-I; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; VIRTANEN I, 1980, J CELL BIOL, V85, P429, DOI 10.1083/jcb.85.2.429; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; WIKSTROM L, 1992, J BIOL CHEM, V267, P5; WIKSTROM L, 1991, J CELL BIOL, V113, P997, DOI 10.1083/jcb.113.5.997; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WILEMAN T, 1991, CELL REGUL, V2, P753, DOI 10.1091/mbc.2.9.753	64	61	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25940	25947						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245027				2022-12-27	WOS:A1993MK10000093
J	ANBORGH, PH; PARMEGGIANI, A				ANBORGH, PH; PARMEGGIANI, A			PROBING THE REACTIVITY OF THE GTP-BOUND AND GDP-BOUND CONFORMATIONS OF ELONGATION FACTOR-TU IN COMPLEX WITH THE ANTIBIOTIC GE2270-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; FACTOR EF-TU; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; POLYPEPTIDE-CHAIN; TERMINAL DOMAIN; MONO-VALENT; FACTOR-TS; KIRROMYCIN; MODULATION	The activity of Escherichia coli elongation factor Tu (EF-Tu) depends on its GTP- and GDP-bound conformations. In this work we have studied the influence of the antibiotic GE2270 A, a new EF-Tu-specific inhibitor of protein biosynthesis, on these two conformations with respect to the interaction with the various ligands and stability. One molecule of GE2270 A bound per EF-Tu is sufficient to block poly(U)-directed poly(Phe) incorporation. This drug binds stably to both EF-Tu.GTP and EF-Tu.GDP but only affects the reactivity of the GTP-bound conformation that is no longer able to interact efficiently with aminoacyl-tRNA (aa-tRNA) and ribosomes. Consequently, the protection by EF-Tu.GTP of the aminoacyl-ester bond against nonenzymatic hydrolysis is strongly weakened. The intrinsic EF-Tu GTPase is little affected, but its response to aa-tRNA and ribosomes is impaired. The specificity of GE2270 A to the GTP-bound form of EF-Tu is supported by the course of temperature- and urea-dependent inactivation or tryptic digestion. Furthermore, in its presence elongation factor Ts (EF-Ts) can enhance the dissociation of EF-Tu.GDP but not that of EF-Tu.GTP. Unlike kirromycin, this antibiotic can bind to EF-Tu.EF-Ts without causing dissociation of this complex. Evidence was obtained that the EF-Tu binding site for GE2270 A is also distinct from those for kirromycin, pulvomycin, and aa-tRNA, even though this antibiotic functionally interferes with all three of these ligands. GE2270 A appears to interact with a crucial regulatory region of the EF-Tu molecule that is activated in the GTP-bound state.	ECOLE POLYTECH,BIOCHIM LAB,CNRS,SDI 61840,F-91128 PALAISEAU,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris								ANBORGH PH, 1991, FEBS LETT, V292, P232, DOI 10.1016/0014-5793(91)80874-3; ANBORGH PH, 1991, EMBO J, V10, P779, DOI 10.1002/j.1460-2075.1991.tb08009.x; BLUMENTHAL T, 1977, P NATL ACAD SCI USA, V74, P3264, DOI 10.1073/pnas.74.8.3264; BOSCH L, 1983, PROG NUCLEIC ACID RE, V30, P91; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHINALI G, 1977, EUR J BIOCHEM, V75, P55, DOI 10.1111/j.1432-1033.1977.tb11503.x; CRECHET JB, 1990, J BIOL CHEM, V265, P1563; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DOUGLASS J, 1979, J BIOL CHEM, V254, P5383; DUISTERWINKEL FJ, 1984, EMBO J, V3, P113, DOI 10.1002/j.1460-2075.1984.tb01770.x; FASANO O, 1978, EUR J BIOCHEM, V89, P557, DOI 10.1111/j.1432-1033.1978.tb12560.x; FASANO O, 1982, J BIOL CHEM, V257, P3145; GORDON J, 1968, P NATL ACAD SCI USA, V59, P179, DOI 10.1073/pnas.59.1.179; GUMUSEL F, 1990, BIOCHIM BIOPHYS ACTA, V1050, P215, DOI 10.1016/0167-4781(90)90169-3; IVELL R, 1981, BIOCHEMISTRY-US, V20, P6852, DOI 10.1021/bi00527a017; JACQUET E, 1992, J BIOL CHEM, V267, P24181; JACQUET E, 1988, EMBO J, V7, P2861, DOI 10.1002/j.1460-2075.1988.tb03142.x; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; MISTOU MY, 1992, EUR J BIOCHEM, V204, P179, DOI 10.1111/j.1432-1033.1992.tb16621.x; OTAKA T, 1974, EUR J BIOCHEM, V50, P101, DOI 10.1111/j.1432-1033.1974.tb03876.x; PARLATO G, 1983, J BIOL CHEM, V258, P995; PARMEGGIANI A, 1981, MOL CELL BIOCHEM, V35, P129, DOI 10.1007/BF02357085; PINGOUD A, 1982, EUR J BIOCHEM, V123, P261, DOI 10.1111/j.1432-1033.1982.tb19762.x; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; SWART GWM, 1987, BIOCHEMISTRY-US, V26, P2047, DOI 10.1021/bi00381a038; WEIJLAND A, 1992, MOL MICROBIOL, V6, P683, DOI 10.1111/j.1365-2958.1992.tb01516.x	29	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24622	24628						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227020				2022-12-27	WOS:A1993MG67300020
J	BARZILAI, N; ROSSETTI, L				BARZILAI, N; ROSSETTI, L			ROLE OF GLUCOKINASE AND GLUCOSE-6-PHOSPHATASE IN THE ACUTE AND CHRONIC REGULATION OF HEPATIC GLUCOSE FLUXES BY INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER GLUCOKINASE; MESSENGER-RNA; MICROSOMAL GLUCOSE-6-PHOSPHATASE; DIABETIC RATS; GENE; SEQUENCE; PATHOGENESIS; SUPPRESSION; EXTRACTS; ISLET	Increased hepatic glucose production (HGP) is the major cause of fasting hyperglycemia in all forms of diabetes. Glucokinase (GK) and glucose-6-phosphatase (Glc-6-Pase) are the proximal and the distal enzymatic steps, respectively, in the regulation of HGP. We examined the impact of changes in GK and Glc-6-Pase activities on in vivo hepatic glucose fluxes in diabetic (D) and control (C) rats. In particular, the acute regulation by insulin was investigated using the euglycemic hyperinsulinemic clamp technique in conscious rats. In experimental diabetes (6 weeks): (a) GK mRNA was decreased by almost-equal-to 40%; (b) the V(max) of GK was markedly decreased (almost-equal-to 4 versus 9 mumol/g wet weight/min) and that of Glc-6-Pase was 2-fold increased (almost-equal-to 30 versus 15 mumol/g wet weight/min, D versus C), while (c) the K(m) of GK (almost-equal-to 10 mM) and Glc-6-Pase (almost-equal-to 1.5 mM) were unchanged. HGP was increased by 65% in diabetes and correlated highly with the ratio of Glc-6-Pase/GK (r = 0.81, p < 0.01). Following acute hyperinsulinemia (2 h): (a) GK mRNA increased by approximately 2-fold in both C and D; (b) GK V(max) did not change in C, but doubled to near-normal in D; (c) Glc-6-Pase V(max) decreased by 23% in C and by 34% in D; (d) the K(m) of GK decreased by almost-equal-to 40% (p < 0.01) in C. Acute hyperinsulinemia almost completely inhibited HGP in both C and D, and no correlation was demonstrated between HGP and the ratio of Glc-6-Pase/GK in these groups. Our data suggest that GK and Glc-6-Pase are important determinants of fasting HGP in diabetes. However, acute changes in Glc-6-Pase and GK activities can account for only a small portion of the in vivo inhibition of hepatic glucose flux by insulin, suggesting additional mechanisms for the short-term regulation of HGP.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DIV ENDOCRINOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,CTR DIABET RES & TRAINING,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NIDDK NIH HHS [DK 20541, R029-DK 42177] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADER M, 1990, AM J PHYSIOL, V258, pE1020, DOI 10.1152/ajpendo.1990.258.6.E1020; ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ASHMORE J, 1959, VITAM HORM NY, V18, P91; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BRADLEY DC, 1993, DIABETES, V42, P296, DOI 10.2337/diabetes.42.2.296; BURCHELL A, 1990, FASEB J, V4, P2978, DOI 10.1096/fasebj.4.12.2168325; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Foglia Virgilio G., 1944, REV SOC ARGENTINA BIOL, V20, P21; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GIACCA A, 1992, J CLIN INVEST, V90, P1769, DOI 10.1172/JCI116051; GIACCARI A, 1989, J CHROMATOGR-BIOMED, V497, P69, DOI 10.1016/0378-4347(89)80006-4; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; HAYZER DJ, 1990, BIOCHEM J, V270, P261, DOI 10.1042/bj2700261; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; KEDZIERSKI W, 1991, BIOTECHNIQUES, V10, P210; KORANYI LI, 1992, DIABETES, V41, P807, DOI 10.2337/diabetes.41.7.807; LANGE AJ, 1986, J BIOL CHEM, V261, P101; LIANG Y, 1991, J BIOL CHEM, V266, P6999; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MICHAL G, 1985, METHODS ENZYMATIC AN, V6; MITHIEUX G, 1990, J BIOL CHEM, V265, P20364; NEWGARD CB, 1984, DIABETES, V33, P192, DOI 10.2337/diabetes.33.2.192; NIEWOEHNER CB, 1988, DIABETES, V37, P1559, DOI 10.2337/diabetes.37.11.1559; PILKIS SJ, 1970, BIOCHIM BIOPHYS ACTA, V215, P461, DOI 10.1016/0304-4165(70)90097-8; PRAGER R, 1987, DIABETES, V36, P607, DOI 10.2337/diabetes.36.5.607; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; ROSSETTI L, 1993, IN PRESS J CLIN INVE; SIBROWSKI W, 1984, J BIOL CHEM, V259, P343; SPENCE JT, 1983, J BIOL CHEM, V258, P9143; SPETH M, 1981, BIOCHEM BIOPH RES CO, V99, P134, DOI 10.1016/0006-291X(81)91723-X; SUZUKI S, 1984, BIOCHEM BIOPH RES CO, V118, P40, DOI 10.1016/0006-291X(84)91064-7; TANIZAWA Y, 1991, P NATL ACAD SCI USA, V88, P7294, DOI 10.1073/pnas.88.16.7294; TSANG SS, 1993, BIOTECHNIQUES, V14, P380; VRANIC M, 1992, DIABETES, V41, P1188, DOI 10.2337/diabetes.41.9.1188; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1	41	151	152	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25019	25025						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227065				2022-12-27	WOS:A1993MG67300075
J	VERKADE, HJ; FAST, DG; RUSINOL, AE; SCRABA, DG; VANCE, DE				VERKADE, HJ; FAST, DG; RUSINOL, AE; SCRABA, DG; VANCE, DE			IMPAIRED BIOSYNTHESIS OF PHOSPHATIDYLCHOLINE CAUSES A DECREASE IN THE NUMBER OF VERY-LOW-DENSITY LIPOPROTEIN PARTICLES IN THE GOLGI BUT NOT IN THE ENDOPLASMIC-RETICULUM OF RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEP G2 CELLS; APOLIPOPROTEIN-B; SECRETION; MEMBRANE; TRANSLOCATION; DEGRADATION; HEPATOCYTES; FRACTIONS; DEFICIENT; PROTEINS	We have investigated the mechanism by which inhibition of phosphatidylcholine biosynthesis in rat hepatocytes by choline deprivation causes a reduction in the secretion of very low density lipoprotein (VLDL) (Yao, Z., and Vance, D. E. (1988) J. Biol. Chem. 263, 2998-3004). Rats ingested a choline-deficient or control diet for 3 days, and subcellular fractions of liver were prepared. No change in the amount of apolipoprotein B in the lumina of the endoplasmic reticulum was observed, but there was a 40-50% decrease of apolipoprotein B in the lumina of the Golgi from choline-deficient compared with control rats. Incubation of microsomes, derived from choline-deficient and -supplemented hepatocytes, with trypsin showed similar degradation of apolipoprotein B, indicating similar quantities of this protein are present on the surface and within the lumina. The VLDL particles in the Golgi of liver cells and in plasma, on average, were larger in samples derived from choline-deficient compared with choline-supplemented animals. Incubation of plasma VLDL with proteases demonstrated that the apolipoprotein B of plasma VLDL particles from choline-deficient animals had a different susceptibility to digestion than did VLDL from choline-supplemented animals. These data indicate that the number of VLDL particles assembled in the endoplasmic reticulum of liver is similar in choline-deficient and -supplemented rats, but the number of particles is decreased in the Golgi from choline-deficient animals.	UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2S2,AB,CANADA	University of Alberta; University of Alberta				Verkade, Henkjan J/0000-0002-7034-2861				BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOREN J, 1994, PROG LIPID RES, V30, P205; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; DASHTI N, 1991, PROG LIPID RES, V30, P219, DOI 10.1016/0163-7827(91)90018-Z; Davis R.A., 1991, BIOCH LIPIDS LIPOPRO, P403; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1993, J LIPID RES, V34, P167; DIXON JL, 1991, J BIOL CHEM, V266, P5080; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GIBBONS GF, 1990, BIOCHEM J, V268, P1; HAMILTON RL, 1991, J LIPID RES, V32, P529; HBOSTROM K, 1986, J BIOL CHEM, V261, P13800; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Lippincott-Schwartz Jennifer, 1993, Trends in Cell Biology, V3, P81, DOI 10.1016/0962-8924(93)90078-F; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; ROBINSON BS, 1989, BIOCHEM J, V260, P207, DOI 10.1042/bj2600207; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; SATO R, 1990, J BIOL CHEM, V265, P11880; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; WETTERAU JR, 1992, SCIENCE, V258, P999; WILKINSON J, 1992, FEBS LETT, V304, P24, DOI 10.1016/0014-5793(92)80581-Z; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373	33	91	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24990	24996						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227061				2022-12-27	WOS:A1993MG67300070
J	QUALLIOTINEMANN, D; AGWU, DE; ELLENBURG, MD; MCCALL, CE; MCPHAIL, LC				QUALLIOTINEMANN, D; AGWU, DE; ELLENBURG, MD; MCCALL, CE; MCPHAIL, LC			PHOSPHATIDIC-ACID AND DIACYLGLYCEROL SYNERGIZE IN A CELL-FREE SYSTEM FOR ACTIVATION OF NADPH OXIDASE FROM HUMAN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; PROTEIN-KINASE-C; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; DEPENDENT SUPEROXIDE PRODUCTION; CHRONIC GRANULOMATOUS-DISEASE; STIMULATED HUMAN-NEUTROPHILS; ADENINE-DINUCLEOTIDE PHOSPHATE; PHOSPHOLIPASE-D ACTIVATION; PHORBOL-MYRISTATE ACETATE; SODIUM DODECYL-SULFATE	NADPH oxidase, the respiratory burst enzyme of human neutrophils, is a multi-component complex that is assembled and activated during stimulation of the cells by inflammatory or phagocytic stimuli. The signal mechanisms leading to activation of the enzyme are unclear, but it is likely that phospholipases are involved. Recent work has shown that phosphatidic acid, the initial product of phospholipase D activation, is a weak activator of NADPH oxidase in a cell-free system. We now show that diacylglycerol enhances the cell-free activation of NADPH oxidase activation by phosphatidic acid. 1,2-Didecanoyl phosphatidic acid (10:0-PA) and 1,2-dioctanoylglycerol (8:0-DG) each increased levels of NADPH oxidase activity in mixtures of membrane and cytosolic fractions about 2-fold. The combination of both lipids increased NADPH oxidase activity approximately 12-fold, indicative of a synergistic response. Fatty acid and neutral lipid metabolites of 10:0-PA or 8:0-DG were ineffective, suggesting activation is directly mediated by phosphatidic acid and diacylglycerol. Activation was time- and concentration-dependent with maximum activation at 30-60 min and a sharp peak of maximal activity at 10 muM 10:0-PA and 30 muM 8:0-DG. In lipid specificity studies, activity of PA or DG decreased with increasing acyl chain length but was restored by introducing unsaturation in the acyl chain. Natural forms of PA stimulated levels of activity comparable to that seen with 10:0-PA. Synthetic and natural phosphatidylserines, but not other phospholipids, could replace phosphatidic acid in the synergistic response. These studies provide direct evidence for a synergistic interaction between phosphatidic acid and diacylglycerol in mediating a cellular function: the assembly and activation of NADPH oxidase. Our results support the concept that the generation of second messenger lipids by phospholipase D is a key step in activation of the respiratory burst enzyme.	WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT BIOCHEM, MED CTR BLVD, WINSTON SALEM, NC 27157 USA; WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT MED, INFECT DIS SECT, WINSTON SALEM, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center			McPhail, Linda C/D-9505-2013	McPhail, Linda C/0000-0002-8670-306X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI009169, R01AI022564, R01AI009169] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI022564, AI-22564, AI-09169] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1992, J BIOL CHEM, V267, P16767; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AGWU DE, 1989, BIOCHEM BIOPH RES CO, V159, P79, DOI 10.1016/0006-291X(89)92407-8; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; AGWU DE, 1989, J BIOL CHEM, V264, P1405; AMBRUSO DR, 1990, J BIOL CHEM, V265, P924; ASAOKA Y, 1992, TRENDS BIOCHEM SCI, V17, P414, DOI 10.1016/0968-0004(92)90011-W; BASS DA, 1987, J BIOL CHEM, V262, P6643; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BELLAVITE P, 1988, J BIOL CHEM, V263, P8210; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOCCKINO SB, 1991, P NATL ACAD SCI USA, V88, P6210, DOI 10.1073/pnas.88.14.6210; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; COCKCROFT S, 1984, BIOCHIM BIOPHYS ACTA, V795, P37, DOI 10.1016/0005-2760(84)90102-4; COX CC, 1986, J IMMUNOL, V136, P4611; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; CURNUTTE JT, 1987, ADV HUM GENET, V16, P229; ENGLISH D, 1991, BIOCHEM BIOPH RES CO, V175, P423, DOI 10.1016/0006-291X(91)91581-V; ERICKSON RW, 1993, FASEB J, V7, pA1059; FUJITA I, 1984, BIOCHEM BIOPH RES CO, V120, P318, DOI 10.1016/0006-291X(84)91256-7; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HONEYCUTT PJ, 1986, J BIOL CHEM, V261, P5900; ISHITOYA J, 1987, BIOCHEM BIOPH RES CO, V144, P1025, DOI 10.1016/S0006-291X(87)80066-9; JALINK K, 1990, J BIOL CHEM, V265, P12232; KANAHO Y, 1991, J IMMUNOL, V146, P3536; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KORCHAK HM, 1988, J BIOL CHEM, V263, P11098; LAMBETH JD, 1988, J BIOENERG BIOMEMBR, V20, P709, DOI 10.1007/BF00762549; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MCPHAIL LC, 1983, J CLIN INVEST, V72, P192, DOI 10.1172/JCI110957; MCPHAIL LC, 1992, GRANULOCYTE RESPONSE, P47; MCPHAIL LC, 1993, NATURAL IMMUNE SYSTE, P63; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; OHTSUKA T, 1989, J BIOCHEM-TOKYO, V106, P259, DOI 10.1093/oxfordjournals.jbchem.a122841; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; PAI JK, 1988, BIOCHEM BIOPH RES CO, V150, P355, DOI 10.1016/0006-291X(88)90528-1; PARK JW, 1992, J BIOL CHEM, V267, P19901; PARK JW, 1992, J BIOL CHEM, V267, P17327; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PERRY D, 1993, FASEB J, V7, pA1259; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; RIDER LG, 1987, J BIOL CHEM, V262, P5603; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SERHAN CN, 1983, BIOCHIM BIOPHYS ACTA, V762, P420, DOI 10.1016/0167-4889(83)90007-1; SMITH CD, 1985, J BIOL CHEM, V260, P5875; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH RM, 1991, BLOOD, V77, P673; TAKENAWA T, 1985, BIOCHEM PHARMACOL, V34, P1931; TAMURA M, 1988, J BIOL CHEM, V263, P17621; TYAGI SR, 1988, J BIOL CHEM, V263, P13191; TYAGI SR, 1992, BIOCHEMISTRY-US, V31, P2765, DOI 10.1021/bi00125a017; UHLINGER DJ, 1991, J BIOL CHEM, V266, P20990; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; VOLPI M, 1983, BIOCHEM BIOPH RES CO, V112, P957, DOI 10.1016/0006-291X(83)91711-4	69	96	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23843	23849						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226922				2022-12-27	WOS:A1993MF29400024
J	HSU, SL; LIN, YF; CHOU, CK				HSU, SL; LIN, YF; CHOU, CK			RETINOIC ACID BIPHASICALLY REGULATES THE GENE-EXPRESSION OF HEPATITIS-B VIRUS SURFACE-ANTIGEN IN HUMAN HEPATOMA HEP3B CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE; X-RECEPTOR; HEPATOCELLULAR-CARCINOMA; RESPONSIVE ELEMENT; RXR-BETA; TRANSCRIPTION; BINDING; LINE; ACTIVATION; ENHANCER	We used human hepatoma Hep3B/C16 cells as a model to examine the effect of all-trans retinoic acid on the gene expression of hepatitis B surface antigen (HBsAg). Hep3B/C16 is a clonal derivative of human hepatoma Hep3B cell which was stably transfected with HBsAg DNA sequences and can produce hepatitis B virus surface antigen. We analyzed the HBsAg product and mRNA in Hep3B/C16 cells which were exposed to retinoic acid for different periods of time. The level of HBsAg started to increase after 24 h and reached maximum at 48 h of retinoic acid treatment. However, the level of HBsAg expression was severely suppressed compared to the control cells after long term (120 h) retinoic acid treatment. Such biphasic regulation of HBsAg production by retinoic acid was paralleled by the changes of HBsAg mRNA. Nuclear run-on assays also demonstrated that the retinoic acid-mediated regulation was determined at least in part at the transcriptional level. Furthermore, an exposure of the cells to retinoic acid for only 8 h was sufficient to show that up- and down-regulation of HBsAg gene occurred 2 and 5 days later. Using a transient expression system, we demonstrated that the retinoic acid response element is located within the 5'-flanking region of the HBsAg gene.	VET GEN HOSP TAIPEI,DEPT MED RES,201,SECT 2,SHIH PAI RD,TAIPEI 11217,TAIWAN; NATL YANG MING MED COLL,GRAD INST MICROBIOL & IMMUNOL,TAIPEI,TAIWAN; ACAD SINICA,INST BIOMED SCI,TAIPEI 112,TAIWAN	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan								ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; BYVOET P, 1986, BIOCH BIOPHY ACTA, V867, P152; CHOU CK, 1992, HEPATOLOGY, V16, P13, DOI 10.1002/hep.1840160104; EICHELE G, 1989, TRENDS GENET, V5, P246, DOI 10.1016/0168-9525(89)90096-6; HSU SL, 1992, BIOCHEM J, V283, P611, DOI 10.1042/bj2830611; HUAN BF, 1992, P NATL ACAD SCI USA, V89, P9059, DOI 10.1073/pnas.89.19.9059; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; NEILSEN DA, 1983, P NATL ACAD SCI USA, V80, P5198; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Roberts A.B., 1984, RETINOIDS, V2, P210; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SPORN MB, 1983, CANCER RES, V43, P3034; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; TURKASPA R, 1986, P NATL ACAD SCI USA, V83, P1627, DOI 10.1073/pnas.83.6.1627; VASIOS G, 1991, EMBO J, V10, P1149, DOI 10.1002/j.1460-2075.1991.tb08055.x; WANEK N, 1991, NATURE, V350, P81, DOI 10.1038/350081a0; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	25	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23093	23097						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226826				2022-12-27	WOS:A1993MF51500023
J	JOSEPH, SK; RYAN, SV				JOSEPH, SK; RYAN, SV			PHOSPHORYLATION OF THE INOSITOL TRISPHOSPHATE RECEPTOR IN ISOLATED RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP-DEPENDENT PHOSPHORYLATION; 1,4,5-TRISPHOSPHATE RECEPTOR; OKADAIC-ACID; PROTEIN-KINASE; CA2+ RELEASE; LUMINAL CA2+; CALCIUM; CA-2+; LIVER; BIOSYNTHESIS	The inositol trisphosphate receptor (IP3R) in brain has been shown to be a substrate for several different protein kinases in vitro. We have studied the phosphorylation of the IP3R in intact cells by using isolated hepatocytes and an antibody to immunoprecipitate the receptor protein from detergent extracts. Stimulation of P-32-labeled hepatocytes with glucagon or N6,2'-O-dibutyryladenosine 3',5'-cyclic monophosphate (db-cAMP) markedly increased phosphorylation of the IP3R. However, no increase was observed in response to angiotensin II, vasopressin, 12-O-tetradecanoyl-phorbol-13-acetate, or epidermal growth factor. The kinetics of phosphorylation in response to glucagon was both rapid and transient. In agreement with previous studies, physiological concentrations of Ca2+ stimulated D-myo-inositol 1,4,5-trisphosphate (IP3) binding to permeabilized hepatocytes (Pietri, F., Hilly, M., and Mauger, J.-P. (1990) J. Biol. Chem. 265, 17478-17485). Pretreatment of cells with db-cAMP had no effect on binding in the absence of added Ca2+ but enhanced binding measured in the presence of basal low concentrations (0.16-0.25 muM) of Ca2+ and decreased the concentration of Ca2+ required for half-maximal stimulation. The effect of db-cAMP was associated with an increase in affinity of the IP3 binding site without a change in maximum number of binding sites. Preincubation of intact hepatocytes with okadaic acid alone produced an increase in basal phosphorylation of the IP3R, and maximal phosphorylation of the receptor was observed in the presence of both okadaic acid and db-cAMP. However, okadaic acid blocked the effect of db-cAMP and inhibited the effect of Ca2+ on IP3 binding. Detergent-solubilized binding sites were already fully activated and insensitive to modulation by Ca2+ or cAMP-dependent protein kinase. It is proposed that the receptor in native membranes is inhibited and that Ca2+ and cAMP-dependent protein kinase may act to relieve this inhibition.			JOSEPH, SK (corresponding author), THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,RM 230A JAH,1020 LOCUST ST,PHILADELPHIA,PA 19107, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA007186] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-07186] Funding Source: Medline; NIDDK NIH HHS [R01-DK-34804] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLAIR JB, 1986, HORMONAL CONTROL GLU, P143; BOND JM, 1991, CELL SIGNAL, V3, P607, DOI 10.1016/0898-6568(91)90037-U; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; BUSHFIELD M, 1991, BIOCHEM J, V274, P317, DOI 10.1042/bj2740317; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; DOSKELAND AP, 1992, EUR J BIOCHEM, V206, P161, DOI 10.1111/j.1432-1033.1992.tb16913.x; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GARCIASAINZ JA, 1991, BIOCHEM BIOPH RES CO, V179, P852, DOI 10.1016/0006-291X(91)91896-K; HAJNOCZKY G, 1993, BIOCHEM J, V293, P413, DOI 10.1042/bj2930413; HATCH GM, 1992, J BIOL CHEM, V267, P15751; HATCH GM, 1992, J BIOL CHEM, V267, P12443; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HIGASHI K, 1991, FASEB J, V5, pA796; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; JOSEPH SK, 1985, J BIOL CHEM, V260, P2508; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; LAI Y, 1990, J BIOL CHEM, V265, P20839; MATTER N, 1993, J BIOL CHEM, V268, P732; MATTINGLY RR, 1992, FEBS LETT, V296, P225, DOI 10.1016/0014-5793(92)80385-T; MAUGER JP, 1989, J BIOL CHEM, V264, P8821; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MIYAZAKI S, 1992, FEBS LETT, V309, P180, DOI 10.1016/0014-5793(92)81090-9; MOUREY RJ, 1990, BIOCHEM J, V272, P383, DOI 10.1042/bj2720383; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PIETRI F, 1990, J BIOL CHEM, V265, P17478; ROONEY TA, 1991, J BIOL CHEM, V266, P12272; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; ROUXEL FP, 1992, J BIOL CHEM, V267, P2; STADDON JM, 1987, BIOCHEM J, V241, P729, DOI 10.1042/bj2410729; STADDON JM, 1989, EUR J BIOCHEM, V179, P47, DOI 10.1111/j.1432-1033.1989.tb14519.x; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; SUPPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR CW, 1992, TRENDS BIOCHEM SCI, V17, P403, DOI 10.1016/0968-0004(92)90009-X; TIJBURG LBM, 1992, BIOCHEM BIOPH RES CO, V182, P1226, DOI 10.1016/0006-291X(92)91862-K; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; ZAMMIT VA, 1992, BIOCHEM J, V284, P901, DOI 10.1042/bj2840901; ZHANG BX, 1993, J BIOL CHEM, V268, P10997	51	92	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23059	23065						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226822				2022-12-27	WOS:A1993MF51500018
J	KRUPSKY, M; FINE, A; BERK, JL; GOLDSTEIN, RH				KRUPSKY, M; FINE, A; BERK, JL; GOLDSTEIN, RH			THE EFFECT OF RETINOIC ACID ON AMINO-ACID-UPTAKE AND PROTEIN-SYNTHESIS BY LUNG FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SYSTEM-A; GENE-EXPRESSION; THYROID-HORMONE; MESSENGER-RNA; RAT-LIVER; TRANSPORT; MEMBRANE; STIMULATION; RECEPTOR	The effect of retinoic acid (RA) on the uptake and utilization of extracellular amino acids by fetal lung fibroblasts was examined. RA decreased the incorporation of [H-3]proline into collagen and other proteins. The effect was maximal at a RA concentration of 10(-5) M; smaller decreases were observed at a RA concentration of 10(-6) M. This decrease in collagen formation was associated with a large decrease in intracellular [H-3] proline. The decrease in intracellular [H-3]proline was first observed at 2 h following the addition of RA to cell cultures. Transport studies employing radiolabeled amino acids revealed that RA decreased the uptake of proline, 2-aminoisobutyric acid, and 2-(methylamino) isobutyric acid but not leucine or methionine. Kinetic analysis of 2-aminoisobutyric acid uptake indicated that this effect was mediated primarily by an increase in apparent K(m), with a lesser decrease in V(max). RA-induced inhibition of proline uptake was not abolished by the presence of cycloheximide nor by pretreatment with indomethacin. Na+,K+-ATPase activity was not affected by RA treatment. These results suggest that RA modulates protein production in fibroblasts by altering the function of the Na+-dependent A transport system for amino acid uptake.	BOSTON UNIV, SCH MED, CTR PULM, K600, 80 E CONCORD ST, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02118 USA; VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA	Boston University; Boston University				Berk, John/0000-0002-1768-2373; Fine, Alan/0000-0001-9351-3048	NHLBI NIH HHS [P01HL-46902] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046902] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALAVOINE S, 1992, J CELL PHYSIOL, V150, P149, DOI 10.1002/jcp.1041500120; BANGHAM AD, 1964, BIOCHEM J, V90, P133, DOI 10.1042/bj0900133; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHAKRABORTY AK, 1990, FEBS LETT, V276, P205, DOI 10.1016/0014-5793(90)80543-R; CHRISTENSEN HN, 1956, J BIOL CHEM, V220, P287; DALLASTA V, 1991, J BIOL CHEM, V266, P1591; DELIMPENS AMPJ, 1980, BRIT J DERMATOL, V103, P319, DOI 10.1111/j.1365-2133.1980.tb07251.x; DINGLE JT, 1965, BIOL REV, V40, P422, DOI 10.1111/j.1469-185X.1965.tb00809.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASS CK, 1991, DNA CELL BIOL, V10, P623, DOI 10.1089/dna.1991.10.623; GLAUERT AM, 1963, J CELL BIOL, V17, P111, DOI 10.1083/jcb.17.1.111; GOLDSTEIN RH, 1986, J BIOL CHEM, V261, P8734; GOSHIMA K, 1984, J CELL BIOL, V98, P801, DOI 10.1083/jcb.98.3.801; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HONG WK, 1986, NEW ENGL J MED, V315, P1501, DOI 10.1056/NEJM198612113152401; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; ISMAILBEIGI F, 1988, J BIOL CHEM, V263, P8162; JETTEN AM, 1981, ANN NY ACAD SCI, V359, P200, DOI 10.1111/j.1749-6632.1981.tb12748.x; JETTEN AM, 1979, EXP CELL RES, V119, P289, DOI 10.1016/0014-4827(79)90356-2; JETTEN AM, 1982, EXP CELL RES, V138, P494, DOI 10.1016/0014-4827(82)90207-5; JOHNSEN S, 1974, J CELL BIOL, V63, P357, DOI 10.1083/jcb.63.2.357; KAPLOWITZ PB, 1987, J CLIN ENDOCR METAB, V64, P563, DOI 10.1210/jcem-64-3-563; KLIP A, 1982, J CELL PHYSIOL, V113, P56, DOI 10.1002/jcp.1041130111; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAINE RO, 1991, J BIOL CHEM, V266, P16969; LEISTER KJ, 1988, J CELL PHYSIOL, V135, P163, DOI 10.1002/jcp.1041350203; LOGAN WJ, 1982, J CELL PHYSIOL, V112, P229, DOI 10.1002/jcp.1041120211; MENDIAZ E, 1986, IN VITRO CELL DEV B, V22, P66, DOI 10.1007/BF02623535; MOFFETT J, 1987, P NATL ACAD SCI USA, V84, P8040, DOI 10.1073/pnas.84.22.8040; OIKARINEN A, 1989, DERMATOLOGICA, V179, P14, DOI 10.1159/000248092; OIKARINEN H, 1985, J CLIN INVEST, V75, P1545, DOI 10.1172/JCI111859; PEARSON D, 1992, J BIOL CHEM, V267, P25364; QIAN NX, 1991, P NATL ACAD SCI USA, V88, P3416, DOI 10.1073/pnas.88.8.3416; SHOTWELL MA, 1983, BIOCHIM BIOPHYS ACTA, V737, P267, DOI 10.1016/0304-4157(83)90003-5; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Snedecor G.W., 1967, STAT METHODS; SPORN MB, 1984, RETINOIDS, V1, P235; STILLWELL W, 1980, BIOCHEM BIOPH RES CO, V97, P148, DOI 10.1016/S0006-291X(80)80147-1; VILLEREAL ML, 1978, J BIOL CHEM, V253, P8257; WASSALL SR, 1990, METHOD ENZYMOL, V189, P383; WASSALL SR, 1988, BIOCHIM BIOPHYS ACTA, V939, P393, DOI 10.1016/0005-2736(88)90085-5; WHITE MF, 1983, J BIOL CHEM, V258, P8028; WILLIAMS ML, 1981, ARCH DERMATOL, V117, P611, DOI 10.1001/archderm.117.10.611	44	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23283	23288						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226851				2022-12-27	WOS:A1993MF51500053
J	CYR, CR; RUDY, B; KRIS, RM				CYR, CR; RUDY, B; KRIS, RM			PROLONGED DESENSITIZATION OF THE HUMAN ENDOTHELIN-A RECEPTOR IN XENOPUS-OOCYTES - COMPARATIVE-STUDIES WITH THE HUMAN NEUROKININ-A RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SMOOTH-MUSCLE CELLS; AGONIST-PROMOTED DESENSITIZATION; BETA-2-ADRENERGIC RECEPTOR; PHOSPHOINOSITIDE HYDROLYSIS; VASOCONSTRICTOR PEPTIDE; MYOCARDIAL-INFARCTION; FUNCTIONAL EXPRESSION; PHOSPHORYLATION SITES; MOLECULAR-CLONING; CDNA	Human endothelin (ET) A receptor (hET(A)R) is a G-protein-mediated receptor that binds ET1 with high affinity and ET2 and ET3 With lower affinities. ET1 is the most potent endogenous vasoconstrictor known at this time. When expressed in Xenopus laevis oocytes, hET(A)R is rapidly desensitized after stimulation with ET1. This desensitization lasts 90-110 min. Human neurokinin A (hNK(A)R) and human serotonin type 2 receptors were also expressed in the Xenopus system for comparison to hET(A)R. hNK(A)R desensitizes for 25-35 min, while the serotonin receptor does not appear to desensitize. To examine the role of the cytoplasmic tail of hET(A)R in desensitization, deletion mutations were constructed which remove 11, 36, and 51 amino acids from the cytoplasmic tail. The mutations removing 11 and 36 residues were functional, but the mutation removing 51 amino acids was not functional. The two functional mutations have a resensitization time similar to that of hET(A)R. In summary, the prolonged desensitization time of hET(A)R is unique for G-protein-mediated receptors and may attenuate the adverse physiological effects of the endothelin family. In addition, the cytoplasmic tail of hET(A)R does not appear to play a role in desensitization or resensitization of this receptor.	NYU MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016; NYU MED CTR,DEPT PHYSIOL CHEM,NEW YORK,NY 10016	New York University; New York University				Rudy, Bernardo/0000-0001-5748-6900; Kris, Richard/0000-0001-6595-7848	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045973] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 45973] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI M, 1991, BIOCHEM BIOPH RES CO, V180, P1265, DOI 10.1016/S0006-291X(05)81332-4; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; CERNACEK P, 1989, BIOCHEM BIOPH RES CO, V161, P1220; CYR C, 1991, BIOCHEM BIOPH RES CO, V181, P184, DOI 10.1016/S0006-291X(05)81399-3; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; ELSHOURBAGY NA, 1992, MOL PHARMACOL, V41, P465; FU T, 1989, FEBS LETT, V257, P351, DOI 10.1016/0014-5793(89)81569-8; HARADA Y, 1987, J NEUROSCI, V7, P3265; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; IVERSON LE, 1990, J NEUROSCI, V10, P2903; KLOOG Y, 1989, FEBS LETT, V253, P199, DOI 10.1016/0014-5793(89)80958-5; KLOOG Y, 1988, SCIENCE, V242, P268, DOI 10.1126/science.2845579; KOHNO M, 1990, METABOL CLIN EXP, V39, P9; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KRIS RM, 1991, CELL GROWTH DIFFER, V2, P15; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; LIN WW, 1989, EUR J PHARMACOL, V166, P581, DOI 10.1016/0014-2999(89)90381-6; LIN WW, 1991, J PHARMACOL EXP THER, V257, P1053; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; MIASIRO N, 1990, EUR J PHARMACOL, V179, P151, DOI 10.1016/0014-2999(90)90412-Y; MIYAUCHI T, 1989, LANCET, V2, P53, DOI 10.1016/S0140-6736(89)90303-6; NAGASE T, 1990, BIOCHEM BIOPH RES CO, V168, P485, DOI 10.1016/0006-291X(90)92347-3; NAKAMUTA M, 1991, BIOCHEM BIOPH RES CO, V177, P34, DOI 10.1016/0006-291X(91)91944-8; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; PAPAC DI, 1992, J BIOL CHEM, V267, P16889; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; RESINK TJ, 1990, EUR J BIOCHEM, V189, P415, DOI 10.1111/j.1432-1033.1990.tb15504.x; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SALMINEN K, 1989, LANCET, V2, P747; SALTZMAN AG, 1991, BIOCHEM BIOPH RES CO, V181, P1469, DOI 10.1016/0006-291X(91)92105-S; SHIMADA S, 1991, EUR J PHARMACOL, V193, P123, DOI 10.1016/0014-2999(91)90211-8; SIMONSON MS, 1990, BIOCHIM BIOPHYS ACTA, V1055, P63, DOI 10.1016/0167-4889(90)90091-Q; STOJILKOVIC SS, 1992, ENDOCRINOLOGY, V130, P465, DOI 10.1210/en.130.1.465; TAKUWA N, 1989, J BIOL CHEM, V264, P7856; TOMITA K, 1989, NEW ENGL J MED, V321, P1127; WATANABE T, 1990, NATURE, V344, P114, DOI 10.1038/344114a0; WOLLBERG Z, 1988, TOXICON, V26, P525, DOI 10.1016/0041-0101(88)90232-2; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	44	30	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26071	26074						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253720				2022-12-27	WOS:A1993MK42500011
J	GARCIA, P; SHOELSON, SE; GEORGE, ST; HINDS, DA; GOLDBERG, AR; MILLER, WT				GARCIA, P; SHOELSON, SE; GEORGE, ST; HINDS, DA; GOLDBERG, AR; MILLER, WT			PHOSPHORYLATION OF SYNTHETIC PEPTIDES CONTAINING TYR-MET-X-MET MOTIFS BY NONRECEPTOR TYROSINE KINASES IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; MURINE LEUKEMIA-VIRUS; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; BACULOVIRUS EXPRESSION; SIGNAL TRANSDUCTION; P85-ALPHA SUBUNIT; TRANSFORMING GENE; ESCHERICHIA-COLI; SH2 DOMAINS	Several tyrosine phosphorylation sites in the insulin receptor kinase substrate IRS-1 are predicted to be within Tyr-Met-X-Met (YMXM) motifs, and synthetic peptides corresponding to these sequences are excellent substrates for the insulin receptor kinase in vitro (Shoelson, S. E., Chatterjee, S., Chaudhuri, M., and White, M. F. (1992) Proc. Natl. Acad. Sci. U. S. A 89, 2027-2031). In this study, YMXM-containing peptides are shown to act as substrates for two members of the nonreceptor subfamily of tyrosine kinases, v-Src and v-Abl (the transforming gene products of Rous sarcoma virus and Abelson murine leukemia virus, respectively). For v-Src, a baculovirus expression system was used which was capable of producing milligram quantities of pure 60-kDa v-Src in Spodoptera frugiperda (Sf9) cells. The source of v-Abl was an Escherichia coli expression vector that produces a fusion protein of glutathione S-transferase with the abl catalytic domain. The synthetic YMXM-containing peptides had among the highest apparent affinities described to date for either tyrosine kinase, with K(m) values as low as 97 muM for v-Src and v-Abl. Comparisons with the results obtained with the insulin receptor kinase revealed differences in substrate specificity among the enzymes. In particular, v-Src was more tolerant of substitutions at the Met+1 and Met+3 positions in the YMXM motif than either v-Abl or the insulin receptor kinase but was more dependent on the presence of a preceding acidic amino acid. For v-Abl, the presence of threonine at any position in the YMXM motif caused a reduction in catalytic efficiency. Phosphorylated YMXM motifs are recognition elements for binding to the src homology 2 domains of phosphatidylinositol 3'-kinase and additional proteins; hence, differences in specificity of tyrosine kinases toward YMXM-containing proteins may have relevance to downstream signaling events.	SUNY STONY BROOK, SCH MED, DEPT PHYSIOL & BIOPHYS, BASIC SCI TOWER T-6, STONY BROOK, NY 11794 USA; BRIGHAM & WOMENS HOSP, DEPT MED, JOSLIN DIABET CTR, DIV RES, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Rockefeller University								BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BARNARD JP, 1980, VIROLOGY, V101, P286; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARSTENS EB, 1980, VIROLOGY, V101, P311, DOI 10.1016/0042-6822(80)90511-5; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; ERIKSON RL, 1979, P NATL ACAD SCI USA, V76, P6260, DOI 10.1073/pnas.76.12.6260; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FERGUSON B, 1985, J BIOL CHEM, V260, P3652; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; GEAHLEN RL, 1990, PEPT PROT PHOSPH, P239; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLOW E, 1988, ANTIBODIES LABORATOR, P302; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; IBA H, 1984, P NATL ACAD SCI-BIOL, V81, P4424, DOI 10.1073/pnas.81.14.4424; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KEMP BE, 1991, METHOD ENZYMOL, V200, P121; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINSON AD, 1980, J BIOL CHEM, V255, P1973; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; Maniatis T., 1982, MOL CLONING; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MORGAN DO, 1991, METHOD ENZYMOL, V200, P645; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; PARK S, 1992, J BIOL CHEM, V267, P11612; RADZIEJEWSKI C, 1989, BIOCHEMISTRY-US, V28, P9047, DOI 10.1021/bi00449a013; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TALMAGE DA, 1989, CELL, V59, P55, DOI 10.1016/0092-8674(89)90869-6; TINKER DA, 1988, J BIOL CHEM, V263, P5024; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WONG TW, 1983, J BIOL CHEM, V258, P1022	40	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25146	25151						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227078				2022-12-27	WOS:A1993MG67300090
J	NILES, EG; CHRISTEN, L				NILES, EG; CHRISTEN, L			IDENTIFICATION OF THE VACCINIA VIRUS MESSENGER-RNA GUANYLTRANSFERASE ACTIVE-SITE LYSINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-GUANYLATE INTERMEDIATE; CAPPING ENZYME; NUCLEOTIDE-SEQUENCE; DNA-LIGASE; ESCHERICHIA-COLI; (GUANINE-7-)METHYLTRANSFERASE COMPLEX; ADENYLYLATION SITE; LARGE SUBUNIT; GUANYLYLTRANSFERASE; GENE	The vaccinia virus mRNA capping enzyme is a heterodimeric protein containing subunits of 97 and 33 kDa, the products of genes D1R and D12L, respectively. The enzyme catalyzes the first three reactions in the mRNA cap formation pathway: mRNA triphosphatase, guanyltransferase and (guanine-7-)methyltransferase. The guanyltransferase reaction proceeds by way of a covalent enzyme GMP (E-GMP) intermediate (Shuman, S. and Hurwitz, J. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 187-191) in which the GMP is linked to the large subunit through a lysine residue (Toyama, R., Mizumoto, K., Nakahara, Y., Tatsuno, T., and Kaziro, Y. (1983) Eur. J. Biochem. 2, 2195-2201; Roth, M. J., and Hurwitz, J. (1984) J. Biol Chem. 259, 13488-13494). In order to identify the map position of the guanyltransferase active site lysine residue, high specific activity [P-32]E-GMP was prepared. Digestion of the E-GMP with hydroxylamine at pH 9.5 yielded a 31-kDa radioactive fragment derived from amino acids 1-273. Cleavage of E-GMP with cyanogen bromide produced a radioactive peptide of 14 kDa corresponding to amino acids 242-365. Lysine residues are found at positions 244 and 260. Staphylococcus aureus V8 protease digestion of cyanogen bromide-cleaved E-GMP yields a radioactive product of about 5 kDa in molecular mass corresponding to the peptide generated by cleavage at glutamic acid residues 253 and 297, demonstrating that lysine 260 is the site of linkage of GMP.			NILES, EG (corresponding author), SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOCHEM,BUFFALO,NY 14214, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028824] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-28824] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMSTRONG J, 1983, NUCLEIC ACIDS RES, V11, P7145, DOI 10.1093/nar/11.20.7145; BAKER DG, 1985, NUCLEIC ACIDS RES, V13, P8323; BARBOSA E, 1978, J BIOL CHEM, V253, P7692; BARKER DG, 1987, EUR J BIOCHEM, V162, P659, DOI 10.1111/j.1432-1033.1987.tb10688.x; Bornstein P, 1977, Methods Enzymol, V47, P132; CONG PJ, 1993, J BIOL CHEM, V268, P7256; CONG PJ, 1992, J BIOL CHEM, V267, P16424; Drapeau G R, 1977, Methods Enzymol, V47, P189; DUNN JJ, 1981, J MOL BIOL, V148, P303, DOI 10.1016/0022-2836(81)90178-9; Gros E., 1967, METHOD ENZYMOL, V11, P238; GUO PX, 1990, P NATL ACAD SCI USA, V87, P4023, DOI 10.1073/pnas.87.11.4023; HEAPHY S, 1987, BIOCHEMISTRY-US, V26, P1688, DOI 10.1021/bi00380a030; HIGMAN MA, 1992, J BIOL CHEM, V267, P16430; ISHINO Y, 1986, MOL GEN GENET, V204, P1, DOI 10.1007/BF00330179; KODAMA K, 1991, NUCLEIC ACIDS RES, V19, P6093, DOI 10.1093/nar/19.22.6093; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; MARTIN SA, 1975, J BIOL CHEM, V250, P9322; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; NILES EG, 1986, VIROLOGY, V153, P96, DOI 10.1016/0042-6822(86)90011-5; NILES EG, 1989, VIROLOGY, V172, P513, DOI 10.1016/0042-6822(89)90194-3; PENA L, 1993, VIROLOGY, V193, P319, DOI 10.1006/viro.1993.1128; ROTH MJ, 1984, J BIOL CHEM, V259, P3488; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT MP, 1987, J MOL BIOL, V193, P479, DOI 10.1016/0022-2836(87)90261-0; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; SMITH GL, 1989, NUCLEIC ACIDS RES, V17, P9051, DOI 10.1093/nar/17.22.9051; THOGERSEN HC, 1985, EUR J BIOCHEM, V147, P325, DOI 10.1111/j.1432-1033.1985.tb08753.x; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; TOYAMA R, 1983, EMBO J, V2, P2195, DOI 10.1002/j.1460-2075.1983.tb01723.x; TUTAS DJ, 1977, J BIOL CHEM, V252, P3092; UPTON C, 1991, VIROLOGY, V183, P773, DOI 10.1016/0042-6822(91)91009-6; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; XU Q, 1990, BIOCHEMISTRY-US, V29, P6132, DOI 10.1021/bi00478a004; [No title captured]	39	39	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24986	24989						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227060				2022-12-27	WOS:A1993MG67300069
J	WU, LNY; YOSHIMORI, T; GENGE, BR; SAUER, GR; KIRSCH, T; ISHIKAWA, Y; WUTHIER, RE				WU, LNY; YOSHIMORI, T; GENGE, BR; SAUER, GR; KIRSCH, T; ISHIKAWA, Y; WUTHIER, RE			CHARACTERIZATION OF THE NUCLEATIONAL CORE COMPLEX RESPONSIBLE FOR MINERAL INDUCTION BY GROWTH-PLATE CARTILAGE MATRIX VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATE-DEHYDROGENASE ISOENZYMES; BOUND ALKALINE-PHOSPHATASE; BINDING-PROTEINS; CALCIUM CHANNELS; MEMBRANE; ACCUMULATION; INVITRO; IDENTIFICATION; ASSOCIATION; ANNEXINS	The factors that drive mineralization of matrix vesicles (MV) have proven difficult to elucidate; in the present studies, various detergent, chemical, and enzyme treatments were used to reveal the nature of the nucleational core. Incubation with detergents that permeabilized the membrane enhanced calcification of treated MV incubated in synthetic cartilage lymph. While detergents removed most of the membrane lipid, they left significant amounts of the MV annexins and nearly all of the Ca2+, P(i), and Zn2+. Extraction with 1 M NaCl removed much of the Ca2+ and P(i) present in MV, markedly reducing Ca2+ accumulation; these effects could be prevented by low levels of Ca2+ and P(i) in the NaCl extractant. Treatment with chymotrypsin appeared to damage proteins required for MV mineralization; further treatment with detergents to bypass the membrane reactivated MV mineralization. Treatment of MV with pH 6 citrate removed Ca2+ and P(i), destroying their ability to mineralize; subsequent treatment with detergents did not reactivate these MV. Incubation of the detergent-resistant core with o-phenanthroline complexed Zn2+ and stimulated mineralization; addition of Zn2+ to synthetic cartilage lymph blocked the ability of the core to mineralize. These studies show that once the nucleational core complex is formed, the membrane-enclosed domain is no longer essential for MV calcification. Our findings indicate that the MV core contains two main components as follows: a smaller membrane-associated complex of Ca2+, P(i), phosphatidylserine, and the annexins that nucleates crystalline mineral formation, and a larger pool of Ca2+ and P(i) bound to lumenal proteins. These proteins appear to bind large amounts of mineral ions, stabilize the nucleational complex, and aid its transformation to the first crystalline phase. Once nucleated, the crystalline phase appears to feed on protein-bound mineral ions until external ions enter through the MV ion channels. Zn2+ appears to regulate gating of the ion channels and conversion of the nucleational complex to the crystalline state.	UNIV S CAROLINA, SCH MED, DEPT CHEM & BIOCHEM, 424 A PHYS SCI BLDG, COLUMBIA, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018983] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR18983] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKISAKA T, 1988, CALCIFIED TISSUE INT, V42, P383, DOI 10.1007/BF02556357; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANDERSON HC, 1969, J CELL BIOL, V41, P59, DOI 10.1083/jcb.41.1.59; BAGINSKI ES, 1973, CLIN CHIM ACTA, V46, P46; Bailey R., 1989, CALCIFIED TISSUE INT, P93, DOI DOI 10.1007/978-1-349-09868-2; BANERJEE P, 1990, BIOCHIM BIOPHYS ACTA, V1044, P305, DOI 10.1016/0005-2760(90)90074-8; BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0; BOSKEY AL, 1980, CALCIFIED TISSUE INT, V32, P139, DOI 10.1007/BF02408533; BOSKEY AL, 1978, METAB BONE DIS RELAT, V1, P137, DOI 10.1016/0221-8747(78)90050-4; BOSKEY AL, 1976, CALCIF TISSUE RES S, V22, P197; CAO X, 1992, Bone and Mineral, V17, P298, DOI 10.1016/0169-6009(92)90757-5; COTMORE JM, 1971, SCIENCE, V172, P1339, DOI 10.1126/science.172.3990.1339; ENNEVER J, 1976, P SOC EXP BIOL MED, V152, P147; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; GENGE BR, 1990, J BIOL CHEM, V265, P4703; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GENGE BR, 1991, J BIOL CHEM, V266, P10678; GENGE BR, 1988, J BIOL CHEM, V263, P18513; HALE JE, 1987, J BIOL CHEM, V262, P1916; Holt C, 1989, CALCIFIED TISSUE, P175; HOSOKAWA R, 1992, BONE MINER, V17, P177, DOI 10.1016/0169-6009(92)90732-S; HOSOKAWA R, 1988, J BIOL CHEM, V263, P10045; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJESKA RJ, 1979, CALCIFIED TISSUE INT, V27, P41, DOI 10.1007/BF02441159; MCLEAN FM, 1987, J BIOL CHEM, V262, P10481; REGISTER TC, 1986, J BIOL CHEM, V261, P9354; ROJAS E, 1992, BONE MINER, V17, P214, DOI 10.1016/0169-6009(92)90739-Z; ROJAS E, 1990, J BIOL CHEM, V265, P21207; SAUER GR, 1988, J BIOL CHEM, V263, P13718; SAUER GR, 1989, BONE MINER, V7, P233, DOI 10.1016/0169-6009(89)90080-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALHMU WB, 1990, BONE MINER, V8, P195, DOI 10.1016/0169-6009(90)90105-O; WU LNY, 1991, J BIOL CHEM, V266, P1195; WU LNY, 1991, J BIOL CHEM, V266, P1187; WU LNY, 1989, BONE MINER, V7, P113, DOI 10.1016/0169-6009(89)90069-X; WUTHIER RE, 1975, BIOCHIM BIOPHYS ACTA, V409, P128, DOI 10.1016/0005-2760(75)90087-9; WUTHIER RE, 1977, CALC TISS RES, V23, P125, DOI 10.1007/BF02012777; WUTHIER RE, 1982, CLIN ORTHOP RELAT R, P219; WUTHIER RE, 1992, INT CONGR SER, V1002, P143; WUTHIER RE, 1993, J NUTR, V123, P301, DOI 10.1093/jn/123.suppl_2.301; WUTHIER RE, 1977, CALC TISS RES, V24, P163, DOI 10.1007/BF02223311	42	101	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25084	25094						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227072				2022-12-27	WOS:A1993MG67300083
J	CARRAWAY, KL; CERIONE, RA				CARRAWAY, KL; CERIONE, RA			INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AGGREGATION BY AN ANTIBODY-DIRECTED AGAINST THE EPIDERMAL GROWTH-FACTOR RECEPTOR EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; EGF-RECEPTOR; SIGNAL TRANSDUCTION; PLASMA-MEMBRANES; CROSS-LINKING; BINDING-SITE; LIVING CELLS; ACTIVATION; KINASE; AUTOPHOSPHORYLATION	We have examined the perturbation of epidermal growth factor (EGF) receptor-receptor interactions by a monoclonal antibody (13A9) that binds to the receptor extracellular domain. While 13A9 did not inhibit EGF binding, it inhibited energy transfer between fluorescent-labeled EGF molecules bound to receptors in membranes from human A431 cells by 70-100%. This antibody also inhibited EGF-stimulated receptor dimerization in membranes as assessed by chemical cross-linking and Fab fragments of the antibody strongly inhibited the EGF-stimulated dimerization of solubilized receptors when assessed by velocity sedimentation. However, under conditions where 13A9 inhibited receptor-receptor interactions within the plasma membranes, the antibody had no effect on EGF-stimulated receptor autophosphorylation or tyrosine kinase activity toward an exogenous substrate. Moreover, although the antibody significantly inhibited receptor dimerization in A431 cells, it had no effect on EGF-stimulated changes in cytosolic free [Ca2+] or I-125-EGF uptake in these cells, or on EGF-stimulated DNA synthesis in Swiss 3T3 cells. We conclude that the dimerization of the EGF receptors in a membrane environment is not required for full activation of tyrosine kinase activity and that inhibition of the dimerization of a large fraction of EGF receptors in cells does not necessarily inhibit several EGF-mediated cellular responses.	CORNELL UNIV,DEPT BIOCHEM MOLEC & CELL BIOL,SCHURMAN HALL,ITHACA,NY 14853; CORNELL UNIV,DEPT PHARMACOL,ITHACA,NY 14853	Cornell University; Cornell University					NIGMS NIH HHS [GM40654] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CADENA DL, 1992, FASEB J, V6, P2332, DOI 10.1096/fasebj.6.6.1312047; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; CARRAWAY KL, 1991, J BIOL CHEM, V266, P8899; CARRAWAY KL, 1989, J BIOL CHEM, V264, P8699; CARRAWAY KL, 1990, BIOCHEMISTRY-US, V29, P8741, DOI 10.1021/bi00489a034; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COCHET C, 1988, J BIOL CHEM, V263, P3290; CONNELLY PA, 1990, P NATL ACAD SCI USA, V266, P22035; ERICKSON JW, 1991, BIOCHEMISTRY-US, V30, P7112, DOI 10.1021/bi00243a011; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KOLAND JG, 1990, BIOCHEM BIOPH RES CO, V166, P90, DOI 10.1016/0006-291X(90)91915-F; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; NORTHWOOD IC, 1989, J BIOL CHEM, V264, P5746; NORTHWOOD IC, 1988, J BIOL CHEM, V263, P7450; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WINKLER ME, 1989, BIOCHEMISTRY-US, V28, P6373, DOI 10.1021/bi00441a033; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1988, BIOCHEMISTRY-US, V27, P3113, DOI 10.1021/bi00409a001; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	25	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23860	23867						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226925				2022-12-27	WOS:A1993MF29400027
J	QIU, ZH; DECARVALHO, MS; LESLIE, CC				QIU, ZH; DECARVALHO, MS; LESLIE, CC			REGULATION OF PHOSPHOLIPASE-A(2) ACTIVATION BY PHOSPHORYLATION IN MOUSE PERITONEAL-MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ARACHIDONOYL-HYDROLYZING PHOSPHOLIPASE-A2; CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2; GROWTH-FACTOR RECEPTOR; OKADAIC ACID; CELL-LINE; MOBILIZING PHOSPHOLIPASE-A2; PROSTAGLANDIN SYNTHESIS; HUMAN-NEUTROPHILS; TUMOR PROMOTER	The regulation of phospholipase A2 (PLA2) activation by phosphorylation, and phosphorylation of an 85-kDa, arachidonoyl-hydrolyzing PLA2 was investigated in mouse peritoneal macrophages. Phorbol 12-myristate 13-acetate (PMA) and okadaic acid, an inhibitor of serine/threonine phosphatases, stimulated arachidonic acid release, supporting a role for phosphorylation events in regulating PLA2 activation. In response to zymosan, PMA, or A23187, arachidonic acid was released at a linear rate up to 30-45 min after stimulation, whereas there was a 30-min lag preceding arachidonic acid release in response to okadaic acid. The 85-kDa PLA2 was phosphorylated on serine in the macrophages, and the level of phosphorylation increased in response to zymosan, PMA, okadaic acid, and, to a lesser extent, A23187. Two-dimensional phosphopeptide mapping revealed multiple phosphopeptides, several of which showed increased phosphorylation in response to zymosan, okadaic acid, and PMA. Zymosan, PMA, A23187, or okadaic acid stimulated time-dependent increases in PLA2 activity in the cytosolic fraction. PLA2 activation was most rapid in response to PMA, whereas activation in response to okadaic acid was delayed similar to the time course of arachidonic acid release. The cytosolic PLA2 had characteristics of the 85-kDa enzyme, including kinetic properties and substrate preference. Phosphatase treatment of the cytosols dephosphorylated the 85-kDa PLA2 and reversed the increase in activity. The results provide evidence that phosphorylation of the 85-kDa PLA2, induced by stimuli that induce arachidonic acid release, is an important mechanism for activation of the enzyme in macrophages.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV BASIC SCI, 1400 JACKSON ST, DENVER, CO 80206 USA; UNIV COLORADO, SCH MED, DEPT PATHOL, DENVER, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NHLBI NIH HHS [HL 34303, P01 HL034303] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADEREM AA, 1986, J EXP MED, V163, P139, DOI 10.1084/jem.163.1.139; ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; BALSINDE J, 1988, J BIOL CHEM, V263, P1929; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLACKWELL GJ, 1980, NATURE, V287, P147, DOI 10.1038/287147a0; BONNEY RJ, 1980, BIOCHIM BIOPHYS ACTA, V633, P410, DOI 10.1016/0304-4165(80)90199-3; BONVENTRE JV, 1990, J BIOL CHEM, V265, P4934; CHAKRABORTI S, 1991, FEBS LETT, V285, P104, DOI 10.1016/0014-5793(91)80735-L; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARK MA, 1987, J BIOL CHEM, V262, P4402; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DIEZ E, 1992, J BIOL CHEM, V267, P18342; DIEZ E, 1990, J BIOL CHEM, V265, P14654; DOLE VP, 1960, J BIOL CHEM, V235, P2595; EMILSSON A, 1986, BIOCHIM BIOPHYS ACTA, V876, P533, DOI 10.1016/0005-2760(86)90041-X; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; GLASER KB, 1993, BIOCHEM PHARMACOL, V45, P711, DOI 10.1016/0006-2952(93)90147-O; GLASER KB, 1990, J BIOL CHEM, V265, P8658; GOLDBERG HJ, 1990, BIOCHEM J, V267, P461, DOI 10.1042/bj2670461; GOPPELTSTRUBE M, 1987, BIOCHEM J, V247, P773, DOI 10.1042/bj2470773; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; GUPTA SK, 1990, SCIENCE, V249, P662, DOI 10.1126/science.2166341; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KIM DK, 1991, BIOCHIM BIOPHYS ACTA, V1083, P80; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LESLIE CC, 1990, METHOD ENZYMOL, V187, P216; LESLIE CC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P261, DOI 10.1016/0005-2760(90)90129-L; LESLIE CC, 1991, J BIOL CHEM, V266, P11366; LESLIE CC, 1994, IN PRESS; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOEB LA, 1986, J BIOL CHEM, V261, P467; MAYER RJ, 1993, FASEB J, V7, P339, DOI 10.1096/fasebj.7.2.8440410; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; NAKAMURA T, 1992, EMBO J, V11, P4917, DOI 10.1002/j.1460-2075.1992.tb05598.x; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; OHUCHI K, 1989, BIOCHIM BIOPHYS ACTA, V1013, P86, DOI 10.1016/0167-4889(89)90132-8; PFANNKUCHE HJ, 1989, BIOCHEM J, V260, P471, DOI 10.1042/bj2600471; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; RAMESHA CS, 1986, J BIOL CHEM, V261, P7592; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SILK ST, 1989, J BIOL CHEM, V264, P21466; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; SPAARGAREN M, 1992, BIOCHEM J, V287, P37, DOI 10.1042/bj2870037; SUGA K, 1990, J BIOL CHEM, V265, P12363; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TEITELBAUM I, 1990, J BIOL CHEM, V265, P4218; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WIJKANDER J, 1991, EUR J BIOCHEM, V202, P873, DOI 10.1111/j.1432-1033.1991.tb16445.x; WIJKANDER J, 1989, FEBS LETT, V244, P51, DOI 10.1016/0014-5793(89)81160-3; WIJKANDER J, 1992, FEBS LETT, V311, P299, DOI 10.1016/0014-5793(92)81124-5; XING MZ, 1992, J BIOL CHEM, V267, P25966; ZUPAN LA, 1992, J BIOL CHEM, V267, P8707	63	146	148	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24506	24513						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8227003				2022-12-27	WOS:A1993MF29400116
J	ROBERTSON, BJ; MOEHRING, JM; MOEHRING, TJ				ROBERTSON, BJ; MOEHRING, JM; MOEHRING, TJ			DEFECTIVE PROCESSING OF THE INSULIN-RECEPTOR IN AN ENDOPROTEASE-DEFICIENT CHINESE-HAMSTER CELL STRAIN IS CORRECTED BY EXPRESSION OF MOUSE FURIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS EXOTOXIN-A; MAMMALIAN-CELLS; POINT MUTATION; PRECURSOR; CLEAVAGE; RESISTANCE; PRORECEPTOR; PROTEINS	Characterization of an endoprotease-deficient mutant Chinese hamster ovary (CHO) cell, designated RPE.40, revealed that it bound less than 10% as much insulin as did its parent, CHO-K1. We examined processing of the endogenous insulin receptor in CHO-K1 and RPE.40 cells, and processing of the human insulin receptor expressed in these cells. RPE.40 cells did not process the endogenous insulin proreceptor to its subunit forms, and processed the human insulin proreceptor inefficiently. Accumulation of the proreceptor form of the insulin receptor was seen in both cases. Furin is a mammalian endoprotease that cleaves proproteins at a consensus sequence of basic amino acids found in the insulin proreceptor. Expression of mouse furin in RPE.40 cells restored normal processing of the endogenous and the human insulin receptor in these cells. In addition, expression of mouse furin corrected the reduced binding of insulin in RPE.40 cells, indicating that receptor function as well as processing was restored.	UNIV VERMONT,DEPT MICROBIOL & MOLEC GENET,MARKEY CTR MOLEC GENET,316 STAFFORD BLDG,BURLINGTON,VT 05405; UNIV VERMONT,COLL MED,VERMONT REG CANC CTR,BURLINGTON,VT 05405	University of Vermont; University of Vermont					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009100] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 09100] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CZECH MP, 1985, ANNU REV PHYSIOL, V47, P357, DOI 10.1146/annurev.ph.47.030185.002041; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; HARRIS RB, 1989, ARCH BIOCHEM BIOPHYS, V275, P315, DOI 10.1016/0003-9861(89)90379-2; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; INOCENCIO NM, 1993, J VIROL, V67, P593, DOI 10.1128/JVI.67.1.593-595.1993; KAKEHI T, 1988, J CLIN INVEST, V81, P2020, DOI 10.1172/JCI113553; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KOBAYASHI M, 1988, BIOCHEM BIOPH RES CO, V153, P657, DOI 10.1016/S0006-291X(88)81145-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOEHRING JM, 1983, INFECT IMMUN, V41, P998, DOI 10.1128/IAI.41.3.998-1009.1983; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOEHRING TJ, 1979, SOMAT CELL GENET, V5, P469, DOI 10.1007/BF01538881; OLSON TS, 1988, J BIOL CHEM, V263, P7342; RHOLAM M, 1986, FEBS LETT, V207, P1, DOI 10.1016/0014-5793(86)80002-3; ROBBINS AR, 1984, J CELL BIOL, V99, P1296, DOI 10.1083/jcb.99.4.1296; STEINER DF, 1992, J BIOL CHEM, V267, P23435; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WATSON DG, 1991, J VIROL, V65, P2332, DOI 10.1128/JVI.65.5.2332-2339.1991; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938	22	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24274	24277						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226974				2022-12-27	WOS:A1993MF29400083
J	ROSTAND, KS; ESKO, JD				ROSTAND, KS; ESKO, JD			CHOLESTEROL AND CHOLESTEROL ESTERS - HOST RECEPTORS FOR PSEUDOMONAS-AERUGINOSA ADHERENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; ADHESION; BINDING; MUCIN; GLYCOSYLATION; MUTANTS; LECTIN; PILI	Bacterial adherence to tissues is a necessary step in infection and results from interactions between surface molecules on the bacteria (adhesins) and plasma membrane receptors on host cells. Using a clinical isolate of Pseudomonas aeruginosa, we have examined the receptors required for adherence to Chinese hamster ovary (CHO) cells. In mutant CHO cell lines and mucin-producing lung epithelial cell lines, adherence did not depend on glycoproteins, glycolipids, or proteoglycans. Treating cells with glutaraldehyde and proteases also did not affect adherence. However, treating cells with ethanol diminished adherence and resulted in removal of factors that would facilitate binding of bacteria when coated on plastic culture plates. These factors were purified by solvent extraction and silica gel chromatography and were identified as cholesterol and cholesterol esters by coelution with authentic standards, gas chromatography, H-1 NMR, and mass spectrometry. Bacterial adherence was reduced to wild-type CHO cells treated with Lovastatin and to cholesterol-requiring insect cells grown in cholesterol-deficient medium, suggesting that the bacteria bound to plasma membrane cholesterol. Thus, this clinical isolate of Pseudomonas uses cholesterol and cholesterol esters for adherence. We propose that binding to cholesterol and cholesterol esters may affect the pathogenicity of similar Pseudomonas strains.	UNIV ALABAMA,SCH DENT,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham	ROSTAND, KS (corresponding author), UNIV ALABAMA,SCH MED,DEPT BIOCHEM,BIRMINGHAM,AL 35294, USA.				NCI NIH HHS [CA46462] Funding Source: Medline; NIGMS NIH HHS [GM33063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; BADDOUR LM, 1990, PRINCIPLES PRACTICE, P9; BAKER N, 1990, INFECT IMMUN, V58, P2361, DOI 10.1128/IAI.58.7.2361-2366.1990; BHAKDI S, 1984, BACTERIAL PROTEIN TO, P173; BHASKAR K R, 1987, European Journal of Respiratory Diseases Supplement, V71, P215; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CERI H, 1986, INFECT IMMUN, V51, P1; CHI E, 1991, INFECT IMMUN, V59, P822, DOI 10.1128/IAI.59.3.822-828.1991; CRAWFORD SW, 1991, APPROACH PULMONARY I, P173; DALTON JP, 1991, EUR J BIOCHEM, V195, P789, DOI 10.1111/j.1432-1033.1991.tb15767.x; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; DOIG P, 1989, CAN J MICROBIOL, V35, P1141, DOI 10.1139/m89-189; DOIG P, 1990, INFECT IMMUN, V58, P124, DOI 10.1128/IAI.58.1.124-130.1990; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; FEINGOLD DS, 1973, ANTIMICROB AGENTS CH, V4, P309; GALABERT C, 1987, CLIN CHIM ACTA, V164, P139, DOI 10.1016/0009-8981(87)90065-9; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Krieger M, 1986, Methods Enzymol, V129, P227; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; LORY S, 1985, CURR TOP MICROBIOL, V118, P53; MACKINNON WB, 1992, EUR J BIOCHEM, V205, P827, DOI 10.1111/j.1432-1033.1992.tb16847.x; Miller V. L., 1992, AMS NEWS, V58, P26; MOORE GE, 1964, CANCER, V17, P170, DOI 10.1002/1097-0142(196402)17:2<170::AID-CNCR2820170206>3.0.CO;2-N; MOORHEAD PS, 1965, EXP CELL RES, V39, P190, DOI 10.1016/0014-4827(65)90022-4; PANJWANI N, 1990, INFECT IMMUN, V58, P114, DOI 10.1128/IAI.58.1.114-118.1990; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; PITT TL, 1990, TOPLEY WILSONS PRINC, P256; Pollack M., 1990, PRINCIPLES PRACTICE, P1673; RAMPHAL R, 1987, INFECT IMMUN, V55, P600, DOI 10.1128/IAI.55.3.600-603.1987; RAMPHAL R, 1984, INFECT IMMUN, V44, P38, DOI 10.1128/IAI.44.1.38-40.1984; RAMPHAL R, 1991, INFECT IMMUN, V59, P1307, DOI 10.1128/IAI.59.4.1307-1311.1991; RAMPHAL R, 1991, INFECT IMMUN, V59, P700, DOI 10.1128/IAI.59.2.700-704.1991; RAVDIN JI, 1989, INFECT IMMUN, V57, P2179, DOI 10.1128/IAI.57.7.2179-2186.1989; REID LM, 1986, EUR J RESPIR DIS, V69, P26; SAIMAN L, 1990, J INFECT DIS, V161, P541, DOI 10.1093/infdis/161.3.541; SAJJAN U, 1992, J CLIN INVEST, V89, P657, DOI 10.1172/JCI115632; SEXTON M, 1992, INFECT IMMUN, V60, P3332, DOI 10.1128/IAI.60.8.3332-3338.1992; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; STRANAHAN PL, 1992, CANCER RES, V52, P2923; TODD TRJ, 1989, AM REV RESPIR DIS, V140, P1585, DOI 10.1164/ajrccm/140.6.1585; WIDDICOMBE J G, 1987, European Journal of Respiratory Diseases Supplement, V71, P197; ZHANG JP, 1992, CELL, V69, P861, DOI 10.1016/0092-8674(92)90296-O	48	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24053	24059						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226950				2022-12-27	WOS:A1993MF29400053
J	TYTGAT, J; NAKAZAWA, K; GROSS, A; HESS, P				TYTGAT, J; NAKAZAWA, K; GROSS, A; HESS, P			PURSUING THE VOLTAGE SENSOR OF A VOLTAGE-GATED MAMMALIAN POTASSIUM CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SHAKER K+-CHANNELS; SODIUM-CHANNEL; SUBUNIT STOICHIOMETRY; GATING CHARGE; S4 REGION; RAT-BRAIN; DROSOPHILA; EXPRESSION; CLONING; S4-SEQUENCE	Ion channels are generally classified as voltage- or ligand-gated channels based upon their ability to respond to a change in the transmembrane voltage or to a specific ligand interaction. The voltage sensor of voltage-gated ion channels is thought to be contained within the fourth putative transmembrane segment, S4, and is characterized by basic residues typically spaced apart. Thus far, a full understanding of all charges contributing to the voltage sensor of voltage-gated potassium channels has been lacking since several neutralization mutants in S4 could not be functionally expressed. By construction of multimeric cDNAs encoding a mammalian RCK1 (Kv1.1) potassium channel, we now report functional expression of all charge neutralizations in the S4 segment, providing a more comprehensive insight into the functioning of the voltage sensor.	HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School			Tytgat, Jan/F-1560-2010	Tytgat, Jan/0000-0003-1778-6022				ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GILLY WF, 1980, BIOPHYS J, V29, P485, DOI 10.1016/S0006-3495(80)85147-2; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; HILLE B, 1992, IONIC CHANNELS EXCIT, P54; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KOREN G, 1990, NEURON, V2, P39; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; TYTGAT J, 1993, BIOPHYS J, V64, pA226	29	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23777	23779						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226910				2022-12-27	WOS:A1993MF29400012
J	APODACA, G; MOSTOV, KE				APODACA, G; MOSTOV, KE			TRANSCYTOSIS OF PLACENTAL ALKALINE PHOSPHATASE-POLYMERIC IMMUNOGLOBULIN RECEPTOR FUSION PROTEINS IS REGULATED BY MUTATIONS OF SER(664)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; CYTOPLASMIC DOMAIN; MDCK CELLS; EXPRESSION; SIGNAL; MODEL; IGA	Two signals are known that regulate the entry of the polymeric immunoglobulin receptor (pIgR) into the transcytotic pathway: binding of the ligand, dimeric IgA, and phosphorylation of Ser664 in the cytoplasmic domain of the receptor. Mutation of Ser664 to an alanine residue generates a receptor that is transcytosed slowly and exhibits increased recycling at the basolateral plasma membrane. In contrast, if Ser664 is mutated to an aspartate (which bears a constant negative charge-like a phosphate group) the receptor is transcytosed at a rate that is greater than the wild-type pIgR. We have constructed fusions of placental alkaline phosphatase (PLAP) with the transmembrane region and cytoplasmic domain of the wild-type or mutant pIgRs described above (PLAP/WT, PLAP/Ala. and PLAP/Asp) in order to study transcytotic signals present in the cytoplasmic domain of the pIgR independently of those present in the lumenal domain. Transcytosis of the fusion proteins was measured by cell surface immunoprecipitation of a single cohort of basolaterally biotinylated fusion proteins as it arrived at the apical plasma membrane. Significantly more of the PLAP/WT fusion (27%) than the PLAP/Ala fusion protein (5%) was transcytosed during a 2-h chase period. In addition, it was found that approximately 10% of a pseudoligand, monovalent I-125-labeled Fabs (derived from affinity-purified anti-PLAP antibodies), was transcyosed by the PLAP/WT fusion, 7% by the PLAP/Ala fusion, and 22% by the PLAP/Asp fusion over a 4-h period. These data are consistent with the hypothesis that the cytoplasmic domain of the pIgR contains information necessary to direct proteins into the transcytotic pathway, albeit inefficiently, and that phosphorylation of Ser664 is at least a partially autonomous signal for transcytosis.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	APODACA, G (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT ANAT, BOX 0452, SAN FRANCISCO, CA 94143 USA.		Apodaca, Gerard/HCJ-0048-2022	mostov, keith/0000-0002-8123-6247	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI25144] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; BRANDTZAEG P, 1981, CLIN EXP IMMUNOL, V44, P221; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HOPKINS CR, 1992, TRENDS BIOCHEM SCI, V17, P27, DOI 10.1016/0968-0004(92)90423-7; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; HUNZIKER W, 1991, CELL, V57, P1; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; MCCOMB RB, 1972, CLIN CHEM, V18, P97; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SOLARI R, 1984, CELL, V36, P61, DOI 10.1016/0092-8674(84)90074-6; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327	22	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23712	23719						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226896				2022-12-27	WOS:A1993MF51500112
J	KUNG, AL; SHERWOOD, SW; SCHIMKE, RT				KUNG, AL; SHERWOOD, SW; SCHIMKE, RT			DIFFERENCES IN THE REGULATION OF PROTEIN-SYNTHESIS, CYCLIN-B ACCUMULATION, AND CELLULAR GROWTH IN RESPONSE TO THE INHIBITION OF DNA-SYNTHESIS IN CHINESE-HAMSTER OVARY AND HELA S3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; PREMATURE MITOSIS; DIVISION; PHASE; REPLICATION; CHECKPOINTS; ENLARGEMENT; ABSENCE	We have shown previously that there are significant differences between mammalian cell lines in response to disruption of the assembly of the mitotic spindle apparatus (Kung, A. L., Sherwood, S. W., and Schimke, R. T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9553-9557). In this paper we report that there are also significant differences between mammalian cell lines in response to the inhibition of DNA synthesis. In HeLa S3 cells protein synthesis is down-regulated, and cellular growth is arrested in response to the inhibition of DNA synthesis. Upon release from inhibition and resumption of normal growth, cellular viability is maintained near untreated control levels. In contrast, Chinese hamster ovary cells continue to accumulate protein and continue to undergo cellular growth during the period of DNA synthesis inhibition. Cyclin B levels accumulate throughout the period of inhibition and rapidly exceed normal levels at mitosis. The degree of aberrant growth during the period of transient DNA synthesis inhibition is directly related to the degree of subsequent cytotoxicity. If protein accumulation and cellular growth are limited with partially inhibitory levels of cycloheximide during the period of DNA synthesis inhibition, the cytotoxic effects are abolished. These results support the concept that aberrant growth and accumulation of proteins during a transient period of DNA synthesis inhibition are primary determinants of subsequent cell killing.	STANFORD UNIV,MED CTR,SCH MED,DEPT BIOL SCI,STANFORD,CA 94305	Stanford University			Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	NATIONAL CANCER INSTITUTE [R01CA016318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM014931] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16318] Funding Source: Medline; NIGMS NIH HHS [GM-14931] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BHUYAN BK, 1989, PHARMACOL THERAPEUT, V42, P307, DOI 10.1016/0163-7258(89)90029-6; CREANOR J, 1984, J CELL SCI, V69, P199; CREANOR J, 1982, J CELL SCI, V58, P263; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; DOWNES CS, 1990, J CELL BIOL, V110, P1855, DOI 10.1083/jcb.110.6.1855; FANTES PA, 1982, J CELL SCI, V55, P383; FRANKFURT OS, 1981, J CELL PHYSIOL, V107, P115, DOI 10.1002/jcp.1041070113; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; KOLBER MA, 1988, J IMMUNOL METHODS, V108, P255, DOI 10.1016/0022-1759(88)90427-9; KUNG AL, 1990, CANCER RES, V50, P7307; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LAMBERT WC, 1967, CANCER RES, V27, P2364; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Maller JL, 1991, CURR OPIN CELL BIOL, V3, P269; MARIANI BD, 1981, P NATL ACAD SCI-BIOL, V78, P4985, DOI 10.1073/pnas.78.8.4985; MITCHISON JM, 1971, BIOL CELL CYCLE; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; NASMYTH K, 1979, J CELL SCI, V39, P215; NURSE P, 1977, EXP CELL RES, V107, P365, DOI 10.1016/0014-4827(77)90358-5; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; REED SI, 1991, TRENDS GENET, V7, P95, DOI 10.1016/0168-9525(91)90064-W; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Rhoads RE, 1991, CURR OPIN CELL BIOL, V3, P1019, DOI 10.1016/0955-0674(91)90123-G; RONNING OW, 1983, EXP CELL RES, V144, P171, DOI 10.1016/0014-4827(83)90451-2; RONNING OW, 1984, EXP CELL RES, V155, P267, DOI 10.1016/0014-4827(84)90788-2; RONNING OW, 1982, J CELL PHYSIOL, V112, P19, DOI 10.1002/jcp.1041120105; SACHSENMAIER W, 1981, CELL CYCLE, P139; SCHIMKE RT, 1991, COLD SH Q B, V56, P417; SHERWOOD SW, 1988, MOL CELL BIOL, V8, P2822, DOI 10.1128/MCB.8.7.2822; SINCLAIR WK, 1967, CANCER RES, V27, P297; STEINMANN KE, 1991, P NATL ACAD SCI USA, V88, P6843, DOI 10.1073/pnas.88.15.6843; YAMASHITA K, 1990, EMBO J, V9, P4331, DOI 10.1002/j.1460-2075.1990.tb07882.x; YEH CJG, 1981, J IMMUNOL METHODS, V43, P269, DOI 10.1016/0022-1759(81)90174-5; ZETTERBERG A, 1983, EXP CELL RES, V144, P199, DOI 10.1016/0014-4827(83)90454-8; ZETTERBERG A, 1984, CYTOMETRY, V5, P368, DOI 10.1002/cyto.990050413; ZETTERBERG A, 1970, ADV CELL BIOL, V1, P211; ZETTERBERG A, 1981, BIOL NORMAL HUMAN GR, P47	42	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23072	23080						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226824				2022-12-27	WOS:A1993MF51500020
J	PANAGIOTIDIS, CH; REYES, M; SIEVERTSEN, A; BOOS, W; SHUMAN, HA				PANAGIOTIDIS, CH; REYES, M; SIEVERTSEN, A; BOOS, W; SHUMAN, HA			CHARACTERIZATION OF THE STRUCTURAL REQUIREMENTS FOR ASSEMBLY AND NUCLEOTIDE-BINDING OF AN ATP-BINDING CASSETTE TRANSPORTER - THE MALTOSE TRANSPORT-SYSTEM OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-COMPONENTS; ADENYLATE KINASE; CYTOPLASMIC MEMBRANE; BACTERIOPHAGE-LAMBDA; MULTIDRUG RESISTANCE; HISTIDINE PERMEASE; INDUCER EXCLUSION; ACTIVE-TRANSPORT; CHLORIDE CHANNEL; MALK PROTEIN	The periplasmic maltose-binding protein-dependent, maltose transport system of Escherichia coli is a well studied member of the ATP-binding cassette family of transport ATPases. In addition to the water-soluble maltose-binding protein, the system comprises three membrane proteins, MalF, MalG, and MalK, which form a heterotetrameric complex (FGK2) in the cytoplasmic membrane. The purified complex exhibits transport-associated ATPase activity. To characterize the requirements for nucleotide binding and hydrolysis by the FGK2 complex, we used plasmids to express different combinations of the individual subunits as well as mutant forms of the MalK subunit. Prior to measuring nucleotide binding, we examined membrane preparations for the presence of each subunit from strains that contained all possible permutations of the three structural genes, malF, malG, and malk. We found that when all three genes were present or when malF and malK were present together, the corresponding antigens were detected easily on Western immunoblots and were soluble in the non-ionic detergent, Triton X- 1 00. In contrast, all other permutations resulted in decreased amounts of antigen or antigen that was Triton X-100-insoluble. We relied on photocross-linking with 8-azido-[P-32]ATP and ATP hydrolysis as indicators of the ability of the transport complex to interact with purine nucleotides. 8-Azido-[P-32]ATP was photocross-linked to the MalK subunit. Photolabeling of MalK was inhibited by ATP, ADP, and GTP and not by other nucleotides. Photolabeling of MalK required the presence of MalF but not MalG. Mutations in malk that affect amino acid residues thought to be directly involved in nucleotide binding did indeed abolish labeling and resulted in loss of transport activity without affecting protein stability. In general, ATP hydrolysis correlated with the photocross-linking. A notable exception is the MalK941 mutant protein which retained the ability to be labeled by 8-azido-[P-32]ATP but was unable to catalyze detectable levels of ATP hydrolysis. Some, but not all, of the malK mutations were dominant to wild type. To study the mechanism of dominance we devised a means of measuring the ability of different wild-type and mutant MalK proteins to interact with the MalF and MalG subunits. This assay relies on the fact that, when a bifunctional MalK-LacZ hybrid protein is associated with the MalF and MalG subunits, it is membrane-bound. Excess MalK competed with the MalK-LacZ hybrid protein for sites in the membrane and resulted in the hybrid fractionating as a soluble protein. We found that the mutant MalK proteins encoded by the strongly dominant malk mutations competed with the MalK-LacZ protein as efficiently as wild type. In contrast, the recessive malK mutations encoded MalK mutant proteins that did not compete with the hybrid, indicating that they were partially defective in the ability to interact with either MalF and/or MalG.	COLUMBIA UNIV COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032; UNIV CONSTANCE,DEPT BIOL,W-7750 CONSTANCE,GERMANY	Columbia University; University of Konstanz					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019276] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19276] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BAVOIL P, 1980, J BIOL CHEM, V255, P8366; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; BROSIUS J, 1985, J BIOL CHEM, V260, P3539; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHAPON C, 1982, J BACTERIOL, V150, P722, DOI 10.1128/JB.150.2.722-729.1982; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DASSA E, 1993, MOL MICROBIOL, V7, P29, DOI 10.1111/j.1365-2958.1993.tb01094.x; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DEAN DA, 1989, J BACTERIOL, V171, P503, DOI 10.1128/jb.171.1.503-510.1989; DEAN DA, 1992, MOL MICROBIOL, V6, P2033, DOI 10.1111/j.1365-2958.1992.tb01376.x; DEAN DA, 1990, J BIOL CHEM, V265, P21005; DUPLAY P, 1987, J MOL BIOL, V194, P663, DOI 10.1016/0022-2836(87)90243-9; EMR SD, 1980, J MOL BIOL, V141, P63, DOI 10.1016/S0022-2836(80)80029-5; FIKES JD, 1987, J BACTERIOL, V169, P2352, DOI 10.1128/jb.169.6.2352-2359.1987; FROSHAUER S, 1984, J BIOL CHEM, V259, P896; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; HOBSON AC, 1984, P NATL ACAD SCI-BIOL, V81, P7333, DOI 10.1073/pnas.81.23.7333; KUHNAU S, 1991, J BACTERIOL, V173, P2180; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCHAL C, 1978, J BACTERIOL, V136, P1109, DOI 10.1128/JB.136.3.1109-1119.1978; Miller J.H., 1972, EXPT MOL GENETICS; MIMIURA CS, 1991, P NATL ACAD SCI USA, V88, P84; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MULLER CW, 1992, J MOL BIOL, V244, P159; PAL PK, 1992, J BIOL CHEM, V267, P25003; REYES M, 1988, J BACTERIOL, V170, P4598, DOI 10.1128/jb.170.10.4598-4602.1988; RIORDAN JR, 1989, SCIENCE, V245, P1066; RONINSON IB, 1990, PEDIATR PULM, V5, P138; ROSE T, 1991, J BIOL CHEM, V266, P23654; Sambrook J, 1989, MOL CLONING LABORATO; Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SHUMAN HA, 1981, J BIOL CHEM, V256, P560; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Silhavy T. J., 1984, EXPT GENE FUSIONS; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAXLER B, 1992, P NATL ACAD SCI USA, V89, P10852, DOI 10.1073/pnas.89.22.10852; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8; TSAI MD, 1991, BIOCHEMISTRY-US, V30, P6806, DOI 10.1021/bi00242a002; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALTER C, 1992, J BIOL CHEM, V267, P8863	49	67	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23685	23696						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226895				2022-12-27	WOS:A1993MF51500109
J	PAUDEL, HK; LEW, J; ALI, Z; WANG, JH				PAUDEL, HK; LEW, J; ALI, Z; WANG, JH			BRAIN PROLINE-DIRECTED PROTEIN-KINASE PHOSPHORYLATES TAU ON SITES THAT ARE ABNORMALLY PHOSPHORYLATED IN TAU ASSOCIATED WITH ALZHEIMERS PAIRED HELICAL FILAMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; BIOCHEMICAL-PROPERTIES; DEPENDENT KINASE; BINDING DOMAINS; DISEASE; EPITOPES; TANGLES; STATE; IDENTIFICATION; PURIFICATION	Brain proline-directed protein kinase (BPDK), which contains a catalytic subunit homologous to and displaying site-specific phosphorylation similar to p34cdc2 kinase (Lew,J., Winkfein, R. J., Paudel, H. K., and Wang, J. H. (1992) J. Biol. Chem. 267, 25922-25926), has been examined for possible involvement in tau phosphorylation. Immunoblot analyses using peptide antibodies specific for BPDK have revealed the presence of the kinase in bovine brain microtubules purified extensively by repeated polymerization and depolymerization cycles. When the microtubule proteins are separated into the tubulin and microtubule-associated protein fractions, BPDK is found exclusively in the latter fraction. BPDK phosphorylates both tau and MAP2, the former protein being phosphorylated to a stoichiometry of 3.8 mol of phosphate/mol of tau. Analysis of the phosphopeptides isolated from the tryptic digest of the phosphorylated bovine tau has revealed seven phosphorylation sites. Based on the sequence alignment between bovine and human tau proteins, these sites correspond to Ser-195, Ser-202, Thr-205, Thr-231, Ser-235, Ser-396, and Ser-404 of human tau. Mass spectrometric analysis of the tau protein isolated from Alzheimer's paired helical filaments (PHFs) has determined three abnormal phosphorylation sites and two phosphopeptides containing a total of five abnormal phosphates (Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., and Ihara, Y. (1992) J. Biol. Chem. 267, 17047-17054). Two of the sites in tau phosphorylated by BPDK, Thr-231 and Ser-235, are among the abnormal phosphorylation sites, and the other sites phosphorylated by BPDK are within phosphopeptides from PHF-tau. These results suggest that BPDK may be one of the kinases responsible for the abnormal phosphorylation-associated PHF-tau.	UNIV CALGARY,FAC MED,DEPT MED BIOCHEM,MED RES COUNCIL,SIGNAL TRANSDUCT GRP,3330 HOSP DR NW,CALGARY T2N 4NI,AB,CANADA	University of Calgary								BAUDIER J, 1987, J BIOL CHEM, V262, P17577; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; FLAMENT S, 1989, J NEUROL SCI, V92, P133, DOI 10.1016/0022-510X(89)90131-7; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HAYES TE, 1991, NEW BIOL, V3, P259; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HISANAGA S, 1991, J BIOL CHEM, V266, P21798; HOSHI M, 1987, FEBS LETT, V217, P237, DOI 10.1016/0014-5793(87)80670-1; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1991, TRENDS NEUROSCI, V14, P218, DOI 10.1016/0166-2236(91)90116-C; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P420, DOI 10.1002/jnr.490250320; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1992, J BIOL CHEM, V267, P13383; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705; MAYERSON M, 1992, EMBO J, V11, P2909; NIXON RA, 1982, J CELL BIOL, V94, P150, DOI 10.1083/jcb.94.1.150; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; UEDA K, 1990, J NEUROSCI, V10, P3295; VINCENT IJ, 1990, BRAIN RES, V531, P127, DOI 10.1016/0006-8993(90)90765-4; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H	50	279	288	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23512	23518						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226879				2022-12-27	WOS:A1993MF51500085
J	SATO, H; KITA, M; SEIKI, M				SATO, H; KITA, M; SEIKI, M			V-SRC ACTIVATES THE EXPRESSION OF 92-KDA TYPE-IV COLLAGENASE GENE THROUGH THE AP-1 SITE AND THE GT BOX HOMOLOGOUS TO RETINOBLASTOMA CONTROL ELEMENTS - A MECHANISM REGULATING GENE-EXPRESSION INDEPENDENT OF THAT BY INFLAMMATORY CYTOKINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS FACTOR-ALPHA; C-JUN ACTIVITY; DEGRADING METALLOPROTEINASES; SUSCEPTIBILITY GENE; CARCINOMA-CELLS; INDUCIBLE GENE; HUMAN-LUNG; TUMOR; SEQUENCE; PROMOTER	The 92-kDa type IV collagenase (matrix metalloproteinase-9; MMP-9) is frequently expressed in cells showing an invasive nature during physiological and pathological processes, and the expression is strictly controlled by a variety of trans-membrane signals. Binding sites for NF-kappaB, Sp-1, and AP-1 are reportedly required for induction of MMP-9 gene expression by tumor necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate. Comparison of the sequence of the newly cloned mouse MMP-9 promoter region with our previous human isolate revealed that, in addition to the above mentioned elements, four units of GGGG(T/A)GGGG sequence (GT box) were conserved between the two species. In this study, we have demonstrated that one of the GT boxes located downstream of the AP-1 site is essential along with the AP-1 site for the activation of the promoter by v-Src but not by tumor necrosis factor-alpha or 12-O-tetradecanoylphorbol-13-acetate. Gel mobility-shift assays revealed that binding proteins for retinoblastoma control element, including Sp-1 family protein, can bind specifically to GT boxes. Thus, the v-Src signals to the AP-1 site and to the GT box homologous to retinoblastoma control element acted synergistically in transcriptional activation. These results suggest that certain v-Src-mediated signals are propagated along pathways that are independent of inflammatory cytokines.			SATO, H (corresponding author), KANAZAWA UNIV,CANC RES INST,DEPT MOLEC VIROL & ONCOL,TAKARA MACHI,KANAZAWA,ISHIKAWA 920,JAPAN.		Seiki, Motoharu/K-9443-2015; SATO, Hiroshi/D-8454-2015					ADLER RR, 1990, DEVELOPMENT, V110, P211; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; APEL I, 1992, MOL CELL BIOL, V12, P3356, DOI 10.1128/MCB.12.8.3356; BAICHWAL VR, 1991, NATURE, V352, P165, DOI 10.1038/352165a0; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; BLOBEL GA, 1991, P NATL ACAD SCI USA, V88, P1162, DOI 10.1073/pnas.88.4.1162; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BRUGGEMAN LA, 1992, ONCOGENE, V7, P1497; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHUA CC, 1985, J BIOL CHEM, V260, P5213; COLLIER IE, 1988, J BIOL CHEM, V263, P10711; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DAILEY L, 1988, GENE DEV, V2, P1700, DOI 10.1101/gad.2.12b.1700; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; FUJII M, 1989, MOL CELL BIOL, V9, P2493, DOI 10.1128/MCB.9.6.2493; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KIM SJ, 1991, P NATL ACAD SCI USA, V88, P3052, DOI 10.1073/pnas.88.8.3052; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Liotta L A, 1982, Cancer Metastasis Rev, V1, P277, DOI 10.1007/BF00124213; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; LIOTTA LA, 1992, SCI AM, V266, P54, DOI 10.1038/scientificamerican0292-54; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MIZEL SB, 1981, P NATL ACAD SCI-BIOL, V78, P2474, DOI 10.1073/pnas.78.4.2474; MULLER D, 1988, BIOCHEM J, V253, P187, DOI 10.1042/bj2530187; MULLER D, 1991, INT J CANCER, V48, P550, DOI 10.1002/ijc.2910480412; NAKAJIMA M, 1987, CANCER RES, V47, P4869; OKADA Y, 1990, BIOCHEM BIOPH RES CO, V171, P610, DOI 10.1016/0006-291X(90)91190-4; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; ROBBINS PD, 1990, NATURE, V352, P541; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO H, 1992, ONCOGENE, V7, P77; SATO H, 1993, ONCOGENE, V8, P395; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; WILHELM SM, 1989, J BIOL CHEM, V264, P17213	56	291	296	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23460	23468						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226872				2022-12-27	WOS:A1993MF51500078
J	TECLEBRHAN, H; OLSSON, J; SWIEZEWSKA, E; DALLNER, G				TECLEBRHAN, H; OLSSON, J; SWIEZEWSKA, E; DALLNER, G			BIOSYNTHESIS OF THE SIDE-CHAIN OF UBIQUINONE-TRANS-PRENYLTRANSFERASE IN RAT-LIVER MICROSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAPRENYL PYROPHOSPHATE SYNTHETASE; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; MICROCOCCUS-LUTEUS; COENZYME-Q; DOLICHOL; TISSUES; IDENTIFICATION; QUANTITATION; SPECIFICITY	The trans-prenyltransferase activity present in rat liver microsomes was investigated using an in vitro system. Geranyl-PP, but not farnesyl-PP is utilized as substrate. The pH optimum is at 8.0, and Mn2+ and Mg2 activate, while Zn2+ completely inhibits the enzyme. Digitonin, taurodeoxycholate, and Tween 80 increase this activity, whereas deoxycholate and SDS are inhibitory. In contrast to the cis-prenyltransferase, the trans-prenyltransferase is not dependent on cytosolic protein factors. The trans-prenyltransferase is present at the cytoplasmic surface of rough and smooth microsomes. Solanesyl-PP and all-trans-geranylgeranyl-PP inhibit the transferase activity but poly-cis-polyprenyl-12-PP, an intermediate in the cis-prenyltransferase reaction, does not. The enzyme reaction gives rise to two products, solanesyl-PP and an unidentified polyprenyl metabolite. Mevinolin treatment distinguishes this enzyme from the cytoplasmic geranylgeranyl-PP synthase. The results demonstrate that rat liver microsomes synthesize solanesyl-PP via a trans-prenyltransferase, which is distinct from cis-prenyltransferase and geranylgeranyl-PP synthase.	KAROLINSKA INST,HUDDINGE HOSP,CLIN RES CTR,S-14186 HUDDINGE,SWEDEN; POLISH ACAD SCI,INST BIOCHEM & BIOPHYS,PL-02532 WARSAW,POLAND	Karolinska Institutet; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	TECLEBRHAN, H (corresponding author), UNIV STOCKHOLM,ARRHENIUS LAB,DEPT BIOCHEM,S-10691 STOCKHOLM,SWEDEN.			Swiezewska, Ewa/0000-0002-3439-8948				ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; APPELKVIST EL, 1991, BIOMED CLIN, V6, P141; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; BEYER RE, 1987, CHEM SCRIPTA, V27, P145; BOSCH H, 1992, ANNU REV BIOCHEM, V61, P157; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY J, 1978, BIOCHIM BIOPHYS ACTA, V530, P487, DOI 10.1016/0005-2760(78)90168-6; CHOJNACKI T, 1975, ANAL BIOCHEM, V69, P505; Dallner G, 1974, Methods Enzymol, V31, P191; EDWARDS PA, 1991, BIOCH LIPIDS LIPOPRO, P383; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x; ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; ERICSSON J, 1991, J BIOL CHEM, V266, P10602; ERICSSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1993, J BIOL CHEM, V268, P832; ERICSSON J, 1991, EUR J BIOCHEM, V202, P789, DOI 10.1111/j.1432-1033.1991.tb16434.x; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FARRANTS AKO, 1989, BIOCHIM BIOPHYS ACTA, V1002, P198, DOI 10.1016/0005-2760(89)90287-7; FUJII H, 1980, BIOCHEM BIOPH RES CO, V96, P1648, DOI 10.1016/0006-291X(80)91363-7; FUJII H, 1982, J BIOL CHEM, V257, P4610; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; ISHII K, 1983, J BIOCHEM-TOKYO, V93, P1635, DOI 10.1093/oxfordjournals.jbchem.a134302; KALEN A, 1990, J BIOL CHEM, V265, P1158; KEENAN RW, 1976, BIOCHEMISTRY-US, V15, P1586, DOI 10.1021/bi00652a032; LIM PH, 1983, BIOCHIM BIOPHYS ACTA, V753, P74, DOI 10.1016/0005-2760(83)90100-5; MEYER RE, 1990, HIGH LIGHTS UBIQUINO, P191; OHNUMA S, 1991, J BIOL CHEM, V266, P23706; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; PAULTER CD, 1981, BIOSYNTHESIS ISOPREN, P161; POPJAK G, 1962, J BIOL CHEM, V237, P56; RAMSAMARA T, 1985, COENZYME Q, P67; RUNQUIST M, 1992, BIOCHEM BIOPH RES CO, V186, P157, DOI 10.1016/S0006-291X(05)80788-0; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; TAKAHASHI I, 1980, J BIOL CHEM, V255, P4539; THELIN A, 1992, FEBS LETT, V313, P118, DOI 10.1016/0014-5793(92)81425-L; TRUMPOWER BL, 1981, J BIOENERG BIOMEMBR, V13, P1, DOI 10.1007/BF00744743; VOELKER DR, 1985, BIOCH LIPIDS MEMBRAN, P475; YUSHIDA I, 1987, BIOCHEMISTRY-US, V26, P6840	41	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23081	23086						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226825				2022-12-27	WOS:A1993MF51500021
J	ZHOU, W; TAKUWA, N; KUMADA, M; TAKUWA, Y				ZHOU, W; TAKUWA, N; KUMADA, M; TAKUWA, Y			PROTEIN KINASE-C-MEDIATED BIDIRECTIONAL REGULATION OF DNA-SYNTHESIS, RB PROTEIN-PHOSPHORYLATION, AND CYCLIN-DEPENDENT KINASES IN HUMAN VASCULAR ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 FIBROBLASTS; RETINOBLASTOMA GENE-PRODUCT; SMOOTH-MUSCLE CELLS; HISTONE-H1 KINASE; FISSION YEAST; MITOGENIC RESPONSE; MESANGIAL CELLS; TUMOR PROMOTER; CDC28 MUTATION; S-PHASE	In human umbilical vein endothelial cells, activators of protein kinase C (PKC) exert cell cycle-dependent, bidirectional growth regulatory effects. Thus, phorbol 12,13-dibutyrate or 1,2-dioctanoylglycerol potentiates growth factor-induced DNA synthesis up to 3-fold when they act during the early G1 phase, whereas they completely inhibit the initiation of DNA synthesis when they act in the late G1 phase. In addition, the PKC activators induce a rapid inhibition of the ongoing DNA synthesis when they are applied after entry into the S phase. The effects of the PKC activators in both stimulatory and inhibitory directions are abolished in PKC-downregulated cells. The cell cycle-dependent, PKC-mediated bidirectional growth regulation is closely associated with either potentiation or inhibition of RB protein phosphorylation and the histone H1 kinase activity of cyclin-dependent kinases (cdks) cdc2 and cdk2, which normally accumulate along the G1 to the S phase transition. Northern and Western blot analyses of cdc2 and cdk2 have revealed that PKC regulates the cdks at multiple steps in distinct ways. Thus, for cdc2, the levels of mRNA and protein as well as the extent of post-translational modification are all subject to the PKC-mediated regulation. In contrast, the level of mRNA or protein of cdk2 is not affected by PKC stimulation at any phase of the cell cycle. These results demonstrate the existence of a complex array of PKC-cdk signaling pathways, which mediate temporally organized bimodal growth regulation in endothelial cells.	UNIV TOKYO,FAC MED,DEPT PHYSIOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT CARDIOVASC BIOL,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo; University of Tokyo				TAKUWA, Noriko/0000-0002-4278-2704				AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DICKER P, 1978, NATURE, V276, P723, DOI 10.1038/276723a0; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HOWE PH, 1991, MOL CELL BIOL, V11, P1185, DOI 10.1128/MCB.11.3.1185; HUANG CL, 1987, NATURE, V329, P849, DOI 10.1038/329849a0; ISSANDOU M, 1991, J BIOL CHEM, V266, P21037; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; KARIYA K, 1987, FEBS LETT, V219, P119, DOI 10.1016/0014-5793(87)81202-4; KARIYA K, 1987, FEBS LETT, V217, P69, DOI 10.1016/0014-5793(87)81245-0; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LABBE JC, 1988, NATURE, V335, P251, DOI 10.1038/335251a0; LABBE JC, 1989, CELL, V57, P253, DOI 10.1016/0092-8674(89)90963-X; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEE MG, 1988, NATURE, V333, P676, DOI 10.1038/333676a0; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; NINOMIYATSUJI J, 1991, P NATL ACAD SCI USA, V88, P9006, DOI 10.1073/pnas.88.20.9006; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1980, GENETICS, V96, P627; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PARIS J, 1991, P NATL ACAD SCI USA, V88, P1039, DOI 10.1073/pnas.88.3.1039; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; ROZENGURT E, 1984, P NATL ACAD SCI-BIOL, V81, P5748, DOI 10.1073/pnas.81.18.5748; ROZENGURT E, 1987, J CELL PHYSIOL, V131, P218, DOI 10.1002/jcp.1041310211; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; TAKUWA N, 1989, J BIOL CHEM, V264, P7856; TAKUWA N, 1987, BIOCHEM J, V243, P647, DOI 10.1042/bj2430647; TAKUWA N, 1993, J BIOL CHEM, V268, P138; TAKUWA N, 1992, FEBS LETT, V306, P173, DOI 10.1016/0014-5793(92)80993-Q; TAKUWA N, 1988, J BIOL CHEM, V263, P9738; TAKUWA N, 1989, AM J PHYSIOL, V257, pF431, DOI 10.1152/ajprenal.1989.257.3.F431; TAKUWA N, 1992, BIOCHEM BIOPH RES CO, V188, P1084, DOI 10.1016/0006-291X(92)91342-N; TAKUWA N, 1991, J BIOL CHEM, V266, P1403; TAKUWA N, 1987, J BIOL CHEM, V262, P182; TAKUWA N, 1991, J BIOL CHEM, V266, P14237; TAYA Y, 1989, BIOCHEM BIOPH RES CO, V164, P580, DOI 10.1016/0006-291X(89)91759-2; THOMAS NSB, 1989, J BIOL CHEM, V264, P13697; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H	65	87	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23041	23048						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226819				2022-12-27	WOS:A1993MF51500015
J	KAMIJO, T; AOYAMA, T; MIYAZAKI, J; HASHIMOTO, T				KAMIJO, T; AOYAMA, T; MIYAZAKI, J; HASHIMOTO, T			MOLECULAR-CLONING OF THE CDNAS FOR THE SUBUNITS OF RAT MITOCHONDRIAL FATTY-ACID BETA-OXIDATION MULTIENZYME COMPLEX - STRUCTURAL AND FUNCTIONAL-RELATIONSHIPS TO OTHER MITOCHONDRIAL AND PEROXISOMAL BETA-OXIDATION ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; 3-HYDROXYACYL-COA DEHYDROGENASE; ENOYL-COA; DELTA-3,DELTA-2-ENOYL-COA ISOMERASE; 3-KETOACYL-COA THIOLASE; BIFUNCTIONAL ENZYME; LIVER MITOCHONDRIA; ZOOGLOEA-RAMIGERA; ESCHERICHIA-COLI; PURIFICATION	Rat liver mitochondrial fatty acid oxidation multienzyme complex consists of 4 mol of the alpha-subunit and 4 mol of the beta-subunit, and has three enzyme activities of long chain enoyl-CoA hydratase, long chain 3-hydroxyacyl-CoA dehydrogenase, and long chain 3-ketoacyl-CoA thiolase. The following cDNA clones for the rat enzyme complex were isolated, sequenced, and expressed: 1) the 2,789-base pair (bp) cDNA clone had a 2,289-bp open reading frame encoding a 82,511-Da precursor and a 78,637-Da mature subunit. The deduced amino acid sequence of this subunit revealed that this cDNA encodes the alpha-subunit and had regions similar to the structure of rat mitochondrial enoyl-CoA hydratase and rat mitochondrial enoyl-CoA isomerase on the amino-terminal side, and a part similar to that of pig mitochondrial 3-hydroxyacyl-CoA dehydrogenase on the carboxyl-terminal side. Expression of this cDNA in COS-1 cells yielded a protein with long chain enoyl-CoA hydratase and long chain 3-hydroxyacyl-CoA dehydrogenase activities. 2) The 1,943-bp cDNA clone had a 1,425-bp open reading frame encoding a 51,413-Da precursor and a 47,583-Da mature subunit. A high similarity of the structure to 3-ketoacyl-CoA thiolases and acetoacetyl-CoA thiolases from various sources suggests that this clone encodes the beta-subunits. Expression of this cDNA in COS-1 cells yielded a protein with long chain 3-ketoacyl-CoA thiolase activity. By phylogenetic analysis of the deduced amino acid sequences of the alpha- and beta-subunits with those of other beta-oxidation enzymes, it was suggested that the alpha-subunit is a descendant of short chain enoyl-CoA hydratase and short chain 3-hydroxyacyl-CoA dehydrogenase while the beta-subunit first diverged from a common ancestor gene of the thiolase family.	UNIV TOKYO,FAC MED,DEPT DIS RELATED GENE REGULAT RES SANDOZ,TOKYO 113,JAPAN; SHINSHU UNIV,SCH MED,DEPT BIOCHEM,MATSUMOTO,NAGANO 390,JAPAN	Novartis; Sandoz; University of Tokyo; Shinshu University	KAMIJO, T (corresponding author), SHINSHU UNIV,SCH MED,DEPT PEDIAT,MATSUMOTO,NAGANO 390,JAPAN.		Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X				ALLISON DS, 1986, P NATL ACAD SCI USA, V83, P9011, DOI 10.1073/pnas.83.23.9011; AMAYA Y, 1986, EUR J BIOCHEM, V156, P9, DOI 10.1111/j.1432-1033.1986.tb09541.x; ARAKAWA H, 1987, EMBO J, V6, P1361, DOI 10.1002/j.1460-2075.1987.tb02376.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BIRKTOFT JJ, 1987, P NATL ACAD SCI USA, V84, P8262, DOI 10.1073/pnas.84.23.8262; BITAR KG, 1980, FEBS LETT, V116, P196, DOI 10.1016/0014-5793(80)80642-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FUKAO T, 1989, J BIOCHEM-TOKYO, V106, P197, DOI 10.1093/oxfordjournals.jbchem.a122832; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; HULTUNEN JK, 1992, J BIOL CHEM, V267, P6646; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; IZAI K, 1992, J BIOL CHEM, V267, P1027; JAVED AA, 1988, P NATL ACAD SCI USA, V85, P1422; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MINAMIISHII N, 1989, EUR J BIOCHEM, V185, P73, DOI 10.1111/j.1432-1033.1989.tb15083.x; MIYAZAWA S, 1981, J BIOCHEM, V90, P511, DOI 10.1093/oxfordjournals.jbchem.a133499; Nei M., 1987, MOL EVOLUT GENET, P293; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NUTTLEY WM, 1988, GENE, V69, P171, DOI 10.1016/0378-1119(88)90428-3; OSUMI T, 1980, ARCH BIOCHEM BIOPHYS, V203, P372, DOI 10.1016/0003-9861(80)90189-7; OSUMI T, 1985, J BIOL CHEM, V260, P8905; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; PEOPLES OP, 1987, J BIOL CHEM, V262, P97; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SAKAI I, 1987, BIOCHEM J, V242, P619, DOI 10.1042/bj2420619; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO S, 1992, J BIOCHEM-TOKYO, V111, P8, DOI 10.1093/oxfordjournals.jbchem.a123722; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; TOMIOKA Y, 1992, BIOCHIM BIOPHYS ACTA, V1130, P109, DOI 10.1016/0167-4781(92)90473-D; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; YANG SY, 1990, J BIOL CHEM, V265, P10424; YANG XYH, 1991, BIOCHEMISTRY-US, V30, P6788, DOI 10.1021/bi00241a023	44	91	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26452	26460						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253773				2022-12-27	WOS:A1993MK42500067
J	KUMAR, KA; MAHALAKSHMI, S; MUNIYAPPA, K				KUMAR, KA; MAHALAKSHMI, S; MUNIYAPPA, K			DNA-INDUCED CONFORMATIONAL-CHANGES IN RECA PROTEIN - EVIDENCE FOR STRUCTURAL HETEROGENEITY AMONG NUCLEOPROTEIN FILAMENTS AND IMPLICATIONS FOR HOMOLOGOUS PAIRING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; PROMOTED ATP HYDROLYSIS; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; INACTIVE FORMS; EXCHANGE; BINDING; COMPLEXES; ACTIVATION; MECHANISM	We have used circular dichroism as a probe to characterize the solution conformational changes in RecA protein upon binding to DNA. This approach revealed that RecA protein acquires significant amounts of alpha-helix upon interaction with DNA. These observations, consistent with the data from crystal structure (Story, R. M., Weber, I., and Steitz, T. (1992) Nature 355, 318-325), support the notion that some basic domains including the DNA binding motifs of RecA protein are unstructured and might contribute to the formation of alpha-helix. A comparison of nucleoprotein filaments comprised of RecA protein and a variety of DNA substrates revealed important structural heterogeneity. The most significant difference was observed with poly(dG) . poly(dC) and related polymers, rich in GC sequences, which induced minimal amounts of alpha-helix in ReaA protein. The magnitude of induction of alpha-helix in RecA protein, which occurred concomitant with the production of ternary complexes, was 2-fold higher with homologous than heterologous duplex DNA. Most importantly, the stimulation of ATP hydrolysis by high salt coincided with that of the induction of alpha-helix in RecA protein. These conformational differences provide a basis for thinking about the biochemical and structural transitions that RecA protein experiences during the formal steps of presynapsis, recognition, and alignment of homologous sequences.	INDIAN INST SCI, DEPT BIOCHEM, BANGALORE 560012, KARNATAKA, INDIA; INDIAN INST SCI, CTR GENET ENGN, BANGALORE 560012, KARNATAKA, INDIA	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore								ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; AMARATUNGA M, 1988, BIOCHEM BIOPH RES CO, V157, P127, DOI 10.1016/S0006-291X(88)80022-6; Blundell T.L., 1976, PROTEIN CRYSTALLOGRA; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; DICAPUA E, 1992, J MOL BIOL, V226, P707, DOI 10.1016/0022-2836(92)90627-V; DICAPUA E, 1990, J STRUCT BIOL, V104, P91, DOI 10.1016/1047-8477(90)90062-H; FLORY J, 1984, P NATL ACAD SCI-BIOL, V81, P7026, DOI 10.1073/pnas.81.22.7026; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; GRIFFITH JD, 1988, CRC CR REV BIOCH MOL, V23, pS43, DOI 10.3109/10409238809083375; GRUSS A, 1991, J BIOL CHEM, V266, P6667; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; JIAN S, 1992, J BIOL CHEM, V267, P4215; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; KOBAYASHI N, 1987, BIOCHEMISTRY-US, V26, P6801, DOI 10.1021/bi00395a033; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KUBISTA M, 1990, J BIOL CHEM, V265, P18891; KUMAR KA, 1992, J BIOL CHEM, V267, P24824; LEAHY MC, 1986, J BIOL CHEM, V261, P6954; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7677, DOI 10.1021/bi00485a017; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MORRICAL SW, 1985, BIOCHEMISTRY-US, V24, P760, DOI 10.1021/bi00324a034; MUENCH KA, 1991, J BIOL CHEM, V266, P844; MUENCH KA, 1990, J BIOL CHEM, V265, P11560; MULLER B, 1990, J MOL BIOL, V212, P97, DOI 10.1016/0022-2836(90)90307-8; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; MUNIYAPPA K, 1990, NUCLEIC ACIDS RES, V18, P3967, DOI 10.1093/nar/18.13.3967; NORDEN B, 1992, J MOL BIOL, V226, P1175, DOI 10.1016/0022-2836(92)91060-3; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PUGH BF, 1988, J BIOL CHEM, V263, P76; RADDING CM, 1991, J BIOL CHEM, V266, P5355; RAMDAS J, 1989, J BIOL CHEM, V264, P17395; RIDDLES PW, 1985, J BIOL CHEM, V260, P170; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; ROULD E, 1992, J MOL BIOL, V226, P127, DOI 10.1016/0022-2836(92)90129-8; SCHUTTE BC, 1988, BIOCHEMISTRY-US, V27, P7886, DOI 10.1021/bi00420a046; Stasiak A, 1988, GENETIC RECOMBINATIO, P265; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; TSANG SS, 1985, J MOL BIOL, V185, P295, DOI 10.1016/0022-2836(85)90405-X; WANG WB, 1988, J BACTERIOL, V170, P4823, DOI 10.1128/jb.170.10.4823-4827.1988; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WUTHRICK K, 1986, NMR PROTEINS NUCLEIC; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L; YU X, 1990, BIOPHYS J, V57, P555, DOI 10.1016/S0006-3495(90)82571-6; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	57	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26162	26170						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253735				2022-12-27	WOS:A1993MK42500026
J	SAGLIOCCO, FA; LASO, MRV; ZHU, DL; TUITE, MF; MCCARTHY, JEG; BROWN, AJP				SAGLIOCCO, FA; LASO, MRV; ZHU, DL; TUITE, MF; MCCARTHY, JEG; BROWN, AJP			THE INFLUENCE OF 5'-SECONDARY STRUCTURES UPON RIBOSOME BINDING TO MESSENGER-RNA DURING TRANSLATION IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; CODON USAGE; 5' LEADER; INITIATION; SEQUENCE; GENE; EFFICIENCY; REGION	The influence of 5'-secondary structure formation and 5'-leader length upon mRNA translation in yeast has been analyzed using a closely related set of cat mRNAs (Vega Laso, M. R., Zhu, D., Sagliocco, F. A., Brown, A. J. P., Tuite, M. F., and McCarthy, J. E. G. (1993) J. Biol. Chem. 268, 6453-6462). A cat mRNA with a relatively short unstructured 5'-leader (22 bases) had a ribosome loading about half that of a cat mRNA with an unstructured 5'-leader of 77 bases. The introduction of 5'-secondary structures at various positions throughout the 5'-leader of the cat mRNA inhibited translation initiation, the degree of inhibition being largely dependent upon the thermodynamic stability of the structure. Each mRNA carrying a 5'-secondary structure had a biphasic polysome distribution, indicating that the mRNA molecules were distributed between untranslated and well translated subpopulations. This suggests that once 5'-secondary structures are unwound, they reform slowly relative to the rate of translation initiation in yeast. Untranslated mRNA accumulated in 43 S preinitiation complexes, even when there were only 5 bases between the 5'-cap and the base of the hairpin. The data are consistent with the scanning hypothesis (Kozak, M. (1989) J. Cell. Biol. 108, 229-241) and suggest that 40 S ribosomal subunits bind to mRNA early in the scanning process, probably before mRNA unwinding has taken place.	UNIV ABERDEEN MARISCHAL COLL,DEPT MOLEC & CELL BIOL,ABERDEEN AB9 1AS,SCOTLAND; GESELL BIOTECHNOL FORSCH MBH,DEPT GENE EXPRESS,W-3300 BRAUNSCHWEIG,GERMANY; UNIV KENT,BIOL LAB,CANTERBURY CT2 7NZ,KENT,ENGLAND	University of Aberdeen; Gesellschaft fur Biotechnologische Forschung mbH; University of Kent			Tuite, Mick/ABC-7909-2020; Brown, Alistair J.P./B-6627-2014	Tuite, Mick/0000-0002-5214-540X; 				BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; BETTANY AJE, 1989, YEAST, V5, P187, DOI 10.1002/yea.320050308; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CIGAN AM, 1987, GENE, V59, P1; CIGAN AM, 1988, MOL CELL BIOL, V8, P2694; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERSTEL B, 1992, MOL MICROBIOL, V6, P2339, DOI 10.1111/j.1365-2958.1992.tb01409.x; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HINNEBUSCH AG, 1990, TRENDS BIOCHEM SCI, V15, P148, DOI 10.1016/0968-0004(90)90215-W; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1992, CRIT REV BIOCHEM MOL, V27, P385, DOI 10.3109/10409239209082567; KOZAK M, 1991, GENE EXPRESSION, V1, P117; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LASO MRV, 1993, J BIOL CHEM, V268, P6453; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LINDQUIST S, 1981, NATURE, V293, P311, DOI 10.1038/293311a0; LINDQUIST S, 1949, ENZYME, V44, P147; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; MAICAS E, 1990, NUCLEIC ACIDS RES, V18, P5823, DOI 10.1093/nar/18.19.5823; MARUYAMA T, 1986, NUCLEIC ACIDS RES, V14, pR151, DOI 10.1093/nar/14.suppl.r151; MOORE PA, 1991, MOL CELL BIOL, V11, P5330, DOI 10.1128/MCB.11.10.5330; OLIVEIRA CC, 1993, MOL MICROBIOL, V9, P521, DOI 10.1111/j.1365-2958.1993.tb01713.x; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SONENBERG N, 1991, TRENDS GENET, V7, P105, DOI 10.1016/0168-9525(91)90440-2; STRUHL K, 1985, NUCLEIC ACIDS RES, V13, P8587, DOI 10.1093/nar/13.23.8587; THACH RE, 1992, CELL, V68, P177, DOI 10.1016/0092-8674(92)90461-K; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TZAMARIAS D, 1989, CELL, V57, P947, DOI 10.1016/0092-8674(89)90333-4; VANDENHEUVEL JJ, 1990, YEAST, V6, P473, DOI 10.1002/yea.320060604; VANDENHEUVEL JJ, 1989, GENE, V79, P83, DOI 10.1016/0378-1119(89)90094-2; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	44	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26522	26530						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253781				2022-12-27	WOS:A1993MK42500075
J	PILBEAM, CC; KAWAGUCHI, H; HAKEDA, Y; VOZNESENSKY, O; ALANDER, CB; RAISZ, LG				PILBEAM, CC; KAWAGUCHI, H; HAKEDA, Y; VOZNESENSKY, O; ALANDER, CB; RAISZ, LG			DIFFERENTIAL REGULATION OF INDUCIBLE AND CONSTITUTIVE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE IN OSTEOBLASTIC MC3T3-E1 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOOXYGENASE MESSENGER-RNA; RAT PREOVULATORY FOLLICLES; HUMAN ENDOTHELIAL-CELLS; GROWTH-FACTOR-BETA; H SYNTHASE; GENE-EXPRESSION; INDUCTION; GLUCOCORTICOIDS; PROTEIN; SERUM	Regulation of mRNA levels for the constitutive and inducible prostaglandin endoperoxide synthases, PGHS-1 and PGHS-2, was examined in murine osteoblastic MC3T3-E1 cells. Serum induction of PGHS-2 mRNA levels was rapid, transient, increased by cycloheximide, and inhibited 72% by cortisol. The cortisol inhibition was blocked by cycloheximide. Serum stimulation of PGHS-1 mRNA was slower, decreased by cycloheximide, and inhibited 28% by cortisol. Increased prostaglandin E2 (PGE2) production and induction of PGHS-2 immunoreactive protein paralleled changes in PGHS-2 mRNA. PGHS-2 mRNA was induced at 2 h in serum-free cells by transforming growth factor-beta (TGF-beta), phorbol 12-myristate 13-acetate, and, to a lesser extent, by forskolin. The combination of phorbol 12-myristate 13-acetate and forskolin was synergistic. TGF-beta induction was prolonged compared with serum, inhibited 67% by cortisol, and the inhibition was not blocked by cycloheximide. TGF-alpha had little effect on PGHS-2 mRNA at 2 h, but the combination of TGF-beta and TGF-alpha was synergistic for PGHS-1 and PGHS-2. PGE2 itself induced PGHS-2 mRNA, and inhibition of PGE2 production decreased the serum induction by 55%, suggesting an important role for autoamplification. The rapidity and amplitude of changes in PGHS-2 suggest that it may be involved in bone responses to acute stresses, such as mechanical strain, inflammation, and injury.			PILBEAM, CC (corresponding author), UNIV CONNECTICUT, CTR HLTH, FARMINGTON, CT 06030 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018063, P01AR038933] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 18063, AR 38933] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAILEY JM, 1991, ANAL BIOCHEM, V196, P11; BAILEY JM, 1988, BIOCHEM BIOPH RES CO, V157, P1159, DOI 10.1016/S0006-291X(88)80995-1; BOGGARAM V, 1991, MOL ENDOCRINOL, V5, P414, DOI 10.1210/mend-5-3-414; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; DEWITT DL, 1990, ADV PROSTAGLANDIN TH, V21, P65; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; FU JY, 1990, J BIOL CHEM, V265, P16737; FULLER K, 1989, J BONE MINER RES, V4, P209; HIRATA F, 1987, J STEROID BIOCHEM, V27, P1053, DOI 10.1016/0022-4731(87)90189-0; HLA T, 1991, J BIOL CHEM, V266, P24059; IWAI Y, 1991, J BIOL CHEM, V266, P17959; KLEINNULEND J, 1991, ENDOCRINOLOGY, V128, P2503, DOI 10.1210/endo-128-5-2503; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; LIN AH, 1989, J BIOL CHEM, V264, P17379; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MARUSIC A, 1991, J IMMUNOL, V146, P2633; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OBANION MK, 1991, J BIOL CHEM, V266, P23261; OSHIMA T, 1991, J BIOL CHEM, V266, P13621; OTTO JC, 1993, J BIOL CHEM, V268, P18234; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1654, DOI 10.1210/endo-126-3-1654; RAISZ LG, 1984, BONE MINERAL RES ANN, V2, P286; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; ROSEN GD, 1989, BIOCHEM BIOPH RES CO, V164, P1358, DOI 10.1016/0006-291X(89)91819-6; SEIBERT K, 1991, ADV PROSTAG THROMB L, V21, P45; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Simmons D.L., 1991, PROSTAGLANDINS LEUKO, P67; SIMONSON MS, 1991, MOL ENDOCRINOL, V5, P441, DOI 10.1210/mend-5-3-441; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; SUMITANI K, 1989, ARCH BIOCHEM BIOPHYS, V270, P588, DOI 10.1016/0003-9861(89)90541-9; WONG WYL, 1992, ENDOCRINOLOGY, V130, P3512, DOI 10.1210/en.130.6.3512; WONG WYL, 1989, MOL ENDOCRINOL, V3, P1714, DOI 10.1210/mend-3-11-1714; WONG WYL, 1991, MOL ENDOCRINOL, V5, P1269, DOI 10.1210/mend-5-9-1269; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YAMAMOTO S, 1990, ADV PROSTAGLANDIN TH, V21, P53	39	161	161	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25643	25649						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245000				2022-12-27	WOS:A1993MK10000054
J	SHEN, BH; MARTIN, LL; BUTT, JN; ARMSTRONG, FA; STOUT, CD; JENSEN, GM; STEPHENS, PJ; LAMAR, GN; GORST, CM; BURGESS, BK				SHEN, BH; MARTIN, LL; BUTT, JN; ARMSTRONG, FA; STOUT, CD; JENSEN, GM; STEPHENS, PJ; LAMAR, GN; GORST, CM; BURGESS, BK			AZOTOBACTER-VINELANDII FERREDOXIN-I - ASPARTATE-15 FACILITATES PROTON-TRANSFER TO THE REDUCED [3FE-4S] CLUSTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; ELECTRON-TRANSFER REACTIONS; SITE-DIRECTED MUTAGENESIS; PUTIDA 7-IRON FERREDOXINS; IRON-SULFUR CLUSTERS; FE-S CLUSTER; SPECTROSCOPIC CHARACTERIZATION; 4FE-4S CLUSTER; 7FE FERREDOXIN; PROTEINS	The [3Fe-4S]+/0 cluster of Azotobacter vinelandii ferredoxin I (AvFdI) has an unusually low and strongly pH-dependent reduction potential (E'0). The reduced cluster exists in two forms, depending upon pH, that exhibit substantially different magnetic circular dichroism (MCD) spectra. Recent studies have established that the MCD changes observed on decreasing the pH from 8.3 (alkaline form) to 6.0 (acid form) cannot be explained either by a change in spin state of the cluster (Stephens, P. J., Jensen, G. M., Devlin, F. J., Morgan, T. V., Stout, C. D., Martin, A. E., and Burgess, B. K. (1991) Biochemistry 30, 3200-3209) or by a major structural change (e.g. ligand exchange) (Stout, C. D. (1993) J. Biol. Chem. 268, 25920-25927). Here, we have examined the influence of aspartate 15 on the pH dependence of the spectroscopic and electrochemical properties of AvFdI by construction of a D15N mutant. Aspartate 15, which is salt-bridged to lysine 84 at the protein surface, is the closest ionizable residue to the [3Fe-4S] cluster. The results show that replacement of aspartate by asparagine results in an approximately 20-mV increase in E' 0 for the [3Fe-4S]+/0 cluster at high pH concomitant with an approximately 0.8-pH unit decrease in the pK of the reduced form. The major pH dependence of E' 0 is preserved as is the effect observed by MCD. These data eliminate the possibility that the MCD change is due to the presence of Asp-15 and support the conclusion that it originates in direct protonation of the [3Fe-4S]0 cluster, probably on a sulfide ion. Voltammetric studies show that interconversion between [3Fe-4S]+ and [3Fe-4S]0 at acidic pH involves rapid electron transfer followed by proton transfer (for reduction) and then proton transfer followed by electron transfer (for oxidation). Ionized aspartate 15 facilitates proton transfer. Thus, protonation and deprotonation are much slower for D15N relative to the native protein at pH >5.5. Proton transfer reactions necessary for further reduction of the [3Fe-4S]0 cluster to the [3Fe-4S]- and [3Fe-4S]2- states are also retarded in D15N. The results suggest that the carboxylate-ammonium salt bridge afforded by Asp-15-Lys-84 conducts protons between the cluster and solvent H2O molecules. Overproduction of D15N FdI, but not native FdI, in A. vinelandii has a negative effect on the growth rate of the organism, suggesting that the rate of protonation or deprotonation of the [3Fe-4S]0 cluster may be important in vivo.	UNIV CALIF IRVINE, DEPT MOLEC BIOL & BIOCHEM, IRVINE, CA 92717 USA; UNIV CALIF IRVINE, DEPT CHEM, IRVINE, CA 92717 USA; SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; UNIV SO CALIF, DEPT CHEM, LOS ANGELES, CA 90089 USA; UNIV CALIF DAVIS, DEPT CHEM, DAVIS, CA 95616 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; University of Southern California; University of California System; University of California Davis			Martin, Lisandra L/E-4482-2010; Butt, Julea/E-2133-2011	Martin, Lisandra L/0000-0003-0486-5813; Butt, Julea/0000-0002-9624-5226; Shen, Binghui/0000-0002-4408-407X	NIGMS NIH HHS [GM-45209, GM-36325] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036325, R01GM045209] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG FA, 1988, FEBS LETT, V234, P107, DOI 10.1016/0014-5793(88)81313-9; ARMSTRONG FA, 1989, FEBS LETT, V259, P15, DOI 10.1016/0014-5793(89)81483-8; ARMSTRONG FA, 1992, ADV INORG CHEM, V38, P117, DOI 10.1016/S0898-8838(08)60063-X; ARMSTRONG FA, 1993, METHOD ENZYMOL, V227, P479, DOI 10.1016/0076-6879(93)27020-H; BEINERT H, 1989, EUR J BIOCHEM, V186, P5, DOI 10.1111/j.1432-1033.1989.tb15170.x; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BUTT JN, 1991, J AM CHEM SOC, V113, P8948, DOI 10.1021/ja00023a054; BUTT JN, 1991, J AM CHEM SOC, V113, P6663, DOI 10.1021/ja00017a045; BUTT JN, 1993, J AM CHEM SOC, V115, P1413, DOI 10.1021/ja00057a026; CHENG H, 1990, J BIOL CHEM, V265, P12388; CHENG H, 1992, J BIOL CHEM, V267, P8073; DEAMER DW, 1989, J MEMBRANE BIOL, V107, P91, DOI 10.1007/BF01871715; FEHER G, 1989, NATURE, V339, P111, DOI 10.1038/339111a0; FUNK WD, 1990, BIOCHEMISTRY-US, V29, P5500, DOI 10.1021/bi00475a013; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; GEORGE SJ, 1984, BIOCHEM J, V224, P247, DOI 10.1042/bj2240247; HOLM L, 1987, EMBO J, V6, P2819, DOI 10.1002/j.1460-2075.1987.tb02578.x; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; IISMAA SE, 1991, J BIOL CHEM, V266, P21563; JOHNSON MK, 1987, BIOCHIM BIOPHYS ACTA, V911, P81, DOI 10.1016/0167-4838(87)90273-1; JOHNSON MK, 1984, J BIOL CHEM, V259, P2274; KANO K, 1993, ANAL CHEM, V65, P1088, DOI 10.1021/ac00056a024; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; LAVIRON E, 1982, ELECTROANAL CHEM, V12, P53; LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3; MARTIN AE, 1989, J BACTERIOL, V171, P3162, DOI 10.1128/jb.171.6.3162-3167.1989; MARTIN AE, 1990, P NATL ACAD SCI USA, V87, P598, DOI 10.1073/pnas.87.2.598; MERRITT EA, 1993, ACTA CRYSTALLOGR D, V49, P272, DOI 10.1107/S0907444992007248; MORGAN TV, 1984, FEBS LETT, V264, P275; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; NAGLE JF, 1983, J MEMBRANE BIOL, V74, P1, DOI 10.1007/BF01870590; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; NICHOLSON RS, 1964, ANAL CHEM, V36, P706, DOI 10.1021/ac60210a007; OKAMURA MY, 1992, ANNU REV BIOCHEM, V61, P861; ONATE YA, 1989, J BIOL CHEM, V264, P18386; REES DC, 1985, P NATL ACAD SCI USA, V82, P3082, DOI 10.1073/pnas.82.10.3082; RODGERS KK, 1991, J AM CHEM SOC, V113, P9419, DOI 10.1021/ja00024a087; RONGEY SH, 1993, P NATL ACAD SCI USA, V90, P1325, DOI 10.1073/pnas.90.4.1325; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SOMAN J, 1991, J BIOL CHEM, V266, P21558; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOUT CD, 1988, J BIOL CHEM, V263, P9256; STOUT CD, 1989, J MOL BIOL, V205, P545, DOI 10.1016/0022-2836(89)90225-8; STOUT CD, 1979, J BIOL CHEM, V254, P3598; STOUT CD, 1993, J BIOL CHEM, V268, P25920; STOUT GH, 1988, P NATL ACAD SCI USA, V85, P1020, DOI 10.1073/pnas.85.4.1020; SUCHETA A, 1993, BIOCHEMISTRY-US, V32, P5455, DOI 10.1021/bi00071a023; TAKAHASHI E, 1991, FEBS LETT, V283, P140, DOI 10.1016/0014-5793(91)80572-K; Thomson A. J., 1985, METALLOPROTEINS 1, P79; THOMSON AJ, 1992, J INORG BIOCHEM, V47, P197, DOI 10.1016/0162-0134(92)84065-U; THOMSON AJ, 1991, FEBS LETT, V285, P230, DOI 10.1016/0014-5793(91)80807-F; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WILLIAMS RJP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P71, DOI 10.1016/S0005-2728(05)80272-5; YOCH DC, 1978, J BACTERIOL, V136, P822, DOI 10.1128/JB.136.2.822-824.1978; ZHAO JD, 1992, BIOCHEMISTRY-US, V31, P5093, DOI 10.1021/bi00137a001	55	94	94	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25928	25939						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245026				2022-12-27	WOS:A1993MK10000092
J	VOGEL, SS; LEIKINA, EA; CHERNOMORDIK, LV				VOGEL, SS; LEIKINA, EA; CHERNOMORDIK, LV			LYSOPHOSPHATIDYLCHOLINE REVERSIBLY ARRESTS EXOCYTOSIS AND VIRAL FUSION AT A STAGE BETWEEN TRIGGERING AND MEMBRANE MERGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; SQUID GIANT SYNAPSE; INFLUENZA HEMAGGLUTININ; CORTICAL REACTION; VESICLE FUSION; CALCIUM; VIRUS; GRANULES; PH; BACULOVIRUS	Little is known of the events occurring between membrane fusion triggering and subsequent fusion steps. To dissect this process we applied a reversible inhibitor of membrane fusion, lysophosphatidylcholine, to arrest exocytosis and virus-mediated syncytia formation. Next Ca2+ or H+ (the respective fusion triggers) was administered and later removed. Then, inhibitor was withdrawn and fusion ensued, demonstrating that triggering causes the formation of an ''activated state,'' which later develops into the fused state. Therefore, while different fusion processes utilize different triggers, the pivotal step involving membrane merger is trigger-independent and lipid-sensitive.	NICHHD, THEORET & PHYS BIOL LAB, BLDG 10, RM 6C-101, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)			Vogel, Steven/A-3585-2012	Vogel, Steven/0000-0002-3005-2667				ADLER EM, 1991, J NEUROSCI, V11, P1496; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; BLUMENTHAL R, 1991, ANN NY ACAD SCI, V635, P285, DOI 10.1111/j.1749-6632.1991.tb36499.x; BRUNNER J, 1991, BIOCHEMISTRY-US, V30, P2432, DOI 10.1021/bi00223a019; CHANDLER DE, 1989, J CELL BIOL, V109, P1269, DOI 10.1083/jcb.109.3.1269; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; CHERNOMORDIK LV, 1985, BIOCHIM BIOPHYS ACTA, V812, P643, DOI 10.1016/0005-2736(85)90257-3; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; DECKER SJ, 1983, DEV BIOL, V96, P37, DOI 10.1016/0012-1606(83)90309-3; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; GURAYA SS, 1982, INT REV CYTOL, V78, P257, DOI 10.1016/S0074-7696(08)60108-4; HOLZ RW, 1991, ANN NY ACAD SCI, V635, P382, DOI 10.1111/j.1749-6632.1991.tb36506.x; HYLANDER BL, 1981, DEV BIOL, V86, P1, DOI 10.1016/0012-1606(81)90309-2; KELSEY DR, 1990, J BIOL CHEM, V265, P12178; KRUMBIEGEL M, 1992, BIOCHIM BIOPHYS ACTA, V1110, P158, DOI 10.1016/0005-2736(92)90353-N; LEIKINA E, 1992, FEBS LETT, V304, P221, DOI 10.1016/0014-5793(92)80623-O; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MERKLE CJ, 1989, J MEMBRANE BIOL, V112, P223, DOI 10.1007/BF01870953; NOVICK SL, 1988, P NATL ACAD SCI USA, V85, P7433, DOI 10.1073/pnas.85.20.7433; SCHOCH C, 1992, FEBS LETT, V311, P221, DOI 10.1016/0014-5793(92)81107-W; SEKIGUCHI K, 1981, BIOCHIM BIOPHYS ACTA, V645, P211, DOI 10.1016/0005-2736(81)90191-7; SIEGEL DP, 1993, VIRAL FUSION MECHANI, P475; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; VOGEL SS, 1992, P NATL ACAD SCI USA, V89, P4749, DOI 10.1073/pnas.89.10.4749; VOGEL SS, 1991, ANN NY ACAD SCI, V635, P35, DOI 10.1111/j.1749-6632.1991.tb36479.x; VOGEL SS, 1992, J BIOL CHEM, V267, P25640; WHALLEY T, 1988, BIOSCIENCE REP, V8, P335, DOI 10.1007/BF01115224; White JM, 1989, CURR OPIN CELL BIOL, V1, P934, DOI 10.1016/0955-0674(89)90061-6; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WUNDERLIALLENSPACH H, 1993, BIOCHEMISTRY-US, V32, P900, DOI 10.1021/bi00054a022; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245; ZIMMERBERG J, 1985, NATURE, V315, P581, DOI 10.1038/315581a0; ZIMMERBERG J, 1985, J CELL BIOL, V101, P2398, DOI 10.1083/jcb.101.6.2398; ZUCKER RS, 1978, BIOCHIM BIOPHYS ACTA, V541, P459, DOI 10.1016/0304-4165(78)90155-1	39	93	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25764	25768						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245012				2022-12-27	WOS:A1993MK10000071
J	FRANCISCO, WA; ABUSOUD, HM; BALDWIN, TO; RAUSHEL, FM				FRANCISCO, WA; ABUSOUD, HM; BALDWIN, TO; RAUSHEL, FM			INTERACTION OF BACTERIAL LUCIFERASE WITH ALDEHYDE SUBSTRATES AND INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABILIZATION; SITE	Bacterial luciferase catalyzes the reaction of FMNH2, O2, and an aliphatic aldehyde to yield the carboxylic acid, FMN, water and blue-green light. The kinetics of the bacterial luciferase reaction were measured by stopped-flow spectrophotometry at pH 7 and 25-degrees-C for the series of aldehydes from n-heptanal to n-undecanal. The rate of formation of the 4a-hydroperoxyflavin intermediate was dependent on the aldehyde concentration when mixtures of enzyme, FMNH2, and aldehyde were rapidly mixed with O2. At saturating aldehyde, the rate of formation of this intermediate was 100-fold slower than in the absence of aldehyde, demonstrating that an enzyme.FMNH2.aldehyde complex can be formed. Numerical simulation of the time courses for these experiments supported the formation of this intermediate and its direct reaction with O2. The kinetics of the light emitting reaction were dependent upon the chain length of the aldehyde substrate. Although the initial light intensity and the light emission decay rate were different for each aldehyde, the quantum yield for the reaction was independent of the aldehyde used. Luciferase was inhibited by high levels of the aldehyde substrate when the enzyme was assayed by mixing FMNH2 with an aerobic mixture of enzyme and aldehyde. The extent of inhibition was dependent on the particular aldehyde used, and the binding affinity of the aldehyde for the free enzyme increased in parallel with the aldehyde chain length. The kinetics of the formation and decay of the various intermediates were also studied in the presence of n-alkylaldehyde analogs. These compounds decreased the rate of formation of the 4a-hydroperoxyflavin intermediate in much the same way as the aldehyde substrate, presumably by the formation of the enzyme FMNH2.analog ternary complex.	TEXAS A&M UNIV SYST,DEPT BIOCHEM & BIOPHYS,COLL STN,TX 77843; TEXAS A&M UNIV SYST,CTR MACROMOLEC DESIGN,COLL STN,TX 77843	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	RAUSHEL, FM (corresponding author), TEXAS A&M UNIV SYST,DEPT CHEM,COLL STN,TX 77843, USA.		Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089	NIGMS NIH HHS [GM33894] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033894] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSOUD H, 1992, BIOCHEMISTRY-US, V31, P3807, DOI 10.1021/bi00130a011; ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; AHRENS M, 1991, PHOTOCHEM PHOTOBIOL, V54, P295, DOI 10.1111/j.1751-1097.1991.tb02019.x; BALDWIN TO, 1989, J BIOLUM CHEMILUM, V4, P40, DOI 10.1002/bio.1170040111; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, P467; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BAUMSTARK AL, 1979, ARCH BIOCHEM BIOPHYS, V193, P449, DOI 10.1016/0003-9861(79)90051-1; CURRY S, 1990, BIOCHEMISTRY-US, V29, P4641, DOI 10.1021/bi00471a020; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; HAMMOCK BD, 1982, PESTIC BIOCHEM PHYS, V17, P76, DOI 10.1016/0048-3575(82)90128-6; HASTINGS JW, 1966, BIOLUMINESCENCE PROG, P151; Hastings JW., 1978, METHOD ENZYMOL, V57, P135; HASTINGS JW, 1963, J BIOL CHEM, V242, P720; MAKEMSON JC, 1992, ARCH BIOCHEM BIOPHYS, V294, P361, DOI 10.1016/0003-9861(92)90696-T; MASSEY V, 1971, FLAVINS FLAVOPROTEIN; TORSSELL K, 1957, ACTA CHEM SCAND, V11, P404, DOI 10.3891/acta.chem.scand.11-0404; TU SC, 1986, METHOD ENZYMOL, V133, P128; TU SC, 1979, BIOCHEMISTRY-US, V18, P5940, DOI 10.1021/bi00593a028; VERVOORT J, 1986, BIOCHEMISTRY-US, V25, P8086; WATANABE T, 1972, BIOCHEM J, V72, P647; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Williams C H Jr, 1979, Methods Enzymol, V62, P185; ZIEGLER MM, 1981, CURR TOP BIOENERG, V12, P65; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	24	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24734	24741						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227032				2022-12-27	WOS:A1993MG67300035
J	KISSELEV, O; GAUTAM, N				KISSELEV, O; GAUTAM, N			SPECIFIC INTERACTION WITH RHODOPSIN IS DEPENDENT ON THE GAMMA-SUBUNIT TYPE IN A G-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOTORECEPTOR-G-PROTEIN; BETA-SUBUNIT; TRANSDUCIN; CDNA; RECONSTITUTION; IDENTIFICATION; RECEPTORS; HOMOLOGY; CONTAIN; SYSTEM	Interaction with a receptor is the first step in the process of signal transduction by heterotrimeric (alphabetagamma) G proteins. We have examined the role of the G protein gamma subunit in interaction between a receptor (rhodopsin) and a G protein, transducin (G(t)). We have obtained recombinant betagamma complexes containing the same beta subunit but three different gamma subunit types by expressing them in the baculovirus/insect cell system. We show that the different recombinant betagamma complexes interact equally well with the alpha subunit of transducin (alpha(t)) but only the gamma subunit specific to rod photoreceptors (gamma1) is able to support interaction of alpha(t) with rhodopsin. This indicates a direct role for the G protein gamma subunits, which are a family of proteins with diverse structures, in conferring specificity to receptor-G protein interaction.	WASHINGTON UNIV,SCH MED,DEPT GENET,BOX 8054,660 S EUCLID AVE,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT ANESTHESIOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046963] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046963, GM 46963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CERIONE RA, 1987, BIOCHEMISTRY-US, V26, P1485, DOI 10.1021/bi00379a041; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GAUTAM N, 1990, P NATL ACAD SCI USA, V87, P7973, DOI 10.1073/pnas.87.20.7973; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRABER SG, 1992, J BIOL CHEM, V267, P13123; HAMM HE, 1991, CELL MOL NEUROBIOL, V11, P563, DOI 10.1007/BF00741446; HEKMAN M, 1987, EUR J BIOCHEM, V169, P431, DOI 10.1111/j.1432-1033.1987.tb13630.x; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; LEE RH, 1992, J BIOL CHEM, V267, P24776; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PRONIN AN, 1993, FEBS LETT, V328, P89, DOI 10.1016/0014-5793(93)80971-V; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; SHINOZAWA T, 1980, P NATL ACAD SCI-BIOL, V77, P1408, DOI 10.1073/pnas.77.3.1408; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPIEGEL AM, 1990, SOC GEN PHY, V45, P185; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868	35	96	96	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24519	24522						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227005				2022-12-27	WOS:A1993MG67300002
J	ERICKSON, PR; HERZBERG, MC				ERICKSON, PR; HERZBERG, MC			EVIDENCE FOR THE COVALENT LINKAGE OF CARBOHYDRATE POLYMERS TO A GLYCOPROTEIN FROM STREPTOCOCCUS-SANGUIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GRAM-POSITIVE BACTERIA; HALOBACTERIUM-SALINARIUM; BACILLUS-THURINGIENSIS; SURFACE GLYCOPROTEIN; PLATELET AGGREGATION; CELL-WALLS; PURIFICATION; PROTEIN; POLYSACCHARIDE; PROTOPLASTS	The platelet aggregation-associated protein (PAAP) from Streptococcus sanguis contains 39% carbohydrate in rhamnose-rich polysaccharides. Synthesized by cultured protoplasts, these polysaccharides were shown to be covalently linked to this cell wall protein using specific inhibitors of glycosylation, glycosidase treatment, amino acid and carbohydrate analyses of prepared minimal glycopeptides and isolated protein, and NMR spectroscopy. To our knowledge, this is the first direct proof of an N-asparaginyl linkage of carbohydrate to a eubacterial protein.	UNIV MINNESOTA,SCH DENT,DEPT PREVENT SCI,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH DENT,GRAD PROGRAM ORAL BIOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NIDCR NIH HHS [2 R01 DE05501, 1 K15 DE00224] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005501, K15DE000224] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABEYGUNAWARDANA C, 1990, BIOCHEMISTRY-US, V29, P234, DOI 10.1021/bi00453a032; ABEYGUNAWARDANA C, 1989, CARBOHYD RES, V191, P279, DOI 10.1016/0008-6215(89)85071-2; ANDREU JM, 1978, FEBS LETT, V86, P1, DOI 10.1016/0014-5793(78)80084-2; ANDREU JM, 1976, FEBS LETT, V65, P198, DOI 10.1016/0014-5793(76)80479-6; ARAKI Y, 1989, CRIT REV MICROBIOL, V17, P121, DOI 10.3109/10408418909105745; BENCHETRIT LC, 1978, J BACTERIOL, V134, P221, DOI 10.1128/JB.134.1.221-228.1978; BERTRAM KC, 1981, J BACTERIOL, V148, P406, DOI 10.1128/JB.148.2.406-412.1981; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BLUMBERG K, 1982, ANAL BIOCHEM, V119, P397, DOI 10.1016/0003-2697(82)90604-2; BROWN WJ, 1984, CELL, V36, P295, DOI 10.1016/0092-8674(84)90223-X; BULLA LA, 1977, J BACTERIOL, V130, P375, DOI 10.1128/JB.130.1.375-383.1977; BUMOL TF, 1984, J BIOL CHEM, V259, P2733; CASSELS FJ, 1989, J BACTERIOL, V171, P4019, DOI 10.1128/jb.171.7.4019-4025.1989; CHIU TH, 1978, J BACTERIOL, V133, P185, DOI 10.1128/JB.133.1.185-195.1978; COLLEY KJ, 1987, J BIOL CHEM, V262, P10296; DEAN MF, 1984, BIOCHEM SOC T, V12, P513; DILL K, 1979, FEBS LETT, V107, P26, DOI 10.1016/0014-5793(79)80454-8; ERICKSON PR, 1990, J BIOL CHEM, V265, P14080; ERICKSON PR, 1993, ANAL BIOCHEM, V268, P1646; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8; GEUSE HJ, 1984, J CELL BIOL, V98, P2047; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HERZBERG MC, 1983, INFECT IMMUN, V42, P394, DOI 10.1128/IAI.42.1.394-401.1983; HERZBERG MC, 1979, J BIOL CHEM, V254, P1487; HERZBERG MC, 1990, INFECT IMMUN, V58, P4117, DOI 10.1128/IAI.58.12.4117-4125.1990; HERZBERG MC, 1985, MOL BASIS ORAL MICRO, P53; KANAOKA M, 1987, JPN J CANCER RES, V78, P1409; KAWAMURA T, 1983, J BIOL CHEM, V258, P9514; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUAN SF, 1989, J BIOL CHEM, V264, P19271; KUPCU Z, 1984, FEBS LETT, V173, P185, DOI 10.1016/0014-5793(84)81043-1; LENNARZ WJ, 1982, BIOCHIM BIOPHYS ACTA, V585, P417; MAEBA PY, 1986, J BACTERIOL, V166, P644, DOI 10.1128/jb.166.2.644-650.1986; MCINTIRE FC, 1987, CARBOHYD RES, V166, P133, DOI 10.1016/0008-6215(87)80050-2; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; MESCHER MF, 1976, P NATL ACAD SCI USA, V73, P2687, DOI 10.1073/pnas.73.8.2687; MESSNER P, 1988, FEBS LETT, V228, P317, DOI 10.1016/0014-5793(88)80023-1; MORRIS EJ, 1987, J BACTERIOL, V169, P164, DOI 10.1128/jb.169.1.164-171.1987; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; NISHIMOTA SK, 1982, BIOCHEM J, V202, P249; OREILLY MA, 1988, BIOCHIM BIOPHYS ACTA, V969, P176, DOI 10.1016/0167-4889(88)90073-0; PAUL G, 1986, J BIOL CHEM, V261, P1020; PFANNENSTIEL MA, 1987, J BACTERIOL, V169, P796, DOI 10.1128/jb.169.2.796-801.1987; ROE JH, 1955, J BIOL CHEM, V212, P335; ROGERS HJ, 1980, MICROBIAL CELL WALLS, P45; ROSAN B, 1988, ORAL MICROBIOL IMMUN, V3, P153, DOI 10.1111/j.1399-302X.1988.tb00002.x; Schwarz RT, 1979, BIOCHEM SOC T, V7, P322, DOI 10.1042/bst0070322; Sharon N., 1975, COMPLEX CARBOHYDRATE; SHOCKMAN GD, 1983, ANNU REV MICROBIOL, V37, P501, DOI 10.1146/annurev.mi.37.100183.002441; SIEWERT G, 1967, P NATL ACAD SCI USA, V57, P767, DOI 10.1073/pnas.57.3.767; TAKATSUKI A, 1975, AGR BIOL CHEM TOKYO, V39, P2089, DOI 10.1080/00021369.1975.10861914; TAKU A, 1976, J BIOL CHEM, V251, P1889; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; WEBSTER JR, 1981, APPL ENVIRON MICROB, V41, P371, DOI 10.1128/AEM.41.2.371-374.1981; WEERKAMP AH, 1982, INFECT IMMUN, V38, P233, DOI 10.1128/IAI.38.1.233-242.1982; WIELAND F, 1983, P NATL ACAD SCI-BIOL, V80, P5470, DOI 10.1073/pnas.80.18.5470; WILLINGHAM MC, 1983, J HISTOCHEM CYTOCHEM, V31, P1; YANG LL, 1979, BIOCHIM BIOPHYS ACTA, V556, P265, DOI 10.1016/0005-2736(79)90047-6	60	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23780	23783						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226911				2022-12-27	WOS:A1993MF29400013
J	HARDY, TA; ROACH, PJ				HARDY, TA; ROACH, PJ			CONTROL OF YEAST GLYCOGEN SYNTHASE-2 BY COOH-TERMINAL PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CYCLIC-AMP; SUBSTRATE RECOGNITION; NUTRIENT LIMITATION; HOST STRAINS; 2ND GENE; 2 FORMS; METABOLISM; ENCODES	The budding yeast Saccharomyces cerevisiae expresses two isoforms of glycogen synthase, of which glycogen synthase-2 (GS-2) appears to be the most important determinant of glycogen accumulation (Farkas, I., Hardy, T. A., Goebl, M. G., and Roach, P. J. (1991) J. Biol. Chem. 266, 15602-15607). Partial proteolysis of purified yeast glycogen synthase activated the enzyme, mimicking the effects of dephosphorylation. The cleavage was localized to the COOH terminus of the molecule and trypsin treatment released P-32 from enzyme labeled in vivo with P-32 or in vitro by cyclic AMP-dependent protein kinase. Similarly, when cells were labeled with P-32, no radioactivity was incorporated into a mutant form of GS-2 truncated at residue 643 while the wild type enzyme was phosphorylated at both Ser and Thr residues. The 9 Ser and Thr residues COOH-terminal to position 643 were mutated individually to Ala, and the GS-2 mutants were expressed from a low copy plasmid in yeast that lacked functional chromosomal copies of the two glycogen synthase genes. Mutations at Ser-650, Ser-654, and Thr-667 resulted in significant activation of yeast glycogen synthase and elevation in the level of accumulated glycogen as compared with wild type. Likewise, expression of the truncated GS-2 resulted in hyperactive enzyme and the overaccumulation of glycogen. None of the other Ser or Thr mutations substantially affected glycogen synthase activity and glycogen storage. We conclude that Ser-650, Ser-654, and Thr-667 are regulatory phosphorylation sites in vivo. However, in vitro, cyclic AMP-dependent protein kinase modified Ser residue(s) COOH-terminal to position 659, and so the identity of the physiological GS-2 kinases is unclear. Yeast strains bearing glc7 and gac1 mutations are defective in genes encoding type 1 protein phosphatase components and are impaired in their ability to accumulate glycogen. Expression of the truncated GS-2 in these strains restored glycogen accumulation, as did the presence of GS-2 mutated at Ser-650, Ser-654, or Thr-667. These data are consistent with the hypothesis that type 1 phosphatase regulates GS-2 by controlling its phosphorylation state.			HARDY, TA (corresponding author), INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, INDIANAPOLIS, IN 46202 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042576] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42576] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; BAI G, 1990, J BIOL CHEM, V265, P7843; Bauminger S, 1980, Methods Enzymol, V70, P151; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V3, P1196; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BROWNER MF, 1989, P NATL ACAD SCI USA, V86, P1443, DOI 10.1073/pnas.86.5.1443; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CANNON JF, 1986, GENETICS, V113, P247; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; CHESTER VE, 1963, BIOCHEM J, V86, P153, DOI 10.1042/bj0860153; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COHEN P, 1991, BIOCHIM BIOPHYS ACTA, V1094, P292, DOI 10.1016/0167-4889(91)90089-G; COHEN P, 1986, ENZYMES, V17, P462; DENIS CL, 1991, J BIOL CHEM, V266, P17932; EDENBERG HJ, 1987, GENE, V58, P297, DOI 10.1016/0378-1119(87)90384-2; FARKAS I, 1991, J BIOL CHEM, V266, P15602; FARKAS I, 1990, J BIOL CHEM, V265, P20879; FENG ZH, 1991, J BIOL CHEM, V266, P23796; FRANCOIS J, 1988, EUR J BIOCHEM, V174, P561, DOI 10.1111/j.1432-1033.1988.tb14135.x; FRANCOIS J, 1988, EUR J BIOCHEM, V174, P551, DOI 10.1111/j.1432-1033.1988.tb14134.x; FRANCOIS J, 1991, J BIOL CHEM, V266, P6174; FRANCOIS JM, 1992, EMBO J, V11, P87, DOI 10.1002/j.1460-2075.1992.tb05031.x; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HUANG KP, 1974, J BIOL CHEM, V249, P3858; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KEMP BE, 1977, J BIOL CHEM, V252, P4888; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PENG ZY, 1990, J BIOL CHEM, V265, P13871; POSAS F, 1993, J BIOL CHEM, V268, P1349; POSAS F, 1991, FEBS LETT, V279, P341, DOI 10.1016/0014-5793(91)80183-4; PROROK M, 1989, BIOCHEM BIOPH RES CO, V165, P368, DOI 10.1016/0006-291X(89)91079-6; Quain D. E, 1988, J I BREWING, V95, P315; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROTHMANDENES LB, 1971, BIOCHEMISTRY-US, V10, P1236; ROTHMANDENES LB, 1970, P NATL ACAD SCI USA, V66, P967, DOI 10.1073/pnas.66.3.967; ROWEN DW, 1992, MOL CELL BIOL, V12, P22, DOI 10.1128/MCB.12.1.22; Rubin G M, 1975, Methods Cell Biol, V12, P45; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHANG WM, 1989, FASEB J, V3, P2532, DOI 10.1096/fasebj.3.13.2509275; ZIONCHECK TF, 1986, J BIOL CHEM, V261, P5637	52	85	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23799	23805						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226915				2022-12-27	WOS:A1993MF29400017
J	PENG, H; MARIANS, KJ				PENG, H; MARIANS, KJ			ESCHERICHIA-COLI TOPOISOMERASE-IV - PURIFICATION, CHARACTERIZATION, SUBUNIT STRUCTURE, AND SUBUNIT INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID GYRASE; DNA GYRASE; CHROMOSOME SEGREGATION; SALMONELLA-TYPHIMURIUM; NUCLEOID SEGREGATION; CATALYTIC PROPERTIES; NALIDIXIC-ACID; GYRB-GENE; REPLICATION; SEQUENCE	DNA sequence analysis of Escherichia coli parC and parE, encoding the subunits of topoisomerase IV (Topo IV) (Kato, J.-I., Suzuki, H., and Ikeda, H. (1992) J. Biol. Chem. 267, 25676-25684), showed that ParC was 22 amino acids longer on the N terminus and ParE was 29 amino acids longer on the C terminus than reported previously. E. coli strains bearing bacteriophage T7 RNA polymerase-based expression plasmids carrying both intact and truncated parC and parE were used to overproduce the ParC and ParE proteins. Full-length ParC and ParE were required to reconstitute Topo IV activity, whereas the truncated ParC and ParE were inactive. Topo IV activity was supported only by ATP or dATP. The [ATP]1/2 for DNA relaxation was 0.45 mM, almost 25-fold higher than the [ATP]1/2 for decatenation of kinetoplast DNA. Topo IV activity was inhibited by the quinolone and coumarin antibiotics, although the concentrations required for 50% inhibition of activity were 3-30-fold higher than those required to inhibit DNA gyrase. The norfloxacin-induced DNA cleavage patterns of Topo IV and DNA gyrase were distinct but overlapping. The native forms of ParC and ParE were a dimer and a monomer, respectively; whereas the active form of Topo IV was a heterotetramer, ParC2ParE2. The inactivity of the truncated forms of ParC and ParE could be attributed to their failure to form the heterotetramer.	CORNELL UNIV,GRAD SCH MED SCI,NEW YORK,NY 10021	Cornell University	PENG, H (corresponding author), MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI T, 1984, NUCLEIC ACIDS RES, V12, P6389, DOI 10.1093/nar/12.16.6389; ADAMS DE, 1992, CELL, V71, P277, DOI 10.1016/0092-8674(92)90356-H; BEEN MD, 1981, P NATL ACAD SCI-BIOL, V78, P2883, DOI 10.1073/pnas.78.5.2883; BROWN PO, 1979, P NATL ACAD SCI USA, V76, P6110, DOI 10.1073/pnas.76.12.6110; Cohn E. J., 1943, PROTEINS AMINO ACIDS; DIGATE RJ, 1992, J BIOL CHEM, V267, P20532; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; DINARDO S, 1982, CELL, V31, P43, DOI 10.1016/0092-8674(82)90403-2; FAIRWEATHER NF, 1980, J BACTERIOL, V142, P153, DOI 10.1128/JB.142.1.153-161.1980; FILUTOWICZ M, 1980, MOL GEN GENET, V177, P301, DOI 10.1007/BF00267443; FILUTOWICZ M, 1982, MOL GEN GENET, V191, P282; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; HELMSTETTER CE, 1987, ESCHERICHIA COLI SAL, P1595; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HILL TM, 1988, CELL, V55, P459, DOI 10.1016/0092-8674(88)90032-3; HUSSAIN K, 1987, MOL MICROBIOL, V1, P73, DOI 10.1111/j.1365-2958.1987.tb00529.x; HUSSAIN K, 1987, MOL MICROBIOL, V1, P259, DOI 10.1111/j.1365-2958.1987.tb01932.x; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO J, 1989, MOL GEN GENET, V217, P178, DOI 10.1007/BF00330959; KATO J, 1992, J BIOL CHEM, V267, P25676; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTTINGER AL, 1991, NEW BIOL, V3, P687; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; MAXWELL A, 1992, J ANTIMICROB CHEMOTH, V30, P409, DOI 10.1093/jac/30.4.409; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; PENG H, 1993, IN PRESS P NATL ACAD; PRUSS GJ, 1982, CELL, V31, P35, DOI 10.1016/0092-8674(82)90402-0; RAJI A, 1985, J BACTERIOL, V162, P1173, DOI 10.1128/JB.162.3.1173-1179.1985; RYAN MJ, 1976, BIOCHEMISTRY-US, V15, P3769, DOI 10.1021/bi00662a020; SAPORITO SM, 1988, J BACTERIOL, V170, P4542, DOI 10.1128/jb.170.10.4542-4547.1988; SCHMID MB, 1990, J BACTERIOL, V172, P5416, DOI 10.1128/jb.172.9.5416-5424.1990; SCHOFIELD MA, 1992, J BACTERIOL, V174, P5168, DOI 10.1128/JB.174.15.5168-5170.1992; SHEN LI, 1985, P NATL ACAD SCI USA, V74, P4767; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SPRINGER AL, 1993, NUCLEIC ACIDS RES, V21, P1805, DOI 10.1093/nar/21.8.1805; STAUDENBAUER WL, 1981, NUCLEIC ACIDS RES, V9, P3589, DOI 10.1093/nar/9.15.3589; STAUDENBAUER WL, 1976, EUR J BIOCHEM, V62, P491, DOI 10.1111/j.1432-1033.1976.tb10183.x; STECK TR, 1984, CELL, V36, P1081, DOI 10.1016/0092-8674(84)90058-8; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767	48	228	236	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24481	24490						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8227000				2022-12-27	WOS:A1993MF29400113
J	ASAHI, M; TANIGUCHI, T; HASHIMOTO, E; INAZU, T; MAEDA, H; YAMAMURA, H				ASAHI, M; TANIGUCHI, T; HASHIMOTO, E; INAZU, T; MAEDA, H; YAMAMURA, H			ACTIVATION OF PROTEIN-TYROSINE KINASE P72(SYK) WITH CONCANAVALIN-A IN POLYMORPHONUCLEAR NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; SUPEROXIDE ANION; RECEPTOR; PHOSPHORYLATION; INHIBITOR; STIMULATION; GENERATION; MEMBRANE; BINDING; CELLS	We studied the abundance, subcellular distribution of a non-receptor protein-tyrosine kinase p72syk (Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S., and Yamamura, H. (1991) J. Biol. Chem. 266, 15790-15796) in porcine polymorphonuclear neutrophils and the activation upon the stimulation with concanavalin A. The abundance was about 0.1% of total proteins and mainly distributed in the particulate fraction. Upon concanavalin A stimulation, the activity of p72syk increased within 30 s, attained to the maximum level at 1 min, and then returned to the basal level within 6 min. This activation was observed in a dose-dependent manner and abrogated by simultaneous addition of methyl alpha-mannopyranoside. When both extra- and intracellular Ca2+ were depleted, the activation of p72syk Was still persistent; in contrast, the deactivation process was completely abrogated even at 6 min after stimulation. The replenishment of Ca2+ in the presence of A23187 resulted in a similar deactivation pattern as seen in the Ca2+-rich condition. In addition, genistein and herbimycin A, potent protein-tyrosine-kinase inhibitors, were capable of reducing concanavalin A-evoked p72syk activation and Ca2+ mobilization as well as the aggregation and lysozyme release. Furthermore, A23187-induced Ca2+ accumulation in inhibitor-treated cells resulted in the restoration of those cellular responses. These lines of evidence suggest that p72syk is activated with concanavalin A in a Ca2+-independent manner, participating in a mechanism of Ca2+ recruitment, and negatively regulated by a feedback mechanism through Ca2+ in neutrophils.	KOBE UNIV,BIOSIGNAL RES CTR,KOBE 657,JAPAN	Kobe University	YAMAMURA, H (corresponding author), FUKUI MED SCH,DEPT BIOCHEM,FUKUI 91011,JAPAN.		Maeda, Hiroyuki/W-1934-2019					APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BECKER JW, 1976, CONCANAVALIN A TOOL, P34; BERKOW RL, 1990, BLOOD, V75, P2445; BERKOW RL, 1987, J LEUKOCYTE BIOL, V41, P441, DOI 10.1002/jlb.41.5.441; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; GEA CE, 1986, P NATL ACAD SCI USA, V83, P5131; GERARD C, 1986, J CLIN INVEST, V77, P61, DOI 10.1172/JCI112302; GOMEZCAMBRONERO J, 1991, J BIOL CHEM, V266, P6240; GUTKIND JS, 1989, P NATL ACAD SCI USA, V86, P8783, DOI 10.1073/pnas.86.22.8783; HASHIMOTO E, 1976, J BIOL CHEM, V251, P6287; HUANG CK, 1990, BIOCHEM J, V269, P431, DOI 10.1042/bj2690431; KOBAYASHI T, 1990, EUR J BIOCHEM, V188, P535, DOI 10.1111/j.1432-1033.1990.tb15433.x; KORCHAK HM, 1988, J BIOL CHEM, V263, P11098; KORCHAK HM, 1984, FED PROC, V43, P2749; KUSUNOKI T, 1992, BIOCHEM BIOPH RES CO, V183, P789, DOI 10.1016/0006-291X(92)90552-V; LACAL PM, 1990, BIOCHEM J, V268, P707, DOI 10.1042/bj2680707; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METCALF JA, 1986, LABORATORY MANUAL NE, P149; NACCACHE PH, 1990, BLOOD, V76, P2098; OHTA S, 1992, EUR J BIOCHEM, V206, P895, DOI 10.1111/j.1432-1033.1992.tb16998.x; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKEUCHI F, 1993, BIOCHEM BIOPH RES CO, V194, P91, DOI 10.1006/bbrc.1993.1789; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TANIGUCHI T, 1992, J BIOL CHEM, V185, P1128; TAUBER AI, 1987, BLOOD, V69, P711; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; YAMADA T, 1991, BIOCHEM BIOPH RES CO, V180, P1325, DOI 10.1016/S0006-291X(05)81340-3; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x; YU G, 1989, J BIOL CHEM, V264, P10276; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	33	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23334	23338						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226857				2022-12-27	WOS:A1993MF51500060
J	BECERRA, SP; PALMER, I; KUMAR, A; STEELE, F; SHILOACH, J; NOTARIO, V; CHADER, GJ				BECERRA, SP; PALMER, I; KUMAR, A; STEELE, F; SHILOACH, J; NOTARIO, V; CHADER, GJ			OVEREXPRESSION OF FETAL HUMAN PIGMENT EPITHELIUM-DERIVED FACTOR IN ESCHERICHIA-COLI - A FUNCTIONALLY ACTIVE NEUROTROPHIC FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE INHIBITORY ACTIVITY; NEURITE-PROMOTING FACTOR; NERVE GROWTH-FACTOR; HUMAN ALPHA-1-ANTICHYMOTRYPSIN; CDNA SEQUENCE; BINDING; DIFFERENTIATION; CHYMOTRYPSIN; EXPRESSION; PROTEINS	Pigment epithelium-derived factor (PEDF) is a neurotrophic protein present in low amounts in conditioned medium of cultured fetal human retinal pigment epithelial cells. Recently, the PEDF cDNA has been cloned from a fetal human cDNA library, and its derived amino acid sequence identified it as a member of the serine protease inhibitor (serpin) supergene family (Steele, F. R., Chader, G. J., Johnson, L. V., and Tombran-Tink, J. (1993) Proc. Natl. Acad, Sci. U. S. A. 90, 1526-1530). We have prepared recombinant expression constructs from the fetal human PEDF cDNA and obtained milligram amounts of biologically active PEDF from Escherichia coli. The full-length open reading frame (Met1-Pro418) and a truncated form (Asp44- Pro41) were used in our constructs. Induction from a vector containing the truncated PEDF version, named pEV-BH, produced a protein (BH) of expected size (M(r) 42,800) associated with inclusion bodies, which contained 25-40% of expressed protein. After solubilization, BH was highly purified by gel filtration and cation exchange chromatography. The NH2-terminal sequence of the purified protein matched that of the pEV-BH construct. We have conducted neurite outgrowth assays in a human retinoblastoma Y-79 cell culture system. Recombinant PEDF (BH) demonstrated neurotrophic activity, as reported for the native PEDF. Thus, unfolded and refolded in vitro BH retained a potent biological activity. In parallel experiments, protease inhibition assays were performed. Recombinant PEDF did not have an effect on trypsin, chymotrypsin, elastase, cathepsin G, endoproteinase Lys-C, endoproteinase Glu-C, or subtilisin activity, suggesting that inhibition of known serine proteases is not the biochemical pathway for the PEDF neurotrophic activity.	NIDDKD, PROT EXPRESS LAB, OFF INTRAMURAL RES, OFF DIRECTOR, BETHESDA, MD 20892 USA; NIDDKD, CELLULAR & DEV BIOL LAB, BETHESDA, MD 20892 USA; UNIV TEXAS, MED BRANCH, CTR MOLEC SCI, GALVESTON, TX 77555 USA; GEORGETOWN UNIV, MED CTR, DEPT RADIAT MED, WASHINGTON, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Medical Branch Galveston; Georgetown University	BECERRA, SP (corresponding author), NEI, RETINAL CELL & MOLEC BIOL LAB, BLDG 6, RM 308, BETHESDA, MD 20892 USA.		/AFP-0764-2022; /AAB-6461-2022					BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; BECERRA SP, 1993, PROTEIN EXPRES PURIF, V4, P187, DOI 10.1006/prep.1993.1025; BLINDER MA, 1988, BIOCHEMISTRY-US, V27, P752, DOI 10.1021/bi00402a039; BOCK SC, 1990, PROTEIN ENG, V4, P107, DOI 10.1093/protein/4.2.107; BOCK SC, 1991, HEMOSTASIS THROMBOSI, P25; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADSHAW RA, 1978, ANNU REV BIOCHEM, V47, P191, DOI 10.1146/annurev.bi.47.070178.001203; BUSTIN M, 1991, NUCLEIC ACIDS RES, V19, P3115, DOI 10.1093/nar/19.11.3115; CHAO MV, 1990, PEPTIDE GROWTH FACTO, V2, P135; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; CROWL R, 1985, GENE, V38, P31, DOI 10.1016/0378-1119(85)90200-8; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; GLOOR S, 1986, CELL, V47, P687; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x; HSIAO J, 1992, ANN NY ACAD SCI, V665, P320, DOI 10.1111/j.1749-6632.1992.tb42595.x; HU GL, 1988, GENE, V70, P57; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KANE JF, 1988, TRENDS BIOTECHNOL, V6, P95, DOI 10.1016/0167-7799(88)90065-0; KUMAR A, 1990, J BIOL CHEM, V265, P2124; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MONARD D, 1973, P NATL ACAD SCI USA, V70, P1894, DOI 10.1073/pnas.70.6.1894; MONARD D, 1990, PEPTIDE GROWTH FACTO, V2, P169; MORII M, 1983, J BIOL CHEM, V258, P2749; PATTSON PA, 1990, J BIOL CHEM, V265, P10786; SOMMER J, 1987, BIOCHEMISTRY-US, V26, P6407, DOI 10.1021/bi00394a016; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; TRAVIS J, 1978, BIOCHEMISTRY-US, V17, P5651, DOI 10.1021/bi00619a011	33	92	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23148	23156						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226833				2022-12-27	WOS:A1993MF51500032
J	CAI, YC; DOUGLASS, J				CAI, YC; DOUGLASS, J			IN-VIVO AND IN-VITRO PHOSPHORYLATION OF THE T-LYMPHOCYTE TYPE-N (KV1.3) POTASSIUM CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BRAIN SODIUM-CHANNELS; SHAKER K+ CHANNEL; ION CHANNELS; FUNCTIONAL EXPRESSION; CALCIUM-CHANNEL; RAT-BRAIN; DENDROTOXIN ACCEPTOR; SIGNAL TRANSDUCTION; BINDING-PROPERTIES	The major species of voltage-gated potassium channel found on mammalian T lymphocytes is referred to as the type n channel. This potassium channel exhibits unique functional properties which distinguish it from other species of potassium channels, including a potential role in the onset of cellular events associated with T cell activation. As a first step in characterizing specific biochemical properties of the type n channel, we have generated polyclonal antisera against bacterial fusion proteins containing peptide regions unique to the mouse and human type n channel. From membranes of T cell lines derived from both mouse (SAK 8 cell line) and human (Jurkat cell line), the type n channel can be immunoprecipitated following either surface labeling with I-125 or metabolic labeling with P-32. The apparent molecular mass of the immunoprecipitated type n channel is approximately 65 kDa, significantly greater than that of the 58-kDa in vitro translated product, and suggestive of post-translational modification events. Phosphoamino acid analysis of the metabolically labeled Jurkat type n channel reveals phosphorylation of serine residues exclusively. In vitro studies also describe the ability of both protein kinase A and protein kinase C to phosphorylate the Jurkat type n channel. The former kinase also appears to phosphorylate a 40-kDa protein which co-immunoprecipitates with the type n channel. These data suggest that direct phosphorylation of the T lymphocyte type n potassium channel or its associated 40-kDa subunit may serve as a means by which channel activity is regulated.	OREGON HLTH SCI UNIV, VOLLUM INST L474, 3181 SW SAM JACKSON PK RD, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT MICROBIOL & IMMUNOL, PORTLAND, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University					NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004154] Funding Source: NIH RePORTER; NIDA NIH HHS [DA04154] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ATTALI B, 1992, J BIOL CHEM, V267, P8650; ATTALI B, 1992, FEBS LETT, V303, P229, DOI 10.1016/0014-5793(92)80526-M; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BLUMENTHAL EM, 1992, J NEUROSCI, V12, P290; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; Cahalan M D, 1990, Semin Immunol, V2, P107; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; CAHALAN MD, 1987, MECHANISMS LYMPHOCYT, P85; CAI YC, 1992, DNA CELL BIOL, V11, P163, DOI 10.1089/dna.1992.11.163; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DECOURSEY TE, 1985, J NEUROIMMUNOL, V10, P71, DOI 10.1016/0165-5728(85)90035-9; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEUTSCH C, 1986, J PHYSIOL-LONDON, V372, P405, DOI 10.1113/jphysiol.1986.sp016016; DEUTSCH C, 1991, J BIOL CHEM, V266, P3668; DEUTSCH C, 1990, PROG CLIN BIOL RES, V334, P251; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; DRISCOLL WJ, 1990, J BIOL CHEM, V265, P12306; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; LEWIS RS, 1988, TRENDS NEUROSCI, V11, P214, DOI 10.1016/0166-2236(88)90129-4; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MORAN O, 1991, FEBS LETT, V279, P256, DOI 10.1016/0014-5793(91)80162-V; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; PATEL HR, 1991, J IMMUNOL, V146, P3332; PAYET MD, 1992, J BIOL CHEM, V267, P18270; PHILIPSON LH, 1991, P NATL ACAD SCI USA, V88, P53, DOI 10.1073/pnas.88.1.53; PLAUT M, 1987, ANNU REV IMMUNOL, V5, P621, DOI 10.1146/annurev.iy.05.040187.003201; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; REHM H, 1989, FEBS LETT, V249, P224, DOI 10.1016/0014-5793(89)80628-3; ROHRKASTEN A, 1988, J BIOL CHEM, V263, P15325; ROSSIE S, 1987, J BIOL CHEM, V262, P12735; ROSSIE S, 1989, J BIOL CHEM, V264, P14220; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SMITH MK, 1990, J BIOL CHEM, V265, P1837; SPENCER RH, 1993, BIOCHEM BIOPH RES CO, V191, P201, DOI 10.1006/bbrc.1993.1203; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TILLY BC, 1992, J BIOL CHEM, V267, P9470; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; VITETTA ES, 1971, J EXP MED, V134, P242, DOI 10.1084/jem.134.1.242; WILKINSON MF, 1991, J EXP MED, V174, P269, DOI 10.1084/jem.174.1.269	63	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23720	23727						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226897				2022-12-27	WOS:A1993MF51500113
J	KIKUCHI, K; NAGANO, T; HAYAKAWA, H; HIRATA, Y; HIROBE, M				KIKUCHI, K; NAGANO, T; HAYAKAWA, H; HIRATA, Y; HIROBE, M			REAL-TIME MEASUREMENT OF NITRIC-OXIDE PRODUCED EX-VIVO BY LUMINOL-H2O2 CHEMILUMINESCENCE METHOD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; RELAXING FACTOR; ENDOTHELIUM; RELEASE; ACTIVATION; ARGININE; BRAIN	Endothelium-derived relaxing factor, identified as nitric oxide (NO), is derived from a guanidino nitrogen of L-arginine via its metabolism by nitric oxide synthase. A newly developed aqua-chemiluminescence system was used to measure the amount of NO release from the isolated, perfused rat kidney concomitantly with the pressure changes (Kikuchi, K., Nagano, T., Hayakawa, H., Hirata, Y., and Hirobe, M. (1993) Anal. Chem. 65, 1794-1799). In normotensive rats, basal NO release was estimated to be 86 +/- 6 fmol min-1 (g of kidney weight)-1, and endothelium-dependent vasodilators increased NO release with a concomitant pressure reduction. Pretreatment of the kidney with detergents to damage the vascular endothelium diminished the responses of NO and perfusion pressure to acetylcholine, while infusion of authentic NO solution caused an increase in the chemiluminescence and a concomitant decrease in the pressure. The half-life of NO in O2-saturated Krebs-Henseleit buffer was determined as 6.41 s, and the decay constant (K(d)) was 0.108 s-1. The measuring system involves a lag time of 15 s after passage of the solution through the kidney, so that the measured value is 13.0% of the true luminal NO concentration in the kidney, up to 400 pM. These observations enabled us to quantitate the degree to which NO released from the rat kidney changes perfusion pressure. Acetylcholine-induced vasodilation and NO release were markedly attenuated in deoxycorticosterone acetate-salt hypertensive rats, in which the endothelium is known to be markedly damaged. Thus, this assay system may make it possible to evaluate the extent of injury to the endothelium in conditions involving vascular damage.	UNIV TOKYO,FAC PHARMACEUT SCI,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 2,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo; University of Tokyo			Kikuchi, Kazuya/D-2370-2009					BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; FEELISCH M, 1991, J CARDIOVASC PHARM, V17, pS25, DOI 10.1097/00005344-199117003-00006; FOSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788; FURCHGOTT RF, 1984, ANNU REV PHARMACOL, V24, P175, DOI 10.1146/annurev.pa.24.040184.001135; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; HIRATA Y, 1991, HYPERTENSION, V17, P1025, DOI 10.1161/01.HYP.17.6.1025; HUTTNER I, 1983, HYPERTENSION PHYSIOP, P473; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; KELM M, 1988, BIOCHEM BIOPH RES CO, V154, P236, DOI 10.1016/0006-291X(88)90675-4; KELM M, 1990, CIRC RES, V66, P1561, DOI 10.1161/01.RES.66.6.1561; KIKUCHI K, 1993, ANAL CHEM, V65, P1794, DOI 10.1021/ac00061a025; KOBAYASHI S, 1980, ANAL CHEM, V52, P1548, DOI 10.1021/ac50059a046; LUSCHER TF, 1986, J HYPERTENS, V4, pS81; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MORDVINTCEV P, 1991, ANAL BIOCHEM, V199, P142, DOI 10.1016/0003-2697(91)90282-X; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Stott R. A. W., 1987, BIOLUMINESCENCE CHEM, P237; SUGIMOTO T, 1986, LIFE SCI, V38, P1351, DOI 10.1016/0024-3205(86)90467-4; TESFAMARIAM B, 1988, HYPERTENSION, V11, P440, DOI 10.1161/01.HYP.11.5.440; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; [No title captured]	23	108	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23106	23110						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226828				2022-12-27	WOS:A1993MF51500025
J	XIA, L; LU, ZM; LO, TCY				XIA, L; LU, ZM; LO, TCY			TRANSCRIPTS FOR THE HIGH AND LOW-AFFINITY HEXOSE TRANSPORTERS IN RAT MYOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOSE TRANSPORTER; PLASMA-MEMBRANE VESICLES; L6 MUSCLE-CELLS; SKELETAL-MUSCLE; MESSENGER-RNA; CYTOCHALASIN-B; 3T3-L1 ADIPOCYTES; DIFFERENTIAL REGULATION; FUNCTIONAL EXPRESSION; GENE LOCALIZATION	The present investigation examined the glucose transporter (GLUT) transcript levels in glucose-grown rat L6 myoblasts, which possessed a high (HAHT) and a low (LAHT) affinity hexose transport system. The most prominent GLUT transcript detected in these cells was a GLUT 3-recognizable 4.1-kilobase transcript. Mutants defective in HAHT contained only residual levels of the GLUT 3 transcript and transporter. Corresponding changes in GLUT 3 transcript levels and HAHT activity were observed in myotubes, confluent cultures, and myogenesis-impaired cells. The other prominent GLUT transcripts detected were the GLUT 4-recognizable 2.8- and 1.4-kilobase transcripts. The close correlation between the GLUT 4 isoform and LAHT activity was indicated by the absence of this isoform in LAHT- mutants, and their corresponding changes in myoblasts grown under different conditions. These findings suggested the HAHT and LAHT transporters might be coded or regulated by the genes responsible for the GLUT 3 and 4 transcripts, respectively. Although relatively high levels of the GLUT 1 transcript and transporter were detected in glucose-grown HAHT-LAHT- mutants, these cells did not exhibit any GLUT 1 transport activity. Since the GLUT 1 transporter was not functional, it was not likely responsible for the HAHT and LAHT activities observed in glucose-grown L6 myoblasts.	UNIV WESTERN ONTARIO,DEPT BIOCHEM,LONDON N6A 5C1,ONTARIO,CANADA	Western University (University of Western Ontario)								BATT ER, 1976, J BIOL CHEM, V251, P7184; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BURNOL AF, 1990, BIOCHEM J, V270, P277, DOI 10.1042/bj2700277; CARTERSU C, 1982, J BIOL CHEM, V257, P5419; CHEN SR, 1989, J CELL PHYSIOL, V138, P338, DOI 10.1002/jcp.1041380217; CHEN SR, 1988, BIOCHEM J, V251, P63, DOI 10.1042/bj2510063; CHEN SR, 1990, BIOCHEM INT, V20, P747; CHEUNG MO, 1984, CAN J BIOCHEM CELL B, V62, P1217, DOI 10.1139/o84-156; CHRISTOPHER CW, 1976, BIOCHEM J, V158, P439, DOI 10.1042/bj1580439; CLANCY BM, 1991, J BIOL CHEM, V266, P10122; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; DAMORE T, 1988, BIOCHEM J, V250, P59, DOI 10.1042/bj2500059; DAMORE T, 1986, BIOCHEM J, V238, P831, DOI 10.1042/bj2380831; DAMORE T, 1986, J CELL PHYSIOL, V127, P95, DOI 10.1002/jcp.1041270113; DAMORE T, 1986, BIOCHEM CELL BIOL, V64, P1081, DOI 10.1139/o86-143; DAMORE T, 1986, J CELL PHYSIOL, V127, P106, DOI 10.1002/jcp.1041270114; DAMORE T, 1986, J CELL PHYSL, V126, P26; DANIEL F, 1983, EMBO J, V2, P1061, DOI 10.1002/j.1460-2075.1983.tb01546.x; DAVIES A, 1987, J BIOL CHEM, V262, P9347; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GERHART DZ, 1992, P NATL ACAD SCI USA, V89, P733, DOI 10.1073/pnas.89.2.733; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P18, DOI 10.1016/0968-0004(90)90125-U; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; HARRISON SA, 1992, J BIOL CHEM, V267, P3783; HASPEL HC, 1988, J BIOL CHEM, V263, P398; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAYANO T, 1988, J BIOL CHEM, V263, P15245; KAYANO T, 1990, J BIOL CHEM, V265, P13276; KELLER K, 1989, J BIOL CHEM, V264, P18884; KITAGAWA T, 1991, J BIOL CHEM, V266, P18066; KITZMAN HH, 1993, J BIOL CHEM, V268, P1320; KLIP A, 1992, J CELL BIOCHEM, V48, P51, DOI 10.1002/jcb.240480109; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; KOZKA IJ, 1984, BIOCHIM BIOPHYS ACTA, V797, P212, DOI 10.1016/0304-4165(84)90124-7; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; KRUPKA R M, 1986, P537; KUDO PA, 1990, J CELL PHYSIOL, V145, P347, DOI 10.1002/jcp.1041450221; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MAY JM, 1985, J BIOL CHEM, V260, P462; MESMER O, 1986, BIOCHEM BIOPH RES CO, V141, P124, DOI 10.1016/S0006-291X(86)80343-6; MESMER OT, 1990, BIOCHEM J, V265, P823, DOI 10.1042/bj2650823; MESMER OT, 1989, BIOCHEM J, V262, P15, DOI 10.1042/bj2620015; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; OKA Y, 1988, J BIOL CHEM, V263, P13432; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; PESSIN JE, 1984, FED PROC, V43, P2258; REED BC, 1990, ARCH BIOCHEM BIOPHYS, V279, P261, DOI 10.1016/0003-9861(90)90490-P; ROBERTS SJ, 1982, BIOCHEM J, V205, P139, DOI 10.1042/bj2050139; Sambrook J, 1989, MOL CLONING LABORATO; SARKAR HK, 1988, P NATL ACAD SCI USA, V85, P5463, DOI 10.1073/pnas.85.15.5463; SHANAHAN MF, 1982, BIOCHEM BIOPH RES CO, V107, P38, DOI 10.1016/0006-291X(82)91666-7; SHANAHAN MF, 1987, J BIOL CHEM, V262, P5978; SILVERMAN M, 1991, ANNU REV BIOCHEM, V60, P757, DOI 10.1146/annurev.bi.60.070191.003545; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; THORENS B, 1990, DIABETES, V39, P712, DOI 10.2337/diabetes.39.6.712; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER PS, 1989, J BIOL CHEM, V264, P6587; WALMSLEY AR, 1988, TRENDS BIOCHEM SCI, V13, P226, DOI 10.1016/0968-0004(88)90089-8; WANG C, 1987, J BIOL CHEM, V262, P15689; WEILAND M, 1990, BIOCHEM J, V270, P331, DOI 10.1042/bj2700331; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; YAMADA Y, 1990, BIOCHEM BIOPH RES CO, V168, P1274, DOI 10.1016/0006-291X(90)91166-P	73	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23258	23266						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226848				2022-12-27	WOS:A1993MF51500050
J	TAKASAWA, S; TOHGO, A; NOGUCHI, N; KOGUMA, T; NATA, K; SUGIMOTO, T; YONEKURA, H; OKAMOTO, H				TAKASAWA, S; TOHGO, A; NOGUCHI, N; KOGUMA, T; NATA, K; SUGIMOTO, T; YONEKURA, H; OKAMOTO, H			SYNTHESIS AND HYDROLYSIS OF CYCLIC ADP-RIBOSE BY HUMAN-LEUKOCYTE ANTIGEN CD38 AND INHIBITION OF THE HYDROLYSIS BY ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PANCREATIC BETA-CELLS; INSULIN-SECRETION; GLUCOSE; EXPRESSION; CHANNELS; ENZYME; GENE; DIFFERENTIATION; PHOSPHATE; CYCLASE	Cyclic ADP-ribose (cADPR) has been recently shown to be generated in pancreatic beta-cells by glucose stimulation, serving as a second messenger for Ca2+ mobilization in the endoplasmic reticulum in the process of insulin secretion (Takasawa, S., Nata, K., Yonekura, H., and Okamoto, H. (1993) Science 259, 370-373). In the present study, we isolated a cDNA for CD38, which has been reported to be a human leukocyte antigen, from a human insulinoma and expressed the cDNA in COS-7 cells. CD38 expression was observed in the plasma membrane and the microsome fractions of the COS-7 cells. When we incubated the plasma membrane fraction with NAD+ and analyzed the reaction products by high pressure liquid chromatography, the formation of cADPR was observed in addition to the ADP-ribose (ADPR) formation. When the plasma membrane fraction was incubated with cADPR, cADPR was converted to ADPR stoichiometrically. These results suggest that CD38 has both cADPR-forming and -hydrolyzing activities. Moreover, we found that ATP (2-10 mM), generated in the glucose metabolism in beta-cells, inhibited the cADPR-hydrolyzing activity, resulting in the increased formation of cADPR. These findings indicate a role for CD38 in the synthesis and hydrolysis of cADPR in the process of insulin secretion in pancreatic beta-cells.	TOHOKU UNIV,SCH MED,DEPT BIOCHEM,2-1 SEIRYO MACHI,AOBA KU,SENDAI,MIYAGI 980,JAPAN	Tohoku University				Takasawa, Shin/0000-0002-4066-0199				ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223, DOI 10.1042/bj1320223; ASHCROFT SJH, 1978, BIOCHIM BIOPHYS ACTA, V538, P334, DOI 10.1016/0304-4165(78)90361-6; BUKOWIECKI L, 1979, BIOCHIM BIOPHYS ACTA, V583, P370, DOI 10.1016/0304-4165(79)90461-6; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CORKEY BE, 1988, J BIOL CHEM, V263, P4247; DALBECCO R, 1954, J EXP MED, V99, P167; GALIONE A, 1993, SCIENCE, V259, P325, DOI 10.1126/science.8380506; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; HUTTON JC, 1980, DIABETOLOGIA, V18, P395; INOUE C, 1987, P NATL ACAD SCI USA, V84, P6659, DOI 10.1073/pnas.84.19.6659; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; JACKSON DG, 1990, J IMMUNOL, V144, P2811; KATO I, 1990, FEBS LETT, V269, P319, DOI 10.1016/0014-5793(90)81184-P; KAWAZU S, 1980, N-S ARCH PHARMACOL, V312, P277, DOI 10.1007/BF00499158; KITAGAWA M, 1991, FEBS LETT, V283, P210, DOI 10.1016/0014-5793(91)80590-Y; KNAPP W, 1989, TISSUE ANTIGENS, V33, P123; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; OKAMOTO H, 1993, DIABETES, V42, pA76; Okamoto H., 1992, 1 C INT UN BIOCH MOL, P218; Okamoto H., 1990, MOL BIOL ISLETS LANG; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; TAKASAWA S, 1986, DIABETES, V35, P1178, DOI 10.2337/diabetes.35.10.1178; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; UNNO M, 1993, J BIOL CHEM, V268, P15974; WATANABE T, 1990, J BIOL CHEM, V265, P7432	32	263	274	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26052	26054						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253715				2022-12-27	WOS:A1993MK42500006
J	PAHEL, G; AULABAUGH, A; SHORT, SA; BARNES, JA; PAINTER, GR; RAY, P; PHELPS, WC				PAHEL, G; AULABAUGH, A; SHORT, SA; BARNES, JA; PAINTER, GR; RAY, P; PHELPS, WC			STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF THE HPV16-E7 PROTEIN EXPRESSED IN BACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; RETINOBLASTOMA GENE-PRODUCT; CELLULAR TRANSCRIPTION FACTOR; KINASE-II PHOSPHORYLATION; OPEN READING FRAMES; HPV-16 E7 PEPTIDES; CERVICAL-CARCINOMA; MUTATIONAL ANALYSIS; HUMAN KERATINOCYTES; SUPPRESSOR PROTEIN	The E7 gene of the human papillomaviruses (HPV) encodes a 98-amino acid, multifunctional nuclear phosphoprotein with functional and structural similarities to adenovirus E1A and the papovavirus T antigens. E7 is a viral oncoprotein, which will cooperate with an activated ras oncogene to transform primary rodent cells, and can cooperate with the HPV E6 protein for the efficient immortalization of primary human keratinocytes. Due to the compelling epidemiological and experimental association between HPV infection and cervical cancer, we have undertaken a detailed study of the structure of the HPV16 E7 protein. The E7 protein was expressed in Escherichia coli as a native, unfused polypeptide, and soluble protein was purified by conventional chromatographic techniques. The purified protein was assessed for various biochemical and biophysical properties. Purified E7 binds the retinoblastoma protein avidly and specifically, and it can dissociate the E2F transcription factor when assayed in vitro. Circular dichroism spectroscopy indicated that E7 reversibly binds Zn2+ and Cd2+, resulting in a substantial increase in the alpha-helical content of the metal-bound E7 consistent with the stabilization of a hydrophobic core in the COOH terminus of the protein.	BURROUGHS WELLCOME CO, WELLCOME RES LABS, DIV VIROL, 3030 CORNWALLIS RD, RES TRIANGLE PK, NC 27709 USA	Burroughs Wellcome Fund; Wellcome Research Laboratories								BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; Baker C.C., 1987, PAPOVAVIRIDAE, V2, P321; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; BANDARA LR, 1991, NATURE, V351, P494, DOI 10.1038/351494a0; BANKS L, 1990, ONCOGENE, V5, P1383; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; BEDELL MA, 1987, J VIROL, V61, P3635, DOI 10.1128/JVI.61.11.3635-3640.1987; BERG JM, 1993, CURR OPIN STRUC BIOL, V3, P11, DOI 10.1016/0959-440X(93)90195-Q; BREAM GL, 1993, J VIROL, V67, P2655, DOI 10.1128/JVI.67.5.2655-2663.1993; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHITTENDEN T, 1991, CELL, V65, P1073, DOI 10.1016/0092-8674(91)90559-H; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; COLE ST, 1987, J MOL BIOL, V193, P599, DOI 10.1016/0022-2836(87)90343-3; CROOK T, 1988, P NATL ACAD SCI USA, V85, P8820, DOI 10.1073/pnas.85.23.8820; DEVEREUX J, 1989, GCG SEQUENCE ANAL SO; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EDMONDS C, 1989, J VIROL, V63, P2650, DOI 10.1128/JVI.63.6.2650-2656.1989; FIRZLAFF JM, 1991, P NATL ACAD SCI USA, V88, P5187, DOI 10.1073/pnas.88.12.5187; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GHARDIRI MR, 1990, J AM CHEM SOC, V112, P1630; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; HIEBERT SW, 1991, J VIROL, V65, P3547, DOI 10.1128/JVI.65.7.3547-3552.1991; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; IMAI Y, 1991, J VIROL, V65, P4966, DOI 10.1128/JVI.65.9.4966-4972.1991; JONES RE, 1992, J BIOL CHEM, V267, P908; JONES RE, 1990, J BIOL CHEM, V265, P12782; KANDA T, 1988, VIROLOGY, V165, P321, DOI 10.1016/0042-6822(88)90694-0; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MATSUKURA T, 1986, J VIROL, V58, P979, DOI 10.1128/JVI.58.3.979-982.1986; MAXFIELD FR, 1976, BIOCHEMISTRY-US, V15, P5138, DOI 10.1021/bi00668a030; MUNGER K, 1991, J VIROL, V65, P3943; MUNGER K, 1993, BIOCHIM BIOPHYS ACTA, V1155, P111, DOI 10.1016/0304-419X(93)90025-8; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; MUNGER K, 1989, J VIROL, V63, P4417; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PATRICK DR, 1992, J BIOL CHEM, V267, P6910; PHELPS WC, 1991, J VIROL, V65, P6922, DOI 10.1128/JVI.65.12.6922-6930.1991; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; RAWLS JA, 1990, J VIROL, V64, P6121, DOI 10.1128/JVI.64.12.6121-6129.1990; RIOU G, 1990, LANCET, V335, P1171; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROTH EJ, 1992, J BIOL CHEM, V267, P16390; RUAN FQ, 1990, J AM CHEM SOC, V112, P9403, DOI 10.1021/ja00181a058; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; STOREY A, 1990, J GEN VIROL, V71, P965, DOI 10.1099/0022-1317-71-4-965; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANAKA A, 1989, J VIROL, V63, P1465, DOI 10.1128/JVI.63.3.1465-1469.1989; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WATANABE S, 1988, INT J CANCER, V41, P896, DOI 10.1002/ijc.2910410622; WATANABE S, 1990, J VIROL, V64, P207, DOI 10.1128/JVI.64.1.207-214.1990; WATANABE S, 1989, J VIROL, V63, P965, DOI 10.1128/JVI.63.2.965-969.1989; WU EW, 1993, J VIROL; YEE AS, 1989, MOL CELL BIOL, V9, P578, DOI 10.1128/MCB.9.2.578; zur Hausen H, 1987, PAPILLOMAVIRUSES, P245	72	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					26018	26025						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245034				2022-12-27	WOS:A1993MK10000103
J	WENG, SA; SPIRO, RG				WENG, SA; SPIRO, RG			DEMONSTRATION THAT A KIFUNENSINE-RESISTANT ALPHA-MANNOSIDASE WITH A UNIQUE PROCESSING ACTION ON N-LINKED OLIGOSACCHARIDES OCCURS IN RAT-LIVER ENDOPLASMIC-RETICULUM AND VARIOUS CULTURED-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMMING MAN9-MANNOSIDASE; GLYCOPROTEIN-BIOSYNTHESIS; PURIFICATION; PROTEIN; RECEPTOR; COMPLEX; ENZYME; SLICES	A novel alpha-mannosidase has been identified in rat liver endoplasmic reticulum (ER) which at neutral pH processes the Man9GlcNAc oligosaccharide of glycoproteins by specifically cleaving the terminal mannose residue of the alpha1,6-linked chain to yield Man8GlcNAc, isomer C. This enzyme accounted for about half of the total ER a-mannosidase activity and was fully active at the concentration (0.25 muM) of kifunensine (KIF) completely inhibitory to the action of the ER enzyme which by removing the terminal sugar of the middle chain converts Man9GlcNAc to Man8GlcNAc isomer B; both ER enzymes, however, were inhibited in a similar manner by 1-deoxymannojirimycin (IC50 = 0.2 mM) and their action could not be distinguished with this agent. The KIF-resistant mannosidase which functioned optimally in the presence of 0.1-0.5% Triton X-100 did not show the high susceptibility to EDTA demonstrated by the KIF-sensitive enzyme and unlike the latter had the capacity to hydrolyze p-nitrophenyl-alpha-D-mannoside (K(m) = 0.45 mM); it had no specific cation requirements, but its activity was greatly reduced in the presence of Zn2+. In isolated ER membranes as well as in intact carbonyl cyanide m-chlorophenylhydrazone-treated cells, the processing pattern was substantially different in the presence of KIF than in its absence; while in the latter instance Man9GlcNAc was readily converted to Man63GlcNAc, the KIF-resistant enzyme was limited in its capacity to go beyond Man8GlcNAc. The KIF-resistant alpha-mannosidase was found in substantial amounts in all cell lines examined (HL-60, BW5147.3, MOLT-4, K-562, HepG2, Chinese hamster ovary, F-9, Madin-Darby canine kidney, FRTL-5). The finding that mannose removal from N-linked oligosaccharides can be initiated in two distinctive manners substantially broadens our concept of the processing events which can occur before a glycoprotein reaches the Golgi complex or to which ER resident molecules can be exposed.	JOSLIN DIABET CTR,ELLIOTT P JOSLIN RES LAB,1 JOSLIN PL,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT BIOL CHEM,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017477] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 17477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BISCHOFF J, 1983, J BIOL CHEM, V258, P7907; BISCHOFF J, 1984, BIOCHEM BIOPH RES CO, V125, P324, DOI 10.1016/S0006-291X(84)80371-X; BISCHOFF J, 1986, J BIOL CHEM, V261, P4768; DePierre J., 1976, BIOCH ANAL MEMBRANES, P79; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; GODELAIN ED, 1981, J BIOL CHEM, V256, P10161; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HASE S, 1987, ANAL BIOCHEM, V72, P248; HICKMAN S, 1984, J CELL BIOL, V98, P407, DOI 10.1083/jcb.98.2.407; HIRAIZUMI S, 1993, J BIOL CHEM, V268, P9927; KABCENELL AK, 1985, J CELL BIOL, V101, P1270, DOI 10.1083/jcb.101.4.1270; KAYAKIRI H, 1989, J ORG CHEM, V54, P4015, DOI 10.1021/jo00278a003; KEDERSHA NL, 1985, BIOCHEMISTRY-US, V24, P5952, DOI 10.1021/bi00342a040; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; LEWIS MJ, 1985, J BIOL CHEM, V260, P6926; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RIZZOLO LJ, 1988, J BIOL CHEM, V263, P9520; ROSENFELD MG, 1984, J CELL BIOL, V99, P1076, DOI 10.1083/jcb.99.3.1076; ROTH J, 1990, EUR J CELL BIOL, V53, P131; SAJI M, 1992, ENDOCRINOLOGY, V130, P520, DOI 10.1210/en.130.1.520; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; SCHWEDEN J, 1986, EUR J BIOCHEM, V157, P563, DOI 10.1111/j.1432-1033.1986.tb09703.x; SPIRO MJ, 1985, J BIOL CHEM, V260, P5808; SPIRO MJ, 1976, J BIOL CHEM, V251, P6400; TARTAKOFF AM, 1977, J EXP MED, V146, P1332, DOI 10.1084/jem.146.5.1332; TULSIANI DRP, 1977, J BIOL CHEM, V252, P3227; VARKI A, 1983, J BIOL CHEM, V258, P2808	33	91	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25656	25663						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245001				2022-12-27	WOS:A1993MK10000056
J	DEGTYAREV, MY; SPIEGEL, AM; JONES, TLZ				DEGTYAREV, MY; SPIEGEL, AM; JONES, TLZ			INCREASED PALMITOYLATION OF THE G(S) PROTEIN-ALPHA SUBUNIT AFTER ACTIVATION BY THE BETA-ADRENERGIC-RECEPTOR OR CHOLERA-TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-2-ADRENERGIC RECEPTOR; GS; STIMULATION; ACYLATION; MEMBRANE; MUTATION; GTP; IDENTIFICATION; CELLS	The alpha subunit of the heterotrimeric G(s) protein that couples the beta-adrenergic receptor to adenylyl cyclase undergoes post-translational palmitoylation. We examined the dynamics of this modification of alpha(s) by metabolic labeling of COS and S49 lymphoma cells under different conditions. The endogenous alpha(s) proteins were immunoprecipitated with a peptide-specific antibody, separated by SDS-polyacrylamide gel electrophoresis, and analyzed by fluorography and densitometry. A pulse-chase study of COS cells incubated with [H-3]palmitate or [S-35]methionine showed that for alpha(s) the palmitate turnover (t1/2 almost-equal-to 50 min) was significantly faster than the protein degradation. Treatment of cells with 10 muM isoproterenol, a beta-adrenergic receptor agonist, in the presence of [H-3]palmitate led to a rapid 4-10-fold increase in the palmitoylation of alpha(s). This increase in palmitoylation was concentration-dependent (EC50 almost-equal-to 0.9 muM) and blocked by the antagonist propranolol. The mutant alpha(s) proteins in the unc and H21a S49 cell lines did not show an increase in [H-3]palmitate incorporation with isoproterenol treatment. Cholera toxin treatment of COS cells increased the [H-3]palmitate incorporation into the alpha(s) subunits. These data indicate that palmitoylation of the alpha(s) subunit is dynamic and regulated by activation of the alpha(s) subunit.	NIDDK,MPB,BLDG 10,RM 8C-101,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CHANG FH, 1989, J BIOL CHEM, V264, P5352; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DEGTYAREV MY, 1993, BIOCHEMISTRY-US, V32, P8057, DOI 10.1021/bi00083a001; DEGTYAREV MY, 1994, IN PRESS CELL SIGNAL; HUANG EM, 1989, BIOCHIM BIOPHYS ACTA, V1011, P134, DOI 10.1016/0167-4889(89)90200-0; JAMES G, 1989, J BIOL CHEM, V264, P20998; JOCHEN A, 1991, BIOCHEM BIOPH RES CO, V177, P797, DOI 10.1016/0006-291X(91)91859-B; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; JUHNN YS, 1992, J CELL BIOL, V119, P523, DOI 10.1083/jcb.119.3.523; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LOCHRIE MA, 1988, BIOCHEMISTRY-US, V27, P4957, DOI 10.1021/bi00414a001; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; MOUILLAC B, 1992, J BIOL CHEM, V267, P21733; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OSAWA S, 1990, MOL CELL BIOL, V10, P2931, DOI 10.1128/MCB.10.6.2931; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; STAUFENBIEL M, 1988, J BIOL CHEM, V263, P13615; SUDO Y, 1992, EMBO J, V11, P2095, DOI 10.1002/j.1460-2075.1992.tb05268.x; SULLIVAN KA, 1987, NATURE, V330, P758, DOI 10.1038/330758a0; VANDOP C, 1984, J BIOL CHEM, V259, P23	24	166	166	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23769	23772						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226908				2022-12-27	WOS:A1993MF29400010
J	KOUDELKA, GB; LAM, CY				KOUDELKA, GB; LAM, CY			DIFFERENTIAL RECOGNITION OF O(R)1 AND O(R)3 BY BACTERIOPHAGE-434 REPRESSOR AND CRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; RESOLUTION; PHAGE-434; OPERATOR; HELIX	The developmental decisions of bacteriophage 434 depend on the ability of 434 repressor and Cro to bind O(R)1 and O(R)3 with different relative affinities; repressor binds O(R)1 tighter than O(R)3, whereas Cro slightly prefers O(R)3 over O(R)1. Studies with operator mutants show that repressor's lower relative affinity for O(R)3 results from a deviation in the sequence of O(R)3 from consensus; an A --> G change at position 4 in one half-site (O(R)1: A-C-A-A-A-C-T-T-T-C-T-T-G-T; O(R)3: A-C-A-G-T-T-T-T-T-C-T-T-G-T). Similar experiments show that Cro binds operators containing either A.T or G.C bases pairs at position 4 equally well, but cannot bind operators containing C.G or T.A base pairs at this position. A Gln33 --> Ala mutation in 434 repressor diminishes, but does not eliminate, its ability to distinguish between purines at position 4. This shows that a glutamine at amino acid 33 is not the sole determinant of repressor's position 4 specificity. Changing Gln33 --> Leu. the amino acid at the homologous position in Cro, does not confer ''Cro-like'' position 4 base specificity on repressor. Similarly, a Cro protein bearing Gln at this position does not exhibit repressor's position 4 base preferences. The residual specificities of these mutant proteins indicates that in each protein, more than 1 amino acid is responsible for recognizing bases at position 4. These were identified by analyzing the binding specificities of multiply mutated repressors, in vitro. The types of substitutions made were guided by sequence homologies between 434 repressor and Cro. At least three mutations are needed to eliminate repressor's position 4 base specificity; Gln33 --> Ala, Glu32 --> Gln, and Thr27 --> Lys, although no set of amino acid substitutions in repressor was able to confer Cro-like position 4 specificity to repressor. These results indicate that at least the amino acids at these positions are involved in recognition of the position 4 base. Other evidence suggests that Cro and repressor use identical amino acids present at homologous positions in the DNA recognition helix in different ways.			KOUDELKA, GB (corresponding author), SUNY BUFFALO,DEPT BIOL SCI,BUFFALO,NY 14260, USA.		Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837	NIGMS NIH HHS [GM42138] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042138, R29GM042138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; BELL AC, 1993, IN PRESS J MOL BIOL; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Maniatis T., 1982, MOL CLONING; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; Ptashne M., 1986, A GENETIC SWITCH; WHARTON RP, 1985, NATURE, V316, P601, DOI 10.1038/316601a0; WHARTON RP, 1984, CELL, V38, P361, DOI 10.1016/0092-8674(84)90491-4; WHARTON RR, 1986, THESIS HARVARD U CAM; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	14	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23812	23817						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226917				2022-12-27	WOS:A1993MF29400019
J	LI, GP; STAHL, PD				LI, GP; STAHL, PD			STRUCTURE-FUNCTION RELATIONSHIP OF THE SMALL GTPASE RAB5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS PROTEIN; BINDING PROTEINS; MOLECULAR-CLONING; P21; MUTANTS; TRANSFERASE; INHIBITION; SECRETION; FARNESYL; DISTINCT	Overexpression of rab5 via a Sindbis virus vector resulted in a 2-3-fold stimulation of horseradish peroxidase uptake in BHK-21 cells. Based on this functional assay of rab5 activity, we conducted extensive mutational analysis of the structure-function relationship of rab5. A total of 21 deletion and substitution mutations were created and their effects on rab5 activity were examined. Deletion of the entire C-terminal tetrapeptide motif CCSN abolished rab5 activity. A mutant with the last three residues deleted, however, showed residual rab5 activity. Truncation of only two residues from the C terminus had no effect on the biological activity of rab5. A mutant containing a 4-residue deletion from the N terminus retained full activity in comparison with wild-type rab5. N-terminal deletion of 19 residues only partially blocked rab5 activity. Substitution mutations in the guanine nucleotide binding motifs showed dramatic effects on rab5 function. In addition to the previously reported N133I mutation, the S34N mutation also resulted in a guanine nucleotide binding defective form that was a dominant inhibitor of endogenous rab5 activity. The Q79L mutation (the ras equivalent Q61L decreases intrinsic and GTPase-activating protein-stimulated GTPase activities), however, had no effect on rab5 activity. The S35N mutation, which is immediately downstream of the first GTP/GDP binding motif, decreased guanine nucleotide binding by approximately 4-fold and partially inactivated rab5. Mutations in several other conserved residues (K22A, F57Y, and R81A) also resulted in partial loss of rab5 activity. Eight mutations in and around the putative effector domain had little effect on rab5 activity. In light of these data, the structure-function relationship of rab5 is discussed and compared with that of ras, the prototype of small GTPases.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110	Washington University (WUSTL)			Li, Guangpu/GRS-5397-2022; Stahl, Philip/D-6315-2012		NIGMS NIH HHS [GM42259-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURSTEIN ES, 1992, P NATL ACAD SCI USA, V89, P1154, DOI 10.1073/pnas.89.4.1154; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; DER CJ, 1988, ONCOGENE, V3, P105; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HAUBRUCK H, 1991, BIOCHIM BIOPHYS ACTA, V1072, P215, DOI 10.1016/0304-419X(91)90015-D; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KHOSRAVIFAR R, 1992, J BIOL CHEM, V267, P24363; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LI GP, 1993, ARCH BIOCHEM BIOPHYS, V304, P471, DOI 10.1006/abbi.1993.1377; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; NUREKAMAL MSA, 1992, MOL BIOL CELL, V3, P1437, DOI 10.1091/mbc.3.12.1437; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; PETER M, 1992, J CELL SCI, V102, P857; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Sambrook J, 1989, MOL CLONING LABORATO; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TONG L, 1989, SCIENCE, V245, P244, DOI 10.1126/science.2665078; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; WOLTERS G, 1976, J CLIN PATHOL, V29, P873, DOI 10.1136/jcp.29.10.873; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	41	185	188	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24475	24480						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226999				2022-12-27	WOS:A1993MF29400112
J	NAKAI, H				NAKAI, H			AMPLIFICATION OF BACTERIOPHAGE-MU DNA BY ROLLING CIRCLE DNA-REPLICATION IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; STRAND-TRANSFER; ENZYMATIC REPLICATION; DEOXYRIBONUCLEIC-ACID; END-PRODUCTS; POLYMERASE-I; B-PROTEIN; TRANSPOSITION; PURIFICATION; MECHANISM	When mini-Mu DNA was allowed to transpose and replicate in vitro over a prolonged period, the products consisted not only of simple inserts and cointegrates but also high molecular weight DNA many times the unit length of mini-Mu. This high molecular weight product contained predominantly full-length mini-Mu DNA and relatively little non-Mu DNA (the vector harboring the mini-Mu element and the target for transposition in the reaction system). It arose from rolling circle DNA replication of templates created by intramolecular strand transfer, which is catalyzed by Mu transposition proteins. A donor substrate, which is a supercoiled plasmid bearing a mini-Mu element, gave rise to large amounts of the high molecular weight product provided that the vector segment outside the mini-Mu element was 2 kilobase pairs or more. When a donor substrate had a vector segment of only 600 base pairs, the mini-Mu element first had to transpose to a larger circular target before giving rise to the high molecular weight product. These results suggest a mechanism by which Mu DNA can be amplified for lytic development without transposing multiple times. By establishing a circular template, multiple copies of Mu can be processively generated from a single initiation event.			NAKAI, H (corresponding author), GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WASHINGTON,DC 20007, USA.							BAKER TA, 1991, CELL, V65, P1003, DOI 10.1016/0092-8674(91)90552-A; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; BUKHARI AI, 1976, NATURE, V264, P580, DOI 10.1038/264580a0; CHACONAS G, 1985, J BIOL CHEM, V260, P2662; CHACONAS G, 1981, J MOL BIOL, V150, P341, DOI 10.1016/0022-2836(81)90551-9; CHACONAS G, 1980, P NATL ACAD SCI-BIOL, V77, P1778, DOI 10.1073/pnas.77.4.1778; CHACONAS G, 1983, VIROLOGY, V128, P48, DOI 10.1016/0042-6822(83)90317-3; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CRAIGIE R, 1985, J BIOL CHEM, V260, P1832; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; CRAIGIE R, 1985, P NATL ACAD SCI USA, V82, P7570, DOI 10.1073/pnas.82.22.7570; CRAIGIE R, 1985, CELL, V41, P867, DOI 10.1016/S0092-8674(85)80067-2; DANIELL E, 1975, J VIROL, V15, P739, DOI 10.1128/JVI.15.4.739-743.1975; DIXON NE, 1984, P NATL ACAD SCI-BIOL, V81, P424, DOI 10.1073/pnas.81.2.424; FAELEN M, 1978, NATURE, V271, P580, DOI 10.1038/271580a0; FAELEN M, 1973, VIROLOGY, V54, P117, DOI 10.1016/0042-6822(73)90121-9; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; HARSHEY RM, 1981, P NATL ACAD SCI-BIOL, V78, P1090, DOI 10.1073/pnas.78.2.1090; HARSHEY RM, 1984, NATURE, V311, P580, DOI 10.1038/311580a0; HARSHEY RM, 1982, CELL, V29, P561, DOI 10.1016/0092-8674(82)90172-6; HOOPES BC, 1981, NUCLEIC ACIDS RES, V9, P5493, DOI 10.1093/nar/9.20.5493; HUBER HE, 1987, J BIOL CHEM, V262, P16224; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; MAXWELL A, 1987, P NATL ACAD SCI USA, V84, P699, DOI 10.1073/pnas.84.3.699; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; MIZUUCHI M, 1985, NUCLEIC ACIDS RES, V13, P1193, DOI 10.1093/nar/13.4.1193; NAKAI H, 1988, J BIOL CHEM, V263, P9831; NAKAI H, 1988, J BIOL CHEM, V263, P9818; O'Day KJ, 1978, MICROBIOLOGY 1978, P48; REUBEN RC, 1974, J BIOL CHEM, V249, P3843; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SAMBROOK J, 1989, MOL CLONING LABORATO, V2; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; SURETTE MG, 1991, J BIOL CHEM, V266, P17306; TABOR S, 1987, J BIOL CHEM, V262, P16212; TOUSSAINT A, 1974, MOL GEN GENET, V131, P209, DOI 10.1007/BF00267960; TOUSSAINT A, 1983, MOBILE GENETIC ELEME, P105; WIJFFELMAN C, 1977, MOL GEN GENET, V151, P169, DOI 10.1007/BF00338691	43	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23997	24004						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226943				2022-12-27	WOS:A1993MF29400046
J	NICKELS, JT; CARMAN, GM				NICKELS, JT; CARMAN, GM			PHOTOAFFINITY-LABELING OF THE 45-KDA AND 55-KDA FORMS OF PHOSPHATIDYLINOSITOL 4-KINASE FROM THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; KINETIC-ANALYSIS; PLASMA-MEMBRANE; KINASE; PURIFICATION; BINDING; SPHINGOLIPIDS; METABOLISM; PROTEINS; TURNOVER	The membrane-associated 45- and 55-kDa forms of phosphatidylinositol (PI) 4-kinase (ATP:phosphatidylinositol 4-phosphotransferase, EC 2.7.1.67) from Saccharomyces cerevisiae are inhibited by ADP by a competitive mechanism with respect to ATP. We initiated studies toward defining the ATP and ADP sites on the PI 4-kinases using azidonucleotide photoaffinity labeling probes. The photoprobe 8-azido-ATP fulfilled the criteria of a specific photoaffinity label for the 45- and 55-kDa PI 4-kinases. 8-Azido-ATP was a substrate and a competitive inhibitor of the PI 4-kinases with K(i) values similar to the K(m) for ATP. 8-Azido-ATP photoinactivated the enzymes and was photoincorporated into the enzymes in a dose-dependent manner at concentrations similar to the K(i) values for the photoprobe. ATP, the true substrate, provided specific protection against photoinactivation and photoincorporation of the PI 4-kinases with 8-azido-ATP, whereas GTP, a nonspecific nucleotide, provided no protection against photoinactivation and photoincorporation. Photoaffinity labeling of the PI 4-kinases with 8-azido-ATP was specifically prevented with ADP. The photoprobe 8-azido-ADP also fulfilled the criteria needed to validate its use as a specific photoprobe for the PI 4-kinases. Photoinactivation of the PI 4-kinases with 8-azido-ADP was prevented specifically with ATP. Taken together, these data supported the conclusion that the ATP and ADP sites on the membrane-associated 45- and 55-kDa PI 4-kinases from S. cerevisiae were the same.	RUTGERS UNIV, COOK COLL, NEW JERSEY AGR EXPT STN, DEPT FOOD SCI, NEW BRUNSWICK, NJ 08903 USA	Rutgers State University New Brunswick					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035655] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35655] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYLEY H, 1984, AZIDES NITRENES, P457; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; BELUNIS CJ, 1988, J BIOL CHEM, V263, P18897; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXEDA RJ, 1993, J BIOL CHEM, V268, P6248; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; COLODZIN M, 1965, J BIOL CHEM, V240, P3771; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; DAHL JS, 1985, BIOCHEM BIOPH RES CO, V133, P844, DOI 10.1016/0006-291X(85)91211-2; DAVIS CB, 1990, J BIOL CHEM, V265, P1300; DOWNES CP, 1990, EUR J BIOCHEM, V193, P1, DOI 10.1111/j.1432-1033.1990.tb19297.x; FRASCOTTI G, 1990, FEBS LETT, V274, P19, DOI 10.1016/0014-5793(90)81319-J; HALEY BE, 1991, METHOD ENZYMOL, V200, P477; HAWKINS PT, 1993, J BIOL CHEM, V268, P3374; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; KAIBUCHI K, 1986, P NATL ACAD SCI USA, V83, P8172, DOI 10.1073/pnas.83.21.8172; KATO H, 1989, J BIOL CHEM, V264, P3116; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS CT, 1989, BIOCHEMISTRY-US, V28, P9248, DOI 10.1021/bi00450a003; MCKENZIE MA, 1982, J FOOD BIOCHEM, V6, P77, DOI 10.1111/j.1745-4514.1982.tb00297.x; NICKELS JT, 1992, J BIOL CHEM, V267, P16297; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; PATIL RV, 1988, EUR J BIOCHEM, V177, P569, DOI 10.1111/j.1432-1033.1988.tb14408.x; PATTON JL, 1992, ARCH BIOCHEM BIOPHYS, V292, P70, DOI 10.1016/0003-9861(92)90052-X; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; REIMANN A, 1988, BIOCHEM J, V254, P723, DOI 10.1042/bj2540723; RUSH J, 1990, J BIOL CHEM, V265, P4821; Segel IH., 1975, ENZYME KINETICS, P1, DOI 10.1016/0014-5793(75)80457-1; STEINER S, 1972, J BACTERIOL, V109, P81, DOI 10.1128/JB.109.1.81-88.1972; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; UNO I, 1988, NATURE, V333, P188, DOI 10.1038/333188a0; VOLONTE C, 1992, J BIOL CHEM, V267, P21663	34	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24083	24088						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226954				2022-12-27	WOS:A1993MF29400058
J	SUQUET, C; SMERDON, MJ				SUQUET, C; SMERDON, MJ			UV DAMAGE TO DNA STRONGLY INFLUENCES ITS ROTATIONAL SETTING ON THE HISTONE SURFACE OF RECONSTITUTED NUCLEOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							THYMINE DIMER FORMATION; PYRIMIDINE DIMERS; INTACT CHROMATIN; CORE PARTICLES; TRANSITIONS	The major photoproduct formed in DNA, following absorption of ultraviolet (UV) light, is the cis-syn cyclobutane pyrimidine dimer (CPD). Formation of CPDs in DNA packaged into chromatin prior to UV irradiation results in a striking preference for these photoproducts to be oriented away from the histone surface in nucleosomes (Gale, J. M., Nissen, K. A., and Smerdon, M. J. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6644-6648). In this report, we show that formation of nucleosomes onto UV-irradiated DNA results in a similar distribution of these photoproducts, indicating that preexisting CPDs in the DNA molecule can influence its rotational setting on the histone surface during nucleosome formation. This bias is less pronounced in the central three helical turns encompassing the dyad axis of nucleosomes, where the helix is overwound (10.7 bases/turn) relative to the ''outer'' portion of core DNA (10.0 bases/turn). Such a change in the rotational setting of DNA on the surface of newly formed nucleosomes could expose normally inaccessible DNA sequences to factors which control DNA processing.			SUQUET, C (corresponding author), WASHINGTON STATE UNIV, DEPT BIOCHEM & BIOPHYS, PULLMAN, WA 99164 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002614, R37ES002614, R01ES004106] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04106, ES02614] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARCHER TK, 1989, STEROID THYROID HORM, P221; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BROWN DW, 1993, IN PRESS BIOCHEMISTR; DREW HR, 1993, J MOL BIOL, V230, P824, DOI 10.1006/jmbi.1993.1204; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; GALE JM, 1988, BIOCHEMISTRY-US, V27, P7197, DOI 10.1021/bi00419a006; GALE JM, 1988, J MOL BIOL, V204, P949, DOI 10.1016/0022-2836(88)90054-X; Harm W, 1980, BIOL EFFECTS ULTRAVI; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; JENSEN KA, 1990, BIOCHEMISTRY-US, V29, P4773, DOI 10.1021/bi00472a005; LIBERTINI LJ, 1988, BIOPHYS J, V53, P477, DOI 10.1016/S0006-3495(88)83126-6; LIBERTINI LJ, 1980, NUCLEIC ACIDS RES, V8, P3517, DOI 10.1093/nar/8.16.3517; LOW CML, 1986, NUCLEIC ACIDS RES, V14, P6785, DOI 10.1093/nar/14.17.6785; MOYER R, 1989, J BIOL CHEM, V264, P12226; PEARLMAN DA, 1985, SCIENCE, V227, P1304, DOI 10.1126/science.3975615; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; PEHRSON JR, 1992, NUCLEIC ACIDS RES, V20, P1321, DOI 10.1093/nar/20.6.1321; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; van Holde KE., 1989, SPRINGER SERIES MOL; WANG CI, 1991, P NATL ACAD SCI USA, V88, P9072, DOI 10.1073/pnas.88.20.9072; Wang SY., 1976, PHOTOCHEM PHOTOBIOL; WOLFFE A, 1992, CHROMATIN STRUCTURE	28	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23755	23757						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226904				2022-12-27	WOS:A1993MF29400006
J	OESTREICHER, N; SCAZZOCCHIO, C				OESTREICHER, N; SCAZZOCCHIO, C			SEQUENCE, REGULATION, AND MUTATIONAL ANALYSIS OF THE GENE ENCODING URATE OXIDASE IN ASPERGILLUS-NIDULANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATOR CONSTITUTIVE MUTATION; EUKARYOTIC MESSENGER-RNA; MOLECULAR CHARACTERIZATION; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; NONSENSE MUTATIONS; ESCHERICHIA-COLI; CLONING; EXPRESSION; SPECIFICITY	The uaZ gene of Aspergillus nidulans codes for a protein of 301 amino acids. The open reading frame is interrupted by two introns. A comparison with the open reading frames of 10 other urate oxidases reveals a number of scattered universally conserved residues and four clusters of high similarity. Two of these are of unknown function, and the other two are the putative sites for copper binding and the signal sequence for peroxisomal entry, respectively. This comparison also reveals that there are at 16 positions at which introns can be found in the gene coding for this enzyme in different species. The sequence of a number of mutations confirms the importance for enzyme activity of the carboxyl terminus of the protein. The most amino-terminal mutation (an ochre codon) results also in strikingly diminished steady-state levels of message. This agrees with results from other systems, suggesting that untranslated mRNA is preferentially degraded in eukaryotic cells. Northern blots show that specific induction, mediated by the UAY protein, and nitrogen metabolite repression, mediated by the AREA GATA factor, affect the steady-state levels of uaZ mRNA and thus act most probably at the level of transcription.	UNIV PARIS 11,CTR ORSAY,INST GENET & MICROBIOL,CNRS,U1354,BATIMENT 409,F-91405 ORSAY,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								AHN BY, 1988, MOL CELL BIOL, V8, P2442, DOI 10.1128/MCB.8.6.2442; ARAMAYO R, 1990, NUCLEIC ACIDS RES, V18, P3415, DOI 10.1093/nar/18.11.3415; ARST HN, 1975, NATURE, V254, P31, DOI 10.1038/254031a0; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BALLANCE DJ, 1986, YEAST, V2, P229, DOI 10.1002/yea.320020404; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CORRICK CM, 1987, GENE, V53, P63, DOI 10.1016/0378-1119(87)90093-X; DARLINGTON AJ, 1967, J BACTERIOL, V93, P937, DOI 10.1128/JB.93.3.937-940.1967; DARLINGTON AJ, 1965, NATURE, V206, P599, DOI 10.1038/206599a0; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; DIALLINAS G, 1989, GENETICS, V122, P341; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIDEL S, 1988, GENE, V70, P283, DOI 10.1016/0378-1119(88)90200-4; Fourney R.M., 1988, FOCUS, V10, P5; FRIEDMAN TB, 1992, J MOL EVOL, V34, P62, DOI 10.1007/BF00163853; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FU YH, 1990, P NATL ACAD SCI USA, V87, P5331, DOI 10.1073/pnas.87.14.5331; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; LABOUREUR P, 1968, B SOC CHIM BIOL, V50, P827; LEGOUX R, 1992, J BIOL CHEM, V267, P8565; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; LISKAY RM, 1987, GENETICS, V115, P161; LOCKINGTON RA, 1985, GENE, V33, P137, DOI 10.1016/0378-1119(85)90088-5; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MCKNIGHT GL, 1986, CELL, V46, P143, DOI 10.1016/0092-8674(86)90868-8; MOTOJIMA K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P116, DOI 10.1016/0167-4781(89)90178-4; MULLER M, 1969, EUR J BIOCHEM, V9, P424, DOI 10.1111/j.1432-1033.1969.tb00626.x; NGUYEN T, 1985, P NATL ACAD SCI USA, V82, P5040, DOI 10.1073/pnas.82.15.5040; OESTREICHER N, 1993, IN PRESS GENE AMST; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PELSY F, 1984, CURR GENET, V8, P277, DOI 10.1007/BF00419725; PROUDFOOT NJ, 1979, NATURE, V279, P376, DOI 10.1038/279376a0; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; REDDY PG, 1988, P NATL ACAD SCI USA, V85, P9081, DOI 10.1073/pnas.85.23.9081; ROBERTS T, 1979, MOL GEN GENET, V177, P57, DOI 10.1007/BF00267253; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCAZZOCC.C, 1968, BIOCHIM BIOPHYS ACTA, V166, P557, DOI 10.1016/0005-2787(68)90243-8; SCAZZOCCHIO C, 1982, GENETICS, V100, P185; SCAZZOCCHIO C, 1973, MOL GEN GENET, V125, P147, DOI 10.1007/BF00268868; SCAZZOCCHIO C, 1978, NATURE, V274, P177, DOI 10.1038/274177a0; SCAZZOCCHIO C, 1993, GENETICS PHYSL ASPER; Scazzocchio C., 1977, GENETICS PHYSL ASPER, P255; SEALYLEWIS HM, 1987, CURR GENET, V12, P141, DOI 10.1007/BF00434669; SEALYLEWIS HM, 1978, MOL GEN GENET, V164, P303, DOI 10.1007/BF00333161; SPECHT CA, 1982, ANAL BIOCHEM, V119, P158, DOI 10.1016/0003-2697(82)90680-7; STANKOVICH M, 1993, MOL MICROBIOL, V7, P81, DOI 10.1111/j.1365-2958.1993.tb01099.x; SUAREZ T, 1991, MOL GEN GENET, V230, P359, DOI 10.1007/BF00280292; SUAREZ T, 1991, MOL GEN GENET, V230, P369, DOI 10.1007/BF00280293; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WALLRATH LL, 1990, MOL CELL BIOL, V10, P5114, DOI 10.1128/MCB.10.10.5114; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; XU X, 1992, J MOL EVOL, V34, P78; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	62	45	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23382	23389						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226863				2022-12-27	WOS:A1993MF51500067
J	TASKEN, K; ANDERSSON, KB; SKALHEGG, BS; TASKEN, KA; HANSSON, V; JAHNSEN, T; BLOMHOFF, HK				TASKEN, K; ANDERSSON, KB; SKALHEGG, BS; TASKEN, KA; HANSSON, V; JAHNSEN, T; BLOMHOFF, HK			RECIPROCAL REGULATION OF MESSENGER-RNA AND PROTEIN FOR SUBUNITS OF CAMP-DEPENDENT PROTEIN-KINASE (RI-ALPHA AND C-ALPHA) BY CAMP IN A NEOPLASTIC B-CELL LINE (REH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SERTOLI CELLS; 3',5'-CYCLIC ADENOSINE-MONOPHOSPHATE; CATALYTIC SUBUNIT; CYCLIC-AMP; MOLECULAR-CLONING; CDNA STRUCTURE; HUMAN TESTIS; SKELETAL-MUSCLE; ACTIVATION; BETA	The present study examines the activity, levels of expression and regulation of cAMP-dependent protein kinase subunits during cAMP-mediated inhibition of Reh cell proliferation. Human Reh cells express mRNAs for the RIalpha and Calpha subunits of cAK at high levels and are practically devoid of cAMP-dependent protein kinase type II Treatment with isoproterenol, forskolin, or a cAMP analog increased RIalpha mRNA in a time- and concentration-dependent manner (maximal, 4-fold, at 4-8 h). Messenger RNA for Calpha was also stimulated by cAMP, although with slower kinetics (maximal, 2-fold, at 16-24 h). Nuclear run-on assays showed a 2-fold increase in RIalpha gene transcription, whereas that of Calpha was unchanged. In spite of the stimulatory effects of cAMP on mRNAs for both RIalpha and Calpha phosphotransferase activity and specific [H-3]cAMP binding decreased rapidly after treatment with either cAMP or forskolin. Interestingly, the decrease in R and C activity preceded the increase in RIalpha and Calpha mRNA levels, raising the question whether increased mRNA levels may be secondary to the decrease in RIalpha or Calpha protein. The finding that the protein synthesis inhibitor cycloheximide gave changes in RIalpha and Calpha mRNA similar to cAMP and that co-treatment with cycloheximide and cAMP resulted in additive effects tend to support this notion.	NORWEGIAN RADIUM HOSP, DEPT IMMUNOL, OSLO 3, NORWAY; NATL HOSP, INST GEN & RHEUMATOL IMMUNOL, OSLO, NORWAY	University of Oslo; University of Oslo; National Hospital Norway	TASKEN, K (corresponding author), UNIV OSLO, INST MED BIOCHEM, POB 1112, N-0317 OSLO, NORWAY.		Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Tasken, Kjetil/0000-0003-2841-4697				ALHANATY E, 1979, BIOCHEM BIOPH RES CO, V89, P323, DOI 10.1016/0006-291X(79)90633-8; ANDERSSON KB, 1993, IN PRESS J CELL PHYS; ANTALIS TM, 1991, NUCLEIC ACIDS RES, V19, P4301, DOI 10.1093/nar/19.15.4301; ATWATER JA, 1990, ANNU REV GENET, V24, P519; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; BEEBE SJ, 1986, ENZYMES, V17, P43; BLOMHOFF HK, 1987, J CELL PHYSIOL, V131, P426, DOI 10.1002/jcp.1041310315; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COBB CE, 1988, METHOD ENZYMOL, V159, P202; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALBRUGGE M, 1990, J BIOL CHEM, V265, P3088; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; JAHNSEN T, 1985, J BIOL CHEM, V260, P5980; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LANDMARK BF, 1991, ENDOCRINOLOGY, V129, P2345, DOI 10.1210/endo-129-5-2345; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; LEVY FO, 1989, ENDOCRINOLOGY, V124, P430; LIU AYC, 1982, J BIOL CHEM, V257, P298; LORIMER IAJ, 1989, BIOCHEM J, V264, P305, DOI 10.1042/bj2640305; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MURAGUCHI A, 1984, J IMMUNOL, V133, P1283; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; OYEN O, 1988, ENDOCRINOLOGY, V122, P2658; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; RICHARDSON JM, 1990, J BIOL CHEM, V265, P13635; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SANDBERG M, 1987, BIOCHEM BIOPH RES CO, V149, P939, DOI 10.1016/0006-291X(87)90499-2; SCHONTHAL A, 1989, ONCOGENE, V4, P629; SCHWARTZ DA, 1983, J BIOL CHEM, V258, P777; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; SKALHEGG BS, 1992, J BIOL CHEM, V267, P5374; SKALHEGG BS, 1992, J BIOL CHEM, V267, P15707; SOLBERG R, 1991, BIOCHEM BIOPH RES CO, V176, P166, DOI 10.1016/0006-291X(91)90904-L; STEINBERG RA, 1981, J BIOL CHEM, V256, P731; TASKEN K, 1990, BIOCHEM BIOPH RES CO, V172, P409, DOI 10.1016/0006-291X(90)90688-J; TASKEN K, 1993, IN PRESS J BIOL CHEM, V268; TASKEN KA, 1992, ENDOCRINOLOGY, V130, P1271, DOI 10.1210/en.130.3.1271; TASKEN KA, 1991, MOL ENDOCRINOL, V5, P21, DOI 10.1210/mend-5-1-21; THOMIS DC, 1992, J BIOL CHEM, V267, P10723; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WIEMANN S, 1991, J BIOL CHEM, V266, P5140	51	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23483	23489						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226875				2022-12-27	WOS:A1993MF51500081
J	TERLECKY, SR; DICE, JF				TERLECKY, SR; DICE, JF			POLYPEPTIDE IMPORT AND DEGRADATION BY ISOLATED LYSOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; MICROINJECTED RIBONUCLEASE-A; PEPTIDE SEQUENCES; AUTOPHAGIC VACUOLE; SERUM WITHDRAWAL; STRESS PROTEINS; MEMBRANE; FIBROBLASTS; PROTEOLYSIS; MECHANISMS	We reported previously that lysosomes derived from human diploid fibroblasts import and degrade polypeptides and that these processes are stimulated by ATP and by the heat shock cognate protein of 73 kDa (hsc73). We now report several new aspects of this in vitro proteolytic pathway. (a) Among four polypeptides tested, this pathway appears to be selective for those containing KFERQ-like peptide motifs. (b) Substrate proteins specifically bind to a protein-containing site on lysosomal membranes. (c) Lysosomes derived from serum-deprived cells are twice as active as those from serum-supplemented cells. (d) A portion of intracellular hsc73 is associated with lysosomes, and the amount of lysosomal hsc73 increases in response to serum withdrawal. Additional characterization of this proteolytic pathway not reported previously-shows that intact lysosomes are required, the import process is saturable with an apparent k(m) of 5 muM for RNase S-peptide, and reducing agents activate this lysosomal import and degradation pathway.	TUFTS UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02111 USA	Tufts University					NATIONAL INSTITUTE ON AGING [R01AG006116, R37AG006116] Funding Source: NIH RePORTER; NIA NIH HHS [AGO6116] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AHLBERG J, 1982, LAB INVEST, V47, P523; BACKER JM, 1983, P NATL ACAD SCI-BIOL, V80, P2166, DOI 10.1073/pnas.80.8.2166; BACKER JM, 1986, P NATL ACAD SCI USA, V83, P5830, DOI 10.1073/pnas.83.16.5830; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; DICE JF, 1986, J BIOL CHEM, V261, P6853; DICE JF, 1987, FASEB J, V1, P347; DIMENT S, 1988, J BIOL CHEM, V263, P6901; DOHERTY FJ, 1989, BIOCHEM J, V263, P47, DOI 10.1042/bj2630047; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; FALLON RJ, 1988, J BIOL CHEM, V263, P13159; GUIDON PT, 1986, J CELL PHYSIOL, V128, P239, DOI 10.1002/jcp.1041280215; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KURIAKOSE NR, 1989, HISTOCHEMISTRY, V92, P499, DOI 10.1007/BF00524761; LINQUIST S, 1988, ANNU REV GENET, V22, P631; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADDEN EA, 1987, ARCH BIOCHEM BIOPHYS, V257, P27, DOI 10.1016/0003-9861(87)90539-X; MAEKAWA M, 1989, BIOL REPROD, V40, P843, DOI 10.1095/biolreprod40.4.843; MARZELLA L, 1982, LB INVEST, V47, P523; Marzella L, 1987, LYSOSOMES THEIR ROLE, P319; MCELLIGOTT MA, 1985, J BIOL CHEM, V260, P1986; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; NEFF NT, 1981, J CELL BIOL, V91, P184, DOI 10.1083/jcb.91.1.184; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Pfeifer U., 1987, LYSOSOMES THEIR ROLE, P3; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; ROME LH, 1981, J BIOL CHEM, V56, P10763; RUTTEN A, 1988, ACTA ANAT, V133, P217; Seglen P O, 1990, Semin Cell Biol, V1, P441; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; UENO T, 1991, J BIOL CHEM, V266, P18995; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; WING SS, 1991, BIOCHEM J, V275, P165, DOI 10.1042/bj2750165	44	84	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23490	23495						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226876				2022-12-27	WOS:A1993MF51500082
J	CUI, T; SANKAR, S; PORTER, AG				CUI, T; SANKAR, S; PORTER, AG			BINDING OF ENCEPHALOMYOCARDITIS VIRUS-RNA POLYMERASE TO THE 3'-NONCODING REGION OF THE VIRAL-RNA IS SPECIFIC AND REQUIRES THE 3'-POLY(A) TAIL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL PROTEIN; POLIOVIRUS RNA; ESCHERICHIA-COLI; MESSENGER-RNA; CODING REGION; LENGTH COPIES; INVITRO; REPLICASE; PURIFICATION; GENOME	An in vitro RNA bandshift assay has been developed to demonstrate the binding of purified recombinant encephalomyocarditis (EMC) virus RNA-dependent RNA polymerase (3D(pol)) to the 3'-noncoding region (NCR) and 30 nucleotides of the adjacent 3'-terminal poly(A) tail (3'-NCR(A)) of EMC virus RNA. The binding of 3D(pol) to the 3'-NCR(A) fragment was specific since four other unrelated proteins including an RNA polymerase did not bind, and unlabeled 3'-NCR(A), but not alpha-globin mRNA, tRNA, or pure poly(A), competed with radiolabeled 3'-NCR(A) for binding. Surprisingly, 3D(pol) failed to bind to the 3'-NCR of EMC virus RNA lacking the poly(A) tail. The results together show that EMC virus RNA template specificity depends only on 3D(pol), the 3'-NCR, and the poly(A) tail. This suggests that 3'-poly(A) is essential for viral RNA template selection by the EMC virus RNA polymerase.	NATL UNIV SINGAPORE,INST MOLEC & CELL BIOL,10 KENT RIDGE CRESCENT,SINGAPORE 0511,SINGAPORE	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore								AHLQUIST P, 1979, NUCLEIC ACIDS RES, V7, P1195, DOI 10.1093/nar/7.5.1195; ANDREWS NC, 1985, J BIOL CHEM, V260, P7628; ANDREWS NC, 1986, P NATL ACAD SCI USA, V83, P221, DOI 10.1073/pnas.83.2.221; BARON MH, 1982, J BIOL CHEM, V257, P2351; BLUMENTHAL T, 1973, BIOCHEM BIOPH RES CO, V55, P680, DOI 10.1016/0006-291X(73)91198-4; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; DASGUPTA A, 1980, CELL, V19, P423, DOI 10.1016/0092-8674(80)90516-4; DASGUPTA A, 1979, P NATL ACAD SCI USA, V76, P2679, DOI 10.1073/pnas.76.6.2679; DILDINE SL, 1992, J VIROL, V66, P4364, DOI 10.1128/JVI.66.7.4364-4376.1992; DMITRIEVA TM, 1979, VIROLOGY, V92, P271, DOI 10.1016/0042-6822(79)90131-4; DORSCHHASLER K, 1975, J VIROL, V16, P1512; FLANEGAN JB, 1990, NEW ASPECTS OF POSITIVE-STRAND RNA VIRUSES, P55; FLANEGAN JB, 1977, P NATL ACAD SCI USA, V74, P3677, DOI 10.1073/pnas.74.9.3677; FRISBY D, 1976, NUCLEIC ACIDS RES, V3, P2789, DOI 10.1093/nar/3.10.2789; GIVENS JF, 1976, NUCLEIC ACIDS RES, V3, P405, DOI 10.1093/nar/3.2.405; HEY TD, 1987, J VIROL, V61, P802, DOI 10.1128/JVI.61.3.802-811.1987; JACOBSON SJ, 1993, J VIROL, V67, P2961, DOI 10.1128/JVI.67.6.2961-2971.1993; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; Kuhn R. J., 1987, The molecular biology of the positive strand RNA viruses, P17; MILLER WA, 1986, J MOL BIOL, V187, P537, DOI 10.1016/0022-2836(86)90332-3; MORROW CD, 1985, CELL, V40, P913, DOI 10.1016/0092-8674(85)90351-4; NEUFELD KL, 1991, J BIOL CHEM, V266, P24212; OBERSTE M S, 1988, Nucleic Acids Research, V16, P10339, DOI 10.1093/nar/16.21.10339; PALMENBERG AC, 1984, NUCLEIC ACIDS RES, V12, P2969, DOI 10.1093/nar/12.6.2969; RICHARDS OC, 1992, J BIOL CHEM, V267, P17141; ROTHSTEIN MA, 1988, VIROLOGY, V164, P301, DOI 10.1016/0042-6822(88)90542-9; Sambrook J, 1989, MOL CLONING LABORATO; SANKAR S, 1992, J BIOL CHEM, V267, P10168; SANKAR S, 1991, J VIROL, V65, P2993, DOI 10.1128/JVI.65.6.2993-3000.1991; SARNOW P, 1986, P NATL ACAD SCI USA, V83, P571, DOI 10.1073/pnas.83.3.571; SO AG, 1970, BIOCHEMISTRY-US, V9, P4788, DOI 10.1021/bi00826a024; SPECTOR DH, 1974, P NATL ACAD SCI USA, V71, P2983, DOI 10.1073/pnas.71.8.2983; SPECTOR DH, 1975, VIROLOGY, V67, P498, DOI 10.1016/0042-6822(75)90450-X; TAKEDA N, 1986, J VIROL, V60, P43, DOI 10.1128/JVI.60.1.43-53.1986; TAKEGAMI T, 1983, P NATL ACAD SCI-BIOL, V80, P7447, DOI 10.1073/pnas.80.24.7447; TENDAM E, 1992, BIOCHEMISTRY-US, V31, P11665, DOI 10.1021/bi00162a001; TOBIN GJ, 1989, CELL, V59, P511, DOI 10.1016/0092-8674(89)90034-2; TUSCHALL DM, 1982, J VIROL, V44, P209, DOI 10.1128/JVI.44.1.209-216.1982; VANDYKE TA, 1982, J BIOL CHEM, V257, P4610; VARTAPETIAN AB, 1984, EMBO J, V3, P2593, DOI 10.1002/j.1460-2075.1984.tb02179.x; YOGO Y, 1975, J MOL BIOL, V92, P467, DOI 10.1016/0022-2836(75)90292-2; YOUNG DC, 1985, J VIROL, V54, P256, DOI 10.1128/JVI.54.2.256-264.1985; ZABEL P, 1979, J VIROL, V29, P21, DOI 10.1128/JVI.29.1.21-33.1979	43	44	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26093	26098						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253725				2022-12-27	WOS:A1993MK42500016
J	DENNING, MF; DLUGOSZ, AA; HOWETT, MK; YUSPA, SH				DENNING, MF; DLUGOSZ, AA; HOWETT, MK; YUSPA, SH			EXPRESSION OF AN ONCOGENIC RAS(HA) GENE IN MURINE KERATINOCYTES INDUCES TYROSINE PHOSPHORYLATION AND REDUCED ACTIVITY OF PROTEIN-KINASE-C DELTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAS ONCOGENE; TERMINAL DIFFERENTIATION; SARCOMA-VIRUSES; PHORBOL ESTER; CELLS; STAUROSPORINE; REQUIREMENT; INHIBITOR; PROMOTER; INVITRO	Murine keratinocytes expressing an oncogenic ras(Ha) gene produce benign tumors in vivo and demonstrate altered responses to phorbol esters in vitro. Cultured keratinocytes transduced with the v-ras(Ha) gene (v-ras(Ha) keratinocytes) are resistant to Ca2+-induced terminal differentiation, a process that is dependent on protein kinase C (PKC) activation in normal keratinocytes. Five PKC isoforms expressed in keratinocytes (alpha, delta, epsilon, zeta, and eta) were examined for quantitative or qualitative changes in v-ras(Ha)-transformed cells. No quantitative changes were detected, but PKC delta was tyrosine-phosphorylated in v-ras(Ha) keratinocytes and in benign neoplastic keratinocyte cell lines expressing an activated allele of the c-ras(Ha) gene. Analysis of phosphorylated and non-phosphorylated forms of PKC delta from keratinocytes indicated that phosphorylated PKC delta was not stimulated by phorbol ester treatment. The protein kinase inhibitor staurosporine was able to induce differentiation in v-ras(Ha) keratinocytes and benign tumor cell lines, and concomitantly tyrosine phosphorylation of PKC delta decreased. This interaction between tyrosine kinases and PKC delta in cells expressing an oncogenic ras(Ha) gene may represent a molecular block to differentiation in neoplastic keratinocytes.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT MICROBIOL & IMMUNOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	DENNING, MF (corresponding author), NCI,DIV CANC ETIOL,CELLULAR CARCINOGENESIS & TUMOR PROMOT,BETHESDA,MD 20892, USA.							BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; DLUGOSZ AA, 1991, CANCER RES, V51, P4677; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIBERSPERGER H, 1991, J BIOL CHEM, V266, P14778; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MORRIS JDH, 1989, ONCOGENE, V4, P27; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; REINERS JJ, 1983, CELL, V32, P247, DOI 10.1016/0092-8674(83)90515-9; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; STACEY DW, 1991, ONCOGENE, V6, P2297; STRICKLAND JE, 1988, CANCER RES, V48, P165; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4; YUSPA SH, 1985, NATURE, V314, P459, DOI 10.1038/314459a0; YUSPA SH, 1982, CANCER RES, V42, P2344	25	162	163	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26079	26081						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253722				2022-12-27	WOS:A1993MK42500013
J	HUDSON, BG; REEDERS, ST; TRYGGVASON, K				HUDSON, BG; REEDERS, ST; TRYGGVASON, K			TYPE-IV COLLAGEN - STRUCTURE, GENE ORGANIZATION, AND ROLE IN HUMAN-DISEASES - MOLECULAR-BASIS OF GOODPASTURE AND ALPORT SYNDROMES AND DIFFUSE LEIOMYOMATOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLOMERULAR-BASEMENT-MEMBRANE; NONCOLLAGENOUS DOMAIN HEXAMER; AMINO-ACID-SEQUENCE; ALPHA-2(IV) COLLAGEN; BIDIRECTIONAL PROMOTER; ALPHA-3(IV) CHAIN; IDENTIFICATION; ANTIGEN; LOCALIZATION; ALPHA-1(IV)		YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	Howard Hughes Medical Institute; Yale University; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	HUDSON, BG (corresponding author), UNIV KANSAS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,KANSAS CITY,KS 66160, USA.			Hudson, Billy/0000-0002-5420-4100	NIDDK NIH HHS [DK-18381] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, R37DK018381] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTIGNAC C, 1992, KIDNEY INT, V42, P1176; AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BERNAL D, 1993, J BIOL CHEM, V268, P12090; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; BRAZEL D, 1987, EUR J BIOCHEM, V168, P529, DOI 10.1111/j.1432-1033.1987.tb13450.x; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; COCHAT P, 1988, J PEDIATR-US, V113, P339, DOI 10.1016/S0022-3476(88)80280-4; COHEN MP, 1980, BIOCHEM BIOPH RES CO, V95, P765, DOI 10.1016/0006-291X(80)90852-9; DEAN DC, 1983, J BIOL CHEM, V258, P590; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; FENG L, 1994, IN PRESS J BIOL CHEM, V269; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; GUNWAR S, 1991, J BIOL CHEM, V266, P15318; GUNWAR S, 1991, AM J RESP CELL MOL, V5, P107, DOI 10.1165/ajrcmb/5.2.107; GUO XD, 1989, J BIOL CHEM, V264, P17574; HARALSON MA, 1985, BIOCHEMISTRY-US, V24, P5792, DOI 10.1021/bi00342a016; HEIKKILA P, 1993, J BIOL CHEM, V268, P24677; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1987, FEBS LETT, V224, P297, DOI 10.1016/0014-5793(87)80473-8; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1989, LAB INVEST, V61, P256; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; KALLURI R, 1994, IN PRESS KIDNEY INT; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; KEFALIDES NA, 1971, BIOCHEM BIOPH RES CO, V45, P226, DOI 10.1016/0006-291X(71)90073-8; KIM Y, 1991, AM J PATHOL, V138, P413; KLEPPEL MM, 1987, J CLIN INVEST, V80, P263, DOI 10.1172/JCI113057; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; LEMMINK HH, 1993, GENOMICS, V17, P485, DOI 10.1006/geno.1993.1351; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MARIYAMA M, 1992, J BIOL CHEM, V267, P1253; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MORRISON KE, 1991, AM J HUM GENET, V49, P545; NAYAK BR, 1991, J BIOL CHEM, V266, P13978; NEILSON EG, 1993, J BIOL CHEM, V268, P8402; PETTITT J, 1991, J BIOL CHEM, V266, P16149; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; QUINONES S, 1992, J BIOL CHEM, V267, P19780; REDDY GK, 1993, BIOCHIM BIOPHYS ACTA, V1157, P241, DOI 10.1016/0304-4165(93)90106-I; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SAUS J, 1989, J BIOL CHEM, V264, P6318; SAUS J, 1988, J BIOL CHEM, V263, P13374; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; SOININEN R, 1988, J BIOL CHEM, V263, P17217; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SOININEN R, 1987, FEBS LETT, V225, P188; SPIRO RG, 1967, J BIOL CHEM, V242, P1923; SPIRO RG, 1988, KIDNEY HYPERTENSION, P117; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; TSILIBARY EC, 1988, J BIOL CHEM, V263, P4302; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WIESLANDER J, 1984, P NATL ACAD SCI-BIOL, V81, P3838, DOI 10.1073/pnas.81.12.3838; Yurchenco P.D., 1993, MOL CELLULAR ASPECTS, P19; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1992, J BIOL CHEM, V267, P12475; ZHOU J, 1994, IN PRESS J BIOL CHEM, V269; [No title captured]	72	514	531	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26033	26036						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253711				2022-12-27	WOS:A1993MK42500001
J	MARSHALL, BA; MURATA, H; HRESKO, RC; MUECKLER, M				MARSHALL, BA; MURATA, H; HRESKO, RC; MUECKLER, M			DOMAINS THAT CONFER INTRACELLULAR SEQUESTRATION OF THE GLUT4 GLUCOSE-TRANSPORTER IN XENOPUS-OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; RAT ADIPOCYTES; INSULIN; PROTEIN; ISOFORMS; MUSCLE; TRANSLOCATION; LOCALIZATION	The Glut4 glucose transporter is poorly functional compared with other glucose transporter isoforms when expressed in Xenopus oocytes. To investigate the molecular basis for this poor functionality, we compared the biosynthesis and targeting of Glut1 and Glut4 in oocytes after microinjection of the corresponding mRNAs. Both Glut1 and Glut4 were present as lower molecular weight endoglycosidase H-sensitive and higher molecular weight endoglycosidase H-resistant forms in oocyte intracellular membranes. Part of the Glut1 immunoreactivity was detected as an incompletely processed form that was endoglycosidase H-resistant. Subcellular fractionation indicated that Glut1 was targeted to the plasma membrane with a 6.6-fold greater efficiency than was Glut4. Confocal immunofluorescence microscopy confirmed the relative enrichment of Glut1 in the plasma membrane and the efficient intracellular sequestration of Glut4. As in mammalian cells, the endoglycosidase H-resistant form of Glut4 was concentrated in low-density intracellular vesicles, whereas Glut1 was distributed in intracellular vesicles of higher average density. The structural basis for the differential localization of Glut1 and Glut4 was investigated by determining the plasma membrane content of a series of chimeric Glut1/Glut4 molecules. These data indicated that two distinct regions of Glut4, encompassing residues 24-132 and the COOH-terminal cytoplasmic tail, confer intracellular sequestration on the chimeric transporter molecules. At least part of the sequestration effect of the more N-terminal domain was due to the incomplete maturation of chimeras containing this region, resulting in the accumulation of lower molecular weight endoglycosidase H-sensitive and endoglycosidase H-resistant forms, whereas the COOH-terminal cytoplasmic tail conferred sequestration of fully glycosylated chimeras in a low-density intracellular membrane compartment.	WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA	Washington University (WUSTL)			Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007120, R01DK038495, R01DK043695] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07120, DK38495, DK43695] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLARD WJ, 1985, J BIOL CHEM, V260, P8668; ASANO T, 1992, J BIOL CHEM, V267, P19636; BALDWIN SA, 1989, METHOD ENZYMOL, V174, P39; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BORNEMANN A, 1992, DIABETES, V41, P215, DOI 10.2337/diabetes.41.2.215; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DAVIES A, 1990, BIOCHEM J, V266, P799; DEVASKAR SU, 1992, PEDIATR RES, V31, P1, DOI 10.1203/00006450-199201000-00001; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JAUNIN P, 1992, J BIOL CHEM, V267, P577; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; KELLER K, 1989, J BIOL CHEM, V264, P18884; KOTLIAR N, 1992, MOL ENDOCRINOL, V6, P337, DOI 10.1210/me.6.3.337; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; MUECKLER M, 1986, CELL, V44, P629, DOI 10.1016/0092-8674(86)90272-2; MUECKLER M, 1990, DIABETES, V39, P6, DOI 10.2337/diabetes.39.1.6; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; PESSINO A, 1991, J BIOL CHEM, V266, P20213; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; SHIBASAKI Y, 1992, BIOCHEM J, V281, P829, DOI 10.1042/bj2810829; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; THOMAS HM, 1993, BIOCHEM J, V290, P707, DOI 10.1042/bj2900707; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	42	66	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26193	26199						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253739				2022-12-27	WOS:A1993MK42500030
J	SHIMODA, N; TOYODAYAMAMOTO, A; AOKI, S; MACHIDA, Y				SHIMODA, N; TOYODAYAMAMOTO, A; AOKI, S; MACHIDA, Y			GENETIC-EVIDENCE FOR AN INTERACTION BETWEEN THE VIRA SENSOR PROTEIN AND THE CHVE SUGAR-BINDING PROTEIN OF AGROBACTERIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-DNA TRANSFER; ESCHERICHIA-COLI; VIRULENCE GENES; NUCLEOTIDE-SEQUENCE; SIGNAL MOLECULES; PLANT-CELLS; TUMEFACIENS; MEMBRANE; PLASMID; MUTANT	Most vir genes of Agrobacterium, which are required for tumorigenicity of the bacterium, are expressed in response to plant phenolics. The induction of vir is markedly enhanced by specific monosaccharides. Signals generated by both types of compound are transduced into Agrobacterium cells via the functions of the VirA membrane-bound sensor protein. A putative sugar-binding protein, known as ChvE, also functions at a step of the enhancement of vir induction by monosaccharides. To investigate the signal pathway of the enhancement by the sugars, we first isolated a virA mutant of Agrobacterium with a base substitution mutation that caused a single amino acid change in the periplasmic domain. The mutant exhibited no enhancement of vir induction by sugar and had severely attenuated tumorigenicity on Kalanchoe leaves. We then isolated two chvE mutants that restored sugar enhancement on the background of this virA mutation. One chvE mutant, which exhibited a higher level of sugar enhancement, restored the tumorigenicity of the virA mutant. Wild-type and suppressor ChvE proteins were localized in the periplasmic space. These results provide genetic evidence for the physical interaction between VirA and ChvE proteins in the periplasmic space of Agrobacterium, which enhances the cytoplasmic signal generated by phenolics. We also discuss the molecular architecture of the operon to which the chvE gene belongs.			SHIMODA, N (corresponding author), NAGOYA UNIV,FAC SCI,DEPT BIOL,CHIKUSA KU,NAGOYA 46401,JAPAN.							AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BURN J, 1987, GENE DEV, V1, P456, DOI 10.1101/gad.1.5.456; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; CHANG CH, 1992, J BACTERIOL, V174, P7033, DOI 10.1128/JB.174.21.7033-7039.1992; CORNISH A, 1989, J GEN MICROBIOL, V135, P3001; ENDOH H, 1993, PLANT CELL PHYSIOL, V34, P227; Gelvin S.B., 1992, MOL SIGNALS PLANT MI, P137; HOGG RW, 1991, MOL GEN GENET, V229, P453, DOI 10.1007/BF00267469; HUANG MW, 1990, J BACTERIOL, V172, P1814, DOI 10.1128/jb.172.4.1814-1822.1990; HUANG Y, 1990, J BACTERIOL, V172, P1142, DOI 10.1128/jb.172.2.1142-1144.1990; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; KLEE HJ, 1982, J BACTERIOL, V150, P327, DOI 10.1128/JB.150.1.327-331.1982; KOSSMANN M, 1988, J BACTERIOL, V170, P4516, DOI 10.1128/jb.170.10.4516-4521.1988; LEE KH, 1992, P NATL ACAD SCI USA, V89, P8666, DOI 10.1073/pnas.89.18.8666; LEROUX B, 1987, EMBO J, V6, P849, DOI 10.1002/j.1460-2075.1987.tb04830.x; LIN JJC, 1978, P NATL ACAD SCI USA, V75, P4891, DOI 10.1073/pnas.75.10.4891; LIU JD, 1991, J BACTERIOL, V173, P4941, DOI 10.1128/jb.173.16.4941-4951.1991; MACHIDA Y, 1984, P NATL ACAD SCI-BIOL, V81, P7495, DOI 10.1073/pnas.81.23.7495; MACHIDA Y, 1989, BOT MAG TOKYO, V102, P331, DOI 10.1007/BF02488571; MANTIS N, 1992, J BACTERIOL, V176, P1189; MATTANOVICH D, 1989, NUCLEIC ACIDS RES, V17, P6747, DOI 10.1093/nar/17.16.6747; MELCHERS LS, 1989, EMBO J, V8, P1919, DOI 10.1002/j.1460-2075.1989.tb03595.x; MELCHERS LS, 1987, PLANT MOL BIOL, V11, P227; MOREL P, 1989, MOL MICROBIOL, V3, P1237, DOI 10.1111/j.1365-2958.1989.tb00274.x; OKAMOTO S, 1991, MOL GEN GENET, V228, P24, DOI 10.1007/BF00282443; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PETIT A, 1978, NATURE, V271, P570, DOI 10.1038/271570a0; SCHOLLE A, 1987, MOL GEN GENET, V208, P247, DOI 10.1007/BF00330450; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; SPENCER PA, 1988, PHYTOCHEMISTRY, V27, P2781, DOI 10.1016/0031-9422(88)80663-0; STACHEL SE, 1986, P NATL ACAD SCI USA, V83, P379, DOI 10.1073/pnas.83.2.379; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; TURK SCHJ, 1991, PLANT MOL BIOL, V16, P1051, DOI 10.1007/BF00016076; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WINANS SC, 1989, J BACTERIOL, V171, P1616, DOI 10.1128/jb.171.3.1616-1622.1989; WINANS SC, 1992, MICROBIOL REV, V56, P12, DOI 10.1128/MMBR.56.1.12-31.1992; ZAMBRYSKI PC, 1992, ANNU REV PLANT PHYS, V43, P465, DOI 10.1146/annurev.pp.43.060192.002341	37	73	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26552	26558						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253785				2022-12-27	WOS:A1993MK42500079
J	DONOSO, P; HIDALGO, C				DONOSO, P; HIDALGO, C			PH-SENSITIVE CALCIUM-RELEASE IN TRIADS FROM FROG SKELETAL-MUSCLE - RAPID FILTRATION STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-INDUCED CA-2+ RELEASE; SARCOPLASMIC-RETICULUM VESICLES; INTRACELLULAR FREE MAGNESIUM; FOOT PROTEIN ISOFORMS; RYANODINE RECEPTOR; GATING BEHAVIOR; CA2+ RELEASE; CHANNEL; CONTRACTION; FIBERS	Triad vesicles from frog skeletal muscle exhibited calcium-induced calcium release highly sensitive to extravesicular pH; calcium induced release at pH > 7.4 but not at pH 6.8. In contrast, triads isolated from rabbit skeletal muscle exhibited significant calcium-induced calcium release at pH 6.8. At pH 7.4, there was no stimulation of calcium release in triads from frog at pCa 7, maximum stimulation at pCa 5, and complete inhibition at pCa 3. Addition of ATP at pCa 5, pH 6.8, induced calcium release with the same high rate constants in both preparations. In triads from frog, ATP-induced calcium release at pCa 5 had the same kinetics at pH 6.8 and 7.4, whereas ATP-induced calcium release at pCa > 8, pH 6.8, was partial, with a decrease in the amounts released but not in rate constants. In contrast, triads from rabbit displayed the opposite behavior, with a decrease in rate constants but not in the amounts of calcium released at pCa > 8, pH 6.8. In triads from frog ATP-induced calcium release decreased at pCa < 4, to reach total inhibition at pCa 2; addition of magnesium (free > 0.5 mM) completely abolished ATP-induced calcium release at pH 6.8, pCa 7 or 5. The potential physiological relevance of these results is discussed.	CTR ESTUDIOS CIENT SANTIAGO, SANTIAGO, CHILE		DONOSO, P (corresponding author), UNIV CHILE, FAC MED, DEPT FISIOL & BIOFIS, CASILLA 70005, SANTIAGO 7, CHILE.		HIDALGO, Cecilia/H-7107-2013					AIREY JA, 1990, J BIOL CHEM, V265, P14187; ALVAREZLEEFMANS FJ, 1986, J PHYSIOL-LONDON, V378, P461, DOI 10.1113/jphysiol.1986.sp016230; BAYLOR SM, 1983, J PHYSIOL-LONDON, V344, P625, DOI 10.1113/jphysiol.1983.sp014959; BLATTER LA, 1990, PFLUG ARCH EUR J PHY, V416, P238, DOI 10.1007/BF00392059; BULL R, 1989, BIOPHYS J, V56, P749, DOI 10.1016/S0006-3495(89)82722-5; BULL R, 1993, IN PRESS FEBS LETT; DETTBARN C, 1991, J BIOL CHEM, V266, P8993; DONOSO P, 1992, Biophysical Journal, V61, pA423; DULHUNTY AF, 1992, PROG BIOPHYS MOL BIO, V57, P181, DOI 10.1016/0079-6107(92)90024-Z; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; GOLDSTEIN DA, 1979, BIOPHYS J, V26, P235, DOI 10.1016/S0006-3495(79)85247-9; HAIN J, 1993, BIOPHYS J, V64, P151; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HIDALGO C, 1993, J BIOL CHEM, V268, P15111; IINO M, 1992, BIOCHEM BIOPH RES CO, V185, P713, DOI 10.1016/0006-291X(92)91684-I; IKEMOTO N, 1989, J BIOENERG BIOMEMBR, V21, P247, DOI 10.1007/BF00812071; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; JAIMOVICH E, 1986, BIOCHIM BIOPHYS ACTA, V855, P89, DOI 10.1016/0005-2736(86)90192-6; KAWAMOTO RM, 1986, J CELL BIOL, V103, P1405, DOI 10.1083/jcb.103.4.1405; KIM DH, 1983, J BIOL CHEM, V258, P9662; KONISHI M, 1993, BIOPHYS J, V64, P223, DOI 10.1016/S0006-3495(93)81359-6; LAI FA, 1992, AM J PHYSIOL, V263, pC365, DOI 10.1152/ajpcell.1992.263.2.C365; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LAI FA, 1989, J BIOENERG BIOMEMBR, V21, P247; LAMB GD, 1992, J PHYSIOL-LONDON, V448, P211, DOI 10.1113/jphysiol.1992.sp019037; LAMB GD, 1992, NEWS PHYSIOL SCI, V7, P270; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MEISSNER G, 1990, SER CENT ES, P475; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MOUTIN MJ, 1988, J BIOL CHEM, V263, P4228; MURAYAMA T, 1992, J BIOCHEM, V112, P514, DOI 10.1093/oxfordjournals.jbchem.a123931; OGAWA Y, 1970, J BIOCHEM-TOKYO, V67, P667, DOI 10.1093/oxfordjournals.jbchem.a129295; OGAWA Y, 1976, J BIOCHEM-TOKYO, V80, P1149, DOI 10.1093/oxfordjournals.jbchem.a131370; OLIVARES EB, 1991, BIOPHYS J, V59, P1153, DOI 10.1016/S0006-3495(91)82331-1; RARDON DP, 1990, CIRC RES, V67, P84, DOI 10.1161/01.RES.67.1.84; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; ROUSSEAU E, 1990, PFLUG ARCH EUR J PHY, V415, P645, DOI 10.1007/BF02583520; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; Smith RM, 1974, CRITICAL STABILITY C, V1-6; SUMBILLA C, 1987, FEBS LETT, V210, P31, DOI 10.1016/0014-5793(87)81292-9; TRIMM JL, 1988, J BIOL CHEM, V263, P17443; VALDIVIA HH, 1990, BIOPHYS J, V58, P471, DOI 10.1016/S0006-3495(90)82392-4; VOLPE P, 1988, J BIOL CHEM, V263, P9901; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pE195	52	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25432	25438						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244976				2022-12-27	WOS:A1993MK10000026
J	GOTT, JM; VISOMIRSKI, LM; HUNTER, JL				GOTT, JM; VISOMIRSKI, LM; HUNTER, JL			SUBSTITUTIONAL AND INSERTIONAL RNA EDITING OF THE CYTOCHROME-C-OXIDASE SUBUNIT-1 MESSENGER-RNA OF PHYSARUM-POLYCEPHALUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MITOCHONDRIAL GENOME; GENE; DNA; EXPRESSION; CYTIDINE; URIDINE	The term RNA editing encompasses two types of specific alterations in the coding potential of RNA molecules: base substitution and the insertion (or deletion) of nucleotides. Such changes in RNA sequence can have profound effects on gene expression, and, indeed, most genes in the mitochondria of plants, trypanosomatids, and Physarum appear to require editing for their expression. We describe here the first instance of the utilization of both types of RNA editing in the processing of a single mRNA, that of the mitochondrially encoded cytochome oxidase subunit I of the acellular slime mold, Physarum polycephalum. Editing of this mRNA includes the insertion of cytidine, guanosine, and uridine residues, as well as the apparent conversion of cytidines to uridines. No edited version of this gene was detected in Physarum DNA, and amino acid alignments suggest that both types of RNA editing are required to produce a functional protein.			GOTT, JM (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,CTR MOLEC PARASITOL,DEPT MOLEC BIOL & MICROBIOL,CLEVELAND,OH 44106, USA.							ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BONEN L, 1987, NUCLEIC ACIDS RES, V15, P6734, DOI 10.1093/nar/15.16.6734; BOSTROM K, 1990, J BIOL CHEM, V265, P22446; BURLAND TG, 1992, CURR GENET, V21, P393, DOI 10.1007/BF00351700; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; CASEY JL, 1992, P NATL ACAD SCI USA, V89, P7149, DOI 10.1073/pnas.89.15.7149; CATTANEO R, 1991, ANNU REV GENET, V25, P71, DOI 10.1146/annurev.ge.25.120191.000443; Clary D O, 1983, Nucleic Acids Res, V11, P6859, DOI 10.1093/nar/11.19.6859; COVELLO PS, 1990, NUCLEIC ACIDS RES, V18, P5189, DOI 10.1093/nar/18.17.5189; DEE J, 1987, TRENDS GENET, V3, P208, DOI 10.1016/0168-9525(87)90237-X; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GUALBERTO JM, 1991, PLANT CELL, V3, P1109, DOI 10.1105/tpc.3.10.1109; HIESEL R, 1987, EMBO J, V6, P29, DOI 10.1002/j.1460-2075.1987.tb04714.x; HODGES PE, 1991, NUCLEIC ACIDS RES, V19, P1197, DOI 10.1093/nar/19.6.1197; JONES EP, 1990, CURR GENET, V17, P331, DOI 10.1007/BF00314881; MAHENDRAN R, 1991, NATURE, V349, P434, DOI 10.1038/349434a0; Miller D. L., 1993, RNA EDITING ALTERATI, P53; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; ROE BA, 1985, J BIOL CHEM, V260, P9759; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; STUART K, 1991, ANNU REV MICROBIOL, V45, P327, DOI 10.1146/annurev.mi.45.100191.001551; SWEENEY GE, 1987, NUCLEIC ACIDS RES, V15, P933, DOI 10.1093/nar/15.3.933; ZHENG HQ, 1992, J VIROL, V66, P4693, DOI 10.1128/JVI.66.8.4693-4697.1992	25	69	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25483	25486						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244983				2022-12-27	WOS:A1993MK10000033
J	PUYET, A; IBANEZ, AM; ESPINOSA, M				PUYET, A; IBANEZ, AM; ESPINOSA, M			CHARACTERIZATION OF THE STREPTOCOCCUS-PNEUMONIAE MALTOSACCHARIDE REGULATOR MALR, A MEMBER OF THE LACI-GALR FAMILY OF REPRESSORS DISPLAYING DISTINCTIVE GENETIC FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; KLEBSIELLA-PNEUMONIAE; MALTOSE SYSTEM; RNA-POLYMERASE; PROTEIN; EXPRESSION; BINDING; DNA; CLONING	The gene encoding a transcriptional repressor of the maltosaccharide utilization operons of the Gram-positive bacterium Streptococcus pneumoniae (malR) has been cloned and sequenced. The genetic structure of the locus reveals the presence of an upstream gene necessary for growth on maltotetraose medium (malA). The phenotype of malR- and malA- mutants obtained by interruption of the coding regions suggests that both genes could belong to the same transcription unit. Two copies of a DNA motif consisting of three conserved regions of 59, 42, and 49 nucleotides were found located upstream and downstream of the malA-malR putative operon. These DNA structures are almost identical to the reported Box sequences associated with several genes of S. pneumoniae. The protein encoded by malR was visualized and partially purified after selective expression in Escherichia coli, whereas the product of malA was identified in vitro. The amino acid sequence of MalR displays similarities with the Lac and Gal family of repressors. The highest similarities were found when comparing MalR with the E. coli Mall repressor, which is related with an indirect induction pathway of the maltose regulon. The significance of these similarities is discussed in terms of the possible evolutionary pathways followed by structural and regulatory genes of sugar utilization systems in bacteria.	CSIC,CTR INVEST BIOL,E-28006 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)			Puyet, Antonio/I-4720-2014; Espinosa, Manuel/M-5282-2019	Puyet, Antonio/0000-0002-2026-7955; 				BALLESTER S, 1986, GENE, V41, P153, DOI 10.1016/0378-1119(86)90094-6; BERNS KI, 1965, J MOL BIOL, V11, P476, DOI 10.1016/S0022-2836(65)80004-3; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BISWAL N, 1967, MOL GEN GENET, V100, P39, DOI 10.1007/BF00425774; BLOCH MA, 1986, J BACTERIOL, V168, P1220, DOI 10.1128/jb.168.3.1220-1227.1986; CHAKERIAN AE, 1992, MOL MICROBIOL, V6, P963, DOI 10.1111/j.1365-2958.1992.tb02162.x; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P22206; CHEN JD, 1987, GENE, V55, P179, DOI 10.1016/0378-1119(87)90278-2; EHRMANN M, 1987, J BACTERIOL, V169, P3539, DOI 10.1128/jb.169.8.3539-3545.1987; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; GILSON E, 1991, NUCLEIC ACIDS RES, V19, P1375, DOI 10.1093/nar/19.7.1375; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V45, P155, DOI 10.1016/0006-3002(60)91436-0; LACKS SA, 1988, GENETIC RECOMBINATIO, P43; LACKS SA, 1986, J MOL BIOL, V192, P743; LACKS SA, 1986, GENETICS, V60, P685; LOPEZ P, 1984, MOL GEN GENET, V195, P402, DOI 10.1007/BF00341440; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; MORRISON DA, 1984, J BACTERIOL, V159, P870, DOI 10.1128/JB.159.3.870-876.1984; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; PUYET A, 1989, J BACTERIOL, V171, P2278, DOI 10.1128/jb.171.5.2278-2286.1989; RAIBAUD O, 1989, J MOL BIOL, V205, P471, DOI 10.1016/0022-2836(89)90218-0; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; REIDL J, 1989, J BACTERIOL, V171, P4888, DOI 10.1128/jb.171.9.4888-4899.1989; RICHET E, 1991, CELL, V66, P1185, DOI 10.1016/0092-8674(91)90041-V; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Sambrook J, 1989, MOL CLONING LABORATO; SAMS CF, 1984, NATURE, V310, P429, DOI 10.1038/310429a0; SCHNEIDER E, 1992, BIOCHIM BIOPHYS ACTA, V1129, P223, DOI 10.1016/0167-4781(92)90492-I; Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482; STASSI DL, 1981, P NATL ACAD SCI-BIOL, V78, P7028, DOI 10.1073/pnas.78.11.7028; STASSI DL, 1982, GENE, V20, P359, DOI 10.1016/0378-1119(82)90204-9; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; VALENTINHANSEN P, 1986, NUCLEIC ACIDS RES, V14, P2215, DOI 10.1093/nar/14.5.2215; VIDALINGIGLIARDI D, 1991, J MOL BIOL, V218, P323, DOI 10.1016/0022-2836(91)90715-I; VIROLLE MJ, 1988, GENE, V74, P321, DOI 10.1016/0378-1119(88)90166-7; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WEINRAUCH Y, 1981, MOL GEN GENET, V183, P7, DOI 10.1007/BF00270130; WILKENBERGMANN B, 1982, P NATL ACAD SCI USA, V79, P2427	44	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25402	25408						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244973				2022-12-27	WOS:A1993MK10000022
J	MCCORMICK, KA; DECKERSHEBESTREIT, G; ALTENDORF, K; CAIN, BD				MCCORMICK, KA; DECKERSHEBESTREIT, G; ALTENDORF, K; CAIN, BD			CHARACTERIZATION OF MUTATIONS IN THE B-SUBUNIT OF F(1)F(0) ATP SYNTHASE IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; NUCLEOTIDE-SEQUENCE; PROPIONIGENIUM-MODESTUM; MEMBRANE-PROTEINS; CLONING VEHICLES; F0 SUBUNITS; F1F0 ATPASE; GENES; OPERON; ORGANIZATION	Site-directed mutagenesis was used to investigate the restrictions on Ala-79 of the b subunit in F1F0 adenosine triphosphate synthase. This amino acid had been previously identified as particularly sensitive to mutation (McCormick, K. A., and Cain, B. D. (1991) J. Bacteriol. 173, 7240-7248). Mutant uncF (b) genes were placed under control of the lac promoter and monitored for F1F0 ATP synthase function in an uncF(b) deletion strain. Three deleterious b(Ala-79) mutations were moved to the unc operon in the chromosome by homologous recombination. Decreases in enzymatic activity in the uncF (b) mutant strains resulted from reduced amounts of enzyme. With the exception of the b(Ala-79-->Pro) mutation, high expression of mutant uncF (b) genes resulted in increases in F1F0 ATP synthase activity which were sufficient to overcome the defects. In addition to the decrease in the amount of enzyme, the b(Ala-79-->Lys) mutation affected ATP synthesis to a much greater extent than ATP-driven proton translocation. The evidence supports our earlier hypothesis, in which b(Ala-79) was proposed to play an important, but not essential, structural role in F1F0 ATP synthase assembly or stability.	UNIV FLORIDA,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610; UNIV OSNABRUCK,FACHBEREICH BIOL CHEM,ARBEITSGRP MIKROBIOL,W-4500 OSNABRUCK,GERMANY	State University System of Florida; University of Florida; University Osnabruck					NIGMS NIH HHS [GM43495] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043495] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIS JP, 1985, J BIOL CHEM, V260, P1207; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRUSILOW WSA, 1989, J BIOL CHEM, V264, P1528; CAIN BD, 1986, J BIOL CHEM, V261, P43; CALOS MP, 1983, P NATL ACAD SCI-BIOL, V80, P3015, DOI 10.1073/pnas.80.10.3015; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; COX GB, 1973, BIOCHEM J, V134, P1015, DOI 10.1042/bj1341015; COX GB, 1984, BIOCHIM BIOPHYS ACTA, V768, P201, DOI 10.1016/0304-4173(84)90016-8; COZENS AL, 1987, J MOL BIOL, V194, P359, DOI 10.1016/0022-2836(87)90667-X; DECKERSHEBESTREIT G, 1992, J BIOL CHEM, V267, P12364; DECKERSHEBESTREIT G, 1986, EUR J BIOCHEM, V161, P225, DOI 10.1111/j.1432-1033.1986.tb10146.x; DRETZEN G, 1981, ANAL BIOCHEM, V112, P295, DOI 10.1016/0003-2697(81)90296-7; DUNN SD, 1992, J BIOL CHEM, V267, P7630; ESSER U, 1990, NUCLEIC ACIDS RES, V18, P5887, DOI 10.1093/nar/18.19.5887; FALK G, 1988, BIOCHEM J, V254, P109, DOI 10.1042/bj2540109; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GAY NJ, 1981, NUCLEIC ACIDS RES, V9, P3919, DOI 10.1093/nar/9.16.3919; GOGOL EP, 1987, FEBS LETT, V219, P274, DOI 10.1016/0014-5793(87)80234-X; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HUMBERT R, 1983, J BACTERIOL, V153, P416, DOI 10.1128/JB.153.1.416-422.1983; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IVEY DM, 1991, MOL GEN GENET, V229, P292, DOI 10.1007/BF00272169; KAIM G, 1992, EUR J BIOCHEM, V207, P463, DOI 10.1111/j.1432-1033.1992.tb17072.x; KRUMHOLZ LR, 1989, NUCLEIC ACIDS RES, V17, P7993, DOI 10.1093/nar/17.19.7993; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; LUCKEN U, 1990, BIOCHEMISTRY-US, V29, P5339; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCARN DF, 1988, J BACTERIOL, V170, P3448, DOI 10.1128/jb.170.8.3448-3458.1988; MCCORMICK KA, 1991, J BACTERIOL, V173, P7240, DOI 10.1128/jb.173.22.7240-7248.1991; Miller J. H., 1972, EXPT MOL GENETICS, P431; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; PORTER ACG, 1985, J BIOL CHEM, V260, P8182; Sambrook J, 1989, MOL CLONING LABORATO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIMMEL P, 1990, BIOCHEMISTRY-US, V29, P9495, DOI 10.1021/bi00493a001; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; SENIOR AE, 1983, BIOCHIM BIOPHYS ACTA, V726, P81, DOI 10.1016/0304-4173(83)90001-0; SHIBATA C, 1992, J BACTERIOL, V174, P6117, DOI 10.1128/JB.174.19.6117-6124.1992; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; TAMARAPPOO BK, 1992, J BIOL CHEM, V267, P2370; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER JE, 1982, NATURE, V298, P867, DOI 10.1038/298867a0; 1992, AMPLITAQ CYCLE SEQUE; 1987, K RT SEQUENCING SYST	50	22	22	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24683	24691						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227028				2022-12-27	WOS:A1993MG67300029
J	NAGATA, K; OZAWA, S; MIYATA, M; SHIMADA, M; GONG, DW; YAMAZOE, Y; KATO, R				NAGATA, K; OZAWA, S; MIYATA, M; SHIMADA, M; GONG, DW; YAMAZOE, Y; KATO, R			ISOLATION AND EXPRESSION OF A CDNA-ENCODING A MALE-SPECIFIC RAT SULFOTRANSFERASE THAT CATALYZES ACTIVATION OF N-HYDROXY-2-ACETYLAMINOFLUORENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL SULFOTRANSFERASE; COMPLEMENTARY-DNA; HYDROXYSTEROID SULFOTRANSFERASE; N-HYDROXYARYLAMINE; SEQUENCE-ANALYSIS; MAMMALIAN-CELLS; GROWTH-HORMONE; LIVER; PURIFICATION; CLONING	A cDNA (ST1C1 cDNA) encoding a N-hydroxyarylamine sulfotransferase (HAST-I) was isolated from a liver cDNA library of a male adult rat and was expressed in COS-1 cells. ST1C1 cDNA (1363 base pairs) encoded a protein of 304 amino acids with a molecular mass of 35,768 daltons, which shared 50.7 and 46.1% sequence identity with rat aryl (ST1A1 (PST-1)) and estrogen (rOST) sulfotransferases, respectively. N-terminal amino acid sequences of three digested polypeptide fragments of HAST-1 were completely identical with two portions of the ST1C1 amino acid sequence. The profile of age- and sex-related expression of ST1C1 mRNA was quite consistent with changes in the sulfating activity of N-hydroxyarylamine and HAST contents in rat livers. ST1C1 expressed in COS-1 cells catalyzed a sulfation of N-hydroxy-2-acetylaminofluorene (N-OH-AAF) at a rate of 4.98 nmol/mg of protein/min and mediated PAPS (3'-phosphoadenosine-5'-phosphosulfate)-dependent DNA binding of N-OH-AAF. Although ASTIV was believed to be responsible for the activation of N-OH-AAF, ST1A1 encoding an arylsulfotransferase ASTIV, showed only a marginal activity in a sulfation and covalent binding of N-OH-AAF. These data clearly indicate that ST1C1 cDNA codes a new form of a male-dominant sulfotransferase (HAST) responsible for the bioactivation of N-hydroxyarylamines in rat livers.			NAGATA, K (corresponding author), KEIO UNIV,SCH MED,DEPT PHARMACOL,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN.		Gong, Dawei/AAB-4283-2020					ABUZEID M, 1992, CARCINOGENESIS, V13, P1307, DOI 10.1093/carcin/13.8.1307; BURTON K, 1960, BIOCHEM J, V75, P17, DOI 10.1042/bj0750017; CHEN X, 1992, PROTEIN EXPRES PURIF, V3, P421, DOI 10.1016/S1046-5928(05)80045-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COUGHTRIE MWH, 1990, BIOCHEM PHARMACOL, V40, P2305, DOI 10.1016/0006-2952(90)90727-3; DEBAUN JR, 1970, CANCER RES, V30, P577; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589; GONG DW, 1991, J BIOCHEM-TOKYO, V110, P226, DOI 10.1093/oxfordjournals.jbchem.a123561; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; JACKSON CD, 1972, CANCER RES, V32, P1590; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P199; KADLUBAR FF, 1976, CANCER RES, V36, P2350; KAUFMAN RJ, 1985, P NATL ACAD SCI USA, V82, P689, DOI 10.1073/pnas.82.3.689; KING CM, 1968, SCIENCE, V159, P1351, DOI 10.1126/science.159.3821.1351; KNUTSON JC, 1987, ANAL BIOCHEM, V164, P44, DOI 10.1016/0003-2697(87)90365-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI CC, 1985, CARCINOGENESIS, V6, P1037, DOI 10.1093/carcin/6.7.1037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T, 1989, DECONTAMINATION DILU; MULDER GJ, 1984, PROG DRUG METAB, V8, P35; OGURA K, 1989, BIOCHEM BIOPH RES CO, V165, P168, DOI 10.1016/0006-291X(89)91050-4; OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R; OZAWA S, 1993, JPN J PHARMACOL, V61, P153, DOI 10.1254/jjp.61.153; OZAWA S, 1990, NUCLEIC ACIDS RES, V18, P4001, DOI 10.1093/nar/18.13.4001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEKURA RD, 1981, ARCH BIOCHEM BIOPHYS, V211, P352, DOI 10.1016/0003-9861(81)90464-1; SEKURA RD, 1979, J BIOL CHEM, V254, P5658; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDENGOORBERGH JAM, 1985, CARCINOGENESIS, V6, P1635, DOI 10.1093/carcin/6.11.1635; WATABE T, 1982, SCIENCE, V215, P403, DOI 10.1126/science.6800033; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; WU SCG, 1976, J BIOL CHEM, V251, P6529; YAMAZOE Y, 1989, CARCINOGENESIS, V10, P1675, DOI 10.1093/carcin/10.9.1675; YAMAZOE Y, 1987, MOL PHARMACOL, V32, P536; YAMAZOE Y, 1993, IN PRESS ENV HLTH PE; YEROKUN T, 1992, CANCER RES, V52, P4779; 1990, APPLIED BIOSYSTEMS P, V42	40	120	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24720	24725						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227031				2022-12-27	WOS:A1993MG67300033
J	SHEN, FS; SEIDAH, NG; LINDBERG, I				SHEN, FS; SEIDAH, NG; LINDBERG, I			BIOSYNTHESIS OF THE PROHORMONE CONVERTASE PC2 IN CHINESE-HAMSTER OVARY CELLS AND IN RAT INSULINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINSULIN-PROCESSING ENDOPEPTIDASE; MICROINJECTED XENOPUS OOCYTES; SITE-DIRECTED MUTAGENESIS; ENDOPLASMIC-RETICULUM; CHROMAFFIN GRANULES; KEX2; ENDOPROTEASE; FURIN; IDENTIFICATION; PITUITARY	The biosynthesis of the prohormone convertase PC2 was studied in Chinese hamster ovary cells stably transfected with PC2 cDNA (CHO/PC2) and in rat insulinoma cells (Rin5f). The major form of PC2 synthesized by CHO/PC2 cells was a 75-kDa protein corresponding to proPC2; this protein was retained intracellularly for 2-4 h following synthesis, suggesting prolonged intracellular residence. In contrast, the major form of PC2 within Rin cells initially exhibited a molecular mass of 72 kDa and was then progressively converted to a 64-kDa species. This 64-kDa species, which required 1-2 h to be released, was the major PC2 form detectable in Rin cell medium. Calcium-dependent benzyloxycarbonyl-Arg-Ser-Lys-Arg-aminomethylcoumarin cleaving activity was found in spent Rin cell medium; this activity could be immunoprecipitated with a carboxyl-terminal PC2 antibody, but not with preimmune serum. In neither cell line did intracellular PC2 become endoglycosidase H-resistant over time. PC2 released from Rin cells was also endoglycosidase H-sensitive. Microsequencing and endoglycosidase H results indicate that 75-kDa CHO cell PC2 and 72-kDa Rin cell PC2 both represent proPC2. We speculate that (a) PC2 undergoes unusual glycosylation, which may be related to its slow release from cells, and (b) the 64-kDa molecule detectable in spent Rin cell medium represents the enzymatically active form of PC2.	LOUISIANA STATE UNIV, MED CTR, DEPT BIOCHEM & MOLEC BIOL, 1901 PERDIDO ST, NEW ORLEANS, LA 70112 USA; CLIN RES INST MONTREAL, MONTREAL H2W 1R7, QUEBEC, CANADA	Louisiana State University System; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal			Lindberg, Iris/Q-3825-2019; Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 05084, R01 DA005084, R56 DA005084] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; BRENNER C, 1992, P NATL ACAD SCI USA, V89, P922, DOI 10.1073/pnas.89.3.922; CHRISTIE DL, 1991, J BIOL CHEM, V266, P15679; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; DOCHERTY K, 1989, J BIOL CHEM, V264, P18335; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; GUEST PC, 1992, J BIOL CHEM, V267, P22401; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; KIRCHMAIR R, 1992, FEBS LETT, V297, P302, DOI 10.1016/0014-5793(92)80560-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG I, 1991, ENDOCRINOLOGY, V128, P1849, DOI 10.1210/endo-128-4-1849; LINDBERG I, 1992, BIOCHEM BIOPH RES CO, V183, P1, DOI 10.1016/0006-291X(92)91599-L; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; RHODES CJ, 1989, BIOCHEM J, V258, P305, DOI 10.1042/bj2580305; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHENNAN KIJ, 1991, J BIOL CHEM, V266, P24011; SHENNAN KIJ, 1991, FEBS LETT, V284, P277, DOI 10.1016/0014-5793(91)80703-6; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; YI Z, 1993, J BIOL CHEM, V268, P5615	39	79	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24910	24915						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227053				2022-12-27	WOS:A1993MG67300060
J	CHEUNG, PH; LUO, WP; QIU, YH; ZHANG, XH; EARLEY, K; MILLIRONS, P; LIN, SH				CHEUNG, PH; LUO, WP; QIU, YH; ZHANG, XH; EARLEY, K; MILLIRONS, P; LIN, SH			STRUCTURE AND FUNCTION OF C-CAM1 - THE 1ST IMMUNOGLOBULIN DOMAIN IS REQUIRED FOR INTERCELLULAR-ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; CARCINOEMBRYONIC ANTIGEN; BILIARY GLYCOPROTEIN; MOLECULE UVOMORULIN; RAT HEPATOCYTES; ECTO-ATPASE; GENE FAMILY; N-CAM; PROTEIN; ISOFORMS	Cell-CAM105 proteins (also called C-CAM) are epithelial cell adhesion molecules of the immunoglobulin (Ig) superfamily. The sequences of C-CAM are highly homologous to those of human carcinoembryonic antigen (CEA)-family proteins. In previous studies using baculoviral vectors, we showed that expression of the L-form cell-CAM105 (also called C-CAM1) in insect cells resulted in cell aggregation (Cheung, P. H., Thompson, N. L., Earley, K., Culic, O., Hixson, D., and Lin, S. H. (1993) J. Biol. Chem. 268, 6139-6146). This result indicates that the insect-cell system is suitable for studying the adhesion function of C-CAM. Since C-CAM1 contains four extracellular Ig-domains, the structural features directly responsible for C-CAM1 adhesion function were investigated by site-directed deletion and expression in the baculovirus/insect cell system. Results from these studies indicated that the first Ig domain located in the NH2-terminal of C-CAM plays a crucial role in intercellular adhesion. Site-directed deletion producing mutants lacking the second, third, or fourth Ig domains had no effect on the adhesion function. In addition, adhesion function was retained when both the third and fourth Ig domains were deleted, although the adhesion activity was reduced to half that in control cells. However, simultaneous deletion of the second, third, and fourth domains abolished adhesion, suggesting that these domains affect the accessibility of the binding site localized in the first domain. In our previous studies, we showed that the cytoplasmic domains of C-CAM play a significant role in the isoforms' adhesion activity since expression of a C-CAM isoform containing only 6 instead of 71 amino acids intracellularly failed to show the adhesion phenotype (Cheung, P. H., Culic, O., Qiu, Y., Earley, K., Thompson, N., Hixson, D. C., and Lin, S.-H. (1993) Biochem. J. 295, in press). These results together suggest that both the cytoplasmic domain and the first N-terminal Ig-like domain are required for C-CAM-mediated cell adhesion activity.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,BOX 89,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138	University of Texas System; UTMD Anderson Cancer Center; Harvard University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043189] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL08893] Funding Source: Medline; NIGMS NIH HHS [GM43189] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BLIKSTAD I, 1992, FEBS LETT, V302, P26, DOI 10.1016/0014-5793(92)80276-M; CHEUNG PH, 1993, J BIOL CHEM, V268, P6139; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; CULIC O, 1992, BIOCHEM J, V285, P47, DOI 10.1042/bj2850047; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM Y P, 1990, Journal of Cell Biology, V111, p355A; LIN SH, 1991, BIOCHEM J, V278, P155, DOI 10.1042/bj2780155; LIN SH, 1989, J BIOL CHEM, V264, P14408; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; OCKLIND C, 1982, J BIOL CHEM, V257, P6788; OCKLIND C, 1984, EXP CELL RES, V151, P29, DOI 10.1016/0014-4827(84)90353-7; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; OIKAWA S, 1991, J BIOL CHEM, V266, P7995; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; SUMMERS MD, 1987, B TEXAS AGR EXPT STA, V1555, P10; THOMPSON JA, 1989, BIOCHEM BIOPH RES CO, V158, P996, DOI 10.1016/0006-291X(89)92821-0; TINGSTROM A, 1990, J CELL SCI, V96, P17; TURBIDE C, 1991, J BIOL CHEM, V266, P309; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	27	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24303	24310						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226979				2022-12-27	WOS:A1993MF29400088
J	EDDY, RJ; SAUTERER, RA; CONDEELIS, JS				EDDY, RJ; SAUTERER, RA; CONDEELIS, JS			AGINACTIN, AN AGONIST-REGULATED F-ACTIN CAPPING ACTIVITY IS ASSOCIATED WITH AN HSC70 IN DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; CHEMOTACTIC STIMULATION; ATPASE FRAGMENT; AMEBOID CELLS; BINDING; PURIFICATION; DISCOIDEUM; POLYMERIZATION; AFFINITY; SEQUENCE	We have previously isolated an agonist-regulated actin filament capping activity, called aginactin, that is associated with a 70-kDa protein (Sauterer, R. A., Eddy, R. J., Hall, A. L., and Coneelis, J. S. (1991) J. Biol. Chem. 266, 24533-24539). A 2.0-kilobase clone isolated from a Dictyostelium lambdagt11 cDNA library screened with affinity-purified aginactin antibodies displays an overall sequence identity of 73% to the 70-kDa heat shock cognate protein, Hsc70, from various species. Aginactin capping activity and the 70-kDa protein bind to ATP-agarose columns and are quantitatively depleted from the load, indicating that an Hsc70 is associated with aginactin activity. Moderate stringency Southern blots indicate the presence of no fewer than six Hsc70-related sequences. Immunofluorescent staining of vegetative Dictyostelium AX3 cells with aginactin antibodies reveals a colocalization of aginactin-associated Hsc70 in F-actin-rich regions of the cell cortex and cell protrusions. Nuclei and organelles lacked positive staining indicating that the aginactin-associated Hsc70 is cytosolic. The levels of cytoskeletal-associated Hsc70 correlate with the loss of barbed end capping activity following cAMP stimulation, suggesting that the uncapping of barbed filament ends through an Hsc70-associated process may account for the increase in nucleation activity observed at 5 s following agonist stimulation.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT ANAT & STRUCT BIOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine								BENNETT H, 1988, CELL MOTIL CYTOSKEL, V11, P303, DOI 10.1002/cm.970110408; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CARSON M, 1986, J CELL BIOL, V103, P2707, DOI 10.1083/jcb.103.6.2707; CONDEELIS J, 1987, METHOD CELL BIOL, V28, P191; CONDEELIS J, 1990, DEV GENET, V11, P333, DOI 10.1002/dvg.1020110504; CONDEELIS J, 1992, CANCER METASTASIS RE, V2, P1; DAS OP, 1983, BIOCHIM BIOPHYS ACTA, V736, P45; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DHARMAWARDHANE S, 1989, CELL MOTIL CYTOSKEL, V13, P57, DOI 10.1002/cm.970130107; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FUKUI Y, 1987, METHOD CELL BIOL, V28, P347; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; HALL AL, 1989, J CELL BIOL, V109, P2207, DOI 10.1083/jcb.109.5.2207; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; JONES JG, 1991, EXP SUPPL, V59, P1; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KNECHT DA, 1990, DEV GENET, V11, P403, DOI 10.1002/dvg.1020110513; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE WS, 1991, J PROTEIN CHEM, V10, P151, DOI 10.1007/BF01024778; LATHANGUE NB, 1984, EMBO J, V3, P1871, DOI 10.1002/j.1460-2075.1984.tb02061.x; Maniatis T., 1982, MOL CLONING; MARGULIS BA, 1991, BIOCHEM BIOPH RES CO, V178, P1, DOI 10.1016/0006-291X(91)91771-4; MARGULIS BA, 1991, J BIOL CHEM, V266, P9295; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; SAUTERER RA, 1991, J BIOL CHEM, V266, P24533; SCHMID SL, 1985, J BIOL CHEM, V260, P57; SHARP PM, 1989, NUCLEIC ACIDS RES, V17, P5029, DOI 10.1093/nar/17.13.5029; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229	34	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23267	23274						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226849				2022-12-27	WOS:A1993MF51500051
J	MCCARTHY, SA; BICKNELL, R				MCCARTHY, SA; BICKNELL, R			INHIBITION OF VASCULAR ENDOTHELIAL-CELL GROWTH BY ACTIVIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID-DIFFERENTIATION FACTOR; SERINE THREONINE KINASE; EXPRESSION CLONING; GENE-EXPRESSION; XENOPUS EMBRYOGENESIS; MESODERM INDUCTION; MOLECULAR-CLONING; AXIAL STRUCTURES; MESSENGER-RNA; FACTOR-BETA	The demonstration of type 2 activin receptor expression in human umbilical vein endothelial cells prompted an investigation of the effects of the activin/inhibin family of hormones on vascular endothelial cell growth. Recombinant activin-A inhibited [H-3]methylthymidine uptake and growth of a panel of endothelial cell types; recombinant inhibin-A was without effect. Affinity cross-linking studies demonstrated the presence of type 1 and type 2 activin receptors on the surface of bovine aortic endothelial cells, while detailed analysis of type 2 activin receptor expression revealed both type 2 and type 2B activin receptor mRNA in all endothelial cell types analyzed. In addition, capillary endothelial cells were found to express activin-beta(A) subunit mRNA and protein, the levels of which were increased in response to transforming growth factor (TGF)-beta. Furthermore, activin-A and TGF-beta caused additive inhibition of capillary endothelial cell [H-3]methylthymidine uptake. These findings implicate the activins in the regulation of endothelial cell function, and suggest that TGF-beta and activin may interact to inhibit capillary endothelial cell growth.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND LABS,OXFORD OX3 9DU,ENGLAND	Cancer Research UK; University of Oxford			McCarthy, Sarah/HCI-8963-2022	Bicknell, Roy/0000-0002-0941-8919				ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; AUSUBL FM, 1987, CURRENT PROTOCOLS MO; BICKNELL R, 1991, EUR J CANCER, V27, P781, DOI 10.1016/0277-5379(91)90189-K; CAMPEN CA, 1988, BIOCHEM BIOPH RES CO, V157, P844, DOI 10.1016/S0006-291X(88)80326-7; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250, DOI 10.1128/MCB.11.1.250; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; DONALDSON CJ, 1992, BIOCHEM BIOPH RES CO, V184, P310, DOI 10.1016/0006-291X(92)91194-U; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; FAWCETT J, 1991, BIOCHEM BIOPH RES CO, V174, P903, DOI 10.1016/0006-291X(91)91503-5; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; GONZALEZMANCHON C, 1989, ENDOCRINOLOGY, V125, P1666, DOI 10.1210/endo-125-3-1666; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GROOME N, 1991, HYBRIDOMA, V10, P309, DOI 10.1089/hyb.1991.10.309; HEDGER MP, 1989, MOL CELL ENDOCRINOL, V61, P133, DOI 10.1016/0303-7207(89)90198-6; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HINO M, 1989, J BIOL CHEM, V264, P10309; KOJIMA I, 1989, BIOCHEM BIOPH RES CO, V159, P1107, DOI 10.1016/0006-291X(89)92223-7; KONDO M, 1991, BIOCHEM BIOPH RES CO, V181, P684, DOI 10.1016/0006-291X(91)91245-8; KONDO S, 1989, BIOCHEM BIOPH RES CO, V161, P1267, DOI 10.1016/0006-291X(89)91379-X; LEGERSKI R, 1992, BIOCHEM BIOPH RES CO, V183, P672, DOI 10.1016/0006-291X(92)90535-S; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MATZUK MM, 1992, BIOCHIM BIOPHYS ACTA, V1130, P105, DOI 10.1016/0167-4781(92)90472-C; MCCARTHY SA, 1992, J BIOL CHEM, V267, P21617; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; MITRANI E, 1990, CELL, V63, P495, DOI 10.1016/0092-8674(90)90446-L; OGAWA Y, 1992, J BIOL CHEM, V267, P14233; Roberts A., 1991, PEPTIDE GROWTH FACTO, P419; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; SAWCHENKO PE, 1988, NATURE, V334, P615, DOI 10.1038/334615a0; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; SHAO LE, 1992, BLOOD, V79, P773; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SUGINO H, 1988, J BIOL CHEM, V263, P15249; TAKAHASHI S, 1990, BIOCHEM BIOPH RES CO, V167, P654, DOI 10.1016/0006-291X(90)92075-B; TAKAHASHI S, 1992, BIOCHEM BIOPH RES CO, V188, P310, DOI 10.1016/0006-291X(92)92386-C; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; VALE W, 1990, PEPTIDE GROWTH FACTO, P211; VANDENEIJNDENVANRAAIJ AJM, 1990, NATURE, V345, P732, DOI 10.1038/345732a0; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMASHITA T, 1992, BLOOD, V79, P304; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0	52	140	142	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23066	23071						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226823				2022-12-27	WOS:A1993MF51500019
J	PACCAUD, JP; REITH, W; JOHANSSON, B; MAGNUSSON, KE; MACH, B; CARPENTIER, JL				PACCAUD, JP; REITH, W; JOHANSSON, B; MAGNUSSON, KE; MACH, B; CARPENTIER, JL			CLATHRIN-COATED PIT-MEDIATED RECEPTOR INTERNALIZATION - ROLE OF INTERNALIZATION SIGNALS AND RECEPTOR MOBILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID-PHOSPHATASE; FACTOR-II RECEPTOR; C3B C4B RECEPTOR; INSULIN-RECEPTOR; CYTOPLASMIC DOMAIN; RAPID INTERNALIZATION; GENERAL-METHOD; ENDOCYTOSIS; TYROSINE; SEQUENCE	Most signals controlling receptor-mediated endocytosis have been identified by alteration of sequences present in receptors normally internalized via clathrin-coated pits. In the present work we have reconsidered the factors that control internalization the other way around: i.e. by introducing potential internalization sequences in complement receptor 1 (CR1) which does not preferentially associate with clathrin-coated pits. The analysis of the internalization efficiency of NPxY related motifs generated by substituting His2010 and/or Glu2015 by either Phe or Tyr indicates that FxNPxY is the stronger promoter of endocytosis and that the signal efficiency depends on the presence of aromatic residues (including a tyrosine) at both ends of the -xNPx- motif. Moreover, CR1-tyr (substitution of Glu2015 for Tyr) internalization was superposable to that of a receptor composed of the extracellular and transmembrane domains of CR1 fused to the intracytoplasmic tail of the low density lipoprotein (LDL) receptor (including the FxNPxY motif) (CR1-LDL). When analyzed by fluorescence recovery after photo-bleaching, the surface mobility of CR1-LDL was decreased as compared with that of either CR1-tyr or CR1-wt, despite a similar association with clathrin-coated pits. The role of receptor mobility in internalization was confirmed by the observation that CR1-wt. with a deletion of the cytoplasmic tail, was more mobile and more efficiently internalized than CR1-wt.	LINKOPING UNIV, DEPT MED MICROBIOL, S-58185 LINKOPING, SWEDEN; UNIV GENEVA, UNIV MED CTR, DEPT GENET & MICROBIOL, CH-1211 GENEVA, SWITZERLAND	Linkoping University; University of Geneva	PACCAUD, JP (corresponding author), UNIV GENEVA, UNIV MED CTR, DEPT MORPHOL, CH-1211 GENEVA, SWITZERLAND.			Magnusson, Karl-Eric/0000-0002-7809-8437				AEGERTERSHAW M, 1987, J IMMUNOL, V138, P3488; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CARPENTIER JL, 1991, CELL REGUL, V2, P41, DOI 10.1091/mbc.2.1.41; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1991, EMBO J, V10, P3247, DOI 10.1002/j.1460-2075.1991.tb04888.x; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FEARON DT, 1990, CURR TOP MICROBIOL, V153, P83; FIRE E, 1991, J CELL BIOL, V115, P1585, DOI 10.1083/jcb.115.6.1585; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JACOBSON K, 1976, J SUPRAMOL STR CELL, V5, P565, DOI 10.1002/jss.400050411; JADOT M, 1992, J BIOL CHEM, V267, P11069; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHANSSON B, 1987, CELL BIOPHYS, V10, P233, DOI 10.1007/BF02797343; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LUBLIN DM, 1986, J BIOL CHEM, V261, P5736; MADI N, 1991, CLIN EXP IMMUNOL, V84, P9; MAJERCIK MH, 1985, J CELL PHYSIOL, V124, P403, DOI 10.1002/jcp.1041240308; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PERRIN S, 1990, NUCLEIC ACIDS RES, V18, P7433, DOI 10.1093/nar/18.24.7433; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; ROY LM, 1991, J CELL PHYSIOL, V146, P63, DOI 10.1002/jcp.1041460109; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THIES RS, 1990, J BIOL CHEM, V265, P10132; VERREY F, 1990, CELL REGUL, V1, P471, DOI 10.1091/mbc.1.6.471; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; [No title captured]	44	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23191	23196						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226838				2022-12-27	WOS:A1993MF51500039
J	NYHOLM, S; MANN, GJ; JOHANSSON, AG; BERGERON, RJ; GRASLUND, A; THELANDER, L				NYHOLM, S; MANN, GJ; JOHANSSON, AG; BERGERON, RJ; GRASLUND, A; THELANDER, L			ROLE OF RIBONUCLEOTIDE REDUCTASE IN INHIBITION OF MAMMALIAN-CELL GROWTH BY POTENT IRON CHELATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DNA-SYNTHESIS; DEPENDENT REGULATION; SUBUNIT; ENZYME; OXYGEN; PURIFICATION; PARABACTIN; MECHANISM; PROTEIN	Ribonucleotide reductase consists of two nonidentical subunits, proteins R1 and R2, the latter of which contains an iron-tyrosyl free radical center essential for activity. We have studied the in vivo effects on the R2 protein of the potent iron chelators parabactin and desferrioxamine using R2-overproducing mouse cells with a tyrosyl free radical signal easily quantifiable by EPR spectroscopy. Both chelators inhibited cell growth, and the inhibition was reversible by iron. Furthermore, both chelators, which penetrate cells and chelate the intracellular iron pool, caused a disappearance of the R2 tyrosyl free radical. In parallel, there was an accumulation of apo-R2 protein in the inhibited cells. In vitro studies using pure, Fe-59-labeled recombinant mouse R2 protein unexpectedly showed that its iron center is labile at physiological temperatures and that iron is spontaneously lost from the protein even in the absence of chelators in a temperature-dependent process. Our conclusion is that parabactin or desferrioxamine inhibits ribonucleotide reduction and cell growth not by directly attacking the iron-radical center of the R2 protein, but instead by chelating the intracellular iron pool. This prevents the regeneration of the iron-radical center both in newly synthesized apo-R2 protein and in apo-R2 protein continuously formed from active R2 protein by the loss of iron.	UMEA UNIV, DEPT MED BIOCHEM & BIOPHYS, S-90187 UMEA, SWEDEN; UNIV FLORIDA, DEPT MED CHEM, GAINESVILLE, FL 32610 USA	Umea University; State University System of Florida; University of Florida			Mann, Graham J/G-4758-2014	Mann, Graham J/0000-0003-1301-405X				ATKIN CL, 1973, J BIOL CHEM, V248, P7464; BECTON DL, 1989, CANCER RES, V49, P4809; BERGERON RJ, 1982, J AM CHEM SOC, V104, P4489, DOI 10.1021/ja00380a032; BERGERON RJ, 1987, CANCER RES, V47, P6010; CAVANAUGH PF, 1985, CANCER RES, V45, P4754; CAZZOLA M, 1990, BLOOD, V75, P1903; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; GANESHAGURU K, 1980, BIOCHEM PHARMACOL, V29, P1275, DOI 10.1016/0006-2952(80)90285-3; GOODWIN JF, 1965, NATURE, V205, P281, DOI 10.1038/205281b0; GRAF E, 1984, J BIOL CHEM, V259, P3620; HOFFBRAND AV, 1976, BRIT J HAEMATOL, V33, P517, DOI 10.1111/j.1365-2141.1976.tb03570.x; HOWELL ML, 1992, J BIOL CHEM, V267, P1705; KARLSSON M, 1992, J BIOL CHEM, V267, P12622; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; NOCENTINI G, 1993, CANCER RES, V53, P19; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; NYHOLM S, 1993, IN PESS BIOCHEMISTRY; PETERSON T, 1980, J AM CHEM SOC, V102, P7715, DOI 10.1021/ja00546a013; PROBST H, 1989, BIOCHEM BIOPH RES CO, V163, P334, DOI 10.1016/0006-291X(89)92140-2; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; SODERMAN K, 1986, ANAL BIOCHEM, V152, P89, DOI 10.1016/0003-2697(86)90124-7; STUBBE J, 1990, ADV ENZYMOL RAMB, V63, P349; SUTTLE DP, 1979, J BIOL CHEM, V254, P4602; TAIT GH, 1975, BIOCHEM J, V146, P191, DOI 10.1042/bj1460191; THELANDER L, 1983, J BIOL CHEM, V258, P4063; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; THELANDER L, 1993, GENE AMPLIFICATION M, P265	28	193	195	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26200	26205						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253740				2022-12-27	WOS:A1993MK42500031
J	POPOV, KM; KEDISHVILI, NY; ZHAO, Y; SHIMOMURA, Y; CRABB, DW; HARRIS, RA				POPOV, KM; KEDISHVILI, NY; ZHAO, Y; SHIMOMURA, Y; CRABB, DW; HARRIS, RA			PRIMARY STRUCTURE OF PYRUVATE-DEHYDROGENASE KINASE ESTABLISHES A NEW FAMILY OF EUKARYOTIC PROTEIN-KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOACID DEHYDROGENASE; ACTIVATOR PROTEIN; BOVINE KIDNEY; COMPLEX; PHOSPHORYLATION; PURIFICATION; GENE	We recently reported molecular cloning of the branched chain alpha-ketoacid dehydrogenase kinase, the first mitochondrial protein kinase to be cloned (Popov, K. M., Zhao, Y., Shimomura, Y., Kuntz, M. J., and Harris, R. A. (1992) J. Biol. Chem. 267,13127-13130). From a search for proteins related to the branched chain alpha-ketoacid dehydrogenase kinase, a cDNA encoding the 434 amino acid residues corresponding to pyruvate dehydrogenase kinase has been cloned from a rat heart cDNA library. Evidence that the clone codes for pyruvate dehydrogenase kinase includes: (a) the deduced amino acid sequence is identical to the partial sequence of the kinase determined by direct sequencing, (b) expression of the cDNA in Escherichia coli resulted in synthesis of a protein that phosphorylated and inactivated the pyruvate dehydrogenase complex; (c) kinase activity of the recombinant protein is sensitive to inhibition by a specific inhibitor of pyruvate dehydrogenase kinase; and (d) antiserum raised against the recombinant protein recognized the protein subunit known to correspond to pyruvate dehydrogenase kinase in a highly purified preparation of the pyruvate dehydrogenase complex. Like the branched chain alpha-ketoacid dehydrogenase kinase, pyruvate dehydrogenase kinase lacks motifs usually associated with eukaryotic Ser/Thr-protein kinases. Considerable sequence similarity exists between these mitochondrial protein kinases and members of the prokaryotic histidine kinase family, a diverse set of sensing and response systems important in the regulation of bacterial processes. Thus, molecular cloning of these proteins establishes a new eukaryotic family of protein kinases that is related to a prokaryotic family of protein kinases.	INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, 635 BARNHILL DR, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT MED, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis				Kedishvili, Natalia/0000-0001-6917-4891	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM020542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019259] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM 20542] Funding Source: Medline; NIDDK NIH HHS [DK 19259] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P2958, DOI 10.1021/bi00281a027; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; JONES BS, 1991, BIOCHEM J, V275, P781, DOI 10.1042/bj2750781; KERBEY AL, 1984, FEBS LETT, V176, P115, DOI 10.1016/0014-5793(84)80923-0; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; PAXTON R, 1982, J BIOL CHEM, V257, P4433; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Popov K M, 1991, Protein Expr Purif, V2, P278, DOI 10.1016/1046-5928(91)90084-V; POPOV KM, 1992, J BIOL CHEM, V267, P13127; ROISE D, 1988, J BIOL CHEM, V263, P4509; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sambrook J, 1989, MOL CLONING LABORATO; STEPP LR, 1983, J BIOL CHEM, V258, P9454; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; WIRTZ E, 1991, MOL BIOCHEM PARASIT, V47, P119, DOI 10.1016/0166-6851(91)90154-X	21	128	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26602	26606						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253790				2022-12-27	WOS:A1993MK42500085
J	RODRIGUEZAGUILERA, JC; NAVARRO, F; ARROYO, A; VILLALBA, JM; NAVAS, P				RODRIGUEZAGUILERA, JC; NAVARRO, F; ARROYO, A; VILLALBA, JM; NAVAS, P			TRANSPLASMA MEMBRANE REDOX SYSTEM OF HL-60 CELLS IS CONTROLLED BY CAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIVER PLASMA-MEMBRANE; CYCLIC-AMP; SEMIDEHYDROASCORBATE REDUCTASE; ELECTRON-TRANSPORT; HUMAN-NEUTROPHILS; 47-KDA PROTEIN; ASCORBIC-ACID; GROWTH; FERRICYANIDE	Transplasma membrane redox activity of HL-60 cells was determined by measuring the prevention of ascorbate chemical oxidation. The ascorbate free radical produced as the first step of ascorbate oxidation was reduced back by the transplasma membrane electron transport system, causing then the regeneration of extracellular ascorbate. Agents that increase intracellular cAMP, such as forskolin and dibutyryl cAMP (db-cAMP), increased the rate of ascorbate regeneration by HL-60 cells. Also, the phosphodiesterase-resistant cAMP analogue S(p)-cAMP-S (agonist of the protein kinase A) increased the electron flow to the ascorbate free radical at the plasma membrane. R(p)-cAMP-S, antagonist of the protein kinase A, partially inhibited the redox activity of cells and abolished the effect of S(p)-cAMP-S. Inhibition obtained after preincubation of cells in R(p)-cAMP-S was reversed by S(p)-cAMP-S. Tunicamycin, a compound that inhibited the electron flow to the ascorbate free radical at the plasma membrane, also reduced the response of transplasma membrane redox system to S(p)-cAMP-S. Lactate slightly affected the ascorbate regeneration in nonstimulated cells, but showed a significant effect on S(P)-cAMP-S-stimulated plasma membrane electron flow. We show here a role for CAMP in the short-term modulation of transplasma membrane redox system measured as the regeneration of ascorbate at the cell surface of HL-60 cells, probably mediated by cAMP-dependent protein kinases.			RODRIGUEZAGUILERA, JC (corresponding author), UNIV CORDOBA, FAC CIENCIAS, DEPT BIOL CELULAR, CORDOBA, SPAIN.		NAVAS, PLACIDO/R-5943-2019; Arroyo, Antonio/K-4441-2012; Navarro Roldán, Francisco/H-8611-2015	NAVAS, PLACIDO/0000-0002-4115-7966; Navarro Roldán, Francisco/0000-0002-6384-5575; Villalba Montoro, Jose Manuel/0000-0001-8554-3802; Rodriguez Aguilera, Juan Carlos/0000-0002-3371-4128				ALCAIN FJ, 1990, CANCER RES, V50, P5887; ALCAIN FJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P380, DOI 10.1016/0304-4165(91)90146-8; BRIGHTMAN AO, 1992, BIOCHIM BIOPHYS ACTA, V1105, P109, DOI 10.1016/0005-2736(92)90168-L; BROWN WJ, 1984, J CELL BIOL, V99, P320, DOI 10.1083/jcb.99.1.320; BURDE R, 1989, N-S ARCH PHARMACOL, V340, P671, DOI 10.1007/BF00717743; COASSIN M, 1991, ARCH BIOCHEM BIOPHYS, V290, P458, DOI 10.1016/0003-9861(91)90566-2; CRANE FL, 1985, BIOCHIM BIOPHYS ACTA, V811, P233, DOI 10.1016/0304-4173(85)90013-8; CRANE FL, 1990, OXIDOREDUCTION PLASM, P101; CROWE RA, 1992, MOL BIOL CELL, V3, pA24; DOSTMANN WRG, 1991, BIOCHEMISTRY-US, V30, P8710, DOI 10.1021/bi00099a032; ELLEM KAO, 1983, BIOCHEM BIOPH RES CO, V112, P183, DOI 10.1016/0006-291X(83)91814-4; GIBSONBERRY KL, 1993, J NEUROIMMUNOL, V43, P59, DOI 10.1016/0165-5728(93)90075-A; GOLDENBERG H, 1980, BIOCHEM BIOPH RES CO, V94, P721, DOI 10.1016/0006-291X(80)91292-9; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; IYANAGI T, 1985, BIOCHIM BIOPHYS ACTA, V806, P255, DOI 10.1016/0005-2728(85)90103-3; KHATAMI M, 1986, EXP EYE RES, V43, P167, DOI 10.1016/S0014-4835(86)80084-7; KRAMER IM, 1988, BIOCHIM BIOPHYS ACTA, V971, P189; KRAMER IM, 1988, J BIOL CHEM, V263, P2352; LANDSCHULZ W, 1984, J CELL BIOL, V98, P596, DOI 10.1083/jcb.98.2.596; LESUISSE E, 1991, BIOCHEM J, V280, P545, DOI 10.1042/bj2800545; MEDINA MA, 1992, FEBS LETT, V311, P99, DOI 10.1016/0014-5793(92)81376-W; NAKAMURA T, 1990, J BIOL CHEM, V265, P22011; NAVAS P, 1988, BIOCHEM BIOPH RES CO, V154, P1029, DOI 10.1016/0006-291X(88)90243-4; NAVAS P, 1992, FEBS LETT, V299, P223, DOI 10.1016/0014-5793(92)80119-2; NAVAS P, 1990, OXIDOREDUCTION PLASM, P225; NJUS D, 1991, FEBS LETT, V284, P147, DOI 10.1016/0014-5793(91)80672-P; PEREIRA ME, 1987, J BIOL CHEM, V262, P6093; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SCHWEINZER E, 1992, EUR J BIOCHEM, V206, P807, DOI 10.1111/j.1432-1033.1992.tb16988.x; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; STAHL RL, 1985, BIOCHIM BIOPHYS ACTA, V839, P119, DOI 10.1016/0304-4165(85)90189-8; SUN IL, 1985, EXP CELL RES, V156, P528, DOI 10.1016/0014-4827(85)90559-2; VILLALBA JM, 1993, J BIOENERG BIOMEMBR, V25, P411, DOI 10.1007/BF00762467; VONFIGURA K, 1979, EUR J BIOCHEM, V101, P103; WENNER CE, 1990, OXIDOREDUCTION PLASM, P131; WINKLER BS, 1987, BIOCHIM BIOPHYS ACTA, V925, P258, DOI 10.1016/0304-4165(87)90190-5; WUNDERLING M, 1986, BIOL CHEM H-S, V367, P1047, DOI 10.1515/bchm3.1986.367.2.1047; YOSHIKAWA K, 1981, J INVEST DERMATOL, V77, P397, DOI 10.1111/1523-1747.ep12494579	38	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26346	26349						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253758				2022-12-27	WOS:A1993MK42500052
J	SAIKI, K; MOGI, T; OGURA, K; ANRAKU, Y				SAIKI, K; MOGI, T; OGURA, K; ANRAKU, Y			IN-VITRO HEME O SYNTHESIS BY THE CYOE GENE-PRODUCT FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CYTOCHROME-C OXIDASES; TERMINAL OXIDASE; UBIQUINOL OXIDASE; COMPLEX; TRANSPORT; YEAST; BO	The cytochrome bo complex is a heme-copper terminal quinol oxidase in the aerobic respiratory chain of Escherichia coli and contains low spin heme B, high spin heme O and CU(B) as the redox metal centers in subunit I. Based on site-directed mutagenesis studies on the cyoE gene in the cytochrome bo operon, we have postulated that the cyoE gene encodes a protoheme IX farnesyltransferase (heme O synthase) (Saiki, K., Mogi, T., and Anraku, Y. (1992) Biochem. Biophys. Res. Commun. 189, 1491-1497). The present study demonstrates that the CyoE protein is localized in the cytoplasmic membrane and that the CyoE-overproduced membranes efficiently catalyze a conversion of exogenous ferrous protoheme IX and farnesyl diphosphate to heme O in the presence of divalent cations such as Mg2+ or Ca2+. Thus, the cyoABCDE operon in E. coli encodes not only subunits of the cytochrome bo complex but also heme O synthase that is specifically required for functional expression of the bo-type quinol oxidase. Heme O seems to be an intermediate in heme A biosynthesis.	UNIV TOKYO,GRAD SCH SCI,DEPT PLANT SCI,BUNKYO KU,TOKYO 113,JAPAN; TOHOKU UNIV,INST CHEM REACT SCI,SENDAI,MIYAGI 980,JAPAN	University of Tokyo; Tohoku University								ANRAKU Y, 1988, ANNU REV BIOCHEM, V57, P101, DOI 10.1146/annurev.bi.57.070188.000533; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; CHEPURI V, 1990, J BIOL CHEM, V265, P11185; CHEPURI V, 1990, J BIOL CHEM, V265, P12978; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; FUTAI M, 1974, J MEMBRANE BIOL, V15, P15, DOI 10.1007/BF01870079; GENNIS RB, 1991, BIOCHIM BIOPHYS ACTA, V1058, P21, DOI 10.1016/S0005-2728(05)80260-9; HANSSON M, 1993, FEMS MICROBIOL LETT, V107, P121; HATA A, 1985, BIOCHIM BIOPHYS ACTA, V810, P62, DOI 10.1016/0005-2728(85)90206-3; HILL J, 1992, BIOCHEMISTRY-US, V31, P11435, DOI 10.1021/bi00161a023; KITA K, 1984, J BIOL CHEM, V259, P3368; MINGHETTI KC, 1992, BIOCHEMISTRY-US, V31, P17; NAKAMURA H, 1990, J BIOL CHEM, V265, P11193; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; PORRA RJ, 1963, BIOCHEM J, V87, P181, DOI 10.1042/bj0870181; PORRA RJ, 1993, FEBS LETT, V323, P31, DOI 10.1016/0014-5793(93)81442-3; Poulter C. D., 1981, BIOSYNTHESIS ISOPREN, V1, P161; PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7; PUUSTINEN A, 1991, P NATL ACAD SCI USA, V88, P6122, DOI 10.1073/pnas.88.14.6122; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SAIKI K, 1993, J BIOL CHEM, V268, P26927; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SINCLAIR P, 1967, BIOCHIM BIOPHYS ACTA, V143, P427, DOI 10.1016/0005-2728(67)90097-7; SVENNSON B, 1992, EBEC SHORT REPORTS, V7, P36; TAIT GH, 1968, PORPHYRINS RELATED C, P19; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P7456; UNO T, 1985, J BIOL CHEM, V260, P6755; WU W, 1992, J AM CHEM SOC, V114, P1182, DOI 10.1021/ja00030a009	29	77	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26041	26045						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253713				2022-12-27	WOS:A1993MK42500003
J	ANTONETTI, DA; KIMBALL, SR; HORETSKY, RL; JEFFERSON, LS				ANTONETTI, DA; KIMBALL, SR; HORETSKY, RL; JEFFERSON, LS			REGULATION OF RDNA TRANSCRIPTION BY INSULIN IN PRIMARY CULTURES OF RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-CHAIN INITIATION; RIBOSOMAL-RNA SYNTHESIS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; AMINO-ACID; RIBONUCLEIC-ACID; SKELETAL-MUSCLE; LIVER INVIVO; HEART-CELLS	The studies presented herein were designed to investigate the role of insulin in maintaining the steady-state number of ribosomes in primary cultures of rat hepatocytes. The RNA content of hepatocytes maintained in the presence of insulin did not change during the 7 days of culture. In contrast, the RNA content declined significantly following 2 days of insulin deprivation and after 4 days without insulin reached a new steady-state value that was approximately 60% of that observed for hepatocytes maintained in the presence of the hormone. Following addition of insulin, the RNA content of insulin-deprived hepatocytes started to increase within 6 h and was restored to the control value within 48 h. The amounts of 18 and 28 S RNA, and thus the number of ribosomes, changed in concert with the total RNA content. Furthermore, synthesis of total cellular protein responded in parallel to the changes in RNA content, suggesting that the number of ribosomes was the primary determinant of protein synthesis under the conditions of these experiments. About one-half of the increase in RNA content following the addition of insulin to insulin-deprived cells could be accounted for by a reduction in the rate of degradation of ribosomes. The remainder of the change in RNA content must have resulted from an increase in ribosome biogenesis. This possibility was confirmed by measuring [H-3]uridine incorporation into ribosomal RNA present in mature ribosomes. The rate of synthesis of ribosomal RNA was reduced in parallel with the fall in RNA content in insulin-deprived hepatocytes and was restored to the control value within 3 h of the addition of insulin. Alterations in the synthesis of ribosomal RNA in response to insulin deprivation and replacement were associated with parallel changes in transcription of rDNA as measured in nuclear run-on assays using a DNA probe corresponding to the external transcribed spacer region of rat rDNA. The data demonstrate that insulin regulates the number of ribosomes in primary cultures of rat hepatocytes by accelerating the rate of transcription of rDNA and by slowing the rate of ribosome degradation.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,POB 850,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health				antonetti, david/0000-0003-1130-6577	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-13499] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHFORD AJ, 1986, J BIOL CHEM, V261, P4066; ASHFORD AJ, 1986, J BIOL CHEM, V261, P4059; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BLOBEL G, 1967, J MOL BIOL, V26, P279, DOI 10.1016/0022-2836(67)90297-5; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DARNELL JE, 1968, BACTERIOL REV, V32, P262, DOI 10.1128/MMBR.32.3.262-290.1968; DEPHILIP RM, 1979, BIOCHEMISTRY-US, V18, P4812, DOI 10.1021/bi00589a008; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLECK A, 1962, BIOCHIM BIOPHYS ACTA, V55, P571; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; HAMMOND ML, 1988, J BIOL CHEM, V263, P17785; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; HSU CJ, 1993, AM J PHYSIOL, V263, pE1106; JEFFERSON LS, 1983, J BIOL CHEM, V258, P1369; KHYM JX, 1978, J BIOL CHEM, V253, P8741; KIMBALL SR, 1990, J BIOL CHEM, V265, P16794; KIMBALL SR, 1990, ELLENBERG RIFKINS DI, P41; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LARDEUX BR, 1987, J BIOL CHEM, V262, P14514; LLOYD CE, 1987, AM J PHYSIOL, V252, pC205, DOI 10.1152/ajpcell.1987.252.2.C205; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MCDERMOTT PJ, 1989, CIRC RES, V64, P542, DOI 10.1161/01.RES.64.3.542; MCDERMOTT PJ, 1989, J BIOL CHEM, V264, P18220; MCNURLAN MA, 1981, AM J PHYSIOL, V241, pE238, DOI 10.1152/ajpendo.1981.241.3.E238; MEISLER MH, 1989, ANNU REV PHYSIOL, V51, P701, DOI 10.1146/annurev.physiol.51.1.701; NEELY AN, 1977, J BIOL CHEM, V252, P6948; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; PALMITER RD, 1974, J BIOL CHEM, V249, P6779; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PETERSON DT, 1973, J CLIN INVEST, V52, P3201, DOI 10.1172/JCI107520; PILKIS SJ, 1972, BIOCHIM BIOPHYS ACTA, V272, P327, DOI 10.1016/0005-2787(72)90257-2; PILKIS SJ, 1971, BIOCHIM BIOPHYS ACTA, V247, P597, DOI 10.1016/0005-2787(71)90695-2; RANNELS SR, 1978, AM J PHYSIOL, V235, pE134, DOI 10.1152/ajpendo.1978.235.2.E134; ROTHBLUM LI, 1982, GENE, V17, P75, DOI 10.1016/0378-1119(82)90102-0; ROTHBLUM LI, 1982, NUCLEIC ACIDS RES, V10, P7345, DOI 10.1093/nar/10.22.7345; SAMBROOK J, 1989, MOL CLONING LABORATO, P15113; SOLLNERWEBB B, 1991, TRENDS BIOCHEM SCI, V16, P58, DOI 10.1016/0968-0004(91)90025-Q; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; STEINER DF, 1966, BIOCHIM BIOPHYS ACTA, V119, P510, DOI 10.1016/0005-2787(66)90127-4; TRAGL KH, 1972, DIABETES, V21, P84, DOI 10.2337/diab.21.2.84; TSURUGI K, 1974, EUR J BIOCHEM, V45, P119, DOI 10.1111/j.1432-1033.1974.tb03536.x; WATSON JD, 1987, MOL BIOL GENE, P1163; WIEGERS U, 1976, EUR J BIOCHEM, V64, P535, DOI 10.1111/j.1432-1033.1976.tb10333.x; WITTMAN JS, 1969, BIOCHIM BIOPHYS ACTA, V174, P536, DOI 10.1016/0005-2787(69)90282-2	48	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25277	25284						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244958				2022-12-27	WOS:A1993MK10000005
J	DRABKIN, HJ; HELK, B; RAJBHANDARY, UL				DRABKIN, HJ; HELK, B; RAJBHANDARY, UL			THE ROLE OF NUCLEOTIDES CONSERVED IN EUKARYOTIC INITIATOR METHIONINE TRANSFER-RNAS IN INITIATION OF PROTEIN-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLMETHIONINE TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; STRUCTURAL GENE; DNA; SEQUENCE; YEAST; EXPRESSION; INVITRO; MUTATIONS; INVIVO	Mutant human initiator tRNA genes carrying changes in each of the three features unique to eukaryotic initiator tRNAs have been constructed, and introduced into CV-1 monkey kidney cells using SV40 virus vectors. The mutant tRNA genes are expressed, and the mutant tRNAs can all be aminoacylated with both rabbit liver and Escherichia coli methionyl-tRNA synthetases. Based on aminoacylation levels, the tRNAs are expressed to 5-15-fold over the level of endogenous initiator tRNA. The activity of the mutant [S-35]methionyl-tRNAs in initiation was studied in rabbit reticulocyte and wheat germ cell-free protein synthesis systems programmed with various mRNAs. Initiation is studied by using a mRNA that codes for a protein whose N-terminal methionine is stable and not removed by methionine aminopeptidase. Changing the A1:U72 base pair to a G1:C72 base pair greatly reduced activity of the tRNA in initiation. Changing the three consecutive G:C base pairs (G29G30G31: C39C40C41) in the anticodon stem to those found in elongator methionine tRNA also reduced initiation activity. Interestingly, changing the A54 and A60 residues in loop IV to T54 and U60 had less of an effect on activity. The tRNA with changes in all three conserved features had virtually no activity in initiation.			DRABKIN, HJ (corresponding author), MIT,DEPT BIOL,CAMBRIDGE,MA 02139, USA.				NIGMS NIH HHS [GM46942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; BOLLUM FJ, 1968, METHODS ENZYMOLOGY B, V12, P169; BYSTROM AS, 1989, MOL GEN GENET, V216, P276, DOI 10.1007/BF00334366; DRABKIN HJ, 1988, NUCLEIC ACIDS RES, V16, P11591, DOI 10.1093/nar/16.24.11591; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5580; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5588; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5596; FRANCIS MA, 1990, MOL CELL BIOL, V10, P4486, DOI 10.1128/MCB.10.9.4486; GILL DS, 1986, P NATL ACAD SCI USA, V83, P8873, DOI 10.1073/pnas.83.23.8873; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; KEITH G, 1993, NUCLEIC ACIDS RES, V21, P2949, DOI 10.1093/nar/21.12.2949; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KOZAK M, 1983, MICROBIOL REV, V47, P1; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LEE CP, 1992, P NATL ACAD SCI USA, V89, P9262, DOI 10.1073/pnas.89.19.9262; LEONTIS N, 1988, NUCLEIC ACIDS RES, V16, P2537, DOI 10.1093/nar/16.6.2537; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MAO JI, 1980, CELL, V21, P509, DOI 10.1016/0092-8674(80)90488-2; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; PEARSON RL, 1973, BIOCHIM BIOPHYS ACTA, V294, P236, DOI 10.1016/0005-2787(73)90296-7; RABA M, 1979, EUR J BIOCHEM, V97, P305, DOI 10.1111/j.1432-1033.1979.tb13115.x; RAJBHANDARY UL, 1969, J BIOL CHEM, V244, P1104; SACHS MS, 1989, MOL CELL BIOL, V9, P566, DOI 10.1128/MCB.9.2.566; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS T, 1981, CELL, V23, P699, DOI 10.1016/0092-8674(81)90433-5; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P8859, DOI 10.1073/pnas.84.24.8859; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P334, DOI 10.1073/pnas.84.2.334; SIMSEK M, 1972, BIOCHEM BIOPH RES CO, V49, P508, DOI 10.1016/0006-291X(72)90440-8; SIMSEK M, 1973, P NATL ACAD SCI USA, V70, P1041, DOI 10.1073/pnas.70.4.1041; SPRINZL M, 1991, NUCLEIC ACIDS RES, V19, P2127, DOI 10.1093/nar/19.suppl.2127; Stanley W M Jr, 1974, Methods Enzymol, V29, P530; TSUNASAWA S, 1985, J BIOL CHEM, V260, P5382; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; VONPAWELRAMMINGEN U, 1992, MOL CELL BIOL, V12, P1432, DOI 10.1128/MCB.12.4.1432; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; ZOLLER MJ, 1982, NUCLEIC ACIDS RES, V10, P6487, DOI 10.1093/nar/10.20.6487	40	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25221	25228						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227087				2022-12-27	WOS:A1993MG67300100
J	WILLEMS, J; ZWIJSEN, A; SLEGERS, H; NICOLAI, S; BETTADAPURA, J; RAYMACKERS, J; SCARCEZ, T				WILLEMS, J; ZWIJSEN, A; SLEGERS, H; NICOLAI, S; BETTADAPURA, J; RAYMACKERS, J; SCARCEZ, T			PURIFICATION AND SEQUENCE OF RAT EXTRACELLULAR-SUPEROXIDE DISMUTASE-B SECRETED BY C(6) GLIOMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CELL-LINES; PROTEINS; BINDING; DNA; ELECTROPHORESIS; CHROMATOGRAPHY; EXPRESSION; QUANTITIES; SITE	An enzyme which converts radical oxygen, produced by phorbol 12-myristate 13-acetate activated neutrophils, into nonluminescent products is secreted by rat C6 glioma. The enzyme was purified from chemically defined conditioned media and identified as an extracellular superoxide dismutase (EC-SOD). The purified enzyme is distinct from human EC-SOD C (Hjalmarsson, K., Marklund, S. L., Engstrom, A., and Edlund, T. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6340-6344) by its elution from heparin-Sepharose at 300-400 mM NaCl, its pI of 6.1-7.2, and its native M(r) of 85,000 +/- 20,000. The rat EC-SOD is a dimer with a subunit M(r) of 34,000-36,000 and is extensively modified by post-translational processing. Although rat EC-SOD has a high sequence homology with the catalytic center and the polybasic heparin-binding site near the COOH terminus of human EC-SOD C, its NH2-terminal sequence and the sequences flanking the heparin-binding site differ substantially. The sequence of the isolated rat EC-SOD cDNA fully confirms the data obtained from amino acid sequence analysis. The amino acid sequence of the enzyme and its biochemical properties support its identification as the rat EC-SOD B.	UNIV INSTELLING ANTWERP, DEPT BIOCHEM, UNIV PL 1, B-2610 Antwerp, BELGIUM; KULAK, INTERDISCIPLINARY RES CTR, B-8500 KORTRIJK, BELGIUM; INNOGENET NV, B-9050 ZWIJNAARDE, BELGIUM	University of Antwerp; KU Leuven; Innogenetics NV			Zwijsen, An/AAK-2897-2020	Zwijsen, An/0000-0002-8583-1721				ADACHI T, 1991, BIOCHEM J, V279, P263, DOI 10.1042/bj2790263; ADACHI T, 1992, ARCH BIOCHEM BIOPHYS, V297, P155, DOI 10.1016/0003-9861(92)90654-F; ADACHI T, 1989, J BIOL CHEM, V264, P8537; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; BAUW G, 1989, P NATL ACAD SCI USA, V86, P7701, DOI 10.1073/pnas.86.20.7701; BOISSINOT M, 1993, BIOCHEM BIOPH RES CO, V190, P250, DOI 10.1006/bbrc.1993.1038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALABRESE L, 1975, FEBS LETT, V59, P29, DOI 10.1016/0014-5793(75)80333-4; CARRICO RJ, 1969, J BIOL CHEM, V244, P6087; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERRARI R, 1989, PHARMACOL RES, V21, P57, DOI 10.1016/S1043-6618(89)80018-0; GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408; Gros E., 1967, METHOD ENZYMOL, V11, P238; HIRS CHW, 1967, METHOD ENZYMOL, V11, P199; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; KARLSSON K, 1988, BIOCHEM J, V255, P223; KARLSSON K, 1987, BIOCHEM J, V242, P55, DOI 10.1042/bj2420055; KARLSSON K, 1989, LAB INVEST, V60, P659; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM R, 1986, CANCER RES, V46, P5241; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1990, BIOCHEM J, V266, P213, DOI 10.1042/bj2660213; MARKLUND SL, 1984, BIOCHEM J, V222, P649, DOI 10.1042/bj2220649; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SAMBROOK I, 1989, MOL CLONING LABORATO; SANDSTROM J, 1992, J BIOL CHEM, V267, P18205; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SJOQUIST PO, 1992, CARDIOVASC RES, V26, P347, DOI 10.1093/cvr/26.4.347; STROMQVIST M, 1991, J CHROMATOGR, V548, P293, DOI 10.1016/S0021-9673(01)88611-8; TIBELL L, 1987, P NATL ACAD SCI USA, V84, P6634, DOI 10.1073/pnas.84.19.6634; TROJAN J, 1992, P NATL ACAD SCI USA, V89, P4874, DOI 10.1073/pnas.89.11.4874; TROUTT AB, 1992, P NATL ACAD SCI USA, V89, P9823, DOI 10.1073/pnas.89.20.9823; VANFLETEREN JR, 1992, BIOTECHNIQUES, V12, P550; WILLEMS J, 1989, IMMUNOLOGY, V67, P540; ZAGURSKY RJ, 1985, GENE ANAL TECH, V2, P89, DOI 10.1016/0735-0651(85)90011-1	42	43	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24614	24621						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227019				2022-12-27	WOS:A1993MG67300019
J	BROOKS, G; GOSS, MW; EAST, JA; HART, IR				BROOKS, G; GOSS, MW; EAST, JA; HART, IR			GROWTH OF MELANOCYTIC CELLS IS ASSOCIATED WITH DOWN-REGULATION OF PROTEIN-KINASE-C ALPHA-ISOFORM, DELTA-ISOFORM, AND EPSILON-ISOFORM - POSSIBLE ROLE OF DIACYLGLYCEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION; MURINE MELANOCYTES; GENE-EXPRESSION; PHORBOL ESTERS; RAS; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; ACTIVATION; FIBROBLASTS; INDUCTION; MELANOMA	Protein kinase C (PKC) down-regulation has been shown to correlate with the growth of murine melanocytic cells in culture (Brooks, G., Wilson, R. E., Dooley, T. P., Goss, M. W., and Hart, I. R. (1991) Cancer Res. 51, 3281-3288). We now show that PKC alpha, delta, epsilon, and zeta isoforms are present at the protein level in quiescent, non-transformed Mel-ab melanocytes, maintained in the absence of phorbol ester. Proliferation of Mel-ab cells, achieved by incubation in the continual presence of phorbol 12,13-dibutyrate, was associated with a down-regulation of the PKC alpha, delta, and epsilon isozymes. Examination of two transformed syngeneic lines (the B16 murine melanoma and the long terminal repeat Ras.2 line), that grew in the absence of exogenous phorbol esters, showed that PKC alpha protein levels were either partially down-regulated or unaffected, the PKC delta and epsilon isoforms were down-regulated completely, and the levels of PKC zeta protein remained unaltered relative to quiescent Mel-ab cells. Basal levels of total diacylglycerol were elevated 5-fold in B16 melanoma cells compared with levels found in quiescent or proliferating Mel-ab melanocytes and appear to arise largely from the breakdown of phosphatidylinositol phospholipids accompanied by a significant rise in phospholipase C activity. Hourly treatments of quiescent Mel-ab melanocytes with the synthetic diacylglycerol analogue, 1,2-dioctanoyl-sn-glycerol, for 24 h, resulted in an induction of DNA synthesis which was associated with a significant down-regulation of PKC levels mediated largely via post-translational rather than transcriptional mechanisms. These results show for the first time that specific isoforms of PKC are down-regulated at the protein level during proliferation of murine melanocytic cells and suggest that the constitutive down-regulation of PKC in transformed melanoma cells may arise as a consequence of elevated endogenous phosphatidylinositol-derived diacylglycerol levels.	IMPERIAL CANC RES FUND,BIOL METASTASIS LAB,LONDON WC2A 3PX,ENGLAND	Cancer Research UK	BROOKS, G (corresponding author), ST THOMAS HOSP,RAYNE INST,LONDON SE1 7EH,ENGLAND.							ANDO H, 1990, PIGM CELL RES, V3, P200, DOI 10.1111/j.1600-0749.1990.tb00290.x; ARITA Y, 1992, CANCER RES, V52, P4514; BECKER D, 1990, ONCOGENE, V5, P1133; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; BORNER C, 1990, CELL GROWTH DIFFER, V1, P653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS G, 1991, CANCER RES, V51, P3281; BROOKS G, 1992, MOL CARCINOGEN, V5, P328, DOI 10.1002/mc.2940050414; CHIARUGI V, 1989, BIOCHEM BIOPH RES CO, V164, P816, DOI 10.1016/0006-291X(89)91532-5; FARESE RV, 1987, SCIENCE, V236, P586, DOI 10.1126/science.3107122; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; HALSEY DL, 1987, J BIOL CHEM, V262, P2234; HANSEN LA, 1990, CANCER RES, V50, P5740; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ONO Y, 1987, FEBS LETT, V226, P125, DOI 10.1016/0014-5793(87)80564-1; PREISS J, 1986, J BIOL CHEM, V261, P8597; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROSEJOHN S, 1988, GENE, V74, P465, DOI 10.1016/0378-1119(88)90179-5; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; STRULOVICI B, 1989, BIOCHEMISTRY-US, V28, P3569, DOI 10.1021/bi00434a063; WILKISON WO, 1989, ONCOGENE, V4, P625; WILSON RE, 1989, CANCER RES, V49, P711; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOODGETT JR, 1987, MOL CELL BIOL, V7, P85, DOI 10.1128/MCB.7.1.85; YAMANISHI DT, 1991, CARCINOGENESIS, V12, P105, DOI 10.1093/carcin/12.1.105; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775	28	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23868	23875						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226926				2022-12-27	WOS:A1993MF29400028
J	DOTSON, DG; PUTKEY, JA				DOTSON, DG; PUTKEY, JA			DIFFERENTIAL RECOVERY OF CA2+ BINDING-ACTIVITY IN MUTATED EF-HANDS OF CARDIAC TROPONIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; X-RAY-SCATTERING; CALCIUM-BINDING; SKELETAL-MUSCLE; PEPTIDE COMPLEX; THIN FILAMENT; I PEPTIDE; CALMODULIN; SITES	Previous studies showed that conversion of the first Ca2+ ligand in Ca2+-binding sites III and IV from Asp to Ala decreased the affinity of cardiac TnC (cTnC) for the thin filament. Here, the functional consequences of mutation of the second ligand in the Ca2+-binding sites of cTnC were determined. Equilibrium dialysis and Tyr fluorescence studies showed that conversion of the second Ca2+ ligand to Ala (Asp-67, site II; Asn-107, site III; and Asn-143, site IV) inactivated all three Ca2+-binding sites in the free protein. Ca2+ binding to the mutated site II was not recovered upon association with a troponin complex, and proteins with this mutation were unable to regulate Ca2+-dependent ATPase activity in TnC-extracted myofibrils. However, Ca2+ binding was recovered at the mutated sites III and IV under the same conditions. Sequential addition of active and inactive cTnC proteins in a myofibril ATPase assay suggested that that Mg2+ binding was not recovered and that the recovered Ca2+ affinity of the mutated sites III and IV was much lower than that of the wild type in that the Ca2+ concentrations required for apparent thin filament binding by proteins containing mutations at sites III and/or IV were significantly greater than that required for the wild-type protein.			DOTSON, DG (corresponding author), UNIV TEXAS, HLTH SCI CTR,SCH MED,DEPT BIOCHEM & MOLEC BIOL, POB 20708, 6431 FANNIN, HOUSTON, TX 77225 USA.				NIAMS NIH HHS [AR-39210] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; BLECHNER SL, 1992, BIOCHEMISTRY-US, V31, P11326, DOI 10.1021/bi00161a010; BRITO RMM, 1993, J BIOL CHEM, V268, P20966; CAMPBELL AP, 1992, BIOCHIM BIOPHYS ACTA, V1160, P35, DOI 10.1016/0167-4838(92)90036-D; CAMPBELL AP, 1991, J MOL BIOL, V222, P405, DOI 10.1016/0022-2836(91)90219-V; COLLINS JH, 1977, J BIOL CHEM, V252, P6356; COX JA, 1981, BIOCHEM J, V195, P205, DOI 10.1042/bj1950205; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; HAIECH J, 1991, J BIOL CHEM, V266, P3427; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MORIMOTO S, 1987, J BIOCHEM-TOKYO, V101, P291, DOI 10.1093/oxfordjournals.jbchem.a121913; NEGELE JC, 1992, J BIOL CHEM, V267, P825; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; PUTKEY JA, 1991, J BIOL CHEM, V266, P14881; PUTKEY JA, 1993, J BIOL CHEM, V268, P6827; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; SHAW GS, 1991, BIOCHEMISTRY-US, V30, P8339, DOI 10.1021/bi00098a009; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P9538, DOI 10.1073/pnas.87.24.9538; SWENSON CA, 1992, BIOCHEMISTRY-US, V31, P3420, DOI 10.1021/bi00128a017; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; VANEERD JP, 1975, BIOCHEM BIOPH RES CO, V64, P122, DOI 10.1016/0006-291X(75)90227-2; VANEYK JE, 1991, BIOCHEMISTRY-US, V30, P9974, DOI 10.1021/bi00105a023; WANG CLA, 1986, EUR J BIOCHEM, V154, P225, DOI 10.1111/j.1432-1033.1986.tb09383.x; YOSHINO H, 1989, J BIOL CHEM, V264, P19706; ZOT HG, 1982, J BIOL CHEM, V257, P7678	41	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24067	24073						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226952				2022-12-27	WOS:A1993MF29400055
J	KIENER, PA; RANKIN, BM; BURKHARDT, AL; SCHIEVEN, GL; GILLILAND, LK; ROWLEY, RB; BOLEN, JB; LEDBETTER, JA				KIENER, PA; RANKIN, BM; BURKHARDT, AL; SCHIEVEN, GL; GILLILAND, LK; ROWLEY, RB; BOLEN, JB; LEDBETTER, JA			CROSS-LINKING OF FC-GAMMA RECEPTOR-I (FC-GAMMA-RI) AND RECEPTOR-II (FC-GAMMA-RII) ON MONOCYTIC CELLS ACTIVATES A SIGNAL-TRANSDUCTION PATHWAY COMMON TO BOTH FC-RECEPTORS THAT INVOLVES THE STIMULATION OF P72 SYK PROTEIN-TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; PHOSPHOLIPASE C-GAMMA-1; PHOSPHORYLATION; SRC; DOMAINS; GTPASE; IGG; GAP; ASSOCIATION; BINDING	Stimulation of the human monocytic cell line THP-1 by cross-linking either Fcgamma receptor I (FcgammaRI) or Fcgamma receptor II (FcgammaRII) gave rise to the rapid phosphorylation of multiple intracellular proteins. The pattern of proteins that were phosphorylated appeared to be identical. Analysis of these proteins by specific immunoprecipitation indicated that stimulation through either receptor did indeed give rise to phosphorylation of the same set of proteins. These included: FcgammaRII, phospholipase C (PLC) gamma1, PLCgamma2, Vav, GAP, and a protein that co-precipitated with the Fcgamma receptors and migrated with a molecular weight of about 70,000. Co-cross-linking an F(ab')2 anti-CD45 monoclonal antibody together with monoclonal antibodies to either of the Fcgamma receptors inhibited phosphorylation of all these proteins. Analysis of the tyrosine kinases in the cells revealed that both receptors stimulated the phosphorylation and activation of a kinase recognized by antibodies to Syk. Furthermore, the Syk kinase became associated with the Fc-gammaRII following receptor cross-linking. These data indicate that although the two Fcgamma receptors have different cytoplasmic tails, they are coupled to the same signal transduction cascade that is regulated by CD45 and involves the activation of Syk.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA	Bristol-Myers Squibb	KIENER, PA (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT AUTOIMMUN & TRANSPLANTAT, 3005 1ST AVE, SEATTLE, WA 98121 USA.							ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; HAMAWY MM, 1993, J BIOL CHEM, V268, P6851; HUANG MM, 1992, J BIOL CHEM, V267, P5467; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KOLANUS W, 1992, EMBO J, V11, P4861, DOI 10.1002/j.1460-2075.1992.tb05592.x; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LIAO F, 1992, P NATL ACAD SCI USA, V89, P3659, DOI 10.1073/pnas.89.8.3659; LIAO F, 1993, J IMMUNOL, V150, P2668; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; PAWSON T, 1988, ONCOGENE, V3, P491; RANKIN BM, 1993, J IMMUNOL, V150, P605; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; REEDIJK M, 1990, MOL CELL BIOL, V10, P5601, DOI 10.1128/MCB.10.11.5601; SCHIEVEN GL, 1992, J IMMUNOL, V149, P1676; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VANDEWINKEL JGJ, 1990, SCAND J IMMUNOL, V31, P315; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	177	177	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24442	24448						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226994				2022-12-27	WOS:A1993MF29400107
J	WANG, YH; ROACH, PJ				WANG, YH; ROACH, PJ			INACTIVATION OF RABBIT MUSCLE GLYCOGEN-SYNTHASE BY GLYCOGEN-SYNTHASE KINASE-3 - DOMINANT ROLE OF THE PHOSPHORYLATION OF SER-640 (SITE 3A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHOSERINE RESIDUES INVIVO; SKELETAL-MUSCLE; CYCLIC-AMP; STATE; SUBSTRATE; SEQUENCE; CLONING; ABSENCE; INSULIN	Rabbit skeletal muscle glycogen synthase, a rate-limiting enzyme for glycogen biosynthesis, is regulated by multisite phosphorylation. The protein kinase glycogen synthase kinase 3 (GSK-3) phosphorylates 4 Ser residues (Ser-640, Ser-644, Ser-648, and Ser-652; also known as sites 3a, 3b, 3c, and 4, respectively) at the COOH terminus of the subunit. Phosphorylation of these sites by GSK-3 is sequential, from COOH- to NH2-terminal, and is wholly dependent on prior phosphorylation by casein kinase II at Ser-656 (site 5). Expression in Escherichia coli was used to generate mutant forms of glycogen synthase, S640A, S644A, and S648A, in which site 3a, site 3b, or site 3c was changed to Ala, respectively. The purified enzymes had -/+ glucose-6-P activity ratios in the range of 0.8-0.9. Phosphorylation by casein kinase II and GSK-3 gave results consistent with the model of obligate sequential action of GSK-3. Phosphorylation at site 5, sites 4 + 5, or sites 3c + 4 + 5 had no measurable effect on activity. When sites 3b + 3c + 4 + 5 were phosphorylated, modest inactivation resulted. Additional phosphorylation at site 3a, however, was potently inactivating, reducing the -/+ glucose-6-P activity ratio to 0.1 and increasing the glucose-6-P concentration needed for half-maximal activation by an order of magnitude. Introduction of each additional phosphate, in the order site 4, 3c, 3b, and 3a, caused an incremental reduction in the mobility of the subunit when analyzed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. The results of this study demonstrate that GSK-3 phosphorylation of site 3a (Ser-640), and to a lesser extent, site 3b, correlates with inactivation of glycogen synthase by GSK-3. Evidence is also presented for an allosteric mechanism of inactivation whereby modification of one subunit influences the activity state of adjacent subunits.	INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R01DK027221] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27221] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAI G, 1990, J BIOL CHEM, V265, P7843; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNER MF, 1989, P NATL ACAD SCI USA, V86, P1443, DOI 10.1073/pnas.86.5.1443; CAMICI M, 1984, J BIOL CHEM, V259, P2466; COHEN P, 1982, EUR J BIOCHEM, V124, P21, DOI 10.1111/j.1432-1033.1982.tb05902.x; COHEN P, 1991, BIOCHIM BIOPHYS ACTA, V1094, P292, DOI 10.1016/0167-4889(91)90089-G; Cohen P., 1986, ENZYMES, VXVII, P461; DEPAOLIROACH AA, 1979, J BIOL CHEM, V254, P4212; DEPAOLIROACH AA, 1983, J BIOL CHEM, V258, P702; DEPAOLIROACH AA, 1981, J BIOL CHEM, V256, P8955; EMBI N, 1981, EUR J BIOCHEM, V115, P405, DOI 10.1111/j.1432-1033.1981.tb05252.x; FARKAS I, 1991, J BIOL CHEM, V266, P15602; FARKAS I, 1990, J BIOL CHEM, V265, P20879; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HUANG KP, 1984, ARCH BIOCHEM BIOPHYS, V232, P111, DOI 10.1016/0003-9861(84)90526-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; PARKER PJ, 1982, EUR J BIOCHEM, V124, P47, DOI 10.1111/j.1432-1033.1982.tb05904.x; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, P147; POULTER L, 1988, EUR J BIOCHEM, V175, P497, DOI 10.1111/j.1432-1033.1988.tb14222.x; Roach P. J., 1986, ENZYMES, VXVII, P499; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1976, J BIOL CHEM, V241, P1913; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; SHEORAIN VS, 1984, J BIOL CHEM, V259, P7024; SHEORAIN VS, 1985, J BIOL CHEM, V260, P1567; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; WANG YH, 1986, J BIOL CHEM, V261, P6909; WANG YH, 1991, P NATL ACAD SCI USA, V88, P2446, DOI 10.1073/pnas.88.6.2446; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; ZHANG W, 1989, FASEB J, V3, P2353; ZHANG W, 1993, IN PRESS ARCH BIOCH	35	59	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23876	23880						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226927				2022-12-27	WOS:A1993MF29400029
J	BARD, JA; ZGOMBICK, J; ADHAM, N; VAYSSE, P; BRANCHEK, TA; WEINSHANK, RL				BARD, JA; ZGOMBICK, J; ADHAM, N; VAYSSE, P; BRANCHEK, TA; WEINSHANK, RL			CLONING OF A NOVEL HUMAN SEROTONIN RECEPTOR (5-HT7) POSITIVELY LINKED TO ADENYLATE-CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG HIPPOCAMPAL MEMBRANES; PORCINE VENA-CAVA; PHARMACOLOGICAL CHARACTERIZATION; 5-HYDROXYTRYPTAMINE RECEPTOR; FUNCTIONAL EXPRESSION; CYCLIC-AMP; RELAXATION; 5-CARBOXAMIDOTRYPTAMINE; ACTIVATION; ELEVATION	An intron-containing gene encoding a novel human serotonin (5-HT) receptor was isolated from human genomic and cDNA libraries with probes directed to transmembrane regions of the adenylate cyclase stimulatory Drosophila serotonin receptor gene, 5-HT(dro1). Membranes harvested from transiently transfected Cos-7 cells displayed high affinity (K(d) = 8.5 nM), saturable (B(max) = 6 pmol/mg protein) [H-3]5-HT binding. The rank order of potencies for serotonergic ligands to displace specific [H-3]5-HT binding was: 5-carboxamido-tryptamine > methiothepin > metergoline > 5-HT > 8-hydroxy-2-(di-n-propylamino)tetralin > sumatriptan > ketanserin > zacopride. 5-HT produced a dose-dependent (EC50 = 992 nM) stimulation (almost-equal-to 20-fold) of cAMP accumulation in transiently transfected cells, and this response was antagonized by the nonselective 5-HT antagonist methiothepin. RNA for this gene was predominantly detected in the human brain and a subset of peripheral tissues including coronary artery and several tissues of the gastrointestinal tract. The molecular biological and pharmacological properties of this receptor suggest that it is the first member of a new serotonin receptor subfamily (5-HT7). The second messenger coupling, and tissue distribution indicate a possible identity to 5-HT receptors that mediate relaxant responses in certain isolated blood vessels.			BARD, JA (corresponding author), SYNAPT PHARMACEUT CORP,215 COLL RD,PARAMUS,NJ 07652, USA.		Adham, Nika/N-4376-2017	Adham, Nika/0000-0002-2773-2522	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS027789] Funding Source: NIH RePORTER; NINDS NIH HHS [2R44NS27789] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADHAM N, 1993, P NATL ACAD SCI USA, V90, P408, DOI 10.1073/pnas.90.2.408; BAXTER GS, 1991, N-S ARCH PHARMACOL, V343, P439; BOCKAERT J, 1990, MOL PHARMACOL, V37, P408; BOCKAERT J, 1992, TRENDS PHARMACOL SCI, V13, P141, DOI 10.1016/0165-6147(92)90051-7; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; CONNER DA, 1990, MOL PHARMACOL, V37, P742; COSSERY JM, 1990, NEUROSCI LETT, V108, P149, DOI 10.1016/0304-3940(90)90722-L; CUSHING D, 1992, J PHARMACOL EXP THER, V263, P129; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; ERLANDER MG, 1993, P NATL ACAD SCI USA, V90, P3452, DOI 10.1073/pnas.90.8.3452; FENIUK W, 1983, EUR J PHARMACOL, V9693, P71; FILLION G, 1980, BRAIN RES, V198, P361, DOI 10.1016/0006-8993(80)90750-7; HUMPHREY PPA, 1993, TRENDS PHAM SCI, V14, P2333; KURSAR JD, 1992, MOL PHARMACOL, V42, P549; MAHLE CD, 1991, EUR J PHARMACOL, V205, P323, DOI 10.1016/0014-2999(91)90919-H; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MATTHES H, 1993, MOL PHARMACOL, V43, P313; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MONSMA FJ, 1993, MOL PHARMACOL, V43, P320; SANDERS L, 1992, N-S ARCH PHARMACOL, V345, P382; SHENKER A, 1987, MOL PHARMACOL, V31, P357; SUMNER MJ, 1989, BRIT J PHARMACOL, V97, P292, DOI 10.1111/j.1476-5381.1989.tb11953.x; TREVETHICK MA, 1984, LIFE SCI, V35, P477, DOI 10.1016/0024-3205(84)90240-6; TREVETHICK MA, 1986, LIFE SCI, V38, P1521, DOI 10.1016/0024-3205(86)90566-7; WEINSHANK RL, 1992, P NATL ACAD SCI USA, V89, P3630, DOI 10.1073/pnas.89.8.3630; WEINSHANK RL, 1990, MOL PHARMACOL, V38, P681; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; ZGOMBICK JM, 1991, MOL PHARMACOL, V40, P1036	28	477	499	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23422	23426						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226867				2022-12-27	WOS:A1993MF51500072
J	SUNNERHAGEN, MS; PERSSON, E; DAHLQVIST, I; DRAKENBERG, T; STENFLO, J; MAYHEW, M; ROBIN, M; HANDFORD, P; TILLEY, JW; CAMPBELL, ID; BROWNLEE, GG				SUNNERHAGEN, MS; PERSSON, E; DAHLQVIST, I; DRAKENBERG, T; STENFLO, J; MAYHEW, M; ROBIN, M; HANDFORD, P; TILLEY, JW; CAMPBELL, ID; BROWNLEE, GG			THE EFFECT OF ASPARTATE HYDROXYLATION ON CALCIUM-BINDING TO EPIDERMAL GROWTH FACTOR-LIKE MODULES IN COAGULATION FACTOR-IX AND FACTOR-X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; GAMMA-CARBOXYGLUTAMIC ACID; FACTOR-LIKE DOMAIN; DEPENDENT PROTEIN-S; EGF-LIKE DOMAINS; BOVINE FACTOR-X; 3-DIMENSIONAL STRUCTURE; CONTAINING REGION; THROMBIN BINDING; MARFAN-SYNDROME	Hydroxylation of aspartic acid to erythro-beta-aspartic acid (Hya) occurs in epidermal growth factor (EGF)-like modules in numerous extracellular proteins with diverse functions. Several EGF-like modules with the consensus sequence for hydroxylation bind Ca2+, and it has therefore been suggested that the hydroxyl group is essential for Ca2+ binding. To determine directly the influence of beta-hydroxylation on calcium binding in the EGF-like modules from coagulation factors IX and X, we have now measured calcium binding to both the fully beta-hydroxylated and the non-beta-hydroxylated modules of the two proteins. At low ionic strength, the Hya-containing module of factor X has a slightly higher Ca2+ affinity, but at physiological salt concentrations this difference is no longer significant for either factor IX or X. Analysis of the H-1 NMR chemical shift differences between the hydroxylated and nonhydroxylated factor X modules show that hydroxylation has no effect on the domain fold. Furthermore, measurements on factor IX show that hydroxylation has no effect on the Ca2+/Mg2+ specificity of the ion binding site. We conclude that the hydroxyl group is not a direct ligand for the calcium ion in these EGF-like modules, nor is it essential for high-affinity Ca2+ binding.	LUND UNIV,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN; UNIV OXFORD,DEPT BIOCHEM,OXFORD OX1 3QU,ENGLAND; UNIV OXFORD,SIR WILLIAM DUNN SCH PATHOL,OXFORD OX1 3RE,ENGLAND	Lund University; University of Oxford; University of Oxford	SUNNERHAGEN, MS (corresponding author), LUND UNIV,CTR CHEM,DEPT PHYS CHEM 2,POB 124,S-22100 LUND,SWEDEN.			Persson, Egon/0000-0003-3005-4926				ASTERMARK J, 1992, J BIOL CHEM, V267, P3249; BAJAJ SP, 1992, P NATL ACAD SCI USA, V89, P152, DOI 10.1073/pnas.89.1.152; BARON M, 1992, PROTEIN SCI, V1, P81; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; DAHLBACK B, 1990, J BIOL CHEM, V265, P16082; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; GIANNELLI F, 1992, NUCLEIC ACIDS RES, V20, P2027, DOI 10.1093/nar/20.suppl.2027; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; GRONKE RS, 1990, J BIOL CHEM, V265, P8558; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; IKEGAMI T, 1975, ACTA MED OKAYAMA, V29, P341; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KORNBERG HL, 1965, BIOCHEM J, V95, P577, DOI 10.1042/bj0950577; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LINSE S, 1991, BIOCHEMISTRY-US, V30, P154, DOI 10.1021/bi00215a023; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; MORITA T, 1984, J BIOL CHEM, V259, P5698; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; OHLIN AK, 1988, J BIOL CHEM, V263, P19240; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; SELANDER M, 1990, BIOCHEMISTRY-US, V29, P8111, DOI 10.1021/bi00487a018; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1988, J BIOL CHEM, V263, P21; STENFLO J, 1987, P NATL ACAD SCI USA, V84, P368, DOI 10.1073/pnas.84.2.368; SUGO T, 1986, J BIOL CHEM, V261, P5116; SUGO T, 1984, J BIOL CHEM, V259, P5705; SUZUKI K, 1989, J BIOL CHEM, V264, P4872; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; ULLNER M, 1992, BIOCHEMISTRY-US, V31, P5974, DOI 10.1021/bi00141a004; WAGNER R, 1990, J ORG CHEM, V55, P6289, DOI 10.1021/jo00313a015	44	34	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23339	23344						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226858				2022-12-27	WOS:A1993MF51500061
J	MATTINGLY, JR; IRIARTE, A; MARTINEZCARRION, M				MATTINGLY, JR; IRIARTE, A; MARTINEZCARRION, M			STRUCTURAL FEATURES WHICH CONTROL FOLDING OF HOMOLOGOUS PROTEINS IN CELL-FREE TRANSLATION SYSTEMS - THE EFFECT OF A MITOCHONDRIAL-TARGETING PRESEQUENCE ON ASPARTATE-AMINOTRANSFERASE ISOZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; MOLECULAR CHAPERONE; PRECURSOR PROTEIN; ESCHERICHIA-COLI; YEAST MITOCHONDRIA; STRESS PROTEINS; ATP HYDROLYSIS; COMPLEX; IMPORT; GROEL	When the precursor to mitochondrial aspartate aminotransferase (pmAspAT) is synthesized in a rabbit reticulocyte lysate translation system (RRL), its properties are quite unlike those of the purified protein (Mattingly, J. R., Jr., Youssef, J., Iriarte, A., and Martinez-Carrion, M. (1993) J. Biol. Chem. 268, 3925-3937). These results suggest that molecular chaperones present in RRL modulate the folding of pmAspAT. To investigate the structural basis for this, we have used protease resistance to monitor the extent of folding for several related AspATs after synthesis in RRL and in wheat germ extract (WGE). In addition to pmAspAT, the following proteins were examined: the mature form of pmAspAT (DELTA2-28 pmAspAT), its cytosolic counterpart (CAspAT), a chimeric protein consisting of the presequence of pmAspAT attached to the amino terminus of cAspAT (pCAspAT), and a pMAspAT variant in which the presequence and the amino-terminal domain of the mature enzyme are deleted (DELTA2-57 pmAspAT). In RRL, DELTA28 pmAspAT folds somewhat faster than intact pmAspAT, whereas the truncated DELTA2-57 pmAspAT is unable to fold. In contrast, CAspAT and pCAspAT both fold with extreme rapidity. After synthesis in WGE, pmAspAT and DELTA2-28 pmAspAT never acquire a protease-resistant conformation, whereas the folding of cAspAT and pcAspAT still occurs rapidly. We conclude that the presequence has only a minor role in determining the folding rate of the pmAspAT mitochondrial precursor protein in RRL or WGE and has no influence on the folding of the homologous cAspAT. Rather, the primary sequence of the mature part of the protein seems to dictate whether or how molecular chaperones regulate folding events.	UNIV MISSOURI,SCH BIOL SCI,DIV MOLEC BIOL & BIOCHEM,KANSAS CITY,MO 64110	University of Missouri System; University of Missouri Kansas City					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038184] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38412] Funding Source: Medline; NIGMS NIH HHS [GM-38184] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRANDSCH R, 1992, J BIOL CHEM, V267, P20844; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; CHIRICO WJ, 1992, BIOCHEM BIOPH RES CO, V189, P1150, DOI 10.1016/0006-291X(92)92324-Q; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CYR DM, 1992, J BIOL CHEM, V267, P20927; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELLIS RJ, 1990, SCIENCE, V250, P954, DOI 10.1126/science.250.4983.954; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GUPTA RS, 1990, BIOCHEM INT, V20, P833; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; HAINAUT P, 1992, EMBO J, V11, P3513, DOI 10.1002/j.1460-2075.1992.tb05434.x; Hartl F U, 1991, Semin Immunol, V3, P5; IRIARTE A, 1984, J BIOL CHEM, V259, P723; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; JAUSSI R, 1982, J BIOL CHEM, V257, P13334; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MATTINGLY JR, 1993, J BIOL CHEM, V268, P3925; MEER L, 1984, CHEM BIOL ASPECTS  B, P227; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MIZZEN LA, 1991, CELL REGUL, V2, P165, DOI 10.1091/mbc.2.2.165; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; MURAKAMI K, 1990, EMBO J, V9, P3201, DOI 10.1002/j.1460-2075.1990.tb07518.x; ONO H, 1990, ARCH BIOCHEM BIOPHYS, V280, P299, DOI 10.1016/0003-9861(90)90333-T; ONO H, 1990, ARCH BIOCHEM BIOPHYS, V277, P368, DOI 10.1016/0003-9861(90)90592-M; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; SANDMEIER E, 1980, J BIOL CHEM, V257, P10284; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHMID D, 1992, EUR J BIOCHEM, V208, P699, DOI 10.1111/j.1432-1033.1992.tb17237.x; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; TRENT JD, 1991, NATURE, V354, P490, DOI 10.1038/354490a0; URSIC D, 1992, NATURE, V356, P392; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; ZAHN R, 1992, BIOCHEMISTRY-US, V31, P3249, DOI 10.1021/bi00127a029	50	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26320	26327						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253754				2022-12-27	WOS:A1993MK42500048
J	PUERTA, C; HERNANDEZ, F; GUTIERREZ, C; PINEIRO, M; LOPEZALARCON, L; PALACIAN, E				PUERTA, C; HERNANDEZ, F; GUTIERREZ, C; PINEIRO, M; LOPEZALARCON, L; PALACIAN, E			EFFICIENT TRANSCRIPTION OF A DNA-TEMPLATE ASSOCIATED WITH HISTONE (H3-CENTER-DOT-H4)(2) TETRAMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; ONE H2A.H2B DIMER; NUCLEOSOMAL TEMPLATES; CHROMATIN STRUCTURE; ELONGATION; INITIATION; INVITRO; CORE; INHIBIT; GENE	A histone-DNA transcription template has been assembled, by dialysis against decreasing salt concentrations, from pGEMEX-1 (4 kilobases), a plasmid containing a promoter for bacteriophage T7 RNA polymerase, and from isolated histone (H3.H4)2 tetramers. Electron microscopy after psoralen cross-linking shows that each histone tetramer protects approximately 80 base pairs of DNA from psoralen action and that, under the employed conditions, an average of 15 tetramer particles are assembled per DNA molecule. This (H3.H4)2-DNA template is efficiently transcribed in vitro by T7 RNA polymerase as compared to naked DNA. The presence of (H3-H4)2 tetramers does not affect initiation, in contrast with the complete histone octamer, (H2A.H2B.H3.H4)2, assembled with the complementary addition of H2A-H2B dimers, which causes transcriptional inhibition mainly by blocking initiation.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC SEVERO OCHOA, E-28049 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Hernandez, Felix/L-2114-2015; Piñeiro, Manuel/I-5910-2015; Gutierrez, Crisanto/ABH-8782-2020	Hernandez, Felix/0000-0001-8753-8249; Piñeiro, Manuel/0000-0002-4640-6511; Gutierrez, Crisanto/0000-0001-8905-8222				ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; ALMOUZNI G, 1991, MOL CELL BIOL, V11, P655, DOI 10.1128/MCB.11.2.655; BAER BW, 1983, NATURE, V301, P482, DOI 10.1038/301482a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECH TR, 1977, COLD SPRING HARB SYM, V42, P191; CLARK DJ, 1991, EMBO J, V10, P3419, DOI 10.1002/j.1460-2075.1991.tb04906.x; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; GONZALEZ PJ, 1989, J BIOL CHEM, V264, P18457; GONZALEZ PJ, 1987, J BIOL CHEM, V262, P11280; GRUSS C, 1990, EMBO J, V9, P2911, DOI 10.1002/j.1460-2075.1990.tb07482.x; GRUSS C, 1993, IN PRESS EMBO J; HANSEN JC, 1991, J BIOL CHEM, V266, P4276; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; HANSON CV, 1976, SCIENCE, V193, P62, DOI 10.1126/science.935855; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HAYES JJ, 1992, P NATL ACAD SCI USA, V89, P1229, DOI 10.1073/pnas.89.4.1229; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; JACKSON V, 1987, BIOCHEMISTRY-US, V26, P2315, DOI 10.1021/bi00382a037; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; PFAFFLE P, 1990, J BIOL CHEM, V265, P16830; PINEIRO M, 1991, BIOCHEM BIOPH RES CO, V177, P370, DOI 10.1016/0006-291X(91)91993-M; RUIZCARRILLO A, 1979, BIOCHEMISTRY-US, V18, P760, DOI 10.1021/bi00572a004; Sambrook J, 1989, MOL CLONING LABORATO; SOGO JM, 1989, METHOD ENZYMOL, V170, P142; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; TREMETHICK D, 1990, J BIOL CHEM, V265, P5014; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; WOLFFE AP, 1989, P NATL ACAD SCI USA, V86, P9817, DOI 10.1073/pnas.86.24.9817	35	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26663	26667						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253798				2022-12-27	WOS:A1993MK42500094
J	GERRIETS, JE; CURWIN, SL; LAST, JA				GERRIETS, JE; CURWIN, SL; LAST, JA			TENDON HYPERTROPHY IS ASSOCIATED WITH INCREASED HYDROXYLATION OF NONHELICAL LYSINE RESIDUES AT 2 SPECIFIC CROSS-LINKING SITES IN TYPE-I COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-HELICAL REGIONS; FIBROTIC COLLAGEN; LYSYL HYDROXYLASE; LUNGS; RATS; CROSSLINKING; AGE; QUANTITATION; METABOLISM; BLEOMYCIN	This study was designed to investigate whether the changes in lysine hydroxylation known to occur in hypertrophic tendon occur randomly or at specific lysine residues in the type I collagen molecule. Peptides corresponding to the two known major cross-linking sites of type I collagen (a lysine (or hydroxylysine) at position 9N cross-linked to a hydroxylysine at 930 and a lysine (or hydroxylysine) at position 16C cross-linked to a hydroxylysine at position 87) were prepared by collagenase digestion, size fractionation, and separation by high performance liquid chromatography from normal chicken tendon and from chicken tendon subjected to increased tensile load as a result of muscle hypertrophy. The ratio of the difunctional cross-links dihydroxylysinonorleucine to hydroxylysinonorleucine in normal tendon is 0.75:1; this ratio is increased to 6:1 in hypertrophic tendon. The dihydroxylysinonorleucine to hydroxylysinonorleucine ratio is increased to the same extent in samples of the purified cross-linked peptides derived from both the N-terminal and C-terminal lysine aldehyde residues. On the other hand, the relative hydroxylysine content of preparations of the pooled larger helical peptides obtained by cyanogen bromide digestion of normal and hypertrophic tendons was essentially identical. These results demonstrate that there is a specific increase in hydroxylation of only the N- and C-terminal non-hellical lysine residues that participate in the formation of the reducible difunctional cross-links of type I collagen in hypertrophic tendon, while the extent of hydroxylation of lysine residues in the helical regions is not affected. The specific mechanism by which the enzyme lysyl hydroxylase acting on its substrate can distinguish between lysine residues destined to be in non-helical versus helical regions in a nascent collagenous peptide that has not yet attained its final secondary structure remains to be defined.	UNIV CALIF DAVIS,SCH MED,CALIF REG PRIMATE RES CTR,DEPT INTERNAL MED,DAVIS,CA 95616	University of California System; University of California Davis					NCRR NIH HHS [RR-00169] Funding Source: Medline; NHLBI NIH HHS [HL32690] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032690] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANTHANARAYANAN VS, 1992, ARCH BIOCHEM BIOPHYS, V298, P21, DOI 10.1016/0003-9861(92)90088-E; BAILEY AJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P412, DOI 10.1016/0005-2795(75)90106-3; BARNES MJ, 1974, BIOCHEM J, V139, P461, DOI 10.1042/bj1390461; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; BRICKLEYPARSONS D, 1981, J BONE JOINT SURG AM, V63, P787, DOI 10.2106/00004623-198163050-00014; CURWIN SL, 1988, J APPL PHYSIOL, V65, P2297, DOI 10.1152/jappl.1988.65.5.2297; GALLOWAY D, 1982, COLLAGEN HLTH DISEAS, P528; GOMEZ MA, 1991, AM J SPORT MED, V19, P347, DOI 10.1177/036354659101900405; HALME T, 1986, BIOCHIM BIOPHYS ACTA, V881, P222, DOI 10.1016/0304-4165(86)90007-3; HARPER JI, 1985, BRIT J DERMATOL, V113, P145, DOI 10.1111/j.1365-2133.1985.tb02056.x; HARWOOD FL, 1992, J APPL PHYSIOL, V72, P1687, DOI 10.1152/jappl.1992.72.5.1687; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; JIANG P, 1991, J BIOL CHEM, V266, P22760; KIRSCH E, 1981, EUR J CLIN INVEST, V11, P39, DOI 10.1111/j.1365-2362.1981.tb01763.x; KIVIRIKKO KI, 1972, BIOCHEMISTRY-US, V11, P122, DOI 10.1021/bi00751a021; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; KUYPERS R, 1992, BIOCHEM J, V283, P129, DOI 10.1042/bj2830129; LAST JA, 1990, AM J RESP CELL MOL, V2, P543, DOI 10.1165/ajrcmb/2.6.543; LAST JA, 1990, AM REV RESPIR DIS, V141, P307, DOI 10.1164/ajrccm/141.2.307; LIGHT ND, 1979, FEBS LETT, V97, P183, DOI 10.1016/0014-5793(79)80080-0; MOREY ER, 1979, BIOSCIENCE, V29, P168, DOI 10.2307/1307797; MORIGUCHI T, 1979, J INVEST DERMATOL, V72, P143, DOI 10.1111/1523-1747.ep12530609; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; REISER K M, 1986, Journal of Biochemical Toxicology, V1, P83, DOI 10.1002/jbt.2570010109; REISER KM, 1986, COLLAGEN REL RES, V6, P313; REISER KM, 1987, BIOCHEM MED METAB B, V37, P16, DOI 10.1016/0885-4505(87)90004-1; REISER KM, 1987, BIOCHIM BIOPHYS ACTA, V926, P339, DOI 10.1016/0304-4165(87)90220-0; REISER KM, 1980, ANAL BIOCHEM, V104, P87, DOI 10.1016/0003-2697(80)90280-8; REISER KM, 1983, J BIOL CHEM, V258, P269; REISER KM, 1983, LIQUID CHROMATOGR, V1, P498; RHYANEN L, 1975, BIOCHIM BIOPHYS ACTA, V397, P50; ROYCE PM, 1985, BIOCHEM J, V230, P475, DOI 10.1042/bj2300475; RUSSELL JE, 1990, J ORTHOPAED RES, V8, P13, DOI 10.1002/jor.1100080103; SCOTT PG, 1980, BIOCHEMISTRY-US, V19, P6118, DOI 10.1021/bi00567a026; TAKAHASHI K, 1987, BIOPOLYMERS, V26, P1781, DOI 10.1002/bip.360261010; VAILAS AC, 1988, J APPL PHYSIOL, V65, P373, DOI 10.1152/jappl.1988.65.1.373; VANDERREST M, 1982, EUR J BIOCHEM, V125, P491, DOI 10.1111/j.1432-1033.1982.tb06709.x; WAITE JH, 1989, J COMP PHYSIOL B, V159, P517, DOI 10.1007/BF00694376; WENSTRUP RJ, 1986, HUM GENET, V74, P47; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027	41	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25553	25560						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244992				2022-12-27	WOS:A1993MK10000043
J	HAUSNER, W; THOMM, M				HAUSNER, W; THOMM, M			PURIFICATION AND CHARACTERIZATION OF A GENERAL TRANSCRIPTION FACTOR, ATFB, FROM THE ARCHAEON METHANOCOCCUS-THERMOLITHOTROPHICUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE TRANSCRIPTION; SODIUM DODECYL-SULFATE; RNA-POLYMERASE; ARCHAEBACTERIAL PROMOTER; TATA BOX; INVITRO TRANSCRIPTION; INITIATION; VANNIELII; SITE; METHANOGENS	We have recently shown that cell-free transcription of homologous templates from the archaeon Methanococcus thermolithotrophicus requires an archaeal transcription factor (aTFA) that separated from the RNA polymerase during phosphocellulose chromatography. We report here the identification and extensive purification of a second activity, aTFB, required for in vitro transcription. This activity copurified with RNA polymerase during initial chromatographic steps but was positively identified as a distinct transcription factor after Superdex 200 sizing chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the intensity of a M(r) = 28,000 polypeptide in silver-stained gels is correlated with transcription factor activity. The same polypeptide, when eluted from a denaturing polyacrylamide gel and subsequently renatured, showed the functional properties of the transcription factor. In conjunction with gel filtration and sedimentation studies, which indicated a molecular mass of 54,000 Da for the native protein, these results suggested that aTFB is a dimer with polypeptide chains of identical molecular mass. Functional studies with highly purified aTFB demonstrated that it is a general factor required for transcription of genes encoding tRNA and proteins.	CHRISTIAN ALBRECHTS UNIV KIEL,INST ALLGEMEINE MIKROBIOL,BOT GARTEN 1-9,W-2300 KIEL 1,GERMANY	University of Kiel								BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JW, 1988, NUCLEIC ACIDS RES, V16, P135, DOI 10.1093/nar/16.1.135; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; FREY G, 1990, NUCLEIC ACIDS RES, V18, P1361, DOI 10.1093/nar/18.6.1361; GOHL HP, 1992, MOL GEN GENET, V231, P286, DOI 10.1007/BF00279802; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HUDEPOHL U, 1990, P NATL ACAD SCI USA, V87, P5851, DOI 10.1073/pnas.87.15.5851; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; OUZOUNIS C, 1992, CELL, V71, P189, DOI 10.1016/0092-8674(92)90347-F; REINBERG D, 1987, J BIOL CHEM, V262, P3322; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; THOMM M, 1985, EUR J BIOCHEM, V149, P345, DOI 10.1111/j.1432-1033.1985.tb08932.x; THOMM M, 1988, NUCLEIC ACIDS RES, V16, P151, DOI 10.1093/nar/16.1.151; THOMM M, 1986, BIOL CHEM H-S, V367, P473, DOI 10.1515/bchm3.1986.367.1.473; THOMM M, 1989, CAN J MICROBIOL, V35, P30, DOI 10.1139/m89-005; THOMM M, 1992, J BACTERIOL, V174, P3508, DOI 10.1128/JB.174.11.3508-3513.1992; XU L, 1992, NUCLEIC ACIDS RES, V24, P6699; Zillig W, 1991, CURR OPIN GENET DEV, V1, P544, DOI 10.1016/S0959-437X(05)80206-0	22	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24047	24052						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226949				2022-12-27	WOS:A1993MF29400052
J	INABA, T; SHIMANO, H; GOTODA, T; HARADA, K; SHIMADA, M; OHSUGA, J; WATANABE, Y; KAWAMURA, M; YAZAKI, Y; YAMADA, N				INABA, T; SHIMANO, H; GOTODA, T; HARADA, K; SHIMADA, M; OHSUGA, J; WATANABE, Y; KAWAMURA, M; YAZAKI, Y; YAMADA, N			EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR ON HUMAN MONOCYTE-DERIVED MACROPHAGES AND EFFECTS OF PLATELET-DERIVED GROWTH-FACTOR BB DIMER ON THE CELLULAR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE CELLS; FACTOR-I RECEPTOR; PDGF RECEPTOR; C-FMS; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY; PHORBOL DIESTER; LEUKEMIA-CELLS	Platelet-derived growth factor (PDGF) plays an important role in the process of atherosclerosis which is characterized by the presence of macrophage-derived foam cells. In the present study, the induction of the mRNA of PDGF-beta receptor was demonstrated during cell differentiation of human monocyte-macrophages, whereas no mRNA was detected in the cells during the early days of culture. Flow cytometry analysis using antibodies specific for PDGF-beta receptor and CD14 showed the presence of both PDGF-beta receptor and CD14 on human monocyte-derived macrophages, whereas no PDGF-beta receptor was detected on human monocytes 4 h after cell adhesion to a culture dish. In the binding assay of PDGF-BB on human monocyte-derived macrophages, a saturable and high affinity binding site with K(d) of 27.5 pM and B(max) of 23.3 fmol/mg of cell protein was demonstrated. When human monocytes were cultured in the presence of the protein kinase C inhibitor staurosporine, PDGF-beta receptor induction was inhibited, and tetradecanoylphorbol acetate enhanced PDGF-beta receptor expression in human monocyte-derived macrophages, indicating that PDGF-beta receptor expression is associated with maturation and differentiation of monocyte-macrophages through the activation of protein kinase C. In response to PDGF-BB homodimer, PDGF-beta receptor was phosphorylated, and thymidine uptake and inositol trisphosphate production were stimulated in monocyte-derived macrophages. Furthermore, PDGF-BB suppressed the production of macrophage colony-stimulating factor in macrophages. The expression of PDGF-beta receptor on human monocyte-derived macrophages suggests that PDGF influences the process of atherosclerosis by regulating the function of macrophages as well as smooth muscle cells in the vascular wall.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN	University of Tokyo			Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572				ABBOUD SL, 1991, BLOOD, V78, P103; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; COHN ZA, 1959, J EXP MED, V110, P419, DOI 10.1084/jem.110.3.419; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; DICORLETO PE, 1984, EXP CELL RES, V153, P167, DOI 10.1016/0014-4827(84)90458-0; DOWNING JR, 1989, EMBO J, V8, P3345, DOI 10.1002/j.1460-2075.1989.tb08496.x; FALKENBURG JHF, 1990, J IMMUNOL, V144, P4657; FOWLER S, 1979, LAB INVEST, V41, P372; FRACKELTON AR, 1984, J BIOL CHEM, V259, P7909; FUKAMI K, 1989, J BIOL CHEM, V264, P14985; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HANAMURA T, 1988, BLOOD, V72, P886; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; HART CE, 1987, J BIOL CHEM, V262, P10780; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; INABA T, 1992, J BIOL CHEM, V267, P5693; INABA T, 1992, J BIOL CHEM, V267, P13107; ISHIBASHI S, 1990, J BIOL CHEM, V265, P14109; ISHIBASHI S, 1990, J BIOL CHEM, V265, P3040; JAYE M, 1985, SCIENCE, V228, P882, DOI 10.1126/science.3890179; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MOTOYOSHI K, 1989, EXP HEMATOL, V17, P68; NAVARRO S, 1989, J IMMUNOL, V142, P4339; PANTAZIS P, 1991, P NATL ACAD SCI USA, V88, P2481, DOI 10.1073/pnas.88.6.2481; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; ROSS R, 1976, NEW ENGL J MED, V295, P420, DOI 10.1056/NEJM197608192950805; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; SEIFERT RA, 1984, NATURE, V311, P669, DOI 10.1038/311669a0; SHERR CJ, 1988, J CELL BIOCHEM, V38, P179, DOI 10.1002/jcb.240380305; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHIMADA M, 1992, J BIOL CHEM, V267, P15455; SHIMANO H, 1990, J BIOL CHEM, V265, P12869; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; TSUCHIYA S, 1982, CANCER RES, V42, P1530; WARREN MK, 1986, J IMMUNOL, V137, P2281; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WILLIAMS LT, 1982, J CLIN INVEST, V69, P1759; WONG GG, 1987, SCIENCE, V235, P1504, DOI 10.1126/science.3493529; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268	53	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24353	24360						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226985				2022-12-27	WOS:A1993MF29400095
J	LEE, JK; WANG, SQ; ERASO, JM; GARDNER, J; KAPLAN, S				LEE, JK; WANG, SQ; ERASO, JM; GARDNER, J; KAPLAN, S			TRANSCRIPTIONAL REGULATION OF PUC OPERON EXPRESSION IN RHODOBACTER-SPHAEROIDES - INVOLVEMENT OF AN INTEGRATION HOST FACTOR-BINDING SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RHODOPSEUDOMONAS-SPHAEROIDES; GENE-EXPRESSION; PHOTOSYNTHETIC MEMBRANES; B800-850 COMPLEX; RNA-POLYMERASE; DNA-SEQUENCE; PROTEIN; PROMOTER; SITES	The putative overlapping consensus sequences (-129 to -105) for binding of fumarate nitrate reductase regulator- and integration host factor (IHF)-like proteins to puc operon upstream DNA of Rhodobacter sphaeroides was protected from DNase I digestion by purified Escherichia coli IHF. The binding of E. coli IHF to the purported IHF-binding site in the puc upstream DNA is highly sequence-specific. The recorded binding affinity was significantly lower than that of E. coli IHF to the lambda attP site. Employing site-directed changes in the DNA sequence within the -129 to -105 region, a loss in IHF binding, as monitored through gel retardation analysis, was correlated with alterations in puc operon expression monitored through the use of puc=lacZ transcriptional fusions. These results suggest that the IHF-binding site is involved in repression of puc operon transcription by oxygen as well as modulation of puc operon transcription levels by incident light intensity. Mutations specific to the upstream half of the putative fumarate nitrate reductase regulator-binding site of the puc upstream DNA did not show any physiological effects under the experimental conditions employed. Taken together, these studies reveal that the DNA sequence between -129 to -105 may involve facilitation of the interaction between upstream and downstream cis-acting regulatory sequences involved in puc operon expression.	UNIV TEXAS,HLTH SCI CTR,DEPT MICROBIOL & MOLEC GENET,POB 20708,HOUSTON,TX 77225; UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801	University of Texas System; University of Texas Health Science Center Houston; University of Illinois System; University of Illinois Urbana-Champaign				Eraso, Jesus/0000-0003-1383-8702	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028717] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28717, GM15590] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AAGAARD J, 1972, PHOTOCHEM PHOTOBIOL, V15, P209, DOI 10.1111/j.1751-1097.1972.tb06240.x; ALAZARD R, 1992, MOL MICROBIOL, V6, P1707, DOI 10.1111/j.1365-2958.1992.tb00895.x; BAUER CE, 1986, J MOL BIOL, V192, P513, DOI 10.1016/0022-2836(86)90273-1; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; CHORY J, 1983, J BACTERIOL, V153, P465, DOI 10.1128/JB.153.1.465-474.1983; CHORY J, 1984, J BACTERIOL, V159, P540, DOI 10.1128/JB.159.2.540-554.1984; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; DEHOFF BS, 1988, J BACTERIOL, V170, P4681, DOI 10.1128/jb.170.10.4681-4692.1988; DISPENSA M, 1992, J BACTERIOL, V174, P5803, DOI 10.1128/jb.174.18.5803-5813.1992; DONOHUE TJ, 1986, J BACTERIOL, V168, P962, DOI 10.1128/jb.168.2.962-972.1986; DONOHUE TJ, 1986, ENCY PLANT PHYSL, V19, P632; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FLAMM EL, 1985, J MOL BIOL, V183, P117, DOI 10.1016/0022-2836(85)90206-2; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GIBSON LCD, 1992, MOL MICROBIOL, V6, P3171, DOI 10.1111/j.1365-2958.1992.tb01773.x; GILADI H, 1992, J MOL BIOL, V227, P985, DOI 10.1016/0022-2836(92)90514-K; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; GRALLA JD, 1991, CELL, V66, P415, DOI 10.1016/0092-8674(81)90001-5; GUEST JR, 1992, J GEN MICROBIOL, V138, P2253, DOI 10.1099/00221287-138-11-2253; HALUZI H, 1991, J BACTERIOL, V173, P6297, DOI 10.1128/jb.173.19.6297-6299.1991; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; KAPLAN S, 1983, J CELL BIOCHEM, V22, P15, DOI 10.1002/jcb.240220103; KAPLAN S, 1982, PHOTOSYNTHESIS, V1, P65; KILEY PJ, 1987, J BACTERIOL, V169, P3268, DOI 10.1128/jb.169.7.3268-3275.1987; LEE JK, 1992, J BACTERIOL, V174, P1158, DOI 10.1128/jb.174.4.1158-1171.1992; LEE JK, 1992, J BACTERIOL, V174, P1146, DOI 10.1128/jb.174.4.1146-1157.1992; LEE JK, 1989, J BACTERIOL, V171, P3391, DOI 10.1128/jb.171.6.3391-3405.1989; MCGLYNN P, 1992, J BIOL CHEM, V267, P11098; MILLER HI, 1984, COLD SPRING HARB SYM, V49, P691, DOI 10.1101/SQB.1984.049.01.078; RAMANI N, 1992, MOL GEN GENET, V231, P248, DOI 10.1007/BF00279798; ROBERTSON CA, 1988, J BIOL CHEM, V263, P3554; Sambrook J, 1989, MOL CLONING LABORATO; SANTERO E, 1992, J MOL BIOL, V227, P602, DOI 10.1016/0022-2836(92)90211-2; Simon R., 1983, BIOTECHNOLOGY, V1, P37; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SUMMERTON J, 1983, ANAL BIOCHEM, V133, P79, DOI 10.1016/0003-2697(83)90224-5; TAI TN, 1988, PLASMID, V19, P175, DOI 10.1016/0147-619X(88)90037-6; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TICHY HV, 1989, J BACTERIOL, V171, P4914, DOI 10.1128/jb.171.9.4914-4922.1989; TICHY HV, 1991, EMBO J, V10, P2949, DOI 10.1002/j.1460-2075.1991.tb07845.x; TSUI P, 1991, J BACTERIOL, V173, P5800, DOI 10.1128/jb.173.18.5800-5807.1991; UNDEN G, 1991, ANTON LEEUW INT J G, V59, P65, DOI 10.1007/BF00445650; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5	45	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24491	24497						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8227001				2022-12-27	WOS:A1993MF29400114
J	EMERICK, MC; FAMBROUGH, DM				EMERICK, MC; FAMBROUGH, DM			INTRAMOLECULAR FUSION OF NA-PUMP SUBUNITS ASSURES EXCLUSIVE ASSEMBLY OF THE FUSED ALPHA-SUBUNIT AND BETA-SUBUNIT DOMAINS INTO A FUNCTIONAL ENZYME IN CELLS ALSO EXPRESSING ENDOGENOUS NA-PUMP SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; INTRACELLULAR-TRANSPORT; NA,K-ATPASE; PROTEINS; K+	Experiments designed to identify Na pump structural features which tag the molecule for asymmetric cell-surface localization are inherently complex because either subunit, or both, may contain targeting information and because the cells which recognize those targeting signals and maintain asymmetric plasma membrane domains also express their own Na pumps, the subunits of which can assemble into hybrid pump molecules with pump subunits expressed from transfected cDNA clones. Cotransfecting cDNA for both subunits only complicates matters further by resulting in expression of four distinct dimeric molecular species. To eliminate the potential for cross-assembly in these and other experiments we have constructed cDNA encoding a ''single-subunit' Na pump (called ''alpha-beta'') in which the alpha and beta subunits are joined by a linker of 17 amino acids. By all criteria tested alpha-beta functioned as a normal heterodimeric Na pump. It was expressed in a variety of mammalian cell lines as a single, high molecular weight polypeptide located primarily on the surface membrane, with the beta subunit exposed to the extracellular medium. Binding of the conformation-sensitive monoclonal antibody 24 to the beta subunit indicated that the fusion protein was folded as a properly ''assembled' sodium pump. Expression of alpha-beta in ouabain-resistant mouse L cells resulted in high affinity ouabain binding and ouabain-sensitive, sodium-dependent rubidium transport. The enzyme was properly targeted to the basolateral plasma membrane in polarized epithelial cells. The functional integrity of the fusion protein renders it suitable for site-directed mutagenesis studies of targeting and enzymology where control of subunit assembly is desired. These results also support topological models in which the carboxyl terminus of the alpha subunit is cytoplasmic.			EMERICK, MC (corresponding author), JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023241] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44375-0141] Funding Source: Medline; NINDS NIH HHS [NS 23241] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		FAMBROUGH DM, 1983, J BIOL CHEM, V258, P3926; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; FORTE JG, 1989, HDB PHYSL, V3, P207; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; GOOD PJ, 1990, P NATL ACAD SCI USA, V87, P9088, DOI 10.1073/pnas.87.23.9088; Gottardi C.J., 1992, J TISS CULT METHODS, V14, P173; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HORISBERGER JD, 1991, P NATL ACAD SCI USA, V88, P8397, DOI 10.1073/pnas.88.19.8397; HORISBERGER JD, 1991, ANNU REV PHYSIOL, V53, P565, DOI 10.1146/annurev.physiol.53.1.565; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; HOROWITZ B, 1990, J BIOL CHEM, V265, P4189; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAS MV, 1992, J BIOL CHEM, V267, P20987; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; MATLIN KS, 1992, KIDNEY PHYSL PATHOPH, P447; PRESSLEY TA, 1986, J GEN PHYSIOL, V87, P591, DOI 10.1085/jgp.87.4.591; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TAMKUN MM, 1986, J BIOL CHEM, V261, P1009	24	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23455	23459						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226871				2022-12-27	WOS:A1993MF51500077
J	KIBAK, H; VANEECKHOUT, D; CUTLER, T; TAIZ, SL; TAIZ, L				KIBAK, H; VANEECKHOUT, D; CUTLER, T; TAIZ, SL; TAIZ, L			SULFITE BOTH STIMULATES AND INHIBITS THE YEAST VACUOLAR H+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROSPORA-CRASSA; HALOBACTERIUM-SACCHAROVORUM; MEMBRANE ATPASES; CATALYTIC SITE; PROTON PUMP; MECHANISM; MITOCHONDRIAL; PURIFICATION; BINDING; ADP	The yeast vacuolar H+-ATPase (V-ATPase) exhibits nonlinear hydrolysis kinetics, i.e. an initial rapid rate followed by a slower, steadily declining rate. Sulfite (50-100 mM) stimulates the yeast V-ATPase specifically during the latter period. Sulfite activation has been observed for the F-ATPases and archaebacterial ATPases and is thought to be caused by the release of tightly bound nucleotide at the catalytic site. However, turnover-dependent inactivation of the yeast V-ATPase, and sulfite stimulation, were only observed at MgATP concentrations > 1.0 mM. Below 1.0 mM MgATP, the hydrolysis time course was linear, and sulfite was inhibitory. The inhibition during the initial phase and the stimulation during the later phase of the time course could be accounted for by a 5.5-fold sulfite-induced increase in the apparent K(m), and a small increase in the apparent V(max) Sulfite also protected the enzyme against inhibition by cold inactivation and by dicyclohexylcarbodiimide but not by bafilomycin. Sulfite stimulation during the later phase was antagonized by DELTAmu(H+)BAR, particularly by DELTApH. In contrast to its effects on hydrolysis, sulfite inhibited the formation of a pH gradient at all times and failed to enhance the membrane potential even when DELTApH was collapsed by nigericin. These results indicate that sulfite partially uncouples hydrolysis from proton transport in a way that preserves regulation by DELTAmu(H+)BAR.	UNIV CALIF SANTA CRUZ,SINSHEIMER LABS,DEPT BIOL,SANTA CRUZ,CA 95064	University of California System; University of California Santa Cruz								ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; AUFFRET CA, 1981, BIOCHIM BIOPHYS ACTA, V648, P186, DOI 10.1016/0005-2736(81)90033-X; AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, V2; BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; BOWMAN BJ, 1989, J BIOL CHEM, V264, P15606; BOWMAN EJ, 1983, J BIOL CHEM, V258, P5238; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOWMAN EJ, 1982, J BACTERIOL, V151, P1326, DOI 10.1128/JB.151.3.1326-1337.1982; CHANSON A, 1985, PLANT PHYSIOL, V78, P232, DOI 10.1104/pp.78.2.232; CHERNYAK BV, 1986, TRENDS BIOCHEM SCI, V11, P32, DOI 10.1016/0968-0004(86)90229-X; CHERNYAK BV, 1988, FEBS LETT, V230, P159, DOI 10.1016/0014-5793(88)80662-8; DU ZY, 1990, BIOCHEMISTRY-US, V29, P402, DOI 10.1021/bi00454a014; EBEL RE, 1975, J BIOL CHEM, V250, P191; FENG Y, 1992, J BIOL CHEM, V267, P19769; FILLINGAME RH, 1909, ANN NY ACAD SCI, V671, P323; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P337; GLUCK S, 1987, J BIOL CHEM, V262, P15780; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; HARVEY WR, 1992, J EXP BIOL, V172, P1; KANE PM, 1989, J BIOL CHEM, V264, P19236; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; KOERBER SC, 1987, ANAL BIOCHEM, V165, P75, DOI 10.1016/0003-2697(87)90203-X; LARSON EM, 1989, BIOCHIM BIOPHYS ACTA, V973, P67, DOI 10.1016/S0005-2728(89)80404-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; MORIYAMA Y, 1988, ION PUMPS STRUCTURE, P387; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; MURATALIEV MB, 1991, BIOCHEMISTRY-US, V30, P8305, DOI 10.1021/bi00098a004; MURATALIEV MB, 1992, BIOCHEMISTRY-US, V31, P12885, DOI 10.1021/bi00166a025; MURATALIEV MB, 1992, EUR J BIOCHEM, V209, P681, DOI 10.1111/j.1432-1033.1992.tb17336.x; NELSON N, 1972, J BIOL CHEM, V247, P7657; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; SCHOBERT B, 1991, J BIOL CHEM, V266, P8008; SCHOBERT B, 1992, J BIOL CHEM, V267, P10252; SCHOBERT B, 1989, J BIOL CHEM, V264, P1208; SHIN K, 1992, J BIOL CHEM, V267, P20835; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; VULFSON EN, 1984, BIOL MEMBRANY, V1, P696; WANG YZ, 1985, J BIOL CHEM, V260, P434	41	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23325	23333						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226856				2022-12-27	WOS:A1993MF51500059
J	PEREZ, P; SCHONTHAL, A; ARANDA, A				PEREZ, P; SCHONTHAL, A; ARANDA, A			REPRESSION OF C-FOS GENE-EXPRESSION BY THYROID-HORMONE AND RETINOIC ACID RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GROWTH-HORMONE; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; X-RECEPTOR; BINDING; TRANSCRIPTION; PROMOTER; PROTEINS; MEDIATE; TARGET	Incubation with 1 nM triiodothyronine (T3) decreased cycloheximide-induced c-fos mRNA levels and the mRNA response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA; 100 nM) or to forskolin (15 muM). T3 also reduced the abundance of nuclear proteins that bind to an AP-1 binding site and the levels of c-Fos protein, as determined by Western blot. In transient transfection assays with a c-fos promoter reporter construct T3 decreased basal promoter activity by more than 50-60% and strongly inhibited the TPA and forskolin-induced activity. T3 further suppressed basal promoter activity and led to a drastic decrease of the response to both stimulatory agents after co-transfection of the promoter with an expression vector for the receptor. A truncated receptor that lacks the DNA binding domain abolished the inhibitory effect of the endogenous and transfected T3 receptor. Retinoic acid (RA) had an effect similar to T3 reducing basal CAT activity and the response to TPA and forskolin by 40-50% in cells co-transfected with the c-fos promoter and an expression vector for the RA receptor. The inhibitory effect of the nuclear receptors on c-Fos is reciprocal, since overexpression of c-Fos repressed induction of the activity of the growth hormone promoter by T3 and RA. Co-transfection with an antisense c-fos vector relieved this inhibition and restored the response to both ligands. These results show the antagonism between the nuclear receptors and the membrane signal transduction pathways that converge on the c-fos oncogene.	CSIC,INST INVEST BIOMED,ARTURO DUPERIER 4,E-28029 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)			Perez, Paloma/K-8841-2017; Aranda, Ana/ABG-8820-2020	Perez, Paloma/0000-0002-7166-2824; Aranda, Ana/0000-0002-8338-9589; Schonthal, Axel/0000-0003-0662-5653				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BEDO G, 1989, NATURE, V339, P231, DOI 10.1038/339231a0; CURRAN T, 1984, VIROLOGY, V135, P218, DOI 10.1016/0042-6822(84)90132-6; DESBOIS C, 1991, CELL, V67, P731, DOI 10.1016/0092-8674(91)90068-A; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; GARCIAVILLALBA P, 1993, BIOCHEM BIOPH RES CO, V191, P580, DOI 10.1006/bbrc.1993.1257; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; LAFYATIS R, 1990, MOL ENDOCRINOL, V4, P973, DOI 10.1210/mend-4-7-973; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; PEREZ P, 1990, 20TH FEBS M; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SCHONTHAL A, 1989, ONCOGENE, V4, P629; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YANGYEN HF, 1991, NEW BIOL, V3, P1206; YE ZS, 1988, J BIOL CHEM, V263, P7821; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	30	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23538	23543						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226882				2022-12-27	WOS:A1993MF51500089
J	SPARKS, DL; DAVIDSON, WS; LUNDKATZ, S; PHILLIPS, MC				SPARKS, DL; DAVIDSON, WS; LUNDKATZ, S; PHILLIPS, MC			EFFECT OF CHOLESTEROL ON THE CHARGE AND STRUCTURE OF APOLIPOPROTEIN-A-I IN RECOMBINANT HIGH-DENSITY-LIPOPROTEIN PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER PROTEIN; LECITHIN; PLASMA; ACYLTRANSFERASE; ESTER; PHOSPHATIDYLCHOLINES; CONFORMATION; APOPROTEIN; COMPLEXES; DISEASE	The effects of cholesterol on the conformation and net charge of apoA-1 have been investigated in homogeneous recombinant high density lipoprotein (HDL) particles. ApoA-I charge and structure in discoidal recombinant HDL complexes containing palmitoyloleoylphosphatidylcholine and cholesterol have been quantitated by guanidine HCl denaturation, circular dichroism, electrokinetic analysis, and NMR spectroscopy of [C-13[lysine-labeled apoA-I. In a discoidal particle containing 2 molecules of apoA-I and 160 molecules of palmitoyloleoylphosphatidylcholine, apoA-I exhibits an alpha-helix content of 75%, and the particle has a net negative surface charge of -5.2e/mol of apoA-I at pH 8.6. Addition of 2 molecules of cholesterol to this complex has no significant effect upon particle size, but slightly decreases the net charge (-5.0e) and alpha-helix content (68%) of apoA-I and enhances the stability of the helical segments, as reflected by an increase in the free energy of unfolding from 2.9 to 3.5 kcal/mol. In contrast, increasing the cholesterol content to 20 molecules/particle progressively increases particle size and apoA-I net negative charge (-6.1e), and there is a concomitant reduction in the free energy of stabilization of the a-helical structure in apoA-1 to 2.2 kcal/Mol. ((CH3)-C-13)2-Lys resonances from apoA-I in discoidal recombinant HDL exhibit six chemical shifts at pH 10; these peaks originate from dimethyl-Lys residues that have pK(a) values ranging from 8.4 to 10.3. The titration behavior of apoA-1 Lys residues is generally similar in the presence and absence of cholesterol, except that 4 Lys residues titrate at a significantly higher pH in the presence of cholesterol. These data are consistent with cholesterol having a direct effect on apoA-1 conformation and charge in HDL. Structural changes of this magnitude can affect the interactions between HDL and various plasma proteins and cell surfaces. It is therefore likely that the cholesterol content of HDL plays an important role in regulating the metabolism of this lipoprotein.	MED COLL PENN,DEPT BIOCHEM,2900 QUEEN LANE,PHILADELPHIA,PA 19129	Drexel University				Davidson, William/0000-0003-2756-2989; Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403; AZEMA C, 1990, BIOCHIM BIOPHYS ACTA, V1046, P73, DOI 10.1016/0005-2760(90)90096-G; BANKA CL, 1991, J BIOL CHEM, V266, P23886; COLLET X, 1991, J BIOL CHEM, V266, P9145; DAVIES JT, 1963, INTERFACIAL PHENOMEN, P56; DOBIASOVA M, 1991, ARTERIOSCLER THROMB, V11, P64, DOI 10.1161/01.ATV.11.1.64; JENTOFT JE, 1979, J BIOL CHEM, V254, P4366; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; JOHANSSON J, 1991, ARTERIOSCLER THROMB, V11, P174, DOI 10.1161/01.ATV.11.1.174; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1985, BIOCHEMISTRY-US, V24, P3508, DOI 10.1021/bi00335a018; Jonas A., 1992, STRUCTURE FUNCTION A, P217; JONAS A, 1987, PLASMA LIPOPROTEINS, P299; JONAS A, 1983, BIOCHIM BIOPHYS ACTA, V794, P361; JONES A, 1990, J BIOL CHEM, V265, P22123; KLAPPAUF E, 1979, HOPPESEYLERS Z PHYSL, V260, P1225; KLIMOV AN, 1992, CHEM PHYS LIPIDS, V62, P229, DOI 10.1016/0009-3084(92)90060-3; LAMBETH JD, 1986, ENDOCR RES, V12, P371, DOI 10.3109/07435808609035446; LONDON Y, 1974, BIOCHIM BIOPHYS ACTA, V332, P69, DOI 10.1016/0005-2736(74)90122-9; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MILLER GJ, 1975, LANCET, V1, P16; MORTON RE, 1988, J BIOL CHEM, V263, P12235; PACE CN, 1986, METHOD ENZYMOL, V131, P267; PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SEGREST JP, 1992, J LIPID RES, V33, P141; SPARKS DL, 1992, J LIPID RES, V33, P123; SPARKS DL, 1989, ATHEROSCLEROSIS, V77, P183, DOI 10.1016/0021-9150(89)90080-4; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SPARKS DL, 1989, J LIPID RES, V30, P1491; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SPARKS DL, 1989, BIOCHEM CELL BIOL, V67, P358, DOI 10.1139/o89-056; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1	38	78	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23250	23257						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226847				2022-12-27	WOS:A1993MF51500049
J	WOLFFLONG, VL; SARASWAT, LD; LOWEY, S				WOLFFLONG, VL; SARASWAT, LD; LOWEY, S			CYSTEINE MUTANTS OF LIGHT CHAIN-2 FORM DISULFIDE BONDS IN SKELETAL-MUSCLE MYOSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 HEADS; SITES; PROTEINS; BINDING	Multiple disulfide bonds form in recombinant myosin light chain-2 mutants that contain an engineered cysteine at positions 2, 73, or 94, in addition to the endogenous cysteines at residues 126 and 155 (Saraswat, L. D., and Lowey, S. (1991) J. Biol. Chem. 266,19777). By replacing one of the native cysteines with an alanine, mutants with a single pair of thiols were created: Cys2/Cys155, Cys2/Cys126, Cys73/Cys55 and Cys94/Cys156. Oxidation of these mutants resulted in a fast migrating band on nonreducing SDS gels, which was attributed to an intramolecular disulfide bond. To determine if disulfide formation could also occur when the light chains (LC) are bound to the myosin heavy chains, LCs were added to myosin which had been depleted of its native LC2 by an immunoadsorbent. When the reconstituted myosin was reacted with 5,5'-dithiobis(2-nitrobenzoic acid) in the absence of divalent cations, intramolecular disulfide bonds formed in the mutant and wild type LCs, but the LCs did not remain bound to the myosin heavy chains. Addition of magnesium ions prevented LC dissociation, but intramolecular disulfide bonds no longer formed. Instead, mutants containing cysteines in the NH2-terminal domain formed intermolecular disulfide bonds between the two heads of myosin. The ability to cross-link the heads demonstrates the existence of close head/head interactions in the myosin molecule, a feature that may be essential for regulation.			WOLFFLONG, VL (corresponding author), BRANDEIS UNIV,ROSENSTIEL BASIC MED SCI RES CTR,DEPT BIOCHEM,WALTHAM,MA 02254, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017350] Funding Source: NIH RePORTER; NIAMS NIH HHS [R37AR17350] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; BOWER SM, 1992, FEBS LETT, V310, P132, DOI 10.1016/0014-5793(92)81313-B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANTLER PD, 1988, J BIOL CHEM, V263, P938; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COLLINS JH, 1991, J MUSCLE RES CELL M, V12, P3, DOI 10.1007/BF01781170; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GAZITH J, 1970, J BIOL CHEM, V245, P15; HARDWICKE PMD, 1985, J MOL BIOL, V183, P203, DOI 10.1016/0022-2836(85)90213-X; HUBER PAJ, 1989, BIOCHEMISTRY-US, V28, P9116, DOI 10.1021/bi00449a024; KATOH T, 1989, J CELL BIOL, V109, P1549, DOI 10.1083/jcb.109.4.1549; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWEY S, 1971, NATURE, V234, P81, DOI 10.1038/234081a0; LOWEY S, 1986, MYOLOGY, P563; METZGER JM, 1992, BIOPHYS J, V63, P460, DOI 10.1016/S0006-3495(92)81614-4; MITCHELL EJ, 1989, J MOL BIOL, V208, P199, DOI 10.1016/0022-2836(89)90096-X; PASTRALANDIS SC, 1986, J BIOL CHEM, V261, P4811; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Sambrook J, 1989, MOL CLONING LABORATO; SARASWAT LD, 1992, J BIOL CHEM, V267, P21112; SARASWAT LD, 1991, J BIOL CHEM, V266, P19777; SILBERSTEIN L, 1981, J MOL BIOL, V148, P153, DOI 10.1016/0022-2836(81)90510-6; SZENTGYORGYI AG, 1986, MYOLOGY, P589; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	24	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23162	23167						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226834				2022-12-27	WOS:A1993MF51500034
J	WULLRICH, A; HAMACHER, C; SCHNEIDER, A; KILIMANN, MW				WULLRICH, A; HAMACHER, C; SCHNEIDER, A; KILIMANN, MW			THE MULTIPHOSPHORYLATION DOMAIN OF THE PHOSPHORYLASE-KINASE ALPHA(M) AND ALPHA(L) SUBUNITS IS A HOTSPOT OF DIFFERENTIAL MESSENGER-RNA PROCESSING AND OF MOLECULAR EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; CDNA CLONING; CATALYTIC SUBUNIT; BETA-SUBUNITS; PHOSPHOSERINE RESIDUES; ISOFORM; PURIFICATION; EXPRESSION; CALMODULIN; LIVER	We have cloned and sequenced human cDNAs encoding the complete phosphorylase kinase alpha subunit muscle isoform (alpha(M)). The predicted polypeptide is highly similar to the sequence known from rabbit muscle but lacks a major part of its multiphosphorylation domain, including the main phosphorylation site for cAMP-dependent protein kinase (PKA). Analysis of this region by reverse-transcribed polymerase chain reaction (RT-PCR) in several human and rabbit tissues demonstrates that it is subject to elaborate differential mRNA splicing. Amino acids 1012-1024 of the full-length rabbit sequence, including the major PKA phosphorylation site, and amino acids 1025-1041, which harbor at least one endogenous phosphorylation site, can be deleted from the predicted polypeptide individually or in combination. Molecules lacking one or both of these segments constitute a major part of the alpha(M) subunit population in many rabbit tissues and constitute the vast majority in all human tissues analyzed. Similar, tissue-dependent differential splicing events could be detected by RT-PCR in the human alpha subunit isoform from liver (alpha(L)). The expression of the differentially spliced alpha(M) subtypes differs markedly between corresponding human and rabbit tissues. Sequence divergence in this region is particularly high, not only between the muscle and liver isoforms, but also between alpha(M) sequences from four different animal species. Moreover, a duplication of the exon encoding the main PKA phosphorylation site was discovered in the mouse. Thus, the multiphosphorylation domain of the phosphorylase kinase alpha subunit isoforms is subject to pronounced structural variation not only between different tissues of one organism via differential splicing, but also in the course of evolution.	RUHR UNIV BOCHUM,INST PHYSIOL CHEM,UNIV STR 150,D-44780 BOCHUM,GERMANY	Ruhr University Bochum								AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BARNARD PJ, 1990, CYTOGENET CELL GENET, V53, P91, DOI 10.1159/000132902; BEESON D, 1990, EMBO J, V9, P2101, DOI 10.1002/j.1460-2075.1990.tb07378.x; BENDER PK, 1987, J BIOL CHEM, V262, P8799; CALALB MB, 1992, J BIOL CHEM, V267, P1455; CAWLEY KC, 1992, J BIOL CHEM, V267, P17287; CHAMBERLAIN JS, 1987, P NATL ACAD SCI USA, V84, P2886, DOI 10.1073/pnas.84.9.2886; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENS PR, 1990, ANN NEUROL, V28, P529, DOI 10.1002/ana.410280410; CRABB JW, 1984, J BIOL CHEM, V259, P6346; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; FRANCKE U, 1989, AM J HUM GENET, V45, P276; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; HARMANN B, 1991, J BIOL CHEM, V266, P15631; HEILMEYER LMG, 1992, BIOCHIM BIOPHYS ACTA, V1094, P168; KILIMANN MW, 1982, BIOCHEMISTRY-US, V21, P1735, DOI 10.1021/bi00537a005; KILIMANN MW, 1990, J INHERIT METAB DIS, V13, P435, DOI 10.1007/BF01799500; KILIMANN MW, 1984, BIOCHEMISTRY-US, V23, P112, DOI 10.1021/bi00296a018; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MEYER HE, 1990, EUR J BIOCHEM, V188, P367, DOI 10.1111/j.1432-1033.1990.tb15413.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NEWSHOLME P, 1992, J BIOL CHEM, V267, P810; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; RAMACHANDRAN C, 1987, J BIOL CHEM, V262, P3210; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER A, 1993, IN PRESS NATURE GENE; SHARMA RK, 1980, J BIOL CHEM, V255, P1102; SILVA EFD, 1987, FEBS LETT, V220, P36, DOI 10.1016/0014-5793(87)80871-2; SINGH TJ, 1977, J BIOL CHEM, V252, P625; SUL HS, 1982, J BIOL CHEM, V257, P3484; YEAMAN SJ, 1977, BIOCHEM J, V162, P411, DOI 10.1042/bj1620411; YEAMAN SJ, 1975, EUR J BIOCHEM, V51, P93, DOI 10.1111/j.1432-1033.1975.tb03910.x; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929	34	29	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23208	23214						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226841				2022-12-27	WOS:A1993MF51500042
J	CHURCHER, Y; MOSS, SE				CHURCHER, Y; MOSS, SE			MODULATION OF PROTEIN-TYROSINE PHOSPHORYLATION DURING G(1)/S TRANSITION IN ACTIVATED HUMAN T-LYMPHOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; IL-2 RECEPTOR; MICE LACKING; KINASE; P56LCK; ASSOCIATION; GROWTH; CD4; CLONING; LINE	We report that in activated human T-lymphoblasts synchronized early in the G1-phase of the cell cycle, addition of interleukin 2 (IL-2) stimulates transition into S-phase in conjunction with specific and reproducible protein tyrosine phosphorylation events. Prominent among these was de novo phosphorylation of the p56lck tyrosine kinase, which appeared as a single polypeptide on SDS-polyacrylamide gel electrophoresis prior to the addition of IL-2, but as a doublet of approximately 56 and 59 kDa 3 h after IL-2 addition. Although the lck polypeptide doublet persisted into S-phase, the 59-kDa form was virtually undetectable in T-lymphoblasts in log phase growth. In T-lymphoblasts metabolically labeled with P-32i, antiphosphotyrosine antisera identified a major 56-kDa tyrosine-phosphorylated protein, whereas antisera to lck showed that phosphorylation of lck occurred on both the 56- and 59-kDa forms. Phosphoamino acid analyses identified phosphoserine as the major phosphoamino acid on both of the lck polypeptides, although small amounts of phosphotyrosine were also detected on the 56-kDa form. Immune complex kinase assays revealed that only the lower band of the lck doublet exhibited autocatalytic activity. Furthermore, the 59-kDa form neither displayed autocatalytic activity, nor was it a substrate for phosphorylation by the 56-kDa form. We conclude that entry into S-phase in activated human T-lymphoblasts is associated with tyrosine phosphorylation of a limited number of proteins and suggest that p56lck activity is regulated during G1/S.			CHURCHER, Y (corresponding author), UNIV LONDON UNIV COLL,DEPT PHYSIOL,LONDON WC1E 6BT,ENGLAND.							APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; BURG DL, 1993, J BIOL CHEM, V268, P2304; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HATEKEYAMA M, 1989, SCIENCE, V244, P551; HISATAKA S, 1991, INT IMMUNOL, V3, P1137; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; LANE D, 1988, ANTIBODIES LABORATOR; LEONARD WJ, 1984, NATURE, V311, P625; LEY SC, 1991, EUR J IMMUNOL, V21, P2203, DOI 10.1002/eji.1830210931; LUO K, 1990, ONCOGENE, V5, P803; MINAMI Y, 1993, EMBO J, V12, P759, DOI 10.1002/j.1460-2075.1993.tb05710.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOSS SE, 1992, BIOCHIM BIOPHYS ACTA, V1160, P120, DOI 10.1016/0167-4838(92)90045-F; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; OANI H, 1992, P NATL ACAD SCI USA, V89, P2789; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; TAIEB J, 1993, J BIOL CHEM, V268, P9169; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TAYLOR SJ, 1993, CURR OPIN GENET DEV, V3, P26, DOI 10.1016/S0959-437X(05)80337-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903	31	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26144	26149						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253732				2022-12-27	WOS:A1993MK42500023
J	CRUZALEGUI, FH; MEANS, AR				CRUZALEGUI, FH; MEANS, AR			BIOCHEMICAL-CHARACTERIZATION OF THE MULTIFUNCTIONAL CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE TYPE-IV EXPRESSED IN INSECT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; CALMODULIN-BINDING; PHOSPHORYLATION; GENE; MECHANISM; GR; AUTOPHOSPHORYLATION; LOCALIZATION; CDNA	We have expressed the rat brain Ca2+/calmodulin (CaM)-dependent protein kinase type IV in insect cells. The recombinant enzyme is produced as a single polypeptide that migrates on SDS-polyacrylamide gel electrophoresis at 61 kDa. Recombinant CaM kinase IV undergoes slow CaM-dependent autophosphorylation. The autophosphorylation of CaM kinase IV occurs on serine residues but is not accompanied by the generation of a CaM-independent activity, as previously reported for the cerebellar enzyme. Comparison of peptide and protein phosphorylation by the recombinant CaM kinase IV and the cerebellar enzyme showed differences in their catalytic activities. The deduced primary sequence of CaM kinase IV contained a domain, 315Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys323 also found in the regulatory domain of CaM kinase IIalpha (residues 293-300). Truncation of CaM kinase IV at Leu313 (at a position analogous to Leu290 in CaM kinase IIalpha) generated a fully active, CaM-independent enzyme. This truncated enzyme no longer bound CaM. These data confirm that CaM kinase IV demonstrates intrasteric regulation by an autoinhibitory domain and provides insight into a potentially common mechanism for the regulation of the CaM-dependent multifunctional protein kinases. A number of synthetic peptides were examined for their phosphorylation by both CaM kinase II and IV. These studies showed that several peptides derived from phospholamban were preferential substrates for CaM kinase II whereas a peptide derived from S6 ribosomal protein was selectively phosphorylated by CaM kinase IV. Kinetic analysis of several peptide substrates suggests that while both CaM kinase II and IV recognize the sequence motif represented by R-X-X-T/S, other structural features are also involved in defining the unique substrate specificity of CaM kinase IV.	DUKE UNIV, MED CTR, DEPT PHARMACOL, BOX 3813, DURHAM, NC 27710 USA	Duke University					NICHD NIH HHS [HD 07503] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONTI MA, 1981, J BIOL CHEM, V256, P3178; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DENIS CL, 1991, J BIOL CHEM, V266, P17932; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P11309; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; KAMESHITA I, 1991, BIOCHEM BIOPH RES CO, V180, P191, DOI 10.1016/S0006-291X(05)81275-6; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; MEANS AR, 1993, RECENT PROG HORM RES, V48, P79; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; MIYANO O, 1992, J BIOL CHEM, V267, P1198; OHMSTEDE CA, 1991, P NATL ACAD SCI USA, V88, P5784, DOI 10.1073/pnas.88.13.5784; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; OLSEN DB, 1990, P NATL ACAD SCI USA, V87, P1451, DOI 10.1073/pnas.87.4.1451; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SIKELA JM, 1989, GENOMICS, V4, P21, DOI 10.1016/0888-7543(89)90309-1; SOBIESZEK A, 1991, EUR J BIOCHEM, V199, P735, DOI 10.1111/j.1432-1033.1991.tb16178.x; SUMMERS MD, 1988, TEX AGR EXP STN B, V1555; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370	33	117	118	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26171	26178						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253736				2022-12-27	WOS:A1993MK42500027
J	LOETSCHER, H; STUEBER, D; BANNER, D; MACKAY, F; LESSLAUER, W				LOETSCHER, H; STUEBER, D; BANNER, D; MACKAY, F; LESSLAUER, W			HUMAN TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) MUTANTS WITH EXCLUSIVE SPECIFICITY FOR THE 55-KDA OR 75-KDA TNF RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL-CELLS; NF-KAPPA-B; MONOCLONAL-ANTIBODIES; MUTATIONAL ANALYSIS; ADHESION MOLECULE-1; HUMAN LYMPHOTOXIN; CYTO-TOXICITY; SEPTIC SHOCK; FACTOR-BETA; BINDING	To probe the ligand receptor interface, a number of point mutations were introduced in selected regions of human tumor necrosis factor (TNF) alpha by site-directed mutagenesis. The mutated proteins were expressed in Escherichia coli and analyzed for selective binding to recombinant 55- and 75-kDa TNF receptors in competition with radiolabeled wild-type TNFalpha. Generally, mutations in the loop from position 29 to 34 and at positions 86 and 146 preferentially impaired binding to the 75-kDa TNF receptor, whereas mutations in the region from 143 to 145 mainly affected binding to the 55-kDa TNF receptor. Mutation of the conserved Tyr87 resulted in a dramatic loss of binding activity to both receptors. The selectivity for one or the other receptor type was found to be enhanced by combining two or three point mutations, the effects of the single mutations with respect to receptor selectivity being at least additive. A combination of the mutations Arg32-->Trp and Ser86-->Thr yielded a double mutant (R32W-S86T) with wild-type binding to the 55 kDa, but no measurable binding to the 75-kDa TNF receptor. In contrast, combining the Asp143-->Asn and Ala145-->Arg mutations (D143N-A145R) resulted in a complete loss of binding to the 55-kDa TNF receptor, whereas binding to the 75-kDa TNF receptor was impaired by only 5-10-fold. In functional assays, selective activation of the 55-kDa TNF receptor by the R32W-S86T mutant elicited a full cytotoxic response in human KYM-1 cells and secretion of interleukin 6 and granulocyte-macrophate colony-stimulating factor in human umbilical vein endothelial cells. In contrast, stimulation of the 75-kDa TNF receptor with the D143N-A145R mutant as well as with agonistic antibodies failed to induce these responses.	F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND	Roche Holding			Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693				BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BEUTLER BE, 1992, TUMOR NECROSIS FACTO; BILIAU A, 1992, CYTOKINE, V4, P259; BRAKEBUSCH C, 1992, EMBO J, V11, P943, DOI 10.1002/j.1460-2075.1992.tb05133.x; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; BROUDY VC, 1986, P NATL ACAD SCI USA, V83, P7467, DOI 10.1073/pnas.83.19.7467; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CORDINGLEY FT, 1988, LANCET, V1, P969; DARCY A, 1993, J MOL BIOL, V229, P555, DOI 10.1006/jmbi.1993.1055; DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ERIKSTEIN BK, 1991, EUR J IMMUNOL, V21, P1033, DOI 10.1002/eji.1830210426; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FISCHER E, 1992, J CLIN INVEST, V89, P1551, DOI 10.1172/JCI115748; GEHR G, 1992, J IMMUNOL, V149, P911; GOH CR, 1991, PROTEIN ENG, V4, P385, DOI 10.1093/protein/4.4.385; GOH CR, 1991, PROTEIN ENG, V4, P785; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; HELLER RA, 1992, CELL, V70, P47; HOHMANN HP, 1990, J BIOL CHEM, V265, P22408; JIRIK FR, 1989, J IMMUNOL, V142, P144; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KIRCHEIS R, 1992, IMMUNOLOGY, V76, P433; KRUPPA G, 1992, J IMMUNOL, V148, P3152; LESSLAUER W, 1991, EUR J IMMUNOL, V21, P2883, DOI 10.1002/eji.1830211134; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LOETSCHER H, 1991, CANCER CELL-MON REV, V3, P221; LOETSCHER H, 1991, J BIOL CHEM, V266, P18324; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Loetscher H, 1991, Oxf Surv Eukaryot Genes, V7, P119; MACKAY F, 1992, J EXP MED, V177, P1277; MEAGER A, 1991, J IMMUNOL METHODS, V144, P141, DOI 10.1016/0022-1759(91)90239-C; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8; NAUME B, 1991, J IMMUNOL, V146, P3045; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PENNICA D, 1992, BIOCHEMISTRY-US, V31, P1134, DOI 10.1021/bi00119a023; POBER JS, 1987, J IMMUNOL, V138, P3319; RANGES GE, 1989, J IMMUNOL, V142, P1203; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHOENFELD HJ, 1991, J BIOL CHEM, V266, P3863; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHALABY MR, 1990, J EXP MED, V172, P1517, DOI 10.1084/jem.172.5.1517; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STUEBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; TAEUBER MG, 1992, J INFECT DIS, V166, P1045; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; TAVERNIER J, 1990, J MOL BIOL, V211, P493, DOI 10.1016/0022-2836(90)90367-U; THORP KM, 1992, CYTOKINE, V4, P313, DOI 10.1016/1043-4666(92)90072-Y; TRACEY KJ, 1989, LANCET, V1, P1122; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; TREFZER U, 1991, J INVEST DERMATOL, V97, P911, DOI 10.1111/1523-1747.ep12491668; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; VANOSTADE X, 1993, NATURE, V361, P266; VANOSTADE X, 1991, EMBO J, V10, P827, DOI 10.1002/j.1460-2075.1991.tb08015.x; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WAAGE A, 1987, LANCET, V1, P355; WAKABAYASHI T, 1990, J BIOL CHEM, V265, P7604; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; ZHANG XM, 1992, J BIOL CHEM, V267, P24069	74	208	238	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26350	26357						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253759				2022-12-27	WOS:A1993MK42500053
J	PAGES, F; DETERRE, P; PFISTER, C				PAGES, F; DETERRE, P; PFISTER, C			ENHANCEMENT BY PHOSPHODIESTERASE SUBUNITS OF THE RATE OF GTP HYDROLYSIS BY TRANSDUCIN IN BOVINE RETINAL RODS - ESSENTIAL ROLE OF THE PHOSPHODIESTERASE CATALYTIC CORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR CGMP PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; OUTER SEGMENTS; ALPHA-SUBUNIT; G-PROTEIN; MOLECULAR MECHANISM; VISUAL TRANSDUCTION; CROSS-LINKING; BETA-SUBUNIT; ACTIVATION	Phosphodiesterase (PDE) in bovine retinal rod outer segments is activated when it forms a membrane-bound complex with the alpha-subunit of transducin loaded with GTP (Talpha*). At maximal activation, this complex contains two Talpha* and all the subunits of native PDE (PDEalpha, PDEbeta, and two inhibitory PDEgamma). We observed previously (Pages, F., Deterre, P., and Pfister, C. (1992) J. Biol. Chem. 267,22018-22021) that the rate of GTP hydrolysis by transducin in a rod outer segment suspension is enhanced when Talpha* is bound to native PDE (PDEalphabetagamma2). In this article, we compare the effects of PDE species with different PDEgamma contents. We show that Talpha* hydrolyzes its GTP faster not only when bound to PDEalphabetagamma2, but also when bound to PDEalphabetagamma or PDEalphabeta. Moreover, trypsin-treated PDE (PDEgamma-deprived soluble PDE) also induces an acceleration of GTP hydrolysis. On the contrary, addition of isolated PDEgamma alone does not accelerate GTP hydrolysis. The interaction between Talpha* and PDEgamma, which is essential for the activation of PDE by Talpha*, is apparently not responsible of the feedback of PDE on Talpha*. The interaction of primary importance for the acceleration of GTP hydrolysis would be that existing between Talpha* and PDEalphabeta.	CENS, DEPT BIOL MOLEC & STRUCT, BIOPHYS MOLEC & CELLULAIRE, F-91191 GIF SUR YVETTE, FRANCE	CEA			Deterre, Philippe/O-8984-2017	Deterre, Philippe/0000-0001-9303-0791				ANTONNY B, 1993, BIOCHEMISTRY-US, V32, P8646, DOI 10.1021/bi00084a036; ARSHAVSKY VY, 1989, FEBS LETT, V250, P353, DOI 10.1016/0014-5793(89)80754-9; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BENNETT N, 1989, BIOCHEMISTRY-US, V28, P7418, DOI 10.1021/bi00444a040; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BHOWN AS, 1980, ANAL BIOCHEM, V103, P184, DOI 10.1016/0003-2697(80)90254-7; BOURNE HR, 1992, NATURE, V358, P541, DOI 10.1038/358541a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; BRUCKERT F, 1992, BIOPHYS J, V63, P616, DOI 10.1016/S0006-3495(92)81650-8; CATTY P, 1991, EUR J BIOCHEM, V199, P263, DOI 10.1111/j.1432-1033.1991.tb16119.x; CATTY P, 1992, J BIOL CHEM, V267, P19489; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; CHABRE M, 1985, ANNU REV BIOPHYS BIO, V14, P331, DOI 10.1146/annurev.biophys.14.1.331; CLERC A, 1992, J BIOL CHEM, V267, P19948; CLERC A, 1992, J BIOL CHEM, V267, P6620; DETERRE P, 1986, Proteins Structure Function and Genetics, V1, P188, DOI 10.1002/prot.340010210; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; ERICKSON MA, 1992, SCIENCE, V257, P1255, DOI 10.1126/science.1519062; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; HINGORANI VN, 1988, J BIOL CHEM, V263, P6916; KROLL S, 1989, J BIOL CHEM, V264, P4490; KUHN H, 1981, CURR TOP MEMBR TRANS, V15, P171; LAMB TD, 1988, J PHYSIOL-LONDON, V407, P463, DOI 10.1113/jphysiol.1988.sp017426; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; PAGES F, 1992, J BIOL CHEM, V267, P22018; PFISTER C, 1993, CELL SIGNAL, V5, P235, DOI 10.1016/0898-6568(93)90015-E; PITTLER SJ, 1990, GENOMICS, V6, P272, DOI 10.1016/0888-7543(90)90567-E; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SITARAMAYYA A, 1988, BIOCHEMISTRY-US, V27, P4880, DOI 10.1021/bi00413a044; STRYER L, 1991, J BIOL CHEM, V266, P10711; SUGINO Y, 1964, J BIOL CHEM, V239, P2360; SWEENEY MI, 1992, FEBS LETT, V310, P66, DOI 10.1016/0014-5793(92)81148-F; TING TD, 1991, BIOCHEMISTRY-US, V30, P8996, DOI 10.1021/bi00101a013; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAMAZAKI A, 1993, J BIOL CHEM, V268, P8899	50	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26358	26364						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253760				2022-12-27	WOS:A1993MK42500054
J	SUPAKAR, PC; SONG, CS; JUNG, MH; SLOMCZYNSKA, MA; KIM, JM; VELLANOWETH, RL; CHATTERJEE, B; ROY, AK				SUPAKAR, PC; SONG, CS; JUNG, MH; SLOMCZYNSKA, MA; KIM, JM; VELLANOWETH, RL; CHATTERJEE, B; ROY, AK			A NOVEL REGULATORY ELEMENT ASSOCIATED WITH AGE-DEPENDENT EXPRESSION OF THE RAT ANDROGEN RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; POLYMERASE CHAIN-REACTION; TRANSCRIPTION FACTOR; ALPHA2U GLOBULIN; DOWN-REGULATION; LIFE-SPAN; RNA; PROTEIN; LIVER; DNA	A large body of evidence indicates that the genetic program of aging has co-evolved with the sexual mode of reproduction (Partridge, L., and Barton, N. H. (1993) Nature 362, 305-311). Age-dependent changes in target cell sensitivity to reproductive hormones can be considered part of this evolutionary linkage. Here we describe a novel regulatory element in the rat androgen receptor (AR) gene promoter associated with its age-dependent expression in the liver. This element consists of two (19 and 25 base pairs) contiguous sites, one specifically binding an Age-dependent Factor (ADF) and the other an Associated Factor (AF). Both deletion and point mutations of the ADF site result in about a 5-fold decline in the AR promoter function. Unlike AF, which is relatively tissue specific, ADF appears to be ubiquitous. The ubiquitous and evolutionarily conserved nature of ADF suggests a fundamental role of this novel transcription factor in programmed gene expression.	UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK014744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010486, P01AG006872] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG06872, R01 AG10486] Funding Source: Medline; NIDDK NIH HHS [R-37 DK14744] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944; BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939; CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518; CHATTERJEE B, 1987, J BIOL CHEM, V262, P822; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIDSON JM, 1983, J CLIN ENDOCR METAB, V57, P71, DOI 10.1210/jcem-57-1-71; DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589; DERMAN E, 1981, P NATL ACAD SCI-BIOL, V78, P5425, DOI 10.1073/pnas.78.9.5425; DEWET JR, 1987, MOL CELL BIOL, V2, P1044; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Finch CE, 1990, LONGEVITY SENESCENCE; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Lee AK., 1985, EVOL ECOL; LEHMANN JM, 1991, NUCLEIC ACIDS RES, V19, P573, DOI 10.1093/nar/19.3.573; Martin G M, 1982, Natl Cancer Inst Monogr, V60, P241; McKusick V.A., 1992, MENDELIAN INHERITANC; Medawar P. B., 1957, UNIQUENESS INDIVIDUA; ONO K, 1988, GERONTOLOGY, V34, P128, DOI 10.1159/000212941; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157; ROBERTSON O, 1961, P NATL ACAD SCI USA, V47, P609, DOI 10.1073/pnas.47.4.609; ROEHRBORN CG, 1987, J CLIN INVEST, V79, P44, DOI 10.1172/JCI112805; ROSE M. R., 1991, EVOLUTIONARY BIOL AG; ROY AK, 1976, FEBS LETT, V70, P137, DOI 10.1016/0014-5793(76)80743-0; ROY AK, 1973, ENDOCRINOLOGY, V92, P957, DOI 10.1210/endo-92-3-957; ROY AK, 1983, J BIOL CHEM, V258, P123; ROY AK, 1983, RECENT PROG HORM RES, V39, P425; SACEDA M, 1988, MOL ENDOCRINOL, V2, P1157, DOI 10.1210/mend-2-12-1157; SIKORA E, 1992, FEBS LETT, V312, P179, DOI 10.1016/0014-5793(92)80930-F; SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779; SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349; TAKAHASHI K, 1986, NATURE, V319, P121, DOI 10.1038/319121a0; TAKANE KK, 1991, ENDOCRINOLOGY, V129, P1093, DOI 10.1210/endo-129-2-1093; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; TRUANT R, 1993, J BIOL CHEM, V268, P2284; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469	49	72	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26400	26408						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253765				2022-12-27	WOS:A1993MK42500059
J	BETTS, JC; CHESHIRE, JK; AKIRA, S; KISHIMOTO, T; WOO, P				BETTS, JC; CHESHIRE, JK; AKIRA, S; KISHIMOTO, T; WOO, P			THE ROLE OF NF-KAPPA-B AND NF-IL6 TRANSACTIVATING FACTORS IN THE SYNERGISTIC ACTIVATION OF HUMAN SERUM AMYLOID-A GENE-EXPRESSION BY INTERLEUKIN-1 AND INTERLEUKIN-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER BINDING-PROTEIN; PHASE RESPONSE ELEMENT; NECROSIS FACTOR-ALPHA; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; INTERFERON-GAMMA; C/EBP-LIKE; ANGIOTENSINOGEN GENE; HEPATOMA-CELLS; P50 SUBUNIT	To understand the mechanisms by which large increases in serum amyloid A (SAA) occur during the acute phase response, human hepatoma cells were transfected with SAA2 gene reporter plasmids and stimulated with combinations of cytokines. Although interleukin-1 (IL-1) and interleukin-6 (IL-6) stimulated transcription from this promoter individually, addition of both mediators produced a response between two and nine times greater than the expected additive response. This synergistic activation was dependent on the integrity of at least two cis-acting sequences in the SAA2 enhancer. The SAA2 NF-kappaB site was required functionally for the response to both IL-1 and IL-6 alone as well as for synergistic activation; however, IL-6 did not directly induce binding of nuclear proteins to the NF-kappaB sequence. A NF-IL-6 site was required for full induction by IL-1 and IL-6, and also mediated strong transactivation by recombinant NF-IL6. Furthermore, transfected NF-IL6 synergized strongly with co-transfected NF-kappaB, particularly with RelA (p65). However synergy between IL-1 and IL-6 was only partly reduced by mutation of the NF-IL6 site, indicating further levels of interaction in addition to the NF-kappaB/NF-IL6 cooperativity.	MRC,CLIN RES CTR,MOLEC RHEUMATOL SECT,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND; OSAKA UNIV,INST MOLEC & CELLULAR BIOL,DIV IMMUNOL,SUITA,OSAKA 565,JAPAN	Medical Research Council Clinical Trials Unit; Osaka University			Kishimoto, Tadamitsu/C-8470-2009; Akira, Shizuo/C-3134-2009	Brusko, Todd/0000-0003-2878-9296				AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BRASIER AR, 1990, EMBO J, V9, P3933, DOI 10.1002/j.1460-2075.1990.tb07614.x; BRINCKERHOFF CE, 1989, SCIENCE, V243, P655, DOI 10.1126/science.2536953; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; EDBROOKE MR, 1991, CYTOKINE, V3, P380, DOI 10.1016/1043-4666(91)90041-B; ELIAS JA, 1989, J IMMUNOL, V142, P509; EMILIE D, 1988, EUR J IMMUNOL, V18, P2043, DOI 10.1002/eji.1830181226; ESPARZA I, 1987, J EXP MED, V166, P589, DOI 10.1084/jem.166.2.589; Fey G H, 1990, Prog Liver Dis, V9, P89; GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x; GOLLAHER CJ, 1989, P SOC EXP BIOL MED, V194, P245; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; HOUSSIAU FA, 1988, EUR J IMMUNOL, V18, P653, DOI 10.1002/eji.1830180427; HUANG JH, 1990, MOL CELL BIOL, V10, P3619, DOI 10.1128/MCB.10.7.3619; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; LI X, 1992, NUCLEIC ACIDS RES, V20, P4765, DOI 10.1093/nar/20.18.4765; LI XX, 1991, J BIOL CHEM, V266, P15192; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; NONAKA M, 1990, MOL CELL BIOL, V10, P6283, DOI 10.1128/MCB.10.12.6283; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; RIENHOFF HY, 1988, MOL CELL BIOL, V8, P3710, DOI 10.1128/MCB.8.9.3710; RIENHOFF HY, 1990, MOL BIOL MED, V7, P287; RON D, 1990, MOL CELL BIOL, V10, P1023, DOI 10.1128/MCB.10.3.1023; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SACK GH, 1989, GENE, V84, P509, DOI 10.1016/0378-1119(89)90528-3; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; STOECKLE MY, 1991, NUCLEIC ACIDS RES, V19, P917, DOI 10.1093/nar/19.4.917; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; THELEN M, 1990, P NATL ACAD SCI USA, V87, P5603, DOI 10.1073/pnas.87.15.5603; WATSON G, 1992, SCAND J IMMUNOL, V36, P703, DOI 10.1111/j.1365-3083.1992.tb03131.x; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; ZURAW BL, 1990, J BIOL CHEM, V265, P12664	59	175	180	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25624	25631						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244997				2022-12-27	WOS:A1993MK10000051
J	CHAPPELL, DA; FRY, GL; WAKNITZ, MA; MUHONEN, LE; PLADET, MW				CHAPPELL, DA; FRY, GL; WAKNITZ, MA; MUHONEN, LE; PLADET, MW			LOW-DENSITY-LIPOPROTEIN RECEPTORS BIND AND MEDIATE CELLULAR CATABOLISM OF NORMAL VERY-LOW-DENSITY LIPOPROTEINS IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERITABLE HYPERLIPIDEMIC RABBITS; TRIGLYCERIDE-RICH LIPOPROTEINS; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE-ACTIVITY; PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR; CULTURED HUMAN-FIBROBLASTS; MONOCLONAL-ANTIBODIES; APOLIPOPROTEIN-E; BLOOD-PLASMA; FAMILIAL HYPERCHOLESTEROLEMIA; STOICHIOMETRIC BINDING	Very low density lipoproteins (VLDL) are heterogeneous, triglyceride-rich particles that are precursors of low density lipoproteins (LDL). Before conversion to LDL, the majority of VLDL are irreversibly cleared from plasma by uncertain mechanisms. To investigate one potential mechanism for VLDL clearance, we studied the ability of LDL receptors to mediate VLDL uptake in vitro. Small, intermediate, and large VLDL from normolipidemic humans were found to bind and undergo catabolism via LDL receptors on normal human fibroblasts. Binding to cell surfaces was up-regulated by lovastatin, an inducer of LDL receptors. Both LDL and a monoclonal antibody against the LDL receptor (IgG-C7) prevented binding of I-125-VLDL. Also, VLDL binding to mutant fibroblasts lacking LDL receptors was low. Thus, LDL receptors mediated VLDL interactions with cells. Binding affinity decreased near saturation, and the apparent number of high affinity sites decreased with increasing VLDL particle size. Because LDL receptors are small (M(r) 115,000) relative to VLDL (M(r) 9-24 x 10(6)) and are clustered in clathrin-coated pits, these findings suggest that steric hindrance becomes an important binding determinant near saturation and are consistent with a lattice model for LDL receptor-ligand interactions. The capacity for cellular catabolism of VLDL decreased with increasing particle size, consistent with a lattice model. The lattice model was also supported by differences between I-125-VLDL binding to cell surfaces and binding to partially purified LDL receptors in solid-phase assays in which steric constraints resulting from clustering in clathrin-coated pits are not present. In both cell-surface and solid-phase assays, VLDL bound via apoE, not apoB-100. Our studies establish that normal VLDL interact with LDL receptors and that steric hindrance due to crowding of particles on clustered LDL receptors is an important determinant of their binding and catabolism. These findings suggest that LDL receptors may participate in normal VLDL clearance in vivo.			CHAPPELL, DA (corresponding author), UNIV IOWA,COLL MED,DEPT INTERNAL MED,E318 GH,IOWA CITY,IA 52242, USA.				NHLBI NIH HHS [T32 HL07413, HL49264] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049264, T32HL007413] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; BRADLEY WA, 1984, J BIOL CHEM, V259, P4728; CAMPOS E, 1992, J LIPID RES, V33, P369; CATAPANO AL, 1979, J BIOL CHEM, V254, P1007; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CHAPPELL DA, 1992, J BIOL CHEM, V267, P270; CHAPPELL DA, 1988, J CLIN INVEST, V82, P628, DOI 10.1172/JCI113642; CHOI SSY, 1991, J CLIN INVEST, V88, P1173, DOI 10.1172/JCI115419; DASHTI N, 1986, BIOCHIM BIOPHYS ACTA, V875, P473, DOI 10.1016/0005-2760(86)90067-6; DELALLERA M, 1979, BIOCHIM BIOPHYS ACTA, V574, P414, DOI 10.1016/0005-2760(79)90237-6; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; DESAI KS, 1980, BIOCHIM BIOPHYS ACTA, V620, P341, DOI 10.1016/0005-2760(80)90125-3; ESPER E, 1993, J LAB CLIN MED, V121, P97; FIELDING PE, 1986, J BIOL CHEM, V261, P5233; FREDRICKSON DS, 1968, J CLIN INVEST, V47, P2446, DOI 10.1172/JCI105927; GIANTURCO SH, 1978, J CLIN INVEST, V61, P320, DOI 10.1172/JCI108942; GIANTURCO SH, 1980, LIPIDS, V15, P456, DOI 10.1007/BF02534072; GIANTURCO SH, 1993, ARTERIOSCLER THROMB, V13, P472, DOI 10.1161/01.ATV.13.4.472; GIANTURCO SH, 1982, J LIPID RES, V23, P984; GIBSON JC, 1987, ARTERIOSCLEROSIS, V7, P401, DOI 10.1161/01.ATV.7.4.401; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HERZ J, 1991, J BIOL CHEM, V266, P21232; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; Innerarity T L, 1986, Methods Enzymol, V129, P542; JACKLE S, 1992, J LIPID RES, V33, P419; KARPE F, 1993, J CLIN INVEST, V91, P748, DOI 10.1172/JCI116293; KLEINBAUM DG, 1988, APPLIED REGRESSION A, P124; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KREMPLER F, 1987, J CLIN INVEST, V80, P401, DOI 10.1172/JCI113086; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAMO JCL, 1991, BIOCHIM BIOPHYS ACTA, V1081, P241, DOI 10.1016/0005-2760(91)90277-O; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MILNE RW, 1982, FEBS LETT, V146, P97, DOI 10.1016/0014-5793(82)80712-6; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; MULDER M, 1993, J BIOL CHEM, V268, P9369; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; PACKARD CJ, 1984, J CLIN INVEST, V74, P2178, DOI 10.1172/JCI111644; RANGANATHAN S, 1989, HEPATOLOGY, V9, P547, DOI 10.1002/hep.1840090407; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; SCHONFELD G, 1979, J CLIN INVEST, V64, P1288, DOI 10.1172/JCI109584; SCHROTT HG, 1982, CIRCULATION, V65, P300, DOI 10.1161/01.CIR.65.2.300; SEHAYEK E, 1991, J CLIN INVEST, V88, P553, DOI 10.1172/JCI115339; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; STALENHOEF AFH, 1984, P NATL ACAD SCI-BIOL, V81, P1839, DOI 10.1073/pnas.81.6.1839; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANDRIEL IR, 1989, J BIOL CHEM, V264, P9533; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; YAMADA N, 1988, J CLIN INVEST, V82, P2106, DOI 10.1172/JCI113832; YAMADA N, 1987, J CLIN INVEST, V80, P507, DOI 10.1172/JCI113099; 1980, NIH801527 NAT HEART	62	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25487	25493						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244984				2022-12-27	WOS:A1993MK10000034
J	SHIFRIN, VI; NEEL, BG				SHIFRIN, VI; NEEL, BG			GROWTH FACTOR-INDUCIBLE ALTERNATIVE SPLICING OF NONTRANSMEMBRANE PHOSPHOTYROSINE PHOSPHATASE PTP-1B PREMESSENGER RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ENDOPLASMIC-RETICULUM; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; HUMAN-PLACENTA; FISSION YEAST; PROLINE-RICH; SH2 DOMAIN; KINASE-C; EXPRESSION	PTP-1B is a major nontransmembrane phosphotyrosine phosphatase in human cell lines and tissues, but its physiological function(s) and mechanism(s) of regulation are largely unknown. We have found that in human diploid fibroblasts a novel PTP-1B mRNA isoform is produced upon stimulation of quiescent cells with a variety of growth factors. Generation of this isoform requires protein synthesis, suggesting that the product(s) of an immediate early response gene(s) is required. RNase protection and reverse transcription polymerase chain reaction analysis demonstrate that the isoform arises as a consequence of alternative pre-mRNA splicing, leading to retention of the last intron. The novel isoform is found on polyribosomes, indicating that it is actively translated, and is variably expressed in human tissues. Sequence analysis indicates that the isoform encodes a PTP-1B protein with an altered C terminus. To our knowledge, this is the first example of growth factor-regulated alternative splicing.			SHIFRIN, VI (corresponding author), BETH ISRAEL HOSP,MOLEC MED UNIT,BOSTON,MA 02215, USA.				NCI NIH HHS [R01 CA 49152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; BORNER C, 1992, J BIOL CHEM, V267, P12892; BRAUTIGAN DL, 1991, P NATL ACAD SCI USA, V88, P6696, DOI 10.1073/pnas.88.15.6696; BROWNSHIMER S, 1992, CANCER RES, V52, P478; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CHAMPIONARNAUD P, 1991, ONCOGENE, V6, P1203; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; COOL DE, 1992, P NATL ACAD SCI USA, V89, P5422, DOI 10.1073/pnas.89.12.5422; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GEBERT JF, 1991, ONCOGENE, V6, P1859; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOMANDBERG GA, 1985, THROMB RES, V39, P203, DOI 10.1016/0049-3848(85)90108-2; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; LATCHMAN D S, 1990, New Biologist, V2, P297; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Maniatis T, 1989, DECONTAMINATION DILU; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; MILLAR JBA, 1992, EMBO J, V11, P4943, DOI 10.1002/j.1460-2075.1992.tb05601.x; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OTTILIE S, 1991, P NATL ACAD SCI USA, V88, P3455, DOI 10.1073/pnas.88.8.3455; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PINES J, 1990, New Biologist, V2, P389; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; RUDD CE, 1989, IMMUNOL REV, V111, P225, DOI 10.1111/j.1600-065X.1989.tb00548.x; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARPE NG, 1989, FEBS LETT, V250, P585, DOI 10.1016/0014-5793(89)80801-4; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; THOMAS GP, 1984, MOL CELL BIOL, V4, P1063, DOI 10.1128/MCB.4.6.1063; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836	60	48	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25376	25384						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244970				2022-12-27	WOS:A1993MK10000018
J	ZIEGLER, M; PENEFSKY, HS				ZIEGLER, M; PENEFSKY, HS			THE ADENINE-NUCLEOTIDE TRANSLOCASE MODULATES OLIGOMYCIN-INDUCED QUENCHING OF PYRANINE FLUORESCENCE IN SUBMITOCHONDRIAL PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP TRANSLOCATOR; OXIDATIVE-PHOSPHORYLATION; ADP/ATP CARRIER; INNER MEMBRANE; MITOCHONDRIA; SYNTHASE; TRANSPORT; DERIVATIVES; DIFFUSION; GENETICS	Incorporation of the fluorescent, nonpermeant pH indicator pyranine into submitochondrial particles (pyranine-SMP) permitted monitoring of intravesicular pH changes brought about by proton translocation due to oxidation of respiratory chain substrates or to hydrolysis of ATP. Addition of oligomycin to beef heart pyranine-SMP was followed by a pH-independent quenching of pyranine fluorescence. Quenching was influenced by the presence of adenine nucleotides both inside and outside the submitochondrial particles. The nature of the nucleotides required for quenching resembled the specificity of the adenine nucleotide translocase rather than F1-ATPase. Removal of F1 from pyranine-SMP by treatment of the particles with urea did not alter oligomycin-induced quenching. Atractyloside, a specific inhibitor of the adenine nucleotide translocase, prevented oligomycin-induced quenching when the inhibitor was coincorporated into submitochondrial particles with pyranine. Bongkrekic acid prevented or reversed the oligomycin-dependent quenching when added to pyranine-SMP either before or after oligomycin, respectively, but only when ATP was present within the particles. A mutant of Saccharomyces cerevisiae, lacking translocase genes, exhibited oligomyc-independent fluorescence quenching which was not inhibited by bongkrekic acid. The results support the interpretation that oligomycin promotes sequestration of the fluorescent probe in a region of the submitochondrial particle, probably the F0F1 complex, that leads to a quenching of fluorescence. The observed quenching can be modulated in a way that suggests an interaction between the translocase and F0.			ZIEGLER, M (corresponding author), SUNY HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, SYRACUSE, NY 13210 USA.			Ziegler, Mathias/0000-0001-6961-2396	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021737] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21737] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEYER RE, 1967, METHOD ENZYMOL, V10, P186; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GAWAZ M, 1990, J BIOL CHEM, V265, P14202; GUPTE SS, 1991, BIOCHIM BIOPHYS ACTA, V1069, P131, DOI 10.1016/0005-2736(91)90114-N; HACKENBERG H, 1980, BIOCHEMISTRY-US, V19, P548, DOI 10.1021/bi00544a024; HARRIS DA, 1977, BIOCHIM BIOPHYS ACTA, V459, P560, DOI 10.1016/0005-2728(77)90054-8; ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; KLINGENBERG M, 1984, BIOCHEMISTRY-US, V23, P2442, DOI 10.1021/bi00306a019; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARDY HA, 1964, J BIOL CHEM, V12, P1961; LAWSON JE, 1990, J BIOL CHEM, V265, P14195; LESTER RL, 1967, METHOD ENZYMOL, V10, P264; Linnett P E, 1979, Methods Enzymol, V55, P472; MAYER I, 1984, BIOCHEMISTRY-US, V23, P2436, DOI 10.1021/bi00306a018; MULLER M, 1984, J BIOL CHEM, V259, P3037; NAGLEY P, 1988, TRENDS GENET, V4, P46, DOI 10.1016/0168-9525(88)90066-2; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; PENEFSKY H, 1991, ADV ENZYMOL REL AREA, V64, P173; PENEFSKY HS, 1960, J BIOL CHEM, V235, P3330; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; RACKER E, 1967, J BIOL CHEM, V242, P2547; SCHAFER G, 1980, FEBS LETT, V109, P197, DOI 10.1016/0014-5793(80)81085-4; SEBALD W, 1981, CURR TOP BIOENERG, V12, P1; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SORGATO MC, 1982, BIOCHIM BIOPHYS ACTA, V682, P184, DOI 10.1016/0005-2728(82)90133-5; SORGATO MC, 1985, FEBS LETT, V181, P323, DOI 10.1016/0014-5793(85)80285-4; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0	31	16	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25320	25328						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244963				2022-12-27	WOS:A1993MK10000010
J	CLANCEY, CJ; CHANG, SC; DOWHAN, W				CLANCEY, CJ; CHANG, SC; DOWHAN, W			CLONING OF A GENE (PSD1) ENCODING PHOSPHATIDYLSERINE DECARBOXYLASE FROM SACCHAROMYCES-CEREVISIAE BY COMPLEMENTATION OF AN ESCHERICHIA-COLI MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; YEAST; EXPRESSION; DNA; SEQUENCE; PROTEIN; PHOSPHATIDYLETHANOLAMINE; TRANSFORMATION; IDENTIFICATION; TRANSLOCATION	A gene (PSD1) encoding a phosphatidylserine decarboxylase of Saccharomyces cerevisiae was cloned by complementation of a conditional lethal mutation in the homologous gene in Escherichia coli strain EH150. Expression of the cDNA clone in EH150 corrected growth, phospholipid, and phosphatidylserine decarboxylase activity defects. Expression of the genomic clone in wild type yeast resulted in 20-fold amplification of phosphatidylserine decarboxylase activity. A 1500-base pair open reading frame encodes a 56,558-Da protein with a potential mitochondrial targeting sequence. Upstream regulatory elements found in other enzymes of the phospholipid biosynthetic pathway are present in PSD1. The derived amino acid sequence shows 44 and 35% identity with the phosphatidylserine decarboxylases from Chinese hamster ovary cells and E. coli, respectively. Near the carboxyl terminus is an LGST sequence which, in E. coli, is the site of proteolytic cleavage of the proenzyme into the alpha and beta subunits and formation of the pyruvate prosthetic group (Dowhan, W., and Li, Q.-X. (1992) Methods Enzymol. 209, 348-359). Disruption of the PSD1 gene in a haploid strain of yeast resulted in loss of detectable decarboxylase activity but little alteration of the growth properties or phospholipid composition. These results suggest that yeast has a second phosphatidylserine decarboxylation activity.	UNIV TEXAS, SCH MED, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX 77225 USA	University of Texas System					NIGMS NIH HHS [GM 35143] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035143] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOLPHUS, 1983, EMBO J, V2, P1765, DOI 10.1002/j.1460-2075.1983.tb01655.x; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CIGAN AM, 1987, GENE, V59, P1; CUMSKY MG, 1985, P NATL ACAD SCI USA, V82, P2235, DOI 10.1073/pnas.82.8.2235; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; DOWHAN W, 1992, METHOD ENZYMOL, V209, P7; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FERBEYRE G, 1993, BIOTECHNIQUES, V14, P386; FINE JB, 1982, J LIPID RES, V23, P660; GLICK B, 1991, ANNU REV GENET, V25, P21; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HENSCHKE PA, 1991, YEASTS, V4, P313; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; KODAKI T, 1991, J BIOCHEM-TOKYO, V109, P276; KODAKI T, 1991, J BACTERIOL, V173, P7992, DOI 10.1128/jb.173.24.7992-7995.1991; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; KUGE O, 1991, J BIOL CHEM, V266, P6370; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMPING E, 1991, J BACTERIOL, V173, P6432, DOI 10.1128/jb.173.20.6432-6437.1991; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; Maniatis T., 1982, MOL CLONING; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; NIKAWA JI, 1988, J BACTERIOL, V170, P4727, DOI 10.1128/jb.170.10.4727-4731.1988; NIKOLOFF DM, 1991, ANNU REV GENET, V25, P559; OVERMEYER JH, 1991, ARCH BIOCHEM BIOPHYS, V290, P511, DOI 10.1016/0003-9861(91)90574-3; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; RUSSO P, 1991, EMBO J, V10, P563, DOI 10.1002/j.1460-2075.1991.tb07983.x; Sambrook J, 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATRE M, 1978, J BIOL CHEM, V253, P479; SCHATZ G, 1987, EUR J BIOCHEM, V165, P1, DOI 10.1111/j.1432-1033.1987.tb11186.x; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SHERMAN F, 1986, LABORATORY COURSE MA, P117; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; TSUKAGOSHI Y, 1991, J BACTERIOL, V173, P2134, DOI 10.1128/jb.173.6.2134-2136.1991; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; VOELKER DR, 1991, MICROBIOL REV, V55, P543, DOI 10.1128/MMBR.55.4.543-560.1991; WARNER TG, 1975, J BIOL CHEM, V250, P8004; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; ZAGURSKY RJ, 1984, GENE, V27, P183, DOI 10.1016/0378-1119(84)90139-2; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; 1991, PROGRAM MANUAL GCG P	61	126	127	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24580	24590						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227017				2022-12-27	WOS:A1993MG67300015
J	FONT, B; AUBERTFOUCHER, E; GOLDSCHMIDT, D; EICHENBERGER, D; VANDERREST, M				FONT, B; AUBERTFOUCHER, E; GOLDSCHMIDT, D; EICHENBERGER, D; VANDERREST, M			BINDING OF COLLAGEN-XIV WITH THE DERMATAN SULFATE SIDE-CHAIN OF DECORIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL PROTEOGLYCAN; BOVINE SKIN; PROTEIN; TENDON; PURIFICATION; CARTILAGE; SEQUENCE; MOLECULE; VARIANT; MATRIX	As an approach to elucidate the role of collagen XIV, which is still unclear, molecules exhibiting affinity for this collagen have been sought in connective tissue. Extracts from fetal bovine tendon were resolved by gel electrophoresis and electrophoretically transferred to nitrocellulose. The blot was overlaid with native collagen XIV and the collagen XIV-binding molecules revealed by immunodecoration with a monoclonal antitype XIV collagen antibody. This experimental approach allowed us to reveal in tendon extracts a diffuse band, with an apparent molecular mass of approximately 100 kDa, that binds collagen XIV. This molecule was also found associated with the fractions containing partially purified type XIV collagen. This 100-kDa molecule was sensitive to chondroitinase ABC and, after chondroitinase digestion, yielded a core protein of about 48 kDa. N-terminal sequence analysis of the proteoglycan after blotting allowed us to identify it as decorin. By solid phase assays we have studied this newly described association between decorin and type XIV collagen and shown that it is a saturable process. In addition, preliminary determination of the domains of the two molecules involved in the association has been performed. The possible role of these interactions is discussed.	INST BIOL & CHEM PROT, CNRS, UNITE PROPRE RECH 412, F-69367 LYON, FRANCE; UNIV LYON 1, F-69622 VILLEURBANNE, FRANCE; ECOLE NORMALE SUPER LYON, F-69367 LYON, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)								AUBERTFOUCHER E, 1992, J BIOL CHEM, V267, P15759; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; BROWN DC, 1990, MATRIX, V9, P468, DOI 10.1016/S0934-8832(11)80016-8; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; DUBLET B, 1991, J BIOL CHEM, V266, P6853; GEOURJON C, 1991, J MOL GRAPHICS, V9, P188, DOI 10.1016/0263-7855(91)80008-N; GEOURJON C, 1993, COMPUT APPL BIOSCI, V9, P87; GERECKE DR, 1993, J BIOL CHEM, V268, P12177; GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539, DOI 10.1146/annurev.bi.55.070186.002543; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433; LUNSTRUM GP, 1992, J BIOL CHEM, V267, P20087; OLSEN BR, 1989, CONNECT TISSUE RES, V23, P115, DOI 10.3109/03008208909002411; PAN TC, 1992, P NATL ACAD SCI USA, V89, P6565, DOI 10.1073/pnas.89.14.6565; PEARSON CH, 1983, J BIOL CHEM, V258, P5101; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SCHUPPAN D, 1991, Journal of Cell Biology, V115, p106A; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; TRUEB J, 1992, EUR J BIOCHEM, V207, P549, DOI 10.1111/j.1432-1033.1992.tb17081.x; VOGEL KG, 1986, J BIOL CHEM, V261, P1334; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WALCHLI C, 1993, EUR J BIOCHEM, V212, P483, DOI 10.1111/j.1432-1033.1993.tb17685.x; WATT SL, 1992, J BIOL CHEM, V267, P20093; WHINNA HC, 1993, J BIOL CHEM, V268, P3920; YAMAGATA M, 1991, J CELL BIOL, V115, P209, DOI 10.1083/jcb.115.1.209	30	96	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25015	25018						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227064				2022-12-27	WOS:A1993MG67300074
J	JEANG, KT; BERKHOUT, B; DROPULIC, B				JEANG, KT; BERKHOUT, B; DROPULIC, B			EFFECTS OF INTEGRATION AND REPLICATION ON TRANSCRIPTION OF THE HIV-1 LONG TERMINAL REPEAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TAT PROTEIN; TRANS-ACTIVATION; PROCESSIVITY FACTOR; MUTATIONAL ANALYSIS; INDUCED EXPRESSION; NASCENT RNA; TRANSACTIVATION; TYPE-1; PROMOTER	The activity of a promoter is influenced by chromosomal and cell cycle/replication context. We analyzed the influences of integration and replication on transcription of the human immunodeficiency virus (HIV)-1 long terminal repeat (LTR). We found that one requirement for Tat trans-activated expression differed for integrated versus unintegrated HIV-1 LTR. Specifically, the second coding exon of Tat, previously regarded as functionally dispensable, plays a role in the optimal activation of integrated LTRs. We also found that the transcription profile produced from the HIV-1 LTR is influenced by replication. Autonomously replicating vectors that contain the HIV-1 LTR produced patterns of transcription different from counterpart vectors that do not replicate. Both replicating and nonreplicating HIV-1 LTRs remained responsive to Tat.			JEANG, KT (corresponding author), NIAID,MOLEC VIROL SECT,MOLEC MICROBIOL LAB,BETHESDA,MD 20892, USA.		Jeang, Kuan-Teh/A-2424-2008					ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; ALMOUZNI G, 1991, MOL CELL BIOL, V11, P655, DOI 10.1128/MCB.11.2.655; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; BERKHOUT B, 1990, NUCLEIC ACIDS RES, V18, P1839, DOI 10.1093/nar/18.7.1839; Bohan Cindy A., 1992, Gene Expression, V2, P391; BRADDOCK M, 1989, CELL, V58, P269, DOI 10.1016/0092-8674(89)90841-6; BRADDOCK M, 1991, NATURE, V350, P439, DOI 10.1038/350439a0; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; CORDINGLEY MG, 1990, P NATL ACAD SCI USA, V87, P8985, DOI 10.1073/pnas.87.22.8985; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; GREENBERG ME, 1989, CURRENT PROTOCOLS MO, P4101; Haseltine W. A., 1991, GENETIC STRUCTURE RE; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002; JEANG KT, 1992, J BIOL CHEM, V267, P17891; JEANG KT, 1988, P NATL ACAD SCI USA, V85, P8291, DOI 10.1073/pnas.85.21.8291; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KASHANCHI F, 1989, P NATL ACAD SCI USA, V87, P7030; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; KESSLER M, 1991, P NATL ACAD SCI USA, V88, P10018, DOI 10.1073/pnas.88.22.10018; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MATSUI T, 1986, MOL CELL BIOL, V6, P4149, DOI 10.1128/MCB.6.12.4149; MEYERS G, 1992, HUMAN RETROVIRUSES A; MICHAEL NL, 1991, J VIROL, V65, P1291, DOI 10.1128/JVI.65.3.1291-1303.1991; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; PROUDFOOT NJ, 1992, NEW BIOL, V4, P369; ROBINSON HL, 1990, J VIROL, V64, P4836, DOI 10.1128/JVI.64.10.4836-4841.1990; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; RUBEN S, 1989, J VIROL, V63, P1; SAKAI H, 1993, J VIROL, V67, P1169, DOI 10.1128/JVI.67.3.1169-1174.1993; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; SAVAGEAU MA, 1991, NEW BIOL, V3, P190; SELBY MJ, 1990, CELL, V62, P769, DOI 10.1016/0092-8674(90)90121-T; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SIEGEL LJ, 1986, VIROLOGY, V148, P226; SOUTHGATE C, 1990, NATURE, V345, P640, DOI 10.1038/345640a0; TOYAMA R, 1992, NUCLEIC ACIDS RES, V20, P2591, DOI 10.1093/nar/20.10.2591; VAISHNAV YN, 1991, ANNU REV BIOCHEM, V60, P577, DOI 10.1146/annurev.bi.60.070191.003045; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	56	72	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24940	24949						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227056				2022-12-27	WOS:A1993MG67300064
J	KAMBAYASHI, Y; BARDHAN, S; TAKAHASHI, K; TSUZUKI, S; INUI, H; HAMAKUBO, T; INAGAMI, T				KAMBAYASHI, Y; BARDHAN, S; TAKAHASHI, K; TSUZUKI, S; INUI, H; HAMAKUBO, T; INAGAMI, T			MOLECULAR-CLONING OF A NOVEL ANGIOTENSIN-II RECEPTOR ISOFORM INVOLVED IN PHOSPHOTYROSINE PHOSPHATASE INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AT2 BINDING-SITES; RAT-BRAIN; TYPE-1 RECEPTOR; TUMOR-CELLS; SUBTYPES; EXPRESSION; PROTEIN; IDENTIFICATION; MECHANISMS; DOMAINS	There are two major isoforms of the angiotensin II receptor, type 1 (AT1) and type 2 (AT2). AT2 is distinguished from AT1 with respect to its ligand selectivity, its insensitivity to non-hydrolyzable GTP analogues, and its as yet unidentified biological functions. In the present study we have expression-cloned AT2 cDNA from a cDNA library of a rat pheochromocytoma cell line (PC12w). Rat AT2 cDNA encodes a 363-amino acid protein that has seven transmembrane domains. AT, is the closest in homology to AT2 but with only a 32% identity of amino acid sequence. Stably expressed in COS-7 cells, the receptor showed selective binding to AT2-specific ligands PD123319 and CGP42112A but not to the AT1-specific ligand, losartan. Northern blot analysis revealed that the mRNA of rat AT2 was expressed not only in PC12w cells but also in the adrenal glands and in the inferior olive of the brain, both of which are known to contain AT2 type binding sites. The expressed AT2 receptor mediated angiotensin II-induced inhibition of protein tyrosine phosphatase, an action that was dependent on a pertussis toxin-sensitive G-protein-coupled mechanism in COS-7 cells. The AT2-specific ligand CGP42112A was an agonist rather than antagonist in the inhibition of phosphotyrosine phosphatase. AT2 did not cause a decrease in cGMP in PC12w or COS-7 cells expressing AT2 stably. These results indicate that the AT2 receptor is structurally and functionally different from AT1 and suggest novel functional roles of the renin-angiotensin system in cross-talk with phosphotyrosine signaling by modulating protein phosphotyrosine levels.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232	Vanderbilt University			Inui, Hiroshi/C-7721-2011	Tsuzuki, Satoshi/0000-0003-4385-0075	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014192, R01HL035323, T32HL007323] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35323, HL14192, HL07323] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOTTARI SP, 1991, EUR J PHARM-MOLEC PH, V207, P157, DOI 10.1016/0922-4106(91)90091-U; BOTTARI SP, 1992, BIOCHEM BIOPH RES CO, V183, P206, DOI 10.1016/0006-291X(92)91629-5; BRECHLER V, 1993, REGUL PEPTIDES, V44, P207, DOI 10.1016/0167-0115(93)90244-3; CATT KJ, 1987, J STEROID BIOCHEM, V27, P915, DOI 10.1016/0022-4731(87)90168-3; CHIU AT, 1989, BIOCHEM BIOPH RES CO, V165, P196, DOI 10.1016/0006-291X(89)91054-1; DUDLEY DT, 1991, MOL PHARMACOL, V40, P360; DUDLEY DT, 1990, MOL PHARMACOL, V38, P370; DUDLEY DT, 1991, FASEB J, V5, pA869; ELTON TS, 1992, BIOCHEM BIOPH RES CO, V184, P1067, DOI 10.1016/0006-291X(92)90700-U; FLORIO T, 1992, J BIOL CHEM, V267, P24169; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; IWAI N, 1991, BIOCHEM BIOPH RES CO, V177, P299, DOI 10.1016/0006-291X(91)91982-I; IWAI N, 1992, FEBS LETT, V298, P257, DOI 10.1016/0014-5793(92)80071-N; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JONES C, 1989, PEPTIDES, V10, P459, DOI 10.1016/0196-9781(89)90059-4; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V183, P1090, DOI 10.1016/S0006-291X(05)80302-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEUNG KH, 1992, EUR J PHARM-MOLEC PH, V227, P63, DOI 10.1016/0922-4106(92)90143-J; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; PAN MG, 1992, SCIENCE, V256, P1215, DOI 10.1126/science.256.5060.1215; PEACH MJ, 1981, BIOCHEM PHARMACOL, V30, P2745, DOI 10.1016/0006-2952(81)90410-X; PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947; ROWE BP, 1992, NEUROENDOCRINOLOGY, V55, P563, DOI 10.1159/000126177; SANDBERG K, 1992, J BIOL CHEM, V267, P9455; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5663; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SPETH RC, 1990, BIOCHEM BIOPH RES CO, V169, P997, DOI 10.1016/0006-291X(90)91993-3; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; SUMNERS C, 1991, P NATL ACAD SCI USA, V88, P7567, DOI 10.1073/pnas.88.17.7567; TANAKA I, 1984, BIOCHEM BIOPH RES CO, V124, P663, DOI 10.1016/0006-291X(84)91606-1; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TSUTSUMI K, 1992, MOL PHARMACOL, V41, P290; TSUTSUMI K, 1991, AM J PHYSIOL, V261, pR209, DOI 10.1152/ajpregu.1991.261.1.R209; WEBB ML, 1992, PEPTIDES, V13, P499, DOI 10.1016/0196-9781(92)90081-D; WHITEBREAD S, 1989, BIOCHEM BIOPH RES CO, V163, P284, DOI 10.1016/0006-291X(89)92133-5; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	38	676	681	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24543	24546						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227011				2022-12-27	WOS:A1993MG67300008
J	SARCEVIC, B; ERIKSON, E; MALLER, JL				SARCEVIC, B; ERIKSON, E; MALLER, JL			PURIFICATION AND CHARACTERIZATION OF A MITOGEN-ACTIVATED PROTEIN-KINASE TYROSINE PHOSPHATASE FROM XENOPUS EGGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MAP KINASE; SIGNAL TRANSDUCTION; HUMAN-PLACENTA; CELL-CYCLE; PHOSPHORYLATION; THREONINE; INSULIN; ACID; QUANTITIES	The mitogen-activated protein (MAP) kinases are serine-threonine protein kinases that are activated by tyrosine and threonine phosphorylation by the dual specificity protein kinase MEK (MAP kinase/ERK kinase). The present report describes the purification to near homogeneity and characterization of a protein tyrosine phosphatase from Xenopus laevis eggs that dephosphorylates MAP kinase phosphorylated by MEK. Bacterially expressed Xenopus MAP kinase phosphorylated by purified Xenopus MEK was used as substrate throughout the purification. The purification procedure included anion-exchange, cation-exchange, gel filtration, heparin-Sepharose, and chromatography on a column of thiophosphorylated MAP kinase-Sepharose, resulting in a >3000-fold purification. Upon analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a protein of 47 kDa correlated with activity. The phosphatase showed absolute specificity toward phosphotyrosine and no activity toward phosphothreonyl-phosphoseryl residues of MAP kinase. The pH optimum of the enzyme was 7.0 with a K(m) of 9.0 muM for phosphorylated MAP kinase. The phosphatase was inhibited by ammonium molybdate (IC50, 2 muM), vanadate (IC50, 250 muM), millimolar concentrations of MnCl2, ZnCl2 and p-nitrophenylphosphate but not by okadaic acid or microcystin. This tyrosine phosphatase may be involved in deactivating MAP kinase in vivo.	UNIV COLORADO, SCH MED, HOWARD HUGHES MED INST, DENVER, CO 80262 USA; UNIV COLORADO, SCH MED, DEPT PHARMACOL, DENVER, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Sarcevic, Boris/0000-0002-8063-1050				Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANDERSON NG, 1991, BIOCHEM J, V277, P573, DOI 10.1042/bj2770573; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BARRETT CB, 1992, J BIOL CHEM, V267, P4408; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; GOTOH Y, 1990, EUR J BIOCHEM, V193, P671, DOI 10.1111/j.1432-1033.1990.tb19385.x; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HAYSTEAD TAJ, 1992, FEBS LETT, V306, P17, DOI 10.1016/0014-5793(92)80828-5; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; POTTS M, 1993, J BIOL CHEM, V268, P7632; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; Ruderman JV, 1993, CURR OPIN CELL BIOL, V5, P207, DOI 10.1016/0955-0674(93)90104-X; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SETH A, 1992, J BIOL CHEM, V267, P24796; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPHO, V23, P1; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217	49	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25075	25083						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227071				2022-12-27	WOS:A1993MG67300082
J	WANG, W; SUPRENANT, K; DENTLER, WL				WANG, W; SUPRENANT, K; DENTLER, WL			REVERSIBLE ASSOCIATION OF A 97-KDA PROTEIN COMPLEX FOUND AT THE TIPS OF CILIARY MICROTUBULES WITH IN-VITRO ASSEMBLED MICROTUBULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-TUBULIN; STRUCTURAL POLARITY; DYNAMIC INSTABILITY; CAPPING STRUCTURES; KINETOCHORE MICROTUBULES; FLAGELLAR MICROTUBULES; ASPERGILLUS-NIDULANS; BACTERIAL FLAGELLA; TETRAHYMENA CILIA; MITOTIC SPINDLE	Using a human autoimmune CREST antiserum, we identified a 97-kDa polypeptide in Tetrahymena cilia at the plus ends of ciliary microtubules and mammalian kinetochores (Miller, J. M., Wang, W., Balczon, R., and Dentler, W. L. (1990) J. Cell Biol. 110, 703-714). In this study, we examined the interactions of the ciliary 97-kDa protein with microtubules assembled from purified bovine brain tubulin. The 97-kDa protein binds to microtubules and is released from them with 75 mM MgCl2, the same condition used to release it from ciliary microtubules. The 97-kDa protein-microtubule association can be disrupted by ATP and by adenosine 5'-O-(thiotriphosphate), and this ATP sensitivity requires a soluble factor in the crude 97-kDa protein fraction. Fractionation of the crude 97-kDa protein fractions by gel filtration chromatography or by sucrose gradient centrifugation causes the loss of the microtubule binding activity of the 97-kDa protein. Fractions containing a high molecular weight protein complex (molecular mass, approximately 1500-2000 kDa) from the column or gradient fractions can restore the microtubule binding ability of the 97-kDa protein. These results suggest that the 97-kDa protein is part of a high molecular weight protein complex and that the complex, not the 97-kDa protein alone, is required for the 97-kDa protein-microtubule association. The association of the 97-kDa protein with microtubules is sensitive to ATP, which suggests that the 97-kDa protein-microtubule interaction may be regulated by an ATPase(s) or protein kinase(s)/phosphatase(s).			WANG, W (corresponding author), UNIV KANSAS, DEPT PHYSIOL & CELL BIOL, LAWRENCE, KS 66045 USA.				NIGMS NIH HHS [GM32556] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032556] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGAIER J, 1988, BIOCHIM BIOPHYS ACTA, V954, P235, DOI 10.1016/0167-4838(88)90078-7; ALLEN C, 1974, J MOL BIOL, V90, P381, DOI 10.1016/0022-2836(74)90381-7; BAAS PW, 1992, J CELL BIOL, V116, P1231, DOI 10.1083/jcb.116.5.1231; BAAS PW, 1987, P NATL ACAD SCI USA, V84, P5272, DOI 10.1073/pnas.84.15.5272; BAYLEY PM, 1990, J CELL SCI, V95, P329; BERGEN LG, 1980, J CELL BIOL, V84, P141, DOI 10.1083/jcb.84.1.141; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Dentler W.L., 1990, P31; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1988, J CELL BIOL, V107, P2679, DOI 10.1083/jcb.107.6.2679; DENTLER WL, 1987, INT REV CYTOL, P391; DENTLER WL, 1980, J CELL SCI, V42, P207; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EMERSON SU, 1970, SCIENCE, V169, P190, DOI 10.1126/science.169.3941.190; EUTENEUER U, 1981, J CELL BIOL, V89, P338, DOI 10.1083/jcb.89.2.338; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; GORBSKY GJ, 1988, J CELL BIOL, V106, P1185, DOI 10.1083/jcb.106.4.1185; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; GROBSKY GJ, 1992, MOL BIOL CELL S, V3, pA344; HARLOW E, 1988, ANTIBODIES LABORATOR; HEIDEMANN SR, 1980, NATURE, V286, P517, DOI 10.1038/286517a0; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYMAN AA, 1990, J CELL BIOL, V110, P1607, DOI 10.1083/jcb.110.5.1607; IINO T, 1969, J GEN MICROBIOL, V56, P227, DOI 10.1099/00221287-56-2-227; IKEDA T, 1985, J MOL BIOL, V184, P735, DOI 10.1016/0022-2836(85)90317-1; IKEDA T, 1987, J BACTERIOL, V169, P1168, DOI 10.1128/jb.169.3.1168-1173.1987; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P306; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; KIMBLE M, 1992, INT REV CYTOL, V136, P1, DOI 10.1016/S0074-7696(08)62049-5; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LUCK DJL, 1984, J CELL BIOL, V98, P789, DOI 10.1083/jcb.98.3.789; MAEKAWA T, 1991, EUR J CELL BIOL, V54, P255; MILLER JM, 1990, J CELL BIOL, V110, P703, DOI 10.1083/jcb.110.3.703; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1988, ANNU REV CELL BIOL, V4, P527, DOI 10.1146/annurev.cellbio.4.1.527; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; MITCHSON TJ, 1987, MOD CELL BIOL, V5, P11; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; PORTMAN RW, 1987, J CELL SCI, V87, P85; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Salmon ED, 1989, MITOSIS MOL MECHANIS, P119; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; SELLITTO C, 1992, CELL MOTIL CYTOSKEL, V22, P7, DOI 10.1002/cm.970220103; SHELDEN E, 1992, J CELL BIOL, V116, P1409, DOI 10.1083/jcb.116.6.1409; SOLTYS BJ, 1985, J CELL BIOL, V100, P1682, DOI 10.1083/jcb.100.5.1682; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; SUPRENANT KA, 1988, J CELL BIOL, V107, P2259, DOI 10.1083/jcb.107.6.2259; VALDIVIA MM, 1985, J CELL BIOL, V101, P1124, DOI 10.1083/jcb.101.3.1124; Witman G.B., 1990, P1; WITMAN GB, 1975, ANN NY ACAD SCI, V253, P178, DOI 10.1111/j.1749-6632.1975.tb19199.x	58	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24796	24807						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227041				2022-12-27	WOS:A1993MG67300044
J	ATTALI, B; LESAGE, F; ZILIANI, P; GUILLEMARE, E; HONORE, E; WALDMANN, R; HUGNOT, JP; MATTEI, MG; LAZDUNSKI, M; BARHANIN, J				ATTALI, B; LESAGE, F; ZILIANI, P; GUILLEMARE, E; HONORE, E; WALDMANN, R; HUGNOT, JP; MATTEI, MG; LAZDUNSKI, M; BARHANIN, J			MULTIPLE MESSENGER-RNA ISOFORMS ENCODING THE MOUSE CARDIAC KV1-5 DELAYED RECTIFIER K+ CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT POTASSIUM CHANNELS; HUMAN LYMPHOCYTES-T; FUNCTIONAL EXPRESSION; ION CHANNELS; DEVELOPMENTAL EXPRESSION; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; RAT-BRAIN; GENE; PROTEIN	The mouse Kv1-5 K+ channel cDNA has been cloned from heart. This channel was highly expressed in heart and, to a lesser extent, in other tissues, including brain and thymus. Two alternatively spliced isoforms were found. The longer form encoded a 602-amino acid protein, while in the short form (Kv1-5DELTA5'), the first 200 amino acids lying upstream the transmembrane segment S1 were deleted. RNase protection experiments showed that both Kv1-5 mRNA isoforms are present in the mouse tissues examined, the longer form being predominant. The short mRNA (Kv1-5DELTA5') arose by an unusual splicing event within the exonic sequence. An additional short cDNA clone (Kv1-5DELTA3') that codes for a carboxyl-terminal truncated protein has been isolated. The gene coding sequence contained a single exon and has been mapped on human chromosome 12 (p13) and on mouse chromosome 6 (band F). Expression in Xenopus oocytes revealed that the long (Kv1-5) and the amino-terminal deleted (Kv1-5DELTA5') isoforms elicited similar K+ currents with a drastically decreased efficacy for Kv1-5DELTA5'. The carboxyl-terminal truncated Kv1-5DELTA3' clone was not functional but inhibited the expression of the long isoform.	INST PHARMACOL MOLEC & CELLULAIRE,660 ROUTE LUCIOLES,SOPHIA ANTIPOLIS,F-06560 VALBONNE,FRANCE; HOP ENFANTS LA TIMONE,CTR GENET MED PHYSIOPATHOL CHROMOSOM,F-13385 MARSEILLE 05,FRANCE	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			Lesage, Florian/D-5097-2011; Lesage, Florian/P-9780-2019; Waldmann, Rainer/Q-2108-2016	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; Waldmann, Rainer/0000-0002-4599-2926; HONORE, Eric/0000-0002-8007-0919				ALDRICH R, 1993, NATURE, V362, P107, DOI 10.1038/362107a0; ATTALI B, 1992, J BIOL CHEM, V267, P8650; ATTALI B, 1992, FEBS LETT, V303, P229, DOI 10.1016/0014-5793(92)80526-M; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BLUMENTHAL EM, 1992, NEUROCHEM RES, V17, P869, DOI 10.1007/BF00993262; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOK NS, 1989, POTASSIUM CHANNELS S, P182; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; CURRAN ME, 1992, GENOMICS, V12, P729, DOI 10.1016/0888-7543(92)90302-9; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; FISBURN CS, 1993, J BIOL CHEM, V268, P5872; GISSELMANN G, 1989, EMBO J, V8, P2359, DOI 10.1002/j.1460-2075.1989.tb08364.x; GRISSMER S, 1992, J BIOL CHEM, V267, P20971; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GUILLEMARE E, 1992, BIOCHEMISTRY-US, V31, P12463, DOI 10.1021/bi00164a024; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOGER JH, 1991, NEURON, V6, P227, DOI 10.1016/0896-6273(91)90358-7; HONORE E, 1992, EMBO J, V11, P2465, DOI 10.1002/j.1460-2075.1992.tb05311.x; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; KACZMAREK LK, 1991, NEW BIOL, V3, P315; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUOB Y, 1993, NATURE, V362, P127; LESAGE F, 1992, FEBS LETT, V310, P162, DOI 10.1016/0014-5793(92)81320-L; LEWIS RS, 1988, TRENDS NEUROSCI, V11, P214, DOI 10.1016/0166-2236(88)90129-4; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; MCPHERSON JD, 1991, CYTOGENET CELL GENET, V58, P1979; MORAN O, 1992, FEBS LETT, V302, P21, DOI 10.1016/0014-5793(92)80275-L; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; OKADA H, 1992, BIOCHEM BIOPH RES CO, V189, P430, DOI 10.1016/0006-291X(92)91576-C; PHILIPSON LH, 1991, P NATL ACAD SCI USA, V88, P53, DOI 10.1073/pnas.88.1.53; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROBERDS SL, 1991, FEBS LETT, V284, P152, DOI 10.1016/0014-5793(91)80673-Q; RUDY B, 1991, Molecular and Cellular Neuroscience, V2, P89, DOI 10.1016/1044-7431(91)90001-5; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; SPENCER R, 1992, FASEB J, V6, pA378; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TAMKUN MM, 1991, FASEB J, V5, P331, DOI 10.1096/fasebj.5.3.2001794; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0	51	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24283	24289						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226976				2022-12-27	WOS:A1993MF29400085
J	BLASCO, MA; LAZARO, JM; BLANCO, L; SALAS, M				BLASCO, MA; LAZARO, JM; BLANCO, L; SALAS, M			PHI-29 DNA-POLYMERASE ACTIVE-SITE - RESIDUE ASP(249) OF CONSERVED AMINO-ACID MOTIF DX(2)SLYP IS CRITICAL FOR SYNTHETIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; TERMINAL PROTEIN; ESCHERICHIA-COLI; REVERSE-TRANSCRIPTASE; DIRECTED MUTAGENESIS; EXONUCLEASE ACTIVITY; SECONDARY-STRUCTURE; DNTP BINDING; VIRUS; MUTANTS	Phi29 DNA polymerase shares with other alpha-like DNA polymerases several regions of amino acid sequence similarity and sensitivity to inhibitors of eukaryotic DNA polymerase alpha. In this paper, site-directed mutants in the phi29 DNA polymerase residues Asp249, Ser252, Leu253, and Pro255 of the conserved amino acid motif ''Dx2SLYP'' are described. Two mutants, D249E and S252R, were drastically affected in all the synthetic activities, whereas their 3' to 5' exonuclease activity and interaction with the TP primer was normal. Mutant D249E, slightly affected in template-primer binding, was completely inactive in all conditions tested, suggesting that Asp249 Could be playing a direct role in catalysis. On the other hand, mutant S252R, strongly affected in template-primer binding, showed some DNA polymerization activity in the presence of Mn2+. Mutants S252G and P255S showed a reduced template-primer binding ability; these mutants, together with mutant L253V, showed metal ion-dependent phenotypes in their synthetic activities and altered sensitivities to the PP(i) analog phosphonoacetic acid. All these results support the hypothesis that the Dx2SLYP motif forms part of the polymerization active site of the phi29 DNA polymerase, being the Asp249 residue critical both for protein-primed initiation and DNA polymerization.	UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC SEVERO OCHOA,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Salas, Margarita/J-9873-2014; Blasco, Maria A./M-1694-2014	Salas, Margarita/0000-0001-5939-3441; Blasco, Maria A./0000-0002-4211-233X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER; NIGMS NIH HHS [5R01 GM27242-13] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNAD A, 1987, EMBO J, V6, P4219, DOI 10.1002/j.1460-2075.1987.tb02770.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BERNAD A, 1990, P NATL ACAD SCI USA, V87, P4610, DOI 10.1073/pnas.87.12.4610; BLANCO L, 1985, NUCLEIC ACIDS RES, V13, P1239, DOI 10.1093/nar/13.4.1239; BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BLANCO L, 1986, VIROLOGY, V153, P179, DOI 10.1016/0042-6822(86)90021-8; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; BLANCO L, 1992, J BIOL CHEM, V267, P1225; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; BLASCO MA, 1993, J BIOL CHEM, V268, P16763; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; BLASCO MA, 1990, NUCLEIC ACIDS RES, V18, P4763; BLASCO MA, 1992, CHROMOSOMA, V102, P32; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBBS JS, 1988, P NATL ACAD SCI USA, V85, P6672, DOI 10.1073/pnas.85.18.6672; HALL JD, 1989, NUCLEIC ACIDS RES, V17, P9231, DOI 10.1093/nar/17.22.9231; HWANG CBC, 1992, J VIROL, V66, P1774, DOI 10.1128/JVI.66.3.1774-1776.1992; INCIARTE MR, 1976, VIROLOGY, V74, P314, DOI 10.1016/0042-6822(76)90338-X; INOKUCHI Y, 1987, J VIROL, V61, P3946, DOI 10.1128/JVI.61.12.3946-3949.1987; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; JABLONSKI SA, 1991, J VIROL, V65, P4565, DOI 10.1128/JVI.65.9.4565-4572.1991; JUNG GH, 1990, BIOCHEM BIOPH RES CO, V170, P1294, DOI 10.1016/0006-291X(90)90534-T; LARDER BA, 1987, EMBO J, V6, P169, DOI 10.1002/j.1460-2075.1987.tb04735.x; LARDER BA, 1989, P NATL ACAD SCI USA, V86, P4803, DOI 10.1073/pnas.86.13.4803; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; MARCY AI, 1990, J VIROL, V64, P5883, DOI 10.1128/JVI.64.12.5883-5890.1990; MATSUMOTO K, 1990, VIROLOGY, V178, P337, DOI 10.1016/0042-6822(90)90416-O; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; OSUMIDAVIS PA, 1992, J MOL BIOL, V226, P37, DOI 10.1016/0022-2836(92)90122-Z; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; REHAKRANTZ LJ, 1993, J VIROL, V67, P60, DOI 10.1128/JVI.67.1.60-66.1993; RIBAS JC, 1992, P NATL ACAD SCI USA, V89, P2185, DOI 10.1073/pnas.89.6.2185; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SANKAR S, 1992, J BIOL CHEM, V267, P10168; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WATABE K, 1984, BIOCHEM BIOPH RES CO, V123, P1019, DOI 10.1016/S0006-291X(84)80235-1; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; ZABALLOS A, 1989, GENE, V83, P187, DOI 10.1016/0378-1119(89)90104-2	49	46	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24106	24113						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226957				2022-12-27	WOS:A1993MF29400061
J	PORTER, DJT; AUSTIN, EA				PORTER, DJT; AUSTIN, EA			CYTOSINE DEAMINASE - THE ROLES OF DIVALENT METAL-IONS IN CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ADENOSINE-DEAMINASE; PURIFICATION; 5-FLUOROCYTOSINE; COMPOUND; GENE	Cytosine deaminase (CDase, EC 3.5.4.1) isolated from Escherichia coli contains a catalytically essential divalent metal ion. Fe2+ was efficiently removed from the enzyme with o-phenanthroline to yield an apoenzyme with less than 5% of the catalytic activity of native enzyme. The time courses for inactivation and for removal of Fe2+ from the enzyme by o-phenanthroline were similar. Apoenzyme reconstituted with Fe2+, Mn2+, Co2+, or Zn2+ (M2+CDase) had k(cat) values of 185, 88, 50, and 32 s-1, respectively. The K(m) values of these M2+CDases for cytosine were similar (0.22-0.39 mM). Cytosine potently inhibited reconstitution of the apoenzyme with Fe2+. Fe2+CDase was rapidly inactivated by 1 mM H2O2 (t1/2 < 1 s), whereas Mn2+CDase, Co2+CDase, and Zn2+CDase were not inactivated by H2O2. CDase was also inhibited by excess divalent cations. Cu2+ and Zn2+ reversibly inhibited Fe2+CDase activity with inhibition constants of 1.8 and 5.8 muM, respectively. Cu2+ dissociated slowly from the secondary binding on CDase with a rate constant of 2 x 10(-3) s-1.	WELLCOME RES LABS,DEPT CELL BIOL,RES TRIANGLE PK,NC 27709	Wellcome Research Laboratories	PORTER, DJT (corresponding author), WELLCOME RES LABS,DIV EXPTL THERAPY,3030 CORNWALLIS RD,RES TRIANGLE PK,NC 27709, USA.							AUSTIN EA, 1993, MOL PHARMACOL, V43, P380; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DANIELSEN S, 1992, MOL MICROBIOL, V6, P1335, DOI 10.1111/j.1365-2958.1992.tb00854.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; KATSURAGI T, 1989, AGR BIOL CHEM TOKYO, V53, P1313, DOI 10.1080/00021369.1989.10869490; KATSURAGI T, 1986, AGR BIOL CHEM TOKYO, V50, P1721, DOI 10.1080/00021369.1986.10867657; KURZ LC, 1992, BIOCHEMISTRY-US, V31, P39, DOI 10.1021/bi00116a008; MULLEN CA, 1992, P NATL ACAD SCI USA, V89, P33, DOI 10.1073/pnas.89.1.33; NISHIYAMA T, 1985, CANCER RES, V45, P1753; ROMAN R, 1972, BIOCHEMISTRY-US, V11, P2076, DOI 10.1021/bi00761a013; SAKAI T, 1975, AGR BIOL CHEM TOKYO, V39, P1623, DOI 10.1080/00021369.1975.10861834; SAKAI T, 1975, AGR BIOL CHEM TOKYO, V39, P2015, DOI 10.1080/00021369.1975.10861902; STEER PL, 1972, ANN INTERN MED, V76, P15, DOI 10.7326/0003-4819-76-1-15; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WEST TP, 1982, BIOCHIM BIOPHYS ACTA, V719, P251, DOI 10.1016/0304-4165(82)90096-4; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YANG C, 1992, BIOCHEMISTRY-US, V31, P4168, DOI 10.1021/bi00132a003; YU TS, 1991, J FERMENT BIOENG, V72, P266, DOI 10.1016/0922-338X(91)90161-9	19	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24005	24011						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226944				2022-12-27	WOS:A1993MF29400047
J	RYAN, KR; JENSEN, RE				RYAN, KR; JENSEN, RE			MAS6P CAN BE CROSS-LINKED TO AN ARRESTED PRECURSOR AND INTERACTS WITH OTHER PROTEINS DURING MITOCHONDRIAL PROTEIN IMPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CYTOCHROME C1 PRESEQUENCE; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; INNER MEMBRANE; MATRIX; CLEAVAGE; SUFFICIENT; SITE	Mas6p is an integral membrane protein of the yeast mitochondrial inner membrane, which is essential for mitochondrial protein import (1). To determine whether Mas6p is directly involved in recognizing precursors or translocating them across the inner membrane, we asked if Mas6p was in close proximity to precursor proteins being imported into mitochondria. We report here that Mas6p can be chemically cross-linked to an imported protein arrested in transit through the mitochondrial inner membrane. Antiserum to Mas6p specifically immunoprecipitates one of several different mitochondrial proteins that are cross-linked to blocked precursors. Our results strongly suggest that Mas6p physically interacts with precursors during their translocation into the matrix. In addition, at least two other mitochondrial proteins that are each cross-linked to arrested precursors can be coimmunoprecipitated along with Mas6p under non-denaturing conditions. These observations provide evidence for a complex of proteins including Mas6p, each of which interacts with mitochondrial precursors during import.	JOHNS HOPKINS UNIV, SCH MED, DEPT CELL BIOL & ANAT, 725 N WOLFE ST, BALTIMORE, MD 21205 USA	Johns Hopkins University					NIGMS NIH HHS [1-RO1-GM46803, GM07309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BOHNI PC, 1983, J BIOL CHEM, V258, P4937; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; DAUM G, 1982, J BIOL CHEM, V257, P3028; EMTAGE JLT, 1993, J CELL BIOL, V122, P1003, DOI 10.1083/jcb.122.5.1003; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; HURT EC, 1984, FEBS LETT, V178, P306, DOI 10.1016/0014-5793(84)80622-5; HWANG S, 1989, J CELL BIOL, V109, P487, DOI 10.1083/jcb.109.2.487; HWANG ST, 1991, J BIOL CHEM, V266, P21083; JENSEN RE, 1992, MOL CELL BIOL, V12, P4677, DOI 10.1128/MCB.12.10.4677; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; MASON TL, 1973, J BIOL CHEM, V248, P1346; MCADA PC, 1982, J BIOL CHEM, V257, P3177; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; ROSE MD, 1988, METHODS YEAST GENETI; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; SHERMAN F, 1964, GENETICS, V49, P39; Sherman F., 1982, METHODS YEAST GENETI; SMITH BL, 1991, J BIOL CHEM, V266, P6407; VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9	26	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23743	23746						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226901				2022-12-27	WOS:A1993MF29400003
J	DRISCOLL, WJ; MARTIN, BM; CHEN, HC; STROTT, CA				DRISCOLL, WJ; MARTIN, BM; CHEN, HC; STROTT, CA			ISOLATION OF 2 DISTINCT 3-HYDROXYSTEROID SULFOTRANSFERASES FROM THE GUINEA-PIG ADRENAL - EVIDENCE FOR 3-ALPHA-HYDROXY VERSUS 3-BETA-HYDROXY STEREOSPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNENOLONE-BINDING PROTEIN; ESTROGEN SULFOTRANSFERASE; POLYACRYLAMIDE GELS; RAT-LIVER; PURIFICATION; PHOSPHORYLATION; ANDROSTERONE	Two physically distinct hydroxysteroid sulfotransferases (HSTs) that demonstrate substrate specificity with respect to the orientation of the ring A 3-hydroxyl group have been isolated from the guinea pig adrenal gland. Nondenaturing liquid-phase isoelectric focusing permitted the separation of the activities, and reverse phase high performance liquid chromatography was used to purify the two proteins to homogeneity. The 3beta-HST had an apparent molecular mass of 33 kDa and utilized pregnenolone, 17-hydroxypregnenolone, and dehydroepiandrosterone as substrates. The 3alpha-HST was slightly smaller at 32 kDa and utilized allopregnanolone and androsterone as substrates. The proteins were further distinguished by isoelectric point, immunoreactivity, and tryptic peptide mapping. Peptides isolated from both guinea pig HSTs demonstrated significant amino acid sequence homology (approximately 65% identity) to rat liver HST; however, available sequence data from the two proteins did not yield differences that might account for their stereospecific substrate selectivity. This paper represents the first definitive report demonstrating the existence of discrete HSTs that exhibit substrate specificity based on the stereochemistry of the 3-hydroxyl group.	NICHHD,ENDOCRINOL & REPROD RES BRANCH,ADRENAL CELL BIOL SECT,BETHESDA,MD 20892; NICHHD,ENDOCRINOL & REPROD RES BRANCH,MOLEC STRUCT & PROT CHEM,BETHESDA,MD 20892; NIMH,CLIN NEUROSCI BRANCH,MOLEC NEUROGENET SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)								ADAMS JB, 1988, MOL CELL ENDOCRINOL, V58, P231, DOI 10.1016/0303-7207(88)90159-1; ADAMS JB, 1974, BIOCHIM BIOPHYS ACTA, V370, P160, DOI 10.1016/0005-2744(74)90042-4; ADAMS JB, 1979, BIOCHIM BIOPHYS ACTA, V567, P144, DOI 10.1016/0005-2744(79)90181-5; Baird D T, 1969, Recent Prog Horm Res, V25, P611; BROOKS SC, 1978, J TOXICOL ENV HEALTH, V4, P283, DOI 10.1080/15287397809529662; DRISCOLL WJ, 1991, MOL ENDOCRINOL, V5, P1229, DOI 10.1210/mend-5-9-1229; FALANY CN, 1991, TRENDS PHARMACOL SCI, V12, P255, DOI 10.1016/0165-6147(91)90566-B; FALANY CN, 1989, BIOCHEM J, V260, P641, DOI 10.1042/bj2600641; FREEMAN DJ, 1983, J STEROID BIOCHEM, V18, P23, DOI 10.1016/0022-4731(83)90325-4; GLASIER MA, 1992, STEROIDS, V57, P295; HOBKIRK R, 1990, BIOCHEM J, V268, P759, DOI 10.1042/bj2680759; HOBKIRK R, 1985, CAN J BIOCHEM CELL B, V63, P1127, DOI 10.1139/o85-141; HOMMA H, 1991, CHEM PHARM BULL, V39, P1499; HUXTABLE RJ, 1986, BIOCH SULFUR, P316; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YC, 1990, P NATL ACAD SCI USA, V87, P2003, DOI 10.1073/pnas.87.5.2003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUI M, 1982, BIOCHEM J, V204, P441, DOI 10.1042/bj2040441; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Mulder G.J., 1990, CONJUGATION REACTION, P107; OGURA K, 1989, BIOCHEM BIOPH RES CO, V165, P168, DOI 10.1016/0006-291X(89)91050-4; OHL VS, 1977, ARCH BIOCHEM BIOPHYS, V180, P186, DOI 10.1016/0003-9861(77)90024-8; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; ROBERTS KD, 1970, CHEM BIOL ASPECTS ST, P219; Roy A.B., 1981, SULFATION DRUGS RELA, P83; SIGEL MB, 1983, METHOD ENZYMOL, V93, P3; STROTT CA, 1983, J STEROID BIOCHEM, V18, P489, DOI 10.1016/0022-4731(83)90070-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Webb E. C., 1992, ENZYME NOMENCLATURE	29	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23496	23503						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226877				2022-12-27	WOS:A1993MF51500083
J	KONG, HY; RAYNOR, K; YASUDA, K; MOE, ST; PORTOGHESE, PS; BELL, GI; REISINE, T				KONG, HY; RAYNOR, K; YASUDA, K; MOE, ST; PORTOGHESE, PS; BELL, GI; REISINE, T			A SINGLE RESIDUE, ASPARTIC ACID-95, IN THE DELTA-OPIOID RECEPTOR SPECIFIES SELECTIVE HIGH-AFFINITY AGONIST BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CLONING; IDENTIFICATION; NALTRINDOLE; ANTAGONIST; PEPTIDES; SODIUM	The enkephalins, dynorphins, and endorphins are endogenous opioids which function as neurotransmitters, neuromodulators, and hormones and are involved in the perception of pain, modulation of behavior, and regulation of autonomic and neuroendocrine function. Pharmacological studies have defined three classes of opioid receptors, designated as delta, kappa, and mu. To investigate mechanisms by which agonists and antagonists interact with the delta opioid receptor, we have substituted aspartic acid 95 in the transmembrane segment 2 of the cloned mouse delta opioid receptor with an asparagine (D95N). The D95N mutant receptor had reduced affinity for delta receptor-selective agonists such as enkephalin, [D-Pen2,D-Pen5]enkephalin and [D-Ser2,Leu5]enkephalin-Thr6 such that it did not bind these peptides even at micromolar concentrations. The binding of delta-selective non-peptide agonists was also reduced. In contrast, the delta receptor-selective antagonists, such as naltrindole, the benzofuran analog of naltrindole, and 7-benyllidenenaltrexone, bound equally well to the wild-type and mutant receptor. Similarly, non-selective opioid agonists such as bremazocine and buprenorphine, which interact with delta, kappa, and mu opioid receptors, showed no difference in binding to the wild-type and mutant delta receptor. The D95N mutant remained coupled to G proteins, and the receptor was functionally active since it mediated agonist inhibition of cAMP accumulation. These results indicate that selective agonists and antagonists bind differently to the delta receptor and show that Asp-95 contributes to high affinity delta-selective agonist binding. The identification of a key residue involved in selective agonist binding to the delta opioid receptor will facilitate the development of novel therapeutic reagents that can be used for the treatment of chronic pain and other conditions.	UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV MINNESOTA,DEPT MED CHEM,MINNEAPOLIS,MN 55455	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities	KONG, HY (corresponding author), UNIV PENN,SCH MED,DEPT PHARMACOL,36TH ST & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048518] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48518, MH45533] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARAKAWA K, 1992, TRANSPLANTATION, V53, P952; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; COWAN A, 1993, IN PRESS BUPRENORPHI; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FROEHLICH J, 1991, RES SOC ALCOHOLISM S; GACEI G, 1980, FEBS LETT, V118, P245, DOI 10.1016/0014-5793(80)80229-8; GILMAN AG, 1990, PHARMACOL BASIS, P485; HERZ A, 1993, OPIOIDS, V1, P6; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KONG H, 1993, IN PRESS MOL PHARM; KOOB G, 1992, SCIENCE, V242, P715; LEE PH, 1992, INT NARCOTICS RES C; MENKENS K, 1992, EUR J PHARMACOL, V219, P345, DOI 10.1016/0014-2999(92)90319-Y; MOSBERG HI, 1983, P NATL ACAD SCI-BIOL, V80, P5871, DOI 10.1073/pnas.80.19.5871; PERT CB, 1974, MOL PHARMACOL, V10, P868; PORTOGHESE PS, 1992, EUR J PHARMACOL, V218, P195, DOI 10.1016/0014-2999(92)90167-3; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SOFUOGLU M, 1991, J PHARMACOL EXP THER, V257, P676; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736; YASUDA K, 1992, J BIOL CHEM, V267, P20422	23	176	180	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23055	23058						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226821				2022-12-27	WOS:A1993MF51500017
J	LAVALLIE, ER; REHEMTULLA, A; RACIE, LA; DIBLASIO, EA; FERENZ, C; GRANT, KL; LIGHT, A; MCCOY, JM				LAVALLIE, ER; REHEMTULLA, A; RACIE, LA; DIBLASIO, EA; FERENZ, C; GRANT, KL; LIGHT, A; MCCOY, JM			CLONING AND FUNCTIONAL EXPRESSION OF A CDNA-ENCODING THE CATALYTIC SUBUNIT OF BOVINE ENTEROKINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE CHAIN-REACTION; BLOOD-COAGULATION FACTOR; 4 TANDEM REPEATS; ESCHERICHIA-COLI; ENZYMATIC AMPLIFICATION; PORCINE ENTEROKINASE; PLASMA PREKALLIKREIN; DNA INVITRO; SEQUENCE; PURIFICATION	Enterokinase (enteropeptidase) is a heterodimeric serine protease that is responsible for the physiological activation of trypsinogen by highly specific cleavage of the trypsinogen activation peptide following the sequence (Asp)4-Lys. In this paper, we report the cloning and functional expression of a cDNA encoding the catalytic domain (light chain) of bovine enterokinase. The nucleotide sequence of this cloned cDNA predicts a 235-amino acid polypeptide that shares a high degree of homology with a variety of mammalian serine proteases involved in digestion, coagulation, and fibrinolysis. We have developed a novel expression method for the enzyme which utilizes the secretory leader and propeptide of the mammalian serine protease PACE fused to the enterokinase light chain amino terminus. Efficient cleavage of the paired dibasic amino acid cleaving enzyme (PACE) propeptide was achieved by coexpression with human PACE or yeast KEX2. The mature product migrates at 43,000 Da on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, comparable to light chain derived from bovine duodena, and exhibited high levels of activity in cleaving the enterokinase-specific fluorogenic substrate Gly(Asp)4-Lys-beta-naphthylamide. The recombinant single-chain form of enterokinase was also capable of activating trypsinogen, indicating that the specificity of the enzyme for its natural substrate is retained even in the absence of the noncatalytic enterokinase heavy chain.	PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus	LAVALLIE, ER (corresponding author), GENET INST INC,DEPT MICROBIOL,87 CAMBRIDGE PK DR,CAMBRIDGE,MA 02140, USA.							ABITA JP, 1969, EUR J BIOCHEM, V8, P314, DOI 10.1111/j.1432-1033.1969.tb00530.x; BARATTI J, 1976, BIOCHIM BIOPHYS ACTA, V452, P488, DOI 10.1016/0005-2744(76)90199-6; BARATTI J, 1973, BIOCHIM BIOPHYS ACTA, V315, P147, DOI 10.1016/0005-2744(73)90138-1; BEAUBIEN G, 1991, BIOCHEMISTRY-US, V30, P1628, DOI 10.1021/bi00220a027; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BRICTEUX.S, 1972, COMP BIOCHEM PHYSIOL, V42, P23, DOI 10.1016/0305-0491(72)90055-7; BROWN JR, 1966, BIOCHEM J, V101, P214, DOI 10.1042/bj1010214; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COOL DE, 1987, J BIOL CHEM, V262, P13662; DAVIE EW, 1955, J BIOL CHEM, V212, P515; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; DYKES CW, 1988, EUR J BIOCHEM, V174, P411, DOI 10.1111/j.1432-1033.1988.tb14113.x; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; FONSECA P, 1983, J BIOL CHEM, V258, P4516; FORSBERG G, 1992, J PROTEIN CHEM, V11, P201, DOI 10.1007/BF01025226; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; GRANT DAW, 1976, BIOCHEM J, V155, P243, DOI 10.1042/bj1550243; GRANT DAW, 1979, BIOCHIM BIOPHYS ACTA, V567, P207, DOI 10.1016/0005-2744(79)90187-6; HARLOW E, 1988, ANTIBODIES LAB MANUA, P92; HERMONTAYLOR J, 1977, GUT, V18, P259, DOI 10.1136/gut.18.4.259; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KAWASHIMA I, 1987, DNA-J MOLEC CELL BIO, V6, P163, DOI 10.1089/dna.1987.6.163; Kunitz M, 1939, J GEN PHYSIOL, V22, P447, DOI 10.1085/jgp.22.4.447; Kunitz M, 1939, J GEN PHYSIOL, V22, P429, DOI 10.1085/jgp.22.4.429; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; LEHEUROU I, 1990, EUR J BIOCHEM, V193, P767; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1037; LIEPNIEKS JJ, 1979, J BIOL CHEM, V254, P1677; LIGHT A, 1989, TRENDS BIOCHEM SCI, V14, P110, DOI 10.1016/0968-0004(89)90133-3; LIGHT A, 1991, J PROTEIN CHEM, V10, P475, DOI 10.1007/BF01025475; LIGHT A, 1984, J BIOL CHEM, V259, P3195; MAGEE AI, 1977, BIOCHEM J, V165, P583, DOI 10.1042/bj1650583; MAROUX S, 1971, J BIOL CHEM, V246, P5031; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; MIKES O, 1966, BIOCHEM BIOPH RES CO, V24, P346, DOI 10.1016/0006-291X(66)90162-8; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OHARA PJ, 1987, P NATL ACAD SCI USA, V84, P5158, DOI 10.1073/pnas.84.15.5158; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Rehemtulla Alnawaz, 1992, Current Opinion in Biotechnology, V3, P560, DOI 10.1016/0958-1669(92)90086-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAIKI RK, 1985, SCIENCE, V150, P1; Sambrook J, 1989, MOL CLONING LABORATO; SEIDAH NG, 1990, DNA CELL BIOL, V9, P737, DOI 10.1089/dna.1990.9.737; TSUJI A, 1991, J BIOL CHEM, V266, P16948; TSUJI A, 1991, BIOMED BIOCHIM ACTA, V50, P791; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; YAMASHINA I, 1956, BIOCHIM BIOPHYS ACTA, V20, P433, DOI 10.1016/0006-3002(56)90329-8; YAMASHINA I, 1956, ACTA CHEM SCAND, V10, P739, DOI 10.3891/acta.chem.scand.10-0739; 1985, EUR J BIOCHEM, V150, P1	56	107	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23311	23317						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226855				2022-12-27	WOS:A1993MF51500057
J	TSUNESHIGE, A; ZHOU, YX; YONETANI, T				TSUNESHIGE, A; ZHOU, YX; YONETANI, T			OXYGEN EQUILIBRIUM STUDIES OF CROSS-LINKED IRON-COBALT HYBRID HEMOGLOBINS - MODELS FOR PARTIALLY LIGATED INTERMEDIATES OF COBALT HEMOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; COOPERATIVE FREE-ENERGIES; EXPERIMENTAL RESOLUTION; QUATERNARY STRUCTURE; CARBON-MONOXIDE; MOLECULAR CODE; COBALTOHEMOGLOBIN; COBOGLOBINS; MYOGLOBINS; LINKAGE	To probe the molecular mechanism of allosteric function of cobaltous protoporphyrin-substituted hemoglobin (CoHb), a series of alpha, alpha-cross-linked symmetric and asymmetric Fe-Co hybrid hemoglobins, which contain (1Co porphyrin/3Fe porphyrins), (2Co porphyrins/2Fe porphyrins), and (3Co porphyrins/1Fe porphyrin) per tetramer, have been prepared. Because only Fe porphyrin-containing subunits react with CO, these Fe-Co hybrids are converted to mono-, di-, and tri-CO-ligated states in the presence of CO, respectively, and are proposed to stand as models for mono-, di-, and tri-ligated intermediates of CoHb, respectively. The oxygen binding properties of these Fe-Co hybrids were investigated by measuring oxygen binding isotherms in the presence of CO as a function of pH in the presence and absence of IHP. The ligation of CO to a beta subunit causes larger changes in the oxygen affinity and the Bohr effect than that to an alpha subunit, indicating that the ligation to a beta subunit induces larger affinity-related structural changes in cross-linked CoHb. Di- and tri-CO-ligated intermediates exhibited substantially increased oxygen affinity, reduced Bohr effect, and reduced IHP effect, indicating that they are in high affinity states. Calculation of the Adair equilibrium constants for the first and last oxygenation steps for each of these intermediates permitted the determination of the level of free energy of cooperation. The intermediately ligated species of cross-linked CoHb are distributed in multiple levels of free energy of cooperation within the free energy difference of 1.14 kcal mol-1 between deoxy and fully ligated states of cross-linked CoHb at pH 7.4. The ligation process in CoHb is determined by the number and distribution of the bound ligands, and ligation takes place through steps that require minimal free energy changes.	UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; TSING HUA UNIV,DEPT BIOL SCI & BIOTECHNOL,BEIJING 100084,PEOPLES R CHINA	University of Pennsylvania; Tsinghua University					NHLBI NIH HHS [HL14508] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL014508, R37HL014508] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; Adair GS, 1925, J BIOL CHEM, V63, P529; ARNONE A, 1974, NATURE, V249, P34, DOI 10.1038/249034a0; BERMAN M, 1971, ARCH BIOCHEM BIOPHYS, V145, P236; BRUNORI M, 1970, J MOL BIOL, V34, P357; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CASSOLY R, 1972, J BIOL CHEM, V247, P7332; CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929; DAUGHERTY MA, 1991, P NATL ACAD SCI USA, V88, P1110, DOI 10.1073/pnas.88.4.1110; DICKINSON LC, 1973, J BIOL CHEM, V248, P5005; DOYLE ML, 1991, BIOCHEMISTRY-US, V30, P7263, DOI 10.1021/bi00243a031; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; FUJII M, 1993, J BIOL CHEM, V268, P15386; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HOFFMAN BM, 1970, P NATL ACAD SCI USA, V67, P637, DOI 10.1073/pnas.67.2.637; HSU GC, 1972, P NATL ACAD SCI USA, V69, P2122, DOI 10.1073/pnas.69.8.2122; IKEDASAITO M, 1978, J BIOL CHEM, V253, P7134; IKEDASAITO M, 1980, J MOL BIOL, V138, P845, DOI 10.1016/0022-2836(80)90068-6; IKEDASAITO M, 1977, J BIOL CHEM, V252, P8639; IMAI K, 1977, J MOL BIOL, V109, P83, DOI 10.1016/S0022-2836(77)80047-8; IMAI K, 1981, BIOCHIM BIOPHYS ACTA, V668, P1, DOI 10.1016/0005-2795(81)90143-4; IMAI K, 1973, BIOCHEMISTRY-US, V12, P798, DOI 10.1021/bi00729a003; IMAI K, 1977, BIOCHIM BIOPHYS ACTA, V490, P164, DOI 10.1016/0005-2795(77)90116-7; Imai K., 1982, ALLOSTERIC EFFECTS H; INUBUSHI T, 1986, J AM CHEM SOC, V108, P3799, DOI 10.1021/ja00273a040; JOHNSON ME, 1974, BIOCHEMISTRY-US, V13, P3653, DOI 10.1021/bi00715a005; KILMARTIN JV, 1977, TRENDS BIOCHEM SCI, V2, P247, DOI 10.1016/0968-0004(77)90214-6; KILMARTIN JV, 1973, P NATL ACAD SCI USA, V70, P1246, DOI 10.1073/pnas.70.4.1246; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LINDSTROM TR, 1972, P NATL ACAD SCI USA, V69, P1707, DOI 10.1073/pnas.69.7.1707; MIURA S, 1984, BIOCHEMISTRY-US, V23, P2492, DOI 10.1021/bi00306a027; MIURA S, 1987, BIOCHEMISTRY-US, V26, P2149, DOI 10.1021/bi00382a013; MIURA S, 1982, BIOCHEMISTRY-US, V21, P6280, DOI 10.1021/bi00267a037; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NISHIKURA K, 1978, Biochemical Journal, V173, P651; OGAWA S, 1972, J MOL BIOL, V70, P315, DOI 10.1016/0022-2836(72)90542-6; PERRELLA M, 1992, J BIOL CHEM, V267, P8744; PERRELLA M, 1990, BIOPHYS CHEM, V35, P97, DOI 10.1016/0301-4622(90)80064-E; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; SAROFF HA, 1972, SCIENCE, V175, P1253, DOI 10.1126/science.175.4027.1253; SHIBAYAMA N, 1987, BIOCHEMISTRY-US, V26, P2194, DOI 10.1021/bi00382a019; SMITH FR, 1985, P NATL ACAD SCI USA, V82, P5347, DOI 10.1073/pnas.82.16.5347; SMITH FR, 1987, P NATL ACAD SCI USA, V84, P7089, DOI 10.1073/pnas.84.20.7089; SPEROS PC, 1991, BIOCHEMISTRY-US, V30, P7254, DOI 10.1021/bi00243a030; WALDER JA, 1979, BIOCHEMISTRY-US, V18, P4265, DOI 10.1021/bi00587a001; WILLIAMS RC, 1973, ANAL BIOCHEM, V54, P137, DOI 10.1016/0003-2697(73)90256-X; YONETANI T, 1974, J BIOL CHEM, V249, P682	49	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23031	23040						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226818				2022-12-27	WOS:A1993MF51500014
J	ALLEGRETTO, EA; MCCLURG, MR; LAZARCHIK, SB; CLEMM, DL; KERNER, SA; ELGORT, MG; BOEHM, MF; WHITE, SK; PIKE, JW; HEYMAN, RA				ALLEGRETTO, EA; MCCLURG, MR; LAZARCHIK, SB; CLEMM, DL; KERNER, SA; ELGORT, MG; BOEHM, MF; WHITE, SK; PIKE, JW; HEYMAN, RA			TRANSACTIVATION PROPERTIES OF RETINOIC ACID AND RETINOID-X RECEPTORS IN MAMMALIAN-CELLS AND YEAST - CORRELATION WITH HORMONE-BINDING AND EFFECTS OF METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D RECEPTOR; THYROID-HORMONE; SACCHAROMYCES-CEREVISIAE; ESTROGEN-RECEPTOR; SIGNALING PATHWAYS; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; ENHANCES BINDING; DNA-BINDING; BETA-GENE	The binding affinities of 9-cis-retinoic acid (9-cis-RA) and all-trans-retinoic acid (t-RA) for retinoic acid receptors (RAR) alpha, beta, and gamma and for retinoid X receptors (RXR) alpha, beta, and gamma were determined using the recombinant receptor proteins and were compared with each hormone's ability to activate transcription through the receptors in mammalian and yeast cell systems. 9-cis-RA bound to both the RXRs (K(d) = 1.4-2.4 nM) and the RARs (K(d) = 0.2-0.8 nM). The ability of 9-cis-RA to bind to the RARs and RXRs correlated with its ability to produce similar transactivation profiles with these receptors in mammalian and yeast cell assays. t-RA bound to the RARs (K(d) = 0.2-0.4 nM) and activated transcription through the RARs in mammalian and yeast cells. In contrast, while t-RA did not bind to the RXRs, it did activate the RXRs, albeit less potently than 9-cis-RA, in mammalian cells. In yeast, however, the RXRs activated transcription only in the presence of 9-cis-RA, not with t-RA. While RARgamma is activated in yeast by either t-RA or 9-cis-RA, the overall level of transcription was increased upon the addition of hormone-occupied RXR. Metabolism studies suggest that while there was no cell-dependent interconversion between t-RA and 9-cis-RA in yeast, there was cell-dependent conversion of 9-cis-RA to t-RA in mammalian cells.	LIGAND PHARMACEUT INC,DEPT CHEM,SAN DIEGO,CA 92121; LIGAND PHARMACEUT INC,DEPT MOLEC BIOL,SAN DIEGO,CA 92121; LIGAND PHARMACEUT INC,DEPT CELL BIOL,SAN DIEGO,CA 92121	Ligand Pharmaceuticals; Ligand Pharmaceuticals; Ligand Pharmaceuticals	ALLEGRETTO, EA (corresponding author), LIGAND PHARMACEUT INC,DEPT BIOCHEM,11149 TORREY PINES RD,SUITE 110,SAN DIEGO,CA 92121, USA.							ALI M, 1992, BIOCHEM BIOPH RES CO, V182, P1032, DOI 10.1016/0006-291X(92)91835-E; ALLEGRETTO EA, 1983, BIOCHEM BIOPH RES CO, V116, P75, DOI 10.1016/0006-291X(83)90382-0; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; APFEL C, 1991, RETINOIDS : 10 YEARS ON, P110; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CRETTAZ M, 1990, BIOCHEM J, V272, P391, DOI 10.1042/bj2720391; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRASER DR, 1973, NATURE-NEW BIOL, V241, P163, DOI 10.1038/newbio241163a0; FULLER PJ, 1991, FASEB J, V5, P3092, DOI 10.1096/fasebj.5.15.1743440; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GILBERT DM, 1993, MOL CELL BIOL, V13, P462, DOI 10.1128/MCB.13.1.462; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; ISHIKAWA T, 1990, MOL ENDOCRINOL, V4, P837, DOI 10.1210/mend-4-6-837; KEIDEL S, 1992, EUR J BIOCHEM, V204, P1141, DOI 10.1111/j.1432-1033.1992.tb16739.x; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MANGELSDORF DJ, 1994, IN PRESS RETINOIDS B; MCDONNELL DP, 1991, J STEROID BIOCHEM, V39, P291, DOI 10.1016/0960-0760(91)90038-7; MCDONNELL DP, 1989, MOL CELL BIOL, V9, P3517, DOI 10.1128/MCB.9.8.3517; METZGER D, 1988, NATURE, V334, P31, DOI 10.1038/334031a0; NERVI C, 1989, P NATL ACAD SCI USA, V86, P5854, DOI 10.1073/pnas.86.15.5854; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P139; Oro AE, 1992, CURR OPIN GENET DEV, V2, P269, DOI 10.1016/S0959-437X(05)80284-9; OZONO K, 1991, J BONE MINER RES, V6, P1021; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PHAM TA, 1991, J BIOL CHEM, V266, P18179; ROBERTS AB, 1984, RETINOIDS, V2, P209; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SONE T, 1991, MOL ENDOCRINOL, V5, P1578, DOI 10.1210/mend-5-11-1578; SONE T, 1990, J BIOL CHEM, V265, P21997; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; THALLER C, 1990, NATURE, V345, P815, DOI 10.1038/345815a0; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; WILLIAMS D, 1974, BIOCHEMISTRY-US, V13, P5537, DOI 10.1021/bi00724a013; YANG N, 1991, P NATL ACAD SCI USA, V88, P3559, DOI 10.1073/pnas.88.9.3559; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	56	184	190	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26625	26633						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253793				2022-12-27	WOS:A1993MK42500089
J	WANG, TF; CHANG, JH; WANG, C				WANG, TF; CHANG, JH; WANG, C			IDENTIFICATION OF THE PEPTIDE BINDING DOMAIN OF HSC70 - 18-KILODALTON FRAGMENT LOCATED IMMEDIATELY AFTER ATPASE DOMAIN IS SUFFICIENT FOR HIGH-AFFINITY BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SHOCK COGNATE PROTEIN; UNCOATING PROTEIN; HOMOLOG; ACTIN	Recombinant hsc70, a purified glutathione S-transferase (GST) fusion protein containing the C-terminal domain of hsc70 (GST-Ct), and an internal 18-kDa polypeptide located immediately after the 44-kDa ATPase domain of hsc70 were investigated for their peptide binding properties. The dissociation constants of the S-peptide for native hsc70 (K(d) = 5-8 muM), GST-Ct (K(d) = 6.5 muM), and the 18-kDa fragment (K(d) = 8.1 muM) are virtually identical. In addition, polylysine and (Pro-Pro-Gly)5 do not show high affinity toward hsc70, GST-Ct, and the 18-kDa fragment, whereas peptide GT4 and P3a show comparably high affinity toward these polypeptides. These observations indicate that the peptide binding domain of hsc70 is confined in the internal 18-kDa fragment.	ACAD SINICA, INST MOL BIOL, TAIPEI 11529, TAIWAN	Academia Sinica - Taiwan			Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505				ATENCIO DP, 1992, MOL CELL BIOL, V12, P283, DOI 10.1128/MCB.12.1.283; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CHANG LH, 1990, BIOCHEMISTRY-US, V29, P744, DOI 10.1021/bi00455a022; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; CYR DM, 1992, J BIOL CHEM, V267, P20927; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; HUANG SP, 1993, J BIOL CHEM, V268, P2063; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; STEITZ TA, 1976, J MOL BIOL, V104, P197, DOI 10.1016/0022-2836(76)90009-7; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; TSAI MY, 1993, IN PRESS J BIOL CHEM; WANG C, 1993, BIOCHEM J, V294, P69, DOI 10.1042/bj2940069	19	159	161	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26049	26051						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253714				2022-12-27	WOS:A1993MK42500005
J	LEE, SB; SHIN, SH; HEPLER, JR; GILMAN, AG; RHEE, SG				LEE, SB; SHIN, SH; HEPLER, JR; GILMAN, AG; RHEE, SG			ACTIVATION OF PHOSPHOLIPASE C-BETA-2 MUTANTS BY G-PROTEIN ALPHA(Q)-SUBUNIT AND BETA-GAMMA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION SYSTEM; ALPHA-SUBUNITS; VACCINIA VIRUS; ISOZYME; PURIFICATION; POLYMERASE; DIVERSITY; SEQUENCE; CLONING; MEMBERS	The beta- but not the gamma- and delta-type isozymes of inositol phospholipid-specific phospholipase C (PLC) are activated by G protein alpha(q) and betagamma subunits. The beta-type PLC isozymes differ from other isozymes in that they contain a long carboxyl-terminal region downstream of the Y catalytic domain and a region rich in acidic amino acids between the two separated X and Y catalytic domains. To determine the sites on PLC-beta2 that participate in the interaction of the enzyme with alpha(q) and betagamma subunits, we introduced specific truncations and substitutions in the PLC-beta2 cDNA at positions corresponding to the carboxyl-terminal and acidic amino acid-rich regions, respectively. After transient expression of these cDNA clones in CV-1 cells, the mutant enzymes were partially purified and their capacity to be activated by alpha(q) and betagamma subunits determined. Substitution of glutamine residues for three or all seven of a stretch of consecutive glutamic acids in the acidic domain of PLC-beta2 affected neither alpha(q)- nor betagamma-dependent activation significantly. Carboxyl-terminal truncation to residue Gly-934 or to residue Ala-867 resulted in enzymes that were activated by betagamma but not by alpha(q). This result suggests that the carboxyl-terminal region of PLC-beta2 is required for activation by alpha(q) and that betagamma subunits interact with a different region of the enzyme. Thus, alpha(q) and betagamma subunits may independently modulate a single PLC-beta2 molecule concurrently.	NHLBI, BIOCHEM LAB, BLDG 3, RM 122, BETHESDA, MD 20892 USA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLANK JL, 1991, J BIOL CHEM, V266, P18206; BOYER JL, 1992, J BIOL CHEM, V267, P25451; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAROZZI AJ, 1993, EUR J BIOCHEM, V210, P521; COCKCROFT S, 1992, BIOCHEM J, V288, P1; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HOFMANN SL, 1982, J BIOL CHEM, V257, P4359; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; LEE CH, 1992, J BIOL CHEM, V267, P16044; LEE CW, 1993, J BIOL CHEM, V268, P21318; LEE KY, 1987, P NATL ACAD SCI USA, V84, P5540, DOI 10.1073/pnas.84.16.5540; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; PARK D, 1992, J BIOL CHEM, V267, P16048; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WU DQ, 1993, J BIOL CHEM, V268, P3704; WU DQ, 1992, J BIOL CHEM, V267, P1811	33	126	127	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25952	25957						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245028				2022-12-27	WOS:A1993MK10000095
J	SEELIG, A; MULTHAUP, G; PESOLDHURT, B; BEYREUTHER, K; KLOETZEL, PM				SEELIG, A; MULTHAUP, G; PESOLDHURT, B; BEYREUTHER, K; KLOETZEL, PM			DROSOPHILA PROTEASOME DM25 SUBUNIT SUBSTITUTES THE MOUSE MC3 SUBUNIT IN HYBRID PROTEASOMES - THE N-TERMINAL DOMAIN IS ESSENTIAL FOR SUBUNIT INCORPORATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PROS-GENE FAMILY; MULTICATALYTIC PROTEINASE; MOLECULAR-CLONING; MULTIFUNCTIONAL PROTEINASE; YEAST PROTEASOME; INVIVO FUNCTION; LINKED LMP; DNA; PATHWAY	The proteasome is a multisubunit 20 S proteinase complex involved in ubiquitin-dependent and -independent intracellular protein metabolism. Individual subunits of the alpha- and beta-type share extensive sequence homology and are encoded as members of two related and evolutionarily conserved gene families. Due to the lack of viable deletion mutants of essential alpha-type proteasome subunits in higher eukaryotes, an identification and analysis of potentially homologous subunits of different species was so far not possible. It is shown here that the novel Drosophila alpha-type Dm25 subunit can be incorporated into mouse proteasomes of stably transfected NIH 3T3 cells. The Dm25 subunit is able to substitute the mouse MC3 alpha-type subunit in proteasomes, indicating a high structural and possibly also functional homology of the two subunits. In contrast and pointing at the importance of the slightly hydrophobic N-terminal region stabile expression of a Dm25 subunit, which is truncated at its N terminus and lacks PROS box I, results in a subunit which cannot be incorporated into mouse proteasomes. The ability to form hybrid proteasomes involving essential nondeletable subunits now opens the possibility for structural and also functional analysis of such subunits by mutagenesis in higher eukaryotes.	UNIV HEIDELBERG,CTR MOLEC BIOL,NEUENHEIMER FELD 282,D-69120 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg								BAIROCH A, 1990, PROSITE DATABASE; BEYREUTHER K, 1983, MODERN METHODS PROTE, P303; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; EMORI Y, 1991, MOL CELL BIOL, V11, P344, DOI 10.1128/MCB.11.1.344; FRENTZEL S, 1992, FEBS LETT, V302, P121, DOI 10.1016/0014-5793(92)80420-L; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; GEORGATSOU E, 1992, FEBS LETT, V299, P39, DOI 10.1016/0014-5793(92)80095-X; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIZWA A, 1991, FEBS LETT, V290, P186; HAASS C, 1990, GENE, V90, P235, DOI 10.1016/0378-1119(90)90185-T; HAASS C, 1989, EXP CELL RES, V180, P243, DOI 10.1016/0014-4827(89)90228-0; HAASS C, 1990, NUCLEIC ACIDS RES, V18, P4018, DOI 10.1093/nar/18.13.4018; HAFFTER P, 1991, NUCLEIC ACIDS RES, V19, P5075, DOI 10.1093/nar/19.18.5075; HARLOW E, 1988, ANTIBODIES LABORATOR; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; KLOETZEL PM, 1991, BIOMED BIOCHIM ACTA, V50, P451; KOPP F, 1993, J MOL BIOL, V229, P14, DOI 10.1006/jmbi.1993.1003; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DH, 1991, BIOCHEM INT, V23, P689; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; RICHTERRUOFF B, 1992, FEBS LETT, V302, P192, DOI 10.1016/0014-5793(92)80438-M; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULDT C, 1985, DEV BIOL, V110, P565; SEELIG A, 1991, BIOCHEM J, V280, P225, DOI 10.1042/bj2800225; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TANAKA K, 1992, NEW BIOL, V4, P173; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; ZWICKL P, 1992, FEBS LETT, V312, P157, DOI 10.1016/0014-5793(92)80925-7	39	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25561	25567						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244993				2022-12-27	WOS:A1993MK10000044
J	STRUM, JC; DANIEL, LW				STRUM, JC; DANIEL, LW			IDENTIFICATION OF A LYSOPHOSPHOLIPASE-C THAT MAY BE RESPONSIBLE FOR THE BIOSYNTHESIS OF CHOLINE PLASMALOGENS BY MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN MICROSOMES; PHOSPHOLIPASE-C; D PATHWAY; ETHANOLAMINE; METABOLISM; PHOSPHATIDYLCHOLINE; PHOSPHOTRANSFERASE; PHOSPHATIDYLETHANOLAMINE; GLYCEROPHOSPHOLIPIDS; QUANTITATION	The biosynthesis of choline plasmalogens was investigated in Madin-Darby canine kidney cells to determine the source of the vinyl ether linkage. 1-O-[H-3] Alk-1'-enyl-2-lyso-sn-glycero-3-phosphoethanolamine was a better precursor than 1-O-[H-3]alkyl-2-lyso-sn-glycero-3-phosphocholine for the synthesis of 1-O-[H-3]alk-1'-enyl-2-acyl-sn-glycero-3-phosphocholine; this suggests that the vinyl ether linkage in choline phosphoglycerides originates from ethanolamine plasmalogens. The contribution of N-methylation and base exchange enzymes to choline plasmalogen biosynthesis was assessed using 1-O-[H-3]alkenyl-2-lyso-sn-glycero-3-[P-32]phosphoethanolamine. While 1-O-[H-3]alkenyl-2-acyl-sn-glycero-3-phosphocholine was formed from this precursor, the P-32 was lost indicating that N-methylation and base exchange enzymes do not contribute significantly to the synthesis of choline plasmalogens. The conversion of a phosphono analog of 1-O-[H-3]alkyl-2-lyso-sn-glycero-3-phosphoethanolamine, which is resistant to phospholipase D hydrolysis, to 1-O-[H-3]alkenyl-2-acyl-sn-glycero-2-phosphocholine was observed demonstrating that phospholipase D is not required for choline plasmalogen biosynthesis. A Mg2+-dependent lysophospholipase C activity was detected in microsomes that actively hydrolyzed ether-linked lysophosphoglycerides as well as the lysophosphono analog. To assess the role of lysophospholipase C in shuttling 1-O-alk-1'-enyl-sn-glycerol (alkenylglycerol) from ethanolamine plasmalogens to choline plasmalogens, cells prelabeled with 1-O-[H-3]alkenyl-2-lyso-sn-glycero-3-phosphoethanolamine were treated with 12-O-tetradecanoylphorbol-13-acetate. This resulted in the rapid deacylation of 1-O-[H-3]alkenyl-2-acyl-sn-glycero-3-phosphoethanolamine to 1-O-[H-3]alkenyl-2-lyso-sn-glycero-3-phosphoethanolamine and the subsequent generation of 1-O-[H-3]alkenylglycerol. A concomitant 2-3-fold increase in 1-O-[H-3]alkenyl-2-acyl-sn-glycero-3-phosphocholine was observed. These studies suggest that the alkenyl linkage in choline phosphoglycerides may originate from 1-O-alkenyl-2-lyso-sn-glycero-3-phosphoethanolamine through an enzymatic pathway involving lysophospholipase C to generate alkenylglycerol that is subsequently converted to choline plasmalogens.	WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT BIOCHEM, WINSTON SALEM, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center					NCI NIH HHS [CA12197, CA48995, CA43297] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA043297, R01CA048995] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERT DH, 1977, LIPIDS, V12, P722, DOI 10.1007/BF02570902; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANSELL GB, 1965, BIOCHEM J, V94, P252, DOI 10.1042/bj0940252; ANSELL GB, 1982, PHOSPHOLIPIDS, P2; BLANK ML, 1993, BIOCHIM BIOPHYS ACTA, V1166, P309, DOI 10.1016/0005-2760(93)90112-M; BLANK ML, 1972, BIOCHEM BIOPH RES CO, V47, P1203, DOI 10.1016/0006-291X(72)90962-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNETTI M, 1979, LIPIDS, V14, P925, DOI 10.1007/BF02533507; CHRISTIANSEN K, 1975, ANAL BIOCHEM, V66, P93, DOI 10.1016/0003-2697(75)90728-9; DANIEL LW, 1981, J BIOL CHEM, V256, P2830; DOMSCHKE W, 1971, H-S Z PHYSIOL CHEM, V352, P275, DOI 10.1515/bchm2.1971.352.1.275; FLORINCHRISTENSEN J, 1986, TRENDS BIOCHEM SCI, V11, P354, DOI 10.1016/0968-0004(86)90198-2; FORD DA, 1992, J BIOL CHEM, V267, P11222; FORD DA, 1988, J BIOL CHEM, V263, P2644; GORACCI G, 1977, FEBS LETT, V80, P41, DOI 10.1016/0014-5793(77)80402-X; GORACCI G, 1981, BIOCHIM BIOPHYS ACTA, V664, P373, DOI 10.1016/0005-2760(81)90059-X; HANAHAN DJ, 1990, J LIPID RES, V31, P2113; HII CST, 1990, BIOCHIM BIOPHYS ACTA, V1052, P327, DOI 10.1016/0167-4889(90)90229-7; Horrocks L. A., 1972, ETHER LIPIDS CHEM BI, P177, DOI [DOI 10.1016/B978-0-12-654150-2.50016-6, 10.1016/b978-0-12-654150-2.50016-6]; HORROCKS LA, 1968, J LIPID RES, V9, P469; HORROCKS LA, 1982, PHOSPHOLIPIDS, P62; HUANG CF, 1992, J BIOL CHEM, V267, P16859; HUANG CF, 1990, J BIOL CHEM, V265, P14858; KANOH H, 1973, BIOCHIM BIOPHYS ACTA, V306, P203; KAPOULAS VM, 1969, BIOCHIM BIOPHYS ACTA, V176, P324, DOI 10.1016/0005-2760(69)90190-8; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KISS Z, 1989, J BIOL CHEM, V264, P1483; LEE TC, 1991, ARCH BIOCHEM BIOPHYS, V286, P498, DOI 10.1016/0003-9861(91)90071-P; LEE TC, 1991, FASEB J, V5, pA1154; Martonosi, 1985, ENZYMES BIOL MEMBR, V2, P1; MOGELSON S, 1981, BIOCHIM BIOPHYS ACTA, V666, P205, DOI 10.1016/0005-2760(81)90108-9; MOZZI R, 1981, FEBS LETT, V131, P115, DOI 10.1016/0014-5793(81)80900-3; NIWA Y, 1986, ARCH BIOCHEM BIOPHYS, V250, P345, DOI 10.1016/0003-9861(86)90736-8; PALTAUF F, 1973, J BIOL CHEM, V248, P1609; PALTAUF F, 1972, BIOCHIM BIOPHYS ACTA, V260, P352, DOI 10.1016/0005-2760(72)90049-5; PALTAUF F, 1972, FEBS LETT, V20, P79, DOI 10.1016/0014-5793(72)80021-8; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; SATO R, 1969, BIOCHIM BIOPHYS ACTA, V176, P748; SCHMID HHO, 1972, BIOCHIM BIOPHYS ACTA, V270, P317, DOI 10.1016/0005-2760(72)90196-8; SNYDER F, 1970, J BIOL CHEM, V245, P4016; STRUM JC, 1992, J BIOL CHEM, V267, P1576; Sugiura T., 1987, PLATELET ACTIVATING, P55; SURLES JR, 1985, J MED CHEM, V28, P73, DOI 10.1021/jm00379a015; THOMPSON GA, 1969, BIOCHIM BIOPHYS ACTA, V176, P330, DOI 10.1016/0005-2760(69)90191-X; THOMPSON GA, 1967, BIOCHEMISTRY-US, V6, P2015, DOI 10.1021/bi00859a020; TIETZ A, 1964, J BIOL CHEM, V239, P4081; VANDENBOSCH H, 1974, ANNU REV BIOCHEM, V43, P243; VIERBUCHEN M, 1979, H-S Z PHYSIOL CHEM, V360, P1091, DOI 10.1515/bchm2.1979.360.2.1091; WARNER HR, 1961, J BIOL CHEM, V236, P2404; WIENTZEK M, 1987, BIOCHEM CELL BIOL, V65, P860, DOI 10.1139/o87-112; WOLF RA, 1985, J BIOL CHEM, V260, P7295; WYKLE RL, 1970, FEBS LETT, V12, P57, DOI 10.1016/0014-5793(70)80595-6; WYKLE RL, 1991, METHOD ENZYMOL, V197, P583; WYKLE RL, 1972, J BIOL CHEM, V247, P5442; WYKLE RL, 1980, BIOCHIM BIOPHYS ACTA, V619, P58, DOI 10.1016/0005-2760(80)90242-8; WYKLE RL, 1974, J BIOL CHEM, V249, P1742; YATES AJ, 1979, J LIPID RES, V20, P428	58	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25500	25508						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244986				2022-12-27	WOS:A1993MK10000036
J	YU, FH; SHULL, GE; ORLOWSKI, J				YU, FH; SHULL, GE; ORLOWSKI, J			FUNCTIONAL-PROPERTIES OF THE RAT NA/H EXCHANGER NHE-2 ISOFORM EXPRESSED IN NA/H EXCHANGER-DEFICIENT CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-H+ EXCHANGER; MICROVILLUS MEMBRANE-VESICLES; GROWTH-FACTOR; MOLECULAR-CLONING; INTRACELLULAR PH; BRUSH-BORDER; ANTIPORTER; AMILORIDE; TRANSPORT; INHIBITION	The primary structure and functional expression of the rat Na/H exchanger (NHE) NHE-2 isoform has recently been reported (Wang, Z., Orlowski, J., and Shull, G. E. (1993) J. Biol. Chem. 268,11925-11928). To further characterize some of its functional properties, biochemical and pharmacological analyses were performed on exchanger-deficient Chinese hamster ovary cells (AP-1) that had been stably transfected with a full-length NHE-2 cDNA. Transport activity for NHE-2 was assayed by measuring amiloride-inhibitable Na-22+ influx following an acute intracellular acid load. Pharmacological analyses revealed that NHE-2 had a relatively high affinity for amiloride and some of its analogues. The most potent analogue was 5-(N-ethyl-N-isopropyl) amiloride (EIPA) (K0.5 = 79 nM), followed by 5-(N,N-dimethyl)amiloride (DMA) (K0.5 = 250 nM), amiloride (K0.5 = 1.4 muM), and benzamil (K0.5 = 320 muM). Nonamiloride compounds known to inhibit the activity of other Na/H exchanger isoforms also inhibited NHE-2 with the following order of potency: clonidine (K0.5 = 42 muM) > harmaline (K0.5 = 330 muM) almost-equal-to cimetidine (K0.5 = 330 muM). Biochemical analyses showed that the extracellular Na+ dependence of NHE-2 followed simple, saturating Michaelis-Menten kinetics with an apparent affinity constant for Na+ (K(Na)) Of 50 mM. In contrast, intracellular H+ appeared to activate NHE-2 by a positive cooperative mechanism with an apparent half-maximal activation value of pK 6.90. Other cations, such as extracellular Li+ and H+, acted as competitive inhibitors of Na-22+ influx by NHE-2, with apparent K(i) values of 3.0 mM and 10 nM, respectively. In contrast, extracellular K+ had no effect on the transport activity of NHE-2. These results indicated that the rat NHE-2 cDNA encodes a functional Na/H exchanger isoform with distinct properties compared to rat NHE-1 and -3.	MCGILL UNIV,DEPT PHYSIOL,MCINTYRE MED SCI BLDG,3655 DRUMMOND ST,MONTREAL H3G 1Y6,QUEBEC,CANADA; UNIV CINCINNATI,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267	McGill University; University System of Ohio; University of Cincinnati				Orlowski, John/0000-0001-7371-175X; Yu, Frank/0000-0001-9306-1731	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039626] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 39626] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONSON PS, 1983, J BIOL CHEM, V258, P6767; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; ARONSON PS, 1980, AM J PHYSIOL, V238, pF210, DOI 10.1152/ajprenal.1980.238.3.F210; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; ARSONSON PS, 1980, AM J PHYSIOL, V238, pF210; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; CLARK JD, 1991, AM J PHYSIOL, V261, pC945, DOI 10.1152/ajpcell.1991.261.6.C945; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; COOKE R, 1988, J PHYSIOL-LONDON, V395, P77, DOI 10.1113/jphysiol.1988.sp016909; CUTHBERT AW, 1978, BRIT J PHARMACOL, V63, P139, DOI 10.1111/j.1476-5381.1978.tb07783.x; DONALDSON SKB, 1978, PFLUG ARCH EUR J PHY, V376, P55; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; FRANCHI A, 1986, J BIOL CHEM, V261, P4614; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GRINSTEIN S, 1984, J GEN PHYSIOL, V83, P341, DOI 10.1085/jgp.83.3.341; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAGGERTY C, 1988, P NATL ACAD SCI USA, V88, P6797; IVES HE, 1983, J BIOL CHEM, V258, P9710; KINSELLA JL, 1980, AM J PHYSIOL, V238, pF461, DOI 10.1152/ajprenal.1980.238.6.F461; KINSELLA JL, 1981, AM J PHYSIOL, V241, pF373; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KNICKELBEIN R, 1983, AM J PHYSIOL, V245, pG504, DOI 10.1152/ajpgi.1983.245.4.G504; KNICKELBEIN RG, 1990, AM J PHYSIOL, V259, pG802, DOI 10.1152/ajpgi.1990.259.5.G802; KULANTHAIVEL P, 1990, J BIOL CHEM, V265, P1249; LALLEMAIN G, 1984, J BIOL CHEM, V259, P4313; MAHENSMITH RL, 1985, J BIOL CHEM, V260, P12586; MAHENSMITH RL, 1985, CIRC RES, V56, P773; MOOLENAAR WH, 1986, ANNU REV PHYSIOL, V48, P363; MRWA U, 1974, BLOOD VESSELS, V11, P277; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; PARIS S, 1983, J BIOL CHEM, V258, P3503; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; RALEYSUSMAN KM, 1991, J BIOL CHEM, V266, P2739; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SARDET C, 1991, J BIOL CHEM, V266, P19166; TAKAICHI K, 1992, AM J PHYSIOL, V262, pC1069, DOI 10.1152/ajpcell.1992.262.4.C1069; TAKAICHI K, 1993, AM J PHYSIOL, V264, pC944, DOI 10.1152/ajpcell.1993.264.4.C944; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TSE CM, 1991, EMBO J, V10, P1957, DOI 10.1002/j.1460-2075.1991.tb07725.x; TSE CM, 1992, J BIOL CHEM, V267, P9340; TSE CM, 1993, J BIOL CHEM, V268, P11917; VIGNE P, 1985, J BIOL CHEM, V260, P8008; VIGNE P, 1988, J BIOL CHEM, V263, P18023; VIGNE P, 1984, MOL PHARMACOL, V25, P131; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WANG Z, 1993, J BIOL CHEM, V268, P11925	48	130	135	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25536	25541						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244989				2022-12-27	WOS:A1993MK10000040
J	VIDALINGIGLIARDI, D; RICHET, E; DANOT, O; RAIBAUD, O				VIDALINGIGLIARDI, D; RICHET, E; DANOT, O; RAIBAUD, O			A SMALL C-TERMINAL REGION OF THE ESCHERICHIA-COLI MALT PROTEIN CONTAINS THE DNA-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSCRIPTIONAL ACTIVATOR; NUCLEOTIDE-SEQUENCE; POSITIVE REGULATOR; CRYSTAL-STRUCTURE; LAMBDA-REPRESSOR; PROMOTERS; OPERATOR; VECTORS; FRAGMENT; INDUCER	MalT, the transcriptional activator of the Escherichia coli maltose regulon, is a 901-amino acid-long protein that specifically binds to short, asymmetric nucleotide sequences present in several copies in the promoters of the regulon. We report that the protein structure involved in this specific binding is carried by a small C-terminal part of MalT encompassing the last 95 amino acid residues. This was demonstrated by fusing the last 95 codons of malT to the gene that encodes glutathione S-transferase, purifying the hybrid protein by affinity chromatography, and comparing the DNase I and dimethyl sulfate footprints of the hybrid and of wild-type MalT on different MalT-binding sites. MalT belongs to a large family of prokaryotic transcriptional activators, which share significant homology in their approximately 60-amino acid C-terminal regions. Our result strongly supports the suggestion that the region of homology corresponds to the DNA-binding domain of the proteins in this family.	INST PASTEUR, CNRS, URA 1149, UNITE GENET MOLEC, 25 RUE DR ROUX, F-75724 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				Danot, Olivier/0000-0003-0002-7097				CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; COLE ST, 1986, GENE, V42, P201, DOI 10.1016/0378-1119(86)90297-0; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; GEISLER N, 1977, BIOCHEMISTRY-US, V16, P938, DOI 10.1021/bi00624a020; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; HENIKOFF SJC, 1990, METHOD ENZYMOL, V183, P111; HOFNUNG M, 1971, J MOL BIOL, V61, P681, DOI 10.1016/0022-2836(71)90072-6; KAHN D, 1991, MOL MICROBIOL, V5, P987, DOI 10.1111/j.1365-2958.1991.tb00774.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; RAIBAUD O, 1985, J BACTERIOL, V161, P1201, DOI 10.1128/JB.161.3.1201-1208.1985; RAIBAUD O, 1989, J MOL BIOL, V205, P471, DOI 10.1016/0022-2836(89)90218-0; RAIBAUD O, 1987, J BACTERIOL, V169, P3059, DOI 10.1128/jb.169.7.3059-3061.1987; RICHET E, 1989, EMBO J, V8, P981, DOI 10.1002/j.1460-2075.1989.tb03461.x; SAUER RT, 1979, NATURE, V279, P396, DOI 10.1038/279396a0; SCHWARTZ M, 1987, CELLULAR MOL BIOL, P1482; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPRATT BG, 1986, GENE, V41, P337, DOI 10.1016/0378-1119(86)90117-4; STOKER NG, 1982, GENE, V18, P335, DOI 10.1016/0378-1119(82)90172-X; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; VIDALINGIGLIARDI D, 1991, J MOL BIOL, V218, P323, DOI 10.1016/0022-2836(91)90715-I; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; ZHENG LB, 1992, J MOL BIOL, V226, P1037, DOI 10.1016/0022-2836(92)91051-P	26	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24527	24530						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227007				2022-12-27	WOS:A1993MG67300004
J	HUANG, CC; TURCO, SJ				HUANG, CC; TURCO, SJ			DEFECTIVE GALACTOFURANOSE ADDITION IN LIPOPHOSPHOGLYCAN BIOSYNTHESIS IN A MUTANT OF LEISHMANIA-DONOVANI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATED-PHOSPHATIDYLINOSITOLS; GLYCOLIPIDS; EXPRESSION; VIRULENCE; ANTIGENS; SURVIVAL; FAMILY	A mutant cell line of Leishmania donovani (R2D2), previously selected for resistance to the cytotoxic lectin ricin agglutinin, was found to be totally deficient in the synthesis and expression of lipophosphoglycan, a dominant surface virulence factor. The metabolic defect in R2D2 parasites responsible for its lipophosphoglycan (LPG-) phenotype was investigated in this study. Following metabolic labeling of R2D2 parasites with either [H-3]galactose or [H-3]mannose, the main glycosylphosphatidylinositide product that accumulated was Glc-PO4-Man-Man-GlcN-lyso-1-O-alkylphosphatidylinositol (PI). The metabolic defect was further defined using a cell-free glycosylation system. When membrane preparations from wild-type cells were incubated with UDP-[H-3]galactose and unlabeled GDP-mannose in the absence of exogenous acceptors, radiolabeled lipophosphoglycan was synthesized. The addition of exogenous Man-Man-GlcN-PI or Gal(f)-Man-Man-GN-PI stimulated lipophosphoglycan synthesis in vitro. In contrast, when membrane preparations from R2D2 cells were incubated with exogenous Man-Man-GlcN-PI as an acceptor or in the absence of exogenous acceptor, the truncated glycosylphosphatidylinositide Glc-PO4-Man-Man-GlcN-PI was the main radioactive product synthesized. However, when exogenous Gal(f)-Man-Man-GN-PI was added to the R2D2 in vitro system, radioactive lipophosphoglycan was synthesized. Collectively, these results indicate that the mutant R2D2 cells are unable to complete the assembly of the glycan core of LPG because of a defect in the synthesis of the ''activated'' galactofuranosyl donor or the lack of a functional galactofuranosyltransferase.	UNIV KENTUCKY,MED CTR,DEPT BIOCHEM,LEXINGTON,KY 40536	University of Kentucky					NIAID NIH HHS [AI26355] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANET EFLJ, 1954, NATURE, V174, P930, DOI 10.1038/174930a0; CARVER MA, 1992, ARCH BIOCHEM BIOPHYS, V295, P309, DOI 10.1016/0003-9861(92)90523-Y; CARVER MA, 1991, J BIOL CHEM, V266, P10974; ELHAY M, 1990, MOL BIOCHEM PARASIT, V40, P255, DOI 10.1016/0166-6851(90)90047-P; HANDMAN E, 1986, J IMMUNOL, V137, P3608; KING DL, 1988, MOL BIOCHEM PARASIT, V28, P285, DOI 10.1016/0166-6851(88)90013-8; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; MCCONVILLE MJ, 1991, CELL BIOL INT REP, V15, P779, DOI 10.1016/0309-1651(91)90033-F; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; MCCONVILLE MJ, 1990, MOL BIOCHEM PARASIT, V38, P57, DOI 10.1016/0166-6851(90)90205-Z; MCNEELY TB, 1990, J IMMUNOL, V144, P2745; Olsnes S, 1978, Methods Enzymol, V50, P330; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; ROSEN G, 1989, J BIOL CHEM, V264, P10457; ROSEN G, 1988, MOL BIOCHEM PARASIT, V27, P93, DOI 10.1016/0166-6851(88)90028-X; RYAN KA, 1993, IN PRESS P NATL ACAD; TREJO AG, 1971, BIOCHEM J, V122, P49, DOI 10.1042/bj1220049; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; VOLWERK JJ, 1989, J CELL BIOCHEM, V39, P315, DOI 10.1002/jcb.240390311	22	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24060	24066						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226951				2022-12-27	WOS:A1993MF29400054
J	MINOWA, MT; MINOWA, T; MOURADIAN, MM				MINOWA, MT; MINOWA, T; MOURADIAN, MM			ACTIVATOR REGION ANALYSIS OF THE HUMAN D(1A) DOPAMINE-RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; PROMOTER REGION; D1; EXPRESSION; DNA; BINDING; PROTEIN; SP1	The human D1A dopamine receptor gene is transcribed from a TATA-less promoter, and its main activator is between nucleotides -1342 and -1102 relative to the first ATG (Minowa, M. T., Minowa, T., Monsma, F. J., Jr., Sibley, D. R., and Mouradian, M. M. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 3045-3049). In the present study, additional serial deletion mutants fused with a reporter gene and used in transient transfections of the D1A-expressing cell line NS20Y further localized this activator to two regions: -1154 to -1137, which increases promoter activity 4-fold, and -1197 to 01154, which confers an additional 2-fold increase in transcriptional activity. Cell specificity of the D1A gene expression is contributed by both the -1197/-1154 region and the core promoter located downstream to -1102. DNase I footprinting and gel shift assays suggested that DNA-protein interactions occur primarily between -1197 and -1116. Competitive co-transfections using different portions of this segment, D1A-Act-1 (-1197 to -1152) and D1A-Act-2 (-1154 to -1116), confirmed the in vivo functional significance of these sequences in activating the D1A promoter. D1A-Act-1 has no consensus sequences for known transcription factors but binds to several proteins as a complex. Although D1A-Act-2 has AP2 consensus sequences and binds to recombinant AP2, the nuclear factors in NS20Y cells interacting with this region are distinct from AP2 itself. Despite the inability of Spl to directly bind to its consensus sequences in D1A-Act-2, Sp1 or another protein antigenically related to Sp1, as well as a novel nuclear factor, is included in the complex that binds to this activator.	NINCDS,EXPTL THERAPEUT BRANCH,GENET PHARMACOL UNIT,BLDG 10,RM 5C116,9000 ROCKVILLE PIKE,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)				Mouradian, M. Maral/0000-0002-9937-412X				AMMENDOLA R, 1990, MOL CELL BIOL, V10, P387, DOI 10.1128/MCB.10.1.387; Ausubel FM, 1988, MOL REPROD DEV; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CHEN HM, 1993, J BIOL CHEM, V268, P8230; CHEN XR, 1992, ONCOGENE, V7, P1805; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELDER GA, 1992, NUCLEIC ACIDS RES, V20, P6281, DOI 10.1093/nar/20.23.6281; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JOLLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267, DOI 10.1093/nar/19.9.2267; LEE T, 1978, NATURE, V274, P897, DOI 10.1038/274897a0; MINOWA MT, 1992, P NATL ACAD SCI USA, V89, P3045, DOI 10.1073/pnas.89.7.3045; MINOWA T, 1992, BIOCHEMISTRY-US, V31, P8389, DOI 10.1021/bi00151a001; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; MONSMA FJ, 1989, BRAIN RES, V492, P314, DOI 10.1016/0006-8993(89)90915-3; MOURADIAN MM, 1988, ANN NEUROL, V24, P372, DOI 10.1002/ana.410240304; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; RANEY AK, 1992, J VIROL, V66, P6912, DOI 10.1128/JVI.66.12.6912-6921.1992; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Sambrook J, 1989, MOL CLONING LABORATO; SIDHU A, 1990, BIOCHEM BIOPH RES CO, V166, P574, DOI 10.1016/0006-291X(90)90847-G; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SUNAHARA RK, 1990, NATURE, V347, P80, DOI 10.1038/347080a0; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; WALTERS JR, 1987, SCIENCE, V236, P719; YAMAGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8773, DOI 10.1093/nar/16.18.8773; ZHANG P, 1993, J VIROL, V67, P1472, DOI 10.1128/JVI.67.3.1472-1481.1993; ZHOU QY, 1992, J NEUROCHEM, V59, P1875, DOI 10.1111/j.1471-4159.1992.tb11023.x; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	34	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23544	23551						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226883				2022-12-27	WOS:A1993MF51500090
J	NAUSEEF, WM; MCCORMICK, S; RENEE, J; LEIDAL, KG; CLARK, RA				NAUSEEF, WM; MCCORMICK, S; RENEE, J; LEIDAL, KG; CLARK, RA			FUNCTIONAL DOMAIN IN AN ARGININE-RICH CARBOXYL-TERMINAL REGION OF P47PHOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PROTEIN-KINASE-C; CELL-FREE SYSTEM; RESPIRATORY BURST OXIDASE; NEUTROPHIL NADPH-OXIDASE; ADENINE-DINUCLEOTIDE PHOSPHATE; SODIUM DODECYL-SULFATE; 2 CYTOSOLIC COMPONENTS; SUPEROXIDE GENERATION; SUBCELLULAR-LOCALIZATION	Activation of the neutrophil respiratory burst oxidase involves phosphorylation-dependent translocation of the cytosolic proteins p47phox and p67phox to the plasma membrane, a process in intact cells that is inhibited by staurosporine. We now report that in a cell-free oxidase system, staurosporine and protein kinase C pseudosubstrate PKC(19-36) both inhibited p47phox phosphorylation but had no effect on superoxide generation. In contrast, p47phox phosphorylation, translocation, and superoxide generation were inhibited by a peptide, p47phox(323-332) (AYRRNSVRFL), based on a putative serine phosphorylation domain. This effect was specific for the 323-332 peptide, as it was not observed with two peptides based on other p47phox phosphorylation domains. All three peptides served as substrates for phosphorylation, but the extent of peptide phosphorylation did not correlate with inhibition of oxidase function. p47phox(325-330), which represents the serine phosphorylation motif of p47phox(323-332), did not inhibit translocation or superoxide production despite its ability to block phosphorylation of p47phox. These data indicate the presence of functionally important sites within the p47phox(323-332) peptide. Although serine 328 is in a consensus phosphorylation motif, the lack of correlation in the cell-free system between p47phox phosphorylation and either protein translocation or superoxide formation suggests that a phosphorylation-independent function resides in the 323-332 segment of p47phox.	DEPT VET AFFAIRS MED CTR,DEPT MED,IOWA CITY,IA 52242	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	NAUSEEF, WM (corresponding author), UNIV IOWA,DEPT MED,200 HAWKINS DR,IOWA CITY,IA 52242, USA.		Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Nauseef, William/0000-0003-4032-757X	NHLBI NIH HHS [HL 34327] Funding Source: Medline; NIAID NIH HHS [R37 AI020866, R01 AI020866, AI 20866, AI 28412] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI028412, R37AI020866, R01AI020866] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BLRD VA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)		ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CHIBA T, 1990, BIOCHEM BIOPH RES CO, V173, P376, DOI 10.1016/S0006-291X(05)81068-X; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CLARK RA, 1987, J BIOL CHEM, V262, P4065; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; DEWALD B, 1989, BIOCHEM J, V264, P879, DOI 10.1042/bj2640879; DOUSSIERE J, 1988, BIOCHEM BIOPH RES CO, V152, P993, DOI 10.1016/S0006-291X(88)80382-6; GABIG TG, 1987, J BIOL CHEM, V262, P1685; HAYAKAWA T, 1986, J BIOL CHEM, V261, P9109; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; HEYWORTH PG, 1986, BIOCHEM J, V239, P723, DOI 10.1042/bj2390723; HEYWORTH PG, 1990, BIOCHIM BIOPHYS ACTA, V1052, P299, DOI 10.1016/0167-4889(90)90225-3; HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1989, BIOCHEM J, V260, P243, DOI 10.1042/bj2600243; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KRAMER IM, 1988, J BIOL CHEM, V263, P2352; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MALECH HL, 1993, CLIN RES, V41, pA323; MUID RE, 1991, FEBS LETT, V293, P169, DOI 10.1016/0014-5793(91)81178-B; NAUSEEF WM, 1990, BLOOD, V76, P2622; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; OKAMURA N, 1988, BLOOD, V72, P811; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; PARK JW, 1992, J BIOL CHEM, V267, P19901; RODAWAY ARF, 1990, MOL CELL BIOL, V10, P5388, DOI 10.1128/MCB.10.10.5388; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SAKO T, 1988, CANCER RES, V48, P4646; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TAUBER AI, 1987, BLOOD, V69, P711; TEAHAN CG, 1990, BIOCHEM J, V267, P485, DOI 10.1042/bj2670485; UHLINGER DJ, 1991, J BIOL CHEM, V266, P20990; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; YASUDA I, 1990, BIOCHEM BIOPH RES CO, V166, P1220, DOI 10.1016/0006-291X(90)90996-Z	46	55	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23646	23651						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226891				2022-12-27	WOS:A1993MF51500104
J	CODIGNOLA, A; TARRONI, P; CLEMENTI, F; POLLO, A; LOVALLO, M; CARBONE, E; SHER, E				CODIGNOLA, A; TARRONI, P; CLEMENTI, F; POLLO, A; LOVALLO, M; CARBONE, E; SHER, E			CALCIUM-CHANNEL SUBTYPES CONTROLLING SEROTONIN RELEASE FROM HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EATON MYASTHENIC SYNDROME; OMEGA-CONOTOXIN; PERIPHERAL NEURONS; GROWTH-FACTORS; CA2+ CHANNELS; FREE CA-2+; P-TYPE; DIHYDROPYRIDINE; CANCER; AUTOANTIBODIES	Small cell lung carcinoma is an aggressive neuroendocrine tumor that secretes several hormones, some of which act as autocrine growth factors. In order to obtain more information on the process of hormone secretion from this tumor, we have studied the role of intracellular free Ca2+ concentrations and voltage-operated calcium channels in the control of [H-3]serotonin release from in vitro growing cell lines. We found that the Ca2+ ionophore ionomycin and the Ca2+-ATPase antagonist thapsigargin induced a dose-dependent increase of intracellular Ca2+ and a parallel enhancement of [H-3]serotonin release. KCl-induced depolarization also stimulated a dose- and Ca2+-dependent [H-3]serotonin release that in the GLC8 cell line was effectively inhibited by Ca2+ channel antagonists (Cd2+, nitrendipine, verapamil, omega-conotoxin GVIA, and omega-agatoxin IVA) and potentiated by the Ca2+ channel agonist BayK8644. Autoantibodies against Ca2+ channels present in the sera of Lambert-Eaton myasthenic patients antagonized KCl- but not ionomycin-induced [H-3]serotonin release. Polymerase chain reaction analysis indicated that GLC8 cells express L-, N-, and P-type neuronal Ca2+ channel alpha1 subunits, together with two types of Ca2+ channel beta subunits. The presence of three functionally distinct high threshold Ca2+ channels was also revealed by patch clamp experiments; high threshold Ca2+ channels were identified as dihydropyridine-sensitive (L-type), omega-conotoxin GVIA-sensitive (N-type), and omega-agatoxin IVA-sensitive (P-type). Our data demonstrate that [H-3]serotonin is released by small cell lung carcinoma cells in a Ca2+-dependent manner and that depolarization-induced [H-3]serotonin release is mediated by Ca2+ influx through distinct, neuron-like, Ca2+ channel subtypes.	UNIV MILAN, DEPT MED PHARMACOL,CNR,CTR CYTOPHARMACOL, VIA VANVITELLI 32, I-20129 MILAN, ITALY; UNIV TURIN, DEPT HUMAN ANAT & PHYSIOL, I-10125 TURIN, ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Turin				Tarroni, Paola/0000-0001-7398-0722; Carbone, Emilio/0000-0003-2239-6280	Telethon [386] Funding Source: Medline	Telethon(Fondazione Telethon)		AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; BARRY ELR, 1991, J CELL BIOL S, V115, P466; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CHINI B, 1992, P NATL ACAD SCI USA, V89, P1572, DOI 10.1073/pnas.89.5.1572; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAYANITHI G, 1988, BIOCHEM BIOPH RES CO, V156, P255, DOI 10.1016/S0006-291X(88)80833-7; DEAIZPURUA HJ, 1988, CANCER RES, V48, P4719; DUBY A, 1990, CURRENT PROTOCOL S20, V1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gandia L, 1990, Neuroreport, V1, P119, DOI 10.1097/00001756-199010000-00009; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERDON H, 1989, N-S ARCH PHARMACOL, V340, P36; HOLZ GG, 1988, J NEUROSCI, V8, P463; HSER E, 1992, EUR J PHARMACOL, V216, P407; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LOGIN IS, 1987, ANN NEUROL, V22, P610, DOI 10.1002/ana.410220509; LUNDY PM, 1991, EUR J PHARM-MOLEC PH, V206, P61, DOI 10.1016/0922-4106(91)90147-A; MCCANN FV, 1981, SCIENCE, V212, P1155, DOI 10.1126/science.6262914; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; NAKANISHI Y, 1988, J CLIN INVEST, V82, P354, DOI 10.1172/JCI113594; OGUROOKANO M, 1992, MAYO CLIN PROC, V67, P1150, DOI 10.1016/S0025-6196(12)61144-6; OSHAUGHNESSY TJ, 1992, SOC NEUR ABSTR, V118, P435; PANCRAZIO JJ, 1992, ACTA PHYSIOL SCAND, V144, P463, DOI 10.1111/j.1748-1716.1992.tb09321.x; PEERS C, 1990, J PHYSIOL-LONDON, V421, P293, DOI 10.1113/jphysiol.1990.sp017945; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; POLLO A, 1992, PFLUG ARCH EUR J PHY, V422, P75; POLLO A, 1993, PFLUG ARCH EUR J PHY, V423, P462, DOI 10.1007/BF00374942; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RINK TJ, 1982, FEBS LETT, V148, P21, DOI 10.1016/0014-5793(82)81234-9; ROBERTS A, 1985, NATURE, V317, P737, DOI 10.1038/317737a0; ROSENFELD MR, 1993, ANN NEUROL, V33, P113, DOI 10.1002/ana.410330126; SHER E, 1989, LANCET, V2, P640; SHER E, 1990, CANCER RES, V50, P3892; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SHER E, 1991, FASEB J, V5, P2677, DOI 10.1096/fasebj.5.12.1655547; SORENSON GD, 1981, CANCER, V47, P1289, DOI 10.1002/1097-0142(19810315)47:6<1289::AID-CNCR2820470610>3.0.CO;2-B; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TARELLI FT, 1991, BRAIN RES, V547, P331, DOI 10.1016/0006-8993(91)90981-Z; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Viglione Michael P., 1992, Society for Neuroscience Abstracts, V18, P435; VINCENT A, 1989, TRENDS NEUROSCI, V12, P496, DOI 10.1016/0166-2236(89)90109-4; WEYNANTS P, 1990, EUR RESPIR J, V3, P699; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WOLL PJ, 1991, BRIT J CANCER, V63, P469, DOI 10.1038/bjc.1991.110; WOLLHEIM CB, 1984, J BIOL CHEM, V259, P2262; YU A, 1991, J CELL BIOL S, V115, P466	53	83	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26240	26247						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253745				2022-12-27	WOS:A1993MK42500037
J	DUFF, JL; MARRERO, MB; PAXTON, WG; CHARLES, CH; LAU, LF; BERNSTEIN, KE; BERK, BC				DUFF, JL; MARRERO, MB; PAXTON, WG; CHARLES, CH; LAU, LF; BERNSTEIN, KE; BERK, BC			ANGIOTENSIN-II INDUCES 3CH134, A PROTEIN-TYROSINE-PHOSPHATASE, IN VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GENE-EXPRESSION; ENCODED PROTEIN; KINASE-ACTIVITY; VACCINIA VIRUS; MAP KINASE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; PROLIFERATION; MOBILIZATION	Angiotensin II is a potent growth factor for vascular smooth muscle cells and shares many signal transduction mechanisms with mitogens, including stimulation of mitogen-activated protein (MAP) kinases and protein tyrosine phosphorylation. Regulation of tyrosine phosphorylation involves both protein-tyrosine kinases and protein-tyrosine phosphatases (PTPases). To investigate the role of PTPases in angiotensin II-mediated events, we studied the expression of a transcriptionally regulated PTPase, 3CH134, which has selective activity toward MAP kinase. Angiotensin II rapidly induced 3CH134 mRNA (30 min maximum) in a concentration-dependent manner (100 nM maximum). Platelet-derived growth factor, alpha-thrombin, hydrogen peroxide, phorbol 12-myristate 13-acetate, and ionomycin also induced 3CH134 but to levels lower than angiotensin H. Induction of 3CH134 by angiotensin II was partially inhibited after down-regulating protein kinase C but was fully inhibited after chelating intracellular Ca2+. Treatment with both phorbol 12-myristate 13-acetate and ionomycin induced 3CH134 mRNA to levels seen with angiotensin II, indicating that Ca2+ mobilization and protein kinase C activation can act synergistically to induce 3CH134. Angiotensin II stimulated 3CH134 protein synthesis after 1 h as measured by immunoprecipitation of 3CH134 from [S-35]methionine-labeled cells using affinity-purified antibodies. These results establish 3CH134 as a dynamically regulated, immediate early gene in vascular smooth muscle cells and suggest a role for PTPases in regulating angiotensin II-stimulated events mediated by MAP kinases and tyrosine kinases.	EMORY UNIV,SCH MED,DEPT MED,DIV CARDIOL,PO DRAWER LL,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PATHOL,ATLANTA,GA 30322; UNIV ILLINOIS,SCH MED,DEPT GENET,CHICAGO,IL 60612	Emory University; Emory University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Bernstein, Kenneth/0000-0001-8097-3272; Lau, Lester/0000-0002-4364-2914; Berk, Bradford/0000-0002-2767-4115				ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BERK BC, 1987, J BIOL CHEM, V262, P5065; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BLANK RS, 1992, J BIOL CHEM, V267, P984; CHARLES CH, 1992, ONCOGENE, V7, P187; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; FORT P, 1985, NUCLEIC ACIDS RES, V13, P141; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUNTHER S, 1980, CIRC RES, V47, P278, DOI 10.1161/01.RES.47.2.278; HUCKLE WR, 1992, P NATL ACAD SCI USA, V89, P8837, DOI 10.1073/pnas.89.18.8837; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KOHNO M, 1986, BIOCHEM J, V238, P451, DOI 10.1042/bj2380451; KRUG LM, 1992, HYPERTENSION, V20, P144, DOI 10.1161/01.HYP.20.2.144; LALLEMAIN G, 1991, MOL CELL BIOL, V11, P1002, DOI 10.1128/MCB.11.2.1002; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; RAO GN, 1990, J BIOL CHEM, V265, P19393; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; STOUFFER GA, 1992, CIRC RES, V70, P820, DOI 10.1161/01.RES.70.4.820; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; TRAVO P, 1980, BLOOD VESSELS, V17, P110; TSUDA T, 1991, FEBS LETT, V285, P44, DOI 10.1016/0014-5793(91)80721-E	35	79	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26037	26040						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253712				2022-12-27	WOS:A1993MK42500002
J	ROBITAILLE, PML; RATH, DP; ABDULJALIL, AM; ODONNELL, JM; JIANG, ZC; ZHANG, HZ; HAMLIN, RL				ROBITAILLE, PML; RATH, DP; ABDULJALIL, AM; ODONNELL, JM; JIANG, ZC; ZHANG, HZ; HAMLIN, RL			DYNAMIC C-13 NMR ANALYSIS OF OXIDATIVE-METABOLISM IN THE IN-VIVO CANINE MYOCARDIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; PERFUSED RAT-HEART; TRICARBOXYLATE CYCLE; CARBON FLUX; WORK LOAD; SPECTROSCOPY; SUBSTRATE; EXCITATION; GLYCOLYSIS; PATHWAYS	Oxidative metabolism in the in vivo canine myocardium was studied noninvasively using C-13-enriched acetate and non-steady state C-13 NMR techniques. Under low workload conditions, the myocardium oxidized the infused [2-C-13]acetate and incorporated the labeled carbon into the glutamate pool as expected. This conclusion stems from the rapid enrichment of the C-2, C-3, and C-4 carbons of glutamic acid both under in vivo conditions and in extracts. Surprisingly, [2-C-13]acetate uptake was not observed at high workloads as reflected by an absence of glutamate pool enrichment at these rate pressure products. Rather, the myocardium selected its substrate from an endogenous pool. Since free acetate can directly cross the inner mitochondrial membrane and be converted to acetyl-CoA through acetyl-CoA synthetase, these results support workload-dependent regulation of substrate access to the mitochondrial CoASH pool. As such, we advance the hypothesis that the selection of substrate for condensation with CoASH and subsequent oxidation in the tricarboxylic acid cycle is regulated kinetically through the K(m) values of the appropriate condensation enzymes and through the absolute levels of free CoASH in the mitochondria.	OHIO STATE UNIV,DEPT MED BIOCHEM,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT RADIOL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT VET PHYSIOL & PHARMACOL,COLUMBUS,OH 43210	Ohio State University; Ohio State University; Ohio State University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045120] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-1 HL45120] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY IA, 1981, FEBS LETT, V123, P315, DOI 10.1016/0014-5793(81)80317-1; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; BENDALL MR, 1986, J MAGN RESON, V67, P376, DOI 10.1016/0022-2364(86)90447-6; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; Chase J.F.A., 1969, METHOD ENZYMOL, V13, P387, DOI 10.1016/0076-6879(69)13066-9; COONEY GJ, 1981, BIOCHEM J, V200, P701, DOI 10.1042/bj2000701; DAVIS EJ, 1977, BIOCHEM BIOPH RES CO, V79, P1155; FROM AHL, 1990, BIOCHEMISTRY-US, V29, P3731, DOI 10.1021/bi00467a020; GEHRING U, 1968, EUR J BIOCHEM, V6, P264, DOI 10.1111/j.1432-1033.1968.tb00446.x; LEWANDOWSKI ED, 1992, CIRC RES, V70, P576, DOI 10.1161/01.RES.70.3.576; LEWANDOWSKI ED, 1991, MAGNET RESON MED, V19, P186, DOI 10.1002/mrm.1910190118; LUMENG L, 1973, FEBS LETT, V29, P124, DOI 10.1016/0014-5793(73)80541-1; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V38, P447, DOI 10.1016/0006-3002(60)91280-4; MASSIE B, 1992, SOC MAGNETIC RES MED; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; Opie L.H., 1991, HEART PHYSL METABOLI; PETTIT FH, 1982, METHOD ENZYMOL, V89, P376; PRUSKI J, 1991, MAGNET RESON MED, V27, P329; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; RANDLE PJ, 1970, BIOCHEM J, V117, P677, DOI 10.1042/bj1170677; ROBITAILLE PM, 1990, MAGN RESON MED, V16, P91, DOI 10.1002/mrm.1910160110; ROBITAILLE PML, 1993, MAGNET RESON MED, V30, P262, DOI 10.1002/mrm.1910300218; RUSSELL RR, 1990, J CLIN INVEST, V87, P384; SHERRY AD, 1988, BIOCHEM J, V254, P593, DOI 10.1042/bj2540593; SHERRY AD, 1985, J BIOL CHEM, V260, P9272; SKINNER TE, 1992, J MAGN RESON, V98, P14, DOI 10.1016/0022-2364(92)90105-G; TAEGTMEYER H, 1983, BASIC RES CARDIOL, V78, P435, DOI 10.1007/BF02070167; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; UGURBIL K, 1988, J MAGN RESON, V80, P448, DOI 10.1016/0022-2364(88)90241-7; WEBSTER LT, 1969, METHOD ENZYMOL, V13, P375; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Williamson J R, 1979, Methods Enzymol, V55, P200; Williamson J R, 1973, Symp Soc Exp Biol, V27, P241; WILLIAMSON JR, 1965, J BIOL CHEM, V240, P2308; WILLIAMSON JR, 1980, FEBS LETT, V117, pK73, DOI 10.1016/0014-5793(80)80572-2; ZHANG J, 1992, SOC MAGNETIC RES MED; ZIMMERMAN ANE, 1962, LANCET, V2, P757	40	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26296	26301						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253751				2022-12-27	WOS:A1993MK42500045
J	DAVIS, JM; BACHINGER, HP				DAVIS, JM; BACHINGER, HP			HYSTERESIS IN THE TRIPLE HELIX-COIL TRANSITION OF TYPE-III COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-IV; THERMAL-STABILITY; RAT SKIN; PROCOLLAGEN; ISOMERIZATION; ISOMERASE; INVITRO; CONFORMATION; MECHANISM; CATALYSIS	A hysteresis is observed in the triple helix-coil transition of type III collagen. This hysteresis appears in the thermal transition, where it is not solvent-dependent, and also in the transition induced by guanidinium hydrochloride. The transitions are observed both by optical rotatory dispersion and by trypsin digestion. Experiments with various fragments of type III collagen, which, like the intact protein, contain a set of disulfide bonds at the carboxyl-terminal end, which functions as an effective nucleus for refolding, indicate that the hysteresis depends on the amino acid sequence, rather than being a general property of the triple helix. The carboxyl-terminal one-quarter fragment of type III collagen does not show a hysteresis, whereas a mutant type III collagen missing residues 595-1008 shows a hysteresis of the same magnitude as normal type III collagen. Several fragments were produced that are missing parts of the amino-terminal end, and these fragments show no hysteresis. The amino-terminal part of the triple helix of type III collagen consists of a stable region containing six Gly-Pro-Hyp tripeptide units within the first 16 tripeptide units. This region forms an amino-terminal clamp for the triple helix and, together with the set of disulfide bonds at the carboxyl-terminal end, allows for highly cooperative unfolding of the triple helix. The presence of this amino-terminal region is a prerequisite for the observed hysteresis.	SHRINERS HOSP CRIPPLED CHILDREN,RES DEPT,3101 SW SAM JACKSON PK RD,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	Oregon Health & Science University								BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1989, CYTOSKELETAL EXTRACE, P171; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P397, DOI 10.1111/j.1432-1033.1984.tb08115.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; BYERS PH, 1974, BIOCHEMISTRY-US, V13, P5243, DOI 10.1021/bi00722a030; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; DANIELSEN CC, 1982, BIOCHEM J, V203, P323, DOI 10.1042/bj2030323; DANIELSEN CC, 1987, BIOCHEM J, V247, P725, DOI 10.1042/bj2470725; FESSLER LI, 1981, J BIOL CHEM, V256, P9646; GERMANN HP, 1988, BIOPOLYMERS, V27, P157, DOI 10.1002/bip.360270112; GLANVILLE RW, 1982, IMMUNOCHEMISTRY EXTR, V1, P43; HILL TL, 1960, STATISTICAL THERMODY, P235; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; KUHN K, 1987, STRUCTURE FUNCTION C, P1; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LIN LN, 1988, BIOCHIM BIOPHYS ACTA, V956, P256, DOI 10.1016/0167-4838(88)90142-2; MATTICE WL, 1988, MACROMOLECULES, V21, P2811, DOI 10.1021/ma00187a029; MORRIS NP, 1990, J BIOL CHEM, V265, P10081; NA GC, 1986, BIOCHEMISTRY-US, V25, P958, DOI 10.1021/bi00353a003; NA GC, 1986, BIOCHEMISTRY-US, V25, P967, DOI 10.1021/bi00353a004; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Rees D A, 1969, Adv Carbohydr Chem Biochem, V24, P267; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; STANKOWSKI S, 1980, BIOPHYS CHEM, V12, P167, DOI 10.1016/0301-4622(80)80049-4; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; VISSING H, 1991, J BIOL CHEM, V266, P5244	33	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25965	25972						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245030				2022-12-27	WOS:A1993MK10000097
J	HAKALA, BE; WHITE, C; RECKLIES, AD				HAKALA, BE; WHITE, C; RECKLIES, AD			HUMAN CARTILAGE GP-39, A MAJOR SECRETORY PRODUCT OF ARTICULAR CHONDROCYTES AND SYNOVIAL-CELLS, IS A MAMMALIAN MEMBER OF A CHITINASE PROTEIN FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE CLEAVAGE SITES; BABOON PAPIO-ANUBIS; NONLACTATING PERIOD; EXPRESSION; SIGNAL; ACID; INHIBITORS; INVITRO; CLONING; DNA	One of the major secreted proteins of human articular chondrocytes in monolayer or explant culture and of synovial fibroblasts is a glycoprotein with an apparent molecular weight of approximately 39,000, referred to as human cartilage glycoprotein-39 (HC gp-39). The protein was purified, and its complete cDNA sequence was determined. It contained an open reading frame coding for a 383-amino acid long peptide. Comparison of the deduced amino acid sequence with known sequences revealed that HC gp-39 contained regions displaying significant homology with a group of bacterial and fungal chitinases and a similar enzyme found in the nematode, Brugia malayi. In addition significant homologies were observed with three mammalian secretory proteins of as yet unknown function, suggesting that a related protein family exists in mammals. The human protein does not possess any glycosidic activity against chitinase substrates, arguing against any function as an endoglycosidase with specificity for N-acetylglucosamine. Analysis by Northern blotting and by reverse transcription/polymerase chain reaction showed mRNA for HC gp-39 to be present in human articular chondrocytes as well is in liver, while mRNA was undetectable in muscle tissues, lung, pancreas, mononuclear cells, or fibroblasts. Neither the protein nor mRNA for HC gp-39 was detectable in normal newborn or adult human articular cartilage obtained at surgery, while mRNA for HC gp-39 was detectable both in synovial specimens and in cartilage obtained from patients with rheumatoid arthritis. These observations suggest that the expression of HC gp-39 may be related to a response of these cells to an altered tissue environment.	SHRINERS HOSP CRIPPLED CHILDREN,JOINT DIS LAB,1529 CEDAR AVE,MONTREAL H3G 1A6,PQ,CANADA; MCGILL UNIV,DEPT SURG,MONTREAL H3G 1Y6,QUEBEC,CANADA; WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110	McGill University; McGill University; Washington University (WUSTL)								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENYA PD, 1988, PATHOL IMMUNOPATH R, V7, P51, DOI 10.1159/000157093; BULAWA CE, 1992, MOL CELL BIOL, V12, P1764, DOI 10.1128/MCB.12.4.1764; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; CHARBONNEAU H, 1989, PRACTICAL GUIDE PROT, P17; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONNELLY KM, 1991, MOL ENDOCRINOL, V5, P356, DOI 10.1210/mend-5-3-356; FISHER KJ, 1989, J BIOL CHEM, V3, P523; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; FUHRMAN JA, 1992, P NATL ACAD SCI USA, V89, P1548, DOI 10.1073/pnas.89.5.1548; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; HAKALA BE, 1991, T ORTHOP RES SOC, V16, P310; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCONNELL M, 1987, J CELL BIOL, V105, P1087, DOI 10.1083/jcb.105.3.1087; MEYER K, 1971, ENZYMES, V2, P307; MIDDLETON JFS, 1992, ANN RHEUM DIS, V51, P440, DOI 10.1136/ard.51.4.440; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; RECKLIES AD, 1992, ARTHRITIS RHEUM, V35, P1510, DOI 10.1002/art.1780351215; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; ROBBINS PW, 1988, J BIOL CHEM, V263, P443; ROSA F, 1988, DEV BIOL, V129, P114, DOI 10.1016/0012-1606(88)90166-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; THOMPSON RC, 1979, J BONE JOINT SURG AM, V61, P407, DOI 10.2106/00004623-197961030-00017; TYLER JA, 1985, BIOCHEM J, V227, P869, DOI 10.1042/bj2270869; VERHAGE HG, 1989, ENDOCRINOLOGY, V124, P2464, DOI 10.1210/endo-124-5-2464; VILLIGER PM, 1992, J CLIN INVEST, V90, P488, DOI 10.1172/JCI115885; VILLIGER PM, 1992, J CELL PHYSIOL, V151, P318, DOI 10.1002/jcp.1041510213; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	38	531	577	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25803	25810						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245017				2022-12-27	WOS:A1993MK10000077
J	NGUYEN, M; MILLAR, DG; YONG, VW; KORSMEYER, SJ; SHORE, GC				NGUYEN, M; MILLAR, DG; YONG, VW; KORSMEYER, SJ; SHORE, GC			TARGETING OF BCL-2 TO THE MITOCHONDRIAL OUTER-MEMBRANE BY A COOH-TERMINAL SIGNAL ANCHOR SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INNER MEMBRANE; CELL-DEATH; CHROMOSOMAL BREAKPOINT; PROTEIN; SURVIVAL; LYMPHOMAS; IMPORT; LINES	The protooncogene product Bcl-2 is an integral membrane protein that functions as a suppressor of programmed cell death. It contains a single predicted transmembrane segment located at its COOH terminus. Here, we show that the transmembrane domain of human Bcl-2 functions as a mitochondrial signal anchor sequence that targets and inserts the protein into the outer membrane in an N(cyto)-C(in). orientation, leaving the bulk of the polypeptide facing the cytosol. Deletion of the COOH-terminal 22 amino acids of Bcl-2 abrogated protein targeting, whereas fusion of this domain to the COOH terminus of dihydrofolate reductase resulted in targeting and insertion of the hybrid protein into the outer membrane in a manner similar to that of Bcl-2. The sequence of the hydrophobic core of the Bcl-2 signal anchor is similar to the corresponding region of the NH2-terminal signal anchor of the mitochondrial outer membrane protein in yeast, Mas70p. A synthetic peptide comprising the Mas70p signal anchor sequence effectively competed for insertion of Bcl-2 into the outer membrane but had no effect on the comparatively low association that Bcl-2 makes with endoplasmic reticulum microsomes. Insertion of Bcl-2 into the mitochondrial outer membrane is mechanistically different than its association with microsomes.	MONTREAL NEUROL HOSP & INST, MONTREAL H3A 2B4, QUEBEC, CANADA; WASHINGTON UNIV, SCH MED, DEPT MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA	McGill University; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	NGUYEN, M (corresponding author), MCGILL UNIV, DEPT BIOCHEM, MONTREAL H3G 1Y6, QUEBEC, CANADA.			Yong, V. Wee/0000-0002-2600-3563; Millar, Douglas/0000-0002-8640-7148				ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BILLETT EE, 1984, BIOCHEM J, V221, P765, DOI 10.1042/bj2210765; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HOCKENBERY DM, 1993, IN PRESS CELL; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LI JM, 1992, BIOCHIM BIOPHYS ACTA, V1106, P233, DOI 10.1016/0005-2736(92)90001-3; LIU XQ, 1988, J CELL BIOL, V107, P503, DOI 10.1083/jcb.107.2.503; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MILLAR DG, 1993, J BIOL CHEM, V268, P18403; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; NGUYEN M, 1987, J BIOL CHEM, V262, P3929; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; POLLOCK V, 1991, FASEB J, V5, pA467; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHORE GC, 1992, MEMBRANE BIOGENESIS, P253; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929	31	336	342	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25265	25268						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244956				2022-12-27	WOS:A1993MK10000002
J	TARLE, I; BORHANI, DW; WILSON, DK; QUIOCHO, FA; PETRASH, JM				TARLE, I; BORHANI, DW; WILSON, DK; QUIOCHO, FA; PETRASH, JM			PROBING THE ACTIVE-SITE OF HUMAN ALDOSE REDUCTASE - SITE-DIRECTED MUTAGENESIS OF ASP-43, TYR-48, LYS-77, AND HIS-110	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE REDUCTASE; DIABETIC COMPLICATIONS; KINETIC MECHANISM; CRYSTAL-STRUCTURE; HYDRIDE TRANSFER; DEHYDROGENASE; CLONING; BINDING; MUSCLE; PURIFICATION	Structural models of human aldose reductase complexed with NADPH have revealed the apposition of C4 of the nicotinamide ring with tyrosine 48 and histidine 110, suggesting that either of these residues could function as the proton donor in the reaction mechanism. Tyrosine 48 is also part of a hydrogen-bonding network that includes lysine 77 and aspartate 43. In order to study the potential catalytic roles of these 4 residues, we evaluated the kinetic properties of mutants containing structurally conservative replacements at these sites. Enzymatic activity was undetectable when Tyr-48 was mutated to phenylalanine (Y48F) although affinity for NADPH was unchanged. In contrast, a mutant containing asparagine substituted for His-110 (H110N) was characterized by an almost 80,000-fold increase in K(m), but only about a 14-fold reduction in k(cat) measured with D-glyceraldehyde. Modest changes in catalytic properties were observed in the mutant containing aspartate 43 substituted with asparagine (D43N): K(m) for aldehyde substrates was elevated up to 17-fold, and k(cat) decreased less than 16-fold. However, the K(d(NADP)) values for D43N were about 5 times higher than those for wild type. Mutant enzyme containing methionine substituted for lysine 77 (K77M) was up to 1,460-fold less active than the wild type. These results are consistent with Tyr-48 acting as the acid-base catalyst in human aldose reductase and confirm the importance of Asp-43, Lys-77, and His-110 to the structure and function of the active site.	WASHINGTON UNIV,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,660 S EUCLID AVE,CAMPUS BOX 8096,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; BIOCRYST PHARMACEUT INC,BIRMINGHAM,AL 35244; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030	Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine				Borhani, David/0000-0002-8486-8792	NEI NIH HHS [5T32 EY07108, EY05856] Funding Source: Medline; NIDDK NIH HHS [P60 DK20579] Funding Source: Medline; NATIONAL EYE INSTITUTE [R55EY005856, R23EY005856, R01EY005856, T32EY007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMARSSON O, 1993, J AM CHEM SOC, V115, P2125, DOI 10.1021/ja00059a005; ALMARSSON O, 1992, J AM CHEM SOC, V114, P8702, DOI 10.1021/ja00048a055; ASKONAS LJ, 1991, BIOCHEM J, V278, P835, DOI 10.1042/bj2780835; BHATNAGAR A, 1988, ARCH BIOCHEM BIOPHYS, V261, P264, DOI 10.1016/0003-9861(88)90341-4; BOHREN KM, 1987, BIOCHIM BIOPHYS ACTA, V916, P185, DOI 10.1016/0167-4838(87)90107-5; BORHANI DW, 1992, J BIOL CHEM, V267, P24841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNE CM, 1985, J AM CHEM SOC, V107, P2703, DOI 10.1021/ja00295a024; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Cleland W W, 1979, Methods Enzymol, V63, P103; CROMLISH JA, 1983, J BIOL CHEM, V258, P3416; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; DAVIDSON WS, 1979, BIOCHEM J, V177, P595, DOI 10.1042/bj1770595; DEJONGH KS, 1987, BIOCHEM J, V242, P143, DOI 10.1042/bj2420143; FELDMAN HB, 1977, BIOCHIM BIOPHYS ACTA, V480, P14, DOI 10.1016/0005-2744(77)90316-3; FERSHT A, 1985, ENZYME STRUCTURE MEC, P190; FLYNN TG, 1986, METABOLISM, V35, P105, DOI 10.1016/0026-0495(86)90197-6; FUJII Y, 1990, J BIOL CHEM, V265, P9914; GRIMSHAW CE, 1990, BIOCHEMISTRY-US, V29, P9947, DOI 10.1021/bi00494a027; HAYMAN S, 1965, J BIOL CHEM, V240, P877; KADOR PF, 1988, MED RES REV, V8, P325, DOI 10.1002/med.2610080302; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU S, 1989, ARCH BIOCHEM BIOPHYS, V275, P112, DOI 10.1016/0003-9861(89)90355-X; LIU SQ, 1992, BIOCHEM PHARMACOL, V44, P2427, DOI 10.1016/0006-2952(92)90693-D; MIZOGUCHI T, 1990, ENZYMOLOGY MOL BIOL, P205; MORJANA NA, 1989, J BIOL CHEM, V264, P2912; NISHIMURA C, 1990, J BIOL CHEM, V265, P9788; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; OLINS PO, 1990, METHOD ENZYMOL, V185, P115; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; PAWLOWSKI JE, 1991, J BIOL CHEM, V266, P8820; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; PETRASH JM, 1991, ELECTROPHORESIS, V12, P84, DOI 10.1002/elps.1150120116; Riordan J F, 1972, Methods Enzymol, V25, P515, DOI 10.1016/S0076-6879(72)25048-0; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; Sarges R, 1993, Prog Drug Res, V40, P99; TAPIA O, 1988, J AM CHEM SOC, V110, P4046, DOI 10.1021/ja00220a058; TILTON RG, 1989, DIABETES, V38, P1258, DOI 10.2337/diabetes.38.10.1258; VANDERJAGT DL, 1990, J BIOL CHEM, V265, P10912; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; WALTON DJ, 1972, BIOCHEMISTRY-US, V12, P3472; WARREN JC, 1993, BIOCHEMISTRY-US, V32, P1401, DOI 10.1021/bi00057a003; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; WINTERS CJ, 1990, BIOCHEMISTRY-US, V29, P1080, DOI 10.1021/bi00456a034; WU YD, 1991, J AM CHEM SOC, V113, P2353, DOI 10.1021/ja00007a002; WU YD, 1987, J AM CHEM SOC, V109, P2226, DOI 10.1021/ja00241a074; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	52	116	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25687	25693						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245005				2022-12-27	WOS:A1993MK10000060
J	HIRATA, Y; KIUCHI, K; CHEN, HC; MILBRANDT, J; GUROFF, G				HIRATA, Y; KIUCHI, K; CHEN, HC; MILBRANDT, J; GUROFF, G			THE PHOSPHORYLATION AND DNA-BINDING OF THE DNA-BINDING DOMAIN OF THE ORPHAN NUCLEAR RECEPTOR NGFI-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CASEIN KINASE-II; CHROMAFFIN CELLS; FIBER OUTGROWTH; PROTEIN; GENE; TRANSCRIPTION; MEMBER; SUPERFAMILY; NEURONS	NGFI-B is an orphan member of the nuclear receptor superfamily encoded by an immediate-early gene. It is rapidly synthesized and phosphorylated in PC12 cells in response to nerve growth factor (NGF) and other agents and is differentially phosphorylated dependent upon the inducing stimulus. The DNA-binding domain (DBD) of NGFI-B has been expressed in bacteria and purified. The purified protein is phosphorylated by protein kinase A or by extracts from NGF-treated PC12 cells. The phosphorylated residues within the DBD have been identified as Ser-340 and Ser-350. The use of mutants in which either or both of these residues were replaced with alanines revealed that phosphorylation of Ser-350, located within the ''A box,'' a motif necessary for DNA binding by NGFI-B, resulted in a decrease in binding to the NGFI-B response element, while phosphorylation of Ser-340 had little or no effect. These findings demonstrate that phosphorylation of a nuclear receptor DBD results in a change in DNA binding and provides another potential mechanism for regulating NGFI-B activity.	NICHHD,GROWTH FACTORS SECT,BLDG 49,RM 5A64,BETHESDA,MD 20892; WASHINGTON UNIV,SCH MED,DEPT PATHOL,DIV LAB MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV LAB MED,ST LOUIS,MO 63110	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Washington University (WUSTL); Washington University (WUSTL)			Hirata, Yoko/L-3142-2019; Hirata, Yoko/AAG-6798-2020	Hirata, Yoko/0000-0002-7081-4937; Milbrandt, Jeffrey/0000-0002-5477-7689				ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HAZEL TG, 1991, MOL CELL BIOL, V11, P3239, DOI 10.1128/MCB.11.6.3239; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; LEVIMONTALCINI R, 1954, CANCER RES, V14, P49; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; TAYLOR LK, 1993, P NATL ACAD SCI USA, V90, P368, DOI 10.1073/pnas.90.2.368; TSUKIYAMA T, 1992, MOL CELL BIOL, V12, P1286, DOI 10.1128/MCB.12.3.1286; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	36	96	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24808	24812						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227042				2022-12-27	WOS:A1993MG67300045
J	BOSSIER, P; FERNANDES, L; ROCHA, D; RODRIGUESPOUSADA, C				BOSSIER, P; FERNANDES, L; ROCHA, D; RODRIGUESPOUSADA, C			OVEREXPRESSION OF YAP2, CODING FOR A NEW YAP PROTEIN, AND YAP1 IN SACCHAROMYCES-CEREVISIAE ALLEVIATES GROWTH-INHIBITION CAUSED BY 1,10-PHENANTHROLINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; DNA-BINDING; CELL-CYCLE; TRANSCRIPTION FACTOR; DRUG-RESISTANCE; COPY NUMBER; YEAST; GENE; THERMOTOLERANCE; ACTIVATOR	A new member of the yeast yAP, designated YAP2, has been isolated and characterized. The protein displays a high homology with the DNA-binding domain of yAP-1, which contains a basic DNA-binding domain and leucine zipper motif and binds in vitro to the same cis-element. Growth arrest of yeast caused by low concentrations of 1,10-phenanthroline, resulting in zinc and/or iron deprivation, is overcome by overexpression of YAP1 or YAP2. In fact, yeast cells overexpressing YAP1 or YAP2 display pleiotropic-drug resistance. On the other hand, a yap2 null mutant has an increased thermotolerance under starvation conditions caused by 1,10-phenanthroline. The latter mutant might become an excellent tool in the study of pathways leading toward thermotolerance acquisition.	INST GULBENKIAN CIENCIAS,GENET MOLEC LAB,RUA QUINTA GRANDE,APARTADO 14,P-2781 OEIRAS,PORTUGAL	Instituto Gulbenkian de Ciencia			fernandes, lisete/E-6522-2016; Bossier, Peter GM/A-8118-2008; Rocha, Dominique/R-5546-2019	fernandes, lisete/0000-0002-3384-2031; Bossier, Peter GM/0000-0002-6165-9111; Rocha, Dominique/0000-0003-4998-9641; Rodrigues-Pousada, Claudina/0000-0002-5075-3639				ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BARNES CA, 1990, J BACTERIOL, V172, P4352, DOI 10.1128/jb.172.8.4352-4358.1990; BOUCHERIE H, 1985, J BACTERIOL, V161, P385, DOI 10.1128/JB.161.1.385-392.1985; BURGERS PMJ, 1987, ANAL BIOCHEM, V163, P391, DOI 10.1016/0003-2697(87)90240-5; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CALLANDER IJ, 1983, BIOTECHNOL BIOENG, V25, P1947, DOI 10.1002/bit.260250805; CIGAN AM, 1987, GENE, V59, P1; CROUZET M, 1987, MOL GEN GENET, V210, P581, DOI 10.1007/BF00327216; DREBOT MA, 1987, P NATL ACAD SCI USA, V84, P7948, DOI 10.1073/pnas.84.22.7948; GALEGO L, 1993, YEAST, V9, P583, DOI 10.1002/yea.320090604; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; HINNEBUSCH AG, 1990, TRENDS BIOCHEM SCI, V15, P148, DOI 10.1016/0968-0004(90)90215-W; HUSSAIN M, 1991, GENE, V101, P149, DOI 10.1016/0378-1119(91)90238-7; IIDA H, 1988, MOL CELL BIOL, V8, P5555, DOI 10.1128/MCB.8.12.5555; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEPPERT G, 1990, GENETICS, V125, P13; MESSENGUY F, 1990, MOL GEN GENET, V224, P257, DOI 10.1007/BF00271559; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; PU WT, 1991, P NATL ACAD SCI USA, V88, P6901, DOI 10.1073/pnas.88.16.6901; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; SHIN DY, 1987, MOL CELL BIOL, V7, P244, DOI 10.1128/MCB.7.1.244; SMITH BJ, 1991, P NATL ACAD SCI USA, V88, P11091, DOI 10.1073/pnas.88.24.11091; SPALDING A, 1989, J GEN MICROBIOL, V135, P1037; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; TZAMARIAS D, 1992, P NATL ACAD SCI USA, V89, P2007, DOI 10.1073/pnas.89.6.2007; WIEMKEN A, 1990, ANTON LEEUW INT J G, V58, P209, DOI 10.1007/BF00548935; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	36	76	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23640	23645						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226890				2022-12-27	WOS:A1993MF51500103
J	ROSSER, BG; POWERS, SP; GORES, GJ				ROSSER, BG; POWERS, SP; GORES, GJ			CALPAIN ACTIVITY INCREASES IN HEPATOCYTES FOLLOWING ADDITION OF ATP - DEMONSTRATION BY A NOVEL FLUORESCENT APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NEUTRAL PROTEASE; RAT HEPATOCYTES; EXTRACELLULAR ATP; CELL-DEATH; CALCIUM; LIVER; PROTEOLYSIS; NEUTROPHILS; ACTIVATION	Our aim was to measure calpain protease activity during increases in cytosolic free calcium (Ca2+i) after addition of extracellular ATP. The calpain protease substrate t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin was synthesized. Nonfluorescent t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin diffuses into the cell where it is conjugated to glutathione forming t-butoxycarbonyl-Leu-Met-7-amino-4-methylcoumarin glutathione conjugate (Boc-Leu-Met-MAC-SG). The nonfluorescent, membrane impermeant Boc-Leu-Met-MAC-SG accumulates in the cell. Intracellular proteolytic hydrolysis of Boc-Leu-Met-MAC-SG releases and unquenches the fluorescence of MAC-SG. Intracellular fluorescence of MAC-SG was quantitated in single, cultured rat hepatocytes using digitized video fluorescent microscopy. Enhancement of intracellular fluorescence generation by increases in Ca2+i and inhibition by a calpain inhibitor indicated the probe was a calpain substrate. After addition of ATP, calpain protease activity increased to 156 +/- 13% of basal concurrent with a 3-fold rise of Ca2+i for 2-4 min. Thereafter, Ca2+i decreased to values of 1.5-fold above basal and protease activity returned to normal. Incubation of cells in Ca2+-free buffer abolished the rise in Ca2+i and calpain protease activity. Calpain protease activity increases concomitantly with increases of Ca2+i supporting the hypothesis that calpain proteases participate in Ca2+-mediated signal transduction.	MAYO CLIN & MAYO FDN,MAYO MED SCH,CTR BASIC RES DIGEST DIS,DEPT INTERNAL MED,ROCHESTER,MN 55905	Mayo Clinic					NIDDK NIH HHS [DK45876] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERTS B, 1983, MOL BIOL CELL, P332; ANAGLI J, 1991, BIOCHEM J, V274, P497, DOI 10.1042/bj2740497; BEAR CE, 1991, AM J PHYSIOL, V261, pC1018, DOI 10.1152/ajpcell.1991.261.6.C1018; BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; BRONK SF, 1991, HEPATOLOGY, V14, P626; BRONK SF, 1991, HEPATOLOGY, V14, P150, DOI 10.1002/hep.1840140125; BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744; BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P1; CHAREST R, 1985, J BIOL CHEM, V260, P5789; Crawford C., 1990, INTRACELLULAR CALCIU, P75; CROALL DE, 1990, INTRACELLULAR CALCIU, P103; DICKSON RC, 1992, GASTROENTEROLOGY, V102, P2098, DOI 10.1016/0016-5085(92)90338-Y; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8; EXTON JH, 1990, ANN NY ACAD SCI, V603, P246; EXTON JH, 1988, HEPATOLOGY, V8, P152, DOI 10.1002/hep.1840080129; FOX JEB, 1983, J BIOL CHEM, V258, P9973; GEBHARD W, 1986, PROTEINASE INHIBITOR, P375; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; GROSKREUTZ JL, 1992, GASTROENTEROLOGY, V102, P1030, DOI 10.1016/0016-5085(92)90193-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MAKI M, 1989, J BIOL CHEM, V264, P18866; MASON RW, 1985, BIOCHEM J, V226, P233, DOI 10.1042/bj2260233; MCMILLIAN MK, 1988, BIOCHEM J, V255, P291; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; MELLONI E, 1986, J BIOL CHEM, V261, P4101; NISHIURA I, 1978, J BIOCHEM-TOKYO, V84, P1657, DOI 10.1093/oxfordjournals.jbchem.a132296; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PONTREMOLI S, 1988, J BIOL CHEM, V263, P1915; PONTREMOLI S, 1986, ANNU REV BIOCHEM, V55, P455, DOI 10.1146/annurev.biochem.55.1.455; Reed P W, 1979, Methods Enzymol, V55, P435; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SUZUKI K, 1992, ANN NY ACAD SCI, V674, P218, DOI 10.1111/j.1749-6632.1992.tb27490.x; SUZUKI K, 1990, CELL STRUCT FUNCT, V15, P1, DOI 10.1247/csf.15.1; Takahashi K, 1990, INTRACELLULAR CALCIU, P55; TAYLOR DL, 1992, AM SCI, V80, P322; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; ZIMNIAK P, 1993, HEPATOLOGY, V17, P330, DOI 10.1002/hep.1840170226	46	110	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23593	23600						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226886				2022-12-27	WOS:A1993MF51500097
J	SCHIRCH, D; DELLEFRATTE, S; IURESCIA, S; ANGELACCIO, S; CONTESTABILE, R; BOSSA, F; SCHIRCH, V				SCHIRCH, D; DELLEFRATTE, S; IURESCIA, S; ANGELACCIO, S; CONTESTABILE, R; BOSSA, F; SCHIRCH, V			FUNCTION OF THE ACTIVE-SITE LYSINE IN ESCHERICHIA-COLI SERINE HYDROXYMETHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTATE-AMINOTRANSFERASE; RABBIT LIVER; 10-FORMYLTETRAHYDROFOLATE SYNTHETASE; REACTION SPECIFICITY; PYRIDOXAL-PHOSPHATE; MUTANT; TETRAHYDROPTEROYLPOLYGLUTAMATES; RACEMIZATION; CONVERSION; MECHANISM	Serine hydroxymethyltransferase has a conserved lysine residue (Lys-229) that forms the internal aldimine with pyridoxal 5'-phosphate. In other pyridoxal 5'-phosphate enzymes investigated so far, this conserved lysine residue also plays a catalytic role as a base that removes the alpha-proton from the amino acid substrate. Three mutant forms of Escherichia coli serine hydroxymethyltransferase (K229Q, K229R, and K229H) were constructed, expressed, and purified. The absorbance spectra, rapid reaction kinetics, and thermal denaturation of the mutant analogs were studied. Only the K229Q mutant serine hydroxymethyltransferase resembled the wild-type enzyme. The results indicate that Lys-229 plays a critical role in expelling the product by converting the external aldimine to an internal aldimine. In the absence of Lys-229, ammonia can also catalyze the same function at a much slower rate. However, Lys-229 apparently is not the base that removes the alpha-proton from the amino acid substrate. The K229Q mutant enzyme could catalyze one turnover of either serine to glycine or glycine to serine at rates approaching those of the wild-type enzyme. After one turnover, the mutant enzyme could not expel the product and bind new substrate. The K229Q mutant enzyme can also transaminate D-alanine, which, like the hydroxymethyltransferase activity, also requires removing the alpha-proton from the substrate. The absorbance spectra of the K229R and K229H serine hydroxymethyltransferases showed that their pyridoxal 5'-phosphate could not readily form an external aldimine with substrates, suggesting that Lys-229 in the wild-type enzyme may never bear a positive charge, further evidence that it is not the base that removes the alpha-proton.	VIRGINIA COMMONWEALTH UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,BOX 614,MCV STN,RICHMOND,VA 23298; UNIV ROMA LA SAPIENZA,CNR,DIPARTIMENTO SCI BIOCHIM A ROSSI FANELLI,I-00185 ROME,ITALY; UNIV ROMA LA SAPIENZA,CNR,CTR BIOL MOLEC,I-00185 ROME,ITALY	Virginia Commonwealth University; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome			Angelaccio, Sebastiana/D-2842-2011; Contestabile, Roberto/J-3467-2019; IURESCIA, Sandra/B-9443-2015	Contestabile, Roberto/0000-0002-5235-9993; IURESCIA, Sandra/0000-0002-8200-9775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028143] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28143] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGELACCIO S, 1992, BIOCHEMISTRY-US, V31, P155, DOI 10.1021/bi00116a023; ARNONE A, 1985, TRANSAMINASES, P326; BARRA D, 1991, BIOTECHNOL APPL BIOC, V13, P48; BHATIA MB, 1993, J BIOL CHEM, V268, P6932; BYRNE PC, 1992, BIOCHEM J, V286, P117, DOI 10.1042/bj2860117; DUNATHAN HC, 1974, P NATL ACAD SCI USA, V71, P3888, DOI 10.1073/pnas.71.10.3888; GRIMM B, 1992, EUR J BIOCHEM, V206, P579, DOI 10.1111/j.1432-1033.1992.tb16962.x; HARRUFF RC, 1976, ARCH BIOCHEM BIOPHYS, V176, P206, DOI 10.1016/0003-9861(76)90157-0; ILAG LL, 1992, BIOCHEMISTRY-US, V31, P7143, DOI 10.1021/bi00146a016; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; LU ZC, 1993, J BIOL CHEM, V268, P8727; MCCLUNG CR, 1992, MOL CELL BIOL, V12, P1412, DOI 10.1128/MCB.12.4.1412; NISHIMURA K, 1991, BIOCHEMISTRY-US, V30, P4072, DOI 10.1021/bi00230a036; PLANAS A, 1991, BIOCHEMISTRY-US, V30, P8268, DOI 10.1021/bi00247a023; SCHIRCH L, 1977, BIOCHEMISTRY-US, V16, P410, DOI 10.1021/bi00622a011; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; SCHIRCH V, 1985, J BACTERIOL, V163, P1; SCHIRCH V, 1991, J BIOL CHEM, V266, P759; SHOSTAK K, 1988, BIOCHEMISTRY-US, V27, P8007, DOI 10.1021/bi00421a006; SMITH DL, 1989, BIOCHEMISTRY-US, V28, P8161, DOI 10.1021/bi00446a030; STOVER P, 1992, J BIOL CHEM, V267, P17679; STRONG W, 1987, J BIOL CHEM, V262, P12519; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P9430, DOI 10.1021/bi00450a028; TONEY MD, 1992, PROTEIN SCI, V1, P107; TONEY MD, 1991, J BIOL CHEM, V266, P23900; VILLAR E, 1985, J BIOL CHEM, V260, P2245; YOSHIMURA T, 1992, BIOCHEMISTRY-US, V31, P11748, DOI 10.1021/bi00162a011; ZIAK M, 1993, EUR J BIOCHEM, V211, P475, DOI 10.1111/j.1432-1033.1993.tb17573.x	29	52	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23132	23138						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226831				2022-12-27	WOS:A1993MF51500030
J	FARINA, AR; DAVISSMYTH, T; GARDNER, K; LEVENS, D				FARINA, AR; DAVISSMYTH, T; GARDNER, K; LEVENS, D			AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; APE LEUKEMIA-VIRUS; DNA-BINDING ACTIVITY; PHORBOL ESTER; TRANSCRIPTIONAL ACTIVITY; HYBRIDIZATION PROBES; 5'-FLANKING REGION; INTERLEUKIN-2 GENE; ENHANCER ELEMENTS; MOUSE FIBROBLASTS	Activated T-cell extracts contain an activity (T-AP1) composed of at least two dissociable protein components which bind to the AP1 consensus sequence in the enhancer of the gibbon ape leukemia virus (GALV)LTR (GALV-TRE). This activity is inducible by 12-O-tetradecanoyl-phorbol-14-acetate (TPA) even in the presence of protein synthesis inhibitors. Although one component of this complex (CORE) is related immunologically and biochemically to junD, it nevertheless displays significant biochemical properties which distinguish CORE from recombinant junD. The second component of the complex, flowthrough, interacts more efficiently with CORE than with recombinant junD. GALV-TRE enhancer activity is increased within 2 h in vivo with T cells treated with TPA in the presence of protein synthesis inhibitors; this increase in enhancer activity is paralleled by the increased GALV-TRE-mediated transcriptional activity present in extracts of these cells. Purified T-cell junD activates GALV-TRE-driven RNA synthesis in vitro. The rapidity and the protein synthesis-independent nature of TPA-induced T-AP1 activation suggests that this complex is involved in the earliest stages of T-cell activation.	NCI,PATHOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Levens, David/C-9216-2009	Levens, David/0000-0002-7616-922X; FARINA, Antonietta Rosella/0000-0003-0962-6088				ALBERT F, 1985, J IMMUNOL, V134, P3649; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BENBROOK DM, 1990, ONCOGENE, V5, P295; BLACKSHEAR PJ, 1987, J BIOL CHEM, V262, P7774; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GIARDINA SL, 1987, ANAL BIOCHEM, V161, P109, DOI 10.1016/0003-2697(87)90659-2; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GQUINN JP, 1989, J VIROL, V63, P4713; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOLBROOK NJ, 1987, VIROLOGY, V159, P178, DOI 10.1016/0042-6822(87)90364-3; HOLBROOK NJ, 1987, MOL CELL BIOL, V7, P2610, DOI 10.1128/MCB.7.7.2610; HSINFANG YY, 1990, NEW BIOL, V2, P351; IMBODEN JB, 1985, J IMMUNOL, V134, P663; KOBIERSKI LA, 1991, P NATL ACAD SCI USA, V88, P10222, DOI 10.1073/pnas.88.22.10222; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MACKAY AR, 1992, INVAS METAST, V12, P168; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MINORI T, 1986, J BIOL CHEM, V261, P10375; MINORI T, 1986, J BIOL CHEM, V261, P2274; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OSHEA JJ, 1986, J IMMUNOL, V137, P971; QUINN JP, 1989, MOL CELL BIOL, V9, P4713, DOI 10.1128/MCB.9.11.4713; QUINN JP, 1987, MOL CELL BIOL, V7, P2735, DOI 10.1128/MCB.7.8.2735; QUINN JP, 1991, FEBS LETT, V286, P225, DOI 10.1016/0014-5793(91)80979-D; ROSENSTREICH DL, 1979, J IMMUNOL, V123, P1749; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; RYSECK RP, 1991, ONCOGENE, V6, P533; SASAKI T, 1987, FEBS LETT, V218, P87, DOI 10.1016/0014-5793(87)81024-4; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SHOEMAKER SG, 1990, P NATL ACAD SCI USA, V87, P9650, DOI 10.1073/pnas.87.24.9650; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TAYLOR MV, 1984, NATURE, V312, P462, DOI 10.1038/312462a0; THEVENIN C, 1991, J BIOL CHEM, V266, P9363; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WANO Y, 1988, P NATL ACAD SCI USA, V85, P9733, DOI 10.1073/pnas.85.24.9733; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	62	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26466	26475						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253775				2022-12-27	WOS:A1993MK42500069
J	KARIYA, K; FARRANCE, IKG; SIMPSON, PC				KARIYA, K; FARRANCE, IKG; SIMPSON, PC			TRANSCRIPTIONAL ENHANCER FACTOR-I IN CARDIAC MYOCYTES INTERACTS WITH AN ALPHA(1)-ADRENERGIC-PROTEIN AND BETA-PROTEIN KINASE-C-INDUCIBLE ELEMENT IN THE RAT BETA-MYOSIN HEAVY-CHAIN PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE ELEMENT; CAT BINDING-FACTOR; DNA-BINDING; CYCLIC-AMP; SIGNAL TRANSDUCTION; NUCLEAR-PROTEIN; HEART MYOCYTES; LEUCINE ZIPPER; PHOSPHORYLATION; ACTIVATION	In cultured rat cardiac myocytes, a 20-base pair sequence (-215/-196) of the rat beta-myosin heavy chain (MHC) promoter mediates induction by both alpha1-adrenergic stimulation and a constitutively activated beta-protein kinase C (PKC), and binds cardiac myocyte nuclear factor(s) through an ''enhancer core'' element (5'-TGTGGTATG-3') (Kariya, K, Karns, L. R., and Simpson, P. C. (1994) J. Biol. Chem. 269, in press). Here, we report identification of this enhancer core binding factor as the rat homologue of transcriptional enhancer factor-1 (TEF-1), a human transcription factor for viral enhancers. In gel mobility shift and immunoblot analyses, the myocyte factor and human TEF-1 were indistinguishable in terms of sequence recognition, mobility, and immunoreactivity. Furthermore, DNA binding activity for the beta-MHC enhancer core and TEF-1 immunoreactivity correlated closely. These results are the first to suggest a role for TEF-1 in transcriptional regulation by PKC. The data also provide direct evidence for interaction of TEF-1 with the beta-MHC promoter, supporting a function for TEF-1 in regulation of cellular gene expression, as well as viral, and outline a pathway for alpha1-adrenergic regulation of beta-MHC gene transcription in cardiac myocytes.	VET AFFAIRS MED CTR, DIV CARDIOL, 4150 CLEMENT ST, SAN FRANCISCO, CA 94121 USA; VET AFFAIRS MED CTR, RES SERV, SAN FRANCISCO, CA 94121 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL031113] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; BAKER SJ, 1992, MOL CELL BIOL, V12, P4694, DOI 10.1128/MCB.12.10.4694; BLATT C, 1993, NUCLEIC ACIDS RES, V21, P747, DOI 10.1093/nar/21.3.747; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; FLINK IL, 1992, J BIOL CHEM, V267, P9917; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GOODE N, 1992, J BIOL CHEM, V267, P16878; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; HATA A, 1989, FEBS LETT, V252, P144, DOI 10.1016/0014-5793(89)80907-X; HATA A, 1993, J BIOL CHEM, V268, P9122; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HORI Y, 1990, ONCOGENE, V5, P1201; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KARIN M, 1992, FASEB J, V6, P2581, DOI 10.1096/fasebj.6.8.1317309; KARIYA K, 1991, J BIOL CHEM, V266, P10023; KARIYA K, 1994, IN PRESS J BIOL CHEM, V269; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MEEK DW, 1992, BIOCHEM J, V287, P1; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OHNO S, 1991, ADV ENZYME REGUL, V31, P287, DOI 10.1016/0065-2571(91)90018-H; ORDAHL CP, 1992, CURR TOP DEV BIOL, V26, P145, DOI 10.1016/S0070-2153(08)60444-5; PARK EA, 1993, J BIOL CHEM, V268, P613; PARKER TG, 1991, J VASC MED BIOL, V3, P38; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; SASSONECORSI P, 1986, TRENDS GENET, V2, P215, DOI 10.1016/0168-9525(86)90233-7; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; WASPE LE, 1990, J CLIN INVEST, V85, P1206, DOI 10.1172/JCI114554; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005; WU JP, 1991, MOL ENDOCRINOL, V5, P1311, DOI 10.1210/mend-5-9-1311; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G	64	90	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26658	26662						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253797				2022-12-27	WOS:A1993MK42500093
J	TSUNEOKA, M; NAKAYAMA, K; HATSUZAWA, K; KOMADA, M; KITAMURA, N; MEKADA, E				TSUNEOKA, M; NAKAYAMA, K; HATSUZAWA, K; KOMADA, M; KITAMURA, N; MEKADA, E			EVIDENCE FOR INVOLVEMENT OF FURIN IN CLEAVAGE AND ACTIVATION OF DIPHTHERIA-TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE SECRETORY PATHWAY; PROCESSING ENDOPROTEASE; FUNCTIONAL EXPRESSION; PRECURSOR CLEAVAGE; KEX2-LIKE ENDOPROTEASE; PROTECTIVE ANTIGEN; FRAGMENT-A; VERO CELLS; YEAST KEX2; SEQUENCE	Proteolytic cleavage (nicking) of diphtheria toxin (DT) in the 14-amino acid loop subtended by the disulfide bond between Cys186 and Cys201 is required for the cytotoxic action of DT. The loop includes the consensus motif for cleavage by a membrane-anchored protease, furin. We found that a soluble form of furin cleaves intact DT between Arg198 and Ser194 in vitro. LoVo cells, a human colon carcinoma cell line, do not produce functional furin. We show here that intact DT is not cleaved by LoVo cells. The cells are resistant to intact DT, although they are sensitive to DT nicked by furin before it is added to the medium. When intact DT is added to LoVo/Fur1 cells, a stable transfectant of LoVo cells expressing mouse furin, nicked DT associated with the cells is observed. LoVo/Fur1 cells are sensitive to both intact and nicked DT. These results indicate that furin is involved in the toxicity of intact DT. Bafilomycin A1, an inhibitor of intracellular vesicle acidification, did not inhibit cleavage of intact DT by LoVo/Fur1 or Vero cells, indicating that cleavage can proceed in a neutral environment. Inhibitors of endocytosis decreased DT cleavage but did not eliminate it. We also found a small amount of nicked DT in the culture medium. These results may indicate that intact DT is cleaved by cell-associated furin on the cell surface as well as in endocytotic vesicles.	KURUME UNIV,FAC LIFE SCI,2432-3 AIKAWA,KURUME,FUKUOKA 830,JAPAN; UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,CTR GENE EXPT,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN; KANSAI MED UNIV,INST LIVER RES,MORIGUCHI,OSAKA 570,JAPAN	Kurume University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Kansai Medical University			Nakayama, Kazuhisa/ABF-2924-2020	Nakayama, Kazuhisa/0000-0001-7701-7183; Mekada, Eisuke/0000-0001-8858-4781				ARIANSEN S, 1993, BIOCHEMISTRY-US, V32, P83, DOI 10.1021/bi00052a012; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CIEPLAK W, 1988, BIOCHEM BIOPH RES CO, V157, P747, DOI 10.1016/S0006-291X(88)80313-9; CIEPLAK W, 1987, J BIOL CHEM, V262, P13246; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DRAZIN R, 1971, J BIOL CHEM, V246, P1504; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; GILL DM, 1971, J BIOL CHEM, V246, P1485; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; IWAMOTO R, 1991, J BIOL CHEM, V266, P20463; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOMADA M, 1993, FEBS LETT, V3288, P25; KORNER J, 1991, P NATL ACAD SCI USA, V88, P6834, DOI 10.1073/pnas.88.15.6834; MEKADA E, 1985, J BIOL CHEM, V260, P2148; MEKADA E, 1988, J CELL BIOL, V107, P511, DOI 10.1083/jcb.107.2.511; MEKADA E, 1979, EXP CELL RES, V123, P137, DOI 10.1016/0014-4827(79)90430-0; MIDDLEBROOK JL, 1982, EXP CELL RES, V138, P175, DOI 10.1016/0014-4827(82)90103-3; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MISUMI Y, 1990, NUCLEIC ACIDS RES, V18, P6719, DOI 10.1093/nar/18.22.6719; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; SANDVIG K, 1981, J BIOL CHEM, V256, P9068; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; TAKAHASHI S, INPRESS BIOCH BIOPHY; UCHIDA T, 1973, J BIOL CHEM, V248, P3838; UMATA T, 1990, J BIOL CHEM, V265, P21940; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; WATANABE T, 1992, J BIOL CHEM, V267, P8270; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378	43	121	127	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26461	26465						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253774				2022-12-27	WOS:A1993MK42500068
J	DELWEL, GO; HOGERVORST, F; KUIKMAN, I; PAULSSON, M; TIMPL, R; SONNENBERG, A				DELWEL, GO; HOGERVORST, F; KUIKMAN, I; PAULSSON, M; TIMPL, R; SONNENBERG, A			EXPRESSION AND FUNCTION OF THE CYTOPLASMIC VARIANTS OF THE INTEGRIN-ALPHA-6 SUBUNIT IN TRANSFECTED K562 CELLS - ACTIVATION-DEPENDENT ADHESION AND INTERACTION WITH ISOFORMS OF LAMININ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE ADHESION; TYROSINE PHOSPHORYLATION; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; SIGNAL TRANSDUCTION; SYNAPTIC CLEFT; BETA-SUBUNIT; ALPHA-CHAIN; LONG ARM; T-CELLS	Two variants of the cytoplasmic domain of the integrin alpha6 subunit have been identified (alpha6A and alpha6B). To determine the role of each variant in mediating cell adhesion to laminin, we have independently expressed the alpha6A and alpha6B subunits in K562 cells. Both variants associated with endogenous beta1 and were present at comparable levels on the surface of transfected K562 cells. After activation with phorbol ester (phorbol 12-myristate 13-acetate; PMA) or the stimulatory anti-beta1 antibody TS2/16, alpha6Abeta1 as well as alpha6Bbeta1 mediated cell adhesion to laminin and more specifically to its fragment E8. Furthermore, both integrin variants interacted with the laminin isoforms kalinin and merosin. Cell adhesion to laminin isoforms was inhibited by the alpha6-specific monoclonal antibody GoH3. PMA was less efficient in stimulating adhesion than TS2/16 and stimulated adhesion of alpha6B transfectants better than of alpha6A transfectants. In contrast, TS2/16 stimulated the adhesion of the alpha6A and alpha6B transfectants to laminin to a similar extent. These findings indicate that the cells may regulate the activation of the two alpha6 variants independently. Activation by PMA was associated with the phosphorylation of both alpha6A and alpha6B subunits, but there was no relationship between the degree of phosphorylation and the ability of the transfectants to adhere to laminin since alpha6A became phosphorylated much more strongly by PMA than alpha6B. Thus, both alpha6Abeta1 and alpha6Bbeta1 on K562 cells are activation-dependent receptors for different isoforms of laminin.	NETHERLANDS CANC INST,DEPT CELL BIOL,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS; UNIV BERN,ME MULLER INST BIOMECH,CH-3010 BERN,SWITZERLAND; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	Netherlands Cancer Institute; University of Bern; Max Planck Society								ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BROWN JC, 1991, FEBS LETT, V282, P5, DOI 10.1016/0014-5793(91)80432-3; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; COOPER HM, 1991, J CELL BIOL, V115, P843, DOI 10.1083/jcb.115.3.843; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; DEUTZMANN R, 1988, EUR J BIOCHEM, V177, P35, DOI 10.1111/j.1432-1033.1988.tb14342.x; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGVALL E, 1992, EXP CELL RES, V198, P115, DOI 10.1016/0014-4827(92)90156-3; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GISMONDI A, 1992, J EXP MED, V176, P1251, DOI 10.1084/jem.176.5.1251; GREEN TL, 1992, J BIOL CHEM, V267, P2014; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HIERCK BP, 1993, CELL ADHES COMMUN, V1, P33, DOI 10.3109/15419069309095680; HOGERVORST F, 1993, J CELL BIOL, V121, P179, DOI 10.1083/jcb.121.1.179; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTT U, 1982, EUR J BIOCHEM, V123, P63, DOI 10.1111/j.1432-1033.1982.tb06499.x; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; PAULSSON M, 1991, J BIOL CHEM, V266, P17546; PAULSSON M, 1989, J BIOL CHEM, V264, P18725; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sambrook J, 1989, MOL CLONING LABORATO; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; SONNENBERG A, 1986, CANCER RES, V46, P5913; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, EXP CELL RES, V197, P234, DOI 10.1016/0014-4827(91)90428-W; SONNENBERG A, 1988, NATURE, V336, P487, DOI 10.1038/336487a0; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; TIMPL R, 1987, METHOD ENZYMOL, V145, P363; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877	60	108	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25865	25875						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245021				2022-12-27	WOS:A1993MK10000084
J	POLAND, BW; SILVA, MM; SERRA, MA; CHO, YJ; KIM, KH; HARRIS, EMS; HONZATKO, RB				POLAND, BW; SILVA, MM; SERRA, MA; CHO, YJ; KIM, KH; HARRIS, EMS; HONZATKO, RB			CRYSTAL-STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA-COLI - EVIDENCE FOR CONVERGENT EVOLUTION OF GTP-BINDING DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CHEMICAL MODIFICATION; ATP-BINDING; SEQUENCE; IDENTIFICATION; SUBUNITS; PROTEINS; RESIDUE; CLONING; CELLS	The structure of the P2(1) crystal form of adenylosuccinate synthetase from Escherichia coli has been determined to a resolution of 2.8 angstrom. The refined model for the enzyme gives an R factor of 0.20 and a root-mean-square deviation from expected bond lengths and angles of 0.016 angstrom and 2.27-degrees, respectively. The dominant structural element of each monomer of the homodimer is a central beta-sheet of 10 strands. The first nine strands of the sheet are mutually parallel with right-handed crossover connections between the strands. The 10th strand is antiparallel with respect to the first nine strands. In addition, the enzyme has two antiparallel beta-sheets, comprised of two strands and three strands each, 11 alpha-helices and two short 3/10-helices. The overall fold of the polypeptide chain has not been observed heretofore in any other protein structure. Residues tentatively assigned to the active site of the enzyme on the basis of chemical modification and directed mutation cluster in two separate regions. Gly12, Gly15, Gly17, Lys18, Ile19, and Lys331 lie at one end of a crevice that measures 12 angstrom by 30 angstrom by 12 angstrom deep. Lys140 and Arg147 are not part of this crevice, but instead lie at the interface between monomers of the dimer. Lys140 makes a salt link with Asp231 of a monomer related by molecular symmetry and Arg147 binds to the carbonyl of the same Asp231. Superposition of the p21 ras protein (Pai, E. F., Kabsch, W., Krengel, U., Holmes, K., John, J., and Wittinghofer, A. (1989) Nature 341, 209-214) onto the synthetase reveals significant correspondences between side chains of the two proteins. Residues which interact with GTP in the p21ras protein have structurally equivalent residues in the synthetase. The GTP molecule, when transformed to the coordinate frame of the synthetase, falls into the crevice defined by studies in directed mutation. We suggest that the similarities in the GTP-binding domains of the synthetase and the p21ras protein are an example of convergent evolution of two distinct families of GTP-binding proteins.	IOWA STATE UNIV SCI & TECHNOL,DEPT BIOCHEM & BIOPHYS,1210 MOLEC BIOL BLDG,AMES,IA 50011	Iowa State University								BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BASS MB, 1986, J BIOL CHEM, V259, P12330; BLOW DM, 1959, ACTA CRYSTALLOGR, V14, P1195; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CLARK SW, 1976, BIOCHIM BIOPHYS ACTA, V437, P87, DOI 10.1016/0304-4165(76)90349-4; COOPER BF, 1986, BIOCHEMISTRY-US, V25, P7323, DOI 10.1021/bi00371a013; COX JM, 1967, J MOL BIOL, V28, P151, DOI 10.1016/S0022-2836(67)80083-4; CROWTHER RA, 1971, MOL REPLACEMENT METH, P173; DONG Q, 1990, ARCH BIOCHEM BIOPHYS, V276, P77, DOI 10.1016/0003-9861(90)90012-N; DONG Q, 1991, J BIOL CHEM, V266, P12228; DONG Q, 1990, J BIOL CHEM, V265, P6235; EICHELE G, 1979, J MOL BIOL, V133, P161, DOI 10.1016/0022-2836(79)90255-9; FROMM HJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P255, DOI 10.1016/0006-3002(58)90182-3; GUICHERIT MO, 1992, J BIOL CHEM, V266, P22582; HALLIDAY KR, 1984, J CYCLIC NUCL PROT, V9, P435; HIGGINS CF, 1988, BIOESSAYS, V8, P111, DOI 10.1002/bies.950080406; ISHII K, 1970, J BIOCHEM-TOKYO, V68, P171, DOI 10.1093/oxfordjournals.jbchem.a129343; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; KANG C, 1993, IN PRESS ARCH BIOCH; KE HM, 1988, J MOL BIOL, V204, P725, DOI 10.1016/0022-2836(88)90365-8; LIEBERMAN I, 1956, J BIOL CHEM, V223, P327; LIU F, 1992, J BIOL CHEM, V267, P2388; LOCHRIE MA, 1988, BIOCHEMISTRY-US, V27, P4957, DOI 10.1021/bi00414a001; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MANTSALA P, 1992, J BACTERIOL, V174, P1883; MARKHAM DG, 1977, ARCH BIOCHEM BIOPHYS, V184, P24; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; POWELL SM, 1992, FEBS LETT, V303, P4, DOI 10.1016/0014-5793(92)80465-S; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SERRA MA, 1988, J MOL BIOL, V200, P753, DOI 10.1016/0022-2836(88)90489-5; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; VANDERWE.MB, 1974, J BIOL CHEM, V249, P7282; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBB MR, 1984, J BIOL CHEM, V259, P3044; WIESMULLER L, 1991, J BIOL CHEM, V266, P2480; WOLFE SA, 1988, J BIOL CHEM, V263, P19147; WYNGAARDEN JB, 1963, J BIOL CHEM, V238, P1054	42	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25334	25342						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244965				2022-12-27	WOS:A1993MK10000012
J	TANIZAWA, A; BERTRAND, R; KOHLHAGEN, G; TABUCHI, A; JENKINS, J; POMMIER, Y				TANIZAWA, A; BERTRAND, R; KOHLHAGEN, G; TABUCHI, A; JENKINS, J; POMMIER, Y			CLONING OF CHINESE-HAMSTER DNA TOPOISOMERASE-I CDNA AND IDENTIFICATION OF A SINGLE-POINT MUTATION RESPONSIBLE FOR CAMPTOTHECIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINE; LUNG-CANCER; DC3F CELLS; GENE; SEQUENCE; BINDING; MECHANISM; REPLICATION; INHIBITION; COVALENT	A camptothecin-resistant (DC3F/C-10) Chinese hamster cell line that contains a catalytically altered and camptothecin (CPT)-resistant DNA topoisomerase I (top 1) (Tanizawa, A., and Pommier, Y. (1992) Cancer Res. 52, 1848-1854) and the parent cell line (DC3F) were used to compare top 1 mRNAs and cDNAs. Northern blot analysis showed a single 4.1-kilobase band without quantitative reduction between the two cell lines. We have cloned and sequenced top 1 cDNAs. DC3F and DC3F/C-10 top 1 c-DNA are 3591 and 3626 base pair long, respectively, and encode 767 amino acids. The homology of deduced amino acid sequences between Chinese hamster and mouse or human top 1 are 98.1 and 96.7, respectively. cDNAs from DC3F/C-10 and DC3F cells differ by a single base point mutation (G to A) which results in an amino acid change from Gly505 to Ser (Gly505 --> Ser). G505 corresponds to Gly503 of human top 1 cDNA and is located 220 amino acids away from the presumed catalytic Tyr725. The point mutation in the Chinese hamster top 1 is located in a region that is highly conserved among all cloned top 1 cDNAs (plant ATH, vaccinia virus, Shope fibroma virus, Drosophila, Saccharomyces cerevisiae, Schizosaccharomyces pombe, mouse, and Human). A mutation of Asp533 to Gly in this same region has been shown to confer CPT resistance for human top 1. Chinese hamster top 1 protein with a Gly505 --> Ser mutation that was expressed in bacteria was resistant to CPT, indicating that this single base mutation is involved in CPT resistance. Our results suggest that the highly conserved region around Gly505 plays an important role in the interactions among top 1, DNA, and CPT.	NCI,DIV CANC TREATMENT,MOLEC PHARMACOL LAB,BLDG 37,RM 5C25,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; ANDOH T, 1987, P NATL ACAD SCI USA, V84, P5565, DOI 10.1073/pnas.84.16.5565; ANDOH T, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P229; CHANG JY, 1992, BIOCHEM PHARMACOL, V43, P2443, DOI 10.1016/0006-2952(92)90325-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1565; CROW RT, 1992, J MED CHEM, V35, P4160, DOI 10.1021/jm00100a022; DARPA P, 1988, P NATL ACAD SCI USA, V85, P2543, DOI 10.1073/pnas.85.8.2543; ENG WK, 1990, MOL PHARMACOL, V38, P471; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUPTA M, 1992, J BIOL CHEM, V34, P24177; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; HSIEH TS, 1992, NUCLEIC ACIDS RES, V20, P6177, DOI 10.1093/nar/20.23.6177; JAXEL C, 1991, J BIOL CHEM, V266, P20418; JAXEL C, 1989, CANCER RES, V49, P1465; Jaxel C., 1991, DNA TOPOISOMERASES C, P182; KANZAWA F, 1990, CANCER RES, V50, P5919; KOIWAI O, 1992, IN PRESS GENE AMST; KUBOTA N, 1992, BIOCHEM BIOPH RES CO, V188, P571, DOI 10.1016/0006-291X(92)91094-7; LETEURTRE F, 1993, BIOCHEMISTRY-US, V32, P8955, DOI 10.1021/bi00085a029; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MADDEN KR, 1992, CANCER RES, V52, P525; MADELAINE I, 1993, BIOCHEM PHARMACOL, V45, P339, DOI 10.1016/0006-2952(93)90069-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORHAM SG, 1992, J BIOL CHEM, V267, P15984; POMMIER Y, 1993, FRONTIERS PHARM CANC, P214; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; SLICHENMYER WJ, 1993, JNCI-J NATL CANCER I, V85, P271, DOI 10.1093/jnci/85.4.271; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; TAMURA H, 1991, NUCLEIC ACIDS RES, V19, P69, DOI 10.1093/nar/19.1.69; TAN KB, 1989, J NATL CANCER I, V81, P1732, DOI 10.1093/jnci/81.22.1732; TANIZAWA A, 1992, CANCER RES, V52, P1848; THRASH C, 1985, P NATL ACAD SCI USA, V82, P4374, DOI 10.1073/pnas.82.13.4374; TSAO YP, 1992, CANCER RES, V52, P1823; UEMURA T, 1987, NUCLEIC ACIDS RES, V15, P9727, DOI 10.1093/nar/15.23.9727; UPTON C, 1990, VIROLOGY, V176, P439, DOI 10.1016/0042-6822(90)90013-H	39	90	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25463	25468						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244980				2022-12-27	WOS:A1993MK10000030
J	CIOSEK, CP; MAGNIN, DR; HARRITY, TW; LOGAN, JVH; DICKSON, JK; GORDON, EM; HAMILTON, KA; JOLIBOIS, KG; KUNSELMAN, LK; LAWRENCE, RM; MOOKHTIAR, KA; RICH, LC; SLUSARCHYK, DA; SULSKY, RB; BILLER, SA				CIOSEK, CP; MAGNIN, DR; HARRITY, TW; LOGAN, JVH; DICKSON, JK; GORDON, EM; HAMILTON, KA; JOLIBOIS, KG; KUNSELMAN, LK; LAWRENCE, RM; MOOKHTIAR, KA; RICH, LC; SLUSARCHYK, DA; SULSKY, RB; BILLER, SA			LIPOPHILIC 1,1-BISPHOSPHONATES ARE POTENT SQUALENE SYNTHASE INHIBITORS AND ORALLY-ACTIVE CHOLESTEROL-LOWERING AGENTS IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; BETA-METHYLGLUTARYL COENZYME; DENSITY LIPOPROTEIN RECEPTOR; COMPETITIVE INHIBITOR; MOLECULAR-CLONING; BIOSYNTHESIS; SYNTHETASE; STEROL; RAT; 3-HYDROXY-3-METHYLGLUTARYL	Squalene synthase catalyzes the reductive dimerization of two molecules of farnesyl diphosphate to form squalene at the final branchpoint of the cholesterol biosynthetic pathway. We report herein that isoprenyl 1,1-bisphosphonates and related analogs are potent inhibitors of rat microsomal squalene synthase (I50 = 0.7-32 nM). In addition, members of this family are potent inhibitors of cholesterol biosynthesis in rats on intravenous and oral dosing, as well as cholesterol lowering agents in rats and hamsters. Significant inhibition of cholesterol biosynthesis in rats by lovastatin occurs with a concomitant inhibition of dolichol and coenzyme-Q9 synthesis. In contrast, bisphosphonate 4 has no effect on dolichol and coenzyme-Q9 biosynthesis in rats under conditions where cholesterol biosynthesis is >90% inhibited.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DIV DISCOVERY CHEM, PRINCETON, NJ 08543 USA	Bristol-Myers Squibb	CIOSEK, CP (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT METAB DIS, PRINCETON, NJ 08543 USA.							AGNEW WS, 1985, METHOD ENZYMOL, V110, P359; AMIN D, 1992, J LIPID RES, V33, P1657; ARBEENY CM, 1991, BIOCHIM BIOPHYS ACTA, V1096, P238, DOI 10.1016/0925-4439(91)90011-W; BAXTER A, 1992, J BIOL CHEM, V267, P11705; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BILLER SA, 1993, BIOORG MED CHEM LETT, V3, P595, DOI 10.1016/S0960-894X(01)81236-1; BILLER SA, 1992, ACS SYM SER, V497, P65; BILLER SA, 1991, J MED CHEM, V34, P1912, DOI 10.1021/jm00110a024; BILLER SA, 1991, J AM CHEM SOC, V113, P8522, DOI 10.1021/ja00022a050; BILLER SA, 1992, Patent No. 5157027; CHRISTOPHE J, 1961, J LIPID RES, V2, P244; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DUGAN RE, 1972, ARCH BIOCHEM BIOPHYS, V152, P21, DOI 10.1016/0003-9861(72)90188-9; ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x; EPSTEIN WW, 1970, J BIOL CHEM, V245, P4597; FEGUEUR M, 1991, CURR GENET, V20, P365, DOI 10.1007/BF00317063; Fleisch H., 1988, HDB EXPT PHARM, V83, P441; GONZALEZPACANOWSKA D, 1988, J BIOL CHEM, V263, P1301; GRUNDY SM, 1988, NEW ENGL J MED, V319, P24; HOEG JM, 1987, JAMA-J AM MED ASSOC, V258, P3532, DOI 10.1001/jama.258.24.3532; HORIE M, 1990, J BIOL CHEM, V265, P18075; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; KELLER RK, 1989, CHEM PHYS LIPIDS, V51, P261, DOI 10.1016/0009-3084(89)90013-3; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; MCKENZIE TL, 1992, J BIOL CHEM, V267, P21368; NAKAMURA CE, 1985, BIOCHEMISTRY-US, V24, P1364, DOI 10.1021/bi00327a014; Poulter C, 1981, BIOSYNTHESIS ISOPREN, P413; Poulter C. D., 1981, BIOSYNTHESIS ISOPREN, V1, P161; POULTER CD, 1990, ACCOUNTS CHEM RES, V23, P70, DOI 10.1021/ar00171a003; RAHIER A, 1990, BIOCHEM SOC T, V18, P48, DOI 10.1042/bst0180048; RILLING HC, 1985, BIOCHEM SOC T, V13, P997, DOI 10.1042/bst0130997; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706, DOI 10.1128/MCB.13.5.2706; SPADY DK, 1985, P NATL ACAD SCI USA, V82, P4526, DOI 10.1073/pnas.82.13.4526; TSUJITA Y, 1986, BIOCHIM BIOPHYS ACTA, V877, P50, DOI 10.1016/0005-2760(86)90117-7; WAREING JR, 1986, Patent No. 4613610	36	105	108	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24832	24837						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227045				2022-12-27	WOS:A1993MG67300049
J	PARYS, JB; MISSIAEN, L; DESMEDT, H; CASTEELS, R				PARYS, JB; MISSIAEN, L; DESMEDT, H; CASTEELS, R			LOADING DEPENDENCE OF INOSITOL 1,4,5-TRISPHOSPHATE-INDUCED CA2+ RELEASE IN THE CLONAL CELL-LINE A7R5 - IMPLICATIONS FOR THE MECHANISM OF QUANTAL CA2+ RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE-SENSITIVE STORES; CALCIUM RELEASE; LUMINAL CA2+; INTRACELLULAR STORES; ENDOPLASMIC-RETICULUM; INTRALUMINAL CA2+; SMOOTH-MUSCLE; RECEPTOR; MOBILIZATION; INSP3	The Ca2+ content of the intracellular Ca2+ stores controls the inositol 1,4,5-trisphosphate receptor (InsPsR) in the clonal cell line A7r5. This regulation was characterized with respect to the understanding of the ''quantal'' release phenomenon. Independent of the loading protocol used, increasing the Ca2+ content of the stores increased the sensitivity of the inositol 1,4,5-trisphosphate (InsP3)-induced Ca2+ release until a Ca2+ content of about 30% of the steady-state value was reached. Loading of the stores to higher levels had only a marginal effect on the Ca2+ release. The effects of luminal Ca2+ were still observed in the presence of 10 mM BAPTA (1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), excluding the possibility that luminal Ca2+ acted indirectly via cytoplasmic binding sites. Conditions were developed to simultaneously measure [H-3]InsP3 binding to the InSP3R and the Ca-45(2+) content of the stores in the same cells. [H-3] InsP3 binding to a high affinity binding site was potentiated by luminal Ca2+. Analysis at the molecular level revealed the simultaneous expression of different splice variants of InsP3R-I, as well as the expression of InsP3R-III, and of the putative InsP3R-IV. We conclude that the control of the InSP3R by luminal Ca2+ could account for quantal release and that the observed heterogeneity of the InsP3R may also contribute to this behavior, especially at high levels of store loading.			PARYS, JB (corresponding author), CATHOLIC UNIV LEUVEN, FYSIOL LAB, CAMPUS GASTHUISBERG O-N, B-3000 LOUVAIN, BELGIUM.			Parys, Jan/0000-0002-3591-4967				BAUMANN O, 1989, J COMP PHYSIOL A, V165, P627, DOI 10.1007/BF00610994; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COMBETTES L, 1992, FEBS LETT, V301, P287, DOI 10.1016/0014-5793(92)80258-I; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; HILLY M, 1993, J BIOL CHEM, V268, P16488; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; ILYIN V, 1992, J PHYSIOL-LONDON, V448, P339, DOI 10.1113/jphysiol.1992.sp019045; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KINDMAN LA, 1993, BIOCHEMISTRY-US, V32, P1270, DOI 10.1021/bi00056a011; LOOMISHUSSELBEE JW, 1993, BIOCHEM J, V289, P861, DOI 10.1042/bj2890861; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MARKS AR, 1990, J BIOL CHEM, V265, P20719; MARSHALL ICB, 1993, J BIOL CHEM, V268, P13214; MENNITI FS, 1991, J BIOL CHEM, V266, P13646; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1993, BIOCHEM BIOPH RES CO, V193, P6, DOI 10.1006/bbrc.1993.1582; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MUALLEM S, 1989, J BIOL CHEM, V264, P205; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NUNN DL, 1990, BIOCHEM J, V270, P227, DOI 10.1042/bj2700227; NUNN DL, 1992, MOL PHARMACOL, V41, P115; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; OLDERSHAW KA, 1991, BIOCHEM J, V278, P705, DOI 10.1042/bj2780705; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; PARYS JB, 1992, J BIOL CHEM, V267, P18776; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; ROUXEL FP, 1992, J BIOL CHEM, V267, P20017; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SAYERS LG, 1993, BIOCHEM J, V289, P883, DOI 10.1042/bj2890883; SCHELL MJ, 1993, MOL BRAIN RES, V17, P212, DOI 10.1016/0169-328X(93)90004-9; SHUTTLEWORTH TJ, 1992, J BIOL CHEM, V267, P3573; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; TAYLOR CW, 1990, BIOCHEM J, V266, P189, DOI 10.1042/bj2660189; TAYLOR CW, 1992, TRENDS BIOCHEM SCI, V17, P403, DOI 10.1016/0968-0004(92)90009-X; TREGEAR RT, 1991, P ROY SOC B-BIOL SCI, V243, P263, DOI 10.1098/rspb.1991.0040; TSHIPAMBA M, 1993, J CELL PHYSIOL, V155, P96, DOI 10.1002/jcp.1041550113	54	100	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25206	25212						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227085				2022-12-27	WOS:A1993MG67300098
J	RUGOLO, M; MASTROCOLA, T; WHORLE, C; RASOLA, A; GRUENERT, DC; ROMEO, G; GALIETTA, LJV				RUGOLO, M; MASTROCOLA, T; WHORLE, C; RASOLA, A; GRUENERT, DC; ROMEO, G; GALIETTA, LJV			ATP AND A(1) ADENOSINE RECEPTOR AGONISTS MOBILIZE INTRACELLULAR CALCIUM AND ACTIVATE K+ AND CL- CURRENTS IN NORMAL AND CYSTIC-FIBROSIS AIRWAY EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; PHOSPHOLIPASE-C; ACINAR-CELLS; CHANNELS; CA-2+; LINE; THAPSIGARGIN; SECRETION	The effect of purinergic compounds on [Ca2+]i and membrane currents of cell lines derived from the airway epithelium of normal and cystic fibrosis individuals has been investigated. 2-Chloroadenosine (2-CADO), as well as other agonists of the A1 adenosine receptors, causes a transient elevation of cytosolic [Ca2+] that is antagonized by the A1 adenosine receptor antagonist 8-cyclopentyl-1,3 dipropylxanthine (DPCPX). ATP is also effective, but at a lower extent. The [Ca2+]i increase induced by 2-CADO and ATP is abolished by preincubation with phorbol 12-myristate 13-acetate and the Ca2+-ATPase inhibitor thapsigargin. This latter result suggests that purinergic agonists mobilize Ca2+ from inositol 1,4,5-trisphosphate-sensitive stores. Pertussis toxin completely inhibits the effect of 2-CADO, whereas only it partially affects that of ATP, suggesting the involvement of different types of G proteins. Perforated patch clamp experiments carried out in both current clamp and voltage clamp modes show that 2-CADO and ATP activate K+- and Cl--selective membrane currents, with a mechanism inhibited by preincubation with DPCPX and thapsigargin. These data indicate that activation of adenosine A1 receptor, in a similar way to ATP receptor, causes [Ca2+]i increase and ion channels activation through a transduction mechanism that is not impaired in cystic fibrosis airway epithelial cells.	UNIV CALIF SAN FRANCISCO,CARDIOVASC & CANC RES INST,DEPT LAB MED,SAN FRANCISCO,CA 94143; IST GIANNINA GASLINI,GENET MOLEC LAB,I-16148 GENOA,ITALY	University of California System; University of California San Francisco; University of Genoa; IRCCS Istituto Giannina Gaslini	RUGOLO, M (corresponding author), UNIV BOLOGNA,DIPARTIMENTO BIOL,BIOCHIM LAB,VIA IRNERIO 42,I-40126 BOLOGNA,ITALY.		Galietta, Luis JV/HCG-8692-2022; Rugolo, Michela/AAY-8640-2020	Rasola, Andrea/0000-0003-4522-3008; Galietta, Luis/0000-0001-8686-3461; Rugolo, Michela/0000-0002-4597-0452				ALI H, 1990, J BIOL CHEM, V265, P745; BROWN HA, 1991, MOL PHARMACOL, V40, P648; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; COZENS AL, 1991, ADV EXP MED BIOL, V290, P187; COZENS AL, 1992, P NATL ACAD SCI USA, V89, P5171, DOI 10.1073/pnas.89.11.5171; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; GALIETTA LJV, 1991, BIOCHEM BIOPH RES CO, V179, P1155, DOI 10.1016/0006-291X(91)91692-6; GALIETTA LJV, 1992, FEBS LETT, V304, P61, DOI 10.1016/0014-5793(92)80589-9; GERWINS P, 1992, J BIOL CHEM, V267, P16081; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HORN R, 1988, J GEN PHYSIOL, V92, P85; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LAZAROWSKI ER, 1992, BRIT J PHARMACOL, V106, P774, DOI 10.1111/j.1476-5381.1992.tb14412.x; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OCONNOR SE, 1991, TRENDS PHARMACOL SCI, V12, P137, DOI 10.1016/0165-6147(91)90530-6; SCHWIEBERT EM, 1992, J CLIN INVEST, V89, P834, DOI 10.1172/JCI115662; STILES GL, 1992, J BIOL CHEM, V267, P6451; STONE TW, 1991, GEN PHARMACOL, V22, P25, DOI 10.1016/0306-3623(91)90305-P; STUTTS MJ, 1992, P NATL ACAD SCI USA, V89, P1621, DOI 10.1073/pnas.89.5.1621; TAN YP, 1992, P NATL ACAD SCI USA, V89, P11229, DOI 10.1073/pnas.89.23.11229; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Trivedi B. H., 1990, ADENOSINE ADENOSINE, P57; WATSON S, 1991, TRENDS PHARMACOL SCI, V12, P25; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WORRELL RT, 1989, AM J PHYSIOL, V256, pC1111, DOI 10.1152/ajpcell.1989.256.6.C1111	29	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24779	24784						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227038				2022-12-27	WOS:A1993MG67300041
J	CHEN, M; SCHNERMANN, J; SMART, AM; BROSIUS, FC; KILLEN, PD; BRIGGS, JP				CHEN, M; SCHNERMANN, J; SMART, AM; BROSIUS, FC; KILLEN, PD; BRIGGS, JP			CYCLIC-AMP SELECTIVELY INCREASES RENIN MESSENGER-RNA STABILITY IN CULTURED JUXTAGLOMERULAR GRANULAR CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; GLUCOSE-TRANSPORTER; CAMP; PROTEIN; CDNA; IDENTIFICATION; TRANSCRIPTION; DETERMINANTS; ELEMENTS; CLONING	This study was undertaken to examine the regulation of renin release and gene expression in primary cultures of juxtaglomerular granular (JGG) cells. JGG cells, isolated from mouse kidney, demonstrated high purity and showed regulated renin release in vitro. Changes in steady-state renin mRNA levels were assessed by quantitative polymerase chain reaction techniques, with polymerase chain reaction amplification efficiency monitored by co-amplification of experimental samples with a dilution series of cDNA for a mutant template. When the cells were incubated in the presence or absence of forskolin, isoproterenol, or 8-bromo-cAMP plus 3-isobutyl-1-methylxanthine for 24 h or cholera toxin for 12 h, renin mRNA levels were increased 3.9-, 4.4-, 5.1-, and 3.3-fold, respectively (all, p < 0.05). A significant increase in renin mRNA levels was observed 8 h after treatment with forskolin, but no change was detectable at 4 h. Cycloheximide did not prevent the increase in renin mRNA by isoproterenol. When RNA synthesis was inhibited by incubation with actinomycin D (5 mug/ml), renin mRNA levels declined with a half-life of 3.0 +/- 0.8 h. Treatment with forskolin increased renin mRNA half-life to 10.8 +/- 2.7 h (p < 0.025). The half-life of beta-actin, endothelin-1, or the facilitative glucose transporter-1 (GLUT-1) mRNA expressed in the same cells was not altered, although the steady-state levels of GLUT-1 mRNA increased 2.2-fold after treatment with forskolin. These data demonstrate that cAMP increases renin release and mRNA levels in JGG cells in vitro, that the stimulatory effect of cAMP on renin mRNA is delayed but does not require new protein synthesis, and that the increased renin mRNA levels induced by cAMP are due in part to a selective increase in renin mRNA stability.	UNIV MICHIGAN,DEPT INTERNAL MED,DIV NEPHROL,1150 W MED CTR DR,1560 MSRB 2,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PHYSIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PATHOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Briggs, Josephine P/B-9394-2009	Briggs, Josephine P/0000-0003-0798-1190	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R01DK040042, R01DK037448] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-37448, DK-39255, DK40042] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BURNHAM CE, 1987, P NATL ACAD SCI USA, V84, P5605, DOI 10.1073/pnas.84.16.5605; BURT DW, 1989, J BIOL CHEM, V264, P7357; CHEN M, 1993, HYPERTENSION, V21, P36, DOI 10.1161/01.HYP.21.1.36; CORNELIUS P, 1991, J CELL PHYSIOL, V146, P298, DOI 10.1002/jcp.1041460215; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; DONG Y, 1989, J BIOL CHEM, V264, P13679; DUNCAN KG, 1990, P NATL ACAD SCI USA, V87, P7588, DOI 10.1073/pnas.87.19.7588; DZAU VJ, 1988, AM J PHYSIOL, V255, pF563, DOI 10.1152/ajprenal.1988.255.4.F563; EVERETT AD, 1990, J CLIN INVEST, V86, P169, DOI 10.1172/JCI114680; FARAJ AH, 1992, APMIS, V100, P29, DOI 10.1111/j.1699-0463.1992.tb00836.x; FUKAMIZU A, 1988, J MOL BIOL, V201, P443, DOI 10.1016/0022-2836(88)90151-9; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; HORIUCHI M, 1991, J BIOL CHEM, V266, P16247; INOUE A, 1989, J BIOL CHEM, V264, P14954; IWAI N, 1992, J HYPERTENS, V10, P717; JUNGMANN RA, 1983, J BIOL CHEM, V258, P5312; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KRANE IM, 1991, MOL ENDOCRINOL, V5, P469, DOI 10.1210/mend-5-4-469; KURTZ A, 1991, KIDNEY INT, V39, pS13; KURTZ A, 1986, AM J PHYSIOL, V250, pC563, DOI 10.1152/ajpcell.1986.250.4.C563; LYKKEGARD S, 1976, ANAL BIOCHEM, V75, P250, DOI 10.1016/0003-2697(76)90076-2; MARSDEN PA, 1991, AM J PHYSIOL, V261, pF117, DOI 10.1152/ajprenal.1991.261.1.F117; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NAKAMURA N, 1989, P NATL ACAD SCI USA, V86, P56, DOI 10.1073/pnas.86.1.56; PAEK I, 1987, MOL CELL BIOL, V7, P1496, DOI 10.1128/MCB.7.4.1496; PANTHIER JJ, 1982, EMBO J, V1, P1417, DOI 10.1002/j.1460-2075.1982.tb01332.x; RAYSON BM, 1992, AM J PHYSIOL, V262, pC563, DOI 10.1152/ajpcell.1992.262.3.C563; RIGHTSEL WA, 1982, CIRC RES, V50, P822, DOI 10.1161/01.RES.50.6.822; RODGERS JR, 1985, METHOD ENZYMOL, V109, P572; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; RUYTER JHC, 1925, Z ZELLFORSCH, V2, P242; SAKAUE M, 1991, J BIOL CHEM, V266, P5743; SAKURAI T, 1991, BIOCHEM BIOPH RES CO, V175, P44, DOI 10.1016/S0006-291X(05)81197-0; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; SMITH DL, 1991, MOL CELL ENDOCRINOL, V80, P139, DOI 10.1016/0303-7207(91)90150-Q; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; WANG Y, 1992, HYPERTENSION, V20, P776, DOI 10.1161/01.HYP.20.6.776; WILKINSON L, 1989, SYSTAT SYSTEM STATIS	41	100	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24138	24144						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226960				2022-12-27	WOS:A1993MF29400064
J	DIMARCO, E; CUTULI, N; GUERRA, L; CANCEDDA, R; DELUCA, M				DIMARCO, E; CUTULI, N; GUERRA, L; CANCEDDA, R; DELUCA, M			MOLECULAR-CLONING OF TRKE, A NOVEL TRK-RELATED PUTATIVE TYROSINE KINASE RECEPTOR ISOLATED FROM NORMAL HUMAN KERATINOCYTES AND WIDELY EXPRESSED BY NORMAL HUMAN TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; NEUROTROPHIN RECEPTORS; CELL-LINES; PROTOONCOGENE; FAMILY; DIFFERENTIATION; INTERNALIZATION; EPITHELIUM; ADHESION	We have identified and cloned a new member of the trk gene family, termed trkE, which generates a 3.9-kilobase (kb) transcript in normal human keratinocytes and in a variety of normal human tissues, but not in liver. Albeit at low level, trkE transcript is expressed also by PC12 cells. The open reading frame codes for a polypeptide of 876 amino acids exhibiting the classic features of cell surface tyrosine protein kinases. trkE catalytic domain is 41% identical to trkA and shows several features unique to the trk gene family. Its extracellular domain does not show significant homology to any known proteins. trkE is the first member of this gene family found abundantly and widely expressed in normal human tissues. Several lines of evidence suggest that NGF is also the ligand for trkE; (i) normal human keratinocytes bind NGF with high affinity, (ii) NGF stimulates keratinocyte growth in an autocrine fashion, (iii) NGF exerts its biological effect on keratinocytes through the stimulation of a trk-specific tyrosine kinase, and (iv) keratinocytes lack trkA but do express large amount of trkE. trkE might also be the NGF receptor by other human peripheral tissues, such as pancreatic islets, and might represent a non-neuronal receptor for this ligand.	IST NAZL RIC CANC,IST,DIFFERENZIAMENTO CELLULARE LAB,VIALE BENEDETTO XV 10,I-16132 GENOA,ITALY	University of Genoa; IRCCS AOU San Martino IST			Guerra, Liliana/G-8849-2016; De Luca, Michele/N-5883-2014	De Luca, Michele/0000-0002-0850-8445; Guerra, Liliana/0000-0001-6274-6607				BARKER PA, 1993, J BIOL CHEM, V268, P15150; BERG MM, 1992, J BIOL CHEM, V267, P13; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DELUCA M, 1988, J CELL BIOL, V107, P1919, DOI 10.1083/jcb.107.5.1919; DELUCA M, 1990, TRANSPLANTATION, V50, P454, DOI 10.1097/00007890-199009000-00019; DELUCA M, 1990, P NATL ACAD SCI USA, V87, P6888, DOI 10.1073/pnas.87.17.6888; DIMARCO E, 1991, J BIOL CHEM, V266, P21718; DIMARCO E, 1993, J BIOL CHEM, V268, P22838; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P5423, DOI 10.1073/pnas.90.12.5423; EVELETH DD, 1992, J CELL BIOL, V117, P291, DOI 10.1083/jcb.117.2.291; EVELETH DD, 1988, NEURON, V1, P929, DOI 10.1016/0896-6273(88)90150-X; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; GRECO A, 1992, ONCOGENE, V7, P237; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAHLE P, 1992, J BIOL CHEM, V267, P13917; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MARCHISIO PC, 1991, J CELL BIOL, V112, P761, DOI 10.1083/jcb.112.4.761; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PARVINEN M, 1992, J CELL BIOL, V117, P629, DOI 10.1083/jcb.117.3.629; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; POLAK M, 1993, P NATL ACAD SCI USA, V90, P5781, DOI 10.1073/pnas.90.12.5781; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROMAGNOLI G, 1990, NEW ENGL J MED, V323, P527, DOI 10.1056/NEJM199008233230806; SAFFIONI S, 1993, ANN REV BIOCH, V62, P823; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TAPLEY P, 1992, ONCOGENE, V7, P371; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VALIUS B, 1993, CELL, V73, P321; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	57	81	87	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24290	24295						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226977				2022-12-27	WOS:A1993MF29400086
J	KOLODNEY, MS; ELSON, EL				KOLODNEY, MS; ELSON, EL			CORRELATION OF MYOSIN LIGHT-CHAIN PHOSPHORYLATION WITH ISOMETRIC CONTRACTION OF FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; STRESS FIBERS; DIFFERENTIAL EXPRESSION; CYTOPLASMIC MYOSINS; COLLAGEN GELS; KINASE; CELLS; INVITRO; ACTIVATION; CULTURE	In vitro studies have indicated that the enzymatic activity of myosin II from non-muscle cells is controlled by phosphorylation of its regulatory light chain (LC20). We have studied one likely functional consequence of phosphorylating LC20 in living chick embryo fibroblasts (CEF) by measuring contractile force developed by these cells. Using a recently developed method, we recorded quantitative changes in isometric force generated by a population of cells following mitogenic stimulation. Fetal bovine serum, thrombin, and lysophosphatidic acid stimulate rapid isometric contraction of CEF. Cells stimulated with thrombin develop maximal force within 5-10 min. Force development correlates temporally with a 3-5-fold increase in the overall fraction of LC20 phosphorylated and with the fractions of LC20 in both the monophosphorylated and diphosphorylated states. Unloaded shortening velocity also increases after thrombin stimulation. Although both force and phosphorylation begin to decline 10 min after stimulation, the level of phosphorylation declined more rapidly than the force. These results suggest that the role of LC20 phosphorylation in regulating fibroblast contractility is analogous to its well established role in regulating smooth muscle contraction and that quantitative measurements of the force developed by populations of fibroblasts (or other cultured cells) can be used to study the regulation of non-sarcomeric myosin at the molecular level in vivo.			KOLODNEY, MS (corresponding author), WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110, USA.			kolodney, Michael/0000-0003-1931-8644	NIGMS NIH HHS [GM-38838, T32 GM-07200] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200, R01GM038838] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; BELLOWS CG, 1982, J CELL SCI, V58, P125; BURRIDGE K, 1981, NATURE, V294, P691, DOI 10.1038/294691a0; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; GIULIANO KA, 1990, CELL MOTIL CYTOSKEL, V16, P14, DOI 10.1002/cm.970160104; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; HENDEY B, 1989, J BIOL CHEM, V264, P19540; HOLZAPFEL G, 1983, EXP CELL RES, V148, P117, DOI 10.1016/0014-4827(83)90192-1; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1986, J BIOL CHEM, V261, P36; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; KUMAR CC, 1989, BIOCHEMISTRY-US, V28, P4027, DOI 10.1021/bi00435a059; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; MURPHY RA, 1980, HDB PHYSL 2, V2, P325; PAUL RJ, 1983, FED PROC, V42, P62; RICHARDSON MR, 1987, IN VITRO CELL DEV B, V23, P21; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; SOBIESZEK A, 1986, ELECTROPHORESIS, V7, P417, DOI 10.1002/elps.1150070906; TAYLOR DA, 1988, J BIOL CHEM, V263, P14456; Titus MA, 1993, CURR OPIN CELL BIOL, V5, P77, DOI 10.1016/S0955-0674(05)80011-0; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431	28	165	169	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23850	23855						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226923				2022-12-27	WOS:A1993MF29400025
J	PLATT, OS; LUX, SE; FALCONE, JF				PLATT, OS; LUX, SE; FALCONE, JF			A HIGHLY CONSERVED REGION OF HUMAN ERYTHROCYTE ANKYRIN CONTAINS THE CAPACITY TO BIND SPECTRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT-MEMBRANE INTERACTIONS; ANION-EXCHANGER; BRAIN ANKYRIN; HEREDITARY SPHEROCYTOSIS; CYTOPLASMIC DOMAIN; FUNCTIONAL DOMAINS; SITE-SPECIFICITY; STRUCTURAL BASIS; ATTACHMENT SITE; PLASMA-MEMBRANE	Ankyrin has a spectrin-binding region within a central 62-kDa chymotryptic peptide. We examined the spectrin binding ability of a series of smaller ankyrin fragments and recombinant peptides within the 62-kDa domain using a ligand blot assay. The smallest proteolytic fragment that bound was a 12-kDa tryptic peptide starting at amino acid 1068. Peptides containing this region expressed as glutathione S-transferase fusion products also bound spectrin and suggested that residues 1101-1192 were important. In contrast, a fusion protein containing residues 826-898 did not bind spectrin, a surprising finding since this region is known to influence binding affinity. Proteins that bound spectrin on ligand blots also competed for binding in solution, but did so with one-tenth the affinity of the native peptide. Comparing the 62-kDa domains of erythrocyte and brain ankyrins (species that bind spectrin but with 10-fold differences in affinity), the NH2-terminal regions are 0-40% identical, while the regions (1136-1160) common to all binding peptides are 80-90% identical. We hypothesize that the highly conserved region contains an important spectrin-binding site, while the poorly conserved region controls the binding affinity. We speculate that this unique NH2-terminal region is what gives different members of the ankyrin family their signature set of affinities, and accordingly their distinctive cellular localization.	CHILDRENS HOSP MED CTR, DEPT LAB MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	PLATT, OS (corresponding author), CHILDRENS HOSP MED CTR, DEPT MED, DIV HEMATOL ONCOL, 300 LONGWOOD AVE, BOSTON, MA 02115 USA.				NHLBI NIH HHS [2P60 HL15157, 5P01 HL32262] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, P60HL015157] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASS EB, 1983, ANN INTERN MED, V99, P192, DOI 10.7326/0003-4819-99-2-192; BENNETT V, 1979, J BIOL CHEM, V254, P2533; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1991, J CLIN INVEST, V87, P1483, DOI 10.1172/JCI115157; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; BENNETT V, 1977, J BIOL CHEM, V252, P2753; BODINE DM, 1984, CELL, V37, P721, DOI 10.1016/0092-8674(84)90408-2; CHILCOTE RR, 1987, BLOOD, V69, P156; CIANCI CD, 1988, J CELL BIOCHEM, V37, P301, DOI 10.1002/jcb.240370305; COETZER TL, 1988, NEW ENGL J MED, V318, P230, DOI 10.1056/NEJM198801283180407; COSTA FF, 1990, NEW ENGL J MED, V323, P1046, DOI 10.1056/NEJM199010113231507; DAVIS J, 1989, J BIOL CHEM, V264, P6417; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; DAVIS JQ, 1984, J BIOL CHEM, V259, P1874; DAVIS L, 1989, J BIOL CHEM, V264, P9665; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HALL TG, 1987, J BIOL CHEM, V262, P10537; HARGREAVES WR, 1980, J BIOL CHEM, V255, P1965; KIMBERLING WJ, 1975, AM J HUM GENET, V27, P586; KITATANI M, 1988, HUM GENET, V78, P94, DOI 10.1007/BF00291244; KLMBERLING WJ, 1978, BLOOD, V52, P859; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LU PW, 1985, J BIOL CHEM, V260, P4958; LUNA EJ, 1979, J BIOL CHEM, V254, P2526; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; OTSUKA A J, 1991, Journal of Cell Biology, V115, p465A; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; PETERS LL, 1992, BLOOD, V80, P2122; PLATT OS, 1985, J CLIN INVEST, V75, P266, DOI 10.1172/JCI111684; PLATT OS, 1988, J CLIN INVEST, V82, P1051, DOI 10.1172/JCI113661; SHINAR E, 1989, J CLIN INVEST, V83, P404, DOI 10.1172/JCI113898; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALLIN R, 1984, P NATL ACAD SCI-BIOL, V81, P4095, DOI 10.1073/pnas.81.13.4095; WEAVER DC, 1984, J BIOL CHEM, V259, P6170; WEAVER DC, 1984, J BIOL CHEM, V259, P6165; WHITE RA, 1992, MAMM GENOME, V3, P281, DOI 10.1007/BF00292156; WHITE RA, 1990, P NATL ACAD SCI USA, V87, P3117, DOI 10.1073/pnas.87.8.3117	47	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24421	24426						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226993				2022-12-27	WOS:A1993MF29400104
J	SAKUMI, K; FURUICHI, M; TSUZUKI, T; KAKUMA, T; KAWABATA, S; MAKI, H; SEKIGUCHI, M				SAKUMI, K; FURUICHI, M; TSUZUKI, T; KAKUMA, T; KAWABATA, S; MAKI, H; SEKIGUCHI, M			CLONING AND EXPRESSION OF CDNA FOR A HUMAN ENZYME THAT HYDROLYZES 8-OXO-DGTP, A MUTAGENIC SUBSTRATE FOR DNA-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERATES G.C->T.A TRANSVERSIONS; ESCHERICHIA-COLI; MOLECULAR-CLONING; MUTATOR LOCUS; GENE-PRODUCT; MUTY GENE; 8-HYDROXYGUANINE; NUCLEOTIDE; DAMAGE; PURIFICATION	8-Oxoguanine (8-oxo-7, 8-dihydroguanine) is produced in DNA, as well as in nucleotide Pools of cells, by active oxygen species normally formed during cellular metabolic processes. 8-Oxoguanine nucleotide can pair with cytosine and adenine nucleotides at almost equal efficiencies, and transversion mutation ensues. Human cells contain enzyme activity, which hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP, and this enzyme is responsible for preventing misincorporation of 8-oxoguanine into DNA. We purified this particular human enzyme to physical homogeneity and determined a partial amino acid sequence. We then cloned the cDNA for human 8-oxo-dGTPase and examined its nucleotide sequence. The human protein comprises 156 amino acid residues and has some sequence homology with the Escherichia coli MutT protein, which has a distinct 8-oxo-dGTPase activity. When the human cDNA was expressed in E. coli mutT- mutant cells, there was a significant amount of 8-oxo-dGTPase activity. In such cells, the frequency of spontaneous mutation was greatly reduced. We propose that the human 8-oxo-dGTPase protects genetic information from the untoward effects of endogenous oxygen radicals.	KYUSHU UNIV, FAC SCI, MED INST BIOREGULAT, FUKUOKA 812, JAPAN; UNIV TOKYO, INST MOLEC & CELLULAR BIOSCI, TOKYO 113, JAPAN; KYUSHU UNIV, FAC SCI, DEPT BIOL, FUKUOKA 812, JAPAN	Kyushu University; University of Tokyo; Kyushu University			Sakumi, Kunihiko/G-4808-2011					AKIYAMA M, 1987, MOL GEN GENET, V206, P9, DOI 10.1007/BF00326530; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; BESSHO T, 1992, BIOCHEM BIOPH RES CO, V188, P372, DOI 10.1016/0006-291X(92)92395-E; BHATNAGAR SK, 1988, J BIOL CHEM, V263, P8953; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CABRERA M, 1988, J BACTERIOL, V170, P5405, DOI 10.1128/jb.170.11.5405-5407.1988; CHENG KC, 1992, J BIOL CHEM, V267, P166; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DZANDU JK, 1988, ANAL BIOCHEM, V174, P157, DOI 10.1016/0003-2697(88)90531-3; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; HORIUCHI T, 1989, B I PASTEUR, V87, P309; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KOIKE G, 1990, J BIOL CHEM, V265, P14754; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU AL, 1988, CELL, V54, P805, DOI 10.1016/S0092-8674(88)91109-9; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; MATHEWS CK, 1988, TRENDS BIOCHEM SCI, V13, P394, DOI 10.1016/0968-0004(88)90182-X; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; MO JY, 1991, J MOL BIOL, V222, P925, DOI 10.1016/0022-2836(91)90586-U; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; YAMAMOTO F, 1992, JPN J CANCER RES, V83, P351, DOI 10.1111/j.1349-7006.1992.tb00114.x; YANOFSKY C, 1966, P NATL ACAD SCI USA, V55, P274, DOI 10.1073/pnas.55.2.274	36	398	415	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23524	23530						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226881				2022-12-27	WOS:A1993MF51500087
J	WEISS, RH; FLICKINGER, AG; RIVERS, WJ; HARDY, MM; ASTON, KW; RYAN, US; RILEY, DP				WEISS, RH; FLICKINGER, AG; RIVERS, WJ; HARDY, MM; ASTON, KW; RYAN, US; RILEY, DP			EVALUATION OF ACTIVITY OF PUTATIVE SUPEROXIDE-DISMUTASE MIMICS - DIRECT ANALYSIS BY STOPPED-FLOW KINETICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULSE-RADIOLYSIS; CYTOCHROME-C; COMPLEXES; ASSAY; MECHANISM; AUTOXIDATION; ANION; EDTA; ACID; DESFERRIOXAMINE	By stopped-flow kinetic analysis, we have directly evaluated the superoxide dismutase (SOD) activity of a number of organic nitroxides and iron- and manganese-based complexes that have been attributed with having SOD activity based upon competition experiments with cytochrome c. In 60 mM HEPES buffer, pH 8.1, or 50 mM potassium phosphate buffer, pH 7.8, Mn(II) and manganese complexes of desferal had no detectable SOD activity by stopped-flow analysis (catalytic rate constant (k(cat) < 10(5.5) M-1 s-1), whereas Mn(II) and manganese complexes of desferal inhibited the reduction of cytochrome c by superoxide generated by the xanthine/xanthine oxidase system. Fe(II)-N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (FeTPEN) was eight times more active than Fe(III)-tris[N-(2-pyridylmethyl)-2-aminoethyl]amine(FeTPAA) in the cytochrome c assay, but only FeTPAA catalyzed the first-order decay of superoxide (k(cat) = 2.15 x 10(6) M-1 s-1) by stopped-flow. Fe(III)-tetrakis(4-N-methylpyridyl)porphine ( FeTMPP) was active at low micromolar concentrations in both the cytochrome c and stopped-flow assays. At high micromolar concentrations, the organic nitroxides 2,2,6,6-tetramethylpiperidin-1-yloxy (TEMPO) and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yloxy (TEMPOL) were inhibitory in the cytochrome c assay, but showed no detectable SOD activity by stopped-flow. None of the tested compounds inhibited xanthine oxidase activity as shown by the measurement of urate production. Under the conditions of the cytochrome c assay, FeTPEN, TEMPO, and TEMPOL oxidized reduced cytochrome c which rationalizes the false positives for these compounds in this assay. The inhibitory activities of Mn(II) and the manganese desferal complexes in the cytochrome c assay appear to be due to a stoichiometric, not catalytic, reaction with superoxide as catalytic amounts of these agents do not induce a first-order decay of superoxide as shown by stopped-flow.	MONSANTO CO, DEPT HLTH SCI, ST LOUIS, MO 63167 USA	Monsanto	WEISS, RH (corresponding author), MONSANTO CO, DEPT CHEM SCI, MAIL ZONE Q3C, 800 N LINDBERGH BLVD, ST LOUIS, MO 63167 USA.							BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BEHAR D, 1970, J PHYS CHEM-US, V74, P3209, DOI 10.1021/j100711a009; BEYER WF, 1989, ARCH BIOCHEM BIOPHYS, V271, P149, DOI 10.1016/0003-9861(89)90265-8; BONNE C, 1991, B SOC CHIM BELG, V100, P673; BULL C, 1983, J AM CHEM SOC, V105, P5290, DOI 10.1021/ja00354a019; BULL C, 1982, ARCH BIOCHEM BIOPHYS, V215, P551, DOI 10.1016/0003-9861(82)90115-1; BUTLER J, 1975, BIOCHIM BIOPHYS ACTA, V408, P215, DOI 10.1016/0005-2728(75)90124-3; BUTLER J, 1982, J BIOL CHEM, V257, P747; CABELLI DE, 1984, J PHYS CHEM-US, V88, P6291, DOI 10.1021/j150669a047; Czapski G, 1988, Free Radic Res Commun, V4, P225, DOI 10.3109/10715768809055146; DARR D, 1987, ARCH BIOCHEM BIOPHYS, V258, P351, DOI 10.1016/0003-9861(87)90354-7; DEGRAFF WG, 1992, ENVIRON MOL MUTAGEN, V19, P21, DOI 10.1002/em.2850190105; DOWNEY JM, 1991, FREE RADICAL RES COM, V12-3, P703, DOI 10.3109/10715769109145850; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; FEE JA, 1974, FEBS LETT, V39, P79, DOI 10.1016/0014-5793(74)80021-9; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Fridovich I., 1982, SUPEROXIDE DISMUTASE, V1, P69; GOLDSTEIN S, 1988, FREE RADICAL BIO MED, V4, P295, DOI 10.1016/0891-5849(88)90050-0; GOLDSTEIN S, 1990, J AM CHEM SOC, V112, P6489, DOI 10.1021/ja00174a006; GOLDSTEIN S, 1991, FREE RADICAL RES COM, V12-3, P5, DOI 10.3109/10715769109145761; GRAY B, 1992, BIOCHEM J, V281, P795, DOI 10.1042/bj2810795; GRISHAM MB, 1988, DIGEST DIS SCI, V33, pS6, DOI 10.1007/BF01538126; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; HOWIE JK, 1976, J AM CHEM SOC, V98, P6698, DOI 10.1021/ja00437a046; ILAN Y, 1981, INORG NUCL CHEM LETT, V17, P93, DOI 10.1016/0020-1650(81)80035-9; IULIANO L, 1992, ARCH BIOCHEM BIOPHYS, V293, P153, DOI 10.1016/0003-9861(92)90378-A; KALCKAR HM, 1947, J BIOL CHEM, V167, P429; KOPPENOL WH, 1986, ARCH BIOCHEM BIOPHYS, V251, P594, DOI 10.1016/0003-9861(86)90368-1; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; LENGFELDER E, 1979, BIOCHIM BIOPHYS ACTA, V567, P492, DOI 10.1016/0005-2744(79)90135-9; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MCCLUNE GJ, 1977, J AM CHEM SOC, V99, P5220, DOI 10.1021/ja00457a074; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MITCHELL JB, 1990, BIOCHEMISTRY-US, V29, P2802, DOI 10.1021/bi00463a024; NAGANO T, 1990, SEIKAGAKU, V62, P447; NAGANO T, 1989, J BIOL CHEM, V264, P9243; NAGANO T, 1991, FREE RADICAL RES COM, V12-3, P221, DOI 10.3109/10715769109145790; PASTERNACK RF, 1979, J AM CHEM SOC, V101, P1026, DOI 10.1021/ja00498a038; POGREBNIAK H, 1991, J SURG RES, V50, P469, DOI 10.1016/0022-4804(91)90026-I; RABINOWITCH HD, 1987, FREE RADICAL BIO MED, V3, P125, DOI 10.1016/S0891-5849(87)80007-2; RILEY DP, 1991, ANAL BIOCHEM, V196, P344, DOI 10.1016/0003-2697(91)90476-A; SAMUNI A, 1988, J BIOL CHEM, V263, P17921; SAWYER DT, 1991, FREE RADICAL RES COM, V12-3, P75, DOI 10.3109/10715769109145770; SORENSON JRJ, 1984, J MED CHEM, V27, P1747, DOI 10.1021/jm00378a040; STEIN J, 1979, INORG CHEM, V18, P3511, DOI 10.1021/ic50202a044; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; WEINSTEIN J, 1980, J AM CHEM SOC, V102, P4916, DOI 10.1021/ja00535a014	51	106	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23049	23054						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226820				2022-12-27	WOS:A1993MF51500016
J	GALLAGHER, PJ; HERRING, BP; TRAFNY, A; SOWADSKI, J; STULL, JT				GALLAGHER, PJ; HERRING, BP; TRAFNY, A; SOWADSKI, J; STULL, JT			A MOLECULAR MECHANISM FOR AUTOINHIBITION OF MYOSIN LIGHT-CHAIN KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; CALMODULIN-BINDING; INTRASTERIC REGULATION; PROTEIN-KINASE; BASIC RESIDUES; ACTIVATION; SKELETAL; PSEUDOSUBSTRATE; SITE; PHOSPHORYLATION	It is postulated that basic residues within the inhibitory region of myosin light chain kinase (MLCK) bind acidic residues within the catalytic core to maintain the kinase in an inactive form. In this study, we identified residues within the catalytic cores of the skeletal and smooth muscle MLCKs that may bind basic residues in inhibitory region. Acidic residues within the catalytic core of the rabbit skeletal and smooth muscle MLCKs were mutated and the kinetic properties of the mutant kinases determined. Mutation of 6 and 8 acidic residues in the skeletal and smooth muscle MLCKs, respectively, result in mutant MLCKs with decreases in K(CaM) (the concentration of calmodulin required for half-maximal activation of myosin light chain kinase) value ranging from 2- to 100-fold. Two inhibitory domain binding residues identified in each kinase also bind a basic residue in light chain substrate. The remaining mutants all have wild-type K(m) values for light chain. The predicted inhibitory domain binding residues are distributed in a linear fashion across the surface of the lower lobe of the proposed molecular model of the smooth muscle MLCK catalytic core. As 6 of the inhibitory domain binding residues in the smooth muscle MLCK are conserved in other Ca2+/calmodulin-dependent protein kinases, the structural basis for autoinhibition and activation may be similar.	UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; UNIV CALIF SAN DIEGO,DEPT MED & BIOL,LA JOLLA,CA 92093	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL026043, R01 HL026043, R01 HL026043-20, HL26043] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGCHI IC, 1992, MOL ENDOCRINOL, V6, P621, DOI 10.1210/me.6.4.621; BILLINGSLEY ML, 1985, P NATL ACAD SCI USA, V82, P7585, DOI 10.1073/pnas.82.22.7585; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; FITZSIMONS DP, 1992, J BIOL CHEM, V267, P23903; FOSTER CJ, 1990, ARCH BIOCHEM BIOPHYS, V280, P397, DOI 10.1016/0003-9861(90)90348-3; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HATHAWAY DR, 1983, ANAL BIOCHEM, V135, P37, DOI 10.1016/0003-2697(83)90726-1; HERRING BP, 1991, J BIOL CHEM, V266, P11838; HERRING BP, 1992, J BIOL CHEM, V267, P25945; HERRING BP, 1990, J BIOL CHEM, V265, P16588; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KEMP BE, 1990, PEPTIDES PROTEIN PHO; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEACHMAN SA, 1992, J BIOL CHEM, V267, P4930; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; MILLER JR, 1983, MOL PHARMACOL, V24, P235; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; STULL JT, 1990, J BIOL CHEM, V265, P16683; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	27	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26578	26582						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253787				2022-12-27	WOS:A1993MK42500082
J	ABOUAKIL, N; MAS, E; BRUNEAU, N; BENAJIBA, A; LOMBARDO, D				ABOUAKIL, N; MAS, E; BRUNEAU, N; BENAJIBA, A; LOMBARDO, D			BILE SALT-DEPENDENT LIPASE BIOSYNTHESIS IN RAT PANCREATIC AR-4-2 J-CELLS - ESSENTIAL REQUIREMENT OF N-LINKED OLIGOSACCHARIDE FOR SECRETION AND EXPRESSION OF A FULLY ACTIVE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; CARBOXYL ESTER HYDROLASE; CHOLESTEROL ESTERASE; ENDOPLASMIC-RETICULUM; CDNA CLONING; PURIFICATION; GLYCOSYLATION; GLYCOPROTEINS; PROTEINS; INHIBITION	This study used the rat pancreatic AR 4-2 J cell line as a model system to investigate the role of glycosylation in bile salt-dependent lipase (BSDL) secretion and esterolytic activity. Results indicated that AR 4-2 J cells synthesized BSDL, the esterolytic activity of which was the greater part of the cell activity toward 4-nitrophenylcaproate. The protein thus expressed was glycosylated and had a molecular mass almost-equal-to 74 kDa. Exposure of these cells to tunicamycin significantly decreased [H-3]mannose incorporation, while [S-35]methionine incorporation in trichloroacetic acid-precipitable material was not modified. Tunicamycin treatment of AR 4-2 J cells lead to a lower molecular mass form (approximately 70 kDa) of BSDL which did not incorporate [H-3]mannose. The nonglycosylated low M(r) form of the enzyme was not secreted as shown by the decreasing activity in cell-free medium which paralleled the time-dependent secretion of the enzyme. Tunicamycin had no effect on BSDL synthesis. Nevertheless, the nonglycosylated BSDL was apparently not degraded in any cell compartment as shown in part by the enzyme activity accumulation within cells upon brefeldin A treatment. The BSDL expressed by AR 4-2 J cells was characterized by a K(m) of 68 +/- 30 muM and a k(cat) of 106 +/- 19 min-1. The sequestrated BSDL due to tunicamycin treatment of cells presents a significant increase of K(m) of over 10 times to 757 +/- 303 muM. k(cat) was affected by a factor of approximately 4-445 +/- 22 min-1. These data correlated with an approximately 2.5-fold decrease of the esterolytic activity following inhibition of the N-glycosylation of the protein. The nonglycosylated BSDL was less stable to temperature than the native form. Processing inhibitors (castano-spermine, 1-deoxymannojirimycin, and swainsonine) had no effect either on the enzyme activity or on its secretion. Results suggested first that the transfer of the oligosaccharide precursor to the nascent BSDL is essential for the folding of the fully active BSDL. Second that the glycan structure is required for the enzyme secretion	FAC MED MARSEILLE,INSERM,U260,UNITE RECH PHYSIOPATHOL REGULAT HORMONONUTR,F-13385 MARSEILLE 5,FRANCE; ECOLE NATL SUPER TETOUAN MARTIL,TETOUAN,MEXICO	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite			Mas, Eric/O-9569-2017; Mas, Eric/AAC-9837-2022; Bruneau, Nadine/O-2100-2016	Mas, Eric/0000-0002-8925-9195; Bruneau, Nadine/0000-0002-1523-3128; ABOUAKIL, Nezha/0000-0002-7293-3702				ABOUAKIL N, 1988, BIOCHIM BIOPHYS ACTA, V961, P299, DOI 10.1016/0005-2760(88)90077-X; ALBERS GHR, 1987, DIFFERENTIATION, V34, P210, DOI 10.1111/j.1432-0436.1987.tb00068.x; AOYAGI T, 1969, J ANTIBIOT, V22, P283, DOI 10.7164/antibiotics.22.283; BABA T, 1991, BIOCHEMISTRY-US, V30, P500, DOI 10.1021/bi00216a028; CHOW V, 1984, J BIOL CHEM, V259, P6622; DANIELSEN EM, 1992, BIOCHEMISTRY-US, V31, P2266, DOI 10.1021/bi00123a008; DIPERSIO LP, 1990, J BIOL CHEM, V265, P16801; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; ERLANSONALBERTS.C, 1986, MOL CELLULAR BASIS D, P297; ESCRIBANO MJ, 1989, J BIOL CHEM, V264, P21865; FUHRMANN U, 1985, BIOCHIM BIOPHYS ACTA, V825, P95, DOI 10.1016/0167-4781(85)90095-8; GJELLESVIK DR, 1992, BIOCHIM BIOPHYS ACTA, V1124, P123, DOI 10.1016/0005-2760(92)90088-D; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HORI H, 1984, ARCH BIOCHEM BIOPHYS, V228, P525, DOI 10.1016/0003-9861(84)90019-5; HUANG Y, 1991, J BIOL CHEM, V266, P6720; HYUN J, 1969, J BIOL CHEM, V244, P1937; JACOBSON PW, 1990, J BIOL CHEM, V265, P515; KISSEL JA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P227, DOI 10.1016/0005-2760(89)90201-4; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KYGER EM, 1989, BIOCHEM BIOPH RES CO, V164, P1302, DOI 10.1016/0006-291X(89)91811-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legler G, 1977, Methods Enzymol, V46, P368; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; MAS E, 1993, BIOCHEM J, V289, P609, DOI 10.1042/bj2890609; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; MIRALLES F, 1993, EUR J CELL BIOL, V60, P115; MOMSEN WE, 1977, BIOCHIM BIOPHYS ACTA, V486, P103, DOI 10.1016/0005-2760(77)90074-1; OLDEN K, 1982, BIOCHIM BIOPHYS ACTA, V650, P209, DOI 10.1016/0304-4157(82)90017-X; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; REUE K, 1991, J LIPID RES, V32, P267; Rudd E.A., 1984, P185; SEMENKOVICH CF, 1990, J BIOL CHEM, V265, P5429; STRUCK DK, 1977, J BIOL CHEM, V252, P1007; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936	42	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25755	25763						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245011				2022-12-27	WOS:A1993MK10000070
J	CAMPBELL, JL				CAMPBELL, JL			YEAST DNA-REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL NUCLEAR ANTIGEN; SINGLE-STRANDED-DNA; POLYMERASE-III HOLOENZYME; CEREVISIAE CDC2 GENE; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; LARGE SUBUNIT; ARS ELEMENTS; FACTOR-C; SUBCELLULAR-LOCALIZATION				CAMPBELL, JL (corresponding author), CALTECH, BRAUN LABS, PASADENA, CA 91125 USA.							ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1992, EMBO J, V11, P733, DOI 10.1002/j.1460-2075.1992.tb05106.x; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; BADARACCO G, 1983, J BIOL CHEM, V258, P720; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; BAUER GA, 1988, J BIOL CHEM, V263, P917; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BISWAS EE, 1993, BIOCHEMISTRY-US, V32, P3020, DOI 10.1021/bi00063a013; BLOW JJ, 1989, J CELL SCI, P183; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; BROWN WC, 1993, J BIOL CHEM, V268, P21706; BROWN WC, 1993, GENE, V127, P99, DOI 10.1016/0378-1119(93)90622-A; BROWN WC, 1993, J BIOL CHEM, V268, P982; BUDD ME, 1989, J BIOL CHEM, V264, P6557; BUDD ME, 1993, MOL CELL BIOL, V13, P496, DOI 10.1128/MCB.13.1.496; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CHEN YR, 1992, P NATL ACAD SCI USA, V89, P10459, DOI 10.1073/pnas.89.21.10459; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; ELBLE R, 1991, P NATL ACAD SCI USA, V88, P10966, DOI 10.1073/pnas.88.23.10966; ELBLE R, 1992, MOL BIOL CELL, V3, P971, DOI 10.1091/mbc.3.9.971; ESTES HG, 1992, P NATL ACAD SCI USA, V89, P11156, DOI 10.1073/pnas.89.23.11156; FANGMAN WL, 1992, CELL, V71, P363, DOI 10.1016/0092-8674(92)90505-7; FANGMAN WL, 1991, ANN REV CELL BIOL, V13, P317; FERGUSON BM, 1991, COLD SH Q B, V56, P293; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; HENNESSY KM, 1991, COLD SPRING HARB SYM, V56, P279; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; HEYER WD, 1989, BIOCHEMISTRY-US, V28, P2856, DOI 10.1021/bi00433a017; HOFMANN JFX, 1991, CELL, V64, P951, DOI 10.1016/0092-8674(91)90319-T; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; HOWELL EA, 1993, IN PRESS MOL CELL BI; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LEE SH, 1991, J BIOL CHEM, V266, P22707; LI X, 1994, IN PRESS P NATL ACAD; LI XY, 1992, CHROMOSOMA, V102, pS93, DOI 10.1007/BF02451791; LI XY, 1992, J BIOL CHEM, V267, P25321; LONGHESE MP, 1993, GENETICS, V133, P183; LUCCHINI G, 1988, MOL GEN GENET, V212, P459, DOI 10.1007/BF00330850; LUCHE RM, 1993, MOL CELL BIOL, V13, P5749, DOI 10.1128/MCB.13.9.5749; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MOIR D, 1982, GENETICS, V100, P547; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NETHANEL T, 1990, J VIROL, V64, P5912, DOI 10.1128/JVI.64.12.5912-5918.1990; NEWLON CS, 1991, GENETICS, V129, P343; ODONNELL M, 1992, BIOESSAYS, V14, P105, DOI 10.1002/bies.950140206; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; PLEVANI P, 1987, NUCLEIC ACIDS RES, V15, P7975; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; RHODE PR, 1992, MOL CELL BIOL, V12, P1064, DOI 10.1128/MCB.12.3.1064; RONG L, 1993, J BIOL CHEM, V268, P1252; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SANTOCANALE C, 1993, J BIOL CHEM, V268, P1343; SCHMIDT AMA, 1991, EMBO J, V10, P981, DOI 10.1002/j.1460-2075.1991.tb08032.x; SHIMIZU K, 1993, J BIOL CHEM, V268, P9578; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; SUGINO A, 1986, J BIOL CHEM, V261, P1744; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; WALKER SS, 1990, P NATL ACAD SCI USA, V87, P4665, DOI 10.1073/pnas.87.12.4665; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867; WANG ZG, 1993, MOL CELL BIOL, V13, P1051, DOI 10.1128/MCB.13.2.1051; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; YODER BL, 1991, J BIOL CHEM, V266, P22689; ZHANG J, 1991, BIOCHEMISTRY-US, V30, P11742, DOI 10.1021/bi00115a002; ZHOU C, 1989, J BIOL CHEM, V264, P9022; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	92	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25261	25264						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244955				2022-12-27	WOS:A1993MK10000001
J	HUANG, CH; REID, M; DANIELS, G; BLUMENFELD, OO				HUANG, CH; REID, M; DANIELS, G; BLUMENFELD, OO			ALTERATION OF SPLICE-SITE SELECTION BY AN EXON MUTATION IN THE HUMAN GLYCOPHORIN-A GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; HUMAN-ERYTHROCYTE MEMBRANE; MOLECULAR ANALYSIS; CDNA CLONES; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; DNA; DELTA; EXPRESSION; MECHANISM	We report the identification in human glycophorin A gene of a novel exon mutation that affects splice site selection. DNA mapping showed that the mutation has abolished a unique MspI site marking the exon III-intron 3 splice junction (ACCG/GT). Genomic sequencing confirmed the occurrence of a single G --> A transition at the terminal nucleotide position of exon III. Analysis of the mRNA composition demonstrated a partial inactivation of the altered 5' splice site as well as skipping of exons involving the alternative use of other constitutive splice sites. The full-length transcript with the cognate A change encodes a variant glycophorin with an arginine replacing a glycine at position 59 and defining the ERIK epitope, whereas the exon III-deleted transcript specifies a shorter glycophorin carrying the St(a) antigen. Also identified were the misspliced mRNA species with exon I-IV and exon I-V connections generated by selection of 5' splice sites far distant from the mutated site. Although having a correct translation frame, the predicted polypeptides of such exon-skipping products were not assembled on the erythrocyte membrane probably due to the severe truncation of the signal sequence required for targeting and translocation. These observations reveal a new mechanism for antigenic diversity of human glycophorins.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,BRONX,NY 10461; MRC,BLOOD GRP UNIT,LONDON NW1 2HE,ENGLAND; NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,NEW YORK,NY 10021	Yeshiva University; Albert Einstein College of Medicine; New York Blood Center					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016389] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 16389] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKLI S, 1990, J BIOL CHEM, V265, P7324; ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; BLANCHARD D, 1987, EUR J BIOCHEM, V167, P361, DOI 10.1111/j.1432-1033.1987.tb13345.x; CARTRON JP, 1990, BLOOD CELL BIOCH, V1, P299; DANIELS GL, 1993, TRANSFUSION MED, V3, P129, DOI 10.1111/j.1365-3148.1993.tb00050.x; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Goossens M, 1981, Methods Enzymol, V76, P805; GOTODA T, 1991, J BIOL CHEM, V266, P24757; Huang C H, 1991, Baillieres Clin Haematol, V4, P821, DOI 10.1016/S0950-3536(06)80032-6; HUANG CH, 1988, P NATL ACAD SCI USA, V85, P9640, DOI 10.1073/pnas.85.24.9640; HUANG CH, 1987, BLOOD, V70, P1830; HUANG CH, 1991, BLOOD, V77, P381; HUANG CH, 1989, BLOOD, V74, P836; HUANG CH, 1992, BLOOD, V80, P2379; HUANG CH, 1992, J BIOL CHEM, V267, P3336; HUANG CH, 1992, BLOOD, V80, P257; HUANG CH, 1991, BLOOD, V77, P1813; HUANG CH, 1991, J BIOL CHEM, V266, P7248; HUANG CH, 1991, J BIOL CHEM, V266, P23306; HUANG CH, 1993, J BIOL CHEM, V268, P4945; HUANG CH, 1992, BLOOD S, V80, pA274; HUANG CH, 1986, CHIN BIOCH J, V2, P9; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KUDO S, 1990, J BIOL CHEM, V265, P13825; KUDO S, 1990, J BIOL CHEM, V265, P1102; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LU YQ, 1987, BLOOD, V69, P618; Maniatis T., 1982, MOL CLONING; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; RAHUEL C, 1988, EUR J BIOCHEM, V172, P147, DOI 10.1111/j.1432-1033.1988.tb13866.x; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; REARDEN A, 1990, J BIOL CHEM, V265, P9259; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIEBERT PD, 1987, P NATL ACAD SCI USA, V84, P6735, DOI 10.1073/pnas.84.19.6735; SIEBERT PD, 1986, P NATL ACAD SCI USA, V83, P1665, DOI 10.1073/pnas.83.6.1665; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TATE CG, 1988, BIOCHEM J, V254, P743, DOI 10.1042/bj2540743; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; VIGNAL A, 1989, EUR J BIOCHEM, V184, P337, DOI 10.1111/j.1432-1033.1989.tb15024.x; VIGNAL A, 1990, EUR J BIOCHEM, V191, P619, DOI 10.1111/j.1432-1033.1990.tb19166.x; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; YOON SH, 1991, J BIOL CHEM, V266, P8490	53	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25902	25908						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245024				2022-12-27	WOS:A1993MK10000088
J	JOSEPH, S; BURKE, JM				JOSEPH, S; BURKE, JM			OPTIMIZATION OF AN ANTI-HIV HAIRPIN RIBOZYME BY IN-VITRO SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TOBACCO RINGSPOT VIRUS; CATALYZED CLEAVAGE; SATELLITE RNA; SEQUENCE; COMPLEMENTARY; REQUIREMENT; EVOLUTION; ENZYME; SITE; DNA	We have applied in vitro selection methods to achieve a large increase in the catalytic activity of a hairpin ribozyme targeted against a highly conserved 14-nucleotide sequence within HIV-1 pol RNA. The substrate specificity was changed by mutating 8 bases within the substrate-binding domain of the parental (-)sTRSV ribozyme. The resulting enzyme cleaved the HIV substrate specifically but with a 20-fold reduction in catalytic efficiency (k(cat)/K(M)). Following random mutagenesis, ribozymes with increased activity against the target sequence were selected through 10 rounds of in vitro selection. Selective pressure was increased by decreasing MgCl2 and spermidine concentrations, and reducing reaction time. Variant ribozymes with base substitutions A11 --> G and U39 --> C were selected in the population. These mutations were introduced singly and in combination into the trans-acting anti-HIV ribozyme. Each of the single-base substitutions significantly increased ribozyme activity, while the activity of double mutant was increased to nearly the level of the parental ribozyme. These findings demonstrate that in vitro selection is a powerful and efficient method to optimize ribozymes for the catalytic inactivation of targeted RNA molecules.	UNIV VERMONT, MARKEY CTR MOLEC GENET, DEPT MICROBIOL & MOLEC GENET, STAFFORD HALL, BURLINGTON, VT 05405 USA	University of Vermont			, John/AAB-5945-2021		NIAID NIH HHS [AI29892] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029892] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberts B. D., 1989, MOL BIOL CELL, P301; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; BERZALHERRANZ A, 1992, GENE DEV, V6, P129, DOI 10.1101/gad.6.1.129; BERZALHERRANZ A, 1993, EMBO J, V12, P2567, DOI 10.1002/j.1460-2075.1993.tb05912.x; BURKE JM, 1993, FASEB J, V7, P106, DOI 10.1096/fasebj.7.1.8422956; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P3030; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8518, DOI 10.1021/bi00099a003; CHOWRIRA BM, 1991, NATURE, V354, P320, DOI 10.1038/354320a0; CHOWRIRA BM, 1993, BIOCHEMISTRY-US, V32, P1088, DOI 10.1021/bi00055a014; FELDSTEIN PA, 1990, P NATL ACAD SCI USA, V87, P2623, DOI 10.1073/pnas.87.7.2623; FELDSTEIN PA, 1989, GENE, V82, P53, DOI 10.1016/0378-1119(89)90029-2; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; HASELOFF J, 1989, GENE, V82, P43, DOI 10.1016/0378-1119(89)90028-0; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; JOSEPH S, 1993, GENE DEV, V7, P130, DOI 10.1101/gad.7.1.130; KIKUCHI Y, 1991, NUCLEIC ACIDS RES, V19, P6751, DOI 10.1093/nar/19.24.6751; OJWANG JO, 1992, P NATL ACAD SCI USA, V89, P10802, DOI 10.1073/pnas.89.22.10802; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; RUBINO L, 1990, J GEN VIROL, V71, P1897, DOI 10.1099/0022-1317-71-9-1897; SAENGER W, 1988, PRINCIPLES NUCLEIC A, P201; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; SCARINGE SA, 1990, NUCLEIC ACIDS RES, V18, P5433, DOI 10.1093/nar/18.18.5433; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121	27	80	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24515	24518						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227004				2022-12-27	WOS:A1993MG67300001
J	YAMADA, M; JAHANGIR, A; HOSOYA, Y; INANOBE, A; KATADA, T; KURACHI, Y				YAMADA, M; JAHANGIR, A; HOSOYA, Y; INANOBE, A; KATADA, T; KURACHI, Y			G(KAPPA)ASTERISK AND BRAIN G(BETA-GAMMA) ACTIVATE MUSCARINIC K+ CHANNEL THROUGH THE SAME MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING PROTEINS; ATRIAL CELL-MEMBRANE; ACETYLCHOLINE ACTIVATION; GAMMA-SUBUNIT; HEART; RECEPTORS	A pertussis toxin-sensitive G protein (G(K)) links muscarinic cholinergic and A1-purinergic receptors with an inwardly rectifying K+ (K(ACh)) channel in cardiac atrial cell membranes. Although the betagamma subunits of pertussis toxin-sensitive G proteins (G(betagamma)) have been reported to fully activate this channel, it is not known whether exogenously applied G(betagamma) interacts with the K(ACh) channel through the same mechanism as the active subunit of endogenous G(K) (G(K)*). We examined in inside-out patches the relationship between the concentration of GTP and K(ACh) channel activity with or without preactivation of the channels by either GTPgammaS (guanosine 5'-3-O-(thio)triphosphate) or G(betagamma) purified from bovine brain. In the control, K(ACh) channels were activated by intracellular GTP (with acetylcholine in the pipette) in a positive cooperative manner (Hill coefficient approximately 2.5). As the channels were preactivated by GTPgammaS to progressively higher levels, the GTP channel activity relationship shifted more to the left, but the Hill coefficients of the curves remained the same. The same changes were observed when K(ACh) channels were preactivated with brain G(betagamma). These results indicate that endogenous G(K)* and exogenous G(betagamma) share a common molecular mechanism to activate the K(ACh) channel.	MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,DIV CARDIOVASC DIS,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; YAMAGATA UNIV,SCH MED,DEPT CELL BIOL & SIGNALING,YAMAGATA 99023,JAPAN; TOKYO INST TECHNOL,FAC SCI,DEPT LIFE SCI,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PHYS CHEM,BUNKYO KU,TOKYO 113,JAPAN	Mayo Clinic; Mayo Clinic; Yamagata University; Tokyo Institute of Technology; University of Tokyo					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047360] Funding Source: NIH RePORTER; NHLBI NIH HHS [R0 1 HL47360] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; COLQUHOUN D, 1983, FITTING STAT ANAL SI, P191; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; ITO H, 1991, J GEN PHYSIOL, V98, P517, DOI 10.1085/jgp.98.3.517; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; KOBAYASHI I, 1990, EUR J BIOCHEM, V191, P499, DOI 10.1111/j.1432-1033.1990.tb19149.x; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; KURACHI Y, 1986, AM J PHYSIOL, V251, pH681, DOI 10.1152/ajpheart.1986.251.3.H681; KURACHI Y, 1990, PFLUG ARCH EUR J PHY, V416, P216, DOI 10.1007/BF00370247; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; LOEWI O., 1926, PFLUGER S ARCH GES PHYSIOL, V214, P678, DOI 10.1007/BF01741946; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; NAKAJIMA T, 1992, J GEN PHYSIOL, V99, P665, DOI 10.1085/jgp.99.5.665; NANAVATI C, 1990, COMP ROLES PURIFIED, P29; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0	21	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24551	24554						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227012				2022-12-27	WOS:A1993MG67300010
J	FUKUMORI, F; HAUSINGER, RP				FUKUMORI, F; HAUSINGER, RP			PURIFICATION AND CHARACTERIZATION OF 2,4-DICHLOROPHENOXYACETATE ALPHA-KETOGLUTARATE DIOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N SYNTHASE; PROLYL 4-HYDROXYLASE; BINDING-SITE; LYSYL HYDROXYLASE; MONOOXYGENASE; DEGRADATION; ASCORBATE; CLONING; ACID; EXPRESSION	The Alcaligenes eutrophus 2,4-dichlorophenoxyacetate/alpha-ketoglutarate dioxygenase, encoded by the tfdA gene of plasmid pJP4, is an Fe(II)-dependent enzyme that catalyzes the conversion of 2,4-dichlorophenoxyacetate to 2,4-dichlorophenol and glyoxylate concomitant with the decomposition of alpha-ketoglutarate to form succinate and carbon dioxide (Fukumori, F., and Hausinger, R. P. (1993) J. Bacteriol. 175, 2083-2086). Using recombinant Escherichia coli cells that overexpress the tfdA gene, the thermolabile enzyme (stable only up to 30-degrees-C) was purified to apparent homogeneity (specific activity of 16.9 mumol of substrate converted min-1 mg of protein-1) by a simple two-step procedure. The native protein has an apparent M(r) of 50,000 +/- 2,500, consistent with a homodimeric structure. Ferrous ion is absolutely required for activity and cannot be replaced by several other divalent cations tested. Ascorbic acid stimulates dioxygenase activity and reduces the rate of enzyme inactivation by a metal ion-mediated process. The enzyme exhibits maximum activity at pH 6.5-7, however, it is stable over a pH range of 6.5-11. Although capable of hydroxylating a wide range of phenoxyacetates and related compounds, the enzyme exhibits the greatest affinity (K(m) 17.5 +/- 1.0 muM) and highest catalytic efficiency for 2,4-dichlorophenoxyacetate. Similarly, alpha-ketoglutarate is the preferred co-substrate (K(m) 3.20 +/- 0.54 muM) for the enzyme, but it can utilize a range of other alpha-ketoacids with lower efficiency. Results from chemical modification studies are consistent with the presence of multiple essential histidine residues in the enzyme.	MICHIGAN STATE UNIV,CTR MICROBIAL ECOL,E LANSING,MI 48824; MICHIGAN STATE UNIV,DEPT MICROBIOL,E LANSING,MI 48824; MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824; RES DEV CORP JAPAN,CHIYODA KU,TOKYO 100,JAPAN	Michigan State University; Michigan State University; Michigan State University; Japan Science & Technology Agency (JST)				Hausinger, Robert/0000-0002-3643-2054				Abbott MT, 1974, MOL MECHANISMS OXYGE, P167; BRADLEY FC, 1986, J BIOL CHEM, V261, P1693; CHAUDHRY GR, 1991, MICROBIOL REV, V55, P59, DOI 10.1128/MMBR.55.1.59-79.1991; COUNTS DF, 1978, P NATL ACAD SCI USA, V75, P2145, DOI 10.1073/pnas.75.5.2145; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; DON RH, 1985, J BACTERIOL, V161, P85, DOI 10.1128/JB.161.1.85-90.1985; FUKUMORI F, 1993, J BACTERIOL, V175, P2083, DOI 10.1128/JB.175.7.2083-2086.1993; HAGGBLOM MM, 1992, FEMS MICROBIOL LETT, V103, P29; HARLOW E, 1988, ANTIBODIES LABORATOR; HAUGLAND RA, 1990, APPL ENVIRON MICROB, V56, P1357, DOI 10.1128/AEM.56.5.1357-1362.1990; HORVATH M, 1990, APPL MICROBIOL BIOT, V33, P213, DOI 10.1007/BF00176527; KING RJ, 1991, APPL ENVIRON MICROB, V57, P1790, DOI 10.1128/AEM.57.6.1790-1792.1991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBLAD B, 1977, J BIOL CHEM, V252, P5073; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Miles E W, 1977, Methods Enzymol, V47, P431; MING LJ, 1990, INORG CHEM, V29, P1111, DOI 10.1021/ic00331a001; MYLLYLA R, 1992, BIOCHEM J, V286, P923, DOI 10.1042/bj2860923; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NG SF, 1991, J BIOL CHEM, V266, P1526; NURK A, 1991, GENE, V102, P13, DOI 10.1016/0378-1119(91)90531-F; PERKINS EJ, 1990, J BACTERIOL, V172, P2351, DOI 10.1128/jb.172.5.2351-2359.1990; PIEPER DH, 1989, ARCH MICROBIOL, V151, P365, DOI 10.1007/BF00406566; SAID WA, 1991, APPL ENVIRON MICROB, V57, P1498, DOI 10.1128/AEM.57.5.1498-1503.1991; SCOTT RA, 1992, BIOCHEMISTRY-US, V31, P4596, DOI 10.1021/bi00134a009; STREBER WR, 1987, J BACTERIOL, V169, P2950, DOI 10.1128/jb.169.7.2950-2955.1987; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	32	161	171	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24311	24317						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226980				2022-12-27	WOS:A1993MF29400089
J	WANG, RW; NEWTON, DJ; JOHNSON, AR; PICKETT, CB; LU, AYH				WANG, RW; NEWTON, DJ; JOHNSON, AR; PICKETT, CB; LU, AYH			SITE-DIRECTED MUTAGENESIS OF GLUTATHIONE-S-TRANSFERASE YAYA - MAPPING THE GLUTATHIONE-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-PI; ACTIVE-SITE; CATALYTIC ACTIVITY; 3-DIMENSIONAL STRUCTURE; CHEMICAL MODIFICATION; CYSTEINE RESIDUES; ESCHERICHIA-COLI; HUMAN PLACENTA; THIOL-GROUP; RAT	Previous studies from our laboratory have shown that aspartic acid 101 plays an important role in glutathione interaction to rat glutathione S-transferase YaYa, while tyrosine 9 is directly involved in catalysis. Based on the available structural information, site-directed mutagenesis was conducted to examine the function of arginine, lysine, glutamine, and proline residues surrounding the GSH binding pocket. Arginine mutants R13K, R15K, R20K, and R20I retained partial enzymatic activities, while R13I and R15I lost most of their activities. Kinetic studies showed a marked increase in K(m) toward GSH for R15I suggesting that arginine 15 contributes significantly to the binding of GSH in the active site of glutathione S-transferase YaYa. A drastic decrease in enzymatic activities for R13I suggested the importance of the charged group of arginine 13 either in maintaining the structural integrity of the enzyme or in serving a vital role in enzymatic function. Replacement of glutamine 54 and 67 with glutamic acid or asparagine resulted in decreased enzymatic activities. Moreover, an 11-, 17-, and 9-fold increase in K(m) values toward GSH for mutant Q54E, Q54N, and Q67N was observed, respectively. These results suggested that glutamine 54 and 67 also contributed significantly to the binding of GSH. Proline at position 56 appears to be important for maintaining the structural integrity of the enzyme since mutants P56A and P56F were much less active and extremely less stable than that of the wild type enzyme. Both lysine mutants, K45R and K45I, exhibited substantially higher catalytic efficiencies toward both 1-chloro-2,4-dinitrobenzene and GSH than the wild type enzyme. Our data clearly show that lysine 45 is not an essential residue for catalysis nor for GSH binding in glutathione S-transferase YaYa.	MERCK FROSST CTR THERAPEUT RES,POINTE CLAIRE H9R 4P8,PQ,CANADA	Merck & Company	WANG, RW (corresponding author), MERCK SHARP & DOHME LTD,DEPT DRUG METAB,RY80A12,POB 2000,RAHWAY,NJ 07065, USA.							ADANG AEP, 1991, BIOCHEM J, V278, P63, DOI 10.1042/bj2780063; ADANG AEP, 1988, BIOCHEM J, V255, P721; ADANG AEP, 1989, BIOCHEM J, V264, P759, DOI 10.1042/bj2640759; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; Asaoka K, 1989, J Enzyme Inhib, V3, P77, DOI 10.3109/14756368909030366; AWASTHI YC, 1987, BIOCHEM BIOPH RES CO, V143, P965, DOI 10.1016/0006-291X(87)90345-7; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BENSON AM, 1976, BIOCHEM BIOPH RES CO, V69, P1073, DOI 10.1016/0006-291X(76)90482-4; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; CARNE T, 1979, BIOCHEM J, V177, P433, DOI 10.1042/bj1770433; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COLES B, 1990, CRIT REV BIOCHEM MOL, V25, P47, DOI 10.3109/10409239009090605; DELBOCCIO G, 1991, J BIOL CHEM, V266, P13777; DENIELSON UH, 1985, BIOCHEM J, P263; DESIDERI A, 1991, J BIOL CHEM, V266, P2063; DIRR HW, 1991, EUR J BIOCHEM, V196, P693, DOI 10.1111/j.1432-1033.1991.tb15867.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HSIEH JC, 1991, BIOCHEM J, V278, P293, DOI 10.1042/bj2780293; HUSKEY SEW, 1991, J AM CHEM SOC, V113, P2283, DOI 10.1021/ja00006a056; JAKOBY WB, 1984, BIOCHEM PHARMACOL, V33, P2539, DOI 10.1016/0006-2952(84)90621-X; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; KATUSZ RM, 1991, BIOCHEMISTRY-US, V30, P11230, DOI 10.1021/bi00111a006; KOLM RH, 1992, BIOCHEM J, V285, P537, DOI 10.1042/bj2850537; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; LIU SX, 1992, J BIOL CHEM, V267, P4296; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; Mannervik B, 1981, Methods Enzymol, V77, P231; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; REDDY CC, 1981, BIOCHEM BIOPH RES CO, V101, P970; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; STENBERG G, 1991, FEBS LETT, V293, P153, DOI 10.1016/0014-5793(91)81174-7; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; TAMAI K, 1990, BIOCHEM BIOPH RES CO, V167, P331, DOI 10.1016/0006-291X(90)91769-O; TAMAI K, 1991, BIOCHEM BIOPH RES CO, V179, P790, DOI 10.1016/0006-291X(91)91886-H; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANOMMEN B, 1988, J BIOL CHEM, V263, P12939; VANOMMEN B, 1989, EUR J BIOCHEM, V181, P423; WANG RW, 1992, ARCH BIOCHEM BIOPHYS, V297, P86, DOI 10.1016/0003-9861(92)90644-C; WANG RW, 1989, ARCH BIOCHEM BIOPHYS, V269, P536, DOI 10.1016/0003-9861(89)90137-9; WANG RW, 1992, J BIOL CHEM, V267, P19866; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V286, P574, DOI 10.1016/0003-9861(91)90082-T; WIDERSTEIN M, 1992, BIOCHEM J, V285, P377, DOI 10.1042/bj2850377; WIDERSTEN M, 1991, FEBS LETT, V293, P156, DOI 10.1016/0014-5793(91)81175-8; ZHANG PH, 1991, J BIOL CHEM, V266, P19475	57	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23981	23985						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226940				2022-12-27	WOS:A1993MF29400043
J	MCENERY, MW; DAWSON, TM; VERMA, A; GURLEY, D; COLOMBINI, M; SNYDER, SH				MCENERY, MW; DAWSON, TM; VERMA, A; GURLEY, D; COLOMBINI, M; SNYDER, SH			MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL - IMMUNOCHEMICAL AND IMMUNOHISTOCHEMICAL CHARACTERIZATION IN RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE-BINDING-SITES; MEMBRANE CONTACT SITES; DIMENSIONAL GEL-ELECTROPHORESIS; PORIN 31 HL; OUTER-MEMBRANE; LIVER MITOCHONDRIA; INTRACELLULAR-LOCALIZATION; NEURAL TISSUE; YEAST MUTANT; CELL-LINE	The purified mitochondrial benzodiazepine receptor (mBzR) is a complex comprising the voltage-dependent anion channel (VDAC), adenine nucleotide carrier, and an 18-kDa protein that binds isoquinoline carboxamide ligands (McEnery, M. W., Snowman, A. M., Trifiletti, R. R., and Snyder, S. H. (1992) Proc. Natl. Acad. Sci. U. S. A. 39, 3170-3174). An antiserum raised against the mBzR complex reacts selectively with VDAC and is used, along with purification, electrophysiological and immunohistochemical techniques, to characterize the properties and distribution of rat brain VDAC. Although purified VDAC displays biochemical and electrical conductance properties similar to VDAC from other sources, the immunohistochemical distribution of VDAC in rat brain is heterogeneous with pronounced regional variations; the pontine nuclei, the supraoptic nucleus, Purkinje cells of the cerebellum, and the caudate putamen evidence the highest density. The distribution of VDAC is inclusive of the more discretely localized 18-kDa mBzR protein, suggesting that only a portion of the total VDAC participates in the mBzR. The histochemical localizations of the mitochondrial marker enzymes glutamate dehydrogenase and cytochrome c oxidase also indicate marked regional variability in both mitochondrial content and composition. The discrete expression of VDAC reflects a striking heterogeneity of rat brain mitochondria and underlying differences in the utilization of mitochondrial outer membrane ion channels.	JOHNS HOPKINS MED INST,DEPT NEUROSCI,725 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT NEUROL,BALTIMORE,MD 21205; UNIV MARYLAND,DEPT ZOOL,CELL BIOL LAB,COLL PK,MD 20742	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland College Park			Colombini, Marco/A-1540-2014	Verma, Ajay/0000-0001-7715-0443	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA-00074] Funding Source: Medline; NINDS NIH HHS [CIDA NS 01578-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANHOLT RRH, 1984, J NEUROSCI, V4, P593; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; ANTKIEWICZMICHALUK L, 1988, J BIOL CHEM, V263, P17317; ARORA KK, 1988, J BIOL CHEM, V263, P17422; BELTRANDELRIO H, 1991, ARCH BIOCHEM BIOPHYS, V286, P183, DOI 10.1016/0003-9861(91)90026-F; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; BRDICZKA D, 1990, EXPERIENTIA, V46, P161, DOI 10.1007/BF02027312; BUREAU MH, 1992, J BIOL CHEM, V267, P8679; BURGESS RW, 1991, J NEUROCHEM, V57, P441, DOI 10.1111/j.1471-4159.1991.tb03771.x; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; COLE T, 1992, BIOL CHEM H-S, V373, P891, DOI 10.1515/bchm3.1992.373.2.891; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; DEPINTO V, 1989, EUR J BIOCHEM, V183, P179; DEPINTO V, 1992, J BIOENERG BIOMEMBR, V24, P21, DOI 10.1007/BF00769526; DEPINTO V, 1987, BIOCHIM BIOPHYS ACTA, V894, P109, DOI 10.1016/0005-2728(87)90180-0; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DEPINTO V, 1985, BIOCHIM BIOPHYS ACTA, V813, P230; DEPINTO V, 1994, MOL BIOL MITOCHONDRI; DIHANICH M, 1987, EMBO J, V6, P723, DOI 10.1002/j.1460-2075.1987.tb04813.x; DIHANICH M, 1989, EUR J BIOCHEM, V181, P703, DOI 10.1111/j.1432-1033.1989.tb14780.x; DOBLE A, 1987, MOL PHARMACOL, V31, P42; DORBANI L, 1987, ARCH BIOCHEM BIOPHYS, V252, P188, DOI 10.1016/0003-9861(87)90023-3; FELGNER PL, 1979, J BIOL CHEM, V254, P4946; FIEK C, 1982, BIOCHIM BIOPHYS ACTA, V688, P429, DOI 10.1016/0005-2736(82)90354-6; FORTE M, 1987, J MEMBRANE BIOL, V99, P65, DOI 10.1007/BF01870622; FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GUZMAN N, 1993, BIOPHYS J, V64, P343; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; KAOJEN J, 1980, J NEUROCHEM, V35, P667, DOI 10.1111/j.1471-4159.1980.tb03706.x; KAYSER H, 1989, BIOL CHEM H-S, V370, P1265; KINNALLY KW, 1992, J BIOENERG BIOMEMBR, V24, P99, DOI 10.1007/BF00769536; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; KLEENE R, 1987, EMBO J, V6, P2627, DOI 10.1002/j.1460-2075.1987.tb02553.x; KOTTKE M, 1988, BIOCHIM BIOPHYS ACTA, V935, P87, DOI 10.1016/0005-2728(88)90111-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; LINDEN M, 1982, BIOCHEM J, V208, P77, DOI 10.1042/bj2080077; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; MANNELLA CA, 1992, J BIOENERG BIOMEMBR, V24, P7, DOI 10.1007/BF00769525; MARANGOS PJ, 1982, MOL PHARMACOL, V22, P26; MCENERY MW, 1992, J BIOENERG BIOMEMBR, V24, P63, DOI 10.1007/BF00769532; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MORAN O, 1990, J BIOL CHEM, V265, P908; MORAN O, 1992, EUR BIOPHYS J BIOPHY, V20, P311, DOI 10.1007/BF00196590; MORAN O, 1992, J BIOENERG BIOMEMBR, V24, P91, DOI 10.1007/BF00769535; MOYNAGH PN, 1991, BIOCHEM J, V275, P419, DOI 10.1042/bj2750419; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; OHLENDIECK K, 1986, BIOCHIM BIOPHYS ACTA, V860, P672, DOI 10.1016/0005-2736(86)90567-5; PARRY DM, 1983, J BIOL CHEM, V258, P904; PARRY DM, 1990, J BIOL CHEM, V265, P1059; PERDEW GH, 1983, ANAL BIOCHEM, V135, P453, DOI 10.1016/0003-2697(83)90711-X; PERT CB, 1974, BRAIN RES, V70, P184, DOI 10.1016/0006-8993(74)90228-5; ROSE IA, 1967, J BIOL CHEM, V242, P1635; SANDRI G, 1988, CELL CALCIUM, V9, P159, DOI 10.1016/0143-4160(88)90020-6; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; SNYDER SH, 1990, NEUROCHEM RES, V15, P119, DOI 10.1007/BF00972201; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; THINNES FP, 1989, BIOL CHEM H-S, V370, P1253; THINNES FP, 1993, BIOPHYS J, V64, pA343; VERMA A, 1989, ANNU REV PHARMACOL, V29, P307; VLASUK GP, 1980, ANAL BIOCHEM, V105, P112, DOI 10.1016/0003-2697(80)90431-5; WEHRLE JP, 1978, J BIOL CHEM, V253, P8598; WHITE TK, 1990, ARCH BIOCHEM BIOPHYS, V277, P26, DOI 10.1016/0003-9861(90)90545-A; WILKIN GP, 1977, J NEUROCHEM, V29, P1039, DOI 10.1111/j.1471-4159.1977.tb06507.x; Wilson J E, 1980, Curr Top Cell Regul, V16, P1; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	70	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23289	23296						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226852				2022-12-27	WOS:A1993MF51500054
J	SHEN, QX; UKNES, SJ; HO, THD				SHEN, QX; UKNES, SJ; HO, THD			HORMONE RESPONSE COMPLEX IN A NOVEL ABSCISIC-ACID AND CYCLOHEXIMIDE-INDUCIBLE BARLEY GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INHIBITORS; AMYLASE SUBTILISIN INHIBITOR; C-FOS; ALEURONE CELLS; BETA-GLUCURONIDASE; SPLICE JUNCTION; MESSENGER-RNAS; HIGHER-PLANTS; 1ST INTRON; EXPRESSION	The phytohormone, abscisic acid (ABA), plays a variety of roles during, seed development and, in the plant's response to environmental stresses. To study the molecular action of ABA, we have isolated a single copy ABA-induced gene, HVA22, which is mapped to barley chromosome 1. The HVA22 gene can be induced by either ABA or the protein synthesis inhibitor, cycloheximide, and addition of both inducers to barley aleurone layers has a synergistic effect on the expression of this gene. Sequence comparison indicates that the HVA22 gene product is highly homologous to the product of human DP1 gene, which is likely to contribute to colorectal tumorigenesis. The hormonal regulation of HVA22 expression has been studied, and there appear to be at least three elements, two located in the promoter and one in the first intron, which are essential for the high level of ABA induction of HVA22 expression. Among the promoter elements is a homolog of ABA response element, which has been shown to be important in the expression of other ABA-induced genes in plants. We suggest that the barley HVA22 gene product is likely a regulatory protein, and the ABA induction of this gene requires the action of a complex set of hormone response elements.	WASHINGTON UNIV, SCH MED,DEPT BIOL,DIV BIOL & BIOMED SCI, PLANT BIOL PROGRAM, ST LOUIS, MO 63110 USA	Washington University (WUSTL)								ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BARTELS D, 1991, EMBO J, V10, P1037, DOI 10.1002/j.1460-2075.1991.tb08042.x; BARTELS D, 1988, PLANTA, V175, P485, DOI 10.1007/BF00393069; BELANGER FC, 1986, P NATL ACAD SCI USA, V83, P1354, DOI 10.1073/pnas.83.5.1354; BERKOWITZ EA, 1992, J BIOL CHEM, V267, P7134; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BORNMAN CH, 1980, PHYSIOL PLANTARUM, V48, P491, DOI 10.1111/j.1399-3054.1980.tb03292.x; BORNSTEIN P, 1970, BIOCHEMISTRY-US, V9, P2408, DOI 10.1021/bi00814a004; BROWN JWS, 1986, NUCLEIC ACIDS RES, V14, P9549, DOI 10.1093/nar/14.24.9549; BRUCE WB, 1989, P NATL ACAD SCI USA, V86, P9692, DOI 10.1073/pnas.86.24.9692; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; CHEN HH, 1983, PLANT PHYSIOL, V71, P362, DOI 10.1104/pp.71.2.362; CHEN J, 1985, EMBO J, V4, P2145, DOI 10.1002/j.1460-2075.1985.tb03908.x; CHEN THH, 1983, PLANT PHYSIOL, V73, P71, DOI 10.1104/pp.73.1.71; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; FRANCO AR, 1990, J BIOL CHEM, V265, P15845; GILMAN M, 1989, CURRENT PROTOCOLS MO; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; GROSS RH, 1986, NUCLEIC ACIDS RES, V14, P591, DOI 10.1093/nar/14.1.591; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HONG BM, 1988, PLANT MOL BIOL, V11, P495, DOI 10.1007/BF00039030; HORNBERG C, 1984, NATURE, V310, P321, DOI 10.1038/310321a0; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; JACOBSEN JV, 1989, PLANT PHYSIOL, V91, P1520, DOI 10.1104/pp.91.4.1520; JEFFERSON RA, 1987, EMBO J, V6, P3901; JOHNSONFLANAGAN AM, 1991, PLANT PHYSIOL, V95, P1044, DOI 10.1104/pp.95.4.1044; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KARSSEN CM, 1983, PLANTA, V157, P158, DOI 10.1007/BF00393650; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KHURSHEED B, 1988, J BIOL CHEM, V263, P18953; KING RW, 1976, PLANTA, V132, P43, DOI 10.1007/BF00390329; KOEHLER SM, 1990, PLANT CELL, V2, P769, DOI 10.1105/tpc.2.8.769; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LACHNO DR, 1986, PHYSIOL PLANTARUM, V68, P215, DOI 10.1111/j.1399-3054.1986.tb01917.x; LANAHAN MB, 1992, PLANT CELL, V4, P203, DOI 10.1105/tpc.4.2.203; LEAH R, 1989, PLANT MOL BIOL, V12, P673, DOI 10.1007/BF00044158; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; LIN LS, 1986, PLANT PHYSIOL, V82, P289, DOI 10.1104/pp.82.1.289; LUDEVID MD, 1992, PLANT J, V2, P999; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; MATHIS JM, 1989, ARCH BIOCHEM BIOPHYS, V269, P93, DOI 10.1016/0003-9861(89)90090-8; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MOORE DD, 1985, P NATL ACAD SCI USA, V82, P699, DOI 10.1073/pnas.82.3.699; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MUNDY J, 1986, PLANTA, V169, P51, DOI 10.1007/BF01369775; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; MUNDY J, 1988, EMBO J, V7, P2279, DOI 10.1002/j.1460-2075.1988.tb03070.x; NAUMANN R, 1982, PLANT SCI LETT, V27, P111, DOI 10.1016/0304-4211(82)90078-5; NOLAN RC, 1987, PLANT MOL BIOL, V8, P13, DOI 10.1007/BF00016430; ROGERS JC, 1992, PLANT CELL, V4, P1443, DOI 10.1105/tpc.4.11.1443; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SINGH NK, 1987, P NATL ACAD SCI USA, V84, P739, DOI 10.1073/pnas.84.3.739; SKRIVER K, 1991, P NATL ACAD SCI USA, V88, P7266, DOI 10.1073/pnas.88.16.7266; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; SUTTON WD, 1974, BIOCHIM BIOPHYS ACTA, V366, P1, DOI 10.1016/0005-2787(74)90312-8; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; VARNER JE, 1976, MOL BIOL HORMONE ACT, P713; VILARDELL J, 1990, PLANT MOL BIOL, V14, P423, DOI 10.1007/BF00028778; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WRIGHT STC, 1969, NATURE, V224, P719, DOI 10.1038/224719a0; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439	75	101	112	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23652	23660						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226892				2022-12-27	WOS:A1993MF51500105
J	BRADFORD, HN; JAMESON, BA; ADAM, AA; WASSELL, RP; COLMAN, RW				BRADFORD, HN; JAMESON, BA; ADAM, AA; WASSELL, RP; COLMAN, RW			CONTIGUOUS BINDING AND INHIBITORY SITES ON KININOGENS REQUIRED FOR THE INHIBITION OF PLATELET CALPAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; THIOL PROTEINASE-INHIBITORS; EGG-WHITE CYSTATIN; BROWN NORWAY RATS; CYSTEINE PROTEINASES; T-KININOGEN; MONOCLONAL-ANTIBODIES; HUMAN-NEUTROPHILS; KATHOLIEK STRAIN; PURIFICATION	Both high molecular weight kininogen (HK) and low molecular weight kininogens (LK) are potent tight binding inhibitors of platelet calpain (K(i) = 2 nM), but the molecular basis for the inhibitory function is not well delineated. The amino acid sequences of the calpain inhibitory domain 2 from human and rat HK were compared for homology with the noninhibitory domains from human and rat domain 3 and from domain 2 of rat T-kininogen, and two areas of nonconserved differences were detected. Computer three-dimensional models were constructed on a template built using the x-ray crystallographic data for cystatin, an evolutionary precursor of HK. Two nonconserved regions in the calpain inhibitory domains flank the highly conserved motif QVVAG to form a continuous surface for interaction with cysteine proteases. Three peptide sequences, components of the modeled surface, were chosen for synthesis from HK D-2: VHPISTQSPDLE (peptide 146-156, NH2-terminal), CTDNAYIDIQLRIASFSQNC (peptide 229-248, COOH-terminal), and CQRQVVAGLNFRIC (185-189, central) containing QVVAG. This last peptide differs from the natural sequence by substitutions of A185C and T195C. Peptides 185-198 and 229-248 were folded by air oxidation of their cysteine residues and then tested for their ability to inhibit calpain and papain. The folded peptide 229-248 inhibited calpain with an IC50 35 muM and unfolding reduced this effect. The folded peptide 185-198 did not inhibit calpain, but when preincubated with calpain, could block the inhibition by HK indicating a probable enzyme binding site. Peptide 146-157 did not inhibit calpain but could inhibit papain with an IC50 of 20 muM. We have thus defined separate binding and inhibitory sequences on HK which form a contiguous surface for thiol protease interactions.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,SOL SHERRY THROMBOSIS RES CTR,3400 N BROAD ST,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT MED,PHILADELPHIA,PA 19140; THOMAS JEFFERSON UNIV,INST CANC,PHILADELPHIA,PA 19107; UNIV MONTREAL,FAC PHARM,MONTREAL H3C 3J7,QUEBEC,CANADA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; Universite de Montreal				Bradford, Harlan/0000-0001-5582-278X	NHLBI NIH HHS [HL45486] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL045486] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAM A, 1989, BIOCHEM CELL BIOL, V67, P86, DOI 10.1139/o89-013; ANASTASI A, 1983, BIOCHEM J, V211, P129, DOI 10.1042/bj2110129; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BRADFORD HN, 1990, BIOCHEM J, V270, P83, DOI 10.1042/bj2700083; BRADFORD HN, 1988, BLOOD, V71, P388; COLLER BS, 1982, BLOOD, V60, P731; COLMAN RW, 1975, J CLIN INVEST, V56, P1650, DOI 10.1172/JCI108247; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENJYOJI K, 1988, J BIOL CHEM, V263, P973; GOUNARIS AD, 1984, BIOCHEM J, V221, P445, DOI 10.1042/bj2210445; GUSTAFSON EJ, 1986, J CLIN INVEST, V78, P310, DOI 10.1172/JCI112567; GUSTAFSON EJ, 1989, J CLIN INVEST, V84, P28, DOI 10.1172/JCI114151; HAYASHI I, 1985, THROMB RES, V39, P313, DOI 10.1016/0049-3848(85)90227-0; HIGASHIYAMA S, 1986, LIFE SCI, V39, P1639, DOI 10.1016/0024-3205(86)90160-8; ISHIGURO H, 1987, BIOCHEMISTRY-US, V26, P7021, DOI 10.1021/bi00396a025; JOHNSON DA, 1987, THROMB RES, V48, P187, DOI 10.1016/0049-3848(87)90415-4; KANAOKA Y, 1977, CHEM PHARM BULL, V25, P3126; KOSOWER NS, 1983, P NATL ACAD SCI-BIOL, V80, P7542, DOI 10.1073/pnas.80.24.7542; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; MATSUEDA R, 1990, CHEM LETT, V389, P191; MOREAU T, 1988, EUR J BIOCHEM, V173, P185, DOI 10.1111/j.1432-1033.1988.tb13983.x; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; OHISHI S, 1982, THROMB RES, V28, P143, DOI 10.1016/0049-3848(82)90043-3; OKADA Y, 1985, CHEM PHARM BULL, V33, P5149; PONTREMOLI S, 1986, P NATL ACAD SCI USA, V83, P1685, DOI 10.1073/pnas.83.6.1685; PONTREMOLI S, 1988, J BIOL CHEM, V263, P1915; PURI RN, 1988, T AM ASS PHYSICIANS, V100, P232; REIS ML, 1985, BIOCHIM BIOPHYS ACTA, V831, P106, DOI 10.1016/0167-4838(85)90156-6; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; SCHMAIER AH, 1986, BLOOD, V67, P119; SCHMAIER AH, 1986, J CLIN INVEST, V77, P1565, DOI 10.1172/JCI112472; SCHMAIER AH, 1983, J CLIN INVEST, V71, P1477, DOI 10.1172/JCI110901; SCHMAIER AH, 1987, J BIOL CHEM, V262, P1405; SCHMAIER AH, 1990, BLOOD, V75, P1273; SCHMAIER AH, 1988, J BIOL CHEM, V263, P1; SCHOLLMEYER JE, 1988, SCIENCE, V240, P911, DOI 10.1126/science.2834825; SCICLI AG, 1984, CLIN EXP HYPERTENS A, V6, P1731, DOI 10.3109/10641968409046068; SCOTT CF, 1985, J BIOL CHEM, V260, P856; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; SHEPPARD A, 1991, BIOCHIM BIOPHYS ACTA, V1076, P156, DOI 10.1016/0167-4838(91)90234-Q; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; TENO N, 1987, INT J PEPT PROT RES, V30, P93	43	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26546	26551						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253784				2022-12-27	WOS:A1993MK42500078
J	FEINSTEIN, R; KANETY, H; PAPA, MZ; LUNENFELD, B; KARASIK, A				FEINSTEIN, R; KANETY, H; PAPA, MZ; LUNENFELD, B; KARASIK, A			TUMOR-NECROSIS-FACTOR-ALPHA SUPPRESSES INSULIN-INDUCED TYROSINE PHOSPHORYLATION OF INSULIN-RECEPTOR AND ITS SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR SIGNAL TRANSDUCTION; SERINE PHOSPHORYLATION; HEPATOMA-CELLS; PROTEIN; KINASE; INVIVO; RESISTANCE; MODULATE; SEPSIS; RATS	Tumor necrosis factor-alpha (TNF) has recently been shown to induce insulin resistance. We have examined the possible effect of TNF on the early events in insulin transmembrane signaling. Incubation of the insulin-sensitive rat hepatoma Fao cells with 5 nM TNF for 1 h led to a 65% decrease in insulin-induced tyrosine phosphorylation of both the insulin receptor beta-subunit and IPS-1, its major cytosolic substrate. TNF-induced impairment of tyrosine phosphorylation was maximal at 0.5 nM and was not accompanied by any reduction in insulin binding. Sixteen hours of TNF incubation led to further impairment in insulin-induced tyrosine phosphorylation of these proteins. Our findings suggest that TNF may exert its anti-insulin effect by interrupting the early insulin-stimulated tyrosine phosphorylation events, which are crucial to insulin transmembrane signature.	BAR ILAN UNIV,DEPT LIFE SCI,IL-52900 RAMAT GAN,ISRAEL; CHAIM SHEBA MED CTR,DEPT SURG,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,INST ENDOCRINOL,IL-52621 TEL HASHOMER,ISRAEL	Bar Ilan University; Chaim Sheba Medical Center; Chaim Sheba Medical Center								BENNEGARD K, 1986, CLIN PHYSIOL, V6, P539; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DONATO NJ, 1992, CELL GROWTH DIFFER, V3, P259; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FONG Y, 1990, CLIN IMMUNOL IMMUNOP, V55, P157, DOI 10.1016/0090-1229(90)90094-7; Holm-Hansen O., 1978, METHOD ENZYMOL, V57, P73, DOI [10.1016/0076-6879(78)57010-9, DOI 10.1016/0076-6879(78)57010-9]; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HURRELL DG, 1989, ENDOCRINOLOGY, V125, P2454, DOI 10.1210/endo-125-5-2454; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; LANG CH, 1989, AM J PHYSIOL, V257, pE301, DOI 10.1152/ajpendo.1989.257.3.E301; MIRALPEIX M, 1992, BIOCHEMISTRY-US, V31, P9031, DOI 10.1021/bi00152a046; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; OFFNER F, 1990, J LAB CLIN MED, V116, P100; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SCHUTZE S, 1990, J IMMUNOL, V144, P2604; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SHAFRIR E, 1990, DIABETES MELLITUS TH, P299; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TAKAYAMA S, 1984, P NATL ACAD SCI-BIOL, V81, P7797, DOI 10.1073/pnas.81.24.7797; TOTPAL K, 1992, CANCER RES, V52, P2557; VANLINT J, 1992, J BIOL CHEM, V267, P25916; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; ZHANG YH, 1988, P NATL ACAD SCI USA, V85, P6802, DOI 10.1073/pnas.85.18.6802	30	445	451	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26055	26058						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253716				2022-12-27	WOS:A1993MK42500007
J	LONGO, FM; MARTIGNETTI, JA; LEBEAU, JM; ZHANG, JS; BARNES, JP; BROSIUS, J				LONGO, FM; MARTIGNETTI, JA; LEBEAU, JM; ZHANG, JS; BARNES, JP; BROSIUS, J			LEUKOCYTE COMMON ANTIGEN-RELATED RECEPTOR-LINKED TYROSINE PHOSPHATASE - REGULATION OF MESSENGER-RNA EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; NEURAL DEVELOPMENT; NEURONAL DIFFERENTIATION; EXTRACELLULAR-MATRIX; ENDOCRINE NEOPLASIA; GROWTH; CLONING; CD45; LAR; DOMAINS	Receptor-linked tyrosine phosphatases regulate cell growth by dephosphorylating proteins involved in tyrosine kinase signal transduction. Within this gene family, the leukocyte common antigen-related (LAR) gene is of particular interest with respect to the nervous system because it has sequence similarity to the neural cell adhesion molecule N-CAM and is located in a chromosomal region (1p32-33) frequently deleted in neuroectodermal tumors. However, immunostaining has detected LAR in non-neural tissues, but not in the central nervous system, peripheral neurons, or adrenal medulla. In this study, rat brain cDNA library LAR clones corresponding to cytoplasmic and 3'-untranslated regions of human LAR were identified. Using probes derived from these clones, high stringency Northern blots revealed approximately 8 kilobase and variable length tissue- and cell-specific LAR transcripts in cortex, brainstem, cerebellum, spinal cord, peripheral tissues, and cultured neural, glial, and pheochromocytoma cells. In situ hybridization showed expression by brain and dorsal root ganglion neurons. LAR expression was developmentally regulated in a region-dependent manner. Changes in LAR expression were also found during nerve growth factor-induced PC12 pheochromocytoma cell differentiation and with contact-mediated inhibition of fibroblast growth. These observations and studies demonstrating neurotrophins functioning via tyrosine kinase receptors suggest that LAR represents an additional mechanism regulating neural development.	UNIV CALIF SAN FRANCISCO,VET AFFAIRS MED CTR,DEPT NEUROL,SAN FRANCISCO,CA 94121; MT SINAI MED CTR,FISHBERG RES CTR NEUROBIOL,NEW YORK,NY 10029; MT SINAI MED CTR,DEPT PEDIAT,NEW YORK,NY 10029; EASTERN VIRGINIA MED SCH,INST DIABET,NORFOLK,VA 23501	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Eastern Virginia Medical School			Brosius, Jürgen/F-5029-2016	Brosius, Jürgen/0000-0003-1650-2059	NIA NIH HHS [R01 AG09873] Funding Source: Medline; NIMH NIH HHS [R01 MH38819] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009873] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		APARICIO LF, 1992, CELL GROWTH DIFFER, V3, P363; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; BRAUTIGAN DL, 1992, BIOCHIM BIOPHYS ACTA, V1114, P63, DOI 10.1016/0304-419X(92)90007-L; Burridge K., 1992, Current Biology, V2, P537, DOI 10.1016/0960-9822(92)90020-B; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; CHO HJ, 1992, BIOCHEMISTRY-US, V31, P133, DOI 10.1021/bi00116a019; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; Doherty P, 1992, Curr Opin Neurobiol, V2, P595, DOI 10.1016/0959-4388(92)90024-F; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; HUTNER T, 1989, CELL, V58, P1013; Jacobson M, 1978, DEV NEUROBIOL, P57; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JIRIK FR, 1992, CYTOGENET CELL GENET, V61, P266, DOI 10.1159/000133418; JOHNSON NA, 1989, J BIOL CHEM, V264, P6220; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KIMMEL DW, 1992, ANN NEUROL, V31, P534, DOI 10.1002/ana.410310512; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEVITT RC, 1991, GENOMICS, V11, P484, DOI 10.1016/0888-7543(91)90168-E; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAGAL E, 1991, J NEUROSCI RES, V30, P560, DOI 10.1002/jnr.490300314; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; MOLEY JF, 1992, CANCER RES, V52, P770; Nairn A C, 1992, Curr Opin Neurobiol, V2, P296, DOI 10.1016/0959-4388(92)90118-5; PALLEN CJ, 1991, P NATL ACAD SCI USA, V88, P6996, DOI 10.1073/pnas.88.16.6996; POT DA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P35, DOI 10.1016/0167-4889(92)90082-M; POT DA, 1991, J BIOL CHEM, V266, P19688; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RITKE MK, 1989, CYTOGENET CELL GENET, V50, P84, DOI 10.1159/000132729; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SAGA Y, 1990, P NATL ACAD SCI USA, V87, P3728, DOI 10.1073/pnas.87.10.3728; Sambrook J, 1989, MOL CLONING LABORATO; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P2579, DOI 10.1073/pnas.74.6.2579; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; YU Q, 1992, ONCOGENE, V7, P1051; ZHANG WR, 1991, BIOCHEM BIOPH RES CO, V178, P1291, DOI 10.1016/0006-291X(91)91034-A	52	71	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26503	26511						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253779				2022-12-27	WOS:A1993MK42500073
J	BARRY, CP; XIE, JL; LEMMON, V; YOUNG, AP				BARRY, CP; XIE, JL; LEMMON, V; YOUNG, AP			MOLECULAR CHARACTERIZATION OF A MULTIPROMOTER GENE ENCODING A CHICKEN FILAMIN PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-PROTEIN; GLUTAMINE-SYNTHETASE; TRANSCRIPTION FACTOR; BETA-GALACTOSIDASE; MAMMALIAN-CELLS; FACTOR E2F; EXPRESSION; CDNA; IDENTIFICATION; SEQUENCE	We report the cloning and sequencing of cDNA encoding a chicken filamin protein. The 2,567 amino acid protein contains an NH2-terminal 267 amino acid actin-binding domain followed by a series of 24 repeating units that are each approximately 95 amino acids in length. The overall primary structure of filamin closely resembles that of human actin-binding protein (ABP). However, filamin lacks a 24-amino-acid insertion prior to repeat 16 that is contained within ABP. This region of human ABP is a site of calpain cleavage and is thought to confer flexibility on the molecule. Hence, it is possible that the properties of actin gels formed with either human ABP or filamin reflect the presence or absence of this insertion. Filamin is encoded within a multi-promoter transcription unit. A downstream filamin promoter (Fil1) resembles those of certain housekeeping genes and has a putative binding site for the transcription factor E2F. Thus, transcription from this promoter may be linked to the cell cycle. A second filamin promoter (Fil2) is located at least 8 kilobases upstream from the Fil1 promoter. This structural arrangement suggests that regulation of filamin gene expression is likely to be complex.	OHIO STATE UNIV,CTR BIOTECHNOL,182 RIGHTMIRE HALL,1060 CARMACK RD,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL,COLUMBUS,OH 43210; OHIO STATE UNIV,OHIO STATE BIOCHEM PROGRAM,COLUMBUS,OH 43210; CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Ohio State University; Ohio State University; Ohio State University; Case Western Reserve University			Lemmon, Vance/A-2565-2008; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576	NEI NIH HHS [EY05063, EY05285, R01 EY005285] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005285, R01EY005063] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARON MD, 1987, J BIOL CHEM, V262, P17623; BRESNICK AR, 1990, J BIOL CHEM, V265, P9236; BROTSCHI EA, 1978, J BIOL CHEM, V253, P8988; BROWN KD, 1992, J CELL SCI, V102, P19; BYERS TJ, 1992, P NATL ACAD SCI USA, V89, P6187, DOI 10.1073/pnas.89.13.6187; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; CORETESE JD, 1988, J CELL BIOL, V107, P1477; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DAVIES PJA, 1978, J BIOL CHEM, V253, P4036; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FOX JEB, 1985, J BIOL CHEM, V260, P1970; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; GOMER RH, 1981, CELL, V23, P524, DOI 10.1016/0092-8674(81)90148-3; GOMER RH, 1983, J CELL BIOL, V96, P321, DOI 10.1083/jcb.96.2.321; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Gros E., 1967, METHOD ENZYMOL, V11, P238; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HARTWIG JH, 1980, J CELL BIOL, V87, P841, DOI 10.1083/jcb.87.3.841; HARTWIG JH, 1981, J MOL BIOL, V145, P563, DOI 10.1016/0022-2836(81)90545-3; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KWAK KB, 1993, BIOCHIM BIOPHYS ACTA, V1175, P243, DOI 10.1016/0167-4889(93)90212-8; LEMAIRE C, 1987, NUCLEIC ACIDS RES, V16, P11815; LEMMON V, 1986, J NEUROSCI, V6, P43; LI HP, 1984, TISSUE CELL, V16, P843, DOI 10.1016/0040-8166(84)90066-1; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; NIEDERMAN R, 1983, J CELL BIOL, V96, P1400, DOI 10.1083/jcb.96.5.1400; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; NOEGEL AA, 1989, J CELL BIOL, V109, P607, DOI 10.1083/jcb.109.2.607; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NORTON PA, 1985, MOL CELL BIOL, V5, P281, DOI 10.1128/MCB.5.2.281; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; PATEJUNAS G, 1987, MOL CELL BIOL, V7, P1070, DOI 10.1128/MCB.7.3.1070; PU HF, 1989, GENE, V81, P169, DOI 10.1016/0378-1119(89)90348-X; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHADIACK AM, 1991, J NEUROBIOL, V6, P617; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; TYLER JM, 1980, J CELL BIOL, V85, P489, DOI 10.1083/jcb.85.2.489; WANG K, 1975, P NATL ACAD SCI USA, V72, P4483, DOI 10.1073/pnas.72.11.4483; WEIHING R, 1988, BIOCHEMISTRY-US, V22, P1865; WEIHING RR, 1983, BIOCHEMISTRY-US, V22, P1839, DOI 10.1021/bi00277a015; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YEE AS, 1989, MOL CELL BIOL, V9, P578, DOI 10.1128/MCB.9.2.578; YOUNG AP, 1983, J BIOL CHEM, V258, P1260	58	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25577	25586						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244995				2022-12-27	WOS:A1993MK10000046
J	BOMSEL, M; MOSTOV, KE				BOMSEL, M; MOSTOV, KE			POSSIBLE ROLE OF BOTH THE ALPHA-SUBUNIT AND BETA-GAMMA-SUBUNIT OF THE HETEROTRIMERIC G-PROTEIN, G(S), IN TRANSCYTOSIS OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEINS; CANINE KIDNEY-CELLS; MDCK CELLS; ADP-RIBOSYLATION; REGULATORY PROTEINS; TRANSPORT VESICLES; MEMBRANE-PROTEIN; EPITHELIAL-CELLS; CHOLERA-TOXIN; BREFELDIN-A	In endosomes the polymeric immunoglobulin receptor (pIgR) is sorted into transcytotic vesicles. Transcytosis of the pIgR in polarized Madin-Darby canine kidney (MDCK) cells is regulated both by phosphorylation of Ser664 and by binding of ligand, dimeric IgA (dIgA). Mutation of Ser664 to Ala (pIgR-Ala664) greatly reduces transcytosis of the pIgR without dIgA bound. Here we report that cholera toxin, which specifically activates the heterotrimeric G protein, G(s), stimulates transcytosis of pIgR-Ala664 when dIgA is not bound. However, transcytosis of the wild-type pIgR without dIgA bound was not stimulated by cholera toxin. To further analyze the involvement of G(s) in transcytosis, we reconstituted part of the transcytotic pathway. Vesicles containing endocytosed ligand bound to the pIgR could be released from MDCK cells whose apical surface had been mechanically perforated. Release of these vesicles was controlled by phosphorylation of the pIgR and by binding of dIgA. The use of perforated cells allowed us to directly address the involvement of G(s). Our data suggest that both subunits of G(s), G(salpha) and betagamma, function together to control vesicular release and may therefore be involved in transcytosis in vivo.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Bomsel, Morgane/GSN-1948-2022	Bomsel, Morgane/0000-0002-9577-7474; mostov, keith/0000-0002-8123-6247	NIAID NIH HHS [R01 AI25144] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; BOMSEL M, 1991, Current Opinion in Cell Biology, V3, P647, DOI 10.1016/0955-0674(91)90036-X; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CODINA J, 1988, BIOCHEM BIOPH RES CO, V150, P848, DOI 10.1016/0006-291X(88)90469-X; COLOMBO MI, 1992, SCIENCE, V255, P1695, DOI 10.1126/science.1348148; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1991, METHOD ENZYMOL, V195, P192; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; LINDER ME, 1991, METHOD ENZYMOL, V195, P202; MERESSE S, 1990, J BIOL CHEM, V265, P18833; MOSS J, 1991, METHOD ENZYMOL, V195, P243; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; NEGISHI M, 1992, J BIOL CHEM, V267, P2364; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; PODBILEWICZ B, 1990, EMBO J, V9, P3477, DOI 10.1002/j.1460-2075.1990.tb07556.x; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; WANG N, 1990, J BIOL CHEM, V265, P1239	43	76	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25824	25835						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245019				2022-12-27	WOS:A1993MK10000080
J	KIRSCH, ML; ZUBERI, AR; HENNER, D; PETERS, PD; YAZDI, MA; ORDAL, GW				KIRSCH, ML; ZUBERI, AR; HENNER, D; PETERS, PD; YAZDI, MA; ORDAL, GW			CHEMOTACTIC METHYLTRANSFERASE PROMOTES ADAPTATION TO REPELLENTS IN BACILLUS-SUBTILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; COVALENT MODIFICATION; SENSORY TRANSDUCTION; BACTERIAL CHEMOTAXIS; PROTEINS; GENES; PHOSPHORYLATION; METHYLATION; EXPRESSION; SEQUENCE	Bacillus subtilis cheR(B), which encodes the chemotactic methyltransferase, has been cloned and sequenced. CheR(B) is a polypeptide of 256 amino acids, with a predicted molecular mass of 28 kDa. A comparison of the predicted amino acid sequence of B. subtilis CheR(B) with that of Escherichia coli CheR(E) demonstrates that the two enzymes share 31% amino acid identity. The homology was functional in that the expression of cheB(B) in an E. coli cheR(E) null mutant made the bacteria Che+. In contrast to cheR(E) null mutants which show a strong smooth swimming bias, cheR(B) null mutants were predominantly tumbly. They respond to the addition and subsequent removal of attractant. They also respond to the addition of repellent but do not adapt; they resume prestimulus bias on removal of repellent. Tethering analysis of a culture of a cheR(B) null mutant revealed two distinct subpopulations, each demonstrating unique behaviors. One showed a strong clockwise flagellar rotation bias, whereas the other was more random. The latter phenotype may be due to a deficiency of CheB and may reflect an interaction of CheB and CheR. Measurements of CheB activity in the cheR null mutant showed them to be only 20% of wild type levels. We conclude from this work that CheR(B) functions to promote adaptation to repellent stimuli in B. subtilis, whereas CheR(E) functions to promote adaptation to attractant stimuli in E. coli.	UNIV ILLINOIS,COLL MED,DEPT BIOCHEM,URBANA,IL 61801; GENENTECH INC,DEPT CELL GENET,S SAN FRANCISCO,CA 94080; UNIV ILLINOIS,COLL LIBERAL ARTS & SCI,URBANA,IL 61801; UNIV SHEFFIELD,DEPT MICROBIOL,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND	University of Illinois System; University of Illinois Urbana-Champaign; Roche Holding; Genentech; University of Illinois System; University of Illinois Urbana-Champaign; University of Sheffield					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020336] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20336] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; BISCHOFF DS, 1991, J BIOL CHEM, V266, P12301; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BOURGESSCASSLER A, 1982, J BIOL CHEM, V257, P12835; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; BURGESSCASSLER A, 1982, J BIOL CHEM, V257, P8412; CHEN J, 1992, THESIS U UTAH; CORARRUBLAS L, 1982, GENE, V17, P79; DUNTEN P, 1991, J BIOL CHEM, V266, P1491; FERRARI FA, 1983, J BACTERIOL, V154, P1513, DOI 10.1128/JB.154.3.1513-1515.1983; FUHRER DK, 1991, J BACTERIOL, V173, P7443, DOI 10.1128/jb.173.23.7443-7448.1991; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HELMANN JD, 1987, P NATL ACAD SCI USA, V84, P6422, DOI 10.1073/pnas.84.18.6422; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HIROYUKI Y, 1983, J BACTERIOL, V156, P1228; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; LEONHARDT H, 1988, J GEN MICROBIOL, V134, P605; MARQUEZ LM, 1990, J BACTERIOL, V172, P3435, DOI 10.1128/jb.172.6.3435-3443.1990; MCCLEARY WR, 1990, J BACTERIOL, V172, P4877, DOI 10.1128/jb.172.9.4877-4887.1990; MUTOH N, 1986, J BACTERIOL, V165, P161, DOI 10.1128/jb.165.1.161-166.1986; OOSAWA K, 1988, CELL, V53, P89, DOI 10.1016/0092-8674(88)90490-4; ORDAL GW, 1983, J BACTERIOL, V154, P1088, DOI 10.1128/JB.154.3.1088-1097.1983; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; PIGGOT PJ, 1984, J GEN MICROBIOL, V130, P2123; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERRIS D, 1981, P NATL ACAD SCI-BIOL, V78, P6051, DOI 10.1073/pnas.78.10.6051; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YAZDI MA, 1990, J GEN MICROBIOL, V136, P1335, DOI 10.1099/00221287-136-7-1335; ZUBERI AR, 1990, J BACTERIOL, V172, P1870, DOI 10.1128/jb.172.4.1870-1876.1990	39	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25350	25356						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244966				2022-12-27	WOS:A1993MK10000014
J	SUNDBY, C; MCCAFFERY, S; ANDERSON, JM				SUNDBY, C; MCCAFFERY, S; ANDERSON, JM			TURNOVER OF THE PHOTOSYSTEM-II D1-PROTEIN IN HIGHER-PLANTS UNDER PHOTOINHIBITORY AND NONPHOTOINHIBITORY IRRADIANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTION CENTER PROTEIN; D1 PROTEIN; CHLOROPLAST MEMBRANES; SPINACH-CHLOROPLASTS; ELECTRON-TRANSPORT; LIGHT; DEGRADATION; PHOTOSYNTHESIS; RECOVERY; LEAVES	The turnover in vivo of the Photosystem II (PS II) reaction center D1 protein was investigated by [S-35]methionine labeling of leaf discs of Brassica napus and subsequent analysis after thylakoid SDS-gel electrophoresis. The rate of D1 protein degradation was found to have a t1/2 of approximately 2 h, at an irradiance corresponding to the growth irradiance. The rate of D1 protein degradation was not increased further by prior photoinhibitory treatment which inactivated 40% of the PS II centers, but the amount of [S-35]methionine label incorporated into the D1 protein during 1 h was increased 3-fold. Whether photoinhibited or not, the incorporation of label into the D1 protein increased with irradiance only up to approximately the growth irradiance and above that it decreased with increasing incident light. These data indicate that a high rate of D1 protein degradation occurs not only after photoinhibition but also under conditions where no net decrease in the number of functional PS II centers occurs and that the number of PS II centers that undergo D1 protein turnover varies depending on prior photoinhibitory damage and on incident irradiance. A down-regulation of PS II in leaves at high irradiances is discussed.	LUND UNIV, DEPT BIOCHEM, POB 124, S-22100 LUND, SWEDEN	Lund University	SUNDBY, C (corresponding author), CSIRO, DIV PLANT IND, GPO BOX 1600, CANBERRA, ACT 2601, AUSTRALIA.							ADIR N, 1990, J BIOL CHEM, V265, P12563; ANDERSSON B., 1991, CURR TOP BIOENERG, V16, P1; ARO EM, 1992, FEBS LETT, V297, P29, DOI 10.1016/0014-5793(92)80320-G; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; CALLAHAN FE, 1986, PLANT PHYSIOL, V82, P261, DOI 10.1104/pp.82.1.261; CHOW WS, 1989, BIOCHIM BIOPHYS ACTA, V973, P105, DOI 10.1016/S0005-2728(89)80408-6; CLELAND RE, 1990, AUST J PLANT PHYSIOL, V17, P641, DOI 10.1071/PP9900641; CRITCHLEY C, 1992, PHOTOSYNTHETICA, V27, P183; CURWIEL VB, 1993, Z NATURFORSCH C, V48, P278; FROMM H, 1985, EMBO J, V4, P291, DOI 10.1002/j.1460-2075.1985.tb03628.x; GODDE D, 1991, Z NATURFORSCH C, V46, P245; GREENBERG BM, 1989, P NATL ACAD SCI USA, V86, P6617, DOI 10.1073/pnas.86.17.6617; GREENBERG BM, 1990, CURRENT RES PHOTOSYN, V1, P209; GREER DH, 1986, PLANTA, V168, P253, DOI 10.1007/BF00402971; GUENTHER JE, 1990, PHOTOSYNTH RES, V23, P105, DOI 10.1007/BF00030070; HART JJ, 1990, PLANT PHYSIOL, V94, P1301, DOI 10.1104/pp.94.3.1301; HEBER U, 1988, PLANTA, V173, P267, DOI 10.1007/BF00403020; HURRY VM, 1992, PLANTA, V188, P369, DOI 10.1007/BF00192804; JEGERSCHOLD C, 1991, FEBS LETT, V280, P87, DOI 10.1016/0014-5793(91)80210-T; KETTUNEN R, 1991, FEBS LETT, V290, P153, DOI 10.1016/0014-5793(91)81247-6; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; MATTOO AK, 1987, P NATL ACAD SCI USA, V84, P1497, DOI 10.1073/pnas.84.6.1497; MELIS A, 1987, PHOTOCHEM PHOTOBIOL, V45, P129, DOI 10.1111/j.1751-1097.1987.tb08413.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHAD I, 1988, BIOCHIM BIOPHYS ACTA, V933, P288, DOI 10.1016/0005-2728(88)90036-9; OHAD N, 1990, Z NATURFORSCH C, V45, P402; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PRAZIL O, 1992, PHOTOSYSTEMS STRUCTU, P295; QUIST G, 1992, PLANTA, V186, P450; RICHTER M, 1990, PHOTOSYNTH RES, V24, P229, DOI 10.1007/BF00032310; SALTER AH, 1992, BIOCHEMISTRY-US, V31, P3990, DOI 10.1021/bi00131a014; SAMUELSSON G, 1987, PLANT PHYSIOL, V83, P438, DOI 10.1104/pp.83.2.438; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; SHIPTON CA, 1991, P NATL ACAD SCI USA, V88, P6691, DOI 10.1073/pnas.88.15.6691; SKOGEN D, 1986, J PLANT PHYSIOL, V126, P195, DOI 10.1016/S0176-1617(86)80021-9; SUNDBY C, 1993, PLANT PHYSIOL, V103, P105, DOI 10.1104/pp.103.1.105; TERASHIMA I, 1985, PLANT CELL PHYSIOL, V26, P781, DOI 10.1093/oxfordjournals.pcp.a076971; TYYSTJARVI E, 1992, PLANT PHYSIOL, V100, P1310, DOI 10.1104/pp.100.3.1310; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; VIRGIN I, 1991, FEBS LETT, V287, P125, DOI 10.1016/0014-5793(91)80031-W; WEIS E, 1987, BIOCHIM BIOPHYS ACTA, V894, P198, DOI 10.1016/0005-2728(87)90190-3	42	91	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25476	25482						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244982				2022-12-27	WOS:A1993MK10000032
J	ANDERSON, ED; THOMAS, L; HAYFLICK, JS; THOMAS, G				ANDERSON, ED; THOMAS, L; HAYFLICK, JS; THOMAS, G			INHIBITION OF HIV-1 GP160-DEPENDENT MEMBRANE-FUSION BY A FURIN-DIRECTED ALPHA(1)-ANTITRYPSIN VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROCESSING ENDOPROTEASES; KEX2-LIKE ENDOPROTEASE; MUTATIONAL ANALYSIS; MAMMALIAN-CELLS; VACCINIA VIRUS; CLEAVAGE SITE; ANTI-THROMBIN; GENE ENCODES; EXPRESSION	Furin is a membrane-associated calcium-dependent serine endoprotease that cleaves proproteins on the carboxyl side of the consensus sequence -Arg-X-Lys/Arg-Arg-. Using site-directed mutagenesis, a variant alpha1-antitrypsin (alpha1-AT) was constructed which contains in its reactive site -Arg-X-X-Arg-, the minimal sequence required for efficient processing by furin (Molloy, S. S., Bresnahan, P. A., Leppla, S. H., Klimpel, K. R., and Thomas, G. (1992) J. Biol. Chem. 267,1639616402). This alpha1-AT variant, [Arg355Arg358]alpha1-AT (alpha1-PDX), is greater than 3,000-fold more effective than [Arg358]alpha1-AT (alpha1-AT Pittsburgh, alpha1-PIT) at inhibiting furin in vitro (K0.5 = 0.03 mug/ml). Furthermore, the P4 Arg in alpha1-PDX greatly attenuates the thrombin inhibitory properties of this serpin (>300-fold) compared with alpha1-PIT (which contains a P4 Ala), thus increasing the selectivity of alpha1-PDX for furin. Expression studies show that alpha1-PDX, and not alpha1-PIT, blocks the processing of two furin substrates, pro-beta-nerve growth factor and human immunodeficiency virus (HIV)-1 gp160 in transfected cells. In addition, a syncytium assay shows that alpha1-PDX blocks the membrane fusogenic properties of HIV-1 gp160. The potential use of alpha1-PDX in manipulating the activation of proproteins in a tissue- and time-specific manner is discussed.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Oregon Health & Science University					NIDDK NIH HHS [DK-44629, DK-37274] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044629, R01DK037274] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BATHURST IC, 1987, SCIENCE, V235, P348, DOI 10.1126/science.3541206; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; BRENNAN SO, 1984, BIOCHIM BIOPHYS ACTA, V802, P24, DOI 10.1016/0304-4165(84)90029-1; BRENNAN SO, 1988, FEBS LETT, V229, P167, DOI 10.1016/0014-5793(88)80819-6; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; BRESNAHAN PA, 1993, MECHANISMS INTRACELL, P225; BRESNAHAN PA, 1989, THESIS OREGON HLTH S; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; HAYFLICK JS, 1992, J NEUROSCI, V12, P705; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; KARSCHIN A, 1992, METHOD ENZYMOL, V207, P408; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEWIS JH, 1978, BLOOD, V51, P129; LU WY, 1993, J BIOL CHEM, V268, P14583; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MATHESON NR, 1991, J BIOL CHEM, V266, P13489; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MCKEEHAN WL, 1977, DEV BIOL STAND, V37, P97; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; ODA K, 1992, BIOCHEM BIOPH RES CO, V189, P1353, DOI 10.1016/0006-291X(92)90223-8; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PERLMUTTER DH, 1989, AM J PHYSIOL, V257, pL147, DOI 10.1152/ajplung.1989.257.4.L147; ROBACK JD, 1992, DEV BRAIN RES, V70, P123, DOI 10.1016/0165-3806(92)90110-I; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SCHAPIRA M, 1987, J CLIN INVEST, V80, P582, DOI 10.1172/JCI113108; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; THORNE BA, 1989, J BIOL CHEM, V264, P3545; VANDERZEE CEEM, 1992, J COMP NEUROL, V326, P91, DOI 10.1002/cne.903260108; YANKER B, 1982, ANN REV BIOCH, V551, P845	40	192	202	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24887	24891						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227051				2022-12-27	WOS:A1993MG67300057
J	KUMAR, MA; TIMM, DE; NEET, KE; OWEN, WG; PEUMANS, WJ; RAO, AG				KUMAR, MA; TIMM, DE; NEET, KE; OWEN, WG; PEUMANS, WJ; RAO, AG			CHARACTERIZATION OF THE LECTIN FROM THE BULBS OF ERANTHIS-HYEMALIS (WINTER ACONITE) AS AN INHIBITOR OF PROTEIN-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; POKEWEED ANTIVIRAL PROTEIN; A-CHAIN; PLANT-LECTINS; ABRIN-A; FLUORESCENCE; RICIN; INVITRO; LEPIDOPTERA; EXPRESSION	The lectin from Eranthis hyemalis has been previously characterized as consisting of two polypeptide chains covalently linked by disulfide bond(s) (Cammue, B. P., Peeters, B., and Peumans, W. J. (1985) Biochem. J. 227, 949-955). We have further characterized the biochemical properties of the lee-tin and demonstrated that it possesses the property of inhibition of protein synthesis using in vitro eukaryotic translation systems. The protein also possesses antiviral activity against the plant virus, alfalfa mosaic virus, and larvicidal activity against the southern corn rootworm, Diabrotica undecimpunctata howardii, a major insect pest of the maize plant. Both isoelectric focusing on gels and chromatofocusing indicated heterogeneity of the protein, with three species having isoelectric points in the range 4-5. The disulfide bond(s) can be rapidly reduced with beta-mercaptoethanol under native conditions. The reduced alkylated polypeptide chains remain associated under native conditions to form a species, EHL', that elutes at the same position as the native protein and has the same molecular weight by sedimentation equilibrium experiments. However, circular dichroism and fluorescence measurements indicated conformational differences between the species.	PIONEER HI BRED INT INC, DEPT BIOTECHNOL RES, JOHNSTON, IA 50131 USA; CASE WESTERN RESERVE UNIV, DEPT BIOCHEM, CLEVELAND, OH 44106 USA; UNIV HLTH SCI CHICAGO MED SCH, DEPT BIOL CHEM, N CHICAGO, IL 60064 USA; MAYO CLIN & MAYO FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA; CATHOLIC UNIV LEUVEN, PLANTENBIOCHEM LAB, B-3030 HEVERLEE, BELGIUM	DuPont; Pioneer Hi-Bred International, Inc.; Case Western Reserve University; Chicago Medical School; Mayo Clinic; KU Leuven								BALASUBRAMANIAM NK, 1991, ARCH BIOCHEM BIOPHYS, V288, P374, DOI 10.1016/0003-9861(91)90209-2; BALZARINI J, 1992, ANTIVIR RES, V18, P191, DOI 10.1016/0166-3542(92)90038-7; CAMMUE BP, 1985, BIOCHEM J, V227, P949, DOI 10.1042/bj2270949; COLLINS EJ, 1990, J BIOL CHEM, V265, P8665; CZAPLA TH, 1990, J ECON ENTOMOL, V83, P2480, DOI 10.1093/jee/83.6.2480; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Etzler ME, 1986, LECTINS PROPERTIES F, P371; FORDHAMSKELTON AP, 1991, MOL GEN GENET, V229, P460, DOI 10.1007/BF00267470; FUNATSU G, 1988, AGR BIOL CHEM TOKYO, V52, P1095; GATEHOUSE AMR, 1984, J SCI FOOD AGR, V35, P373, DOI 10.1002/jsfa.2740350402; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; HABUKA N, 1989, J BIOL CHEM, V264, P6629; HARLEY SM, 1982, P NATL ACAD SCI-BIOL, V79, P5935, DOI 10.1073/pnas.79.19.5935; HOUSTON LL, 1980, BIOCHEM BIOPH RES CO, V92, P319, DOI 10.1016/0006-291X(80)91555-7; Hull R, 1969, Adv Virus Res, V15, P365, DOI 10.1016/S0065-3527(08)60880-5; JANZEN DH, 1976, SCIENCE, V192, P795, DOI 10.1126/science.1265481; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KATAOKA J, 1992, PLANT MOL BIOL, V20, P879, DOI 10.1007/BF00027159; KUBO S, 1990, Annals of the Phytopathological Society of Japan, V56, P481, DOI 10.3186/jjphytopath.56.481; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB FI, 1985, EUR J BIOCHEM, V148, P265, DOI 10.1111/j.1432-1033.1985.tb08834.x; LAPPI DA, 1978, P NATL ACAD SCI USA, V75, P1096, DOI 10.1073/pnas.75.3.1096; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; MATHESON IBC, 1990, COMPUT CHEM, V14, P49, DOI 10.1016/0097-8485(90)80007-O; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCLURE WO, 1967, BIOCHEMISTRY-US, V6, P559, DOI 10.1021/bi00854a025; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; MURDOCK LL, 1990, PHYTOCHEMISTRY, V29, P85, DOI 10.1016/0031-9422(90)89016-3; OUCHTERLONY O, 1948, ACTA PATHOL MIC SC, V25, P186; Parker C. A., 1968, PHOTOLUMINESCENCE SO, P220; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; READY MP, 1986, P NATL ACAD SCI USA, V83, P5053, DOI 10.1073/pnas.83.14.5053; READY MP, 1988, PROTEINS, V3, P53, DOI 10.1002/prot.340030105; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SHUKLE RH, 1983, ENVIRON ENTOMOL, V12, P787, DOI 10.1093/ee/12.3.787; STEINER M, 1980, BIOCHEMISTRY-US, V19, P4492, DOI 10.1021/bi00560a017; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; STROSBERG D, 1986, LECTINS, P251; YORK WS, 1986, METHOD ENZYMOL, V118, P3	39	55	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25176	25183						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227081				2022-12-27	WOS:A1993MG67300094
J	MILEYKOVSKAYA, EI; DOWHAN, W				MILEYKOVSKAYA, EI; DOWHAN, W			ALTERATIONS IN THE ELECTRON-TRANSFER CHAIN IN MUTANT STRAINS OF ESCHERICHIA-COLI LACKING PHOSPHATIDYLETHANOLAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROBIC RESPIRATORY-CHAIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; DOUBLE QUINONE MUTANT; CYTOCHROME-C-OXIDASE; NADH DEHYDROGENASE; MEMBRANE-VESICLES; TERMINAL OXIDASES; BC1 COMPLEX; COENZYME-Q; UBIQUINONE	Inside-out sealed membrane vesicles were prepared from strains of Escherichia coli engineered to be lacking in the major phospholipid of this organism, phosphatidylethanolamine (DeChavigny, A., Heacock, P. N., and Dowhan, W. (1991) J. Biol. Chem. 266, 5323-5332). The energy transducing properties, namely the ability to generate a proton gradient directed inward and to transport electrons to molecular oxygen, were compared to those of membranes isolated from wild type cells containing normal levels of phosphatidylethanolamine. Membranes from both cell types were equal in their ability to oxidize succinate and lactate as well as hydrolyze ATP with the generation of proton gradients of similar magnitude, thus establishing the structural integrity of the membrane barrier and basic functionality of the energy transducing systems in the mutant membranes. However, mutant membranes were reduced by about 80% in their type II NADH dehydrogenase-dependent oxidase activity which resulted in a reduced ability to generate a proton gradient using NADH as an energy source. Use of artificial electron acceptors indicated that the level of type II NADH dehydrogenase activity was normal. Whole chain NADH oxidase activity could be restored by addition of short chain analogs of the naturally occurring Q8, even though the level of the Q8 pool in both cell types was the same. These results suggest that the function of Q8 in linking type II NADH dehydrogenase with the terminal oxidase(s) is dependent on the phosphatidylethanolamine content of the surrounding phospholipid matrix.	UNIV TEXAS,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77025	University of Texas System				Mileykovskaya, Eugenia/0000-0002-8775-4467	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020478, R37GM020478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; BERRY EA, 1991, J BIOL CHEM, V266, P9064; COX GB, 1983, BIOCHEM J, V216, P143, DOI 10.1042/bj2160143; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DOWHAN W, 1992, METHOD ENZYMOL, V209, P7; FINE JB, 1982, J LIPID RES, V23, P660; Haddock B A, 1974, Biochem J, V142, P703; HEACOCK PN, 1989, J BIOL CHEM, V264, P14972; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; HORECKER BL, 1948, J BIOL CHEM, V175, P385; JAWOROWSKI A, 1981, BIOCHEMISTRY-US, V20, P3621, DOI 10.1021/bi00515a049; KIMURA T, 1963, BIOCHEM BIOPH RES CO, V11, P83, DOI 10.1016/0006-291X(63)90070-6; KITA K, 1984, J BIOL CHEM, V259, P3368; KITA K, 1984, J BIOL CHEM, V259, P3375; KRANZ RG, 1983, J BIOL CHEM, V258, P614; LANG JK, 1987, J CHROMATOGR, V385, P109, DOI 10.1016/S0021-9673(01)94626-6; Lenaz G., 1985, COENZYME Q, P165; LESTER RL, 1959, BIOCHIM BIOPHYS ACTA, V33, P169, DOI 10.1016/0006-3002(59)90511-6; LORENCE RM, 1987, J BIOL CHEM, V262, P10532; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MEINHARDT SW, 1989, BIOCHEMISTRY-US, V28, P2153, DOI 10.1021/bi00431a029; MILEYKOVSKAYA E, 1992, EBEC SHORT REPORTS, V7, P59; MILEYKOVSKAYA E, 1992, FASEB J, V6, P1125; Miller J.H., 1972, EXPT MOL GENETICS; Osborn M J, 1974, Methods Enzymol, V31, P642; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; POOLE RK, 1974, BIOCHEM J, V144, P77, DOI 10.1042/bj1440077; PUDEK MR, 1974, ARCH BIOCHEM BIOPHYS, V196, P682; RAGAN CI, 1978, BIOCHEM J, V136, P711; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; SCHAGGER H, 1990, EUR J BIOCHEM, V190, P123, DOI 10.1111/j.1432-1033.1990.tb15554.x; SINGER M, 1989, MICROBIOL REV, V53, P1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STROOBANT P, 1979, BIOCHEMISTRY-US, V18, P226, DOI 10.1021/bi00568a035; SZARKOWSKA L, 1966, ARCH BIOCHEM BIOPHYS, V113, P519, DOI 10.1016/0003-9861(66)90228-1; TSAI A, 1986, BIOCHIM BIOPHYS ACTA, V852, P100, DOI 10.1016/0005-2728(86)90061-7; TSAI AL, 1985, ANAL BIOCHEM, V151, P131, DOI 10.1016/0003-2697(85)90062-4; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; VONJAGOW G, 1990, HIGHLIGHTS UBIQUINON, P93; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; YOUNG IG, 1978, GENE, V4, P25, DOI 10.1016/0378-1119(78)90012-4; ZHOU D, 1991, BIOCHEM J, V273, P627, DOI 10.1042/bj2730627	45	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24824	24831						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227044				2022-12-27	WOS:A1993MG67300048
J	MUKOYAMA, M; NAKAJIMA, M; HORIUCHI, M; SASAMURA, H; PRATT, RE; DZAU, VJ				MUKOYAMA, M; NAKAJIMA, M; HORIUCHI, M; SASAMURA, H; PRATT, RE; DZAU, VJ			EXPRESSION CLONING OF TYPE-2 ANGIOTENSIN-II RECEPTOR REVEALS A UNIQUE CLASS OF 7-TRANSMEMBRANE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SOMATOSTATIN RECEPTORS; RAT; SUBTYPES; IDENTIFICATION; KINASE; TISSUES; BINDING; ENCODES; PROTEIN; LIGAND	Angiotensin II acts on at least two distinct receptor subtypes (AT1 and AT2). Most known effects of angiotensin II in adult tissues are attributable to the AT1 receptor. The function of AT2 receptor is undefined, but its abundant expressions in fetal tissues, immature brain, skin wound, and atretic ovarian follicles suggest a role in growth and development. Previous studies suggested that AT2 receptor may not be G protein-coupled. Here, from a rat fetus expression library, we cloned a cDNA encoding a unique 363-amino acid protein with pharmacological specificity, tissue distribution, and developmental pattern of the AT2 receptor. It is 34% identical in sequence to the AT1 receptor, sharing a seven-transmembrane domain topology. A review of prior data on other receptors suggests that this receptor may belong to a unique class of seven-transmembrane receptors (including somatostatin SSTR1, dopamine D3, and frizzled protein Fz) for which G protein coupling has not been demonstrated. All members of this class exhibit fetal and developmental and/or neuronal-specific expression. A conserved motif in the third intracellular loop, distinguishing this class from ''classical'' G protein-coupled receptors, may mediate novel intracellular effects.	STANFORD UNIV,MED CTR,SCH MED,FALK CARDIOVASC RES CTR,300 PASTEUR DR,STANFORD,CA 94305	Stanford University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL035610, R01HL035252, R01HL046631, R01HL035610] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL46631, HL35610, HL35252] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; CHIU AT, 1989, BIOCHEM BIOPH RES CO, V165, P196, DOI 10.1016/0006-291X(89)91054-1; DUDLEY DT, 1991, MOL PHARMACOL, V40, P360; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; GRESSENS P, 1993, NATURE, V362, P155, DOI 10.1038/362155a0; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; IWAI N, 1992, FEBS LETT, V298, P257, DOI 10.1016/0014-5793(92)80071-N; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; MILLAN MA, 1991, P NATL ACAD SCI USA, V88, P11440, DOI 10.1073/pnas.88.24.11440; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947; RENSDOMIANO S, 1992, MOL PHARMACOL, V42, P28; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SHAW G, 1986, CELL, V46, P6596; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SREEDHARAN SP, 1991, P NATL ACAD SCI USA, V88, P4986, DOI 10.1073/pnas.88.11.4986; TSUTSUMI K, 1991, ENDOCRINOLOGY, V129, P1075, DOI 10.1210/endo-129-2-1075; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; WHITEBREAD S, 1989, BIOCHEM BIOPH RES CO, V163, P284, DOI 10.1016/0006-291X(89)92133-5; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	30	710	726	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24539	24542						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227010				2022-12-27	WOS:A1993MG67300007
J	PREISS, T; HALL, AG; LIGHTOWLERS, RN				PREISS, T; HALL, AG; LIGHTOWLERS, RN			IDENTIFICATION OF BOVINE GLUTAMATE-DEHYDROGENASE AS AN RNA-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CYTOCHROME-C-OXIDASE; MESSENGER-RNA; SUBUNIT-VIIA; 2 ISOFORMS; STABILITY; SEQUENCE; LIVER; EXPRESSION; POLYMERASE; HEART	Two RNA binding activities were demonstrated in bovine liver homogenate. One binding protein was isolated by a simple ion exchange and gel filtration protocol and was shown by N-terminal protein sequence analysis to be glutamate dehydrogenase. Using identical RNA substrate and assay conditions, no detectable RNA binding was observed with equimolar amounts of other representative dehydrogenases and proteins. Furthermore, excesses of tRNA, salmon testis DNA, or each of the four homoribopolymers were unable to compete for the RNA-binding site. Total cytosolic RNA, however, successfully prevented binding of radiolabeled RNA substrate. These data are consistent with glutamate dehydrogenase containing a binding site for heteropolymeric RNA with highest affinity for an as yet undefined nucleotide consensus sequence or structure. The potential physiological relevance of these observations is discussed.	UNIV NEWCASTLE UPON TYNE,SCH MED,DIV CLIN NEUROSCI,FRAMLINGTON PL,NEWCASTLE TYNE NE2 4HH,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,MED MOLEC BIOL GRP,NEWCASTLE TYNE NE2 4HH,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT BIOCHEM & GENET,NEWCASTLE TYNE NE2 4HH,ENGLAND	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK			Hall, Andrew G/B-3485-2009; Hall, Andy/AAD-8622-2020; Preiss, Thomas/F-7355-2010	Preiss, Thomas/0000-0001-6273-784X				ATWATER JA, 1990, ANNU REV GENET, V24, P519; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BERNARDI A, 1972, P NATL ACAD SCI USA, V69, P3033, DOI 10.1073/pnas.69.10.3033; BRUSILOW SW, 1989, METABOLIC BASIS INHE, V1, P629; DANON A, 1991, EMBO J, V10, P3993, DOI 10.1002/j.1460-2075.1991.tb04974.x; DEDUVE C, 1962, ADV ENZYMOL REL S BI, V24, P291; FABRIZI GM, 1989, NUCLEIC ACIDS RES, V17, P7107, DOI 10.1093/nar/17.17.7107; FISHER HF, 1985, METHOD ENZYMOL, V113, P16; FRANKEL AD, 1991, CELL, V67, P1041, DOI 10.1016/0092-8674(91)90282-4; HENTZE MW, 1991, BIOCHIM BIOPHYS ACTA, V1090, P281, DOI 10.1016/0167-4781(91)90191-N; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; KWON TK, 1991, P NATL ACAD SCI USA, V88, P3548; LIGHTOWLERS R, 1990, J BIOL CHEM, V265, P2677; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P111; PREISS T, 1993, J BIOL CHEM, V268, P10659; SEELAN RS, 1991, J BIOL CHEM, V266, P19752; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VANBEEUMEN JJ, 1990, FEBS LETT, V263, P213, DOI 10.1016/0014-5793(90)81376-Y; VANKUILENBURG ABP, 1992, EUR J BIOCHEM, V203, P193; YANAMURA W, 1988, BIOCHEMISTRY-US, V27, P4909, DOI 10.1021/bi00413a048	25	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24523	24526						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227006				2022-12-27	WOS:A1993MG67300003
J	RODRIGUEZ, CG; MONTERO, M; ALVAREZ, J; GARCIASANCHO, J; CRESPO, MS				RODRIGUEZ, CG; MONTERO, M; ALVAREZ, J; GARCIASANCHO, J; CRESPO, MS			DISSOCIATION OF PLATELET-ACTIVATING-FACTOR PRODUCTION AND ARACHIDONATE RELEASE BY THE ENDOMEMBRANE CA2+-ATPASE INHIBITOR THAPSIGARGIN - EVIDENCE FOR THE INVOLVEMENT OF A CA2+-DEPENDENT ROUTE OF PRIMING IN THE PRODUCTION OF LIPID MEDIATORS BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2; ACETYL-COA ACETYLTRANSFERASE; LYSO-PAF-ACETYLTRANSFERASE; DEPENDENT PROTEIN-KINASE; RAT SPLENIC MICROSOMES; HUMAN-NEUTROPHILS; INDEPENDENT TRANSACYLASE; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; CALCIUM ENTRY	The production of platelet-activating factor (PAF) and the release of [H-3]arachidonate were studied in human polymorphonuclear leukocytes (PMN) stimulated with thapsigargin, an inhibitor of endomembrane Ca2+-ATPase. Concentrations of thapsigargin as low as 10-25 nM primed PMN for both PAF production and [H-3]arachidonate release in response to the chemotactic peptide (fMLP), whereas concentrations in the range 25-200 nM induced a time- and dose-dependent production of PAF, which occurred in the absence of both [H-3]arachidonate release and [H-3]phosphatidylethanol formation. Studies in fura-2/AM-loaded cells showed that concentrations of thapsigargin that elicited PAF production induced a protracted and long lasting elevation of cytosolic free calcium concentration ([Ca2+]i) between 200 and 700 nM. The lower concentrations primed the cells for a late [Ca2+]i elevation in response to fMLP similar to that elicited by cytochalasin B or ionomycin. PAF production showed a good correlation with the increase of [Ca2+]i (r = 0.91) irrespective of the procedure used to grade [Ca2+]i. In contrast, phorbol 12,13-dibutyrate failed to induce both PAF production and elevation of [Ca2+]i, but it was a very effective stimulator of [H-3]arachidonate release and [H-3]phosphatidylethanol production. These data indicate that PAF production and [H-3]arachidonate release in PMN differ in both biochemical pathway and modulatory mechanisms. Whereas PAF production seems extremely sensitive to changes in [Ca2+]i, which seems to exert its modulatory effect at the lyso-PAF:acetyl-CoA acetyltransferase step, [H-3] arachidonate release seems tightly modulated by protein kinase C-dependent mechanisms and is coincidental with activation of phospholipase D.			RODRIGUEZ, CG (corresponding author), FAC MED VALLADOLID,CSIC,DEPT BIOQUIM & BIOL MOLEC & FISIOL,E-47005 VALLADOLID,SPAIN.		Alvarez, Javier/K-8210-2014; Montero, Mayte/K-8212-2014; Garcia, Carmen/L-9961-2017; Garcia-Sancho, Javier/K-2975-2014	Alvarez, Javier/0000-0003-0636-5521; Montero, Mayte/0000-0001-7702-6653; Garcia, Carmen/0000-0002-7205-4572; Garcia-Sancho, Javier/0000-0003-4573-7930				ALBERT DH, 1983, J BIOL CHEM, V258, P97; ALONSO F, 1982, J BIOL CHEM, V257, P3376; ALVAREZ J, 1991, BIOCHEM J, V274, P194; BAULDRY SA, 1988, J BIOL CHEM, V263, P16787; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLANK ML, 1983, J CHROMATOGR, V273, P415, DOI 10.1016/S0378-4347(00)80963-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOURGOIN S, 1990, J EXP MED, V172, P767, DOI 10.1084/jem.172.3.767; CHILTON FH, 1984, J BIOL CHEM, V259, P2014; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DIEZ FL, 1989, J CLIN INVEST, V83, P1733, DOI 10.1172/JCI114074; DOMENECH C, 1987, J BIOL CHEM, V262, P5671; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; FRADIN A, 1989, J IMMUNOL, V143, P3680; GARCIA C, 1993, J BIOL CHEM, V268, P4001; GOMEZCAMBRONERO J, 1985, BIOCHIM BIOPHYS ACTA, V845, P511, DOI 10.1016/0167-4889(85)90218-6; GOMEZCAMBRONERO J, 1985, BIOCHIM BIOPHYS ACTA, V845, P516, DOI 10.1016/0167-4889(85)90219-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HENSON PM, 1976, J EXP MED, V143, P937, DOI 10.1084/jem.143.4.937; HOLLAND MR, 1992, J BIOL CHEM, V267, P22883; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LEYRAVAUD S, 1989, J IMMUNOL, V143, P245; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN PY, 1991, J IMMUNOL, V146, P1609; MONTERO M, 1991, BIOCHEM J, V277, P73, DOI 10.1042/bj2770073; MONTERO M, 1992, BIOCHEM J, V288, P519, DOI 10.1042/bj2880519; NIETO ML, 1988, J BIOL CHEM, V263, P2217; NIETO ML, 1988, J BIOL CHEM, V263, P4607; NINIO E, 1987, J IMMUNOL, V139, P154; NINIO E, 1982, BIOCHIM BIOPHYS ACTA, V710, P23, DOI 10.1016/0005-2760(82)90185-0; PARKER J, 1987, J BIOL CHEM, V262, P5385; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SANCHEZCRESPO M, 1980, IMMUNOLOGY, V40, P645; SHARP JD, 1991, J BIOL CHEM, V266, P14850; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; THASTRUP O, 1987, BIOCHIM BIOPHYS ACTA, V927, P65, DOI 10.1016/0167-4889(87)90066-8; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; THASTRUP O, 1987, BIOCHEM BIOPH RES CO, V142, P654, DOI 10.1016/0006-291X(87)91464-1; UEMURA Y, 1991, J BIOL CHEM, V266, P8268; VENABLE ME, 1991, J BIOL CHEM, V266, P18691; WIJKANDER J, 1992, BIOCHEM BIOPH RES CO, V184, P118, DOI 10.1016/0006-291X(92)91166-N; WYKLE RL, 1980, J BIOL CHEM, V255, P256	47	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24751	24757						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227034				2022-12-27	WOS:A1993MG67300037
J	NISHIMURA, H; TAKEYA, H; MIYATA, T; SUEHIRO, K; OKAMURA, T; NIHO, Y; IWANAGA, S				NISHIMURA, H; TAKEYA, H; MIYATA, T; SUEHIRO, K; OKAMURA, T; NIHO, Y; IWANAGA, S			FACTOR-IX FUKUOKA - SUBSTITUTION OF ASN(92) BY HIS IN THE 2ND EPIDERMAL GROWTH FACTOR-LIKE DOMAIN RESULTS IN DEFECTIVE INTERACTION WITH FACTORS-VIIIA/X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-IX; GAMMA-CARBOXYGLUTAMIC ACID; BOVINE FACTOR-IX; AFFINITY CALCIUM-BINDING; RUSSELLS VIPER VENOM; FACTOR-X ACTIVATION; CLOTTING FACTOR-IX; HUMAN FACTOR-VII; TRIMERESURUS-FLAVOVIRIDIS; CHRISTMAS FACTOR	Hemophilia B Fukuoka, a moderately severe bleeding disorder, is a naturally occurring mutant of factor IX. Plasma from our patient had 3% clotting activity even though 64% of factor IX antigen was present. The purified mutant protein was cleaved normally by factor Xla, factor VIIa-tissue factor complex, or RVV-X (factor X-activating enzyme from Russell's viper venom), yielding a two-chain factor IXa. Amino acid composition and sequence analyses of one of the lysyl endopeptidase peptides derived from factor IX Fukuoka revealed that Asn92 in the second epidermal growth factor (EGF)-like domain had been replaced by His. The active site of the factor IXa Fukuoka was normally competent for the incorporation of p-aminobenzamidine and for the hydrolysis of a synthetic substrate, N(alpha)-benzyloxycarbonyl-L-arginine p-nitrobenzyl ester. Factor Xa formation by factor IXa Fukuoka was only 8% of the normal factor IXa, even in the presence of polylysine, and only 0.2% of the normal in the system containing phospholipids, Ca2+, and factor VIIIa, thereby indicating a functional defect in interaction of the mutant with factors VIIIa/X. Furthermore, catalytic efficiency (k(cat)/K(m)) of factor IXa Fukuoka toward factor X in the presence of Ca2+, phospholipids, and factor VIIIa was only 2.3% of the normal factor IXa. These results suggest that an Asn-to-His substitution at position 92 in the second EGF-like domain of factor IX Fukuoka would have an untoward effect on the specific conformational state of factor IX for binding with factors VIIIa/X.	KYUSHU UNIV 33,FAC SCI,DEPT BIOL,HIGASHI KU,FUKUOKA 812,JAPAN; KYUSHU UNIV 33,FAC MED,DEPT INTERNAL MED 1,FUKUOKA 812,JAPAN; KYUSHU UNIV 33,GRAD SCH MED SCI,DEPT MOLEC BIOL,FUKUOKA 812,JAPAN	Kyushu University; Kyushu University; Kyushu University								AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ASTERMARK J, 1991, J BIOL CHEM, V266, P2430; ASTERMARK J, 1992, J BIOL CHEM, V267, P3249; ASTERMARK J, 1991, J BIOL CHEM, V266, P2438; ATODA H, 1991, J BIOL CHEM, V266, P14903; ATODA H, 1989, J BIOCHEM, V106, P808, DOI 10.1093/oxfordjournals.jbchem.a122935; CHEUNG WF, 1991, J BIOL CHEM, V266, P8797; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; ESNOUF MP, 1973, BIOCHEM J, V131, P781, DOI 10.1042/bj1310781; EVANS JP, 1989, BLOOD, V74, P207; FOSTER D, 1984, P NATL ACAD SCI-BIOL, V81, P4766, DOI 10.1073/pnas.81.15.4766; GIANNELLI F, 1990, NUCLEIC ACIDS RES, V18, P4053, DOI 10.1093/nar/18.14.4053; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; HASHIMOTO N, 1985, J BIOCHEM, V97, P1347, DOI 10.1093/oxfordjournals.jbchem.a135187; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HIGASHI S, 1992, J BIOL CHEM, V267, P17990; HOUGIE C, 1967, LANCET, V1, P698; JACKSON CM, 1972, BIOCHEMISTRY-US, V11, P4873, DOI 10.1021/bi00776a001; KATAYAMA K, 1979, P NATL ACAD SCI USA, V76, P4990, DOI 10.1073/pnas.76.10.4990; KAWABATA S, 1985, J BIOCHEM, V97, P1073, DOI 10.1093/oxfordjournals.jbchem.a135150; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYTUS SP, 1984, P NATL ACAD SCI-BIOL, V81, P3699, DOI 10.1073/pnas.81.12.3699; LIN SW, 1990, J BIOL CHEM, V265, P144; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; LUNDBLAD RL, 1982, THROMB RES, V25, P319, DOI 10.1016/0049-3848(82)90232-8; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; MONROE DM, 1988, ANAL BIOCHEM, V172, P427, DOI 10.1016/0003-2697(88)90465-4; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; PENDURTHI UR, 1992, THROMB RES, V65, P177, DOI 10.1016/0049-3848(92)90237-5; RAWALASHEIKH R, 1990, BIOCHEMISTRY-US, V29, P2606, DOI 10.1021/bi00462a025; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; SPITZER SG, 1990, BLOOD, V76, P1530; SUEHIRO K, 1989, J BIOL CHEM, V264, P21257; SUGO T, 1990, THROMB RES, V58, P603, DOI 10.1016/0049-3848(90)90306-W; THOMPSON AR, 1986, BLOOD, V67, P565; WILLIAMS WJ, 1962, BIOCHEM J, V84, P52, DOI 10.1042/bj0840052; WU SM, 1990, GENE, V86, P275, DOI 10.1016/0378-1119(90)90290-8; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; ZUR M, 1978, J BIOL CHEM, V253, P2203	46	21	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24041	24046						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226948				2022-12-27	WOS:A1993MF29400051
J	OON, SH; HONG, A; YANG, XH; CHIA, W				OON, SH; HONG, A; YANG, XH; CHIA, W			ALTERNATIVE SPLICING IN A NOVEL TYROSINE PHOSPHATASE GENE (DPTP4E) OF DROSOPHILA-MELANOGASTER GENERATES 2 LARGE RECEPTOR-LIKE PROTEINS WHICH DIFFER IN THEIR CARBOXYL TERMINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE-COMMON ANTIGEN; NERVOUS-SYSTEM AXONS; SIGNAL TRANSDUCTION; HUMAN-PLACENTA; HOMEOTIC GENE; CATALYTIC DOMAINS; KINASE; FAMILY; CLONING; ENCODES	A novel Drosophila receptor-like protein tyrosine phosphatase gene, DPTP4E, was isolated and characterized. DPTP4E, located at cytological position 4E1-2, is comprised of 10 exons; its RNA products are widely expressed during embryonic development, including the developing central nervous system. DPTP4E produces three major developmentally regulated transcripts of 6.5, 7.0, and 7.5 kilobases. The two major embryonic transcripts arise as the result of the alternative splicing of exon IX; as a consequence, two proteins (200 and 183 kDa) are produced which differ in their carboxyl-terminal sequences. The deduced extracellular domain, which lies between two putative hydrophobic transmembrane segments, contains 11 fibronectin type III-like repeats and 25 putative N-glycosylation sites. A single conserved protein tyrosine phosphatase (PTPase) catalytic domain, which shows a high level of amino acid identity to the Drosophila PTPase DPTP10D and human HPTPbeta, is found in the predicted intracellular domain; this PTPase domain, when expressed as a fusion protein in Escherichia coli, exhibits PTPase activity. The possible implications of these findings are discussed.	NATL UNIV SINGAPORE, INST MOLEC & CELL BIOL, DROSOPHILA NEUROBIOL LAB, SINGAPORE 0511, SINGAPORE	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore								ALEXANDER D R, 1990, New Biologist, V2, P1049; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHARBONNEAU H, 1989, P NATL ACAD SCI USA, V86, P5252, DOI 10.1073/pnas.86.14.5252; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; COOL DE, 1990, P NATL ACAD SCI USA, V87, P7280, DOI 10.1073/pnas.87.18.7280; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DUNPHY WG, 1989, CELL, V58, P181, DOI 10.1016/0092-8674(89)90414-5; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARIHARAN IK, 1991, P NATL ACAD SCI USA, V88, P11266, DOI 10.1073/pnas.88.24.11266; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAUGHON A, 1985, COLD SPRING HARB SYM, V50, P253, DOI 10.1101/SQB.1985.050.01.032; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NORTON PA, 1990, CELL, V61, P15, DOI 10.1016/0092-8674(90)90209-W; Pallen Catherine J., 1992, Current Opinion in Cell Biology, V4, P1000, DOI 10.1016/0955-0674(92)90132-V; PALLEN CJ, 1991, BIOCHEM J, V276, P315, DOI 10.1042/bj2760315; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PAWSON T, 1990, TRENDS GENET, V6, P350, DOI 10.1016/0168-9525(90)90276-C; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; RALPH SJ, 1987, EMBO J, V6, P1251, DOI 10.1002/j.1460-2075.1987.tb02361.x; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; Sambrook J, 1989, MOL CLONING LABORATO; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SIMON MA, 1989, P NATL ACAD SCI USA, V86, P8333, DOI 10.1073/pnas.86.21.8333; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; STRECKER TR, 1989, SCIENCE, V243, P1062, DOI 10.1126/science.2922596; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; STREULI M, 1989, J EXP MED, V86, P3698; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TONKS NK, 1990, MOL CELL BIOL, V10, P458, DOI 10.1128/MCB.10.2.458; TONKS NK, 1989, TRENDS BIOCHEM SCI, V14, P497, DOI 10.1016/0968-0004(89)90184-9; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	58	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23964	23971						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226938				2022-12-27	WOS:A1993MF29400041
J	RATCLIFFE, JV; FURIE, B; FURIE, BC				RATCLIFFE, JV; FURIE, B; FURIE, BC			THE IMPORTANCE OF SPECIFIC GAMMA-CARBOXYGLUTAMIC ACID RESIDUES IN PROTHROMBIN - EVALUATION BY SITE-SPECIFIC MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVITRO ANTICOAGULANT ACTIVITY; ACTIVATED PROTEIN-C; FACTOR-IX; BOVINE PROTHROMBIN; MEMBRANE-BINDING; RECOGNITION SITE; CALCIUM-BINDING; FACTOR-VA; FACTOR-X; PURIFICATION	Prothrombin has 10 gamma-carboxyglutamic acid residues which are essential for the metal ion binding properties and membrane binding function of the protein. To assess the importance of each gamma-carboxyglutamic acid residue we made, by site directed mutagenesis, a series of mutant human prothrombins each with a single glutamic acid to aspartic acid substitution at positions 6, 7, 14, 16, 19, 20, 25, 26, 29, or 32 which are gamma-carboxylated in native prothrombin. Along with wild-type prothrombin, the prothrombin mutants were expressed in Chinese hamster ovary cells, purified by immunoaffinity chromatography using polyclonal anti-prothrombin antibodies, and shown by amino acid analysis to contain the expected number of gamma-carboxyglutamic acid residues. Only substitution of gamma-carboxyglutamic acid 6 with aspartic acid yields a protein with procoagulant activity, affinity for phospholipid and K(M(app)) for prothrombinase indistinguishable from wild-type prothrombin. In contrast, the conservative gamma-carboxyglutamic acid to aspartic acid mutation at positions 16, 26, or 29 results in proteins with little or no procoagulant activity, K(d(app)) for binding to phospholipid at least 200-fold higher than wild-type prothrombin and a K(M(app)) for interaction with the prothrombinase complex nearly 100-fold higher than wild-type prothrombin. The mutations at residues 7, 14, 19, 20, 25, or 32 yielded proteins with intermediate procoagulant activities, between 15 and 52% of wild-type prothrombin. These data have been interpreted to suggest that there are certain gamma-carboxyglutamic acid residues which are important to maintaining the basic structure of the calcium-liganded Gla domain while other gamma-carboxyglutamic acid residues subserve other functions including membrane binding and interdomain interactions.	TUFTS UNIV, SCH MED, DEPT MED, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02111 USA; SACKLER SCH GRAD BIOMED SCI, BOSTON, MA 02111 USA	Tufts University; Tufts University	RATCLIFFE, JV (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR, CTR HEMOSTASIS & THROMBOSIS RES, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA.				NHLBI NIH HHS [HL42443, HL18834] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL018834, R37HL018834, P01HL042443] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJAJ SP, 1988, J BIOL CHEM, V263, P9725; BAJAJ SP, 1982, J BIOL CHEM, V257, P3726; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BERKNER KL, 1989, THROMB HAEMOSTASIS, V62, P345; BLANCHARD RA, 1983, J LAB CLIN MED, V101, P242; BOROWSKI M, 1985, J BIOL CHEM, V260, P9258; BOROWSKI M, 1986, J BIOL CHEM, V261, P4969; BOROWSKI M, 1986, J BIOL CHEM, V261, P1624; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE BC, 1979, J BIOL CHEM, V254, P2521; HERTZBERG MS, 1992, J BIOL CHEM, V267, P14759; HUBBARD BR, 1989, J BIOL CHEM, V264, P14145; JORGENSEN MJ, 1987, CELL, V48, P185, DOI 10.1016/0092-8674(87)90422-3; JORGENSEN MJ, 1987, J BIOL CHEM, V262, P6729; KAUFMAN RJ, 1986, J BIOL CHEM, V261, P9622; KOTKOW KJ, 1993, J BIOL CHEM, V268, P15633; KOTKOW KJ, 1993, METHOD ENZYMOL, V222, P435; KUSTER H, 1992, J BIOL CHEM, V267, P12782; KUWADA M, 1983, ANAL BIOCHEM, V131, P173, DOI 10.1016/0003-2697(83)90150-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; MALHOTRA OP, 1982, BIOCHIM BIOPHYS ACTA, V702, P178, DOI 10.1016/0167-4838(82)90500-3; MALHOTRA OP, 1979, THROMB RES, V15, P427, DOI 10.1016/0049-3848(79)90149-X; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANN KG, 1982, BIOPHYS J, V37, P106, DOI 10.1016/S0006-3495(82)84624-9; MCCRACKEN A A, 1984, Biotechniques, V2, P82; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335; PUSEY ML, 1983, BIOCHEM BIOPH RES CO, V114, P526, DOI 10.1016/0006-291X(83)90812-4; RATCLIFFE JV, 1991, BLOOD, V78, P180; ROSING J, 1980, J BIOL CHEM, V255, P274; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; WELSCH DJ, 1988, BIOCHEMISTRY-US, V27, P4939, DOI 10.1021/bi00413a052; WINSHIP PR, 1991, BRIT J HAEMATOL, V77, P102, DOI 10.1111/j.1365-2141.1991.tb07955.x; ZAPATA GA, 1988, J BIOL CHEM, V263, P8150; ZHANG L, 1990, BIOCHEMISTRY-US, V29, P10828, DOI 10.1021/bi00500a016; ZHANG L, 1992, BLOOD, V80, P942; ZHANG L, 1991, BIOCHEMISTRY-US, V30, P6696, DOI 10.1021/bi00241a009	42	78	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24339	24345						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226983				2022-12-27	WOS:A1993MF29400093
J	RAULSTON, JE; DAVIS, CH; SCHMIEL, DH; MORGAN, MW; WYRICK, PB				RAULSTON, JE; DAVIS, CH; SCHMIEL, DH; MORGAN, MW; WYRICK, PB			MOLECULAR CHARACTERIZATION AND OUTER-MEMBRANE ASSOCIATION OF A CHLAMYDIA-TRACHOMATIS PROTEIN RELATED TO THE HSP70 FAMILY OF PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; 75-KILODALTON PROTEIN; PHAGOLYSOSOME FUSION; POLYACRYLAMIDE GELS; EPITHELIAL-CELLS; STRESS PROTEINS; MURAMIC ACID; MCCOY CELLS; PSITTACI	One route by which Chlamydia trachomatis is internalized into host endometrial epithelial cells is receptor-mediated endocytosis. Although this implies an adhesin-receptor interaction exists, specific chlamydial surface molecules have not been identified. We are investigating potential adhesin molecules using an in vitro functional assay to select for chlamydial recombinant Escherichia coli expressing an adherent phenotype. We have previously shown that E. coli JM109(pPBW58) attaches to epithelial cells by a specific process paralleling C. trachomatis and expresses at least three plasmid-encoded proteins (18,28, and 82 kDa; Schmiel, D. H., Knight, S. T., Raulston, J. E., Choong, J., Davis, C. H., and Wyrick, P. B. (1991) Infect. Immun. 59, 4001-4012). In this report, we demonstrate that (i) the 82-kDa protein is associated with the outer membrane of both E. coli JM109-(pPBW58) and C. trachomatis serovar E elementary bodies; (ii) the plasmid-encoded protein is identical to the native chlamydial protein by mass, charge, antigenicity, and partial proteolytic peptide profiles; (iii) a highly homologous protein is present in C. trachomatis biovariant lymphogranuloma venereum; (iv) the 82-kDa protein is not covalently linked by disulfide bonds to other protein species in either E. coli JM109(pPBW58) or C. trachomatis; (v) sequence analysis of the open reading frame indicates this protein is a relative of the heat shock 70 family of proteins; and (vi) the inferred amino acid sequence contains a contiguous 73-amino acid region having 51% identity with the extracellular sperm receptor binding domain in Strongylocentrosus purpuratus (Foltz, K. R., Partin, J. S., and Lennarz, W. J. (1993) Science 259,1421-1425). The potential involvement of an hsp70 protein in attachment may provide new insight on adherence mechanisms by obligate intracellular pathogens.			RAULSTON, JE (corresponding author), UNIV N CAROLINA,SCH MED,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599, USA.		Schmiel, Deborah/B-2875-2011		NCRR NIH HHS [1 S10RR05554-01] Funding Source: Medline; NIAID NIH HHS [AI13446, AI07001] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR005554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013446] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDHOUS P, 1993, SCIENCE, V259, P1403, DOI 10.1126/science.8383877; ALLAN I, 1983, J GEN MICROBIOL, V129, P2001; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Batteiger B E, 1987, Infect Dis Clin North Am, V1, P55; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; BIRKELUND S, 1990, INFECT IMMUN, V58, P2098, DOI 10.1128/IAI.58.7.2098-2104.1990; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BROWNRIDGE E, 1979, INFECT IMMUN, V24, P697, DOI 10.1128/IAI.24.3.697-700.1979; BRUNHAM RC, 1987, J INFECT DIS, V155, P749, DOI 10.1093/infdis/155.4.749; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHOW WH, 1987, EPIDEMIOL REV, V9, P70, DOI 10.1093/oxfordjournals.epirev.a036309; DANILITION SL, 1990, INFECT IMMUN, V58, P189, DOI 10.1128/IAI.58.1.189-196.1990; DUNBAR BS, 1987, 2 DIMENSIONAL ELECTR, P227; EISSENBERG LG, 1981, INFECT IMMUN, V32, P889, DOI 10.1128/IAI.32.2.889-896.1981; EISSENBERG LG, 1983, INFECT IMMUN, V40, P741, DOI 10.1128/IAI.40.2.741-751.1983; ENGEL JN, 1990, J BACTERIOL, V172, P6959, DOI 10.1128/jb.172.12.6959-6972.1990; FOLTZ KR, 1993, SCIENCE, V259, P1421, DOI 10.1126/science.8383878; FRUTOS R, 1989, J BACTERIOL, V171, P4511, DOI 10.1128/JB.171.8.4511-4513.1989; GARRETT AJ, 1974, J GEN MICROBIOL, V80, P315, DOI 10.1099/00221287-80-1-315; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; HATCH TP, 1981, J BACTERIOL, V146, P426, DOI 10.1128/JB.146.1.426-429.1981; HATCH TP, 1988, MICROBIOLOGY CHLAMYD, P101; HODINKA RL, 1986, INFECT IMMUN, V54, P855, DOI 10.1128/IAI.54.3.855-863.1986; HODINKA RL, 1988, INFECT IMMUN, V56, P1456, DOI 10.1128/IAI.56.6.1456-1463.1988; INGRAHAM JL, 1983, GROWTH BACTERIAL CEL, P9; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; ITO K, 1977, CELL, V11, P551, DOI 10.1016/0092-8674(77)90073-3; JONES CH, 1992, INFECT IMMUN, V60, P4445, DOI 10.1128/IAI.60.11.4445-4451.1992; KENNELL WL, 1991, INFECT IMMUN, V59, P3740, DOI 10.1128/IAI.59.10.3740-3749.1991; KORNAK JM, 1991, INFECT IMMUN, V59, P721, DOI 10.1128/IAI.59.2.721-725.1991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; MACLEAN IW, 1988, CAN J MICROBIOL, V34, P141, DOI 10.1139/m88-028; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATSUMOTO A, 1988, MICROBIOLOGY CHLAMYD, P24; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; MOORMAN DR, 1986, J GEN MICROBIOL, V132, P1055; NEWHALL WJ, 1987, INFECT IMMUN, V55, P162, DOI 10.1128/IAI.55.1.162-168.1987; NEWHALL WJ, 1983, J BACTERIOL, V154, P998, DOI 10.1128/JB.154.2.998-1001.1983; NEWHALL WJV, 1988, MICROBIOLOGY CHLAMYD, P57; PEELING RW, 1991, INFECT IMMUN, V59, P2624, DOI 10.1128/IAI.59.8.2624-2630.1991; PEELING RW, 1989, INFECT IMMUN, V57, P3338, DOI 10.1128/IAI.57.11.3338-3344.1989; REYNOLDS DJ, 1991, INFECT IMMUN, V59, P3033, DOI 10.1128/IAI.59.9.3033-3039.1991; Sambrook J, 1989, MOL CLONING LABORATO; SCHEIDTMANN KH, 1989, PROTEIN STRUCTURE PR, P93; SCHMIEL DH, 1991, INFECT IMMUN, V59, P4001, DOI 10.1128/IAI.59.11.4001-4012.1991; SHERMAN MY, 1992, EMBO J, V11, P71; SOLBRIG MV, 1990, MOL MICROBIOL, V4, P1535, DOI 10.1111/j.1365-2958.1990.tb02064.x; Stamm WE, 1990, SEXUALLY TRANSMITTED, P181; STEPHENS RS, 1988, MICROBIOLOGY CHLAMYD, P113; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; TAM JE, 1992, BIOTECHNIQUES, V13, P374; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG C, 1981, P NATL ACAD SCI-BIOL, V78, P3531, DOI 10.1073/pnas.78.6.3531; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WYRICK PB, 1989, INFECT IMMUN, V57, P2378, DOI 10.1128/IAI.57.8.2378-2389.1989; ZHANG JP, 1992, CELL, V69, P861, DOI 10.1016/0092-8674(92)90296-O; ZHONG GM, 1992, INFECT IMMUN, V60, P3143, DOI 10.1128/IAI.60.8.3143-3149.1992; ZHONG GM, 1992, INFECT IMMUN, V60, P1221, DOI 10.1128/IAI.60.3.1221-1224.1992	65	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23139	23147						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226832				2022-12-27	WOS:A1993MF51500031
J	BARFOD, ET; ZHENG, Y; KUANG, WJ; HART, MJ; EVANS, T; CERIONE, RA; ASHKENAZI, A				BARFOD, ET; ZHENG, Y; KUANG, WJ; HART, MJ; EVANS, T; CERIONE, RA; ASHKENAZI, A			CLONING AND EXPRESSION OF A HUMAN CDC42 GTPASE-ACTIVATING PROTEIN REVEALS A FUNCTIONAL SH3-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE GENE; BINDING PROTEIN; CELL POLARITY; MOLECULAR-CLONING; FOCAL ADHESIONS; HUMAN HOMOLOG; IDENTIFICATION; RHO; PURIFICATION; THROMBIN	CDC42, a member of the Rho family of small GTP-binding proteins, regulates cytoskeletal rearrangements required for cell division. Activating mutations in CDC42 that are refractory to GTPase activation confer a phenotype of large, multinucleated cells. Like other small GTP-binding proteins, CDC42 is activated by a guanosine exchange factor and inactivated by a GTPase-activating protein (GAP). An unidentified 25-kDa platelet protein has been shown to function as a specific CDC42GAP. Here we report the cloning of a cDNA encoding this GAP from a human platelet-precursor cell line. Sequence analysis reveals the presence of three consensus box regions characteristic of rhoGAPs. A glutathione S-transferase fusion protein containing the three boxes derived from the new clone strongly stimulated the GTPase activity of CDC42 but was much less effective on other Rho proteins. This indicates that the cDNA clone encodes a specific GAP for CDC42. Sequence analysis also reveals a potential proline-rich Src homology 3 (SH3)-binding domain preceding the first consensus box. Binding experiments show that this motif can interact with the SH3 domains of p85alpha and of c-Src. Thus, CDC42GAP may function as a link between CDC42 and other signaling pathways.	GENENTECH INC, DEPT MOLEC BIOL, S SAN FRANCISCO, CA 94080 USA; CORNELL UNIV, DEPT PHARMACOL, ITHACA, NY 14853 USA	Roche Holding; Genentech; Cornell University			Zheng, Yi/J-7235-2015; Ashkenazi, Avi/ABG-2712-2020	Zheng, Yi/0000-0001-7089-6074; Ashkenazi, Avi/0000-0002-6890-4589; Hart, Matthew/0000-0002-2683-480X	NIGMS NIH HHS [GM47458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BOGUSKI MS, 1993, IN PRESS NATURE; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN WN, 1993, J BIOL CHEM, V268, P13280; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; EVANS T, 1986, J BIOL CHEM, V261, P7052; GARRETT MD, 1991, BIOCHEM J, V276, P833, DOI 10.1042/bj2760833; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hall A, 1993, CURR OPIN CELL BIOL, V5, P265, DOI 10.1016/0955-0674(93)90114-6; HART MJ, 1990, J BIOL CHEM, V265, P5990; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HART MJ, 1991, J BIOL CHEM, V266, P20840; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; POLAKIS PG, 1989, BIOCHEM BIOPH RES CO, V160, P25, DOI 10.1016/0006-291X(89)91615-X; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; YERAMIAN P, 1987, NUCLEIC ACIDS RES, V15, P1869, DOI 10.1093/nar/15.4.1869; ZHANG J, 1992, J BIOL CHEM, V267, P4686; ZHENG Y, 1993, J BIOL CHEM, V268, P24629; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	40	113	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26059	26062						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253717				2022-12-27	WOS:A1993MK42500008
J	SHIAO, YJ; VANCE, JE				SHIAO, YJ; VANCE, JE			SPHINGOMYELIN TRANSPORT TO THE CELL-SURFACE OCCURS INDEPENDENTLY OF PROTEIN SECRETION IN RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BREFELDIN-A; ENDOPLASMIC-RETICULUM; GOLGI-COMPLEX; INTRACELLULAR-TRANSPORT; CULTURED FIBROBLASTS; LIPID TRANSPORT; KIDNEY CELLS; CHOLESTEROL; LIVER	The transport of sphingomyelin from its site of synthesis, in the cis/medial-Golgi, to the plasma membrane has been investigated in monolayer cultures of rat hepatocytes. Sphingomyelin was synthesized intracellularly from [methyl-H-3]choline, and the arrival of sphingomyelin at the plasma membrane was monitored by treatment of the cells with sphingomyelinase, which hydrolyzed only sphingomyelin at the cell surface. When hepatocytes were maintained at temperatures from 5 to 37-degrees-C, both protein secretion and sphingomyelin trafficking to the cell surface were inhibited at low temperatures, especially at temperatures below 25-degrees-C. Treatment of cells with the energy poison potassium cyanide prevented protein secretion and reduced the incorporation of [H-3]choline into sphingomyelin, but did not affect the percentage of newly synthesized sphingomyelin that was transported to the cell surface. Brefeldin A and monensin, both of which disrupt protein movement through the Golgi apparatus, were used to evaluate the mechanism of transport of sphingomyelin to the plasma membrane. Although brefeldin A and monensin each effectively blocked protein secretion, sphingomyelin movement to the cell surface was not inhibited, even though sphingomyelin synthesis normally occurs in the Golgi. We conclude that the most likely mechanism of sphingomyelin transport to the cell surface is a vesicle-mediated process (because of the known topology of sphingomyelin synthesis and distribution). However, the putative vesicles that are involved in the movement of sphingomyelin to the plasma membrane are distinct from those that transport proteins for secretion. In addition, the route of trafficking of sphingomyelin to the plasma membrane is not one that requires an obligatory passage through the Golgi apparatus.	UNIV ALBERTA,DEPT MED,EDMONTON T6G 2S2,AB,CANADA	University of Alberta	SHIAO, YJ (corresponding author), UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,AB,CANADA.		Shiao, Young-Ji/AAA-9647-2022					ALLAN D, 1988, BIOCHEM J, V254, P765, DOI 10.1042/bj2540765; BERNERT JT, 1981, BIOCHIM BIOPHYS ACTA, V666, P99, DOI 10.1016/0005-2760(81)90095-3; BRUNING A, 1992, J BIOL CHEM, V267, P5052; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; DAVIDOWICZ EA, 1987, ANNU REV BIOCHEM, V56, P43; DAVIS RA, 1979, J BIOL CHEM, V254, P2010; DEGRELLA RF, 1982, J BIOL CHEM, V257, P4256; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; HATCH GM, 1992, J BIOL CHEM, V267, P12443; HELMS JB, 1990, J BIOL CHEM, V265, P20027; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; KALLEN KJ, 1993, BIOCHEM J, V289, P307, DOI 10.1042/bj2890307; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; KOBAYASHI T, 1989, J BIOL CHEM, V264, P5966; KOBAYASHI T, 1992, FEBS LETT, V300, P227, DOI 10.1016/0014-5793(92)80851-7; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LINARDIC CM, 1992, J BIOL CHEM, V267, P14909; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARGGRAF WD, 1987, BIOCHIM BIOPHYS ACTA, V897, P57, DOI 10.1016/0005-2736(87)90315-4; MARTIN OC, 1987, J BIOL CHEM, V262, P5890; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; PERRET B, 1979, BIOCHIM BIOPHYS ACTA, V556, P434, DOI 10.1016/0005-2736(79)90131-7; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; QUINN P, 1983, J CELL BIOL, V96, P851, DOI 10.1083/jcb.96.3.851; SRIBNEY M, 1971, CAN J BIOCHEM CELL B, V49, P306, DOI 10.1139/o71-044; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; URBANI L, 1990, J BIOL CHEM, V265, P1919; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; Van Meer Gerrit, 1992, Trends in Cell Biology, V2, P332; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; VANCE JE, 1991, J LIPID RES, V32, P1971; VANCE JE, 1991, J BIOL CHEM, V266, P8241; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VANTHOF W, 1992, BIOCHEM J, V283, P913, DOI 10.1042/bj2830913; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; VOELKER DR, 1991, MICROBIOL REV, V55, P543, DOI 10.1128/MMBR.55.4.543-560.1991; VOELKER DR, 1991, BIOCH LIPIDS LIPOPRO, P489; WATTENBERG BW, 1983, J BIOL CHEM, V258, P2284; WATTENBERG BW, 1990, J CELL BIOL, V111, P421, DOI 10.1083/jcb.111.2.421; WEIGEL PH, 1975, J BIOL CHEM, V250, P8536; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YEAGLE PL, 1986, J BIOL CHEM, V261, P8175; YOUNG WW, 1992, J BIOL CHEM, V267, P12011	51	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26085	26092						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253724				2022-12-27	WOS:A1993MK42500015
J	DAS, G; HERR, W				DAS, G; HERR, W			ENHANCED ACTIVATION OF THE HUMAN HISTONE H2B PROMOTER BY AN OCT-1 VARIANT GENERATED BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN OCT-1; RNA POLYMERASE-III; TRANSCRIPTION FACTOR; POU DOMAIN; TRANSLATIONAL CONTROL; IMMUNOGLOBULIN GENES; REGULATORY ELEMENTS; CONSERVED SEQUENCE; U2 SNRNA; OCTAMER	POU homeodomain proteins are important regulators of ubiquitous as well as tissue-specific transcription. These factors include the broadly expressed octamer motif-binding protein Oct-1 and the related cell-specifically expressed protein Oct-2. These two proteins differ in the types of octamer motif-containing promoters they preferentially activate; Oct-1 can activate RNA polymerase II transcription from a small nuclear RNA promoter better than Oct-2, which can better activate an mRNA-type promoter. We describe a variant Oct-1-encoding cDNA resulting from two separate alternate splices of the human oct-1 primary transcript; these alternate splices were present in all cell lines tested. This cDNA encodes an amino-terminally and carboxyl-terminally truncated form of Oct-1, called Oct-1B, which retains the DNA-binding POU domain and acquires a unique 12-amino acid carboxyl-terminal extension. In a transient expression assay, Oct-1B displayed an enhanced ability compared to the larger form of Oct-1 (called Oct-1A in this report) to activate the human histone H2B promoter, an mRNA-type promoter where a natural octamer motif is involved in cell cycle dependent transcription. Thus, the ability of Oct-1 related proteins to activate a natural regulatory target can be influenced by alternative splicing.	COLD SPRING HARBOR LAB,POB 100,COLD SPRING HARBOR,NY 11724	Cold Spring Harbor Laboratory			Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA-13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARK C, 1987, NATURE, V328, P356, DOI 10.1038/328356a0; BELL J, 1992, DEV BIOL, V150, P363, DOI 10.1016/0012-1606(92)90248-F; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; HARVEY RP, 1982, NUCLEIC ACIDS RES, V10, P7851, DOI 10.1093/nar/10.23.7851; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERR W, 1992, TRANSCRIPTIONAL REGU, P1103; HINKLEY C, 1992, MOL CELL BIOL, V12, P4400, DOI 10.1128/MCB.12.10.4400; HSIEH CL, 1990, GENOMICS, V6, P666, DOI 10.1016/0888-7543(90)90502-L; HWANG IH, 1989, MOL CELL BIOL, V9, P1005, DOI 10.1128/MCB.9.3.1005; KEMLER I, 1991, NUCLEIC ACIDS RES, V19, P237, DOI 10.1093/nar/19.2.237; KESSEL M, 1988, NATURE, V332, P117, DOI 10.1038/332117c0; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUNKEL GR, 1988, GENE DEV, V2, P196, DOI 10.1101/gad.2.2.196; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MANFIOLETTI G, 1988, NUCLEIC ACIDS RES, V16, P2873, DOI 10.1093/nar/16.7.2873; MANGIN M, 1986, EMBO J, V5, P987, DOI 10.1002/j.1460-2075.1986.tb04313.x; MANIATIS T, 1978, MOL CLONING; MATTAJ IW, 1985, NATURE, V316, P163, DOI 10.1038/316163a0; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MORIMOTO R I, 1992, Current Opinion in Cell Biology, V4, P480, DOI 10.1016/0955-0674(92)90015-5; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SHEPARD A, 1988, J VIROL, V62, P3364, DOI 10.1128/JVI.62.9.3364-3370.1988; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; STURM RA, 1993, GENOMICS, V16, P333, DOI 10.1006/geno.1993.1194; SUZUKI N, 1993, NUCLEIC ACIDS RES, V21, P245, DOI 10.1093/nar/21.2.245; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TANAKA M, 1988, GENE DEV, V2, P1764, DOI 10.1101/gad.2.12b.1764; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	45	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25026	25032						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227066				2022-12-27	WOS:A1993MG67300076
J	HWANG, YW; ZHONG, JM; POULLET, P; PARMEGGIANI, A				HWANG, YW; ZHONG, JM; POULLET, P; PARMEGGIANI, A			INHIBITION OF SDC25-C-DOMAIN-INDUCED GUANINE-NUCLEOTIDE EXCHANGE BY GUANINE RING BINDING DOMAIN MUTANTS OF V-H-RAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-TU; SACCHAROMYCES-CEREVISIAE CDC25; ESCHERICHIA-COLI; MOLECULAR MECHANISM; GENE-PRODUCT; FACTOR-TS; PROTEINS; IDENTIFICATION; ACTIVATION; MUTATIONS	Guanine-nucleotide exchange is the reaction that controls the activation of H-ras p21. This reaction is stimulated by the guanine-nucleotide exchange factor. In this study we show that H-ras p21 harboring guanine ring binding domain (the conserved NKXD motif) mutations, such as N116I or K117E, are potent inhibitors of H-ras p21 guanine-nucleotide exchange reaction promoted by SDC25C (Saccharomyces cerevisiae SDC25 C-domain gene product), a guanine-nucleotide exchange factor. The inhibition is due to the formation of a stable but catalytically inactive complex consisting of the H-ras mutant and SDC25C. By examining the interaction of v-H-ras(N116I) or v-H-ras(K117E) with SDC25C at different concentrations of guanine-nucleotide, we demonstrate that the mechanism of SDC25C-promoted guanine-nucleotide exchange proceeds through the following pathway. First, SDC25C binds to H-ras and forms an intermediate H-ras.SDC25C complex; subsequently, an incoming guanine-nucleotide dissociates the complex, releasing SDC25C from H-ras and causes guanine-nucleotide exchange. This mechanism is similar to the one proposed for Escherichia coli elongation factor Ts-catalyzed guanine-nucleotide exchange.	CSI,IBR,CTR DEV NEUROSCI,STATEN ISL,NY 10314; ECOLE POLYTECH,BIOCHIM LAB,F-91128 PALAISEAU,FRANCE	Institute for Basic Research in Developmental Disabilities; Institut Polytechnique de Paris	HWANG, YW (corresponding author), NEW YORK STATE INST BASIC RES DEV DISABIL,DEPT MOLEC BIOL,1050 FOREST HILL RD,STATEN ISL,NY 10314, USA.				NATIONAL CANCER INSTITUTE [R29CA053782] Funding Source: NIH RePORTER; NCI NIH HHS [CA53782] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; BACCI C, 1992, CELL, V70, P715; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; CEN H, 1992, EMBO J, V11, P4007, DOI 10.1002/j.1460-2075.1992.tb05494.x; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; CUNNINGHAM PR, 1990, BIOCHIM BIOPHYS ACTA, V1050, P18, DOI 10.1016/0167-4781(90)90135-O; DER CJ, 1988, ONCOGENE, V3, P105; DOWNWARD J, 1992, Current Biology, V2, P329, DOI 10.1016/0960-9822(92)90897-J; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GUMUSEL F, 1990, BIOCHIM BIOPHYS ACTA, V1050, P215, DOI 10.1016/0167-4781(90)90169-3; HALL A, 1986, J BIOL CHEM, V261, P963; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HUGHES DA, 1990, NATURE, V344, P355, DOI 10.1038/344355a0; HWANG YW, 1985, J BIOL CHEM, V260, P1498; HWANG YW, 1987, J BIOL CHEM, V262, P13081; HWANG YW, 1989, J BIOL CHEM, V264, P8304; HWANG YW, 1992, J BIOL CHEM, V267, P22198; JACQUET E, 1992, J BIOL CHEM, V267, P24181; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MILLER DL, 1977, FACTORS INVOLVED TRA, P323; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; MUNDER T, 1992, MOL CELL BIOL, V12, P2091, DOI 10.1128/MCB.12.5.2091; OGISO Y, 1990, CELL GROWTH DIFFER, V1, P217; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; REY I, 1991, ONCOGENE, V6, P347; SATOH T, 1988, BIOCHIM BIOPHYS ACTA, V949, P97, DOI 10.1016/0167-4781(88)90059-0; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SCHWEIGHOFFER F, 1992, SCIENCE, V256, P825, DOI 10.1126/science.1317056; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WEI W, 1992, P NATL ACAD SCI USA, V89, P7100, DOI 10.1073/pnas.89.15.7100	49	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24692	24698						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227029				2022-12-27	WOS:A1993MG67300030
J	SWOPE, SL; HUGANIR, RL				SWOPE, SL; HUGANIR, RL			MOLECULAR-CLONING OF 2 ABUNDANT PROTEIN-TYROSINE KINASES IN TORPEDO ELECTRIC ORGAN THAT ASSOCIATE WITH THE ACETYLCHOLINE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED MUSCLE-CELLS; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; GENE-PRODUCT; SRC FAMILY; PHOSPHORYLATION; YES; PROTOONCOGENE; DOMAINS; IDENTIFICATION	The nicotinic acetylcholine receptor (AChR) is phosphorylated on tyrosine residues both in vitro and in vivo. This phosphorylation appears to regulate the rate of receptor desensitization and is associated with AChR clustering induced by the neuronal extracellular matrix protein agrin. To identify the protein tyrosine kinase(s) that phosphorylates the nicotinic receptor, we have used molecular cloning techniques to identify and characterize two protein tyrosine kinases that are highly expressed in Torpedo electric organ, a tissue enriched in synaptic components including the AChR. One of the kinases was identified as the Torpedo homolog of neuronal fyn, whereas the other was a novel kinase we have named fyk due to its homology to both fyn and yes protein tyrosine kinases. Using antibodies to fyn and fyk, Fyn was shown to be a 55-kDa protein phosphorylated on tyrosine residues, whereas Fyk was a 56-kDa/53-kDa doublet phosphorylated on serine and tyrosine residues. At the mRNA and/or protein level, fyn and fyk were present in Torpedo electric organ, skeletal muscle, and brain. Both kinases were detected in the membrane fractions enriched in the AChR, with Fyn and Fyk representing 36 and 8%, respectively, of the protein tyrosine kinase activity in these postsynaptic membranes. In addition, Fyn and Fyk were shown by coimmunoprecipitation to be specifically associated with the AChR. Furthermore, the AChR was phosphorylated in Fyn and Fyk immunoprecipitates. These results indicate that Fyn and Fyk are involved in the regulation of postsynaptic membrane function and suggest that these protein tyrosine kinases may phosphorylate the AChR.	JOHNS HOPKINS UNIV, SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI, 725 N WOLFE ST,900 PCTB, BALTIMORE, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University								ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; CHASE BA, 1987, NEUROSCIENCE, V21, P959, DOI 10.1016/0306-4522(87)90051-0; CHENG SH, 1991, J VIROL, V65, P170, DOI 10.1128/JVI.65.1.170-179.1991; CICHOWSKI K, 1992, J BIOL CHEM, V267, P5025; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COOKE M P, 1989, New Biologist, V1, P66; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; Grant S. G. N., 1992, Society for Neuroscience Abstracts, V18, P638; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; HUGANIR RL, 1987, NEUROMODULATION BIOC, P86; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KAWAKAMI Y, 1989, ONCOGENE, V4, P389; KINGSTON RE, 1991, CURRENT PROTOCOLS MO; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI DOI 10.1083/JCB.108.2.229; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; KYPTA RM, 1988, EMBO J, V7, P3837, DOI 10.1002/j.1460-2075.1988.tb03269.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LEVEY AI, 1990, FEBS LETT, V275, P65, DOI 10.1016/0014-5793(90)81440-Y; Maniatis T., 1982, MOL CLONING LABORATO, P76; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PETERS DJ, 1990, ONCOGENE, V5, P1313; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SELDEN RF, 1987, CURRENT PROTOCOLS MO; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SHORES CG, 1987, J BIOL CHEM, V262, P9477; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STEELE RE, 1989, ONCOGENE RES, V4, P223; SUDOL M, 1993, ONCOGENE, V8, P823; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; SUDOL M, 1993, MOL BASIS HUMAN CANC, P203; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wagner K R, 1991, Curr Opin Neurobiol, V1, P65, DOI 10.1016/0959-4388(91)90011-U; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WILKS AF, 1991, METHOD ENZYMOL, V200, P533; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZAVOICO GB, 1984, BIOCHIM BIOPHYS ACTA, V770, P225, DOI 10.1016/0005-2736(84)90134-2	64	58	60	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25152	25161						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227079				2022-12-27	WOS:A1993MG67300091
J	AU, WC; SU, Y; RAJ, NBK; PITHA, PM				AU, WC; SU, Y; RAJ, NBK; PITHA, PM			VIRUS-MEDIATED INDUCTION OF INTERFERON-A GENE REQUIRES COOPERATION BETWEEN MULTIPLE BINDING-FACTORS IN THE INTERFERON-ALPHA PROMOTER REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IFN-INDUCIBLE GENES; BETA-GENE; REGULATORY ELEMENTS; DNA-BINDING; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; TYPE-1 PROVIRUS; ACTIVATION; CELLS	Transcriptional activation of interferon A (IFNA) gene in virus-infected cells is controlled by a 35-nucleotide inducible element that is cell type specific. Within this region, two elements, alphaF1 and IRF-1 binding sites, were shown by mutation analysis to play a crucial role in the expression of inducible element. In this study, we have analyzed the binding of nuclear proteins to the alphaF1 sequence and have shown that the induction is associated with the formation of a novel complex alphaF1/B, which contains at least two DNA binding proteins of 68 and 96 kDa. In contrast, no binding of the purified interferon regulatory factor 1 (IRF-1) either to the alphaF1 or IRF-1 binding sites could be detected in vitro. However, the oligonucleotides corresponding to alphaF1 or IRF-1 binding sites competed efficiently for the induction of IFNA4 promoter region in a transient transfection assay. We suggest that the induction of IFNA promoter region requires cooperation between alphaF1 binding proteins and IRF-1. Interestingly, our data also show that the inability of IFNA6 promoter to be expressed in infected L-cells may be a result of a viral-induced repressor, which could act by binding and inactivating alphaF1 or by competing for the IRF-1 binding site. These results suggest that cell-specific expression of IFNA genes results from corecruitment of trans-acting factors that bind to alphaF1 and the IRF-1 binding site with the cell-specific virus-induced activator or repressor.	JOHNS HOPKINS UNIV, CTR ONCOL, 418 N BOND ST, BALTIMORE, MD 21231 USA; JOHNS HOPKINS UNIV, DEPT MOLEC BIOL & GENET, BALTIMORE, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University					NIAID NIH HHS [AI19737] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI019737, R01AI019737] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADERKA D, 1986, J IMMUNOL, V136, P2938; AU WC, 1992, NUCLEIC ACIDS RES, V20, P2877, DOI 10.1093/nar/20.11.2877; BISAT F, 1988, NUCLEIC ACIDS RES, V16, P6067, DOI 10.1093/nar/16.13.6067; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; CLEARY MA, 1993, GENE DEV, V7, P72, DOI 10.1101/gad.7.1.72; COHEN L, 1991, CELL GROWTH DIFFER, V2, P323; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1985, CELL, V41, P509, DOI 10.1016/S0092-8674(85)80024-6; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HISCOTT J, 1984, NUCLEIC ACIDS RES, V12, P3727, DOI 10.1093/nar/12.9.3727; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KELLER AD, 1988, P NATL ACAD SCI USA, V85, P3309, DOI 10.1073/pnas.85.10.3309; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; KELLEY KA, 1985, NUCLEIC ACIDS RES, V13, P825, DOI 10.1093/nar/13.3.825; LEBLANC JF, 1990, MOL CELL BIOL, V10, P3987, DOI 10.1128/MCB.10.8.3987; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; POPIK W, 1992, VIROLOGY, V189, P435, DOI 10.1016/0042-6822(92)90567-9; RAJ NBK, 1989, J BIOL CHEM, V264, P11149; RAJ NBK, 1981, P NATL ACAD SCI-BIOL, V78, P7426, DOI 10.1073/pnas.78.12.7426; RAJ NBK, 1991, J BIOL CHEM, V266, P11360; RAJ NBK, 1989, J BIOL CHEM, V264, P16658; RAJ NBK, 1983, P NATL ACAD SCI-BIOL, V80, P3923, DOI 10.1073/pnas.80.13.3923; RAY A, 1988, P NATL ACAD SCI USA, V85, P6701, DOI 10.1073/pnas.85.18.6701; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; REIS LFL, 1993, J INTERFERON RES S1, V12, P552; SHUTTLEWORTH J, 1983, EUR J BIOCHEM, V133, P399, DOI 10.1111/j.1432-1033.1983.tb07476.x; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; SINGH H, 1989, BIOTECHNIQUES, V7, P252; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VLACH J, 1992, VIROLOGY, V187, P63, DOI 10.1016/0042-6822(92)90295-Z; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329	45	49	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24032	24040						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226947				2022-12-27	WOS:A1993MF29400050
J	DONG, Q; COPELAND, WC; WANG, TSF				DONG, Q; COPELAND, WC; WANG, TSF			MUTATIONAL STUDIES OF HUMAN DNA POLYMERASE-ALPHA - IDENTIFICATION OF RESIDUES CRITICAL FOR DEOXYNUCLEOTIDE BINDING AND MISINSERTION FIDELITY OF DNA-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISPAIR EXTENSION KINETICS; I KLENOW FRAGMENT; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; REPLICATION FIDELITY; INSERTION FIDELITY; GENE; SITE	Conserved site-directed mutations were introduced into the second most conserved amino acid region, region II, of the human DNA polymerase alpha catalytic subunit. These mutants were expressed in the baculovirus system and purified to near homogeneity. The mutants had polymerase activity ranging from 4 to 60% compared with the wild type polymerase alpha. Steady-state kinetic analysis of mutants G841A, D860A, D860S, D860N, Y865S, and Y865F demonstrated no significant difference in their K(m) values for primer-template compared with that of the wild type enzyme. In contrast, mutants D860A, Y865S, and Y865F showed a 5-10-fold increase in the K(m) for deoxynucleotide triphosphate (dNTP) compared with the wild type enzyme. DNA synthetic fidelity studies of these mutants showed that mutant Y865S but not Y865F had a greater than 10-fold higher misinsertion efficiency than the wild type enzyme Mg2+-catalyzed reactions. However, with Mn2+ as the metal activator, Y865S and Y865F demonstrated a 2- and 9-fold higher misinsertion efficiency, respectively. These results indicate that Asp860 and Tyr865 in region II of human DNA polymerase alpha are involved in incoming dNTP substrate binding. Using three deoxynucleotide structural analogs as probes, we show that the nucleotide base is the structural requirement for dNTP binding with Tyr865. Furthermore, abolishing the hydrophobic phenyl ring side chain of Tyr865 by replacing tyrosine with serine rendered the enzyme resistant to aphidicolin. Results of these studies strongly suggest that the phenyl ring of Tyr865 directly interacts with the nucleotide base moiety of the dNTP and plays a critical role in the misinsertion fidelity of DNA synthesis. Although mutation of Gly841 to Ala did not affect the binding of primer-template, it had a significant decrease in k(cat), an increase in K(m) for dNTP, a striking decrease of processivity, and also resistance to aphidicolin. Thus, mutation of this residue, Gly841, which is highly conserved among the alpha-like DNA polymerases, appears to affect both catalysis and substrate deoxynucleotide binding. This suggests that Gly841 is essential for the maintenance of the overall structure of the polymerase alpha catalytic site.	STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,STANFORD,CA 94305	Stanford University			Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	NATIONAL CANCER INSTITUTE [R01CA014835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028873] Funding Source: NIH RePORTER; NCI NIH HHS [CA14835] Funding Source: Medline; NIAID NIH HHS [AI28873] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEBENEK K, 1990, J BIOL CHEM, V265, P13878; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; CHUNG DW, 1991, P NATL ACAD SCI USA, V88, P11197, DOI 10.1073/pnas.88.24.11197; COPELAND WC, 1993, J BIOL CHEM, V268, P11041; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; COPELAND WC, 1992, J BIOL CHEM, V267, P21459; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; CREIGHTON TE, 1984, PROTEINS STRUCTURES, P236; DAMAGNEZ V, 1991, MOL GEN GENET, V226, P182, DOI 10.1007/BF00273602; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DONG Q, 1993, J BIOL CHEM, V268, P24175; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; FRY M, 1992, P NATL ACAD SCI USA, V89, P763, DOI 10.1073/pnas.89.2.763; GOODMAN MF, 1988, MUTAT RES, V200, P11, DOI 10.1016/0027-5107(88)90067-X; HALL ZW, 1968, J MOL BIOL, V36, P321, DOI 10.1016/0022-2836(68)90158-7; HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; KHAN NN, 1984, NUCLEIC ACIDS RES, V12, P3695, DOI 10.1093/nar/12.8.3695; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KORNBERG A, 1992, DNA REPLICATION, P127; KRAUSS SW, 1980, BIOCHEMISTRY-US, V19, P220, DOI 10.1021/bi00542a033; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; PARK H, 1993, MOL BIOL CELL, V4, P145, DOI 10.1091/mbc.4.2.145; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; SEAL G, 1979, J BIOL CHEM, V254, P5229; SUMMERS M, 1988, TEX AGR EXP STN B, V1555, P3; TANAKA S, 1982, J BIOL CHEM, V257, P8386; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; ZHANG J, 1991, BIOCHEMISTRY-US, V30, P11742, DOI 10.1021/bi00115a002	44	78	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24163	24174						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226963				2022-12-27	WOS:A1993MF29400068
J	GIARDINA, C; LIS, JT				GIARDINA, C; LIS, JT			POLYMERASE PROCESSIVITY AND TERMINATION ON DROSOPHILA HEAT-SHOCK GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II ELONGATION COMPLEXES; TRANSCRIPTION TERMINATION; MECHANISM INVIVO; HSP70 GENE; RNA; PROMOTER; INVITRO; MELANOGASTER; DNA; 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE	5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) limits RNA polymerase II transcription to a gene's 5'-end. Transcription of the uninduced Drosophila hsp70 gene is likewise restricted to the 5'-end, where the polymerase resides in a paused state. Furthermore, paused elongation complexes formed on the uninduced hsp70 gene and in DRB-inhibited reactions can both be restarted by Sarkosyl or high salt. These similarities prompted us to explore whether these complexes were generated by a block at the same polymerase modification step. In vivo UV cross-linking and KMnO4 hyperreactive site mapping show that while the naturally paused polymerase is restricted to the first approximately 42 base pairs of hsp70, DRB treatment of heat-induced cells allows the polymerase to transcribe past this site. Therefore, the DRB-sensitive step is probably not rate-limiting for hsp70 transcription under uninduced conditions. DRB treatment did, however, lead to the reduction of KMnO4 hyper-reactivity on hsp70 and hsp26 in a region correlating with open polymerase and/or early elongation complexes, suggesting a site for the DRB-sensitive polymerase modification step. Finally, we used the techniques of polymerase-DNA cross-linking and KMnO4 hyper-reactive site mapping to analyze the natural polymerase termination process at the 3'-end of the hsp26 gene. The data obtained are consistent with polymerases terminating at multiple sites downstream of the polyadenylation site.	CORNELL UNIV,BIOCHEM MOLEC & CELL BIOL SECT,BIOTECHNOL BLDG,ITHACA,NY 14853	Cornell University								CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; CITRON B, 1984, NUCLEIC ACIDS RES, V12, P8723, DOI 10.1093/nar/12.22.8723; CONNELLY S, 1989, CELL, V57, P561, DOI 10.1016/0092-8674(89)90126-8; ENRIQUEZHARRIS P, 1991, EMBO J, V10, P1833, DOI 10.1002/j.1460-2075.1991.tb07709.x; FRASER NW, 1978, NATURE, V272, P590, DOI 10.1038/272590a0; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GILMOUR DS, 1985, MOL CELL BIOL, V5, P2009, DOI 10.1128/MCB.5.8.2009; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; RASMUSSEN EB, 1993, IN PRESS P NATL ACAD; ROBERTS S, 1992, EMBO J, V11, P1085, DOI 10.1002/j.1460-2075.1992.tb05147.x; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sambrook J, 1989, MOL CLONING LABORATO; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SOUTHGATE R, 1983, J MOL BIOL, V165, P35, DOI 10.1016/S0022-2836(83)80241-1; SPENCER CA, 1990, ONCOGENE, V5, P777; TAMM I, 1977, P NATL ACAD SCI USA, V74, P5011, DOI 10.1073/pnas.74.11.5011; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; TOMIZAWA J, 1987, CELL, V51, P623, DOI 10.1016/0092-8674(87)90131-0; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZANDOMENI R, 1983, J MOL BIOL, V167, P561, DOI 10.1016/S0022-2836(83)80098-9	32	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23806	23811						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226916				2022-12-27	WOS:A1993MF29400018
J	MALI, M; ELENIUS, K; MIETTINEN, HM; JALKANEN, M				MALI, M; ELENIUS, K; MIETTINEN, HM; JALKANEN, M			INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR-INDUCED GROWTH PROMOTION BY OVEREXPRESSION OF SYNDECAN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE PROTEOGLYCAN; HEPARAN-SULFATE PROTEOGLYCAN; MAMMARY EPITHELIAL-CELLS; FACTOR BINDING; TUMOR-CELLS; EXPRESSION; RECEPTOR; MATRIX; PROLIFERATION; LOCALIZATION	The expression of syndecan-1, the prototype member of the cell surface proteoglycan family, follows morphogenetic rather than histological boundaries during organ formation. As a heparan sulfate-containing cell surface molecule, syndecan-1 can simultaneously bind various components of the extracellular matrix and members of the heparin-binding growth factors. Indeed, syndecan-1 may act as a co-receptor for basic fibroblast growth factor (bFGF) (Salmivirta, M., Heino, J., and Jalkanen, M. (1992) J. Biol. Chem. 267, 17606-17610), allowing the growth factor to bind the tyrosine kinase bFGF receptor. We have studied the role of syndecan-1 in growth factor response by growing 3T3 cells transfected with syndecan-1 in the presence of bFGF. The enhanced expression of syndecan-1 caused down-regulation of bFGF-induced cell proliferation and, at the same time, enhancement of cell matrix interactions. Thus, the induced expression of the heparan sulfate co-receptor (syndecan-1) may provide a mechanism to restrict FGF action and modulate cell-matrix interactions to maintain co-ordinated growth of cells during organ formation.	TURKU CTR BIOTECHNOL,TYKISTOKATU 6,BIOCITY,POB 123,SF-20521 TURKU,FINLAND; UNIV TURKU,DEPT MED BIOCHEM,SF-20520 TURKU 52,FINLAND	University of Turku; University of Turku				Elenius, Klaus/0000-0001-5700-0827	NIDCR NIH HHS [DE09399-01] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009399] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; ELENIUS K, 1990, J BIOL CHEM, V265, P17837; ELENIUS K, 1992, J BIOL CHEM, V267, P6435; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; INKI P, 1991, AM J PATHOL, V139, P1333; INKI P, 1992, LAB INVEST, V66, P314; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; JALKANEN M, 1993, TRENDS GLYCOSCI GLYC, V5, P107; JALKANEN M, 1991, RECEPTORS EXTRACELLU, P1; JOSEPHSILVERSTEIN J, 1989, J CELL BIOL, V108, P2459, DOI 10.1083/jcb.108.6.2459; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; LEPPA S, 1991, CELL REGUL, V2, P1; MALI M, 1990, J BIOL CHEM, V265, P6884; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; OLWIN B, 1992, J CELL BIOL, V118, P621; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SAARNI H, 1977, BIOCHEM PHARMACOL, V27, P1029; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SALMIVIRTA M, 1992, J BIOL CHEM, V267, P17606; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTALA P, 1991, J BIOL CHEM, V266, P23505; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V107, P1199; SOLURSH M, 1990, DEV BIOL, V140, P83, DOI 10.1016/0012-1606(90)90055-N; STAHLI C, 1983, METHOD ENZYMOL, V92, P242; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TANAKA A, 1990, J STEROID BIOCHEM, V37, P23, DOI 10.1016/0960-0760(90)90368-U; THESLEFF I, 1988, DEV BIOL, V129, P565, DOI 10.1016/0012-1606(88)90401-0; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; VAINIO S, 1992, DIFFERENTIATION, V50, P97, DOI 10.1111/j.1432-0436.1992.tb00490.x; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; VOGEL A, 1978, P NATL ACAD SCI USA, V75, P2810, DOI 10.1073/pnas.75.6.2810; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WRIGHT TC, 1989, P NATL ACAD SCI USA, V86, P3199, DOI 10.1073/pnas.86.9.3199; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	46	104	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24215	24222						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226969				2022-12-27	WOS:A1993MF29400075
J	MARIE, S; DIAZGUERRA, MJ; MIQUEROL, L; KAHN, A; IYNEDJIAN, PB				MARIE, S; DIAZGUERRA, MJ; MIQUEROL, L; KAHN, A; IYNEDJIAN, PB			THE PYRUVATE-KINASE GENE AS A MODEL FOR STUDIES OF GLUCOSE-DEPENDENT REGULATION OF GENE-EXPRESSION IN THE ENDOCRINE PANCREATIC BETA-CELL TYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POST-TRANSCRIPTIONAL REGULATION; GLUCOKINASE MESSENGER-RNA; INSULIN-I GENE; RAT-LIVER; CYCLIC-AMP; HEXOSAMINE BIOSYNTHESIS; HORMONAL-CONTROL; TRANSGENIC MICE; RIN-5F CELLS; B-CELLS	The insulinoma beta-cell line INS-1 expresses the L-type pyruvate kinase gene at high level and responds to a rise in extracellular glucose by strong induction of gene expression. Following the addition of glucose to the culture medium in the 3.5-33 mM concentration range, the cellular level of L-type pyruvate kinase mRNA increases within 2 h and reaches a maximum 15-fold above basal in 8-12 h. By run-on nuclear assay, the relative transcription rate of the pyruvate kinase gene is shown to increase 4-fold at maximal stimulation, suggesting that both transcriptional and post-transcriptional effects contribute to mRNA accumulation. The glucose effect is totally suppressed by the hexokinase inhibitor mannoheptulose, indicating a requirement for glucose phosphorylation. The mRNA induction is not inhibited in glutamine-free culture medium or by azaserine, suggesting that the hexosamine biosynthetic pathway is not involved. Moreover, metabolism along the glycolytic pathway does not appear to be an absolute requisite, since 2-deoxyglucose partly mimics the inductive effect of glucose. The glucose effect on the pyruvate kinase gene is reversibly antagonized by agents increasing intracellular cAMP. In addition, the effect is highly specific to the pyruvate kinase gene. Neither proinsulin I mRNA nor glucokinase mRNA are increased in glucose-stimulated INS-1 cells. Short term transfection with CAT plasmids driven by the pyruvate kinase L promoter reveals specific glucose-inducible reporter activity with the 183-base pair promoter region upstream of the cap site. Within this region, the previously described L4 cis-acting element is crucial for glucose responsiveness, as demonstrated by the fact that a plasmid with a mutation in this element does not elicit glucose-inducible CAT activity. Induction of L-type pyruvate kinase mRNA occurs in the islets of rats subjected to fasting and carbohydrate refeeding. In conclusion, the L-type pyruvate kinase gene provides an interesting model of glucose-regulated gene in the endocrine beta-cell type.	UNIV GENEVA,CTR MED UNIV,SCH MED,DIV CLIN BIOCHEM,1 RUE MICHEL SERVET,CH-1211 GENEVA 4,SWITZERLAND; INST COCHIN GENET MOLEC,INSERM,U129,F-75014 PARIS,FRANCE	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm)			Díaz-Guerra, María José M/M-2855-2014	Díaz-Guerra, María José M/0000-0003-3843-3912				AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; BESSELL EM, 1973, BIOCHEM J, V131, P83, DOI 10.1042/bj1310083; BESSELL EM, 1973, BIOCHEM J, V131, P77, DOI 10.1042/bj1310077; BRUNSTEDT J, 1982, BIOCHEM BIOPH RES CO, V106, P1383, DOI 10.1016/0006-291X(82)91267-0; CARTIER N, 1992, ONCOGENE, V7, P1413; CHICK WL, 1977, P NATL ACAD SCI USA, V74, P628, DOI 10.1073/pnas.74.2.628; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COGNET M, 1991, J BIOL CHEM, V266, P7368; COLLINS HW, 1990, P NATL ACAD SCI USA, V87, P5494, DOI 10.1073/pnas.87.14.5494; CUIF MH, 1993, J BIOL CHEM, V268, P13769; CUIF MH, 1992, MOL CELL BIOL, V12, P4852, DOI 10.1128/MCB.12.11.4852; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; EFRAT S, 1991, J BIOL CHEM, V266, P11141; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; GOODISON S, 1992, BIOCHEM J, V285, P563, DOI 10.1042/bj2850563; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GORUS FK, 1984, J BIOL CHEM, V259, P1196; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HAMMONDS P, 1987, FEBS LETT, V213, P149, DOI 10.1016/0014-5793(87)81481-3; HAYZER DJ, 1990, BIOCHEM J, V270, P261, DOI 10.1042/bj2700261; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JOHNSON JH, 1990, J BIOL CHEM, V265, P6548; LONE YC, 1986, FEBS LETT, V195, P97, DOI 10.1016/0014-5793(86)80138-7; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MARIE J, 1986, EUR J BIOCHEM, V158, P33, DOI 10.1111/j.1432-1033.1986.tb09717.x; MARIE J, 1981, NATURE, V292, P70, DOI 10.1038/292070a0; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MCCLAIN DA, 1992, P NATL ACAD SCI USA, V89, P8150, DOI 10.1073/pnas.89.17.8150; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MUNNICH A, 1984, J BIOL CHEM, V259, P228; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1985, J BIOL CHEM, V260, P4393; NOGUCHI T, 1991, BIOCHEM BIOPH RES CO, V181, P259, DOI 10.1016/S0006-291X(05)81411-1; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Sambrook J, 1989, MOL CLONING LABORATO; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sladek FM, 1992, CURR OPIN GENET DEV, V2, P256, DOI 10.1016/S0959-437X(05)80282-5; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; TRAXINGER RR, 1992, J BIOL CHEM, V267, P9718; TZE WJ, 1976, TRANSPLANTATION, V22, P201, DOI 10.1097/00007890-197608000-00017; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; VAULONT S, 1984, BIOCHEM BIOPH RES CO, V125, P135, DOI 10.1016/S0006-291X(84)80345-9; VAULONT S, 1986, J BIOL CHEM, V261, P7621; VAULONT S, 1989, MOL CELL BIOL, V9, P4409, DOI 10.1128/MCB.9.10.4409; WALKER D. G., 1966, ESSAYS BIOCHEM, V2, P33; WELSH M, 1985, J BIOL CHEM, V260, P3590; YAMADA K, 1990, J BIOL CHEM, V265, P19885	72	118	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23881	23890						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226928				2022-12-27	WOS:A1993MF29400030
J	NEYROZ, P; DESDOUITS, F; BENFENATI, F; KNUTSON, JR; GREENGARD, P; GIRAULT, JA				NEYROZ, P; DESDOUITS, F; BENFENATI, F; KNUTSON, JR; GREENGARD, P; GIRAULT, JA			STUDY OF THE CONFORMATION OF DARPP-32, A DOPAMINE-REGULATED AND CAMP-REGULATED PHOSPHOPROTEIN, BY FLUORESCENCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE INHIBITOR-1; TIME-RESOLVED FLUORESCENCE; 3'-5'-MONOPHOSPHATE-REGULATED NEURONAL PHOSPHOPROTEIN; RABBIT SKELETAL-MUSCLE; CASEIN KINASE-II; GLYCOGEN-PHOSPHORYLASE; ALCOHOL-DEHYDROGENASE; DECAY; TRYPTOPHAN; CLONING	DARPP-32 is a potent inhibitor of protein phosphatase 1 when it is phosphorylated on Thr34 by cAMP-dependent protein kinase. DARPP-32 is also phosphorylated on Ser45 and Ser102 by casein kinase II, resulting in a facilitation of phosphorylation by cAMP-dependent protein kinase. We have studied the conformation of recombinant rat DARPP-32 by steady-state and time-resolved fluorescence. The steady-state emission spectra and quenching of the intrinsic (Trp163) and extrinsic fluorescence (acrylodan or lucifer yellow linked to Cys72) were consistent with a complete exposure of these residues to the aqueous environment. The intrinsic fluorescence of DARPP-32 was resolved into three decay components with lifetimes of 1, 3.4, and 7 ns, with the intermediate lifetime component giving the major contribution. The ratio between the amplitudes associated with the short and long decay constants was decreased upon denaturation. The rotational behavior of DARPP-32 measured by anisotropy decay revealed that Trp163 is located in a highly flexible peptide chain, whereas Cys72 is embedded in a more rigid environment. Phosphorylation by cAMP-dependent protein kinase did not alter any of the fluorescence parameters, whereas only minor effects were associated with casein kinase II phosphorylation. These findings indicate that DARPP-32 contains at least two distinct domains and that phosphorylation has no dramatic effects on its conformation.	COLL FRANCE,CHAIR NEUROPHARMACOL,INSERM,U114,F-75231 PARIS 05,FRANCE; UNIV ROMA TOR VERGATA,DIPARTIMENTO MED SPERIMENTALE & SCI BIOCHIM,ROME,ITALY; NHLBI,CELL BIOL LAB,BETHESDA,MD 20892; ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Rome Tor Vergata; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Rockefeller University	NEYROZ, P (corresponding author), UNIV BOLOGNA,DIPARTIMENTO BIOCHIM G MORUZZI,SEZ BIOCHIM FARMACEUT,I-40126 BOLOGNA,ITALY.		Girault, Jean-Antoine/F-7518-2013	Girault, Jean-Antoine/0000-0002-7900-1705; NEYROZ, PAOLO/0000-0002-9790-4027				AITKEN A, 1982, EUR J BIOCHEM, V126, P235, DOI 10.1111/j.1432-1033.1982.tb06771.x; AMELOOT M, 1984, BIOPHYS J, V46, P525, DOI 10.1016/S0006-3495(84)84050-3; AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019; Badea M G, 1979, Methods Enzymol, V61, P378; BARFORD D, 1991, BIOCHIM BIOPHYS ACTA, V1133, P55, DOI 10.1016/0167-4889(91)90241-O; BEECHEM JM, 1985, ANAL INSTRUM, V14, P379; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; BENFENATI F, 1990, J BIOL CHEM, V265, P12584; Bevington P. R, 1969, DATA REDUCTION ERROR; Birks J., 1970, PHOTOPHYSICS AROMATI, DOI DOI 10.1002/BBPC.19700741223; CHEN RF, 1991, BIOCHEMISTRY-US, V30, P5184, DOI 10.1021/bi00235a011; CROSS AJ, 1984, BIOPHYS J, V46, P45, DOI 10.1016/S0006-3495(84)83997-1; DAHMS TES, 1993, BIOPHYS J, V64, pA55; DALE RE, 1977, J BIOL CHEM, V252, P7500; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EHRLICH ME, 1990, J MOL NEUROSCI, V2, P1, DOI 10.1007/BF02896920; ELBRECHT A, 1990, J BIOL CHEM, V265, P13415; FOULKES JG, 1983, EUR J BIOCHEM, V132, P309, DOI 10.1111/j.1432-1033.1983.tb07363.x; Gilbert C. W., 1983, TIME RESOLVED FLUORE, P605; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HATHAWAY GM, 1983, METHOD ENZYMOL, V99, P317, DOI 10.1016/0076-6879(83)99067-5; Haugland R.P., 1992, HDB FLUORESCENT PROB; HEMMINGS HC, 1984, J NEUROSCI, V4, P99; HEMMINGS HC, 1987, TRENDS NEUROSCI, V10, P377, DOI 10.1016/0166-2236(87)90075-0; HEMMINGS HC, 1992, J NEUROCHEM, V59, P1053, DOI 10.1111/j.1471-4159.1992.tb08347.x; HEMMINGS HC, 1990, J BIOL CHEM, V265, P20369; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4486; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; JOHNSON ML, 1983, BIOPHYS J, V44, P101, DOI 10.1016/S0006-3495(83)84281-7; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KING MM, 1984, J BIOL CHEM, V259, P8080; KNIGHT AEW, 1971, SPECTROCHIM ACTA A-M, VA 27, P1223, DOI 10.1016/0584-8539(71)80073-9; KNUTSON JR, 1982, BIOCHEMISTRY-US, V21, P4671, DOI 10.1021/bi00262a024; KNUTSON JR, 1983, CHEM PHYS LETT, V102, P501, DOI 10.1016/0009-2614(83)87454-5; KURIHARA T, 1988, J NEUROSCI, V8, P508; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NEYROZ P, 1987, J BIOL CHEM, V262, P15900; O'Connor D. V., 1984, TIME CORRELATED SING; PAOLETTI J, 1969, ANAL BIOCHEM, V31, P33, DOI 10.1016/0003-2697(69)90238-3; Parker C. A., 1968, PHOTOLUMINESCENCE SO, P220; PETRICH JW, 1983, J AM CHEM SOC, V105, P3824, DOI 10.1021/ja00350a014; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; PRIVAT JP, 1980, BIOPHYS CHEM, V11, P239, DOI 10.1016/0301-4622(80)80026-3; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROSS JBA, 1981, BIOCHEMISTRY-US, V20, P4369, DOI 10.1021/bi00518a021; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; TAO T, 1969, BIOPOLYMERS, V8, P609, DOI 10.1002/bip.1969.360080505; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; WAHL P, 1969, BIOCHIM BIOPHYS ACTA, V175, P55, DOI 10.1016/0005-2795(69)90145-7; WAHL P, 1974, REV SCI INSTRUM, V45, P28, DOI 10.1063/1.1686442; WARE RW, 1972, CREATION DETECTION A, V1, P213; WILLIAMS KR, 1986, J BIOL CHEM, V261, P1890; Yguerabide J, 1972, Methods Enzymol, V26, P498	64	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24022	24031						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226946				2022-12-27	WOS:A1993MF29400049
J	QIN, J; PANDE, U; LAMAR, GN; ASCOLI, F; ASCENZI, P; CUTRUZZOLA, F; TRAVAGLINIALLOCATELLI, C; BRUNORI, M				QIN, J; PANDE, U; LAMAR, GN; ASCOLI, F; ASCENZI, P; CUTRUZZOLA, F; TRAVAGLINIALLOCATELLI, C; BRUNORI, M			H-1-NMR STUDY OF THE DYNAMICS OF THE PH MODULATION OF AXIAL COORDINATION IN APLYSIA-LIMACINA (VAL(E7)) AND SPERM WHALE DOUBLE MUTANT HIS(E7)-]VAL,THR(E10)-]ARG METMYOGLOBIN - ROLE OF DISTAL HYDROGEN-BONDING IN LIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SPIN FERRIC HEMOPROTEINS; ELECTRONIC-STRUCTURE; IRON(III) PORPHYRINS; ANIONIC LIGANDS; CARBON-MONOXIDE; HEME CAVITY; MYOGLOBIN; EQUILIBRIUM; RESOLUTION	The molecular and electronic structure, thermodynamics, dynamics, and mechanism of interconversion of the pH-modulated reversible equilibria of Aplysia limacina metmyoglobin, (metMb), have been investigated by H-1 NMR spectroscopy. The four identified species which interconvert slowly on the NMR time scale (lifetime > 1 ms) are metMbOH (B) at alkaline pH, five coordinate metMb (N) at acidic to neutral pH, an acidic form, A, near pH approximately 4 and an extremely low pH form, D, attributed to an equilibrium unfolded species. The presence of strong distal hydrogen bonding by Arg (E10) to bound hydroxide is detected via a significant solvent isotope effect on the metMbOH (B) hyperfine shifts. Integration of the peak intensities yields pK values of 7.7 and approximately 4 for the B reversible N and N reversible A equilibria, respectively. Saturation transfer via chemical exchange is observed for B reversible N and N reversible A, where the rates for forming metMbOH (B) and the acidic form A from N are base- and acid-catalyzed, respectively, while the reverse rates are first-order. The much slower interconversion rate for N reversible B in A. limacina metMb than His(E7) containing mammalian metMb is attributed to the fact that a ligand bond is broken rather than just proton transferred and that the equilibrium involves a major rearrangement of the orientation of Arg(E10). This conclusion is supported by H-1 NMR data for the sperm whale double mutant His(E7) --> Val/Thr(E10) --> Arg metMb, which exhibits a pK approximately 8.7 for the equilibrium between five-coordinate metMb (N) and metMbOH (B) with an even slower interconversion rate than in A. limacina metMb. This double mutant metMbOH (B) exhibits hydrogen bonding by Arg (E10) with coordinated hydroxide similar to that in A. limacina metMbOH. The slow but acid-catalyzed rates of conversion of A. limacina metMb (N) to the acid species A with significantly weakened bonding of the heme iron to the axial His(F8) residue is consistent with protonation of an inaccessible residue and/or a structural change accompanying the protonation equilibrium. It is concluded that metMb will coordinate water strongly only when there is a distal hydrogen bond acceptor residue, while the hydroxide ion is coordinated strongly only if there is a distal hydrogen bond donor residue.	UNIV CALIF DAVIS,DEPT CHEM,DAVIS,CA 95616; UNIV ROMA TOR VERGATA,DEPT EXPTL MED & BIOCHEM SCI,I-00173 ROME,ITALY; UNIV ROMA LA SAPIENZA,DEPT BIOCHEM SCI A ROSSI FANELLI,I-00185 ROME,ITALY; UNIV ROMA LA SAPIENZA,CTR MOLEC BIOL,CNR,I-00185 ROME,ITALY	University of California System; University of California Davis; University of Rome Tor Vergata; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome			Cutruzzola', Francesca/G-4052-2011	Cutruzzola', Francesca/0000-0002-4621-2135; Travaglini-Allocatelli, Carlo/0000-0001-8735-1126; Qin, Jun/0000-0002-2647-9270; Brunori, Maurizio/0000-0002-7795-1635	NCRR NIH HHS [RR-04795] Funding Source: Medline; NHLBI NIH HHS [HL-16087] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004795] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016087, R37HL016087] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P40; ASCENZI P, 1981, J BIOL CHEM, V256, P5383; BOERSMA AD, 1982, INORG CHEM, V21, P581, DOI 10.1021/ic00132a023; BOLOGNESI M, 1989, J MOL BIOL, V205, P529, DOI 10.1016/0022-2836(89)90224-6; BOLOGNESI M, 1990, J MOL BIOL, V213, P621, DOI 10.1016/S0022-2836(05)80249-9; BRUNORI M, 1972, J MOL BIOL, V63, P139, DOI 10.1016/0022-2836(72)90526-8; CHIU ML, 1992, THESIS U ILLINOIS UR; COLETTA M, 1985, J BIOL CHEM, V260, P4151; CUTRUZZOLA F, 1991, FEBS LETT, V282, P281, DOI 10.1016/0014-5793(91)80495-O; GIACOMETTI GM, 1981, J MOL BIOL, V151, P315, DOI 10.1016/0022-2836(81)90518-0; GIACOMETTI GM, 1975, BIOCHEMISTRY-US, V14, P1584, DOI 10.1021/bi00679a006; GIACOMETTI GM, 1979, BIOPHYS CHEM, V10, P119, DOI 10.1016/0301-4622(79)80012-5; GIACOMETTI GM, 1981, J MOL BIOL, V146, P363, DOI 10.1016/0022-2836(81)90393-4; GOFF H, 1980, J AM CHEM SOC, V102, P31, DOI 10.1021/ja00521a007; IIZUKA T, 1975, BIOCHIM BIOPHYS ACTA, V400, P143, DOI 10.1016/0005-2795(75)90135-X; ILLGENFRITZ G, 1971, PROBES STRUCTURE FUN, V2, P299; JANES SM, 1987, BIOPHYS J, V51, P653, DOI 10.1016/S0006-3495(87)83390-8; LAMAR GN, 1984, J AM CHEM SOC, V106, P6395, DOI 10.1021/ja00333a050; LAMAR GN, 1988, BIOCHIM BIOPHYS ACTA, V956, P267, DOI 10.1016/0167-4838(88)90143-4; LAMAR GN, 1980, J AM CHEM SOC, V102, P1822, DOI 10.1021/ja00526a011; LAMAR GN, 1978, PORPHYRINS         C, V4, P61; LECOMTE JTJ, 1987, J AM CHEM SOC, V109, P7219, DOI 10.1021/ja00257a068; Mattevi A, 1991, J Mol Recognit, V4, P1, DOI 10.1002/jmr.300040102; MCGRATH TM, 1978, BIOCHIM BIOPHYS ACTA, V534, P99, DOI 10.1016/0005-2795(78)90480-4; MORIKIS D, 1990, J BIOL CHEM, V265, P12143; PANDE U, 1986, BIOCHEMISTRY-US, V25, P5638, DOI 10.1021/bi00367a044; PEYTON DH, 1989, BIOCHEMISTRY-US, V28, P4880, DOI 10.1021/bi00437a053; QIN J, 1992, J MOL BIOL, V224, P891, DOI 10.1016/0022-2836(92)90456-T; RAJARATHNAM K, 1991, J AM CHEM SOC, V113, P7886, DOI 10.1021/ja00021a010; RIZZI M, 1993, FEBS LETT, V320, P13, DOI 10.1016/0014-5793(93)81647-I; ROSSIFANELLI A, 1957, BIOKHIMIYA, V22, P335; ROUSSEAU DL, 1989, J BIOL CHEM, V264, P7878; Sandstrom J., 1982, DYNAMIC NMR SPECTROS, P53; SANTUCCI RF, 1990, BIOPHYS CHEM, V37, P241; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; TAKANO T, 1977, J MOL BIOL, V110, P537, DOI 10.1016/S0022-2836(77)80111-3; TENTORI L, 1973, INT J PEPT PROT RES, V5, P187; THANABAL V, 1988, J AM CHEM SOC, V110, P3027, DOI 10.1021/ja00218a005; TRAVAGLINIALLOC.C, 1993, BIOCHEMISTRY-US, V32, P6041; UNGER SW, 1985, J MAGN RESON, V64, P521, DOI 10.1016/0022-2364(85)90117-9; WITTENBERG BA, 1965, ARCH BIOCHEM BIOPHYS, V111, P576, DOI 10.1016/0003-9861(65)90237-7; YAMAMOTO Y, 1992, FEBS LETT, V310, P71, DOI 10.1016/0014-5793(92)81149-G; [No title captured]; [No title captured]; [No title captured]	45	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24012	24021						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226945				2022-12-27	WOS:A1993MF29400048
J	RENARDROONEY, DC; HAJNOCZKY, G; SEITZ, MB; SCHNEIDER, TG; THOMAS, AP				RENARDROONEY, DC; HAJNOCZKY, G; SEITZ, MB; SCHNEIDER, TG; THOMAS, AP			IMAGING OF INOSITOL 1,4,5-TRISPHOSPHATE-INDUCED CA2+ FLUXES IN SINGLE PERMEABILIZED HEPATOCYTES - DEMONSTRATION OF BOTH QUANTAL AND NONQUANTAL PATTERNS OF CA2+ RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CALCIUM OSCILLATIONS; RAT-LIVER MICROSOMES; ENDOPLASMIC-RETICULUM; POSSIBLE MECHANISM; ACINAR-CELLS; TRISPHOSPHATE; CA-2+; MOBILIZATION; GTP; STORES	The subcellular organization and function of inositol 1,4,5-trisphosphate (InsP3)-sensitive Ca2+ stores has been investigated in permeabilized hepatocytes using fluorescent probe techniques that monitor InsP3 action at the level of the Ca2+ storage organelles. Chlortetracycline fluorescence was used to follow alterations in luminal Ca2+, and InsP3-activated Mn2+ quench of compartmentalized fura-2 was used as a measure of the distribution and permeability of the InsP3-sensitive channels. Fluorescence imaging of single permeabilized hepatocytes attached to coverslips demonstrated that InsP3-sensitive Ca2+ stores are distributed throughout the cytoplasm, but are not present within the nuclear matrix. When hepatocytes were permeabilized in suspension, InsP3, activation of channel opening and Ca2+ release occurred in a quantal manner, such that the incremental magnitude of the response was determined by the dose of InsP3. Under these conditions dose-dependent steps of InsP3-induced Mn2+ entry into the stores occurred in the absence of changes in cytosolic or luminal Ca2+, providing evidence for a series of separate compartments with different sensitivities to InsP3. Electron microscopy studies revealed that the endoplasmic reticulum was extensively vesicularized when hepatocytes were permeabilized in suspension, whereas essentially normal endoplasmic reticulum structure was retained in cells attached to coverslips. In these attached cells the Ca2+ release and channel opening responses to InsP3 occurred in a nonquantal manner at the single cell level. Submaximal doses of InsP3 gave the same magnitude of response as a maximal InsP3 dose, although the rates of Ca2+ release and Mn2+ permeation through the InsP3-activated channels increased in a dose-dependent manner. Thus, in each cell the entire Ca2+ store was accessible for mobilization by an effective InsP3 concentrations. We conclude that the quantal release properties of the InsP3 receptor are not expressed in attached permeabilized liver cells because there is extensive luminal continuity within the InsP3-sensitive Ca2+ stores. This continuity appears to be disrupted when hepatocytes are permeabilized in suspension.	THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,RM 271 JAH,PHILADELPHIA,PA 19107	Jefferson University			Thomas, Andrew/C-6755-2013	Thomas, Andrew/0000-0002-9026-7467	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038422, R01DK038422] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA07215] Funding Source: Medline; NIDDK NIH HHS [DK38422] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; CASWELL AH, 1972, BIOCHEM BIOPH RES CO, V46, P1757, DOI 10.1016/0006-291X(72)90047-2; CHANDLER DE, 1978, J CELL BIOL, V76, P371, DOI 10.1083/jcb.76.2.371; CONROY DM, 1986, BIOCHIM BIOPHYS ACTA, V861, P457, DOI 10.1016/0005-2736(86)90454-2; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DAWSON AP, 1987, BIOCHEM J, V244, P87, DOI 10.1042/bj2440087; DAWSON AP, 1985, FEBS LETT, V185, P147, DOI 10.1016/0014-5793(85)80759-6; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; GIRARD S, 1992, BIOPHYS J, V61, P509, DOI 10.1016/S0006-3495(92)81855-6; GLENNON MC, 1992, J BIOL CHEM, V267, P8230; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JACOB R, 1990, CELL CALCIUM, V11, P241, DOI 10.1016/0143-4160(90)90075-6; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LUKACS GL, 1987, BIOCHIM BIOPHYS ACTA, V931, P251, DOI 10.1016/0167-4889(87)90213-8; MENNITI FS, 1991, J BIOL CHEM, V266, P13646; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MIYAZAKI S, 1986, DEV BIOL, V118, P259, DOI 10.1016/0012-1606(86)90093-X; MOLLENHAUER HH, 1964, STAIN TECHNOL, V39, P111; MUALLEM S, 1989, J BIOL CHEM, V264, P205; NEYLON CB, 1990, AM J PHYSIOL, V259, pC675, DOI 10.1152/ajpcell.1990.259.4.C675; OLDERSHAW KA, 1991, BIOCHEM J, V278, P705, DOI 10.1042/bj2780705; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PAYNE R, 1988, PHILOS T ROY SOC B, V320, P359, DOI 10.1098/rstb.1988.0082; RAWLINGS SR, 1991, J BIOL CHEM, V266, P22755; RENARD DC, 1992, BIOCHEM J, V284, P507, DOI 10.1042/bj2840507; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROONEY TA, 1991, J BIOL CHEM, V266, P12272; ROONEY TA, 1991, PHARMACOL THERAPEUT, V49, P223, DOI 10.1016/0163-7258(91)90056-R; ROSSIER MF, 1991, TRENDS NEUROSCI, V14, P310, DOI 10.1016/0166-2236(91)90143-I; SCHNEIDER AS, 1983, BIOCHEMISTRY-US, V22, P1680, DOI 10.1021/bi00276a025; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; TAYLOR CW, 1990, BIOCHEM J, V266, P189, DOI 10.1042/bj2660189; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; TERASAKI M, 1984, CELL, V38, P101, DOI 10.1016/0092-8674(84)90530-0; Thomas Andrew P., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P225; THOMAS AP, 1991, CELL CALCIUM, V12, P111, DOI 10.1016/0143-4160(91)90013-5; THOMAS AP, 1988, J BIOL CHEM, V263, P2704; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WAITE JH, 1983, J BIOL CHEM, V258, P2911	48	93	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23601	23610						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226887				2022-12-27	WOS:A1993MF51500098
J	BELDENT, V; MICHAUD, A; WEI, L; CHAUVET, MT; CORVOL, P				BELDENT, V; MICHAUD, A; WEI, L; CHAUVET, MT; CORVOL, P			PROTEOLYTIC RELEASE OF HUMAN ANGIOTENSIN-CONVERTING ENZYME - LOCALIZATION OF THE CLEAVAGE SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 HOMOLOGOUS DOMAINS; IMMOBILIZED ANHYDROTRYPSIN; CONSENSUS SEQUENCE; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; MONOBASIC SITES; MESSENGER-RNAS; PRECURSOR; PROTEINS; MEMBRANE	Angiotensin-converting enzyme (EC 3.4.15.1, ACE) is a transmembrane protein with a short carboxyl-terminal cytoplasmic domain, a 17-amino acid hydrophobic anchor domain, and a large N-terminal extracellular region containing two catalytically homologous domains. An active soluble form of ACE circulates in human plasma and is produced in culture medium of Chinese hamster ovary (CHO) cells transfected with the full-length human ACE cDNA. The mechanism of ACE release in CHO cells involves a post-translational proteolytic cleavage occurring in the carboxyl-terminal region. The carboxyl terminus of the secreted recombinant ACE, AGQR, was established by carboxyl-terminal microsequencing and corresponds to a cleavage site between Arg-1137 and Leu-1138. Two independent studies confirmed this proposed cleavage site: amino acid analysis of a carboxyl-terminal peptide derived from soluble ACE and immunocharacterization of membrane-bound and soluble ACE with antibodies raised against three peptides located along the carboxyl-terminal ACE sequence. In order to assess the importance of. Arg-1137, this amino acid was mutated to a glutamine residue. This mutation did not prevent the secretion of ACE, suggesting that the solubilizing enzyme can accommodate this change or can use an alternative cleavage site. Finally, the production of soluble ACE in CHO cells appears to be proportional to the level of cellular ACE, implying that the solubilizing enzyme is not a limiting factor. In addition, the carboxyl-terminal sequence of the human plasma ACE was identified as AGQR, thus supporting the fact that a similar mechanism could operate in human vascular cells.	COLL FRANCE,INSERM,U36,3 RUE ULM,F-75231 PARIS 05,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France								BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BREDDAM K, 1987, CARLSBERG RES COMMUN, V52, P55, DOI 10.1007/BF02910427; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DEVI L, 1991, FEBS LETT, V280, P189, DOI 10.1016/0014-5793(91)80290-J; DICKINSON ES, 1986, ARTERIOSCLEROSIS, V6, P627, DOI 10.1161/01.ATV.6.6.627; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; HOOPER NM, 1987, BIOCHEM J, V241, P25; HORIUCHI M, 1982, J CHROMATOGR, V233, P123, DOI 10.1016/S0378-4347(00)81738-7; HUBERT C, 1991, J BIOL CHEM, V266, P15377; ISHII SI, 1983, METHOD ENZYMOL, V91, P378; JONES BN, 1986, METHODS PROTEIN MICR, P337; KUMAR RS, 1991, J BIOL CHEM, V266, P3854; KUMAR RS, 1989, J BIOL CHEM, V264, P16754; KUMAZAKI T, 1987, J BIOCHEM-TOKYO, V102, P1539, DOI 10.1093/oxfordjournals.jbchem.a122202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAROUX S, 1987, STRUCTURAL TOPOLOGIC, P15; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V179, P1670, DOI 10.1016/0006-291X(91)91767-7; MENDELSOHN FAO, 1982, J CLIN INVEST, V70, P684, DOI 10.1172/JCI110663; NAKAYAMA K, 1992, J BIOL CHEM, V267, P16335; PANTOLIANO MW, 1984, BIOCHEMISTRY-US, V23, P1037, DOI 10.1021/bi00300a036; SAHASRABUDHE SR, 1992, J BIOL CHEM, V267, P25602; SEN I, 1991, J BIOL CHEM, V266, P21985; SHAI SY, 1992, CIRC RES, V70, P1274, DOI 10.1161/01.RES.70.6.1274; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; SKIGDEL RA, 1985, P NATL ACAD SCI USA, V82, P1025; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; THEKKUMKARA TJ, 1992, NUCLEIC ACIDS RES, V20, P683, DOI 10.1093/nar/20.4.683; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WANG R, 1991, J BIOL CHEM, V266, P16960; WEI L, 1991, J BIOL CHEM, V266, P9002; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6	44	114	120	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26428	26434						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253769				2022-12-27	WOS:A1993MK42500063
J	COPELAND, WC; WANG, TSF				COPELAND, WC; WANG, TSF			ENZYMATIC CHARACTERIZATION OF THE INDIVIDUAL MAMMALIAN PRIMASE SUBUNITS REVEALS A BIPHASIC MECHANISM FOR INITIATION OF DNA-REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER EMBRYOS; SINGLE ESSENTIAL GENE; POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; P49 SUBUNIT; KB CELLS; COMPLEX; PURIFICATION; CLONING	The enzymatic mechanism of primase was investigated using Escherichia coli and baculoviral overexpressed mouse primase subunits, p49 and p58. Neither of the singly purified primase subunits displayed primase activity alone, but the p49 subunit was able to extend a riboprimer, indicating that this subunit contains an RNA polymerase activity. The p58 subunit cooperated with the p49 subunit in binding the initiating purine to form the initial dinucleotide. After initiation, the p49 subunit alone was sufficient to extend the growing primer, but both the rate of p49 primer extension and its stability were influenced by the p58 subunit. The K(m(ATP)) in primer synthesis on poly(dT) of the p49-p58 heterodimeric primase complex was 10-fold higher than the K(m(ATP)) of the single p49 subunit in a ribo(A) primer extension assay. In addition, labeled ATP cross-linked to both of the individually purified subunits but with a striking difference in affinities; cross-linking was 11-fold more efficient to the p49 subunit. The interaction of the two primase subunits with polymerase a was also investigated. Immunoprecipitation experiments indicate that only the p58 subunit directly contacts the p180 subunit of DNA polymerase alpha. Competition experiments in the coupled primase-polymerase assay with a catalytically inactive mutant of DNA polymerase alpha and the Klenow fragment suggest that the DNA polymerase alpha-primase complex does not dissociate from the primer during the transition from RNA to DNA synthesis.	STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,300 PASTEUR DR,STANFORD,CA 94305	Stanford University			Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	NCI NIH HHS [CA14835] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014835] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER DA, 1991, GENOMICS, V9, P642, DOI 10.1016/0888-7543(91)90357-K; BISWAS SB, 1984, J BIOL CHEM, V259, P7990; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; COTTERILL S, 1987, J BIOL CHEM, V262, P16105; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; FIOANI M, 1988, J BIO LCHEM, V264, P2189; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; FRANCESCONI S, 1993, IN PRESS MOL GEN GEN; GRONOSTAJSKI RM, 1984, J BIOL CHEM, V259, P9479; HU SZ, 1984, J BIOL CHEM, V259, P2602; KAGUNI LS, 1983, J BIOL CHEM, V258, P9037; KORNBERG A, 1992, DNA REPLICATION, P243; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; LONGHESE MP, 1993, GENETICS, V133, P183; LUCCHINI G, 1987, EMBO J, V6, P737, DOI 10.1002/j.1460-2075.1987.tb04815.x; MIYAZAWA H, 1993, J BIOL CHEM, V268, P8111; NASHEUER HP, 1988, J BIOL CHEM, V263, P8981; PLEVANI P, 1987, NUCLEIC ACIDS RES, V15, P7975; PRUSSAK CE, 1989, J BIOL CHEM, V264, P4957; ROTH YF, 1987, EUR J BIOCHEM, V165, P473, DOI 10.1111/j.1432-1033.1987.tb11463.x; SANTOCANALE C, 1993, J BIOL CHEM, V268, P1343; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; SHIODA M, 1982, P NATL ACAD SCI-BIOL, V79, P7209, DOI 10.1073/pnas.79.23.7209; TSENG BY, 1983, J BIOL CHEM, V258, P9845; TSENG BY, 1979, J MOL BIOL, V129, P531, DOI 10.1016/0022-2836(79)90467-4; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WANG TSF, 1984, J BIOL CHEM, V259, P1854	29	98	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26179	26189						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253737				2022-12-27	WOS:A1993MK42500028
J	EPPLER, CM; HULMES, JD; WANG, JB; JOHNSON, B; CORBETT, M; LUTHIN, DR; UHL, GR; LINDEN, J				EPPLER, CM; HULMES, JD; WANG, JB; JOHNSON, B; CORBETT, M; LUTHIN, DR; UHL, GR; LINDEN, J			PURIFICATION AND PARTIAL AMINO-ACID-SEQUENCE OF A MU-OPIOID RECEPTOR FROM RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPIATE RECEPTORS; ADENYLATE-CYCLASE; BINDING-PROTEIN; KAPPA-RECEPTOR; GUINEA-PIG; MEMBRANES; EXPRESSION; PITUITARY; CLONING; LIGAND	A rat brain opioid receptor protein was isolated by binding [epsilon-biotinyl-Lys32]beta-endorphin to membranes, solubilizing the receptor-ligand (R.L) complex with deoxycholate-lysophosphatidylcholine and purifying on immobilized streptavidin and wheat germ agglutinin. The purified glycoprotein had a molecular mass of 60-70 kDa. Recovery of this protein was blocked by the nonselective opioid antagonist naloxone and the highly mu-selective agonist [D-Ala2,N-methyl-Phe4,Glyol5]enkephalin but not by the highly delta-selective agonist [D-Pen2,4'-Cl-Phe4 D-Pen5]enkephalin when these compounds were added as competitors at the binding step. The 60-70-kDa receptor protein co-purified through the streptavidin column with 40-kDa protein recognized by anti-G(ialpha) antibodies. GTP and Na+ influenced dissociation of the solubilized R.I-125-L complex and elution of the receptor and G protein from streptavidin in fashions consistent with the pharmacology of mu-opioid receptors. A 23-amino acid residue sequence from the purified receptor differs at 4 positions from a similar sequence in the murine delta-opioid receptor and is encoded within a novel rat brain cDNA isolated by polymerase chain reaction with oligonucleotide primers related to the murine delta-opioid receptor gene.	AMER CYANAMID CO,MED RES DIV,PEARL RIVER,NY 10965; UNIV VIRGINIA,DEPT INTERNAL MED CARDIOL,CHARLOTTESVILLE,VA 22908; NIDA,CTR ADDICT RES,MOLEC NEUROBIOL BRANCH,BALTIMORE,MD; JOHNS HOPKINS UNIV,DEPT NEUROL,BALTIMORE,MD 21224; UNIV VIRGINIA,DEPT PHYSIOL,CHARLOTTESVILLE,VA 22908; JOHNS HOPKINS UNIV,DEPT GEOSCI,BALTIMORE,MD 21224	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; University of Virginia; Johns Hopkins University	EPPLER, CM (corresponding author), AMER CYANAMID CO,AGR RES DIV,PRINCETON,NJ 08543, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049078] Funding Source: NIH RePORTER; NHLBI NIH HHS [R0I HL49078] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMED MS, 1989, LIFE SCI, V44, P861, DOI 10.1016/0024-3205(89)90586-9; AKIYAMA K, 1985, P NATL ACAD SCI USA, V82, P2543, DOI 10.1073/pnas.82.8.2543; BIDLACK JM, 1981, P NATL ACAD SCI-BIOL, V78, P636, DOI 10.1073/pnas.78.1.636; BLUME AJ, 1978, P NATL ACAD SCI USA, V75, P1713, DOI 10.1073/pnas.75.4.1713; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; CHILDERS SR, 1978, LIFE SCI, V23, P759, DOI 10.1016/0024-3205(78)90077-2; CHO TM, 1986, P NATL ACAD SCI USA, V83, P4138, DOI 10.1073/pnas.83.12.4138; CLARK MJ, 1988, EUR J PHARMACOL, V148, P343, DOI 10.1016/0014-2999(88)90112-4; COTTON R, 1984, EUR J PHARMACOL, V97, P331, DOI 10.1016/0014-2999(84)90470-9; DEMOLIOUMASON CD, 1986, J NEUROCHEM, V46, P1118, DOI 10.1111/j.1471-4159.1986.tb00626.x; EPPLER CM, 1992, J BIOL CHEM, V267, P15603; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FRANCES B, 1985, EUR J PHARMACOL, V117, P223, DOI 10.1016/0014-2999(85)90607-7; GILLAN MGC, 1982, BRIT J PHARMACOL, V77, P461, DOI 10.1111/j.1476-5381.1982.tb09319.x; GIOANNINI TL, 1985, J BIOL CHEM, V260, P5117; HOCHHAUS G, 1988, J BIOL CHEM, V263, P92; HULMES JD, 1992, BIOCHEM BIOPH RES CO, V184, P131, DOI 10.1016/0006-291X(92)91168-P; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KNAPP RJ, 1992, BIOCHEM PHARMACOL, V44, P1687, DOI 10.1016/0006-2952(92)90060-V; KOSKI G, 1982, J BIOL CHEM, V257, P4035; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; KOSTERLITZ HW, 1980, PHLOS T R SOC LONDON, V20, P113; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHTI RA, 1985, EUR J PHARMACOL, V109, P281, DOI 10.1016/0014-2999(85)90431-5; LUTHIN DR, 1993, J BIOL CHEM, V268, P5990; MAKMAN MH, 1988, BRAIN RES, V400, P185; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; NICOLAS P, 1991, METHODS NEUROSCIENCE, V5, P385; PASTERNAK GW, 1986, BIOCHEM PHARMACOL, V35, P361, DOI 10.1016/0006-2952(86)90205-4; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SENOGLES SE, 1987, J BIOL CHEM, V262, P4860; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; SIMON EJ, 1973, P NATL ACAD SCI USA, V70, P1947, DOI 10.1073/pnas.70.7.1947; SIMON J, 1987, NEUROPEPTIDES, V10, P19, DOI 10.1016/0143-4179(87)90085-0; SIMONDS WF, 1985, P NATL ACAD SCI USA, V82, P4974, DOI 10.1073/pnas.82.15.4974; SLATER P, 1991, METHODS NEUROSCI, V5, P459; TERENIUS L, 1973, ACTA PHARMACOL TOX, V32, P317; UEDA H, 1987, NEUROSCI LETT, V75, P339, DOI 10.1016/0304-3940(87)90546-5; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	42	58	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26447	26451						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253772				2022-12-27	WOS:A1993MK42500066
J	WHEELAN, P; ZIRROLLI, JA; MORELLI, JG; MURPHY, RC				WHEELAN, P; ZIRROLLI, JA; MORELLI, JG; MURPHY, RC			METABOLISM OF LEUKOTRIENE-B(4) BY CULTURED HUMAN KERATINOCYTES - FORMATION OF GLUTATHIONE CONJUGATES AND DIHYDRO METABOLITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; IONIZATION MASS-SPECTROMETRY; ISOLATED RAT HEPATOCYTES; OMEGA-OXIDATION; ARACHIDONIC-ACID; HUMAN-LUNG; IDENTIFICATION; CELLS; DIHYDRO-LEUKOTRIENE-B4; PATHWAY	Six previously unidentified leukotriene (LT) B4 metabolites formed during incubation of LTB4 with human keratinocytes in primary culture indicate the importance of the 12-hydroxyeicosanoid dehydrogenase pathway in LTB4 metabolism. The ultraviolet absorption spectra obtained for all keratinocyte metabolites revealed the presence of a conjugated diene structural moiety rather than the conjugated triene structure of LTB4. Metabolites were characterized using fast atom bombardment-mass spectrometry, gas chromatography-mass spectrometry of the pentafluorobenzyl ester, trimethylsilyl ether derivatives and specific degradation reactions. The previously identified 10,11-dihydro-LTB4 and 10,11-dihydro-12-epi-LTB4 were observed as well as 20-OH-10,11-dihydro-LTB4, consistent with the reductase pathway of LTB4 metabolism. This pathway involves initial formation of 12-oxo-LTB4-catalyzed by 12-hydroxyeicosanoid dehydrogenase followed by reduction by DELTA10-reductase. The most lipophilic metabolite of LTB4 was identified as 10-hydroxy-4,6,12-octadecatrienoic acid which could result from beta-oxidation reactions of LTB4 following reduction of the 10,11-double bond. One of the most abundant metabolites was characterized as 3,7,14-trihydroxy-8,10,16-docosatrienoic acid which could result from fatty acid elongation following reduction of the 10,11-double bond. Additional abundant LTB4 metabolites were identified that result from glutathione conjugation of 12-oxo-LTB4. These were characterized using fast atom bombardment-mass spectrometry and by chemical degradation using hypochlorous acid as well as transpeptidases. These metabolites were identified as 5,12-dihydroxy-6-glutathionyl-7,9,14-eicosatrienoic acid (c-LTB3), 5,12-dihydroxy-6-cysteinyl-glycyl-7,9,14-eicosatrienoic acid (d-LTB3), and 5,12-dihydroxy-6-cysteinyl-7,9,14-eicosatrienoic acid (eLTB3). We propose that these metabolites result from a 1,8 Michael-type addition of glutathione to the 12-oxo-LTB4 intermediate.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, 1400 JACKSON ST, DENVER, CO 80206 USA; UNIV COLORADO, SCH MED, DEPT DERMATOL, DENVER, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NHLBI NIH HHS [HL25785] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL025785, R01HL025785] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1989, J AM CHEM SOC, V111, P435, DOI 10.1021/ja00184a004; ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; ATSMON J, 1990, CANCER RES, V50, P1879; ATSMON J, 1990, BIOCHEMISTRY-US, V29, P3760, DOI 10.1021/bi00467a023; BLAIR IA, 1990, METHOD ENZYMOL, V187, P13; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P2148, DOI 10.1073/pnas.76.5.2148; BRAIN S, 1984, J INVEST DERMATOL, V83, P70, DOI 10.1111/1523-1747.ep12261712; CAGEN LM, 1976, J BIOL CHEM, V251, P6550; CAMP RDR, 1982, PROSTAGLANDINS, V23, P631, DOI 10.1016/S0090-6980(82)80003-8; CHAN CC, 1985, J INVEST DERMATOL, V85, P333, DOI 10.1111/1523-1747.ep12276933; CHAUDHARI A, 1978, BIOCHIM BIOPHYS ACTA, V531, P56, DOI 10.1016/0005-2760(78)90181-9; DELACLOS BF, 1993, BIOL MASS SPECTROM, V22, P9, DOI 10.1002/bms.1200220103; FAULER J, 1989, PROSTAG LEUKOTR ESS, V37, P193, DOI 10.1016/0952-3278(89)90085-9; FORDHUTCHINSON AW, 1983, PROSTAGLANDINS, V25, P29, DOI 10.1016/0090-6980(83)90132-6; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; HADJIAGAPIOU C, 1987, PROSTAG OTH LIPID M, V34, P579, DOI 10.1016/0090-6980(87)90100-6; HARPER TW, 1986, J BIOL CHEM, V261, P5414; HEAVEY DJ, 1987, PROSTAG OTH LIPID M, V33, P693, DOI 10.1016/0090-6980(87)90035-9; IVERSEN L, 1993, J INVEST DERMATOL, V100, P293, DOI 10.1111/1523-1747.ep12469865; JUBIZ W, 1982, J BIOL CHEM, V257, P6106; KAEVER V, 1987, BIOCHIM BIOPHYS ACTA, V922, P337, DOI 10.1016/0005-2760(87)90056-7; KAEVER V, 1988, FEBS LETT, V231, P385, DOI 10.1016/0014-5793(88)80855-X; KAEVER V, 1990, LIFE SCI, V46, P1465, DOI 10.1016/0024-3205(90)90463-2; KRAGBALLE K, 1985, BRIT J DERMATOL, V113, P43, DOI 10.1111/j.1365-2133.1985.tb02043.x; KRAGBALLE K, 1983, J INVEST DERMATOL, V81, P293; KUMLIN M, 1990, BIOCHEM BIOPH RES CO, V170, P23, DOI 10.1016/0006-291X(90)91235-K; LEE CW, 1982, P NATL ACAD SCI-BIOL, V79, P4166, DOI 10.1073/pnas.79.13.4166; MEDRANO EE, 1993, P NATL ACAD SCI USA, V90, P1790, DOI 10.1073/pnas.90.5.1790; MORELLI JG, 1990, J INVEST DERMATOL, V94, P681, DOI 10.1111/1523-1747.ep12876260; MORELLI JG, 1992, J INVEST DERMATOL, V98, P55, DOI 10.1111/1523-1747.ep12494602; MORELLI JG, 1992, J INVEST DERMATOL, V98, P290, DOI 10.1111/1523-1747.ep12497951; MORELLI JG, 1989, J INVEST DERMATOL, V93, P719, DOI 10.1111/1523-1747.ep12284392; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; MUKHTAR H, 1989, J INVEST DERMATOL, V93, P231, DOI 10.1111/1523-1747.ep12277578; PIPER PJ, 1989, LEUKOTRIENES CHEM BI, P215; POWELL WS, 1987, BIOCHEM BIOPH RES CO, V145, P991, DOI 10.1016/0006-291X(87)91533-6; POWELL WS, 1989, J BIOL CHEM, V264, P5364; RAFTERY MJ, 1990, BIOMED ENVIRON MASS, V19, P465, DOI 10.1002/bms.1200190804; SALA A, 1991, J AM SOC MASS SPECTR, V2, P314, DOI 10.1016/1044-0305(91)80023-Z; SCHONFELD W, 1988, IMMUNOLOGY, V65, P529; SHAK S, 1985, J CLIN INVEST, V76, P1218, DOI 10.1172/JCI112077; SHAK S, 1984, J BIOL CHEM, V259, P181; SHIRLEY MA, 1990, J BIOL CHEM, V265, P16288; SHIRLEY MA, 1992, J AM SOC MASS SPECTR, V3, P762, DOI 10.1016/1044-0305(92)87090-L; Smith W L, 1990, Methods Enzymol, V187, P1; SODERSTROM M, 1988, BIOCHEM J, V250, P713, DOI 10.1042/bj2500713; STRIFE RJ, 1984, J CHROMATOGR, V305, P3, DOI 10.1016/S0378-4347(00)83309-5; WAINWRIGHT S, 1990, BIOCHEMISTRY-US, V29, P1180, DOI 10.1021/bi00457a013; WAINWRIGHT SL, 1991, J BIOL CHEM, V266, P20899; WHEELAN P, 1993, BIOL MASS SPECTROM, V22, P465, DOI 10.1002/bms.1200220808; WHEELAN P, 1992, 40TH P ASMS C MASS S, P1077; YOHN JJ, 1993, J INVEST DERMATOL, V100, P23, DOI 10.1111/1523-1747.ep12349932	52	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25439	25448						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244977				2022-12-27	WOS:A1993MK10000027
J	MYERS, RW; WRAY, JW; FISH, S; ABELES, RH				MYERS, RW; WRAY, JW; FISH, S; ABELES, RH			PURIFICATION AND CHARACTERIZATION OF AN ENZYME INVOLVED IN OXIDATIVE CARBON-CARBON BOND-CLEAVAGE REACTIONS IN THE METHIONINE SALVAGE PATHWAY OF KLEBSIELLA-PNEUMONIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-METHYLTHIORIBOSE KINASE; 5'-METHYLTHIOADENOSINE; CONVERSION; 5'-DEOXY-5'-METHYLTHIOADENOSINE; 5'-S-METHYLTHIOADENOSINE; IDENTIFICATION; METABOLISM	The 5-methylthio-D-ribose moiety of 5'-(methylthio)-adenosine is converted to methionine in a wide variety of organisms. 2,3-Diketo-5-methylthio-1-phosphopentane is an advanced intermediate in the methionine recycling pathway present in the Gram-negative bacterium Klebsiella pneumoniae. This unusual metabolite is oxidatively cleaved to yield formate (from C-1), 2-keto-4-methylthiobutyrate (the transamination product of methionine), and 3-methylthiopropionate. To further characterize this oxidative conversion, the desthio analog of the naturally occurring diketone, namely 2,3-diketo-1-phosphohexane I, was synthesized. If the metabolism of I is analogous to that of 2,3-diketo-5-methylthio-1-phosphopentane it should be converted to formate, 2-ketopentanoate, and butyrate. An enzyme (E-1), which mediates the oxidative conversion of I to formate and 2-ketopentanoate, was isolated from extracts of K. pneumoniae. E-1 was purified 100-fold to homogeneity in 10% yield. The native enzyme is a monomeric protein of M(r) 27,000. The activity of E-1 requires magnesium ion as a cofactor. No other prosthetic groups were detected. Incubation of the enzyme with I, under anaerobic conditions, led to the discovery of two intermediates. These species have been identified by H-1 and C-13 NMR, UV-visible spectroscopy, and model chemistry studies as 2-hydroxy-3-keto-1-phospho-1-hexene II, generated by enolization of I; and 1,2-dihydroxy-3-keto-1-hexene III, generated by enzymatic dephosphorylation of II. Intermediates II and III are released from the active site of the enzyme; III accumulates under anaerobic conditions. Under aerobic conditions, III is non-enzymically oxidized to 2-ketopentanoate, formate, and other products. Compound II was also generated by heating I at pH 7.5 for 7 min. Action of alkaline phosphatase on II produces III.	MERCK SHARP & DOHME LTD,DEPT BIOCHEM PARASITOL,RAHWAY,NJ 07065; BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254	Merck & Company; Brandeis University								BACKLUND PS, 1981, J BIOL CHEM, V256, P1533; BACKLUND PS, 1982, J BIOL CHEM, V257, P4196; BERGMEYER HU, 1990, METHOD ENZYMAT AN, V1, P470; DUERRE JA, 1962, J BIOL CHEM, V237, P3737; FERRO AJ, 1978, J BIOL CHEM, V253, P6021; FERRO AJ, 1976, BIOCHIM BIOPHYS ACTA, V438, P487, DOI 10.1016/0005-2744(76)90264-3; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; GHODA LY, 1984, J BIOL CHEM, V259, P6715; GIANOTTI AJ, 1990, J BIOL CHEM, V265, P831; KUSHAD MM, 1983, PLANT PHYSIOL, V73, P257, DOI 10.1104/pp.73.2.257; MARCHITTO KS, 1985, J GEN MICROBIOL, V131, P2153; MYERS RW, 1990, J BIOL CHEM, V265, P16913; MYERS RW, 1989, J BIOL CHEM, V264, P10547; SCHLENK F, 1983, ADV ENZYMOL RAMB, V54, P195; SHAPIRO SK, 1980, BIOCHIM BIOPHYS ACTA, V633, P176, DOI 10.1016/0304-4165(80)90403-1; SHAPIRO SK, 1981, BIOCHEM BIOPH RES CO, V102, P302, DOI 10.1016/0006-291X(81)91521-7; SUGIMOTO Y, 1976, ARCH MICROBIOL, V108, P175, DOI 10.1007/BF00428948; TRACKMAN PC, 1981, BIOCHEM BIOPH RES CO, V103, P1238, DOI 10.1016/0006-291X(81)90255-2; TRACKMAN PC, 1983, J BIOL CHEM, V258, P6717; WANG SY, 1982, PLANT PHYSIOL, V70, P117, DOI 10.1104/pp.70.1.117; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; YUNG KH, 1982, BIOCHEM BIOPH RES CO, V104, P771, DOI 10.1016/0006-291X(82)90704-5	22	65	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24785	24791						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227039				2022-12-27	WOS:A1993MG67300042
J	RAMACHANDRAN, B; HOUBEN, K; ROZENBERG, YY; HAIGH, JR; VARPETIAN, A; HOWARD, BD				RAMACHANDRAN, B; HOUBEN, K; ROZENBERG, YY; HAIGH, JR; VARPETIAN, A; HOWARD, BD			DIFFERENTIAL EXPRESSION OF TRANSPORTERS FOR NOREPINEPHRINE AND GLUTAMATE IN WILD-TYPE, VARIANT, AND WNT1-EXPRESSING PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SENSITIVE DOPAMINE TRANSPORTER; PHEOCHROMOCYTOMA CELLS; RAT-BRAIN; NEURONAL DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; POSSIBLE INVOLVEMENT; GLYCINE TRANSPORTER; INT-1 PROTOONCOGENE; MEMBRANE-VESICLES	Wild type PC12 pheochromocytoma cells express a Na+-dependent norepinephrine transporter that operates in the uptake of catecholamines, including dopamine. This transporter is not expressed in two spontaneously occurring flat cell variants of PC12 or in two other flat cell variants whose phenotype was induced by expression of the Wnt-1 oncogene. However, each of the flat cell variants, including those that express Wnt-1, exhibit a Na+-dependent, Cl--independent glutamate/aspartate transporter activity that is not present in wild type PC12 cells. The flat cell variants took up glycine by a Na+-dependent process as well as did wild type cells. All of the flat cell variants have decreased levels of norepinephrine transporter mRNA but normal levels of glycine transporter mRNA. Glutamate/aspartate transporter mRNA was detected only in the variants that exhibited glutamate/aspartate transporter activity, and the nucleotide sequence of a partial glutamate/aspartate transporter cDNA from these cells demonstrated that it was the glial form of the transporter that was expressed. These variants were more sensitive than was wild type PC12 to alanosine, a toxic aspartate analog that enters cells by a transporter-mediated system such as the glutamate/aspartate transporter; however, these variants were as sensitive as wild type cells to another toxic aspartate analog, N-(phosphonacetyl)-L-aspartic acid, which is believed to enter cells by endocytosis. We suggest that the Wnt-1 gene product, or a homolog, may be involved in glial differentiation and that the mechanisms that alter the expression of the norepinephrine and glutamate/aspartate transporters in wild type and variant PC12 cells may also operate to regulate neurotransmitter transporter expression in vivo.			RAMACHANDRAN, B (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038633, R37MH038633] Funding Source: NIH RePORTER; NIMH NIH HHS [MH38633] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANANDARAJ SJ, 1980, BIOCHEM PHARMACOL, V29, P227, DOI 10.1016/0006-2952(80)90333-0; ANDERSEN JK, 1990, J NEUROCHEM, V55, P559, DOI 10.1111/j.1471-4159.1990.tb04170.x; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BANNON MJ, 1992, P NATL ACAD SCI USA, V89, P7095, DOI 10.1073/pnas.89.15.7095; BITLER CM, 1986, J NEUROCHEM, V47, P1286; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; CHRISTENSEN HN, 1984, BIOCHIM BIOPHYS ACTA, V779, P255, DOI 10.1016/0304-4157(84)90012-1; DENTON T, 1987, J NEUROCHEM, V49, P622, DOI 10.1111/j.1471-4159.1987.tb02909.x; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1977, BRAIN RES, V129, P247, DOI 10.1016/0006-8993(77)90005-1; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; Iversen L L, 1970, Adv Biochem Psychopharmacol, V2, P109; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KOIDE M, 1986, J NEUROCHEM, V47, P1277; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1992, CELL, V69, P103; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Sambrook J., 1982, MOL CLONING LAB MANU, V1; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHNEIDER EG, 1980, J BIOL CHEM, V255, P7650; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; SHACKLEFORD GM, 1993, IN PRESS NEURON; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; SIPS HJ, 1982, EUR J BIOCHEM, V122, P259, DOI 10.1111/j.1432-1033.1982.tb05875.x; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; SUGIMOTO Y, 1988, J BIOL CHEM, V263, P12102; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TYAGI AK, 1984, ADV PHARMACOL CHEMOT, V20, P69, DOI 10.1016/S1054-3589(08)60265-3; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; WHITE JC, 1984, CANCER RES, V44, P507	50	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23891	23897						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226929				2022-12-27	WOS:A1993MF29400031
J	WRENN, CK; KATZENELLENBOGEN, BS				WRENN, CK; KATZENELLENBOGEN, BS			STRUCTURE-FUNCTION ANALYSIS OF THE HORMONE-BINDING DOMAIN OF THE HUMAN ESTROGEN-RECEPTOR BY REGION-SPECIFIC MUTAGENESIS AND PHENOTYPIC SCREENING IN YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSCRIPTIONAL ACTIVATION; BREAST-CANCER-CELLS; ZINC FINGER REGION; SACCHAROMYCES-CEREVISIAE; STEROID-RECEPTORS; DNA-BINDING; ANTIESTROGEN; EXPRESSION; PROMOTER; IDENTIFICATION	To investigate the structural requirements for recognition and response to ligands by the human estrogen receptor (hER), a series of point mutations were generated in the hormone binding domain (HBD) of the receptor using a limited formic acid treatment of its cDNA. Receptors having a reduced sensitivity to the estrogen, 17beta-estradiol (E2), or to the antiestrogen, trans-hydroxytamoxifen, were selected from a library of intact hER cDNAs containing these mutant HBDs by expression and phenotypic screening in yeast (Saccharomyces cerevisiae). Several were sequenced, and the encoded receptors were characterized in both yeast and mammalian (Chinese hamster ovary) cells using hormone-binding and transactivation assays. In general, parallel phenotypes were observed in yeast and in Chinese hamster ovary cells following estrogen exposure. We report on 15 receptors having point mutations located at various positions throughout the HBD. Four categories of mutants were identified: 1) those showing no change from wild type in their response to E2; 2) those showing a greatly reduced transactivation response over the range of ligand concentrations tested; 3) those requiring much higher concentrations of E2 for maximal transactivation, indicating a reduced sensitivity to ligand; and 4) those showing reduced response to E2, but little change in response to trans-hydroxytamoxifen in yeast. Two mutations in the carboxyl terminus of the HBD eliminated hormone-dependent transactivation despite the continued ability to bind E2 with high affinity. Therefore, our results show a separation of the transactivation and hormone-binding functions of the hER, and indicate that the integrity of many regions throughout the large, approximately 250-amino acid HBD is important for these functions. Our studies also demonstrate the advantages of using regional mutagenesis combined with phenotypic screening in yeast to complement site-directed mutagenesis when investigating a large, functionally complex region.	UNIV ILLINOIS,DEPT PHYSIOL & BIOPHYS,URBANA,IL 61801; UNIV ILLINOIS,COLL MED,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign					NCI NIH HHS [CA18119] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA018119, R01CA018119] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Ausubel FM, 1988, MOL REPROD DEV; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; BROU C, 1993, NUCLEIC ACIDS RES, V21, P5, DOI 10.1093/nar/21.1.5; CHANG TC, 1990, J BIOL CHEM, V265, P8176; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; ECKERT RL, 1982, J BIOL CHEM, V257, P8840; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; GARABEDIAN MJ, 1992, MOL BIOL CELL, V3, P1245, DOI 10.1091/mbc.3.11.1245; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Ham J, 1989, CURR OPIN CELL BIOL, V1, P503, DOI 10.1016/0955-0674(89)90012-4; HARLOW KW, 1989, J BIOL CHEM, V264, P17476; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LYTTLE CR, 1992, J STEROID BIOCHEM, V42, P677, DOI 10.1016/0960-0760(92)90108-U; MCDONNELL DP, 1991, J STEROID BIOCHEM, V39, P291, DOI 10.1016/0960-0760(91)90038-7; MCDONNELL DP, 1992, P NATL ACAD SCI USA, V89, P10563, DOI 10.1073/pnas.89.22.10563; METZGER D, 1992, NUCLEIC ACIDS RES, V20, P2813, DOI 10.1093/nar/20.11.2813; MYERS RM, 1985, SCIENCE, V229, P242, DOI 10.1126/science.2990046; PAKDEL F, 1992, J BIOL CHEM, V267, P3429; PHAM TA, 1991, P NATL ACAD SCI USA, V88, P3125, DOI 10.1073/pnas.88.8.3125; REESE JC, 1992, J BIOL CHEM, V267, P9868; REESE JC, 1992, MOL ENDOCRINOL, V6, P2160, DOI 10.1210/me.6.12.2160; REESE JC, 1991, J BIOL CHEM, V266, P10880; Sambrook J, 1989, MOL CLONING LABORATO; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WRENN CK, 1990, MOL ENDOCRINOL, V4, P1647, DOI 10.1210/mend-4-11-1647; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	37	172	175	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24089	24098						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226955				2022-12-27	WOS:A1993MF29400059
J	JUNG, M; JUST, I; VANDAMME, J; VANDEKERCKHOVE, J; AKTORIES, K				JUNG, M; JUST, I; VANDAMME, J; VANDEKERCKHOVE, J; AKTORIES, K			NAD-BINDING SITE OF THE C3-LIKE ADP-RIBOSYLTRANSFERASE FROM CLOSTRIDIUM-LIMOSUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GENE-PRODUCT; BOTULINUM TYPE-C; DIPHTHERIA-TOXIN; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; EXOTOXIN-A; PROTEIN	Treatment of the Rho-ADP-ribosylating C3-like transferase from Clostridium limosum by ultraviolet irradiation in the presence of [carbonyl-C-14]NAD incorporated 1 mol of label/mol of exoenzyme. Concomitantly, the transferase and NAD glycohydrolase activity was impaired. A peptide containing the radiolabel was obtained by proteolysis with either staphylococcal protease V8 or trypsin. Their amino acid sequences were Ala/Asp-Gly-Tyr-Ile-Glu-Pro-Ile-Ser-Thr-Phe-Lys-Gly-Gln-Leu-X-Val-Leu-Leu-Pro-Arg and Gly-Gln-Leu-X-Val-Leu-Leu-Pro-Arg, respectively. These sequences correspond with regions Ala-160 through Arg-179 and Gly-171 through Arg-179, respectively, of the very similar Clostridium botulinum C3 transferase, with X being Glu in the unlabeled enzyme. This identifies the glutamic acid residue that corresponds to Glu-174 of C. botulinum C3 transferase as part of the NAD-binding site of the catalytic center of the C. limosum exoenzyme.	UNIV SAARLAND, INST PHARMAKOL & TOXIKOL, D-66421 HOMBURG, GERMANY; LAB FYSIOL SCHEIKUNDE, B-9000 GHENT, BELGIUM	Saarland University			Jung, Martin/AAM-4547-2021; Jung, Martin/D-2207-2012; Aktories, Klaus/CAJ-5682-2022	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Aktories, Klaus/0000-0002-5397-0436				AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; BRAUN U, 1989, FEBS LETT, V243, P70, DOI 10.1016/0014-5793(89)81220-7; CARROLL SF, 1984, P NATL ACAD SCI-BIOL, V81, P3307, DOI 10.1073/pnas.81.11.3307; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1985, P NATL ACAD SCI USA, V82, P7237, DOI 10.1073/pnas.82.21.7237; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; CHAVAN AJ, 1992, J BIOL CHEM, V267, P14866; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1990, ADP RIBOSYLATING TOX, P3, DOI DOI 10.1126/SCIENCE.250.4982.841-A; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; JAKOBS KH, 1982, J BIOL CHEM, V257, P2829; JUST I, 1992, J BIOL CHEM, V267, P10274; JUST I, 1992, BIOCHEM BIOPH RES CO, V183, P931, DOI 10.1016/S0006-291X(05)80279-7; KIKUCHI A, 1988, J BIOL CHEM, V263, P16303; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; POPOFF M, 1990, NUCLEIC ACIDS RES, V18, P1291, DOI 10.1093/nar/18.5.1291; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SUGAI M, 1990, BIOCHEM BIOPH RES CO, V173, P92, DOI 10.1016/S0006-291X(05)81026-5; UI M, 1990, ADP RIBOSYLATING TOX, P45; WICK MJ, 1990, ADP RIBOSYLATING TOX, P31	29	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23215	23218						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226842				2022-12-27	WOS:A1993MF51500043
J	KRUIP, J; BOEKEMA, EJ; BALD, D; BOONSTRA, AF; ROGNER, M				KRUIP, J; BOEKEMA, EJ; BALD, D; BOONSTRA, AF; ROGNER, M			ISOLATION AND STRUCTURAL CHARACTERIZATION OF MONOMERIC AND TRIMERIC PHOTOSYSTEM-I COMPLEXES (P700-CENTER-DOT-FA/FB AND P700-CENTER-DOT-FX) FROM THE CYANOBACTERIUM SYNECHOCYSTIS PCC-6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS-SP PCC-6301; CHEMICAL CROSS-LINKING; REACTION CENTER CORE; ELECTRON-MICROSCOPY; BINDS FERREDOXIN; POLYPEPTIDE; PROTEINS; SUBUNIT; RECONSTITUTION; PURIFICATION	An isolation procedure was developed for the cyanobacterium Synechocystis 6803 (and 6714) which yields both monomeric and trimeric photosystem I complexes (P700.F(A)/F(B) complexes) depleted of the stroma-exposed subunits PsaC, -D, and -E (P700-F(x) complexes). Analysis by high resolution gel electrophoresis in combination with immunoblotting and N-terminal sequencing reveals the selective and quantitative removal of PsaC, -D, and -E from the P700-F(A)/F(B) complex, containing PsaA, -B, -C, -D, -E, -F, -K, -L and at least two subunits less-than-or-equal-to 4 kDa. Monomeric and trimeric P700-F(x) complexes show an identical subunit composition and an identical charge recombination half-time of 750 +/- 250 mus as determined by flash-induced absorption change measurements, reflecting the quantitative loss of iron-sulfur clusters F(A)/F(B) and the presence of cluster F(x). The existence of a stable trimeric P700.F(x) complex enables a detailed structural analysis by electron microscopy with high resolution. Comparison of averaged top and side view projections of P700.F(x) and P700.F(A)/F(B) complexes show that the height of the complex is reduced by about 2.5-3.3 nm upon removal of the three stroma-exposed subunits and indicate the position of these three subunits on the PS I surface. While the outer contours of the stroma exposed mass of PS I agree very well. with the three-dimensional crystal analysis recently published for trimeric PS I of Synechococcus elongatus (Krauss, N., Hinrichs, W., Witt, I., Fromme, P., Pritzkow, W., Dauter, Z., Betzel, C., Wilson, K. S., Witt, H. T., and Saenger, W. (1993) Nature 361, 326-330), only the structural analysis presented here is able to assign the stroma-exposed mass exclusively to the subunits PsaC, -D, and -E and to exclude a contribution of other subunits.	UNIV MUNSTER, INST BOT, SCHLOSSGARTEN 3, D-48149 MUNSTER, GERMANY; UNIV GRONINGEN, BIOSON, BIOPHYS CHEM RES INST, 9747 AG GRONINGEN, NETHERLANDS	University of Munster; University of Groningen								ANDERSEN B, 1992, FEBS LETT, V311, P169, DOI 10.1016/0014-5793(92)81391-X; Bald D., 1992, RES PHOTOSYNTHESIS, VI, P629; BOEKEMA EJ, 1990, BIOCHIM BIOPHYS ACTA, V1017, P49, DOI 10.1016/0005-2728(90)90177-6; BOEKEMA EJ, 1989, BIOCHIM BIOPHYS ACTA, V974, P81, DOI 10.1016/S0005-2728(89)80168-9; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; BOTTCHER B, 1992, BIOCHIM BIOPHYS ACTA, V1100, P125, DOI 10.1016/0167-4838(92)90544-N; BRYANT DA, 1992, CURRENT TOPICS PHOTO, V11, P501; FORD RC, 1990, EMBO J, V9, P3067, DOI 10.1002/j.1460-2075.1990.tb07503.x; GOLBECK JH, 1988, FEBS LETT, V228, P268, DOI 10.1016/0014-5793(88)80013-9; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; GOLBECK JH, 1988, FEBS LETT, V240, P9, DOI 10.1016/0014-5793(88)80331-4; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; HIPPLER M, 1989, FEBS LETT, V250, P280, DOI 10.1016/0014-5793(89)80738-0; HLADIK J, 1991, PHOTOSYNTH RES, V29, P171, DOI 10.1007/BF00036220; IKEUCHI M, 1992, PLANT CELL PHYSIOL, V33, P669; IKEUCHI M, 1992, PLANT CELL PHYSIOL, V33, P1057; KRAUSS N, 1993, NATURE, V361, P326, DOI 10.1038/361326a0; LAGOUTTE B, 1992, EUR J BIOCHEM, V205, P1175, DOI 10.1111/j.1432-1033.1992.tb16888.x; LI N, 1991, BIOCHIM BIOPHYS ACTA, V1059, P215, DOI 10.1016/S0005-2728(05)80206-3; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MUHLENHOFF U, 1993, GENE, V127, P71, DOI 10.1016/0378-1119(93)90618-D; NECHUSHTAI R, 1992, TOPICS PHTOOSYNTHESI, V11, P443; NYHUS KJ, 1992, J BIOL CHEM, V267, P12489; OKKELS JS, 1991, J BIOL CHEM, V266, P6767; ROGNER M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P415, DOI 10.1016/0005-2728(90)90074-E; ROGNER M, 1990, J BIOL CHEM, V265, P6189; ROGNER M, 1990, J CHROMATOGR, V512, P219, DOI 10.1016/S0021-9673(01)89488-7; RUMBERG B, 1964, Z NATURFORSCH PT B, VB 19, P693; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHELLER HV, 1990, PHYSIOL PLANTARUM, V78, P484, DOI 10.1034/j.1399-3054.1990.780326.x; VANDERLEE J, 1993, PHOTOSYNTH RES, V35, P311, DOI 10.1007/BF00016562; WARREN PV, 1993, BIOCHEMISTRY-US, V32, P849, DOI 10.1021/bi00054a016; WITT HT, 1992, RES PHOTOSYNTHESIS, V1, P521; WYNN RM, 1988, BIOCHEMISTRY-US, V27, P5863, DOI 10.1021/bi00416a007; WYNN RM, 1989, BIOCHEMISTRY-US, V28, P5554, DOI 10.1021/bi00439a032; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; ZHAO JD, 1990, FEBS LETT, V276, P175, DOI 10.1016/0014-5793(90)80536-R	38	68	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23353	23360						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226860				2022-12-27	WOS:A1993MF51500063
J	SCHECHTER, NM; JORDAN, LM; JAMES, AM; COOPERMAN, BS; WANG, ZM; RUBIN, H				SCHECHTER, NM; JORDAN, LM; JAMES, AM; COOPERMAN, BS; WANG, ZM; RUBIN, H			REACTION OF HUMAN CHYMASE WITH REACTIVE-SITE VARIANTS OF ALPHA-1-ANTICHYMOTRYPSIN - MODULATION OF INHIBITOR VERSUS SUBSTRATE PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHYMOTRYPSIN-LIKE PROTEINASE; MAST-CELL; ANGIOTENSIN-II; CRYSTAL-STRUCTURE; CATHEPSIN-G; IDENTIFICATION; ANTITHROMBIN; SPECIFICITY; CONVERSION; PURIFICATION	Inhibition of human chymase by alpha1-antichymotrypsin produces 3.5 mol of degraded inhibitor for every mol of chymase inhibited, resulting in a stoichiometry of inhibition (SI) of 4.5. In the present study, the substrate versus inhibitor properties of this reaction were examined further using wild type and mutant recombinant antichymotrypsins (rACT). Titration of chymase hydrolytic activity with rACT-L358 (wild type) and reactive site (P1) variants of ACT, L358W, L358M, and L358F revealed that the SI was sensitive to P1 residue replacements. SI values increased in the order of Trp < Met < Leu < Phe where SI values were 1.5, 2, 4, and 7, respectively. Chymase inhibitor complex and cleaved inhibitor were demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis for all variants; the relative intensities of each band were consistent with SI values established by titration. NH2-terminal sequence analyses of the products formed in the reaction of chymase with rACT-L358F indicated that the P1-P1' bond was the primary site of cleavage resulting in the hydrolysis and inactivation of this variant. The apparent second-order rate constant for chymase inhibition (k'/[I]) by rACT also was affected by P1 substitution. k'/[I] values increased in an order opposite that obtained for SI values (Phe < Leu < Met < Trp). The reactive loop mutant (rACT-P3P3') produced by replacing the reactive site region of ACT (Thr356 Val) with that of alpha1-proteinase inhibitor (Ile356-Pro361) revealed a different reaction pattern. Although its SI was near 1, the value for k'/[I] was the lowest among variants. rACT-L358R, another P1 variant, did not inhibit chymase. These results are evaluated with respect to the substrate preferences of human chymase and with respect to partitioning schemes proposed to explain SI values greater than 1.	UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; UNIV PENN,DEPT CHEM,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT MED & MICROBIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	SCHECHTER, NM (corresponding author), UNIV PENN,SCH MED,DEPT DERMATOL,CLIN RES BLDG,422 CURIE BLVD,PHILADELPHIA,PA 19104, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039674] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39674] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BJORK I, 1982, J BIOL CHEM, V257, P9487; BJORK I, 1992, J BIOL CHEM, V267, P19047; BOCK SC, 1991, PROTEIN ENG, V4, P221; BOSWELL DR, 1983, BIOCHIM BIOPHYS ACTA, V744, P212, DOI 10.1016/0167-4838(83)90093-6; CARRELL RW, 1986, RES MONOGRAPHS CELL, V12, P403; CHASE T, 1970, METHOD ENZYMOL, V19, P20; COOPERMAN BS, 1993, J BIOL CHEM, V268, P23616; DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693; JENNE DE, 1991, BIOCHEM J, V276, P567, DOI 10.1042/bj2760567; KILPATRICK L, 1991, J IMMUNOL, V146, P2388; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; MORII M, 1979, J BIOCHEM, V86, P915, DOI 10.1093/oxfordjournals.jbchem.a132623; OLSON ST, 1985, J BIOL CHEM, V260, P153; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; PETERSEN LC, 1981, BIOCHEM J, V199, P121, DOI 10.1042/bj1990121; POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037; REILLY CF, 1982, J BIOL CHEM, V257, P8619; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SAYAMA S, 1987, J BIOL CHEM, V262, P6808; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schechter N M, 1990, Monogr Allergy, V27, P114; SCHECHTER NM, 1989, J BIOL CHEM, V264, P21308; SCHECHTER NM, 1988, ARCH BIOCHEM BIOPHYS, V262, P232, DOI 10.1016/0003-9861(88)90185-3; SCHECHTER NM, 1986, J IMMUNOL, V137, P962; SCHECHTER NM, 1990, J IMMUNOL, V145, P2652; SCHELLENBERGER V, 1991, EUR J BIOCHEM, V199, P623, DOI 10.1111/j.1432-1033.1991.tb16163.x; SCHONBAUM G, 1961, J BIOL CHEM, V236, P2930; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; Speicher D.W., 1989, TECHNIQUES PROTEIN C, P24; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1301, DOI 10.1021/bi00379a015; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WINTROUB BU, 1984, J INVEST DERMATOL, V83, P336, DOI 10.1111/1523-1747.ep12264144	36	71	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23626	23633						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226889				2022-12-27	WOS:A1993MF51500101
J	XING, H; SHAPIRO, DJ				XING, H; SHAPIRO, DJ			AN ESTROGEN-RECEPTOR MUTANT EXHIBITING HORMONE-INDEPENDENT TRANSACTIVATION AND ENHANCED AFFINITY FOR THE ESTROGEN RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; CANCER CELL-LINE; XENOPUS-LAEVIS; TRANSCRIPTIONAL ACTIVATION; VITELLOGENIN SYNTHESIS; GENE-TRANSCRIPTION; MAMMALIAN-CELLS; STEROID BINDING; DNA COMPLEXES; TARGET GENE	To study transactivation by the Xenopus laevis estrogen receptor (XER), we inserted one or two copies of a synthetic amphipathic helix at amino acid 276 of the XER. The XER mutants containing one or two copies of the amphipathic helix (XER/1AH and XER/2AH, respectively) and wild-type XER were expressed at similar levels. In transient transfection assays, XER/1AH exhibited only a modest, promoter-specific increase in transactivation. Constitutive (estrogen-independent) transcription of a synthetic promoter containing two estrogen response elements (EREs) was approximately 10-fold higher for the XER/2AH mutant than for wild-type XER. The XER/2AH mutant and wild-type XER exhibited similar l7beta-estradiol dose-response curves for transactivation. In studies carried out over a broad range of DNA concentrations using the simple 2ERE-TATA promoter or a complex vitellogenin-derived promoter, the XER/2AH mutant exhibited an estrogen-dependent 2-3-fold increase in transactivation. A 2-3-fold increase in transactivation by XER/2AH was also observed using synthetic promoters in which the two EREs exhibit synergistic interactions with the NF1, AP1, or vitellogenin activator upstream activator sequences. Using a promoter interference assay to investigate intracellular interactions between the estrogen receptor and the ERE, we showed that binding of wild-type XER to the ERE was strongly estrogen-dependent. In the presence of 17beta-estradiol, XER/2AH and wild-type XER exhibited similar promoter interference curves. In the absence of 17beta-estradiol, the expression plasmid encoding the XER/2AH mutant achieved levels of promoter interference with 0.25-0.5 mug of transfected DNA that were similar to those observed with 5-10 mug of the expression plasmid encoding wild-type XER. The ability of the XER/2AH mutant to activate transcription in the absence of estrogen therefore is likely to be related to the approximately 20-fold increase in its apparent ability to bind to the ERE. Since XER/2AH was unable to activate transcription from a glucocorticoid response element, enhanced binding of XER/2AH to the ERE did not result from a general increase in binding to DNA. The XER/2AH mutant appears to be the first nuclear receptor mutant to retain hormone-dependent transactivation and to exhibit enhanced hormone-independent binding to its hormone response element.	UNIV ILLINOIS, DEPT BIOCHEM, B-4 RAL, 600 S MATHEWS AVE, URBANA, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016720] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-16720] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; BAGCHI MK, 1991, MOL CELL BIOL, V11, P4998, DOI 10.1128/MCB.11.10.4998; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; BROWN M, 1990, J BIOL CHEM, V265, P11238; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; CHAKRABORTI PK, 1991, J BIOL CHEM, V266, P22075; CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686; CHANG TC, 1990, J BIOL CHEM, V265, P8176; CHANG TC, 1992, MOL ENDOCRINOL, V6, P346, DOI 10.1210/me.6.3.346; CURTIS SW, 1990, MOL ENDOCRINOL, V4, P276, DOI 10.1210/mend-4-2-276; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; ELLISTON JF, 1990, J BIOL CHEM, V265, P11517; ELLISTON JF, 1990, MOL CELL BIOL, V10, P6607, DOI 10.1128/MCB.10.12.6607; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GUIOCHONMANTEL A, 1988, NATURE, V336, P695, DOI 10.1038/336695a0; HAYWARD MA, 1980, J BIOL CHEM, V255, P1308; HIGUCHI K, 1970, J CELL PHYSIOL, V75, P65, DOI 10.1002/jcp.1040750108; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; INCE BA, 1993, J BIOL CHEM, V268, P14026; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; MCDONNELL DP, 1991, MOL CELL BIOL, V11, P4350, DOI 10.1128/MCB.11.9.4350; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MURDOCH FE, 1990, BIOCHEMISTRY-US, V29, P8377, DOI 10.1021/bi00488a026; NARDULLI AM, 1991, J BIOL CHEM, V266, P24070; NARDULLI AM, 1993, MOL ENDOCRINOL, V7, P331, DOI 10.1210/me.7.3.331; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; REESE JC, 1992, MOL CELL BIOL, V12, P4531, DOI 10.1128/MCB.12.10.4531; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; RODRIGUEZ R, 1989, MOL ENDOCRINOL, V3, P356, DOI 10.1210/mend-3-2-356; SEILERTUYNS A, 1986, NUCLEIC ACIDS RES, V14, P8755, DOI 10.1093/nar/14.22.8755; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TZUKERMAN M, 1990, New Biologist, V2, P613; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEILER IJ, 1987, MOL ENDOCRINOL, V1, P355, DOI 10.1210/mend-1-5-355; WESTLEY B, 1978, CELL, V15, P367, DOI 10.1016/0092-8674(78)90005-3	44	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23227	23233						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226845				2022-12-27	WOS:A1993MF51500046
J	ADHAM, IM; BURKHARDT, E; BENAHMED, M; ENGEL, W				ADHAM, IM; BURKHARDT, E; BENAHMED, M; ENGEL, W			CLONING OF A CDNA FOR A NOVEL INSULIN-LIKE PEPTIDE OF THE TESTICULAR LEYDIG-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-I; PORCINE RELAXIN; GEL-ELECTROPHORESIS; MOLECULAR-CLONING; RIBONUCLEIC-ACID; SEQUENCE; GENE; SPERMATOGENESIS; EXPRESSION; PRECURSOR	We have isolated complementary DNA clones coding for a novel member of the insulin-like hormone superfamily from a boar testis cDNA library. Northern blot analysis and in situ hybridization revealed that the gene is expressed exclusively in prenatal and postnatal Leydig cells. We have tentatively proposed the name Leydig insulin-like (Ley I-L) for the gene and its encoded protein. The Leydig insulin-like protein is synthesized as a 131-amino acid preproprotein, which contains a 24-amino acid signal peptide. Comparison of the deduced amino acid sequence of pro-Leydig insulin-like protein with members of the insulin-like hormone superfamily predicts that the biologically active protein, after proteolytic processing of the C-peptide, consists of a 32-residue-long B-chain and a 26-residue-long A-chain and has a molecular size of 6.25 kDa.	UNIV GOTTINGEN,INST HUMANGENET,GOSSLERSTR 12D,D-37073 GOTTINGEN,GERMANY; CTR HOSP LYON SUD,HOP ST EUGENIE,BIOCHEM LAB,F-69310 PIERRE BENITE,FRANCE	University of Gottingen; CHU Lyon								ADHAM IM, 1989, EUR J BIOCHEM, V182, P563, DOI 10.1111/j.1432-1033.1989.tb14864.x; ADHAM IM, 1990, HUM GENET, V84, P125; BEDARKAR S, 1977, NATURE, V270, P449, DOI 10.1038/270449a0; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; BELL GI, 1984, NATURE, V310, P775, DOI 10.1038/310775a0; BENAHMED M, 1987, MOL CELL ENDOCRINOL, V50, P69, DOI 10.1016/0303-7207(87)90078-5; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; BLUNDELL TL, 1980, NATURE, V287, P781, DOI 10.1038/287781a0; CHANCE RE, 1968, SCIENCE, V161, P165, DOI 10.1126/science.161.3837.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FRANCIS GL, 1989, J ENDOCRINOL, V122, P681, DOI 10.1677/joe.0.1220681; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GUBLER U, 1983, P NATL ACAD SCI-BIOL, V80, P4311, DOI 10.1073/pnas.80.14.4311; HALEY J, 1987, J BIOL CHEM, V262, P11940; HANAUER A, 1983, NUCLEIC ACIDS RES, V11, P3503, DOI 10.1093/nar/11.11.3503; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; JAMES R, 1977, NATURE, V267, P544, DOI 10.1038/267544a0; JANSEN M, 1983, NATURE, V306, P609, DOI 10.1038/306609a0; KOTAKI A, 1963, J BIOCHEM-TOKYO, V53, P61, DOI 10.1093/oxfordjournals.jbchem.a127658; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MANSOURI A, 1983, DIFFERENTIATION, V24, P149, DOI 10.1111/j.1432-0436.1983.tb01315.x; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; Sambrook J, 1989, MOL CLONING LABORATO; SARGENT TD, 1987, METHOD ENZYMOL, V152, P423; SCHWABE C, 1977, BIOCHEM BIOPH RES CO, V75, P503, DOI 10.1016/0006-291X(77)91070-1; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SHARPE RM, 1990, AM J ANAT, V188, P3, DOI 10.1002/aja.1001880103; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; SODER O, 1992, ENDOCRINOLOGY, V131, P2344, DOI 10.1210/en.131.5.2344; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAVAKKOL A, 1988, MOL ENDOCRINOL, V2, P674, DOI 10.1210/mend-2-8-674	38	232	241	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26668	26672						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253799				2022-12-27	WOS:A1993MK42500095
J	CHUANG, TH; BOHL, BP; BOKOCH, GM				CHUANG, TH; BOHL, BP; BOKOCH, GM			BIOLOGICALLY-ACTIVE LIPIDS ARE REGULATORS OF RAC-CENTER-DOT-GDI COMPLEXATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; CELL-FREE SYSTEM; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; DEPENDENT SUPEROXIDE PRODUCTION; GDP/GTP EXCHANGE PROTEINS; SODIUM DODECYL-SULFATE; NADPH OXIDASE; HUMAN-NEUTROPHILS; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-D	Members of the Rho family of GTP-binding proteins are localized in the cytosol of cells by complexation with a protein known as (Rho)GDI. We show by sucrose gradient equilibrium sedimentation analysis that all of the Rac protein present in human neutrophil cytosol exists as a complex with (Rho)GDI under non-activating conditions. This interaction can be disrupted in the presence of various lipids which have been shown to have biological activity in a variety of systems, including NADPH oxidase activation. Particularly effective were arachidonic acid, phosphatidic acid, and phosphatidylinositols. These lipids were active at concentrations from 0.5-50 muM and were capable of disrupting complexation of (Rho)GD1 with both GDP- and GTP-bound forms of Rac, although the latter were more sensitive to lipid. These data suggest that certain lipids generated in chemoattractant-stimulated neutrophils may play a role in modulating the activity of Rac and thus NADPH oxidase activity.	Scripps Res Inst, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute			Chuang, Tsung-Hsien/F-9679-2010		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL48008] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; BADWEY JA, 1984, J BIOL CHEM, V259, P7870; BARSAGI D, 1988, J CELL BIOL, V106, P1649, DOI 10.1083/jcb.106.5.1649; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BELLAVITE P, 1988, J BIOL CHEM, V263, P8210; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BOKOCH GM, 1980, J BIOL CHEM, V255, P223; BOKOCH GM, 1988, J CELL BIOL, V106, P1927, DOI 10.1083/jcb.106.6.1927; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; BORMANN BJ, 1984, P NATL ACAD SCI-BIOL, V81, P767, DOI 10.1073/pnas.81.3.767; BOSNER RW, 1989, BIOCHEM J, V264, P617; BOURMEYSTER N, 1992, BIOCHEMISTRY-US, V31, P12863, DOI 10.1021/bi00166a022; BROMBERG Y, 1983, CELL IMMUNOL, V79, P240, DOI 10.1016/0008-8749(83)90067-9; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; CHUANG TH, 1993, J BIOL CHEM, V268, P775; CLARK RA, 1987, J BIOL CHEM, V262, P4065; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; EXTON JH, 1990, J BIOL CHEM, V265, P1; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HENDERSON LM, 1989, BIOCHEM J, V264, P249, DOI 10.1042/bj2640249; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; KAKINUMA K, 1974, BIOCHIM BIOPHYS ACTA, V348, P76; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; LEONARD D, 1992, J BIOL CHEM, V267, P22860; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; OHTSUKA T, 1989, J BIOCHEM-TOKYO, V106, P259, DOI 10.1093/oxfordjournals.jbchem.a122841; PAI JK, 1988, J BIOL CHEM, V263, P12472; QUINN MT, 1993, J BIOL CHEM, V268, P20983; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; SMOLEN JE, 1980, BIOCHEM PHARMACOL, V29, P533, DOI 10.1016/0006-2952(80)90373-1; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; TSAI MH, 1989, MOL CELL BIOL, V9, P5260, DOI 10.1128/MCB.9.11.5260; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; UEDA T, 1990, J BIOL CHEM, V265, P9373	48	195	197	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26206	26211						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253741				2022-12-27	WOS:A1993MK42500032
J	HOESCHE, C; SAUERWALD, A; VEH, RW; KRIPPL, B; KILIMANN, MW				HOESCHE, C; SAUERWALD, A; VEH, RW; KRIPPL, B; KILIMANN, MW			THE 5'-FLANKING REGION OF THE RAT SYNAPSIN-I GENE DIRECTS NEURON-SPECIFIC AND DEVELOPMENTALLY-REGULATED REPORTER GENE-EXPRESSION IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING NERVOUS-SYSTEM; LOOP-HELIX GENES; CHLORAMPHENICOL ACETYLTRANSFERASE; PROTEIN-I; TRANSCRIPTION; BRAIN; CELLS; POU; PROMOTER; CNS	The expression of the synapsin I gene is neuron-specific and developmentally regulated. As a step toward characterizing the molecular mechanisms that are responsible for its transcriptional regulation in vivo, we have generated transgenic mice that carry the chloramphenicol acetyltransferase (CAT) reporter gene under the control of approximately 4,300 nucleotides of 5'-flanking sequence of the rat synapsin I gene. In four independent transgenic mouse lines, high level CAT expression is observed specifically in the brain and other neural tissues. Two of these lines also exhibit notable CAT expression in testis. The transgene is expressed at similar levels in many different regions of the central nervous system. Immunohistochemical staining detects the CAT marker protein in various cell populations of neuronal morphology within the brain and the spinal cord. Transgene expression is developmentally regulated in a way that correlates well with the expression of the endogenous synapsin I gene. Both follow a characteristic, biphasic postnatal time course with a maximum around day 20. We conclude that the DNA region investigated contains cis-regulatory elements sufficient to drive the expression of a reporter gene in a spatial and temporal pattern that resembles the expression of the endogenous synapsin I gene.	RUHR UNIV BOCHUM,INST PHYSIOL CHEM,BIOCHEM SUPRAMOLEK SYST ABT,D-44780 BOCHUM,GERMANY; RUHR UNIV BOCHUM,INST ANAT,D-44780 BOCHUM,GERMANY; RUHR UNIV BOCHUM,INST PHYSIOL CHEM,BIOCHEM INTERMEDIARSTOFFWECHSELS ABT,D-44780 BOCHUM,GERMANY	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum								ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN L, 1992, P NATL ACAD SCI USA, V89, P8492, DOI 10.1073/pnas.89.18.8492; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; DECAMILLI P, 1979, P NATL ACAD SCI USA, V76, P5977; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DESMARAIS D, 1992, EMBO J, V11, P2971, DOI 10.1002/j.1460-2075.1992.tb05367.x; DONOGHUE MJ, 1991, J CELL BIOL, V115, P423, DOI 10.1083/jcb.115.2.423; FORSSPETTER S, 1990, NEURON, V5, P17; GOELZ SE, 1981, P NATL ACAD SCI-BIOL, V78, P2130, DOI 10.1073/pnas.78.4.2130; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GRUMMT I, 1980, MOL GEN GENET, V177, P223, DOI 10.1007/BF00267433; HAAS CA, 1988, J CELL BIOL, V106, P195, DOI 10.1083/jcb.106.1.195; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; HARLAN RE, 1991, BIOTECHNIQUES, V10, P304; HE X, 1991, NEURON, V7, P183, DOI 10.1016/0896-6273(91)90257-Z; HOGAN B, 1986, MANIPULATING MOUSE E; HOWLAND DS, 1991, MOL BRAIN RES, V11, P345, DOI 10.1016/0169-328X(91)90044-X; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; KILIMANN MW, 1985, EMBO J, V4, P1997, DOI 10.1002/j.1460-2075.1985.tb03883.x; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; LIPKOWITZ S, 1992, J BIOL CHEM, V267, P21065; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; PATIL N, 1990, NEURON, V2, P437; PERSSON H, 1990, MOL CELL BIOL, V10, P4701, DOI 10.1128/MCB.10.9.4701; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; STOYKOVA AS, 1992, NEURON, V8, P541, DOI 10.1016/0896-6273(92)90282-I; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; WANG YB, 1992, J BIOL CHEM, V267, P15105; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WIRAK DO, 1991, EMBO J, V10, P289, DOI 10.1002/j.1460-2075.1991.tb07949.x; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	45	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26494	26502						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253778				2022-12-27	WOS:A1993MK42500072
J	LAHAYE, A; LETERME, S; FOURY, F				LAHAYE, A; LETERME, S; FOURY, F			PIF1 DNA HELICASE FROM SACCHAROMYCES-CEREVISIAE - BIOCHEMICAL-CHARACTERIZATION OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; YEAST MITOCHONDRIA; PUTATIVE HELICASES; REPLICATION FORK; GENE-4 PROTEIN; REP PROTEIN; BACTERIOPHAGE-T4; RECOMBINATION; PURIFICATION; REQUIREMENTS	Overexpressed PIF1 DNA helicase was purified from mitochondria to near homogeneity. Its ATPase and unwinding properties were characterized. The enzyme specifically utilizes ATP (or dATP) and MgCl2 (and to a lesser extent MnCl2). ATPase activity requires single-stranded DNA as an effector, duplex DNA being 100-fold less effective. The K(eff), defined as the concentration of DNA required to achieve half-maximal ATPase activity, does not depend on single-stranded DNA length. Long duplex DNAs are poorly unwound and, moreover, dilution of the enzyme and its DNA substrate in the assay decreases DNA helicase activity. These data indicate that PIF1 helicase is a distributive enzyme, frequently turning from one DNA molecule to another. When forked substrates are used, unwinding by PIF1 is markedly stimulated. The enzyme has a sedimentation coefficient of 6.5 S, suggesting that it exists as a monomer in solution.	UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, PL CROIX SUD 2-20, B-1348 LOUVAIN, BELGIUM	Universite Catholique Louvain								Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ARAI N, 1981, J BIOL CHEM, V256, P5294; DAUM G, 1982, J BIOL CHEM, V257, P3028; EICHLER DC, 1977, J BIOL CHEM, V252, P499; FOURY F, 1987, EMBO J, V6, P1441, DOI 10.1002/j.1460-2075.1987.tb02385.x; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; FOURY F, 1990, THESIS U CATHOLIQUE; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1988, NATURE, V333, P22, DOI 10.1038/333022a0; HODGMAN TC, 1988, NATURE, V333, P578, DOI 10.1038/333578a0; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2925; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LIU CC, 1981, J BIOL CHEM, V256, P2813; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1983, J BIOL CHEM, V258, P4017; NAKAI H, 1988, J BIOL CHEM, V263, P9818; OH EY, 1989, J BIOL CHEM, V264, P1336; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; ROBERTS B, 1989, BIOCHIM BIOPHYS ACTA, V1008, P263, DOI 10.1016/0167-4781(89)90016-X; SMITH KR, 1989, J BIOL CHEM, V264, P6119; SUISSA M, 1983, ANAL BIOCHEM, V133, P511, DOI 10.1016/0003-2697(83)90117-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V87, P5363; VEKNATESAN M, 1982, J BIOL CHEM, V257, P12426; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	34	83	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26155	26161						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253734				2022-12-27	WOS:A1993MK42500025
J	LAPPALAINEN, P; AASA, R; MALMSTROM, BG; SARASTE, M				LAPPALAINEN, P; AASA, R; MALMSTROM, BG; SARASTE, M			SOLUBLE CU(A)-BINDING DOMAIN FROM THE PARACOCCUS CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-STUTZERI; MULTICOPPER ENZYME; REDUCTASE; EPR; DENITRIFICANS; SPECTROSCOPY; PROTEINS; OXYGEN	In cytochrome c oxidase the C-terminal part of subunit II is outside the membrane and contains a copper center called Cu(A). We have expressed this domain of the Paracoccus denitrificans oxidase in a soluble form. Data obtained by quantitative copper-to-protein measurements, electrospray mass spectrometry, and electron paramagnetic resonance spectroscopy show that the center contains two copper atoms probably in a mixed valence configuration. Its absorbance spectrum is similar to that of the copper center A in nitrous oxide reductase. The EPR spectrum suggests that the center in the soluble protein is closely related to the native Cu(A) site in the cytochrome oxidase complex. However, it seems likely that the copper center in the soluble domain is more exposed to the aqueous milieu than in the intact complex because its absorbance and EPR spectra are sensitive to pH. At alkaline pH one of the coppers in the site acquires type-2 character, indicating that it may be coordinated to a new ligand. The pK of this reversible change is about 8.2. The Cu(A)-binding fragment is able to oxidize cytochrome c.	EUROPEAN MOLEC BIOL LAB, MEYERHOFSTR 1, POSTFACH 102209, D-69012 HEIDELBERG, GERMANY; CHALMERS UNIV TECHNOL, DEPT BIOCHEM & BIOPHYS, S-41296 GOTHENBURG, SWEDEN; GOTHENBURG UNIV, S-41296 GOTHENBURG, SWEDEN	European Molecular Biology Laboratory (EMBL); Chalmers University of Technology; University of Gothenburg				Lappalainen, Pekka/0000-0001-6227-0354				AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; ANTHOLINE WE, 1992, EUR J BIOCHEM, V209, P875, DOI 10.1111/j.1432-1033.1992.tb17360.x; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BROMAN L, 1962, J MOL BIOL, V5, P301, DOI 10.1016/S0022-2836(62)80074-6; BROWN S, 1993, FEBS LETT, V316, P216, DOI 10.1016/0014-5793(93)81296-C; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; COYLE CL, 1985, EUR J BIOCHEM, V153, P459, DOI 10.1111/j.1432-1033.1985.tb09324.x; FARRAR JA, 1991, FEBS LETT, V294, P11, DOI 10.1016/0014-5793(91)81331-2; GREENWOOD C, 1988, ANN NY ACAD SCI, V550, P47, DOI 10.1111/j.1749-6632.1988.tb35321.x; HALTIA T, 1992, MOL MECHANISMS BIOEN, P217; HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9; HILL BC, 1991, J BIOL CHEM, V266, P2219; HOSLER JP, 1993, J BIOENERG BIOMEMBR, V25, P121, DOI 10.1007/BF00762854; KELLY M, 1993, J BIOL CHEM, V268, P16781; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALMSTROM BG, 1993, FEBS LETT, V325, P49, DOI 10.1016/0014-5793(93)81411-R; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; RAITIO M, 1987, EMBO J, V6, P2825, DOI 10.1002/j.1460-2075.1987.tb02579.x; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; STEFFENS GCM, 1993, EUR J BIOCHEM, V213, P1149, DOI 10.1111/j.1432-1033.1993.tb17865.x; STEINRUCKE P, 1987, EUR J BIOCHEM, V167, P431, DOI 10.1111/j.1432-1033.1987.tb13356.x; TAHA TSM, 1992, BIOCHEMISTRY-US, V31, P9090, DOI 10.1021/bi00152a053; ZUMFT WG, 1992, EUR J BIOCHEM, V11, P3209	26	166	166	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26416	26421						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253767				2022-12-27	WOS:A1993MK42500061
J	LEE, EH; HARPEL, MR; CHEN, YR; HARTMAN, FC				LEE, EH; HARPEL, MR; CHEN, YR; HARTMAN, FC			PERTURBATION OF REACTION-INTERMEDIATE PARTITIONING BY A SITE-DIRECTED MUTANT OF RIBULOSE-BISPHOSPHATE CARBOXYLASE OXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; RHODOSPIRILLUM-RUBRUM; 1,5-BISPHOSPHATE CARBOXYLASE; INTERSUBUNIT INTERACTION; CRYSTAL-STRUCTURE; MUTAGENESIS; CATALYSIS; RESOLUTION	To explore the roles of active-site Glu48 of ribulose-bisphosphate carboxylase/oxygenase from Rhodospirillum rubrum, the E48Q mutant has been characterized with respect to kinetics and product distribution. Although the k(cat) for carboxylase activity is only 0.6% of the wild-type value, the mutant retains full activity in catalyzing the conversion of the carboxylated reaction intermediate to 3-phosphoglycerate and retains 10% of the normal activity in catalyzing the enolization of ribulore bisphosphate. Thus, the mutant is preferentially impaired in the carboxylation step. Partitioning of the enediol(ate) intermediate during turnover of ribulose bisphosphate is perturbed dramatically in the case of the mutant protein. Whereas the wild-type enzyme displays a CO2/O2 specificity factor of 11, the corresponding parameter of the mutant is only 0.3, thereby signifying a shift of the relative reactivity of the enediol(ate) in favor of O2. The mutant protein is also unable to protect the enediol(ate) against misprotonation with consequential conversion of ribulose bisphosphate to xylulose bisphosphate. This side reaction, undetected with wild-type R. rubrum enzyme, proceeds as rapidly as carboxylation Of D-ribulose 1,5-bisphosphate by the E48Q mutant. Formation of xylulose bisphosphate by the mutant does not appear to account for the decline in carboxylase activity that occurs during the course of an assay. These studies demonstrate the multiple functionalities of Glu48 in the facilitation of catalysis and in directing intermediate partitioning in the preferred direction.	OAK RIDGE NATL LAB,DIV BIOL,PROT ENGN PROGRAM,POB 2009,OAK RIDGE,TN 37831	United States Department of Energy (DOE); Oak Ridge National Laboratory								ANDERSSON I, 1989, NATURE, V337, P229, DOI 10.1038/337229a0; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ANDREWS TJ, 1991, J BIOL CHEM, V266, P9447; CHAPMAN MS, 1988, SCIENCE, V241, P71, DOI 10.1126/science.3133767; DAY AG, 1993, BIOCHEMISTRY-US, V32, P1940, DOI 10.1021/bi00059a009; EDMONDSON DL, 1990, FEBS LETT, V260, P62, DOI 10.1016/0014-5793(90)80066-R; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; GUTTERIDGE S, 1993, J BIOL CHEM, V268, P7818; HARPEL MR, 1993, ANAL BIOCHEM, V209, P367, DOI 10.1006/abio.1993.1136; HARPEL MR, 1991, J BIOL CHEM, V266, P24734; HARTMAN FC, 1987, BIOCHEM BIOPH RES CO, V145, P1158, DOI 10.1016/0006-291X(87)91558-0; HARTMAN FC, 1993, ADV ENZYMOL RAMB, V67, P1; HARTMAN FC, 1989, J BIOL CHEM, V264, P11784; HARTMAN FC, 1992, PLANT PROTEIN ENG, V1, P61; Horecker B. L., 1958, BIOCHEM PREP, V6, P83; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LARIMER FW, 1987, J BIOL CHEM, V262, P15327; LEE EH, 1987, BIOCHEMISTRY-US, V26, P4599, DOI 10.1021/bi00389a001; LORIMER GH, 1981, BIOCHEMISTRY-US, V20, P1236, DOI 10.1021/bi00508a028; LORIMER GH, 1993, BIOCHEMISTRY-US, V32, P9018, DOI 10.1021/bi00086a006; LUNDQVIST T, 1991, BIOCHEMISTRY-US, V30, P904, DOI 10.1021/bi00218a004; MURAL RJ, 1990, J BIOL CHEM, V265, P6501; NIYOGI SK, 1986, J BIOL CHEM, V261, P87; PIERCE J, 1986, J BIOL CHEM, V261, P248; PIERCE J, 1986, BIOCHEMISTRY-US, V25, P1635; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; SCHLOSS JV, 1982, METHOD ENZYMOL, V23, P570; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; SMITH HB, 1990, J BIOL CHEM, V265, P1243; SOPER TS, 1988, PROTEIN ENG, V2, P39, DOI 10.1093/protein/2.1.39; SUE JM, 1982, BIOCHEMISTRY-US, V21, P5404, DOI 10.1021/bi00265a004; YOKOTA A, 1991, PLANT CELL PHYSIOL, V32, P755; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354; ZHU GH, 1991, PLANT PHYSIOL, V97, P1348, DOI 10.1104/pp.97.4.1348	36	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26583	26591						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253788				2022-12-27	WOS:A1993MK42500083
J	MULLER, A; SAENGER, W				MULLER, A; SAENGER, W			STUDIES ON THE INHIBITORY-ACTION OF MERCURY UPON PROTEINASE-K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY; 3-DIMENSIONAL STRUCTURE; RESOLUTION; DETECTOR	In proteinase K, Cys73 is located ''below'' the imidazole of the active site His69. In a 2.4-angstrom resolution x-ray crystal structure of the complex formed between the enzyme and HgAc2, two Hg(II) positions are found: a fully occupied site, covalently bound to Cys73(Sgamma), which disrupts the catalytic triad (Asp39-His69-Ser224), and a 2-fold disordered (25 and 35% occupancy), noncovalent complexation to His72, Cys73, and Thr76 of lower affinity. The enzyme is inhibited noncompetitively at low concentrations and competitively above stoichiometric concentrations of Hg(II), but it retains 7% residual activity. This can be rationalized if the molecule is flexible enough to permit transient formation of the catalytic triad. Except for the active site, only minor structural changes are observed upon binding of Hg(II), but the thermal stability is reduced by 4-degrees-C.	FREE UNIV BERLIN,INST KRISTALLOG,TAKUSTR 6,D-14195 BERLIN,GERMANY	Free University of Berlin								BAGGER S, 1991, J INORG BIOCHEM, V42, P97, DOI 10.1016/0162-0134(91)80036-H; BAJORATH J, 1988, EUR J BIOCHEM, V176, P441, DOI 10.1111/j.1432-1033.1988.tb14301.x; BELCHER S, 1977, FLUORESCENCE PHOSPHO; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; Blundell T. L., 1976, PROTEIN CRYSTALLOGRA, P183; CARTY AJ, 1976, J CHEM SOC CHEM COMM, P214; CLARKSON TW, 1972, ANNU REV PHARMACOLOG, V12, P375, DOI 10.1146/annurev.pa.12.040172.002111; COTTON FA, 1980, ADV INORG CHEM, P589; HUBBARD R, 1990, FRODO VERSION E4 4; JANY KD, 1986, BIOL CHEM HOPPESEYLE, V366, P485; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KELLER E, 1988, SCHAKAL88; LAVERY R, 1981, INT J QUANTUM CHEM, V20, P49, DOI 10.1002/qua.560200106; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MESSERSCHMIDT A, 1987, J APPL CRYSTALLOGR, V20, P306, DOI 10.1107/S002188988708662X; PAHLER A, 1984, EMBO J, V3, P1311, DOI 10.1002/j.1460-2075.1984.tb01968.x; TAYLOR NJ, 1975, J CHEM SOC DALTON, P438, DOI 10.1039/dt9750000438; TAYLOR NJ, 1977, J AM CHEM SOC, V99, P6143, DOI 10.1021/ja00460a072; TOMARELLI RM, 1949, J LAB CLIN MED, V34, P428; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WOLF WM, 1991, J BIOL CHEM, V266, P17695; WONG YS, 1977, J CHEM SOC DALTON, P1157, DOI 10.1039/dt9770001157	22	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26150	26154						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253733				2022-12-27	WOS:A1993MK42500024
J	STRAUSAK, D; WASER, M; SOLIOZ, M				STRAUSAK, D; WASER, M; SOLIOZ, M			FUNCTIONAL EXPRESSION OF THE ENTEROCOCCUS-HIRAE NAH-ANTIPORTER IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ ANTIPORTER; STREPTOCOCCUS-FAECALIS; MOLECULAR-CLONING; PROTON ANTIPORTER; ALKALINE PH; GENE; EXCHANGER; SODIUM; SEQUENCE; ATPASE	We recently described the cloning of napA, the putative structural gene for the NaH-antiporter of Enterococcus hirae (Waser, M., Bienz-Hess, D., Davies, K., and Solioz, M. (1992) J. Biol. Chem 267, 5396-5400). To analyze the gene product of napA, we expressed it in Escherichia coli. When placed under the control of a T7 promotor, napA could be transcribed and labeled specifically with [S-35]methionine. The resultant gene product exhibited an apparent M(r) of 3,4 x 10(4) when subjected to sodium dodecyl sulfate-gel electrophoresis. The function of NapA was tested by expressing it from its own promotor in the E. coli mutant EP432. This mutant lacks both of the endemic NaH-antiporters, NhaA and NhaB; its growth is thus very sensitive to Na+ and Li+ and membranes derived from this strain do not exhibit NaH-antiport activity. When complemented with napA, EP432 gained tolerance to Na+ or Li+. Membranes prepared from the complemented mutant exhibited NaH-antiport activity. The properties of this activity were determined by acridine fluorescence measurements on vesicles energized with lactate. The NaH-antiporter expressed by napA exhibited a K(m) of 1 mM for Na+ and 0.1 mM for Li+ at pH 7.5. At pH 8.5, the relative rate of NaH-antiport activity was 50%, with little change in the K(m), and approached zero at pH 9. These results demonstrate that napA is the structural gene for the NaH-antiporter of E. hirae. NapA exhibits properties different from those of the two E. coli NaH-antiporters encoded by nhaA and nhaB, yet functionally complements a defect in these genes.	UNIV BERN,DEPT CLIN PHARMACOL,MURTENSTR 35,CH-3010 BERN,SWITZERLAND	University of Bern			Solioz, Marc/I-3162-2013	Solioz, Marc/0000-0002-7989-6721				Ausubel FM., 1988, CURRENT PROTOCOLS MO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREY RN, 1980, J BIOL CHEM, V255, P39; DEGUCHI Y, 1990, J BIOL CHEM, V265, P21704; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HILDEBRANDT F, 1991, BIOCHIM BIOPHYS ACTA, V1129, P105, DOI 10.1016/0167-4781(91)90221-7; IVEY DM, 1991, J BIOL CHEM, V266, P23483; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; KAKINUMA Y, 1990, FEBS LETT, V261, P135, DOI 10.1016/0014-5793(90)80654-2; KAKINUMA Y, 1990, J BACTERIOL, V172, P1732, DOI 10.1128/jb.172.4.1732-1735.1990; KAKINUMA Y, 1989, J BIOENERG BIOMEMBR, V21, P679, DOI 10.1007/BF00762686; KAKINUMA Y, 1987, J BACTERIOL, V169, P3886, DOI 10.1128/jb.169.9.3886-3890.1987; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KINOSHITA N, 1984, J BACTERIOL, V158, P844, DOI 10.1128/JB.158.3.844-848.1984; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; PADAN E, 1989, J BIOL CHEM, V264, P20297; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAKASE K, 1993, J BIOL CHEM, V268, P11610; TSE CM, 1991, EMBO J, V10, P1957, DOI 10.1002/j.1460-2075.1991.tb07725.x; TSE CM, 1992, J BIOL CHEM, V267, P9340; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; WASER M, 1992, J BIOL CHEM, V267, P5396; [No title captured]	28	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26334	26337						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253756				2022-12-27	WOS:A1993MK42500050
J	BURNS, EL; PRICE, EM				BURNS, EL; PRICE, EM			RANDOM MUTAGENESIS OF THE SHEEP NA,K-ATPASE-ALPHA-1 SUBUNIT GENERATES A NOVEL T797N MUTATION THAT RESULTS IN A OUABAIN-RESISTANT ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ALPHA-SUBUNIT; PRIMARY SEQUENCE; BETA-SUBUNIT; BINDING; DNA	Site-directed mutagenesis of the Na,K-ATPase has provided a rational approach to identify several amino acids that appear to be involved in ouabain sensitivity. In order to identify additional amino acids that play a role in ouabain binding, we used formic acid to randomly mutagenize a cDNA cassette encoding amino acids 691-946 of the sheep Na,K-ATPase alpha subunit. This was then used to replace the wild type cDNA cassette in the full-length cDNA, and pools of mutants were electroporated into HeLa cells. Ouabain-resistant cells were selected in 0.5 muM ouabain, and the polymerase chain reaction was used to amplify the region corresponding to the mutagenized cassette from the genomic DNA of the resistant cells. Sequence analysis of the polymerase chain reaction product revealed a single amino acid substitution, T797N. Site-directed mutagenesis was used to reproduce this change in the wild type sheep alpha subunit, and this construct was able to confer resistance to HeLa cells, verifying the role of the mutation in ouabain resistance. The mutant sheep enzyme was found to be as resistant to ouabain as is the rat Na,K-ATPase. These data suggest that T797N, predicted to be in the fifth putative transmembrane domain, is involved in the interaction between ouabain and the Na,K-ATPase.	UNIV N CAROLINA, DEPT PHARMACOL, CB7365, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046469] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL46469] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNAIZ GRD, 1992, MOL NEUROBIOL, V6, P359, DOI 10.1007/BF02757941; ARYSTARKHOVA E, 1992, J BIOL CHEM, V267, P13694; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; JAISSER F, 1992, J BIOL CHEM, V267, P16895; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; MEFORD RM, 1991, J BIOL CHEM, V266, P18308; OBRIEN WJ, 1993, J BIOL CHEM, V268, P7707; PRICE EM, 1989, J BIOL CHEM, V264, P21902; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTHEIS PJ, 1993, BIOCHEMISTRY-US, V32, P544, DOI 10.1021/bi00053a020; SCHWARTZ A, 1969, J PHARMACOL EXP THER, V168, P31; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; VERREY F, 1989, AM J PHYSIOL, V256, pF1034, DOI 10.1152/ajprenal.1989.256.6.F1034; ZHAO X, 1993, FASEB J, V7, pA1	20	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25632	25635						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244998				2022-12-27	WOS:A1993MK10000052
J	HUANG, LY; THOLANIKUNNEL, BG; VAKALOPOULOU, E; MALBON, CC				HUANG, LY; THOLANIKUNNEL, BG; VAKALOPOULOU, E; MALBON, CC			THE M(R) 35,000 BETA-ADRENERGIC-RECEPTOR MESSENGER RNA-BINDING PROTEIN-INDUCED BY AGONISTS REQUIRES BOTH AN AUUUA PENTAMER AND U-RICH DOMAINS FOR RNA RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; 3' UNTRANSLATED REGION; CELL-FREE SYSTEM; STABILITY INVITRO; BETA-2-ADRENERGIC RECEPTORS; GM-CSF; TURNOVER; GENE; SPECIFICITIES; DEGRADATION	Delineating the molecular basis for agonist-induced destabilization of mRNA of G-protein-linked receptors that contributes to receptor down-regulation is fundamental to our understanding of long-term regulation of receptors by agonist. Previously we identified a prominent, M(r) 35,000 cytosolic RNA-binding protein that (i) binds selectively to beta1- and beta2-adrenergic receptor mRNAs, both of which undergo agonist-induced down-regulation; (ii) does not bind either to alpha1b-adrenergic receptor mRNA, which does not undergo agonist-induced down-regulation, or to beta-globin mRNA; (iii) displays binding to beta2-adrenergic receptor mRNA that is selectively competed by poly(U) RNA, but not poly(A), -(C), or -(G) RNA; and (iv) its abundance varies inversely with the level of receptor mRNA, being induced by agonists that down-regulate receptor mRNA (Port, J. D., Huang, L.-y., and Malbon (1992) J. Biol. Chem. 267,24103-24108). We demonstrate here that the binding of beta-adrenergic receptor mRNA by this protein, termed beta-ARB protein, is sensitive to competition by AU-rich domains of the 3'-untranslated regions of c-fos, c-myc, and human granulocyte-macrophage colony-stimulating factor. Using the AU-rich 3'-untranslated regions of wild-type adenovirus IVa2 mRNA and variants with defined mutations in the AUUUA pentamer, AU-rich, and U-rich domains, we were able to define sequences critical to the binding of the beta2-receptor mRNA by the beta-ARB protein. Recognition of beta-ARB protein requires not only an AUUUA destabilization pentamer, but also a flanking U-rich domain(s). Using radiolabeled 3'-untranslated regions of short-lived mRNA, we were able to identify this same M(r) 35,000 cytosolic RNA-binding protein(s), beta-ARB protein, as selective for beta2-adrenergic receptor mRNA.	SUNY STONY BROOK, HLTH SCI CTR, SCH MED, DEPT PHARMACOL, DMDRP, STONY BROOK, NY 11794 USA; SCHERING AG, INST BIOCHEM, W-1000 BERLIN, GERMANY	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Schering AG			malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK30111, DK25410] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025410, R01DK030111] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; BOHJANEN PR, 1992, J BIOL CHEM, V267, P6302; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CLEVELAND DW, 1988, TRENDS BIOCHEM SCI, V13, P339, DOI 10.1016/0968-0004(88)90103-X; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HADCOCK JR, 1989, J BIOL CHEM, V264, P13956; HADCOCK JR, 1989, J BIOL CHEM, V264, P19928; HADCOCK JR, 1991, TRENDS NEUROSCI, V14, P242, DOI 10.1016/0166-2236(91)90124-D; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MORRIS GM, 1991, J BIOL CHEM, V266, P2233; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PELTZ SW, 1991, CRIT REV EUKAR GENE, V1, P99; PORT JD, 1992, J BIOL CHEM, V267, P24103; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; ROSS J, 1988, MOL BIOL MED, V5, P1; SCARPACE PJ, 1985, MOL PHARMACOL, V28, P495; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIMOMURA H, 1990, NUCLEIC ACIDS RES, V18, P4591, DOI 10.1093/nar/18.15.4591; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; STEITZ JA, 1982, COLD SPRING HARB SYM, V47, P893, DOI 10.1101/SQB.1983.047.01.103; STOLLE CA, 1988, GENE, V62, P65, DOI 10.1016/0378-1119(88)90580-X; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; WILUSZ J, 1990, MOL CELL BIOL, V10, P6397, DOI 10.1128/MCB.10.12.6397; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; WRESCHNER DH, 1988, EUR J BIOCHEM, V172, P333, DOI 10.1111/j.1432-1033.1988.tb13891.x	43	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25769	25775						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245013				2022-12-27	WOS:A1993MK10000072
J	SHORT, AD; KLEIN, MG; SCHNEIDER, MF; GILL, DL				SHORT, AD; KLEIN, MG; SCHNEIDER, MF; GILL, DL			INOSITOL 1,4,5-TRISPHOSPHATE-MEDIATED QUANTAL CA2+ RELEASE MEASURED BY HIGH-RESOLUTION IMAGING OF CA2+ WITHIN ORGANELLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-LINE; ENDOPLASMIC-RETICULUM; CALCIUM RELEASE; INTRACELLULAR CALCIUM; REGULATORY MECHANISM; GUANINE-NUCLEOTIDES; CA-2+ RELEASE; GTP; THAPSIGARGIN; RECEPTOR	The distribution and operation of Ca2+ pools within cells has been directly studied in situ by monitoring the Ca2+ inside Ca2+ dye-loaded organelles using high resolution imaging procedures. Using DDT1MF-2 smooth muscle cells, loaded with fura-2 under conditions favoring dye entry into organelles and subjected to carefully controlled permeabilization still attached to coverslips, the Ca2+ within organelles was analyzed by high resolution, z axis-controlled imaging, and deblurring methods. Saturation analysis of entrapped fura-2 indicated that the dye reported Ca2+ identically to fura-2 in solution. Areas containing high Ca2+-sequestering organelles (>5 muM free Ca2+) were observed to predominate around the nucleus and close to the periphery of the cell. Analysis of the actions of inositol 1,4,5-trisphosphate (InsP3) within small (3 mum2) selected intracellular areas, revealed a ''quantal' release phenomenon, with rapid attainment of limited stable release at submaximal InsPs levels. The apparent EC50 for InsP3 Was approximately 3 muM, higher than within suspensions of permeabilized cells. The action of InsP3 was competitively blocked by 10 mug/ml of the InsP3 antagonist, heparin. Applied after maximal InsP3-mediated Ca2+ release, heparin reversed InsP3-induced Ca2+ release resulting in reuptake of Ca2+ into Ca2+-pumping organelles with identical spatial distribution as before Ca2+ release. InsP3 released Ca2+ from all areas of high Ca2+-pumping organelles; extensive areas of high fura-2-loading, but low intraorganelle Ca2+, were unchanged by InsP3. GTP induced no alteration in Ca2+ release (in contrast to suspensions of permeabilized cells), suggesting that the InsP3-sensitive Ca2+ pool was functioning as a single homogeneous pool. Opening of InsP3-sensitive channels was also monitored by assessing InsP3-activated channel-mediated Mn2+ quenching of organelle-loaded fura-2; the results revealed a similar pattern of quantal release, with slightly increased apparent InsP3 sensitivity. The results provide the first high resolution in situ localization of Ca2+ signaling organelles and demonstrate the quantal operation of InsP3-sensitive Ca2+ pools within highly discrete subcellular loci.	UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,108 N GREENE ST,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore					NINDS NIH HHS [NS19304] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019304] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKSH S, 1991, J BIOL CHEM, V266, P21458; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; CHUEH SH, 1986, J BIOL CHEM, V261, P13883; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; GILL DL, 1985, J BIOL CHEM, V260, P9289; GILL DL, 1986, NATURE, V320, P461, DOI 10.1038/320461a0; Gill Donald L., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P265; GLENNON MC, 1992, J BIOL CHEM, V267, P8230; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1988, AM J PHYSIOL, V255, pC304, DOI 10.1152/ajpcell.1988.255.3.C304; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KLEIN MG, 1988, BIOPHYS J, V53, P971, DOI 10.1016/S0006-3495(88)83178-3; KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105; LODISH HF, 1992, J BIOL CHEM, V267, P12753; MEYER T, 1990, P NATL ACAD SCI USA, V87, P3841, DOI 10.1073/pnas.87.10.3841; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; MUALLEM S, 1989, J BIOL CHEM, V264, P205; MULLANEY JM, 1987, J BIOL CHEM, V262, P13865; MULLANEY JM, 1988, P NATL ACAD SCI USA, V85, P2499, DOI 10.1073/pnas.85.8.2499; OLDERSHAW KA, 1991, BIOCHEM J, V278, P705, DOI 10.1042/bj2780705; OZAWA M, 1993, J BIOL CHEM, V268, P699; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSSIER MF, 1991, TRENDS NEUROSCI, V14, P311; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; TSIEN R, 1989, CELL CALCIUM, V11, P93; UEDA T, 1986, J BIOL CHEM, V261, P3184; VOLPE P, 1988, P NATL ACAD SCI USA, V85, P1091, DOI 10.1073/pnas.85.4.1091; VOLPE P, 1991, FEBS LETT, V278, P274, DOI 10.1016/0014-5793(91)80134-O	40	85	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25887	25893						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245023				2022-12-27	WOS:A1993MK10000086
J	WILSON, RB; MASTICK, CC; MURPHY, RF				WILSON, RB; MASTICK, CC; MURPHY, RF			A CHINESE-HAMSTER OVARY CELL-LINE WITH A TEMPERATURE-CONDITIONAL DEFECT IN RECEPTOR RECYCLING IS PLEIOTROPICALLY DEFECTIVE IN LYSOSOME BIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; HUMAN HEPATOMA-CELLS; TRANSFERRIN RECEPTOR; MANNOSE 6-PHOSPHATE; ENDOCYTIC VESICLES; HUMAN-FIBROBLASTS; RAT HEPATOCYTES; ASIALOGLYCOPROTEIN RECEPTOR; HORSERADISH-PEROXIDASE; MEDIATED ENDOCYTOSIS	We have previously described the isolation of a Chinese hamster ovary cell line, TfT1.11, that has a pleiotropic, temperature-conditional defect in receptor recycling (Cain, C. C., Wilson, R. B., and Murphy, R. F. (1991) J. Biol. Chem. 266, 11746-11752). These cells show a rapid loss of cell surface receptors upon temperature shift due to a reduction in the rate of receptor recycling. We show here that, in addition to altered receptor recycling, TfT1.11 cells show three defects in lysosome biogenesis. At the nonpermissive temperature, they 1) redistribute at least one lysosomal enzyme from lysosomes to endosomes, 2) fail to transfer fluid-phase material from early endosomes to later compartments, and 3) fail to accumulate fluid-phase markers due to increased efflux of internalized material. The results suggest that the processes of recycling from the endosome and movement of material from endosomes to lysosomes are tightly linked.	CARNEGIE MELLON UNIV,DEPT BIOL SCI,4400 5TH AVE,PITTSBURGH,PA 15213; CARNEGIE MELLON UNIV,CTR LIGHT MICROSCOPE IMAGING & BIOTECHNOL,PITTSBURGH,PA 15213	Carnegie Mellon University; Carnegie Mellon University			Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM013179, R01GM032508] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM13179, GM32508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; BERG T, 1983, EXP CELL RES, V148, P319, DOI 10.1016/0014-4827(83)90156-8; CAIN CC, 1991, J BIOL CHEM, V266, P11746; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CHANG PL, 1988, EXP CELL RES, V176, P258, DOI 10.1016/0014-4827(88)90329-1; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; COLBAUGH PA, 1989, J CELL BIOL, V108, P2211, DOI 10.1083/jcb.108.6.2211; COLBAUGH PA, 1993, ADV CELL MOL BIOL M, V1, P169; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; DUNN WA, 1980, J BIOL CHEM, V255, P5971; EBERT DL, 1989, J CELL BIOL, V109, P1445, DOI 10.1083/jcb.109.4.1445; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GREEN SA, 1992, J CELL BIOL, V117, P47, DOI 10.1083/jcb.117.1.47; Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HARDING CV, 1990, EUR J IMMUNOL, V20, P323, DOI 10.1002/eji.1830200214; HARFORD J, 1983, J CELL BIOL, V96, P1824, DOI 10.1083/jcb.96.6.1824; HEDLEY DW, 1986, BIOCHEM BIOPH RES CO, V138, P1216, DOI 10.1016/S0006-291X(86)80412-0; HELENIUS A, 1983, TRENDS BIOCHEM SCI, V8, P245, DOI 10.1016/0968-0004(83)90350-X; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hubbard AL, 1989, CURR OPIN CELL BIOL, V1, P675, DOI 10.1016/0955-0674(89)90033-1; KAPLAN J, 1981, CELL, V24, P925, DOI 10.1016/0092-8674(81)90118-5; KINDBERG GM, 1990, J BIOL CHEM, V265, P8999; LINDERMAN JJ, 1988, J THEOR BIOL, V132, P203, DOI 10.1016/S0022-5193(88)80157-7; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2; MURPHY RF, 1988, ADV CELL BIOL, V2, P159; OKA JA, 1983, J BIOL CHEM, V258, P253; ROBBINS AR, 1979, P NATL ACAD SCI USA, V76, P1911, DOI 10.1073/pnas.76.4.1911; Rodman JS, 1990, CURR OPIN CELL BIOL, V2, P664, DOI 10.1016/0955-0674(90)90108-Q; ROEDERER M, 1989, EUR J CELL BIOL, V48, P37; ROFF CF, 1986, J CELL BIOL, V103, P2283, DOI 10.1083/jcb.103.6.2283; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; SIPE DM, 1991, J BIOL CHEM, V266, P3469; SIPE DM, 1987, P NATL ACAD SCI USA, V84, P7119, DOI 10.1073/pnas.84.20.7119; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; STEIN BS, 1986, J BIOL CHEM, V261, P319; STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186; STOORVOGEL W, 1989, J CELL BIOL, V108, P2137, DOI 10.1083/jcb.108.6.2137; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; STROUS GJ, 1985, J CELL BIOL, V101, P531, DOI 10.1083/jcb.101.2.531; SULLIVAN PC, 1987, J CELL PHYSIOL, V131, P58, DOI 10.1002/jcp.1041310110; WARD DM, 1989, J BIOL CHEM, V264, P8164; WHITTERS EA, 1993, ADV CELL MOL BIOL M, V1, P307; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375	55	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25357	25363						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244967				2022-12-27	WOS:A1993MK10000015
J	COLEMAN, CS; STANLEY, BA; PEGG, AE				COLEMAN, CS; STANLEY, BA; PEGG, AE			EFFECT OF MUTATIONS AT ACTIVE-SITE RESIDUES ON THE ACTIVITY OF ORNITHINE DECARBOXYLASE AND ITS INHIBITION BY ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-PHOSPHATE-DEPENDENT HISTIDINE-DECARBOXYLASE; COENZYME-BINDING-SITES; ESCHERICHIA-COLI; AMINO-ACID; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE METABOLISM; PYRIDOXAL-PHOSPHATE; LEISHMANIA-DONOVANI; MOLECULAR-CLONING; INACTIVATION	Mouse ornithine decarboxylase (ODC) and mutant changing residues thought to be involved at the active site were expressed in Escherichia coli, purified to homogeneity by affinity chromatography on a pyridoxamine 5'-phosphate-agarose affinity column, and tested for their kinetic properties and their inactivation by enzyme-activated irreversible inhibitors. All of the mutant enzymes were expressed at comparable levels to the wild type protein (2-4% of the total soluble protein), all bound to the affinity column, and there were only small differences in the apparent K(m) values for L-ornithine providing strong evidence that the mutations did not lead to any gross changes in the protein structure. The mutation K69A led to a change in the spectrum of the enzyme and a 550-fold decrease in the k(cat)/K(m) (specificity constant) value. These results are consistent with lysine 69 being the residue that forms a Schiff base with the pyridoxal 5'-phosphate co-factor. Mutation C70S did not greatly affect the activity despite its proximity to this lysine but increased the K(m) about 2-fold. In contrast, the mutation C360A greatly reduced the specificity constant (by 26-fold) despite a 2-fold decrease in the K(m), suggesting that this cysteine residue is critically involved at the active site. Although cysteine 360 is known to be the major site of binding of the inhibitor, alpha-difluoromethylornithine (DFMO), the C360A mutant was still sensitive to inhibition by this drug. However, the kinetics of inactivation were altered, the partition ratio was 10 times greater, and the labeled adduct formed by reaction with [5-C-14]DFMO was removed from the protein under some denaturing conditions. This adduct was found to occur at lysine 69. The K69A mutant was also sensitive to DFMO with a lower partition ratio than the wild type enzyme. These results indicate that inactivation of ODC by DFMO can occur via interaction with either of two separate residues that form essential parts of the active site. This renders it unlikely that resistant mutants will arise from changes in the enzyme structure. In contrast to the results with DFMO, the C360A mutant ODC was completely resistant to inactivation by (R,R)-delta-methyl-alpha-acetylenicputrescine and was much less sensitive than the wild type enzyme to alpha-monofluoromethyldehydromethylornithine, showing that the reactive species formed from these inhibitors either cannot be formed by this mutant or are unable to react with lysine 69. Finally, the well known, extreme reliance of mammalian ODC on the presence of thiol-reducing agents to maintain activity is probably explained by the critical role of cysteine 360, since the C360A mutant was much less sensitive to inactivation by incubation in the absence of dithiothreitol.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,POB 850,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT PHARMACOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health			Stanley, Bruce/R-9856-2019	Stanley, Bruce/0000-0003-1338-2928	NATIONAL CANCER INSTITUTE [R01CA018138, R37CA018138] Funding Source: NIH RePORTER; NCI NIH HHS [CA-18138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACCHI CJ, 1993, PARASITOL TODAY, V9, P190, DOI 10.1016/0169-4758(93)90145-6; BEY P, 1983, J MED CHEM, V26, P1551, DOI 10.1021/jm00365a002; Bey P., 1987, INHIBITION POLYAMINE, P1; BHATTACHARJEE MK, 1990, J BIOL CHEM, V265, P6664; BOEKER EA, 1972, ENZYMES, V6, P217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COONS T, 1990, MOL BIOCHEM PARASIT, V39, P77, DOI 10.1016/0166-6851(90)90010-J; DANZIN C, 1982, BIOCHEM PHARMACOL, V31, P3871, DOI 10.1016/0006-2952(82)90304-5; DANZIN C, 1983, BIOCHEM BIOPH RES CO, V116, P237, DOI 10.1016/0006-291X(83)90406-0; DEBIASE D, 1991, BIOCHEMISTRY-US, V30, P2239, DOI 10.1021/bi00222a029; DOMINICI P, 1991, EUR J BIOCHEM, V201, P393, DOI 10.1111/j.1432-1033.1991.tb16296.x; FARACI WS, 1989, BIOCHEMISTRY-US, V28, P431, DOI 10.1021/bi00428a004; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; FUTAKI S, 1990, J BIOL CHEM, V265, P22306; GOLDSMITH JO, 1991, J BIOL CHEM, V266, P18626; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; HANSON S, 1992, J BIOL CHEM, V267, P2350; HAYASHI H, 1986, J BIOL CHEM, V261, P1003; HAYASHI H, 1990, ANNU REV BIOCHEM, V59, P87, DOI 10.1146/annurev.biochem.59.1.87; HAYASHI S, 1989, ORNITHINE DECARBOXYL, P1; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; JANNE J, 1971, J BIOL CHEM, V246, P1725; JOHNSON R, 1992, ANIM GENET, V23, P403, DOI 10.1111/j.1365-2052.1992.tb02158.x; KITZ R, 1962, J BIOL CHEM, V237, P3245; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; LU L, 1991, BIOCHEM J, V277, P671, DOI 10.1042/bj2770671; MALCOLM BA, 1985, BIOCHEM BIOPH RES CO, V132, P915, DOI 10.1016/0006-291X(85)91894-7; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; MCCANN PP, 1987, INHIBITION POLYAMINE, P1; NISHIMURA K, 1991, BIOCHEMISTRY-US, V30, P4072, DOI 10.1021/bi00230a036; Pegg  A., 1981, POLYAMINES BIOL MED, P3; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PEGG AE, 1987, BIOCHEM J, V241, P305, DOI 10.1042/bj2410305; PHILLIPS RS, 1989, J BIOL CHEM, V264, P10627; POULIN R, 1992, J BIOL CHEM, V267, P150; SEELY JE, 1982, BIOCHEMISTRY-US, V21, P3394, DOI 10.1021/bi00257a023; SEELY JE, 1982, J BIOL CHEM, V257, P7549; SILVERMAN RB, 1986, BIOCHEMISTRY-US, V25, P6817, DOI 10.1021/bi00370a013; SJOERDSMA A, 1984, CLIN PHARMACOL THER, V35, P287, DOI 10.1038/clpt.1984.33; STANLEY BA, 1991, J BIOL CHEM, V266, P18502; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; VAALER GL, 1989, BIOCHEMISTRY-US, V28, P7306, DOI 10.1021/bi00444a024	47	84	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24572	24579						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227016				2022-12-27	WOS:A1993MG67300014
J	GASQUE, P; ISCHENKO, A; LEGOEDEC, J; MAUGER, C; SCHOUFT, MT; FONTAINE, M				GASQUE, P; ISCHENKO, A; LEGOEDEC, J; MAUGER, C; SCHOUFT, MT; FONTAINE, M			EXPRESSION OF THE COMPLEMENT CLASSICAL PATHWAY BY HUMAN GLIOMA IN CULTURE - A MODEL FOR COMPLEMENT EXPRESSION BY NERVE-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL-CELLS; INTERFERON-GAMMA; ALTERNATIVE PATHWAY; GENE-EXPRESSION; ALZHEIMER-DISEASE; EPITHELIAL-CELLS; BLOOD MONOCYTES; 1ST COMPONENT; C1 INHIBITOR; BIOSYNTHESIS	In this paper we demonstrate the synthesis of the components of the classical complement pathway, namely C1q, C1r, C1s, C1-Inh, C2, C4, and C5, by human glioma cell lines (U118MG, T193, and T98G). All these components were structurally, antigenically, and functionally similar to their serum counterparts as determined by biosynthetic labeling experiments, Western blot analysis, and hemolytic assays. Northern blot analysis of mRNA demonstrated that, for each of these components, their specific mRNA had the same size as the equivalent mRNA from hepatic tissue. We could not detect the synthesis of C4bp by these cell lines, and the secretion of C1q was only detected after stimulation by interferon-gamma. All these syntheses were up-regulated by interferon-gamma and tumor necrosis factor. Interleukin-1beta only increased C2 expression and reproducibly down-regulated C5 secretion when used at high doses. Glioma cell lines appear to be an efficient and convenient model for the analysis of complement expression in human astrocytic cells.			GASQUE, P (corresponding author), EUROPEAN INST PEPTIDE RES,INSERM,U78,BP 73,F-76233 BOIS GUILLAUME,FRANCE.							ALSALIHI A, 1982, ANN IMMUNOL I PAST C, V133, P299; BARNUM SR, 1992, J NEUROIMMUNOL, V38, P275, DOI 10.1016/0165-5728(92)90020-L; BARNUM SR, 1902, BIOCHEM J, V287, P595; BASSETSEGUIN N, 1990, J INVEST DERMATOL, V95, P621, DOI 10.1111/1523-1747.ep12513524; BEATTY DW, 1981, CLIN IMMUNOL IMMUNOP, V18, P334, DOI 10.1016/0090-1229(81)90126-4; BOTTO M, 1992, J IMMUNOL, V149, P1348; BROOIMANS RA, 1989, J IMMUNOL, V142, P2024; BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOY LN, 1992, J BIOL CHEM, V267, P12736; DAUCHEL H, 1990, EUR J IMMUNOL, V20, P1669, DOI 10.1002/eji.1830200808; GASQUE P, 1992, J IMMUNOL, V149, P1381; GOUDIS D, 1987, BIOCHEM SOC T, V15, P650; JULEN N, 1992, EUR J IMMUNOL, V22, P213, DOI 10.1002/eji.1830220131; KATZ Y, 1989, J IMMUNOL, V142, P2041; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KULICS J, 1990, J CLIN INVEST, V85, P943, DOI 10.1172/JCI114523; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPPIN DF, 1992, BIOCHEM J, V281, P437, DOI 10.1042/bj2810437; LEMERCIER C, 1992, EUR J IMMUNOL, V22, P909, DOI 10.1002/eji.1830220405; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; LOOS M, 1982, PROTIDES BIOL FLUIDS, V29, P439; LOTZ M, 1987, J IMMUNOL, V139, P3382; MOFFAT GJ, 1992, J BIOL CHEM, V267, P20400; MORRIS KM, 1978, J EXP MED, V148, P1007, DOI 10.1084/jem.148.4.1007; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; PETRY F, 1991, J IMMUNOL, V147, P3988; PLATASALAMAN CR, 1991, NEUROSCI BIOBEHAV R, V15, P185, DOI 10.1016/S0149-7634(05)80001-6; REID KBM, 1977, BIOCHEM J, V167, P647, DOI 10.1042/bj1670647; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; ROTHMAN BL, 1989, AM REV RESPIR DIS, V139, P212, DOI 10.1164/ajrccm/139.1.212; ROTHMAN BL, 1990, J IMMUNOL, V145, P592; RUSS HG, 1992, J IMMUNOL, V148, P928; SAKIYAMA H, 1991, J IMMUNOL, V146, P183; SANDERS KM, 1986, J IMMUNOL, V137, P876; SCHMAIER AH, 1989, J BIOL CHEM, V264, P18173; Shin Moon Lee, 1992, P801; SKOK J, 1981, NATURE, V292, P549, DOI 10.1038/292549a0; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER DG, 1992, MOL BRAIN RES, V14, P109, DOI 10.1016/0169-328X(92)90017-6; WHALEY K, 1980, J EXP MED, V151, P501, DOI 10.1084/jem.151.3.501	44	107	107	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25068	25074						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227070				2022-12-27	WOS:A1993MG67300081
J	VEYHL, M; SPANGENBERG, J; PUSCHEL, B; POPPE, R; DEKEL, C; FRITZSCH, G; HAASE, W; KOEPSELL, H				VEYHL, M; SPANGENBERG, J; PUSCHEL, B; POPPE, R; DEKEL, C; FRITZSCH, G; HAASE, W; KOEPSELL, H			CLONING OF A MEMBRANE-ASSOCIATED PROTEIN WHICH MODIFIES ACTIVITY AND PROPERTIES OF THE NA+-D-GLUCOSE COTRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER-MEMBRANE; XENOPUS-LAEVIS; NA+/GLUCOSE COTRANSPORTER; PHLORIZIN BINDING; INTESTINAL NA+; RAT-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; RADIATION-INACTIVATION; GLUTAMATE TRANSPORTER; MONOCLONAL-ANTIBODIES	An expression library from porcine kidney cortex was screened with a monoclonal antibody (R4A6) which stimulates high-affinity phlorizin binding in kidney and intestine but does not react with the membrane protein (SGLT1) which mediates Na+-coupled transport Of D-glucose (Hediger, M. A., Coady, M. J., Ikeda, T. S., and Wright, E. M. (1987) Nature 330, 379-381). A cDNA (RS1) was obtained which codes for a hydrophilic M(r) 66,832 polypeptide and contains a predicted hydrophobic alpha-helix at the COOH terminus. After expression in Xenopus oocytes RS1 protein was found associated with the plasma membrane. RS1-homologous mRNAs were detected in renal outer cortex and outer medulla, small intestine, liver, and LLCPK1 cells, but not in skeletal muscle, heart muscle, Madin-Darby canine kidney (MDCK) cells, renal inner medulla, and Xenopus oocytes. After nondenaturing gel electrophoresis of renal brush-border membranes comigration of RS1- and SGLT1-homologous proteins as a high molecular weight complex was demonstrated. RS1 altered the expression of Na+-glucose cotransport by SGLT1 in Xenopus oocytes. There was no effect on the expression of the nonhomologous transporters for Na+-gamma-aminobutyric acid cotransport and for Na+-independent glucose transport. However, RS1 also changed the expression of the SGLT1-homologous Na+-myo-inositol cotransporter from MDCK cells. The V(max) of methyl-alpha-D-glucopyranoside (AMG) transport expressed after injection of a small amount of SGLT1-cRNA was increased 40-fold when a stoichiometric amount of RS1-cRNA was coinjected. In addition the voltage and glucose dependence of expressed AMG uptake and the concentration dependence of transport inhibition by phlorizin were changed when stoichiometric amounts of RS1-cRNA were coinjected with SGLT1-cRNA. Thus with SGLT1 one apparent transport site (K0.5 about 100 muM) and one apparent phlorizin inhibition site (K(i) about 5 pm) was observed whereas with SGLT1 plus RS1 two apparent transport sites (K0.5(1) about 20 muM, K0.5(2) about 1 mM) and two apparent phlorizin inhibition sites (K(i)(1) about 0.3 muM, K(i)(2) about 30 muM) were found as has been described in brush-border membrane vesicles of kidney and intestine (see eg. Koepsell, H., Fritzsch, G., Korn, K., and Madrala, A. (1990) J. Membr. Biol. 114, 113-132). The data suggest that the Na+-D-glucose cotransporter and possibly also other SGLT1-type Na+-cotransporters contain RS1-type regulatory subunits.	MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY	Max Planck Society								ARGOS P, 1982, EUR J BIOCHEM, V128, P565; ARONSON PS, 1978, J MEMBRANE BIOL, V42, P81, DOI 10.1007/BF01870395; BARFUSS DW, 1981, AM J PHYSIOL, V240, pF322; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BELIVEAU R, 1988, BIOCHEM J, V252, P807, DOI 10.1042/bj2520807; BIRNIR B, 1990, BIOCHIM BIOPHYS ACTA, V1048, P100, DOI 10.1016/0167-4781(90)90028-Z; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLANK ME, 1989, AM J PHYSIOL, V257, pC385, DOI 10.1152/ajpcell.1989.257.2.C385; BROTLAROCHE E, 1988, P NATL ACAD SCI USA, V85, P6370, DOI 10.1073/pnas.85.17.6370; BROTLAROCHE E, 1986, J BIOL CHEM, V261, P6168; CELENZA JL, 1988, P NATL ACAD SCI USA, V85, P2130, DOI 10.1073/pnas.85.7.2130; COADY MJ, 1990, AM J PHYSIOL, V259, pC605, DOI 10.1152/ajpcell.1990.259.4.C605; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; DEBIEC H, 1991, EUR J BIOCHEM, V201, P709, DOI 10.1111/j.1432-1033.1991.tb16332.x; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FREEMAN TC, 1992, BIOCHEM SOC T, V20, P1865; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HAASE W, 1989, EUR J CELL BIOL, V48, P360; HAASE W, 1990, EUR J CELL BIOL, V52, P297; HAZZARD CE, 1992, AM J PHYSIOL, V262, pR412, DOI 10.1152/ajpregu.1992.262.3.R412; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HWANG ES, 1991, BIOCHEM BIOPH RES CO, V181, P1208, DOI 10.1016/0006-291X(91)92067-T; IKEDA TS, 1989, J MEMBRANE BIOL, V110, P87, DOI 10.1007/BF01870995; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KOEPSELL H, 1988, J BIOL CHEM, V263, P18419; KOEPSELL H, 1990, J MEMBRANE BIOL, V114, P113, DOI 10.1007/BF01869093; KONG CT, 1993, J BIOL CHEM, V268, P1509; KORNELUK RG, 1985, GENE, V40, P317, DOI 10.1016/0378-1119(85)90055-1; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KWON HM, 1992, J BIOL CHEM, V267, P6297; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESCALEMATYS L, 1993, BIOCHEM J, V291, P435, DOI 10.1042/bj2910435; LESCALEMATYS L, 1992, FASEB J, V6, P4817; LIN JT, 1984, BIOCHIM BIOPHYS ACTA, V777, P201, DOI 10.1016/0005-2736(84)90421-8; MALO C, 1990, BIOCHIM BIOPHYS ACTA, V1022, P8, DOI 10.1016/0005-2736(90)90394-4; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MIYAMOTO K, 1991, BIOCHEM BIOPH RES CO, V181, P1110, DOI 10.1016/0006-291X(91)92053-M; MORRISON AI, 1991, BIOCHIM BIOPHYS ACTA, V1089, P121, DOI 10.1016/0167-4781(91)90093-2; MUECKLER M, 1986, CELL, V44, P629, DOI 10.1016/0092-8674(86)90272-2; NOGUCHI S, 1992, BIOCHEM BIOPH RES CO, V182, P659, DOI 10.1016/0006-291X(92)91783-M; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; PAJOR AM, 1992, BIOCHIM BIOPHYS ACTA, V1106, P216, DOI 10.1016/0005-2736(92)90241-D; PAJOR AM, 1992, J BIOL CHEM, V267, P3557; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; QUAMME GA, 1987, AM J PHYSIOL, V253, pF151, DOI 10.1152/ajprenal.1987.253.1.F151; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RESTREPO D, 1986, J MEMBRANE BIOL, V89, P269, DOI 10.1007/BF01870669; Sambrook J, 1989, MOL CLONING LABORATO; SANDER I, 1992, BIOCHIM BIOPHYS ACTA, V1112, P129, DOI 10.1016/0005-2736(92)90263-L; SCHLOSS P, 1992, FEBS LETT, V307, P76, DOI 10.1016/0014-5793(92)80905-V; SCHMALZING G, 1991, BIOCHEM J, V279, P329, DOI 10.1042/bj2790329; SHIRAZIBEECHEY SP, 1991, J PHYSIOL-LONDON, V437, P699, DOI 10.1113/jphysiol.1991.sp018620; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMITH CD, 1992, BIOCHIM BIOPHYS ACTA, V1104, P151, DOI 10.1016/0005-2736(92)90144-B; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STEFFGEN J, 1991, BIOCHIM BIOPHYS ACTA, V1066, P14, DOI 10.1016/0005-2736(91)90244-3; STEVENS BR, 1990, P NATL ACAD SCI USA, V87, P1456, DOI 10.1073/pnas.87.4.1456; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TAKAHASHI M, 1985, J BIOL CHEM, V260, P551; TAKATA K, 1991, J HISTOCHEM CYTOCHEM, V39, P287, DOI 10.1177/39.3.1993828; TAKATA K, 1992, CELL TISSUE RES, V267, P3, DOI 10.1007/BF00318685; TOGGENBURGER G, 1982, BIOCHIM BIOPHYS ACTA, V688, P557, DOI 10.1016/0005-2736(82)90367-4; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; TURNER RJ, 1982, J MEMBRANE BIOL, V70, P37, DOI 10.1007/BF01871587; TURNER RJ, 1982, AM J PHYSIOL, V242, pF406, DOI 10.1152/ajprenal.1982.242.4.F406; VEYHL M, 1992, FASEB J, V6, pA1459; WEBER WM, 1991, BIOCHIM BIOPHYS ACTA, V1063, P73, DOI 10.1016/0005-2736(91)90355-C; WEBER WM, 1989, J MEMBRANE BIOL, V111, P93, DOI 10.1007/BF01869212; WELLS RG, 1992, AM J PHYSIOL, V263, pF459, DOI 10.1152/ajprenal.1992.263.3.F459; ZIEGLER K, 1990, J BIOL CHEM, V265, P3270	75	90	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25041	25053						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227068				2022-12-27	WOS:A1993MG67300078
J	SHAPIRO, SD; KOBAYASHI, DK; LEY, TJ				SHAPIRO, SD; KOBAYASHI, DK; LEY, TJ			CLONING AND CHARACTERIZATION OF A UNIQUE ELASTOLYTIC METALLOPROTEINASE PRODUCED BY HUMAN ALVEOLAR MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONONUCLEAR PHAGOCYTES; MOLECULAR-CLONING; EXPRESSION; ELASTASE; INHIBITORS; LOCALIZATION; BIOSYNTHESIS; DEGRADATION; ENZYME	Human alveolar macrophages have the capacity to degrade elastin. As an approach to define proteinases responsible for this activity, we recently cloned a murine macrophage elastase cDNA and demonstrated that it is a member of the matrix metalloproteinase gene family (Shapiro, S. D., Griffin, G. L., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Welgus, H. G., Senior, R. M., and Ley, T. J. (1992) J. Biol. Chem. 267, 4664-4671). We now report that there is a human orthologue of murine macrophage metalloelastase that we call human macrophage metalloelastase (HME). The full-length HME cDNA spans 1.8 kilobases and contains an open reading frame of 1410 base pairs; the predicted molecular mass of the HME proenzyme is 54 kDa. HME mRNA and protein were detected in human alveolar macrophages. Similar to murine macrophage metalloelastase, HME readily undergoes NH2- and COOH-terminal processing to a mature 22-kDa form. Both recombinant HME expressed in Escherichia coli and native HME derived from human alveolar macrophage-conditioned media degraded insoluble elastin. HME is a unique human metalloproteinase that possesses elastolytic activity and is expressed in alveolar macrophages; it is therefore a candidate molecule for the causation of diseases characterized by damage to the extracellular matrix.	WASHINGTON UNIV,MED CTR,JEWISH HOSP,DEPT MED,DIV HEMATOL ONCOL,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,JEWISH HOSP,DEPT GENET,ST LOUIS,MO 63110	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	SHAPIRO, SD (corresponding author), WASHINGTON UNIV,MED CTR,JEWISH HOSP,DEPT MED,DIV RESP & CRIT CARE,ST LOUIS,MO 63110, USA.				NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NCI NIH HHS [CA49712] Funding Source: Medline; NHLBI NIH HHS [HL29594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBIN RJ, 1987, AM REV RESPIR DIS, V135, P1281; BANDA MJ, 1981, BIOCHEM J, V193, P589, DOI 10.1042/bj1930589; BIRKEDALHANSEN B, 1988, BIOCHEMISTRY-US, V27, P6751, DOI 10.1021/bi00418a016; BUSIEK DF, 1992, J BIOL CHEM, V267, P9087; CHAPMAN HA, 1984, J CLIN INVEST, V73, P806, DOI 10.1172/JCI111275; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MCCACHREN SS, 1991, ARTHRITIS RHEUM-US, V34, P1085; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; REILLY JJ, 1989, BIOCHEM J, V257, P493, DOI 10.1042/bj2570493; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SENIOR RM, 1989, AM REV RESPIR DIS, V139, P1251, DOI 10.1164/ajrccm/139.5.1251; SHAPIRO SD, 1990, J CLIN INVEST, V86, P1204, DOI 10.1172/JCI114826; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1992, J BIOL CHEM, V267, P13890; SHI GP, 1992, J BIOL CHEM, V267, P7258; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	23	396	419	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23824	23829						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226919				2022-12-27	WOS:A1993MF29400021
J	WAHLS, WP; SONG, JM; SMITH, GR				WAHLS, WP; SONG, JM; SMITH, GR			SINGLE-STRANDED-DNA BINDING-ACTIVITY OF C(1)-TETRAHYDROFOLATE SYNTHASE ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHYDROLASE-FORMYLTETRAHYDROFOLATE SYNTHETASE; METHENYL-METHYLENETETRAHYDROFOLATE SYNTHETASE; RAT C1-TETRAHYDROFOLATE SYNTHASE; GAMMA-L-GLUTAMATES; 10-FORMYLTETRAHYDROFOLATE SYNTHETASE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; SACCHAROMYCES-CEREVISIAE; PORCINE LIVER; CLOSTRIDIUM-FORMICOACETICUM; MULTIFUNCTIONAL ENZYME	In eukaryotes C1-5,6,7,8-tetrahydrofolate (THF) synthase is a trifunctional enzyme that catalyzes the interconversion of reduced forms of folate to supply activated one-carbon units required for a variety of metabolic pathways. The enzymatic activities include 10-formyl-THF synthetase (EC 6.3.4.3), 5,10-methenyl-THF cyclohydrolase (EC 3.5.4.9), and 5,10-methylene-THF dehydrogenase (EC 1.5.1.5). In bacteria separate, monofunctional or bifunctional polypeptides catalyze the same reactions. We have purified C1-THF synthase from the fission yeast Schizosaccharomyces pombe and found its physical and enzymatic properties similar to those of other eukaryotic C1-THF synthase enzymes. Unexpectedly, the S. pombe enzyme bound strongly (K(eq) = 100 pM) to single-stranded DNA, but not to double-stranded DNA or to RNA. The binding was sequence-independent, apparently not cooperative, and not detectably inhibited by C1-THF synthase substrates or cofactors. Trifunctional cytoplasmic enzyme from Saccharomyces cerevisiae and monofunctional (synthetase) enzyme from Clostridium acidiurici also bound tightly to single-stranded DNA, while bifunctional (dehydrogenase and cyclohydrolase) enzyme from Escherichia coli did not, suggesting that single-stranded DNA binding is a conserved function of the synthetase domain of C1-THF synthase enzymes.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	WAHLS, WP (corresponding author), FRED HUTCHINSON CANC RES CTR, 1124 COLUMBIA ST, SEATTLE, WA 98104 USA.			Smith, Gerald/0000-0002-8747-1352	NATIONAL CANCER INSTITUTE [T32CA009437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031693, R56GM031693] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09437] Funding Source: Medline; NIDDK NIH HHS [DK02109-35] Funding Source: Medline; NIGMS NIH HHS [GM31693] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLING DR, 1985, BIOCHEMISTRY-US, V24, P3540, DOI 10.1021/bi00335a023; BLAKLEY RL, 1969, BIOCH FOLIC ACID REL, P219; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPERELLI CA, 1978, BIOCHEM BIOPH RES CO, V82, P403, DOI 10.1016/0006-291X(78)90890-2; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; CHEEK WD, 1989, ARCH BIOCHEM BIOPHYS, V270, P504, DOI 10.1016/0003-9861(89)90532-8; CLARK JE, 1982, J BIOL CHEM, V257, P3833; COWARD JK, 1975, BIOCHEMISTRY-US, V14, P1548, DOI 10.1021/bi00678a032; COWARD JK, 1974, BIOCHEMISTRY-US, V13, P3899, DOI 10.1021/bi00716a013; DARI L, 1991, J BIOL CHEM, V266, P23953; DEV IK, 1978, J BIOL CHEM, V253, P4245; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; HUM DW, 1988, J BIOL CHEM, V263, P15946; JONES EW, 1977, GENETICS, V85, P209; KISLIUK RL, 1981, BIOCHEMISTRY-US, V20, P929, DOI 10.1021/bi00507a044; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ljungdahl L G, 1980, Methods Enzymol, V66, P599; LOVELL CR, 1990, BIOCHEMISTRY-US, V29, P5687, DOI 10.1021/bi00476a007; MacKenzie R E, 1984, FOLATES PTERINS CHEM, V1, P255; MACKENZIE RE, 1980, BIOCHIM BIOPHYS ACTA, V611, P187, DOI 10.1016/0005-2744(80)90054-6; MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005; MCGUIRE JJ, 1978, J BIOL CHEM, V253, P1079; MOORE MR, 1974, J BIOL CHEM, V249, P5250; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; NOUR JM, 1991, J BIOL CHEM, V266, P18363; NOUR JM, 1992, J BIOL CHEM, V267, P16292; OBRIEN WE, 1973, J BIOL CHEM, V248, P403; PAUKERT JL, 1976, J BIOL CHEM, V251, P5104; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; PERUCHO M, 1980, BIOCHIM BIOPHYS ACTA, V606, P181, DOI 10.1016/0005-2787(80)90028-3; Rabinowitz J.C., 1960, ENZYMES, V2, P185; RABINOWITZ JC, 1962, J BIOL CHEM, V237, P2898; RAGSDALE SW, 1984, J BIOL CHEM, V259, P3499; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; STABEN C, 1986, J BIOL CHEM, V261, P4629; STABEN C, 1983, P NATL ACAD SCI-BIOL, V80, P6799, DOI 10.1073/pnas.80.22.6799; STRONG W, 1987, J BIOL CHEM, V262, P12519; SUAREZDEMATA Z, 1980, J BIOL CHEM, V255, P2569; SZANKASI P, 1988, J MOL BIOL, V204, P917, DOI 10.1016/0022-2836(88)90051-4; TAN LUL, 1979, CAN J BIOCHEM CELL B, V57, P806, DOI 10.1139/o79-100; TAN LUL, 1977, J BIOL CHEM, V252, P1117; TAN LUL, 1977, BIOCHIM BIOPHYS ACTA, V485, P52, DOI 10.1016/0005-2744(77)90192-9; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; UEMURA T, 1984, EMBO J, V9, P663; UYEDA K, 1967, J BIOL CHEM, V242, P24; VILLAR E, 1985, J BIOL CHEM, V260, P2245; WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269; WAHLS WP, 1993, CHROMOSOMES TODAY, V11, P351; WHITEHEAD TR, 1988, J BACTERIOL, V170, P3255, DOI 10.1128/jb.170.7.3255-3261.1988	51	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23792	23798						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226914				2022-12-27	WOS:A1993MF29400016
J	WU, ZL; WONG, ST; STORM, DR				WU, ZL; WONG, ST; STORM, DR			MODIFICATION OF THE CALCIUM AND CALMODULIN SENSITIVITY OF THE TYPE-I ADENYLYL-CYCLASE BY MUTAGENESIS OF ITS CALMODULIN-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CELLS; STIMULATION; EXPRESSION; RUTABAGA; MEMORY	The type I adenylyl cyclase is directly stimulated by Ca2+ and calmodulin in vitro, and the enzyme is also stimulated by increases in intracellular Ca2+ in vivo. Ca2+ stimulation of the enzyme in vivo may be due to direct interactions of the enzyme with Ca2+ and calmodulin or to an indirect mechanism involving stimulation of the enzyme by Ca2+-activated protein kinases. In this study, we have made several point mutations within the calmodulin binding domain to determine if the Ca2+ sensitivity of the enzyme can be modified by mutagenesis. The catalytic activities of the mutant enzymes were comparable to wild type type I adenylyl cyclase. Substitution of Cys-507 with Ser-507 did not have significant effects on the calmodulin or Ca2+ sensitivity of the enzyme. However, replacement of Lys-504 with Asp caused a 4-fold decrease in sensitivity to Ca2+. Ca2+ and calmodulin stimulation were abolished by substitution of Phe-503 with Arg-503. Stimulation of type I adenylyl cyclase activity in vivo by intracellular Ca2+ was also greatly diminished with the Arg-503 mutant indicating that Ca2+ stimulation of the enzyme in vivo is due primarily to direct interactions with calmodulin and Ca2+. These data demonstrate that the Ca2+ sensitivity of this enzyme can be modulated by point mutagenesis within the putative calmodulin binding domain and indicate that the enzyme can be directly regulated by Ca2+ and calmodulin in vivo.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NINDS NIH HHS [NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; CHOI EJ, 1992, J BIOL CHEM, V267, P12440; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1891, DOI 10.1021/bi00059a001; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; DEGRADO WF, 1987, PROTEINS, V2, P20, DOI 10.1002/prot.340020104; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; OLDENBURG DJ, 1992, BIOCHEMISTRY-US, V31, P8884, DOI 10.1021/bi00152a027; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T	21	88	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23766	23768						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226907				2022-12-27	WOS:A1993MF29400009
J	YAMADA, S; HATA, J; YAMASHITA, S				YAMADA, S; HATA, J; YAMASHITA, S			MOLECULAR-CLONING OF FISH PIT-1 CDNA AND ITS FUNCTIONAL BINDING TO PROMOTER OF GENE EXPRESSED IN THE PITUITARY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE GENE; TRANSCRIPTION FACTOR-TFIIB; TROUT SALMO-GAIRDNERI; RAINBOW-TROUT; PROLACTIN FAMILY; PLASMA PROLACTIN; SOMATOLACTIN; ADAPTATION; SEQUENCE; ACTIVATION	Pit-1 is a pituitary-specific transcription factor responsible for activating growth hormone (GH) and prolactin genes. Here, we describe the isolation of a rainbow trout cDNA clone that contains the entire Pit-1 coding region. The deduced amino acid sequence contains 358 residues, encoding a 39-kDa protein. Comparison of the protein sequences of the rainbow trout and rat Pit-1 shows that the 160 residue POU domain at the C terminus is highly conserved (86% identical). However, homology is much weaker in the N-terminal region (56% identical), and the rainbow trout Pit-1 contains segments of 29 and 33 amino acids that are not present in rat Pit-1. The protein produced by expression of rainbow trout Pit-1 cDNA in Escherichia coli binds specifically to at least four sites in the rainbow trout GH gene promoter. Moreover, we demonstrate that the promoter region of salmon somatolactin gene, which belongs to the GH prolactin gene family and is also expressed specifically in the pituitary, has at least five rainbow trout Pit-1 binding sites. The consensus sequence of these binding sites closely matches the 9-base pair motif, (T/A)(T/A)TATNCAT, recognized by rat Pit-1. Rainbow trout Pit-1 specifically activates rainbow trout GH promoter fusion gene expression, confirming the ability of Pit-1 to bind in a transcriptionally active conformation in GH gene promoter.	NIPPON SUISAN KAISHA LTD,CENT RES LAB,559-6 KITANOMACHI,HACHIOJI,TOKYO 192,JAPAN; NINCDS,MOLEC BIOL LAB,BETHESDA,MD 20892	Nippon Suisan Kaisha, Ltd.; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)								AGELLON LB, 1988, P NATL ACAD SCI USA, V85, P5136, DOI 10.1073/pnas.85.14.5136; AGELLON LB, 1988, CAN J FISH AQUAT SCI, V45, P146, DOI 10.1139/f88-016; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BOLTON JP, 1987, J ENDOCRINOL, V112, P63, DOI 10.1677/joe.0.1120063; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; INOUE K, 1990, CELL DIFFER DEV, V29, P123, DOI 10.1016/0922-3371(90)90030-Z; INOUE K, 1991, NIPPON SUISAN GAKK, V57, P1511, DOI 10.2331/suisan.57.1511; INOUE K, 1990, BIOCHEM BIOPH RES CO, V173, P1311, DOI 10.1016/S0006-291X(05)80930-1; INOUE K, 1992, BIOCHEM BIOPH RES CO, V185, P1108, DOI 10.1016/0006-291X(92)91740-H; KAMEI Y, 1987, FISH PATHOL, V22, P147, DOI 10.3147/jsfp.22.147; KARIN M, 1990, TRENDS GENET, V6, P92, DOI 10.1016/0168-9525(90)90100-K; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; LORETZ CA, 1982, NEUROENDOCRINOLOGY, V35, P292, DOI 10.1159/000123397; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; MCCORMICK A, 1991, GENE DEV, V5, P1490, DOI 10.1101/gad.5.8.1490; NATHAN LC, 1989, FISH PHYSIOL BIOCHEM, V7, P315; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; OGASAWARA T, 1989, FISH PHYSIOL BIOCHEM, V7, P309, DOI 10.1007/BF00004722; ONO M, 1990, P NATL ACAD SCI USA, V87, P4330, DOI 10.1073/pnas.87.11.4330; PRUNET P, 1989, GEN COMP ENDOCR, V74, P355, DOI 10.1016/S0016-6480(89)80031-0; SAKAMOTO T, 1991, GEN COMP ENDOCR, V82, P184, DOI 10.1016/0016-6480(91)90182-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO N, 1988, BIOCHIM BIOPHYS ACTA, V949, P35, DOI 10.1016/0167-4781(88)90051-6; SEKINE S, 1985, P NATL ACAD SCI USA, V82, P4306, DOI 10.1073/pnas.82.13.4306; TAKAYAMA Y, 1991, MOL ENDOCRINOL, V5, P778, DOI 10.1210/mend-5-6-778; TAKAYAMA Y, 1991, GEN COMP ENDOCR, V83, P366, DOI 10.1016/0016-6480(91)90141-R; THEILL LE, 1992, EMBO J, V11, P2261, DOI 10.1002/j.1460-2075.1992.tb05285.x; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; YAMASHITA S, 1992, P NATL ACAD SCI USA, V89, P2839, DOI 10.1073/pnas.89.7.2839	32	79	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24361	24366						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226986				2022-12-27	WOS:A1993MF29400096
J	ALLEN, RM; HOMER, MJ; CHATTERJEE, R; LUDDEN, PW; ROBERTS, GP; SHAH, VK				ALLEN, RM; HOMER, MJ; CHATTERJEE, R; LUDDEN, PW; ROBERTS, GP; SHAH, VK			DINITROGENASE REDUCTASE-DEPENDENT AND MGATP-DEPENDENT MATURATION OF APODINITROGENASE FROM AZOTOBACTER-VINELANDII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-MOLYBDENUM COFACTOR; KLEBSIELLA-PNEUMONIAE; MOFE PROTEIN; NITROGENASE; GENE; PURIFICATION; MUTANTS; NIFB	The requirements for iron-molybdenum cofactor (FeMo-co) activation of apodinitrogenase from Azotobacter vinelandii strain UW97, which lacks dinitrogenase reductase activity as,assayed by substrate reduction, have been examined. Activation of apodinitrogenase from strain UW97 by FeMo-co requires the addition of both dinitrogenase reductase and MgATP. When the same apodinitrogenase is pretreated with dinitrogenase reductase and MgATP and then partially purified, however, it does not require these components for activation by FeMo-co. This suggests that dinitrogenase reductase and MgATP are involved in processing apodinitrogenase to a FeMo-co activatable form. This processing step coincides with a change in the subunit composition of apodinitrogenase from alpha2beta2 to a form with an additional subunit (gamma) attached. The apodinitrogenase with the associated gamma subunit is apparently the form of the protein that is competent for activation by FeMo-co.	UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,MADISON,WI 53706; UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BACTERIOL,MADISON,WI 53706; UNIV WISCONSIN,COLL AGR & LIFE SCI,CTR STUDY NITROGEN FIXAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NIGMS NIH HHS [GM 35332] Funding Source: Medline; PHS HHS [T326M07215] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035332, R37GM035332] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P797; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; GAVINI N, 1992, J BIOL CHEM, V267, P21179; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; LJONES T, 1978, BIOCHEMISTRY-US, V17, P1866, DOI 10.1021/bi00603a010; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; ROBINSON AC, 1989, J BIOL CHEM, V264, P10088; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; Shah V. K., 1988, Nitrogen fixation: Hundred years after. Proceedings of the 7th International Congress on Nitrogen Fixation, Koln (Cologne), FRG, March 13-20, 1988., P115; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1986, P NATL ACAD SCI USA, V83, P1636, DOI 10.1073/pnas.83.6.1636; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V292, P246, DOI 10.1016/0005-2728(73)90269-7; SHAH VK, 1985, J BIOL CHEM, V260, P3891; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAL S, 1991, J BIOL CHEM, V266, P10654; WHITE TC, 1992, J BIOL CHEM, V267, P24007; WOLLE D, 1992, SCIENCE, V258, P992, DOI 10.1126/science.1359643	25	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23670	23674						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226893				2022-12-27	WOS:A1993MF51500107
J	WHITING, JF; NARCISO, JP; CHAPMAN, V; RANSIL, BJ; SWANK, RT; GOLLAN, JL				WHITING, JF; NARCISO, JP; CHAPMAN, V; RANSIL, BJ; SWANK, RT; GOLLAN, JL			DECONJUGATION OF BILIRUBIN-IX-ALPHA GLUCURONIDES - A PHYSIOLOGICAL-ROLE OF HEPATIC-MICROSOMAL BETA-GLUCURONIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONJUGATED BILIRUBIN; NATIVE BILE; UDP-GLUCURONYLTRANSFERASE; RAT; EGASYN; MONOGLUCURONIDE; CHOLELITHIASIS; DIGLUCURONIDE; HYDROLYSIS; GALLSTONES	Beta-glucuronidase is an acid hydrolase located in both the lysosomal and microsomal compartments of the hepatocyte. The function of the latter remains undefined. We postulated that microsomal beta-glucuronidase may be responsible for the deconjugation of bilirubin-IXalpha glucuronides which are synthesized primarily in the hepatic microsomal compartment. We utilized two unique congenic strains of mice to characterize the role of hepatic beta-glucuronidase in the metabolism and disposition of bilirubin-IXalpha; the first exhibited less than 1% of total hepatic beta-glucuronidase activity (ATM), the second lacked only the microsomal enzyme activity (AT1). The biliary excretion of bilirubin-IXalpha conjugates was quantitated using reverse-phase high performance liquid chromatography. Under basal conditions, there was a 2-fold increase in the biliary excretion of bilirubin-IXalpha monoglucuronides and total glucuronides in the AT1 and ATM mutants compared to the normal controls. When the plasma bilirubin-IXalpha level was increased to almost-equal-to 7 mg/dl to simulate hyperbilirubinemia, by intravenous administration of [C-14]bilirubin-IXalpha, mathematical modeling of the biliary excretion curves of bilirubin-IXalpha glucuronides revealed qualitative differences between control and mutant animals, whereas both mutant groups were similar. Collectively, these data demonstrate that microsomal beta-glucuronidase modulates the net rate of bilirubin-IXalpha glucuronidation and glucuronide excretion in bile, under both basal and hyperbilirubinemic conditions, and that lysosomal beta-glucuronidase has no such effects. Hepatic microsomal beta-glucuronidase appears likely to influence the biliary excretion and hence the hepatic elimination of endogenous and xenobiotic substrates (e.g. carcinogens) which undergo hepatic glucuronidation.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, DIV GASTROENTEROL,75 FRANCIS ST, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT SURG, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, CHARLES A DANA RES INST, BOSTON, MA 02215 USA; BETH ISRAEL HOSP, DEPT MED, HARVARD THORNDIKE LAB, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; ROSWELL PK CANC INST, BUFFALO, NY 14214 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Roswell Park Cancer Institute					NIDDK NIH HHS [DK-36887] Funding Source: Medline; NIGMS NIH HHS [GM07806] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036887] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BILLING BH, 1964, CLIN SCI, V27, P245; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BLANCKAERT N, 1980, BIOCHEM J, V185, P115, DOI 10.1042/bj1850115; BOONYAPISIT ST, 1978, GASTROENTEROLOGY, V74, P70; BRANDT EJ, 1975, J CELL BIOL, V67, P776; BROWN J, 1987, J CELL BIOL, V105, P1571, DOI 10.1083/jcb.105.4.1571; Burchell Brain, 1993, P489; CRAWFORD JM, 1992, J BIOL CHEM, V267, P16943; CRAWFORD JM, 1987, J CLIN INVEST, V79, P1171; CUYPERS HTM, 1984, HEPATOLOGY, V4, P918, DOI 10.1002/hep.1840040522; DWIVEDI C, 1987, FASEB J, V1, P303, DOI 10.1096/fasebj.1.4.3115856; GOLLAN J, 1981, J CLIN INVEST, V67, P1003, DOI 10.1172/JCI110111; GOURLEY GR, 1985, HEPATOLOGY, V5, P610, DOI 10.1002/hep.1840050415; HAUSER SC, 1984, J BIOL CHEM, V259, P4527; HAUSER SC, 1992, LIVER BILIARY DISEAS, P317; HO KJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P197, DOI 10.1016/0167-4838(85)90203-1; LARUSSO NF, 1979, J CLIN INVEST, V64, P948, DOI 10.1172/JCI109561; LILIENBLUM W, 1984, BIOCHEM PHARMACOL, V33, P2041, DOI 10.1016/0006-2952(84)90571-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUSIAS AJ, 1977, ISOZYMES CURRENT TOP, P63; MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010; MASUDA H, 1979, J LAB CLIN MED, V93, P353; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; MCDONAGH AF, 1971, FEBS LETT, V18, P315, DOI 10.1016/0014-5793(71)80475-1; MEDDA S, 1987, J BIOL CHEM, V262, P7248; MEDDA S, 1987, CELL, V50, P301, DOI 10.1016/0092-8674(87)90225-X; MYANT NB, 1961, J LIPID RES, V2, P363; OSTROW JD, 1961, J CLIN INVEST, V40, P1442, DOI 10.1172/JCI104375; PFISTER K, 1985, J BIOL CHEM, V260, P1588; SKUDLAREK MD, 1984, LYSOSOM BIOL PATHOL, P17; SPIVAK W, 1987, BIOCHEM J, V242, P323, DOI 10.1042/bj2420323; SPIVAK W, 1985, BIOCHEM J, V225, P787, DOI 10.1042/bj2250787; SPIVAK W, 1986, BIOCHEM J, V234, P101, DOI 10.1042/bj2340101; TALALAY PAUL, 1960, METHODS BIOCHEM ANAL, V8, P119; TROTMAN BW, 1981, GASTROENTEROLOGY, V81, P232; WALASZEK Z, 1984, CARCINOGENESIS, V5, P767, DOI 10.1093/carcin/5.6.767; WINCH J, 1969, GUT, V10, P954	37	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23197	23201						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226839				2022-12-27	WOS:A1993MF51500040
J	NEGISHI, M; NAMBA, T; SUGIMOTO, Y; IRIE, A; KATADA, T; NARUMIYA, S; ICHIKAWA, A				NEGISHI, M; NAMBA, T; SUGIMOTO, Y; IRIE, A; KATADA, T; NARUMIYA, S; ICHIKAWA, A			OPPOSITE COUPLING OF PROSTAGLANDIN-E RECEPTOR EP(3C) WITH G(S) AND G(0) - STIMULATION OF G(S) AND INHIBITION OF G(0)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING PROTEIN; ADENYLATE-CYCLASE; PERTUSSIS-TOXIN; RAT; G0; RECONSTITUTION; VESICLES	We recently identified four isoforms of bovine prostaglandin E receptor EP3 subtype, which are coupled to different signaling pathways; EP3A is coupled to inhibition of adenylate cyclase, while EP3B and EP3C are coupled to its stimulation and EP3D is coupled to phosphatidylinositol turnover, in addition to the adenylate cyclase system (Namba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, Ito, S., A., Ichikawa, A., and Narumiya, S. (1993) Nature 365, 166-170). We examined here the identity of coupled G proteins and their regulation by one of the isoforms, EP3C, in the membranes of EP3C cDNA-transfected Chinese hamster ovary cells. M&B 28767, an EP3 agonist, stimulated the GTPase activity in the pertussis toxin (PT)-treated cell membrane, but inhibited it in the cholera toxin (CT)-treated cell membrane, while the agonist neither stimulated nor inhibited it in the both PT- and CT-treated cell membrane. In the PT- and CT-treated cell membrane reconstituted with various G proteins, M&B 28767 inhibited the GTPase activity of G(o), but stimulated that of G(s). On the other hand, M&B 28767 did not affect the GTPase activity of G(i1), G(i2), or G(i3). M&B 28767 increased the apparent affinity of G(o) for GDP without any change in that for GTP, as assessed by displacement of [S-35]GTPgammaS (guanosine 5'-O-(3-thiotriphosphate)) binding to G(o). In contrast, M&B 28767 increased the apparent affinity of G(s) for GTP but decreased that for GDP. These results demonstrated that the EP3 receptor isoform is coupled to two different G proteins, and oppositely regulates their activities, inhibition of G(o), and stimulation of G(s).	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,SAKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,TOKYO 113,JAPAN	University of Tokyo; Kyoto University; University of Tokyo			Sugimoto, Yukihiko/AAV-6470-2021	Sugimoto, Yukihiko/0000-0001-6973-932X				ASANO T, 1984, BIOCHEMISTRY-US, V23, P5460, DOI 10.1021/bi00318a013; ASANO T, 1988, J NEUROCHEM, V50, P1164, DOI 10.1111/j.1471-4159.1988.tb10588.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT DR, 1986, J BIOL CHEM, V261, P1656; COLEMAN R A, 1987, British Journal of Pharmacology, V91, p407P; COLEMAN RA, 1989, COMPREHENSIVE MED CH, V3, P643; EDET S, 1990, J PHARMACOL EXP THER, V255, P11; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; KATADA T, 1986, J BIOL CHEM, V261, P8182; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KRALL JF, 1984, J ENDOCRINOL, V102, P329, DOI 10.1677/joe.0.1020329; LAW SF, 1993, J BIOL CHEM, V268, P10721; MONCADA S, 1985, PHARMACOL BASIS THER, P660; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V161, P1280, DOI 10.1016/0006-291X(89)91381-8; MULLANEY I, 1993, BIOCHEM J, V289, P125, DOI 10.1042/bj2890125; NAKAO A, 1989, AM J PHYSIOL, V256, pC652, DOI 10.1152/ajpcell.1989.256.3.C652; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SHIOZAKI K, 1992, BIOCHEMISTRY-US, V31, P10634, DOI 10.1021/bi00158a028; TANAKA T, 1990, J NEUROCHEM, V54, P86, DOI 10.1111/j.1471-4159.1990.tb13286.x; UEDA H, 1990, FEBS LETT, V266, P178, DOI 10.1016/0014-5793(90)81534-U	25	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26067	26070						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253719				2022-12-27	WOS:A1993MK42500010
J	TATHAM, AS; FIELD, JM; MORRIS, VJ; IANSON, KJ; CARDLE, L; DUFTON, MJ; SHEWRY, PR				TATHAM, AS; FIELD, JM; MORRIS, VJ; IANSON, KJ; CARDLE, L; DUFTON, MJ; SHEWRY, PR			SOLUTION CONFORMATIONAL-ANALYSIS OF THE ALPHA-ZEIN PROTEINS OF MAIZE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; CIRCULAR-DICHROISM; SEQUENCE-ANALYSIS; PREDICTIONS; REVEALS; SUBUNIT; GLUTEN	Small angle x-ray scattering and viscometric analyses of the alpha-zeins of maize in solution indicated that the molecules were asymmetric. Structure predictions of consensus sequences for the two classes of alpha-zeins, Z19 and Z22, were in good agreement with the alpha-helical contents determined by circular dichroism. Dimensions determined by small angle x-ray scattering and viscometry indicated a predominantly alpha-helical conformation. The data are discussed in relation to models for the solution conformation and to earlier models for alpha-zeins structure.	ZENECA SEEDS UK LTD, CTR PLANT BREEDING & RES, NORFOLK PE31 8LS, ENGLAND; INST FOOD RES, NORWICH LAB, NORWICH NR4 7UA, NORFOLK, ENGLAND; UNIV STRATHCLYDE, DEPT PURE & APPL CHEM, GLASGOW G1 1XL, SCOTLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Strathclyde	TATHAM, AS (corresponding author), UNIV BRISTOL, LONG ASHTON RES STN, DEPT AGR SCI, AFRC, INST ARABLE CROPS RES, BRISTOL BS18 9AF, AVON, ENGLAND.			Milne, Linda/0000-0002-1798-8022; Tatham, Arthur/0000-0001-5080-5585				ARGOS P, 1982, J BIOL CHEM, V257, P9984; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CLARK DC, 1989, J AGR FOOD CHEM, V37, P627, DOI 10.1021/jf00087a011; CONIO G, 1970, J BIOL CHEM, V245, P3355; DANZER LA, 1975, BIOCHIM BIOPHYS ACTA, V386, P26, DOI 10.1016/0005-2795(75)90242-1; DIFONZO N, 1991, PLANT MOL BIOL, V2, P627; DUFTON MJ, 1977, J MOL BIOL, V115, P177, DOI 10.1016/0022-2836(77)90095-X; Elliott MA, 1939, J AM CHEM SOC, V61, P718, DOI 10.1021/ja01872a051; ESEN A, 1990, J PROTEIN CHEM, V9, P453, DOI 10.1007/BF01024621; FIELD JM, 1987, BIOCHEM J, V247, P215, DOI 10.1042/bj2470215; FOSTER JF, 1945, J AM CHEM SOC, V67, P617, DOI 10.1021/ja01220a034; GARRATT R, 1993, PROTEINS, V15, P88, DOI 10.1002/prot.340150111; Gianazza E., 1976, Maydica, V21, P1; Gortner Ross Aiken, 1944, CEREAL CHEM, V21, P324; HEIDECKER G, 1991, GENOMICS, V10, P719, DOI 10.1016/0888-7543(91)90456-O; KRETSCHMER CB, 1957, J PHYS CHEM-US, V61, P1627, DOI 10.1021/j150558a014; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; MARKS MD, 1985, J BIOL CHEM, V260, P6451; MATSUSHIMA N, 1992, BIOCHEM BIOPH RES CO, V186, P1057, DOI 10.1016/0006-291X(92)90854-E; MEHL J. W., 1940, SCIENCE, V92, P132, DOI 10.1126/science.92.2380.132; MILES MJ, 1991, P NATL ACAD SCI USA, V88, P68, DOI 10.1073/pnas.88.1.68; MULLER K, 1985, SMALL ANGLE XRAY SCA, P215; NUCCA R, 1978, MAYDICA, V23, P239; ONCLEY JL, 1949, J PHYS COLLOID CHEM, V53, P162, DOI 10.1021/j150466a013; PEZOLET M, 1992, FEBS LETT, V299, P247, DOI 10.1016/0014-5793(92)80125-Z; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rubenstein I., 1986, Advances in Cereal Science and Technology, V8, P297; Simha R, 1940, J PHYS CHEM-US, V44, P25, DOI 10.1021/j150397a004; THOMPSON GA, 1992, PLANT MOL BIOL, V18, P827, DOI 10.1007/BF00020030; THOMSON NH, 1992, ULTRAMICROSCOPY, V42, P1204, DOI 10.1016/0304-3991(92)90425-J; Watson C C, 1936, NATURE, V137, P322; WILLIAMS JW, 1938, COLD SPRING HARB SYM, V6, P208; WILSON CM, 1985, CEREAL CHEM, V62, P361; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; WU YV, 1983, CEREAL CHEM, V60, P342; Wyman J, 1931, J BIOL CHEM, V90, P443	36	81	86	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26253	26259						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253747				2022-12-27	WOS:A1993MK42500039
J	KLOSE, M; STORIKO, A; STIERHOF, YD; HINDENNACH, I; MUTSCHLER, B; HENNING, U				KLOSE, M; STORIKO, A; STIERHOF, YD; HINDENNACH, I; MUTSCHLER, B; HENNING, U			MEMBRANE ASSEMBLY OF THE OUTER-MEMBRANE PROTEIN OMPA OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ENVELOPE MEMBRANE; BACTERIOPHAGE RECEPTOR; RHODOBACTER-CAPSULATUS; TRANSLATIONAL CONTROL; PORIN OVEREXPRESSION; ELECTRON-MICROSCOPY; MAJOR PROTEINS; II-STAR; K-12; EXPORT	The membrane part (residues 1 to approximately 170) of the 325-residue Escherichia coli outer membrane protein OmpA is thought to exist in the membrane as an 8-stranded beta-barrel, subdividing this part into four segments. The influence of proline residues on membrane assembly of the protein has been studied. These were introduced, using site-directed mutagenesis, into each of seven of the antiparallel beta-strands. One important parameter for allowing or not allowing membrane assembly was the potential H(beta)(i) which is the potential to form an amphiphilic beta-strand. When H(beta)(i) remained unaltered, 2 prolines were tolerated. Lowering H(beta)(i) in most cases caused failure of assembly when 2 such residues were present. An insert of 10 residues, including 3 prolines, did not alter H(beta)(i) and was tolerated, but caused ''looping out'' of the strand to the outer face of the membrane; displacement to its inner side would not have allowed for an amphiphilic beta-strand. Thus, a beta-structured protein is as adaptable as it has been shown for an alpha-helix. The wild type segment order 1-2-3-4 has been changed to 1-3-3-4 and 1-4-3-4. Since the proteins were found associated with the outer membrane but could not be incorporated into it, it appears that sorting is less sensitive to alterations than assembly. A regulatory circuit was affected (missense mutants of outer membrane proteins can cause inhibition of synthesis of other such proteins); expression of the two rearranged genes effected a strong inhibition of synthesis of the unrelated porins OmpC and F as well as that of the maltoporin LamB and wild type OmpA. Hence, outer membrane proteins are designed not only for efficient membrane assembly but also for proper regulation of their synthesis.	MAX PLANCK INST BIOL,D-72076 TUBINGEN,GERMANY	Max Planck Society								BECK E, 1980, NUCLEIC ACIDS RES, V8, P3011, DOI 10.1093/nar/8.13.3011; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; CARLEMALM E, 1982, J MICROSC-OXFORD, V126, P123, DOI 10.1111/j.1365-2818.1982.tb00362.x; CATRON KM, 1987, J BACTERIOL, V169, P4237; CHEN R, 1980, P NATL ACAD SCI-BIOL, V77, P4592, DOI 10.1073/pnas.77.8.4592; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CLICK EM, 1989, J BACTERIOL, V171, P616, DOI 10.1128/jb.171.1.616-619.1989; CLICK EM, 1988, J BACTERIOL, V170, P2005, DOI 10.1128/jb.170.5.2005-2011.1988; COLE ST, 1983, J BACTERIOL, V153, P581, DOI 10.1128/JB.153.2.581-587.1983; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DATTA DB, 1977, J BACTERIOL, V131, P821, DOI 10.1128/JB.131.3.821-829.1977; DORNMAIR K, 1990, J BIOL CHEM, V265, P18907; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; FREUDL R, 1986, J BIOL CHEM, V261, P1355; FREUDL R, 1985, EMBO J, V4, P3593, DOI 10.1002/j.1460-2075.1985.tb04122.x; FREUDL R, 1989, GENE, V82, P229, DOI 10.1016/0378-1119(89)90048-6; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; HELLER KB, 1978, J BACTERIOL, V134, P1181, DOI 10.1128/JB.134.3.1181-1183.1978; JAHNIG F, 1990, TRENDS BIOCHEM SCI, V15, P93, DOI 10.1016/0968-0004(90)90188-H; JAHNIG F, 1989, PREDICTION PROTEIN S, P707; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; KLOSE M, 1989, J BIOL CHEM, V264, P21842; KLOSE M, 1988, J BIOL CHEM, V263, P13291; KLOSE M, 1988, J BIOL CHEM, V263, P13297; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACINTYRE S, 1991, MOL GEN GENET, V227, P224; MACINTYRE S, 1987, J BIOL CHEM, V262, P8416; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; Miller J.H., 1972, EXPT MOL GENETICS; MIZUNO T, 1983, J BIOL CHEM, V258, P6932; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; MORONA R, 1982, J BACTERIOL, V150, P1016, DOI 10.1128/JB.150.3.1016-1023.1982; MORONA R, 1985, J BACTERIOL, V164, P539, DOI 10.1128/JB.164.2.539-543.1985; MORONA R, 1985, EUR J BIOCHEM, V150, P161, DOI 10.1111/j.1432-1033.1985.tb09002.x; MOVVA NR, 1980, J MOL BIOL, V143, P317, DOI 10.1016/0022-2836(80)90193-X; PAUL C, 1985, EMBO J, V4, P1593, DOI 10.1002/j.1460-2075.1985.tb03822.x; RIED G, 1990, J MOL BIOL, V216, P39, DOI 10.1016/S0022-2836(05)80059-2; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; SARSERO JP, 1991, J BACTERIOL, V173, P3231, DOI 10.1128/JB.173.10.3231-3234.1991; SAUER UH, 1992, J BIOL CHEM, V267, P2393; SCHILTZ E, 1991, EUR J BIOCHEM, V199, P587, DOI 10.1111/j.1432-1033.1991.tb16158.x; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WARNER HR, 1978, NATURE, V272, P32, DOI 10.1038/272032a0; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2; YANISCHPERRON Y, 1985, GENE, V38, P103	56	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25664	25670						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245002				2022-12-27	WOS:A1993MK10000057
J	KNEZEVIC, I; BORG, C; LEBRETON, GC				KNEZEVIC, I; BORG, C; LEBRETON, GC			IDENTIFICATION OF G(Q) AS ONE OF THE G-PROTEINS WHICH COPURIFY WITH HUMAN PLATELET THROMBOXANE-A(2) PROSTAGLANDIN-H(2) RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-PROTEIN; STIMULATE PHOSPHOLIPASE-C; ALPHA-SUBUNITS; REGULATORY PROTEINS; POLYACRYLAMIDE GELS; BETA-1 ISOZYME; PURIFICATION; ACTIVATION; MEMBRANES; MECHANISM	The present study employed ligand affinity and immunoaffinity chromatography to isolate human platelet thromboxane A2/prostaglandin H-2 (TXA2/PGH2) receptor-coupled G-proteins. Purification of TXA2/PGH2 receptors by ligand (SQ31,491)-affinity chromatography resulted in the elution of receptor binding and GTPase activity in the same fraction. GTPase activity of this fraction was enriched (6-fold) relative to solubilized platelet membranes, was stimulated (65%) by 500 nM U46619, and was blocked (74%) by 250 nM SQ29,548. Furthermore, GTP (100 muM) increased [H-3]SQ29,548 receptor binding by 48%. Immunoblotting of this fraction against QL antiserum identified a 42-kDa protein as a member of the G(q) family. In separate experiments, TXA2/PGH2 receptors were purified by immunoaffinity chromatography using P1Ab, P2Ab, and TxAb affinity columns. QL-immunoreactive proteins at 42 kDa were found in all three column eluates. Studies using G(alpha,common) antiserum (GA/1) demonstrated immunoblotting of two proteins of approximately 42 and 85 kDa in both the ligand and P2Ab affinity column fractions. On the other hand, the P1Ab and TxAb affinity column eluates contained GA/1 immunoreactivity only in the 42 kDa region. Collectively, these data identify G(q) as a TXA2/PGH2 receptor-coupled G-protein and suggest the association of this receptor with additional G(alpha) subunits.	UNIV ILLINOIS,DEPT PHARMACOL MC 868,835 S WOLCOTT AVE,CHICAGO,IL 60680	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024530] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-24530] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVDONIN PV, 1985, THROMB RES, V40, P101, DOI 10.1016/0049-3848(85)90354-8; BLANK JL, 1991, J BIOL CHEM, V266, P18206; BORG C, 1993, BIOCHEM PHARMACOL, V45, P2071, DOI 10.1016/0006-2952(93)90018-R; BORG C, 1993, FASEB J, V7, P656; BORG C, 1992, BLOOD, V80, P217; BRACE LD, 1985, PROSTAGLANDINS LEUKO, P333; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASS LF, 1988, J BIOL CHEM, V263, P5348; BRASS LF, 1987, J CLIN INVEST, V79, P1269, DOI 10.1172/JCI112947; BROWN AM, 1991, FASEB J, V5, P2175, DOI 10.1096/fasebj.5.8.1708737; FITZGERALD GA, 1987, FASEB J, V46, P154; GOLDSMITH P, 1988, J BIOL CHEM, V263, P6476; GRESELE P, 1984, LANCET, V1, P991; HALUSHKA PV, 1988, CELLULAR MOL ASPECTS, P335; HOUSLAY MD, 1986, BIOCHEM J, V234, P737, DOI 10.1042/bj2340737; IM MJ, 1990, J BIOL CHEM, V265, P18944; KAWAHARA Y, 1986, THROMB RES, V41, P811, DOI 10.1016/0049-3848(86)90379-8; KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313; KNEZEVIC I, 1992, J PHARMACOL EXP THER, V260, P947; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBRETON GC, 1979, P NATL ACAD SCI USA, V76, P4097; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MUNSHI R, 1989, J BIOL CHEM, V264, P14853; MURRAY R, 1989, P NATL ACAD SCI USA, V86, P124, DOI 10.1073/pnas.86.1.124; NAKAHATA N, 1989, EUR J PHARMACOL, V162, P407, DOI 10.1016/0014-2999(89)90331-2; PANG IH, 1990, J BIOL CHEM, V265, P18707; POLLOCK WK, 1984, BIOCHEM J, V219, P833, DOI 10.1042/bj2190833; RYBICKI JP, 1983, BIOCHIM BIOPHYS ACTA, V751, P66, DOI 10.1016/0005-2760(83)90257-6; SENOGLES SE, 1987, J BIOL CHEM, V262, P4860; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIESS W, 1985, BLOOD, V65, P1141; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SUGANUMA A, 1992, THROMB HAEMOSTASIS, V68, P341; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; TAYLOR SJ, 1991, FEBS LETT, V286, P214, DOI 10.1016/0014-5793(91)80976-A; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALDO GL, 1991, J BIOL CHEM, V266, P14217; WU KK, 1981, J CLIN INVEST, V67, P1801, DOI 10.1172/JCI110221; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	40	101	102	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					26011	26017						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245033				2022-12-27	WOS:A1993MK10000102
J	MARKLUND, U; BRATTSAND, G; OSTERMAN, O; OHLSSON, PI; GULLBERG, M				MARKLUND, U; BRATTSAND, G; OSTERMAN, O; OHLSSON, PI; GULLBERG, M			MULTIPLE SIGNAL-TRANSDUCTION PATHWAYS INDUCE PHOSPHORYLATION OF SERINE-16, SERINE-25, AND SERINE-38 OF ONCOPROTEIN-18 IN T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL ANTIGEN RECEPTOR; NEURON-ENRICHED PHOSPHOPROTEIN; TYROSINE PHOSPHORYLATION; MAP KINASE; DEPENDENT PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-1; RAPID PHOSPHORYLATION; MONOCLONAL-ANTIBODY; DOWN-REGULATION	A multitude of external signals induce extensive phosphorylation of Oncoprotein 18 (Op18), which suggests a putative role for this protein in signal transduction. We have recently identified two distinct proline-directed kinase families that phosphorylates Op18 with overlapping but distinct site preference. These two kinase families, mitogen-activated protein (MAP) kinases and cyclin-dependent cdc2 kinases, are involved in receptor- and cell cycle-regulated phosphorylation events, respectively. In the present study, site-specific phosphorylation of Op18 in response to stimulation of the antigen receptor-associated CD3 complex was analyzed in the Jurkat T cell-line. The results show that CD3-induced phosphorylation of Ser-25 of Op18, which is the primary MAP kinase phosphorylation site, can be induced by an apparently protein kinase C (PKC)-independent signal transduction pathway. We also demonstrate that Ser-16 of Op18 is specifically phosphorylated in response to the Ca2+ signal generated by CD3 stimulation or by the Ca2+ ionophore ionomycin. Ser-16 phosphorylation occurs independently of both PKC and MAP kinase activation. Using site-specific Op18 mutants and tryptic phosphopeptide mapping, we show that phosphorylation of Ser-16 of Op18 together with Ser-25, or Ser-25 and Ser-38, generates two Op18 phosphoisomers showing a dramatic electrophoretic retardation. In conclusion, site-mapping studies of Op18 reveal that CD3 stimulation results in an apparently PKC-independent activation of both the MAP kinase and a Ca2+-regulated kinase pathway, which results in phosphorylation of distinct sites of Op18. The data also pinpoints the specific phosphorylation events that result in electrophoretic retardation of Op18.	UMEA UNIV,DEPT CELL & MOLEC BIOL,S-90187 UMEA,SWEDEN; UMEA UNIV,DEPT PHYSIOL CHEM,S-90187 UMEA,SWEDEN	Umea University; Umea University				Gullberg, Martin/0000-0002-3984-4572				Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRATTSAND G, 1993, LEUKEMIA, V7, P569; CANTRELL DA, 1989, J IMMUNOL, V142, P1626; CAO TO, 1992, J BIOL CHEM, V267, P19876; CHNEIWEISS H, 1989, J NEUROCHEM, V53, P856, DOI 10.1111/j.1471-4159.1989.tb11783.x; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COOPER HL, 1991, J IMMUNOL, V146, P3689; CREWS CM, 1992, CELL GROWTH DIFFER, V3, P135; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DASGUPTA JD, 1992, J EXP MED, V175, P285, DOI 10.1084/jem.175.1.285; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DOYE V, 1992, DIFFERENTIATION, V50, P89, DOI 10.1111/j.1432-0436.1992.tb00489.x; DOYE V, 1989, J BIOL CHEM, V264, P12134; DOYE V, 1990, J BIOL CHEM, V265, P11650; FRIEDRICH B, 1988, IMMUNOBIOLOGY, V176, P465, DOI 10.1016/S0171-2985(88)80027-5; GRATIOTDEANS J, 1992, J CLIN INVEST, V90, P1576, DOI 10.1172/JCI116026; GRAVES JD, 1992, J IMMUNOL, V148, P2417; GULLBERG M, 1990, J BIOL CHEM, V265, P17499; HAILAT N, 1990, ONCOGENE, V5, P1615; HANASH SM, 1988, J BIOL CHEM, V263, P12813; HANEKOM C, 1989, BIOCHEM J, V262, P449, DOI 10.1042/bj2620449; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHI M, 1989, EUR J BIOCHEM, V184, P477, DOI 10.1111/j.1432-1033.1989.tb15040.x; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Maniatis T, 1989, DECONTAMINATION DILU; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; MELHEM RF, 1991, BIOCHEM BIOPH RES CO, V179, P1649, DOI 10.1016/0006-291X(91)91764-4; MELHEM RF, 1991, J BIOL CHEM, V266, P17747; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; NEL AE, 1990, J IMMUNOL, V144, P2683; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PASMANTIER R, 1986, ENDOCRINOLOGY, V199, P1229; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHUBART UK, 1989, DNA-J MOLEC CELL BIO, V8, P389, DOI 10.1089/dna.1.1989.8.389; SCHUBART UK, 1987, J BIOL CHEM, V262, P11871; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SOBEL A, 1989, J BIOL CHEM, V264, P3765; STRAHLER JR, 1992, J IMMUNOL, V149, P1191; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHU XX, 1989, J BIOL CHEM, V264, P14556	62	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25671	25680						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245003				2022-12-27	WOS:A1993MK10000058
J	LAWRENCE, DL; ENGELSBERG, BN; FARID, RS; HUGHES, EN; BILLINGS, PC				LAWRENCE, DL; ENGELSBERG, BN; FARID, RS; HUGHES, EN; BILLINGS, PC			LOCALIZATION OF THE BINDING REGION OF HIGH-MOBILITY GROUP PROTEIN-2 TO CISPLATIN-DAMAGED DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-DETERMINING REGION; TRANSCRIPTION FACTOR; OVARIAN-CANCER; ALPHA-ENHANCER; GENE; CIS-DIAMMINEDICHLOROPLATINUM(II); CHEMOTHERAPY; RESISTANCE; HOMOLOGY; SEQUENCE	Cisplatin (CDDP) is an effective cancer chemotherapeutic drug used in the treatment of several human malignancies. The effectiveness of cisplatin therapy is limited by intrinsic resistance of tumors to this drug as well as the development of secondary tumors, which are also drug resistant. A potential mechanism influencing the sensitivity of cells to CDDP may result from the interaction of specific proteins with CDDP-damaged DNA (CDDP-DNA). In an earlier report, we demonstrated that high mobility group (HMG) proteins 1 and 2 bind with high affinity to CDDP-DNA. In the present study partial proteolytic digestion was used to localize the binding region of HMG2. A proteolytic fragment of approximately 20 kDa, containing the amino-terminal region of the protein, maintains the ability to bind with high affinity to CDDP-DNA, while an amino-terminal fragment of 14 kDa binds with slightly reduced affinity. In contrast, a peptide fragment lacking 51 NH2-terminal amino acids from HMG2 has greatly reduced affinity for damaged DNA. Recombinant peptide fragments containing HMG box-1 or HMG box 2 bind weakly to damaged DNA, while a recombinant fragment containing HMG boxes 1 and 2 binds with high affinity. Hence, our results indicate that the amino-terminal region of HMG2 contains the damaged DNA binding recognition site and that both HMG boxes 1 and 2, present in the parental molecule, are required for high affinity binding of this protein to CDDP-DNA.	UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104	University of Pennsylvania	LAWRENCE, DL (corresponding author), UNIV PENN,SCH MED,DEPT RADIAT ONCOL,PHILADELPHIA,PA 19104, USA.				NATIONAL CANCER INSTITUTE [R01CA058526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027309, R01GM027309] Funding Source: NIH RePORTER; NCI NIH HHS [CA58526] Funding Source: Medline; NIGMS NIH HHS [GM27309] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AISNER J, 1989, SEMIN ONCOL, V16, P2; ALBERTS DS, 1991, SEMIN ONCOL, V18, P11; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; BILLINGS PC, 1992, BIOCHEM BIOPH RES CO, V188, P1286, DOI 10.1016/0006-291X(92)91371-V; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CLUGSTON CK, 1992, CANCER RES, V52, P6375; DEWIT L, 1987, INT J RADIAT ONCOL, V13, P403, DOI 10.1016/0360-3016(87)90015-0; EINHORN LH, 1990, J CLIN ONCOL, V8, P1777, DOI 10.1200/JCO.1990.8.11.1777; Fojo A T, 1991, Adv Intern Med, V36, P195; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GOODWIN GH, 1975, BIOCHIM BIOPHYS ACTA, V405, P280, DOI 10.1016/0005-2795(75)90094-X; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HAYES JD, 1990, BIOCHEM J, V272, P281, DOI 10.1042/bj2720281; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JAVAHERIAN K, 1979, NUCLEIC ACIDS RES, V6, P3569, DOI 10.1093/nar/6.11.3569; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAJUMDAR A, 1991, NUCLEIC ACIDS RES, V19, P6643, DOI 10.1093/nar/19.23.6643; OZOLS RF, 1991, SEMIN ONCOL, V18, P222; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; PINTO A L, 1985, Biochimica et Biophysica Acta, V780, P167, DOI 10.1016/0304-419X(85)90001-0; RAGHAVAN D, 1991, SEMIN ONCOL, V18, P56; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SHIRAKATA M, 1991, MOL CELL BIOL, V11, P4528, DOI 10.1128/MCB.11.9.4528; SHIRAKAWA H, 1992, J BIOL CHEM, V267, P6641; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINGH J, 1990, BIOCHEMISTRY-US, V29, P6295, DOI 10.1021/bi00478a026; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; 1991, SEMIN ONCOL       S3, V18, P1	35	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23940	23945						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226934				2022-12-27	WOS:A1993MF29400037
J	SANFORD, JC; PAN, Y; WESSLINGRESNICK, M				SANFORD, JC; PAN, Y; WESSLINGRESNICK, M			PRENYLATION OF RAB5 IS DEPENDENT ON GUANINE-NUCLEOTIDE-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GTP-BINDING; PROTEIN FARNESYLTRANSFERASE; CYSTEINE MOTIFS; ALPHA-SUBUNIT; YEAST; ISOPRENYLATION; SELECTION; DISTINCT; INVITRO; P21RAS	Rab5 is a small molecular weight GTP-binding protein that functions in endocytic vesicle traffic. Like other Ras-related proteins, Rab5 is prenylated on C-terminal cysteine residues, although it lacks the typical C-terminal CAAX motif (where A is any aliphatic amino acid and X is any amino acid) to direct this post-translational modification. We have investigated structural requirements for the in vitro geranylgeranylation of Rab5. Rab5N133I, a point mutant that has impaired ability to bind GTP or GDP, undergoes modification to a limited extent and at a severely reduced rate when compared to cognate Rab5. A second point mutant, Rab5Q79L, can be processed to approximately the same extent as wild-type albeit at a reduced rate. Since the latter mutation results in defective GTPase activity, these combined observations indicate that guanine nucleotide binding plays an important role in the geranylgeranylation reaction and suggest that the GDP-bound form of Rab5 is the preferred conformation for interaction with Rab prenyltransferase. This idea is supported by the finding that non-hydrolyzable GTP analogs inhibit Rab5 prenylation, while in vitro processing of both H-ras and the gamma2 subunit of regulatory G proteins is unaffected at concentrations of guanosine 5'-O-(thiotriphosphate) (GTP-gammaS) up to 400 muM. Moreover, a truncation mutant lacking the C-terminal cysteines, Rab5(1-211), serves as an inhibitor of Rab5wt geranylgeranylation when liganded with GDP but not GTPgammaS. Thus, the recognition of Rab5 as a substrate by Rab prenyltransferase involves structural elements exclusive of the C terminus and dependent upon the GDP-binding conformation of the protein.			SANFORD, JC (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115, USA.				NIDDK NIH HHS [DK45737] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045737] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARMSTRONG SA, 1993, J BIOL CHEM, V268, P12221; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DER CJ, 1986, MOL CELL BIOL, V6, P3291, DOI 10.1128/MCB.6.9.3291; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; KHOSRAVIFAR R, 1992, J BIOL CHEM, V267, P24363; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MOORES SL, 1991, J BIOL CHEM, V266, P14603; PETER M, 1992, J CELL SCI, V102, P857; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; SANFORD J, 1991, J BIOL CHEM, V266, P9570; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; STRUHL K, 1983, GENE, V26, P231, DOI 10.1016/0378-1119(83)90193-2; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; WILSON AL, 1993, J BIOL CHEM, V268, P14561; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	24	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23773	23776						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226909				2022-12-27	WOS:A1993MF29400011
J	SHIMURA, H; IKUYAMA, S; SHIMURA, Y; KOHN, LD				SHIMURA, H; IKUYAMA, S; SHIMURA, Y; KOHN, LD			THE CAMP RESPONSE ELEMENT IN THE RAT THYROTROPIN RECEPTOR PROMOTER - REGULATION BY EACH DECANUCLEOTIDE OF A FLANKING TANDEM REPEAT USES DIFFERENT, ADDITIVE, AND NOVEL MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; GROWTH FACTOR-I; C-MYC GENE; H-DNA; TRANSCRIPTIONAL SILENCER; 5'-FLANKING REGION; EXPRESSION; ENHANCER; CELLS; IDENTIFICATION	A decanucleotide tandem repeat (TR) sequence, between -162 and -140 base pairs (bp) of the minimal thyrotropin receptor promoter, decreases gene expression by repressing constitutive enhancer activity of its cAMP response element (CRE). Each decanucleotide acts additively. CRE-binding proteins and liver or thyroid nuclear extracts footprint a region including the CRE and the 3' decanucleotide, -148 to -124 bp; nuclear proteins interacting with the 3' decanucleotide protect a smaller region, -148 to -135 bp. Separate groups of nuclear proteins interact with the CRE and the 3' decanucleotide; mutations of the CRE affect protein interactions with the 3' decanucleotide and the converse. Nuclear proteins bind to single- or double-stranded 3' decanucleotide DNA; those interacting with the CRE bind only double-stranded DNA. The repressor action of the 5' decanucleotide is associated with an interaction between the coding strand and a single-stranded binding protein in liver and thyroid nuclear extracts. The 5' decanucleotide is in a CT-rich region with Sl nuclease hypersensitivity, near perfect mirror images, and direct repeats. The data therefore indicate that each TR decanucleotide modulates CRE constitutive enhancer activity by different but additive mechanisms, competition versus interaction with a single-stranded binding protein, and each interacts with different nuclear proteins that are not thyroid-specific. The same region in the human thyrotropin receptor represses CRE constitutive enhancer activity by the same mechanisms, despite a nonidentical sequence and no overt TR.	NIDDKD,BIOCHEM & METAB LAB,CELL REGULAT SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								AKAMIZU T, 1990, P NATL ACAD SCI USA, V87, P5677, DOI 10.1073/pnas.87.15.5677; Ambesi Impiombato FS., 1986, United States Patent, Patent No. [US 4608341, 4608341]; Ambesi-Impiombato F S, 1979, Int Rev Cytol Suppl, P163; BANIAHMAD A, 1987, EMBO J, V6, P2297, DOI 10.1002/j.1460-2075.1987.tb02504.x; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; DAVIS LG, 1986, BASIC METHODS MOL BI, P93; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; EKHOLM R, 1989, ADV EXPT MED BIOL, V261, P1; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747, DOI 10.1128/MCB.12.2.747; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GROSS B, 1991, BIOCHEM BIOPH RES CO, V177, P679, DOI 10.1016/0006-291X(91)91842-Z; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HOEFFLER JP, 1991, MOL ENDOCRINOL, V5, P256, DOI 10.1210/mend-5-2-256; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; IKUYAMA S, 1992, MOL ENDOCRINOL, V6, P1701, DOI 10.1210/me.6.10.1701; IKUYAMA S, 1992, MOL ENDOCRINOL, V6, P793, DOI 10.1210/me.6.5.793; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; KINNIBURGH AJ, 1989, NUCLEIC ACIDS RES, V17, P7771, DOI 10.1093/nar/17.19.7771; KIYAMA R, 1991, P NATL ACAD SCI USA, V88, P10450, DOI 10.1073/pnas.88.23.10450; KOHWI Y, 1988, P NATL ACAD SCI USA, V85, P3781, DOI 10.1073/pnas.85.11.3781; KOLLURI R, 1992, NUCLEIC ACIDS RES, V20, P111, DOI 10.1093/nar/20.1.111; LAIMINS L, 1986, P NATL ACAD SCI USA, V83, P3151, DOI 10.1073/pnas.83.10.3151; LARSEN PR, 1986, P NATL ACAD SCI USA, V83, P8283, DOI 10.1073/pnas.83.21.8283; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; Maxam A M, 1980, Methods Enzymol, V65, P499; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; PESTOV DG, 1991, NUCLEIC ACIDS RES, V19, P6527, DOI 10.1093/nar/19.23.6527; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAJI M, 1991, BIOCHEM BIOPH RES CO, V176, P94, DOI 10.1016/0006-291X(91)90894-D; SAJI M, 1992, ENDOCRINOLOGY, V130, P520, DOI 10.1210/en.130.1.520; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; STROMSTEDT PE, 1991, MOL CELL BIOL, V11, P3379, DOI 10.1128/MCB.11.6.3379; TAKADA K, 1990, J CLIN INVEST, V86, P1548, DOI 10.1172/JCI114874; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TEWARI DS, 1989, J BIOL CHEM, V264, P16238; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WOLOSHIN PI, 1992, MOL ENDOCRINOL, V6, P1725, DOI 10.1210/me.6.10.1725	46	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24125	24137						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226959				2022-12-27	WOS:A1993MF29400063
J	GORFINKIEL, L; DIALLINAS, G; SCAZZOCCHIO, C				GORFINKIEL, L; DIALLINAS, G; SCAZZOCCHIO, C			SEQUENCE AND REGULATION OF THE UAPA GENE ENCODING A URIC ACID-XANTHINE PERMEASE IN THE FUNGUS ASPERGILLUS-NIDULANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE ZINC FINGER; INITIATOR CONSTITUTIVE MUTATION; NITROGEN METABOLITE REPRESSION; POSITIVELY CHARGED RESIDUES; DNA-BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PROLINE TRANSPORT; NEUROSPORA-CRASSA; MEMBRANE-PROTEIN	The nucleotide sequence of the uapA gene, coding for the uric acid-xanthine permease of Aspergillus nidulans, has been determined. The predicted uapA gene product comprises 595 amino acids (M(r) 63,365); it is a highly hydrophobic protein with 12-14 putative transmembrane segments and shows no striking similarity to any other membrane protein of either prokaryotes or eukaryotes, except for a short highly hydrophobic amino acid sequence conserved in a number of different permeases. The presence of an acidic, amphipathic region overlapping with the last hydrophobic segment of UAPA could also be of interest. The results presented suggest that the UAPA permease represents a new type of membrane protein, not described previously. The transcription of uapA is inducible by 2-thiouric acid, and it is highly repressible by ammonium. It is almost absolutely dependent on the presence of functional uaY and areA regulatory gene products. A specific mutation in the GATA binding zinc finger of the AREA protein nearly abolishes uapA transcription. The uap100 cis-acting, up-promoter, constitutive mutation is a duplication that comprises two GATA sites and suppresses weakly the AREA zinc finger mutation but does not alleviate the need for functional UAY and AREA proteins.	UNIV PARIS 11,CTR ORSAY,INST GENET & MICROBIOL,CNRS,U1354,BATIMENT 409,F-91405 ORSAY,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay			Diallinas, George/AAE-8457-2019	Diallinas, George/0000-0002-3426-726X				ABE A, 1990, EMBO J, V9, P3691, DOI 10.1002/j.1460-2075.1990.tb07581.x; ARST HN, 1975, NATURE, V254, P31, DOI 10.1038/254031a0; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; ARST HN, 1980, J GEN MICROBIOL, V116, P285; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURKE JF, 1984, GENE, V30, P63, DOI 10.1016/0378-1119(84)90105-7; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DARLINGTON AJ, 1967, J BACTERIOL, V93, P937, DOI 10.1128/JB.93.3.937-940.1967; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; DIALLINAS G, 1989, GENETICS, V122, P341; FIDEL S, 1988, GENE, V70, P283, DOI 10.1016/0378-1119(88)90200-4; FU YH, 1990, P NATL ACAD SCI USA, V87, P5331, DOI 10.1073/pnas.87.14.5331; FU YH, 1990, MOL CELL BIOL, V10, P1056, DOI 10.1128/MCB.10.3.1056; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; HAENPTLE MT, 1989, J CELL BIOL, V108, P1227; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HAWKINS AR, 1988, MOL GEN GENET, V214, P224, DOI 10.1007/BF00337715; HOFFMANN W, 1985, J BIOL CHEM, V260, P1831; HYNES MJ, 1975, AUST J BIOL SCI, V28, P301, DOI 10.1071/BI9750301; JUND R, 1988, EUR J BIOCHEM, V171, P417, DOI 10.1111/j.1432-1033.1988.tb13806.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOCKINGTON RA, 1985, GENE, V33, P137, DOI 10.1016/0378-1119(85)90088-5; MANIATIS T, 1982, MOL CLONING LABORATO, V18, P3387; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; MYEUS RM, 1986, SCIENCE, V232, P613; OESTREICHER N, 1993, J BIOL CHEM, V268, P23382; PROUDFOOT NJ, 1979, NATURE, V279, P376, DOI 10.1038/279376a0; RAI R, 1987, J BACTERIOL, V170, P266; RASSCHAERT D, 1987, BIOCHIMIE, V69, P591, DOI 10.1016/0300-9084(87)90178-7; SANDER F, 1977, P NATL ACAD SCI USA, V74, P5463; SCAZZOCC.C, 1968, BIOCHIM BIOPHYS ACTA, V166, P557, DOI 10.1016/0005-2787(68)90243-8; SCAZZOCCHIO C, 1990, TRENDS GENET, V6, P311, DOI 10.1016/0168-9525(90)90238-2; SCAZZOCCHIO C, 1982, GENETICS, V100, P185; SCAZZOCCHIO C, 1973, MOL GEN GENET, V125, P147, DOI 10.1007/BF00268868; SCAZZOCCHIO C, 1978, NATURE, V274, P177, DOI 10.1038/274177a0; Scazzocchio C., 1977, GENETICS PHYSL ASPER, P255; SEALYLEWIS HM, 1978, MOL GEN GENET, V164, P303, DOI 10.1007/BF00333161; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SOPHIANOPOULOU V, 1989, MOL MICROBIOL, V3, P705, DOI 10.1111/j.1365-2958.1989.tb00219.x; SOPHIANOPOULOU V, 1993, MOL GEN GENET, V236, P209, DOI 10.1007/BF00277114; STRUCK DK, 1978, J BIOL CHEM, V253, P5786; SUAREZ T, 1991, MOL GEN GENET, V230, P359, DOI 10.1007/BF00280292; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; TSUAREZ T, 1991, MOL GEN GENET, V230, P369; UNKLES SE, 1991, P NATL ACAD SCI USA, V88, P204, DOI 10.1073/pnas.88.1.204; VANDENBOL M, 1989, GENE, V83, P153, DOI 10.1016/0378-1119(89)90413-7; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WEBER E, 1988, J MOL EVOL, V27, P341, DOI 10.1007/BF02101197; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOO HS, 1992, YEAST, V8, P997, DOI 10.1002/yea.320081202	56	86	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23376	23381						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226862				2022-12-27	WOS:A1993MF51500066
J	LUO, JH; WEINSTEIN, IB				LUO, JH; WEINSTEIN, IB			CALCIUM-DEPENDENT ACTIVATION OF PROTEIN-KINASE-C - THE ROLE OF THE C2 DOMAIN IN DIVALENT-CATION SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; SUBSTRATE-SPECIFICITY; REGULATORY DOMAIN; CONTAINS; ZINC; REGION; PKC	Activation of certain isoforms of protein kinase C (cPKCs) requires Ca2+ and is associated with a conserved C2 domain that is not present in Ca2+-independent isoforms (nPKCs). The site(s) of Ca2+ binding and the role of the C2 domain have not been previously identified. We have analyzed phosphatidylserine-dependent Ca2+ binding to fusion proteins expressed in Escherichia coli that carry various modifications in the regulatory region of cPKCbeta1 or nPKCepsilon. Ca2+ is bound mainly to the C1 domain of PKCbeta1, but the C2 domain confers specificity for Ca2+ binding when compared with Mg2+ and Mn2+. We propose that in cPKCs there is selective binding of Ca2+ to a pocket formed by the C1 and C2 domains. This induces a change in conformation that activates the enzyme. In nPKCs, the cation binding pocket is less specific for Ca2+ because it lacks the C2 domain. Therefore, divalent cations like Mg2+ can bind to it, thereby abrogating the requirement of Ca2+ for enzyme activation.	COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; COLUMBIA UNIV,COLUMBIA PRESBYTERIAN CANC CTR,NEW YORK,NY 10027	Columbia University; Columbia University; Columbia University					NCI NIH HHS [CA-02656] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BAZZI MD, 1990, BIOCHEMISTRY-US, V29, P7624, DOI 10.1021/bi00485a012; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P971, DOI 10.1021/bi00218a013; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CAZAUBON S, 1990, EUR J BIOCHEM, V194, P799, DOI 10.1111/j.1432-1033.1990.tb19472.x; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; HOUSE C, 1987, J BIOL CHEM, V262, P772; HUBBARD SR, 1991, SCIENCE, V254, P1776; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MH, 1986, J BIOL CHEM, V261, P4867; LUO JH, 1993, J BIOL CHEM, V268, P3715; MAKOWSKE M, 1989, J BIOL CHEM, V264, P16155; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NORBY JG, 1980, ANAL BIOCHEM, V102, P318, DOI 10.1016/0003-2697(80)90160-8; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; QUEST AFG, 1992, J BIOL CHEM, V267, P10193; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEINSTEIN IB, 1991, ORIGINS OF HUMAN CANCER, P113	27	78	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23580	23584						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226885				2022-12-27	WOS:A1993MF51500095
J	JACONI, MEE; LEW, DP; MONOD, A; KRAUSE, KH				JACONI, MEE; LEW, DP; MONOD, A; KRAUSE, KH			THE REGULATION OF STORE-DEPENDENT CA2+ INFLUX IN HL-60 GRANULOCYTES INVOLVES GTP-SENSITIVE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN-NEUTROPHILS; BINDING PROTEINS; PLASMA-MEMBRANE; INOSITOL PHOSPHATES; CHOLERA-TOXIN; CA-2+ INFLUX; CELLS; INHIBITION; ENTRY	In granulocytes, emptying of intracellular Ca2+ stores activates Ca2+ influx across the plasma membrane. To study the putative role of GTP-binding proteins in this process, we have introduced non-hydrolyzable guanosine phosphate analogues into the cytosol of non-permeabilized HL-60 granulocytes using an endocytosis-hypoosmotic shock procedure. At the cytosolic concentrations obtained (100-500 muM), neither guanosine 5'-3-O-(thio)triphosphate (GTPgammaS) nor guanosine 5'-3-O-(thio)diphosphate (GDPbetaS) affected basal [Ca2+]i. Call release in response to the receptor agonist fMet-Leu-Phe, the Ca2+-ATPase inhibitor thapsigargin, or the Ca2+ ionophore ionomycin was also unaffected by GTPgammaS or GDPbetaS. In contrast, the activation of the Ca2+ influx pathway by fMet-Leu-Phe or by thapsigargin was blocked by GTPgammaS but not by GDPbetaS. The GTPgammaS effect was mimicked by NaF. The GTPgammaS and NaF effects were independent of protein kinase C activation and actin polymerization. Our results demonstrate that a GTP-sensitive element is involved in the signaling between intracellular Ca2+ stores and plasma membrane Ca2+ channels. The identical effects of GTPgammaS and NaF suggest that the GTP-sensitive element is a heterotrimeric G-protein.			JACONI, MEE (corresponding author), UNIV GENEVA,HOP CANTONAL,DIV INFECT DIS,CH-1211 GENEVA 4,SWITZERLAND.			Jaconi, Marisa/0000-0002-2004-8226				BENGTSSON T, 1990, P NATL ACAD SCI USA, V87, P2921, DOI 10.1073/pnas.87.8.2921; BIRD GS, 1993, J BIOL CHEM, V268, P21486; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CLAPHAM DE, 1993, NATURE, V364, P763, DOI 10.1038/364763a0; DEMAUREX N, 1993, J PHYSIOL-LONDON, V466, P329; DEMAUREX N, 1992, J CLIN INVEST, V90, P830, DOI 10.1172/JCI115958; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; FASOLATO C, 1993, J BIOL CHEM, V288, P20737; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOUY H, 1991, J IMMUNOL, V147, P757; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; INGUEZLLUHI J, 1993, TRENDS CELL BIOL, V3, P230; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KRAUSE KH, 1993, BLOOD CELLS, V19, P165; KRAUSE KH, 1985, J CLIN INVEST, V76, P1348, DOI 10.1172/JCI112109; MONTERO M, 1993, J BIOL CHEM, V268, P13055; NARASIMHAN V, 1988, J BIOL CHEM, V263, P19626; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; Penner R, 1993, Curr Opin Neurobiol, V3, P368, DOI 10.1016/0959-4388(93)90130-Q; PITTET D, 1989, J BIOL CHEM, V264, P7251; PRENTKI M, 1984, J BIOL CHEM, V259, P3777; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RECHSTEINER M, 1992, METHOD ENZYMOL, V149, P42; RODBELL M, 1992, CURR TOP CELL REGUL, V32, P1; ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; VOSTAL JG, 1991, J BIOL CHEM, V266, P16911; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	32	60	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26075	26078						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253721				2022-12-27	WOS:A1993MK42500012
J	MORI, Y; MATSUBARA, H; FOLCO, E; SIEGEL, A; KOREN, G				MORI, Y; MATSUBARA, H; FOLCO, E; SIEGEL, A; KOREN, G			THE TRANSCRIPTION OF A MAMMALIAN VOLTAGE-GATED POTASSIUM CHANNEL IS REGULATED BY CAMP IN A CELL-SPECIFIC MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; GENE-EXPRESSION; RESPONSE ELEMENT; FACTOR CREB; SOMATOSTATIN GENE; NERVOUS-SYSTEM; RAT-BRAIN; BINDING; SHAKER	The transcript of Kv1.5, a Shaker-like delayed rectifier K+ channel cloned in our laboratory, is regulated in both tissue and developmentally specific manners. In this study we characterized the 5'-flanking region of the Kv1.5 gene. The gene lacks a canonical TATA box, has several transcription start sites, and the 5'-noncoding sequence is intronless. A cAMP response element (CRE) consensus signal was identified in the 5'-noncoding region. cAMP regulates the expression of Kv1.5 gene in a cell-specific manner. In primary cardiac cells, cAMP induces a 6-fold increase in the steady state levels of Kv1.5 transcript. However, in GH3 cells cAMP induces a 5-6-fold decrease in steady state levels of Kv1.5 transcript. The half-life of Kv1.5 transcript is 37 min and is not affected by cAMP. Nuclear run-on experiments show that in GH3 cells, cAMP reduces the transcription rate of Kv1.5 gene. Transient transfection assays using 5'-deletion mutations of Kv1.5 5'-flanking sequences revealed that the CRE located at +636 can confer the cAMP inducibility to Kv1.5 reporter gene constructs and binds to CRE-binding protein (CREB) and CRE modulator protein (CREM) in electromobility gel shift assays. Furthermore, KCl-induced depolarization can increase the steady state levels of Kv1.5 transcript in primary atrial cells and decrease it in GH3 cells. We conclude that cAMP and depolarization play an important role in regulating K+ channel expression and thus may induce long term effects on the pattern of electrical activity of excitable cells.	BRIGHAM & WOMENS HOSP,DIV CARDIOL,75 FRANCIS ST,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046005] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 46005] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSBEL FM, 1988, CURRENT PROTOCOLS MO; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BERGER SL, 1987, METHODS ENZYMOLOGY G; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; CELENO P, 1989, BIOTECHNIQUES, V7, P942; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; COLLINS S, 1990, J BIOL CHEM, V265, P19330; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GRIESHAMMER U, 1992, CELL, V69, P79, DOI 10.1016/0092-8674(92)90120-2; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; ILBOURNE EJ, 1992, J BIOL CHEM, V267, P7563; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KOREN G, 1990, NEURON, V2, P39; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MAHDAVI V, 1989, CELLULAR MOL BIOL MU, P369; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MEYER TE, 1993, ENDOCRINOLOGY, V132, P770, DOI 10.1210/en.132.2.770; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NGUYEN TV, 1990, J NEUROSCI, V10, P285; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STROKE IL, 1985, J MOL BIOL, V184, P183, DOI 10.1016/0022-2836(85)90372-9; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242	42	97	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26482	26493						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253777				2022-12-27	WOS:A1993MK42500071
J	OHTAKI, T; MASUDA, Y; ISHIBASHI, Y; KITADA, C; ARIMURA, A; FUJINO, M				OHTAKI, T; MASUDA, Y; ISHIBASHI, Y; KITADA, C; ARIMURA, A; FUJINO, M			PURIFICATION AND CHARACTERIZATION OF THE RECEPTOR FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; BINDING-SITES; HIGH-AFFINITY; RAT-BRAIN; HYPOTHALAMIC POLYPEPTIDE; MOLECULAR-IDENTIFICATION; STRUCTURAL REQUIREMENTS; HORMONE-RECEPTOR; PEPTIDE PACAP; CELLS	Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid peptide (PACAP38) or a truncated peptide with the same 27 amino-terminal residues (PACAP27). The PACAP receptor was solubilized from bovine brain membranes with digitonin and purified 30-fold by the combination of DEAE-Toyopearl and hydroxylapatite chromatographic analyses. The partially purified PACAP receptors were mixed with biotinylated PACAP27 to form receptor-ligand complexes and then adsorbed onto avidin-agarose. The adsorbed PACAP receptors were eluted with an acidic buffer containing 1.0 M NaCl (pH 4.0). The eluted receptors were purified further by hydroxylapatite and gel filtration chromatography. A single protein band with a M(r) 55,000-60,000 was found in the final preparation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. Affinity labeling of the purified receptors with I-125-PACAP27 labeled the M(r) 55,000-60,000 protein specifically. The dissociation constant and the specific activity of the purified receptors were 25.8 pM and 17.2 nmol of ligand binding per mg of protein, respectively. Inhibitory constants determined by competitive binding experiments were 30.0 pM for PACAP27, 4.6 pM for PACAP38, and 37.3 nM for vasoactive intestinal peptide. Therefore, the purified PACAP receptor retained high affinity and ligand specificity. The sequence of the amino-terminal 29 residues was derived from the purified receptor.	TULANE UNIV,HEBERT CTR,US JAPAN BIOMED RES LABS,BELLE CHASSE,LA 70037; TULANE UNIV,SCH MED,DEPT MED,NEW ORLEANS,LA 70112; TULANE UNIV,SCH MED,DEPT ANAT,NEW ORLEANS,LA 70112; TULANE UNIV,SCH MED,DEPT PHYSIOL,NEW ORLEANS,LA 70112	Tulane University; Tulane University; Tulane University; Tulane University	OHTAKI, T (corresponding author), TAKEDA CHEM IND LTD,DIV DISCOVERY RES,DISCOVERY RES LABS 1,WADAI 10,TSUKUBA,IBARAKI 30042,JAPAN.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSCAIL L, 1990, FEBS LETT, V262, P77, DOI 10.1016/0014-5793(90)80158-F; CAUVIN A, 1991, REGUL PEPTIDES, V35, P161, DOI 10.1016/0167-0115(91)90478-Y; CAUVIN A, 1990, PEPTIDES, V11, P773, DOI 10.1016/0196-9781(90)90194-A; CHANG KJ, 1975, BIOCHIM BIOPHYS ACTA, V406, P294, DOI 10.1016/0005-2736(75)90011-5; CULLER MD, 1991, ENDOCRINOLOGY, V129, P2260, DOI 10.1210/endo-129-4-2260; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; EPPLER CM, 1992, J BIOL CHEM, V267, P15603; FELDMAN RI, 1990, J BIOL CHEM, V265, P17364; GOTTSCHALL PE, 1990, ENDOCRINOLOGY, V127, P272, DOI 10.1210/endo-127-1-272; GOTTSCHALL PE, 1991, FASEB J, V5, P194, DOI 10.1096/fasebj.5.2.1848519; GOURLET P, 1991, EUR J BIOCHEM, V195, P535, DOI 10.1111/j.1432-1033.1991.tb15734.x; HAZUM E, 1986, J BIOL CHEM, V261, P3043; HOSOYA M, 1993, BIOCHEM BIOPH RES CO, V194, P133, DOI 10.1006/bbrc.1993.1795; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; KAWAI K, 1992, LIFE SCI, V50, P257, DOI 10.1016/0024-3205(92)90332-J; KIMURA C, 1990, BIOCHEM BIOPH RES CO, V166, P81, DOI 10.1016/0006-291X(90)91914-E; KOZUKA M, 1991, J BIOL CHEM, V266, P16892; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM HC, 1990, EUR J BIOCHEM, V193, P725, DOI 10.1111/j.1432-1033.1990.tb19392.x; MASUDA Y, 1990, BIOCHEM BIOPH RES CO, V172, P709, DOI 10.1016/0006-291X(90)90732-3; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; MAZELLA J, 1988, J BIOL CHEM, V263, P144; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; MURPHY JB, 1960, BIOCHIM BIOPHYS ACTA, V45, P382, DOI 10.1016/0006-3002(60)91464-5; OGI K, 1990, BIOCHEM BIOPH RES CO, V173, P1271, DOI 10.1016/S0006-291X(05)80924-6; OHTAKI T, 1990, BIOCHEM BIOPH RES CO, V171, P838, DOI 10.1016/0006-291X(90)91222-E; ROBBERECHT P, 1992, EUR J BIOCHEM, V207, P239, DOI 10.1111/j.1432-1033.1992.tb17043.x; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SHIVERS BD, 1991, ENDOCRINOLOGY, V128, P3055, DOI 10.1210/endo-128-6-3055; TATSUNO I, 1990, BIOCHEM BIOPH RES CO, V168, P1027, DOI 10.1016/0006-291X(90)91132-C; TATSUNO I, 1991, ENDOCRINOLOGY, V129, P1797, DOI 10.1210/endo-129-4-1797; WATANABE T, 1992, BIOCHEM BIOPH RES CO, V182, P403, DOI 10.1016/S0006-291X(05)80159-7; WATANABE T, 1990, BIOCHEM BIOPH RES CO, V173, P252, DOI 10.1016/S0006-291X(05)81049-6	35	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26650	26657						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253796				2022-12-27	WOS:A1993MK42500092
J	TERRY, MJ; MAINES, MD; LAGARIAS, JC				TERRY, MJ; MAINES, MD; LAGARIAS, JC			INACTIVATION OF PHYTOCHROME-CHROMOPHORE AND PHYCOBILIPROTEIN-CHROMOPHORE PRECURSORS BY RAT-LIVER BILIVERDIN REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG HYPOCOTYL MUTANTS; INVITRO ATTACHMENT; BILE-PIGMENTS; EXPRESSION; ADDUCT; APOPHYCOCYANIN; BIOSYNTHESIS; ARABIDOPSIS; VARIANTS; BILINS	The phytochrome chromophore precursor, 3E-phytochromobilin, and the phycobiliprotein chromophore precursors, 3E-phycocyanobilin and 3E-phycoerythrobilin, are enzymatically converted to novel rubinoid products by purified rat liver biliverdin reductase. Phytochromobilin and phycocyanobilin are particularly good substrates for biliverdin reductase with K(m) and V(max) values very similar to those of the natural substrate, biliverdin IXalpha. Phycoerythrobilin is the least preferred of the three bilin substrates. H-1 NMR spectroscopy of phycocyanorubin, the product of phycocyanobilin catalysis by biliverdin reductase, and comparison of absorption spectra of all three rubinoid products reveal that the C10 methine bridge is selectively reduced by biliverdin reductase without altering the A-ring ethylidene substituent. In vitro phytochrome assembly experiments demonstrate that the phytorubin products do not form photoactive adducts with recombinant apophytochrome. These results suggest that ectopic expression of biliverdin reductase in plants will prevent assembly of the functional photoreceptor and thus will potentially alter light-mediated plant growth and development.	UNIV CALIF DAVIS,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616; UNIV ROCHESTER,EASTMAN SCH MUS,DEPT BIOPHYS,ROCHESTER,NY 14627	University of California System; University of California Davis; University of Rochester			Lagarias, John Clark/L-3139-2013; Terry, Matthew/B-3000-2012; Terry, Matthew/ABE-6419-2020	Lagarias, John Clark/0000-0002-2093-0403; Terry, Matthew/0000-0001-5002-2708; Terry, Matthew/0000-0001-5002-2708	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04066] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; AWRUCH J, 1984, BIOCHIM BIOPHYS ACTA, V87, P146; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; BEALE SI, 1991, J BIOL CHEM, V266, P22333; CHAPMAN DJ, 1967, J AM CHEM SOC, V89, P5976, DOI 10.1021/ja00999a058; CHORY J, 1989, PLANT CELL, V1, P867, DOI 10.1105/tpc.1.9.867; COLE WJ, 1967, J AM CHEM SOC, V89, P3643, DOI 10.1021/ja00990a055; CORNEJO J, 1992, J BIOL CHEM, V267, P14790; ELICH TD, 1989, J BIOL CHEM, V264, P12902; ELICH TD, 1989, J BIOL CHEM, V264, P183; FAKHRAI H, 1992, J BIOL CHEM, V267, P4023; Falk H., 1989, CHEM LINEAR OLIGOPYR; FRYDMAN RB, 1987, BIOCHIM BIOPHYS ACTA, V916, P500, DOI 10.1016/0167-4838(87)90197-X; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GOSSAUER A, 1974, LIEBIGS ANN CHEM, P1496; HUANG TJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P617, DOI 10.1016/0003-9861(89)90477-3; HUANG TJ, 1990, MOL PHARMACOL, V37, P25; HUANG TJ, 1989, J BIOL CHEM, V264, P7844; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; LAGARIAS JC, 1987, PHOTOCHEM PHOTOBIOL, V46, P5, DOI 10.1111/j.1751-1097.1987.tb04729.x; LI LM, 1992, J BIOL CHEM, V267, P19204; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1990, MOL PHARMACOL, V38, P481; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; PARKS BM, 1989, PLANT MOL BIOL, V12, P425, DOI 10.1007/BF00017582; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; SINGLETON JW, 1965, J BIOL CHEM, V240, P4780; STOLL MS, 1977, BIOCHEM J, V163, P59, DOI 10.1042/bj1630059; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; WAHLEITHNER JA, 1991, P NATL ACAD SCI USA, V88, P10387, DOI 10.1073/pnas.88.23.10387; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439	36	96	101	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26099	26106						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253726				2022-12-27	WOS:A1993MK42500017
J	VIDUGIRIS, GJA; HARRINGTON, JP; FRIEDMAN, JM; HIRSCH, RE				VIDUGIRIS, GJA; HARRINGTON, JP; FRIEDMAN, JM; HIRSCH, RE			ABSENCE OF LIGAND BINDING-INDUCED TERTIARY CHANGES IN THE MULTIMERIC EARTHWORM LUMBRICUS-TERRESTRIS HEMOGLOBIN - A RESONANCE RAMAN-STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR HEMOGLOBIN; QUATERNARY STRUCTURE; HEME PROTEINS; DISSOCIATION; DYNAMICS; PH; REASSOCIATION; SPECTROSCOPY; SCATTERING; SUBUNIT	In vertebrate hemoglobins, changes in protein tertiary structure induced by either ligand binding or changes in quaternary state are manifested at the heme as reflected in resonance Raman spectral changes involving the iron-proximal histidine stretching mode. No such changes are observed for Lumbricus terrestris hemoglobin. The iron-histidine stretching mode and the porphyrin breathing motion in the deoxy-, oxy-, or CO-photodissociated forms of Lumbricus hemoglobin and human hemoglobin A (pH 7.0 and 9.2, the latter to effect Lumbricus hemoglobin subunit dissociation) were studied using pulsed (10 ns) light at 435 nm. In contrast to that observed for hemoglobin A, a comparison of the spectra of the deoxy and photoproduct forms of Lumbricus hemoglobin reveal minimal differences in the region of the iron-histidine and the pi electron distribution in the heme moiety. The spectral frequencies are similar to that observed in R-state vertebrate hemoglobins. Such average behavior of the approximately 192 hemes present in Lumbricus hemoglobin is more analogous to the Raman spectral properties observed in myoglobin.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PHYSIOL BIOPHYS,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV HEMATOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT ANAT & STRUCT BIOL,BRONX,NY 10461; UNIV SO ALABAMA,DEPT CHEM,MOBILE,AL 36688	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of South Alabama					NIDDK NIH HHS [DK 41253] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041253] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAMPION PM, 1992, J RAMAN SPECTROSC, V23, P557, DOI 10.1002/jrs.1250231008; FINDSEN EW, 1985, J AM CHEM SOC, V107, P3355, DOI 10.1021/ja00297a056; FRIEDMAN JM, 1982, SCIENCE, V218, P1244, DOI 10.1126/science.7146910; FRIEDMAN JM, 1982, ANNU REV PHYS CHEM, V33, P471, DOI 10.1146/annurev.pc.33.100182.002351; FRIEDMAN JM, 1985, SCIENCE, V228, P1273, DOI 10.1126/science.4001941; FUSHITANI K, 1986, J BIOL CHEM, V261, P8414; GIBSON QH, 1991, J BIOL CHEM, V266, P13097; HARRINGT.JP, 1973, BIOCHIM BIOPHYS ACTA, V328, P61, DOI 10.1016/0005-2795(73)90330-9; HARRINGTON JP, 1991, BIOCHIM BIOPHYS ACTA, V1076, P351, DOI 10.1016/0167-4838(91)90475-F; HERSKOVITS TT, 1975, BIOCHEMISTRY-US, V14, P4964, DOI 10.1021/bi00693a027; KAPP OH, 1984, J BIOL CHEM, V259, P628; KITAGAWA T, 1976, J AM CHEM SOC, V98, P5169, DOI 10.1021/ja00433a019; MAINWARING MG, 1986, J BIOL CHEM, V261, P899; OWNBY DW, 1993, J BIOL CHEM, V268, P13539; ROUSSEAU DL, 1993, J BIOL CHEM, V268, P5719; ROUSSEAU DL, 1983, ANNU REV BIOPHYS BIO, V12, P357, DOI 10.1146/annurev.bb.12.060183.002041; ROUSSEAU DL, 1988, BIOL APPLICATIONS RA, V3, P133; SCOTT TW, 1984, J AM CHEM SOC, V106, P5677, DOI 10.1021/ja00331a044; SPIRO TG, 1990, BIOCHEMISTRY-US, V29, P4497, DOI 10.1021/bi00471a001; Vinogrador S.N., 1986, P25; VINOGRADOV SN, 1988, COMP BIOCHEM PHYS B, V91, P577, DOI 10.1016/0305-0491(88)90024-7; VINOGRADOV SN, 1986, P NATL ACAD SCI USA, V83, P8034, DOI 10.1073/pnas.83.21.8034; VINOGRADOV SN, 1991, J BIOL CHEM, V266, P13091	23	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26190	26192						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253738				2022-12-27	WOS:A1993MK42500029
J	BRADSHER, JN; JACKSON, KW; CONAWAY, RC; CONAWAY, JW				BRADSHER, JN; JACKSON, KW; CONAWAY, RC; CONAWAY, JW			RNA POLYMERASE-II TRANSCRIPTION FACTOR-SIII .1. IDENTIFICATION, PURIFICATION, AND PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL INITIATION-FACTOR; MAJOR LATE PROMOTER; ELONGATION FACTOR-SII; ASCITES TUMOR-CELLS; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; UPSTREAM ELEMENT; FACTOR-EPSILON; FACTOR-TAU	A transcription factor that stimulates synthesis of accurately initiated transcripts by RNA polymerase II has been identified and purified to apparent homogeneity from rat liver nuclear extracts. This factor, which we designate SIII, has a native molecular mass of approximately 140 kDa and is composed of three polypeptides of 110, 18, and 15 kDa. All three polypeptides are required to reconstitute SIII transcriptional activity. SIII appears distinct from previously identified mammalian transcription factors.	OKLAHOMA MED RES FDN,PROGRAM MOLEC & CELL BIOL,825 NE 13TH ST,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,WILLIAM K WARREN MED RES INST,OKLAHOMA CITY,OK 73190	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center				Conaway, Joan/0000-0002-2786-0663	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASO T, 1992, NATURE, V355, P461, DOI 10.1038/355461a0; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CHAFIN DR, 1991, J BIOL CHEM, V266, P9256; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, J BIOL CHEM, V265, P7552; CONAWAY JW, 1987, J BIOL CHEM, V262, P8293; CONAWAY JW, 1992, J BIOL CHEM, V267, P10142; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; CORTES P, 1992, MOL CELL BIOL, V12, P413, DOI 10.1128/MCB.12.1.413; EGLY JM, 1984, EMBO J, V3, P363; FEAVER WJ, 1991, J BIOL CHEM, V266, P19000; FINKELSTEIN A, 1992, NATURE, V355, P464, DOI 10.1038/355464a0; FLORES O, 1989, J BIOL CHEM, V264, P8913; FLORES O, 1990, J BIOL CHEM, V265, P5629; FLORES O, 1992, J BIOL CHEM, V267, P2786; GARRETT KP, 1992, J BIOL CHEM, V267, P23942; GERARD M, 1991, J BIOL CHEM, V266, P20940; GREENBLATT J, 1991, CELL, V66, P1067, DOI 10.1016/0092-8674(91)90027-V; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HENRY NL, 1992, J BIOL CHEM, V267, P23388; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; KRAUSKOPF A, 1991, MOL CELL BIOL, V11, P3515, DOI 10.1128/MCB.11.7.3515; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NATORI S, 1973, J BIOCHEM, V73, P879, DOI 10.1093/oxfordjournals.jbchem.a130150; NUGENT KD, 1988, J CHROMATOGR, V443, P381, DOI 10.1016/S0021-9673(00)94809-X; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; PETERSON MG, 1991, NATURE, V354, P369; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; PUGH BF, 1992, J BIOL CHEM, V267, P679; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; RANISH JA, 1991, J BIOL CHEM, V266, P19320; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINBERG D, 1987, J BIOL CHEM, V262, P3322; REINES D, 1989, J BIOL CHEM, V264, P10799; SAMUELS M, 1986, J BIOL CHEM, V261, P2003; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SAYRE MH, 1992, J BIOL CHEM, V267, P23383; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; SCHMIDT MC, 1989, P NATL ACAD SCI USA, V86, P7785, DOI 10.1073/pnas.86.20.7785; SEKIMIZU K, 1979, BIOCHEMISTRY-US, V18, P1582, DOI 10.1021/bi00575a031; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SIVARAMAN L, 1990, J BIOL CHEM, V265, P14554; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; TSCHOCHNER H, 1992, P NATL ACAD SCI USA, V89, P11292, DOI 10.1073/pnas.89.23.11292; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; USUDA Y, 1991, EMBO J, V10, P2305, DOI 10.1002/j.1460-2075.1991.tb07767.x; WIEST DK, 1992, J BIOL CHEM, V267, P7733; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	62	120	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25587	25593						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244996				2022-12-27	WOS:A1993MK10000047
J	LEVINE, SA; MONTROSE, MH; TSE, CM; DONOWITZ, M				LEVINE, SA; MONTROSE, MH; TSE, CM; DONOWITZ, M			KINETICS AND REGULATION OF 3 CLONED MAMMALIAN NA+/H+ EXCHANGERS STABLY EXPRESSED IN A FIBROBLAST CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CYCLIC-AMP; MOLECULAR-CLONING; SODIUM-HYDROGEN; PHORBOL ESTERS; H+ EXCHANGER; KIDNEY-CELLS; MEMBRANE; ANTIPORTER; PH	The kinetics and second messenger regulation of three cloned mammalian intestinal Na+/H+ exchangers were studied using fluorometric techniques. These exchangers, NHE1, NHE2, and NHE3, were stably expressed in PS120 fibroblasts, which lack an endogenous Na+/H+ exchanger. H+ kinetic data indicated cooperativity by internal protons, with Hill coefficients of approximately 2 for all three isoforms. In contrast, Na+ kinetic data fit Michaelis-Menten kinetics, with K(m)(Na+) 15-18 mM and a Hill coefficient of approximately 1. The exchangers were all activated by growth factors and thrombin; in NHE1 these agonists increased the apparent affinity for intracellular H+, but did not change V(max), while for NHE2 and NHE3 the effect was on V(max) alone. Phorbol ester stimulated NHE1 and NHE2, but inhibited NHE3 with a decrease in V(max) ATP-depletion decreased V(max) and the apparent affinity for H+ for all three isoforms, and reduced the Hill coefficient to approximately 1, suggesting that a basal level of phosphorylation was required for the cooperativity. The differences in kinetics and second messenger regulation suggest that the NHE isoforms may serve different cellular functions. The up- and down-regulation of NHE3 by kinases indicates that this isoform may be involved in a specialized function such as Na+ absorption.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Johns Hopkins University	LEVINE, SA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV PHYSIOL,918 ROSS RES BLDG,720 RUTLAND AVE,BALTIMORE,MD 21205, USA.				NIDDK NIH HHS [R01DK26523, F32DK08820, P01DK44484] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044484, F32DK008820, R01DK026523] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BESTERMAN JM, 1985, J BIOL CHEM, V260, P1155; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; BORON WF, 1977, AM J PHYSIOL, V233, pC61, DOI 10.1152/ajpcell.1977.233.3.C61; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; CANTRELLO HF, 1989, J BIOL CHEM, V260, P8008; CASAVOLA V, 1989, BIOCHEM BIOPH RES CO, V165, P833, DOI 10.1016/S0006-291X(89)80041-5; CASSEL D, 1986, J BIOL CHEM, V261, P5460; CLARK JD, 1991, AM J PHYSIOL, V261, pC945, DOI 10.1152/ajpcell.1991.261.6.C945; COUNILLON L, 1992, Cellular Physiology and Biochemistry, V2, P138, DOI 10.1159/000154636; EMMER E, 1989, J MEMBRANE BIOL, V108, P207, DOI 10.1007/BF01871735; FAN CC, 1988, AM J PHYSIOL, V244, pG375; FRANCHI A, 1986, J BIOL CHEM, V261, P4614; GRINSTEIN S, 1985, AM J PHYSIOL, V248, pC379, DOI 10.1152/ajpcell.1985.248.3.C379; HAGGERTY JG, 1988, P NATL ACAD SCI USA, V85, P6797, DOI 10.1073/pnas.85.18.6797; HELMLEKOLB C, 1990, PFLUG ARCH EUR J PHY, V415, P461, DOI 10.1007/BF00373624; HENDEY B, 1989, J BIOL CHEM, V259, P5809; KNICKELBEIN RG, 1988, J CLIN INVEST, V82, P2158, DOI 10.1172/JCI113838; KRAYERPAWLOWSKA D, 1991, J MEMBRANE BIOL, V120, P173, DOI 10.1007/BF01872400; LEATHERBARROW RJ, 1987, ENZFITTER MANUAL; MAHNENSMITH RL, 1985, CIRC RES, V56, P773, DOI 10.1161/01.RES.56.6.773; MOULE SK, 1990, EUR J BIOCHEM, V187, P677, DOI 10.1111/j.1432-1033.1990.tb15353.x; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; REUSS L, 1985, J GEN PHYSIOL, V85, P409, DOI 10.1085/jgp.85.3.409; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1991, J BIOL CHEM, V266, P19166; Segel I.H., 1975, ENZYME KINETICS; SEMRAD CE, 1987, AM J PHYSIOL, V252, pC315, DOI 10.1152/ajpcell.1987.252.3.C315; TSE CM, 1991, EMBO J, V10, P1957, DOI 10.1002/j.1460-2075.1991.tb07725.x; TSE CM, 1992, J BIOL CHEM, V267, P9340; TSE CM, 1993, J BIOL CHEM, V268, P11917; TSE CM, 1993, IN PRESS P NATL ACAD; VIGNE P, 1985, J BIOL CHEM, V260, P8008; WAKABAYASHI S, 1992, REV PHYSIOL BIOCH P, V119, P157; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WANG Z, 1993, J BIOL CHEM, V268, P11925; WATSON AJM, 1991, AM J PHYSIOL, V261, pG299	38	232	235	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25527	25535						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244988				2022-12-27	WOS:A1993MK10000039
J	MACDONALD, NJ; DELAROSA, A; BENEDICT, MA; FREIJE, JMP; KRUTSCH, H; STEEG, PS				MACDONALD, NJ; DELAROSA, A; BENEDICT, MA; FREIJE, JMP; KRUTSCH, H; STEEG, PS			A SERINE PHOSPHORYLATION OF NM23, AND NOT ITS NUCLEOSIDE DIPHOSPHATE KINASE-ACTIVITY, CORRELATES WITH SUPPRESSION OF TUMOR METASTATIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; DUCTAL BREAST CARCINOMAS; 2 CELLULAR PROTEINS; LARGE T-ANTIGEN; WILD-TYPE; SV40-TRANSFORMED CELLS; TRANSFORMING PROTEINS; PROGESTERONE-RECEPTOR; CHEMICAL-PROPERTIES; MYXOCOCCUS-XANTHUS	We describe a serine phosphorylation of the putative metastasis suppressor protein Nm23, and present evidence of its relevance to the signal transduction and tumor metastatic processes. Nm23 was previously demonstrated to exhibit nucleoside diphosphate kinase (NDPK) activity, which transfers a phosphate among nucleoside tri- and diphosphates via an Nm23-phosphohistidine intermediate. Recent data have dissociated the NDPK activity of Nm23 from its phenotypic effects; therefore we have asked whether Nm23 possesses additional biochemical functions. An acid-stable (nonhistidine) phosphorylation was identified on autophosphorylated purified recombinant Nm23 proteins and [P-32]orthophosphate-labeled human breast carcinoma and murine melanoma Nm23. Phosphoamino acid analysis identified serine as the acid-stable phosphorylation and serine 44 as the major site of phosphorylation. The acid stable phosphorylation (serine) of Nm23 was inhibited by cAMP in vitro and forskolin in vivo, suggesting that this phosphorylation pathway is regulated in signal transduction. No effect of cAMP was observed on Nm223 NDPK activity. Once phosphorylated, Nm23-phosphoserine can release free phosphate in vitro. The biological relevance of the novel phosphorylation identified herein is suggested by the direct correlation of in vivo Nm23 acid-stable phosphorylation levels, but not Nm23 NDPK activity, with suppression of tumor metastatic potential among control and nm23-1 transfected murine melanoma cells.	UNIV OVIEDO, DEPT BIOL FUNCT, E-33006 OVIEDO, SPAIN	University of Oviedo	MACDONALD, NJ (corresponding author), NCI, PATHOL LAB, WOMENS CANC SECT, BLDG 10, RM 2A33, BETHESDA, MD 20892 USA.		Freije, José M.P./A-6535-2008	Freije, José M.P./0000-0002-4688-8266				ADKINS B, 1982, J VIROL, V43, P448, DOI 10.1128/JVI.43.2.448-455.1982; ALBERTY RA, 1969, J BIOL CHEM, V244, P3290; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BARNES R, 1991, AM J PATHOL, V139, P245; BERG P, 1953, NATURE, V172, P1008, DOI 10.1038/1721008a0; BEVILACQUA G, 1989, CANCER RES, V49, P5185; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; CALIGO MA, 1992, ANTICANCER RES, V12, P969; CARLIER MF, 1989, INT REV CYTOL, V115, P139; COHN KH, 1991, LANCET, V338, P722, DOI 10.1016/0140-6736(91)91444-Y; COLOMB MG, 1966, BIOCHEM BIOPH RES CO, V24, P909, DOI 10.1016/0006-291X(66)90336-6; DAYAN J, 1963, BIOCHIM BIOPHYS ACTA, V77, P446, DOI 10.1016/0006-3002(63)90519-5; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; DOUGHERTY JJ, 1984, J BIOL CHEM, V259, P8004; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; EDLUND B, 1969, EUR J BIOCHEM, V9, P451, DOI 10.1111/j.1432-1033.1969.tb00630.x; ELMAGHRABI MR, 1980, J BIOL CHEM, V255, P668; FANNING E, 1992, J VIROL, V66, P1289, DOI 10.1128/JVI.66.3.1289-1293.1992; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FLORENES VA, 1992, CANCER RES, V52, P6088; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; FUKUCHI T, 1993, IN PRESS GENE AMST; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GILLES AM, 1991, J BIOL CHEM, V266, P8784; GOLDEN A, 1993, ONCOGENES TUMOR SUPP, P345; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; HEMMERICH S, 1992, BIOCHEMISTRY-US, V31, P4580, DOI 10.1021/bi00134a007; HENNESSY C, 1991, J NATL CANCER I, V83, P281, DOI 10.1093/jnci/83.4.281; HIGASHIYAMA M, 1992, BRIT J CANCER, V66, P533, DOI 10.1038/bjc.1992.308; HIRAYAMA R, 1991, J NATL CANCER I, V83, P1249, DOI 10.1093/jnci/83.17.1249; HOSSLER FE, 1971, BIOCHEM BIOPH RES CO, V43, P530, DOI 10.1016/0006-291X(71)90646-2; INESI G, 1992, ADV ENZYMOL RAMB, V65, P185; ISHIKAWA N, 1992, J BIOL CHEM, V267, P14366; JOAB I, 1984, NATURE, V308, P850, DOI 10.1038/308850a0; KANTOR JD, 1993, CANCER RES, V53, P1971; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Krebs EG, 1986, ENZYMES, V17, P3, DOI 10.1016/S1874-6047(08)60426-6; KREIL G, 1964, BIOCHEM BIOPH RES CO, V16, P551, DOI 10.1016/0006-291X(64)90191-3; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1993, ONCOGENE, V8, P2325; LEONE A, 1993, ONCOGENE, V8, P855; LEONE A, 1991, CANCER RES, V51, P2490; LERCH K, 1975, BIOCHEMISTRY-US, V14, P2015, DOI 10.1021/bi00680a032; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LIPSICH LA, 1982, MOL CELL BIOL, V2, P875, DOI 10.1128/MCB.2.7.875; MARTENSEN TM, 1984, METHOD ENZYMOL, V107, P3; MUNOZDORADO J, 1993, J BACTERIOL, V175, P1176; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2707; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2702; NAKAYAMA H, 1993, JPN J CANCER RES, V84, P184, DOI 10.1111/j.1349-7006.1993.tb02853.x; NAKAYAMA T, 1992, J NATL CANCER I, V84, P1349, DOI 10.1093/jnci/84.17.1349; NICOLSON GL, 1987, CANCER RES, V47, P1473; OKABEKADO J, 1992, BIOCHEM BIOPH RES CO, V182, P987, DOI 10.1016/0006-291X(92)91829-F; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; RABINOWITZ M, 1960, J BIOL CHEM, V235, P1043; RADINSKY R, 1992, CANCER RES, V52, P5808; RANDAZZO PA, 1991, SCIENCE, V254, P850, DOI 10.1126/science.1658935; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; REDEUILH G, 1987, J BIOL CHEM, V262, P6969; RENOIR JM, 1986, BIOCHEMISTRY-US, V25, P6405, DOI 10.1021/bi00369a010; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; ROYDS JA, 1993, J NATL CANCER I, V85, P727, DOI 10.1093/jnci/85.9.727; SANCHEZ ER, 1986, J STEROID BIOCHEM, V24, P9, DOI 10.1016/0022-4731(86)90025-7; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SASTREGARAU X, 1992, INT J CANCER, V50, P533, DOI 10.1002/ijc.2910500406; SBURLATI AR, 1993, BIOCHEMISTRY-US, V32, P4587, DOI 10.1021/bi00068a015; SCHMID SL, 1985, J BIOL CHEM, V260, P57; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; SHIMADA N, 1993, J BIOL CHEM, V268, P2583; SHIZUTA Y, 1975, J BIOL CHEM, V250, P6891; STAHL JA, 1991, CANCER RES, V51, P445; STEEG P S, 1992, Current Opinion in Oncology, V4, P134, DOI 10.1097/00001622-199202000-00018; STEEG PS, 1993, BREAST CANCER RES TR, V25, P175, DOI 10.1007/BF00662142; STEEG PS, 1988, CANCER RES, V48, P6550; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; SU ZZ, 1993, ONCOGENE, V8, P1211; TAKEMOTO F, 1992, PFLUG ARCH EUR J PHY, V421, P302, DOI 10.1007/BF00374216; TENG DHF, 1991, NATURE, V353, P437, DOI 10.1038/353437a0; URANO T, 1992, FEBS LETT, V309, P358, DOI 10.1016/0014-5793(92)80807-S; WALINDER O, 1968, J BIOL CHEM, V243, P3947; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WANG LM, 1993, CANCER RES, V53, P717; WEI YF, 1991, METHOD ENZYMOL, V200, P388; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; ZIEMIECKI A, 1986, VIROLOGY, V151, P265, DOI 10.1016/0042-6822(86)90048-6	97	207	218	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25780	25789						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245015				2022-12-27	WOS:A1993MK10000074
J	MONNO, S; OGAWA, H; DATE, T; FUJIOKA, M; MILLER, WL; KOBAYASHI, M				MONNO, S; OGAWA, H; DATE, T; FUJIOKA, M; MILLER, WL; KOBAYASHI, M			MUTATION OF HISTIDINE-373 TO LEUCINE IN CYTOCHROME-P450C17 CAUSES 17-ALPHA-HYDROXYLASE DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPOUND HETEROZYGOUS MUTATIONS; N-TERMINAL REGION; 17,20-LYASE DEFICIENCY; MOLECULAR-BASIS; GENE; DNA; EXPRESSION; P450C17; LYASE; ALDOSTERONISM	We identified a new homozygous missense mutation His373 --> Leu in the CYP17 gene of two sisters with 17alpha-hydroxylase deficiency with an elevated plasma aldosterone concentration by sequencing their genomic DNAs amplified by polymerase chain reaction. Using polymerase chain reaction-based site-directed mutagenesis, we prepared a DNA that encoded the Leu373 mutant protein. COS-1 cells transfected with the mutant DNA, despite having an RNA hybridizable to the P450c17 cDNA, did not show 17alpha-hydroxylase and 17,20-lyase activities. Also, the cells were devoid of 11beta-hydroxylase and aldosterone synthase activities. To examine the mechanism by which the single amino acid change His373 --> Leu eliminates activity, we expressed N-terminally modified P450c17 proteins with and without the Leu373 Mutation in Escherichia coli and performed spectral studies. Membrane preparations from E. coli cells expressing the wild-type form of the modified enzyme showed an absorption peak at 449 nm upon addition of carbon monoxide in the reduced state and produced characteristic substrate-induced difference spectra, whereas those from the cells expressing the mutant form did not show these spectral changes. The 17alpha-hydroxylase and 17,20-lyase activities were observed only in E. coli cells expressing the wild-type enzyme. These results show that the His373 --> Leu mutant does not incorporate the heme prosthetic group properly and suggest a critical role of His373 in heme binding.	TOYAMA MED & PHARMACEUT UNIV, FAC MED, DEPT INTERNAL MED, TOYAMA, TOYAMA 93001, JAPAN; TOYAMA MED & PHARMACEUT UNIV, FAC MED, DEPT BIOCHEM, TOYAMA, TOYAMA 93001, JAPAN; KANAZAWA MED UNIV, DEPT BIOCHEM, KAHOKU, ISHIKAWA 92002, JAPAN; UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA	University of Toyama; University of Toyama; Kanazawa Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Miller, Walter L/J-3696-2012					AHLGREN R, 1992, J CLIN ENDOCR METAB, V74, P667, DOI 10.1210/jc.74.3.667; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; BIASON A, 1991, MOL ENDOCRINOL, V5, P2037, DOI 10.1210/mend-5-12-2037; BIGLIERI EG, 1966, J CLIN INVEST, V45, P1946, DOI 10.1172/JCI105499; BIGLIERI EG, 1991, ENDOCRIN METAB CLIN, V20, P257, DOI 10.1016/S0889-8529(18)30267-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; DARMIENTO M, 1983, J CLIN ENDOCR METAB, V56, P697, DOI 10.1210/jcem-56-4-697; FARDELLA CE, 1993, IN PRESS J CLIN ENDO; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; KAGIMOTO M, 1988, MOL ENDOCRINOL, V2, P564, DOI 10.1210/mend-2-6-564; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; LIN D, 1991, J BIOL CHEM, V266, P15992; MATTESON KJ, 1986, J CLIN ENDOCR METAB, V63, P789, DOI 10.1210/jcem-63-3-789; MONNO S, 1989, ENDOCRINOL JAPON, V36, P315; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; NAKAJIN S, 1984, J BIOL CHEM, V259, P3971; NARASIMHULU S., 1965, LIFE SCI, V4, P2101, DOI 10.1016/0024-3205(65)90328-0; OMURA T, 1962, J BIOL CHEM, V237, P1375; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPARKES RS, 1991, DNA CELL BIOL, V10, P359, DOI 10.1089/dna.1991.10.359; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TARTOF KD, 1987, FOCUS, V9, P12; YANASE T, 1992, BIOCHIM BIOPHYS ACTA, V1139, P275, DOI 10.1016/0925-4439(92)90100-2; YANASE T, 1988, MOL CELL ENDOCRINOL, V59, P249; YANASE T, 1990, J CLIN ENDOCR METAB, V70, P1325, DOI 10.1210/jcem-70-5-1325; YANASE T, 1989, J BIOL CHEM, V264, P18076; YANASE T, 1991, ENDOCR REV, V12, P91, DOI 10.1210/edrv-12-1-91; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	37	70	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25811	25817						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245018				2022-12-27	WOS:A1993MK10000078
J	SCHMIDT, CJ; SLADEK, TE				SCHMIDT, CJ; SLADEK, TE			A RAT HOMOLOG OF THE DROSOPHILA ENHANCER OF SPLIT (GROUCHO) LOCUS LACKING WD-40 REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BETA-SUBUNIT; SACCHAROMYCES-CEREVISIAE; GENE-PRODUCT; MELANOGASTER; FAMILY	In Drosophila, neurogenic loci function in defining cellular fate by interpreting the identity of other cells in the immediate environment. To begin studies of mammalian homologs of these genes, we have isolated two rat homologs of the neurogenic locus Enhancer of split. The protein encoded by the Drosophila Enhancer of split locus is complex and contains five distinct regions based on amino acid composition. One region contains six WD-40 repeats, which were first described in the beta subunit of the heterotrimeric guanine nucleotide-binding protein. One of the rat cDNAs we isolated, R-esp1, encodes a novel form that lacks the WD-40 repeating units. Data are presented demonstrating that the R-esp1 cDNA is a full-length clone encoding an expressed 24-kDa protein. Antibodies raised against this protein stain the nucleus of both PC-12 and GH3 cells. The second clone, R-esp2, encodes a full-length homolog containing WD-40 repeats. The hydrodynamic properties of in vitro translated R-esp1 and R-esp2 proteins indicate that they do not stably self-associate or form heterodimers. A model is presented for the possible role of the R-esp1 protein in the negative regulation of Enhancer of split proteins containing WD-40 repeats.			SCHMIDT, CJ (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOL,75 FRANCIS ST,BOSTON,MA 02115, USA.			Schmidt, Carl/0000-0002-8386-4781				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ARTAVANISTSAKONAS S, 1991, ANNU REV CELL BIOL, V7, P427; BJORN SP, 1989, MOL CELL BIOL, V9, P3698, DOI 10.1128/MCB.9.9.3698; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DURONIO RJ, 1992, PROTEINS, V13, P41, DOI 10.1002/prot.340130105; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARTENSTEIN AY, 1992, DEVELOPMENT, V116, P1203; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; Paine PL., 1980, CELL BIOL COMPREHENS, V4, P299; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT CJ, 1989, CELL REGUL, V1, P125, DOI 10.1091/mbc.1.1.125; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; TAKAGAKI Y, 1992, J BIOL CHEM, V267, P23471; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500	20	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25681	25686						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245004				2022-12-27	WOS:A1993MK10000059
J	LEGENDRE, L; YUEH, YG; CRAIN, R; HADDOCK, N; HEINSTEIN, PF; LOW, PS				LEGENDRE, L; YUEH, YG; CRAIN, R; HADDOCK, N; HEINSTEIN, PF; LOW, PS			PHOSPHOLIPASE-C ACTIVATION DURING ELICITATION OF THE OXIDATIVE BURST IN CULTURED PLANT-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNIT; INOSITOL 1,4,5-TRISPHOSPHATE; SIGNAL TRANSDUCTION; DUNALIELLA-SALINA; PLASMA-MEMBRANE; SOYBEAN CELLS; RAPID CHANGES; PHOSPHATIDYLINOSITOL; STIMULATION; METABOLISM	Although phospholipase C hydrolysis of polyphosphoinositides constitutes one of the major second messenger pathways in animal cells, its participation in signal transduction in higher plants has not been established. To determine whether activation of phosphatidylinositol-directed phospholipase C might be involved in signaling the elicitor-induced oxidative burst in plants, suspension-cultured soybean cells were treated with two stimulants of the H2O2 burst and examined for polyphosphoinositide turnover. Both polygalacturonic acid elicitor and the G protein activator, mastoparan, promoted a transient increase in inositol 1,4,5-trisphosphate (IP3) content that exceeded basal IP3 levels (0.9 +/- 0.4 pmol of IP3/10(6) cells, n = 28) by 2.6- and 7-fold, respectively. In each case, intracellular IP3 content reached a maximum at 1 min post-stimulation and declined to near basal levels during the subsequent 5-10 min. Neomycin sulfate, an inhibitor of polyphosphoinositide hydrolysis, blocked the IP3 transient, and Mas-17, an inactive analogue of mastoparan, induced no change in IP3. Thin layer chromatography of lipid extracts of the soybean cells corroborated the above results by revealing a rapid decrease in phosphatidylinositol monophosphate and phosphatidylinositol 4,5-bisphosphate following polygalacturonic acid elicitor and mastoparan (but not Mas-17) stimulation. Since the rise in IP3 preceded H2O2 production and since neomycin sulfate inhibited the appearance of both, we hypothesize that phospholipase C activation might constitute one pathway by which elicitors trigger the soybean oxidative burst.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA; UNIV CONNECTICUT, DEPT MOLEC & CELL BIOL, STORRS, CT 06269 USA; PURDUE UNIV, DEPT MED CHEM & PHARMACOGNOSY, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Connecticut; Purdue University System; Purdue University; Purdue University West Lafayette Campus			Yueh, Yir Gloria/U-1699-2019	Low, Philip/0000-0001-9042-5528				ANDERSON RA, 1989, RED BLOOD CELL MEMBR, P187; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; APOSTOL I, 1987, PLANT PHYSIOL, V84, P1276, DOI 10.1104/pp.84.4.1276; BAGGIOLINI M, 1990, TRENDS BIOCHEM SCI, V15, P69, DOI 10.1016/0968-0004(90)90179-F; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; CHEN QY, 1990, PLANT PHYSIOL, V94, P1820, DOI 10.1104/pp.94.4.1820; CHEN QY, 1991, PLANT PHYSIOL, V96, P340, DOI 10.1104/pp.96.1.340; COTE GG, 1990, PLANT BIOL, V9, P113; COTE GG, 1993, ANNU REV PLANT PHYS, V44, P333, DOI 10.1146/annurev.pp.44.060193.002001; DILLENSCHNEIDER M, 1986, FEBS LETT, V208, P413, DOI 10.1016/0014-5793(86)81059-6; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; DROBAK BK, 1991, ESSAYS BIOCHEM, V26, P27; DROBAK BK, 1992, BIOCHEM J, V288, P697, DOI 10.1042/bj2880697; EINSPAHR KJ, 1989, PLANT PHYSIOL, V90, P1115, DOI 10.1104/pp.90.3.1115; EINSPAHR KJ, 1990, PLANT PHYSIOL, V93, P361, DOI 10.1104/pp.93.2.361; EINSPAHR KJ, 1988, J BIOL CHEM, V263, P5775; ETTLINGER C, 1988, NATURE, V331, P176, DOI 10.1038/331176a0; HASEGAWA PM, 1980, PLANT CELL PHYSIOL, V21, P1347, DOI 10.1093/pcp/21.8.1347; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HORN MA, 1989, PLANT CELL, V1, P1003, DOI 10.1105/tpc.1.10.1003; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; KUROSAKI F, 1987, PLANT PHYSIOL, V85, P601, DOI 10.1104/pp.85.3.601; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; LEGENDRE L, 1992, J BIOL CHEM, V267, P20140; LEGENDRE L, 1993, PLANT PHYSIOL, V102, P233, DOI 10.1104/pp.102.1.233; LOW PS, 1986, ARCH BIOCHEM BIOPHYS, V249, P472, DOI 10.1016/0003-9861(86)90024-X; MA H, 1991, GENE, V107, P189; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MEMON AR, 1990, J BIOL CHEM, V265, P14817; MORRE DJ, 1984, J BIOL CHEM, V259, P5364; MORSE MJ, 1990, PLANT BIOL, V9, P201; MORSE MJ, 1989, PHYSIOL PLANTARUM, V76, P118, DOI 10.1111/j.1399-3054.1989.tb05462.x; NIGAM S, 1992, BIOCHIM BIOPHYS ACTA, V1135, P301, DOI 10.1016/0167-4889(92)90235-4; NORGAUER J, 1992, BIOCHEM J, V282, P393, DOI 10.1042/bj2820393; NOTHNAGEL EA, 1983, PLANT PHYSIOL, V71, P916, DOI 10.1104/pp.71.4.916; PALMER S, 1990, METHODS INOSITIDE RE, P127; PEELER TC, 1990, PHYSIOL PLANTARUM, V78, P324, DOI 10.1034/j.1399-3054.1990.780302.x; QUARMBY LM, 1992, J CELL BIOL, V116, P737, DOI 10.1083/jcb.116.3.737; RYAN CA, 1992, PLANT MOL BIOL, V19, P123, DOI 10.1007/BF00015610; RYAN CA, 1991, ANNU REV PLANT PHYS, V42, P651, DOI 10.1146/annurev.pp.42.060191.003251; SCHWACKE R, 1992, PLANTA, V187, P136, DOI 10.1007/BF00201635; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; STRASSER H, 1986, Z NATURFORSCH C, V41, P717; VANHAASTERT PJM, 1989, ANAL BIOCHEM, V177, P115, DOI 10.1016/0003-2697(89)90024-9; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; YUEH YG, 1993, IN PRESS J CELL BIOL; ZBELL B, 1988, J PLANT PHYSIOL, V133, P353, DOI 10.1016/S0176-1617(88)80215-3	49	184	195	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24559	24563						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227014				2022-12-27	WOS:A1993MG67300012
J	INGLESE, J; FREEDMAN, NJ; KOCH, WJ; LEFKOWITZ, RJ				INGLESE, J; FREEDMAN, NJ; KOCH, WJ; LEFKOWITZ, RJ			STRUCTURE AND MECHANISM OF THE G-PROTEIN-COUPLED RECEPTOR KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-GAMMA-SUBUNITS; RHODOPSIN KINASE; FAMILY; PHOSPHORYLATION; DESENSITIZATION; EXPRESSION; CELLS; IDENTIFICATION; ISOPRENYLATION; SEQUENCE		DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT BIOCHEM, DURHAM, NC 27710 USA	Duke University; Howard Hughes Medical Institute	INGLESE, J (corresponding author), DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT MED, DURHAM, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021					ADAM G, 1969, STRUCTURAL CHEM MOL, P198; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CHUANG TT, 1992, J BIOL CHEM, V267, P6886; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; COX A D, 1992, Critical Reviews in Oncogenesis, V3, P365; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; HAGA K, 1990, FEBS LETT, V268, P43, DOI 10.1016/0014-5793(90)80968-O; HAGA T, 1993, LIFE SCI, V52, P421, DOI 10.1016/0024-3205(93)90297-G; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARGRAVE PA, 1993, INT REV CYTOL, P49; HARIBABU B, 1993, P NATL ACAD SCI USA, V90, P9398, DOI 10.1073/pnas.90.20.9398; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KEMP BE, 1989, CELL SIGNAL, V1, P303, DOI 10.1016/0898-6568(89)90049-1; KIM CM, 1993, J BIOL CHEM, V268, P15412; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; LEE RH, 1990, J BIOL CHEM, V265, P15867; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SIMONDS WF, 1993, TRENDS BIOCHEM SCI, V18, P315; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; STRASSER RH, 1986, BIOCHEMISTRY-US, V25, P1371, DOI 10.1021/bi00354a027; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R	54	403	415	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23735	23738						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226899				2022-12-27	WOS:A1993MF29400001
J	LADERMAN, KA; DAVIS, BR; KRUTZSCH, HC; LEWIS, MS; GRIKO, YV; PRIVALOV, PL; ANFINSEN, CB				LADERMAN, KA; DAVIS, BR; KRUTZSCH, HC; LEWIS, MS; GRIKO, YV; PRIVALOV, PL; ANFINSEN, CB			THE PURIFICATION AND CHARACTERIZATION OF AN EXTREMELY THERMOSTABLE ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEBACTERIUM PYROCOCCUS-FURIOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUBACTERIUM THERMOTOGA-MARITIMA; COMPLETE NUCLEOTIDE-SEQUENCE; THERMAL-STABILITY; AMYLOLYTIC ENZYME; GENE; PROTEINS; SUBTILIS	The alpha-amylase from Pyrococcus furiosus, a hyperthermophilic archaebacterium, has been purified to homogeneity. The enzyme is a homodimer with a subunit molecular mass of 66 kDa. The isoelectric point is 4.3. The enzyme displays optimal activity, with substantial thermal stability, at 100-degrees-C, with the onset of activity at approximately 40-degrees-C. Unlike mesophilic alpha-amylases there is no dependence on Ca2+ for activity or thermostability. The enzyme displays a broad range of substrate specificity, with the capacity to hydrolyze carbohydrates as simple as maltotriose. No subtrate binding occurs below the temperature threshold of activity, and a decrease in K(m) accompanies an increase in temperature. Except for a decrease in Asp and an increase in Glu, the amino acid composition does not confirm previously defined trends in thermal adaption. Fourth derivative UV spectroscopy and intrinsic fluorescence measurements detected no temperature-dependent structural reorganization. Hydrogen exchange results indicate that the molecule is rigid, with only a slight increase in conformational flexibility at elevated temperature. Scanning microcalorimetry detected no considerable change in the heat capacity function, at the pH of optimal activity, within the temperature range in which activity is induced. The heat absorption peak due to denaturation, under these conditions, occurred within the temperature range of 90-120-degrees-C. When the pH was increased, a change in the shape of the heat absorption peak was observed, which when analyzed thermodynamically shows that the process of heat denaturation is complex and includes at least three stages, indicating that the protein structure consists of three domains. At temperatures below 90-degrees-C no excess heat absorption or change in the CD spectra were observed which could be associated with the cooperative conformational transition of the protein. According to the thermodynamic characteristics of the heat denaturation, the cold denaturation of this protein can be expected only at -3-degrees-C. Therefore, the observed inactivation of this enzyme is not caused by the cooperative change of its tertiary structure. It can be associated only with the gradual changes of protein domain interaction.	JOHNS HOPKINS UNIV,DEPT BIOL,34TH & CHARLES ST,BALTIMORE,MD 21218; NCI,PATHOL LAB,BETHESDA,MD 20892; NIH,NATL CTR RES RESOURCES,BIOMED ENGN & INSTRUMENTAT PROGRAM,BETHESDA,MD 20892	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA								[Anonymous], 1982, JACKKNIFE BOOTSTRAP; ANTRANIKIAN G, 1989, APPL BIOCHEM BIOTECH, V20-1, P267, DOI 10.1007/BF02936488; ARGOS P, 1979, BIOCHEMISTRY-US, V18, P5698, DOI 10.1021/bi00592a028; BAHL H, 1991, APPL ENVIRON MICROB, V57, P1554, DOI 10.1128/AEM.57.5.1554-1559.1991; BALDWIN R, 1987, PROTEIN ENG; BLUMENTALS II, 1990, APPL ENVIRON MICROB, V56, P1992, DOI 10.1128/AEM.56.7.1992-1998.1990; BROWN SH, 1990, APPL ENVIRON MICROB, V56, P1985, DOI 10.1128/AEM.56.7.1985-1991.1990; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; FREIRE E, 1978, BIOPOLYMERS, V17, P463, DOI 10.1002/bip.1978.360170212; GALLY J. A., 1964, BIOPOLYMERS SYMP, V1, P367; GLYMPH JL, 1977, APPL ENVIRON MICROB, V34, P391, DOI 10.1128/AEM.34.4.391-397.1977; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANSEN SA, 1975, J CHROMATOGR, V105, P388, DOI 10.1016/S0021-9673(01)82270-6; HASEGAWA A, 1976, J BIOCHEM, V79, P35, DOI 10.1093/oxfordjournals.jbchem.a131055; HSIU J, 1964, BIOCHEMISTRY-US, V3, P61, DOI 10.1021/bi00889a011; IHARA H, 1985, J BIOCHEM-TOKYO, V98, P95, DOI 10.1093/oxfordjournals.jbchem.a135279; INGHAM KC, 1984, J BIOL CHEM, V259, P1901; KOCH R, 1990, FEMS MICROBIOL LETT, V71, P21, DOI 10.1111/j.1574-6968.1990.tb03792.x; KOCH R, 1991, ARCH MICROBIOL, V155, P572, DOI 10.1007/BF00245352; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS MS, 1992, ANAL ULTRACENTRIFUGA; MAKHATADZE GI, 1990, BIOPOLYMERS, V30, P1001, DOI 10.1002/bip.360301102; MANNING JB, 1961, J BIOL CHEM, V236, P2952; MELASNIEMI H, 1988, BIOCHEM J, V250, P813, DOI 10.1042/bj2500813; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSELEY MH, 1970, BIOTECHNOL BIOENG, V12, P251, DOI 10.1002/bit.260120207; PIHL TD, 1991, J BACTERIOL, V173, P1839, DOI 10.1128/jb.173.6.1839-1844.1991; Privalov P L, 1986, Methods Enzymol, V131, P4; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; STONE KL, 1989, PRACTICAL GUIDE PROT, P33; TAKAGI T, 1971, ENZYMES; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; VALLEE BL, 1959, J BIOL CHEM, V234, P2901; WRBA A, 1990, BIOCHEMISTRY-US, V29, P7584, DOI 10.1021/bi00485a007; YANG M, 1983, NUCLEIC ACIDS RES, V11, P237, DOI 10.1093/nar/11.2.237; YUUKI T, 1985, J BIOCHEM-TOKYO, V98, P1147, DOI 10.1093/oxfordjournals.jbchem.a135381	38	135	142	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24394	24401						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226989				2022-12-27	WOS:A1993MF29400100
J	NAGAO, M; PARIMOO, B; TANAKA, K				NAGAO, M; PARIMOO, B; TANAKA, K			DEVELOPMENTAL, NUTRITIONAL, AND HORMONAL-REGULATION OF TISSUE-SPECIFIC EXPRESSION OF THE GENES ENCODING VARIOUS ACYL-COA DEHYDROGENASES AND ALPHA-SUBUNIT OF ELECTRON-TRANSFER FLAVOPROTEIN IN RAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE SYNTHESIS; FATTY-ACID OXIDATION; NUCLEOTIDE-SEQUENCE; LIVER MITOCHONDRIA; MOLECULAR-CLONING; MEDIUM-CHAIN; GLUCOSE-UTILIZATION; PURIFICATION; ENZYMES	Short chain (SCAD), medium chain (MCAD), and long chain acyl-CoA dehydrogenases (LCAD) catalyze the first step of fatty acid oxidation, while isovaleryl-CoA dehydrogenase (IVD) is involved in leucine oxidation. They are homologous flavoproteins belonging to the acyl-CoA dehydrogenase (ACD) family. Electron transfer flavoprotein (ETF) serves as an obligatory electron acceptor for these reactions. We demonstrated that the expression of SCAD, MCAD, and LCAD and the alpha-subunit of ETF (alpha-ETF) showed a similar developmental pattern, while that of IVD was distinctly different from others. The ontogenic pattern of each enzyme in the liver differed distinctly from that in the heart. The degree of glucagon-enhanced ACD expression in vivo and in vitro in both the liver and heart was especially high in fasted rats. Dexamethasone induced all ACD mRNAs in the heart. In contrast, it strongly suppressed mRNAs of all ACDs and alpha-ETF mRNA in the liver, except IVD mRNA. Dexamethasone induced IVD mRNA in both the liver and heart. Starvation strongly stimulated expression of all five genes in various tissues, with the highest in the heart, except the IVD gene which was down-regulated. The degree of induction by 3-day starvation differed in different age groups of rats. Feeding the rats a fat-free diet for 7 days caused a marked increase of IVD mRNA in the heart, whereas the high fat diet for the same period resulted in a severe decrease of the same degree, suggesting a protein-sparing mechanism. However, these manipulations of dietary fat content had little effect on the expression of other ACD genes.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA	Yale University					NIDDK NIH HHS [DK38154] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038154] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAILEY E, 1973, ENZYME, V15, P239, DOI 10.1159/000481063; BRADY LJ, 1989, DIABETES, V38, P65, DOI 10.2337/diabetes.38.1.65; BRADY PS, 1988, J NUTR, V118, P1128, DOI 10.1093/jn/118.9.1128; BRADY PS, 1989, BIOCHEM J, V260, P93, DOI 10.1042/bj2600093; BRADY PS, 1989, BIOCHEM J, V258, P677, DOI 10.1042/bj2580677; BRADY PS, 1987, BIOCHEM J, V246, P641, DOI 10.1042/bj2460641; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CARROLL JE, 1989, BIOL NEONATE, V55, P185; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COMPERE SJ, 1981, J BIOL CHEM, V256, P6341; DENNE SC, 1987, AM J PHYSIOL, V253, pE608, DOI 10.1152/ajpendo.1987.253.6.E608; DRAHOTA Z, 1964, BIOCHEM J, V93, P61, DOI 10.1042/bj0930061; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELIG P, 1970, NEW ENGL J MED, V282, P166; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; FOSTER PC, 1976, BIOCHEM J, V154, P49, DOI 10.1042/bj1540049; FRERMAN FE, 1983, J BIOL CHEM, V258, P7087; GIBBONS GF, 1991, BIOCHEM J, V275, P87, DOI 10.1042/bj2750087; Greengard O., 1971, Essays Biochem, V7, P159; HARANO Y, 1982, J BIOCHEM-TOKYO, V91, P1739, DOI 10.1093/oxfordjournals.jbchem.a133866; HOLNESS MJ, 1990, BIOCHEM J, V270, P245, DOI 10.1042/bj2700245; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1983, J BIOL CHEM, V258, P9477; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IKEDA Y, 1983, J BIOL CHEM, V258, P1077; INDO Y, 1991, GENOMICS, V11, P609, DOI 10.1016/0888-7543(91)90068-P; ISSAD T, 1987, BIOCHEM J, V246, P241, DOI 10.1042/bj2460241; KELLY DP, 1989, J BIOL CHEM, V264, P18921; KELLY DP, 1992, NEW DEV FATTY ACID O, P143; KILLEWICH LA, 1977, P NATL ACAD SCI USA, V74, P5392, DOI 10.1073/pnas.74.12.5392; KRAUS JP, 1985, NUCLEIC ACIDS RES, V13, P943, DOI 10.1093/nar/13.3.943; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; LAMERS WH, 1982, P NATL ACAD SCI USA, V6, P85; LEVINE S, 1967, ENDOCRINOLOGY, V80, P910, DOI 10.1210/endo-80-5-910; LIN ECC, 1957, BIOCHIM BIOPHYS ACTA, V26, P85, DOI 10.1016/0006-3002(57)90057-4; LOCKWOOD EA, 1970, BIOCHEM J, V120, P49, DOI 10.1042/bj1200049; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MILKOVIC K, 1963, ENDOCRINOLOGY, V73, P535, DOI 10.1210/endo-73-5-535; NAGAO M, 1992, J BIOL CHEM, V267, P17925; PARIMOO B, 1993, GENOMICS, V15, P582, DOI 10.1006/geno.1993.1111; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROSS NS, 1987, BIOCHEM J, V244, P387, DOI 10.1042/bj2440387; RUIZBRAVO N, 1985, ENDOCRINOLOGY, V116, P2489, DOI 10.1210/endo-116-6-2489; RYALL JC, 1986, EUR J BIOCHEM, V156, P453, DOI 10.1111/j.1432-1033.1986.tb09603.x; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; TESSARI P, 1986, J CLIN INVEST, V77, P575, DOI 10.1172/JCI112339; TOWBIN H, 1979, P NATL ACAD SCI USA, V79, P4530; VANVEEN LCP, 1987, METABOLISM, V36, P48, DOI 10.1016/0026-0495(87)90062-X; WARSHAW JB, 1972, DEV BIOL, V28, P537, DOI 10.1016/0012-1606(72)90001-2; WOHLHUET.RM, 1970, J BIOL CHEM, V245, P2391; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013	54	76	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24114	24124						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226958				2022-12-27	WOS:A1993MF29400062
J	SELBIE, LA; SCHMITZPEIFFER, C; SHENG, YH; BIDEN, TJ				SELBIE, LA; SCHMITZPEIFFER, C; SHENG, YH; BIDEN, TJ			MOLECULAR-CLONING AND CHARACTERIZATION OF PKC(IOTA), AN ATYPICAL ISOFORM OF PROTEIN-KINASE-C DERIVED FROM INSULIN-SECRETING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; PANCREATIC-ISLETS; INOSITOL 1,4,5-TRISPHOSPHATE; CYTOSOLIC CA-2+; FAMILY; EXPRESSION; ZETA; ACTIVATION; RELEASE; GLUCOSE	The protein kinase C (PKC) family of serine-threonine kinases comprises at least eight members. These are differentially expressed, show varying affinities for activators such as Ca2+ and lipid species, and are therefore thought to play wide-ranging roles in the regulation of such cellular processes as differentiation, growth, and secretion. The aim of this study was to identify new PKC isoforms in the insulin-secreting cell line RINm5F that might be activated by the alterations in lipid metabolism that accompany nutrient-stimulated insulin release. Fragments of cDNA, derived from RINm5F cell mRNA, were amplified by the polymerase chain reaction using degenerate oligonucleotide primers corresponding to highly conserved regions in the catalytic domains of all known PKCs. A novel sequence generated by this approach was subsequently used to screen cDNA libraries. The entire 587-amino acid coding region of a new PKC isoform, PKCiota, was deduced from two overlapping clones isolated from a human kidney cDNA library. The amino acid sequence of PKCiota showed greatest homology to PKCzeta, with 72% identity overall rising to 84% in the catalytic domain. In contrast, the homology of PKCiota to the other isoforms was less pronounced, with <53% identity even in the highly conserved catalytic region. Further similarities between PKCzeta and PKCiota included a highly conserved pseudosubstrate sequence, the absence of an apparent Ca2+-binding region, and the presence of only one cysteine-rich, zinc finger-like domain. Northern blot analysis, using the full-length PKCiota clone as a probe, revealed a single 4.6-kilobase transcript present predominantly in lung and brain, but also expressed at lower levels in many tissues including pancreatic islets. In CHO-K1 cells stably expressing the PKCiota cDNA under the human beta-actin promoter, the protein was detected as a 65-kDa band by Western blotting using an antibody to the COOH terminus of PKCzeta (conserved in PKCiota). Extracts of transfected CHO-K1 cells also displayed a significantly increased kinase activity using myelin basic protein as a substrate. The results suggest that PKCiota should be included in the atypical subgroup of PKCs whose definitive member is PKCzeta. As such, PKCiota is unlikely to be activated by the diacylglycerol that is derived from phosphoinositide hydrolysis, but might be a target for novel lipid activators that are elevated during nutrient-stimulated insulin secretion.	ST VINCENTS HOSP,GARVAN INST MED RES,384 VICTORIA ST,DARLINGHURST,NSW 2010,AUSTRALIA	Garvan Institute of Medical Research; St Vincents Hospital Sydney			sheng, yong H/C-5052-2013; Schmitz-Peiffer, Carsten/J-6918-2012; Biden, Trevor/AAW-2829-2021	sheng, yong H/0000-0002-4623-9098; Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Biden, Trevor/0000-0001-5211-0234				ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; BACHER N, 1991, MOL CELL BIOL, V11, P126, DOI 10.1128/MCB.11.1.126; BAIER G, 1993, J BIOL CHEM, V268, P4997; BASTA P, 1992, BIOCHIM BIOPHYS ACTA, V1132, P154, DOI 10.1016/0167-4781(92)90006-L; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; EASOM RA, 1990, J BIOL CHEM, V265, P14938; FINKENZELLER G, 1990, NUCLEIC ACIDS RES, V18, P2183, DOI 10.1093/nar/18.8.2183; GENESAN S, 1992, J CELL BIOL, V119, P313; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GOODNIGHT J, 1992, GENE, V122, P305, DOI 10.1016/0378-1119(92)90219-F; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HII CST, 1987, BIOCHEM J, V246, P489, DOI 10.1042/bj2460489; HUBBARD SR, 1991, SCIENCE, V254, P1776; JONES PM, 1991, J MOL ENDOCRINOL, V6, P121, DOI 10.1677/jme.0.0060121; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METZ SA, 1988, DIABETES, V37, P3, DOI 10.2337/diabetes.37.1.3; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ONO Y, 1988, J BIOL CHEM, V263, P6927; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; OSADA S, 1990, J BIOL CHEM, V265, P22434; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PEARS C, 1991, BIOCHEM J, V276, P257, DOI 10.1042/bj2760257; PERSAUD SJ, 1989, BIOCHEM J, V264, P753, DOI 10.1042/bj2640753; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; REGAZZI R, 1990, J BIOL CHEM, V265, P15003; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WOLLHEIM CB, 1990, FEBS LETT, V268, P376, DOI 10.1016/0014-5793(90)81289-Z; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314; YAMATANI T, 1988, ENDOCRINOLOGY, V122, P2826, DOI 10.1210/endo-122-6-2826	42	330	341	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24296	24302						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226978				2022-12-27	WOS:A1993MF29400087
J	URATA, H; KARNIK, SS; GRAHAM, RM; HUSAIN, A				URATA, H; KARNIK, SS; GRAHAM, RM; HUSAIN, A			DIPEPTIDE PROCESSING ACTIVATES RECOMBINANT HUMAN PROCHYMASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CHYMASE; VASOACTIVE INTESTINAL PEPTIDE; MOLECULAR-CLONING; ANGIOTENSIN-II; HUMAN HEART; SUBSTRATE-SPECIFICITY; SUBSTANCE-P; GENE; PROTEASE; IDENTIFICATION	Human chymase (h-chymase) is a serine protease that efficiently converts angiotensin I to II. Its structure and homology to other serine proteases suggest that it is synthesized as a zymogen, and is processed to the active form by cleavage of a 19-residue signal peptide and of a dipeptide pro-segment. To evaluate maturational processing of this enzyme, the proteins encoded by three h-chymase cDNA constructs (wild-type, lacking the pro- or lacking the prepro-segment) were characterized after expression in COS-1 cells. These recombinant proteins were not catalytically active. Purification and NH2-terminal sequence analysis of the protein expressed from the wild-type construct revealed processing to the proenzyme. Prochymase activation was achieved by incubation with a B-cell lymphoma homogenate, which apparently contains a heterologous processing enzyme sensitive to thiol protease inhibitors. NH2-terminal sequence analysis of the activated h-chymase revealed cleavage of the pro-segment, and its biochemical characteristics were identical to those of native h-chymase purified from the myocardium. These findings indicate that processing of the dipeptide pro-segment is necessary and sufficient for activation of human chymase. Such processing is probably also required for the activation of related serine proteases, e.g., cathepsin G, which have homologous dipeptide pro-segments.	CLEVELAND CLIN FDN,RES INST,DEPT CARDIOVASC BIOL,9500 EUCLID AVE,CLEVELAND,OH 44195; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106	Cleveland Clinic Foundation; Case Western Reserve University			Karnik, Sadashiva/Y-2477-2019; Husain, Ahsan/J-6861-2012	Karnik, Sadashiva/0000-0003-0746-2753; Husain, Ahsan/0000-0003-3426-3469	NCRR NIH HHS [RR04871] Funding Source: Medline; NHLBI NIH HHS [HL33713, HL44201] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004871] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044201, P50HL033713] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENFEY PN, 1987, J BIOL CHEM, V262, P5377; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; CAUGHEY GH, 1990, BIOCHEMISTRY-US, V29, P5166, DOI 10.1021/bi00473a024; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956; CHUNG KN, 1989, SCIENCE, V243, P192, DOI 10.1126/science.2911732; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; FRANCONI GM, 1989, J PHARMACOL EXP THER, V248, P947; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P537, DOI 10.1016/0076-6879(90)85044-O; KENDALL RL, 1992, J BIOL CHEM, V267, P20667; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; REILLY CF, 1982, J BIOL CHEM, V257, P8619; SALVESEN G, 1987, BIOCHEMISTRY-US, V26, P2289, DOI 10.1021/bi00382a032; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SOMMERHOFF CP, 1989, J IMMUNOL, V142, P2450; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Trong H Le, 1989, BIOCHEMISTRY-US, V28, P391, DOI 10.1021/BI00427A054; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; WINTROUB BU, 1984, J INVEST DERMATOL, V83, P336, DOI 10.1111/1523-1747.ep12264144	31	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24318	24322						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226981				2022-12-27	WOS:A1993MF29400090
J	COLBY, SM; ALONSO, WR; KATAHIRA, EJ; MCGARVEY, DJ; CROTEAU, R				COLBY, SM; ALONSO, WR; KATAHIRA, EJ; MCGARVEY, DJ; CROTEAU, R			4S-LIMONENE SYNTHASE FROM THE OIL GLANDS OF SPEARMINT (MENTHA-SPICATA) - CDNA ISOLATION, CHARACTERIZATION, AND BACTERIAL EXPRESSION OF THE CATALYTICALLY ACTIVE MONOTERPENE CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; ESCHERICHIA-COLI; SESQUITERPENE CYCLASE; DIPHOSPHATE SYNTHASE; POLYACRYLAMIDE GELS; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; X-PIPERITA; BIOSYNTHESIS; GENE	The committed step in the biosynthesis of monoterpenes in mint (Mentha) species is the cyclization of geranyl pyrophosphate to the olefin (-)-4S-limonene catalyzed by limonene synthase (cyclase). Internal amino acid sequences of the purified enzyme from spearmint oil glands were utilized to design three distinct oligonucleotide probes. These probes were subsequently employed to screen a spearmint leaf cDNA library, and four clones were isolated. Three of these cDNA isolates were full-length and were functionally expressed in Escherichia coli, yielding a peptide that is immunologically recognized by polyclonal antibodies raised against the purified limonene synthase from spearmint and that is catalytically active in generating from geranyl pyrophosphate a product distribution identical to that of the native enzyme (principally limonene with small amounts of the coproducts alpha- and beta-pinene and myrcene). The longest open reading frame is 1800 nucleotides and the deduced amino acid sequence contains a putative plastidial transit peptide of approximately 90 amino acids and a mature protein of about 510 residues corresponding to the native enzyme. Several nucleotide differences in the 5'-untranslated region of all three full-length clones suggest the presence of several limonene synthase genes and/or alleles in the allotetraploid spearmint genome. Sequence comparisons with a sesquiterpene cyclase, epi-aristolochene synthase from tobacco, and a diterpene cyclase, casbene synthase from castor bean, demonstrated a significant degree of similarity between the three terpenoid cyclase types, the first three example of this large family of catalysts to be described from higher plants.	WASHINGTON STATE UNIV, INST BIOL CHEM, PULLMAN, WA 99164 USA	Washington State University					NIGMS NIH HHS [GM-31354] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031354, R01GM031354] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALONSO WR, 1993, ARCH BIOCHEM BIOPHYS, V301, P58, DOI 10.1006/abbi.1993.1114; ALONSO WR, 1992, J BIOL CHEM, V267, P7582; ALONSO WR, 1992, ENVIR SCI R, V44, P239; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON MS, 1989, J BIOL CHEM, V264, P19176; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; ASHBY MN, 1990, MOL BIOL ATHEROSCLER, P27; BREMS DN, 1981, BIOCHEMISTRY-US, V20, P3711, DOI 10.1021/bi00516a007; CANE DE, 1993, GENETICS BIOCH ANTIB; CARATTOLI A, 1991, J BIOL CHEM, V266, P5854; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAMOVITZ D, 1992, FEBS LETT, V296, P305, DOI 10.1016/0014-5793(92)80310-D; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CORI O, 1983, PHYTOCHEMISTRY, V22, P331; CRAMER F, 1967, TETRAHEDRON, V23, P3015, DOI 10.1016/S0040-4020(01)83356-1; CROTEAU R, 1989, J BIOL CHEM, V264, P15309; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROTEAU R, 1976, ARCH BIOCHEM BIOPHYS, V176, P734, DOI 10.1016/0003-9861(76)90217-4; CROTEAU R, 1985, METHOD ENZYMOL, V110, P383; Croteau R, 1991, PLANTA MED S, V57, P10; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; GERSHENZON J, 1990, RECENT ADV PHYTOCHEM, V24, P99; GERSHENZON J, 1992, ANAL BIOCHEM, V200, P130, DOI 10.1016/0003-2697(92)90288-I; GERSHENZON J, 1989, PLANT PHYSIOL, V89, P1351, DOI 10.1104/pp.89.4.1351; GERSHENZON J, 1991, RECENT ADV PHYTOCHEM, V25, P347; Gershenzon J., 1992, HERBIVORES THEIR INT, VVolume 1, P165; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Guenther E, 1972, ESSENTIAL OILS, VIII; HALEY RC, 1969, J CHEM SOC C, P264, DOI 10.1039/j39690000264; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; HARBORNE JB, 1991, ECOLOGICAL CHEM BIOC, P399; HARLEY RM, 1977, BOT J LINN SOC, V74, P71, DOI 10.1111/j.1095-8339.1977.tb01168.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1992, MOL PLANT MICROBE IN, V5, P249, DOI 10.1094/MPMI-5-249; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KJONAAS R, 1983, ARCH BIOCHEM BIOPHYS, V220, P79, DOI 10.1016/0003-9861(83)90389-2; KOBAYASHI S, 1976, CHEM LETT, P1137, DOI 10.1246/cl.1976.1137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanznaster N, 1991, Protein Expr Purif, V2, P69, DOI 10.1016/1046-5928(91)90013-9; MATH SK, 1992, P NATL ACAD SCI USA, V89, P6761, DOI 10.1073/pnas.89.15.6761; MCCASKILL D, 1992, PLANTA, V187, P445, DOI 10.1007/BF00199962; MEADOWS JW, 1991, PLANT MOL BIOL, V17, P1241, DOI 10.1007/BF00028739; PAULY G, 1984, PLANT CELL REP, V5, P19; PEREZ LM, 1990, PLANT PHYSIOL BIOCH, V28, P221; Poulter C. D., 1981, BIOSYNTHESIS ISOPREN, V1, P161; PROCTOR RH, 1993, J BIOL CHEM, V268, P4543; RAJAONARIVONY JIM, 1992, ARCH BIOCHEM BIOPHYS, V296, P49, DOI 10.1016/0003-9861(92)90543-6; RAJAONARIVONY JIM, 1992, ARCH BIOCHEM BIOPHYS, V299, P77, DOI 10.1016/0003-9861(92)90246-S; Sambrook J, 1989, MOL CLONING LABORATO; SATTERWHITE DM, 1987, J CHROMATOGR, V452, P61; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SUGA T, 1988, CHEM LETT, P115, DOI 10.1246/cl.1988.115; Titus DE, 1991, PROMEGA PROTOCOLS AP; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIAL MV, 1981, TETRAHEDRON, V37, P2351, DOI 10.1016/S0040-4020(01)88888-8; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WAGSCHAL K, 1991, TETRAHEDRON, V47, P5933, DOI 10.1016/S0040-4020(01)86486-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZINEKL DF, 1989, NAVAL STORES PRODUCT; [No title captured]	66	212	238	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23016	23024						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226816				2022-12-27	WOS:A1993MF51500012
J	HU, G; QUERIMIT, LA; DOWNING, LA; CHARNESS, ME				HU, G; QUERIMIT, LA; DOWNING, LA; CHARNESS, ME			ETHANOL DIFFERENTIALLY INCREASES ALPHA-2-ADRENERGIC AND MUSCARINIC ACETYLCHOLINE-RECEPTOR GENE-EXPRESSION IN NG108-15 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-PROTEIN; GLIOMA HYBRID-CELLS; DELTA-OPIOID RECEPTORS; ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE; PERTUSSIS TOXIN; HETEROLOGOUS DESENSITIZATION; CHOLINERGIC RECEPTORS; SIGNAL TRANSDUCTION; ALCOHOL WITHDRAWAL	Modulation of alpha2-adrenergic and opioid neurotransmission may contribute to ethanol intoxication, tolerance, and physical dependence. We showed previously that ethanol increased the expression of functional delta-opioid receptors in NG108-15 cells (Charness, M. E., Querimit, L. A., and Diamond, 1. (1986) J. Biol. Chem. 261, 3164-3169). Here we report that long-term (2 days) treatment of NG108-15 cells with ethanol increased the binding of the alpha2-adrenergic receptor (alpha2AR) antagonist [H-3]rauwolscine and the muscarinic acetylcholine receptor (mAChR) antagonist [H-3]quinuclidinyl benzilate by 2.8- and 1.4-fold, respectively. Increased receptor expression was associated with a proportionate increase in the potency of oxymetazoline and carbachol in inhibiting cAMP accumulation. Ethanol did not change the expression of Galpha(i2) and reduced levels of Galpha(s). Pertussis toxin pretreatment did not prevent the ethanol-induced increase in alpha2AR, mAChR, and delta-opioid receptor expression. Ethanol caused a large (3.6-fold), dose-dependent increase in the abundance of alpha(2B)AR mRNA (rat cDNA probe RNG, 4.1-kb transcript). Ethanol-induced increases in alpha(2B)AR and alpha(2C)AR (rat probe RG10, 2.5-kb transcript) mRNAs were first detected after 6 h of exposure to 100 mM ethanol, became maximal after 24 h, and persisted for up to 5 days. In contrast, ethanol caused only a small (1.3-fold) increase in the abundance of hm4 mAChR mRNA and did not change levels of Galpha(i2) and Galpha(s). mRNAs. Our data indicate that clinically attainable concentrations of ethanol regulate alpha2AR gene expression within the time frame of a single session of drinking.	VET ADM MED CTR W ROXBURY,NEUROL SECT 127,1400 VFW PKWY,BOSTON,MA 02132; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV NEUROL,BOSTON,MA 02115; UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIOL,SAN FRANCISCO,CA 94143	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco				Charness, Michael/0000-0002-3301-8966	PHS HHS [R01 06662] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BELCHEVA MM, 1991, J PHARMACOL EXP THER, V259, P302; Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61; BJORKQVIST SE, 1975, ACTA PSYCHIAT SCAND, V52, P256, DOI 10.1111/j.1600-0447.1975.tb00041.x; BLAXALL HS, 1991, J PHARMACOL EXP THER, V259, P323; BURGERMEISTER W, 1978, MOL PHARMACOL, V14, P751; BYLUND D B, 1984, Alcohol, V1, P369, DOI 10.1016/0741-8329(84)90005-3; BYLUND DB, 1992, FASEB J, V6, P832, DOI 10.1096/fasebj.6.3.1346768; BYLUND DB, 1992, MOL PHARMACOL, V42, P1; BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600; CHARNESS ME, 1986, J BIOL CHEM, V261, P3164; CHARNESS ME, 1988, BIOCHEM BIOPH RES CO, V155, P138, DOI 10.1016/S0006-291X(88)81060-X; CHARNESS ME, 1983, SCIENCE, V222, P1426; CHARNESS ME, 1992, DIAGNOSIS TREATMENT, P155; DIEHL AM, 1992, HEPATOLOGY, V16, P1212, DOI 10.1002/hep.1840160518; DUZIC E, 1992, J BIOL CHEM, V267, P9844; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FREEDMAN JE, 1985, J NEUROSCI, V5, P3016; GAYER GG, 1991, J BIOL CHEM, V266, P22279; GEORGE ST, 1988, BIOCHEM BIOPH RES CO, V150, P655; GOLD MS, 1978, LANCET, V2, P599; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; Hamprecht B, 1977, Int Rev Cytol, V49, P99; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HILLER JM, 1984, MOL PHARMACOL, V25, P249; KAHN DJ, 1982, MOL PHARMACOL, V21, P17; KENAKIN TP, 1986, TRENDS PHARMACOL SCI, V7, P93, DOI 10.1016/0165-6147(86)90271-3; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LANIER SM, 1988, J BIOL CHEM, V263, P14491; LANIER SM, 1991, J BIOL CHEM, V266, P10470; LAW PY, 1982, MOL PHARMACOL, V22, P1; LEE S, 1988, FASEB J, V2, P52, DOI 10.1096/fasebj.2.1.2891579; LINNOILA M, 1987, ANN INTERN MED, V107, P875, DOI 10.7326/0003-4819-107-6-875; LORENZ W, 1990, MOL PHARMACOL, V38, P599; MCCLUE SJ, 1990, FEBS LETT, V269, P430, DOI 10.1016/0014-5793(90)81209-7; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MCKENZIE FR, 1990, J BIOL CHEM, V265, P17084; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; MESSING RO, 1991, J BIOL CHEM, V266, P23428; MILES MF, 1991, J BIOL CHEM, V266, P2409; MILES MF, 1992, BIOCHIM BIOPHYS ACTA, V1138, P268, DOI 10.1016/0925-4439(92)90003-6; MOCHLYROSEN D, 1988, NATURE, V333, P848, DOI 10.1038/333848a0; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; NORONHABLOB L, 1987, MOL PHARMACOL, V32, P669; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; TABAKOFF B, 1979, LIFE SCI, V25, P2173, DOI 10.1016/0024-3205(79)90089-4; TATSUMI H, 1990, J NEUROSCI, V10, P1675; THOMAS JM, 1990, J PHARMACOL EXP THER, V252, P616; THOMAS JM, 1986, ENDOCRINOLOGY, V119, P1305, DOI 10.1210/endo-119-3-1305; WAND GS, 1991, ALCOHOL CLIN EXP RES, V15, P705, DOI 10.1111/j.1530-0277.1991.tb00583.x; WILLIAMS RJ, 1993, MOL PHARMACOL, V43, P158; WILSON PD, 1986, J BIOL CHEM, V261, P1503; ZENG DW, 1991, MOL BRAIN RES, V10, P219, DOI 10.1016/0169-328X(91)90064-5; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102; ZHU XZ, 1987, LIFE SCI, V41, P1133, DOI 10.1016/0024-3205(87)90632-1	57	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23441	23447						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226869				2022-12-27	WOS:A1993MF51500075
J	MILGROM, YM; CROSS, RL				MILGROM, YM; CROSS, RL			NUCLEOTIDE-BINDING SITES ON BEEF-HEART MITOCHONDRIAL F(1)-ATPASE - COOPERATIVE INTERACTIONS BETWEEN SITES AND SPECIFICITY OF NONCATALYTIC SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHTLY BOUND ADP; COUPLING FACTOR-I; ADENOSINE-TRIPHOSPHATASE; ATP HYDROLYSIS; CATALYTIC SITES; CHLOROPLAST F1-ATPASE; ESCHERICHIA-COLI; OXIDATIVE-PHOSPHORYLATION; BETA-SUBUNIT; ADENINE-NUCLEOTIDES	We have studied the properties of beef heart mitochondrial F1 having inhibitory MgADP bound at one of the three catalytic sites and various levels of occupancy of the three noncatalytic nucleotide sites including zero, two, or three ADP/ATPs or two ADP/ATP plus one GTP. The properties examined include the rate of MgATP-dependent reactivation and the rate of increase in the fraction of F1 containing transiently bound intermediates. For each form of the enzyme tested, the rate of reactivation closely paralleled the rate of increase in the level of bound intermediates, indicating that when one catalytic site on F1 is blocked by inhibitory MgADP, the remaining two sites are incapable of residual uni- or bi-site activity. It was also found that the stability of the MgADP-inhibited complex decreases with full occupancy of the noncatalytic sites. This demonstrates that the noncatalytic sites modulate the properties of catalytic sites. Finally, it was found that the noncatalytic sites on mitochondrial F1 do not, as has long been believed, bind adenine nucleotides exclusively. Evidence is presented that both GTP and PP(i) bind tightly at noncatalytic sites.	SUNY HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, ADAMS ST, SYRACUSE, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023152, R37GM023152] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 23152] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171; BULYGIN VV, 1988, FEBS LETT, V236, P497, DOI 10.1016/0014-5793(88)80085-1; CNERNYAK BV, 1992, ARCH BIOCHEM BIOPHYS, V295, P247; CROSS RL, 1987, P NATL ACAD SCI USA, V84, P5715, DOI 10.1073/pnas.84.16.5715; CROSS RL, 1982, J BIOL CHEM, V257, P2101; CROSS RL, 1982, J BIOL CHEM, V257, P2874; CROSS RL, 1988, J BIOENERG BIOMEMBR, V20, P395, DOI 10.1007/BF00762200; Cross RL, 1992, MOL MECHANISMS BIOEN, P317; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; DAGGETT SG, 1985, ARCH BIOCHEM BIOPHYS, V236, P815, DOI 10.1016/0003-9861(85)90688-5; DIPIETRO A, 1980, BIOCHEMISTRY-US, V19, P5671, DOI 10.1021/bi00566a002; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; EBEL RE, 1975, J BIOL CHEM, V250, P191; FELDMAN RI, 1985, J BIOL CHEM, V260, P3088; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; GIRAULT G, 1988, J BIOL CHEM, V263, P14690; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; GUERRERO KJ, 1990, FEBS LETT, V270, P187, DOI 10.1016/0014-5793(90)81264-O; HACKNEY DD, 1979, BIOCHEM BIOPH RES CO, V91, P233, DOI 10.1016/0006-291X(79)90608-9; HARRIS DA, 1978, BIOCHIM BIOPHYS ACTA, V504, P364, DOI 10.1016/0005-2728(78)90060-9; HARRIS DA, 1978, BIOCHIM BIOPHYS ACTA, V463, P245, DOI 10.1016/0304-4173(78)90002-2; HARRIS DA, 1993, FEBS LETT, V316, P209, DOI 10.1016/0014-5793(93)81295-B; ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429; JAULT JM, 1993, J BIOL CHEM, V268, P1558; KALASHNIKOVA TY, 1988, FEBS LETT, V230, P163, DOI 10.1016/0014-5793(88)80663-X; KALASHNIKOVA TY, 1988, EUR J BIOCHEM, V177, P213, DOI 10.1111/j.1432-1033.1988.tb14364.x; KAYALAR C, 1977, J BIOL CHEM, V252, P2486; KIRONDE FAS, 1986, J BIOL CHEM, V261, P2544; KIRONDE FAS, 1987, J BIOL CHEM, V262, P3488; KNOWLES AF, 1972, J BIOL CHEM, V247, P6617; MELESE T, 1988, J BIOL CHEM, V263, P5833; MILGROM YM, 1986, BIOL MEMBRANY, V3, P781; MILGROM YM, 1990, J BIOL CHEM, V265, P18725; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; MILGROM YM, 1991, EUR J BIOCHEM, V200, P789, DOI 10.1111/j.1432-1033.1991.tb16246.x; MILGROM YM, 1991, J BIOL CHEM, V266, P11551; MOYLE J, 1975, FEBS LETT, V56, P55, DOI 10.1016/0014-5793(75)80110-4; MURATALIEV MB, 1991, BIOCHEMISTRY-US, V30, P8305, DOI 10.1021/bi00098a004; MURATALIEV MB, 1992, BIOCHEMISTRY-US, V31, P12885, DOI 10.1021/bi00166a025; MURATALIEV MB, 1992, EUR J BIOCHEM, V209, P681, DOI 10.1111/j.1432-1033.1992.tb17336.x; ONEAL CC, 1984, J BIOL CHEM, V259, P5761; PAGAN J, 1990, FEBS LETT, V273, P147, DOI 10.1016/0014-5793(90)81071-U; PEINNEQUIN A, 1992, BIOCHEMISTRY-US, V31, P2088, DOI 10.1021/bi00122a028; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; ROVERI OA, 1980, BIOCHIM BIOPHYS ACTA, V589, P241, DOI 10.1016/0005-2728(80)90041-9; SCHAFER HJ, 1984, J BIOL CHEM, V259, P5301; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; VOGEL PD, 1991, J BIOL CHEM, V266, P6101; VULFSON EN, 1986, BIOL MEMBR, V4, P339; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343; XUE ZX, 1988, J BIOL CHEM, V263, P16880; XUE ZX, 1989, EUR J BIOCHEM, V179, P677, DOI 10.1111/j.1432-1033.1989.tb14600.x; YALAMOVA MV, 1982, BIOCHEM INT, V4, P337; ZHOU JM, 1988, BIOCHEMISTRY-US, V27, P5129, DOI 10.1021/bi00414a027; ZHUO SQ, 1992, J BIOL CHEM, V267, P12916; [No title captured]	63	46	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23179	23185						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226836				2022-12-27	WOS:A1993MF51500037
J	TU, AY; NISHIDA, HI; NISHIDA, T				TU, AY; NISHIDA, HI; NISHIDA, T			HIGH-DENSITY-LIPOPROTEIN CONVERSION MEDIATED BY HUMAN PLASMA PHOSPHOLIPID TRANSFER PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ESTER TRANSFER PROTEIN; LIPID TRANSFER PROTEIN; A-II; EXCHANGE PROTEIN; HDL CONVERSION; PARTICLE-SIZE; FATTY-ACIDS; PURIFICATION; LIPOSOMES	Phospholipid transfer protein (PLTP) was purified from lipoprotein-free human plasma, obtained upon treatment of plasma with dextran sulfate and Ca2+, by employing a series of column chromatography. Upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the purified PLTP showed a single main band, corresponding to the molecular mass of 78 kDa. However, isoelectric focusing of the purified preparation gave multiple bands with pI ranging from 4.3 to 5.1, indicative of microheterogeneity. Purified PLTP was shown to possess not only phospholipid transfer activity, but also high density lipoprotein (HDL) conversion activity (Tu, A.-Y., Nishida, H. I., and Nishida, T. (1990), FASEB J. 4, A2148; Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., and Ehnholm, C. (1993) J. Biol. Chem. 268, 4032-4036). Isolated HDL3 was enlarged to the size of HDL2b upon incubation with purified PLTP for 6 h at 37-degrees-C at the PLTP/HDL3 molar ratio of approximately 1:45. Both the HDL conversion and the phosphatidylcholine transfer activities of purified PLTP were effectively inhibited by rabbit anti-PLTP immunoglobulin G. The primary importance of PLTP in the HDL enlargement that occurs in human plasma upon incubation at 37-degrees-C was shown by the strong inhibitory effect of the anti-PLTP immunoglobulin G. The process of PLTP-mediated HDL enlargement was accompanied by the release of apoproteins, primarily apoA-I. HDL3 enlargement mediated by PLTP was effectively inhibited by the addition of free fatty acids.	UNIV ILLINOIS,DEPT FOOD SCI,BURNSIDES RES LAB,1208 W PENN AVE,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NHLBI NIH HHS [HL-17597] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017597, R37HL017597] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALAUPOVIC P, 1984, CLIN METABOLIC ASPEC, P1; ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, P49, DOI 10.1161/01.ATV.4.1.49; BARTER PJ, 1988, BIOCHEM J, V254, P179, DOI 10.1042/bj2540179; BARTER PJ, 1990, BIOCHIM BIOPHYS ACTA, V1045, P81, DOI 10.1016/0005-2760(90)90206-D; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BREWSTER ME, 1978, BIOCHIM BIOPHYS ACTA, V529, P147, DOI 10.1016/0005-2760(78)90113-3; CHEUNG MC, 1982, J LIPID RES, V23, P747; DAMEN J, 1981, BIOCHIM BIOPHYS ACTA, V665, P538, DOI 10.1016/0005-2760(81)90268-X; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; DOI Y, 1983, J BIOL CHEM, V258, P5840; Doi Y, 1981, Methods Enzymol, V71 Pt C, P753; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; GAMBERT P, 1982, BIOCHIM BIOPHYS ACTA, V713, P1, DOI 10.1016/0005-2760(82)90159-X; GAMBLE W, 1978, J LIPID RES, V19, P1068; GROOT PHE, 1984, J LIPID RES, V25, P684; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; IHM J, 1980, BIOCHEM BIOPH RES CO, V93, P1114, DOI 10.1016/0006-291X(80)90604-X; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; KATO H, 1989, J BIOL CHEM, V264, P4082; KIM YC, 1979, J BIOL CHEM, V254, P9621; KUNITAKE ST, 1982, J LIPID RES, V23, P936; LAGROST L, 1991, BIOCHIM BIOPHYS ACTA, V1082, P204, DOI 10.1016/0005-2760(91)90195-N; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORTON RE, 1982, J LIPID RES, V23, P1058; MUESING RA, 1971, BIOCHEMISTRY-US, V10, P2952; NICHOLS AV, 1989, BIOCHIM BIOPHYS ACTA, V1001, P325, DOI 10.1016/0005-2760(89)90117-3; NICHOLS AV, 1985, BIOCHIM BIOPHYS ACTA, V834, P285, DOI 10.1016/0005-2760(85)90001-3; NICHOLS AV, 1976, BIOCHIM BIOPHYS ACTA, V446, P226, DOI 10.1016/0005-2795(76)90113-6; NISHIDA HI, 1986, J BIOL CHEM, V261, P2028; NISHIDA HI, 1993, FASEB J, V7, pA1269; NISHIDA HI, 1992, FASEB J, V6, pA371; NISHIDA HI, 1990, J BIOL CHEM, V265, P4876; PATTNAIK NM, 1978, BIOCHIM BIOPHYS ACTA, V530, P428, DOI 10.1016/0005-2760(78)90163-7; RYE KA, 1986, BIOCHIM BIOPHYS ACTA, V875, P429, DOI 10.1016/0005-2760(86)90062-7; Spector A., 1986, BIOCH BIOL PLASMA LI, P247; SWEENY SA, 1985, BIOCHIM BIOPHYS ACTA, V835, P279, DOI 10.1016/0005-2760(85)90283-8; Tall A R, 1986, Methods Enzymol, V129, P469; TALL AR, 1983, J BIOL CHEM, V258, P2174; TALL AR, 1977, BIOCHIM BIOPHYS ACTA, V487, P145, DOI 10.1016/0005-2760(77)90051-0; TOLLEFSON JH, 1988, J LIPID RES, V29, P1593; TU AY, 1991, FASEB J, V5, pA794; TU AY, 1991, THESIS U ILLINOIS UR; TU AY, 1990, FASEB J, V4, pA2148; YAMAZAKI S, 1983, J BIOL CHEM, V258, P5847	46	195	197	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23098	23105						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226827				2022-12-27	WOS:A1993MF51500024
J	WATTS, JD; SANGHERA, JS; PELECH, SL; AEBERSOLD, R				WATTS, JD; SANGHERA, JS; PELECH, SL; AEBERSOLD, R			PHOSPHORYLATION OF SERINE-59 OF P56(LCK) IN ACTIVATED T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PROTEIN-KINASE; ANTIGEN RECEPTOR; SIGNAL TRANSDUCTION; INTERLEUKIN-2 PRODUCTION; PHOSPHOLIPASE C-GAMMA-1; LYMPHOCYTES-T; P56LCK; CD4; ASSOCIATION; LCK	p56lck, a member of the src family of non-receptor protein tyrosine kinases, is expressed almost exclusively in cells of lymphoid origin. Recent evidence has implicated p56lck in a critical role both in T cell development and activation. A variety of T cell stimuli induce a shift in the electrophoretic mobility of p56lck from an apparent molecular mass of 56 kDa (p56lck) to 60 kDa (p60lck). This shift in electrophoretic mobility correlates with an increase in the phosphoserine content of the p60lck. We have shown that both 4alpha-phorbol 12beta-myristate acetate and OKT3 treatment of Jurkat cells, as well as 4alpha-phorbol 12beta-myristate acetate treatment of 171.CD4 and LSTRA cells, induced phosphorylation of serine-59 on p56lck in vivo, which correlated with the shift to p60lck. We also demonstrated that the same serine residue could be phosphorylated in vitro with mitogen-activated protein kinases and that this event was capable of reducing p56lck activity in vitro. Combined, these data suggest a novel pathway for the in vivo regulation of p56lck activity.	UNIV BRITISH COLUMBIA, BIOMED RES CTR, 2222 HLTH SCI MALL, VANCOUVER V6T 1Z3, BC, CANADA; UNIV BRITISH COLUMBIA, DEPT BIOCHEM, VANCOUVER V6T 1W5, BC, CANADA; UNIV BRITISH COLUMBIA, DEPT MED, VANCOUVER V6T 1W5, BC, CANADA; KINETEK BIOTECHNOL CORP, RICHMOND V7C 1T6, BC, CANADA	University of British Columbia; University of British Columbia; University of British Columbia								ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ACRES RB, 1986, J BIOL CHEM, V261, P6210; AEBERSOLD R, 1991, ANAL BIOCHEM, V199, P51, DOI 10.1016/0003-2697(91)90268-X; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; BLUE ML, 1987, J IMMUNOL, V139, P3949; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CASNELLIE JE, 1986, J BIOL CHEM, V261, P4921; CHALUPNY NJ, 1991, EMBO J, V10, P1201, DOI 10.1002/j.1460-2075.1991.tb08061.x; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COLLINS TL, 1992, J IMMUNOL, V148, P2159; DIANZANI U, 1992, J IMMUNOL, V148, P678; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; ETTEHADIEH E, 1992, SCIENCE, V255, P853, DOI 10.1126/science.1311128; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; HOXIE JA, 1986, J IMMUNOL, V137, P1194; HURLEY TR, 1989, ONCOGENE, V4, P265; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LUO K, 1990, ONCOGENE, V5, P803; LUO KX, 1992, MOL CELL BIOL, V12, P4724, DOI 10.1128/MCB.12.10.4724; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MARTH JD, 1989, J IMMUNOL, V142, P2430; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NEL AE, 1990, J IMMUNOL, V145, P971; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OSTERGAARD HL, 1990, J EXP MED, V172, P347, DOI 10.1084/jem.172.1.347; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297, DOI 10.1139/o90-194; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; RATNOFSKY SE, 1987, J EXP MED, V166, P1747, DOI 10.1084/jem.166.6.1747; ROSENSTEIN Y, 1989, J EXP MED, V169, P149, DOI 10.1084/jem.169.1.149; ROSSOMANDO AJ, 1991, J BIOL CHEM, V266, P20270; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TREVILLYAN JM, 1986, BIOCHIM BIOPHYS ACTA, V888, P286, DOI 10.1016/0167-4889(86)90228-4; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; WATTS JD, 1992, J BIOL CHEM, V267, P901; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; WETTENHALL REH, 1991, METHOD ENZYMOL, V201, P186; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230	59	80	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23275	23282						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226850				2022-12-27	WOS:A1993MF51500052
J	KITAGAWA, H; NAKADA, H; FUKUI, S; FUNAKOSHI, I; KAWASAKI, T; TATE, S; INAGAKI, F; YAMASHINA, I				KITAGAWA, H; NAKADA, H; FUKUI, S; FUNAKOSHI, I; KAWASAKI, T; TATE, S; INAGAKI, F; YAMASHINA, I			NOVEL GANGLIOSIDES CONTAINING THE SIALYL-LE(A) STRUCTURE FROM A HUMAN RECTAL ADENOCARCINOMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-FUCOPENTAOSE-II; MONOCLONAL-ANTIBODY; HUMAN-MILK; LEA STRUCTURE; OLIGOSACCHARIDES; ANTIGEN; CANCER; MUCIN; GLYCOPROTEINS; RECOGNIZES	Oligosaccharides were released from the gangliosides of a human rectal adenocarcinoma with endoglycoceramidase (Rhodococcus sp. G-74-2) and then purified by affinity chromatography on a column of an immobilized monoclonal antibody, MSW 113. Structural studies, involving 600-MHz H-1 NMR spectrometry, indicated the structures of these compounds to be as follows. [GRAPHICS]. Three of these oligosaccharides, 2, 3, and 4, are novel as to ganglioside sugar chains and contain both lacto series types 1 and 2 chains. Oligosaccharides 3 and 4 are unique in that they contain the sialyl-Le(a)-X structure in linear and branched structures. Gangliosides with the oligosaccharide structures presented above might be new potential tumor markers.	KYOTO SANGYO UNIV,FAC ENGN,DEPT BIOTECHNOL,KITA KU,KYOTO 603,JAPAN; KYOTO UNIV,FAC PHARMACEUT SCI,DEPT BIOL CHEM,SAKYO KU,KYOTO 606,JAPAN; TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC PHYSIOL,BUNKYO KU,TOKYO 113,JAPAN	Kyoto Sangyo University; Kyoto University; Tokyo Metropolitan Institute of Medical Science			Tate, Shin-ichi/E-3057-2015; Kitagawa, Hiroshi/AAJ-1344-2020	Tate, Shin-ichi/0000-0002-5556-7712; Kitagawa, Hiroshi/0000-0002-9307-7079				FUKUI S, 1988, JPN J CANCER RES, V79, P1119, DOI 10.1111/j.1349-7006.1988.tb01535.x; FUKUSHI Y, 1986, BIOCHEMISTRY-US, V25, P2859, DOI 10.1021/bi00358a018; HAKOMORI S, 1985, CANCER RES, V45, P2405; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; HAKOMORI S, 1981, BIOCHEM BIOPH RES CO, V100, P1578, DOI 10.1016/0006-291X(81)90699-9; HOLMES EH, 1986, J BIOL CHEM, V261, P3737; ITO M, 1986, J BIOL CHEM, V261, P14278; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; KITAGAWA H, 1988, J BIOCHEM-TOKYO, V104, P817, DOI 10.1093/oxfordjournals.jbchem.a122555; KITAGAWA H, 1988, J BIOCHEM-TOKYO, V104, P591, DOI 10.1093/oxfordjournals.jbchem.a122516; KITAGAWA H, 1990, J BIOL CHEM, V265, P4859; KITAGAWA H, 1989, BIOCHEMISTRY-US, V28, P8891, DOI 10.1021/bi00448a031; KITAGAWA H, 1991, BIOCHEMISTRY-US, V30, P2869, DOI 10.1021/bi00225a020; KITAGAWA H, 1991, BIOCHEM BIOPH RES CO, V178, P1429, DOI 10.1016/0006-291X(91)91053-F; KUROSAKA A, 1988, J BIOL CHEM, V263, P8724; KUROSAKA A, 1987, FEBS LETT, V215, P137, DOI 10.1016/0014-5793(87)80128-X; LANGONE JJ, 1980, METHOD ENZYMOL, V70, P365; LEDEEN RW, 1973, J NEUROCHEM, V21, P829, DOI 10.1111/j.1471-4159.1973.tb07527.x; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MAGNANI JL, 1983, CANCER RES, V43, P5489; MARTENSSON S, 1988, CANCER RES, V48, P2125; NUDELMAN E, 1986, J BIOL CHEM, V261, P5487; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; SMITH DF, 1987, J BIOL CHEM, V262, P12040; WIERUSZESKI JM, 1985, CARBOHYD RES, V137, P127, DOI 10.1016/0008-6215(85)85154-5; YAMASHITA K, 1977, J BIOL CHEM, V252, P5408	26	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26541	26545						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253783				2022-12-27	WOS:A1993MK42500077
J	ARDAIL, D; GASNIER, F; LERME, F; SIMONOT, C; LOUISOT, P; GATEAUROESCH, O				ARDAIL, D; GASNIER, F; LERME, F; SIMONOT, C; LOUISOT, P; GATEAUROESCH, O			INVOLVEMENT OF MITOCHONDRIAL CONTACT SITES IN THE SUBCELLULAR COMPARTMENTALIZATION OF PHOSPHOLIPID BIOSYNTHETIC-ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ENDOPLASMIC-RETICULUM; PHOSPHATIDYLSERINE IMPORT; PROTEIN TRANSLOCATION; LIPOPROTEIN SECRETION; OUTER-MEMBRANE; FRACTION; PHOSPHATIDYLETHANOLAMINE; HETEROGENEITY; DOLICHOL	The concerted synthesis of phospholipids derived from serine involving two microsomal enzymes (phosphatidylserine synthase and phosphatidylethanolamine N-methyltransferase) and a mitochondrial one (phosphatidylserine decarboxylase) occurs in reconstituted cell-free systems. Subfractionation of crude mitochondria after swelling and separating on a sucrose density gradient resulted in the isolation of two contact site-enriched fractions from total outer membranes and inner membranes, respectively. Estimation of marker enzyme activities shows a high recovery of glucose-6-phosphate phosphatase (a marker for the endoplasmic reticulum) associated with contact site-enriched fractions. Accordingly, the linked synthesis of phosphatidylserine, phosphatidylethanolamine, and at a lesser extent phosphatidylcholine can occur. This biosynthetic pathway was absent from purified contact site-enriched fractions correlative with the absence of glucose-6-phosphate phosphatase activity. Reconstitution experiments, including contact site-enriched fractions incubated with endoplasmic reticulum-rich fraction, led to the restoration of the linked synthesis of phospholipids, thereby demonstrating that a reversible association between these two fractions can occur. These functional interactions between the endoplasmic reticulum and mitochondria are confirmed at the ultra-structural level using either chemical or physical fixation before resin embedding. These results show that the interorganelle trafficking of lipids may involve only highly specialized microdomains of both membranes, thereby allowing the maintenance of a specific lipid composition and distribution within membranes.	LYON SUD MED SCH, DEPT BIOCHEM, CNRS 189, INSERM, BP 12, F-69921 OULLINS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)								AMARCOSTESEC A, 1981, J THEOR BIOL, V89, P217, DOI 10.1016/0022-5193(81)90309-X; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; ARDAIL D, 1991, J BIOL CHEM, V266, P7978; ARDAIL D, 1989, BIOCHEM BIOPH RES CO, V164, P1009, DOI 10.1016/0006-291X(89)91770-1; BARANSKA J, 1980, BIOCHIM BIOPHYS ACTA, V619, P258, DOI 10.1016/0005-2760(80)90074-0; BIERMANS W, 1990, BIOCHIM BIOPHYS ACTA, V1018, P225, DOI 10.1016/0005-2728(90)90254-2; BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R; CASCARANO J, 1982, EXP CELL RES, V139, P39, DOI 10.1016/0014-4827(82)90316-0; DEPIERRE JW, 1975, BIOCHIM BIOPHYS ACTA, V415, P411, DOI 10.1016/0304-4157(75)90006-4; ERIKSSON LC, 1977, CELL TISSUE RES, V179, P17; FOLCH J, 1957, J BIOL CHEM, V226, P497; GASNIER F, 1989, BIOCHIM BIOPHYS ACTA, V980, P339, DOI 10.1016/0005-2736(89)90322-2; GATEAU O, 1978, EUR J BIOCHEM, V88, P613, DOI 10.1111/j.1432-1033.1978.tb12488.x; GIEROW P, 1989, BIOCHEM J, V262, P55, DOI 10.1042/bj2620055; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Humbel B. M., 1989, IMMUNOGOLD LABELING, P115; LEWIS JA, 1973, J CELL SCI, V13, P447; MEIER PJ, 1981, BIOCHIM BIOPHYS ACTA, V646, P283, DOI 10.1016/0005-2736(81)90335-7; MONTISANO DF, 1982, ANAT RECORD, V203, P441, DOI 10.1002/ar.1092030403; OHLENDIECK K, 1986, BIOCHIM BIOPHYS ACTA, V860, P672, DOI 10.1016/0005-2736(86)90567-5; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PFANNER N, 1990, BIOCHIM BIOPHYS ACTA, V1018, P239, DOI 10.1016/0005-2728(90)90257-5; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; ROJO M, 1991, J BIOL CHEM, V266, P20290; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHMID PC, 1981, J LIPID RES, V22, P882; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; SIMBENI R, 1990, J BIOL CHEM, V265, P281; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANCE JE, 1991, J BIOL CHEM, V266, P89; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANDENBOSCH H, 1991, METHOD ENZYMOL, V197, P365; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921	36	95	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25985	25992						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245031				2022-12-27	WOS:A1993MK10000099
J	OKAZAWA, K; SATO, Y; NAKAGAWA, T; ASADA, K; KATO, I; TOMITA, E; NISHITANI, K				OKAZAWA, K; SATO, Y; NAKAGAWA, T; ASADA, K; KATO, I; TOMITA, E; NISHITANI, K			MOLECULAR-CLONING AND CDNA SEQUENCING OF ENDOXYLOGLUCAN TRANSFERASE, A NOVEL CLASS OF GLYCOSYLTRANSFERASE THAT MEDIATES MOLECULAR GRAFTING BETWEEN MATRIX POLYSACCHARIDES IN PLANT-CELL WALLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPAEOLUM-MAJUS L; VIGNA-ANGULARIS; XYLOGLUCAN; CLEAVAGE; AUXIN; GENE; SIZE	Endoxyloglucan transferase is a novel class of glycosyltransferase recently purified from Vigna angularis (Nishitani, K., and Tominaga, R. (1992) J. Biol. Chem. 267, 21058-21064). This enzyme is the first transferase identified that catalyzes molecular grafting between polysaccharide cross-links in the cell wall matrix and participates in reconstruction of the network structure in the cell wall. Based on the NH2-terminal amino acid sequence information of the purified transferase, we have here cloned and sequenced cDNAs derived from five different plant species, V angularis, Triticum aestivum, Arabidopsis thaliana, Lycopersicon esculentum, and Glycine max. In the five plant species, the amino acid sequence of the mature proteins is conserved in the range of 71-90% throughout their length. The consensus sequence for N-linked glycosylation, and four cysteine residues are all conserved in the five species. Thus, the endoxyloglucan transferase protein is ubiquitous among higher plants. The highly conserved DNA sequence will serve as a promising tool for exploring the molecular process by which cell wall construction, and hence cell growth, is regulated.	KAGOSHIMA UNIV, COLL LIBERAL ARTS, DEPT BIOL, KAGOSHIMA 890, JAPAN	Kagoshima University	OKAZAWA, K (corresponding author), TAKARA SHUZO CO LTD, BIOTECHNOL RES LABS, OTSU, SHIGA 52021, JAPAN.			Nishitani, Kazuhiko/0000-0002-0073-9564				Albersheim P, 1976, PLANT BIOCH, P225; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BORRISS R, 1990, MOL GEN GENET, V222, P278, DOI 10.1007/BF00633829; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLELAND RE, 1987, PHYSL CELL EXPANSION, P18; COSGROVE D J, 1989, Planta (Heidelberg), V177, P121, DOI 10.1007/BF00392162; Darvill A., 1980, The biochemistry of plants. A comprehensive treatise. Volume 1. The plant cell., P91; DESILVA J, 1993, PLANT J, V3, P701, DOI 10.1111/j.1365-313X.1993.00701.x; EDWARDS M, 1986, J BIOL CHEM, V261, P9489; EDWARDS M, 1985, PLANTA, V163, P133, DOI 10.1007/BF00395907; FANUTTI C, 1993, PLANT J, V3, P691, DOI 10.1111/j.1365-313X.1993.00691.x; FARKAS V, 1992, ARCH BIOCHEM BIOPHYS, V298, P365, DOI 10.1016/0003-9861(92)90423-T; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; FRY SC, 1988, GROWING PLANT CELL W, P238; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; MEDFORD JI, 1991, PLANT CELL, V3, P359, DOI 10.1105/tpc.3.4.359; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; NISHITANI K, 1981, PHYSIOL PLANTARUM, V52, P482, DOI 10.1111/j.1399-3054.1981.tb02720.x; NISHITANI K, 1991, PHYSIOL PLANTARUM, V82, P490, DOI 10.1111/j.1399-3054.1991.tb02937.x; NISHITANI K, 1992, PLANT CELL PHYSIOL, V33, P1159; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; RAY PM, 1967, J CELL BIOL, V35, P659, DOI 10.1083/jcb.35.3.659; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P357, DOI 10.1104/pp.98.1.357; TALBOTT LD, 1992, PLANT PHYSIOL, V98, P369, DOI 10.1104/pp.98.1.369; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	30	121	142	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25364	25368						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244968				2022-12-27	WOS:A1993MK10000016
J	YOST, JC; SAGE, EH				YOST, JC; SAGE, EH			SPECIFIC INTERACTION OF SPARC WITH ENDOTHELIAL-CELLS IS MEDIATED THROUGH A CARBOXYL-TERMINAL SEQUENCE CONTAINING A CALCIUM-BINDING EF HAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; ANGIOGENESIS INVITRO; NONMINERALIZED TISSUES; PROTEIN SPARC; IMMUNE-SYSTEM; GLYCOPROTEIN; RECEPTOR; THROMBOSPONDIN	SPARC is a secreted, Ca2+-binding protein that modulates cell shape and gene expression (Sage, E. H., and Bornstein, P. (1991) J. Biol. Chem. 266, 14831-14834). In the present study we questioned whether SPARC interacted with an endothelial cell surface receptor. The binding of I-125-SPARC to bovine aortic endothelial cells was dependent on Ca2+ and was sensitive to small changes in extracellular pH; maximal binding occurred at pH 7.1. Scatchard analysis indicated approximately 2.3 x 10(7) binding sites/cell with an apparent K(I) of 1.1 nM. The interaction was diminished specifically by competition with synthetic peptides corresponding to amino acids 54-73 (SPARC54-73) and 254-273 (SPARC254-273). The binding of I-125-SPARC254-273, a sequence containing a Ca2+-binding EF-hand, was saturated within 45 min at a concentration of 5 muM; Scatchard analysis indicated 4.2 x 10(7) sites/cell and a K(I) of 2.4 nM. Iodinated proteins from plasma membranes were affinity-chromatographed on SPARC254-273; several proteins with apparent masses ranging from 153 to 100 kDa (unreduced) or from 153 to 122 kDa (reduced) were eluted with the soluble peptide. These proteins represent candidates for a SPARC receptor(s) that mediates the biological activity of this protein on endothelial cells.	UNIV WASHINGTON,DEPT BIOL STRUCT,SM-20,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL08571, HL03174] Funding Source: Medline; NIGMS NIH HHS [GM 40711] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BADET J, 1989, P NATL ACAD SCI USA, V86, P8427, DOI 10.1073/pnas.86.21.8427; BEEBE DP, 1989, BLOOD, V74, P2034; BENNETT JS, 1991, ANN NY ACAD SCI, V614, P214, DOI 10.1111/j.1749-6632.1991.tb43704.x; CLEZARDIN P, 1988, EUR J BIOCHEM, V175, P275, DOI 10.1111/j.1432-1033.1988.tb14194.x; DARDIK R, 1989, EUR J BIOCHEM, V185, P581, DOI 10.1111/j.1432-1033.1989.tb15153.x; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; ENGSTROM U, 1992, J BIOL CHEM, V267, P16581; FLAUMENHAFT R, 1992, MOL BIOL CELL, V3, P1057, DOI 10.1091/mbc.3.10.1057; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; FUNK SE, 1992, J CELL PHYSL, V154, P53; HASSELAAR P, 1991, J BIOL CHEM, V266, P13178; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; HERMAN IM, 1987, TISSUE CELL, V19, P1, DOI 10.1016/0040-8166(87)90052-8; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; IRUELAARISPE ML, 1991, ARTERIOSCLER THROMB, V11, P805, DOI 10.1161/01.ATV.11.4.805; IRUELAARISPE ML, 1991, LAB INVEST, V64, P174; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P7478; KNIGHTON D, 1987, CURRENT COMMUNICATIO, P150; KOSFELD MD, 1992, J BIOL CHEM, V267, P16230; LANE TF, 1992, J BIOL CHEM, V267, P16736; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; LAWLER J, 1989, BLOOD, V74, P2022; LEUNG LLK, 1992, J BIOL CHEM, V267, P18244; LIBBY P, 1991, LAB INVEST, V64, P5; MADRI JA, 1988, AM J PATHOL, V132, P18; MALAVAL L, 1987, J BONE MINER RES, V2, P457; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; MAYER U, 1991, EUR J BIOCHEM, V198, P141, DOI 10.1111/j.1432-1033.1991.tb15996.x; MORRIS JC, 1990, J BIOL CHEM, V265, P1881; MURPHYULLRICH JE, 1991, J CELL BIOL, V115, P1127, DOI 10.1083/jcb.115.4.1127; PAULI BU, 1988, LAB INVEST, V58, P379; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PURCELL L, 1993, J EXP ZOOL, V265, P153, DOI 10.1002/jez.1402650207; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; RYBAK ME, 1989, BLOOD, V73, P1534; SAGE EH, 1991, J BIOL CHEM, V266, P14831; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; SAGE H, 1986, VASCULAR ENDOTHELIUM, V2, P198; SANZO MA, 1990, BIOCHEM J, V269, P475, DOI 10.1042/bj2690475; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SIMIONESCU N, 1988, ENDOTHELIAL CELL BIO; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; VANZOELEN EJJ, 1989, BIOCHEM J, V262, P549, DOI 10.1042/bj2620549; WIGHT TN, 1989, ARTERIOSCLEROSIS, V9, P1, DOI 10.1161/01.ATV.9.1.1; WRENN DS, 1988, J BIOL CHEM, V263, P2280	49	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25790	25796						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245016				2022-12-27	WOS:A1993MK10000075
J	FABER, S; OBRIEN, RM; IMAI, E; GRANNER, DK; CHALKLEY, R				FABER, S; OBRIEN, RM; IMAI, E; GRANNER, DK; CHALKLEY, R			DYNAMIC ASPECTS OF DNA-PROTEIN INTERACTIONS IN THE TRANSCRIPTIONAL INITIATION COMPLEX AND THE HORMONE-RESPONSIVE DOMAINS OF THE PHOSPHOENOLPYRUVATE CARBOXYKINASE PROMOTER IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; ENHANCER-BINDING-PROTEIN; GTP GENE; REGULATORY ELEMENTS; MULTIHORMONAL REGULATION; PREINITIATION COMPLEX; MECHANISM INVIVO; NUCLEAR FACTORS; IDENTIFICATION; EXPRESSION	Transcription initiation of the gene encoding phosphoenolpyruvate carboxykinase (PEPCK) is stimulated by glucocorticoids and glucagon, via cAMP, and dominantly inhibited by insulin in rat liver and H4IIE cells. Lysolecithin-permeabilized H4IIE cells recover completely and continue to multiply, yet are transiently penetrable by macromolecules. These cells, after various hormonal treatments, were utilized for in situ DNase I protection studies of the PEPCK promoter. Nearly all of the sites of protein interaction observed in vitro are protected in vivo as well as several additional sites. The DNase I protection pattern is the same in cells without or with any of the hormone treatments, suggesting that hormonal modulation of transcription does not involve addition or removal of factors from the hormone response elements of the promoter. We focused on the organization and stability of the transcription initiation complex as well as the dynamic nature of distal promoter factors in their interaction with DNA. The transcription initiation complex was detected, and it appears to be coexistent with a short region of naked single-stranded DNA over the TATA box on the template strand, as determined by potassium permanganate reactivity. This complex is quite stable, even under conditions of much reduced RNA synthesis, which suggests that the complex is not broken down and reformed with each round of initiation by RNA polymerase II. Other factors bind to the PEPCK promoter with half-lives ranging from a few minutes to more than 40 min. The cAMP response element apparently involves transcriptional modulation achieved through modification of a bound factor (presumably cAMP response element-binding protein), whereas the glucocorticoid/insulin-responsive region of the promoter functions through factors which are involved in a rapid exchange, suggesting quite different modes of transcriptional regulation.	VANDERBILT UNIV, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Vanderbilt University					NIDDK NIH HHS [DK 42502] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEALE EG, 1985, J BIOL CHEM, V260, P748; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BURATOWSKI S, 1991, P NATL ACAD SCI USA, V88, P7509, DOI 10.1073/pnas.88.17.7509; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; CHU DTW, 1986, J BIOL CHEM, V261, P6848; CONTRERAS R, 1981, NUCLEIC ACIDS RES, V9, P215, DOI 10.1093/nar/9.2.215; FABER S, 1991, NUCLEIC ACIDS RES, V19, P4681, DOI 10.1093/nar/19.17.4681; GIRALT M, 1991, J BIOL CHEM, V266, P21991; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IP YT, 1989, MOL CELL BIOL, V9, P1289, DOI 10.1128/MCB.9.3.1289; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LI Z, 1989, GENE DEV, V3, P1814, DOI 10.1101/gad.3.11.1814; LIU JS, 1991, J BIOL CHEM, V266, P19095; MAGNUSON MA, 1987, J BIOL CHEM, V262, P14917; MANIATIS T, 1982, MOL CLONING LAB MANU, pE3; Maxam A M, 1980, Methods Enzymol, V65, P499; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MILLER MR, 1978, BIOCHEMISTRY-US, V17, P1073, DOI 10.1021/bi00599a021; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; TRUS M, 1990, MOL CELL BIOL, V10, P2418, DOI 10.1128/MCB.10.5.2418; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714; ZHANG L, 1990, NUCLEIC ACIDS RES, V18, P1797, DOI 10.1093/nar/18.7.1797	44	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24976	24985						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227059				2022-12-27	WOS:A1993MG67300068
J	HE, ZP; DUNKER, AK; WESSON, CR; TRUMBLE, WR				HE, ZP; DUNKER, AK; WESSON, CR; TRUMBLE, WR			CA2+-INDUCED FOLDING AND AGGREGATION OF SKELETAL-MUSCLE SARCOPLASMIC-RETICULUM CALSEQUESTRIN - THE INVOLVEMENT OF THE TRIFLUOPERAZINE-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; CALMODULIN-BINDING; CALCIUM RELEASE; PHENYL-SEPHAROSE; TROPONIN-C; PROTEIN; PURIFICATION; LOCALIZATION; VESICLES; DOMAINS	Calsequestrin is an intermediate affinity, high capacity Ca2+-binding protein found in the lumen of the sarcoplasmic reticulum of both skeletal and cardiac muscle cells. Previous sequence analysis suggested that calsequestrin may contain a hydrophobic binding site for the drug trifluoperazine, a site shared by the calmodulin family and shown to play a role in calmodulin/calmodulin receptor interaction. Previous studies showed that, upon Ca2+ binding, calsequestrin undergoes a conformational change, burying the trifluoperazine-binding site, folding into a more compact structure that is trypsin-resistant, and increasing the negative ellipticity of the circular dichroism spectrum. In this study, the structural and functional roles of the trifluoperazine-binding site in the Ca2+-induced conformational change of calsequestrin are further studied using the calmodulin antagonists trifluoperazine and melittin. If trifluoperazine or melittin is added to calsequestrin prior to Ca2+ addition, then Ca2+-induced folding is inhibited as determined by the changes in circular dichroism spectra and protein sensitivity to trypsin digestion. If, however, Ca2+ is added prior to trifluoperazine or melittin, calsequestrin remains resistant to trypsin digestion, just as if the calmodulin antagonists are not present, suggesting that the conformational change is not affected. Aggregates of calsequestrin that exhibit high Ca2+ binding capacity have previously been shown to occur at high Ca2+ and calsequestrin concentrations. By preventing a prerequisite folding step, trifluoperazine or melittin also prevents the Ca2+-induced aggregation of calsequestrin, thus decreasing the maximal Ca2+ binding by calsequestrin. These data suggest that the trifluoperazine-binding site is critically involved in the Ca2+-induced intramolecular folding step required for the intermolecular interactions leading to high capacity Ca2+-binding by calsequestrin.	UNIV IDAHO, DEPT BACTERIOL & BIOCHEM, MOSCOW, ID 83843 USA; WASHINGTON STATE UNIV, DEPT BIOCHEM & BIOPHYS, PULLMAN, WA 99164 USA	Idaho; University of Idaho; Washington State University								AARON BMB, 1984, J BIOL CHEM, V259, P1876; BARNETTE MS, 1983, PSYCHOPHARMACOL BULL, V19, P387; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; CACHIA PJ, 1985, CALMODULIN ANTAGONIS, P63; CALA SE, 1983, J BIOL CHEM, V258, P1932; CHIESI M, 1981, J CELL BIOL, V91, P728, DOI 10.1083/jcb.91.3.728; CIFUENTES ME, 1989, ARCH BIOCHEM BIOPHYS, V273, P554, DOI 10.1016/0003-9861(89)90515-8; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COZENS B, 1984, J BIOL CHEM, V259, P6248; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; GARIEPY J, 1983, BIOCHEMISTRY-US, V22, P1586, DOI 10.1021/bi00276a010; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; IKEMOTO N, 1972, J BIOL CHEM, V247, P7835; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; IKEMOTO N, 1991, BIOCHEMISTRY-US, V30, P5230, DOI 10.1021/bi00235a017; IKEMOTO N, 1971, BIOCHEM BIOPH RES CO, V44, P1510, DOI 10.1016/S0006-291X(71)80257-7; JARRETT HW, 1984, J BIOL CHEM, V259, P136; JORGENSEN AO, 1979, J CELL BIOL, V80, P372, DOI 10.1083/jcb.80.2.372; JORGENSEN AO, 1983, J CELL BIOL, V97, P1573, DOI 10.1083/jcb.97.5.1573; KATOH N, 1982, BIOCHEM J, V202, P217, DOI 10.1042/bj2020217; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; KEMP BE, 1987, J BIOL CHEM, V262, P2542; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN RM, 1977, MOL PHARMACOL, V13, P690; MacLennan D., 1983, CALCIUM CELL FUNCT, V4, P151; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MASSOM L, 1990, BIOCHEMISTRY-US, V29, P671, DOI 10.1021/bi00455a012; MASSOM LR, 1991, BIOCHEMISTRY-US, V30, P663, DOI 10.1021/bi00217a011; MAURER A, 1985, P NATL ACAD SCI USA, V82, P4036, DOI 10.1073/pnas.82.12.4036; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; OHNISHI M, 1987, BIOCHEMISTRY-US, V26, P7458, DOI 10.1021/bi00397a039; OSTWALD TJ, 1974, J BIOL CHEM, V249, P5867; PALLEROS DR, 1993, BIOCHEMISTRY-US, V32, P4314, DOI 10.1021/bi00067a021; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SOMLYO AV, 1981, J CELL BIOL, V90, P577, DOI 10.1083/jcb.90.3.577; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TANAKA M, 1986, ARCH BIOCHEM BIOPHYS, V251, P369, DOI 10.1016/0003-9861(86)90084-6; Weiss B, 1978, Adv Cyclic Nucleotide Res, V9, P285; WILLIAMS RW, 1986, J BIOL CHEM, V261, P2408	43	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24635	24641						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227022				2022-12-27	WOS:A1993MG67300022
J	LISSOOS, TW; BENO, DWA; DAVIS, BH				LISSOOS, TW; BENO, DWA; DAVIS, BH			1,25-DIHYDROXYVITAMIN-D(3) ACTIVATES RAF KINASE AND RAF PERINUCLEAR TRANSLOCATION VIA A PROTEIN-KINASE C-DEPENDENT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ITO-CELL ACTIVATION; RETINOIC ACID; SIGNAL TRANSDUCTION; FOS/EGR EXPRESSION; PHOSPHORYLATION; LIPOCYTES; MEMBRANE; COLLAGEN; CASCADE; CULTURE	1,25-Dihydroxyvitamin D3's (D3) potential mitogenic mechanism of action was pursued in cultured rat hepatic Ito cells, a fibrogenic effector cell which proliferates in vivo during liver injury and fibrogenesis. D3 stimulated Ito cell DNA synthesis and potentiated platelet-derived growth factor-induced mitogenesis. D3's enhancement of [H-3]thymidine incorporation was associated with nuclear Egr expression. Recent studies have causally linked the activated proto-oncogene c-Raf with downstream Egr induction. The serine-threonine kinase Raf protein is phosphorylation-activated by a large array of agonists including plasma membrane and cytoplasmic tyrosine kinases but has not previously been associated with the steroid superfamily of mediators. To consider potential prenuclear acute pathways of D3-induced stimulation, the activation of Raf was examined following D3 exposure. D3 induced Raf activation as assessed via (a) enhanced Raf phosphorylation following in vivo P-32 labeling, (b) enhanced kinase function utilizing exogenous histone 1 protein as substrate, and (c) the shift in Raf physical localization changing from a diffuse cytoplasmic distribution to a perinuclear domain. A similar activation of Raf kinase was found in 3T3 cells exposed to D3 with enhanced histone phosphorylation detectable within 1 min following stimulation. The proximal cascade leading to Raf kinase activation may involve a protein kinase C-dependent pathway, since vitamin D-stimulated kinase activity was severely attenuated by previous phorbol ester treatment for 20 h or staurosporine pretreatment.	UNIV CHICAGO,DEPT MED,GASTROENTEROL SECT,MC 4076,5841 S MARYLAND AVE,CHICAGO,IL 60637	University of Chicago					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040223, T32DK007074, P30DK042086] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42086, DK40223, DK 07074-18] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENO DWA, 1992, HEPATOLOGY, V16, pA157; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; DAVIS BH, 1988, J CELL PHYSIOL, V136, P547, DOI 10.1002/jcp.1041360323; DAVIS BH, 1991, BIOCHEM J, V278, P43, DOI 10.1042/bj2780043; DAVIS BH, 1992, HEPATOLOGY, V16, pA96; DAVIS BH, 1990, J CLIN INVEST, V86, P2062, DOI 10.1172/JCI114943; DRITTANTI L, 1989, BIOCHIM BIOPHYS ACTA, V1014, P112, DOI 10.1016/0167-4889(89)90022-0; FRIEDMAN SL, 1992, HEPATOLOGY, V16, pA143; KOBAYASHI Y, 1992, HEPATOLOGY, V16, pA143; KOLCH W, 1990, ONCOGENE, V5, P713; LASKIN DL, 1990, SEMIN LIVER DIS, V10, P293, DOI 10.1055/s-2008-1040485; MITSUHASHI T, 1991, J CLIN INVEST, V87, P112; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; OBEID LM, 1990, J BIOL CHEM, V265, P2370; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; RAPP UR, 1991, ONCOGENE, V6, P495; REICHEL H, 1989, NEW ENGL J MED, V320, P980, DOI 10.1056/NEJM198904133201506; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; SIMPSON RU, 1989, J BIOL CHEM, V264, P19710; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SOZERI O, 1992, ONCOGENE, V7, P2259; SUKHATME VP, 1992, P NATL ACAD SCI USA, V89, P1; TIEN X Y, 1992, Gastroenterology, V102, pA581; TIEN XY, 1993, GASTROENTEROLOGY, V104, pA649; TIEN XY, 1992, CLIN RES, V40, pA265; WALI RK, 1990, J CLIN INVEST, V85, P1296, DOI 10.1172/JCI114567	26	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25132	25138						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227076				2022-12-27	WOS:A1993MG67300088
J	NAKAI, M; ENDO, T; HASE, T; MATSUBARA, H				NAKAI, M; ENDO, T; HASE, T; MATSUBARA, H			INTRAMITOCHONDRIAL PROTEIN SORTING - ISOLATION AND CHARACTERIZATION OF THE YEAST MSP1 GENE WHICH BELONGS TO A NOVEL FAMILY OF PUTATIVE ATPASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PRECURSOR PROTEINS; ESCHERICHIA-COLI; IMPORT RECEPTOR; 70-KD PROTEIN; EXPRESSION; IDENTIFICATION; CYTOCHROME-C1; INSERTION; SIGNAL	Replacement of the presequence of yeast cytochrome cl by the amino-terminal 61 residues of MAS70, a yeast mitochondrial outer membrane protein, resulted in exclusive localization of the fusion protein (termed the 61mC1 protein) to the outer membrane. When a cytochrome c1-deficient yeast strain was transformed with a plasmid encoding the fusion protein, the cells could not grow on nonfermentable carbon sources such as glycerol. We isolated a novel yeast gene MSP1 (mitochondrial sorting of proteins) whose overexpression causes mislocalization of the 61mC1 fusion protein to the inner membrane, probably via the intermembrane space, and thereby allows the host cells to grow on glycerol. The predicted MSP1 protein (MSP1) is a hydrophilic 40-kDa polypeptide containing a putative membrane-spanning domain near the amino terminus. Further sequence analyses revealed that MSP1 is a member of a novel family of putative ATPases which share a highly conserved domain of about 185 amino acid residues, including a consensus motif for a nucleotide binding site. MSP1 was found to be an intrinsic mitochondrial outer membrane protein of an apparent molecular mass of 40 kDa with a large domain facing to the cytosol. The MSP1 gene is not essential for the cell growth either on fermentable or nonfermentable carbon sources.	OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN	Osaka University; Osaka University	NAKAI, M (corresponding author), NAGOYA UNIV,FAC SCI,DEPT CHEM,CHIKUSA KU,NAGOYA 46401,JAPAN.		Hase, Toshiharu/H-9271-2013					AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DREUSICKE D, 1986, FEBS LETT, V208, P301, DOI 10.1016/0014-5793(86)81037-7; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; GLICK BS, 1992, TRENDS BIOCHEM SCI, V17, P453, DOI 10.1016/0968-0004(92)90487-T; HAID A, 1983, METHOD ENZYMOL, V96, P192; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HASE T, 1986, FEBS LETT, V197, P199, DOI 10.1016/0014-5793(86)80326-X; HASE T, 1987, J BIOCHEM-TOKYO, V102, P411, DOI 10.1093/oxfordjournals.jbchem.a122068; HASE T, 1983, EMBO J, V2, P2169, DOI 10.1002/j.1460-2075.1983.tb01718.x; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HASE T, 1987, J BIOCHEM, V102, P401, DOI 10.1093/oxfordjournals.jbchem.a122067; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3192; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LI JM, 1992, BIOCHIM BIOPHYS ACTA, V1106, P233, DOI 10.1016/0005-2736(92)90001-3; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; MITOMA J, 1992, J BIOCHEM-TOKYO, V111, P20, DOI 10.1093/oxfordjournals.jbchem.a123712; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; NAKAI M, 1989, J BIOCHEM-TOKYO, V105, P513, DOI 10.1093/oxfordjournals.jbchem.a122698; NAKAI M, 1989, J BIOCHEM-TOKYO, V106, P181, DOI 10.1093/oxfordjournals.jbchem.a122811; NEBLOCK P, 1990, SCIENCE, V248, P1650; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; PAIN D, 1990, NATURE, V347, P444, DOI 10.1038/347444a0; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PFALLER R, 1988, J CELL BIOL, V107, P2483, DOI 10.1083/jcb.107.6.2483; PFANNER N, 1991, TRENDS BIOCHEM SCI, V16, P63, DOI 10.1016/0968-0004(91)90026-R; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; SAMBROOK J, 1988, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHATZ G, 1987, EUR J BIOCHEM, V165, P1, DOI 10.1111/j.1432-1033.1987.tb11186.x; SHERMAN F, 1986, LABORATORY COURSE MA; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; YAFFE MP, 1989, J BIOL CHEM, V264, P21091; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	47	54	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24262	24269						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226973				2022-12-27	WOS:A1993MF29400081
J	LIU, YC; MATTHEWS, KS				LIU, YC; MATTHEWS, KS			DEPENDENCE OF TRP REPRESSOR-OPERATOR AFFINITY, STOICHIOMETRY, AND APPARENT COOPERATIVITY ON DNA-SEQUENCE AND SIZE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRYPTOPHAN-SPECIFIC PERMEASE; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; MET REPRESSOR; NMR ASSIGNMENTS; LAC REPRESSOR; BINDING; PROTEIN; APOREPRESSOR	A series of chemically synthesized trp and mutant operator DNAs was employed to examine trp repressor binding. Although only a single repressor-operator complex was observed for most DNAs as reported previously, varying DNA sequence revealed two retarded complexes with an additional band of faster mobility. The relative intensity of the two retarded bands with varying repressor concentrations suggests that cooperative interactions between dimers may occur in the formation of the predominant repressor-operator complex. Direct stoichiometry measurements demonstrated that a 2:1 stoichiometry (two dimers per operator) is found in the primary repressor-operator complex band and that a 1:1 stoichiometry is observed, when present, for the minor repressor-operator complex band of faster mobility. Similar retardation patterns with a single complex of 2:1 stoichiometry were observed for 40-base pair (bp) trp operators corresponding to TrpEDCBA, aroH, and Trp-PL (a derivative of TrpEDCBA with increased symmetry) operator sequences as well as to hybrid operators containing a half-binding site from TrpEDCBA in conjunction with lac operator sequences, although the apparent affinity for the half-site DNAs was diminished by 10-fold. In contrast, the prominence of the 1:1 dimer-operator complex for Trp-PR, a different derivative of TrpEDCBA with increased symmetry, suggests that sequence context may diminish cooperativity between dimers. The stoichiometry observed was also dependent on the length of TrpEDCBA operator DNA used, shifting from primarily 2:1 for 40- and 33-bp TrpEDCBA DNA to primarily 1:1 for 29-, 26-, and 20-bp TrpEDCBA DNAs. In addition, the stability of the repressor-operator complex to electrophoresis is reduced for DNA lengths of 33, 29, and 26 bp. Based on the binding data and footprinting patterns for two hybrid 40-bp TrpEDCBA/lac half-binding site DNAs, it appears that repressor associates tightly to the specific trp half-site, whereas the non-specific half of the DNA is more loosely bound. These results suggest that repressor dimer-dimer interaction may be an important feature in the trp repressor-operator interaction.	RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251	Rice University					NIGMS NIH HHS [GM22441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARROWSMITH C, 1991, EUR J BIOCHEM, V202, P53, DOI 10.1111/j.1432-1033.1991.tb16344.x; ARROWSMITH CH, 1990, BIOCHEMISTRY-US, V29, P6332, DOI 10.1021/bi00479a002; ARROWSMITH CH, 1989, BIOCHEMISTRY-US, V28, P3875, DOI 10.1021/bi00435a037; ARROWSMITH CH, 1991, J AM CHEM SOC, V113, P4020, DOI 10.1021/ja00010a070; ARVIDSON DN, 1986, J BIOL CHEM, V261, P238; BASS S, 1987, GENE DEV, V1, P565, DOI 10.1101/gad.1.6.565; BENNETT GN, 1978, J MOL BIOL, V121, P179, DOI 10.1016/S0022-2836(78)80004-7; BORDEN KLB, 1992, EUR J BIOCHEM, V204, P137, DOI 10.1111/j.1432-1033.1992.tb16616.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BRENOWITZ M, 1990, BIOCHEMISTRY-US, V29, P3374, DOI 10.1021/bi00465a033; CANN JR, 1989, J BIOL CHEM, V264, P17032; CAREY J, 1989, J BIOL CHEM, V264, P1941; CAREY J, 1991, J BIOL CHEM, V266, P24509; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; CHO KO, 1988, J MOL BIOL, V204, P51, DOI 10.1016/0022-2836(88)90598-0; CHOU WY, 1989, J BIOL CHEM, V264, P18314; FERNANDO T, 1992, BIOCHEMISTRY-US, V31, P3429, DOI 10.1021/bi00128a018; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GROVE CL, 1987, J BACTERIOL, V169, P2158, DOI 10.1128/jb.169.5.2158-2164.1987; GUNSALUS RP, 1986, J BACTERIOL, V167, P272, DOI 10.1128/jb.167.1.272-278.1986; GUNSALUS RP, 1980, P NATL ACAD SCI-BIOL, V77, P7117, DOI 10.1073/pnas.77.12.7117; HARAN TE, 1992, EMBO J, V11, P3021, DOI 10.1002/j.1460-2075.1992.tb05372.x; HAYDOCK PV, 1984, BIOCHEM BIOPH RES CO, V119, P926, DOI 10.1016/0006-291X(84)90862-3; HE JJ, 1990, J BIOL CHEM, V265, P731; HEATWOLE VM, 1991, J BACTERIOL, V173, P3601, DOI 10.1128/jb.173.11.3601-3604.1991; HEATWOLE VM, 1992, J BACTERIOL, V174, P331, DOI 10.1128/jb.174.1.331-335.1992; HEATWOLE VM, 1991, J BACTERIOL, V173, P108, DOI 10.1128/jb.173.1.108-115.1991; HURLBURT BK, 1992, J BIOL CHEM, V267, P16783; HURLBURT BK, 1992, NUCLEIC ACIDS RES, V20, P337, DOI 10.1093/nar/20.2.337; HURLBURT BK, 1990, J BIOL CHEM, V265, P7853; JOACHIMIAK A, 1983, P NATL ACAD SCI-BIOL, V80, P668, DOI 10.1073/pnas.80.3.668; KLEINSCHMIDT C, 1991, NUCLEIC ACIDS RES, V19, P1021, DOI 10.1093/nar/19.5.1021; KLIG LS, 1988, J MOL BIOL, V202, P769, DOI 10.1016/0022-2836(88)90557-8; KUMAMOTO AA, 1987, GENE DEV, V1, P556, DOI 10.1101/gad.1.6.556; LAWSON CL, 1988, NATURE, V333, P869, DOI 10.1038/333869a0; LEPECQ JB, 1966, ANAL BIOCHEM, V17, P100, DOI 10.1016/0003-2697(66)90012-1; LETILLY V, 1993, IN PRESS BIOCHEMISTR; LIU YC, 1991, THESIS RICE U HOUSTO; LUISI BF, 1990, BIOCHIM BIOPHYS ACTA, V1048, P113, DOI 10.1016/0167-4781(90)90047-6; Maniatis T., 1982, MOL CLONING; MARMORSTEIN RQ, 1991, BIOCHEMISTRY-US, V30, P1141, DOI 10.1021/bi00218a036; MARMORSTEIN RQ, 1987, J BIOL CHEM, V262, P4922; Maxam A M, 1980, Methods Enzymol, V65, P499; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PALUH JL, 1986, NUCLEIC ACIDS RES, V14, P7851, DOI 10.1093/nar/14.20.7851; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; Sambrook J, 1989, MOL CLONING LABORATO; SARSERO JP, 1991, J BACTERIOL, V173, P4133, DOI 10.1128/jb.173.13.4133-4143.1991; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; SCHMITZ A, 1979, NUCLEIC ACIDS RES, V6, P111, DOI 10.1093/nar/6.1.111; SCHNEIDER GJ, 1990, J BIOL CHEM, V265, P10198; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; STAACKE D, 1990, EMBO J, V9, P1963, DOI 10.1002/j.1460-2075.1990.tb08324.x; WICK KL, 1991, J BIOL CHEM, V266, P6106; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0; ZHAO D, 1993, J MOL BIOL, V229, P735, DOI 10.1006/jmbi.1993.1076	61	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23239	23249						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226846				2022-12-27	WOS:A1993MF51500048
J	LUNDKATZ, S; WEISGRABER, KH; MAHLEY, RW; PHILLIPS, MC				LUNDKATZ, S; WEISGRABER, KH; MAHLEY, RW; PHILLIPS, MC			CONFORMATION OF APOLIPOPROTEIN-E IN LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-BINDING DOMAIN; A-I; REDUCTIVE METHYLATION; HUMAN-FIBROBLASTS; PROTEIN; COMPLEXES; RESIDUES; CELLS	Lysine (Lys) residues in apolipoprotein (apo) E are known to be involved in binding of apoE-containing lipoproteins to the low density lipoprotein (LDL) receptor. To examine the microenvironments of the Lys residues of apoE-3 in a variety of lipid-associated states, we have used a high resolution C-13-NMR method in which Lys were reductively methylated with [C-13] formaldehyde. Over a wide pH range, the spectrum of apoE in canine HDL(c), a spherical lipoprotein particle, exhibited two peaks from Lys epsilon-amino groups. The two pools of Lys in HDL(c) titrate with pK(a) values of 10.4 (''normal') and 9.3 (''active''). In contrast, eight epsilon-[(CH3)-C-13]2Lys peaks (delta = 42.5-44.5 parts/million) with pK(a) values ranging from 8.2 to 10.1 and 7.8 to 10.5 were observed at pH 9.5 for human and canine apoE, respectively, in discoidal complexes with dimyristoyl glycerophosphocholine. A single Lys microenvironment was observed for apoE present in a disordered, lipid-free, state in 8 M urea, confirming the fact that the lipid environment is modulating the conformation of apoE. The above data demonstrate that the conformation of apoE, as reflected by the Lys microenvironments, on spherical HDL(c) particles is different from that on discoidal complexes.	UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, GLADSTONE INST CARDIOVASC DIS, DEPT PATHOL, SAN FRANCISCO, CA 94140 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, GLADSTONE INST CARDIOVASC DIS, DEPT MED, SAN FRANCISCO, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes	LUNDKATZ, S (corresponding author), MED COLL PENN, DEPT BIOCHEM, PHILADELPHIA, PA 19129 USA.			Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVIRAM M, 1988, J BIOL CHEM, V263, P16842; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHEN GC, 1984, BIOCHEMISTRY-US, V23, P6530, DOI 10.1021/bi00321a039; CHEN GC, 1986, METHOD ENZYMOL, V128, P519; DICK LR, 1988, J BIOL CHEM, V263, P18864; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; GERKEN TA, 1982, J BIOL CHEM, V257, P2894; HAMILTON JA, 1986, METHOD ENZYMOL, V128, P472; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; JENTOFT JE, 1979, J BIOL CHEM, V254, P4366; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1989, J BIOL CHEM, V264, P4818; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDKATZ S, 1991, J BIOL CHEM, V266, P2701; LUNDKATZ S, 1988, J BIOL CHEM, V263, P13831; MAHLEY RW, 1974, CIRC RES, V35, P722, DOI 10.1161/01.RES.35.5.722; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1990, CURRENT OPINION LIPI, V1, P87; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; NOBLE RP, 1968, J LIPID RES, V9, P693; PITAS RE, 1980, J BIOL CHEM, V255, P5454; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; POWNALL HJ, 1987, PLASMA LIPOPROTEINS, P75; RALL SC, 1986, METHOD ENZYMOL, V128, P273; REIJNGOUD DJ, 1984, BIOCHEMISTRY-US, V23, P726, DOI 10.1021/bi00299a022; SCANU A, 1968, P NATL ACAD SCI USA, V59, P890, DOI 10.1073/pnas.59.3.890; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TANFORD C, 1962, ADV PROTEIN CHEM, V17, P69; WARDELL MR, 1991, J LIPID RES, V32, P521; Weisgraber K H, 1986, Methods Enzymol, V129, P145; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1985, ADV EXP MED BIOL, V183, P159; WEISGRABER KH, 1978, J BIOL CHEM, V253, P4171; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194	38	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23008	23015						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226815				2022-12-27	WOS:A1993MF51500011
J	ORNELASSOARES, A; DELENCASTRE, H; DEJONGE, B; GAGE, D; CHANG, YS; TOMASZ, A				ORNELASSOARES, A; DELENCASTRE, H; DEJONGE, B; GAGE, D; CHANG, YS; TOMASZ, A			THE PEPTIDOGLYCAN COMPOSITION OF A STAPHYLOCOCCUS-AUREUS MUTANT SELECTED FOR REDUCED METHICILLIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTIONAL INACTIVATION; STRAIN; GENE; TN551	The peptidoglycan of a Tn551 mutant of Staphylococcus aureus (RUSA208) selected for reduced methicillin resistance was analyzed by reversed-phase high pressure liquid chromatography and mass spectrometry. RUSA208 is a member of a cluster of Tn551 mutants located on fragment A of SmaI digests but is distinct from the femA and femB class of mutants. The peptidoglycan of RUSA208 contained normal parental muropeptides but in diminished amounts only. The major muropeptides of RUSA208 were new components eluting with somewhat longer retention times from the column. Amino acid analysis of these new muropeptides showed identical compositions to the corresponding peaks in the parental strain, but mass spectrometry revealed increased molecular weights by the following mass units: 1 (in monomers), 1 or 2 (in dimers), and 2 or 3 (in trimers). These observations suggest that in RUSA208 the mutational block may be in the amidation of the stem peptide glutamate residues, resulting in the replacement of isoglutamine with free glutamic acid in one or more of the cell wall stem peptides.	INST TECNOL QUIM & BIOL,OEIRAS,PORTUGAL; MICHIGAN STATE UNIV,E LANSING,MI 48824; MIT,DEPT CHEM,CAMBRIDGE,MA 02139	Michigan State University; Massachusetts Institute of Technology (MIT)	ORNELASSOARES, A (corresponding author), ROCKEFELLER UNIV,NEW YORK,NY 10021, USA.		DeJonge, Boudewijn/AAR-6717-2020	Ornelas-Soares, Antonio/0000-0002-2080-2858; Tomasz, Alexander/0000-0003-1520-1983; /0000-0001-6816-8932; Chang, Yoon-Seok/0000-0002-0623-2932				BERGERBACHI B, 1983, J BACTERIOL, V154, P479; BERGERBACHI B, 1992, ANTIMICROB AGENTS CH, V36, P1367, DOI 10.1128/AAC.36.7.1367; DEJONGE BLM, 1993, J BACTERIOL, V175, P2779, DOI 10.1128/JB.175.9.2779-2782.1993; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11255; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOERING RV, 1990, J CLIN MICROBIOL, V28, P426, DOI 10.1128/JCM.28.3.426-429.1990; GUSTAFSON JE, 1993, 93RD P GEN M AM SOC; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; LINDBERG M, 1972, J BACTERIOL, V109, P844, DOI 10.1128/JB.109.2.844-847.1972; MATTHEWS P, 1990, ANTIMICROB AGENTS CH, V34, P1777, DOI 10.1128/AAC.34.9.1777; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; PATTEE PA, 1987, GENET MAPS, V4, P148; Sambrook J, 1989, MOL CLONING LABORATO; SIEWERT G, 1968, J BIOL CHEM, V243, P783; SINHA RK, 1991, ANTIMICROB AGENTS CH, V35, P1753, DOI 10.1128/AAC.35.9.1753; TOMASZ A, 1989, ANTIMICROB AGENTS CH, V33, P1869, DOI 10.1128/AAC.33.11.1869; TOMASZ A, 1990, MOL BIOL STAPHYLOCOC, P565	19	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26268	26272						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253748				2022-12-27	WOS:A1993MK42500041
J	ROBINSON, LJ; RAZZACK, ZF; LAWRENCE, JC; JAMES, DE				ROBINSON, LJ; RAZZACK, ZF; LAWRENCE, JC; JAMES, DE			MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION IS NOT SUFFICIENT FOR STIMULATION OF GLUCOSE-TRANSPORT OR GLYCOGEN-SYNTHASE IN 3T3-L1 ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; SKELETAL-MUSCLE; INSULIN; PHOSPHORYLATION; TRANSLOCATION; LOCALIZATION; PRECEDES; CELLS; RAS	The role of mitogen-activated protein (MAP) kinase in the regulation of glucose metabolism has been investigated by comparing the effects of insulin and epidermal growth factor (EGF) on MAP kinase activation, glucose transport, and glycogen synthase in 3T3-L1 adipocytes. Insulin or EGF treatment for 5 min increased p42mapk and p44mapk activity to the same extent as determined by myelin basic protein kinase activity measurements and phosphotyrosine immunoblotting. The profiles of myelin basic protein kinase activity following MonoQ chromatography of extracts obtained from cells incubated with insulin or EGF were almost identical. Insulin increased glucose transport and GLUT4 translocation to the cell surface by 15- and 7-fold, respectively. EGF had no significant effect on these processes. Insulin increased the glycogen synthase ratio (-Glc-6-P/+Glc-6-P) by 7.5- and 3.5-fold in the presence and absence of glucose, respectively. EGF increased the ratios by only 2- and 1.3-fold, respectively. EGF did not appear to inhibit downstream of MAP kinase, because when adipocytes were incubated with insulin plus EGF, the stimulation of glucose transport and glycogen synthase was similar to that observed with insulin alone. These findings indicate that activation of the MAP kinase isoforms p42mapk and p44mapk is not sufficient for the activation of glucose transport and glycogen synthase in 3T3-L1 adipocytes.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)				James, David/0000-0001-5946-5257	NIDDK NIH HHS [DK42503, DK28312] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042503, R01DK028312] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1993, J BIOL CHEM, V268, P8204; BARSAGI D, 1987, BIOSCIENCE REP, V7, P427, DOI 10.1007/BF01362505; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; CHAN CP, 1987, J BIOL CHEM, V262, P276; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHENG HC, 1986, J BIOL CHEM, V261, P989; CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; GIBBS EM, 1986, J BIOL CHEM, V261, P3944; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; HAYSTEAD TAJ, 1986, BIOCHEM J, V234, P279, DOI 10.1042/bj2340279; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; LAWRENCE JC, 1978, J BIOL CHEM, V253, P2104; LAWRENCE JC, 1992, ANNU REV PHYSIOL, V54, P177, DOI 10.1146/annurev.ph.54.030192.001141; LOTEN EG, 1970, BIOCHEM J, V120, P187, DOI 10.1042/bj1200187; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; PORRAS A, 1992, J BIOL CHEM, V267, P21124; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; REED BC, 1977, P NATL ACAD SCI USA, V74, P4876, DOI 10.1073/pnas.74.11.4876; ROBINSON LJ, 1992, AM J PHYSIOL, V263, pE383, DOI 10.1152/ajpendo.1992.263.2.E383; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; STAGSTED J, 1993, J BIOL CHEM, V268, P1770; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9	29	128	128	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26422	26427						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253768				2022-12-27	WOS:A1993MK42500062
J	WAY, BA; MOONEY, RA				WAY, BA; MOONEY, RA			ACTIVATION OF PHOSPHATIDYLINOSITOL-3-KINASE BY PLATELET-DERIVED GROWTH-FACTOR AND INSULIN-LIKE GROWTH FACTOR-I IS INHIBITED BY A TRANSMEMBRANE PHOSPHOTYROSINE PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDGF BETA-RECEPTOR; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; FACTOR-I; KINASE-ACTIVITY; RAT ADIPOCYTES; GLUCOSE-TRANSPORT; SH2 DOMAINS; ASSOCIATION; PROTEIN	Expression of the transmembrane phosphotyrosine phosphatase (PTPase) CD45 has been shown to inhibit hormone-dependent tyrosine phosphorylation and mitogenesis (Mooney, R. A., Freund, G. G., Way, B. A., and Bordwell, K. L. (1992) J. Biol. Chem. 267, 23443-23446). Here the impact of PTPase expression on insulin-like growth factor-1 (IGF-1) and platelet-derived growth factor- (PDGF) dependent activation of PI-3-K was investigated. In PTPase+ cells, IGF-I and PDGF-dependent PI-3-K activity in antiphosphotyrosine immunoprecipitates was decreased by 62 +/- 13 and 46 +/- 17%, respectively, compared to control cells. Similar decreases in PI-3-K activity associated with anti-PDGF receptor and anti-insulin receptor substrate-1 (IRS-1) immunoprecipitates were also observed. Association of PI-3-K with the hormone-activated PDGF receptor decreased approximately 55%, paralleling its loss of activation in PTPase+ cells. Tyrosine phosphorylation of the 85-kDa subunit of PI-3-K was also inhibited. Similarly, IGF-1 dependent tyrosine phosphorylation of IRS-1 was decreased by 45%, and its association with PI-3-K was decreased by 65% in PTPase+ cells. Finally, PDGF-dependent tyrosine phosphorylation of phospholipase C-gamma1 and GTPase-activating protein was reduced by 60-70% in the PTPase+ cells as was tyrosine phosphorylation of the PDGF receptor associated with these proteins. In summary, expression of a transmembrane PTPase decreased hormone-dependent PI-3-K activation, tyrosine phosphorylation of receptor substrates, and their association with signaling complexes. These data support a role for transmembrane PTPases in the regulation of receptor signal transduction pathways.	UNIV ROCHESTER,SCH MED & DENT,DEPT PATHOL & LAB MED,601 ELMWOOD AVE,ROCHESTER,NY 14642	University of Rochester					NIDDK NIH HHS [DK-38138] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038138] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BJORGE JD, 1990, P NATL ACAD SCI USA, V87, P3816, DOI 10.1073/pnas.87.10.3816; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUGHLIN SR, 1989, SCIENCE, V243, P1191; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; EZAKI O, 1989, J BIOL CHEM, V264, P16118; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; FROST SC, 1987, J BIOL CHEM, V262, P9872; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; GOLD MR, 1993, J IMMUNOL, V150, P377; HAYASHI H, 1992, J BIOL CHEM, V267, P22575; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAVANAUGH WM, 1992, MOL CELL BIOL, V12, P3419; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P3991; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MOONEY RA, 1992, J BIOL CHEM, V267, P23443; MOONEY RA, 1992, J BIOL CHEM, V267, P14054; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; STREULI M, 1988, J IMMUNOL, V141, P3910; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1992, J BIOL CHEM, V267, P22662; SUNG CK, 1992, BIOCHEM BIOPH RES CO, V189, P1024, DOI 10.1016/0006-291X(92)92306-I; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; YAMAMOTO K, 1992, J BIOL CHEM, V267, P11337; YAMAMOTO K, 1992, ENDOCRINOLOGY, V130, P1490, DOI 10.1210/en.130.3.1490; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YU JC, 1991, MOL CELL BIOL, V11, P3780, DOI 10.1128/MCB.11.7.3780; ZHANG B, 1992, J BIOL CHEM, V267, P18320	45	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26409	26415						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253766				2022-12-27	WOS:A1993MK42500060
J	GAO, JL; MURPHY, PM				GAO, JL; MURPHY, PM			SPECIES AND SUBTYPE VARIANTS OF THE N-FORMYL PEPTIDE CHEMOTACTIC RECEPTOR REVEAL MULTIPLE IMPORTANT FUNCTIONAL DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTES REQUIRES; INTERLEUKIN-8 RECEPTOR; EXPRESSION; CLONING; CDNA; AFFINITY	The N-formyl peptide receptor (FPR) is a seven transmembrane-domain receptor that mediates trafficking and activation of phagocytic leukocytes in response to N-formyl oligopeptides such as fMet-Leu-Phe. cDNAs for high affinity FPRs have been cloned from both human (huFPR) and rabbit (rabFPR). To identify functional domains of FPR, we have studied two structurally related ''natural mutants'' that are 100-10,000-fold less sensitive than huFPR and rabFPR to fMet-Leu-Phe owing to sequence differences that are located predominantly in the proposed extracellular and transmembrane domains. The first is murine FPR (muFPR, 76% identical to huFPR) whose gene we have now cloned and expressed in Xenopus oocytes; the second is the previously reported human FPR-like 1 receptor (FPRL1R, 69% identical to huFPR) which was used to construct huFPR-FPRL1R chimeras. Comparison of the structure and function of huFPR, FPRL1R, muFPR, rabFPR, and huFPR-FPRL1R chimeras suggests that multiple non-contiguous residues must be apposed by coordinate folding of all of the extracellular and transmembrane domains in order to form the high affinity fMLF-binding site.	NIAID,HOST DEF LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Gao, Ji-Liang/Y-4397-2019					BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P111; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P389; DIDSBURY JR, 1992, FEBS LETT, V297, P275, DOI 10.1016/0014-5793(92)80555-U; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; KOO C, 1982, BIOCHEM BIOPH RES CO, V106, P442, DOI 10.1016/0006-291X(82)91130-5; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KROLL B, 1991, FEBS LETT, V291, P208, DOI 10.1016/0014-5793(91)81285-G; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; MACKIN WM, 1982, J IMMUNOL, V129, P1608; Maniatis T., 1982, MOL CLONING; MURPHY PM, 1991, J BIOL CHEM, V266, P12560; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; MURPHY PM, 1993, IN PRESS GENE AMST; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAGAWA S, 1992, IMMUNOPHARM IMMUNOT, V14, P625, DOI 10.3109/08923979209005414; Schiffmann E, 1979, Curr Top Cell Regul, V15, P203; SCHULTZ P, 1992, BIOCHEM J, V284, P207, DOI 10.1042/bj2840207; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P421; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALKER BAM, 1991, J LEUKOCYTE BIOL, V50, P600, DOI 10.1002/jlb.50.6.600; XIE YB, 1990, J BIOL CHEM, V265, P21411; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; YE RD, 1993, J IMMUNOL, V150, P1383	36	119	121	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25395	25401						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244972				2022-12-27	WOS:A1993MK10000021
J	HEISLER, LM; SUZUKI, H; LANDICK, R; GROSS, CA				HEISLER, LM; SUZUKI, H; LANDICK, R; GROSS, CA			4 CONTIGUOUS AMINO-ACIDS DEFINE THE TARGET FOR STREPTOLYDIGIN RESISTANCE IN THE BETA-SUBUNIT OF ESCHERICHIA-COLI RNA-POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-DEPENDENT TERMINATION; LAMBDA-PR PROMOTER; LAC UV5 PROMOTER; TRANSCRIPTION TERMINATION; FUNCTIONAL TOPOGRAPHY; COLIPHAGE-LAMBDA; RPOB GENE; INITIATION; DNA; ELONGATION	Streptolydigin (stl), a bacteriostatic inhibitor of transcription elongation, interacts with the beta subunit of Escherichia coli RNA polymerase. We have defined the target for stl resistance using chemical mutagenesis and mutagenic polymerase chain reaction. Mutations resulting in stl resistance are confined to a small cluster of contiguous amino acids, amino acids 543 to 546. These stl(r) mutants differ from one another in their levels of resistance to stl in vivo and in vitro. We have analyzed two of the mutants, A543V and F545S, for their effects on elongation and termination in vivo and in vitro. Neither affected termination at rho-dependent or rho-independent terminators. These mutants were indistinguishable from wild type in a T7 in vitro elongation assay. F545S, however, did exhibit slower elongation kinetics in a lambdaktR1 pausing assay. We conclude that mutations in the stl(r) region can influence transcription elongation, but that these amino acids are not directly involved in catalysis.	UNIV WISCONSIN,DEPT BACTERIOL,MADISON,WI 53706; WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)					NIAID NIH HHS [AI 19635] Funding Source: Medline; NIGMS NIH HHS [GM 38660] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038660, R37GM038660, R01GM038660] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRIGGS J, 1985, CELL, V42, P611; Burgess R.R., 1987, RNA POLYM REGULATION, P3; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CASSANI G, 1971, NATURE-NEW BIOL, V230, P197, DOI 10.1038/newbio230197a0; CHAMBERLIN MJ, 1979, J BIOL CHEM, V254, P61; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; FALKENBURG D, 1987, J MOL BIOL, V195, P929, DOI 10.1016/0022-2836(87)90496-7; GLASS RE, 1986, MOL GEN GENET, V203, P492, DOI 10.1007/BF00422075; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; GRACHEV MA, 1980, FEBS LETT, V115, P23, DOI 10.1016/0014-5793(80)80718-6; GROSS C, 1976, J BACTERIOL, V128, P382, DOI 10.1128/JB.128.1.382-389.1976; GUARENTE L, 1979, J MOL BIOL, V129, P295, DOI 10.1016/0022-2836(79)90283-3; GUARENTE LP, 1978, P NATL ACAD SCI USA, V75, P294, DOI 10.1073/pnas.75.1.294; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HALLING SM, 1978, NATURE, V272, P837, DOI 10.1038/272837a0; HEIL A, 1970, FEBS LETT, V11, P165, DOI 10.1016/0014-5793(70)80519-1; HUDSON GS, 1988, J MOL BIOL, V200, P639, DOI 10.1016/0022-2836(88)90477-9; IWAKURA Y, 1973, MOL GEN GENET, V121, P181, DOI 10.1007/BF00277531; JIN DJ, 1988, J MOL BIOL, V202, P245, DOI 10.1016/0022-2836(88)90455-X; JIN DJ, 1991, J BIOL CHEM, V266, P14478; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JIN J, 1989, MOL GEN GENET, V216, P269, DOI 10.1007/BF00334365; JOHNSTON DE, 1976, RNA POLYM, P101; KASHLEV M, 1990, SCIENCE, V248, P1006, DOI 10.1126/science.1693014; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; LANDICK R, 1990, J BACTERIOL, V172, P2844, DOI 10.1128/jb.172.6.2844-2854.1990; LANDICK R, 1990, GENE DEV, V4, P1626; Leung D, 1988, TECHNIQUE, V1, P11; LUK KC, 1982, GENE, V20, P127, DOI 10.1016/0378-1119(82)90030-0; LUK KC, 1983, VIROLOGY, V125, P403, DOI 10.1016/0042-6822(83)90212-X; LYSITSYN NA, 1985, BIOORG KHIM, V11, P132; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; MATHEWS DE, 1990, J BIOL CHEM, V265, P493; MCCLURE WR, 1979, J BIOL CHEM, V255, P1610; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3652; Miller J.H., 1972, EXPT MOL GENETICS; MORGAN WD, 1983, J BIOL CHEM, V258, P9565; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; OOSAWA K, 1988, CELL, V53, P89, DOI 10.1016/0092-8674(88)90490-4; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; RABUSSAY D, 1969, FEBS LETT, V5, P104, DOI 10.1016/0014-5793(69)80305-4; Sambrook J, 1989, MOL CLONING LABORATO; SCHLEIF R, 1969, NATURE, V223, P1068, DOI 10.1038/2231068a0; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; SIDDHIKOL C, 1969, J BACTERIOL, V99, P151, DOI 10.1128/JB.99.1.151-155.1969; SINGER M, 1989, MICROBIOL REV, V53, P1; SINGER M, 1993, J MOL BIOL, V231, P1, DOI 10.1006/jmbi.1993.1251; SIPPEL A, 1968, BIOCHIM BIOPHYS ACTA, V157, P218, DOI 10.1016/0005-2787(68)90286-4; SPARKOWSKI J, 1992, GENETICS, V130, P411; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; STUDIER W, 1975, FEBS P M, V10, P45; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; UMEZAWA H, 1968, J ANTIBIOT, V21, P234, DOI 10.7164/antibiotics.21.234; VONDERHELM K, 1972, NATURE-NEW BIOL, V235, P82, DOI 10.1038/newbio235082a0; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	66	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25369	25375						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8244969				2022-12-27	WOS:A1993MK10000017
J	CASTUMA, CE; CROOKE, E; KORNBERG, A				CASTUMA, CE; CROOKE, E; KORNBERG, A			FLUID MEMBRANES WITH ACIDIC DOMAINS ACTIVATE DNAA, THE INITIATOR PROTEIN OF REPLICATION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME-REPLICATION; MICROSOMAL MEMBRANE; ORIGIN; CHOLESTEROL; PHOSPHOLIPIDS	Acidic phospholipids in a fluid phase dissociate ADP or ATP tightly bound to DnaA protein and, in the presence of ATP and DNA, can restore an inactive ADP form to full activity (Sekimizu, K., and Kornberg, A. (1988) J. Biol. Chem. 263, 7131-7135). Further studies of the interactions between DnaA protein and lipids have used two functional assays: 1) release of ADP or ATP from DnaA and 2) DNA replication upon rejuvenation of an inactive ADP-DnaA protein complex. Among a variety of phospholipids tested were pure synthetic compounds and the mixtures from Escherichia coli auxotrophs (fabA), which are unable to synthesize unsaturated fatty acids and can be supplemented with different acyl derivatives. Fatty acid composition was determined by gas-liquid chromatography and membrane fluidity by fluorescence spectroscopy using 1,6-diphenyl-1,3,5-hexatriene as a probe. Lipid requirements of DnaA protein were shown to be: 1) phospholipids in a fluid phase (i.e. above the transition temperature), 2) a charged polar head group, 3) a lamellar phase (i.e. hexagonal II structures were inactive), and 4) a certain degree of fluidity imparted by the fatty acids esterified to the glycerol backbone. This conclusion was based on the incorporation of. 1) cholesterol, known to increase the packing of lipids, or 2) a branched fatty acyl derivative, which exhibits a fluidizing effect similar to that of a cis double bond. Both agents demonstrated that membrane fluidity is required for DnaA protein function in vitro, consistent with early studies of chromosome initiation in growing cells.			CASTUMA, CE (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM07851] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CASTUMA CE, 1989, BIOCHEM J, V258, P723, DOI 10.1042/bj2580723; CASTUMA CE, 1991, BIOCHEMISTRY-US, V30, P9492, DOI 10.1021/bi00103a015; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CROOKE E, 1992, J BIOL CHEM, V267, P16779; FRALICK JA, 1973, J MOL BIOL, V80, P459, DOI 10.1016/0022-2836(73)90416-6; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FULLER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5817, DOI 10.1073/pnas.80.19.5817; GRUNER SM, 1985, ANNU REV BIOPHYS BIO, V14, P211, DOI 10.1146/annurev.biophys.14.1.211; HANSEN FG, 1987, EMBO J, V6, P255, DOI 10.1002/j.1460-2075.1987.tb04747.x; HWANG DS, 1990, J BIOL CHEM, V265, P19244; LANDOULSI A, 1990, CELL, V63, P1053, DOI 10.1016/0092-8674(90)90508-C; OGDEN GB, 1988, CELL, V54, P127, DOI 10.1016/0092-8674(88)90186-9; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7136; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Silbert D F, 1974, Methods Enzymol, V32, P856; STRAUME M, 1987, BIOCHEMISTRY-US, V26, P5121, DOI 10.1021/bi00390a034; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; VANDERENDE A, 1985, P NATL ACAD SCI USA, V82, P3954; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; YUNG BYM, 1988, P NATL ACAD SCI USA, V85, P7202, DOI 10.1073/pnas.85.19.7202	23	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24665	24668						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227025				2022-12-27	WOS:A1993MG67300026
J	CEREGHINO, JL; HELINSKI, DR				CEREGHINO, JL; HELINSKI, DR			ESSENTIALITY OF THE 3 CARBOXYL-TERMINAL AMINO-ACIDS OF THE PLASMID RK2 REPLICATION INITIATION PROTEIN TRFA FOR DNA-BINDING AND REPLICATION ACTIVITY IN GRAM-NEGATIVE BACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-RANGE PLASMID-RK2; SITE-DIRECTED MUTAGENESIS; GENETIC-ANALYSIS; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-SEQUENCE; COPY NUMBER; MAINTENANCE; MUTATIONS; ORIGIN; REGION	In a previous study of mutations in trfA, the gene encoding the replication initiation protein of the broad host-range plasmid RK2, a carboxyl-terminal deletion of 3 amino acids of the TrfA protein was found to be completely nonfunctional for RK2 replication in Escherichia coli and other Gram-negative bacteria. In this work site-directed mutagenesis of the trfA gene was carried out to construct TrfA proteins altered in the three carboxyl-terminal positions. Specifically, TrfA proteins with deletions or substitutions of the terminal cysteine, lysine, and arginine (codons 380-382, respectively) were constructed and characterized for their ability to initiate replication from an RK2 origin in vivo in E. coli, Azotobacter vinelandii, Pseudomonas putida, and Agrobacterium tumefaciens and for binding activity to the iterons at the replication origin. Substitutions of the cysteine at position 380 with a glycine or an arginine resulted in a TrfA protein defective in binding to the RK2 origin and, therefore, defective in replication initiation activity in all four Gram-negative bacteria. Substitution of a serine at that position preserved limited function in replication and DNA binding. The lysine at position 381 could be changed to a glutamine without any obvious change in TrfA function. Deletion of the terminal arginine at position 382 did not affect the ability of TrfA to bind to origin iterons but caused a complete loss of replication activity in all four bacteria. Substitution of this terminal arginine with alanine, serine, or glutamic acid also produced replication-defective TrfA protein in all four bacterial hosts while not affecting iteron binding activity. However, substitution of this arginine with a lysine resulted in a loss of replication activity in E. coli and A. vinelandii but had no effect in P. putida and A. tumefaciens. These observations suggest that the terminal arginine plays an essential role in the activity of the TrfA protein, possibly interaction with host proteins, which can be separated from its iteron binding activity.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,DEPT BIOL,9500 GILMAN DR,LA JOLLA,CA 92093	University of California System; University of California San Diego					NIAID NIH HHS [AI-07194] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI007194] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BISHOP PE, 1977, J BACTERIOL, V130, P954, DOI 10.1128/JB.130.2.954-956.1977; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; CHAKRABARTY AM, 1975, P NATL ACAD SCI USA, V72, P3647, DOI 10.1073/pnas.72.9.3647; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; DURLAND RH, 1990, J BACTERIOL, V172, P3859, DOI 10.1128/jb.172.7.3859-3867.1990; DURLAND RH, 1990, J BACTERIOL, V172, P3849, DOI 10.1128/jb.172.7.3849-3858.1990; DURLAND RH, 1987, PLASMID, V18, P164, DOI 10.1016/0147-619X(87)90044-8; DURLAND RH, 1988, THESIS U CALIFORNIA; FANG FC, 1991, J BACTERIOL, V173, P5861, DOI 10.1128/jb.173.18.5861-5868.1991; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; GERMINO J, 1983, P NATL ACAD SCI USA, V79, P5475; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; INGRAM LC, 1973, ANTIMICROB AGENTS CH, V3, P279, DOI 10.1128/AAC.3.2.279; KAHN M, 1980, MOL GEN GENET, V177, P399, DOI 10.1007/BF00271478; KITTELL BL, 1991, P NATL ACAD SCI USA, V88, P1389, DOI 10.1073/pnas.88.4.1389; KORNACKI JA, 1984, PLASMID, V11, P48, DOI 10.1016/0147-619X(84)90006-4; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN J, 1992, J BACTERIOL, V174, P4110, DOI 10.1128/jb.174.12.4110-4119.1992; Maniatis T., 1982, MOL CLONING; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; NEWTON JW, 1953, J BIOL CHEM, V204, P445; PERRI S, 1991, J BIOL CHEM, V266, P12536; PERRI S, 1993, J BIOL CHEM, V268, P3662; PINKNEY M, 1988, J MOL BIOL, V203, P927, DOI 10.1016/0022-2836(88)90118-0; SCHMIDHAUSER TJ, 1983, PLASMID, V9, P325, DOI 10.1016/0147-619X(83)90010-0; SCHMIDHAUSER TJ, 1985, J BACTERIOL, V164, P446, DOI 10.1128/JB.164.1.446-455.1985; SHINGLER V, 1984, J MOL BIOL, V175, P229, DOI 10.1016/0022-2836(84)90346-2; SHINGLER V, 1989, BIOCHIM BIOPHYS ACTA, V1007, P301, DOI 10.1016/0167-4781(89)90152-8; SMITH CA, 1984, J MOL BIOL, V175, P251, DOI 10.1016/0022-2836(84)90347-4; STALKER DM, 1981, MOL GEN GENET, V181, P8, DOI 10.1007/BF00338997; STEMMER WPC, 1991, BIOTECHNIQUES, V10, P726; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TERAWAKI Y, 1988, J BACTERIOL, V170, P1261, DOI 10.1128/jb.170.3.1261-1267.1988; THOMAS CM, 1984, EMBO J, V3, P1513, DOI 10.1002/j.1460-2075.1984.tb02004.x; THOMAS CM, 1981, MOL GEN GENET, V181, P1, DOI 10.1007/BF00338996; THOMAS CM, 1981, PLASMID, V5, P277, DOI 10.1016/0147-619X(81)90005-6; THOMAS CM, 1980, J BACTERIOL, V141, P213, DOI 10.1128/JB.141.1.213-222.1980; Thomas CM, 1989, PROMISCUOUS PLASMIDS, P1; VALLA S, 1991, PLASMID, V25, P131, DOI 10.1016/0147-619X(91)90025-R; VOCKE C, 1983, P NATL ACAD SCI-BIOL, V80, P6557, DOI 10.1073/pnas.80.21.6557; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZENG H, 1990, J BACTERIOL, V172, P2535, DOI 10.1128/jb.172.5.2535-2540.1990	47	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24926	24932						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227054				2022-12-27	WOS:A1993MG67300062
J	HUDER, JB; DIMROTH, P				HUDER, JB; DIMROTH, P			SEQUENCE OF THE SODIUM-ION PUMP METHYLMALONYL-COA DECARBOXYLASE FROM VEILLONELLA-PARVULA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXALOACETATE DECARBOXYLASE; KLEBSIELLA-PNEUMONIAE; GEL-ELECTROPHORESIS; MEMBRANE-PROTEIN; ALCALESCENS; SUBUNIT; TRANSPORT; BACTERIA; CARBOXYLTRANSFERASE; INHIBITORS	The genes encoding methylmalonyl-CoA decarboxylase from Veillonella parvula were cloned on plasmids using oligonucleotides derived from N-terminal amino acid sequences as specific probes. The entire DNA sequence of the methylmalonyl-CoA decarboxylase genes together with upstream and downstream regions was determined. The genes encoding subunits alpha (mmdA), delta (mmdD), epsilon (mmdE), gamma (mmdC), and beta (mmdB) of the decarboxylase were clustered on the chromosome in the given order. The previously unnoted epsilon-chain (M(r) 5,888) was clearly shown to be a subunit of the decarboxylase by correspondence of the N-terminal amino acid sequence with that deduced from the DNA sequence of mmdE. The alpha-subunit was 60% identical with the carboxyltransferase domain of rat liver propionyl-CoA carboxylase, the beta-subunit showed 61% sequence identity with the beta-subunit of oxaloacetate decarboxylase from Klebsiella pneumoniae, and the biotin-containing gamma-subunit was 29-39% identical with biotin-domains of other biotin enzymes. The delta-subunit of methylmalonyl-CoA decarboxylase and the gamma-subunit of oxaloacetate decarboxylase did not show significant sequence homology. The gross structure of both proteins, however, was similar, consisting of a hydrophobic membrane anchor near the N terminus, a proline/alanine linker, and a remarkable accumulation of charged amino acids in the C-terminal part. The sequence of the small epsilon-subunit could be aligned to the C-terminal region of the delta-subunit downstream of the proline/alanine linker, where the two subunits were 47% identical. Of considerable interest for the mechanism of Na+ transport are the long stretches of complete sequence identity between the hydrophobic beta-subunits of methylmalonyl-CoA decarboxylase and oxaloacetate decarboxylase and the presence of two conserved aspartic acid residues within putative membrane-spanning helices.	SWISS FED INST TECHNOL,INST MIKROBIOL,CH-8092 ZURICH,SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich								BEATRIX B, 1990, ARCH MICROBIOL, V154, P362, DOI 10.1007/BF00276532; BENDRAT K, 1993, EUR J BIOCHEM, V211, P697, DOI 10.1111/j.1432-1033.1993.tb17598.x; BUCKEL W, 1986, EUR J BIOCHEM, V156, P281; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DELSAL G, 1988, NUCLEIC ACIDS RES, V16, P9878; DIMROTH P, 1987, MICROBIOL REV, V51, P320, DOI 10.1128/MMBR.51.3.320-340.1987; DIMROTH P, 1983, EUR J BIOCHEM, V137, P107, DOI 10.1111/j.1432-1033.1983.tb07802.x; DIMROTH P, 1992, FEBS LETT, V300, P67, DOI 10.1016/0014-5793(92)80165-D; DIMROTH P, 1990, PHILOS T ROY SOC B, V326, P465, DOI 10.1098/rstb.1990.0025; HILPERT W, 1986, METHOD ENZYMOL, V125, P540; HILPERT W, 1983, EUR J BIOCHEM, V132, P579, DOI 10.1111/j.1432-1033.1983.tb07403.x; HILPERT W, 1991, EUR J BIOCHEM, V195, P79, DOI 10.1111/j.1432-1033.1991.tb15678.x; HOFFMANN A, 1989, EUR J BIOCHEM, V179, P645, DOI 10.1111/j.1432-1033.1989.tb14596.x; KUMAR GK, 1982, J BIOL CHEM, V257, P13828; LAMHONWAH AM, 1987, ARCH BIOCHEM BIOPHYS, V254, P631, DOI 10.1016/0003-9861(87)90146-9; LAUSSERMAIR E, 1989, J BIOL CHEM, V264, P14710; MALOY WL, 1979, J BIOL CHEM, V254, P1615; MILES JS, 1988, J MOL BIOL, V202, P97, DOI 10.1016/0022-2836(88)90522-0; NORTHROP DB, 1969, J BIOL CHEM, V244, P5801; Rodriguez R.L., 1983, RECOMBINANT DNA TECH; Sambrook J, 1989, MOL CLONING LABORATO; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWARZ E, 1988, J BIOL CHEM, V263, P9640; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WOEHLKE G, 1992, J BIOL CHEM, V267, P22798	30	37	65	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24564	24571						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227015				2022-12-27	WOS:A1993MG67300013
J	NOHARA, K; SANO, T; SHIRAISHI, F				NOHARA, K; SANO, T; SHIRAISHI, F			AN ACTIVATION-ASSOCIATED GANGLIOSIDE IN RAT THYMOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; CELL ACTIVATION; SPLEEN; DISIALOGANGLIOSIDE; LYMPHOCYTES; PROLIFERATION; BRAIN	During the activation of rat thymocytes elicited by stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187, the total amount of gangliosides per cell was demonstrated to increase, reaching a maximum level several times higher than that of resting cells at 48 h after activation when measured at 24-h intervals. The amount of the overwhelmingly predominant ganglioside in resting thymocytes, G(D1c)(NeuGc,NeuGc) (Nohara, K., Suzuki, M., Inagaki, F., and Kaya, K. (1991) J. Biochem. (Tokyo) 110, 274-278), was found to increase further as a result of activation. Furthermore, another ganglioside, which was barely recognizable in resting thymocytes, was found to increase in activated and proliferating thymocytes to a level similar to that of G(D1c). This activation-associated ganglioside was isolated and its structure examined. On the basis of the results of compositional analysis, methylation analysis, sialidase hydrolysis followed by detection with cholera toxin B subunit on TLC, and proton NMR spectroscopy, this ganglioside was clarified to be a rare species of G(D1b) containing two N-glycolylneuraminic acid residues. On the other hand, when the thymocytes were activated using concanavalin A (ConA) as a stimulant, the amount of gangliosides per cell was increased more strikingly than that in thymocytes activated with TPA and A23187. In the ConA-activated thymocytes, many other gangliosides, in addition to G(D1c) and G(D1b)(NeuGc,NeuGc), were demonstrated to appear in large amounts. The cause of this difference in gangliosides between thymocytes activated with a combination of TPA and A23187 and those activated with ConA is also discussed.	NATL INST ENVIRONM STUDIES,DIV ENVIRONM CHEM,YATABE,IBARAKI 305,JAPAN	National Institute for Environmental Studies - Japan	NOHARA, K (corresponding author), NATL INST ENVIRONM STUDIES,DIV ENVIRONM HLTH SCI,YATABE,IBARAKI 305,JAPAN.							AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; BERRY N, 1990, EUR J BIOCHEM, V189, P205, DOI 10.1111/j.1432-1033.1990.tb15478.x; FELDINGHABERMANN B, 1990, BIOCHEMISTRY-US, V29, P6314, DOI 10.1021/bi00478a028; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HERSEY P, 1986, CANCER RES, V46, P6083; INOUYE Y, 1974, J BIOCHEM-TOKYO, V76, P791; MUTHING J, 1987, EUR J BIOCHEM, V163, P407, DOI 10.1111/j.1432-1033.1987.tb10813.x; MUTHING J, 1989, BIOCHEMISTRY-US, V28, P2923; NAKAMURA K, 1991, J BIOCHEM-TOKYO, V110, P832, DOI 10.1093/oxfordjournals.jbchem.a123667; NARASIMHAN R, 1976, BIOCHIM BIOPHYS ACTA, V431, P578, DOI 10.1016/0005-2760(76)90222-8; NOHARA K, 1990, J BIOCHEM, V108, P684, DOI 10.1093/oxfordjournals.jbchem.a123263; NOHARA K, 1990, J BIOL CHEM, V265, P14335; NOHARA K, 1992, J BIOL CHEM, V267, P14982; NOHARA K, 1991, J BIOCHEM-TOKYO, V110, P274, DOI 10.1093/oxfordjournals.jbchem.a123570; OFFNER H, 1987, J IMMUNOL, V139, P3295; SELA BA, 1978, EUR J IMMUNOL, V8, P268, DOI 10.1002/eji.1830080410; SPIEGEL S, 1985, SCIENCE, V230, P1285, DOI 10.1126/science.2999979; STOUT RD, 1987, J IMMUNOL, V139, P2123; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; SVENNERHOLM L, 1973, J BIOL CHEM, V248, P740; VANEIJK RVW, 1977, EUR J BIOCHEM, V78, P41; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WELTE K, 1987, J IMMUNOL, V139, P1763; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x	26	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24997	25000						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227062				2022-12-27	WOS:A1993MG67300071
J	PAN, QW; TANASE, S; FUKUMOTO, Y; NAGASHIMA, F; RHEE, S; ROGERS, PH; ARNONE, A; MORINO, Y				PAN, QW; TANASE, S; FUKUMOTO, Y; NAGASHIMA, F; RHEE, S; ROGERS, PH; ARNONE, A; MORINO, Y			FUNCTIONAL ROLES OF VALINE-37 AND GLYCINE-38 IN THE MOBILE LOOP OF PORCINE CYTOSOLIC ASPARTATE-AMINOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; ENZYME; CONSTRUCTION; EXPRESSION; INHIBITORS; CLOSURE; CHICKEN; YEAST	The functional roles of Val37 and Gly38 in porcine cytosolic aspartate aminotransferase have been studied in the site-directed mutants V37A, G38A, and G38S where the size and hydrophobic character of these residues has been altered. Previous x-ray studies have shown that Val37 and Gly38, which are part of a flexible loop, interact directly with bound substrate. From x-ray and solution experiments we find that the V37A, G38A, and G38S mutations do not cause significant perturbations to the unliganded enzyme. Replacing Val37 with a less bulky alanine residue does not affect the maximal catalytic rate (k(cat)), but it does increase significantly the Michaelis constants for substrates in the overall transamination reaction between aspartate and 2-oxoglutarate. On the other hand, replacing Gly38 with alanine or serine results in striking decreases in k(cat) to 5 and 0.6%, respectively, of the value observed for the wild-type enzyme, as well as in considerable increases in K(m) values. Consequently, the catalytic competence, k(cat)/K(m), decreases by 3 orders of magnitude for G38A and by 4 orders of magnitude for G38S. Single turnover reactions of G38A and G38S with four individual substrates (aspartate, glutamate, oxalacetate, and 2-oxoglutarate) are characterized by kinetic parameters that are largely consistent with those of the overall reaction. In addition, the mutations at position 38 impair more seriously the catalytic competence of the enzyme toward C5-substrates than toward C4-substrates. We conclude that Gly38 is probably required for proper function of the enzyme because it permits a high level of flexibility for the 36-39 peptide, which in turn allows the essential substrate-induced movement of the small domain.	KUMAMOTO UNIV, SCH MED, DEPT BIOCHEM, KUMAMOTO 860, JAPAN; UNIV IOWA HOSP & CLIN, DEPT BIOCHEM, IOWA CITY, IA 52242 USA	Kumamoto University; University of Iowa					NIGMS NIH HHS [GM-40852] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040852] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNONE A, 1977, J MOL BIOL, V112, P509, DOI 10.1016/S0022-2836(77)80196-4; Arnone A, 1985, TRANSAMINASES, P138; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; Cleland W W, 1979, Methods Enzymol, V63, P103; DREUSICKE D, 1988, J MOL BIOL, V203, P1021, DOI 10.1016/0022-2836(88)90126-X; FASELLA P, 1966, BIOCHEMISTRY-US, V5, P197, DOI 10.1021/bi00865a026; FUKUMOTO Y, 1991, J BIOL CHEM, V266, P4187; GERSTEIN M, 1991, J MOL BIOL, V220, P133, DOI 10.1016/0022-2836(91)90387-L; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; JANSONIUS JN, 1985, TRANSAMINASES, P110; JENKINS WT, 1966, BIOCHEM BIOPH RES CO, V22, P376, DOI 10.1016/0006-291X(66)90656-5; JENKINS WT, 1959, J BIOL CHEM, V234, P51; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Metzler C M, 1979, Methods Enzymol, V62, P551; MICHUDA CM, 1969, J BIOL CHEM, V244, P5920; MIKI T, 1987, PROTEIN ENG, V1, P327, DOI 10.1093/protein/1.4.327; MORINO Y, 1977, J BIOCHEM, V82, P847, DOI 10.1093/oxfordjournals.jbchem.a131760; MURAO S, 1984, AGR BIOL CHEM TOKYO, V48, P2163, DOI 10.1080/00021369.1984.10866470; NAGASHIMA F, 1989, BIOCHEMISTRY-US, V28, P1153, DOI 10.1021/bi00429a033; NAGASHIMA F, 1986, J BIOCHEM, V99, P1017, DOI 10.1093/oxfordjournals.jbchem.a135565; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAYLOR JE, 1990, ANN NY ACAD SCI, V585, P58, DOI 10.1111/j.1749-6632.1990.tb28041.x; VELICK SF, 1962, J BIOL CHEM, V237, P2109; WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W	28	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24758	24765						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227035				2022-12-27	WOS:A1993MG67300038
J	RYE, HS; DREES, BL; NELSON, HCM; GLAZER, AN				RYE, HS; DREES, BL; NELSON, HCM; GLAZER, AN			STABLE FLUORESCENT DYE-DNA COMPLEXES IN HIGH-SENSITIVITY DETECTION OF PROTEIN-DNA INTERACTIONS - APPLICATION TO HEAT-SHOCK TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED DNA; ELECTROPHORETIC MOBILITY SHIFT; GEL-ELECTROPHORESIS; BINDING-PROTEIN; NEGATIVE REGULATION; ETHIDIUM HOMODIMER; MOLECULAR-CLONING; THIAZOLE ORANGE; FACTOR CONTAINS; LAC PROMOTER	The gel mobility-shift assay is an important tool for the study of protein-nucleic acid interactions. High detection sensitivity is typically attained by radioisotopic labeling of the target nucleic acid fragments. A novel fluorescence methology offers significant advantages over this conventional approach. Ethidium, thiazole orange, and oxazole yellow homodimers form stable, highly fluorescent complexes with double-stranded DNA that can be detected in gels by a laser-excited, confocal, fluorescence scanning system with a sensitivity higher than that attainable with radioisotopic labeling. We describe here the use of these dyes in a gel-mobility assay to detect complexes of a truncation of the Kluyveromyces lactis heat shock transcription factor, containing the trimerization and DNA-binding domains (HSF(DT)), with target DNA. At an appropriate molar DNA base pair to dye ratio, the labeling of a DNA fragment with dimeric dye did not affect the binding to HSF(DT). The detection of the fluorescent-dye labeled HSF(DT)-DNA complexes with the laser scanner achieves a spatial resolution far superior to that of conventional autoradiography and permits analysis of multimer protein-DNA complexes that are not resolved by traditional detection methods. We have used this technique to demonstrate that HSF forms multimeric complexes on DNA by addition of trimeric units. The latter conclusion is based on an analysis of the mobilities of the multiple HSF(DT)-DNA complexes and on a two-color mobility-shift fluorescence assay that uses a mutant of HSF(DT) engineered for site-specific labeling with fluorescein and target DNA labeled with an ''energy transfer'' dye, thiazole orange-thiazole blue heterodimer.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley				Rye, Hays/0000-0002-9420-3137	NIGMS NIH HHS [GM-44086, GM-07232C] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044086, T32GM007232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; BADING H, 1988, NUCLEIC ACIDS RES, V16, P5241, DOI 10.1093/nar/16.12.5241; BENSON SC, 1993, ORNLM2588 US DEP EN, P91; BIENZ M, 1987, ADV GENET, V24, P31, DOI 10.1016/S0065-2660(08)60006-1; BOORSTEIN WR, 1990, J BIOL CHEM, V265, P18912; CHEN JJ, 1993, J BIOL CHEM, V268, P7442; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIED MG, 1983, NUCLEIC ACIDS RES, V11, P141, DOI 10.1093/nar/11.1.141; GALLO GJ, 1993, MOL CELL BIOL, V13, P749, DOI 10.1128/MCB.13.2.749; GARNER MM, 1982, BIOCHEMISTRY-US, V21, P6032, DOI 10.1021/bi00267a001; GLAZER AN, 1992, NATURE, V359, P859, DOI 10.1038/359859a0; GLAZER AN, 1990, P NATL ACAD SCI USA, V87, P3851, DOI 10.1073/pnas.87.10.3851; GRANGERSCHNARR M, 1988, ANAL BIOCHEM, V174, P235, DOI 10.1016/0003-2697(88)90540-4; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; HAUGLAND RP, 1992, MOL PROBES HDB FLUOR, P221; HENDRICKSON W, 1985, P NATL ACAD SCI USA, V82, P3129, DOI 10.1073/pnas.82.10.3129; JAKOBSEN BK, 1991, EMBO J, V10, P369, DOI 10.1002/j.1460-2075.1991.tb07958.x; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; KOLB A, 1983, NUCLEIC ACIDS RES, V11, P7833, DOI 10.1093/nar/11.22.7833; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; MATHIES RA, 1992, NATURE, V359, P167, DOI 10.1038/359167a0; NAKAI A, 1993, MOL CELL BIOL, V13, P1983, DOI 10.1128/MCB.13.4.1983; NIETOSOTELO J, 1990, CELL, V62, P807, DOI 10.1016/0092-8674(90)90124-W; PARK CW, 1992, J BIOL CHEM, V267, P15642; PARK HO, 1989, MOL CELL BIOL, V9, P2025, DOI 10.1128/MCB.9.5.2025; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; PETERANDERL R, 1992, BIOCHEMISTRY-US, V31, P12272, DOI 10.1021/bi00163a042; QUESADA MA, 1991, BIOTECHNIQUES, V10, P616; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; REVZIN A, 1989, BIOTECHNIQUES, V7, P346; RYE HS, 1991, NUCLEIC ACIDS RES, V19, P327, DOI 10.1093/nar/19.2.327; RYE HS, 1993, ANAL BIOCHEM, V208, P144, DOI 10.1006/abio.1993.1020; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; RYE HS, 1993, METHOD ENZYMOL, V217, P414; RYE HS, 1993, ORNLM2588 US DEP EN, P96; SAMBROOK J, 1966, MOL CLONING LABORATO; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHARF KD, 1990, EMBO J, V9, P4495, DOI 10.1002/j.1460-2075.1990.tb07900.x; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SHUEY DJ, 1986, J BIOL CHEM, V261, P7934; SHUEY DJ, 1986, NATURE, V323, P459, DOI 10.1038/323459a0; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOPOL J, 1985, CELL, V42, P527, DOI 10.1016/0092-8674(85)90110-2; WEI R, 1986, NUCLEIC ACIDS RES, V14, P8183, DOI 10.1093/nar/14.20.8183; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q	57	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25229	25238						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227088				2022-12-27	WOS:A1993MG67300101
J	ALI, H; RICHARDSON, RM; TOMHAVE, ED; DIDSBURY, JR; SNYDERMAN, R				ALI, H; RICHARDSON, RM; TOMHAVE, ED; DIDSBURY, JR; SNYDERMAN, R			DIFFERENCES IN PHOSPHORYLATION OF FORMYLPEPTIDE AND C5A CHEMOATTRACTANT RECEPTORS CORRELATE WITH DIFFERENCES IN DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MUSCARINIC CHOLINERGIC RECEPTORS; BETA-ADRENERGIC-RECEPTOR; GTP-BINDING PROTEIN; POLYMORPHONUCLEAR LEUKOCYTES; BETA-2-ADRENERGIC RECEPTOR; DEPENDENT PHOSPHORYLATION; SIGNAL TRANSDUCTION; HUMAN-NEUTROPHILS; PERTUSSIS TOXIN	To define the regulation of chemoattractant receptors, epitope-tagged human formyl peptide and C5a receptor cDNAs (ET-FR and ET-C5aR) were stably expressed in rat basophilic leukemia, RBL-2H3 cells. An antibody (12CA5) specific to ''ET'' was used to immunoprecipitate ET-FR and ET-C5aR. fMLP and C5a caused time- and dose-dependent phosphorylation of their respective receptors. Phosphorylated ET-FR migrated as a single broad band between 50 and 70 kDa on SDS-polyacrylamide gel electrophoresis, whereas ET-C5aR exhibited both fast (39-45 kDa) and broadly (39-52 kDa) migrating forms. Fast form phosphorylation alone was observed at low concentrations of C5a (0.001-0.01 muM), or at early times (5-30 s) with a higher concentration of C5a (0.1 muM). Phorbol 12-myristate 13-acetate, thrombin, or antigen caused no phosphorylation of ET-FR but stimulated exclusively fast form phosphorylation of ET-C5aR. The protein kinase C inhibitor staurosporine did not inhibit phosphorylation of ET-FR but blocked the fast migrating component of phosphorylated ET-C5aR. Homologous desensitization correlated with ligand-induced phosphorylation of both receptors. Of note, ET-C5aR but not ET-FR underwent heterologous desensitization by antigen, phorbol 12-myristate 13-acetate, and thrombin. The data suggest that protein kinase C mediates heterologous phosphorylation and desensitization of C5aR but not FR, yet, both receptors are homologously desensitized by a staurosporine-resistant kinase.			ALI, H (corresponding author), DUKE UNIV, MED CTR, DEPT MED, BOX 3680, DURHAM, NC 27710 USA.				NCI NIH HHS [CA-29589] Funding Source: Medline; NIDCR NIH HHS [DE-03738] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA029589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003738] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALBER G, 1992, J IMMUNOL, V149, P2428; ALI H, 1990, J BIOL CHEM, V265, P745; BEAVEN MA, 1984, J BIOL CHEM, V259, P7137; BENHAMOU M, 1990, J IMMUNOL, V144, P3071; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BRAUNWALDER AF, 1992, MOL IMMUNOL, V29, P1319, DOI 10.1016/0161-5890(92)90168-W; CHUANG TT, 1992, J BIOL CHEM, V267, P6886; CLARK RB, 1988, P NATL ACAD SCI USA, V85, P1442, DOI 10.1073/pnas.85.5.1442; COBBOLD PH, 1987, BIOCHEM J, V248, P313, DOI 10.1042/bj2480313; CUNHAMELO JR, 1989, J IMMUNOL, V143, P2617; DIDSBURY JR, 1992, FEBS LETT, V297, P275, DOI 10.1016/0014-5793(92)80555-U; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; GERARD NP, 1990, BIOCHEMISTRY-US, V29, P9274, DOI 10.1021/bi00491a024; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; HAGA K, 1992, J BIOL CHEM, V267, P2222; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HIDE M, 1991, MOL PHARMACOL, V40, P473; HOWARD TH, 1984, J CELL BIOL, V98, P1265, DOI 10.1083/jcb.98.4.1265; JANECZEK AH, 1989, J CELL SCI, V94, P155; JESAITIS AJ, 1988, J CELL BIOL, V107, P921, DOI 10.1083/jcb.107.3.921; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KLEIN P, 1987, J BIOL CHEM, V262, P358; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KOO C, 1982, BIOCHEM BIOPH RES CO, V106, P442, DOI 10.1016/0006-291X(82)91130-5; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880; MCLEISH KR, 1989, MOL PHARMACOL, V36, P384; MILLER L, 1990, J BIOL CHEM, V265, P12444; NEWTON AC, 1991, J BIOL CHEM, V266, P17725; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; OKAJIMA F, 1985, J BIOL CHEM, V260, P6761; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; OZAWA K, 1993, J BIOL CHEM, V268, P1749; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; POLAKIS PG, 1988, J BIOL CHEM, V263, P4969; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; RICHARDSON RM, 1992, J BIOL CHEM, V267, P10127; RICHARDSON RM, 1992, J BIOL CHEM, V267, P22249; ROLLINS TE, 1991, P NATL ACAD SCI USA, V88, P971, DOI 10.1073/pnas.88.3.971; SCHICHI H, 1989, RECEPTOR PHOSPHORYLA, P177; SKLAR LA, 1985, J CELL BIOL, V101, P1161, DOI 10.1083/jcb.101.3.1161; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P421; SNYDERMAN R, 1990, ADP RIBOSYLATING TOX, P295; STADEL JM, 1983, P NATL ACAD SCI-BIOL, V80, P3173, DOI 10.1073/pnas.80.11.3173; TARDIF M, 1993, J IMMUNOL, V150, P3534; WILDE MW, 1989, J BIOL CHEM, V264, P190	50	164	167	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24247	24254						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226971				2022-12-27	WOS:A1993MF29400079
J	MCKIERNAN, CJ; BRONDYK, WH; MACARA, IG				MCKIERNAN, CJ; BRONDYK, WH; MACARA, IG			THE RAB3A GTPASE INTERACTS WITH MULTIPLE FACTORS THROUGH THE SAME EFFECTOR DOMAIN - MUTATIONAL ANALYSIS OF CROSS-LINKING OF RAB3A TO A PUTATIVE TARGET PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-RELEASING FACTOR; RAS-LIKE PROTEIN-P25RAB3A; BINDING PROTEIN; 3-DIMENSIONAL STRUCTURES; GUANINE-NUCLEOTIDES; SYNAPTIC VESICLES; MOLECULAR-CLONING; ENCODED PROTEINS; BOVINE BRAIN; SMG P25A	Rab3A/smg25A is a small Ras-like guanine nucleotide binding protein implicated in the control of regulated secretion from cells. Rab3A is approximately 30% cytosolic and 70% associated with the membranes of secretory vesicles. It cross-links specifically to a rat brain membrane protein of about 85 kilodaltons (p85). To identify epitopes on Rab3A that are important for its interaction with this putative target protein, we have determined the effects of point mutations on the cross-linking efficiency of Rab3A to p85. Rab3A, which was preincubated with a non-hydrolyzable analog of GTP, cross-linked more efficiently to p85 than did Rab3A.GDP. Rab3A mutants that had decreased nucleotide binding also exhibited poor cross-linking to p85. Mutations in the effector domain, a site important for the interaction of Rab3A with its guanine nucleotide releasing factor, guanine nucleotide dissociation inhibitor, and GTPase-activating protein, eliminated the ability of Rab3A to cross-link to p85. However, short peptides corresponding to the effector domain did not reduce cross-linking efficiency when present at a concentration of 50 muM.	UNIV VERMONT,COLL MED,VERMONT COMPREHENS CANC CTR,BURLINGTON,VT 05405	University of Vermont	MCKIERNAN, CJ (corresponding author), UNIV VERMONT,COLL MED,DEPT PATHOL,MED ALUMNI BLDG,BURLINGTON,VT 05405, USA.				NATIONAL CANCER INSTITUTE [R01CA056300] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006411] Funding Source: NIH RePORTER; NCI NIH HHS [CA56300] Funding Source: Medline; NEI NIH HHS [F32EY06411] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BURSTEIN E, 1989, MOL CELL BIOL, V9, P4807, DOI 10.1128/MCB.9.11.4807; BURSTEIN ES, 1992, BIOCHEM J, V282, P387, DOI 10.1042/bj2820387; BURSTEIN ES, 1991, J BIOL CHEM, V266, P2689; BURSTEIN ES, 1992, P NATL ACAD SCI USA, V89, P1154, DOI 10.1073/pnas.89.4.1154; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; EDWARDSON JM, 1993, FEBS LETT, V320, P52, DOI 10.1016/0014-5793(93)81656-K; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; GIBBS JB, 1987, J BIOL CHEM, V262, P10426; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JACOB J, 1993, J BIOL CHEM, V268, P923; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MUSHA T, 1992, J BIOL CHEM, V267, P9821; OBERHAUSER AF, 1992, NATURE, V360, P270, DOI 10.1038/360270a0; PADFIELD PJ, 1992, P NATL ACAD SCI USA, V89, P1656, DOI 10.1073/pnas.89.5.1656; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PATEL G, 1992, ONCOGENE, V7, P283; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PLUTNER H, 1990, EMBO J, V9, P2375, DOI 10.1002/j.1460-2075.1990.tb07412.x; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHIRATAKI H, 1992, J BIOL CHEM, V267, P10946; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VALENCIA A, 1991, P NATL ACAD SCI USA, V88, P5443, DOI 10.1073/pnas.88.12.5443; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	38	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24449	24452						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226995				2022-12-27	WOS:A1993MF29400108
J	SASAKI, T; KATO, M; TAKAI, Y				SASAKI, T; KATO, M; TAKAI, Y			CONSEQUENCES OF WEAK INTERACTION OF RHO GDI WITH THE GTP-BOUND FORMS OF RHO P21 AND RAC P21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEINS; BOVINE BRAIN CYTOSOL; BOTULINUM ADP-RIBOSYLTRANSFERASE; BINDING PROTEIN; ACTIVATING PROTEIN; NADPH OXIDASE; GENE-PRODUCT; DISSOCIATION INHIBITOR; REGULATORY PROTEIN; POSTTRANSLATIONAL MODIFICATIONS	rho GDI is an inhibitory GDP/GTP exchange protein for the rho family. Recently, rho GDI has been reported to interact with the GTP-bound form of G25K and rac1 p21 and to inhibit their basal and GTPase-activating protein (GAP)-stimulated GTPase activity. Here, we examined whether rho GDI interacts with the GTP-bound form of rho p21 and rac p21 and inhibits their basal and rho GAP-stimulated GTPase activity. rho GDI interacted with both the GDP- and GTP-bound forms of rhoA p21 and rac1 p21 as estimated by measuring its ability to form a complex with both forms and to inhibit the membrane-binding activity of both forms. The efficiency of rho GDI for interaction with the GTP-bound form was, however, about 10% that for interaction with the GDP-bound form. Moreover, rho GDI inhibited both the basal and rho GAP-stimulated GTPase activity of rhoA p21 and rac1 p21 in a dose-dependent manner. The doses of rho GDI necessary for this action were, however, about 10-fold higher than those necessary for the action to inhibit their GDP/GTP exchange reaction. These results indicate that rho GDI interacts with the GTP-bound form of its substrate small G proteins, as well as with the GDP-bound form, but much less efficiently than with the GDP-bound form.	KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN; NATL INST PHYSIOL SCI,DEPT CELL PHYSIOL,OKAZAKI,AICHI 444,JAPAN	Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)								ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ANDO S, 1992, J BIOL CHEM, V267, P25709; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN U, 1989, FEBS LETT, V243, P70, DOI 10.1016/0014-5793(89)81220-7; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; CHUANG TH, 1993, J BIOL CHEM, V268, P775; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; GARRETT MD, 1991, BIOCHEM J, V276, P833, DOI 10.1042/bj2760833; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HIRATA K, 1992, J BIOL CHEM, V267, P8719; HORI Y, 1991, ONCOGENE, V6, P515; ISOMURA M, 1990, BIOCHEM BIOPH RES CO, V169, P652, DOI 10.1016/0006-291X(90)90380-6; ISOMURA M, 1991, ONCOGENE, V6, P119; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; KIKUCHI A, 1988, J BIOL CHEM, V263, P16303; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; LEONARD D, 1992, J BIOL CHEM, V267, P22860; MIURA Y, 1993, J BIOL CHEM, V268, P510; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MORII N, 1991, J BIOL CHEM, V266, P7646; MORII N, 1992, J BIOL CHEM, V267, P20921; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SUGAI M, 1990, BIOCHEM BIOPH RES CO, V173, P92, DOI 10.1016/S0006-291X(05)81026-5; SUGAI M, 1992, J BIOL CHEM, V267, P2600; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; UEDA T, 1990, J BIOL CHEM, V265, P9373; YAMAMOTO J, 1990, MOL BRAIN RES, V8, P105, DOI 10.1016/0169-328X(90)90054-H; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626	49	67	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23959	23963						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226937				2022-12-27	WOS:A1993MF29400040
J	WALES, R; ROBERTS, LM; LORD, JM				WALES, R; ROBERTS, LM; LORD, JM			ADDITION OF AN ENDOPLASMIC-RETICULUM RETRIEVAL SEQUENCE TO RICIN-A CHAIN SIGNIFICANTLY INCREASES ITS CYTOTOXICITY TO MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSIDASE ACTIVITY; TRANS-GOLGI NETWORK; BREFELDIN-A; PSEUDOMONAS EXOTOXIN; GALACTOSE BINDING; INTRACELLULAR FUNCTIONS; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; INTERNALIZED RICIN; SHIGA TOXIN	An Escherichia coli expression system was used to produce recombinant ricin A chain (RTA) and RTA modified either by the addition of a carboxyl-terminal endoplasmic reticulum retrieval sequence Lys-Asp-Glu-Leu (RTAKDEL) or a nonfunctional analogue Lys-Asp-Glu-Ala (RTAKDEA). These RTA molecules can enter mammalian cells by fluid phase endocytosis. RTAKDEL was significantly more cytotoxic than either RTA or RTAKDEA to both Vero cells and HeLa cells (250- and 10-fold, respectively), despite the fact that all these RTA molecules had comparable enzymatic activities. This difference did not result from KDEL-mediated binding of RTAKDEL to the cell surface. Enhanced cytotoxicity could be correlated with an increased level of ribosome inactivation, measured as the RTA-catalyzed depurination of 28 S ribosomal RNA. These results indicate that the added KDEL sequence facilitated RTA entry into the cytosol. We propose that interaction with the intracellular KDEL receptor promotes retrograde transport of the toxin to the endoplasmic reticulum, where translocation of RTA into the cytosol occurs.	UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND	University of Warwick								ANDRES DA, 1990, J BIOL CHEM, V265, P5952; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GONATAS NK, 1977, J CELL BIOL, V73, P1, DOI 10.1083/jcb.73.1.1; GREEN SA, 1990, J BIOL CHEM, V265, P21269; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LORD JM, 1992, BIOCHEM SOC T, V20, P734, DOI 10.1042/bst0200734; MAY MJ, 1989, EMBO J, V8, P301, DOI 10.1002/j.1460-2075.1989.tb03377.x; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; OLSNES S, 1976, J BIOL CHEM, V251, P3985; OLSNES S, 1985, ENDOCYTOSIS, P195; PASTAN I, 1992, ANNU REV BIOCHEM, V61, P331, DOI 10.1146/annurev.bi.61.070192.001555; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; PELHAM H R B, 1992, Trends in Cell Biology, V2, P183, DOI 10.1016/0962-8924(92)90230-K; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; PETER F, 1992, J BIOL CHEM, V267, P10631; ROTH J, 1980, J CELL BIOL, V92, P223; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1981, J BIOL CHEM, V256, P9068; SEETHARAM S, 1991, J BIOL CHEM, V266, P17376; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; SPICER EK, 1982, J BIOL CHEM, V257, P5716; THOMAS L, 1990, J BIOL CHEM, V265, P10821; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; VANDEURS B, 1988, J CELL BIOL, V106, P253, DOI 10.1083/jcb.106.2.253; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; WALES R, 1991, J BIOL CHEM, V266, P19172; WALES R, 1992, EXP CELL RES, V203, P1, DOI 10.1016/0014-4827(92)90032-4; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z; YOULE RJ, 1987, J BIOL CHEM, V262, P4676	42	98	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23986	23990						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226941				2022-12-27	WOS:A1993MF29400044
J	HARTINGER, J; JAHN, R				HARTINGER, J; JAHN, R			AN ANION-BINDING SITE THAT REGULATES THE GLUTAMATE TRANSPORTER OF SYNAPTIC VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR AMINE TRANSPORTER; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; CEREBRAL-CORTEX; RAT-LIVER; QUANTITATION; GRADIENTS; GABA	Glutamate, the major excitatory neurotransmitter of the mammalian central nervous system, is stored in synaptic vesicles and released by exocytosis upon depolarization of the, presynaptic nerve terminal. Synaptic vesicles possess an active glutamate-specific transporter that is driven by an electrochemical proton gradient across the vesicle membrane and requires chloride for maximal activity. In this study, we have characterized the role of chloride in vesicular glutamate transport using 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), a potent inhibitor of anion translocators. DIDS inhibited glutamate uptake with an IC50 of 0.7 muM or less. In contrast, all energy gradient parameters (membrane potential, pH gradient, and ATPase activity) required at least 5-fold higher concentration of DIDS for inhibition. Furthermore, high concentrations of chloride but not of glutamate or other anions prevented DIDS inhibition of glutamate uptake. In contrast to uptake, glutamate efflux from glutamate-loaded vesicles was independent of chloride over a wide concentration range. However, efflux was still susceptible to DIDS inhibition. DIDS inhibition was prevented by excess chloride. We conclude that the vesicular glutamate transporter possesses a DIDS-sensitive chloride binding site on the cytoplasmic side, distinct from the substrate binding site, which regulates transport activity.	YALE UNIV,SCH MED,BOYER CTR MOLEC MED,HOWARD HUGHES MED INST,POB 9812,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; Yale University; Yale University; Yale University				Jahn, Reinhard/0000-0003-1542-3498				BAHR BA, 1992, BIOCHEMISTRY-US, V31, P5763, DOI 10.1021/bi00140a011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CARLSON MD, 1990, NEUROSCI LETT, V110, P325, DOI 10.1016/0304-3940(90)90868-A; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FYKSE EM, 1991, BIOCHEM J, V276, P363, DOI 10.1042/bj2760363; HELL JW, 1991, BIOCHEMISTRY-US, V30, P11795, DOI 10.1021/bi00115a009; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MAYCOX PR, 1990, EMBO J, V9, P1465, DOI 10.1002/j.1460-2075.1990.tb08263.x; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; NELSON N, 1992, Current Opinion in Cell Biology, V4, P654, DOI 10.1016/0955-0674(92)90086-R; PASSOW H, 1986, REV PHYSL BIOCH PHAR, V103, P62; SHIOI J, 1990, BIOCHEM J, V267, P63, DOI 10.1042/bj2670063; STERNBACH Y, 1992, P NATL ACAD SCI USA, V89, P9730, DOI 10.1073/pnas.89.20.9730; TABB JS, 1992, J BIOL CHEM, V267, P15412; VANDYKE RW, 1984, P NATL ACAD SCI-BIOL, V81, P3108; VANDYKE RW, 1988, J BIOL CHEM, V263, P2603; WINTER HC, 1993, NEUROCHEM RES, V18, P79, DOI 10.1007/BF00966925; XIE XS, 1983, J BIOL CHEM, V258, P4834	25	91	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23122	23127						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226829				2022-12-27	WOS:A1993MF51500028
J	MOHAMEDALI, KA; GUICHERIT, OM; KELLEMS, RE; RUDOLPH, FB				MOHAMEDALI, KA; GUICHERIT, OM; KELLEMS, RE; RUDOLPH, FB			THE HIGHEST LEVELS OF PURINE CATABOLIC ENZYMES IN MICE ARE PRESENT IN THE PROXIMAL SMALL-INTESTINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER XANTHINE DEHYDROGENASE; SEVERE COMBINED IMMUNODEFICIENCY; ADENOSINE-DEAMINASE DEFICIENCY; NUCLEOSIDE PHOSPHORYLASE; URIC-ACID; DEVELOPMENTAL EXPRESSION; OXIDASE ACTIVITIES; MOUSE; TISSUES; EMBRYO	Recent studies on the tissue distribution and developmental regulation of adenosine deaminase (ADA) activity in mice show that very high ADA levels exist in the murine alimentary tract (tongue, esophagus, forestomach, proximal small intestine) and at the fetal-maternal interface. To understand the role of ADA in these tissues, we measured the levels of three other enzymes involved in purine catabolism, purine nucleoside phosphorylase (PNP), guanine deaminase (GDA), and xanthine dehydrogenase (XDH), to see how their levels correlated with ADA activity. Our results show that the highest level of PNP, GDA, and XDH is present in the proximal small intestine. Levels of these purine catabolic enzymes are much lower in the tongue, esophagus, forestomach, and fetal-maternal interface in marked contrast to ADA distribution. We also determined mRNA levels encoding PNP, XDH, and ADA in a variety of tissues. Tissue-specific differences in PNP, XDH, and ADA activity correlated with RNA abundance, indicating that the regulation of gene expression is at the level of mRNA production. Thus, ADA is part of a purine catabolic pathway leading to the production of uric acid that is present at the highest known level in the proximal small intestine. ADA may have additional roles in other tissues.	RICE UNIV, DEPT BIOCHEM & CELL BIOL, HOUSTON, TX 77005 USA; RICE UNIV, INST BIOSCI & BIOENGN, HOUSTON, TX 77005 USA; BAYLOR COLL MED, VERNA & MARRS MCLEAN DEPT BIOCHEM, HOUSTON, TX 77030 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA	Rice University; Rice University; Baylor College of Medicine; Baylor College of Medicine					NCI NIH HHS [CA14030] Funding Source: Medline; NIDDK NIH HHS [DK46207] Funding Source: Medline; NIGMS NIH HHS [GM30204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030204] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS A, 1976, CLIN EXP IMMUNOL, V26, P647; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; BATTELLI MG, 1972, BIOCHEM J, V126, P747, DOI 10.1042/bj1260747; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BLACKBURN MR, 1992, DEV DYNAM, V194, P155, DOI 10.1002/aja.1001940208; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY TG, 1965, COMP BIOCHEM PHYSIOL, V14, P101, DOI 10.1016/0010-406X(65)90011-3; BRONK JR, 1986, J PHYSIOL-LONDON, V378, P229, DOI 10.1113/jphysiol.1986.sp016216; CARSON DA, 1977, P NATL ACAD SCI USA, V74, P5677, DOI 10.1073/pnas.74.12.5677; CHINSKY JM, 1990, DIFFERENTIATION, V42, P172, DOI 10.1111/j.1432-0436.1990.tb00759.x; CHINSKY JM, 1989, GENE TRANSFER GENE T, P255; DARDENNE SC, 1990, BIOCHEMISTRY-US, V29, P9046, DOI 10.1021/bi00490a023; ELSAYED NM, 1989, ARCH BIOCHEM BIOPHYS, V273, P281, DOI 10.1016/0003-9861(89)90485-2; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIUSTI G, 1974, METHOD ENZYMAT AN, V2, P1086; HENDERSON JF, 1985, P SOC EXP BIOL MED, V179, P419; HINDMAN HB, 1978, ENZYME, V23, P395, DOI 10.1159/000458608; HIRSCHHORN R, 1978, CLIN IMMUNOL IMMUNOP, V9, P287, DOI 10.1016/0090-1229(78)90100-9; HONG L, 1991, BIOL REPROD, V44, P83, DOI 10.1095/biolreprod44.1.83; JOYCE P, 1971, BIOCHEM J, V125, pP111, DOI 10.1042/bj1250111Pa; KIZAKI H, 1983, CELL IMMUNOL, V82, P343, DOI 10.1016/0008-8749(83)90168-5; KNUDSEN TB, 1991, BIOL REPROD, V44, P171, DOI 10.1095/biolreprod44.1.171; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; KNUDSEN TB, 1987, DIFFERENTIATION, V33, P270, DOI 10.1111/j.1432-0436.1987.tb01567.x; KNUDSEN TB, 1989, TERATOLOGY, V40, P615, DOI 10.1002/tera.1420400609; KNUDSEN TB, 1988, BIOL REPROD, V39, P937, DOI 10.1095/biolreprod39.4.937; KORNBERG A, 1953, BIOCHEM PREP, V3, P23; KREDICH NM, 1989, METABOLIC BASIS INHE, P1045; KRENITSKY TA, 1974, COMP BIOCHEM PHYSIOL, V49, P687, DOI 10.1016/0305-0491(74)90256-9; KURASHIGE S, 1982, MICROBIOL IMMUNOL, V26, P77, DOI 10.1111/j.1348-0421.1982.tb00155.x; LEE PC, 1973, DEV BIOL, V31, P227, DOI 10.1016/0012-1606(73)90259-5; LYERLA TA, 1983, COMP BIOCHEM PHYS B, V76, P497, DOI 10.1016/0305-0491(83)90282-1; NAKAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1279, DOI 10.1093/oxfordjournals.jbchem.a134046; NARDIELLO S, 1978, ENZYME, V23, P353, DOI 10.1159/000458600; NELSON DM, 1992, GENE, V113, P215, DOI 10.1016/0378-1119(92)90398-9; PARKMAN R, 1975, NEW ENGL J MED, V292, P714, DOI 10.1056/NEJM197504032921402; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0; PUGH ME, 1984, COMP BIOCHEM PHYS B, V77, P619, DOI 10.1016/0305-0491(84)90286-4; RAMAGOPAL S, 1984, CELL BIOL INT REP, V8, P401, DOI 10.1016/0309-1651(84)90142-5; RAMAMURTHY V, 1989, MOL CELLULAR MECHANI, P125; RATECH H, 1989, AM J PATHOL, V135, P1145; RAVID K, 1989, BIOCHEM J, V258, P653, DOI 10.1042/bj2580653; SEEGMILLER JE, 1985, ANN NY ACAD SCI, V451, P9, DOI 10.1111/j.1749-6632.1985.tb27091.x; SENBA E, 1987, J COMP NEUROL, V255, P217, DOI 10.1002/cne.902550206; SEVINIAN A, 1985, J FREE RADICAL BIOL, V1, P117; SHAW MI, 1984, BIOCHIM BIOPHYS ACTA, V778, P530, DOI 10.1016/0005-2736(84)90404-8; SMITS P, 1987, J CARDIOVASC PHARM, V10, P136, DOI 10.1097/00005344-198708000-00002; SNYDER SL, 1982, THESIS RICE U HOUSTO; STIRPE F, 1969, J BIOL CHEM, V244, P3855; STOCKER R, 1986, BIOCHEM BIOPH RES CO, V134, P152, DOI 10.1016/0006-291X(86)90540-1; TERAO J, 1988, FREE RADICAL BIO MED, V4, P205, DOI 10.1016/0891-5849(88)90040-8; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; TUTTLE JV, 1984, J BIOL CHEM, V259, P4065; VANDERWEYDEN MB, 1976, J BIOL CHEM, V251, P5448; VIJAYALAKSHMI D, 1988, J BIOL CHEM, V263, P19419; WAJNER M, 1989, BIOCHIM BIOPHYS ACTA, V991, P79, DOI 10.1016/0304-4165(89)90031-7; WINSTON JH, 1992, J BIOL CHEM, V267, P13472; WITTE DP, 1991, J CELL BIOL, V115, P179, DOI 10.1083/jcb.115.1.179; YEUNG CY, 1985, J BIOL CHEM, V260, P299; ZIELKE CL, 1971, ENZYMES, V4, P47; ZUBAY G, 1988, BIOCHEMISTRY-US, P818	64	54	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23728	23733						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226898				2022-12-27	WOS:A1993MF51500114
J	PING, J; SCHILDBACH, JF; SHAW, SY; QUERTERMOUS, T; NOVOTNY, J; BRUCCOLERI, R; MARGOLIES, MN				PING, J; SCHILDBACH, JF; SHAW, SY; QUERTERMOUS, T; NOVOTNY, J; BRUCCOLERI, R; MARGOLIES, MN			EFFECT OF HEAVY-CHAIN SIGNAL PEPTIDE MUTATIONS AND NH(2)-TERMINAL CHAIN-LENGTH ON BINDING OF ANTIDIGOXIN ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SEQUENCE CLEAVAGE SITES; B-CELL DEVELOPMENT; 3-DIMENSIONAL STRUCTURE; SOMATIC MUTATION; ANTIDIGOXIN ANTIBODIES; IMMUNOGLOBULIN GENES; INCREASED AFFINITY; A-II; SPECIFICITY	In certain instances, antibody variable region mutations outside of the antigen-combining site influence antigen binding. We reported previously that a heavy chain mutation (Ser-94 --> Arg) decreased binding of the anti-digoxin antibody 40-150, whereas an additional signal peptide mutation at the -2 position (Gln --> Pro) causing NH2-terminal 2-residue truncation partially restored binding. To assess the combined effects on binding of two seemingly distant mutations, we constructed signal peptide mutations and NH2-terminal deletions in the presence of Ser-94 and Arg-94. Deletions of one to three amino acids had little effect on binding for Ser-94 mutants, whereas 2-residue truncations produced directly or by signal peptide mutation increased affinity approximately 40-fold for Arg-94 mutants. These observations are consistent with the reported computer-generated model of antibody 40-150. Introduction of Pro at the signal peptide -3 position in 40-150 resulted in cleavage at alternative sites, with varying effects on affinity. Introduction of Pro at -2 into the anti-digoxin antibody 26-10 resulted, unexpectedly, in expression of heavy chains with 3 extra NH2-terminal residues,.causing an approximately 100-fold reduction in affinity. Thus, both extensions and deletions of the heavy chain amino terminus can enhance or reduce antigen binding, depending on the structural context of specific antigen combining sites.	MASSACHUSETTS GEN HOSP,DEPT SURG,JACKSON 4,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT MED,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115; BRISTOL MYERS SQUIBB,PHARMACEUT RES INST,PRINCETON,NJ 08543	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Bristol-Myers Squibb				Schildbach, Joel/0000-0002-3038-9745; Quertermous, Thomas/0000-0002-7645-9067	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047415] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL47415-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BATRA JK, 1990, BIOCHEM BIOPH RES CO, V171, P1, DOI 10.1016/0006-291X(90)91347-U; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BRUCCOLERI RE, 1987, BIOPOLYMERS, V26, P137, DOI 10.1002/bip.360260114; CHIEN NC, 1989, P NATL ACAD SCI USA, V86, P5532, DOI 10.1073/pnas.86.14.5532; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CLAFLIN JL, 1987, J IMMUNOL, V138, P3060; CLARKE C, 1982, NUCLEIC ACIDS RES, V10, P7731, DOI 10.1093/nar/10.23.7731; CLARKE S, 1990, J IMMUNOL, V145, P2286; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; FOLZ RJ, 1986, J BIOL CHEM, V261, P4752; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; HUDSON NW, 1987, J IMMUNOL, V139, P2715; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Kabat EA, 1991, SEQUENCES PROTEINS I; KELLEY DE, 1982, CELL, V29, P681, DOI 10.1016/0092-8674(82)90184-2; LASCOMBE MB, 1989, P NATL ACAD SCI USA, V86, P607, DOI 10.1073/pnas.86.2.607; LAVOIE TB, 1992, J IMMUNOL, V148, P503; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MOOS M, 1988, J BIOL CHEM, V263, P6005; MUDGETTHUNTER M, 1985, MOL IMMUNOL, V22, P477, DOI 10.1016/0161-5890(85)90132-4; MUDGETTHUNTER M, 1982, J IMMUNOL, V129, P1165; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; NEAR RI, 1990, MOL IMMUNOL, V27, P901, DOI 10.1016/0161-5890(90)90157-U; NEAR RI, 1991, J IMMUNOL, V146, P627; NEWELL N, 1980, SCIENCE, V209, P1128, DOI 10.1126/science.6250219; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; NOVOTNY J, 1990, PROTEINS, V7, P93, DOI 10.1002/prot.340070109; PANKA DJ, 1988, P NATL ACAD SCI USA, V85, P3080, DOI 10.1073/pnas.85.9.3080; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Sambrook J, 1989, MOL CLONING LABORATO; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHILDBACH JF, 1993, PROTEIN SCI, V2, P206; SCHILDBACH JF, 1991, J BIOL CHEM, V266, P4640; SHAW SY, 1992, MOL IMMUNOL, V29, P525, DOI 10.1016/0161-5890(92)90010-U; SMITH TW, 1970, BIOCHEMISTRY-US, V9, P331, DOI 10.1021/bi00804a020; TAI MS, 1990, BIOCHEMISTRY-US, V29, P8024, DOI 10.1021/bi00487a005; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WEISMAN LS, 1986, J BIOL CHEM, V261, P2309; WU TT, 1970, J EXP MED, V32, P221; 1968, J BIOL CHEM, V243, P3557	49	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23000	23007						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226814				2022-12-27	WOS:A1993MF51500010
J	STRITTMATTER, P; KITTLER, JM; COGHILL, JE; OZOLS, J				STRITTMATTER, P; KITTLER, JM; COGHILL, JE; OZOLS, J			INTERACTION OF NON-MYRISTOYLATED NADH-CYTOCHROME-B(5) REDUCTASE WITH CYTOCHROME-B(5)-DIMYRISTOYLPHOSPHATIDYLCHOLINE VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME B5 REDUCTASE; RAT-LIVER MICROSOMES; SITE-DIRECTED MUTAGENESIS; COENZYME-A DESATURASE; ACTIVE-SITES; ACID; BINDING; PARTICIPATION; INVOLVEMENT; OXIDATION	An expression vector for NADH-cytochrome b5 reductase containing a thrombin cleavage site directly before the N-terminal glycine residue of the flavoprotein was used to isolate the non-myristoylated enzyme by thrombin cleavage of the initial fusion protein of a short segment of the multiple cloning site of the plasmid vector and the reductase. This flavoprotein preparation, containing only the 28-residue N-terminal peptide segment of the membrane-binding domain of the mammalian enzyme, binds to phospholipid vesicles and interacts with membrane-bound cytochrome b5. The effect of N-myristoylation of the enzyme therefore appears to be limited to facilitating and stabilizing interactions with phospholipid vesicles. However, the relatively short intervening peptide sequence that separates the crucial peptide membrane-binding domain from lysine 41, which has been implicated in the active-site interaction with cytochrome b5, (Strittmatter, P., Kittler, J. M., Coghill, J. E., and Ozols, J. (1992) J. Biol. Chem. 267, 2519-2523), provides some limitation of the distance from the membrane surface for the interactions required for rapid electron transfer from the flavin of the reductase to the heme of cytochrome b5.			STRITTMATTER, P (corresponding author), UNIV CONNECTICUT, CTR HLTH, DEPT BIOCHEM, FARMINGTON, CT 06030 USA.				NIGMS NIH HHS [GM-26351, GM-15924] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026351] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARINC E, 1987, J BIOL CHEM, V262, P15563; CHESTER DW, 1987, BIOPHYS J, V52, P1021, DOI 10.1016/S0006-3495(87)83295-2; DAILEY HA, 1980, J BIOL CHEM, V255, P5184; DAILEY HA, 1979, J BIOL CHEM, V254, P5388; HACKETT CS, 1984, J BIOL CHEM, V259, P3275; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; KENSIL CR, 1986, J BIOL CHEM, V261, P7316; KEYES SR, 1979, J BIOL CHEM, V254, P7778; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MATHEWS FS, 1976, ENZYMES BIOL MEMBR, V4, P143; OKAYASU T, 1977, LIPIDS, V12, P267, DOI 10.1007/BF02533345; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; OZOLS J, 1985, J BIOL CHEM, V260, P1953; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; ROGERS MJ, 1973, J BIOL CHEM, V248, P800; SPATZ L, 1971, P NATL ACAD SCI USA, V68, P1042, DOI 10.1073/pnas.68.5.1042; SPATZ L, 1973, J BIOL CHEM, V248, P793; Strittmatter P, 1978, Methods Enzymol, V52, P97; STRITTMATTER P, 1975, P NATL ACAD SCI USA, V72, P2658, DOI 10.1073/pnas.72.7.2658; STRITTMATTER P, 1992, J BIOL CHEM, V267, P20164; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STRITTMATTER P, 1972, J BIOL CHEM, V247, P2768; STRITTMATTER P, 1992, J BIOL CHEM, V267, P2519; STRITTMATTER P, 1990, J BIOL CHEM, V265, P21709; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348	27	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23168	23171						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226835				2022-12-27	WOS:A1993MF51500035
J	PREUSS, U; GU, XB; GU, TJ; YU, RK				PREUSS, U; GU, XB; GU, TJ; YU, RK			PURIFICATION AND CHARACTERIZATION OF CMP-N-ACETYLNEURAMINIC ACID-LACTOSYLCERAMIDE (ALPHA-2-3) SIALYLTRANSFERASE (G(M3)-SYNTHASE) FROM RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; TISSUE-SPECIFIC EXPRESSION; SIALIC ACID; CHROMATOGRAPHY; BIOSYNTHESIS; LIVER; GLYCOLIPIDS; HOMOGENEITY; PROTEINS; INVITRO	CMP-N-acetylneuraminic acid:lactosylceramide (alpha2-3) sialyltransferase (G(M3)-synthase) was purified to homogeneity from a Triton CF-54 extract of young rat brain. The enzyme was separated by affinity chromatography on CDP-Sepharose column and resolved by linear NaCl gradient elution from the same adsorbent. Final purification of G(M3)-synthase was achieved by chromatography on a ''lactosylceramide acid''-Sepharose column and specific elution with lactosylceramide. The enzyme activity was highest at pH 6.5 and required the presence of Triton CF-54 (0.15%) and Mn2+ (10 mM) for its full activity. The product of the reaction catalyzed by the enzyme was identified as G(M3) based on its mobility on thin layer chromatographic plates using two different solvent systems. Comparison with several glycolipid substrates showed high specificity of G(M3)-synthase for lactosylceramide. The apparent K(m) value for lactosylceramide and CMP-N-acetylneuraminic acid were 80 and 210 muM, respectively. The apparent molecular mass of the enzyme determined on SDS-polyacrylamide gel electrophoresis was 76 kDa.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT BIOCHEM & MOLEC BIOPHYS,RICHMOND,VA 23298; MED COLL SHANGHAI,DEPT BIOCHEM,SHANGHAI,PEOPLES R CHINA	Virginia Commonwealth University					NINDS NIH HHS [NS 11853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASU M, 1987, METHOD ENZYMOL, V138, P575; Basu S, 1982, GLYCOCONJUGATES, V3, P265; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCZAK JD, 1984, BIOCHIM BIOPHYS ACTA, V804, P442, DOI 10.1016/0167-4889(84)90072-7; BURCZAK JD, 1984, J LIPID RES, V25, P1541; CHATTERJEE S, 1992, J BIOL CHEM, V267, P7148; CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; GU TJ, 1990, FEBS LETT, V275, P83, DOI 10.1016/0014-5793(90)81444-S; GU XB, 1990, ANAL BIOCHEM, V185, P151, DOI 10.1016/0003-2697(90)90271-A; GU XB, 1990, BIOCHEM BIOPH RES CO, V166, P387, DOI 10.1016/0006-291X(90)91957-T; HAKOMORI S, 1984, MONOCLONAL ANTIBODIE, P67; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; KEENAN TW, 1974, J BIOL CHEM, V249, P310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDEEN R, 1985, TRENDS NEUROSCI, V8, P169, DOI 10.1016/0166-2236(85)90064-5; LEDEEN RW, 1989, NEUROBIOLOGY GLYCOCO, P43; MACDONALD DL, 1980, J LIPID RES, V21, P642; MELKERSONWATSON LJ, 1991, J BIOL CHEM, V266, P4448; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NAKAMURA M, 1987, ANAL BIOCHEM, V166, P230, DOI 10.1016/0003-2697(87)90569-0; OHANLON TP, 1989, J BIOL CHEM, V264, P17389; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; SCHACTER H, 1990, BIOCH GLYCOPROTEINS, P85; STOFFYN A, 1975, BIOCHIM BIOPHYS ACTA, V409, P97, DOI 10.1016/0005-2760(75)90084-3; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; SVENSSON EC, 1992, J BIOL CHEM, V267, P3466; SVENSSON EC, 1990, J BIOL CHEM, V265, P20863; Wilchek M, 1974, Methods Enzymol, V34, P475; XIA XJ, 1989, J LIPID RES, V30, P181; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x; YU RK, 1976, J BIOL CHEM, V251, P198	33	28	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26273	26278						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253749				2022-12-27	WOS:A1993MK42500042
J	ROMI, R; CREST, M; GOLA, M; SAMPIERI, F; JACQUET, G; ZERROUK, H; MANSUELLE, P; SOROKINE, O; VANDORSSELAER, A; ROCHAT, H; MARTINEAUCLAIRE, MF; VANRIETSCHOTEN, J				ROMI, R; CREST, M; GOLA, M; SAMPIERI, F; JACQUET, G; ZERROUK, H; MANSUELLE, P; SOROKINE, O; VANDORSSELAER, A; ROCHAT, H; MARTINEAUCLAIRE, MF; VANRIETSCHOTEN, J			SYNTHESIS AND CHARACTERIZATION OF KALIOTOXIN - IS THE 26-32 SEQUENCE ESSENTIAL FOR POTASSIUM CHANNEL RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY BINDING-SITES; PERFORMANCE LIQUID-CHROMATOGRAPHY; CA-2+-ACTIVATED K+ CHANNEL; AORTIC SMOOTH-MUSCLE; RAT-BRAIN; PEPTIDYL INHIBITOR; DIRECT ASSOCIATION; SCORPION TOXINS; CHARYBDOTOXIN; VENOM	Kaliotoxin (KTX), a scorpion toxin characterized as a 37-residue inhibitor of the neuronal high conductance Ca2+-activated K+ channels (KCa channels), has been chemically synthesized. Differences were observed between natural toxin and the two peptides, KTX(1-37) and KTX(1-37)-amide. Re-examination of the KTX sequence showed that an extra lysine residue was present at the C-terminal end. The 38-residue synthetic peptide was found identical with natural toxin. All three peptides had comparable activities, with LD50 Values of 6-9 pmol/mouse after intracerebroventricular injection, and K(d) = 2-8 nM for blockage of the whole cell and unitary molluscan KCa currents. Pairing of the disulfide bonds in synthetic KTX corresponded to that in charybdotoxin and iberiotoxin. A competition assay between I-125-KTX(1-37) and different toxins (KTX, dendrotoxin, charybdotoxin, MCD peptide, and iberiotoxin) for binding to rat brain synaptosomal membranes suggested that KTX interacts also with voltage-gated K+ channels. Shorter peptides, KTX(25-35)-amide and KTX(26-32)amide, expressed no KTX activity, but were able to compete in binding. They were further shown to antagonize KTX in both its toxicity and blocking activity. The (26-32) sequence of KTX, which is a highly conserved region, may contain a low affinity binding subsite essential for potassium channel recognition.	CNRS,NEUROBIOL LAB,F-13402 MARSEILLE 20,FRANCE; CNRS,CHIM ORGAN SUBST NAT LAB,F-67084 STRASBOURG,FRANCE; INST PASTEUR,PURIFICAT PROT LAB,CASABLANCA,MOROCCO	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	ROMI, R (corresponding author), FAC MED NORD,BIOCHIM LAB,CNRS,URA 1455,BLVD PIERRE DRAMARD,F-13916 MARSEILLE 20,FRANCE.			mansuelle, pascal/0000-0002-4504-6809				BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BLAUSTEIN MP, 1991, MOL PHARMACOL, V40, P932; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; BRIAND JB, 1990, PEPTIDES; CARBONE E, 1982, NATURE, V296, P90, DOI 10.1038/296090a0; CEARD B, 1992, TOXICON, V30, P105, DOI 10.1016/0041-0101(92)90506-Z; CREST M, 1990, J EXP BIOL, V152, P211; CREST M, 1992, J BIOL CHEM, V267, P1640; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; DEUTSCH C, 1991, J BIOL CHEM, V266, P3668; DREYER F, 1990, REV PHYSL BIOCH PHAR, V15, P94; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GIANGIACOMO KM, 1992, BIOCHEMISTRY-US, V31, P6719, DOI 10.1021/bi00144a011; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; GORDON D, 1984, BIOCHIM BIOPHYS ACTA, V778, P349, DOI 10.1016/0005-2736(84)90379-1; GROSS E, 1961, J AM CHEM SOC, V83, P1510, DOI 10.1021/ja01467a052; HALLIWELL JV, 1986, P NATL ACAD SCI USA, V83, P493, DOI 10.1073/pnas.83.2.493; HARVEY AL, 1980, N-S ARCH PHARMACOL, V312, P1, DOI 10.1007/BF00502565; HAWKE D, 1982, ANAL BIOCHEM, V120, P302, DOI 10.1016/0003-2697(82)90351-7; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; JOHNSON BA, 1992, BIOCHEMISTRY-US, V31, P8151, DOI 10.1021/bi00150a006; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; JOVER E, 1980, BIOCHEMISTRY-US, V19, P463, DOI 10.1021/bi00544a010; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; MARTIN MF, 1986, TOXICON, V24, P1131, DOI 10.1016/0041-0101(86)90139-X; MCKINNON R, 1991, NATURE, V350, P232; MCKINNON R, 1988, J GEN PHYSIOL, V91, P335; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NIALL HD, 1972, J CHEM BIOL PEPTIDE, V3, P695; NOBLE RL, 1976, J AM CHEM SOC, V98, P2324, DOI 10.1021/ja00424a055; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PONGS O, 1992, TRENDS PHARMACOL SCI, V13, P359, DOI 10.1016/0165-6147(92)90109-J; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; SCHWEITZ H, 1989, BIOCHEMISTRY-US, V28, P9708, DOI 10.1021/bi00451a025; SEAGAR MJ, 1984, J BIOL CHEM, V259, P1491; SUGG EE, 1990, J BIOL CHEM, V265, P18745; VALVIDIA HV, 1988, FEBS LETT, V226, P280; VANDORSSELAER A, 1990, BIOMED ENVIRON MASS, V19, P692, DOI 10.1002/bms.1200191108; VANRIETSCHOTEN J, 1975, EUR J BIOCHEM, V56, P35, DOI 10.1111/j.1432-1033.1975.tb02204.x; VAZQUEZ J, 1990, J BIOL CHEM, V265, P15564; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902	45	71	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26302	26309						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253752				2022-12-27	WOS:A1993MK42500046
J	BLANK, JL; SHAW, K; ROSS, AH; EXTON, JH				BLANK, JL; SHAW, K; ROSS, AH; EXTON, JH			PURIFICATION OF A 110-KDA PHOSPHOINOSITIDE PHOSPHOLIPASE-C THAT IS ACTIVATED BY G-PROTEIN BETA-GAMMA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE HYDROLYSIS; ALPHA-SUBUNITS; ADENYLYL CYCLASE; BOVINE BRAIN; IMMUNOLOGICAL IDENTIFICATION; SIGNAL TRANSDUCTION; ISOZYMES; STIMULATION; RECEPTOR; CELLS	We report the purification from bovine brain cytosol of a 110-kDa phosphoinositide-specific phospholipase C (PLC-110) that was markedly stimulated by G-protein betagamma-subunits. The enzyme was purified approximately 2000-fold with a yield of 4%. On the basis of size and immunological cross-reactivity, PLC-110 was distinct from 150-kDa PLC-beta1, 145-kDa PLC-gamma1, and 85-kDa PLC-delta1. An antiserum to a peptide corresponding to a conserved PLC Y domain sequence cross-reacted with PLC-110. PLC-110 was also recognized by two antisera selective for NH2-terminal and internal sequences in PLC-beta3, but not by a third peptide antiserum to the COOH terminus of this enzyme, suggesting that PLC-110 is related to PLC-beta3. Reconstitution of purified PLC-110 with betagamma-subunits produced greater than 100-fold activation, indicating that no other proteins were required. Half-maximal activation was observed at approximately 60 nM betagamma and full activation at approximately 500 nM betagamma. PLC-110 maximally hydrolyzed phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate at 1 muM Ca2+, but showed no activity toward phosphatidylinositol at Ca2+ concentrations up to 1 mM. Concentrations of purified guanosine 5'-O-(3-thiotriphosphate)-liganded alpha(q) that fully activated PLC-beta1 failed to stimulate PLC-110. This observation indicates that the site at which betagamma interacts with PLC-110 is distinct from that at which alpha(q) regulates the activity of PLC-beta isozymes.	VANDERBILT UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University								ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BLANK JL, 1991, J BIOL CHEM, V266, P18206; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CAROZZI A, 1993, FEBS LETT, V315, P340, DOI 10.1016/0014-5793(93)81190-B; CAROZZI AJ, 1992, EUR J BIOCHEM, V210, P521, DOI 10.1111/j.1432-1033.1992.tb17450.x; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; FAIN JN, 1990, BIOCHIM BIOPHYS ACTA, V1053, P81, DOI 10.1016/0167-4889(90)90029-D; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KRIZ R, 1990, CIBA F SYMP, V150, P112; LEE CH, 1992, J BIOL CHEM, V267, P16044; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; MORIARTY TM, 1990, NATURE, V343, P79, DOI 10.1038/343079a0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PADRELL E, 1991, J BIOL CHEM, V266, P9771; PANG IH, 1990, J BIOL CHEM, V265, P18707; PARK D, 1992, J BIOL CHEM, V267, P16048; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RUY SH, 1987, J BIOL CHEM, V262, P12511; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SUH PG, 1988, J BIOL CHEM, V263, P14497; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; TAYLOR SJ, 1991, FEBS LETT, V286, P214, DOI 10.1016/0014-5793(91)80976-A; WANGE RL, 1991, J BIOL CHEM, V266, P11409; WU DQ, 1993, J BIOL CHEM, V268, P3704; WU DQ, 1992, J BIOL CHEM, V267, P1811	50	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25184	25191						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227082				2022-12-27	WOS:A1993MG67300095
J	DOOIJES, D; VANDEWETERING, M; KNIPPELS, L; CLEVERS, H				DOOIJES, D; VANDEWETERING, M; KNIPPELS, L; CLEVERS, H			THE SCHIZOSACCHAROMYCES-POMBE MATING-TYPE GENE MAT-MC ENCODES A SEQUENCE-SPECIFIC DNA-BINDING HIGH-MOBILITY GROUP BOX PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-DETERMINING REGION; TRANSCRIPTION FACTOR; CELL-TYPE; FISSION YEAST; REGULATORY PROTEINS; ALPHA-ENHANCER; MINOR GROOVE; HMG DOMAIN; FACTOR-I; MOTIF	The Schizosaccharomyces pombe gene mat-Mc plays a determinative role in the sexual differentiation of the fission yeast. The mat-Mc protein has been suggested to belong to a novel family of so-called high mobility group (HMG) box proteins, characterized by homology to high mobility group-1 and -2 proteins. Several HMG box proteins, including the mammalian sex-determining gene product SRY and the lymphoid transcription factors TCF-1 and LEF-1, have been shown to bind to DNA in a sequence-specific fashion. To analyze possible DNA-binding properties of mat-Mc, we have cloned and expressed its putative HMG box in Escherichia coli. Gel retardation analysis revealed that the mat-Mc HMG box recognizes the AACAAAG heptamer in a sequence-specific fashion. Combined T-->C and A-->I substitutions on both strands of the AACAAAG heptamer, which change the surface of the major groove while leaving the minor groove intact, did not interfere with sequence-specific binding of mat-Mc. Methylation interference analysis confirmed that the mat-Mc HMG box contacts adenine residues in the minor groove. By using a circular permutation assay, the mat-Mc HMG box was observed to bend DNA. These results indicate that mat-Mc is indeed a member of the HMG box family with DNA-binding characteristics assigned earlier to other members of this novel transcription factor family.			DOOIJES, D (corresponding author), UNIV HOSP UTRECHT,DEPT IMMUNOL,POB 88500,3508 GA UTRECHT,NETHERLANDS.							BEACH DH, 1983, NATURE, V305, P682, DOI 10.1038/305682a0; BENDER A, 1987, CELL, V50, P681, DOI 10.1016/0092-8674(87)90326-6; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; EGEL R, 1984, CURR GENET, V8, P199, DOI 10.1007/BF00417816; EGEL R, 1981, CURR GENET, V3, P5, DOI 10.1007/BF00419574; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HERSKOWITZ I, 1981, MOL BIOL YEAST SACCH, P180; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAUDET V, 1993, IN PRESS NUCLEIC ACI; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; LEUPOLD U, 1958, COLD SPRING HARB SYM, V23, P161, DOI 10.1101/SQB.1958.023.01.020; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; PABO CO, 1984, ANN REV BIOCH, V53, P2932; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1992, EMBO J, V11, P3039, DOI 10.1002/j.1460-2075.1992.tb05374.x; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANDEWETERING M, 1993, IN PRESS EMBO J; VANHOUTE L, 1993, J BIOL CHEM, V268, P18083; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	38	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24813	24817						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227043				2022-12-27	WOS:A1993MG67300046
J	FRANCO, M; CHARDIN, P; CHABRE, M; PARIS, S				FRANCO, M; CHARDIN, P; CHABRE, M; PARIS, S			MYRISTOYLATION IS NOT REQUIRED FOR GTP-DEPENDENT BINDING OF ADP-RIBOSYLATION FACTOR-ARF1 TO PHOSPHOLIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CHOLERA-TOXIN; GUANINE-NUCLEOTIDE; ESCHERICHIA-COLI; FACTOR ARF; BOVINE BRAIN; BREFELDIN-A; PROTEIN; PURIFICATION; EXPRESSION; MEMBRANES	Membrane binding of ADP-ribosylation factors (ARFs) is GTP-dependent and seems to require amino-terminal myristoylation. Recently it has been proposed that myristoylation is needed not for the activation of ARF by GTP but for its subsequent association to membranes. Here we show that unmyristoylated bovine ARF1, expressed in bacteria, can be efficiently loaded with GTPgammaS (guanosine 5'-O-(thio)triphosphate) at 1 muM free Mg2+, in the presence of phospholipids. Unmyristoylated ARF(GTPgammaS) cosediments with phospholipid vesicles and totally binds to phospholipid-cholate micelles, as seen by gel filtration chromatography. We therefore propose that, in vivo, myristoylation is required for the interaction of ARF(GDP) with its membrane-bound exchange factor rather than for the association of ARF(GTP) with lipid membranes. Phospholipid-bound ARF(GTPgammaS) pan also stably interact with and activate the catalytic subunit of cholera toxin, suggesting that ARF(GTP) provides a membrane anchor for cholera toxin and thereby facilitates its access to membrane-bound substrates.			FRANCO, M (corresponding author), INST PHARMACOL MOLEC & CELLULAIRE, CNRS, 660 ROUTE LUCIOLES, F-06560 VALBONNE, FRANCE.		FRANCO, michel/AAA-9735-2021; Franco, Michel/ABH-4993-2020	Franco, Michel/0000-0003-1853-8661				BALCH WE, 1992, J BIOL CHEM, V267, P13053; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; BOBAK DA, 1990, ADP RIBOSYLATING TOX, P439; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; BORNANCIN F, 1993, J BIOL CHEM, V268, P17026; BORNANCIN F, 1991, FEBS LETT, V291, P273, DOI 10.1016/0014-5793(91)81300-W; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LOOMAN AC, 1987, EMBO J, V6, P2489, DOI 10.1002/j.1460-2075.1987.tb02530.x; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PRICE SR, 1992, J BIOL CHEM, V267, P17766; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; TSAI SC, 1993, J BIOL CHEM, V268, P10820; TSAI SC, 1991, BIOCHEMISTRY-US, V30, P3697, DOI 10.1021/bi00229a015; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; WALKER MW, 1992, J BIOL CHEM, V267, P3230; WEISS O, 1989, J BIOL CHEM, V264, P21066; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	30	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24531	24534						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227008				2022-12-27	WOS:A1993MG67300005
J	LEAMON, CP; PASTAN, I; LOW, PS				LEAMON, CP; PASTAN, I; LOW, PS			CYTOTOXICITY OF FOLATE-PSEUDOMONAS EXOTOXIN CONJUGATES TOWARD TUMOR-CELLS - CONTRIBUTION OF TRANSLOCATION DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; GLYCOSYL-PHOSPHATIDYLINOSITOL; RECOMBINANT FORM; RECEPTOR; MEMBRANE; CYTOSOL; TRANSPORT; CLEAVAGE; FRAGMENT; ABRIN	Folate-protein conjugates can be nondestructively delivered into a cell's cytoplasm via folate receptor-mediated endocytosis if (i) the target cells express a folate-binding protein, and (ii) if the folate is linked to its attached protein at a site that does not interfere with receptor recognition. Because such conjugates have been observed to remain in endosomal compartments for extended periods following cellular uptake, we decided to evaluate whether release into the cytoplasm might be expedited by inclusion of a translocation domain in the folate-protein construct. To test this possibility, momordin-folate and truncated Pseudomonas exotoxin-folate conjugates (LysPE38 and CysPE35), i.e. protein synthesis inhibitors either lacking or containing the desired translocation domain, respectively, were examined for their abilities to block protein synthesis in a variety of cell types. The translocation competent LysPE38-folate construct was found to kill cells six times more rapidly with 10-fold greater potency than the permeation-incompetent momordin-folate. Further, cells expressing low levels of folate receptors could only be exterminated by the translocation competent Pseudomonas exotoxin-folate conjugates. When the translocation capability of CysPE35-folate was inactivated by modification of Cys287, the construct also lost most of its cytotoxicity. These data suggest that autocatalysis of transport from an internal vesicular compartment into the cytoplasm can greatly augment the cytotoxicity of a protein toxin entering cells via the folate endocytosis pathway. Because the folate ligand can selectively target a protein conjugate to cancer cells in the presence of normal cells, such translocatable toxin-folate constructs warrant further study as a possible treatment for some malignancies.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA; GLAXO RES INST, DEPT OLIGOMER DEV, RES TRIANGLE PK, NC 27709 USA; NCI, DEPT MOLEC BIOL, BETHESDA, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Low, Philip/0000-0001-9042-5528				ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BATRA JK, 1989, P NATL ACAD SCI USA, V86, P8545, DOI 10.1073/pnas.86.21.8545; BIRN H, 1993, AM J PHYSIOL, V264, pC302, DOI 10.1152/ajpcell.1993.264.2.C302; CAMPBELL IG, 1991, CANCER RES, V51, P5329; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; CONEY LR, 1991, CANCER RES, V51, P6125; EIKLID K, 1980, EXP CELL RES, V126, P321, DOI 10.1016/0014-4827(80)90270-0; ELWOOD PC, 1991, J BIOL CHEM, V266, P2346; FAN J, 1992, ADV ENZYME REGUL, V32, P3; HJELLE JT, 1991, AM J PHYSIOL, V260, pC338, DOI 10.1152/ajpcell.1991.260.2.C338; HOLM J, 1991, BIOCHEM J, V280, P267, DOI 10.1042/bj2800267; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; KANE MA, 1989, LAB INVEST, V60, P737; LACEY SW, 1989, J CLIN INVEST, V84, P715, DOI 10.1172/JCI114220; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAMON CP, 1991, P NATL ACAD SCI USA, V88, P5572, DOI 10.1073/pnas.88.13.5572; LEAMON CP, 1993, BIOCHEM J, V291, P855, DOI 10.1042/bj2910855; LEAMON CP, 1992, J BIOL CHEM, V267, P24966; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; OGATA M, 1990, J BIOL CHEM, V265, P20678; OGATA M, 1992, J BIOL CHEM, V267, P25396; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; SIEGALL CB, 1990, J BIOL CHEM, V265, P16318; SIEGALL CB, 1989, J BIOL CHEM, V264, P14256; STIRPE F, 1988, NUCLEIC ACIDS RES, V16, P1349, DOI 10.1093/nar/16.4.1349; THEUER CP, 1992, J BIOL CHEM, V267, P16872; THEUER CP, 1993, CANCER RES, V53, P1; VERMA RS, 1992, J BIOL CHEM, V267, P4119; WEITMAN SD, 1992, CANCER RES, V52, P6708	31	162	200	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24847	24854						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227046				2022-12-27	WOS:A1993MG67300051
J	VANNOCKER, S; VIERSTRA, RD				VANNOCKER, S; VIERSTRA, RD			MULTIUBIQUITIN CHAINS LINKED THROUGH LYSINE-48 ARE ABUNDANT IN-VIVO AND ARE COMPETENT INTERMEDIATES IN THE UBIQUITIN PROTEOLYTIC PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN; ARABIDOPSIS-THALIANA; DEGRADATION; ENZYME; GENE; CONJUGATE; WHEAT; E2	A prerequisite for the selective degradation of intracellular proteins by the ubiquitin-dependent proteolytic pathway is the attachment of a chain of ubiquitin monomers to the targeted protein. In these multiubiquitin chains, the carboxyl-terminal glycine 76 of ubiquitin is linked via an isopeptide bond to the epsilon-amino group of lysine 48 in the adjacent ubiquitin. It remains to be determined whether these chains are preassembled and attached en masse to the target, are made by sequential conjugation of ubiquitin monomers to ubiquitins already linked to the protein, or both. Using the 20-kDa ubiquitin-conjugating enzyme TaUBC7 from wheat, we have generated free, glycine 76-->lysine 48-linked multiubiquitin chains (Ubq(n)), and have individually purified Ubq(n) species (n less-than-or-equal-to 6) by anion-exchange, high pressure liquid chromatography. The migration of these chains during SDS-polyacrylamide gel electrophoresis was indistinguishable from those of major ubiquitin immunoreactive proteins in cell lysates from a variety of eukaryotes suggesting that free, multiubiquitin chains are abundant in vivo. One of these chain members (Ubq2) was purified from wheat and was demonstrated via amino acid sequence analysis of tryptic fragments to consist of two ubiquitin monomers joined via a glycine 76-->lysine 48 linkage. We also show in vitro that purified Ubq2 and Ubq4 are competent in activation by ubiquitin-activating enzyme (E1), in transfer to E2s, and in ubiquitin-protein ligase (E3)-independent conjugation to other Ubq(n) species and to histones H2A/B. These data demonstrate that multiubiquitin chains exist as free, functional structures in vivo and support the possibility that at least a portion of free ubiquitin is preassembled into multiubiquitin chains prior to its attachment to proteolytic substrates.	UNIV WISCONSIN,DEPT HORT,1575 LINDEN DR,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NIGMS NIH HHS [2T32GM07215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BAMEZAI S, 1989, BIOCHEM BIOPH RES CO, V162, P89, DOI 10.1016/0006-291X(89)91966-9; BEERS EP, 1992, J BIOL CHEM, V267, P15432; BOND U, 1986, MOL CELL BIOL, V6, P4602, DOI 10.1128/MCB.6.12.4602; BURKE TJ, 1988, MOL GEN GENET, V213, P435, DOI 10.1007/BF00339613; Callis J., 1989, OXFORD SURV PLANT MO, V6, P1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; COOK WJ, 1992, J BIOL CHEM, V267, P16467; COX MJ, 1986, ANAL BIOCHEM, V154, P345, DOI 10.1016/0003-2697(86)90535-X; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GIROD PA, 1993, J BIOL CHEM, V268, P955; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HADARI T, 1992, J BIOL CHEM, V267, P719; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HTFIELD PM, 1990, J BIOL CHEM, V265, P15813; JABBEN M, 1989, J BIOL CHEM, V264, P4998; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORI S, 1992, J BIOL CHEM, V267, P6429; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SULLIVAN ML, 1989, P NATL ACAD SCI USA, V86, P9861, DOI 10.1073/pnas.86.24.9861; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; VANNOCKER S, 1991, P NATL ACAD SCI USA, V88, P10297, DOI 10.1073/pnas.88.22.10297; VIERSTRA RD, 1986, BIOCHEMISTRY-US, V25, P3105, DOI 10.1021/bi00359a006; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; VIERSTRA RD, 1985, J BIOL CHEM, V260, P1015	32	71	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24766	24773						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227036				2022-12-27	WOS:A1993MG67300039
J	DONG, Q; COPELAND, WC; WANG, TSF				DONG, Q; COPELAND, WC; WANG, TSF			MUTATIONAL STUDIES OF HUMAN DNA POLYMERASE-ALPHA - SERINE 867 IN THE 2ND MOST CONSERVED REGION AMONG ALPHA-LIKE DNA-POLYMERASES IS INVOLVED IN PRIMER BINDING AND MISPAIR PRIMER EXTENSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLENOW FRAGMENT; KINETICS; FIDELITY; SITE; MUTAGENESIS; EXPRESSION	The second most conserved region of alpha-like DNA polymerases, region II, spans a block of 40 amino acid residues centered at the core sequence -DFNSLYPSII-. In the previous paper, we described mutational studies of 3 amino acid residues in region II which includes 2 amino acid residues in the core sequence. We showed that residues Asp860 and Tyr865 in the core sequence are involved in substrate deoxynucleotide triphosphate (dNTP) binding. We further showed that the phenyl moiety of the Tyr865 side chain interacts with the incoming dNTP and is responsible for the misinsertion fidelity of the enzyme. In this report, we investigated the function of 2 serine residues, Ser863 and Ser867, in this core sequence. Mutation of these 2 Ser residues to either Ala or Thr yielded mutant enzymes with similar K(m) for dNTPs, k(cat), processivity, and misinsertion fidelity of DNA synthesis as the wild type enzyme. However, mutation of Ser867 to Ala demonstrated a 30-fold increase in K(m) for primer-template and a 5-fold higher K(D) for binding primer-template. DNA footprinting experiments of primer with the dideoxynucleotide terminus indicated that the structural feature of the primer recognized by Ser867 is the 3'-OH terminus. Single-stranded DNA inhibition data suggest that removal of the hydroxyl side chain of Ser867 affects the polymerase's interaction with primer and not with template. Mutation of Ser867 to Ala also decreases the mutant enzyme's K(m) for dNTP to extend a mispaired primer and thus enhances its capacity to extend a mispaired primer terminus. These data support the conclusion that the hydroxyl side chain of Ser867 of human DNA polymerase alpha is involved in primer interaction during DNA synthesis and plays an essential role in mispair extension fidelity of DNA synthesis.	STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,STANFORD,CA 94305	Stanford University			Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	NCI NIH HHS [CA14835] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA014835] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COPELAND WC, 1993, J BIOL CHEM, V268, P11041; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DONG Q, 1993, J BIOL CHEM, V268, P24163; GOODMAN MF, 1988, MUTAT RES, V200, P11, DOI 10.1016/0027-5107(88)90067-X; GUEST CR, 1991, BIOCHEMISTRY-US, V30, P8759, DOI 10.1021/bi00100a007; HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231; KESTI T, 1993, J BIOL CHEM, V268, P10238; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NG L, 1989, J BIOL CHEM, V264, P13018; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; SUMMERS M, 1988, TEX AGR EXP STN B, V1555, P3; TANAKA S, 1982, J BIOL CHEM, V257, P8386; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x	23	39	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24175	24182						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226964				2022-12-27	WOS:A1993MF29400069
J	FURUKAWA, K; TAGAYA, M; TANIZAWA, K; FUKUI, T				FURUKAWA, K; TAGAYA, M; TANIZAWA, K; FUKUI, T			ROLE OF THE CONSERVED LYS-X-GLY-GLY SEQUENCE AT THE ADP-GLUCOSE-BINDING SITE IN ESCHERICHIA-COLI GLYCOGEN-SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE KINASE; ADENOSINE DIPHOSPHOPYRIDOXAL; SKELETAL-MUSCLE; ACTIVE-SITE; PROTEIN; GENE; PHOSPHORYLASE; BACTERIAL; CLONING; ENZYMES	Although bacterial and mammalian glycogen synthases differ in the primary structure and specificity for glucosyl donor, lysyl residues identified at their substrate-binding sites by affinity labeling are present in a conserved tetrapeptide sequence, Lys-X-Gly-Gly, where X is a residue not conserved (Tagaya, M., Nakano, K., and Fukui, T. (1985) J. Biol. Chem. 260, 6670-6676; Furukawa, K., Tagaya, M., Inouye, M., Preiss, J., and Fukui, T. (1990) J. Biol. Chem. 265, 2086-2090). To elucidate the functional role of this conserved sequence, Lys-15, Gly-17, and Gly-18 in Escherichia coli glycogen synthase have been replaced by other amino acid residues via site-directed mutagenesis. Kinetic analyses of the Lys-15 mutant enzymes showed that the epsilon-amino group of Lys-15 is mainly involved in binding of the phosphate moiety adjacent to the glycosidic linkage in the substrate ADP-glucose, presumably through an ionic interaction. The mutant enzyme in which Ala was substituted for Gly-17 had a catalytic rate constant 3 orders of magnitude smaller than that of the wild-type enzyme with a slightly increased Michaelis constant for ADP-glucose, whereas the Gly-18 --> Ala mutant showed a rate constant only 3.2-fold smaller. In addition, mutations of Gly-17 and Gly-18 resulted in marked changes in the reactivity of Lys-15 with affinity labeling reagents. These results suggest that the 2 glycyl residues in the conserved Lys-X-Gly-Gly sequence, in particular the one closer to the ADP-glucose-binding lysyl residue, participate in catalysis by assisting conformational change(s) of the active site or stabilizing the transition state.	OSAKA UNIV,INST SCI & IND RES,IBARAKI,OSAKA 567,JAPAN	Osaka University			Furukawa, Koji/L-6909-2018	Furukawa, Koji/0000-0002-5701-2497				BAI G, 1990, J BIOL CHEM, V265, P7843; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNER MF, 1989, P NATL ACAD SCI USA, V86, P1443, DOI 10.1073/pnas.86.5.1443; Cleland W W, 1979, Methods Enzymol, V63, P103; Cohen P, 1978, Curr Top Cell Regul, V14, P117; FARKAS I, 1990, J BIOL CHEM, V265, P20879; FOX J, 1972, METHOD ENZYMOL, V28, P539; FURUKAWA K, 1990, J BIOL CHEM, V265, P2086; Higuchi R., 1989, PCR TECHNOLOGY, P61; KLOESGEN R B, 1986, Molecular and General Genetics, V203, P237; KUMAR A, 1986, J BIOL CHEM, V261, P6256; MOHRENHOLZ AM, 1988, J BIOL CHEM, V263, P10561; PREISS J, 1969, CURRENT TOPICS CELLU, V1, P125; REINSTEIN J, 1988, BIOCHEMISTRY-US, V27, P4712, DOI 10.1021/bi00413a020; STALMANS W, 1973, ENZYMES, V9, P309; TAGAYA M, 1984, J BIOL CHEM, V259, P4860; TAGAYA M, 1987, J BIOL CHEM, V262, P8257; TAGAYA M, 1985, J BIOL CHEM, V260, P6670; TAGAYA M, 1986, BIOCHEMISTRY-US, V25, P2958, DOI 10.1021/bi00358a034; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YAGAMI T, 1988, FEBS LETT, V229, P261, DOI 10.1016/0014-5793(88)81137-2; YONEYA T, 1989, J BIOCHEM-TOKYO, V105, P158, DOI 10.1093/oxfordjournals.jbchem.a122631; YU F, 1988, J BIOL CHEM, V263, P13706; ZHANG WM, 1989, FASEB J, V3, P2532, DOI 10.1096/fasebj.3.13.2509275	26	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23837	23842						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226921				2022-12-27	WOS:A1993MF29400023
J	HOLLANDER, MC; ALAMO, I; JACKMAN, J; WANG, MG; MCBRIDE, OW; FORNACE, AJ				HOLLANDER, MC; ALAMO, I; JACKMAN, J; WANG, MG; MCBRIDE, OW; FORNACE, AJ			ANALYSIS OF THE MAMMALIAN GADD45 GENE AND ITS RESPONSE TO DNA-DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSITU HYBRIDIZATION; CHROMOSOMAL LOCALIZATION; CELLS; EXPRESSION; DIFFERENTIATION; SEQUENCE; PROTEIN; AGENTS; PROBE; STEP	The gadd45 gene is transcriptionally activated through at least two different mechanisms; one following treatment with base-damaging agents such as methylmethane sulfonate and UV radiation and the other following ionizing radiation. To investigate the sequences involved in induction of gadd45 by agents producing high levels of base damage, the hamster, human, and mouse genes were sequenced. Comparison of these sequences revealed a high level of conservation between species of 1500 base pairs of the proximal promoter and 700 base pairs within the third intron. However, in the promoter regions, there was no conservation between species of any transcription factor binding sites known to confer DNA damage responsiveness. The promoter of the hamster gene was inducible by base-damaging agents in both rodent and human cell lines and the human gene was inducible in a rodent cell line. This indicates that both sequence elements in the gadd45 promoter and factors binding to these sites are conserved in mammalian cells. Deletion analysis of the hamster promoter did not reveal any specific sequence which conferred damage inducibility and the maximal response required a large portion of the promoter. The hamster promoter was not inducible by ionizing radiation, suggesting that sequences outside the promoter region used, such as a p53 binding site in the third intron, are necessary. The human GADD45 gene was mapped to chromosome 1p31.1-31.2.	NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	HOLLANDER, MC (corresponding author), NCI, DIV CANC TREATMENT, DEV THERAPEUT PROGRAM, MOLEC PHARMACOL LAB, BETHESDA, MD 20892 USA.		Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X				ABDOLLAHI A, 1991, ONCOGENE, V6, P165; BHATT B, 1988, NUCLEIC ACIDS RES, V16, P3951, DOI 10.1093/nar/16.9.3951; BOHR VA, 1989, LAB INVEST, V61, P143; CALLIS J, 1987, NUCLEIC ACIDS RES, V15, P5823; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; GARSON JA, 1987, CYTOGENET CELL GENET, V45, P10, DOI 10.1159/000132417; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; GHOSH D, 1992, NUCLEIC ACIDS RES, V20, P2091, DOI 10.1093/nar/20.suppl.2091; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HOLLANDER MC, 1990, BIOTECHNIQUES, V9, P174; LANDEGENT JE, 1985, NATURE, V317, P175, DOI 10.1038/317175a0; LORD KA, 1990, ONCOGENE, V5, P387; LUETHY JD, 1990, J BIOL CHEM, V265, P16521; PAPATHANASIOU MA, 1991, MOL CELL BIOL, V11, P1009, DOI 10.1128/MCB.11.2.1009; PARK JS, 1992, GENE, V116, P259, DOI 10.1016/0378-1119(92)90523-R; PRIVES C, 1993, GENE DEV, V7, P529, DOI 10.1101/gad.7.4.529; SHAH G, 1993, CANCER RES, V53, P38; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; YAROSH DB, 1993, J INVEST DERMATOL, V100, P790, DOI 10.1111/1523-1747.ep12476573; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	28	220	231	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24385	24393						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226988				2022-12-27	WOS:A1993MF29400099
J	HUANG, ZX; DOSTAL, L; ROSAZZA, JPN				HUANG, ZX; DOSTAL, L; ROSAZZA, JPN			MECHANISMS OF FERULIC ACID CONVERSIONS TO VANILLIC ACID AND GUAIACOL BY RHODOTORULA-RUBRA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS SPOROTRICHUM-PULVERULENTUM; HYDROXYCINNAMIC ACIDS; STREPTOMYCES-SETONII; HPLC DETERMINATION; ORANGE JUICE; METABOLISM; DECARBOXYLATION; CATABOLISM	Resting cells of Rhodotorula rubra converted trans-ferulic acid (1) to vanillic acid (2), then to guaiacol (3) and protocatechuic acid (4), under aerobic conditions. In an argon atmosphere, R. rubra transformed ferulic acid to vanillic acid and 4-hydroxy-3-methoxystyrene (5). Metabolites were isolated by solid-phase extraction and characterized by mass spectrometry, H-1, and C-13-nuclear magnetic resonance spectroscopy (NMR). The biotransformation of ferulic acid to vanillic acid by R. rubra cell-free extracts required CoA, ATP, and NAD+. Mass spectrometry and C-13-NMR were used to demonstrate the incorporation of oxygen from (H2O)-O-18 during the conversion of ferulic acid to vanillic acid. The results suggest a parallel between this bioconversion reaction and the beta-oxidation of fatty acids. Proton-carbon correlation NMR spectroscopy was used to demonstrate the specific incorporation of deuterium from D2O into guaiacol obtained from vanillic acid. The incorporation of deuterium implicates the involvement of a quinoid vanillic acid tautomer as an intermediate in the decarboxylation reaction.	UNIV IOWA,COLL PHARM,DIV MED & NAT PROD CHEM,IOWA CITY,IA 52242; UNIV IOWA,COLL PHARM,CTR BIOCATALYSIS & BIOPROC,IOWA CITY,IA 52242	University of Iowa; University of Iowa								ANDER P, 1988, CELL CHEM TECHNOL, V22, P255; ANDER P, 1980, ARCH MICROBIOL, V125, P189, DOI 10.1007/BF00446876; ANDREONI V, 1984, SYST APPL MICROBIOL, V5, P299, DOI 10.1016/S0723-2020(84)80032-6; ARFMANN HA, 1989, Z NATURFORSCH C, V44, P765; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BETTS RE, 1974, J MED CHEM, V17, P599, DOI 10.1021/jm00252a006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSWELL JA, 1982, ARCH MICROBIOL, V131, P366, DOI 10.1007/BF00411188; BUSWELL JA, 1979, FEBS LETT, V104, P258, DOI 10.1016/0014-5793(79)80827-3; BUSWELL JA, 1981, J CHROMATOGR, V215, P99, DOI 10.1016/S0021-9673(00)81390-4; BUSWELL JA, 1979, FEBS LETT, V103, P98, DOI 10.1016/0014-5793(79)81258-2; CRAWFORD RL, 1978, APPL ENVIRON MICROB, V36, P539, DOI 10.1128/AEM.36.4.539-543.1978; FINKLE BJ, 1962, J BIOL CHEM, V237, P2926; FRENCH CJ, 1976, PHYTOCHEMISTRY, V15, P564, DOI 10.1016/S0031-9422(00)88979-7; GRBICGALIC D, 1985, APPL ENVIRON MICROB, V50, P1052; GURUJEYALAKSHMI G, 1987, CURR MICROBIOL, V16, P69, DOI 10.1007/BF01588174; HUANG ZX, 1993, APPL ENVIRON MICROB, V59, P2244, DOI 10.1128/AEM.59.7.2244-2250.1993; JONES CA, 1992, J ANTIBIOT, V45, P1492, DOI 10.7164/antibiotics.45.1492; KIRK TK, 1973, APPL MICROBIOL, V26, P173, DOI 10.1128/AEM.26.2.173-175.1973; NALI M, 1985, EXPERIENTIA, V41, P1351, DOI 10.1007/BF01952091; NAZARETH S, 1986, CAN J MICROBIOL, V32, P494, DOI 10.1139/m86-090; POMETTO AL, 1981, CAN J MICROBIOL, V27, P636, DOI 10.1139/m81-097; RAHOUTI M, 1989, APPL ENVIRON MICROB, V55, P2391, DOI 10.1128/AEM.55.9.2391-2398.1989; ROUSEFF RL, 1992, J CHROMATOGR SCI, V30, P383, DOI 10.1093/chromsci/30.10.383; ROUSEFF RL, 1992, J AGR FOOD CHEM, V40, P1139, DOI 10.1021/jf00019a010; SAMEJIMA M, 1987, MOKUZAI GAKKAISHI, V33, P728; SUTHERLAND JB, 1983, CAN J MICROBIOL, V29, P1253, DOI 10.1139/m83-195; TOMS A, 1970, BIOCHEMISTRY-US, V9, P337, DOI 10.1021/bi00804a021	28	96	103	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23954	23958						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226936				2022-12-27	WOS:A1993MF29400039
J	LEE, S; WOLFRAIM, LA; WANG, E				LEE, S; WOLFRAIM, LA; WANG, E			DIFFERENTIAL EXPRESSION OF S1 AND ELONGATION FACTOR-1-ALPHA DURING RAT DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; FACTOR EF-1-ALPHA; XENOPUS-LAEVIS; 2 GENES; NUCLEOTIDE-SEQUENCE; 1-ALPHA EF-1-ALPHA; PROTEIN-SYNTHESIS; CHROMOSOMAL GENE; BINDING PROTEIN; 3 GENES	Elongation factor-1alpha (EF-1alpha) is a highly conserved protein functioning in peptide elongation during translation. A cDNA, S1, was isolated; its deduced amino acid sequence shares high similarity with mammalian EF-1alphas (92%). While EF-1alpha is present in all tissues, S1 mRNA can only be detected in brain, heart, and muscle. We report here that the retropseudogene phenomenon is attributable to EF-1alpha and not S1, the latter being represented by a single copy in the rat genome. The S1 steady-state mRNA levels are consistently higher than EF-1alpha in S1-positive tissues. S1 mRNA can only be detected late during brain, heart, and muscle development in vivo and increases to a plateau in early postnatal life. In a cultured muscle system, S1 expression is dependent upon the formation of myotubes, although the accumulation of S1 mRNA is significantly lower than that observed in adult skeletal muscle. EF-1alpha mRNA levels are down-regulated during brain, heart, and muscle development, but stay relatively steady in liver. We show here that EF-1alpha and S1 are differentially expressed during rat development and that the activation of S1 gene expression is subsequent to the terminal differentiation process in brain, heart, and muscle.	SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,BLOOMFIELD CTR RES AGING,MONTREAL H3T 1E2,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3T 1E2,PQ,CANADA	Lady Davis Institute; McGill University; McGill University					NIA NIH HHS [AG07444] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG007444, R37AG007444] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABDALLAH B, 1991, P NATL ACAD SCI USA, V88, P9277, DOI 10.1073/pnas.88.20.9277; ANN DK, 1992, J BIOL CHEM, V267, P699; ANN DK, 1991, J BIOL CHEM, V266, P10429; BEC G, 1989, J BIOL CHEM, V264, P21131; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; CAVALLIUS J, 1992, NUCLEIC ACIDS RES, V20, P1422, DOI 10.1093/nar/20.6.1422; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVER TE, 1989, J BIOL CHEM, V264, P20518; DEVLIN BH, 1983, DEV BIOL, V95, P175, DOI 10.1016/0012-1606(83)90016-7; DJE MK, 1990, NUCLEIC ACIDS RES, V18, P3489, DOI 10.1093/nar/18.12.3489; ENDO T, 1986, MOL CELL BIOL, V6, P1412, DOI 10.1128/MCB.6.5.1412; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; FRYDENBERG J, 1991, GENE, V109, P185, DOI 10.1016/0378-1119(91)90608-E; GILMAN M, 1993, CURRENT PROTOCOLS MO, P471; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; GREENBERG JR, 1987, FEBS LETT, V224, P54, DOI 10.1016/0014-5793(87)80421-0; GUNNING P, 1987, MOL CELL BIOL, V7, P4100, DOI 10.1128/MCB.7.11.4100; HAYASHI Y, 1989, J BIOCHEM-TOKYO, V106, P560, DOI 10.1093/oxfordjournals.jbchem.a122895; HERSHEY JWB, 1990, ENZYME, V44, P17, DOI 10.1159/000468744; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HOVEMANN B, 1988, NUCLEIC ACIDS RES, V16, P3175, DOI 10.1093/nar/16.8.3175; KOCH I, 1990, ONCOGENE, V5, P839; KREIG PA, 1989, DEV BIOL, V133, P93; LEE S, 1992, J BIOL CHEM, V267, P24064; LEE S, 1993, J HISTOCHEM CYTOCHEM, V41, P1093, DOI 10.1177/41.7.8515051; LEMISCHKA I, 1982, NATURE, V300, P330, DOI 10.1038/300330a0; LENSTRA JA, 1986, EUR J BIOCHEM, V155, P475, DOI 10.1111/j.1432-1033.1986.tb09514.x; LINZ JE, 1987, MOL CELL BIOL, V7, P1925, DOI 10.1128/MCB.7.5.1925; MADSEN HO, 1990, NUCLEIC ACIDS RES, V18, P1513, DOI 10.1093/nar/18.6.1513; MERRICK WC, 1990, ENZYME, V44, P7, DOI 10.1159/000468743; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; MORALES J, 1991, BIOCHIMIE, V73, P1249, DOI 10.1016/0300-9084(91)90011-O; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; NAGATA S, 1984, EMBO J, V3, P1825, DOI 10.1002/j.1460-2075.1984.tb02053.x; OHTA K, 1990, J BIOL CHEM, V265, P3240; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Sambrook J, 1989, MOL CLONING LABORATO; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SASSOON DA, 1993, DEV BIOL, V156, P11, DOI 10.1006/dbio.1993.1055; SASSOON DA, 1989, NATURE, V342, P303; SCHIRMAIER F, 1984, EMBO J, V3, P3311, DOI 10.1002/j.1460-2075.1984.tb02295.x; SHIRASAWA T, 1992, NUCLEIC ACIDS RES, V20, P909, DOI 10.1093/nar/20.4.909; SUNDSTROM P, 1990, J BACTERIOL, V172, P2036, DOI 10.1128/jb.172.4.2036-2045.1990; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0	51	69	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24453	24459						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226996				2022-12-27	WOS:A1993MF29400109
J	POITRAS, M; BERNIER, S; SERVANT, M; RICHARD, DE; BOULAY, G; GUILLEMETTE, G				POITRAS, M; BERNIER, S; SERVANT, M; RICHARD, DE; BOULAY, G; GUILLEMETTE, G			THE HIGH-AFFINITY STATE OF INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR IS A FUNCTIONAL-STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENAL-CORTEX; TRISPHOSPHATE RECEPTOR; CALCIUM RELEASE; ACINAR-CELLS; SMOOTH-MUSCLE; CA2+ RELEASE; HAMSTER EGGS; THIMEROSAL; BINDING; OSCILLATIONS	Inositol 1,4,5-trisphosphate (InsP3) is a second messenger responsible for the rapid and discontinuous release of Ca2+ from intracellular stores. In this study, the effects of the sulfhydryl reagent thimerosal were investigated on Ca2+ mobilization and on InsP3 binding. Thimerosal was shown to release Ca2+, in a dose-dependent manner, with an EC50 of 135.8 +/- 5.2 muM, from bovine adrenal cortex microsomes. Thimerosal-induced Ca2+ release was not prevented by heparin (250 mug/ml), ruling out a participation of InsP3 receptor in that effect. The slow rate of thimerosal-induced Ca2+ release rather suggested an inhibition of microsomal Ca2+ ATPase. At submaximal concentration, thimerosal (100 muM) was also shown to potentiate the release of Ca2+ induced by InsP3. Dose-response experiments revealed that thimerosal enhanced the apparent affinity of InsP3 by a factor 2.21 +/- 0.28, without modifying the maximal amount of Ca2+ released by InsP3. Thimerosal also enhanced, in a dose-dependent manner, [H-3]InsP3 binding to adrenal cortex microsomes (EC50 = 43.3 +/- 7.6 muM). A similar effect was also observed on [H-3]InsP3 binding to solubilized receptors, suggesting a direct modification of the receptor protein by thimerosal. The effects of thimerosal on Ca2+ release and [H-3]InsP3 binding were abolished in the presence of the reducing agent dithiothreitol (1 mM), suggesting a modification by thimerosal of specific thiol groups on these microsomal proteins. Scatchard analysis revealed that thimerosal (100 muM) increased InsP3 receptor affinity by 1.87 +/- 0.26-fold. Kinetic analysis indicated that this increased affinity was due to an enhancement of InsP3 association rate constant. The concomitant increases of binding affinity and Ca2+ releasing potency suggest that the high affinity state of InsP3 receptor is a functional state.	UNIV SHERBROOKE,FAC MED,DEPT PHARMACOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA	University of Sherbrooke			Boulay, Guylain/D-9773-2010; Richard, Darren E./K-6760-2019	Richard, Darren/0000-0003-2690-0480				ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRD GS, 1992, J BIOL CHEM, V267, P17722; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GUILLEMETTE G, 1988, MOL ENDOCRINOL, V2, P1249, DOI 10.1210/mend-2-12-1249; GUILLEMETTE G, 1988, J BIOL CHEM, V263, P4541; GUILLEMETTE G, 1987, J BIOL CHEM, V262, P1010; GUILLEMETTE G, 1989, MOL PHARMACOL, V35, P339; GUILLEMETTE G, 1987, P NATL ACAD SCI USA, V84, P8195, DOI 10.1073/pnas.84.23.8195; HATZELMANN A, 1990, BIOCHEM PHARMACOL, V39, P559, DOI 10.1016/0006-2952(90)90064-R; HECKER M, 1989, BIOCHEM BIOPH RES CO, V159, P961, DOI 10.1016/0006-291X(89)92202-X; MAUGER JP, 1989, J BIOL CHEM, V264, P8821; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; MELDOLESI J, 1990, BIOCHIM BIOPHYS ACTA, V1055, P130, DOI 10.1016/0167-4889(90)90113-R; MEYER T, 1990, BIOCHEMISTRY-US, V29, P32, DOI 10.1021/bi00453a004; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MIYAZAKI S, 1992, FEBS LETT, V309, P180, DOI 10.1016/0014-5793(92)81090-9; MOUILLAC B, 1992, EUR J PHARM-MOLEC PH, V225, P179, DOI 10.1016/0922-4106(92)90019-R; MUALLEM S, 1989, J BIOL CHEM, V264, P205; PARYS JB, 1992, J BIOL CHEM, V267, P18776; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; RIBEIRODOVALLE RM, 1993, IN PRESS CELL CALCIU; SAYERS LG, 1993, BIOCHEM J, V289, P883, DOI 10.1042/bj2890883; SPAT A, 1986, BIOCHEM J, V233, P929; SPAT A, 1986, NATURE, V319, P514, DOI 10.1038/319514a0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; SWANN K, 1991, FEBS LETT, V278, P175, DOI 10.1016/0014-5793(91)80110-O; TAYLOR CW, 1991, PHARMACOL THERAPEUT, V51, P97, DOI 10.1016/0163-7258(91)90043-L; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	40	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24078	24082						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226953				2022-12-27	WOS:A1993MF29400057
J	RISINGER, C; BLOMQVIST, AG; LUNDELL, I; LAMBERTSSON, A; NASSEL, D; PIERIBONE, VA; BRODIN, L; LARHAMMAR, D				RISINGER, C; BLOMQVIST, AG; LUNDELL, I; LAMBERTSSON, A; NASSEL, D; PIERIBONE, VA; BRODIN, L; LARHAMMAR, D			EVOLUTIONARY CONSERVATION OF SYNAPTOSOME-ASSOCIATED PROTEIN-25-KDA (SNAP-25) SHOWN BY DROSOPHILA AND TORPEDO CDNA CLONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION; SYNAPTIC VESICLES; MEMBRANE-PROTEIN; NEUROPEPTIDE-Y; MESSENGER-RNAS; RAT-BRAIN; TRANSPORT; ORGANIZATION; POLYPEPTIDE; TERMINALS	The neuron-specific proteins SNAP-25 (synaptosome-associated protein 25 kDa), synaptobrevin and syntaxin, are localized to presynaptic terminals in mammals and have been found to associate with proteins involved in vesicle docking and membrane fusion. We describe here SNAP-25 cDNA clones from the fruit fly Drosophila melanogaster and the ray Torpedo marmorata. In situ hybridization showed that SNAP-25 mRNA is exclusively found in brain and ganglia in Drosophila with a pattern suggesting expression in most neurons. The Drosophila and Torpedo proteins show 61 and 81% amino acid identity to mouse SNAP-25, a degree of conservation similar to that previously reported for synaptobrevin. None of the SNAP-25 sequences has a membrane-spanning region, but all contain a cluster of cysteine residues that can be palmitoylated for membrane attachment. SNAP-25 displays sequence similarity to syntaxin A and B. These data show that SNAP-25 and synaptobrevin, which are both implicated in vesicle docking and/or membrane fusion, have both been highly conserved during evolution. This supports the existence of a basic molecular machinery for synaptic vesicle docking in vertebrate and invertebrate synapses.	UNIV UPPSALA,DEPT MED GENET,BOX 589,S-75123 UPPSALA,SWEDEN; UNIV OSLO,DEPT GENET,N-0315 OSLO,NORWAY; UNIV STOCKHOLM,DEPT ZOOL,S-10691 STOCKHOLM,SWEDEN; KAROLINSKA INST,DEPT HISTOL & NEUROBIOL,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,NOBEL INST NEUROPHYSIOL,S-10401 STOCKHOLM 60,SWEDEN	Uppsala University; University of Oslo; Stockholm University; Karolinska Institutet; Karolinska Institutet				Pieribone, Vincent/0000-0002-5836-5454				BARK IC, 1993, IN PRESS J MOL BIOL, V232; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BIRMAN S, 1990, FEBS LETT, V261, P303, DOI 10.1016/0014-5793(90)80577-6; BLOMQVIST AG, 1992, P NATL ACAD SCI USA, V89, P2350, DOI 10.1073/pnas.89.6.2350; BRANKS PL, 1986, MOL BRAIN RES, V1, P1, DOI 10.1016/0169-328X(86)90015-X; CATSICAS S, 1991, P NATL ACAD SCI USA, V88, P785, DOI 10.1073/pnas.88.3.785; CATSICAS S, 1992, J NEUROSCI RES, V33, P1, DOI 10.1002/jnr.490330102; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HESS DT, 1992, J NEUROSCI, V12, P4634; JAKOBSEN KS, 1990, NUCLEIC ACIDS RES, V18, P3669, DOI 10.1093/nar/18.12.3669; LOEWY A, 1991, J NEUROSCI, V11, P3412; Nei M., 1987, MOL EVOLUTIONARY GEN; OCONNOR M, 1988, EMBO J, V7, P534; OYLER GA, 1991, P NATL ACAD SCI USA, V88, P5247, DOI 10.1073/pnas.88.12.5247; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; OYLER GA, 1992, DEV BRAIN RES, V65, P133, DOI 10.1016/0165-3806(92)90172-S; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; PERIN MS, 1991, J BIOL CHEM, V266, P615; PIERIBONE VA, 1992, J NEUROSCI, V12, P3361; RISINGER C, 1993, IN PRESS P NATL ACAD; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; WARREN G, 1993, NATURE, V362, P297, DOI 10.1038/362297a0; WILLARD M, 1974, P NATL ACAD SCI USA, V71, P2183, DOI 10.1073/pnas.71.6.2183	30	62	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24408	24414						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226991				2022-12-27	WOS:A1993MF29400102
J	SCHIAVO, G; ROSSETTO, O; CATSICAS, S; DELAURETO, PP; DASGUPTA, BR; BENFENATI, F; MONTECUCCO, C				SCHIAVO, G; ROSSETTO, O; CATSICAS, S; DELAURETO, PP; DASGUPTA, BR; BENFENATI, F; MONTECUCCO, C			IDENTIFICATION OF THE NERVE-TERMINAL TARGETS OF BOTULINUM NEUROTOXIN SEROTYPE-A, SEROTYPE-D, AND SEROTYPE-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SYNAPTOSOMAL-ASSOCIATED PROTEIN; MEMBRANE-PROTEIN; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; TETANUS TOXIN; ZINC; TRANSPORT; SNAP-25; FUSION; GENES	Botulinum neurotoxins are metalloproteins with one zinc atom bound to the zinc binding motif of zinc endopeptidases. Here we show that botulinum neurotoxin serotypes A, D, and E are zinc endoproteases specific for components of the synaptic vesicle docking and fusion complex. Serotypes A and E cleave SNAP-25, a 25-kDa protein of the synaptic terminal, while serotype D is specific for VAMP/synaptobrevin, a membrane protein of synaptic vesicles. Both rat brain VAMP isoforms are cleaved at a single Lys-Leu peptide bond. The proteolytic activity of these neurotoxins is inhibited by EDTA and captopril.	UNIV PADUA,DIPARTIMENTO SCI BIOMED,I-35121 PADUA,ITALY; UNIV PADUA,CRIBI,I-35121 PADUA,ITALY; GLAXO INST MOLEC BIOL SA,CH-1228 PLAN LES OUATES,SWITZERLAND; UNIV WISCONSIN,FOOD RES INST,MADISON,WI 53706; UNIV MODENA,IST FISIOL UMANA,I-41100 MODENA,ITALY	University of Padua; University of Padua; GlaxoSmithKline; University of Wisconsin System; University of Wisconsin Madison; Universita di Modena e Reggio Emilia	SCHIAVO, G (corresponding author), UNIV PADUA,CTR BIOMEMBRANE,CNR,VIA TRIESTE 75,I-35121 PADUA,ITALY.		rossetto, ornella/AAC-3866-2022	rossetto, ornella/0000-0002-6113-3857; Schiavo, Giampietro/0000-0002-4319-8745	NINDS NIH HHS [NS17742] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017742] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BINZ T, 1990, NUCLEIC ACIDS RES, V18, P5556, DOI 10.1093/nar/18.18.5556; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; GANSEL M, 1987, PFLUG ARCH EUR J PHY, V409, P533, DOI 10.1007/BF00583812; HESS DT, 1992, J NEUROSCI, V12, P4634; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KOCHWESER J, 1982, NEW ENGL J MED, V306, P214; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; MOLGO J, 1990, J PHYSIOLOGY PARIS, V84, P152; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; POULAIN B, 1993, J NEUROCHEM, V61, P1175, DOI 10.1111/j.1471-4159.1993.tb03640.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Schiavo G, 1993, Trends Microbiol, V1, P170, DOI 10.1016/0966-842X(93)90086-7; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; Simpson L.L., 1989, BOTULINUM NEUROTOXIN; Smith L. D. S., 1988, BOTULISM ORGANISM IT; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; [No title captured]	31	372	403	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23784	23787						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226912				2022-12-27	WOS:A1993MF29400014
J	SHWORAK, NW; OCONNOR, T; WONG, NCW; GEDAMU, L				SHWORAK, NW; OCONNOR, T; WONG, NCW; GEDAMU, L			DISTINCT TATA MOTIFS REGULATE DIFFERENTIAL EXPRESSION OF HUMAN METALLOTHIONEIN-I GENES MT-I(F) AND MT-I(G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; BINDING PROTEINS; MAMMALIAN-CELLS; HEAVY-METALS; ALBUMIN GENE; DNA; TRANSCRIPTION; PROMOTER; GLUCOCORTICOIDS; MUTAGENESIS	In this report, we have measured the cadmium (Cd2+)-induced expression of all known metallothionein I (MT-I) mRNAs in a human hepatoma cell line, Hep G2. Among the human MT-I gene family promoters, marked sequence conservation exists; despite this, the mRNA accumulation level for each species was found to be quite unique. This differential Cd2+ induction of MT-I family members provides an ideal opportunity to assess whether the characteristic response results from subtle isoform-specific variations in promoter structure. Accordingly, we have examined the mechanism for differential expression of two isoforms, MT-I(G) and MT-I(F), by transient transfection into Hep G2 cells. In the presence of Cd2+, MT-I(G) promoter activity and endogenous mRNA level were, respectively, 4.7- and 3-fold greater than those of MT-I(F). This close correlation between promoter activity and mRNA accumulation strongly suggests that differential expression occurs at the level of transcription. The difference in Cd2+-stimulated activity was found to be conferred by 240- and 243-base pair promoter fragments spanning nucleotides -174 to +66 and -172 to +71 of the MT-I(G) and MT-I(F) genes, respectively. One of the most striking nonhomologies between the promoters is a single A (TATAAA) to C (TATCAA) transversion in the TATA motifs of MT-I(G) and MT-I(F) genes, respectively. To determine whether such a subtle change in the TATA motif could account for the marked differences in promoter function, we constructed MT-I(G)-TATCA and MT-I(F)-TATAA promoters and measured their activities in transient transfection and cell-free transcription assays. Results of both assays showed a profound difference between the two motifs that paralleled the difference in Cd2+-stimulated MT-I(G) and MT-I(F) mRNA levels. In summary, we have shown that differential regulation of two MT-I promoters is primarily due to a single base alteration in their TATA motifs.	UNIV CALGARY,DEPT BIOL SCI,2500 UNIV DR NW,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV CALGARY,DEPT MED,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV CALGARY,DEPT MED BIOCHEM,CALGARY T2N 1N4,ALBERTA,CANADA	University of Calgary; University of Calgary; University of Calgary			Shworak, Nicholas/AAJ-6770-2020	Shworak, Nicholas/0000-0001-7783-4634				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FALASCHI A, 1963, J BIOL CHEM, V238, P3080; Favaloro J, 1980, Methods Enzymol, V65, P718; FOSTER R, 1988, J BIOL CHEM, V263, P11528; GARRITY PA, 1990, MOL CELL BIOL, V10, P5646, DOI 10.1128/MCB.10.11.5646; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HAGER LJ, 1981, NATURE, V291, P340, DOI 10.1038/291340a0; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HEGUY A, 1986, MOL CELL BIOL, V6, P2149, DOI 10.1128/MCB.6.6.2149; JAHROUDI N, 1988, THESIS U CALGARY CAL; Kagi J.H.R., 1979, METALLOTHIONEIN; KAMBADUR R, 1990, P NATL ACAD SCI USA, V87, P9168, DOI 10.1073/pnas.87.23.9168; KARIN M, 1984, CELL, V36, P371, DOI 10.1016/0092-8674(84)90230-7; KARIN M, 1982, NATURE, V299, P797, DOI 10.1038/299797a0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KARIN M, 1984, P NATL ACAD SCI-BIOL, V81, P5494, DOI 10.1073/pnas.81.17.5494; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LICHTSTEINER S, 1989, CELL, V57, P1179, DOI 10.1016/0092-8674(89)90055-X; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MANIATIS T, 1982, MOL CLONING LABORATO, P122; MCDONNELL RE, 1987, PLANT MOL BIOL REP, V5, P380; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; PETERSON MG, 1988, EUR J BIOCHEM, V174, P417, DOI 10.1111/j.1432-1033.1988.tb14114.x; PETERSON MG, 1988, EUR J BIOCHEM, V174, P425, DOI 10.1111/j.1432-1033.1988.tb14115.x; RICHARDS RI, 1984, CELL, V37, P263, DOI 10.1016/0092-8674(84)90322-2; SADHU C, 1989, MOL CELL BIOL, V9, P5738, DOI 10.1128/MCB.9.12.5738; SADHU C, 1988, J BIOL CHEM, V263, P2679; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHMIDT CJ, 1984, SCIENCE, V224, P1104, DOI 10.1126/science.6719135; SCHMIDT CJ, 1986, P NATL ACAD SCI USA, V83, P3346, DOI 10.1073/pnas.83.10.3346; SCHMIDT CJ, 1985, J BIOL CHEM, V260, P7731; SEARLE PF, 1984, MOL CELL BIOL, V4, P1221, DOI 10.1128/MCB.4.7.1221; VARSHNEY U, 1986, MOL CELL BIOL, V6, P26, DOI 10.1128/MCB.6.1.26; WALLACE RB, 1987, METHOD ENZYMOL, V152, P432; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WILLIAMS JG, 1985, NUCLEIC ACID HYBRIDI, P139; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	44	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24460	24466						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226997				2022-12-27	WOS:A1993MF29400110
J	WELLING, PA; CAPLAN, M; SUTTERS, M; GIEBISCH, G				WELLING, PA; CAPLAN, M; SUTTERS, M; GIEBISCH, G			ALDOSTERONE-MEDIATED NA/K-ATPASE EXPRESSION IS ALPHA-1 ISOFORM-SPECIFIC IN THE RENAL CORTICAL COLLECTING DUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; RAT NA,K-ATPASE ALPHA-1; CULTURED KIDNEY-CELLS; BASOLATERAL MEMBRANE; TRANSPORT-PROPERTIES; SODIUM-TRANSPORT; MESSENGER-RNAS; TUBULES; SUBUNIT; PUMP	In the renal cortical collecting duct (CCD), mineral-ocorticoid hormones, like aldosterone, augment the abundance of Na/K-ATPase molecules. It has been postulated that this response involves an isoform switch of the Na/K-ATPase catalytic subunit, alpha, as the molecular basis for the differential regulation of mineralocorticoid-induced and constitutively expressed Na/K-ATPase pools. In opposition to this attractive hypothesis, three lines of independent evidence are presented which demonstrate that the CCD exclusively expresses the alpha1 form despite mineralocorticoid-mediated changes in functional Na/K pump density. First, aldosterone increased [H-3]ouabain binding in CCD 2.5-fold without changing the ouabain dissociation constant. Second, an electrophysiological assay for pump activity revealed that aldosterone increased maximum Na/K pump current in parallel with the change in ouabain binding without altering the apparent sodium affinity. Third, Western blot analysis with alpha isoform-specific, antipeptide antibodies demonstrated that aldosterone exclusively increased the total chemical pool of the alpha1 form of the pump without inducing other alpha subunit isoforms. In summary, aldosterone increases the abundance of Na/K-ATPase molecules in the CCD which are pharmacologically, physiologically, and chemically indistinguishable from those that are normally expressed.	YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA	Yale University				Caplan, Michael/0000-0001-5768-4405	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 17433-18] Funding Source: Medline; PHS HHS [5T320K07259] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARYSTARKHOVA EA, 1989, FEBS LETT, V250, P545, DOI 10.1016/0014-5793(89)80793-8; ASKARI A, 1988, J BIOL CHEM, V263, P235; BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; BARLETBAS C, 1988, P NATL ACAD SCI USA, V85, P1707, DOI 10.1073/pnas.85.5.1707; BARLETBAS CL, 1990, AM J PHYSIOL, V259, pF111; BLOTCHABAUD M, 1990, J BIOL CHEM, V265, P11676; BRODSKY JL, 1990, AM J PHYSIOL, V258, pC803, DOI 10.1152/ajpcell.1990.258.5.C803; BRODSKY JL, 1990, AM J PHYSIOL, V258, pC812, DOI 10.1152/ajpcell.1990.258.5.C812; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; CHARLES PGP, 1992, RENAL PHYSIOL BIOCH, V15, P10; CHARLES PGP, 1972, RENAL PHYSL BIOCH, V15, P10; DOUCET A, 1986, J BIOL CHEM, V261, P990; ELMERNISSI G, 1984, AM J PHYSIOL, V247, pF158, DOI 10.1152/ajprenal.1984.247.1.F158; EMANUEL JR, 1988, J BIOL CHEM, V263, P7726; EMANUEL JR, 1989, MOL CELL BIOL, V9, P3744, DOI 10.1128/MCB.9.9.3744; FEIGE G, 1986, PROGR CLIN BIOL RES, P377; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; GEERING K, 1982, J BIOL CHEM, V257, P338; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; HAMM DR, 1983, J GEN PHYSIOL, V82, P315; HARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P102, DOI 10.1016/0006-291X(89)92104-9; HELMAN SI, 1971, AM J PHYSIOL, V220, P1825, DOI 10.1152/ajplegacy.1971.220.6.1825; HENSLEY CB, 1992, AM J PHYSIOL, V262, pC484, DOI 10.1152/ajpcell.1992.262.2.C484; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KARLISH SJD, 1985, J PHYSIOL-LONDON, V359, P119, DOI 10.1113/jphysiol.1985.sp015578; KIRK KL, 1980, NATURE, V287, P237, DOI 10.1038/287237a0; KOEPPEN BM, 1983, AM J PHYSIOL, V244, pF35, DOI 10.1152/ajprenal.1983.244.1.F35; KOEPPEN BM, 1985, REGULATION DEV MEMBR, P89; KONE BC, 1990, SODIUM PUMP RECENT D, P265; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNER RA, 1981, P NATL ACAD SCI-BIOL, V78, P3403, DOI 10.1073/pnas.78.6.3403; LEWIS SA, 1983, J PHYSIOL-LONDON, V341, P169, DOI 10.1113/jphysiol.1983.sp014799; LEWIS SA, 1978, J MEMBRANE BIOL, V41, P117, DOI 10.1007/BF01972629; LYTTON J, 1985, J BIOL CHEM, V260, P75; MCGILL DL, 1991, J BIOL CHEM, V266, P15824; MUJAIS SK, 1985, J CLIN INVEST, V76, P170, DOI 10.1172/JCI111942; ONEIL RG, 1984, AM J PHYSIOL, V247, pC314, DOI 10.1152/ajpcell.1984.247.5.C314; ONEIL RG, 1984, AM J PHYSIOL, V247, pF14, DOI 10.1152/ajprenal.1984.247.1.F14; ONEIL RG, 1984, J MEMBRANE BIOL, V82, P281, DOI 10.1007/BF01871637; ONEIL RG, 1985, J MEMBRANE BIOL, V85, P169, DOI 10.1007/BF01871269; PACCOLAT MP, 1987, AM J PHYSIOL, V252, pC468, DOI 10.1152/ajpcell.1987.252.5.C468; PETTY KJ, 1981, J CLIN INVEST, V68, P1514, DOI 10.1172/JCI110405; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; ROSSIER BC, 1991, COLLOQ INSE, V215, P123; SANSOM S, 1987, AM J PHYSIOL, V253, pF753, DOI 10.1152/ajprenal.1987.253.4.F753; SANSOM SC, 1985, AM J PHYSIOL, V248, pF858, DOI 10.1152/ajprenal.1985.248.6.F858; SANSOM SC, 1986, AM J PHYSIOL, V251, pF743, DOI 10.1152/ajprenal.1986.251.4.F743; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHWARTZ GJ, 1978, AM J PHYSIOL, V235, pF576, DOI 10.1152/ajprenal.1978.235.6.F576; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1990, P NATL ACAD SCI USA, V87, P1178, DOI 10.1073/pnas.87.3.1178; SKOU JC, 1962, BIOCHIM BIOPHYS ACTA, V58, P314, DOI 10.1016/0006-3002(62)91015-6; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; VERREY F, 1989, MOL ENDOCRINOL, V3, P1369, DOI 10.1210/mend-3-9-1369; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; WARDEN DH, 1988, AM J PHYSIOL, V255, pF720, DOI 10.1152/ajprenal.1988.255.4.F720; YOUNG RM, 1987, BIOCHEM BIOPH RES CO, V145, P52, DOI 10.1016/0006-291X(87)91286-1	59	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23469	23476						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226873				2022-12-27	WOS:A1993MF51500079
J	MIYAGI, T; KONNO, K; EMORI, Y; KAWASAKI, H; SUZUKI, K; YASUI, A; TSUIKI, S				MIYAGI, T; KONNO, K; EMORI, Y; KAWASAKI, H; SUZUKI, K; YASUI, A; TSUIKI, S			MOLECULAR-CLONING AND EXPRESSION OF CDNA-ENCODING RAT SKELETAL-MUSCLE CYTOSOLIC SIALIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; NEURAMINIDASE GENE; INFLUENZA-VIRUS; TRYPANOSOMA-CRUZI; AVIAN INFLUENZA; MESSENGER-RNA; LIVER; AMPLIFICATION; BACTERIAL; TISSUES	We have isolated a cDNA clone encoding the cytosolic sialidase of rat skeletal muscle. Degenerate oligonucleotides, based on amino acid sequence data for the purified enzyme, were used as primers to amplify fragments of the gene from rat skeletal muscle cDNA by the polymerase chain reaction. The amplified cDNA fragment was then applied as probe to screen a rat skeletal muscle cDNA library. The longest cDNA clone thus isolated was incomplete at the 5'-end, and therefore an amplified cDNA from the 5'-end portion of the gene was further generated by polymerase chain reaction. These two cDNAs were used to construct a cDNA encoding the entire sequence of rat sialidase. The composite sequence encodes an open reading frame of 379 amino acids that include all sequenced peptides. Although the deduced amino acid sequence is not largely similar to those of bacterial and parasite sialidases, it contains two Asp blocks, the conserved sequence of the sialidases from these microorganisms. When the cDNA was inserted into an expression vector followed by transformation in Escherichia coli, sialidase activity appeared in the cell extract. The sialidase could be completely immunoprecipitated by antiserum against the cytosolic sialidase of rat skeletal muscle.	TOHOKU UNIV,INST DEV AGING & CANC,SENDAI,MIYAGI 980,JAPAN; UNIV TOKYO,FAC SCI,TOKYO 113,JAPAN; UNIV TOKYO,INST APPL MICROBIOL,TOKYO 113,JAPAN; TOKYO METROPOLITAN INST MED SCI,TOKYO 113,JAPAN; TOHOKU COLL PHARMACEUT SCI,SENDAI,MIYAGI 983,JAPAN	Tohoku University; University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Tohoku Medical & Pharmaceutical University	MIYAGI, T (corresponding author), MIYAGI CANC CTR,RES INST,DIV BIOCHEM,47-1 NODAYAMA,MEDESHIMA SHIODE,NATORI,MIYAGI 98112,JAPAN.		Kawasaki, Hiroshi/C-3048-2011	Kawasaki, Hiroshi/0000-0002-2517-159X				AIR GM, 1990, VIROLOGY, V177, P578, DOI 10.1016/0042-6822(90)90523-T; AIR GM, 1987, VIROLOGY, V160, P346, DOI 10.1016/0042-6822(87)90005-5; DAIRAKU K, 1986, BIOCHEM INT, V13, P741; DALE B, 1986, VIROLOGY, V155, P460, DOI 10.1016/0042-6822(86)90207-2; FIELDS S, 1981, NATURE, V290, P213, DOI 10.1038/290213a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HARLEY VR, 1989, VIROLOGY, V169, P239, DOI 10.1016/0042-6822(89)90063-9; HITI AL, 1982, J VIROL, V41, P730, DOI 10.1128/JVI.41.2.730-734.1982; HOYER LL, 1992, MOL MICROBIOL, V6, P873, DOI 10.1111/j.1365-2958.1992.tb01538.x; JORGENSEN ED, 1987, VIROLOGY, V156, P12, DOI 10.1016/0042-6822(87)90431-4; KAHN S, 1991, P NATL ACAD SCI USA, V88, P4481, DOI 10.1073/pnas.88.10.4481; KAWASAKI H, 1990, ANAL BIOCHEM, V191, P332, DOI 10.1016/0003-2697(90)90227-Z; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAUSS JH, 1988, ARCH MICROBIOL, V150, P584, DOI 10.1007/BF00408254; MARKOFF L, 1982, VIROLOGY, V119, P288, DOI 10.1016/0042-6822(82)90089-7; MIURA N, 1985, FEBS LETT, V188, P112, DOI 10.1016/0014-5793(85)80885-1; MIYAGI T, 1985, J BIOL CHEM, V260, P6710; MIYAGI T, 1990, J BIOCHEM-TOKYO, V107, P794, DOI 10.1093/oxfordjournals.jbchem.a123127; MIYAGI T, 1984, EUR J BIOCHEM, V141, P75, DOI 10.1111/j.1432-1033.1984.tb08159.x; MIYAGI T, 1990, J BIOCHEM-TOKYO, V107, P787, DOI 10.1093/oxfordjournals.jbchem.a123126; MIYAGI T, 1993, GLYCOCONJUGATE J, V10, P45, DOI 10.1007/BF00731186; MOREMEN KW, 1989, P NATL ACAD SCI USA, V86, P5276, DOI 10.1073/pnas.86.14.5276; PEREIRA MEA, 1991, J EXP MED, V174, P179, DOI 10.1084/jem.174.1.179; POTIER M, 1990, BIOCHEM BIOPH RES CO, V173, P449, DOI 10.1016/S0006-291X(05)81079-4; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; ROGGENTIN P, 1988, FEBS LETT, V238, P31, DOI 10.1016/0014-5793(88)80219-9; ROTH J, 1992, SCIENCE, V256, P673, DOI 10.1126/science.1585182; ROTHE B, 1989, J GEN MICROBIOL, V135, P3087; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAUER R, 1985, TRENDS BIOCHEM SCI, V10, P357, DOI 10.1016/0968-0004(85)90112-4; SHAW MW, 1982, P NATL ACAD SCI-BIOL, V79, P6817, DOI 10.1073/pnas.79.22.6817; STEULER H, 1984, VIROLOGY, V135, P118, DOI 10.1016/0042-6822(84)90122-3; VIMR ER, 1988, J BACTERIOL, V170, P1495, DOI 10.1128/jb.170.4.1495-1504.1988	34	110	114	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1993	268	35					26435	26440						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK425	8253770				2022-12-27	WOS:A1993MK42500064
J	STAUFFER, TP; HILFIKER, H; CARAFOLI, E; STREHLER, EE				STAUFFER, TP; HILFIKER, H; CARAFOLI, E; STREHLER, EE			QUANTITATIVE-ANALYSIS OF ALTERNATIVE SPLICING OPTIONS OF HUMAN PLASMA-MEMBRANE CALCIUM-PUMP GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; CA-2+ PUMP; MOLECULAR-CLONING; MESSENGER-RNAS; CA2+ PUMP; CA-2+-TRANSPORTING ATPASE; SEQUENCE-ANALYSIS; SKELETAL-MUSCLE; SMOOTH-MUSCLE; ISOFORMS	The alternative splicing options and the quantitative tissue distribution of the transcripts of the four currently known human plasma membrane calcium pump (PMCA) genes have been analyzed in seven tissues (cerebral cortex, skeletal and heart muscle, stomach, liver, lung, and kidney) by quantitative polymerase chain reaction on reverse transcribed mRNA with glyceraldehyde-3-phosphate dehydrogenase as the internal standard. The mRNAs of genes 1 and 4 were found to be present in similar amounts in all tissues, whereas the transcripts of genes 2 and 3 were expressed in a tissue-specific manner, i.e. their amounts were highest in fetal skeletal muscle and brain. Alternative splicing was found to occur in the PMCA transcripts at two major regulatory sites (sites A and C), adjacent to the amino-terminal phospholipid-responsive region and within the carboxyl-terminal calmodulin binding domain, respectively. Novel splicing variants not described previously for human genes were detected for hPMCA3 and 4 at site A and for hPMCA1, 2, and 3 at site C. For all genes a common splice variant was found at both splice sites. The common splice variant at site A was characterized by the inclusion of a small exon (hPMCA1, 39 base pairs (bp); hPMCA2, 42 bp; hPMCA3, 42 bp; hPMCA4, 36 bp). In the common splice variant at site C, an exon (hPMCA1, 154 bp; hPMCA2, 227 bp; hPMCA3, 154 bp; hPMCA4, 178 bp) was excluded in the mRNA. All genes normally express these main splice variants in all tissues in which the corresponding isoform is present. The splicing complexity at site C was found to be augmented in the transcripts of PMCA2 and PMCA3 through the use of additional exons, and in PMCA1 and 3 through the use of additional internal splice sites in the single alternatively spliced 154-base pair exon.	SWISS FED INST TECHNOL,BIOCHEM LAB,CH-8092 ZURICH,SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094				ADAMO HP, 1992, BIOCHEM J, V283, P355, DOI 10.1042/bj2830355; BRANDT P, 1992, J BIOL CHEM, V267, P4376; BURK SE, 1992, J BIOL CHEM, V267, P19683; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEJAEGERE S, 1990, BIOCHEM J, V271, P655, DOI 10.1042/bj2710655; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIEFFENBACH CW, 1989, J BIOL CHEM, V264, P13281; Dveksler G S, 1992, PCR Methods Appl, V1, P283; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; GREEB J, 1989, J BIOL CHEM, V264, P18569; HEIM R, 1992, EUR J BIOCHEM, V205, P333, DOI 10.1111/j.1432-1033.1992.tb16784.x; HILFIKER H, 1993, J BIOL CHEM, V268, P19717; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HOWARD A, 1992, BIOCHEM BIOPH RES CO, V183, P499, DOI 10.1016/0006-291X(92)90510-R; INGHIRAMI G, 1990, SCIENCE, V250, P682, DOI 10.1126/science.2237417; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; KEETON TP, 1993, J BIOL CHEM, V268, P2740; KESSLER F, 1992, BIOCHEMISTRY-US, V31, P11785, DOI 10.1021/bi00162a016; KHAN I, 1991, BIOCHEM J, V277, P345, DOI 10.1042/bj2770345; MAGOCSI M, 1992, AM J PHYSIOL, V263, pF7, DOI 10.1152/ajprenal.1992.263.1.F7; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHULL GE, 1988, J BIOL CHEM, V263, P8646; SIEBERT P, 1991, HUMAN GENOME, V3; SIEBERT P, 1991, RT PCR METHODS APPLI, P29; STAHL WL, 1992, MOL BRAIN RES, V16, P223, DOI 10.1016/0169-328X(92)90229-5; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; STREHLER EE, 1991, J MEMBRANE BIOL, V120, P1, DOI 10.1007/BF01868586; STREHLER EE, 1989, P NATL ACAD SCI USA, V86, P6908, DOI 10.1073/pnas.86.18.6908; STREHLER EE, 1989, HORM CELL REGUL, V198, P105; VERMA AK, 1988, J BIOL CHEM, V263, P14152; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WANG KKW, 1991, J BIOL CHEM, V266, P9078; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220	38	146	152	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1993	268	34					25993	26003						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MK100	8245032				2022-12-27	WOS:A1993MK10000100
J	CHAPPEL, MS; ISENMAN, DE; OOMEN, R; XU, YY; KLEIN, MH				CHAPPEL, MS; ISENMAN, DE; OOMEN, R; XU, YY; KLEIN, MH			IDENTIFICATION OF A SECONDARY FC-GAMMA-RI BINDING-SITE WITHIN A GENETICALLY-ENGINEERED HUMAN-IGG ANTIBODY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G; TUMOR-CELLS; RECEPTORS; EXPRESSION; AFFINITY; FRAGMENT; DISTINCT; DOMAIN; REGION	Although human IgG2 is not cytophilic, we have shown previously that an IgG2 antibody expressing the sequence PLLGG (underline = substitution) spanning C(H)2 domain residues 233-237 (Eu numbering) displayed IgG1-like FcgammaRI binding activity. In contrast, IgG1 PLLGG exhibited 3-fold less affinity, whereas IgG2 ELLGG was 3-fold more active than native IgG1. These results suggested that additional site(s) conferred enhanced binding properties to the engineered, cytophilic IgG2 variant. These sites were shown to reside in the IgG2 C(H)2 domain, since the IgG1 C(H)2 module did not have enhanced activity in a panel of hybrid IgG1/IgG2 antibodies. To map these sites further, human IgG1 and IgG2 constant region gene segments were modified to allow reciprocal COOH-terminal half segment exchanges of C(H)2 exons. These were cloned into a pSV2neo expression vector bearing a rearranged MOPC 315 heavy chain variable region gene and transfected into a MOPC 315 heavy chain deletion mutant. The dinitrophenol affinity-purified IgGs were radiolabeled and assessed for FcgammaRI binding activity in direct binding assays using U937 cells. The COOH terminus of the IgG2 C(H)2 domain was found to contain accessory site(s) since it enhanced the binding properties of both IgG1 PLLGG and native IgG1. In contrast, grafting of the COOH terminus of the IgG1 C(H)2 domain onto IgG2 PLLGG and IgG2 ELLGG diminished their cytophilic activity. The amino acid responsible for the enhancing properties of the COOH terminus of the IgG2 C(H)2 domain was shown to be threonine 339, since IgG1 PLLGG/Thr339 displayed increased FcgammaRI binding affinity. Kinetics studies revealed that this is accomplished through an increase in the forward rate constant of the IgG-FcgammaRI interaction.	UNIV TORONTO,DEPT IMMUNOL,MED SCI BLDG,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA; CONNAUGHT CTR BIOTECHNOL RES,N YORK M2R 3T4,ON,CANADA	University of Toronto; University of Toronto								ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749; ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; BAKER MD, 1988, P NATL ACAD SCI USA, V85, P6432, DOI 10.1073/pnas.85.17.6432; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERZOFSKY JA, 1981, MOL IMMUNOL, V18, P751, DOI 10.1016/0161-5890(81)90067-5; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; LUND J, 1991, J IMMUNOL, V147, P2657; LUND J, 1990, MOL IMMUNOL, V27, P1145, DOI 10.1016/0161-5890(90)90103-7; MATSUDA H, 1990, MOL IMMUNOL, V27, P571, DOI 10.1016/0161-5890(90)90076-C; MOSMANN TR, 1979, EUR J IMMUNOL, V9, P511, DOI 10.1002/eji.1830090705; MUNCK A, 1976, RECEPTORS MECHANIS 1; ORTALDO JR, 1987, J IMMUNOL, V138, P3566; RAYCHAUDHURI G, 1985, MOL IMMUNOL, V22, P1009, DOI 10.1016/0161-5890(85)90104-X; RINFRET A, 1990, J IMMUNOL, V145, P925; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEGAL DM, 1977, J IMMUNOL, V118, P1338; SHEN L, 1989, MOL IMMUNOL, V26, P959, DOI 10.1016/0161-5890(89)90114-4; SHOPES B, 1990, J IMMUNOL, V145, P3842; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; WOOF JM, 1990, BIOCHEM SOC T, V18, P217, DOI 10.1042/bst0180217; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3	31	16	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25124	25131						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227075				2022-12-27	WOS:A1993MG67300087
J	KUMAGAI, N; MORII, N; FUJISAWA, K; NEMOTO, Y; NARUMIYA, S				KUMAGAI, N; MORII, N; FUJISAWA, K; NEMOTO, Y; NARUMIYA, S			ADP-RIBOSYLATION OF RHO P21 INHIBITS LYSOPHOSPHATIDIC ACID-INDUCED PROTEIN-TYROSINE PHOSPHORYLATION AND PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IN CULTURED SWISS 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GENE-PRODUCT; RIBOSYLTRANSFERASE; KINASE; IDENTIFICATION; BOMBESIN; BINDING; VASOPRESSIN; EXPRESSION; PP125(FAK); PLATELETS	Botulinum C3 exoenzyme was used to specifically ADP-ribosylate and inactivate rho p21, and the effects of rho p21 inactivation on lysophosphatidic acid (LPA)-induced tyrosine phosphorylation were examined in cultured Swiss 3T3 cells. LPA induced a rapid increase in the tyrosine phosphorylation of a number of proteins. Pretreatment of the cells with the C3 exoenzyme caused ADP-ribosylation of rho p21 in the cells and selectively attenuated the phosphorylation of several proteins, including p43 mitogen-activated protein kinase, p125 focal adhesion kinase, and two proteins of 72 and 88 kDa. C3 exoenzyme pretreatment did not block the initial phosphorylation and activation of mitogen-activated protein kinase but suppressed its subsequent rise. In contrast, the enzyme treatment inhibited the induction of phosphorylation of the 72- and 88-kDa proteins and suppressed the basal and LPA-induced tyrosine phosphorylation of p125 focal adhesion kinase. In addition, immunoprecipitation of cell lysates with an antibody directed against the 85-kDa subunit of phosphatidylinositol 3-kinase (PI 3-kinase) co-precipitated a tyrosine-phosphorylated band of 180 kDa. C3 exoenzyme pretreatment suppressed both the phosphorylation of this band and PI 3-kinase activation associated with LPA stimulation. These findings suggest that rho p21 works as a link between the LPA receptor signal and the subsequent tyrosine phosphorylation and PI 3-kinase activation in these cells.	KYOTO UNIV, FAC MED, DEPT PHARMACOL, SAKYO KU, KYOTO 606, JAPAN	Kyoto University			Watanabe, Mamoru/AHE-0489-2022					AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HIRATA K, 1992, J BIOL CHEM, V267, P8719; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KUMAGAI N, 1993, FEBS LETT, V329, P273, DOI 10.1016/0014-5793(93)80236-N; LEEBLUNDBERG LMF, 1991, J BIOL CHEM, V266, P7746; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MABUCHI I, 1993, IN PRESS ZYGOTE; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; MORII N, 1992, J BIOL CHEM, V267, P20921; NARUMIYA S, 1993, CELL SIGNAL, V5, P9, DOI 10.1016/0898-6568(93)90003-5; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SEKINE A, 1989, J BIOL CHEM, V264, P8602; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; TANAKA S, 1993, JPN J CANCER RES, V84, P279, DOI 10.1111/j.1349-7006.1993.tb02868.x; TIGYI G, 1992, J BIOL CHEM, V267, P21360; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; VANDERBEND RL, 1992, EMBO J, V11, P2495, DOI 10.1002/j.1460-2075.1992.tb05314.x; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; YOSHIMASA T, 1992, FEBS LETT, V311, P195, DOI 10.1016/0014-5793(92)81100-Z; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	36	210	212	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24535	24538						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227009				2022-12-27	WOS:A1993MG67300006
J	PERIDES, G; HU, G; RUEGER, DC; CHARNESS, ME				PERIDES, G; HU, G; RUEGER, DC; CHARNESS, ME			OSTEOGENIC PROTEIN-1 REGULATES L1 AND NEURAL CELL-ADHESION MOLECULE GENE-EXPRESSION IN NEURAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NG108-15 HYBRID-CELLS; GROWTH-FACTOR-BETA; N-CAM; MESSENGER-RNA; TGF-BETA; PC12 CELLS; NERVE; NCAM; SURFACE; DIFFERENTIATION	Osteogenic protein-1 (OP-1) is a member of the TGF-beta superfamily that is expressed in the nervous system. We recently showed that human recombinant osteogenic protein-1 (hOP-1) strongly promotes the aggregation of dividing neuroblastoma x glioma hybrid NG108-15 cells, in part by inducing the major isoforms of the neural cell adhesion molecule (N-CAM) (Perides, G., Safran, R. M., Rueger, D. C., and Charness, M. E. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10326-10330). Here we show that hOP-1 induces L1 expression approximately 6-fold in NG108-15 cells without changing the levels of N-cadherin, neurofilament 200, Thy-1, tau, and Galpha(s). OP-1 induction of L1 and N-CAM was unassociated with changes in cell proliferation and was not reproduced by cellular differentiation. The increased adhesiveness of hOP-1-treated NG108-15 cells could be inhibited in part by Fab fragments of an anti-L1 polyclonal antiserum. L1 and N-CAM expression first increased 12-18 h after hOP-1 treatment, reached a maximum after 2-3 days, persisted for up to 5 days, and returned to control levels 3 days after hOP-1 withdrawal. The increases in L1 and N-CAM protein levels were preceded or accompanied by large increases in the abundance of L1 and all detectable N-CAM mRNAs. Actinomycin D prevented the induction by hOP-1 of L1 and N-CAM mRNAs, suggesting that hOP-1 regulates immunoglobulin CAM gene transcription. OP-1 is the first described growth factor that regulates both N-CAM and L1 gene expression.	HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; DEPT VET AFFAIRS MED CTR, SPINAL CORD INJURY LAB, BOSTON, MA 02132 USA; CREAT BIOMOLECULES INC, HOPKINTON, MA 01748 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV NEUROL, BOSTON, MA 02115 USA; DEPT VET AFFAIRS MED CTR, NEUROL SECT, BOSTON, MA 02132 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital				Charness, Michael/0000-0002-3301-8966	NIAAA NIH HHS [AA06662] Funding Source: Medline; NINDS NIH HHS [NS13034] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006662] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDERSSON AM, 1990, FEBS LETT, V263, P385, DOI 10.1016/0014-5793(90)81420-S; ARRICK BA, 1992, J CELL BIOL, V118, P715, DOI 10.1083/jcb.118.3.715; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BARTON CH, 1990, BIOCHEM J, V268, P161, DOI 10.1042/bj2680161; BRAAS KM, 1983, J NEUROSCI, V3, P1713; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHARNESS ME, 1986, J BIOL CHEM, V261, P3164; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; COLWELL G, 1992, GENOMICS, V14, P875, DOI 10.1016/S0888-7543(05)80108-9; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DOHERTY P, 1988, J CELL BIOL, V107, P333, DOI 10.1083/jcb.107.1.333; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDLANDER DR, 1986, J CELL BIOL, V102, P413, DOI 10.1083/jcb.102.2.413; GENNARINI G, 1986, J NEUROSCI, V6, P1983; HEMPERLY JJ, 1990, J MOL NEUROSCI, V2, P71, DOI 10.1007/BF02876913; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; HUSMANN M, 1989, DEV BIOL, V136, P194, DOI 10.1016/0012-1606(89)90141-3; JONES FS, 1992, P NATL ACAD SCI USA, V89, P2986; JORGENSEN OS, 1983, NEUROSCIENCE, V9, P665, DOI 10.1016/0306-4522(83)90182-3; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KOBAYASHI H, 1992, NEUROSCIENCE, V49, P437, DOI 10.1016/0306-4522(92)90108-E; KOHL A, 1992, J NEUROSCI RES, V32, P167, DOI 10.1002/jnr.490320206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINNEMANN D, 1989, DEV NEUROSCI-BASEL, V11, P149, DOI 10.1159/000111896; LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R; MANN DA, 1989, J NEUROCHEM, V53, P1581, DOI 10.1111/j.1471-4159.1989.tb08555.x; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MURRAY BA, 1986, J CELL BIOL, V102, P189, DOI 10.1083/jcb.102.1.189; OHTA S, 1992, FEBS LETT, V314, P356, DOI 10.1016/0014-5793(92)81505-G; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; PERIDES G, 1992, P NATL ACAD SCI USA, V89, P10326, DOI 10.1073/pnas.89.21.10326; PRENTICE HM, 1987, EMBO J, V6, P1859, DOI 10.1002/j.1460-2075.1987.tb02444.x; RATHJEN FG, 1984, EMBO J, V3, P1; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; ROUBIN R, 1990, J CELL BIOL, V111, P673, DOI 10.1083/jcb.111.2.673; RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; TACKE R, 1990, NEUROSCI LETT, V120, P227, DOI 10.1016/0304-3940(90)90045-B; THIERY JP, 1982, P NATL ACAD SCI-BIOL, V79, P6737, DOI 10.1073/pnas.79.21.6737; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	50	49	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					25197	25205						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227084				2022-12-27	WOS:A1993MG67300097
J	ZANOTTI, G; MALPELI, G; BERNI, R				ZANOTTI, G; MALPELI, G; BERNI, R			THE INTERACTION OF N-ETHYL RETINAMIDE WITH PLASMA RETINOL-BINDING PROTEIN (RBP) AND THE CRYSTAL-STRUCTURE OF THE RETINOID-RBP COMPLEX AT 1.9-ANGSTROM RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSTHYRETIN COMPLEX; HUMAN SERUM; PURIFICATION; METABOLISM; REFINEMENT	The three-dimensional structure of bovine plasma retinol-binding protein (RBP) complexed with N-ethyl retinamide has been determined at 1.9-angstrom resolution. The crystals of the complex (space group P2(1)2(1)2(1), a = 46.27, b = 49.11, c = 76.41 angstrom) are isomorphous with those of bovine holo and apoRBP. The final crystallographic R factor is 0.172 for 11,261 observed reflections. The model of the retinoid-RBP complex is nearly identical to that of bovine retinol-RBP complex; the root mean square deviations between the alpha-carbons in the two proteins is 0.15 angstrom. The N-ethyl retinamide molecule fits in the beta-barrel in the same position previously occupied by the vitamin. The ethyl group of the retinoid replaces the retinol hydroxyl group and a water molecule hydrogen bonded to it. This substitution has no consequence on the overall conformation of the protein. The modification of the functional end group of retinol does not lead to an apparent loss of affinity of the retinol analog for apoRBP, as established by means of fluorometric titrations with N-ethyl retinamide. However, the binding of the retinoid to RBP abolishes or greatly reduces the affinity of RBP for transthyretin. This behavior further supports the hypothesis that the area of the entrance of the beta-barrel, which includes the ethyl group of the retinoid bound to RBP, is involved in the interaction with transthyretin. Moreover, it indicates a high degree of complementarity of interacting surfaces between RBP and transthyretin. In fact, the replacement of the retinol hydroxyl group and quite small structural changes in the above region of the RBP molecule drastically affect the protein-protein recognition.	UNIV PARMA,INST BIOCHEM SCI,I-43100 PARMA,ITALY; CNR,BIOPOLYMER RES CTR,I-35131 PADUA,ITALY	University of Parma; Consiglio Nazionale delle Ricerche (CNR)	ZANOTTI, G (corresponding author), UNIV PADUA,DEPT ORGAN CHEM,I-35131 PADUA,ITALY.			Berni, Rodolfo/0000-0002-1839-0479; Malpeli, Giorgio/0000-0002-2996-2903; Zanotti, Giuseppe/0000-0002-0945-6501				AQVIST J, 1992, J MOL GRAPHICS, V10, P120, DOI 10.1016/0263-7855(92)80065-L; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; BERNI R, 1992, EUR J BIOCHEM, V204, P99, DOI 10.1111/j.1432-1033.1992.tb16610.x; BERNI R, 1989, COMP BIOCHEM PHYS B, V94, P79, DOI 10.1016/0305-0491(89)90014-X; BERNI R, 1993, RETINOIDS PROGR RES, P91; BLOMHOFF R, 1991, PHYSIOL REV, V71, P951, DOI 10.1152/physrev.1991.71.4.951; BOYD AS, 1989, AM J MED, V86, P568, DOI 10.1016/0002-9343(89)90386-0; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; GAWINOWICZ MA, 1985, J PROTEIN CHEM, V4, P199, DOI 10.1007/BF01025298; GOLLNICK H, 1990, METHOD ENZYMOL, V190, P291; GOODMAN DS, 1972, J LIPID RES, V13, P338; Goodman DS, 1984, RETINOIDS, V2, P42; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; MOON RC, 1990, METHOD ENZYMOL, V190, P395; NOY N, 1992, BIOCHEMISTRY-US, V31, P11118, DOI 10.1021/bi00160a023; NOY N, 1990, BIOCHEMISTRY-US, V29, P3878, DOI 10.1021/bi00468a012; PETERSON PA, 1971, J BIOL CHEM, V246, P34; SMITH MA, 1992, J CLIN ONCOL, V10, P839, DOI 10.1200/JCO.1992.10.5.839; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VAHLQUIS.A, 1973, EUR J CLIN INVEST, V3, P352, DOI 10.1111/j.1365-2362.1973.tb00362.x; VANBENNEKUM AM, 1993, BIOCHEMISTRY-US, V32, P1727, DOI 10.1021/bi00058a005; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173; ZANOTTI G, 1993, J BIOL CHEM, V268, P10728	25	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1993	268	33					24873	24879						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG673	8227049				2022-12-27	WOS:A1993MG67300055
J	MARTIN, A; GOMEZMUNOZ, A; WAGGONER, DW; STONE, JC; BRINDLEY, DN				MARTIN, A; GOMEZMUNOZ, A; WAGGONER, DW; STONE, JC; BRINDLEY, DN			DECREASED ACTIVITIES OF PHOSPHATIDATE PHOSPHOHYDROLASE AND PHOSPHOLIPASE-D IN RAS AND TYROSINE KINASE (FPS) TRANSFORMED FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACTIVATING PROTEIN; PHOSPHATIDYLCHOLINE BREAKDOWN; LYSOPHOSPHATIDIC ACID; HUMAN NEUTROPHILS; KINETIC-ANALYSIS; ALPHA-THROMBIN; MIXED MICELLES; 3T3 CELLS; GROWTH; HYDROLYSIS	The activity of N-ethylmaleimide-insensitive phosphatidate phosphohydrolase (PAP-2) was characterized in control, ras-transformed, and tyrosine kinase-(fps) transformed rat fibroblasts. PAP-2 was assayed in two different ways: 1) within its natural membrane using liposomes of phosphatidate and 2) in the presence of sufficient Triton X-100 to solubilize PAP-2, and to form mixed micelles with the phosphatidate. Harvesting the fibroblasts in medium containing orthovanadate and Zn2+ gave up to 3-fold higher PAP-2 activities when measured in the absence, but not in the presence, of Triton X-100. PAP-2-specific activities from both assays increased in the control fibroblasts as the cells reached confluence. Both specific activities were lower in the oncogenically transformed fibroblasts than in controls at all cell densities tested. The specific activities of PAP-2 did not increase with time in culture in transformed cells which continued to divide. The relative increase in activity of phospholipase D after stimulation with serum or phorbol myristate acetate was lower in the transformed fibroblasts compared to control cells. This indicates a coordinated decrease in. the phospholipase D/phosphatidate phosphohydrolase pathway at the level of both enzymes in ras and fps transformed fibroblasts. The ratio of the production of diacylglycerol relative to phosphatidate, after stimulation with serum, or phorbol ester, was lower in both transformed fibroblasts relative to the controls. This is compatible with the decreased specific activity of PAP-2 and indicates functional significance for the differences in PAP-2 activity in regulating the balance between the two mitogenic lipids, phosphatidate and diacylglycerol. Control of PAP-2 activity could be an important factor in regulating appropriate signals for cell division.	UNIV ALBERTA, HERITAGE MED RES CTR 328, DEPT BIOCHEM, EDMONTON T6G 2S2, AB, CANADA; UNIV ALBERTA, HERITAGE MED RES CTR 328, LIPID & LIPOPROT RES GRP, ALBERTA T6G 2S2, AB, CANADA	University of Alberta; University of Alberta				GOMEZ MUNOZ, ANTONIO/0000-0002-2539-016X				ARIDORPITERMAN O, 1992, EUR J BIOCHEM, V204, P561, DOI 10.1111/j.1432-1033.1992.tb16668.x; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BELL RM, 1991, J BIOL CHEM, V266, P4661; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BOCCKINO SB, 1991, P NATL ACAD SCI USA, V88, P6210, DOI 10.1073/pnas.88.14.6210; BOURGOIN S, 1992, J BIOL CHEM, V267, P11908; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLEY DN, 1987, CRC SERIES ENZYME BI, P1; COLLINS MLP, 1979, BIOCHIM BIOPHYS ACTA, V553, P40, DOI 10.1016/0005-2736(79)90029-4; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; COOK SJ, 1992, BIOCHEM J, V285, P247, DOI 10.1042/bj2850247; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x; DOMINGUEZ I, 1991, EMBO J, V10, P3215, DOI 10.1002/j.1460-2075.1991.tb04884.x; EXTON JH, 1990, J BIOL CHEM, V265, P1; FREEMAN M, 1989, BIOCHEM J, V263, P589, DOI 10.1042/bj2630589; FU T, 1992, BIOCHEM J, V283, P347, DOI 10.1042/bj2830347; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; GOMEZMUNOZ A, 1992, BIOCHIM BIOPHYS ACTA, V1127, P49, DOI 10.1016/0005-2760(92)90200-F; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; HUANG C, 1992, BIOCHIM BIOPHYS ACTA, V1127, P242, DOI 10.1016/0005-2760(92)90227-M; HUANG CF, 1990, J BIOL CHEM, V265, P17468; JALINK K, 1990, J BIOL CHEM, V265, P12232; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; JOHNSON KA, 1990, J VIROL, V64, P3337, DOI 10.1128/JVI.64.7.3337-3349.1990; KATO H, 1988, BIOCHEM BIOPH RES CO, V154, P959, DOI 10.1016/0006-291X(88)90233-1; KELLY SJ, 1975, BIOCHEMISTRY-US, V14, P4983, DOI 10.1021/bi00693a030; KUMJIAN DA, 1991, J BIOL CHEM, V266, P3973; LEACH KL, 1991, J BIOL CHEM, V266, P3215; LIN YP, 1990, J BIOL CHEM, V265, P166; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; MARTIN A, 1987, BIOCHEM J, V245, P347, DOI 10.1042/bj2450347; MARTIN TFJ, 1990, J BIOL CHEM, V265, P7623; MARTINSON EA, 1990, J BIOL CHEM, V265, P22282; MORITZ A, 1992, J BIOL CHEM, V267, P7207; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; PREISS J, 1986, J BIOL CHEM, V261, P8597; RHEE SG, 1992, J BIOL CHEM, V267, P12393; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; STATHOPOULOS VM, 1990, BIOCHEM J, V272, P569, DOI 10.1042/bj2720569; STONE JC, 1991, MOL CELL BIOL, V11, P6158, DOI 10.1128/MCB.11.12.6158; TING AE, 1991, EUR J CELL BIOL, V56, P401; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; TRUETT AP, 1992, FASEB J, V6, P2720, DOI 10.1096/fasebj.6.9.1612297; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; TSAI MH, 1990, SCIENCE, V250, P982, DOI 10.1126/science.2237442; UINGS IJ, 1992, BIOCHEM J, V281, P597, DOI 10.1042/bj2810597; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; VOLWERK JJ, 1992, J CELL PHYSIOL, V151, P613, DOI 10.1002/jcp.1041510322; WAHL MI, 1992, J BIOL CHEM, V267, P10447; WRIGHT TM, 1992, BIOCHEM J, V285, P395, DOI 10.1042/bj2850395	58	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23924	23932						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226932				2022-12-27	WOS:A1993MF29400035
J	MEAH, YS; BRYANT, FR				MEAH, YS; BRYANT, FR			ACTIVATION OF A RECOMBINASE-DEFICIENT MUTANT RECA PROTEIN WITH ALTERNATE NUCLEOSIDE TRIPHOSPHATE COFACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; ESCHERICHIA-COLI; ATP HYDROLYSIS; ISOMERIZATION	We recently described two mutant recA proteins, (G160N)recA and (H163A)recA, which have full single-stranded DNA-dependent ATP hydrolysis activity but which are unable to promote the ATP-dependent strand exchange reaction under standard reaction conditions (pH 7.5). These mutant proteins, however, are able to promote strand exchange at pH 6.0 to 6.8. Here we show that this activation correlates with a pH-dependent decrease in the S0.5 value for ATP, with the (H163A)recA protein becoming active in strand exchange at pH values where the S0.5(ATP) decreases below 100 muM. We also show that the (H163A)recA protein is active in strand exchange over the range of pH 6.0-8.2 if dATP (or ddATP) is used in place of ATP as a cofactor; dATP is hydrolyzed by (H163A)recA protein at the same rate as ATP but has an S0.5, value lower than 100 muM across this pH range. These results are discussed with regard to the general significance of the S0.5 value in determining whether a nucleoside triphosphate will be able to stabilize the recA-single-stranded DNA filament in the strand exchange active conformational state.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOCHEM,BALTIMORE,MD 21205	Johns Hopkins University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036516] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 36516] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRYANT FR, 1988, J BIOL CHEM, V263, P8716; COX MM, 1981, J BIOL CHEM, V256, P4676; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; GRIFFITH JD, 1988, CRC CRIT REV BIOC S1, V23, P43; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7677, DOI 10.1021/bi00485a017; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7666, DOI 10.1021/bi00485a016; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENGE KL, 1988, BIOCHEMISTRY-US, V27, P2635, DOI 10.1021/bi00407a055; MENGE KL, 1992, BIOCHEMISTRY-US, V31, P5151, DOI 10.1021/bi00137a009; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1483; MUENCH KA, 1991, J BIOL CHEM, V266, P844; MUENCH KA, 1990, J BIOL CHEM, V265, P11560; PINSINCE JM, 1993, IN PRESS J MOL BIOL; RADDING CM, 1982, ANNU REV GENET, V16, P495; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; STASIAK A, 1986, BIOPHYS J, V49, P5, DOI 10.1016/S0006-3495(86)83569-X; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126	23	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					23991	23996						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226942				2022-12-27	WOS:A1993MF29400045
J	RABINOVICH, E; BARNUN, S; AMITAY, R; SHACHAR, I; GUR, B; TAYA, M; HAIMOVICH, J				RABINOVICH, E; BARNUN, S; AMITAY, R; SHACHAR, I; GUR, B; TAYA, M; HAIMOVICH, J			DIFFERENT ASSEMBLY SPECIES OF IGM ARE DIRECTED TO DISTINCT DEGRADATION SITES ALONG THE SECRETORY PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC GENES; ENDOPLASMIC-RETICULUM; LYMPHOCYTES-B; LIGHT-CHAIN; BREFELDIN-A; PROTEIN; MEMBRANE; EXPRESSION; OCCURS; GOLGI	In 38C B lymphocytes the membrane form of IgM is displayed on the cell surface whereas the secretory form of IgM is degraded. In the EH cell line, a light chain-deficient variant of 38C cells, the mu heavy chains are partially assembled with surrogate light chains characteristic of pre-B cells. In these cells neither the membrane (mum) nor the secretory (mus) forms of the mu heavy chain reach their final destination, and both are rapidly degraded. The degradation of mu chains in EH cells, like that of mus in 38C cells, is nonlysosomal and occurs prior to the trans-Golgi. However, while As degradation in 38C cells is inhibited by brefeldin A, in EH cells mus and mum are retained and degraded by a brefeldin A-insensitive mechanism. These results indicate that degradation in EH cells occurs within the endoplasmic reticulum, whereas degradation in 38C cells requires exit from this compartment. Thus, mu heavy chains can be degraded in multiple sites along the secretory pathway. The location of the degradation process is determined by the developmentally regulated assembly species of the mu chains with either ''classical'' or surrogate light chains.	TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,IL-69978 TEL AVIV,ISRAEL; TEL AVIV UNIV,GEORGE S WISE FAC LIFE SCI,DEPT BIOCHEM,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University								AMITAY R, 1991, J BIOL CHEM, V266, P12568; AMITAY R, 1992, J BIOL CHEM, V267, P20694; BERGMAN Y, 1978, EUR J IMMUNOL, V8, P876, DOI 10.1002/eji.1830081210; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; CHUN KT, 1990, J BIOL CHEM, V265, P22004; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DULIS BH, 1983, J BIOL CHEM, V258, P2181; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRIENINGER G, 1984, J BIOL CHEM, V259, P4973; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LE AQ, 1992, J BIOL CHEM, V267, P1072; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; SCHIMKE RT, 1973, ADV ENZYMOL RAMB, V37, P135; SHACHAR I, 1992, J BIOL CHEM, V267, P24241; SIDMAN C, 1981, CELL, V23, P379, DOI 10.1016/0092-8674(81)90133-1; TAYA M, 1992, IMMUNOL LETT, V33, P173, DOI 10.1016/0165-2478(92)90044-O; TAYA M, 1991, CANCER IMMUNOL IMMUN, V34, P43, DOI 10.1007/BF01741323; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973	25	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1993	268	32					24145	24148						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF294	8226961				2022-12-27	WOS:A1993MF29400065
J	RITTER, JK; YEATMAN, MT; KAISER, C; GRIDELLI, B; OWENS, IS				RITTER, JK; YEATMAN, MT; KAISER, C; GRIDELLI, B; OWENS, IS			A PHENYLALANINE CODON DELETION AT THE UGT1 GENE-COMPLEX LOCUS OF A CRIGLER-NAJJAR TYPE-I PATIENT GENERATES A PH-SENSITIVE BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COS-1 CELLS; CLONING; EXPRESSION; PHENOL; CDNA; RAT; IDENTIFICATION; SPECIFICITY; DEFICIENCY; SUBSTRATE	The characterization (Ritter, J. K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S., Yeatman, M. T., and Owens, I. S. (1992) J. Biol. Chem. 267,3257-3261) of the single-copy UGT1 gene complex encoding both bilirubin and phenol UDP-glucuronosyltransferases (transferase) has been critical to the determination of genetic defects in Crigler-Najjar Type I patients. The complex (UGT1A-UGT1G) codes for at least two bilirubin, three bilirubin-like, and two phenol transferases. Seven different exons 1, each with an upstream promoter and each encoding the amino terminus of an isoform, are arrayed in series with four common exons (encoding seven identical carboxyl termini) in the 3'-region of the locus. Predictably, a critical mutation in a common exon inactivates the entire locus. A deleterious mutation in an exon 1, as we report here for the UGT1A gene in a Crigler-Najjar Type I patient, predictably affects the amino terminus of that single isoform. The code for the predominant bilirubin isozyme, the HUG-Br1 protein, is missing the phenylalanine codon at position 170 in exon 1 of UGT1A, abolishing a conserved diphenylalanine. We demonstrate that, at the pH (7.6) routinely used for bilirubin glucuronidation studies, both the HUG-Br1 protein and human liver microsomes have approximately one-third the activity seen at the major pH optimum of 6.4 and at low ionic strength. The altered isozyme with nearly normal activity at pH 7.6 is inactive at pH 6.4, a result consistent with the definition of a pH-sensitive mutant. The K(m) value for bilirubin using the wild-type protein is approximately 2.5 muM at both pH 6.4 and 7.6 and that for the mutant is 5.0 muM at pH 7.6. The structure of the wild-type enzyme compared to that of the mutant indicates that hydrophobic properties at the active center are critical for metabolizing the lipophile-like substrate. The low ion/pH requirements for bilirubin glucuronidation may signal the basis for the distribution of these isozymes to an organelle (endoplasmic reticulum) that can establish compatible conditions/compartments for each catalysis.	NICHHD,HUMAN GENET BRANCH,GENET DISORDERS DRUG METAB SECT,BLDG 10,RM 9S-242,BETHESDA,MD 20892; OSPED MAGGIORE MILANO,CTR LIVER TRANSPLANTAT & METAB ASSISTANCE ACUTE HEPAT COMA,I-20122 MILAN,ITALY	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ARION WJ, 1972, J BIOL CHEM, V247, P2558; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; BOSMA PJ, 1992, FASEB J, V6, P2859, DOI 10.1096/fasebj.6.10.1634050; BOSMA PJ, 1992, HEPATOLOGY, V15, P941, DOI 10.1002/hep.1840150531; CHEN F, 1993, IN PRESS BIOCHEMISTR; CHOWDHURY JR, 1989, METABOLIC BASIS INHE, P1367; GONZALEZ FJ, 1983, J BIOL CHEM, V258, P1363; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; HARDING D, 1988, P NATL ACAD SCI USA, V85, P8381, DOI 10.1073/pnas.85.22.8381; HARDING D, 1990, ANN HUM GENET, V54, P17, DOI 10.1111/j.1469-1809.1990.tb00356.x; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; KAUFMAN SS, 1986, HEPATOLOGY, V6, P1259, DOI 10.1002/hep.1840060606; OWENS IS, 1992, PHARMACOGENETICS, V2, P93, DOI 10.1097/00008571-199206000-00001; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, J BIOL CHEM, V267, P3257; RITTER JK, 1991, J BIOL CHEM, V266, P1043; RITTER JK, 1990, J BIOL CHEM, V265, P7900; SATO H, 1990, BIOCHEM BIOPH RES CO, V169, P260, DOI 10.1016/0006-291X(90)91462-2; THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954; TOGHROL F, 1990, BIOCHEMISTRY-US, V29, P2349, DOI 10.1021/bi00461a020; VANES HHG, 1990, J CLIN INVEST, V85, P1199, DOI 10.1172/JCI114553; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WHITMER DI, 1986, J BIOL CHEM, V261, P7170; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465	25	62	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1993	268	31					23573	23579						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MF515	8226884				2022-12-27	WOS:A1993MF51500094
